Citrus Sinensis ID: 014024

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430--
Protein Sequence
MERCPIFISIIASVSLIFLILSFTVTTNRTIFLALSATLAGMAALGLTIFCFRRNTTNKGEDLMKFDLGMNLKVDVELTEGNNKCKKGCEKEVDQFPLFSFSSVSSATGNFSAANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQPAFCNLRNMESSTSTTEKSWADCSINEVTVSILDAR
Secondary Structure (PSIPRED)
cccccEEEEEEcccHHHHHHHcccccccEEEEEEHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccHHHHHcccccccccccccccccccccHHHHHHHHcccccccccccccccccEEEcccccEEEEEEcccccccHHHHHHHHHHHHHHccccccccEEcccccccEEEEEEEEccccccccccccccccccccHHHHHHHHHHHHHHHHHHcccccccEEcccccccccccccccccccccccHHHHcccccccccccccccEEEEEcccccHHHHcccccccccccccHHHEEEEEEEccccccccccccccHHHHHHHHccccccccccccHHHccccHHHHHHHHHHHHccccccccccccHHHHHHHHccccccccccccccEEEccccccccccccccccccccccEEEEEEEcc
Secondary Structure Prediction (SSPRO)
cccccEEEEEEccccccccccccccccccEEEEEHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccEEcHHHHHHHHccccHHccccccccccEEcccccccEEEEEEccccccccHHHHHHHHHHHHHHHHHHHHHHHHcccccccEEEEEEEcccccccEEEccccccccccHHHHHHHHHHHHHHHHHHHHccHccEEcccccHHHEEEcccccEEEccHHHcEEccccccEccccccHHHccEEccHccHHHHHHccccHHHHHHHHHHHHHHHHcccccccccccccccHHHHHHHHHHccccEEHccccHcccccHHHHHHHHHHHHHHHcccHcccccHHHHEEEccccccccccccccEEEEEEccccccccccccccccEcccEEEEEEccc
Coil and Loop (DISEMBL)
MERCPIFISIIASVSLIFLILSFTVTTNRTIFLALSATLAGMAALGLTIFCFrrnttnkgedlmkfDLGMNLKVDVELtegnnkckkgcekevdqfplfsfssvssatgnfsaanklgeggfgtvyKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIyeympnksldcflfdptkreiLDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNilldkdmnskisdfgmarivfggndedelqgntsrisgtygymspeyaLEGIFSIKSDVFSFGVLLLEIVSgkkntgfyrtkslNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQeraedrptmSDVVSMLTNeassllppkqpafcnlrnmesststtekswadcsinEVTVSILDAR
Flexible Loop (DISEMBL)
MERCPIFISIIASVSLIFLILSFTVTTNRTIFLALSATLAGMAALGLTIFCFRRNTTNKGEDLMKFDLGMNLKVDVELTEGNNKCKKGCEKEVDQFPLFSFSSVSSATGNFSAANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFggndedelqgnTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVsgkkntgfyRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEassllppkqpafCNLRNMESStsttekswadcsinevtvsildar
Low Complexity Region (SEG)
MERCPIFISIIASVSLIFLILSFTVTTNRTIFlalsatlagmaalgltIFCFRRNTTNKGEDLMKFDLGMNLKVDVELTEGNNKCKKGCEKEVDQFPLFSFSSVSSATGNFSAANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQPAFCNLRNMESSTSTTEKSWADCSINEVTVSILDAR
Disordered region (IsUnstruct)
***CPIFISIIASVSLIFLILSFTVTTNRTIFLALSATLAGMAALGLTIFCFRRNTTNKGEDLMKFDLGMNLKVDVELTEGNNKCKKGCEKEVDQFPLFSFSSVSSATGNFSAANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDE**L*GNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQE**********************************************WADCSINEVTV******
Disordered Region (DISOPRED)
**RCPIFISIIASVSL*************TIFLALSATLAGMAALGLTIFCFRRNT*************************************DQFPLFSFSSVSSATGNFSAANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQPAFC***********************VTVSILDAR
Disordered Region (DISEMBL)
MERCPIFISIIASVSLIFLILSFTVTTNRTIFLALSATLAGMAALGLTIFCFRRNTTNKGEDLMKFDLGMNLKVDVELTEGNNKCKKGCEKEVDQFPLFSFSSVSSATGNFSAANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQPAFCNLRN***********WADCSINEVTVSILDAR
Disordered Region (DISPRO)
*ERCPIFISIIASVSLIFLILSFTVTTNRTIFLALSATLAGMAALGLTIFCFRRNTTNKG*********************************DQFPLFSFSSVSSATGNFSAANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQPAFCNLRN*************DCSINEVTVSILD**
Transmembrane Helix (TMHMM)
iiiiiiHHHHHHHHHHHHHHHHHHHHoooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
iiiiiHHHHHHHHHHHHHHHHHHHHooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooHHHHHHHHHHHHHHHHHHHHiiiiHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
iiiiiiHHHHHHHHHHHHHHHHHHHoooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
SSSSSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MERCPIFISIIASVSLIFLILSFTVTTNRTIFLALSATLAGMAALGLTIFCFRRNTTNKGEDLMKFDLGMNLKVDVELTEGNNKCKKGCEKEVDQFPLFSFSSVSSATGNFSAANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQPAFCNLRNMESSTSTTEKSWADCSINEVTVSILDAR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	432	2.2.26 [Sep-21-2011]
Q9SXB8	842	G-type lectin S-receptor-	yes	no	0.777	0.399	0.545	1e-105
Q9ZR08	852	G-type lectin S-receptor-	no	no	0.768	0.389	0.572	1e-103
Q9ZT07	833	G-type lectin S-receptor-	no	no	0.905	0.469	0.464	1e-103
O64793	818	G-type lectin S-receptor-	no	no	0.907	0.479	0.491	1e-102
Q9SY89	842	Putative G-type lectin S-	no	no	0.724	0.371	0.572	1e-102
Q9LW83	850	G-type lectin S-receptor-	no	no	0.775	0.394	0.547	1e-101
O81906	849	G-type lectin S-receptor-	no	no	0.706	0.359	0.567	1e-101
Q9S972	847	Receptor-like serine/thre	no	no	0.773	0.394	0.547	1e-101
Q39086	843	Receptor-like serine/thre	no	no	0.75	0.384	0.549	1e-100
O81905	850	Receptor-like serine/thre	no	no	0.773	0.392	0.553	1e-99

>sp|Q9SXB8|Y1133_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330 OS=Arabidopsis thaliana GN=At1g11330 PE=1 SV=3

 Score =  381 bits (978), Expect = e-105,   Method: Compositional matrix adjust.
 Identities = 187/343 (54%), Positives = 253/343 (73%), Gaps = 7/343 (2%)

Query: 92  EVDQFPLFSFSSVSSATGNFSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKSGQEIKE 150
           ++ + PLF F  ++++T +FS  NKLG+GGFG VYKG + +G EIAVKRL  KSGQ ++E
Sbjct: 505 KLKELPLFEFQVLATSTDSFSLRNKLGQGGFGPVYKGKLPEGQEIAVKRLSRKSGQGLEE 564

Query: 151 LKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRV 210
           L NE  VI+++QH+NLVKLLGCCIE +ER+L+YEYMP KSLD +LFDP K++ILDW+TR 
Sbjct: 565 LMNEVVVISKLQHRNLVKLLGCCIEGEERMLVYEYMPKKSLDAYLFDPMKQKILDWKTRF 624

Query: 211 QIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQ 270
            I++G+ +GLLYLH+ SR++IIHRDLKASNILLD+++N KISDFG+ARI     DE    
Sbjct: 625 NIMEGICRGLLYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFRANEDE---- 680

Query: 271 GNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTK-SLNLIGY 329
            NT R+ GTYGYMSPEYA+EG FS KSDVFS GV+ LEI+SG++N+  ++ + +LNL+ Y
Sbjct: 681 ANTRRVVGTYGYMSPEYAMEGFFSEKSDVFSLGVIFLEIISGRRNSSSHKEENNLNLLAY 740

Query: 330 AWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS 389
           AW LW   +   L D  + +  F + + + VHI LLCVQE A DRP +S+V+ MLT E  
Sbjct: 741 AWKLWNDGEAASLADPAVFDKCFEKEIEKCVHIGLLCVQEVANDRPNVSNVIWMLTTENM 800

Query: 390 SLLPPKQPAFCNLRNMESSTSTTEKSWADCSINEVTVSILDAR 432
           SL  PKQPAF  +R   S   ++++S    SIN+V+++ +  R
Sbjct: 801 SLADPKQPAFI-VRRGASEAESSDQSSQKVSINDVSLTAVTGR 842

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9ZR08|Y4230_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g03230 OS=Arabidopsis thaliana GN=At4g03230 PE=3 SV=3

 Score =  375 bits (964), Expect = e-103,   Method: Compositional matrix adjust.
 Identities = 194/339 (57%), Positives = 254/339 (74%), Gaps = 7/339 (2%)

Query: 97  PLFSFSSVSSATGNFSAANKLGEGGFGTVYKGVI-GQGEIAVKRLLGKSGQEIKELKNEA 155
           P F   ++  AT NFS ANKLG+GGFG VYKG+  G  EIAVKRL   SGQ ++E KNE 
Sbjct: 518 PSFELETILYATSNFSNANKLGQGGFGPVYKGMFPGDQEIAVKRLSRCSGQGLEEFKNEV 577

Query: 156 SVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKG 215
            +IA++QH+NLV+LLG C+  +E+LL+YEYMP+KSLD F+FD    + LDW+ R  II G
Sbjct: 578 VLIAKLQHRNLVRLLGYCVAGEEKLLLYEYMPHKSLDFFIFDRKLCQRLDWKMRCNIILG 637

Query: 216 VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR 275
           +A+GLLYLHQ SR+RIIHRDLK SNILLD++MN KISDFG+ARI FGG+   E   NT+R
Sbjct: 638 IARGLLYLHQDSRLRIIHRDLKTSNILLDEEMNPKISDFGLARI-FGGS---ETSANTNR 693

Query: 276 ISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRT-KSLNLIGYAWDLW 334
           + GTYGYMSPEYALEG+FS KSDVFSFGV+++E +SGK+NTGF+   KSL+L+G+AWDLW
Sbjct: 694 VVGTYGYMSPEYALEGLFSFKSDVFSFGVVVIETISGKRNTGFHEPEKSLSLLGHAWDLW 753

Query: 335 ISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML-TNEASSLLP 393
            + + I+L+D  L+E+   E   + +++ LLCVQE   DRPTMS+VV ML ++EA++L  
Sbjct: 754 KAERGIELLDQALQESCETEGFLKCLNVGLLCVQEDPNDRPTMSNVVFMLGSSEAATLPT 813

Query: 394 PKQPAFCNLRNMESSTSTTEKSWADCSINEVTVSILDAR 432
           PKQPAF   R   SS +++      CS NE+T+++ D R
Sbjct: 814 PKQPAFVLRRCPSSSKASSSTKPETCSENELTITLEDGR 852

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3

 Score =  375 bits (962), Expect = e-103,   Method: Compositional matrix adjust.
 Identities = 194/418 (46%), Positives = 281/418 (67%), Gaps = 27/418 (6%)

Query: 25  VTTNRTIFLALSATLAGMAALGLTIFCF--------RRNTTNKGEDLMKFDLGMNLKVDV 76
           ++  R + L L + +A +  L + +FC         R  +++     + FD   + +   
Sbjct: 433 LSGKRRVLLILISLIAAVMLLTVILFCVVRERRKSNRHRSSSANFAPVPFDFDESFRF-- 490

Query: 77  ELTEGNNKCKKGCEKEVDQFPLFSFSSVSSATGNFSAANKLGEGGFGTVYKGVI-GQGEI 135
           E  +  N+          + PLF  +++ +AT NFS+ NKLG GGFG VYKGV+  + EI
Sbjct: 491 EQDKARNR----------ELPLFDLNTIVAATNNFSSQNKLGAGGFGPVYKGVLQNRMEI 540

Query: 136 AVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFL 195
           AVKRL   SGQ ++E KNE  +I+++QH+NLV++LGCC+E +E++L+YEY+PNKSLD F+
Sbjct: 541 AVKRLSRNSGQGMEEFKNEVKLISKLQHRNLVRILGCCVELEEKMLVYEYLPNKSLDYFI 600

Query: 196 FDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFG 255
           F   +R  LDW  R++I++G+A+G+LYLHQ SR+RIIHRDLKASNILLD +M  KISDFG
Sbjct: 601 FHEEQRAELDWPKRMEIVRGIARGILYLHQDSRLRIIHRDLKASNILLDSEMIPKISDFG 660

Query: 256 MARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKN 315
           MARI FGGN   +++G TSR+ GT+GYM+PEYA+EG FSIKSDV+SFGVL+LEI++GKKN
Sbjct: 661 MARI-FGGN---QMEGCTSRVVGTFGYMAPEYAMEGQFSIKSDVYSFGVLMLEIITGKKN 716

Query: 316 TGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNE-SLSRYVHIALLCVQERAEDR 374
           + F+   S NL+G+ WDLW + +  ++ID+++++ +++E  + + + I LLCVQE A DR
Sbjct: 717 SAFHEESS-NLVGHIWDLWENGEATEIIDNLMDQETYDEREVMKCIQIGLLCVQENASDR 775

Query: 375 PTMSDVVSMLTNEASSLLPPKQPAFCNLRNMESSTSTTEKSWADCSINEVTVSILDAR 432
             MS VV ML + A++L  PK PAF + R          K     S+N+VT S +  R
Sbjct: 776 VDMSSVVIMLGHNATNLPNPKHPAFTSARRRGGENGACLKGQTGISVNDVTFSDIQGR 833

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O64793|Y1675_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g67520 OS=Arabidopsis thaliana GN=At1g67520 PE=2 SV=3

 Score =  372 bits (955), Expect = e-102,   Method: Compositional matrix adjust.
 Identities = 202/411 (49%), Positives = 276/411 (67%), Gaps = 19/411 (4%)

Query: 27  TNRTIFLALSATLAGMAALGLTIFCFRRNTTNKGEDLMKFDLGMNLKVDVELTEGNNKCK 86
           T++T+ +++   L  +  +   I   R  +T   E L++      L +D       N+ K
Sbjct: 422 THKTVLVSMVFLLTMIGFIRRRILSLRFGSTIDQEMLLR-----ELGIDRSCIHKRNERK 476

Query: 87  KGCEKEVDQFPLFSFSSVSSATGNFSAANKLGEGGFGTVYKGVIGQGE-IAVKRLLGKSG 145
              E ++     FSF SV SAT +FS  NKLGEGGFG VYKG +  GE +A+KRL   SG
Sbjct: 477 SNNELQI-----FSFESVVSATDDFSDENKLGEGGFGPVYKGKLLNGEEVAIKRLSLASG 531

Query: 146 QEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILD 205
           Q + E KNEA +IA++QH NLV++LGCCIEKDE++LIYEYM NKSLD FLFDP ++ +LD
Sbjct: 532 QGLVEFKNEAILIAKLQHTNLVQVLGCCIEKDEKMLIYEYMQNKSLDYFLFDPLRKNVLD 591

Query: 206 WRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGND 265
           W  R +I++G+ QGLLYLH+YSR+++IHRD+KASNILLD+DMN KISDFG+ARI FG   
Sbjct: 592 WTLRFRIMEGIIQGLLYLHKYSRLKVIHRDIKASNILLDEDMNPKISDFGLARI-FGA-- 648

Query: 266 EDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYR--TKS 323
            +E + NT R++GT+GYMSPEY  EG+FS KSDVFSFGVL+LEI+ G+KN  F+      
Sbjct: 649 -EETRANTKRVAGTFGYMSPEYFREGLFSAKSDVFSFGVLMLEIICGRKNNSFHHDLEGP 707

Query: 324 LNLIGYAWDLWISNKIIDLIDSVLEEASFN-ESLSRYVHIALLCVQERAEDRPTMSDVVS 382
           LNLI + W+L+  NKI ++ID  L +++ +   + R V +ALLCVQE AEDRP+M DVVS
Sbjct: 708 LNLIVHVWNLFKENKIREVIDLSLRDSALDYPQVLRCVQVALLCVQENAEDRPSMLDVVS 767

Query: 383 MLTNEASSLLP-PKQPAFCNLRNMESSTSTTEKSWADCSINEVTVSILDAR 432
           M+  E ++ L  PK+PAF +           E    +     +T+++L+AR
Sbjct: 768 MIYGEGNNALSLPKEPAFYDGPRRSFPEMKVEPQEPENVSASITITVLEAR 818

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SY89|Y1661_ARATH Putative G-type lectin S-receptor-like serine/threonine-protein kinase At1g61610 OS=Arabidopsis thaliana GN=At1g61610 PE=2 SV=1

 Score =  372 bits (954), Expect = e-102,   Method: Compositional matrix adjust.
 Identities = 182/318 (57%), Positives = 233/318 (73%), Gaps = 5/318 (1%)

Query: 88  GCEKEVDQFPLFSFSSVSSATGNFSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKSGQ 146
           G + +    P+FSF SV+SATG+F+  NKLG+GGFGTVYKG   +G EIAVKRL GKS Q
Sbjct: 502 GDQVDTPDLPIFSFDSVASATGDFAEENKLGQGGFGTVYKGNFSEGREIAVKRLSGKSKQ 561

Query: 147 EIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDW 206
            ++E KNE  +IA++QH+NLV+LLGCCIE +E++L+YEYMPNKSLD FLFD +K+  LDW
Sbjct: 562 GLEEFKNEILLIAKLQHRNLVRLLGCCIEDNEKMLLYEYMPNKSLDRFLFDESKQGSLDW 621

Query: 207 RTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDE 266
           R R ++I G+A+GLLYLH+ SR++IIHRDLKASNILLD +MN KISDFGMARI     D 
Sbjct: 622 RKRWEVIGGIARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKISDFGMARIFNYRQD- 680

Query: 267 DELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNL 326
                NT R+ GTYGYM+PEYA+EGIFS KSDV+SFGVL+LEIVSG+KN  F  T   +L
Sbjct: 681 ---HANTIRVVGTYGYMAPEYAMEGIFSEKSDVYSFGVLILEIVSGRKNVSFRGTDHGSL 737

Query: 327 IGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN 386
           IGYAW LW   K  ++ID ++++        R +H+ +LC Q+    RP M  V+ ML +
Sbjct: 738 IGYAWHLWSQGKTKEMIDPIVKDTRDVTEAMRCIHVGMLCTQDSVIHRPNMGSVLLMLES 797

Query: 387 EASSLLPPKQPAFCNLRN 404
           + S L PP+QP F +  N
Sbjct: 798 QTSQLPPPRQPTFHSFLN 815

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LW83|CE101_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase CES101 OS=Arabidopsis thaliana GN=CES101 PE=2 SV=2

 Score =  370 bits (951), Expect = e-101,   Method: Compositional matrix adjust.
 Identities = 189/345 (54%), Positives = 253/345 (73%), Gaps = 10/345 (2%)

Query: 94  DQFPLFSFSSVSSATGNFSAANKLGEGGFGTVYKGVIGQGE-IAVKRLLGKSGQEIKELK 152
           ++  +FSF SV+ AT  FS ANKLGEGGFG VYKG +  GE +A+KRL   SGQ + E K
Sbjct: 510 NELQIFSFESVAFATDYFSDANKLGEGGFGPVYKGRLIDGEEVAIKRLSLASGQGLVEFK 569

Query: 153 NEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQI 212
           NEA +IA++QH NLVKLLGCC+EKDE++LIYEYMPNKSLD FLFDP ++ +LDW+ R +I
Sbjct: 570 NEAMLIAKLQHTNLVKLLGCCVEKDEKMLIYEYMPNKSLDYFLFDPLRKIVLDWKLRFRI 629

Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
           ++G+ QGLLYLH+YSR+++IHRD+KA NILLD+DMN KISDFGMARI FG     E + N
Sbjct: 630 MEGIIQGLLYLHKYSRLKVIHRDIKAGNILLDEDMNPKISDFGMARI-FGA---QESKAN 685

Query: 273 TSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTK--SLNLIGYA 330
           T R++GT+GYMSPEY  EG+FS KSDVFSFGVL+LEI+ G+KN  F+      LNLI + 
Sbjct: 686 TKRVAGTFGYMSPEYFREGLFSAKSDVFSFGVLMLEIICGRKNNSFHHDSEGPLNLIVHV 745

Query: 331 WDLWISNKIIDLIDSVLEEASF-NESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS 389
           W+L+  N++ ++ID  L +++  N  + R V +ALLCVQ+ A+DRP+M DVVSM+  + +
Sbjct: 746 WNLFKENRVREVIDPSLGDSAVENPQVLRCVQVALLCVQQNADDRPSMLDVVSMIYGDGN 805

Query: 390 SLLP-PKQPAFCNLRNMES-STSTTEKSWADCSINEVTVSILDAR 432
           + L  PK+PAF +     S           + S N VT+++++AR
Sbjct: 806 NALSLPKEPAFYDGPPRSSPEMEVEPPEMENVSANRVTITVMEAR 850

Promotes the expression of genes involved in photosynthesis at least in dedifferentiated calli.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1

 Score =  369 bits (948), Expect = e-101,   Method: Compositional matrix adjust.
 Identities = 176/310 (56%), Positives = 234/310 (75%), Gaps = 5/310 (1%)

Query: 95  QFPLFSFSSVSSATGNFSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKSGQEIKELKN 153
           + P+FS ++++ AT +F   N+LG GGFG VYKGV+  G EIAVKRL GKSGQ + E KN
Sbjct: 513 ELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVDEFKN 572

Query: 154 EASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQII 213
           E  +IA++QH+NLV+LLGCC E +E++L+YEYMPNKSLD FLFD TK+ ++DW+ R  II
Sbjct: 573 EIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRFSII 632

Query: 214 KGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNT 273
           +G+A+GLLYLH+ SR+RIIHRDLK SN+LLD +MN KISDFGMARI FGGN     + NT
Sbjct: 633 EGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARI-FGGNQN---EANT 688

Query: 274 SRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDL 333
            R+ GTYGYMSPEYA+EG+FS+KSDV+SFGVLLLEIVSGK+NT    ++  +LIGYAW L
Sbjct: 689 VRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSEHGSLIGYAWYL 748

Query: 334 WISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLP 393
           +   +  +L+D  +          R +H+A+LCVQ+ A +RP M+ V+ ML ++ ++L  
Sbjct: 749 YTHGRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMASVLLMLESDTATLAA 808

Query: 394 PKQPAFCNLR 403
           P+QP F + R
Sbjct: 809 PRQPTFTSTR 818

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2

 Score =  369 bits (948), Expect = e-101,   Method: Compositional matrix adjust.
 Identities = 189/345 (54%), Positives = 249/345 (72%), Gaps = 11/345 (3%)

Query: 95  QFPLFSFSSVSSATGNFSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKSGQEIKELKN 153
           + PL  + +++ AT NFS  NKLG+GGFG VYKG++  G EIAVKRL   S Q   E  N
Sbjct: 507 ELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSKMSSQGTDEFMN 566

Query: 154 EASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQII 213
           E  +IA++QH NLV+LLGCC++K E++LIYEY+ N SLD  LFD T+   L+W+ R  II
Sbjct: 567 EVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDII 626

Query: 214 KGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNT 273
            G+A+GLLYLHQ SR RIIHRDLKASN+LLDK+M  KISDFGMARI FG    +E + NT
Sbjct: 627 NGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARI-FG---REETEANT 682

Query: 274 SRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRT-KSLNLIGYAWD 332
            R+ GTYGYMSPEYA++GIFS+KSDVFSFGVLLLEI+SGK+N GFY + + LNL+G+ W 
Sbjct: 683 RRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWR 742

Query: 333 LWISNKIIDLIDSVLEEASFNE----SLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEA 388
            W   K ++++D +  +A  +E     + R + I LLCVQERAEDRP MS V+ ML +E 
Sbjct: 743 HWKEGKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSET 802

Query: 389 SSLLPPKQPAFCNLRNMESSTSTTEKSWAD-CSINEVTVSILDAR 432
           +++  PK+P FC  R+     S++     D C++N+VT+S++DAR
Sbjct: 803 TAIPQPKRPGFCVGRSSLEVDSSSSTQRDDECTVNQVTLSVIDAR 847

Involved in the regulation of cellular expansion and differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1

 Score =  365 bits (938), Expect = e-100,   Method: Compositional matrix adjust.
 Identities = 184/335 (54%), Positives = 244/335 (72%), Gaps = 11/335 (3%)

Query: 105 SSATGNFSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKSGQEIKELKNEASVIAQVQH 163
           ++AT NFS  NKLG+GGFG VYKG +  G EIAVKRL   S Q   E  NE  +IA++QH
Sbjct: 513 ATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQH 572

Query: 164 KNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYL 223
            NLV+LLGCC++K E++LIYEY+ N SLD  LFD T+   L+W+ R  II G+A+GLLYL
Sbjct: 573 INLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYL 632

Query: 224 HQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYM 283
           HQ SR RIIHRDLKASN+LLDK+M  KISDFGMARI FG    +E + NT R+ GTYGYM
Sbjct: 633 HQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARI-FG---REETEANTRRVVGTYGYM 688

Query: 284 SPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRT-KSLNLIGYAWDLWISNKIIDL 342
           SPEYA++GIFS+KSDVFSFGVLLLEI+SGK+N GFY + + LNL+G+ W  W     +++
Sbjct: 689 SPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWKEGNELEI 748

Query: 343 IDSV----LEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQPA 398
           +D +    L        + R + I LLCVQERAEDRP MS V+ ML +E +++  PK+P 
Sbjct: 749 VDPINIDSLSSKFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSETTAIPQPKRPG 808

Query: 399 FCNLRN-MESSTSTTEKSWADCSINEVTVSILDAR 432
           FC  R+ +E+ +S++ +   +C++N++T+S++DAR
Sbjct: 809 FCIGRSPLEADSSSSTQRDDECTVNQITLSVIDAR 843

Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1

 Score =  363 bits (932), Expect = 1e-99,   Method: Compositional matrix adjust.
 Identities = 191/345 (55%), Positives = 247/345 (71%), Gaps = 11/345 (3%)

Query: 95  QFPLFSFSSVSSATGNFSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKSGQEIKELKN 153
           + PL  F  V+ AT NFS ANKLG+GGFG VYKG +  G E+AVKRL   S Q   E KN
Sbjct: 510 ELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMAVKRLSKTSVQGTDEFKN 569

Query: 154 EASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQII 213
           E  +IA++QH NLV+LL CC++  E++LIYEY+ N SLD  LFD ++   L+W+ R  II
Sbjct: 570 EVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRNSKLNWQMRFDII 629

Query: 214 KGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNT 273
            G+A+GLLYLHQ SR RIIHRDLKASNILLDK M  KISDFGMARI FG    DE + NT
Sbjct: 630 NGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARI-FG---RDETEANT 685

Query: 274 SRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRT-KSLNLIGYAWD 332
            ++ GTYGYMSPEYA++GIFS+KSDVFSFGVLLLEI+S K+N GFY + + LNL+G  W 
Sbjct: 686 RKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDRDLNLLGCVWR 745

Query: 333 LWISNKIIDLIDSVLEEASF---NESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS 389
            W   K +++ID ++ ++S       + R + I LLCVQERAEDRPTMS V+ ML +E++
Sbjct: 746 NWKEGKGLEIIDPIITDSSSTFRQHEILRCIQIGLLCVQERAEDRPTMSLVILMLGSEST 805

Query: 390 SLLPPKQPAFCNLRNMESSTSTTEKSWADCS--INEVTVSILDAR 432
           ++  PK P +C  R++  + S++ K   D S  +N++TVS+LDAR
Sbjct: 806 TIPQPKAPGYCLERSLLDTDSSSSKQRDDESWTVNQITVSVLDAR 850

Involved in the regulation of cellular expansion and differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	432
359484155	865	PREDICTED: receptor-like serine/threonin	0.898	0.448	0.646	1e-133
297742753	637	unnamed protein product [Vitis vinifera]	0.898	0.609	0.646	1e-132
356514857	834	PREDICTED: G-type lectin S-receptor-like	0.861	0.446	0.622	1e-129
359493705	830	PREDICTED: receptor-like serine/threonin	0.851	0.443	0.645	1e-129
302143120	674	unnamed protein product [Vitis vinifera]	0.851	0.545	0.645	1e-128
357516499	750	S-locus receptor kinase [Medicago trunca	0.861	0.496	0.588	1e-126
296090091	674	unnamed protein product [Vitis vinifera]	0.851	0.545	0.638	1e-125
302143114	457	unnamed protein product [Vitis vinifera]	0.851	0.805	0.631	1e-125
302143128	692	unnamed protein product [Vitis vinifera]	0.872	0.544	0.594	1e-125
359493709	894	PREDICTED: receptor-like serine/threonin	0.789	0.381	0.672	1e-125

>gi|359484155|ref|XP_002272509.2| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Vitis vinifera]

 Score =  480 bits (1236), Expect = e-133,   Method: Compositional matrix adjust.
 Identities = 260/402 (64%), Positives = 304/402 (75%), Gaps = 14/402 (3%)

Query: 35  LSATLAGMAALGLTIFCFRRNTTNKGEDLMKFDLGMNLKVDV--ELTEGNNKCKKGCEKE 92
           L  TLA        I+  RR    KGE+L+ FDL  N  VD   EL+E  +K   G +KE
Sbjct: 474 LIVTLAISVTSAFVIWGIRRRLRRKGENLLLFDLS-NSSVDTNYELSE-TSKLWSGEKKE 531

Query: 93  VDQFPLFSFSSVSSATGNFSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKSGQEIKEL 151
           VD  P+FSF+SVS+AT NFS  NKLGEGGFG VYKG   +G E+AVKRL  +SGQ  +EL
Sbjct: 532 VD-LPMFSFASVSAATNNFSIENKLGEGGFGPVYKGKSQKGYEVAVKRLSKRSGQGWEEL 590

Query: 152 KNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQ 211
           KNE  +IA++QHKNLVKL G CIEKDE++LIYEYMPNKSLD FLFDPTK  IL+W+TRV 
Sbjct: 591 KNEVMLIAKLQHKNLVKLFGYCIEKDEKILIYEYMPNKSLDFFLFDPTKHGILNWKTRVH 650

Query: 212 IIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQG 271
           IIKGVAQGLLYLHQYSR+RIIHRDLKASNILLDKDMN +ISDFGMARI FGGN+      
Sbjct: 651 IIKGVAQGLLYLHQYSRLRIIHRDLKASNILLDKDMNPQISDFGMARI-FGGNESKA--- 706

Query: 272 NTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAW 331
            T+ I GTYGYMSPEYALEG+FS KSDVFSFGVLLLEI+SGKKNTGFY+T SLNL+GYAW
Sbjct: 707 -TNHIVGTYGYMSPEYALEGLFSTKSDVFSFGVLLLEILSGKKNTGFYQTDSLNLLGYAW 765

Query: 332 DLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSL 391
           DLW  ++  +L+D  LEE      L RY++I LLCVQE A+DRPTMSDVVSML NE+  L
Sbjct: 766 DLWKDSRGQELMDPGLEETLPTHILLRYINIGLLCVQESADDRPTMSDVVSMLGNESVRL 825

Query: 392 LPPKQPAFCNLRN-MESSTSTTEKSWADCSINEVTVSILDAR 432
             PKQPAF NLR+ +E   S  +     CS+N VT+S+++AR
Sbjct: 826 PSPKQPAFSNLRSGVEPHISQNKP--KICSLNGVTLSVMEAR 865

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297742753|emb|CBI35387.3| unnamed protein product [Vitis vinifera]

 Score =  478 bits (1231), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 260/402 (64%), Positives = 304/402 (75%), Gaps = 14/402 (3%)

Query: 35  LSATLAGMAALGLTIFCFRRNTTNKGEDLMKFDLGMNLKVDV--ELTEGNNKCKKGCEKE 92
           L  TLA        I+  RR    KGE+L+ FDL  N  VD   EL+E  +K   G +KE
Sbjct: 246 LIVTLAISVTSAFVIWGIRRRLRRKGENLLLFDLS-NSSVDTNYELSE-TSKLWSGEKKE 303

Query: 93  VDQFPLFSFSSVSSATGNFSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKSGQEIKEL 151
           VD  P+FSF+SVS+AT NFS  NKLGEGGFG VYKG   +G E+AVKRL  +SGQ  +EL
Sbjct: 304 VD-LPMFSFASVSAATNNFSIENKLGEGGFGPVYKGKSQKGYEVAVKRLSKRSGQGWEEL 362

Query: 152 KNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQ 211
           KNE  +IA++QHKNLVKL G CIEKDE++LIYEYMPNKSLD FLFDPTK  IL+W+TRV 
Sbjct: 363 KNEVMLIAKLQHKNLVKLFGYCIEKDEKILIYEYMPNKSLDFFLFDPTKHGILNWKTRVH 422

Query: 212 IIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQG 271
           IIKGVAQGLLYLHQYSR+RIIHRDLKASNILLDKDMN +ISDFGMARI FGGN+      
Sbjct: 423 IIKGVAQGLLYLHQYSRLRIIHRDLKASNILLDKDMNPQISDFGMARI-FGGNESKA--- 478

Query: 272 NTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAW 331
            T+ I GTYGYMSPEYALEG+FS KSDVFSFGVLLLEI+SGKKNTGFY+T SLNL+GYAW
Sbjct: 479 -TNHIVGTYGYMSPEYALEGLFSTKSDVFSFGVLLLEILSGKKNTGFYQTDSLNLLGYAW 537

Query: 332 DLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSL 391
           DLW  ++  +L+D  LEE      L RY++I LLCVQE A+DRPTMSDVVSML NE+  L
Sbjct: 538 DLWKDSRGQELMDPGLEETLPTHILLRYINIGLLCVQESADDRPTMSDVVSMLGNESVRL 597

Query: 392 LPPKQPAFCNLRN-MESSTSTTEKSWADCSINEVTVSILDAR 432
             PKQPAF NLR+ +E   S  +     CS+N VT+S+++AR
Sbjct: 598 PSPKQPAFSNLRSGVEPHISQNKPK--ICSLNGVTLSVMEAR 637

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356514857|ref|XP_003526119.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g11300-like [Glycine max]

 Score =  468 bits (1204), Expect = e-129,   Method: Compositional matrix adjust.
 Identities = 242/389 (62%), Positives = 302/389 (77%), Gaps = 17/389 (4%)

Query: 52  FRRNTTNKGEDLMKFDLGMNLKV-DVELTEGNNKCKKGCEKEVDQFPLFSFSSVSSATGN 110
           + R    KGEDL++F + M++KV D EL E +   K   +KEV + PLFSF SV++AT N
Sbjct: 455 WTRRQRRKGEDLLRFHVSMSMKVEDSELAEAHRGAKVK-KKEV-KLPLFSFVSVAAATNN 512

Query: 111 FSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKL 169
           FS ANKLGEGGFG VYKG++  G E+AVKRL  +SGQ  +EL+NEA +IA++QH NLV+L
Sbjct: 513 FSDANKLGEGGFGPVYKGILLNGDEVAVKRLSRRSGQGWEELRNEALLIAKLQHNNLVRL 572

Query: 170 LGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRV 229
           LGCCI++DE++LIYE MPNKSLD FLFD TKR +LDW TRV+II G+AQG+LYLHQYSR 
Sbjct: 573 LGCCIDRDEKMLIYELMPNKSLDVFLFDATKRRMLDWGTRVRIIDGIAQGILYLHQYSRF 632

Query: 230 RIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL 289
           RIIHRDLKASNILLD +MN KISDFGMARI FG N   ELQ NT+RI GTYGYMSPEYA+
Sbjct: 633 RIIHRDLKASNILLDTNMNPKISDFGMARI-FGDN---ELQANTNRIVGTYGYMSPEYAM 688

Query: 290 EGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEE 349
           EG+FSIKSDVFSFGVLLLEI+SGKKNTGFY+T S NL+GYAWDLW +N  +DL+D  L++
Sbjct: 689 EGLFSIKSDVFSFGVLLLEILSGKKNTGFYQTNSFNLLGYAWDLWTNNSGMDLMDPALDD 748

Query: 350 ASFNES----LSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQPAFCNLRNM 405
           +    S    + RYV+I LLCVQE   DRPTMSDVVSM+ N+  +L  PK PAF N+R  
Sbjct: 749 SDTTSSSMHTVPRYVNIGLLCVQESPADRPTMSDVVSMIGNDTVALPSPKPPAFLNVRGN 808

Query: 406 ESS--TSTTEKSWADCSINEVTVSILDAR 432
           ++S   ++  +S+   S+N +T ++++AR
Sbjct: 809 QNSILPASMPESF---SLNLITDTMVEAR 834

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359493705|ref|XP_003634654.1| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Vitis vinifera]

 Score =  466 bits (1199), Expect = e-129,   Method: Compositional matrix adjust.
 Identities = 248/384 (64%), Positives = 298/384 (77%), Gaps = 16/384 (4%)

Query: 52  FRRNTTNKGEDLMKFDLGMNLK-VDVELTEGNNKCKKGCEKEVDQFPLFSFSSVSSATGN 110
           FRR    KGEDL+ FD G + +    EL E  N+  +G ++EVD  P+FSF+SVS++T N
Sbjct: 460 FRR----KGEDLLVFDFGNSSEDTSYELDE-TNRLWRGEKREVD-LPMFSFASVSASTNN 513

Query: 111 FSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKL 169
           FS  NKLGEGGFG+VYKG   +  E+AVKRL  +S Q  +ELKNEA +IA++QHKNLVK+
Sbjct: 514 FSIENKLGEGGFGSVYKGKSQRRYEVAVKRLSKRSKQGWEELKNEAMLIAKLQHKNLVKV 573

Query: 170 LGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRV 229
           LG CIE+DE++LIYEYM NKSLD FLFDPTK  IL+W+TRV II+GVAQGLLYLHQYSR+
Sbjct: 574 LGYCIERDEKILIYEYMSNKSLDFFLFDPTKHGILNWKTRVHIIEGVAQGLLYLHQYSRL 633

Query: 230 RIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL 289
           RIIHRDLKASNILLDKDMN KISDFGMARI FGGN+       T+ I GTYGYMSPEYAL
Sbjct: 634 RIIHRDLKASNILLDKDMNPKISDFGMARI-FGGNESKV----TNHIVGTYGYMSPEYAL 688

Query: 290 EGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEE 349
           EG+FS KSDVFSFGVLLLEI+SGKKNTGFY+T SLNL+GYAWDLW  ++ ++L+D  LEE
Sbjct: 689 EGLFSTKSDVFSFGVLLLEILSGKKNTGFYQTDSLNLLGYAWDLWKDSRGLELMDPGLEE 748

Query: 350 ASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQPAFCNLRN-MESS 408
                 L RY+++ LLCVQE A+DRPTMSDVVSML NE+  L  PKQPAF NLR+ +E  
Sbjct: 749 TLPTHILLRYINVGLLCVQESADDRPTMSDVVSMLGNESVRLPSPKQPAFSNLRSGVEPH 808

Query: 409 TSTTEKSWADCSINEVTVSILDAR 432
            S        CS+N VT+S+++AR
Sbjct: 809 ISQNRPE--VCSLNGVTLSVMEAR 830

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|302143120|emb|CBI20415.3| unnamed protein product [Vitis vinifera]

 Score =  464 bits (1194), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 248/384 (64%), Positives = 298/384 (77%), Gaps = 16/384 (4%)

Query: 52  FRRNTTNKGEDLMKFDLGMNLK-VDVELTEGNNKCKKGCEKEVDQFPLFSFSSVSSATGN 110
           FRR    KGEDL+ FD G + +    EL E  N+  +G ++EVD  P+FSF+SVS++T N
Sbjct: 304 FRR----KGEDLLVFDFGNSSEDTSYELDE-TNRLWRGEKREVD-LPMFSFASVSASTNN 357

Query: 111 FSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKL 169
           FS  NKLGEGGFG+VYKG   +  E+AVKRL  +S Q  +ELKNEA +IA++QHKNLVK+
Sbjct: 358 FSIENKLGEGGFGSVYKGKSQRRYEVAVKRLSKRSKQGWEELKNEAMLIAKLQHKNLVKV 417

Query: 170 LGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRV 229
           LG CIE+DE++LIYEYM NKSLD FLFDPTK  IL+W+TRV II+GVAQGLLYLHQYSR+
Sbjct: 418 LGYCIERDEKILIYEYMSNKSLDFFLFDPTKHGILNWKTRVHIIEGVAQGLLYLHQYSRL 477

Query: 230 RIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL 289
           RIIHRDLKASNILLDKDMN KISDFGMARI FGGN+       T+ I GTYGYMSPEYAL
Sbjct: 478 RIIHRDLKASNILLDKDMNPKISDFGMARI-FGGNESKV----TNHIVGTYGYMSPEYAL 532

Query: 290 EGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEE 349
           EG+FS KSDVFSFGVLLLEI+SGKKNTGFY+T SLNL+GYAWDLW  ++ ++L+D  LEE
Sbjct: 533 EGLFSTKSDVFSFGVLLLEILSGKKNTGFYQTDSLNLLGYAWDLWKDSRGLELMDPGLEE 592

Query: 350 ASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQPAFCNLRN-MESS 408
                 L RY+++ LLCVQE A+DRPTMSDVVSML NE+  L  PKQPAF NLR+ +E  
Sbjct: 593 TLPTHILLRYINVGLLCVQESADDRPTMSDVVSMLGNESVRLPSPKQPAFSNLRSGVEPH 652

Query: 409 TSTTEKSWADCSINEVTVSILDAR 432
            S        CS+N VT+S+++AR
Sbjct: 653 ISQNRPE--VCSLNGVTLSVMEAR 674

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357516499|ref|XP_003628538.1| S-locus receptor kinase [Medicago truncatula] gi|355522560|gb|AET03014.1| S-locus receptor kinase [Medicago truncatula]

 Score =  457 bits (1176), Expect = e-126,   Method: Compositional matrix adjust.
 Identities = 242/411 (58%), Positives = 303/411 (73%), Gaps = 39/411 (9%)

Query: 52  FRRNTTNKGEDLMKFDLGMNLKV-DVELTEGNNKCKKGCEKEVDQFPLFSFSSVSSATGN 110
           + R    KG+DL+ F++GM +KV D E+T+ + K  K   KEV + PLFS  SVS+AT N
Sbjct: 349 WTRKQRRKGDDLLNFEVGMTMKVKDSEITKAD-KGAKVRRKEV-KLPLFSLVSVSAATNN 406

Query: 111 FSAANKLGEGGFGTVYKG-VIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKL 169
           FS   KLGEGGFG VYKG ++  GE+A+KRL   SGQ  +EL+NEA +IA++QH NLV+L
Sbjct: 407 FSDTKKLGEGGFGPVYKGTLLNGGEVAIKRLSRISGQGWEELRNEALLIAKLQHNNLVRL 466

Query: 170 LGCCIEKDERLLIYEYMPNKSLDCFLF--------------------------DPTKREI 203
           LGCCIE+DE++LIYE+MPNKSLD F+F                          D  KR +
Sbjct: 467 LGCCIERDEKMLIYEFMPNKSLDFFIFGLYFSETKISILFNSNCSCDIFLFKTDAVKRRM 526

Query: 204 LDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGG 263
           LDW TRV+II G+AQGLLYLHQYSR RIIHRDLKASNILLD +MN KISDFGMARI FG 
Sbjct: 527 LDWETRVRIIDGIAQGLLYLHQYSRFRIIHRDLKASNILLDANMNPKISDFGMARI-FG- 584

Query: 264 NDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKS 323
             E+ LQ NT+RI GTYGYMSPEYA+EG++SIKSDVFSFGVLLLEI+SGKKNTGFY+T S
Sbjct: 585 --ENVLQANTNRIVGTYGYMSPEYAMEGVYSIKSDVFSFGVLLLEIISGKKNTGFYQTNS 642

Query: 324 LNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM 383
            NL+GYAWDLW +N  +DLIDS L++ S    + +YV+I LLCVQ+  EDRPTMSDVV+M
Sbjct: 643 FNLLGYAWDLWTNNSGMDLIDSKLDDISNKHLVPKYVNIGLLCVQQSPEDRPTMSDVVTM 702

Query: 384 LTNEASSLLPPKQPAFCNLRNMESS--TSTTEKSWADCSINEVTVSILDAR 432
           + N+ +SLL PK PAF N+R +E+S  + + E+   + S+N VT S+++AR
Sbjct: 703 IGNDTTSLLSPKPPAFQNVRGIENSRLSRSIEE---NVSVNVVTNSLVEAR 750

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|296090091|emb|CBI39910.3| unnamed protein product [Vitis vinifera]

 Score =  456 bits (1173), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 246/385 (63%), Positives = 293/385 (76%), Gaps = 17/385 (4%)

Query: 52  FRRNTTNKGEDLMKFDLGMNLKVDVELTE--GNNKCKKGCEKEVDQFPLFSFSSVSSATG 109
           FRR    KGEDL+ FD G N   D    E    N+  +G +KEVD  P+FSF+SVS++T 
Sbjct: 303 FRR----KGEDLLLFDFG-NSSEDTSCYELGETNRLWRGEKKEVD-LPMFSFASVSASTN 356

Query: 110 NFSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
           NF   NKLGEGGFG+VYKG   +  E+AVKRL  +S Q  +ELKNEA +IA++QHKNLVK
Sbjct: 357 NFCNENKLGEGGFGSVYKGKSQRRYEVAVKRLSKRSKQGWEELKNEAMLIAKLQHKNLVK 416

Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSR 228
           +LG CIE+DE++LIYEYM NKSLD FLFDPTK  IL+W+T V II+GVAQGLLYLHQYSR
Sbjct: 417 VLGYCIERDEKILIYEYMSNKSLDFFLFDPTKHGILNWKTWVHIIEGVAQGLLYLHQYSR 476

Query: 229 VRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYA 288
           +RIIHRDLKASNILLDKDMN KISDFGMARI FGGN+       T+ I GTYGYMSPEYA
Sbjct: 477 MRIIHRDLKASNILLDKDMNPKISDFGMARI-FGGNEPKA----TNHIVGTYGYMSPEYA 531

Query: 289 LEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLE 348
           LEG+FS KSDVFSFGVLL+EI+SGKKNTGFY+T SLNL+GYAWDLW  ++  +L+D  LE
Sbjct: 532 LEGLFSTKSDVFSFGVLLMEILSGKKNTGFYQTDSLNLLGYAWDLWKDSRGQELMDPGLE 591

Query: 349 EASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQPAFCNLRN-MES 407
           E S    L RY+++ LLCVQE A+DRPTMSDVVSML NE+  L  PKQPAF NLR+ +E 
Sbjct: 592 ETSPTHILLRYINVGLLCVQESADDRPTMSDVVSMLGNESVRLPSPKQPAFSNLRSGVEP 651

Query: 408 STSTTEKSWADCSINEVTVSILDAR 432
             S         S+N VT+S+++AR
Sbjct: 652 HISQNRP--GIYSLNGVTLSVMEAR 674

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|302143114|emb|CBI20409.3| unnamed protein product [Vitis vinifera]

 Score =  455 bits (1170), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 242/383 (63%), Positives = 290/383 (75%), Gaps = 15/383 (3%)

Query: 52  FRRNTTNKGEDLMKFDLGMNLK-VDVELTEGNNKCKKGCEKEVDQFPLFSFSSVSSATGN 110
           FRR    KGEDL+ FD G + +    EL E  N+  +G +KEVD  P+FSF+SVS++T N
Sbjct: 88  FRR----KGEDLLVFDFGNSSEDTSYELGE-TNRLWRGEKKEVD-LPMFSFASVSASTNN 141

Query: 111 FSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKL 169
           FS  NKLGEGGFG+VYKG + +G E+AVKRL  +S Q  +ELKNEA +IA++QHKNLVK+
Sbjct: 142 FSIENKLGEGGFGSVYKGKLQRGYEVAVKRLSKRSKQGWEELKNEAMLIAKLQHKNLVKV 201

Query: 170 LGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRV 229
           LG CIE+DE++LIYEYM NKSLD FLFDP KR IL+W  RV+II+GVAQGLLYLHQYSR+
Sbjct: 202 LGYCIERDEKILIYEYMSNKSLDFFLFDPAKRGILNWEMRVRIIEGVAQGLLYLHQYSRL 261

Query: 230 RIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL 289
           R+IHRDLKASNILLDKDMN KISDFGMARI FGGN+       T  I GTYGYMSPEY L
Sbjct: 262 RVIHRDLKASNILLDKDMNPKISDFGMARI-FGGNESKA----TKHIVGTYGYMSPEYVL 316

Query: 290 EGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEE 349
            G+FS KSDVFSFGVLLLEI+SGKK T FY + SLNL+GYAWDLW +NK  +LID VL E
Sbjct: 317 RGLFSTKSDVFSFGVLLLEILSGKKITEFYHSGSLNLLGYAWDLWKNNKGQELIDPVLNE 376

Query: 350 ASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQPAFCNLRNMESST 409
            S    + RY+++ALLCVQE A+DRPTM DVVSML  E   L  P +PAF NL +M+   
Sbjct: 377 ISLRHIMLRYINVALLCVQESADDRPTMFDVVSMLVKENVLLSSPNEPAFSNLSSMKPHA 436

Query: 410 STTEKSWADCSINEVTVSILDAR 432
           S  +     CS+N+VT+S + AR
Sbjct: 437 S--QDRLEICSLNDVTLSSMGAR 457

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|302143128|emb|CBI20423.3| unnamed protein product [Vitis vinifera]

 Score =  454 bits (1168), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 235/395 (59%), Positives = 296/395 (74%), Gaps = 18/395 (4%)

Query: 48  TIFCFR-------RNTTNKGEDLMKFDLGMNLKV-DVELTEGNNKCKKGCEKEVDQF-PL 98
           +  C+R       R      +D++ ++ GM  K  + EL EGN   + G +K  D + PL
Sbjct: 306 SYICYRQMKRVQDREEMTTSQDILLYEFGMGSKATENELNEGN---RVGKDKNKDAWLPL 362

Query: 99  FSFSSVSSATGNFSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKSGQEIKELKNEASV 157
           FSF+SVS+AT +FS  NKLG+GGFG VYKG +  G EIAVKRL   SGQ ++ELKNE  +
Sbjct: 363 FSFASVSAATEHFSTENKLGQGGFGPVYKGELFNGQEIAVKRLSRSSGQGLEELKNETVL 422

Query: 158 IAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVA 217
           +A++QH+NLV+LLGCCIE+ E++LIYEYMPNKSLD FLFDP KR  LDW  RV II+G+A
Sbjct: 423 LAELQHRNLVRLLGCCIEQGEKILIYEYMPNKSLDSFLFDPNKRGQLDWAKRVSIIEGIA 482

Query: 218 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRIS 277
           QGLLYLH+YSR+RIIHRDLKASNILLD DMN KISDFGMAR+ FGGN   E   NT+RI 
Sbjct: 483 QGLLYLHEYSRLRIIHRDLKASNILLDNDMNPKISDFGMARM-FGGN---ESYANTNRIV 538

Query: 278 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISN 337
           GTYGYMSPEYALEG+FS KSDVFSFGVL+LEI+SGKKNTGFY + +LNLIGYAW+LW S+
Sbjct: 539 GTYGYMSPEYALEGLFSTKSDVFSFGVLMLEILSGKKNTGFYNSDTLNLIGYAWELWKSD 598

Query: 338 KIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQP 397
             I+L+D +LE  S    L RY+++ LLCV+E A DRPT+S+VVSMLTNE + L  PK P
Sbjct: 599 MAINLMDPMLEGQSSQYMLLRYINVGLLCVEEIAADRPTLSEVVSMLTNELAVLPSPKHP 658

Query: 398 AFCNLRNMESSTSTTEKSWADCSINEVTVSILDAR 432
           AF  +R+ME+  S+  +     S N +++S+++AR
Sbjct: 659 AFSTVRSMENPRSSMSRP-EIYSANGLSISVMEAR 692

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359493709|ref|XP_002281056.2| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Vitis vinifera]

 Score =  453 bits (1166), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 240/357 (67%), Positives = 279/357 (78%), Gaps = 16/357 (4%)

Query: 52  FRRNTTNKGEDLMKFDLGMNLKVDV---ELTEGNNKCKKGCEKEVDQFPLFSFSSVSSAT 108
           FRR    KGEDL+ FD G N   D    EL E  N+  +G +KEVD  P+FSF SVS++T
Sbjct: 463 FRR----KGEDLLVFDFG-NSSEDTSCYELGE-TNRLWRGEKKEVD-LPMFSFVSVSAST 515

Query: 109 GNFSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLV 167
            NF   NKLGEGGFG+VYKG   +G E+AVKRL  +S Q  +ELKNEA +IA++QHKNLV
Sbjct: 516 NNFCIENKLGEGGFGSVYKGKSQRGYEVAVKRLSKRSKQGWEELKNEAMLIAKLQHKNLV 575

Query: 168 KLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYS 227
           K+LG CIE+DE++LIYEYM NKSLD FLFDP KR IL+W TRV+II+GVAQGLLYLHQYS
Sbjct: 576 KVLGYCIERDEKILIYEYMSNKSLDFFLFDPAKRGILNWETRVRIIEGVAQGLLYLHQYS 635

Query: 228 RVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEY 287
           R+R+IHRDLKASNILLDKDMN KISDFGMARI FGGN+       T  I GTYGYMSPEY
Sbjct: 636 RLRVIHRDLKASNILLDKDMNPKISDFGMARI-FGGNESKA----TKHIVGTYGYMSPEY 690

Query: 288 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVL 347
           ALEG+FS KSDVFSFGVLLLEI+SGKKNTGFY+T SLNL+GYAWDLW  ++  +L+D  L
Sbjct: 691 ALEGLFSTKSDVFSFGVLLLEILSGKKNTGFYQTDSLNLLGYAWDLWKDSRGQELMDPGL 750

Query: 348 EEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQPAFCNLRN 404
           EE      L RY+++ LLCVQE A+DRPTMSDVVSML NE+  L  PKQPAF NLR+
Sbjct: 751 EETLPTHILLRYINVGLLCVQESADDRPTMSDVVSMLGNESVRLPSPKQPAFSNLRS 807

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	432
TAIR|locus:2018546	843	RK1 "receptor kinase 1" [Arabi	0.784	0.402	0.537	3.3e-96
TAIR|locus:2093397	850	CES101 "CALLUS EXPRESSION OF R	0.807	0.410	0.534	5.9e-96
TAIR|locus:2018506	847	RK2 "receptor kinase 2" [Arabi	0.782	0.399	0.546	1.2e-95
UNIPROTKB|O49974	848	KIK1 "Serine/threonine-protein	0.844	0.430	0.497	1.8e-94
TAIR|locus:2141176	849	B120 [Arabidopsis thaliana (ta	0.791	0.402	0.521	4.8e-94
TAIR|locus:2200908	842	AT1G61610 [Arabidopsis thalian	0.784	0.402	0.544	6.1e-94
TAIR|locus:2141181	850	RK3 "receptor kinase 3" [Arabi	0.773	0.392	0.556	6.1e-94
TAIR|locus:2131684	783	AT4G27290 [Arabidopsis thalian	0.858	0.473	0.513	7.8e-94
TAIR|locus:2131694	815	AT4G27300 [Arabidopsis thalian	0.791	0.419	0.532	9e-93
TAIR|locus:2200151	830	SD1-13 "S-domain-1 13" [Arabid	0.777	0.404	0.536	1.1e-92

TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 939 (335.6 bits), Expect = 3.3e-96, Sum P(2) = 3.3e-96
 Identities = 188/350 (53%), Positives = 254/350 (72%)

Query:    90 EKEVDQFPLFSFSSVSSATGNFSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKSGQEI 148
             + E  + PL    ++++AT NFS  NKLG+GGFG VYKG +  G EIAVKRL   S Q  
Sbjct:   498 KSEYLELPLLELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAVKRLSKMSSQGT 557

Query:   149 KELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRT 208
              E  NE  +IA++QH NLV+LLGCC++K E++LIYEY+ N SLD  LFD T+   L+W+ 
Sbjct:   558 DEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQK 617

Query:   209 RVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDE 268
             R  II G+A+GLLYLHQ SR RIIHRDLKASN+LLDK+M  KISDFGMARI FG    +E
Sbjct:   618 RFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARI-FG---REE 673

Query:   269 LQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRT-KSLNLI 327
              + NT R+ GTYGYMSPEYA++GIFS+KSDVFSFGVLLLEI+SGK+N GFY + + LNL+
Sbjct:   674 TEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLL 733

Query:   328 GYAWDLWISNKIIDLIDSV-LEEAS--F-NESLSRYVHIALLCVQERAEDRPTMSDVVSM 383
             G+ W  W     ++++D + ++  S  F    + R + I LLCVQERAEDRP MS V+ M
Sbjct:   734 GFVWRHWKEGNELEIVDPINIDSLSSKFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVM 793

Query:   384 LTNEASSLLPPKQPAFCNLRN-MESSTSTTEKSWADCSINEVTVSILDAR 432
             L +E +++  PK+P FC  R+ +E+ +S++ +   +C++N++T+S++DAR
Sbjct:   794 LGSETTAIPQPKRPGFCIGRSPLEADSSSSTQRDDECTVNQITLSVIDAR 843

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0009875 "pollen-pistil interaction" evidence=TAS

GO:0016020 "membrane" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0019199 "transmembrane receptor protein kinase activity" evidence=ISS

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2093397 CES101 "CALLUS EXPRESSION OF RBCS 101" [Arabidopsis thaliana (taxid:3702)]

 Score = 954 (340.9 bits), Expect = 5.9e-96, P = 5.9e-96
 Identities = 192/359 (53%), Positives = 258/359 (71%)

Query:    80 EGNNKCKKGCEKEVDQFPLFSFSSVSSATGNFSAANKLGEGGFGTVYKGVIGQGE-IAVK 138
             E   + K+      ++  +FSF SV+ AT  FS ANKLGEGGFG VYKG +  GE +A+K
Sbjct:   496 ERRRRGKRSARNNNNELQIFSFESVAFATDYFSDANKLGEGGFGPVYKGRLIDGEEVAIK 555

Query:   139 RLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDP 198
             RL   SGQ + E KNEA +IA++QH NLVKLLGCC+EKDE++LIYEYMPNKSLD FLFDP
Sbjct:   556 RLSLASGQGLVEFKNEAMLIAKLQHTNLVKLLGCCVEKDEKMLIYEYMPNKSLDYFLFDP 615

Query:   199 TKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMAR 258
              ++ +LDW+ R +I++G+ QGLLYLH+YSR+++IHRD+KA NILLD+DMN KISDFGMAR
Sbjct:   616 LRKIVLDWKLRFRIMEGIIQGLLYLHKYSRLKVIHRDIKAGNILLDEDMNPKISDFGMAR 675

Query:   259 IVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGF 318
             I FG     E + NT R++GT+GYMSPEY  EG+FS KSDVFSFGVL+LEI+ G+KN  F
Sbjct:   676 I-FGAQ---ESKANTKRVAGTFGYMSPEYFREGLFSAKSDVFSFGVLMLEIICGRKNNSF 731

Query:   319 YRTKS--LNLIGYAWDLWISNKIIDLIDSVLEEASF-NESLSRYVHIALLCVQERAEDRP 375
             +      LNLI + W+L+  N++ ++ID  L +++  N  + R V +ALLCVQ+ A+DRP
Sbjct:   732 HHDSEGPLNLIVHVWNLFKENRVREVIDPSLGDSAVENPQVLRCVQVALLCVQQNADDRP 791

Query:   376 TMSDVVSMLTNEASSLLP-PKQPAFCNLRNMESSTSTTEK-SWADCSINEVTVSILDAR 432
             +M DVVSM+  + ++ L  PK+PAF +     S     E     + S N VT+++++AR
Sbjct:   792 SMLDVVSMIYGDGNNALSLPKEPAFYDGPPRSSPEMEVEPPEMENVSANRVTITVMEAR 850

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 951 (339.8 bits), Expect = 1.2e-95, P = 1.2e-95
 Identities = 193/353 (54%), Positives = 258/353 (73%)

Query:    90 EKEVD--QFPLFSFSSVSSATGNFSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKSGQ 146
             E + D  + PL  + +++ AT NFS  NKLG+GGFG VYKG++  G EIAVKRL   S Q
Sbjct:   500 ENKTDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSKMSSQ 559

Query:   147 EIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDW 206
                E  NE  +IA++QH NLV+LLGCC++K E++LIYEY+ N SLD  LFD T+   L+W
Sbjct:   560 GTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNW 619

Query:   207 RTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDE 266
             + R  II G+A+GLLYLHQ SR RIIHRDLKASN+LLDK+M  KISDFGMARI FG    
Sbjct:   620 QKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARI-FG---R 675

Query:   267 DELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRT-KSLN 325
             +E + NT R+ GTYGYMSPEYA++GIFS+KSDVFSFGVLLLEI+SGK+N GFY + + LN
Sbjct:   676 EETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLN 735

Query:   326 LIGYAWDLWISNKIIDLIDSVLEEASFNE----SLSRYVHIALLCVQERAEDRPTMSDVV 381
             L+G+ W  W   K ++++D +  +A  +E     + R + I LLCVQERAEDRP MS V+
Sbjct:   736 LLGFVWRHWKEGKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVMSSVM 795

Query:   382 SMLTNEASSLLPPKQPAFCNLRN-ME-SSTSTTEKSWADCSINEVTVSILDAR 432
              ML +E +++  PK+P FC  R+ +E  S+S+T++   +C++N+VT+S++DAR
Sbjct:   796 VMLGSETTAIPQPKRPGFCVGRSSLEVDSSSSTQRD-DECTVNQVTLSVIDAR 847

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0034613 "cellular protein localization" evidence=IGI

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

UNIPROTKB|O49974 KIK1 "Serine/threonine-protein kinase" [Zea mays (taxid:4577)]

 Score = 940 (336.0 bits), Expect = 1.8e-94, P = 1.8e-94
 Identities = 190/382 (49%), Positives = 265/382 (69%)

Query:    53 RRNTTNKGEDLMKFDLGMNLKVDVELTEGNNKCKKGCEKEVDQFPLFSFSSVSSATGNFS 112
             R ++T   ++    D+  +++ D ++ +G     K  E +V     +S   + +AT NFS
Sbjct:   482 RHSSTQSQQNSAMLDISQSIRFDDDVEDG-----KSHELKV-----YSLDRIRTATSNFS 531

Query:   113 AANKLGEGGFGTVYKGVIGQGE-IAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLG 171
              +NKLGEGGFG VY G +  GE +AVKRL   SGQ ++E KNE  +IA++QH+NLV+LLG
Sbjct:   532 DSNKLGEGGFGPVYMGTLPGGEEVAVKRLCRNSGQGLEEFKNEVILIAKLQHRNLVRLLG 591

Query:   172 CCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRI 231
             CCI ++E++L+YEYMPNKSLD FLF+P K+ +LDW+ R  II+G+A+GLLYLH+ SR+R+
Sbjct:   592 CCIPREEKILVYEYMPNKSLDAFLFNPEKQRLLDWKKRFDIIEGIARGLLYLHRDSRLRV 651

Query:   232 IHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEG 291
             +HRDLKASNILLD DM  KISDFGMAR+ FGG   D+ Q NT+R+ GT+GYMSPEYA+EG
Sbjct:   652 VHRDLKASNILLDADMKPKISDFGMARM-FGG---DQNQFNTNRVVGTFGYMSPEYAMEG 707

Query:   292 IFSIKSDVFSFGVLLLEIVSGKKNTGFY-RTKSLNLIGYAWDLWISNKIIDLIDSVLEEA 350
             IFS+KSDV+ FGVL+LEI++GK+   F+    SLN+ GYAW  W  +   +LID V+  +
Sbjct:   708 IFSVKSDVYGFGVLILEIITGKRAVSFHCHEDSLNIAGYAWRQWNEDNAAELIDPVIRAS 767

Query:   351 SFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQPAFCNLRNMESSTS 410
                  + R +HIALLCVQ+ A++RP +  V+ ML+N++SSL  P+ P    LR  E  +S
Sbjct:   768 CSVRQVLRCIHIALLCVQDHADERPDIPTVILMLSNDSSSLPNPRPPTLM-LRGREIESS 826

Query:   411 TTEKSWADCSINEVTVSILDAR 432
              + +     SI  VT++ L  R
Sbjct:   827 KSSEKDRSHSIGTVTMTQLHGR 848

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)]

 Score = 936 (334.5 bits), Expect = 4.8e-94, P = 4.8e-94
 Identities = 182/349 (52%), Positives = 250/349 (71%)

Query:    87 KGCEKEVDQFPLFSFSSVSSATGNFSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKSG 145
             +G      + P+FS ++++ AT +F   N+LG GGFG VYKGV+  G EIAVKRL GKSG
Sbjct:   505 EGKAVNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSG 564

Query:   146 QEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILD 205
             Q + E KNE  +IA++QH+NLV+LLGCC E +E++L+YEYMPNKSLD FLFD TK+ ++D
Sbjct:   565 QGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALID 624

Query:   206 WRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGND 265
             W+ R  II+G+A+GLLYLH+ SR+RIIHRDLK SN+LLD +MN KISDFGMARI FGGN 
Sbjct:   625 WKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARI-FGGNQ 683

Query:   266 EDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLN 325
              +    NT R+ GTYGYMSPEYA+EG+FS+KSDV+SFGVLLLEIVSGK+NT    ++  +
Sbjct:   684 NE---ANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSEHGS 740

Query:   326 LIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLT 385
             LIGYAW L+   +  +L+D  +          R +H+A+LCVQ+ A +RP M+ V+ ML 
Sbjct:   741 LIGYAWYLYTHGRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMASVLLMLE 800

Query:   386 NEASSLLPPKQPAFCNLR--NMESSTSTTEKSWADCSINEVTVSILDAR 432
             ++ ++L  P+QP F + R  +++ + +         S NE+T +++  R
Sbjct:   801 SDTATLAAPRQPTFTSTRRNSIDVNFALDSSQQYIVSSNEITSTVVLGR 849

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0006979 "response to oxidative stress" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)]

 Score = 935 (334.2 bits), Expect = 6.1e-94, P = 6.1e-94
 Identities = 189/347 (54%), Positives = 245/347 (70%)

Query:    88 GCEKEVDQFPLFSFSSVSSATGNFSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKSGQ 146
             G + +    P+FSF SV+SATG+F+  NKLG+GGFGTVYKG   +G EIAVKRL GKS Q
Sbjct:   502 GDQVDTPDLPIFSFDSVASATGDFAEENKLGQGGFGTVYKGNFSEGREIAVKRLSGKSKQ 561

Query:   147 EIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDW 206
              ++E KNE  +IA++QH+NLV+LLGCCIE +E++L+YEYMPNKSLD FLFD +K+  LDW
Sbjct:   562 GLEEFKNEILLIAKLQHRNLVRLLGCCIEDNEKMLLYEYMPNKSLDRFLFDESKQGSLDW 621

Query:   207 RTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDE 266
             R R ++I G+A+GLLYLH+ SR++IIHRDLKASNILLD +MN KISDFGMARI F    +
Sbjct:   622 RKRWEVIGGIARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKISDFGMARI-FNYRQD 680

Query:   267 DELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNL 326
                  NT R+ GTYGYM+PEYA+EGIFS KSDV+SFGVL+LEIVSG+KN  F  T   +L
Sbjct:   681 ---HANTIRVVGTYGYMAPEYAMEGIFSEKSDVYSFGVLILEIVSGRKNVSFRGTDHGSL 737

Query:   327 IGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN 386
             IGYAW LW   K  ++ID ++++        R +H+ +LC Q+    RP M  V+ ML +
Sbjct:   738 IGYAWHLWSQGKTKEMIDPIVKDTRDVTEAMRCIHVGMLCTQDSVIHRPNMGSVLLMLES 797

Query:   387 EASSLLPPKQPAFCNLRNMESSTSTTEKSWAD-CSINEVTVSILDAR 432
             + S L PP+QP F +  N  S          D  S+N+VT + +  R
Sbjct:   798 QTSQLPPPRQPTFHSFLN--SGDIELNFDGHDVASVNDVTFTTIVGR 842

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0009693 "ethylene biosynthetic process" evidence=RCA

TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 935 (334.2 bits), Expect = 6.1e-94, P = 6.1e-94
 Identities = 192/345 (55%), Positives = 249/345 (72%)

Query:    95 QFPLFSFSSVSSATGNFSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKSGQEIKELKN 153
             + PL  F  V+ AT NFS ANKLG+GGFG VYKG +  G E+AVKRL   S Q   E KN
Sbjct:   510 ELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMAVKRLSKTSVQGTDEFKN 569

Query:   154 EASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQII 213
             E  +IA++QH NLV+LL CC++  E++LIYEY+ N SLD  LFD ++   L+W+ R  II
Sbjct:   570 EVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRNSKLNWQMRFDII 629

Query:   214 KGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNT 273
              G+A+GLLYLHQ SR RIIHRDLKASNILLDK M  KISDFGMARI FG    DE + NT
Sbjct:   630 NGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARI-FG---RDETEANT 685

Query:   274 SRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRT-KSLNLIGYAWD 332
              ++ GTYGYMSPEYA++GIFS+KSDVFSFGVLLLEI+S K+N GFY + + LNL+G  W 
Sbjct:   686 RKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDRDLNLLGCVWR 745

Query:   333 LWISNKIIDLIDSVLEEAS--FNE-SLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS 389
              W   K +++ID ++ ++S  F +  + R + I LLCVQERAEDRPTMS V+ ML +E++
Sbjct:   746 NWKEGKGLEIIDPIITDSSSTFRQHEILRCIQIGLLCVQERAEDRPTMSLVILMLGSEST 805

Query:   390 SLLPPKQPAFCNLRNMESSTSTTEKSWADCS--INEVTVSILDAR 432
             ++  PK P +C  R++  + S++ K   D S  +N++TVS+LDAR
Sbjct:   806 TIPQPKAPGYCLERSLLDTDSSSSKQRDDESWTVNQITVSVLDAR 850

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0005773 "vacuole" evidence=IDA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0009506 "plasmodesma" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=RCA

TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)]

 Score = 934 (333.8 bits), Expect = 7.8e-94, P = 7.8e-94
 Identities = 196/382 (51%), Positives = 265/382 (69%)

Query:    54 RNTTNKGEDLMKFDLGMNLKVDVELTEGNNKCKKGCEKEVDQFPLFSFSSVSSATGNFSA 113
             R     G+DL    L  + +++    E +    +  E+E  + P     +VS AT  FSA
Sbjct:   410 REYNENGQDLY-VRLASS-EIETLQRESSRVSSRKQEEEDLELPFLDLDTVSEATSGFSA 467

Query:   114 ANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGC 172
              NKLG+GGFG VYKG +  G E+AVKRL   S Q ++E KNE  +IA++QH+NLVK+LG 
Sbjct:   468 GNKLGQGGFGPVYKGTLACGQEVAVKRLSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGY 527

Query:   173 CIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRII 232
             C++++ER+LIYEY PNKSLD F+FD  +R  LDW  RV+IIKG+A+G+LYLH+ SR+RII
Sbjct:   528 CVDEEERMLIYEYQPNKSLDSFIFDKERRRELDWPKRVEIIKGIARGMLYLHEDSRLRII 587

Query:   233 HRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGI 292
             HRDLKASN+LLD DMN+KISDFG+AR + GG   DE + NT+R+ GTYGYMSPEY ++G 
Sbjct:   588 HRDLKASNVLLDSDMNAKISDFGLARTL-GG---DETEANTTRVVGTYGYMSPEYQIDGY 643

Query:   293 FSIKSDVFSFGVLLLEIVSGKKNTGFYRTK-SLNLIGYAWDLWISNKIIDLIDSVLEEAS 351
             FS+KSDVFSFGVL+LEIVSG++N GF   +  LNL+G+AW  ++ +K  ++ID  + E+ 
Sbjct:   644 FSLKSDVFSFGVLVLEIVSGRRNRGFRNEEHKLNLLGHAWRQFLEDKAYEIIDEAVNESC 703

Query:   352 FNES-LSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQPAFCNLRNMESSTS 410
              + S + R +HI LLCVQ+  +DRP MS VV ML++E   LL P+QP F N RN+  S  
Sbjct:   704 TDISEVLRVIHIGLLCVQQDPKDRPNMSVVVLMLSSEML-LLDPRQPGFFNERNLLFS-D 761

Query:   411 TTEKSWADCSINEVTVSILDAR 432
             T   +    S N  T+S++D R
Sbjct:   762 TVSINLEIPSNNFQTMSVIDPR 783

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0048765 "root hair cell differentiation" evidence=RCA

TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)]

 Score = 924 (330.3 bits), Expect = 9.0e-93, P = 9.0e-93
 Identities = 189/355 (53%), Positives = 252/355 (70%)

Query:    81 GNNKCKKGCEKEVDQFPLFSFSSVSSATGNFSAANKLGEGGFGTVYKGVIGQG-EIAVKR 139
             G N  +KG E+E    P+F   ++S AT +FS  N LG GGFG VYKG +  G EIAVKR
Sbjct:   471 GEN-FRKGIEEEDLDLPIFDRKTISIATDDFSYVNFLGRGGFGPVYKGKLEDGQEIAVKR 529

Query:   140 LLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPT 199
             L   SGQ ++E KNE  +IA++QH+NLV+LLGCCI+ +E +LIYEYMPNKSLD F+FD  
Sbjct:   530 LSANSGQGVEEFKNEVKLIAKLQHRNLVRLLGCCIQGEECMLIYEYMPNKSLDFFIFDER 589

Query:   200 KREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARI 259
             +   LDW+ R+ II GVA+G+LYLHQ SR+RIIHRDLKA N+LLD DMN KISDFG+A+ 
Sbjct:   590 RSTELDWKKRMNIINGVARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGLAKS 649

Query:   260 VFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGF- 318
              FGG   D+ + +T+R+ GTYGYM PEYA++G FS+KSDVFSFGVL+LEI++GK N GF 
Sbjct:   650 -FGG---DQSESSTNRVVGTYGYMPPEYAIDGHFSVKSDVFSFGVLVLEIITGKTNRGFR 705

Query:   319 YRTKSLNLIGYAWDLWISNKIIDLIDSV-LEEASFNESLSRYVHIALLCVQERAEDRPTM 377
             +    LNL+G+ W +W+ ++ I++ +   LEE S    + R +H+ALLCVQ++ EDRPTM
Sbjct:   706 HADHDLNLLGHVWKMWVEDREIEVPEEEWLEETSVIPEVLRCIHVALLCVQQKPEDRPTM 765

Query:   378 SDVVSMLTNEASSLLPPKQPAFCNLRNMESSTSTTEKSWADCSINEVTVSILDAR 432
             + VV M  ++ SSL  P QP F   RN+   +S+        S NEV++++L  R
Sbjct:   766 ASVVLMFGSD-SSLPHPTQPGFFTNRNVPDISSSLSLR----SQNEVSITMLQGR 815

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0009506 "plasmodesma" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=RCA

TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)]

 Score = 923 (330.0 bits), Expect = 1.1e-92, P = 1.1e-92
 Identities = 184/343 (53%), Positives = 251/343 (73%)

Query:    92 EVDQFPLFSFSSVSSATGNFSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKSGQEIKE 150
             ++ + PLF F  ++ AT NFS  NKLG+GGFG VYKG + +G +IAVKRL   SGQ ++E
Sbjct:   493 KLKELPLFEFQVLAVATNNFSITNKLGQGGFGAVYKGRLQEGLDIAVKRLSRTSGQGVEE 552

Query:   151 LKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRV 210
               NE  VI+++QH+NLV+LLG CIE +ER+L+YE+MP   LD +LFDP K+ +LDW+TR 
Sbjct:   553 FVNEVVVISKLQHRNLVRLLGFCIEGEERMLVYEFMPENCLDAYLFDPVKQRLLDWKTRF 612

Query:   211 QIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQ 270
              II G+ +GL+YLH+ SR++IIHRDLKASNILLD+++N KISDFG+ARI F GN EDE+ 
Sbjct:   613 NIIDGICRGLMYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARI-FQGN-EDEV- 669

Query:   271 GNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRT-KSLNLIGY 329
              +T R+ GTYGYM+PEYA+ G+FS KSDVFS GV+LLEIVSG++N+ FY   ++ NL  Y
Sbjct:   670 -STVRVVGTYGYMAPEYAMGGLFSEKSDVFSLGVILLEIVSGRRNSSFYNDGQNPNLSAY 728

Query:   330 AWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS 389
             AW LW + + I L+D V+ E  F   + R VH+ LLCVQ+ A DRP+++ V+ ML++E S
Sbjct:   729 AWKLWNTGEDIALVDPVIFEECFENEIRRCVHVGLLCVQDHANDRPSVATVIWMLSSENS 788

Query:   390 SLLPPKQPAFCNLRNMESSTSTTEKSWADCSINEVTVSILDAR 432
             +L  PKQPAF   R   S   ++ +S    SIN V+++ +  R
Sbjct:   789 NLPEPKQPAFIPRRGT-SEVESSGQSDPRASINNVSLTKITGR 830

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=RCA;IDA

GO:0009637 "response to blue light" evidence=RCA

GO:0010155 "regulation of proton transport" evidence=RCA

GO:0016556 "mRNA modification" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.824
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00003111001 SubName- Full=Chromosome undetermined scaffold_139, whole genome shotgun sequence; (827 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	432
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-59
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	4e-58
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	6e-58
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	9e-58
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	9e-50
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-45
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	5e-44
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-41
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-38
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	6e-38
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-35
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	8e-35
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	6e-33
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-32
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	5e-32
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	9e-32
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	9e-32
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-31
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-31
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-30
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-30
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	4e-30
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	4e-30
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	4e-30
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-29
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	5e-29
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	9e-29
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-28
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-28
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-28
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	4e-28
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	4e-28
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-27
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-27
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	3e-27
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	6e-27
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	7e-27
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	7e-27
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-26
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-26
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	3e-26
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	4e-26
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	4e-26
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	8e-26
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-25
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	9e-25
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	9e-25
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-24
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-24
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-24
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-24
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	3e-24
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	4e-24
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	7e-24
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	7e-24
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-23
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-23
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-23
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-23
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-23
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-23
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-23
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-23
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-23
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	6e-23
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	7e-23
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	7e-23
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	9e-23
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-22
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-22
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-22
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-22
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	3e-22
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	4e-22
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	5e-22
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	6e-22
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	9e-22
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-21
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-21
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-21
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-21
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-21
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-21
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	4e-21
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	4e-21
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	4e-21
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	6e-21
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	7e-21
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-20
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-20
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-20
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	4e-20
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	4e-20
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	5e-20
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	5e-20
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	5e-20
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	5e-20
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	5e-20
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	7e-20
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	7e-20
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	9e-20
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-19
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-19
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-19
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-19
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-19
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-19
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	3e-19
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	4e-19
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	5e-19
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	6e-19
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	6e-19
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	8e-19
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-18
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-18
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-18
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-18
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-18
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-18
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-18
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-18
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	4e-18
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	4e-18
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	5e-18
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	5e-18
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	5e-18
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	6e-18
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	6e-18
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	6e-18
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	7e-18
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	7e-18
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	7e-18
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	7e-18
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-17
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-17
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	4e-17
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	5e-17
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	9e-17
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-16
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-16
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-16
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-16
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-16
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-16
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-16
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	4e-16
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	4e-16
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	4e-16
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	5e-16
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	5e-16
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	6e-16
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	7e-16
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	8e-16
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	8e-16
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-15
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-15
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-15
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-15
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-15
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-15
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	3e-15
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	4e-15
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	6e-15
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	6e-15
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	8e-15
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	9e-15
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-14
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-14
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-14
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	4e-14
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	4e-14
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	6e-14
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	8e-14
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	8e-14
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	8e-14
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	9e-14
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-13
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-13
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-13
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-13
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-13
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-13
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-13
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-13
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	3e-13
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	5e-13
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	6e-13
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	6e-13
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	7e-13
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	7e-13
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	8e-13
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	9e-13
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	9e-13
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	9e-13
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-12
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-12
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-12
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-12
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	3e-12
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	4e-12
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	4e-12
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	4e-12
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	5e-12
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	6e-12
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	8e-12
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	9e-12
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	9e-12
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-11
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-11
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-11
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-11
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-11
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-11
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-11
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-11
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-11
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-11
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-11
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-11
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-11
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-11
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	4e-11
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	5e-11
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	5e-11
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	7e-11
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	8e-11
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	9e-11
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	9e-11
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-10
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-10
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-10
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-10
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-10
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-10
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-10
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-10
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	5e-10
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	5e-10
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	5e-10
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	8e-10
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	9e-10
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-09
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-09
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-09
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-09
pfam11883	48	pfam11883, DUF3403, Domain of unknown function (DU	2e-09
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	3e-09
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	3e-09
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	3e-09
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-09
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	4e-09
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	4e-09
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	5e-09
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	5e-09
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	5e-09
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	6e-09
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	7e-09
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	8e-09
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	8e-09
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	8e-09
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-08
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-08
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-08
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-08
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-08
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	3e-08
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	4e-08
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	4e-08
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	5e-08
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	5e-08
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	5e-08
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	6e-08
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	7e-08
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	7e-08
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-07
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-07
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-07
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-07
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-07
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-07
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-07
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	2e-07
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-07
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	3e-07
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	3e-07
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	4e-07
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	5e-07
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	6e-07
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	7e-07
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	9e-07
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	9e-07
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	1e-06
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-06
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-06
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-06
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-06
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	3e-06
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	4e-06
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	4e-06
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	4e-06
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	7e-06
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	7e-06
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	3e-05
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	1e-04
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	1e-04
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-04
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	3e-04
PRK09605	535	PRK09605, PRK09605, bifunctional UGMP family prote	8e-04
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	0.001
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	0.003
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	0.004

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  194 bits (496), Expect = 2e-59
 Identities = 94/285 (32%), Positives = 137/285 (48%), Gaps = 37/285 (12%)

Query: 115 NKLGEGGFGTVYKGVIGQG-----EIAVKRL-LGKSGQEIKELKNEASVIAQVQHKNLVK 168
            KLGEG FG VYKG +        E+AVK L    S +E K+   EA V+ ++ H N+V+
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFL------FDPTKREILDWRTRVQIIKGVAQGLLY 222
           LLG C E++   L+ EYM    L  +L      F   ++  L  +  +     +A+G+ Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 223 LHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGY 282
           L      + +HRDL A N L+ +D+  KISDFG++R V+  +   +  G    I     +
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR----W 173

Query: 283 MSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIID 341
           M+PE   +GIF+ KSDV+SFGVLL EI + G      Y   S           +   +  
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATP---YPGLSNE--------EVLEYLRK 222

Query: 342 LIDSVLEEASFNESLSRYVH-IALLCVQERAEDRPTMSDVVSMLT 385
                L      E     ++ + L C Q   EDRPT S++V  L 
Sbjct: 223 --GYRLP---KPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  191 bits (487), Expect = 4e-58
 Identities = 92/281 (32%), Positives = 141/281 (50%), Gaps = 40/281 (14%)

Query: 116 KLGEGGFGTVYKGVIGQG------EIAVKRLL-GKSGQEIKELKNEASVIAQVQHKNLVK 168
           KLGEG FG VYKG +         E+AVK L    S Q+I+E   EA ++ ++ H N+VK
Sbjct: 6   KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65

Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSR 228
           LLG C E++  +++ EYMP   L  +L    + + L     +     +A+G+ YL     
Sbjct: 66  LLGVCTEEEPLMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQIARGMEYLE---S 121

Query: 229 VRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYA 288
              IHRDL A N L+ +++  KISDFG++R ++   D+D  +    ++     +M+PE  
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLY---DDDYYKVKGGKL--PIRWMAPESL 176

Query: 289 LEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVL 347
            EG F+ KSDV+SFGVLL EI + G++    Y   S                 +++   L
Sbjct: 177 KEGKFTSKSDVWSFGVLLWEIFTLGEE---PYPGMSN---------------AEVL-EYL 217

Query: 348 EEASFNESLSR----YVHIALLCVQERAEDRPTMSDVVSML 384
           ++                + L C  E  EDRPT S++V +L
Sbjct: 218 KKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  190 bits (485), Expect = 6e-58
 Identities = 90/290 (31%), Positives = 141/290 (48%), Gaps = 58/290 (20%)

Query: 116 KLGEGGFGTVYKGVI------GQGEIAVKRLL-GKSGQEIKELKNEASVIAQVQHKNLVK 168
           KLGEG FG VYKG +       + ++AVK L  G S +E +E   EAS++ ++ H N+V+
Sbjct: 6   KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65

Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSR 228
           LLG C + +   ++ EYMP   L  FL      E L  +  +Q+   +A+G+ YL     
Sbjct: 66  LLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYLE---S 120

Query: 229 VRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYA 288
              +HRDL A N L+ +++  KISDFG++R ++   D+   +    ++     +M+PE  
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIY--EDDYYRKRGGGKLP--IKWMAPESL 176

Query: 289 LEGIFSIKSDVFSFGVLLLEIVS-------GKKNTGFYRTKSLNLIGYAWDLWISNKIID 341
            +G F+ KSDV+SFGVLL EI +       G  N                      ++++
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNE---------------------EVLE 215

Query: 342 LIDSVLEEASFNESLSRYVH-------IALLCVQERAEDRPTMSDVVSML 384
           L++           L R  +       + L C     EDRPT S++V  L
Sbjct: 216 LLED-------GYRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  190 bits (484), Expect = 9e-58
 Identities = 92/281 (32%), Positives = 137/281 (48%), Gaps = 41/281 (14%)

Query: 116 KLGEGGFGTVYKGVIGQG------EIAVKRLL-GKSGQEIKELKNEASVIAQVQHKNLVK 168
           KLGEG FG VYKG +         E+AVK L    S Q+I+E   EA ++ ++ H N+VK
Sbjct: 6   KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65

Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSR 228
           LLG C E++   ++ EYM    L  +L     R  L     +     +A+G+ YL     
Sbjct: 66  LLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE---S 120

Query: 229 VRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYA 288
              IHRDL A N L+ +++  KISDFG++R ++   D+D  +    ++     +M+PE  
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLY---DDDYYRKRGGKL--PIRWMAPESL 175

Query: 289 LEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVL 347
            EG F+ KSDV+SFGVLL EI + G++    Y   S                 +++   L
Sbjct: 176 KEGKFTSKSDVWSFGVLLWEIFTLGEQ---PYPGMSN---------------EEVL-EYL 216

Query: 348 EEASFNESLSR----YVHIALLCVQERAEDRPTMSDVVSML 384
           +                 + L C  E  EDRPT S++V +L
Sbjct: 217 KNGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  167 bits (426), Expect = 9e-50
 Identities = 70/198 (35%), Positives = 107/198 (54%), Gaps = 16/198 (8%)

Query: 117 LGEGGFGTVYKGVIGQG--EIAVKRL-LGKSGQEIKELKNEASVIAQVQHKNLVKLLGCC 173
           LGEGGFGTVY     +   ++A+K +    S   ++EL  E  ++ ++ H N+VKL G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
            +++   L+ EY    SL   L +   +  L     ++I+  + +GL YLH      IIH
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGK--LSEDEILRILLQILEGLEYLHS---NGIIH 115

Query: 234 RDLKASNILLDKDMNS-KISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL-EG 291
           RDLK  NILLD D    K++DFG+++++               I GT  YM+PE  L +G
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSL------LKTIVGTPAYMAPEVLLGKG 169

Query: 292 IFSIKSDVFSFGVLLLEI 309
            +S KSD++S GV+L E+
Sbjct: 170 YYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  157 bits (398), Expect = 3e-45
 Identities = 72/203 (35%), Positives = 109/203 (53%), Gaps = 17/203 (8%)

Query: 116 KLGEGGFGTVYKGV-IGQGEI-AVKRL--LGKSGQEIKELKNEASVIAQVQHKNLVKLLG 171
           KLG G FGTVYK    G G+I AVK L    +  ++ +  + E  ++ ++ H N+V+L+ 
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 172 CCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRI 231
              +KD   L+ EY     L  +L   ++   L      +I   + +GL YLH      I
Sbjct: 66  AFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLHSN---GI 119

Query: 232 IHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEG 291
           IHRDLK  NILLD++   KI+DFG+A+ +   +       + +   GT  YM+PE  L G
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSS------SSLTTFVGTPWYMAPEVLLGG 173

Query: 292 I-FSIKSDVFSFGVLLLEIVSGK 313
             +  K DV+S GV+L E+++GK
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGK 196

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  153 bits (390), Expect = 5e-44
 Identities = 65/202 (32%), Positives = 103/202 (50%), Gaps = 16/202 (7%)

Query: 115 NKLGEGGFGTVYKGV-IGQGEI-AVKRL-LGKSGQEIKELKNEASVIAQVQHKNLVKLLG 171
            KLGEG FG VY       G++ A+K +   K  ++ + +  E  ++ +++H N+V+L  
Sbjct: 5   EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64

Query: 172 CCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRI 231
              ++D+  L+ EY     L   L    KR  L        ++ +   L YLH      I
Sbjct: 65  VFEDEDKLYLVMEYCEGGDLFDLL---KKRGRLSEDEARFYLRQILSALEYLHSK---GI 118

Query: 232 IHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEG 291
           +HRDLK  NILLD+D + K++DFG+AR +  G          +   GT  YM+PE  L  
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPG-------EKLTTFVGTPEYMAPEVLLGK 171

Query: 292 IFSIKSDVFSFGVLLLEIVSGK 313
            +    D++S GV+L E+++GK
Sbjct: 172 GYGKAVDIWSLGVILYELLTGK 193

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  147 bits (374), Expect = 2e-41
 Identities = 86/291 (29%), Positives = 137/291 (47%), Gaps = 33/291 (11%)

Query: 115 NKLGEGGFGTVYKGVI-----GQGE-IAVKRLLGKSG-QEIKELKNEASVIAQVQHKNLV 167
            +LGEG FG V            GE +AVK L      Q   + + E  ++  + H+N+V
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 168 KLLGCCIEKDER--LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ 225
           K  G C +   R   LI EY+P+ SL  +L     R+ ++ +  +     + +G+ YL  
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLGS 127

Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
               R IHRDL A NIL++ +   KISDFG+A+++    D+D         S  + Y +P
Sbjct: 128 Q---RYIHRDLAARNILVESEDLVKISDFGLAKVL--PEDKDYYYVKEPGESPIFWY-AP 181

Query: 286 EYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDS 345
           E      FS  SDV+SFGV L E+ +    +     + L +IG A    I  ++++L   
Sbjct: 182 ECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL--- 238

Query: 346 VLEEASFNESLSR--------YVHIALLCVQERAEDRPTMSDVVSMLTNEA 388
            L+E    E L R        Y  +  LC +   +DRP+ +D++ ++    
Sbjct: 239 -LKE---GERLPRPPSCPDEVY-DLMKLCWEAEPQDRPSFADLILIVDRLR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  139 bits (353), Expect = 2e-38
 Identities = 66/210 (31%), Positives = 107/210 (50%), Gaps = 26/210 (12%)

Query: 115 NKLGEGGFGTVYKG--VIGQGEIAVK--RLLGKSGQEIKELKNEASVIAQVQHKNLVKLL 170
             LG G FG+VY          +AVK   L G S +E++ L+ E  +++ +QH N+V+  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 171 GCCIEKDER-LLIY-EYMPNKSLDCFL-----FDPTKREILDWRTRVQIIKGVAQGLLYL 223
           G   ++++  L I+ EY+   SL   L            I  + TR QI+    +GL YL
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEP--VIRKY-TR-QIL----EGLAYL 117

Query: 224 HQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYM 283
           H      I+HRD+K +NIL+D D   K++DFG A+ +     + E    T  + GT  +M
Sbjct: 118 H---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRL----GDIETGEGTGSVRGTPYWM 170

Query: 284 SPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           +PE      +   +D++S G  ++E+ +GK
Sbjct: 171 APEVIRGEEYGRAADIWSLGCTVIEMATGK 200

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  137 bits (348), Expect = 6e-38
 Identities = 62/212 (29%), Positives = 107/212 (50%), Gaps = 28/212 (13%)

Query: 111 FSAANKLGEGGFGTVYKG--VIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
           F    K+G+GGFG VYK        E+A+K +  +S ++ +++ NE  ++ + +H N+VK
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRV-------QIIKGVAQGLL 221
             G  ++KDE  ++ E+    SL         +++L    +         + K + +GL 
Sbjct: 62  YYGSYLKKDELWIVMEFCSGGSL---------KDLLKSTNQTLTESQIAYVCKELLKGLE 112

Query: 222 YLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYG 281
           YLH      IIHRD+KA+NILL  D   K+ DFG++  +      +        + GT  
Sbjct: 113 YLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN-------TMVGTPY 162

Query: 282 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           +M+PE      +  K+D++S G+  +E+  GK
Sbjct: 163 WMAPEVINGKPYDYKADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  131 bits (331), Expect = 2e-35
 Identities = 76/201 (37%), Positives = 111/201 (55%), Gaps = 19/201 (9%)

Query: 116 KLGEGGFGTVYKGV-IGQGEIAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNLVKLLGCC 173
           KLG G FG V+ G   G  ++AVK L  K G    E    EA ++ +++H  LV+L   C
Sbjct: 13  KLGAGQFGEVWMGTWNGTTKVAVKTL--KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVC 70

Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
            E++   ++ EYM   SL  FL     ++ L     V +   +A+G+ YL        IH
Sbjct: 71  SEEEPIYIVTEYMSKGSLLDFLKSGEGKK-LRLPQLVDMAAQIAEGMAYLE---SRNYIH 126

Query: 234 RDLKASNILLDKDMNSKISDFGMARIVFGGNDEDEL---QGNTSRISGTYGYMSPEYALE 290
           RDL A NIL+ +++  KI+DFG+AR++    ++DE    +G    I  T    +PE A  
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARLI----EDDEYTAREGAKFPIKWT----APEAANY 178

Query: 291 GIFSIKSDVFSFGVLLLEIVS 311
           G F+IKSDV+SFG+LL EIV+
Sbjct: 179 GRFTIKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  130 bits (328), Expect = 8e-35
 Identities = 75/210 (35%), Positives = 119/210 (56%), Gaps = 26/210 (12%)

Query: 117 LGEGGFGTVYKGV-IGQGE-----IAVKRLLGKSGQE-IKELKNEASVIAQVQHKNLVKL 169
           LG G FGTVYKGV I +GE     +A+K L  ++  +  KE+ +EA V+A V H ++V+L
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 170 LGCCIEKDERLLIYEYMPNKSLDCFLFDPTKR----EILDWRTRVQIIKGVAQGLLYLHQ 225
           LG C+   +  LI + MP   L  ++ +         +L+W   VQI    A+G+ YL +
Sbjct: 75  LGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWC--VQI----AKGMSYLEE 127

Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
               R++HRDL A N+L+    + KI+DFG+A+++     E   +G    I     +M+ 
Sbjct: 128 ---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIK----WMAL 180

Query: 286 EYALEGIFSIKSDVFSFGVLLLEIVS-GKK 314
           E  L  I++ KSDV+S+GV + E+++ G K
Sbjct: 181 ESILHRIYTHKSDVWSYGVTVWELMTFGAK 210

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  124 bits (313), Expect = 6e-33
 Identities = 65/195 (33%), Positives = 100/195 (51%), Gaps = 14/195 (7%)

Query: 117 LGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEK 176
           +G+G FG V  G     ++AVK L   S    +    EASV+  ++H NLV+LLG  ++ 
Sbjct: 14  IGKGEFGDVMLGDYRGQKVAVKCLKDDSTA-AQAFLAEASVMTTLRHPNLVQLLGVVLQG 72

Query: 177 DERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDL 236
           +   ++ EYM   SL  +L     R ++    ++     V +G+ YL +      +HRDL
Sbjct: 73  NPLYIVTEYMAKGSLVDYL-RSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDL 128

Query: 237 KASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIK 296
            A N+L+ +D+ +K+SDFG+A+                 +  T    +PE   E  FS K
Sbjct: 129 AARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWT----APEALREKKFSTK 179

Query: 297 SDVFSFGVLLLEIVS 311
           SDV+SFG+LL EI S
Sbjct: 180 SDVWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  124 bits (313), Expect = 1e-32
 Identities = 74/219 (33%), Positives = 112/219 (51%), Gaps = 34/219 (15%)

Query: 117 LGEGGFGTVYKG-VIGQGE------IAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVK 168
           LGEG FG VYKG + G  E      +A+K L      +  +E + EA +++ +QH N+V 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFLF-------------DPTKREILDWRTRVQIIKG 215
           LLG C ++    +++EY+ +  L  FL              D T +  LD    + I   
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 216 VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTS- 274
           +A G+ YL   S    +HRDL A N L+ + +  KISDFG++R ++   D   +Q  +  
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSA-DYYRVQSKSLL 188

Query: 275 --RISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
             R      +M PE  L G F+ +SD++SFGV+L EI S
Sbjct: 189 PVR------WMPPEAILYGKFTTESDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  122 bits (307), Expect = 5e-32
 Identities = 88/285 (30%), Positives = 130/285 (45%), Gaps = 44/285 (15%)

Query: 115 NKLGEGGFGTVYKGVI-----GQGEIAVKRLL-GKSGQEIKELKNEASVIAQVQHKNLVK 168
            +LG G FG+V KGV       + E+AVK L         KE   EASV+AQ+ H  +V+
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFLFDP---TKREILDWRTRVQIIKGVAQGLLYLHQ 225
           L+G C   +  +L+ E  P   L  +L         ++ +   +V      A G+ YL  
Sbjct: 61  LIGVCKG-EPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV------AMGMAYLES 113

Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY--GYM 283
                 +HRDL A N+LL     +KISDFGM+R +  G+D        +  +G +   + 
Sbjct: 114 ---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY-----YRATTAGRWPLKWY 165

Query: 284 SPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIIDL 342
           +PE    G FS KSDV+S+GV L E  S G K    Y                  ++I +
Sbjct: 166 APECINYGKFSSKSDVWSYGVTLWEAFSYGAKP---YGEMK------------GAEVIAM 210

Query: 343 IDSVLEEASFNESLSRYVH-IALLCVQERAEDRPTMSDVVSMLTN 386
           ++S        E   + ++ I L C + R EDRPT S++ S    
Sbjct: 211 LESGERLPRPEEC-PQEIYSIMLSCWKYRPEDRPTFSELESTFRR 254

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  121 bits (306), Expect = 9e-32
 Identities = 88/283 (31%), Positives = 142/283 (50%), Gaps = 47/283 (16%)

Query: 117 LGEGGFGTVYKGVI---GQGEI--AVKRL-LGKSGQEIKELKNEASVIAQVQHKNLVKLL 170
           +G G FG V +G +   G+ EI  A+K L  G S ++  +   EAS++ Q  H N+++L 
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71

Query: 171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVR 230
           G   +    ++I EYM N SLD FL +            V +++G+A G+ YL   S + 
Sbjct: 72  GVVTKSRPVMIITEYMENGSLDKFLRE--NDGKFTVGQLVGMLRGIASGMKYL---SEMN 126

Query: 231 IIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE 290
            +HRDL A NIL++ ++  K+SDFG++R +         +G    I  T    +PE    
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT----APEAIAY 182

Query: 291 GIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEE 349
             F+  SDV+SFG+++ E++S G++    Y           WD+  SN+  D+I +V  E
Sbjct: 183 RKFTSASDVWSFGIVMWEVMSYGERP---Y-----------WDM--SNQ--DVIKAV--E 222

Query: 350 ASFN--------ESLSRYVHIALLCVQERAEDRPTMSDVVSML 384
             +          +L +   + L C Q+   +RPT S +VS L
Sbjct: 223 DGYRLPPPMDCPSALYQ---LMLDCWQKDRNERPTFSQIVSTL 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  121 bits (305), Expect = 9e-32
 Identities = 68/202 (33%), Positives = 111/202 (54%), Gaps = 11/202 (5%)

Query: 111 FSAANKLGEGGFGTVYKGV-IGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKL 169
           F+   KLG G FG V++G+   +  +A+K L      + ++ + E   + +++HK+L+ L
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67

Query: 170 LGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRV 229
              C   +   +I E M   SL  FL  P  + +L   + + +   VA+G+ YL +    
Sbjct: 68  FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQ-VLPVASLIDMACQVAEGMAYLEEQ--- 123

Query: 230 RIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL 289
             IHRDL A NIL+ +D+  K++DFG+AR++     ED    +  +I   Y + +PE A 
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLI----KEDVYLSSDKKIP--YKWTAPEAAS 177

Query: 290 EGIFSIKSDVFSFGVLLLEIVS 311
            G FS KSDV+SFG+LL E+ +
Sbjct: 178 HGTFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  120 bits (303), Expect = 1e-31
 Identities = 73/200 (36%), Positives = 107/200 (53%), Gaps = 13/200 (6%)

Query: 116 KLGEGGFGTVYKGVI-GQGEIAVK--RLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGC 172
           K+G+G FG VYKGV+ G  E+AVK  R       + K L+ EA ++ Q  H N+VKL+G 
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQ-EAEILKQYDHPNIVKLIGV 60

Query: 173 CIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRII 232
           C++K    ++ E +P  SL  FL     R  L  +  +Q+    A G+ YL   +    I
Sbjct: 61  CVQKQPIYIVMELVPGGSLLTFLRKKKNR--LTVKKLLQMSLDAAAGMEYLESKN---CI 115

Query: 233 HRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGI 292
           HRDL A N L+ ++   KISDFGM+R   GG     +     +I     + +PE    G 
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSREEEGG--IYTVSDGLKQIP--IKWTAPEALNYGR 171

Query: 293 FSIKSDVFSFGVLLLEIVSG 312
           ++ +SDV+S+G+LL E  S 
Sbjct: 172 YTSESDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  120 bits (303), Expect = 3e-31
 Identities = 74/222 (33%), Positives = 111/222 (50%), Gaps = 35/222 (15%)

Query: 117 LGEGGFGTVYKGVIGQGE-------IAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNLVK 168
           LGEG FG V+ G     E       +AVK L   +  + ++  + EA ++   QH+N+VK
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFL------------FDPTKREILDWRTRVQIIKGV 216
             G C E D  ++++EYM +  L+ FL             D    E L     +QI   +
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGE-LTLSQLLQIAVQI 131

Query: 217 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTS-- 274
           A G++YL   +    +HRDL   N L+  D+  KI DFGM+R V+   D   + G+T   
Sbjct: 132 ASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVY-TTDYYRVGGHTMLP 187

Query: 275 -RISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKK 314
            R      +M PE  +   F+ +SDV+SFGV+L EI + GK+
Sbjct: 188 IR------WMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQ 223

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  121 bits (303), Expect = 1e-30
 Identities = 75/275 (27%), Positives = 122/275 (44%), Gaps = 15/275 (5%)

Query: 116 KLGEGGFGTVYKGVIGQGEIAVKRLLGK---SGQEIKELKNEASVIAQVQH-KNLVKLLG 171
           KLGEG FG VY     +  +A+K L  K     +E++    E  ++A + H  N+VKL  
Sbjct: 7   KLGEGSFGEVYLARDRK-LVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65

Query: 172 CCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRI 231
              ++    L+ EY+   SL+  L    ++  L     + I+  +   L YLH      I
Sbjct: 66  FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGI 122

Query: 232 IHRDLKASNILLDKDMN-SKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL- 289
           IHRD+K  NILLD+D    K+ DFG+A+++        +    S   GT GYM+PE  L 
Sbjct: 123 IHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLG 182

Query: 290 --EGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVL 347
                 S  SD++S G+ L E+++G     F   K+ +         I       + S L
Sbjct: 183 LSLAYASSSSDIWSLGITLYELLTGL--PPFEGEKNSSATSQTLK-IILELPTPSLASPL 239

Query: 348 EEASFNESLSRYVHIALLCVQERAEDRPTMSDVVS 382
             ++          +    + +  ++R + S  +S
Sbjct: 240 SPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274

Length = 384

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  118 bits (297), Expect = 1e-30
 Identities = 64/214 (29%), Positives = 108/214 (50%), Gaps = 28/214 (13%)

Query: 110 NFSAANKLGEGGFGTVYKGV-IGQGEI-AVKR--LLGKSGQEIKELKNEASVIAQVQHKN 165
           N+   + +G G FG VYKG+ +  G+  A+K+  L     + +K +  E  ++  ++H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQ------IIKGVAQG 219
           +VK +G     D   +I EY  N SL         R+I+              +  V QG
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSL---------RQIIKKFGPFPESLVAVYVYQVLQG 111

Query: 220 LLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGT 279
           L YLH+     +IHRD+KA+NIL  KD   K++DFG+A  +      +++  + + + GT
Sbjct: 112 LAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKL------NDVSKDDASVVGT 162

Query: 280 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
             +M+PE       S  SD++S G  ++E+++G 
Sbjct: 163 PYWMAPEVIEMSGASTASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  117 bits (294), Expect = 4e-30
 Identities = 79/213 (37%), Positives = 111/213 (52%), Gaps = 25/213 (11%)

Query: 117 LGEGGFGTVYKGV------IGQGEI--AVKRLL-GKSGQEIKELKNEASVIAQVQHKNLV 167
           LG G FG VY+G        G G I  AVK L  G + QE KE   EA +++   H N+V
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 168 KLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKRE----ILDWRTRVQIIKGVAQGLLYL 223
           KLLG C+  + + +I E M    L  +L D         +L  +  + I   VA+G +YL
Sbjct: 63  KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122

Query: 224 HQYSRVRIIHRDLKASNILL-----DKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
            Q   +  IHRDL A N L+     D D   KI DFG+AR ++  +D    +G       
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIY-KSDYYRKEGEGLL--- 175

Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
              +M+PE  L+G F+ +SDV+SFGVL+ EI++
Sbjct: 176 PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  117 bits (294), Expect = 4e-30
 Identities = 70/198 (35%), Positives = 106/198 (53%), Gaps = 13/198 (6%)

Query: 116 KLGEGGFGTVYKGVI-GQGEIAVKRLLGKSG-QEIKELKNEASVIAQVQHKNLVKLLGCC 173
           KLG G FG V++G+      +AVK L  K G  + K+   EA ++ +++H  L++L   C
Sbjct: 13  KLGAGQFGEVWEGLWNNTTPVAVKTL--KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVC 70

Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
             ++   ++ E M   SL  +L     R  L     + +   VA G+ YL   +    IH
Sbjct: 71  TLEEPIYIVTELMKYGSLLEYLQGGAGRA-LKLPQLIDMAAQVASGMAYLEAQN---YIH 126

Query: 234 RDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIF 293
           RDL A N+L+ ++   K++DFG+AR V   +  +  +G    I  T    +PE AL   F
Sbjct: 127 RDLAARNVLVGENNICKVADFGLAR-VIKEDIYEAREGAKFPIKWT----APEAALYNRF 181

Query: 294 SIKSDVFSFGVLLLEIVS 311
           SIKSDV+SFG+LL EIV+
Sbjct: 182 SIKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  117 bits (294), Expect = 4e-30
 Identities = 80/301 (26%), Positives = 130/301 (43%), Gaps = 72/301 (23%)

Query: 117 LGEGGFGTVYKGVI-------GQGEIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVK 168
           LG+G FG VY+G+         +  +A+K +    S +E  E  NEASV+ +    ++V+
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 169 LLGCCIEKDERLLIYEYM-------------PNKSLDCFLFDPTKREILDWRTRVQIIKG 215
           LLG        L++ E M             P    +  L  PT ++ +      +I  G
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMA--AEIADG 131

Query: 216 VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR 275
           +A    YL      + +HRDL A N ++ +D+  KI DFGM R ++        + +  R
Sbjct: 132 MA----YLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIY--------ETDYYR 176

Query: 276 ISGT----YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-------GKKNTGFYRTKSL 324
             G       +M+PE   +G+F+ KSDV+SFGV+L E+ +       G  N      + L
Sbjct: 177 KGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN-----EEVL 231

Query: 325 NLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVH-IALLCVQERAEDRPTMSDVVSM 383
             +       I    +DL           E+    +  +  +C Q   + RPT  ++VS 
Sbjct: 232 KFV-------IDGGHLDL----------PENCPDKLLELMRMCWQYNPKMRPTFLEIVSS 274

Query: 384 L 384
           L
Sbjct: 275 L 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  115 bits (291), Expect = 1e-29
 Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 18/203 (8%)

Query: 116 KLGEGGFGTVYKGV-IGQGEI-AVKRLLGKSGQEI-KELKNEASVIAQVQHKNLVKLLGC 172
            LG+G  G VYK      G+I A+K++     +E  K+L  E   +   +   +VK  G 
Sbjct: 8   VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67

Query: 173 CIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRV--QIIKGVAQGLLYLHQYSRVR 230
             ++ E  ++ EYM   SL   L     +++      V   I + + +GL YLH      
Sbjct: 68  FYKEGEISIVLEYMDGGSLADLL-----KKVGKIPEPVLAYIARQILKGLDYLHTKRH-- 120

Query: 231 IIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE 290
           IIHRD+K SN+L++     KI+DFG+++++     E+ L    + + GT  YMSPE    
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGISKVL-----ENTLDQCNTFV-GTVTYMSPERIQG 174

Query: 291 GIFSIKSDVFSFGVLLLEIVSGK 313
             +S  +D++S G+ LLE   GK
Sbjct: 175 ESYSYAADIWSLGLTLLECALGK 197

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  113 bits (286), Expect = 5e-29
 Identities = 74/281 (26%), Positives = 125/281 (44%), Gaps = 43/281 (15%)

Query: 115 NKLGEGGFGTVYKGVIGQ-GEI-AVKR--LLGKSGQEIKELKNEASVIAQVQHKNLVKLL 170
            ++G+G FG VY       G++  +K   L   S +E ++  NE  ++ ++ H N++K  
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65

Query: 171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKR-------EILDWRTRVQIIKGVAQGLLYL 223
               EK +  ++ EY     L   +    K        +ILDW   VQ+       L YL
Sbjct: 66  ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWF--VQL----CLALKYL 119

Query: 224 HQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYM 283
           H  SR +I+HRD+K  NI L  +   K+ DFG+++++            T  + GT  Y+
Sbjct: 120 H--SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVL----SSTVDLAKT--VVGTPYYL 170

Query: 284 SPEYALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDL 342
           SPE   +   ++ KSD++S G +L E+ + K    F     L L      L I       
Sbjct: 171 SPE-LCQNKPYNYKSDIWSLGCVLYELCTLKH--PFEGENLLELA-----LKILKGQYPP 222

Query: 343 IDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM 383
           I S      ++  L   V      +Q+  E+RP+++ ++  
Sbjct: 223 IPS-----QYSSELRNLVSS---LLQKDPEERPSIAQILQS 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  113 bits (284), Expect = 9e-29
 Identities = 67/199 (33%), Positives = 111/199 (55%), Gaps = 12/199 (6%)

Query: 115 NKLGEGGFGTVYKGVIGQGE--IAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGC 172
           +KLG G +G VY+GV  +    +AVK L  +   E++E   EA+V+ +++H NLV+LLG 
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70

Query: 173 CIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRII 232
           C  +    +I E+M   +L  +L +   R+ ++    + +   ++  + YL + +    I
Sbjct: 71  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKKN---FI 126

Query: 233 HRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGI 292
           HRDL A N L+ ++   K++DFG++R++  G+      G    I  T    +PE      
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWT----APESLAYNK 181

Query: 293 FSIKSDVFSFGVLLLEIVS 311
           FSIKSDV++FGVLL EI +
Sbjct: 182 FSIKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  112 bits (283), Expect = 1e-28
 Identities = 62/216 (28%), Positives = 109/216 (50%), Gaps = 37/216 (17%)

Query: 111 FSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
           F    KLGEG +G+VYK +  +    +A+K +  +   +++E+  E S++ Q     +VK
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVK 62

Query: 169 LLGCCIEKDERLLIYEY-----------MPNKSLDCFLFDPTKREILDWRTRVQIIKGVA 217
             G   +  +  ++ EY           + NK+L       T+ EI        I+    
Sbjct: 63  YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTL-------TEEEI------AAILYQTL 109

Query: 218 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRIS 277
           +GL YLH     + IHRD+KA NILL+++  +K++DFG++  +         + NT  + 
Sbjct: 110 KGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA----KRNT--VI 160

Query: 278 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           GT  +M+PE   E  ++ K+D++S G+  +E+  GK
Sbjct: 161 GTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGK 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score =  112 bits (282), Expect = 2e-28
 Identities = 84/298 (28%), Positives = 133/298 (44%), Gaps = 50/298 (16%)

Query: 110 NFSAANKLGEGGFGTVYKG-VIGQG------EIAVKRL-LGKSGQEIKELKNEASVIAQV 161
           + +    LG G FG VY+G   G+       ++AVK L    S Q+  +   EA ++++ 
Sbjct: 7   SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF 66

Query: 162 QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFD----PTKREILDWRTRVQIIKGVA 217
            H+N+V+L+G   E+  R ++ E M    L  FL +    P +   L  +  +   + VA
Sbjct: 67  NHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVA 126

Query: 218 QGLLYLHQYSRVRIIHRDLKASNILLD---KDMNSKISDFGMARIVFGGNDEDELQGNTS 274
           +G  YL +      IHRD+ A N LL        +KI+DFGMAR ++  +          
Sbjct: 127 KGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRAS--------YY 175

Query: 275 RISGT----YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYA 330
           R  G       +M PE  L+GIF+ K+DV+SFGVLL EI S               +GY 
Sbjct: 176 RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS---------------LGYM 220

Query: 331 WDLWISNKIIDLIDSVLEEASFNESLS---RYVHIALLCVQERAEDRPTMSDVVSMLT 385
                +N+  ++++ V      +           I   C Q   EDRP  + ++  + 
Sbjct: 221 PYPGRTNQ--EVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  111 bits (279), Expect = 3e-28
 Identities = 85/279 (30%), Positives = 123/279 (44%), Gaps = 44/279 (15%)

Query: 117 LGEGGFGTVYKGV-IGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIE 175
           LG G FG V+ G   G+ ++A+K +   +  E  +   EA V+ ++ H NLV+L G C +
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE-DDFIEEAKVMMKLSHPNLVQLYGVCTK 70

Query: 176 KDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRD 235
           +    ++ EYM N  L  +L    ++  L     + +   V + + YL        IHRD
Sbjct: 71  QRPIFIVTEYMANGCLLNYL--RERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRD 125

Query: 236 LKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY--GYMSPEYALEGIF 293
           L A N L+ +D   K+SDFG+AR V     +D+    TS     +   +  PE      F
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVL----DDQY---TSSQGTKFPVKWAPPEVFDYSRF 178

Query: 294 SIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFN 353
           S KSDV+SFGVL+ E+ S  K    Y   S N                    V+E  S  
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGKMP--YERFS-NS------------------EVVESVSAG 217

Query: 354 ESLSR-------YVHIALLCVQERAEDRPTMSDVVSMLT 385
             L R          I   C  E+ EDRP    ++S LT
Sbjct: 218 YRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  111 bits (279), Expect = 4e-28
 Identities = 73/198 (36%), Positives = 111/198 (56%), Gaps = 14/198 (7%)

Query: 116 KLGEGGFGTVYKGVI-GQGEIAVKRLLGKSGQ-EIKELKNEASVIAQVQHKNLVKLLGCC 173
           KLG G FG V+ G   G  ++A+K L  K G    +    EA+++ Q+QH  LV+L    
Sbjct: 13  KLGAGQFGEVWMGYYNGHTKVAIKSL--KQGSMSPEAFLAEANLMKQLQHPRLVRLYAV- 69

Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
           + ++   +I EYM N SL  FL  P   + L     + +   +A+G+ ++    R   IH
Sbjct: 70  VTQEPIYIITEYMENGSLVDFLKTPEGIK-LTINKLIDMAAQIAEGMAFIE---RKNYIH 125

Query: 234 RDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIF 293
           RDL+A+NIL+ + +  KI+DFG+AR++   N+    +G    I  T    +PE    G F
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARLI-EDNEYTAREGAKFPIKWT----APEAINYGTF 180

Query: 294 SIKSDVFSFGVLLLEIVS 311
           +IKSDV+SFG+LL EIV+
Sbjct: 181 TIKSDVWSFGILLTEIVT 198

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  111 bits (279), Expect = 4e-28
 Identities = 81/277 (29%), Positives = 136/277 (49%), Gaps = 53/277 (19%)

Query: 117 LGEGGFGTVYKGVIGQ-GE-IAVKRLL----GKSGQE-IKELKNEASVIAQVQHKNLVKL 169
           LG G FG+VY+G+    G+  AVK +     G++GQE +K+L+ E ++++++QH N+V+ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 170 LGCCIEKDERLLIY-EYMPNKSLDCFL--FDPTKREILDWRTRVQIIKGVAQGLLYLHQY 226
           LG   E ++ L I+ E +P  SL   L  +      ++   TR QI+ G+     YLH  
Sbjct: 68  LGTERE-EDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-QILLGLE----YLH-- 119

Query: 227 SRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPE 286
            R   +HRD+K +NIL+D +   K++DFGMA+ V                 G+  +M+PE
Sbjct: 120 DR-NTVHRDIKGANILVDTNGVVKLADFGMAKQV-------VEFSFAKSFKGSPYWMAPE 171

Query: 287 YAL-EGIFSIKSDVFSFGVLLLEIVSGKKNTG-FYRTKSLNLIGYAWDL-----WISNKI 339
               +G + + +D++S G  +LE+ +GK          ++  IG + +L      +S++ 
Sbjct: 172 VIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEA 231

Query: 340 IDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPT 376
            D I                    L C+Q     RPT
Sbjct: 232 KDFI--------------------LKCLQRDPSLRPT 248

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  109 bits (275), Expect = 2e-27
 Identities = 64/203 (31%), Positives = 101/203 (49%), Gaps = 9/203 (4%)

Query: 115 NKLGEGGFGTVYKG--VIGQGEIAVKRL-LGKSGQEIKELKNEASVIAQVQHKNLVKLLG 171
             +G G    VY    +    ++A+KR+ L K    + EL+ E   ++Q  H N+VK   
Sbjct: 7   EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66

Query: 172 CCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRI 231
             +  DE  L+  Y+   SL   +     R  LD      ++K V +GL YLH   +   
Sbjct: 67  SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ--- 123

Query: 232 IHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEG 291
           IHRD+KA NILL +D + KI+DFG++  +  G D       T    GT  +M+PE   + 
Sbjct: 124 IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKT--FVGTPCWMAPEVMEQV 181

Query: 292 I-FSIKSDVFSFGVLLLEIVSGK 313
             +  K+D++SFG+  +E+ +G 
Sbjct: 182 HGYDFKADIWSFGITAIELATGA 204

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  109 bits (274), Expect = 3e-27
 Identities = 73/277 (26%), Positives = 120/277 (43%), Gaps = 48/277 (17%)

Query: 115 NKLGEGGFGTVYKGV-IGQGEI-AVKR-LLGKSGQEIKELKNEASVIAQVQHKNLVKLLG 171
            +LG G  G V K +    G+I AVK   L  +    K++  E  ++ +     +V   G
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66

Query: 172 CCIEKDERLLIYEYMPNKSLDCFL---FDPTKREILDWRTRVQIIKGVAQGLLYLHQYSR 228
                 +  +  EYM   SLD  L          IL      +I   V +GL YLH   +
Sbjct: 67  AFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLH--EK 119

Query: 229 VRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYA 288
            +IIHRD+K SNIL++     K+ DFG++     G   + L   T    GT  YM+PE  
Sbjct: 120 HKIIHRDVKPSNILVNSRGQIKLCDFGVS-----GQLVNSL-AKTF--VGTSSYMAPERI 171

Query: 289 LEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLW--ISNKIIDLIDSV 346
               +S+KSD++S G+ L+E+ +G+               + +       + I +L+  +
Sbjct: 172 QGNDYSVKSDIWSLGLSLIELATGR---------------FPYPPENDPPDGIFELLQYI 216

Query: 347 LEEAS-------FNESLSRYVHIALLCVQERAEDRPT 376
           + E         F+     +V+   LC+ +   +RP+
Sbjct: 217 VNEPPPRLPSGKFSPDFQDFVN---LCLIKDPRERPS 250

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score =  109 bits (274), Expect = 3e-27
 Identities = 64/211 (30%), Positives = 112/211 (53%), Gaps = 23/211 (10%)

Query: 117 LGEGGFGTVYKGVIGQ-----GEIAVK--RLLGKSGQEIKELKNEASVIAQVQHKNLVKL 169
           LGEG FG+V +G + Q      ++AVK  +L   +  EI+E  +EA+ +    H N++KL
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 170 LGCCIEKDER------LLIYEYMPNKSLDCFLFDP---TKREILDWRTRVQIIKGVAQGL 220
           +G C E          ++I  +M +  L  FL         E L  +T ++ +  +A G+
Sbjct: 67  IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126

Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY 280
            YL   S    IHRDL A N +L +DM   ++DFG+++ ++ G+     QG  +++    
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYR--QGRIAKMP--V 179

Query: 281 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
            +++ E   + +++ KSDV++FGV + EI +
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score =  108 bits (270), Expect = 6e-27
 Identities = 85/276 (30%), Positives = 133/276 (48%), Gaps = 42/276 (15%)

Query: 116 KLGEGGFGTV-YKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCI 174
           +LG G FG V Y    GQ ++A+K +   S  E  E   EA V+ ++ H+ LV+L G C 
Sbjct: 11  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMKLSHEKLVQLYGVCT 69

Query: 175 EKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQII---KGVAQGLLYL--HQYSRV 229
           ++    ++ EYM N  L  +L     RE        Q++   K V +G+ YL   Q+   
Sbjct: 70  KQRPIYIVTEYMSNGCLLNYL-----REHGKRFQPSQLLEMCKDVCEGMAYLESKQF--- 121

Query: 230 RIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY--GYMSPEY 287
             IHRDL A N L+D     K+SDFG++R V     +DE    TS +   +   +  PE 
Sbjct: 122 --IHRDLAARNCLVDDQGCVKVSDFGLSRYVL----DDEY---TSSVGSKFPVRWSPPEV 172

Query: 288 ALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSV 346
            L   FS KSDV++FGVL+ E+ S GK                 ++ + +++ ++ +   
Sbjct: 173 LLYSKFSSKSDVWAFGVLMWEVYSLGKM---------------PYERFNNSETVEKVSQG 217

Query: 347 LEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVS 382
           L     + +  +   I   C  E+AE+RPT   ++S
Sbjct: 218 LRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLS 253

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  107 bits (270), Expect = 7e-27
 Identities = 68/211 (32%), Positives = 113/211 (53%), Gaps = 20/211 (9%)

Query: 110 NFSAANKLGEGGFGTVYKGV--IGQGEIAVKR--LLGKSGQEIKELKNEASVIAQVQHKN 165
           +F   NK+G+G FG V+K V    +   A+K+  L   + +E +E  +EA V+A++    
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKR---EILDWRTRVQIIKGVAQGLLY 222
           +++     ++K +  ++ EY  N  L   L     R   E   WR  +QI+ G+A    +
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLA----H 116

Query: 223 LHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGY 282
           LH     +I+HRD+K+ N+ LD   N KI D G+A+++     ++    NT  I GT  Y
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLL----SDNTNFANT--IVGTPYY 167

Query: 283 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           +SPE   +  ++ KSDV++ GV+L E  +GK
Sbjct: 168 LSPELCEDKPYNEKSDVWALGVVLYECCTGK 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  107 bits (269), Expect = 7e-27
 Identities = 81/274 (29%), Positives = 130/274 (47%), Gaps = 46/274 (16%)

Query: 116 KLGEGGFGTVYKGV-IGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCI 174
           ++G G FG V+ G  + + ++A+K +   +  E ++   EA V+ ++ H  LV+L G C 
Sbjct: 11  EIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE-EDFIEEAQVMMKLSHPKLVQLYGVCT 69

Query: 175 EKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHR 234
           E+    L++E+M +  L  +L    +R      T + +   V +G+ YL   +   +IHR
Sbjct: 70  ERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHR 124

Query: 235 DLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGT---YGYMSPEYALEG 291
           DL A N L+ ++   K+SDFGM R V     +D+   +T    GT     + SPE     
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVL----DDQYTSST----GTKFPVKWSSPEVFSFS 176

Query: 292 IFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEAS 351
            +S KSDV+SFGVL+ E+ S  K     R+ S                      V+E  +
Sbjct: 177 KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS---------------------EVVETIN 215

Query: 352 FNESL------SRYVH-IALLCVQERAEDRPTMS 378
               L      S+ V+ +   C +ER EDRP+ S
Sbjct: 216 AGFRLYKPRLASQSVYELMQHCWKERPEDRPSFS 249

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  108 bits (271), Expect = 1e-26
 Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 26/205 (12%)

Query: 116 KLGEGGFGTVYKG---VIGQGEIAVKRL-LGKSGQEIKELKNEASVIAQVQHKNLVKLLG 171
           K+GEG  G VYK      G+ E+A+K++ L K  Q  + + NE  ++   +H N+V    
Sbjct: 26  KIGEGASGEVYKATDRATGK-EVAIKKMRLRK--QNKELIINEILIMKDCKHPNIVDYYD 82

Query: 172 CCIEKDERLLIYEYMPNKSL----DCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYS 227
             +  DE  ++ EYM   SL            + +I        + + V QGL YLH   
Sbjct: 83  SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQI------AYVCREVLQGLEYLHSQ- 135

Query: 228 RVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEY 287
              +IHRD+K+ NILL KD + K++DFG A  +       + +   + + GT  +M+PE 
Sbjct: 136 --NVIHRDIKSDNILLSKDGSVKLADFGFAAQL------TKEKSKRNSVVGTPYWMAPEV 187

Query: 288 ALEGIFSIKSDVFSFGVLLLEIVSG 312
                +  K D++S G++ +E+  G
Sbjct: 188 IKRKDYGPKVDIWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score =  106 bits (267), Expect = 3e-26
 Identities = 85/277 (30%), Positives = 133/277 (48%), Gaps = 19/277 (6%)

Query: 117 LGEGGFGTV--YK---GVIGQGE-IAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNLVKL 169
           LGEG FG V  Y       G GE +AVK L  + GQ+     K E +++  + H+N+VK 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 170 LGCCIEKDER--LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYS 227
            GCC E+  +   LI EY+P  SL  +L     +  L+    +   + + +G+ YLH   
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSLRDYL----PKHKLNLAQLLLFAQQICEGMAYLHSQ- 126

Query: 228 RVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEY 287
               IHRDL A N+LLD D   KI DFG+A+ V  G++   ++ +    S  + Y + E 
Sbjct: 127 --HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD--SPVFWY-AVEC 181

Query: 288 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVL 347
             E  FS  SDV+SFGV L E+++   +      K   +IG         ++I+L++  +
Sbjct: 182 LKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGM 241

Query: 348 EEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML 384
                         +   C +  A+ RPT   ++ +L
Sbjct: 242 RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPIL 278

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score =  106 bits (267), Expect = 3e-26
 Identities = 71/224 (31%), Positives = 113/224 (50%), Gaps = 36/224 (16%)

Query: 117 LGEGGFGTVYK-------GVIGQGEIAVKRLL-GKSGQEIKELKNEASVIAQVQHKNLVK 168
           LGEG FG V K       G  G   +AVK L    S  E+++L +E +++ QV H +++K
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFLFDPTK---------------------REILDWR 207
           L G C +    LLI EY    SL  FL +  K                        L   
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127

Query: 208 TRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDED 267
             +     +++G+ YL   + ++++HRDL A N+L+ +    KISDFG++R V+   ++ 
Sbjct: 128 DLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVY--EEDS 182

Query: 268 ELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
            ++ +  RI     +M+ E   + I++ +SDV+SFGVLL EIV+
Sbjct: 183 YVKRSKGRIP--VKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  105 bits (264), Expect = 4e-26
 Identities = 76/198 (38%), Positives = 110/198 (55%), Gaps = 14/198 (7%)

Query: 116 KLGEGGFGTVYKGVI-GQGEIAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNLVKLLGCC 173
           KLG G FG V+ G   G  ++AVK L  K G    E    EA ++ +++H  LV+L    
Sbjct: 13  KLGNGQFGEVWMGTWNGNTKVAVKTL--KPGTMSPESFLEEAQIMKKLRHDKLVQLYAV- 69

Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
           + ++   ++ EYM   SL  FL D   R  L     V +   VA G+ Y+    R+  IH
Sbjct: 70  VSEEPIYIVTEYMSKGSLLDFLKDGEGRA-LKLPNLVDMAAQVAAGMAYIE---RMNYIH 125

Query: 234 RDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIF 293
           RDL+++NIL+   +  KI+DFG+AR++   N+    QG    I  T    +PE AL G F
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLI-EDNEYTARQGAKFPIKWT----APEAALYGRF 180

Query: 294 SIKSDVFSFGVLLLEIVS 311
           +IKSDV+SFG+LL E+V+
Sbjct: 181 TIKSDVWSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score =  106 bits (265), Expect = 4e-26
 Identities = 82/278 (29%), Positives = 146/278 (52%), Gaps = 36/278 (12%)

Query: 117 LGEGGFGTVYKGVI---GQGEIAVKRLLGKSGQEIKELKN---EASVIAQVQHKNLVKLL 170
           +G G FG V++G++   G+ E+AV     K G   K+ ++   EAS++ Q  H N+++L 
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72

Query: 171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVR 230
           G   +    ++I EYM N +LD +L D    E   ++  V +++G+A G+ YL   S + 
Sbjct: 73  GVVTKFKPAMIITEYMENGALDKYLRD-HDGEFSSYQL-VGMLRGIAAGMKYL---SDMN 127

Query: 231 IIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYG--YMSPEYA 288
            +HRDL A NIL++ ++  K+SDFG++R++     ED+ +G  +   G     + +PE  
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVL-----EDDPEGTYTTSGGKIPIRWTAPEAI 182

Query: 289 LEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISN-KIIDLIDSV 346
               F+  SDV+SFG+++ E++S G++                WD+  SN +++  I+  
Sbjct: 183 AYRKFTSASDVWSFGIVMWEVMSFGERPY--------------WDM--SNHEVMKAINDG 226

Query: 347 LEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML 384
               +  +  S    + L C Q+    RP   D+V++L
Sbjct: 227 FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLL 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  105 bits (264), Expect = 8e-26
 Identities = 69/220 (31%), Positives = 104/220 (47%), Gaps = 32/220 (14%)

Query: 117 LGEGGFGTVYKG--VIGQGEIAVKRLLGKSGQEIKELK-----NEASVIAQV-QHKNLVK 168
           +GEG F TV          E A+K L  +  Q IKE K      E  V+ ++  H  ++K
Sbjct: 9   IGEGSFSTVVLAKEKETNKEYAIKILDKR--QLIKEKKVKYVKIEKEVLTRLNGHPGIIK 66

Query: 169 LLGCCIEKDERL-LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYS 227
           L     + +E L  + EY PN  L  ++    K   LD +        +   L YLH   
Sbjct: 67  LY-YTFQDEENLYFVLEYAPNGELLQYI---RKYGSLDEKCTRFYAAEILLALEYLHS-- 120

Query: 228 RVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRIS---------- 277
              IIHRDLK  NILLDKDM+ KI+DFG A+++   +  +  +G+ + I           
Sbjct: 121 -KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRF 179

Query: 278 ----GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
               GT  Y+SPE   E      SD+++ G ++ ++++GK
Sbjct: 180 ASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score =  104 bits (260), Expect = 2e-25
 Identities = 65/212 (30%), Positives = 97/212 (45%), Gaps = 28/212 (13%)

Query: 117 LGEGGFGTVYKGVIGQGEIAVKRL--LGKSGQEIK------ELKNEASVIAQVQHKNLVK 168
           LG G FG V+       E        L K+ Q+ K      E + E  +  ++ HKN+V+
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72

Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFL------FDPTKREILDWRTRVQIIKGVAQGLLY 222
           LLG C E +   +I EY     L  FL       +  K   L  + +V +   +A G+ +
Sbjct: 73  LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132

Query: 223 LHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNT---SRISGT 279
           L   S  R +HRDL A N L+      K+S   +++ V+  N E     N     R    
Sbjct: 133 L---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVY--NSEYYKLRNALIPLR---- 183

Query: 280 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
             +++PE   E  FS KSDV+SFGVL+ E+ +
Sbjct: 184 --WLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  102 bits (255), Expect = 9e-25
 Identities = 68/211 (32%), Positives = 107/211 (50%), Gaps = 23/211 (10%)

Query: 115 NKLGEGGFGTVYKGV-IGQGEI-AVKRLLGKSGQE--IKELKNEASVIAQVQHKNLVKLL 170
           NK+G G FG VY  V +  GE+ AVK +  +      IKE+ +E  V+  ++H NLVK  
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWR-TRV---QIIKGVAQGLLYLHQY 226
           G  + +++  +  EY    +L+  L       ILD    RV   Q+++G+A    YLH +
Sbjct: 66  GVEVHREKVYIFMEYCSGGTLEELL---EHGRILDEHVIRVYTLQLLEGLA----YLHSH 118

Query: 227 SRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPE 286
               I+HRD+K +NI LD +   K+ DFG A  +         +  +    GT  YM+PE
Sbjct: 119 ---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLA--GTPAYMAPE 173

Query: 287 YALEGIFSIK---SDVFSFGVLLLEIVSGKK 314
               G        +D++S G ++LE+ +GK+
Sbjct: 174 VITGGKGKGHGRAADIWSLGCVVLEMATGKR 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score =  102 bits (256), Expect = 9e-25
 Identities = 66/222 (29%), Positives = 108/222 (48%), Gaps = 34/222 (15%)

Query: 117 LGEGGFGTVYK----GVIGQGE---IAVKRLL-GKSGQEIKELKNEASVIAQVQHKNLVK 168
           +G+G FG V++    G++       +AVK L    S     + + EA+++A+  H N+VK
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFLFD--PTKREILDWRT-----------------R 209
           LLG C       L++EYM    L+ FL    P  +  L   T                 +
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 210 VQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDEL 269
           + I K VA G+ YL   S  + +HRDL   N L+ ++M  KI+DFG++R ++     D  
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS---ADYY 186

Query: 270 QGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
           + + +       +M PE      ++ +SDV+++GV+L EI S
Sbjct: 187 KASENDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  102 bits (254), Expect = 1e-24
 Identities = 78/263 (29%), Positives = 131/263 (49%), Gaps = 28/263 (10%)

Query: 116 KLGEGGFGTVYKGVI-GQGEIAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNLVKLLGCC 173
           KLG+G FG V+ G   G   +A+K L  K G    E    EA V+ +++H+ LV+L    
Sbjct: 13  KLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV- 69

Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
           + ++   ++ EYM   SL  FL     +  L     V +   +A G+ Y+    R+  +H
Sbjct: 70  VSEEPIYIVTEYMSKGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVH 125

Query: 234 RDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIF 293
           RDL+A+NIL+ +++  K++DFG+AR++   N+    QG    I  T    +PE AL G F
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWT----APEAALYGRF 180

Query: 294 SIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFN 353
           +IKSDV+SFG+LL E+ +  +                +   ++ +++D ++         
Sbjct: 181 TIKSDVWSFGILLTELTTKGR--------------VPYPGMVNREVLDQVERGYRMPCPP 226

Query: 354 ESLSRYVHIALLCVQERAEDRPT 376
           E       +   C ++  E+RPT
Sbjct: 227 ECPESLHDLMCQCWRKEPEERPT 249

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score =  101 bits (253), Expect = 2e-24
 Identities = 81/286 (28%), Positives = 144/286 (50%), Gaps = 50/286 (17%)

Query: 117 LGEGGFGTVYKG---VIGQGEI--AVKRL-LGKSGQEIKELKNEASVIAQVQHKNLVKLL 170
           +G G FG V +G   + G+ EI  A+K L  G + ++ ++  +EAS++ Q  H N++ L 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 171 GCCIEKDERLLIYEYMPNKSLDCFL------FDPTKREILDWRTRVQIIKGVAQGLLYLH 224
           G   +    ++I E+M N +LD FL      F   +         V +++G+A G+ YL 
Sbjct: 72  GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQ--------LVGMLRGIAAGMKYLS 123

Query: 225 QYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYG--Y 282
           + + V   HRDL A NIL++ ++  K+SDFG++R +    D+      TS + G     +
Sbjct: 124 EMNYV---HRDLAARNILVNSNLVCKVSDFGLSRFL---EDDTSDPTYTSSLGGKIPIRW 177

Query: 283 MSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIID 341
            +PE      F+  SDV+S+G+++ E++S G++                WD+  SN+  D
Sbjct: 178 TAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY--------------WDM--SNQ--D 219

Query: 342 LIDSVLEEASFNESL--SRYVHIALL-CVQERAEDRPTMSDVVSML 384
           +I+++ ++      +     +H  +L C Q+    RP    +VS L
Sbjct: 220 VINAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTL 265

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  101 bits (252), Expect = 2e-24
 Identities = 68/212 (32%), Positives = 113/212 (53%), Gaps = 25/212 (11%)

Query: 115 NKLGEGGFGTVYKGVIGQGE-IAVKRL-LGKSGQ-----EIKELKNEASVIAQVQHKNLV 167
             LG+G +GTVY G+  QG+ IAVK++ L  S       E ++L+ E  ++  ++H N+V
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 168 KLLGCCIEKDERLLIYEYMPNKSLDCFL--FDPTKREILDWRTRVQIIKGVAQGLLYLHQ 225
           + LG C++ +   +  E++P  S+   L  F P    +    T+ QI+ GVA    YLH 
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK-QILDGVA----YLHN 120

Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMAR----IVFGGNDEDELQGNTSRISGTYG 281
                ++HRD+K +N++L  +   K+ DFG AR    +   G   + L+     + GT  
Sbjct: 121 NC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKS----MHGTPY 173

Query: 282 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           +M+PE   E  +  KSD++S G  + E+ +GK
Sbjct: 174 WMAPEVINESGYGRKSDIWSIGCTVFEMATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score =  101 bits (252), Expect = 2e-24
 Identities = 82/281 (29%), Positives = 142/281 (50%), Gaps = 42/281 (14%)

Query: 117 LGEGGFGTVYKG---VIGQGEI--AVKRL-LGKSGQEIKELKNEASVIAQVQHKNLVKLL 170
           +G G FG V  G   + G+ EI  A+K L  G + ++ ++  +EAS++ Q  H N++ L 
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQII---KGVAQGLLYLHQYS 227
           G   +    +++ EYM N SLD FL     R+     T +Q++   +G+A G+ YL    
Sbjct: 72  GVVTKSKPVMIVTEYMENGSLDAFL-----RKHDGQFTVIQLVGMLRGIASGMKYLSDMG 126

Query: 228 RVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEY 287
            V   HRDL A NIL++ ++  K+SDFG++R++    D+ E    T        + +PE 
Sbjct: 127 YV---HRDLAARNILVNSNLVCKVSDFGLSRVL---EDDPEAAYTTRGGKIPIRWTAPEA 180

Query: 288 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVL 347
                F+  SDV+S+G+++ E++S       Y  +        W++  SN+  D+I ++ 
Sbjct: 181 IAYRKFTSASDVWSYGIVMWEVMS-------YGERPY------WEM--SNQ--DVIKAIE 223

Query: 348 E----EASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML 384
           E     A  +   + +  + L C Q+   +RP    +VS+L
Sbjct: 224 EGYRLPAPMDCPAALH-QLMLDCWQKDRNERPKFEQIVSIL 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score =  101 bits (253), Expect = 3e-24
 Identities = 72/217 (33%), Positives = 114/217 (52%), Gaps = 28/217 (12%)

Query: 116 KLGEGGFGTVYKGVI---GQGE----IAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNLV 167
           +LGE  FG VYKG +     GE    +A+K L  K+   ++E  K+EA + +++QH N+V
Sbjct: 12  ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71

Query: 168 KLLGCCIEKDERLLIYEYMPNKSLDCFLF-------------DPTKREILDWRTRVQIIK 214
            LLG   ++    +I+ Y  +  L  FL              D T +  L+    V I+ 
Sbjct: 72  CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131

Query: 215 GVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTS 274
            +A G+ +L  +    ++H+DL   N+L+   +N KISD G+ R V+   D  +L GN+ 
Sbjct: 132 QIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAA-DYYKLMGNSL 187

Query: 275 RISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
                  +MSPE  + G FSI SD++S+GV+L E+ S
Sbjct: 188 L---PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score =  100 bits (252), Expect = 4e-24
 Identities = 67/218 (30%), Positives = 111/218 (50%), Gaps = 31/218 (14%)

Query: 117 LGEGGFGTV----YKGVIGQGE---IAVKRLLG-KSGQEIKELKNEASVIAQV-QHKNLV 167
           LGEG FG V      G+    E   +AVK L    + +++ +L +E  ++  + +HKN++
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79

Query: 168 KLLGCCIEKDERLLIYEYMPNKSLDCFL-------------FDPTKREILDWRTRVQIIK 214
            LLG C ++    ++ EY  + +L  FL                   E L  +  V    
Sbjct: 80  NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139

Query: 215 GVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTS 274
            VA+G+ +L      + IHRDL A N+L+ +D   KI+DFG+AR +   +  D  +  T+
Sbjct: 140 QVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDI---HHIDYYRKTTN 193

Query: 275 -RISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
            R+     +M+PE   + +++ +SDV+SFGVLL EI +
Sbjct: 194 GRLP--VKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 99.5 bits (249), Expect = 7e-24
 Identities = 63/205 (30%), Positives = 101/205 (49%), Gaps = 23/205 (11%)

Query: 117 LGEGGFGTVYKGV--IGQGEIAVKRLLGKSG----QEIKELKNEASVIAQVQHKNLVKLL 170
           LG+G FG V   V     G++   ++L K      +E++    E ++++++ H  +VKL 
Sbjct: 1   LGKGSFGKVLL-VRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH 59

Query: 171 GCCIEKDERL-LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKG-VAQGLLYLHQYSR 228
               + +E+L L+ EY P   L   L   +K        R +     +   L YLH    
Sbjct: 60  -YAFQTEEKLYLVLEYAPGGELFSHL---SKEGRFS-EERARFYAAEIVLALEYLH---S 111

Query: 229 VRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYA 288
           + II+RDLK  NILLD D + K++DFG+A+ +            T+   GT  Y++PE  
Sbjct: 112 LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR------TNTFCGTPEYLAPEVL 165

Query: 289 LEGIFSIKSDVFSFGVLLLEIVSGK 313
           L   +    D +S GVLL E+++GK
Sbjct: 166 LGKGYGKAVDWWSLGVLLYEMLTGK 190

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 99.7 bits (248), Expect = 7e-24
 Identities = 68/196 (34%), Positives = 101/196 (51%), Gaps = 16/196 (8%)

Query: 117 LGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEK 176
           +G+G FG V  G     ++AVK +  K+    +    EASV+ Q++H NLV+LLG  +E+
Sbjct: 14  IGKGEFGDVMLGDYRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 71

Query: 177 DERLLIY-EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRD 235
              L I  EYM   SL  +L     R +L     ++    V + + YL   +    +HRD
Sbjct: 72  KGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRD 127

Query: 236 LKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSI 295
           L A N+L+ +D  +K+SDFG+ +      D  +L            + +PE   E  FS 
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL---------PVKWTAPEALREKKFST 178

Query: 296 KSDVFSFGVLLLEIVS 311
           KSDV+SFG+LL EI S
Sbjct: 179 KSDVWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 99.8 bits (249), Expect = 1e-23
 Identities = 66/203 (32%), Positives = 105/203 (51%), Gaps = 16/203 (7%)

Query: 117 LGEGGFGTVYKGVI-----GQGE-IAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLL 170
           LG+G FG+V            GE +AVK+L   + + +++ + E  ++  +QH N+VK  
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71

Query: 171 GCCIEKDER--LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSR 228
           G C     R   L+ EY+P  SL  +L     RE LD R  +     + +G+ YL     
Sbjct: 72  GVCYSAGRRNLRLVMEYLPYGSLRDYL--QKHRERLDHRKLLLYASQICKGMEYL---GS 126

Query: 229 VRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYA 288
            R +HRDL   NIL++ +   KI DFG+ +++    D++  +      S  + Y +PE  
Sbjct: 127 KRYVHRDLATRNILVESENRVKIGDFGLTKVL--PQDKEYYKVREPGESPIFWY-APESL 183

Query: 289 LEGIFSIKSDVFSFGVLLLEIVS 311
            E  FS+ SDV+SFGV+L E+ +
Sbjct: 184 TESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 99.5 bits (248), Expect = 1e-23
 Identities = 61/205 (29%), Positives = 106/205 (51%), Gaps = 20/205 (9%)

Query: 117 LGEGGFGTVYKG--VIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCI 174
           LG+G +G VY    +  Q  IA+K +  +  + ++ L  E ++ + ++H+N+V+ LG   
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75

Query: 175 EKDERLLIYEYMPNKSLDCFL---FDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRI 231
           E     +  E +P  SL   L   + P K    + +T +   K + +GL YLH     +I
Sbjct: 76  ENGFFKIFMEQVPGGSLSALLRSKWGPLKD---NEQTIIFYTKQILEGLKYLHD---NQI 129

Query: 232 IHRDLKASNILLDKDMNS-KISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE 290
           +HRD+K  N+L++      KISDFG ++ + G N        T   +GT  YM+PE   +
Sbjct: 130 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP------CTETFTGTLQYMAPEVIDK 183

Query: 291 GI--FSIKSDVFSFGVLLLEIVSGK 313
           G   +   +D++S G  ++E+ +GK
Sbjct: 184 GPRGYGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 98.9 bits (246), Expect = 1e-23
 Identities = 84/276 (30%), Positives = 140/276 (50%), Gaps = 37/276 (13%)

Query: 116 KLGEGGFGTVYKGVIGQG-EIAVKRLLGKSG-QEIKELKNEASVIAQVQHKNLVKLLGCC 173
           KLG G FG V+ G      ++AVK L  K G   ++    EA+++  +QH  LV+L    
Sbjct: 13  KLGAGQFGEVWMGYYNNSTKVAVKTL--KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV 70

Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
            +++   +I EYM   SL  FL      ++L  +  +     +A+G+ Y+    R   IH
Sbjct: 71  TKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKL-IDFSAQIAEGMAYIE---RKNYIH 126

Query: 234 RDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY--GYMSPEYALEG 291
           RDL+A+N+L+ + +  KI+DFG+AR++    +++E    T+R    +   + +PE    G
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVI----EDNEY---TAREGAKFPIKWTAPEAINFG 179

Query: 292 IFSIKSDVFSFGVLLLEIVSGKK--NTGFYRTKSLNLIGYAWDL-WISNKIIDLIDSVLE 348
            F+IKSDV+SFG+LL EIV+  K    G   +  ++ +   + +  + N   +L D    
Sbjct: 180 SFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYD---- 235

Query: 349 EASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML 384
                        I   C +E+AE+RPT   + S+L
Sbjct: 236 -------------IMKTCWKEKAEERPTFDYLQSVL 258

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 99.0 bits (246), Expect = 1e-23
 Identities = 72/198 (36%), Positives = 112/198 (56%), Gaps = 14/198 (7%)

Query: 116 KLGEGGFGTVYKGVI-GQGEIAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNLVKLLGCC 173
           KLG+G FG V+ G   G  ++A+K L  K G  + E    EA ++ +++H  LV L    
Sbjct: 13  KLGQGCFGEVWMGTWNGTTKVAIKTL--KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAV- 69

Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
           + ++   ++ E+M   SL  FL +   +  L     V +   +A G+ Y+    R+  IH
Sbjct: 70  VSEEPIYIVTEFMGKGSLLDFLKEGDGKY-LKLPQLVDMAAQIADGMAYIE---RMNYIH 125

Query: 234 RDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIF 293
           RDL+A+NIL+  ++  KI+DFG+AR++   N+    QG    I  T    +PE AL G F
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARLI-EDNEYTARQGAKFPIKWT----APEAALYGRF 180

Query: 294 SIKSDVFSFGVLLLEIVS 311
           +IKSDV+SFG+LL E+V+
Sbjct: 181 TIKSDVWSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 99.1 bits (247), Expect = 1e-23
 Identities = 62/208 (29%), Positives = 112/208 (53%), Gaps = 17/208 (8%)

Query: 117 LGEGGFGTVYKGVIGQ-GEI-AVKRLLGKSGQE---------IKELKNEASVIAQVQHKN 165
           +G G FG+VY G+    GE+ AVK++   S            +  L  E +++ ++QH+N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ 225
           +V+ LG  ++ D   +  EY+P  S+   L         +       ++ + +GL YLH 
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALL---NNYGAFEETLVRNFVRQILKGLNYLH- 123

Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
            +R  IIHRD+K +NIL+D     KISDFG+++ +   +   +  G    + G+  +M+P
Sbjct: 124 -NR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181

Query: 286 EYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           E   +  ++ K+D++S G L++E+++GK
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 98.5 bits (245), Expect = 2e-23
 Identities = 68/196 (34%), Positives = 103/196 (52%), Gaps = 16/196 (8%)

Query: 116 KLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIE 175
            +GEG FG V +G     ++AVK +  K     +    E +V+ ++ HKNLV+LLG  I 
Sbjct: 13  IIGEGEFGAVLQGEYTGQKVAVKNI--KCDVTAQAFLEETAVMTKLHHKNLVRLLGV-IL 69

Query: 176 KDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRD 235
            +   ++ E M   +L  FL     R ++     +Q    VA+G+ YL      +++HRD
Sbjct: 70  HNGLYIVMELMSKGNLVNFL-RTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRD 125

Query: 236 LKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSI 295
           L A NIL+ +D  +K+SDFG+AR+   G D  +L            + +PE      FS 
Sbjct: 126 LAARNILVSEDGVAKVSDFGLARVGSMGVDNSKL---------PVKWTAPEALKHKKFSS 176

Query: 296 KSDVFSFGVLLLEIVS 311
           KSDV+S+GVLL E+ S
Sbjct: 177 KSDVWSYGVLLWEVFS 192

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 98.5 bits (246), Expect = 2e-23
 Identities = 74/278 (26%), Positives = 132/278 (47%), Gaps = 42/278 (15%)

Query: 111 FSAANKLGEGGFGTVYKGVI---GQGEIAVKRL-LGKSGQEIKELKNEASVIAQVQHKNL 166
           F+    +G+G FG VYK +     Q  +A+K + L ++  EI++++ E   ++Q +   +
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQ-VVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYI 61

Query: 167 VKLLGCCIEKDERL-LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ 225
            K  G  + K  +L +I EY    S      D  K   LD      I++ V  GL YLH+
Sbjct: 62  TKYYGSFL-KGSKLWIIMEYCGGGSC----LDLLKPGKLDETYIAFILREVLLGLEYLHE 116

Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRIS---GTYGY 282
                 IHRD+KA+NILL ++ + K++DFG++          +L    S+ +   GT  +
Sbjct: 117 E---GKIHRDIKAANILLSEEGDVKLADFGVS---------GQLTSTMSKRNTFVGTPFW 164

Query: 283 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK-NTGFYRTKSLNLIGYAWDLWISNKIID 341
           M+PE   +  +  K+D++S G+  +E+  G+   +  +  + L LI         N    
Sbjct: 165 MAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLI-------PKNNP-- 215

Query: 342 LIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSD 379
                LE   F++    +V    LC+ +  ++RP+  +
Sbjct: 216 ---PSLEGNKFSKPFKDFVS---LCLNKDPKERPSAKE 247

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 98.4 bits (245), Expect = 3e-23
 Identities = 75/280 (26%), Positives = 132/280 (47%), Gaps = 40/280 (14%)

Query: 117 LGEGGFGTVYKGV-IGQGEI-AVKRL----LGKSGQE--IKELKNEASVIAQVQHKNLVK 168
           LG G F + Y+   +  G + AVK++       S QE  ++ L+ E  ++A++ H ++++
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFL--FDPTKREILDWRTRVQIIKGVAQGLLYLHQY 226
           +LG   E     L  E+M   S+   L  +   K  ++     +   + + +GL YLH+ 
Sbjct: 68  MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI-----INYTEQLLRGLSYLHEN 122

Query: 227 SRVRIIHRDLKASNILLDKD-MNSKISDFGMA-RIVFGGNDEDELQGNTSRISGTYGYMS 284
              +IIHRD+K +N+L+D      +I+DFG A R+   G    E QG   ++ GT  +M+
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQG---QLLGTIAFMA 176

Query: 285 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISN--KIIDL 342
           PE      +    DV+S G +++E+ + K      +               SN   +I  
Sbjct: 177 PEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEK--------------HSNHLALIFK 222

Query: 343 IDSVLEEASFNESLSRYVH-IALLCVQERAEDRPTMSDVV 381
           I S     S  E LS  +  + L C++ + EDRP   +++
Sbjct: 223 IASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELL 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 98.5 bits (245), Expect = 3e-23
 Identities = 69/217 (31%), Positives = 110/217 (50%), Gaps = 28/217 (12%)

Query: 116 KLGEGGFGTVYKGVI---GQGE---IAVKRLLG-KSGQEIKELKNEASVIAQVQHKNLVK 168
           +LGE  FG +YKG +   G      +A+K L    + Q+  E + EAS++A++ H N+V 
Sbjct: 12  ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71

Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFLF--------------DPTKREILDWRTRVQIIK 214
           LLG   ++    +++EY+    L  FL               D T +  LD    + I  
Sbjct: 72  LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131

Query: 215 GVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTS 274
            +A G+ YL  +     +H+DL A NIL+ + ++ KISD G++R ++   D   +Q  + 
Sbjct: 132 QIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSA-DYYRVQPKSL 187

Query: 275 RISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
                  +M PE  + G FS  SD++SFGV+L EI S
Sbjct: 188 L---PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 98.1 bits (244), Expect = 6e-23
 Identities = 72/212 (33%), Positives = 118/212 (55%), Gaps = 25/212 (11%)

Query: 111 FSAANKLGEGGFGTVYKGV-IGQGE-----IAVKRLL-GKSGQEIKELKNEASVIAQVQH 163
           F     LG G FGTVYKG+ I +GE     +A+K L    S +  KE+ +EA V+A V +
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 164 KNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKR----EILDWRTRVQIIKGVAQG 219
            ++ +LLG C+    +L I + MP   L  ++ +         +L+W   VQI    A+G
Sbjct: 69  PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQI----AKG 121

Query: 220 LLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGT 279
           + YL +    R++HRDL A N+L+    + KI+DFG+A+++  G DE E      ++   
Sbjct: 122 MNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GADEKEYHAEGGKVP-- 174

Query: 280 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
             +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 175 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 97.4 bits (242), Expect = 7e-23
 Identities = 72/226 (31%), Positives = 112/226 (49%), Gaps = 31/226 (13%)

Query: 110 NFSAANKLGEGGFGTV-----YKGVIGQGEI--AVKRLLGKSGQEIKELKNEASVIAQVQ 162
           N     +LGEG FG V     Y     Q +I  AVK L   S    K+   EA ++  +Q
Sbjct: 6   NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65

Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLF-------------DPTKREILDWRTR 209
           H+++VK  G C+E D  ++++EYM +  L+ FL               P +   L     
Sbjct: 66  HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAE---LTQSQM 122

Query: 210 VQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDEL 269
           + I + +A G++YL   +    +HRDL   N L+ +++  KI DFGM+R V+   D   +
Sbjct: 123 LHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVY-STDYYRV 178

Query: 270 QGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKK 314
            G+T        +M PE  +   F+ +SDV+S GV+L EI + GK+
Sbjct: 179 GGHTML---PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ 221

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 96.7 bits (241), Expect = 7e-23
 Identities = 78/283 (27%), Positives = 115/283 (40%), Gaps = 43/283 (15%)

Query: 116 KLGEGGFGTVYKGVIGQG-----EIAVKRLLGKSGQEI-KELKNEASVIAQVQHKNLVKL 169
           KLG+G FG V +G           +AVK L      +I  +   EA+++  + H+NL++L
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 170 LGCCIEKDERLLIYEYMPNKSL-DCFLFDPTKREILD---WRTRVQIIKGVAQGLLYLHQ 225
            G  +     +++ E  P  SL D  L        L        VQI  G+     YL  
Sbjct: 62  YGVVLT-HPLMMVTELAPLGSLLDR-LRKDALGHFLISTLCDYAVQIANGMR----YLES 115

Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
               R IHRDL A NILL  D   KI DFG+ R +    D   ++ +       + + +P
Sbjct: 116 K---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV---PFAWCAP 169

Query: 286 EYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWI---SNKIIDL 342
           E      FS  SDV+ FGV L E+ +                 Y  + W     ++I+  
Sbjct: 170 ESLRTRTFSHASDVWMFGVTLWEMFT-----------------YGEEPWAGLSGSQILKK 212

Query: 343 IDSVLEEASFNESLS-RYVHIALLCVQERAEDRPTMSDVVSML 384
           ID   E     E+      ++ L C      DRPT + +   L
Sbjct: 213 IDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 97.1 bits (242), Expect = 9e-23
 Identities = 61/216 (28%), Positives = 99/216 (45%), Gaps = 27/216 (12%)

Query: 109 GNFSAANKLGEGGFGTVYKGVIGQGE--IAVKRLLGKSGQEI-KELKNEASVIAQVQHKN 165
                 ++LGEG  G+V K  +       A+K +      ++ K++  E  +    +   
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 166 LVKLLGCCIEKDERLL--IYEYMPNKSLDCFLFDPTKREILDWRTRV------QIIKGVA 217
           +VK  G  +++    +    EY    SLD        +++     R+      +I + V 
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIY-----KKVKKRGGRIGEKVLGKIAESVL 115

Query: 218 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRIS 277
           +GL YLH     +IIHRD+K SNILL +    K+ DFG++     G   + L G     +
Sbjct: 116 KGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVS-----GELVNSLAGT---FT 164

Query: 278 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           GT  YM+PE      +SI SDV+S G+ LLE+   +
Sbjct: 165 GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 96.2 bits (239), Expect = 1e-22
 Identities = 65/197 (32%), Positives = 104/197 (52%), Gaps = 12/197 (6%)

Query: 117 LGEGGFGTVYKGVI-GQGEIAVKRLLGKSGQEIK-ELKNEASVIAQVQHKNLVKLLGCCI 174
           LG+G FG V+KG +  +  +AVK       QE+K +  +EA ++ Q  H N+VKL+G C 
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62

Query: 175 EKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHR 234
           ++    ++ E +P      FL    K++ L  +  V+     A G+ YL   +    IHR
Sbjct: 63  QRQPIYIVMELVPGGDFLSFL--RKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117

Query: 235 DLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFS 294
           DL A N L+ ++   KISDFGM+R      ++D +  ++        + +PE    G +S
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR-----QEDDGIYSSSGLKQIPIKWTAPEALNYGRYS 172

Query: 295 IKSDVFSFGVLLLEIVS 311
            +SDV+S+G+LL E  S
Sbjct: 173 SESDVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 96.6 bits (240), Expect = 1e-22
 Identities = 68/229 (29%), Positives = 113/229 (49%), Gaps = 27/229 (11%)

Query: 116 KLGEGGFGTVYKG-------VIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
           +LGEG FG V+            +  +AVK L   +    K+ + EA ++  +QH+++VK
Sbjct: 12  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71

Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFL--FDPTKREILDWRTR-----------VQIIKG 215
             G C + D  ++++EYM +  L+ FL    P    ++D + R           + I   
Sbjct: 72  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131

Query: 216 VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR 275
           +A G++YL   +    +HRDL   N L+  ++  KI DFGM+R V+   D   + G+T  
Sbjct: 132 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVY-STDYYRVGGHTML 187

Query: 276 ISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSL 324
                 +M PE  +   F+ +SDV+SFGV+L EI +  K   F  + + 
Sbjct: 188 ---PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE 233

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 96.5 bits (241), Expect = 1e-22
 Identities = 65/221 (29%), Positives = 104/221 (47%), Gaps = 48/221 (21%)

Query: 115 NKLGEGGFGTVYKGV-IGQGEI-AVKRLLGKSG---------QEIKELKNEASVIAQVQH 163
            ++GEG +G VYK      GE+ A+K++  ++          +EIK L+       +++H
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQ-------KLRH 57

Query: 164 KNLVKLLGCCIEKDER--LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQI----IKGVA 217
            N+V+L      K +    +++EYM          D T   +LD    V+     IK   
Sbjct: 58  PNIVRLKEIVTSKGKGSIYMVFEYMD--------HDLTG--LLD-SPEVKFTESQIKCYM 106

Query: 218 Q----GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNT 273
           +    GL YLH      I+HRD+K SNIL++ D   K++DFG+AR       +      T
Sbjct: 107 KQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPY----TKRNSADYT 159

Query: 274 SRISGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGK 313
           +R+  T  Y  PE  L    +  + D++S G +L E+  GK
Sbjct: 160 NRVI-TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 95.6 bits (238), Expect = 2e-22
 Identities = 66/219 (30%), Positives = 113/219 (51%), Gaps = 38/219 (17%)

Query: 117 LGEGGFGTVYKGV-IGQGE-IAVK------RLLGKSGQEIKE----LKNEASVIAQVQHK 164
           +G+G +G VY  + +  GE +AVK       + G+     K+    L++E   +  + H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 165 NLVKLLGCCIEKDERLLIY-EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQ----G 219
           N+V+ LG     +E L I+ EY+P  S+   L    + E        Q+++   +    G
Sbjct: 69  NIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRTYGRFE-------EQLVRFFTEQVLEG 120

Query: 220 LLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRIS-- 277
           L YLH      I+HRDLKA N+L+D D   KISDFG+++        D++  N   +S  
Sbjct: 121 LAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISK------KSDDIYDNDQNMSMQ 171

Query: 278 GTYGYMSPE--YALEGIFSIKSDVFSFGVLLLEIVSGKK 314
           G+  +M+PE  ++    +S K D++S G ++LE+ +G++
Sbjct: 172 GSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 95.9 bits (238), Expect = 3e-22
 Identities = 66/206 (32%), Positives = 118/206 (57%), Gaps = 25/206 (12%)

Query: 117 LGEGGFGTVYKGV-IGQGE-----IAVKRLLGKSGQEIK-ELKNEASVIAQVQHKNLVKL 169
           LG G FGTVYKG+ + +GE     +A+K L   +G +   E  +EA ++A + H +LV+L
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74

Query: 170 LGCCIEKDERLLIYEYMPNKSLDCFLFDPT----KREILDWRTRVQIIKGVAQGLLYLHQ 225
           LG C+    +L + + MP+  L  ++ +       + +L+W  ++      A+G++YL +
Sbjct: 75  LGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYLEE 127

Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
               R++HRDL A N+L+    + KI+DFG+AR++ G  DE E   +  ++     +M+ 
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEG--DEKEYNADGGKMP--IKWMAL 180

Query: 286 EYALEGIFSIKSDVFSFGVLLLEIVS 311
           E      F+ +SDV+S+GV + E+++
Sbjct: 181 ECIHYRKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 95.4 bits (237), Expect = 4e-22
 Identities = 66/219 (30%), Positives = 112/219 (51%), Gaps = 27/219 (12%)

Query: 116 KLGEGGFGTVY----KGVIGQGE---IAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
           +LGEG FG V+      ++ + +   +AVK L   S    ++ + EA ++  +QH+++V+
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71

Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFL--FDPTKREI----------LDWRTRVQIIKGV 216
             G C E    L+++EYM +  L+ FL    P  + +          L     + I   +
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 217 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRI 276
           A G++YL   + +  +HRDL   N L+ + +  KI DFGM+R ++   D   + G T   
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIY-STDYYRVGGRTML- 186

Query: 277 SGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKK 314
                +M PE  L   F+ +SD++SFGV+L EI + GK+
Sbjct: 187 --PIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQ 223

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 94.5 bits (235), Expect = 5e-22
 Identities = 67/213 (31%), Positives = 105/213 (49%), Gaps = 34/213 (15%)

Query: 117 LGEGGFGTVYKGV-IGQG-EIAVKRL-LGKSGQ----EIKELKNEASVIAQVQHKNLVKL 169
           LG+G FG VY    +  G E+AVK++           E+  L+ E  ++  +QH+ +V+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 170 LGCCIEKDERLLIY-EYMPNKSLDCFL--FDPTKREILDWRTRVQIIKGVAQGLLYLHQY 226
            GC +  DE L I+ EYMP  S+   L  +      +    TR QI+    +G+ YLH  
Sbjct: 70  YGC-LRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTR-QIL----EGVEYLH-- 121

Query: 227 SRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQ------GNTSRISGTY 280
               I+HRD+K +NIL D   N K+ DFG ++          LQ           ++GT 
Sbjct: 122 -SNMIVHRDIKGANILRDSAGNVKLGDFGASK---------RLQTICSSGTGMKSVTGTP 171

Query: 281 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
            +MSPE      +  K+DV+S G  ++E+++ K
Sbjct: 172 YWMSPEVISGEGYGRKADVWSVGCTVVEMLTEK 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 94.4 bits (235), Expect = 6e-22
 Identities = 59/206 (28%), Positives = 105/206 (50%), Gaps = 20/206 (9%)

Query: 119 EGGFGTVYKGVIGQG------EIAVKRLL-GKSGQEIKELKNEASVIAQVQHKNLVKLLG 171
           EG FG ++ G++         E+ VK +    S  ++  L  E+ ++  + H+N++ +L 
Sbjct: 16  EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75

Query: 172 CCIEKDER-LLIYEYMPNKSLDCFLFDP-----TKREILDWRTRVQIIKGVAQGLLYLHQ 225
            CIE  E   ++Y YM   +L  FL           + L  +  V +   +A G+ YLH+
Sbjct: 76  VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK 135

Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
                +IH+D+ A N ++D+++  KI+D  ++R +F   D   L  N +R      +M+ 
Sbjct: 136 R---GVIHKDIAARNCVIDEELQVKITDNALSRDLF-PMDYHCLGDNENR---PVKWMAL 188

Query: 286 EYALEGIFSIKSDVFSFGVLLLEIVS 311
           E  +   +S  SDV+SFGVLL E+++
Sbjct: 189 ESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 93.9 bits (233), Expect = 9e-22
 Identities = 61/217 (28%), Positives = 116/217 (53%), Gaps = 36/217 (16%)

Query: 117 LGEGGFGTVYKGVIGQGE----IAVK--RLLGKSGQEIKELKNEASVIAQVQHKNLVKLL 170
           LGEG FG+V +G + Q +    +AVK  ++   +  E+++  +EA  + +  H N+++L+
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 171 GCCIEKDER------LLIYEYMPNKSL----------DCFLFDPTKREILDWRTRVQIIK 214
           G C++  E       ++I  +M +  L          DC  + PT+         V+ + 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQ-------MLVKFMT 119

Query: 215 GVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTS 274
            +A G+ YL   S    IHRDL A N +L+++MN  ++DFG+++ ++ G+     QG  +
Sbjct: 120 DIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYR--QGRIA 174

Query: 275 RISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
           ++     +++ E   + +++ KSDV+SFGV + EI +
Sbjct: 175 KMP--VKWIAIESLADRVYTTKSDVWSFGVTMWEIAT 209

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 93.7 bits (233), Expect = 1e-21
 Identities = 59/206 (28%), Positives = 106/206 (51%), Gaps = 26/206 (12%)

Query: 117 LGEGGFGTVYKGV-IGQGEI-AVKRL-LGKSGQEIKELKNEASVIAQVQH---KNLVKLL 170
           +G G +G VY+G  +  G + A+K + L     ++ +++ E ++++Q++     N+ K  
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVR 230
           G  ++     +I EY    S+   +    K   +  +    II+ V   L Y+H   +V 
Sbjct: 69  GSYLKGPRLWIIMEYAEGGSVRTLM----KAGPIAEKYISVIIREVLVALKYIH---KVG 121

Query: 231 IIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRIS---GTYGYMSPEY 287
           +IHRD+KA+NIL+    N K+ DFG+A           L  N+S+ S   GT  +M+PE 
Sbjct: 122 VIHRDIKAANILVTNTGNVKLCDFGVAA---------LLNQNSSKRSTFVGTPYWMAPEV 172

Query: 288 ALEGI-FSIKSDVFSFGVLLLEIVSG 312
             EG  +  K+D++S G+ + E+ +G
Sbjct: 173 ITEGKYYDTKADIWSLGITIYEMATG 198

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 93.1 bits (231), Expect = 2e-21
 Identities = 65/210 (30%), Positives = 100/210 (47%), Gaps = 34/210 (16%)

Query: 116 KLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKN----------------EASVIA 159
           +LG+G FGTVY          VK     + + +K LK                 EA +++
Sbjct: 7   RLGKGSFGTVY---------LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLS 57

Query: 160 QVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQG 219
           ++ H  +VK     +E+D   +I EY   + LDC L +          +  Q+ +   Q 
Sbjct: 58  KLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTG--KTLSENQVCEWFIQL 115

Query: 220 LLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGT 279
           LL +H   + RI+HRDLKA NI L  ++  KI DFG++R++ G  D        +  +GT
Sbjct: 116 LLGVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDL------ATTFTGT 168

Query: 280 YGYMSPEYALEGIFSIKSDVFSFGVLLLEI 309
             YMSPE      +  KSD++S G +L E+
Sbjct: 169 PYYMSPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 93.7 bits (233), Expect = 2e-21
 Identities = 67/211 (31%), Positives = 103/211 (48%), Gaps = 17/211 (8%)

Query: 110 NFSAANKLGEGGFGTVYK----GVIGQG---EIAVKRLLGKSGQEIKE-LKNEASVIAQV 161
           N S    LG G FG V +    G+       ++AVK L   +    +E L +E  +++ +
Sbjct: 36  NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHL 95

Query: 162 -QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
             H+N+V LLG C      L+I EY     L  FL    +   L     +     VA+G+
Sbjct: 96  GNHENIVNLLGACTIGGPILVITEYCCYGDLLNFL-RRKRESFLTLEDLLSFSYQVAKGM 154

Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY 280
            +L   +    IHRDL A N+LL      KI DFG+AR +   ND + +    +R+    
Sbjct: 155 AFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIM--NDSNYVVKGNARLP--V 207

Query: 281 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
            +M+PE     +++ +SDV+S+G+LL EI S
Sbjct: 208 KWMAPESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 93.5 bits (232), Expect = 2e-21
 Identities = 69/215 (32%), Positives = 106/215 (49%), Gaps = 30/215 (13%)

Query: 116 KLGEGGFGTVYKGV---IGQGE----IAVKRL-LGKSGQEIKELKNEASVIAQVQHKNLV 167
           +LG+G FG VY+G    I +GE    +AVK +    S +E  E  NEASV+      ++V
Sbjct: 13  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72

Query: 168 KLLGCCIEKDERLLIYEYMPNKSLDCFLF-------DPTKREILDWRTRVQIIKGVAQGL 220
           +LLG   +    L++ E M +  L  +L        +   R     +  +Q+   +A G+
Sbjct: 73  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132

Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGT- 279
            YL+     + +HRDL A N ++  D   KI DFGM R        D  + +  R  G  
Sbjct: 133 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR--------DIYETDYYRKGGKG 181

Query: 280 ---YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
                +M+PE   +G+F+  SD++SFGV+L EI S
Sbjct: 182 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 93.5 bits (232), Expect = 2e-21
 Identities = 71/222 (31%), Positives = 114/222 (51%), Gaps = 33/222 (14%)

Query: 116 KLGEGGFGTVY----KGV---IGQGE---------IAVKRLLGKSGQEIK-ELKNEASVI 158
           KLGEG FG V+    +G+   +G+G          +AVK L     +  + +   E  ++
Sbjct: 12  KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71

Query: 159 AQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVA- 217
           +++++ N+++LLG C+  D   +I EYM N  L+ FL   ++REI    T    I  V+ 
Sbjct: 72  SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFL---SQREIESTFTHANNIPSVSI 128

Query: 218 QGLLYLH-------QY-SRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDEL 269
             LLY+        +Y + +  +HRDL   N L+      KI+DFGM+R ++ G D   +
Sbjct: 129 ANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSG-DYYRI 187

Query: 270 QGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
           QG   R      +M+ E  L G F+  SDV++FGV L E+ +
Sbjct: 188 QG---RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 92.9 bits (231), Expect = 3e-21
 Identities = 56/200 (28%), Positives = 107/200 (53%), Gaps = 18/200 (9%)

Query: 117 LGEGGFGTVYKGVIGQGEI--AVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCI 174
           LG+G FG VYK    +  +  A K +  +S +E+++   E  ++++ +H N+V L     
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 175 EKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHR 234
            +++  ++ E+    +LD  +    +R + + + R  + + + + L +LH +   ++IHR
Sbjct: 73  YENKLWILIEFCDGGALDS-IMLELERGLTEPQIRY-VCRQMLEALNFLHSH---KVIHR 127

Query: 235 DLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFS 294
           DLKA NILL  D + K++DFG++       ++  LQ   + I GT  +M+PE      F 
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVS-----AKNKSTLQKRDTFI-GTPYWMAPEVVACETFK 181

Query: 295 -----IKSDVFSFGVLLLEI 309
                 K+D++S G+ L+E+
Sbjct: 182 DNPYDYKADIWSLGITLIEL 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 92.4 bits (229), Expect = 4e-21
 Identities = 72/206 (34%), Positives = 116/206 (56%), Gaps = 25/206 (12%)

Query: 117 LGEGGFGTVYKGV-IGQGE-----IAVKRLL-GKSGQEIKELKNEASVIAQVQHKNLVKL 169
           LG G FGTVYKG+ I  GE     +A+K L    S +  KE+ +EA V+A V    + +L
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74

Query: 170 LGCCIEKDERLLIYEYMPNKSLDCFLFDPTKR----EILDWRTRVQIIKGVAQGLLYLHQ 225
           LG C+    +L + + MP   L  ++ +   R    ++L+W   VQI    A+G+ YL +
Sbjct: 75  LGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWC--VQI----AKGMSYLEE 127

Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
              VR++HRDL A N+L+    + KI+DFG+AR++    DE E   +  ++     +M+ 
Sbjct: 128 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLL--DIDETEYHADGGKVP--IKWMAL 180

Query: 286 EYALEGIFSIKSDVFSFGVLLLEIVS 311
           E  L   F+ +SDV+S+GV + E+++
Sbjct: 181 ESILHRRFTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 92.0 bits (228), Expect = 4e-21
 Identities = 82/279 (29%), Positives = 135/279 (48%), Gaps = 40/279 (14%)

Query: 116 KLGEGGFGTVYKGVIGQ-GEIAVKRLLGKSGQ-EIKELKNEASVIAQVQHKNLVKLLGCC 173
           KLG G FG V+     +  ++AVK +  K G   ++    EA+V+  +QH  LVKL    
Sbjct: 13  KLGAGQFGEVWMATYNKHTKVAVKTM--KPGSMSVEAFLAEANVMKTLQHDKLVKL-HAV 69

Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIK------GVAQGLLYLHQYS 227
           + K+   +I E+M   SL  FL         D  ++  + K       +A+G+ ++ Q +
Sbjct: 70  VTKEPIYIITEFMAKGSLLDFLKS-------DEGSKQPLPKLIDFSAQIAEGMAFIEQRN 122

Query: 228 RVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEY 287
               IHRDL+A+NIL+   +  KI+DFG+AR++   N+    +G    I  T    +PE 
Sbjct: 123 ---YIHRDLRAANILVSASLVCKIADFGLARVI-EDNEYTAREGAKFPIKWT----APEA 174

Query: 288 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVL 347
              G F+IKSDV+SFG+LL+EIV+      + R     +         + ++I  ++   
Sbjct: 175 INFGSFTIKSDVWSFGILLMEIVT------YGRIPYPGM--------SNPEVIRALERGY 220

Query: 348 EEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN 386
                        +I + C + R E+RPT   + S+L +
Sbjct: 221 RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 92.4 bits (229), Expect = 4e-21
 Identities = 64/222 (28%), Positives = 122/222 (54%), Gaps = 19/222 (8%)

Query: 111 FSAANKLGEGGFGTVYKGVIGQGE--IAVKRL-LGKSGQEIKELKNEASVIAQVQHKNLV 167
           F+   ++G+G FG VYKG+  + +  +A+K + L ++  EI++++ E +V++Q     + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 168 KLLGCCIEKDERLLIYEYMPNKS-LDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQY 226
           +  G  ++  +  +I EY+   S LD     P +   +       I++ + +GL YLH  
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYI-----ATILREILKGLDYLHSE 120

Query: 227 SRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPE 286
              R IHRD+KA+N+LL +  + K++DFG+A    G   + +++ NT    GT  +M+PE
Sbjct: 121 ---RKIHRDIKAANVLLSEQGDVKLADFGVA----GQLTDTQIKRNT--FVGTPFWMAPE 171

Query: 287 YALEGIFSIKSDVFSFGVLLLEIVSGK-KNTGFYRTKSLNLI 327
              +  +  K+D++S G+  +E+  G+  N+  +  + L LI
Sbjct: 172 VIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI 213

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 91.1 bits (226), Expect = 6e-21
 Identities = 79/278 (28%), Positives = 127/278 (45%), Gaps = 40/278 (14%)

Query: 116 KLGEGGFGTVYKGVI-GQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCI 174
           +LG G FG V+ G    Q ++A+K +   +  E ++   EA V+ ++ H  LV+L G C 
Sbjct: 11  ELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSE-EDFIEEAKVMMKLSHPKLVQLYGVCT 69

Query: 175 EKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHR 234
           ++    ++ E+M N  L  +L    ++  L     + + + V +G+ YL + S    IHR
Sbjct: 70  QQKPLYIVTEFMENGCLLNYLRQ--RQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHR 124

Query: 235 DLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFS 294
           DL A N L+      K+SDFGM R V      D+   ++S       +  PE      +S
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVL-----DDEYTSSSGAKFPVKWSPPEVFNFSKYS 179

Query: 295 IKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNE 354
            KSDV+SFGVL+ E+ +  K    +  KS N                    V+E  S   
Sbjct: 180 SKSDVWSFGVLMWEVFTEGKMP--FEKKS-NY------------------EVVEMISRGF 218

Query: 355 SLSR------YVH-IALLCVQERAEDRPTMSDVVSMLT 385
            L R       V+ +   C  E+ E RPT ++++  +T
Sbjct: 219 RLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 92.3 bits (229), Expect = 7e-21
 Identities = 75/219 (34%), Positives = 116/219 (52%), Gaps = 31/219 (14%)

Query: 117 LGEGGFGTVYK----GVIGQGE-----IAVKRLL-GKSGQEIKELKNEASVIAQV-QHKN 165
           LGEG FG V +    G+          +AVK L    + +++ +L +E  ++  + +HKN
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSLDCFL-----------FDPTK--REILDWRTRVQI 212
           ++ LLG C ++    +I EY    +L  FL           FD TK   E L ++  V  
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
              VA+G+ YL   SR R IHRDL A N+L+ +D   KI+DFG+AR   G +D D  +  
Sbjct: 140 AYQVARGMEYLE--SR-RCIHRDLAARNVLVTEDNVMKIADFGLAR---GVHDIDYYK-K 192

Query: 273 TSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
           TS       +M+PE   + +++ +SDV+SFG+L+ EI +
Sbjct: 193 TSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 90.6 bits (226), Expect = 1e-20
 Identities = 53/162 (32%), Positives = 85/162 (52%), Gaps = 40/162 (24%)

Query: 116 KLGEGGFGTVYKGV-IGQGEI-AVKRLLGKSGQE------IKELKNEASVIAQVQHKNLV 167
           KLGEG +G VYK      GEI A+K++   + +E      ++E+    S++ +++H N+V
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREI----SLLKELKHPNIV 61

Query: 168 KLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRV-----------QIIKGV 216
           KLL     + +  L++EY      D  L     ++ LD R              Q+++G+
Sbjct: 62  KLLDVIHTERKLYLVFEYC-----DMDL-----KKYLDKRPGPLSPNLIKSIMYQLLRGL 111

Query: 217 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMAR 258
           A    Y H     RI+HRDLK  NIL+++D   K++DFG+AR
Sbjct: 112 A----YCHS---HRILHRDLKPQNILINRDGVLKLADFGLAR 146

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 90.8 bits (225), Expect = 2e-20
 Identities = 66/206 (32%), Positives = 108/206 (52%), Gaps = 21/206 (10%)

Query: 117 LGEGGFGTVY------KGVIGQGEIAVKRLLGKSGQE-IKELKNEASVIAQVQHKNLVKL 169
           LGEG FG V       +G     ++AVK L  +SG   I +LK E  ++  + H+N+VK 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 170 LGCCIEKDER--LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYL--HQ 225
            G C E       LI E++P+ SL  +L  P  +  ++ + +++    + +G+ YL   Q
Sbjct: 72  KGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINLKQQLKYAVQICKGMDYLGSRQ 129

Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
           Y     +HRDL A N+L++ +   KI DFG+ + +    D++         S  + Y +P
Sbjct: 130 Y-----VHRDLAARNVLVESEHQVKIGDFGLTKAI--ETDKEYYTVKDDLDSPVFWY-AP 181

Query: 286 EYALEGIFSIKSDVFSFGVLLLEIVS 311
           E  ++  F I SDV+SFGV L E+++
Sbjct: 182 ECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 90.3 bits (224), Expect = 3e-20
 Identities = 69/220 (31%), Positives = 104/220 (47%), Gaps = 42/220 (19%)

Query: 111 FSAANKLGEGGFGTVY--KGVIGQGEIAVKRLL--GKSGQE-----IKELKNEASVIAQV 161
           F+   ++G G FG VY  + V     +A+K++   GK   E     IKE++     + Q+
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVR----FLQQL 72

Query: 162 QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKR-----EILDWRTRVQIIKGV 216
           +H N ++  GC + +    L+ EY    + D  + +  K+     EI        I  G 
Sbjct: 73  RHPNTIEYKGCYLREHTAWLVMEYCLGSASD--ILEVHKKPLQEVEI------AAICHGA 124

Query: 217 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRI 276
            QGL YLH + R   IHRD+KA NILL +    K++DFG A +V   N            
Sbjct: 125 LQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANS----------F 171

Query: 277 SGTYGYMSPEYAL---EGIFSIKSDVFSFGVLLLEIVSGK 313
            GT  +M+PE  L   EG +  K DV+S G+  +E+   K
Sbjct: 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 211

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 89.2 bits (222), Expect = 4e-20
 Identities = 62/225 (27%), Positives = 100/225 (44%), Gaps = 49/225 (21%)

Query: 115 NKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEI---KELK-------------NEASVI 158
             +G+G FGTV K         V+R   KS  +I   KE+              +E +++
Sbjct: 6   ETIGKGSFGTVRK---------VRR---KSDGKILVWKEIDYGNMTEKEKQQLVSEVNIL 53

Query: 159 AQVQHKNLVKLLGCCIEKD-ERLLIY-EYMPNKSLDCFLFDPTKREILDWRTRV---QII 213
            +++H N+V+     I++  + L I  EY     L   +    K+E    R  +    I 
Sbjct: 54  RELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLI-QKCKKE----RKYIEEEFIW 108

Query: 214 KGVAQGLLYLH-----QYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDE 268
           + + Q LL L+           ++HRDLK +NI LD + N K+ DFG+A+I+   +    
Sbjct: 109 RILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF-- 166

Query: 269 LQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
                    GT  YMSPE      +  KSD++S G L+ E+ +  
Sbjct: 167 ----AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 90.7 bits (225), Expect = 4e-20
 Identities = 73/239 (30%), Positives = 111/239 (46%), Gaps = 52/239 (21%)

Query: 102 SSVSSATGNFSAA----------NKLGEGGFGTVYKGVIGQG---EIAVKRLLGKSGQEI 148
           SS SSA+G+  +A          N++G G  GTVYK VI +      A+K + G     +
Sbjct: 57  SSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYK-VIHRPTGRLYALKVIYGNHEDTV 115

Query: 149 K-ELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWR 207
           + ++  E  ++  V H N+VK         E  ++ E+M   SL+          I D +
Sbjct: 116 RRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLE-------GTHIADEQ 168

Query: 208 TRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDED 267
               + + +  G+ YLH   R  I+HRD+K SN+L++   N KI+DFG++RI+    D  
Sbjct: 169 FLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP- 224

Query: 268 ELQGNTSRISGTYGYMSPE-------------YALEGIFSIKSDVFSFGVLLLEIVSGK 313
               N+S   GT  YMSPE             YA         D++S GV +LE   G+
Sbjct: 225 ---CNSS--VGTIAYMSPERINTDLNHGAYDGYA--------GDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 89.1 bits (221), Expect = 5e-20
 Identities = 80/280 (28%), Positives = 129/280 (46%), Gaps = 39/280 (13%)

Query: 117 LGEGGFGTVYKGV-IGQGEIAVKR--LLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCC 173
           LG G  G+V K   I  G +  K+   +G      K++  E  ++ + +   +V   G  
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 174 IEKDERLLIYEYMPNKSLDCFL--FDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRI 231
           + ++   +  E+M   SLD       P   EIL      +I   V +GL YL  Y+  RI
Sbjct: 73  LNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYL--YNVHRI 125

Query: 232 IHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR-ISGTYGYMSPEYALE 290
           +HRD+K SNIL++     K+ DFG++          EL  + +    GT  YMSPE    
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGVS---------GELINSIADTFVGTSTYMSPERIQG 176

Query: 291 GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEA 350
           G +++KSDV+S G+ ++E+  GK    F    S N+     D  +   I+DL+  +++E 
Sbjct: 177 GKYTVKSDVWSLGISIIELALGK----FPFAFS-NIDDDGQDDPMG--ILDLLQQIVQEP 229

Query: 351 S-------FNESLSRYVHIALLCVQERAEDRPTMSDVVSM 383
                   F E L  +V     C+ +   +RPT   + +M
Sbjct: 230 PPRLPSSDFPEDLRDFVDA---CLLKDPTERPTPQQLCAM 266

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 88.9 bits (220), Expect = 5e-20
 Identities = 64/211 (30%), Positives = 103/211 (48%), Gaps = 22/211 (10%)

Query: 116 KLGEGGFGTVYKGVIG-------QGEIAVKRL-LGKSGQEIKELKNEASVIAQVQHKNLV 167
           +LG+G FG VY+G+         +  +A+K +    S +E  E  NEASV+ +    ++V
Sbjct: 13  ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72

Query: 168 KLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKRE-------ILDWRTRVQIIKGVAQGL 220
           +LLG   +    L+I E M    L  +L                  +  +Q+   +A G+
Sbjct: 73  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132

Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY 280
            YL+     + +HRDL A N ++ +D   KI DFGM R ++    E +      +     
Sbjct: 133 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY----ETDYYRKGGKGLLPV 185

Query: 281 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
            +MSPE   +G+F+  SDV+SFGV+L EI +
Sbjct: 186 RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 89.0 bits (220), Expect = 5e-20
 Identities = 63/207 (30%), Positives = 114/207 (55%), Gaps = 18/207 (8%)

Query: 111 FSAANKLGEGGFGTVYKGVIG--QGEIAVKRL-LGKSGQEIKELKNEASVIAQVQHKNLV 167
           F+   K+G+G FG V+KG+    Q  +A+K + L ++  EI++++ E +V++Q     + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 168 KLLGCCIEKDERLLIYEYMPNKS-LDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQY 226
           K  G  ++  +  +I EY+   S LD  L +P     LD      I++ + +GL YLH  
Sbjct: 66  KYYGSYLKDTKLWIIMEYLGGGSALD--LLEPGP---LDETQIATILREILKGLDYLHSE 120

Query: 227 SRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPE 286
            +   IHRD+KA+N+LL +    K++DFG+A    G   + +++ N     GT  +M+PE
Sbjct: 121 KK---IHRDIKAANVLLSEHGEVKLADFGVA----GQLTDTQIKRN--TFVGTPFWMAPE 171

Query: 287 YALEGIFSIKSDVFSFGVLLLEIVSGK 313
              +  +  K+D++S G+  +E+  G+
Sbjct: 172 VIKQSAYDSKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 89.3 bits (222), Expect = 5e-20
 Identities = 68/229 (29%), Positives = 104/229 (45%), Gaps = 46/229 (20%)

Query: 116 KLGEGGFGTVY----KGVIGQGE--------------IAVKRLL-GKSGQEIKELKNEAS 156
           KLGEG FG V+     G+    E              +AVK L    S    ++   E  
Sbjct: 12  KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71

Query: 157 VIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILD----------- 205
           +++++   N+ +LLG C       +I EYM N  L+ FL    K                
Sbjct: 72  ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFL---QKHVAETSGLACNSKSLS 128

Query: 206 WRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGND 265
           + T + +   +A G+ YL     +  +HRDL   N L+ K+   KI+DFGM+R ++  +D
Sbjct: 129 FSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY-SSD 184

Query: 266 EDELQGNTS---RISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
              +QG      R      +M+ E  L G F+ KSDV++FGV L EI++
Sbjct: 185 YYRVQGRAPLPIR------WMAWESVLLGKFTTKSDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 89.3 bits (222), Expect = 5e-20
 Identities = 55/215 (25%), Positives = 101/215 (46%), Gaps = 41/215 (19%)

Query: 116 KLGEGGFGTVYKG---VIGQGEIAVKRLLGKSGQEIKELKN--EASVIAQVQHKNLVKLL 170
           K+GEG +G VYK    + G+  +A+K++  +   E        E  ++ ++ H N++KLL
Sbjct: 6   KIGEGTYGVVYKARDKLTGE-IVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLL 64

Query: 171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRV-----------QIIKGVAQG 219
                K +  L++E+M          D    +++  R R            Q+++G+A  
Sbjct: 65  DVFRHKGDLYLVFEFM----------DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLA-- 112

Query: 220 LLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGT 279
             + H +    I+HRDLK  N+L++ +   K++DFG+AR              T  +  T
Sbjct: 113 --FCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP-----YTHYVV-T 161

Query: 280 YGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGK 313
             Y +PE  L +  +S   D++S G +  E++S +
Sbjct: 162 RWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 88.4 bits (219), Expect = 7e-20
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 16/203 (7%)

Query: 117 LGEGGFGTVY--KGVIGQGEIAVKRL--LGKSGQEIKELKNEASVIAQVQHKNLVKLLGC 172
           +G G FG V+  +    Q  + +K++     +  E    +NE  V+  + H N+++    
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67

Query: 173 CIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRII 232
            +E    +++ EY P  +L  ++       +LD  T   I+    Q LL LH      I+
Sbjct: 68  FLEDKALMIVMEYAPGGTLAEYIQK-RCNSLLDEDT---ILHFFVQILLALHHVHTKLIL 123

Query: 233 HRDLKASNILLDK-DMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEG 291
           HRDLK  NILLDK  M  KI DFG+++I+         +     + GT  Y+SPE     
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKILSS-------KSKAYTVVGTPCYISPELCEGK 176

Query: 292 IFSIKSDVFSFGVLLLEIVSGKK 314
            ++ KSD+++ G +L E+ S K+
Sbjct: 177 PYNQKSDIWALGCVLYELASLKR 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 89.0 bits (220), Expect = 7e-20
 Identities = 61/207 (29%), Positives = 113/207 (54%), Gaps = 18/207 (8%)

Query: 111 FSAANKLGEGGFGTVYKGVIG--QGEIAVKRL-LGKSGQEIKELKNEASVIAQVQHKNLV 167
           F+   ++G+G FG V+KG+    Q  +A+K + L ++  EI++++ E +V++Q     + 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 168 KLLGCCIEKDERLLIYEYMPNKS-LDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQY 226
           K  G  ++  +  +I EY+   S LD     P      D      ++K + +GL YLH  
Sbjct: 66  KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGP-----FDEFQIATMLKEILKGLDYLHSE 120

Query: 227 SRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPE 286
            +   IHRD+KA+N+LL +  + K++DFG+A    G   + +++ NT    GT  +M+PE
Sbjct: 121 KK---IHRDIKAANVLLSEQGDVKLADFGVA----GQLTDTQIKRNT--FVGTPFWMAPE 171

Query: 287 YALEGIFSIKSDVFSFGVLLLEIVSGK 313
              +  +  K+D++S G+  +E+  G+
Sbjct: 172 VIQQSAYDSKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 89.0 bits (220), Expect = 9e-20
 Identities = 75/279 (26%), Positives = 133/279 (47%), Gaps = 39/279 (13%)

Query: 111 FSAANKLGEGGFGTVY--KGVIGQGEIAVKRLL--GK-SGQEIKELKNEASVIAQVQHKN 165
           FS   ++G G FG VY  + V     +A+K++   GK S ++ +++  E   + +++H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ 225
            ++  GC + +    L+ EY    + D  L +  K+ + +      +  G  QGL YLH 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEI-AAVTHGALQGLAYLHS 133

Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
           ++   +IHRD+KA NILL +    K+ DFG A I+   N             GT  +M+P
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX----------FVGTPYWMAP 180

Query: 286 EYAL---EGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDL 342
           E  L   EG +  K DV+S G+  +E+   ++    +   +++ + +         I   
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYH---------IAQN 229

Query: 343 IDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVV 381
               L+   ++E    +V     C+Q+  +DRPT S+V+
Sbjct: 230 ESPALQSGHWSEYFRNFVDS---CLQKIPQDRPT-SEVL 264

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 88.1 bits (218), Expect = 1e-19
 Identities = 67/208 (32%), Positives = 114/208 (54%), Gaps = 29/208 (13%)

Query: 117 LGEGGFGTVYKGV-IGQGE-----IAVKRLLGKSG-QEIKELKNEASVIAQVQHKNLVKL 169
           LG G FGTV+KG+ I +G+     +A+K +  +SG Q  +E+ +    +  + H  +V+L
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74

Query: 170 LGCCIEKDERLLIYEYMPNKSLDCFL------FDPTKREILDWRTRVQIIKGVAQGLLYL 223
           LG C     +L + +  P  SL   +       DP +  +L+W   VQI    A+G+ YL
Sbjct: 75  LGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDPQR--LLNWC--VQI----AKGMYYL 125

Query: 224 HQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYM 283
            ++   R++HR+L A NILL  D   +I+DFG+A +++     D+ +   S       +M
Sbjct: 126 EEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLY----PDDKKYFYSEHKTPIKWM 178

Query: 284 SPEYALEGIFSIKSDVFSFGVLLLEIVS 311
           + E  L G ++ +SDV+S+GV + E++S
Sbjct: 179 ALESILFGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 87.7 bits (217), Expect = 1e-19
 Identities = 70/208 (33%), Positives = 113/208 (54%), Gaps = 21/208 (10%)

Query: 116 KLGEGGFGTVYKGVI----GQGEIAVKRLLGKSGQE-IK-ELKNEASVIAQVQHKNLVKL 169
           +LG G FGTV KG+      +  +AVK L   +    +K EL  EA+V+ Q+ +  +V++
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 170 LGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRV 229
           +G C E +  +L+ E      L+ FL    K + +  +   +++  V+ G+ YL + +  
Sbjct: 62  IGIC-EAESWMLVMELAELGPLNKFL---QKNKHVTEKNITELVHQVSMGMKYLEETN-- 115

Query: 230 RIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY--GYMSPEY 287
             +HRDL A N+LL     +KISDFG+++ +  G DE+  +  T    G +   + +PE 
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSKAL--GADENYYKAKT---HGKWPVKWYAPEC 169

Query: 288 ALEGIFSIKSDVFSFGVLLLEIVS-GKK 314
                FS KSDV+SFGVL+ E  S G+K
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWEAFSYGQK 197

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 88.6 bits (219), Expect = 1e-19
 Identities = 62/201 (30%), Positives = 108/201 (53%), Gaps = 18/201 (8%)

Query: 116 KLGEGGFGTVYKGVIGQGEI--AVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCC 173
           +LG+G FG VYK    +     A K +  KS +E+++   E  ++A   H  +VKLLG  
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78

Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
               +  ++ E+ P  ++D  + +   R + + + +V I + + + L YLH    ++IIH
Sbjct: 79  YWDGKLWIMIEFCPGGAVDAIMLE-LDRGLTEPQIQV-ICRQMLEALQYLHS---MKIIH 133

Query: 234 RDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL---- 289
           RDLKA N+LL  D + K++DFG++       +   LQ   S I GT  +M+PE  +    
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVS-----AKNVKTLQRRDSFI-GTPYWMAPEVVMCETM 187

Query: 290 -EGIFSIKSDVFSFGVLLLEI 309
            +  +  K+D++S G+ L+E+
Sbjct: 188 KDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 87.7 bits (217), Expect = 2e-19
 Identities = 69/223 (30%), Positives = 112/223 (50%), Gaps = 34/223 (15%)

Query: 116 KLGEGGFGTVY----KGVIGQGE--------------IAVKRLLGKSGQEIK-ELKNEAS 156
           KLGEG FG V+    +G+    +              +AVK L   + +  + +   E  
Sbjct: 12  KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71

Query: 157 VIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLF------DPTKREI--LDWRT 208
           ++++++  N+++LL  CI  D   +I EYM N  L+ FL          K ++  + + T
Sbjct: 72  IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131

Query: 209 RVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDE 268
            + +   +A G+ YL   S +  +HRDL   N L+ K+   KI+DFGM+R ++ G D   
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSG-DYYR 187

Query: 269 LQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
           +QG   R      +MS E  L G F+  SDV++FGV L EI++
Sbjct: 188 IQG---RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 86.5 bits (214), Expect = 3e-19
 Identities = 65/209 (31%), Positives = 111/209 (53%), Gaps = 23/209 (11%)

Query: 116 KLGEGGFGTVYKGVI----GQGEIAVKRLLGKSGQE---IKELKNEASVIAQVQHKNLVK 168
           +LG G FG V KGV      Q ++A+K L  K+  E     E+  EA ++ Q+ +  +V+
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVL--KNENEKSVRDEMMREAEIMHQLDNPYIVR 59

Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSR 228
           ++G C E +  +L+ E      L+ FL    K++ +     V+++  V+ G+ YL   + 
Sbjct: 60  MIGVC-EAEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKN- 115

Query: 229 VRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY--GYMSPE 286
              +HRDL A N+LL     +KISDFG+++ +  G D+       +R +G +   + +PE
Sbjct: 116 --FVHRDLAARNVLLVNQHYAKISDFGLSKAL--GADDSYY---KARSAGKWPLKWYAPE 168

Query: 287 YALEGIFSIKSDVFSFGVLLLEIVS-GKK 314
                 FS +SDV+S+G+ + E  S G+K
Sbjct: 169 CINFRKFSSRSDVWSYGITMWEAFSYGQK 197

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 87.0 bits (216), Expect = 3e-19
 Identities = 54/184 (29%), Positives = 87/184 (47%), Gaps = 33/184 (17%)

Query: 116 KLGEGGFGTVYK-GVIGQGEI-AVKRLLGKSGQE--IKELKNEASVIAQVQHKNLVKLL- 170
           ++GEG  G V+K      GE  A+K++  +  +     +   E   +   QH  +VKLL 
Sbjct: 7   RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66

Query: 171 ----GCCIEKDERLLIYEYMPNKSLDCFLFD----PTKREILDWRTRVQIIKGVAQGLLY 222
               G        +L+ EYMP+  L   L D      + ++        ++KGVA    Y
Sbjct: 67  VFPHGSGF-----VLVMEYMPS-DLSEVLRDEERPLPEAQVK--SYMRMLLKGVA----Y 114

Query: 223 LHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGY 282
           +H      I+HRDLK +N+L+  D   KI+DFG+AR+      E+E +  + ++  T  Y
Sbjct: 115 MHA---NGIMHRDLKPANLLISADGVLKIADFGLARL----FSEEEPRLYSHQV-ATRWY 166

Query: 283 MSPE 286
            +PE
Sbjct: 167 RAPE 170

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 86.2 bits (213), Expect = 3e-19
 Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 14/200 (7%)

Query: 116 KLGEGGFGTVYKGVI--GQGEIAVKRLLGKSGQEIK-ELKNEASVIAQVQHKNLVKLLGC 172
           ++G G FG V+ G +      +AVK        ++K +   EA ++ Q  H N+V+L+G 
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61

Query: 173 CIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRII 232
           C +K    ++ E +       FL     R  L  +  +Q+++  A G+ YL        I
Sbjct: 62  CTQKQPIYIVMELVQGGDFLTFLRTEGPR--LKVKELIQMVENAAAGMEYLESKH---CI 116

Query: 233 HRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGT-YGYMSPEYALEG 291
           HRDL A N L+ +    KISDFGM+R      +ED +  +T  +      + +PE    G
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR-----EEEDGVYASTGGMKQIPVKWTAPEALNYG 171

Query: 292 IFSIKSDVFSFGVLLLEIVS 311
            +S +SDV+SFG+LL E  S
Sbjct: 172 RYSSESDVWSFGILLWEAFS 191

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 86.6 bits (214), Expect = 4e-19
 Identities = 62/201 (30%), Positives = 108/201 (53%), Gaps = 18/201 (8%)

Query: 116 KLGEGGFGTVYKGVIGQGEI--AVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCC 173
           +LG+G FG VYK    +  +  A K +  KS +E+++   E  ++A   H N+VKLL   
Sbjct: 12  ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
             ++   ++ E+    ++D  + +  +R + + + RV + K   + L YLH+    +IIH
Sbjct: 72  YYENNLWILIEFCAGGAVDAVMLE-LERPLTEPQIRV-VCKQTLEALNYLHEN---KIIH 126

Query: 234 RDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL---- 289
           RDLKA NIL   D + K++DFG++       +   +Q   S I GT  +M+PE  +    
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVS-----AKNTRTIQRRDSFI-GTPYWMAPEVVMCETS 180

Query: 290 -EGIFSIKSDVFSFGVLLLEI 309
            +  +  K+DV+S G+ L+E+
Sbjct: 181 KDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 85.8 bits (213), Expect = 5e-19
 Identities = 57/207 (27%), Positives = 103/207 (49%), Gaps = 22/207 (10%)

Query: 115 NKLGEGGFGTVYKGV-IGQGEI-AVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGC 172
            ++G G +G VYK   I  GE+ A+K +  + G + + ++ E S++ + +H N+V   G 
Sbjct: 9   QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68

Query: 173 CIEKDERLLIYEYMPNKSLD---CFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRV 229
            + +D+  ++ EY    SL         P     + +  R        +GL YLH+  + 
Sbjct: 69  YLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCR-----ETLKGLAYLHETGK- 122

Query: 230 RIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL 289
             IHRD+K +NILL +D + K++DFG++  +        +    S I GT  +M+PE A 
Sbjct: 123 --IHRDIKGANILLTEDGDVKLADFGVSAQLT-----ATIAKRKSFI-GTPYWMAPEVAA 174

Query: 290 E---GIFSIKSDVFSFGVLLLEIVSGK 313
               G +  K D+++ G+  +E+   +
Sbjct: 175 VERKGGYDGKCDIWALGITAIELAELQ 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 86.6 bits (214), Expect = 6e-19
 Identities = 69/279 (24%), Positives = 126/279 (45%), Gaps = 38/279 (13%)

Query: 111 FSAANKLGEGGFGTVYKGVIGQ-GEIAVKRLLGKSGQEIKE----LKNEASVIAQVQHKN 165
           F   +++G G FG VY        E+   + +  SG++  E    +  E   + Q++H N
Sbjct: 23  FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82

Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ 225
            ++  GC +++    L+ EY    + D  L +  K+ + +      I  G  QGL YLH 
Sbjct: 83  TIEYKGCYLKEHTAWLVMEYCLGSASD--LLEVHKKPLQEVEI-AAITHGALQGLAYLHS 139

Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
           ++   +IHRD+KA NILL +    K++DFG A      N             GT  +M+P
Sbjct: 140 HN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS----------FVGTPYWMAP 186

Query: 286 EYAL---EGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDL 342
           E  L   EG +  K DV+S G+  +E+   ++    +   +++ + +         I   
Sbjct: 187 EVILAMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYH---------IAQN 235

Query: 343 IDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVV 381
               L+   + +S   +V     C+Q+  ++RP  ++++
Sbjct: 236 DSPTLQSNEWTDSFRGFVD---YCLQKIPQERPASAELL 271

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 86.5 bits (214), Expect = 6e-19
 Identities = 68/220 (30%), Positives = 108/220 (49%), Gaps = 19/220 (8%)

Query: 98  LFSFSSVSSATGNFSAANKLGEGGFGTVYKGV---IGQGEIAVKRLLGKSGQEIKELK-N 153
           L +  SV      ++   K+G+G  GTVY  +    GQ E+A+K++     Q  KEL  N
Sbjct: 8   LRTIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQ-EVAIKQM-NLQQQPKKELIIN 65

Query: 154 EASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQII 213
           E  V+ + +H N+V  L   +  DE  ++ EY+   SL     D      +D      + 
Sbjct: 66  EILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVC 121

Query: 214 KGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNT 273
           +   Q L +LH     ++IHRD+K+ NILL  D + K++DFG     F      E Q   
Sbjct: 122 RECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG-----FCAQITPE-QSKR 172

Query: 274 SRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           S + GT  +M+PE      +  K D++S G++ +E+V G+
Sbjct: 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 85.6 bits (212), Expect = 8e-19
 Identities = 62/206 (30%), Positives = 97/206 (47%), Gaps = 18/206 (8%)

Query: 116 KLGEGGFGTVYKGVIGQGE-----IAVKRLLGKSGQEIKEL-KNEASVIAQVQHKNLVKL 169
            +GEG FG VY+GV    E     +AVK     +   ++E    EA ++ Q  H ++VKL
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 170 LGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRV 229
           +G   E +   ++ E  P   L  +L     +  LD  + +     ++  L YL      
Sbjct: 73  IGVITE-NPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLES---K 126

Query: 230 RIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL 289
           R +HRD+ A N+L+      K+ DFG++R +     EDE     S+      +M+PE   
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYL-----EDESYYKASKGKLPIKWMAPESIN 181

Query: 290 EGIFSIKSDVFSFGVLLLEIVS-GKK 314
              F+  SDV+ FGV + EI+  G K
Sbjct: 182 FRRFTSASDVWMFGVCMWEILMLGVK 207

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 85.2 bits (211), Expect = 1e-18
 Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 17/207 (8%)

Query: 110 NFSAANKLGEGGFGTV---YKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNL 166
                 K+GEG  G V        G+ ++AVK++  +  Q  + L NE  ++   QH N+
Sbjct: 20  YLDNFVKIGEGSTGIVCIATDKSTGR-QVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78

Query: 167 VKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQY 226
           V++    +  DE  ++ E++   +L     D      ++      +   V + L +LH  
Sbjct: 79  VEMYSSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLAVLKALSFLHAQ 134

Query: 227 SRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPE 286
               +IHRD+K+ +ILL  D   K+SDFG     F      E+    S + GT  +M+PE
Sbjct: 135 ---GVIHRDIKSDSILLTSDGRVKLSDFG-----FCAQVSKEVPRRKSLV-GTPYWMAPE 185

Query: 287 YALEGIFSIKSDVFSFGVLLLEIVSGK 313
                 +  + D++S G++++E+V G+
Sbjct: 186 VISRLPYGTEVDIWSLGIMVIEMVDGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 85.0 bits (210), Expect = 1e-18
 Identities = 60/217 (27%), Positives = 112/217 (51%), Gaps = 23/217 (10%)

Query: 111 FSAANKLGEGGFGTVYKGVIGQGE-----IAVKRLLGK--SGQEIKELKNEASVIAQVQH 163
           F+    LG+G FG+V +  +   +     +AVK L     S  +I+E   EA+ + +  H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 164 KNLVKLLGCCIEKDER------LLIYEYMPNKSLDCFLFDPTKRE---ILDWRTRVQIIK 214
            N++KL+G  +    +      ++I  +M +  L  FL      E    L  +T V+ + 
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120

Query: 215 GVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTS 274
            +A G+ YL   S    IHRDL A N +L+++M   ++DFG+++ ++ G+     QG  S
Sbjct: 121 DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYR--QGCAS 175

Query: 275 RISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
           ++     +++ E   + +++  SDV++FGV + EI++
Sbjct: 176 KLP--VKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 85.9 bits (212), Expect = 1e-18
 Identities = 76/280 (27%), Positives = 129/280 (46%), Gaps = 38/280 (13%)

Query: 111 FSAANKLGEGGFGTVY--KGVIGQGEIAVKRLL--GK-SGQEIKELKNEASVIAQVQHKN 165
           F+   ++G G FG VY  + V     +A+K++   GK S ++ +++  E   + +++H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ 225
            ++  GC + +    L+ EY    + D  L +  K+ + +      I  G  QGL YLH 
Sbjct: 87  SIEYKGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEI-AAITHGALQGLAYLHS 143

Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
           ++   +IHRD+KA NILL +    K++DFG A I    N             GT  +M+P
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANS----------FVGTPYWMAP 190

Query: 286 EYAL---EGIFSIKSDVFSFGVLLLEIVSGK-------KNTGFY---RTKSLNLIGYAWD 332
           E  L   EG +  K DV+S G+  +E+   K         +  Y   + +S  L    W 
Sbjct: 191 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWS 250

Query: 333 LWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAE 372
            +  N     +DS L++   +   S  +   +  ++ER E
Sbjct: 251 DYFRN----FVDSCLQKIPQDRPTSEELLKHMFVLRERPE 286

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 84.8 bits (209), Expect = 2e-18
 Identities = 61/217 (28%), Positives = 108/217 (49%), Gaps = 23/217 (10%)

Query: 109 GNFSAANKLGEGGFGTVYKGV-IGQGEIAVKRLLGKSGQEIKELKNEASVIAQV-QHKNL 166
           G F     +G G +G VYKG  +  G++A  +++  +G E +E+K E +++ +   H+N+
Sbjct: 6   GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNI 65

Query: 167 VKLLGCCIEK------DERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
               G  I+K      D+  L+ E+    S+   L   TK   L       I + + +GL
Sbjct: 66  ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSV-TDLIKNTKGNTLKEEWIAYICREILRGL 124

Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY 280
            +LHQ+   ++IHRD+K  N+LL ++   K+ DFG++  +      D   G  +   GT 
Sbjct: 125 SHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL------DRTVGRRNTFIGTP 175

Query: 281 GYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSG 312
            +M+PE        +  +  KSD++S G+  +E+  G
Sbjct: 176 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 84.5 bits (210), Expect = 2e-18
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 43/216 (19%)

Query: 116 KLGEGGFGTVYKGV-IGQGEI-AVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLG 171
           +LG+G FG+VY       GE+ A+K++  K  S +E   L+   S+    +H N+VKL  
Sbjct: 6   QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKE 65

Query: 172 CCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQ--------IIKGVAQGLLYL 223
              E DE   ++EYM     +  L+   K      R            II  + QGL ++
Sbjct: 66  VFRENDELYFVFEYM-----EGNLYQLMKD-----RKGKPFSESVIRSIIYQILQGLAHI 115

Query: 224 HQ--YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN---TSRISG 278
           H+  +      HRDLK  N+L+      KI+DFG+AR         E++     T  +S 
Sbjct: 116 HKHGF-----FHRDLKPENLLVSGPEVVKIADFGLAR---------EIRSRPPYTDYVS- 160

Query: 279 TYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGK 313
           T  Y +PE  L    +S   D+++ G ++ E+ + +
Sbjct: 161 TRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 85.1 bits (210), Expect = 2e-18
 Identities = 69/219 (31%), Positives = 112/219 (51%), Gaps = 31/219 (14%)

Query: 117 LGEGGFGTVYKG-VIGQGE--------IAVKRLLGKSGQ-EIKELKNEASVIAQV-QHKN 165
           LGEG FG V     IG  +        +AVK L   + + ++ +L +E  ++  + +HKN
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSLDCFL-----------FDPTK--REILDWRTRVQI 212
           ++ LLG C +     +I EY    +L  +L           ++PT+   E L ++  V  
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
              VA+G+ YL   +  + IHRDL A N+L+ +D   KI+DFG+AR +       +    
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI----HHIDYYKK 198

Query: 273 TSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
           T+       +M+PE   + I++ +SDV+SFGVLL EI +
Sbjct: 199 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 84.7 bits (209), Expect = 2e-18
 Identities = 69/214 (32%), Positives = 109/214 (50%), Gaps = 29/214 (13%)

Query: 117 LGEGGFGTVYKGVI---GQGEIAVKRLLGK--SGQEIKELKNEASVIAQV-QHKNLVKLL 170
           +GEG FG V + +I   G    A  ++L +  S  + ++   E  V+ ++  H N++ LL
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69

Query: 171 GCCIEKDERLLIYEYMPNKSLDCFL-------FDPT-KRE-----ILDWRTRVQIIKGVA 217
           G C  +    +  EY P  +L  FL        DP   +E      L  +  +Q    VA
Sbjct: 70  GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129

Query: 218 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRIS 277
            G+ YL   S  + IHRDL A N+L+ +++ SKI+DFG++R      +E  ++    R+ 
Sbjct: 130 TGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR-----GEEVYVKKTMGRLP 181

Query: 278 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
               +M+ E     +++ KSDV+SFGVLL EIVS
Sbjct: 182 --VRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 83.5 bits (207), Expect = 3e-18
 Identities = 62/207 (29%), Positives = 92/207 (44%), Gaps = 27/207 (13%)

Query: 120 GGFGTVY---KGVIGQGEIAVK-----RLLGKSGQEIKELKNEASVIAQVQHKNLVKLLG 171
           G +G V+   K   G    A+K      ++ K+  ++ ++  E  +++Q Q   +VKL  
Sbjct: 4   GAYGRVFLAKKKSTGD-IYAIKVIKKADMIRKN--QVDQVLTERDILSQAQSPYVVKLYY 60

Query: 172 CCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRI 231
               K    L+ EY+P   L   L        LD       I  +   L YLH      I
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLL---ENVGSLDEDVARIYIAEIVLALEYLHSNG---I 114

Query: 232 IHRDLKASNILLDKDMNSKISDFG------MARIVFGGNDEDELQGNTSRISGTYGYMSP 285
           IHRDLK  NIL+D + + K++DFG      + R +   +DE E      RI GT  Y++P
Sbjct: 115 IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE----DKRIVGTPDYIAP 170

Query: 286 EYALEGIFSIKSDVFSFGVLLLEIVSG 312
           E  L    S   D +S G +L E + G
Sbjct: 171 EVILGQGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 84.7 bits (209), Expect = 4e-18
 Identities = 71/220 (32%), Positives = 115/220 (52%), Gaps = 33/220 (15%)

Query: 117 LGEGGFGTVYKG-VIGQGE--------IAVKRLLGK-SGQEIKELKNEASVIAQV-QHKN 165
           LGEG FG V     IG  +        +AVK L    + +++ +L +E  ++  + +HKN
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSLDCFL-----------FDPTK--REILDWRTRVQI 212
           ++ LLG C +     ++ EY    +L  +L           FD  K   E L ++  V  
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
              VA+G+ YL   +  + IHRDL A N+L+ +D   KI+DFG+AR V   ++ D  +  
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDV---HNIDYYKKT 193

Query: 273 TS-RISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
           T+ R+     +M+PE   + +++ +SDV+SFGVLL EI +
Sbjct: 194 TNGRLP--VKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 83.6 bits (206), Expect = 4e-18
 Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 29/214 (13%)

Query: 117 LGEGGFGTVYKGVIGQGEI---AVKRLLGKSGQEI--KELKNEASVIAQV-QHKNLVKLL 170
           +GEG FG V K  I +  +   A  + + +   +   ++   E  V+ ++  H N++ LL
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 171 GCCIEKDERLLIYEYMPNKSLDCFL-------FDPT-KRE-----ILDWRTRVQIIKGVA 217
           G C  +    L  EY P+ +L  FL        DP           L  +  +     VA
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122

Query: 218 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRIS 277
           +G+ YL   S+ + IHRDL A NIL+ ++  +KI+DFG++R       E  ++    R+ 
Sbjct: 123 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGRLP 174

Query: 278 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
               +M+ E     +++  SDV+S+GVLL EIVS
Sbjct: 175 --VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 83.3 bits (206), Expect = 5e-18
 Identities = 81/296 (27%), Positives = 140/296 (47%), Gaps = 46/296 (15%)

Query: 110 NFSAANKLGEGGFGTVY---KGVIGQGEIAVKRL------LGKSGQE----IKELKNEAS 156
            ++    LG G FG VY   K   GQ  +A+K +       GK  +E    I ++ +E +
Sbjct: 1   EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60

Query: 157 VI-AQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSL-DCFLFDPTKREILD----WRTRV 210
           +I  Q++H N+V+     +E D   ++ + +    L + F     K++       W   V
Sbjct: 61  IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120

Query: 211 QIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQ 270
           Q++      L YLH+  R  I+HRDL  +NI+L +D    I+DFG+A+       E +L 
Sbjct: 121 QMV----LALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKL- 170

Query: 271 GNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYA 330
             TS + GT  Y  PE      +  K+DV++FG +L ++ +      FY T  L+L    
Sbjct: 171 --TSVV-GTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT--LQPPFYSTNMLSL---- 221

Query: 331 WDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN 386
                + KI++ +   L E  ++E ++  +     C+   AE RP +  V +M+++
Sbjct: 222 -----ATKIVEAVYEPLPEGMYSEDVTDVIT---SCLTPDAEARPDIIQVSAMISD 269

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 82.9 bits (205), Expect = 5e-18
 Identities = 69/230 (30%), Positives = 105/230 (45%), Gaps = 58/230 (25%)

Query: 110 NFSAANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELK-------------NEAS 156
           +F    KLG+G +G+VYK         VKRL       +KE+              NE  
Sbjct: 1   DFKVLKKLGKGSYGSVYK---------VKRLSDNQFYALKEVDLGSMSQKEREDAVNEIR 51

Query: 157 VIAQVQHKNLVK-----LLGC--CIEKDERLLIYEYMPNKSLDCFLFDPTKR-----EIL 204
           ++A V H N++      L G   CI       + EY P   L   +    K+     E  
Sbjct: 52  ILASVNHPNIISYKEAFLDGNKLCI-------VMEYAPFGDLSKAISKRKKKRKLIPEQE 104

Query: 205 DWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGN 264
            WR  +Q+++G    L  LH+    +I+HRDLK++NILL  +   KI D G++++     
Sbjct: 105 IWRIFIQLLRG----LQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKV----- 152

Query: 265 DEDELQGNTSRIS-GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
               L+ N ++   GT  YM+PE      +S KSD++S G LL E+ +  
Sbjct: 153 ----LKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFA 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 83.6 bits (206), Expect = 5e-18
 Identities = 64/218 (29%), Positives = 108/218 (49%), Gaps = 15/218 (6%)

Query: 98  LFSFSSVSSATGNFSAANKLGEGGFGTVYKGV-IGQG-EIAVKRLLGKSGQEIKELKNEA 155
           L S  SV      ++   K+G+G  GTVY  + I  G E+A+K++  +   + + + NE 
Sbjct: 8   LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEI 67

Query: 156 SVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKG 215
            V+ + ++ N+V  L   +  DE  ++ EY+   SL     D      +D      + + 
Sbjct: 68  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 123

Query: 216 VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR 275
             Q L +LH     ++IHRD+K+ NILL  D + K++DFG     F      E Q   S 
Sbjct: 124 CLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG-----FCAQITPE-QSKRST 174

Query: 276 ISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           + GT  +M+PE      +  K D++S G++ +E+V G+
Sbjct: 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 83.1 bits (206), Expect = 6e-18
 Identities = 61/205 (29%), Positives = 92/205 (44%), Gaps = 24/205 (11%)

Query: 117 LGEGGFGTVYK-GVIGQGEIAVKRLLGKS-----GQEIKELKNEASVIAQVQHKNLVKLL 170
           LG GGFG V    V  +      + + K      GQ+ + + +E  ++ +  H  +VKL 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQ-EHIFSEKEILEECNHPFIVKLY 59

Query: 171 GCCIEKDERLL--IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSR 228
                KD++ +  + EY     L   L D   R + D  T    I  V     YLH    
Sbjct: 60  --RTFKDKKYIYMLMEYCLGGELWTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG- 113

Query: 229 VRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYA 288
             II+RDLK  N+LLD +   K+ DFG A+ +  G         T    GT  Y++PE  
Sbjct: 114 --IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-------KTWTFCGTPEYVAPEII 164

Query: 289 LEGIFSIKSDVFSFGVLLLEIVSGK 313
           L   +    D +S G+LL E+++G+
Sbjct: 165 LNKGYDFSVDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 83.5 bits (206), Expect = 6e-18
 Identities = 67/219 (30%), Positives = 107/219 (48%), Gaps = 39/219 (17%)

Query: 117 LGEGGFGTVYKGVIGQG----EIAVKRLLGKSGQEI-KELKNEASVIAQV-QHKNLVKLL 170
           +GEG FG V K  I +     + A+KR+   + ++  ++   E  V+ ++  H N++ LL
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74

Query: 171 GCCIEKDERLLIYEYMPNKSLDCFL-------FDP------TKREILDWRTRVQIIKGVA 217
           G C  +    L  EY P+ +L  FL        DP      +    L  +  +     VA
Sbjct: 75  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134

Query: 218 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRIS 277
           +G+ YL   S+ + IHRDL A NIL+ ++  +KI+DFG++R            G    + 
Sbjct: 135 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR------------GQEVYVK 179

Query: 278 GTYG-----YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
            T G     +M+ E     +++  SDV+S+GVLL EIVS
Sbjct: 180 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 82.9 bits (205), Expect = 6e-18
 Identities = 78/289 (26%), Positives = 128/289 (44%), Gaps = 43/289 (14%)

Query: 108 TGNFSAANKLGEGGFGTVYKG-------VIGQGEIAVKRLLGKSGQE--IKELKNEASVI 158
            GNF    K+G+G F  VYK        V+   ++ +  ++    ++  +KE+     ++
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEID----LL 56

Query: 159 AQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFL--FDPTKREILD---WRTRVQII 213
            Q+ H N++K L   IE +E  ++ E      L   +  F   KR I +   W+  VQ+ 
Sbjct: 57  KQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQL- 115

Query: 214 KGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNT 273
                 L ++H     RI+HRD+K +N+ +      K+ D G+ R         +     
Sbjct: 116 ---CSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFF-----SSKTTAAH 164

Query: 274 SRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDL 333
           S + GT  YMSPE   E  ++ KSD++S G LL E+ + +  + FY  K +NL    + L
Sbjct: 165 SLV-GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ--SPFYGDK-MNL----YSL 216

Query: 334 WISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVS 382
               KI       L    ++E L   V     C+    E RP +S V+ 
Sbjct: 217 C--KKIEKCDYPPLPADHYSEELRDLVSR---CINPDPEKRPDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 83.2 bits (205), Expect = 7e-18
 Identities = 62/218 (28%), Positives = 103/218 (47%), Gaps = 15/218 (6%)

Query: 98  LFSFSSVSSATGNFSAANKLGEGGFGTVYKGV-IGQGEIAVKRLLGKSGQEIKELK-NEA 155
           L S  SV      ++   K+G+G  GTVY  + +  G+    R +    Q  KEL  NE 
Sbjct: 9   LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68

Query: 156 SVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKG 215
            V+ + ++ N+V  L   +  DE  ++ EY+   SL     D      +D      + + 
Sbjct: 69  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 124

Query: 216 VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR 275
             Q L +LH     ++IHRD+K+ NILL  D + K++DFG    +         Q   S 
Sbjct: 125 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI------TPEQSKRST 175

Query: 276 ISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           + GT  +M+PE      +  K D++S G++ +E++ G+
Sbjct: 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 83.4 bits (206), Expect = 7e-18
 Identities = 65/234 (27%), Positives = 112/234 (47%), Gaps = 48/234 (20%)

Query: 116 KLGEGGFGTVYKGVIGQGE------------------IAVKRLLGKSGQEIK-ELKNEAS 156
           KLGEG FG V+   +   +                  +AVK L   + +  + +   E  
Sbjct: 12  KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71

Query: 157 VIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILD----------- 205
           ++++++  N+++LLG C+++D   +I EYM N  L+ FL   +   + D           
Sbjct: 72  ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFL---SSHHLDDKEENGNDAVPP 128

Query: 206 --------WRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMA 257
                   + + + +   +A G+ YL   S +  +HRDL   N L+ +++  KI+DFGM+
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185

Query: 258 RIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
           R ++ G D   +QG   R      +M+ E  L G F+  SDV++FGV L EI+ 
Sbjct: 186 RNLYAG-DYYRIQG---RAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 83.5 bits (207), Expect = 7e-18
 Identities = 54/176 (30%), Positives = 87/176 (49%), Gaps = 30/176 (17%)

Query: 105 SSATGNFSAANKLGEGGFGTVYKGV-IGQGE-IAVKRLL---GKSGQEIKELKNEASVIA 159
            S   ++    KLGEG FG VYK   I  G  +A+K++L    K G  I  L+ E  ++ 
Sbjct: 4   CSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILK 62

Query: 160 QVQHKNLVKLLGCCIEK-----DERLLIYEYMP--NKSLDCFLFDPTKREILDWRTRVQ- 211
           +++H N+V L+   +E+      +R  +Y   P  +  L   L +P          ++  
Sbjct: 63  KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENP--------SVKLTE 114

Query: 212 -----IIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFG 262
                 +  + +G+ YLH+     I+HRD+KA+NIL+D     KI+DFG+AR   G
Sbjct: 115 SQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDG 167

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 82.9 bits (205), Expect = 7e-18
 Identities = 66/206 (32%), Positives = 98/206 (47%), Gaps = 24/206 (11%)

Query: 117 LGEGGFGTVYK-GVIGQGEI-AVKRL----LGKSGQEIKELKNEASVIAQVQHKNLVKLL 170
           LG+GGFG V    V   G++ A K+L    L K   E   L NE  ++ +V  + +V L 
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMAL-NEKKILEKVSSRFIVSLA 59

Query: 171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTR---VQIIKGVAQGLLYLHQYS 227
                KD+  L+   M    L   +++  +    + R      QII     GL +LHQ  
Sbjct: 60  YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQII----CGLEHLHQ-- 113

Query: 228 RVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEY 287
             RI++RDLK  N+LLD   N +ISD G+A  + GG             +GT GYM+PE 
Sbjct: 114 -RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK-------KIKGRAGTPGYMAPEV 165

Query: 288 ALEGIFSIKSDVFSFGVLLLEIVSGK 313
               ++    D F+ G  L E+++G+
Sbjct: 166 LQGEVYDFSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 82.1 bits (202), Expect = 2e-17
 Identities = 58/219 (26%), Positives = 108/219 (49%), Gaps = 17/219 (7%)

Query: 98  LFSFSSVSSATGNFSAANKLGEGGFGTVYKGV---IGQGEIAVKRLLGKSGQEIKELKNE 154
           L +  S+      ++   K+G+G  GTV+  +    GQ E+A+K++  +   + + + NE
Sbjct: 8   LRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQ-EVAIKQINLQKQPKKELIINE 66

Query: 155 ASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIK 214
             V+ ++++ N+V  L   +  DE  ++ EY+   SL     D      +D      + +
Sbjct: 67  ILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCR 122

Query: 215 GVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTS 274
              Q L +LH     ++IHRD+K+ N+LL  D + K++DFG    +         Q   S
Sbjct: 123 ECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQI------TPEQSKRS 173

Query: 275 RISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
            + GT  +M+PE      +  K D++S G++ +E+V G+
Sbjct: 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 82.0 bits (202), Expect = 2e-17
 Identities = 72/247 (29%), Positives = 124/247 (50%), Gaps = 38/247 (15%)

Query: 90  EKEVDQFPLFSFSSVSSATGNFSAANKLGEGGFGTVYKG-VIGQGE--------IAVKRL 140
           E E+ + P + FS         +    LGEG FG V     +G  +        +AVK L
Sbjct: 1   EYELPEDPRWEFSR-----DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKML 55

Query: 141 LGKSGQ-EIKELKNEASVIAQV-QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFL--- 195
              + + ++ +L +E  ++  + +HKN++ LLG C +     +I EY    +L  +L   
Sbjct: 56  KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRAR 115

Query: 196 --------FDPTK--REILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDK 245
                   +D  +   E + ++  V     VA+G+ YL   +  + IHRDL A N+L+ +
Sbjct: 116 RPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTE 172

Query: 246 DMNSKISDFGMARIVFGGNDEDELQGNTS-RISGTYGYMSPEYALEGIFSIKSDVFSFGV 304
           +   KI+DFG+AR V   N+ D  +  T+ R+     +M+PE   + +++ +SDV+SFGV
Sbjct: 173 NNVMKIADFGLARDV---NNIDYYKKTTNGRLP--VKWMAPEALFDRVYTHQSDVWSFGV 227

Query: 305 LLLEIVS 311
           L+ EI +
Sbjct: 228 LMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 81.0 bits (200), Expect = 4e-17
 Identities = 64/213 (30%), Positives = 112/213 (52%), Gaps = 24/213 (11%)

Query: 110 NFSAANKLGEGGFGTVYKG-------VIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQ 162
           NF    KLGEG + TVYKG       ++   EI +    G     I+E+    S++ +++
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREI----SLMKELK 56

Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLY 222
           H+N+V+L      +++ +L++EYM +K L  ++     R  LD  T       + +G+ +
Sbjct: 57  HENIVRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAF 115

Query: 223 LHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNT-SRISGTYG 281
            H+    R++HRDLK  N+L++K    K++DFG+AR  FG      +  NT S    T  
Sbjct: 116 CHEN---RVLHRDLKPQNLLINKRGELKLADFGLAR-AFG------IPVNTFSNEVVTLW 165

Query: 282 YMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGK 313
           Y +P+  L    +S   D++S G ++ E+++G+
Sbjct: 166 YRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 80.2 bits (198), Expect = 5e-17
 Identities = 63/206 (30%), Positives = 104/206 (50%), Gaps = 22/206 (10%)

Query: 117 LGEGGFGTVYKGVI---GQGEI--AVKRLLGKSG-QEIKELKNEASVIAQVQHKNLVKLL 170
           +G+G FG VY G +      +I  AVK L   +  +E+++   E  ++    H N++ LL
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 171 GCCIEKD-ERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKG----VAQGLLYLHQ 225
           G C+  +   L++  YM +  L  F+   T          V+ + G    VA+G+ YL  
Sbjct: 63  GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPT------VKDLIGFGLQVAKGMEYLAS 116

Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
               + +HRDL A N +LD+    K++DFG+AR ++  + E     N +       +M+ 
Sbjct: 117 K---KFVHRDLAARNCMLDESFTVKVADFGLARDIY--DKEYYSVHNHTGAKLPVKWMAL 171

Query: 286 EYALEGIFSIKSDVFSFGVLLLEIVS 311
           E      F+ KSDV+SFGVLL E+++
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 79.9 bits (197), Expect = 9e-17
 Identities = 70/264 (26%), Positives = 124/264 (46%), Gaps = 30/264 (11%)

Query: 117 LGEGGFGTVYKG--VIGQGEIAVKRLLGKSGQEI-KELKNEASVIAQVQHKNLVKLLGCC 173
           LG G  GTVYK   ++ +  +AVK +      E+ K++ +E  ++ +     ++   G  
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68

Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
             ++   +  E+M   SLD +   P   E +  R  V ++KG    L YL     ++I+H
Sbjct: 69  FVENRISICTEFMDGGSLDVYRKIP---EHVLGRIAVAVVKG----LTYLWS---LKILH 118

Query: 234 RDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRI-SGTYGYMSPEYALEGI 292
           RD+K SN+L++     K+ DFG++          +L  + ++   GT  YM+PE      
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVST---------QLVNSIAKTYVGTNAYMAPERISGEQ 169

Query: 293 FSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASF 352
           + I SDV+S G+  +E+  G+    F   +     G    L +   I+D    VL    F
Sbjct: 170 YGIHSDVWSLGISFMELALGR----FPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQF 225

Query: 353 NESLSRYVHIALLCVQERAEDRPT 376
           +E    +VH    C++++ ++RP 
Sbjct: 226 SEK---FVHFITQCMRKQPKERPA 246

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 79.6 bits (197), Expect = 1e-16
 Identities = 61/228 (26%), Positives = 103/228 (45%), Gaps = 37/228 (16%)

Query: 107 ATGNFSAANKLGEGGFGTVYKGV-IGQGEIAVKRLLGKSGQEIKELKNEASVIAQV-QHK 164
            TG F     +GEG +G VYK      G++   +++     E +E+K E +++ +   H 
Sbjct: 4   PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHP 63

Query: 165 NLVKLLGCCIEK------DERLLIYEY--------MPNKSLDCFLFDPTKREILDWRTRV 210
           N+    G  I+K      D+  L+ E         +             K E + +    
Sbjct: 64  NIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKG--KRLKEEWIAY---- 117

Query: 211 QIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQ 270
            I++   +GL YLH+    ++IHRD+K  NILL K+   K+ DFG++  +    D    +
Sbjct: 118 -ILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQL----DSTLGR 169

Query: 271 GNTSRISGTYGYMSPE-----YALEGIFSIKSDVFSFGVLLLEIVSGK 313
            NT    GT  +M+PE        +  +  +SDV+S G+  +E+  GK
Sbjct: 170 RNTF--IGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 79.7 bits (197), Expect = 1e-16
 Identities = 62/216 (28%), Positives = 112/216 (51%), Gaps = 42/216 (19%)

Query: 116 KLGEGGFGTVYKG--VIGQGEIAVKRLLGKSGQE------IKELKNEASVIAQVQHKNLV 167
           K+GEG +G VYK    +    +A+K++  ++  E      I+E+    S++ ++ H N+V
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREI----SLLKELNHPNIV 61

Query: 168 KLLGCCIEKDERL-LIYEYMPNKSLDCFL---FDPTKREILDWRTRV-----QIIKGVAQ 218
           +LL   +  + +L L++E+     LD  L    D +    LD    +     Q+++G+A 
Sbjct: 62  RLLDV-VHSENKLYLVFEF-----LDLDLKKYMDSSPLTGLD-PPLIKSYLYQLLQGIA- 113

Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
              Y H +   R++HRDLK  N+L+D++   K++DFG+AR  FG      ++  T  +  
Sbjct: 114 ---YCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARA-FG----VPVRTYTHEVV- 161

Query: 279 TYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGK 313
           T  Y +PE  L    +S   D++S G +  E+V+ +
Sbjct: 162 TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 79.2 bits (195), Expect = 1e-16
 Identities = 72/293 (24%), Positives = 118/293 (40%), Gaps = 47/293 (16%)

Query: 115 NKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQ------------VQ 162
           +++G G FG V  G   +G ++  R++      +KEL+  A+   Q            + 
Sbjct: 1   DEIGNGWFGKVLLGEAHRG-MSKARVV------VKELRASATPDEQLLFLQEVQPYRELN 53

Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQ--IIKGVAQGL 220
           H N+++ LG CIE    LL+ E+ P   L  +L           +  V   +   VA GL
Sbjct: 54  HPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGL 113

Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY 280
           L+LHQ      IH DL   N  L  D++ KI D+G+A        ED             
Sbjct: 114 LWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLA---LEQYPEDYYITKDCHAV-PL 166

Query: 281 GYMSPEYALEGIFSI-------KSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDL 333
            +++PE        +       KS+++S GV + E+ +       Y   S        D 
Sbjct: 167 RWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP--YPDLS--------DE 216

Query: 334 WISNKIIDLIDSVLEEASFNESLS-RYVHIALLCVQERAEDRPTMSDVVSMLT 385
            +  +++   D  L +   +   S R+  +   C  +  E RPT  +V  +LT
Sbjct: 217 QVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCWLD-PETRPTAEEVHELLT 268

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 78.8 bits (194), Expect = 1e-16
 Identities = 65/216 (30%), Positives = 103/216 (47%), Gaps = 29/216 (13%)

Query: 110 NFSAANKLGEGGFGTVY--KGVIGQGEIAVKR--LLGKSGQEIKELKNEASVIAQVQHKN 165
            +    K+GEG FG +Y  K         +K   L     +E +  K E  ++A+++H N
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60

Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSL-------DCFLFDPTKREILDWRTRVQIIKGVAQ 218
           +V       E     ++ EY     L          LF  ++ +IL W   VQI    + 
Sbjct: 61  IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLF--SEDQILSWF--VQI----SL 112

Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKD-MNSKISDFGMARIVFGGNDEDELQGNTSRIS 277
           GL ++H     +I+HRD+K+ NI L K+ M +K+ DFG+AR +   ND  EL        
Sbjct: 113 GLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL---NDSMEL---AYTCV 163

Query: 278 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           GT  Y+SPE      ++ K+D++S G +L E+ + K
Sbjct: 164 GTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLK 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 79.4 bits (196), Expect = 1e-16
 Identities = 61/213 (28%), Positives = 110/213 (51%), Gaps = 23/213 (10%)

Query: 110 NFSAANKLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQE------IKELKNEASVIAQV 161
           +++   K+GEG +G VYKG        +A+K++  +S +E      I+E+    S++ ++
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREI----SLLKEL 56

Query: 162 QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLL 221
           QH N+V L    +++    LI+E++ +  L  +L    K + +D       +  + QG+L
Sbjct: 57  QHPNIVCLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGIL 115

Query: 222 YLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYG 281
           + H     R++HRDLK  N+L+D     K++DFG+AR  FG      ++  T  +  T  
Sbjct: 116 FCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLAR-AFG----IPVRVYTHEVV-TLW 166

Query: 282 YMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
           Y +PE  L    +S   D++S G +  E+ + K
Sbjct: 167 YRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 78.9 bits (194), Expect = 1e-16
 Identities = 75/289 (25%), Positives = 128/289 (44%), Gaps = 43/289 (14%)

Query: 109 GNFSAANKLGEGGFGTVYKG--VIGQGEIAVKRLL------GKSGQE-IKELKNEASVIA 159
            NF    K+G G F  VY+   ++    +A+K++        K+  + IKE+     ++ 
Sbjct: 2   ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEI----DLLK 57

Query: 160 QVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFL--FDPTKREILD---WRTRVQIIK 214
           Q+ H N++K     IE +E  ++ E      L   +  F   KR I +   W+  VQ+  
Sbjct: 58  QLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCS 117

Query: 215 GVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTS 274
            +       H +SR R++HRD+K +N+ +      K+ D G+ R                
Sbjct: 118 ALE------HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA------AH 164

Query: 275 RISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLW 334
            + GT  YMSPE   E  ++ KSD++S G LL E+ + +  + FY  K +NL        
Sbjct: 165 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ--SPFYGDK-MNLYS------ 215

Query: 335 ISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM 383
           +  KI       L    ++E L + V+   +C+    E RP ++ V  +
Sbjct: 216 LCKKIEQCDYPPLPSDHYSEELRQLVN---MCINPDPEKRPDITYVYDV 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 78.2 bits (192), Expect = 3e-16
 Identities = 65/219 (29%), Positives = 108/219 (49%), Gaps = 30/219 (13%)

Query: 110 NFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLL-----GKSGQEIKELKNEASVIAQVQ 162
           N+     LG+G FG VY    V    E+A K++       ++ +E+  L+ E  ++  +Q
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62

Query: 163 HKNLVKLLGCCIEKDERLL--IYEYMPNKSLDCFL--FDPTKREILDWRTRVQIIKGVAQ 218
           H+ +V+  GC  ++ E+ L    EYMP  S+   L  +      +    TR QI++G++ 
Sbjct: 63  HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTR-QILEGMS- 120

Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMAR----IVFGGNDEDELQGNTS 274
              YLH      I+HRD+K +NIL D   N K+ DFG ++    I   G           
Sbjct: 121 ---YLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGT-------GIR 167

Query: 275 RISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
            ++GT  +MSPE      +  K+DV+S G  ++E+++ K
Sbjct: 168 SVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 77.8 bits (192), Expect = 4e-16
 Identities = 81/303 (26%), Positives = 140/303 (46%), Gaps = 66/303 (21%)

Query: 111 FSAAN-----KLGEGGFGTVYKGVIGQG--EIAVKRL-LGKSGQEIKELKNEASVIAQVQ 162
           F+A +     ++G G FGTV K +       +AVKR+      +E K L  +  V+ +  
Sbjct: 1   FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS 60

Query: 163 H-KNLVKLLGCCIEKDERLLIYEYMPNKSLDCF---LFDPTKREILDWRTRVQIIKGVA- 217
               +VK  G    + +  +  E M + SLD F   +++  K  I +     +I+  +A 
Sbjct: 61  DCPYIVKFYGALFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPE-----EILGKIAV 114

Query: 218 ---QGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTS 274
              + L YL +   ++IIHRD+K SNILLD++ N K+ DFG++     G   D +    +
Sbjct: 115 ATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGIS-----GQLVDSIA--KT 165

Query: 275 RISGTYGYMSPE----YALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYA 330
           R +G   YM+PE     A +G + ++SDV+S G+ L E+ +GK               + 
Sbjct: 166 RDAGCRPYMAPERIDPSARDG-YDVRSDVWSLGITLYEVATGK---------------FP 209

Query: 331 WDLWISNKIIDLIDSVL----------EEASFNESLSRYVHIALLCVQERAEDRPTMSDV 380
           +  W  N + D +  V+          EE  F+ S   +++   LC+ +    RP   ++
Sbjct: 210 YPKW--NSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFIN---LCLIKDESKRPKYKEL 264

Query: 381 VSM 383
           +  
Sbjct: 265 LEH 267

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 77.5 bits (191), Expect = 4e-16
 Identities = 77/283 (27%), Positives = 131/283 (46%), Gaps = 51/283 (18%)

Query: 117 LGEGGFG--TVYK-----GVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKL 169
           LG+G FG  T+Y+      ++   E+ + RL   S +E ++  NE  +++ +QH N++  
Sbjct: 8   LGKGAFGEATLYRRTEDDSLVVWKEVNLTRL---SEKERRDALNEIVILSLLQHPNIIAY 64

Query: 170 LGCCIEKDERLLI-YEYMPNKSL-------DCFLFDPTKREILDWRTRVQIIKGVAQGLL 221
                  D  LLI  EY    +L          LF+  +  +L +    QI+  V+    
Sbjct: 65  YNH-FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFE--EEMVLWYL--FQIVSAVS---- 115

Query: 222 YLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYG 281
           Y+H+     I+HRD+K  NI L K    K+ DFG+++I+       E     + + GT  
Sbjct: 116 YIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKIL-----GSEYSMAET-VVGTPY 166

Query: 282 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIID 341
           YMSPE      ++ KSD+++ G +L E+++ K+   F  T  LNL+          KI+ 
Sbjct: 167 YMSPELCQGVKYNFKSDIWALGCVLYELLTLKRT--FDATNPLNLV---------VKIVQ 215

Query: 342 LIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML 384
              +    + ++  L   VH     +Q+  E RPT  +V+   
Sbjct: 216 GNYTP-VVSVYSSELISLVH---SLLQQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 78.0 bits (193), Expect = 4e-16
 Identities = 51/167 (30%), Positives = 82/167 (49%), Gaps = 38/167 (22%)

Query: 115 NKLGEGGFGTVYKG---VIGQGEIAVKRLLGKSGQEIKELKN--------EASVIAQVQH 163
            KLGEG +  VYK      G+  +A+K++  K G E KE K+        E  ++ +++H
Sbjct: 6   KKLGEGTYAVVYKARDKETGR-IVAIKKI--KLG-ERKEAKDGINFTALREIKLLQELKH 61

Query: 164 KNLVKLLGCCIEKDERLLIYEYMP--------NKSLDCFLFDPTKREILDWRTRVQIIKG 215
            N++ LL     K    L++E+M         +KS+   L     +  +     +  +  
Sbjct: 62  PNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSI--VLTPADIKSYM-----LMTL-- 112

Query: 216 VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFG 262
             +GL YLH      I+HRDLK +N+L+  D   K++DFG+AR  FG
Sbjct: 113 --RGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARS-FG 153

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 77.6 bits (192), Expect = 5e-16
 Identities = 69/218 (31%), Positives = 100/218 (45%), Gaps = 54/218 (24%)

Query: 117 LGEGGFGTV----YKGVIGQGEI-AVKRLLGKSGQEIKELK------NEASVIAQVQHKN 165
           LG G FG V    +KG    G+  A+K L   S  +I +LK      NE  ++  ++H  
Sbjct: 9   LGTGSFGRVMLVRHKG---SGKYYALKIL---SKAKIVKLKQVEHVLNEKRILQSIRHPF 62

Query: 166 LVKLLGCCIEKDERLL--IYEYMPNKSLDCF-LFDPTKREILDWRTRVQIIKGVAQGLL- 221
           LV L G    +D+  L  + EY+P   L  F     + R       R       AQ +L 
Sbjct: 63  LVNLYGS--FQDDSNLYLVMEYVPGGEL--FSHLRKSGRFPEPV-ARFY----AAQVVLA 113

Query: 222 --YLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGT 279
             YLH      I++RDLK  N+LLD D   KI+DFG A+ V         +G T  + GT
Sbjct: 114 LEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRV---------KGRTYTLCGT 161

Query: 280 YGYMSPEYALEGIFSIK-----SDVFSFGVLLLEIVSG 312
             Y++PE     I   K      D ++ G+L+ E+++G
Sbjct: 162 PEYLAPE-----IILSKGYGKAVDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 77.7 bits (192), Expect = 5e-16
 Identities = 58/211 (27%), Positives = 109/211 (51%), Gaps = 32/211 (15%)

Query: 115 NKLGEGGFGTVYKG--VIGQGEIAVKRL---LGKSGQEIKELKNEASVIAQVQ---HKNL 166
            ++GEG +GTVYK   +     +A+K++   L + G  +  L+ E +++ Q++   H N+
Sbjct: 5   AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLR-EIALLKQLESFEHPNI 63

Query: 167 VKLLGCC-IEKDER----LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLL 221
           V+LL  C   + +R     L++E++ ++ L  +L    K  +     +  +++ + +G+ 
Sbjct: 64  VRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIK-DLMRQLLRGVD 121

Query: 222 YLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG--- 278
           +LH +   RI+HRDLK  NIL+  D   KI+DFG+ARI                ++    
Sbjct: 122 FLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIY----------SFEMALTSVVV 168

Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEI 309
           T  Y +PE  L+  ++   D++S G +  E+
Sbjct: 169 TLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 77.4 bits (190), Expect = 6e-16
 Identities = 77/285 (27%), Positives = 127/285 (44%), Gaps = 43/285 (15%)

Query: 110 NFSAANKLGEGGFGTVYKGV--IGQGEIAVKRLL------GKSGQE-IKELKNEASVIAQ 160
           NF    K+G G F  VY+    + +  +A+K++        K+ Q+ +KE+     ++ Q
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEI----DLLKQ 58

Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFL--FDPTKREILD---WRTRVQIIKG 215
           + H N++K L   IE +E  ++ E      L   +  F   KR I +   W+  VQ+   
Sbjct: 59  LNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSA 118

Query: 216 VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR 275
           V       H +SR R++HRD+K +N+ +      K+ D G+ R         +     S 
Sbjct: 119 VE------HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFF-----SSKTTAAHSL 166

Query: 276 ISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWI 335
           + GT  YMSPE   E  ++ KSD++S G LL E+ +    + FY  K +NL        +
Sbjct: 167 V-GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA--LQSPFYGDK-MNLFS------L 216

Query: 336 SNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDV 380
             KI       L    ++E L   V    +C+    + RP +  V
Sbjct: 217 CQKIEQCDYPPLPTEHYSEKLRELVS---MCIYPDPDQRPDIGYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 77.4 bits (191), Expect = 7e-16
 Identities = 57/205 (27%), Positives = 96/205 (46%), Gaps = 22/205 (10%)

Query: 116 KLGEGGFGTVYKG-VIGQGEI-AVKRLLGKSGQEIKELKN----EASVIAQVQHKNLVKL 169
            +GEG +G V K      GEI A+K+   K  ++ +++K     E  V+ Q++H+N+V L
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKF--KESEDDEDVKKTALREVKVLRQLRHENIVNL 65

Query: 170 LGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRV-QIIKGVAQGLLYLHQYSR 228
                 K    L++EY+    L+     P        R+ + Q+++ +A    Y H    
Sbjct: 66  KEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIA----YCH---S 118

Query: 229 VRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYA 288
             IIHRD+K  NIL+ +    K+ DFG AR +            T  ++ T  Y +PE  
Sbjct: 119 HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL----TDYVA-TRWYRAPELL 173

Query: 289 LEGIFSIKS-DVFSFGVLLLEIVSG 312
           +      K  DV++ G ++ E++ G
Sbjct: 174 VGDTNYGKPVDVWAIGCIMAELLDG 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 78.0 bits (192), Expect = 8e-16
 Identities = 73/262 (27%), Positives = 107/262 (40%), Gaps = 73/262 (27%)

Query: 117 LGEGGFGTVYKG-VIGQGE------IAVKRL-LGKSGQEIKELKNEASVIAQV-QHKNLV 167
           LG G FG V +    G  +      +AVK L  G +  E K L  E  ++  +  H N+V
Sbjct: 15  LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVV 74

Query: 168 KLLGCCIEKDERLL-IYEYMPNKSLDCFL------FDPTKREILDWRTRVQIIKGVAQGL 220
            LLG C +    L+ I EY    +L  +L      F P + +    R R    K   +  
Sbjct: 75  NLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNK--STRKREMKQKEGKKQR 132

Query: 221 L--------------------------------------------YLHQYSR-------V 229
           L                                            Y  Q +R        
Sbjct: 133 LDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASR 192

Query: 230 RIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL 289
           + IHRDL A NILL ++   KI DFG+AR ++   D D ++   +R+     +M+PE   
Sbjct: 193 KCIHRDLAARNILLSENNVVKICDFGLARDIY--KDPDYVRKGDARLP--LKWMAPESIF 248

Query: 290 EGIFSIKSDVFSFGVLLLEIVS 311
           + +++ +SDV+SFGVLL EI S
Sbjct: 249 DKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 77.4 bits (191), Expect = 8e-16
 Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 32/210 (15%)

Query: 117 LGEGGFGTV----YKGVIGQGEI-AVKRLLGKSG-----QEIKELKNEASVIAQV-QHKN 165
           LG+G FG V     KG     E+ AVK L  K        +++    E  V+A   +H  
Sbjct: 3   LGKGSFGKVLLAELKGT---DELYAVKVL--KKDVILQDDDVECTMTEKRVLALAGKHPF 57

Query: 166 LVKLLGCCIEKDERL-LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLH 224
           L +L   C +  +RL  + EY+    L   +F   +    D          +  GL +LH
Sbjct: 58  LTQLH-SCFQTKDRLFFVMEYVNGGDL---MFHIQRSGRFDEPRARFYAAEIVLGLQFLH 113

Query: 225 QYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR-ISGTYGYM 283
           +     II+RDLK  N+LLD + + KI+DFGM +       E  L G T+    GT  Y+
Sbjct: 114 ERG---IIYRDLKLDNVLLDSEGHIKIADFGMCK-------EGILGGVTTSTFCGTPDYI 163

Query: 284 SPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           +PE      +    D ++ GVLL E+++G+
Sbjct: 164 APEILSYQPYGPAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 76.8 bits (189), Expect = 1e-15
 Identities = 64/219 (29%), Positives = 113/219 (51%), Gaps = 36/219 (16%)

Query: 110 NFSAANKLGEGGFGTVYKG---VIGQGEIAVKRLL------GKSGQEIKELKNEASVIAQ 160
           NF    K+GEG +G VYK    + G+  +A+K++       G     I+E+    S++ +
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGE-VVALKKIRLDTETEGVPSTAIREI----SLLKE 55

Query: 161 VQHKNLVKLLGCCIEKDERL-LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKG---- 215
           + H N+VKLL   I  + +L L++E++ ++ L  F+       I      + +IK     
Sbjct: 56  LNHPNIVKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASPLSGI-----PLPLIKSYLFQ 108

Query: 216 VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR 275
           + QGL + H +   R++HRDLK  N+L++ +   K++DFG+AR  FG      ++  T  
Sbjct: 109 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFG----VPVRTYTHE 160

Query: 276 ISGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGK 313
           +  T  Y +PE  L    +S   D++S G +  E+V+ +
Sbjct: 161 VV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 76.6 bits (188), Expect = 1e-15
 Identities = 59/225 (26%), Positives = 109/225 (48%), Gaps = 23/225 (10%)

Query: 101 FSSVSSATGNFSAANKLGEGGFGTVYKGV-IGQGEIAVKRLLGKSGQEIKELKNEASVIA 159
            S++    G F     +G G +G VYKG  +  G++A  +++  +  E +E+K E +++ 
Sbjct: 8   LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLK 67

Query: 160 QV-QHKNLVKLLGCCIEK------DERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQI 212
           +   H+N+    G  I+K      D+  L+ E+    S+   L   TK   L       I
Sbjct: 68  KYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSV-TDLVKNTKGNALKEDWIAYI 126

Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
            + + +GL +LH +   ++IHRD+K  N+LL ++   K+ DFG++  +      D   G 
Sbjct: 127 CREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL------DRTVGR 177

Query: 273 TSRISGTYGYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSG 312
            +   GT  +M+PE        +  +  +SD++S G+  +E+  G
Sbjct: 178 RNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 76.2 bits (187), Expect = 1e-15
 Identities = 64/219 (29%), Positives = 105/219 (47%), Gaps = 30/219 (13%)

Query: 110 NFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLL-----GKSGQEIKELKNEASVIAQVQ 162
           N+     LG+G FG VY         E+AVK++       ++ +E+  L+ E  ++  + 
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 163 HKNLVKLLGCCIEKDERLL--IYEYMPNKSLDCFL--FDPTKREILDWRTRVQIIKGVAQ 218
           H+ +V+  GC  +  ER L    E+MP  S+   L  +      +    TR QI++GV  
Sbjct: 63  HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTR-QILEGV-- 119

Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMAR----IVFGGNDEDELQGNTS 274
              YLH      I+HRD+K +NIL D   N K+ DFG ++    I   G           
Sbjct: 120 --SYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGT-------GMK 167

Query: 275 RISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
            ++GT  +MSPE      +  K+D++S G  ++E+++ K
Sbjct: 168 SVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 76.4 bits (188), Expect = 1e-15
 Identities = 66/215 (30%), Positives = 113/215 (52%), Gaps = 39/215 (18%)

Query: 116 KLGEGGFGTVYKGV--IGQGEIAVKRLL------GKSGQEIKELKNEASVIAQVQHKNLV 167
           K+GEG +G VYK    +    IA+K++       G     I+E+    S++ ++QH N+V
Sbjct: 9   KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREI----SLLKEMQHGNIV 64

Query: 168 KLLGCCIEKDERL-LIYEYMP---NKSLDC---FLFDPTKREILDWRTRVQIIKGVAQGL 220
           +L    +  ++RL L++EY+     K +D    F  +P   +   +    QI++G+A   
Sbjct: 65  RLQDV-VHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLY----QILRGIA--- 116

Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNS-KISDFGMARIVFGGNDEDELQGNTSRISGT 279
            Y H +   R++HRDLK  N+L+D+  N+ K++DFG+AR  FG      ++  T  +  T
Sbjct: 117 -YCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLAR-AFG----IPVRTFTHEVV-T 166

Query: 280 YGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGK 313
             Y +PE  L    +S   D++S G +  E+V+ K
Sbjct: 167 LWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 75.8 bits (187), Expect = 1e-15
 Identities = 63/255 (24%), Positives = 108/255 (42%), Gaps = 33/255 (12%)

Query: 110 NFSAANKLGEGGFGTVY-------KGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQ 162
           +F     +G+G FG V        K +     +  ++ + K    ++ + NE  ++ ++ 
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEK--GSVRNVLNERRILQELN 58

Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQI-IKGVAQGLL 221
           H  LV L     +++   L+ + +    L    +  +++       +V+  I  +   L 
Sbjct: 59  HPFLVNLWYSFQDEENMYLVVDLLLGGDLR---YHLSQKVKFS-EEQVKFWICEIVLALE 114

Query: 222 YLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYG 281
           YLH      IIHRD+K  NILLD+  +  I+DF +A  V            T+  SGT G
Sbjct: 115 YLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-------LTTSTSGTPG 164

Query: 282 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYA--------WDL 333
           YM+PE      +S+  D +S GV   E + GK+    +     + I              
Sbjct: 165 YMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPAT 224

Query: 334 WISNKIIDLIDSVLE 348
           W S + ID I+ +LE
Sbjct: 225 W-STEAIDAINKLLE 238

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 75.1 bits (184), Expect = 3e-15
 Identities = 64/219 (29%), Positives = 105/219 (47%), Gaps = 30/219 (13%)

Query: 110 NFSAANKLGEGGFGTVY--KGVIGQGEIAVKRL-----LGKSGQEIKELKNEASVIAQVQ 162
           N+     LG G FG VY         E+AVK++       ++ +E+  L+ E  ++  ++
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 163 HKNLVKLLGCCIEKDERLL--IYEYMPNKSLDCFL--FDPTKREILDWRTRVQIIKGVAQ 218
           H  +V+  GC  + +E+ L    EYMP  S+   L  +      +    TR QI++GV+ 
Sbjct: 63  HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTR-QILQGVS- 120

Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMAR----IVFGGNDEDELQGNTS 274
              YLH      I+HRD+K +NIL D   N K+ DFG ++    I   G           
Sbjct: 121 ---YLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGT-------GIK 167

Query: 275 RISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
            ++GT  +MSPE      +  K+DV+S    ++E+++ K
Sbjct: 168 SVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 75.0 bits (184), Expect = 3e-15
 Identities = 60/202 (29%), Positives = 98/202 (48%), Gaps = 18/202 (8%)

Query: 117 LGEGGFGTVYKGVI---GQGE--IAVKRL-LGKSGQEIKELKNEASVIAQVQHKNLVKLL 170
           LG G FG + +G +    + E  +A+  L  G S ++ +    EA  + Q  H N+V+L 
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72

Query: 171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKRE-ILDWRTRVQIIKGVAQGLLYLHQYSRV 229
           G     +  +++ EYM N +LD FL    K E  L     + ++ G+A G+ YL   S +
Sbjct: 73  GVITRGNTMMIVTEYMSNGALDSFL---RKHEGQLVAGQLMGMLPGLASGMKYL---SEM 126

Query: 230 RIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL 289
             +H+ L A  +L++ D+  KIS F          D+ E    T        + +PE   
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKISGFRR-----LQEDKSEAIYTTMSGKSPVLWAAPEAIQ 181

Query: 290 EGIFSIKSDVFSFGVLLLEIVS 311
              FS  SDV+SFG+++ E++S
Sbjct: 182 YHHFSSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 75.0 bits (184), Expect = 4e-15
 Identities = 59/204 (28%), Positives = 99/204 (48%), Gaps = 20/204 (9%)

Query: 117 LGEGGFGTVYK-GVIGQGEIAV------KRLLGKSGQEIKELKNEASVIAQVQHKNLVKL 169
           LG+GGFG V    V   G++        KRL  KSG+++  L+ E  ++ +V    +V L
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKE--ILEKVNSPFIVNL 58

Query: 170 LGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRV 229
                 K    L+   M    L   +++  +R  L+    +     +  G+L+LH    +
Sbjct: 59  AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERG-LEMERVIHYSAQITCGILHLHS---M 114

Query: 230 RIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL 289
            I++RD+K  N+LLD   N ++SD G+A  +  G          ++ +GT GYM+PE   
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-------TITQRAGTNGYMAPEILK 167

Query: 290 EGIFSIKSDVFSFGVLLLEIVSGK 313
           E  +S   D F+ G  + E+V+G+
Sbjct: 168 EEPYSYPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 74.8 bits (184), Expect = 6e-15
 Identities = 58/226 (25%), Positives = 98/226 (43%), Gaps = 54/226 (23%)

Query: 110 NFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGK---SGQEIKELKNEASVIAQVQHK 164
           +      +G G FG V+  +  I +   A+K +        ++ + + NE  V+ +V H 
Sbjct: 2   DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61

Query: 165 NLVKLLGCCIEKDERLL--IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQ---- 218
            +++L     E D+R L  + EY+P   L  +L           R   +           
Sbjct: 62  FIIRLF--WTEHDQRFLYMLMEYVPGGELFSYL-----------RNSGRFSNSTGLFYAS 108

Query: 219 ----GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTS 274
                L YLH      I++RDLK  NILLDK+ + K++DFG A+         +L+  T 
Sbjct: 109 EIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAK---------KLRDRTW 156

Query: 275 RISGTYGYMSPEYALEGIFSIKS-------DVFSFGVLLLEIVSGK 313
            + GT  Y++PE        I+S       D ++ G+L+ E++ G 
Sbjct: 157 TLCGTPEYLAPE-------VIQSKGHNKAVDWWALGILIYEMLVGY 195

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 74.7 bits (183), Expect = 6e-15
 Identities = 57/207 (27%), Positives = 107/207 (51%), Gaps = 25/207 (12%)

Query: 116 KLGEGGFGTVYKG---VIGQGEIAVKRLLGKSGQEIKELKN--EASVIAQVQ---HKNLV 167
           ++GEG +G V+K      G   +A+KR+  ++G+E   L    E +V+  ++   H N+V
Sbjct: 8   EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67

Query: 168 KLLGCCI----EKDERL-LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLY 222
           +L   C     +++ +L L++E++ ++ L  +L D      +   T   ++  + +GL +
Sbjct: 68  RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDF 125

Query: 223 LHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGY 282
           LH +   R++HRDLK  NIL+      K++DFG+ARI          Q   + +  T  Y
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY-------SFQMALTSVVVTLWY 175

Query: 283 MSPEYALEGIFSIKSDVFSFGVLLLEI 309
            +PE  L+  ++   D++S G +  E+
Sbjct: 176 RAPEVLLQSSYATPVDLWSVGCIFAEM 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 74.0 bits (182), Expect = 8e-15
 Identities = 61/216 (28%), Positives = 103/216 (47%), Gaps = 39/216 (18%)

Query: 117 LGEGGFGTVYK------GVIGQGEIAVKRLLGK-SGQEIKELKNEASVIAQVQH-KNLVK 168
           LG G +G V K      G I    +AVKR+    + QE K L  +  +  +       V 
Sbjct: 9   LGRGAYGVVDKMRHVPTGTI----MAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVT 64

Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCF---LFDPTKR---EILDWRTRVQIIKGVAQGLLY 222
             G    + +  +  E M + SLD F   ++D       +IL      +I   + + L Y
Sbjct: 65  FYGALFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILG-----KIAVSIVKALEY 118

Query: 223 LHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGY 282
           LH  S++ +IHRD+K SN+L++++   K+ DFG++     G   D +       +G   Y
Sbjct: 119 LH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGIS-----GYLVDSVAKTID--AGCKPY 169

Query: 283 MSPE-----YALEGIFSIKSDVFSFGVLLLEIVSGK 313
           M+PE        +G + +KSDV+S G+ ++E+ +G+
Sbjct: 170 MAPERINPELNQKG-YDVKSDVWSLGITMIELATGR 204

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 74.1 bits (182), Expect = 9e-15
 Identities = 66/221 (29%), Positives = 99/221 (44%), Gaps = 36/221 (16%)

Query: 117 LGEGGFGTVYK-------GVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKL 169
           LG+GGFG V          +    ++  KRL  + G E   +  E  ++A+V  + +V L
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMV--EKRILAKVHSRFIVSL 58

Query: 170 LGCCIEKDERLLIYEYMPNKSLDCFLFD--------PTKREILDWRTRVQIIKGVAQGLL 221
                 K +  L+   M    L   +++        P  R         QII     GL 
Sbjct: 59  AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACF---YTAQII----SGLE 111

Query: 222 YLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYG 281
           +LHQ    RII+RDLK  N+LLD D N +ISD G+A  +  G      Q  T   +GT G
Sbjct: 112 HLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG------QSKTKGYAGTPG 162

Query: 282 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTK 322
           +M+PE      +    D F+ GV L E+++ +   G +R +
Sbjct: 163 FMAPELLQGEEYDFSVDYFALGVTLYEMIAAR---GPFRAR 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 73.9 bits (181), Expect = 1e-14
 Identities = 55/200 (27%), Positives = 98/200 (49%), Gaps = 15/200 (7%)

Query: 116 KLGEGGFGTVYKGVI-GQGE-IAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCC 173
           K+GEG  G V    +   G+ +AVK++  +  Q  + L NE  ++   QH+N+V++    
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86

Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
           +  DE  ++ E++   +L     D      ++      +   V + L  LH      +IH
Sbjct: 87  LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---VIH 139

Query: 234 RDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIF 293
           RD+K+ +ILL  D   K+SDFG     F      E+    S + GT  +M+PE      +
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFG-----FCAQVSKEVPRRKSLV-GTPYWMAPELISRLPY 193

Query: 294 SIKSDVFSFGVLLLEIVSGK 313
             + D++S G++++E+V G+
Sbjct: 194 GPEVDIWSLGIMVIEMVDGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 76.0 bits (187), Expect = 1e-14
 Identities = 71/296 (23%), Positives = 125/296 (42%), Gaps = 57/296 (19%)

Query: 115 NKLGEGGFGTVYKGVIGQGEI--AVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGC 172
           N +  G  G  YKG   +  +   VK +       I    +E + + ++QH N+VKL+G 
Sbjct: 696 NVISRGKKGASYKGKSIKNGMQFVVKEI--NDVNSIPS--SEIADMGKLQHPNIVKLIGL 751

Query: 173 CIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRII 232
           C  +    LI+EY+  K+L   L +      L W  R +I  G+A+ L +LH      ++
Sbjct: 752 CRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVV 805

Query: 233 HRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQ---------GNTSRISGTYGYM 283
             +L    I++D                  G DE  L+              IS    Y+
Sbjct: 806 VGNLSPEKIIID------------------GKDEPHLRLSLPGLLCTDTKCFISS--AYV 845

Query: 284 SPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYA--------WDLWI 335
           +PE       + KSD++ FG++L+E+++GK           +++ +A         D+WI
Sbjct: 846 APETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWI 905

Query: 336 SNKIIDLIDSVLEEASFNES-LSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASS 390
                    S+  + S N++ +   +++AL C       RP  +DV+  L + + S
Sbjct: 906 DP-------SIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954

Length = 968

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 73.7 bits (181), Expect = 2e-14
 Identities = 60/220 (27%), Positives = 114/220 (51%), Gaps = 22/220 (10%)

Query: 117 LGEGGFGTVY--KGVIGQ--GEIAVKRLLGKSGQEIKE---LKNEASVIAQVQHKNLVKL 169
           LG+G FG V+  + + G   G++   ++L K+  ++++    K E  ++A+V H  +VKL
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63

Query: 170 LGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQI-IKGVAQGLLYLHQYSR 228
                 + +  LI +++    L    F    +E++     V+  +  +A  L +LH    
Sbjct: 64  HYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALDHLH---S 116

Query: 229 VRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYA 288
           + II+RDLK  NILLD++ + K++DFG+++      +  + +       GT  YM+PE  
Sbjct: 117 LGIIYRDLKPENILLDEEGHIKLTDFGLSK------ESIDHEKKAYSFCGTVEYMAPEVV 170

Query: 289 LEGIFSIKSDVFSFGVLLLEIVSGK-KNTGFYRTKSLNLI 327
                +  +D +SFGVL+ E+++G     G  R +++ +I
Sbjct: 171 NRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI 210

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 72.4 bits (177), Expect = 4e-14
 Identities = 55/200 (27%), Positives = 99/200 (49%), Gaps = 15/200 (7%)

Query: 116 KLGEGGFGTV--YKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCC 173
           K+GEG  G V   +      ++AVK +  +  Q  + L NE  ++   QH+N+V++    
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87

Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
           +  +E  ++ E++   +L     D   +  L+      + + V Q L YLH      +IH
Sbjct: 88  LVGEELWVLMEFLQGGALT----DIVSQTRLNEEQIATVCESVLQALCYLHSQG---VIH 140

Query: 234 RDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIF 293
           RD+K+ +ILL  D   K+SDFG     F      ++    S + GT  +M+PE      +
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFG-----FCAQISKDVPKRKSLV-GTPYWMAPEVISRTPY 194

Query: 294 SIKSDVFSFGVLLLEIVSGK 313
             + D++S G++++E+V G+
Sbjct: 195 GTEVDIWSLGIMVIEMVDGE 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 71.4 bits (175), Expect = 4e-14
 Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 34/217 (15%)

Query: 111 FSAANKLGEGGFGT---VYKGVIGQ----GEIAVKRLLGKSGQEIKELKNEASVIAQVQH 163
           +    K+GEG FG    V     G+     EI + ++   S +E +E + E +V++ ++H
Sbjct: 2   YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM---SPKEREESRKEVAVLSNMKH 58

Query: 164 KNLVKLLGCCIEKDERLLIYEYMPNKSL-------DCFLFDPTKREILDWRTRVQIIKGV 216
            N+V+      E     ++ +Y     L          LF   + +ILDW   VQI   +
Sbjct: 59  PNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLF--PEDQILDWF--VQICLAL 114

Query: 217 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRI 276
                  H + R +I+HRD+K+ NI L KD   K+ DFG+AR++   N   EL       
Sbjct: 115 K------HVHDR-KILHRDIKSQNIFLTKDGTIKLGDFGIARVL---NSTVEL---ARTC 161

Query: 277 SGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
            GT  Y+SPE      ++ KSD+++ G +L E+ + K
Sbjct: 162 IGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLK 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 71.6 bits (176), Expect = 6e-14
 Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 41/214 (19%)

Query: 116 KLGEGGFGTVYK------GVIGQGEIAVKRLLGKSG---------QEIKELKNEASVIAQ 160
           K+GEG +G V+K      G I    +A+K+ +             +EI+ LK       Q
Sbjct: 8   KIGEGSYGVVFKCRNRETGQI----VAIKKFVESEDDPVIKKIALREIRMLK-------Q 56

Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           ++H NLV L+     K +  L++EY  +  L+    +P     +      +II    Q +
Sbjct: 57  LKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRG---VPEHLIKKIIWQTLQAV 113

Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY 280
            + H+++    IHRD+K  NIL+ K    K+ DFG ARI+ G  D+      T  ++ T 
Sbjct: 114 NFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD-----YTDYVA-TR 164

Query: 281 GYMSPEYALEG--IFSIKSDVFSFGVLLLEIVSG 312
            Y +PE  L G   +    DV++ G +  E+++G
Sbjct: 165 WYRAPEL-LVGDTQYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 71.1 bits (174), Expect = 8e-14
 Identities = 50/149 (33%), Positives = 75/149 (50%), Gaps = 10/149 (6%)

Query: 116 KLGEGGFGTVYKGVIGQG----EIAVKRLLGKSG-QEIKELKNEASVIAQVQHKNLVKLL 170
           ++G G FG V  G +  G    ++ VK L   +  QE  +   EA     +QH NL++ L
Sbjct: 2   EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61

Query: 171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREIL--DWRTRVQIIKGVAQGLLYLHQYSR 228
           G C E    LL+ E+ P   L  +L    K E++  D  T  ++   +A GLL+LH+ + 
Sbjct: 62  GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120

Query: 229 VRIIHRDLKASNILLDKDMNSKISDFGMA 257
              IH DL   N LL  D+  KI D+G++
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLS 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 71.7 bits (176), Expect = 8e-14
 Identities = 54/229 (23%), Positives = 101/229 (44%), Gaps = 42/229 (18%)

Query: 115 NKLGEGGFGTVYKGV--IGQGEIAVKRL--------LGKSGQEIKE------LKNEASVI 158
             LGEG +G V K    +    +A+K++        + K  Q +           E  ++
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 159 AQVQHKNLVKLLGCCIEKDERLLIYEYMPN---KSLD--CFLFDPTKREILDWRTRVQII 213
            +++H+N++ L+   +E D   L+ + M +   K +D    L +   + IL     +QI+
Sbjct: 75  NEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCIL-----LQIL 129

Query: 214 KGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMAR-----IVFGGNDEDE 268
            G+      LH++     +HRDL  +NI ++     KI+DFG+AR            +DE
Sbjct: 130 NGLNV----LHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDE 182

Query: 269 LQGNTSRISG---TYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGK 313
                  ++    T  Y +PE  +    +    D++S G +  E+++GK
Sbjct: 183 TMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 71.3 bits (175), Expect = 8e-14
 Identities = 65/225 (28%), Positives = 112/225 (49%), Gaps = 40/225 (17%)

Query: 111 FSAANKLGEGGFGTVYKGVIGQ-GEI-AVKRLLGKSGQE------IKELKNEASVIAQVQ 162
           F    ++GEG +G VYK      GE+ A+K++   + +E      I+E+K    ++ Q+ 
Sbjct: 9   FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIK----ILRQLN 64

Query: 163 HKNLVKLLGCCIEKDERL----------LIYEYMPNK---SLDCFLFDPTKREILDWRTR 209
           H+N+V L     +K + L          L++EYM +     L+  L   ++  I      
Sbjct: 65  HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHI------ 118

Query: 210 VQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDEL 269
              +K + +GL Y H+ +    +HRD+K SNILL+     K++DFG+AR+     + +E 
Sbjct: 119 KSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLY----NSEES 171

Query: 270 QGNTSRISGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGK 313
           +  T+++  T  Y  PE  L E  +    DV+S G +L E+ + K
Sbjct: 172 RPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 71.6 bits (175), Expect = 9e-14
 Identities = 42/96 (43%), Positives = 63/96 (65%), Gaps = 7/96 (7%)

Query: 216 VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR 275
           VA+G+ +L   SR + IHRDL A NILL ++   KI DFG+AR ++   D D ++   +R
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIY--KDPDYVRKGDAR 242

Query: 276 ISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
           +     +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 243 LP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 41/96 (42%), Positives = 63/96 (65%), Gaps = 7/96 (7%)

Query: 216 VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR 275
           VA+G+ +L   SR + IHRDL A NILL ++   KI DFG+AR ++   D D ++  ++R
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIY--KDPDYVRKGSAR 237

Query: 276 ISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
           +     +M+PE   + +++ +SDV+SFGVLL EI S
Sbjct: 238 LP--LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 70.9 bits (174), Expect = 1e-13
 Identities = 58/188 (30%), Positives = 96/188 (51%), Gaps = 22/188 (11%)

Query: 115 NKLGEGGFGTVYKG--VIGQGEIAVKRLL---GKSGQEIKELKNEASVIAQVQHKNLVKL 169
            K+G+G FG V+K      +  +A+K++L    K G  I  L+ E  ++  ++H+N+V L
Sbjct: 18  AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNL 76

Query: 170 LGCCIEKDER--------LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLL 221
           +  C  K            L++E+  +  L   L +   +  L    +V  +K +  GL 
Sbjct: 77  IEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKV--MKMLLNGLY 133

Query: 222 YLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYG 281
           Y+H   R +I+HRD+KA+NIL+ KD   K++DFG+AR  F  +   +    T+R+  T  
Sbjct: 134 YIH---RNKILHRDMKAANILITKDGILKLADFGLAR-AFSLSKNSKPNRYTNRVV-TLW 188

Query: 282 YMSPEYAL 289
           Y  PE  L
Sbjct: 189 YRPPELLL 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 71.4 bits (175), Expect = 1e-13
 Identities = 40/158 (25%), Positives = 75/158 (47%), Gaps = 13/158 (8%)

Query: 154 EASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQII 213
           EA ++  V H +++++    +      ++   +P+ S D + +   +   L     + I 
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163

Query: 214 KGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNT 273
           K + +GL YLH     RIIHRD+K  NI ++      I D G A+  F       L    
Sbjct: 164 KQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQ--FPVVAPAFLG--- 215

Query: 274 SRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
             ++GT    +PE      ++ K+D++S G++L E+++
Sbjct: 216 --LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251

Length = 357

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 70.9 bits (174), Expect = 2e-13
 Identities = 56/214 (26%), Positives = 96/214 (44%), Gaps = 30/214 (14%)

Query: 109 GNFSAANKLGEGGFGTVYKGVIGQ----GEI-AVKRLLGK---SGQEIKELKNEASVIAQ 160
            +F    ++G+GG+G V+   + +    GEI A+KR+         E++ +  E  ++  
Sbjct: 1   KDFQILTQVGQGGYGQVF---LAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTT 57

Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
            + + LVKLL    + +   L  EY+P       L       + +   R  + +     +
Sbjct: 58  TKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLL--NNLGVLSEDHARFYMAEMFE-AV 114

Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMAR-IVFGGNDEDELQGNTSRISGT 279
             LH+      IHRDLK  N L+D   + K++DFG+++ IV   N           + G+
Sbjct: 115 DALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANS----------VVGS 161

Query: 280 YGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSG 312
             YM+PE  L G  +    D +S G +L E + G
Sbjct: 162 PDYMAPE-VLRGKGYDFTVDYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 69.8 bits (171), Expect = 2e-13
 Identities = 59/209 (28%), Positives = 91/209 (43%), Gaps = 42/209 (20%)

Query: 120 GGFGTVYKGVIGQGEIAVKRLLGK-------------SGQEIKELKNE-ASVIAQVQHKN 165
           G FG+VY        +A KR  G              +  ++  +K E A ++ Q +   
Sbjct: 7   GAFGSVY--------LAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPY 58

Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREI-LDWRTRVQIIKGVAQGLLYLH 224
           + KL      KD   L+ EY+     DC     T   +  DW    Q I  V  G+  LH
Sbjct: 59  VAKLYYSFQSKDYLYLVMEYLNGG--DCASLIKTLGGLPEDWAK--QYIAEVVLGVEDLH 114

Query: 225 QYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMS 284
           Q     IIHRD+K  N+L+D+  + K++DFG++R                +  GT  Y++
Sbjct: 115 QRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGL----------ENKKFVGTPDYLA 161

Query: 285 PEYALEGIFSIK-SDVFSFGVLLLEIVSG 312
           PE  + G+   K SD +S G ++ E + G
Sbjct: 162 PE-TILGVGDDKMSDWWSLGCVIFEFLFG 189

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 70.1 bits (172), Expect = 2e-13
 Identities = 66/221 (29%), Positives = 102/221 (46%), Gaps = 52/221 (23%)

Query: 117 LGEGGFGTVYK------GVIGQGEIAVKRLLGKSG--QEIKELKNEASVIAQVQH--KNL 166
           +G G  G VYK      G +    +AVK++  ++G  +E K +  +  V+    H    +
Sbjct: 23  IGSGTCGQVYKMRFKKTGHV----MAVKQMR-RTGNKEENKRILMDLDVV-LKSHDCPYI 76

Query: 167 VKLLGCCIEKDERLLIYEYMPNKSLDCF------LFDPTKREILDWRTRVQIIKGVAQGL 220
           VK  G  I   +  +  E M      C       +  P   +IL   T V I+K     L
Sbjct: 77  VKCYGYFITDSDVFICMELMST----CLDKLLKRIQGPIPEDILGKMT-VAIVKA----L 127

Query: 221 LYL---HQYSRVRIIHRDLKASNILLDKDMNSKISDFGMA-RIVFGGNDEDELQGNTSRI 276
            YL   H      +IHRD+K SNILLD   N K+ DFG++ R+V       + +  T R 
Sbjct: 128 HYLKEKHG-----VIHRDVKPSNILLDASGNVKLCDFGISGRLV-------DSKAKT-RS 174

Query: 277 SGTYGYMSPEY----ALEGIFSIKSDVFSFGVLLLEIVSGK 313
           +G   YM+PE          + I++DV+S G+ L+E+ +G+
Sbjct: 175 AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 69.7 bits (170), Expect = 3e-13
 Identities = 53/200 (26%), Positives = 95/200 (47%), Gaps = 15/200 (7%)

Query: 116 KLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCC 173
           K+GEG  G V          ++AVK++  +  Q  + L NE  ++    H+N+V +    
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88

Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
           +  DE  ++ E++   +L     D      ++      +   V + L YLH      +IH
Sbjct: 89  LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIH 141

Query: 234 RDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIF 293
           RD+K+ +ILL  D   K+SDFG     F      E+    S + GT  +M+PE      +
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFG-----FCAQVSKEVPKRKSLV-GTPYWMAPEVISRLPY 195

Query: 294 SIKSDVFSFGVLLLEIVSGK 313
             + D++S G++++E++ G+
Sbjct: 196 GTEVDIWSLGIMVIEMIDGE 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 69.7 bits (171), Expect = 3e-13
 Identities = 55/208 (26%), Positives = 100/208 (48%), Gaps = 29/208 (13%)

Query: 116 KLGEGGFGTVYK------GVIGQGEIAVKRLLGKSGQEIKELKN----EASVIAQVQHKN 165
            +GEG +G V K      G I    +A+K+ L    ++ K +K     E  ++ Q++H+N
Sbjct: 8   LVGEGSYGMVMKCKHKETGQI----VAIKKFL--ESEDDKMVKKIAMREIRMLKQLRHEN 61

Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ 225
           LV L+     K    L++E++ +  LD     P     LD     + +  + +G+ + H 
Sbjct: 62  LVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG---LDESRVRKYLFQILRGIEFCHS 118

Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
           ++   IIHRD+K  NIL+ +    K+ DFG AR +    +       T  ++ T  Y +P
Sbjct: 119 HN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV-----YTDYVA-TRWYRAP 169

Query: 286 EYALEGI-FSIKSDVFSFGVLLLEIVSG 312
           E  +    +    D+++ G L+ E+++G
Sbjct: 170 ELLVGDTKYGRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 69.6 bits (171), Expect = 3e-13
 Identities = 69/224 (30%), Positives = 109/224 (48%), Gaps = 45/224 (20%)

Query: 110 NFSAANKLGEGGFGTVYKGV-IGQGEI-AVKRLL---GKSGQEIKELKNEASVIAQVQHK 164
            +   N++ EG +G VY+      GEI A+K+L     K G  I  L+ E +++ ++QH 
Sbjct: 6   EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILLKLQHP 64

Query: 165 NLVKL----LGCCIEKDERLLIY---EYMPN--KSL-----DCFLFDPTKREILDWRTRV 210
           N+V +    +G  ++K     IY   EY+ +  KSL       FL    K  +L      
Sbjct: 65  NIVTVKEVVVGSNLDK-----IYMVMEYVEHDLKSLMETMKQPFLQSEVKCLML------ 113

Query: 211 QIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQ 270
           Q++ GVA    +LH      I+HRDLK SN+LL+     KI DFG+AR  +G        
Sbjct: 114 QLLSGVA----HLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAR-EYGSP-----L 160

Query: 271 GNTSRISGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGK 313
              +++  T  Y +PE  L    +S   D++S G +  E+++ K
Sbjct: 161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 69.4 bits (170), Expect = 5e-13
 Identities = 56/223 (25%), Positives = 98/223 (43%), Gaps = 45/223 (20%)

Query: 117 LGEGGFGTVYKGVIGQGE--IAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCI 174
           LG G  G V+  V    +  +AVK+++    Q +K    E  +I ++ H N+VK      
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK------ 66

Query: 175 EKDERLLIYEYMPNKS--LDCFLFDPTK-------REILDWRTRVQIIKG---------- 215
                  +YE +      L   +   T+       +E ++      + +G          
Sbjct: 67  -------VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLF 119

Query: 216 ---VAQGLLYLHQYSRVRIIHRDLKASNILLD-KDMNSKISDFGMARIVFGGNDEDELQG 271
              + +GL Y+H      ++HRDLK +N+ ++ +D+  KI DFG+ARIV   +     +G
Sbjct: 120 MYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIV---DPHYSHKG 173

Query: 272 NTSRISGTYGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGK 313
             S    T  Y SP   L      K+ D+++ G +  E+++GK
Sbjct: 174 YLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 68.9 bits (169), Expect = 6e-13
 Identities = 63/209 (30%), Positives = 92/209 (44%), Gaps = 31/209 (14%)

Query: 117 LGEGGFGTV----YKGVIGQGEI-AVKRLLGKSG-----QEIKELKNEASV---IAQVQH 163
           LG G FG V    YK     GE+ A+K L  K G      E++ L  E  +       +H
Sbjct: 7   LGRGHFGKVLLAEYKK---TGELYAIKAL--KKGDIIARDEVESLMCEKRIFETANSERH 61

Query: 164 KNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYL 223
             LV L  C   +D    + EY     L   +      ++      V     V  GL YL
Sbjct: 62  PFLVNLFACFQTEDHVCFVMEYAAGGDLMMHI----HTDVFSEPRAVFYAACVVLGLQYL 117

Query: 224 HQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYM 283
           H+    +I++RDLK  N+LLD +   KI+DFG+ +   G  D       TS   GT  ++
Sbjct: 118 HEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR------TSTFCGTPEFL 168

Query: 284 SPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           +PE   E  ++   D +  GVL+ E++ G
Sbjct: 169 APEVLTETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 70.6 bits (173), Expect = 6e-13
 Identities = 48/190 (25%), Positives = 88/190 (46%), Gaps = 14/190 (7%)

Query: 132 QGEIAVK--RLLGKSGQ-EIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLL-IYEYMP 187
             E+A+K  R      + +    + E ++ A++ H N+V LL         L  ++EY+P
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62

Query: 188 NKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILL---D 244
            ++L   L        L      +++  V   L   H      I+HRDLK  NI++    
Sbjct: 63  GRTLREVL---AADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTG 116

Query: 245 KDMNSKISDFGMARIVFGGNDEDELQGN-TSRISGTYGYMSPEYALEGIFSIKSDVFSFG 303
              ++K+ DFG+  ++ G  D D      T+ + GT  Y +PE       +  SD++++G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176

Query: 304 VLLLEIVSGK 313
           ++ LE ++G+
Sbjct: 177 LIFLECLTGQ 186

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 68.7 bits (168), Expect = 7e-13
 Identities = 59/205 (28%), Positives = 101/205 (49%), Gaps = 22/205 (10%)

Query: 117 LGEGGFGTVYKGVI-GQGEIAVKRLLGK----SGQEIKELKNEASVIAQVQHKNLVKLLG 171
           LG+G FG V    + G  E+   ++L K       ++     E  ++A       +  L 
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62

Query: 172 CCIEKDERLL-IYEYMPNKSLDCFLFDPTK-REILDWRTRVQIIKGVAQGLLYLHQYSRV 229
           CC +  +RL  + EY+    L   +F   + R+  + R+R    + V   L++LH++   
Sbjct: 63  CCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRFYAAE-VTLALMFLHRHG-- 116

Query: 230 RIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN-TSRISGTYGYMSPEYA 288
            +I+RDLK  NILLD + + K++DFGM +       E  L G  T+   GT  Y++PE  
Sbjct: 117 -VIYRDLKLDNILLDAEGHCKLADFGMCK-------EGILNGVTTTTFCGTPDYIAPEIL 168

Query: 289 LEGIFSIKSDVFSFGVLLLEIVSGK 313
            E  +    D ++ GVL+ E+++G+
Sbjct: 169 QELEYGPSVDWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 68.1 bits (166), Expect = 7e-13
 Identities = 61/231 (26%), Positives = 103/231 (44%), Gaps = 44/231 (19%)

Query: 117 LGEGGFGTV----YKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVK---- 168
           +G+G +G V    ++    Q  I    L   S +E K  + EA +++Q++H N+V     
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67

Query: 169 ----------LLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQ 218
                     ++G C   D    +Y  +  +          + ++++W   VQI    A 
Sbjct: 68  WEGEDGLLYIVMGFCEGGD----LYHKLKEQKGKLLP----ENQVVEWF--VQI----AM 113

Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
            L YLH+     I+HRDLK  N+ L +    K+ D G+AR++    D        S + G
Sbjct: 114 ALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDM------ASTLIG 164

Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGY 329
           T  YMSPE      ++ KSDV++ G  + E+ + K     +  K +N + Y
Sbjct: 165 TPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHA---FNAKDMNSLVY 212

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 68.7 bits (168), Expect = 8e-13
 Identities = 37/99 (37%), Positives = 57/99 (57%), Gaps = 11/99 (11%)

Query: 216 VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR 275
           +A GL +LH      II+RDLK  N++LD + + KI+DFGM +       E+   G T+R
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCK-------ENIFGGKTTR 159

Query: 276 -ISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
              GT  Y++PE      +    D ++FGVLL E+++G+
Sbjct: 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 68.7 bits (168), Expect = 9e-13
 Identities = 38/95 (40%), Positives = 55/95 (57%), Gaps = 9/95 (9%)

Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
           GL +LH+     II+RDLK  N+LLDKD + KI+DFGM +      +    +G  S   G
Sbjct: 108 GLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCK------ENMNGEGKASTFCG 158

Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           T  Y++PE      ++   D +SFGVLL E++ G+
Sbjct: 159 TPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 68.2 bits (167), Expect = 9e-13
 Identities = 45/147 (30%), Positives = 79/147 (53%), Gaps = 10/147 (6%)

Query: 116 KLGEGGFGTVYKGVIGQ-GEI-AVKRLLGKSGQE--IKELKNEASVIAQVQHKNLVKLLG 171
           K+GEG +GTV+K    +  EI A+KR+      E        E  ++ +++HKN+V+L  
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66

Query: 172 CCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRI 231
                 +  L++EY  ++ L  + FD    +I D       +  + +GL + H +    +
Sbjct: 67  VLHSDKKLTLVFEYC-DQDLKKY-FDSCNGDI-DPEIVKSFMFQLLKGLAFCHSH---NV 120

Query: 232 IHRDLKASNILLDKDMNSKISDFGMAR 258
           +HRDLK  N+L++K+   K++DFG+AR
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 68.1 bits (167), Expect = 9e-13
 Identities = 49/207 (23%), Positives = 84/207 (40%), Gaps = 21/207 (10%)

Query: 117 LGEGGFGTVYKGVIGQGEIAVKR--LLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCI 174
             +     + K       +AVK+  L   S +++K L+ E     Q+QH N++  +   I
Sbjct: 10  FEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFI 69

Query: 175 EKDERLLIYEYMPNKSLDCF-----LFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRV 229
              E  ++   M       +     L      E L       I+K V   L Y+H     
Sbjct: 70  VDSELYVVSPLM------AYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG-- 121

Query: 230 RIIHRDLKASNILLDKDMNSKISDFGMAR-IVFGGNDEDELQGNTSRISGTYGYMSPEY- 287
             IHR +KAS+ILL  D    +S    +  ++  G  +  +            ++SPE  
Sbjct: 122 -FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVL 180

Query: 288 --ALEGIFSIKSDVFSFGVLLLEIVSG 312
              L+G ++ KSD++S G+   E+ +G
Sbjct: 181 QQNLQG-YNEKSDIYSVGITACELANG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 67.7 bits (165), Expect = 1e-12
 Identities = 66/205 (32%), Positives = 97/205 (47%), Gaps = 22/205 (10%)

Query: 117 LGEGGFGTVYK-GVIGQGEI-AVKRLLGKSGQEIKELK------NEASVIAQVQHKNLVK 168
           LG+GGFG V    V   G++ A K+L  K    IK+ K      NE  ++ +V  + +V 
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKK---RIKKRKGESMALNEKQILEKVNSRFVVS 64

Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSR 228
           L      KD   L+   M    L   ++   +    + R  V     +  GL  LHQ   
Sbjct: 65  LAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRA-VFYAAEICCGLEDLHQE-- 121

Query: 229 VRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYA 288
            RI++RDLK  NILLD   + +ISD G+A  V       E Q    R+ GT GYM+PE  
Sbjct: 122 -RIVYRDLKPENILLDDHGHIRISDLGLAVHV------PEGQTIKGRV-GTVGYMAPEVV 173

Query: 289 LEGIFSIKSDVFSFGVLLLEIVSGK 313
               ++   D ++ G LL E+++G+
Sbjct: 174 KNERYTFSPDWWALGCLLYEMIAGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 67.4 bits (164), Expect = 1e-12
 Identities = 54/207 (26%), Positives = 105/207 (50%), Gaps = 21/207 (10%)

Query: 110 NFSAANKLGEGGFGTVYKGV-IGQGEIA-VKRLLGKSGQEIKELKNEASVIAQVQHKNLV 167
           +F    ++G G +G VYK   +  GE+A +K +  + G++   ++ E  ++   +H N+V
Sbjct: 10  DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIV 69

Query: 168 KLLGCCIEKDERLLIYEYMPNKSL-DCF-LFDPTKREILDWRTRVQIIKGVAQGLLYLHQ 225
              G  + +D+  +  E+    SL D + +  P     + + +R  +     QGL YLH 
Sbjct: 70  AYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLHS 124

Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
             +   +HRD+K +NILL  + + K++DFG++  +        +    S I GT  +M+P
Sbjct: 125 KGK---MHRDIKGANILLTDNGHVKLADFGVSAQITA-----TIAKRKSFI-GTPYWMAP 175

Query: 286 EYAL---EGIFSIKSDVFSFGVLLLEI 309
           E A    +G ++   D+++ G+  +E+
Sbjct: 176 EVAAVERKGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 67.9 bits (166), Expect = 1e-12
 Identities = 57/220 (25%), Positives = 105/220 (47%), Gaps = 25/220 (11%)

Query: 101 FSSVSSATGNFSAANKLGEGGFGTV---YKGVIGQGEIAVKRLLG--KSGQEIKELKNEA 155
           F +V   T  +     +G G FG V      + GQ  +A+K+++    +    K    E 
Sbjct: 2   FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQ-NVAIKKIMKPFSTPVLAKRTYREL 60

Query: 156 SVIAQVQHKNLVKLLGCCIEKDERL-LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIK 214
            ++  ++H+N++ L    I   E +  + E +           P +++ + +    QI++
Sbjct: 61  KLLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFL-YQILR 119

Query: 215 GVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTS 274
           G    L Y+H      ++HRDLK SNIL++++ + KI DFG+ARI      + ++ G  S
Sbjct: 120 G----LKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI-----QDPQMTGYVS 167

Query: 275 RISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGK 313
               T  Y +PE  L    + ++ D++S G +  E++ GK
Sbjct: 168 ----TRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 67.6 bits (165), Expect = 2e-12
 Identities = 41/113 (36%), Positives = 66/113 (58%), Gaps = 15/113 (13%)

Query: 216 VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR 275
           VAQG+ +L   +    IHRD+ A N+LL     +KI DFG+AR +   ND + +    +R
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIM--NDSNYVVKGNAR 275

Query: 276 ISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKK-------NTGFYR 320
           +     +M+PE   + +++++SDV+S+G+LL EI S GK        N+ FY+
Sbjct: 276 LP--VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYK 326

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 66.3 bits (162), Expect = 3e-12
 Identities = 64/218 (29%), Positives = 103/218 (47%), Gaps = 36/218 (16%)

Query: 117 LGEGGFGTVYKGVI-----------GQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKN 165
           LG+G F  +YKGV+           GQ    V ++LG   ++       AS+++Q+ HK+
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ 225
           LVKL G C+ +DE +++ EY+    LD FL        L W  ++ + K +A  L YL  
Sbjct: 63  LVKLYGVCV-RDENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLED 119

Query: 226 YSRVRIIHRDLKASNILLDKDMNS-------KISDFGMARIVFGGNDEDELQGNTSRISG 278
               +++H ++   NIL+ +   +       K+SD G+   V      +E      RI  
Sbjct: 120 ---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVL---SREERV---ERIP- 169

Query: 279 TYGYMSPEYALEGIFSIKS--DVFSFGVLLLEIVSGKK 314
              +++PE    G  S+    D +SFG  LLEI S  +
Sbjct: 170 ---WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGE 204

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 66.5 bits (163), Expect = 4e-12
 Identities = 42/168 (25%), Positives = 76/168 (45%), Gaps = 35/168 (20%)

Query: 116 KLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQE--IKELK--------------NEASVIA 159
            +G G +G VYK          KR  GK G+E  IK+ K               E +++ 
Sbjct: 7   CIGRGTYGRVYK---------AKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLR 57

Query: 160 QVQHKNLVKLLGCCIEKDERL--LIYEYMPNKSLDCFLFDPTKREI-LDWRTRVQIIKGV 216
           +++H+N+V L+   +E  ++   L+++Y  +       F    + + +       ++  +
Sbjct: 58  ELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQI 117

Query: 217 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNS----KISDFGMARIV 260
             G+ YLH      ++HRDLK +NIL+  +       KI D G+AR+ 
Sbjct: 118 LNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF 162

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 66.5 bits (162), Expect = 4e-12
 Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 24/205 (11%)

Query: 117 LGEGGFGTVYKGVIGQ-GEIAVKRLLGK----SGQEIKELKNEASVIAQV-QHKNLVKLL 170
           LG+G FG V    + + G +   ++L K       +++    E  +++    H  L +L 
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 171 GCCIEKDERLL-IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKG-VAQGLLYLHQYSR 228
            CC +  +RL  + E++    L   +F   K    D   R +     +   L++LH    
Sbjct: 63  -CCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFD-EARARFYAAEITSALMFLHDKG- 116

Query: 229 VRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQG-NTSRISGTYGYMSPEY 287
             II+RDLK  N+LLD + + K++DFGM +       E    G  TS   GT  Y++PE 
Sbjct: 117 --IIYRDLKLDNVLLDHEGHCKLADFGMCK-------EGIFNGKTTSTFCGTPDYIAPEI 167

Query: 288 ALEGIFSIKSDVFSFGVLLLEIVSG 312
             E ++    D ++ GVLL E++ G
Sbjct: 168 LQEMLYGPSVDWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 66.1 bits (161), Expect = 4e-12
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 24/210 (11%)

Query: 116 KLGEGGFGTVYKGVIGQGE--IAVKRLLGKSGQEIKELKNEASV-----IAQVQHKNLVK 168
           ++G G +GTVYK         +A+K +  ++ ++   L     V     +    H N+V+
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66

Query: 169 LLGCC--IEKDERL---LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYL 223
           L+  C     D      L++E++ ++ L  +L D      L   T   +++   +GL +L
Sbjct: 67  LMDVCATSRTDRETKVTLVFEHV-DQDLRTYL-DKVPPPGLPAETIKDLMRQFLRGLDFL 124

Query: 224 HQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYM 283
           H      I+HRDLK  NIL+      K++DFG+ARI          Q   + +  T  Y 
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY-------SCQMALTPVVVTLWYR 174

Query: 284 SPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           +PE  L+  ++   D++S G +  E+   K
Sbjct: 175 APEVLLQSTYATPVDMWSVGCIFAEMFRRK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 66.1 bits (162), Expect = 5e-12
 Identities = 67/228 (29%), Positives = 112/228 (49%), Gaps = 59/228 (25%)

Query: 115 NKLGEGGFGTVYKGVIGQ-GEI-AVKRLLG---------KSGQEI---KELKNEASVIAQ 160
            KLG+G +G V+K +  +  E+ A+K++           ++ +EI   +EL +       
Sbjct: 13  QKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGD------- 65

Query: 161 VQHKNLVKLLGCCIEKDER--LLIYEYMPN-------KSLDCFLFDPTKREILDWRTRVQ 211
             H N+VKLL     ++++   L++EYM          ++   L D  KR I+      Q
Sbjct: 66  --HPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANI---LEDVHKRYIM-----YQ 115

Query: 212 IIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQG 271
           ++K +     Y+H  S   +IHRDLK SNILL+ D   K++DFG+AR +    +  E   
Sbjct: 116 LLKALK----YIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPV 168

Query: 272 NTSRISGTYGYMSPEYAL------EGIFSIKSDVFSFGVLLLEIVSGK 313
            T  ++ T  Y +PE  L      +G+     D++S G +L E++ GK
Sbjct: 169 LTDYVA-TRWYRAPEILLGSTRYTKGV-----DMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 66.1 bits (161), Expect = 6e-12
 Identities = 60/204 (29%), Positives = 93/204 (45%), Gaps = 20/204 (9%)

Query: 117 LGEGGFGTVYKGVI-GQGEIAVKRLLGKS----GQEIKELKNEASVIAQVQHKNLVKLLG 171
           LG+G FG V    + G+GE    + L K       +++    E  V+A       +  L 
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62

Query: 172 CCIE-KDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVR 230
           C  + K+    + E++    L   +F    +   D          +  GL +LH      
Sbjct: 63  CTFQTKEHLFFVMEFLNGGDL---MFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG--- 116

Query: 231 IIHRDLKASNILLDKDMNSKISDFGMARI-VFGGNDEDELQGNTSRISGTYGYMSPEYAL 289
           II+RDLK  N++LD+D + KI+DFGM +  VFG N         S   GT  Y++PE   
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN-------RASTFCGTPDYIAPEILQ 169

Query: 290 EGIFSIKSDVFSFGVLLLEIVSGK 313
              ++   D +SFGVLL E++ G+
Sbjct: 170 GLKYTFSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 66.1 bits (161), Expect = 8e-12
 Identities = 37/96 (38%), Positives = 57/96 (59%), Gaps = 7/96 (7%)

Query: 216 VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR 275
           VA+G+ +L   +    IHRDL A NILL     +KI DFG+AR +   ND + +    +R
Sbjct: 223 VAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDI--RNDSNYVVKGNAR 277

Query: 276 ISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
           +     +M+PE     +++ +SDV+S+G+LL EI S
Sbjct: 278 LP--VKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 65.4 bits (159), Expect = 9e-12
 Identities = 61/208 (29%), Positives = 92/208 (44%), Gaps = 28/208 (13%)

Query: 117 LGEGGFGTVYKGVI-GQGEIAVKRLLGKS----GQEIKELKNEASVIAQVQHKNLVKLLG 171
           LG+G FG V+   + G  +    + L K       +++    E  V++       +  L 
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62

Query: 172 CCIEKDERLL-IYEYMPNKSL-----DCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ 225
           C  +  E L  + EY+    L      C  FD  +          +II     GL +LH 
Sbjct: 63  CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFY----AAEII----CGLQFLHS 114

Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
                I++RDLK  NILLD D + KI+DFGM +    G+        T    GT  Y++P
Sbjct: 115 KG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD------AKTCTFCGTPDYIAP 165

Query: 286 EYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           E  L   ++   D +SFGVLL E++ G+
Sbjct: 166 EILLGQKYNTSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 65.5 bits (159), Expect = 9e-12
 Identities = 65/214 (30%), Positives = 103/214 (48%), Gaps = 30/214 (14%)

Query: 110 NFSAANKLGEGGFGTVYKGVIGQGEIAVKRLL-------GKSGQEIKELKNEASVIAQVQ 162
           +F   ++LG G  G V K       + + R L           Q I+EL+    V+ +  
Sbjct: 6   DFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQ----VLHECN 61

Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTK--REILDWRTRVQIIKGVAQGL 220
              +V   G      E  +  E+M   SLD  L +  +   EIL    +V I   V +GL
Sbjct: 62  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG---KVSI--AVLRGL 116

Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY 280
            YL +  + +I+HRD+K SNIL++     K+ DFG++     G   D +    +   GT 
Sbjct: 117 AYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSM---ANSFVGTR 166

Query: 281 GYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
            YMSPE  L+G  +S++SD++S G+ L+E+  G+
Sbjct: 167 SYMSPE-RLQGTHYSVQSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 65/209 (31%), Positives = 96/209 (45%), Gaps = 30/209 (14%)

Query: 117 LGEGGFGTVYK-GVIGQGEI-AVKRLLGKSGQEIKELK------NEASVIAQVQHKNLVK 168
           LG+GGFG V    V   G++ A K+L  K    IK+ K      NE  ++ +V  + +V 
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKK---RIKKRKGEAMALNEKQILEKVNSRFVVS 64

Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFLFD---PTKREILDWRTRVQIIKG-VAQGLLYLH 224
           L      KD   L+   M    L   +++   P   E      R       +  GL  LH
Sbjct: 65  LAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDE-----ERAVFYAAEITCGLEDLH 119

Query: 225 QYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMS 284
              R RI++RDLK  NILLD   + +ISD G+A  +  G   + ++G      GT GYM+
Sbjct: 120 ---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG---ETIRGRV----GTVGYMA 169

Query: 285 PEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           PE      ++   D +  G L+ E++ GK
Sbjct: 170 PEVVKNERYTFSPDWWGLGCLIYEMIEGK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 65.1 bits (159), Expect = 1e-11
 Identities = 47/137 (34%), Positives = 74/137 (54%), Gaps = 27/137 (19%)

Query: 184 EYMPNKSLDCFLFDPTKR------EILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLK 237
           E+M   SLD  L    K+       IL      +I   V +GL YL +  + +I+HRD+K
Sbjct: 79  EHMDGGSLDQVL----KKAGRIPENILG-----KISIAVLRGLTYLRE--KHKIMHRDVK 127

Query: 238 ASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGI-FSIK 296
            SNIL++     K+ DFG++     G   D +  N+    GT  YMSPE  L+G  ++++
Sbjct: 128 PSNILVNSRGEIKLCDFGVS-----GQLIDSM-ANS--FVGTRSYMSPE-RLQGTHYTVQ 178

Query: 297 SDVFSFGVLLLEIVSGK 313
           SD++S G+ L+E+  G+
Sbjct: 179 SDIWSLGLSLVEMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 65.4 bits (160), Expect = 1e-11
 Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 50/219 (22%)

Query: 117 LGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEI--KELKNEASVIAQVQHKNLVKLLGC 172
           +G G +G V      +   ++A+K+L       I  K    E  ++  + H+N++ LL  
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDV 82

Query: 173 CIEKDERLLIYEYMPNKSLDCF-------------LFDPTKREIL-DWRTRV---QIIKG 215
                       + P  SL+ F             L +  K + L D   +    QI++G
Sbjct: 83  ------------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRG 130

Query: 216 VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR 275
               L Y+H      IIHRDLK SNI +++D   KI DFG+AR       +DE+ G    
Sbjct: 131 ----LKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHT-----DDEMTGYV-- 176

Query: 276 ISGTYGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGK 313
              T  Y +PE  L  +   ++ D++S G ++ E+++GK
Sbjct: 177 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 64.6 bits (157), Expect = 1e-11
 Identities = 60/205 (29%), Positives = 96/205 (46%), Gaps = 22/205 (10%)

Query: 117 LGEGGFGTVYK-GVIGQGEI-AVKRLLGKSGQEIKELK------NEASVIAQVQHKNLVK 168
           LG+GGFG V    V   G++ A KRL  K    IK+ K      NE  ++ +V  + +V 
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKRLEKK---RIKKRKGESMALNEKQILEKVNSQFVVN 64

Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSR 228
           L      KD   L+   M    L   +++       + R  +     +  GL  LH+ + 
Sbjct: 65  LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERA-LFYAAEILCGLEDLHREN- 122

Query: 229 VRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYA 288
              ++RDLK  NILLD   + +ISD G+A  +  G   + ++G      GT GYM+PE  
Sbjct: 123 --TVYRDLKPENILLDDYGHIRISDLGLAVKIPEG---ESIRGRV----GTVGYMAPEVL 173

Query: 289 LEGIFSIKSDVFSFGVLLLEIVSGK 313
               +++  D +  G L+ E++ G+
Sbjct: 174 NNQRYTLSPDYWGLGCLIYEMIEGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 64.7 bits (158), Expect = 1e-11
 Identities = 64/227 (28%), Positives = 105/227 (46%), Gaps = 51/227 (22%)

Query: 110 NFSAANKLGEGGFGTVYKGVIGQ-GEI-AVKRLL---GKSGQEIKELKNEASVIAQVQHK 164
            F   N++GEG +G VY+      GEI A+K++     + G  I  L+ E +++  ++H 
Sbjct: 8   EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNLRHP 66

Query: 165 NLVKLLGCCIEK--DERLLIYEY-----------MPN----KSLDCFLFDPTKREILDWR 207
           N+V+L    + K  D   L+ EY           MP       + C +            
Sbjct: 67  NIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLML----------- 115

Query: 208 TRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDED 267
              Q+++G+     YLH+     IIHRDLK SN+LL      KI+DFG+AR  +G   + 
Sbjct: 116 ---QLLRGLQ----YLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR-TYGLPAKP 164

Query: 268 ELQGNTSRISGTYGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGK 313
                T ++  T  Y +PE  L       + D+++ G +L E+++ K
Sbjct: 165 M----TPKVV-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 65.1 bits (158), Expect = 1e-11
 Identities = 64/213 (30%), Positives = 105/213 (49%), Gaps = 28/213 (13%)

Query: 110 NFSAANKLGEGGFGTVYKGV-IGQGEIAVKRLLGKSGQEIK-----ELKNEASVIAQVQH 163
           +F   ++LG G  G V+K      G I  ++L+     EIK     ++  E  V+ +   
Sbjct: 6   DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIH---LEIKPAIRNQIIRELQVLHECNS 62

Query: 164 KNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTK--REILDWRTRVQIIKGVAQGLL 221
             +V   G      E  +  E+M   SLD  L    +   +IL  +  + +IKG    L 
Sbjct: 63  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-KVSIAVIKG----LT 117

Query: 222 YLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYG 281
           YL +  + +I+HRD+K SNIL++     K+ DFG++     G   D +    +   GT  
Sbjct: 118 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSM---ANSFVGTRS 167

Query: 282 YMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
           YMSPE  L+G  +S++SD++S G+ L+E+  G+
Sbjct: 168 YMSPE-RLQGTHYSVQSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 64.6 bits (157), Expect = 2e-11
 Identities = 57/205 (27%), Positives = 101/205 (49%), Gaps = 20/205 (9%)

Query: 115 NKLGEGGFGTVYKG--VIGQGEIAVK--RLLGKSGQEIKELKNEASVIAQVQHKNLVKLL 170
           +KLGEG + TVYKG   +    +A+K  RL  + G     ++ E S++  ++H N+V L 
Sbjct: 12  DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLH 70

Query: 171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVR 230
                +    L++EY+ +K L  +L D      ++       +  + +GL Y H   R +
Sbjct: 71  DIIHTEKSLTLVFEYL-DKDLKQYLDDCGN--SINMHNVKLFLFQLLRGLNYCH---RRK 124

Query: 231 IIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNT-SRISGTYGYMSPEYAL 289
           ++HRDLK  N+L+++    K++DFG+AR          +   T S    T  Y  P+  L
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLAR-------AKSIPTKTYSNEVVTLWYRPPDILL 177

Query: 290 EGI-FSIKSDVFSFGVLLLEIVSGK 313
               +S + D++  G +  E+ +G+
Sbjct: 178 GSTDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 50/163 (30%), Positives = 80/163 (49%), Gaps = 43/163 (26%)

Query: 116 KLGEGGFGTVYKGV--IGQGEIAVK--RLLGKSGQEIKELKNEASVIAQVQHKNLVKLLG 171
           KLGEG + TVYKG   +    +A+K  RL  + G     ++ EAS++  ++H N+V  L 
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIV-TLH 69

Query: 172 CCIEKDERL-LIYEYM-----------PN----KSLDCFLFDPTKREILDWRTRVQIIKG 215
             I   + L L++EY+                  ++  FLF              Q+++G
Sbjct: 70  DIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLF--------------QLLRG 115

Query: 216 VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMAR 258
           +A    Y HQ    R++HRDLK  N+L+ +    K++DFG+AR
Sbjct: 116 LA----YCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 54/206 (26%), Positives = 101/206 (49%), Gaps = 19/206 (9%)

Query: 110 NFSAANKLGEGGFGTVYKGV-IGQGEIA-VKRLLGKSGQEIKELKNEASVIAQVQHKNLV 167
           ++    ++G G +G VYK   +  GE+A VK +  + G +   ++ E  ++ + +H N+V
Sbjct: 10  DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIV 69

Query: 168 KLLGCCIEKDERLLIYEYMPNKSL-DCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQY 226
              G  + +++  +  EY    SL D +       E+        + +   QGL YLH  
Sbjct: 70  AYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSEL----QIAYVCRETLQGLAYLHSK 125

Query: 227 SRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPE 286
            +   +HRD+K +NILL  + + K++DFG+A  +        +    S I GT  +M+PE
Sbjct: 126 GK---MHRDIKGANILLTDNGDVKLADFGVAAKITA-----TIAKRKSFI-GTPYWMAPE 176

Query: 287 YAL---EGIFSIKSDVFSFGVLLLEI 309
            A     G ++   D+++ G+  +E+
Sbjct: 177 VAAVEKNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 65.9 bits (161), Expect = 2e-11
 Identities = 57/228 (25%), Positives = 95/228 (41%), Gaps = 42/228 (18%)

Query: 116 KLGEGGFGTVYKG--VIGQGEIAVKRLLGKSGQEIKELKN----EASVIAQVQHKNLVKL 169
            +G+GG G VY     +    +A+K++  +   E   LK     EA + A + H  +V +
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIR-EDLSENPLLKKRFLREAKIAADLIHPGIVPV 67

Query: 170 LGCCIEKDERLLIYEYMP---NKSLDCFLFDPTKREIL--------DWRTRVQIIKGVAQ 218
              C + D    +Y  MP     +L   L    ++E L             + I   +  
Sbjct: 68  YSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICA 124

Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTS---- 274
            + Y+H  S+  ++HRDLK  NILL       I D+G A        E+E   +      
Sbjct: 125 TIEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFK---KLEEEDLLDIDVDER 178

Query: 275 -----------RISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
                      +I GT  YM+PE  L    S  +D+++ GV+L ++++
Sbjct: 179 NICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 17/208 (8%)

Query: 111 FSAANKLGEGGFGTVYKGVIGQGE--IAVKRLLGKSG-QEIKELK-NEASVIAQVQHKNL 166
           F     +GEG +G V K    + +  +A+K+       +E+KE    E  ++  ++ +N+
Sbjct: 3   FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENI 62

Query: 167 VKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRV-QIIKGVAQGLLYLHQ 225
           V+L      + +  L++EY+    L+     P        R+ + Q+IK +       H 
Sbjct: 63  VELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAI-------HW 115

Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
             +  I+HRD+K  N+L+  +   K+ DFG AR +  G++      N +    T  Y SP
Sbjct: 116 CHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN-----ANYTEYVATRWYRSP 170

Query: 286 EYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           E  L   +    D++S G +L E+  G+
Sbjct: 171 ELLLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 64.3 bits (156), Expect = 2e-11
 Identities = 50/178 (28%), Positives = 84/178 (47%), Gaps = 13/178 (7%)

Query: 137 VKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERL-LIYEYMPNKSLDCFL 195
           VK+ L    ++I  ++ E  V  Q      +  L  C +   RL L+ EY+     D   
Sbjct: 28  VKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGG--DLMF 85

Query: 196 FDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFG 255
               +R++ +   R    + +   L +LH+     II+RDLK  N+LLD D + K++D+G
Sbjct: 86  HMQRQRKLPEEHARFYAAE-ICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYG 141

Query: 256 MARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           M +   G  D       TS   GT  Y++PE      +    D ++ GVL+ E+++G+
Sbjct: 142 MCKEGLGPGD------TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 63.9 bits (155), Expect = 3e-11
 Identities = 56/204 (27%), Positives = 99/204 (48%), Gaps = 18/204 (8%)

Query: 115 NKLGEGGFGTVYKG--VIGQGEIAVK--RLLGKSGQEIKELKNEASVIAQVQHKNLVKLL 170
            KLGEG + TV+KG   + +  +A+K  RL  + G     ++ E S++  ++H N+V L 
Sbjct: 12  EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLH 70

Query: 171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVR 230
                     L++EY+ +K L  ++ D     I+        +  + +GL Y H   R +
Sbjct: 71  DIVHTDKSLTLVFEYL-DKDLKQYMDDCGN--IMSMHNVKIFLYQILRGLAYCH---RRK 124

Query: 231 IIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL- 289
           ++HRDLK  N+L+++    K++DFG+AR       +       S    T  Y  P+  L 
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARA------KSVPTKTYSNEVVTLWYRPPDVLLG 178

Query: 290 EGIFSIKSDVFSFGVLLLEIVSGK 313
              +S + D++  G +  E+ SG+
Sbjct: 179 SSEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 63.7 bits (155), Expect = 3e-11
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 23/215 (10%)

Query: 110 NFSAANKLGEGGFGTVY----KGVIGQGEIAVKRLLGKSG--QEIKEL---KNEASVIAQ 160
           NF     LG G +G V+     G    G++   ++L K+   Q+ K     + E  V+  
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60

Query: 161 VQHKNLVKLLGCCIEKDERL-LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQG 219
           V+    +  L    + D +L LI +Y+    L   L+   +RE     + V++   +A+ 
Sbjct: 61  VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLY---QREHFT-ESEVRVY--IAEI 114

Query: 220 LLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGT 279
           +L L    ++ II+RD+K  NILLD + +  ++DFG+++      +E           GT
Sbjct: 115 VLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-----RAYSFCGT 169

Query: 280 YGYMSPEYALEGI--FSIKSDVFSFGVLLLEIVSG 312
             YM+PE    G        D +S GVL  E+++G
Sbjct: 170 IEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 62.9 bits (153), Expect = 4e-11
 Identities = 60/215 (27%), Positives = 105/215 (48%), Gaps = 35/215 (16%)

Query: 117 LGEGGFGTVYKGV---------IGQGEIAVKRLLGKSGQEIKELKNE-ASVIAQVQHKNL 166
           LG+G F  ++KG+         + + E+ +K +L KS +   E   E AS+++Q+ HK+L
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLK-VLDKSHRNYSESFFEAASMMSQLSHKHL 61

Query: 167 VKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQY 226
           V   G C+  DE +++ EY+   SLD +L        + W  ++++ K +A  L +L   
Sbjct: 62  VLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDK 119

Query: 227 SRVRIIHRDLKASNILLDKDMNS--------KISDFGMARIVFGGNDEDELQGNTSRISG 278
               + H ++ A N+LL ++ +         K+SD G++  V     ++ L     RI  
Sbjct: 120 G---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP---KEIL---LERIP- 169

Query: 279 TYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSG 312
              ++ PE        S+ +D +SFG  L EI SG
Sbjct: 170 ---WVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 63.1 bits (153), Expect = 5e-11
 Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 20/204 (9%)

Query: 117 LGEGGFGTVYKGVI-GQGEIAVKRLLGK----SGQEIKELKNEASVIAQVQHKNLVKLLG 171
           LG+G FG V      G  E+   ++L K       +++    E  V+A       +  L 
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67

Query: 172 CCIEKDERL-LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVR 230
            C +  +RL  + EY+    L   ++   +         V     ++ GL +LH   R  
Sbjct: 68  SCFQTVDRLYFVMEYVNGGDL---MYHIQQVGKFKEPQAVFYAAEISVGLFFLH---RRG 121

Query: 231 IIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR-ISGTYGYMSPEYAL 289
           II+RDLK  N++LD + + KI+DFGM +       E  + G T+R   GT  Y++PE   
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCK-------EHMVDGVTTRTFCGTPDYIAPEIIA 174

Query: 290 EGIFSIKSDVFSFGVLLLEIVSGK 313
              +    D +++GVLL E+++G+
Sbjct: 175 YQPYGKSVDWWAYGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 62.7 bits (152), Expect = 5e-11
 Identities = 60/204 (29%), Positives = 100/204 (49%), Gaps = 20/204 (9%)

Query: 116 KLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQEIK-ELKNEASVIAQVQHKNLVKLLGC 172
           KLGEG + TVYKG+  I    +A+K +  K+ + +      EAS++  ++H N+V LL  
Sbjct: 12  KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIV-LLHD 70

Query: 173 CIEKDERL-LIYEYMPNKSLDCFLFDPTKREILDWRTRV-QIIKGVAQGLLYLHQYSRVR 230
            I   E L  ++EYM        +  P      + R  + Q+++G+A    Y+H      
Sbjct: 71  IIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLA----YIH---GQH 123

Query: 231 IIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE 290
           I+HRDLK  N+L+      K++DFG+AR           Q  +S +  T  Y  P+  L 
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLAR-----AKSIPSQTYSSEVV-TLWYRPPDVLLG 177

Query: 291 GI-FSIKSDVFSFGVLLLEIVSGK 313
              +S   D++  G + +E++ G+
Sbjct: 178 ATDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 62.9 bits (154), Expect = 7e-11
 Identities = 41/109 (37%), Positives = 58/109 (53%), Gaps = 21/109 (19%)

Query: 211 QIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQ 270
           QI++G    L YLH      +IHRDLK SNIL++ + + KI DFG+AR V    DEDE  
Sbjct: 111 QILRG----LKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGV--DPDEDEKG 161

Query: 271 GNTSRISGTYGYMSPEYAL------EGIFSIKSDVFSFGVLLLEIVSGK 313
             T  +  T  Y +PE  L      + I     D++S G +  E+++ K
Sbjct: 162 FLTEYVV-TRWYRAPELLLSSSRYTKAI-----DIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 62.2 bits (151), Expect = 8e-11
 Identities = 59/213 (27%), Positives = 100/213 (46%), Gaps = 29/213 (13%)

Query: 115 NKLGEGGFGTVYK------GVI-GQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLV 167
           ++LG+G +G+VYK      GV     EI ++    K  Q I EL     ++ +     +V
Sbjct: 7   DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMEL----DILHKAVSPYIV 62

Query: 168 KLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYS 227
              G    +    +  EYM   SLD         E +      +I   V +GL +L +  
Sbjct: 63  DFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE-- 120

Query: 228 RVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRIS-GTYGYMSPE 286
              IIHRD+K +N+L++ +   K+ DFG++     GN    L  + ++ + G   YM+PE
Sbjct: 121 EHNIIHRDVKPTNVLVNGNGQVKLCDFGVS-----GN----LVASLAKTNIGCQSYMAPE 171

Query: 287 YALEG------IFSIKSDVFSFGVLLLEIVSGK 313
               G       ++++SDV+S G+ +LE+  G+
Sbjct: 172 RIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 61.9 bits (150), Expect = 9e-11
 Identities = 60/228 (26%), Positives = 104/228 (45%), Gaps = 22/228 (9%)

Query: 98  LFSFSSVSSATGNFSAANKLGEGGFGTVYKGVIGQ-GEIAVKRLLGKSGQEIKELKNEAS 156
           +    S+   T  +     +G+G +G VYK    + G +A  ++L       +E++ E +
Sbjct: 11  MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYN 70

Query: 157 VIAQV-QHKNLVKLLGCCIEKDERL-----LIYEYMPNKSLDCFLFDPTKR-EILDWRTR 209
           ++  +  H N+VK  G   + D+ +     L+ E     S+   +       + LD    
Sbjct: 71  ILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMI 130

Query: 210 VQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDEL 269
             I+ G   GL +LH     RIIHRD+K +NILL  +   K+ DFG++  +        L
Sbjct: 131 SYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQL----TSTRL 183

Query: 270 QGNTSRISGTYGYMSPEY-----ALEGIFSIKSDVFSFGVLLLEIVSG 312
           + NTS   GT  +M+PE        +  +  + DV+S G+  +E+  G
Sbjct: 184 RRNTS--VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 61.9 bits (151), Expect = 9e-11
 Identities = 63/222 (28%), Positives = 97/222 (43%), Gaps = 57/222 (25%)

Query: 115 NKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQE--IKELKNEASVIAQVQ---------- 162
            K+GEG F  V K          +    K+G+   IK +K     + QV           
Sbjct: 5   GKIGEGTFSEVLK---------AQSR--KTGKYYAIKCMKKHFKSLEQVNNLREIQALRR 53

Query: 163 ---HKNLVKLLGCCIE-KDERL-LIYEYMPNKSLDCFLFDPTK--REILDWRTRV----- 210
              H N+++L+    + K  RL L++E M     D  L++  K  +  L    RV     
Sbjct: 54  LSPHPNILRLIEVLFDRKTGRLALVFELM-----DMNLYELIKGRKRPLP-EKRVKSYMY 107

Query: 211 QIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQ 270
           Q++K     L ++H   R  I HRD+K  NIL+  D   K++DFG  R ++         
Sbjct: 108 QLLKS----LDHMH---RNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSK------P 153

Query: 271 GNTSRISGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVS 311
             T  IS T  Y +PE  L +G +  K D+++ G +  EI+S
Sbjct: 154 PYTEYIS-TRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 26/207 (12%)

Query: 117 LGEGGFGTVYKGVIGQ--GEIAVKRLLGKSGQEI--KELKNEASVIAQVQHKNLVKLLGC 172
           +G G +GTV   +  +   ++A+K+L      E+  K    E  ++  ++H+N++ LL  
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82

Query: 173 CIEKDERLL----IYEYMPNKSLDCFLFDPTKREILDWRTRVQ-IIKGVAQGLLYLHQYS 227
               D  L      Y  MP    D  L    K E L    R+Q ++  + +GL Y+H   
Sbjct: 83  -FTPDLSLDRFHDFYLVMPFMGTD--LGKLMKHEKLS-EDRIQFLVYQMLKGLKYIHAAG 138

Query: 228 RVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEY 287
              IIHRDLK  N+ +++D   KI DFG+AR       + E+ G       T  Y +PE 
Sbjct: 139 ---IIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYVV----TRWYRAPEV 186

Query: 288 ALEGI-FSIKSDVFSFGVLLLEIVSGK 313
            L  + ++   D++S G ++ E+++GK
Sbjct: 187 ILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 62.4 bits (151), Expect = 1e-10
 Identities = 48/178 (26%), Positives = 85/178 (47%), Gaps = 13/178 (7%)

Query: 137 VKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLL-IYEYMPNKSLDCFL 195
           VK+ L    ++I  ++ E  V  Q  +   +  L  C + + RL  + EY+     D   
Sbjct: 28  VKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG--DLMF 85

Query: 196 FDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFG 255
               +R++ +   R    + ++  L YLH+     II+RDLK  N+LLD + + K++D+G
Sbjct: 86  HMQRQRKLPEEHARFYSAE-ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYG 141

Query: 256 MARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           M +      D       TS   GT  Y++PE      +    D ++ GVL+ E+++G+
Sbjct: 142 MCKEGLRPGD------TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 20/209 (9%)

Query: 110 NFSAANKLGEGGFGTVYKGV--IGQGEIAVK--RLLGKSGQEIKELKNEASVIAQVQHKN 165
           ++    KLGEG + TVYKG   +    +A+K  RL  + G     ++ EAS++  ++H N
Sbjct: 6   SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHAN 64

Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ 225
           +V L      K+   L++EY+      C   D     +     ++ + + + +GL Y+HQ
Sbjct: 65  IVLLHDIIHTKETLTLVFEYVHTDL--CQYMDKHPGGLHPENVKLFLFQ-LLRGLSYIHQ 121

Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNT-SRISGTYGYMS 284
                I+HRDLK  N+L+      K++DFG+AR          +  +T S    T  Y  
Sbjct: 122 RY---ILHRDLKPQNLLISDTGELKLADFGLAR-------AKSVPSHTYSNEVVTLWYRP 171

Query: 285 PEYALEGI-FSIKSDVFSFGVLLLEIVSG 312
           P+  L    +S   D++  G + +E++ G
Sbjct: 172 PDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 62.0 bits (150), Expect = 2e-10
 Identities = 58/216 (26%), Positives = 102/216 (47%), Gaps = 44/216 (20%)

Query: 117 LGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEI---KELKNEASVIAQVQHKNLVKLLG 171
           +G G +G+V      +    +AVK+L  +  Q I   K    E  ++  ++H+N++ LL 
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 83

Query: 172 CCIEKDERLLIYEYMPNKSL----DCFLFDPTKREILDWRTRVQ---------IIKGVAQ 218
                        + P +SL    D +L        L+   + Q         +I  + +
Sbjct: 84  V------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 131

Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
           GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR     + +DE+ G  +    
Sbjct: 132 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVA---- 179

Query: 279 TYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
           T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 180 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 61.8 bits (150), Expect = 2e-10
 Identities = 60/222 (27%), Positives = 94/222 (42%), Gaps = 48/222 (21%)

Query: 110 NFSAANKLGEGGFGTV----YKGVIGQGEIAVKRLLGKSGQEIKELKN------EASVIA 159
           +F     LG G FG V    +KG    GE    + L K  +EI ++K       E S++ 
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKG---TGEYYAIKCLKK--REILKMKQVQHVAQEKSILM 73

Query: 160 QVQHKNLVKLLGCCIEKDERL-LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQ 218
           ++ H  +V ++ C  + + R+  + E++    L   L           R   +    VA+
Sbjct: 74  ELSHPFIVNMM-CSFQDENRVYFLLEFVVGGELFTHL-----------RKAGRFPNDVAK 121

Query: 219 --------GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQ 270
                      YLH      II+RDLK  N+LLD   + K++DFG A+ V          
Sbjct: 122 FYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKV---------P 169

Query: 271 GNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
             T  + GT  Y++PE           D ++ GVLL E ++G
Sbjct: 170 DRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 61/205 (29%), Positives = 95/205 (46%), Gaps = 22/205 (10%)

Query: 117 LGEGGFGTVYK-GVIGQGEI-AVKRLLGKSGQEIKELK------NEASVIAQVQHKNLVK 168
           LG+GGFG V    V   G++ A K+L  K    IK+ K      NE  ++ +V  + +V 
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKK---RIKKRKGEAMALNEKRILEKVNSRFVVS 64

Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSR 228
           L      KD   L+   M    L   +++       D +  +     +  GL  L    R
Sbjct: 65  LAYAYETKDALCLVLTIMNGGDLKFHIYN-MGNPGFDEQRAIFYAAELCCGLEDLQ---R 120

Query: 229 VRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYA 288
            RI++RDLK  NILLD   + +ISD G+A  +  G   + ++G      GT GYM+PE  
Sbjct: 121 ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG---ETVRGRV----GTVGYMAPEVI 173

Query: 289 LEGIFSIKSDVFSFGVLLLEIVSGK 313
               ++   D +  G L+ E++ G+
Sbjct: 174 NNEKYTFSPDWWGLGCLIYEMIQGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 60.4 bits (146), Expect = 3e-10
 Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 37/212 (17%)

Query: 117 LGEGGFGT--VYKGVIGQGEIAVKRL-LGKSGQEIKELKNEASVIAQVQHKNLVKLLGCC 173
           +GEG FG   + + V    + A+K + L KS   +++ + EA ++A+++H N+V      
Sbjct: 8   VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES- 66

Query: 174 IEKDERL-LIYEYMPNKSLDCFLFDP-----TKREILDWRTRVQIIKGVAQGLLYLHQYS 227
            E D  L ++ EY     L   +         +  IL W   VQ+  GV     ++H+  
Sbjct: 67  FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWF--VQMCLGVQ----HIHEK- 119

Query: 228 RVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRIS------GTYG 281
             R++HRD+K+ NI L ++   K+ DFG AR++            TS  +      GT  
Sbjct: 120 --RVLHRDIKSKNIFLTQNGKVKLGDFGSARLL------------TSPGAYACTYVGTPY 165

Query: 282 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           Y+ PE      ++ KSD++S G +L E+ + K
Sbjct: 166 YVPPEIWENMPYNNKSDIWSLGCILYELCTLK 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 60.8 bits (147), Expect = 3e-10
 Identities = 36/99 (36%), Positives = 57/99 (57%), Gaps = 11/99 (11%)

Query: 216 VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR 275
           +A GL +LH      II+RDLK  N++LD + + KI+DFGM +       E+   G T++
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK-------ENMWDGVTTK 159

Query: 276 -ISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
              GT  Y++PE      +    D ++FGVLL E+++G+
Sbjct: 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 60.2 bits (146), Expect = 5e-10
 Identities = 61/203 (30%), Positives = 93/203 (45%), Gaps = 20/203 (9%)

Query: 117 LGEGGFGTVY--KGVIGQGEIAVKRLLGKSGQEIKELKN---EASVIAQ-VQHKNLVKLL 170
           +G+G FG V   K        AVK L  K+  + KE K+   E +V+ + V+H  LV L 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVR 230
                 D+   + +Y+    L  F     +R   + R R    + +A  L YLH    + 
Sbjct: 63  YSFQTADKLYFVLDYVNGGEL--FFHLQRERSFPEPRARFYAAE-IASALGYLHS---LN 116

Query: 231 IIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDED-ELQGNTSRISGTYGYMSPEYAL 289
           II+RDLK  NILLD   +  ++DFG+ +       E  E    TS   GT  Y++PE   
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK-------EGIEHSKTTSTFCGTPEYLAPEVLR 169

Query: 290 EGIFSIKSDVFSFGVLLLEIVSG 312
           +  +    D +  G +L E++ G
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 60.0 bits (145), Expect = 5e-10
 Identities = 60/202 (29%), Positives = 95/202 (47%), Gaps = 18/202 (8%)

Query: 117 LGEGGFGTVYKGVIGQGEI--AVKRLLGKS---GQEIKELKNEASVIAQ-VQHKNLVKLL 170
           +G+G FG V        E   AVK L  K+    +E K + +E +V+ + V+H  LV L 
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62

Query: 171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVR 230
                 D+   + +Y+    L  F     +R  L+ R R    + +A  L YLH    + 
Sbjct: 63  FSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFYAAE-IASALGYLHS---LN 116

Query: 231 IIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE 290
           I++RDLK  NILLD   +  ++DFG+ +      +  E  G TS   GT  Y++PE   +
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCK------ENIEHNGTTSTFCGTPEYLAPEVLHK 170

Query: 291 GIFSIKSDVFSFGVLLLEIVSG 312
             +    D +  G +L E++ G
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 60.2 bits (146), Expect = 5e-10
 Identities = 64/225 (28%), Positives = 107/225 (47%), Gaps = 30/225 (13%)

Query: 117 LGEGGFGTVY--KGVIGQ--GEIAVKRLLGK-----SGQEIKELKNEASVIAQVQHKNLV 167
           LG+GG+G V+  + V G   G+I   ++L K     + ++    K E +++  V+H  +V
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63

Query: 168 KLLGCCIEKDERL-LIYEYMPNKSLDCFLFDPTKRE-ILDWRTRVQIIKGVAQGLLYLHQ 225
            L+    +   +L LI EY+    L    F   +RE I    T    +  ++  L +LHQ
Sbjct: 64  DLI-YAFQTGGKLYLILEYLSGGEL----FMHLEREGIFMEDTACFYLSEISLALEHLHQ 118

Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN--TSRISGTYGYM 283
                II+RDLK  NILLD   + K++DFG+ +        + +     T    GT  YM
Sbjct: 119 QG---IIYRDLKPENILLDAQGHVKLTDFGLCK--------ESIHEGTVTHTFCGTIEYM 167

Query: 284 SPEYALEGIFSIKSDVFSFGVLLLEIVSGKKN-TGFYRTKSLNLI 327
           +PE  +        D +S G L+ ++++G    T   R K+++ I
Sbjct: 168 APEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKI 212

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 59.2 bits (143), Expect = 8e-10
 Identities = 60/215 (27%), Positives = 104/215 (48%), Gaps = 23/215 (10%)

Query: 110 NFSAANKLGEGGFGTVY--KGVIGQ--GEIAVKRLLGKS-----GQEIKELKNEASVIAQ 160
           NF     LG G +G V+  + V G   G++   ++L K+      +  +  + E  V+  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 161 VQHKNLVKLLGCCIEKDERL-LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQG 219
           ++    +  L    + D +L LI +Y+    L   L   ++RE       VQI  G  + 
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHL---SQRERFK-EQEVQIYSG--EI 114

Query: 220 LLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGT 279
           +L L    ++ II+RD+K  NILLD + +  ++DFG+++       EDE++   S   GT
Sbjct: 115 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH----EDEVERAYS-FCGT 169

Query: 280 YGYMSPEYAL--EGIFSIKSDVFSFGVLLLEIVSG 312
             YM+P+     +G      D +S GVL+ E+++G
Sbjct: 170 IEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 59.3 bits (143), Expect = 9e-10
 Identities = 56/202 (27%), Positives = 92/202 (45%), Gaps = 17/202 (8%)

Query: 117 LGEGGFGTV-YKGVIGQGEIAVKRLLGK----SGQEIKELKNEASVIAQVQHKNLVKLLG 171
           LG+G FG V        G+    ++L K    +  E+     E+ V+   +H  L  L  
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62

Query: 172 CCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRI 231
               KD    + EY+    L  F     +R   + RTR    + +   L YLH     +I
Sbjct: 63  SFQTKDRLCFVMEYVNGGEL--FFHLSRERVFSEDRTRFYGAE-IVSALDYLHSG---KI 116

Query: 232 IHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEG 291
           ++RDLK  N++LDKD + KI+DFG+ +   G  D   ++       GT  Y++PE   + 
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMK----TFCGTPEYLAPEVLEDN 170

Query: 292 IFSIKSDVFSFGVLLLEIVSGK 313
            +    D +  GV++ E++ G+
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 59.9 bits (145), Expect = 1e-09
 Identities = 36/97 (37%), Positives = 58/97 (59%), Gaps = 4/97 (4%)

Query: 218 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRIS 277
           Q LL +H      +IHRD+K++NILL  +   K+ DFG +++ +     D++ G T    
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKM-YAATVSDDV-GRT--FC 206

Query: 278 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK 314
           GT  Y++PE      +S K+D+FS GVLL E+++ K+
Sbjct: 207 GTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR 243

Length = 496

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 58.8 bits (142), Expect = 2e-09
 Identities = 53/209 (25%), Positives = 90/209 (43%), Gaps = 21/209 (10%)

Query: 110 NFSAANKLGEGGFGTVYKGVIGQGE---IAVKRLLGKS---GQEIKELKNEASVIAQVQH 163
           +F+    LG G FG V        +   +A+KR         +++  + +E  ++  + H
Sbjct: 31  DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINH 90

Query: 164 KNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYL 223
              V L G   ++    L+ E++       FL     R    +   V      AQ +L  
Sbjct: 91  PFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL-----RRNKRFPNDVGCFYA-AQIVLIF 144

Query: 224 HQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYM 283
                + I++RDLK  N+LLDKD   K++DFG A++V            T  + GT  Y+
Sbjct: 145 EYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV---------DTRTYTLCGTPEYI 195

Query: 284 SPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           +PE  L       +D ++ G+ + EI+ G
Sbjct: 196 APEILLNVGHGKAADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 58.6 bits (142), Expect = 2e-09
 Identities = 62/219 (28%), Positives = 93/219 (42%), Gaps = 50/219 (22%)

Query: 117 LGEGGFGTV---YKGVIGQGEIAVKRLLGKSGQEIKELKN---EASVIAQVQHKNLVKLL 170
           +G G  G V   Y  V GQ  +A+K+L  +  Q +   K    E  ++  V HKN++ LL
Sbjct: 24  IGSGAQGIVCAAYDTVTGQ-NVAIKKL-SRPFQNVTHAKRAYRELVLMKLVNHKNIIGLL 81

Query: 171 GCCIEKDERLLIYEYMPNKSLDCF--------LFDPTKREI----LDWRTRVQIIKGVAQ 218
                         + P KSL+ F        L D    ++    LD      ++  +  
Sbjct: 82  NV------------FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLC 129

Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
           G+ +LH      IIHRDLK SNI++  D   KI DFG+AR              TS +  
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART-----------AGTSFMMT 175

Query: 279 TY----GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
            Y     Y +PE  L   +    D++S G ++ E++ G 
Sbjct: 176 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 57/228 (25%), Positives = 100/228 (43%), Gaps = 42/228 (18%)

Query: 117 LGEGGFGTVY------KGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLL 170
           +G G FG V+       G +   ++  K  + K  Q I  ++ E  ++A      +VKL 
Sbjct: 9   IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQ-IAHVRAERDILADADSPWIVKLY 67

Query: 171 GCCIEKDERL-LIYEYMPNKSLDCFLFDPTKREILD--WRTRVQIIKGVAQGLLYLHQYS 227
               + +E L L+ EYMP   L   L    ++++       R  I    A+ +L L    
Sbjct: 68  -YSFQDEEHLYLVMEYMPGGDLMNLL---IRKDVFPEET-ARFYI----AELVLALDSVH 118

Query: 228 RVRIIHRDLKASNILLDKDMNSKISDFGMA-RIVFGGNDEDELQGNTSRIS--------- 277
           ++  IHRD+K  NIL+D D + K++DFG+  ++    + E  L  + + +          
Sbjct: 119 KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRR 178

Query: 278 -------------GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
                        GT  Y++PE      + ++ D +S GV+L E++ G
Sbjct: 179 DHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|221289 pfam11883, DUF3403, Domain of unknown function (DUF3403)

 Score = 52.3 bits (126), Expect = 2e-09
 Identities = 18/48 (37%), Positives = 32/48 (66%), Gaps = 1/48 (2%)

Query: 386 NEASSLLPPKQPAFCNLRN-MESSTSTTEKSWADCSINEVTVSILDAR 432
           +E + +  PKQP FC  R+  E+ +S++ +     ++N+VTVS++DAR
Sbjct: 1   SETTEIPQPKQPGFCVGRSPYETDSSSSTQRDESWTVNQVTVSVIDAR 48

This domain is functionally uncharacterized. This domain is found in eukaryotes. This presumed domain is about 50 amino acids in length. This domain is found associated with pfam00069, pfam08276, pfam00954, pfam01453. Length = 48

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 57.6 bits (139), Expect = 3e-09
 Identities = 35/105 (33%), Positives = 61/105 (58%), Gaps = 10/105 (9%)

Query: 224 HQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYM 283
           H ++R  +++RDLK +NILLD+  + +ISD G+A       D  + + + S   GT+GYM
Sbjct: 112 HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLA------CDFSKKKPHAS--VGTHGYM 162

Query: 284 SPEYALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLI 327
           +PE   +G+ +   +D FS G +L +++ G      ++TK  + I
Sbjct: 163 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 207

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 58.3 bits (141), Expect = 3e-09
 Identities = 61/241 (25%), Positives = 102/241 (42%), Gaps = 19/241 (7%)

Query: 78  LTEGNNKCKKGCEKEVDQFPLFSFSSVSSATGNFSAANKLGEGGFGTVYKGVIGQGEIAV 137
           L+   + C++ CE      P       S     ++  + L  G  G V+      G+   
Sbjct: 67  LSPQTDVCQEPCETTSSSDP------ASVVRMQYNILSSLTPGSEGEVFVCT-KHGDEQR 119

Query: 138 KRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFD 197
           K+++ K+    K    E  ++  + H+ ++ L+     K    ++   MP    D F + 
Sbjct: 120 KKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMV---MPKYKCDLFTY- 175

Query: 198 PTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMA 257
             +   L     + I + + + L YLH      IIHRD+K  NI LD+  N+ + DFG A
Sbjct: 176 VDRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAA 232

Query: 258 RIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTG 317
             +    D  +  G     SGT    SPE      +  K+D++S G++L E+ S K  T 
Sbjct: 233 CKLDAHPDTPQCYG----WSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM-SVKNVTL 287

Query: 318 F 318
           F
Sbjct: 288 F 288

Length = 392

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 58.6 bits (141), Expect = 3e-09
 Identities = 52/190 (27%), Positives = 87/190 (45%), Gaps = 23/190 (12%)

Query: 132 QGEIAVKRLLGK----SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMP 187
           QG+   +RL+ K      +   +L+NE   + ++ H+N++K     IE+  R     YM 
Sbjct: 187 QGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK-----IEEILRSEANTYMI 241

Query: 188 NKSLDCFLFDPTKREILDWRTRV------QIIKGVAQGLLYLHQYSRVRIIHRDLKASNI 241
            +  D  L+     E  DW+ R        I+K +   + Y+H     ++IHRD+K  NI
Sbjct: 242 TQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENI 298

Query: 242 LLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFS 301
            L+ D    + DFG A        E E +       GT    SPE      +   +D++S
Sbjct: 299 FLNCDGKIVLGDFGTAMPF-----EKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWS 353

Query: 302 FGVLLLEIVS 311
            G++LL+++S
Sbjct: 354 CGLILLDMLS 363

Length = 501

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 58/202 (28%), Positives = 94/202 (46%), Gaps = 18/202 (8%)

Query: 117 LGEGGFGTVY--KGVIGQGEIAVKRLLGKSGQEIKELKN---EASVIAQ-VQHKNLVKLL 170
           +G+G FG V   K        AVK L  K+  + KE  +   E +V+ + ++H  LV L 
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62

Query: 171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVR 230
                 ++   + +Y+    L  F     +R  L+ R R    + VA  + YLH    + 
Sbjct: 63  YSFQTAEKLYFVLDYVNGGEL--FFHLQRERCFLEPRARFYAAE-VASAIGYLHS---LN 116

Query: 231 IIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE 290
           II+RDLK  NILLD   +  ++DFG+ +      +  E +  TS   GT  Y++PE   +
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK------EGVEPEETTSTFCGTPEYLAPEVLRK 170

Query: 291 GIFSIKSDVFSFGVLLLEIVSG 312
             +    D +  G +L E++ G
Sbjct: 171 EPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 57.7 bits (140), Expect = 4e-09
 Identities = 57/236 (24%), Positives = 99/236 (41%), Gaps = 66/236 (27%)

Query: 110 NFSAANKLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQ--------EIKELKNEASVIA 159
            +   + +GEG +G V          ++A+K++     Q        EIK L+       
Sbjct: 6   RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILR------- 58

Query: 160 QVQHKNLVKLLGCCIEKD-----ERLLIYEYMP-------------NKSLDCFLFDPTKR 201
           + +H+N++ +L            +  ++ E M              N  +  FL+     
Sbjct: 59  RFKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLY----- 113

Query: 202 EILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVF 261
                    QI++G    L Y+H      ++HRDLK SN+LL+ + + KI DFG+ARI  
Sbjct: 114 ---------QILRG----LKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIA- 156

Query: 262 GGNDEDELQGNTSRIS---GTYGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGK 313
                D    +T  ++    T  Y +PE  L      K+ D++S G +L E++S +
Sbjct: 157 -----DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 56.8 bits (138), Expect = 4e-09
 Identities = 47/160 (29%), Positives = 71/160 (44%), Gaps = 33/160 (20%)

Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREI-LDWRTRVQIIKGVAQGLL 221
           + N +KL          +LI +Y+     D  LFD  K+E  L      +II+ + + L 
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIK----DGDLFDLLKKEGKLSEAEVKKIIRQLVEALN 123

Query: 222 YLHQYSRVRIIHRDLKASNILLDKDMNS-KISDFGMARIVFGGNDEDELQGNTSRISGTY 280
            LH++    IIH D+K  N+L D+  +   + D+G+ +I+          G  S   GT 
Sbjct: 124 DLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKII----------GTPSCYDGTL 170

Query: 281 GYMSPEYALEGIFSIKSDV--FSF-----GVLLLEIVSGK 313
            Y SPE        IK      SF     GVL  E+++GK
Sbjct: 171 DYFSPE-------KIKGHNYDVSFDWWAVGVLTYELLTGK 203

Length = 267

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 57.1 bits (138), Expect = 5e-09
 Identities = 55/212 (25%), Positives = 88/212 (41%), Gaps = 37/212 (17%)

Query: 117 LGEGGFGTV-----------YKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKN 165
           LG+G FG V           Y   I + E+ + +       E+     E+ V+   +H  
Sbjct: 3   LGKGTFGKVILVREKATGKYYAMKILKKEVIIAK------DEVAHTLTESRVLQNTRHPF 56

Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTR---VQIIKGVAQGLLY 222
           L  L       D    + EY     L  F     +R   + R R    +I+      L Y
Sbjct: 57  LTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIV----SALGY 110

Query: 223 LHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNT-SRISGTYG 281
           LH      +++RDLK  N++LDKD + KI+DFG+ +       E    G T     GT  
Sbjct: 111 LH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK-------EGISDGATMKTFCGTPE 160

Query: 282 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           Y++PE   +  +    D +  GV++ E++ G+
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 56.7 bits (137), Expect = 5e-09
 Identities = 58/237 (24%), Positives = 100/237 (42%), Gaps = 64/237 (27%)

Query: 110 NFSAANKLGEGGFGTVYKGV-IGQGE-IAVKRLLGKSGQE---IKELKNEASVIAQVQHK 164
            +    K+GEG +G VYK      G+ +A+K+   +  +E      L+ E S++  +   
Sbjct: 2   AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALR-EISLLQMLSES 60

Query: 165 N-LVKLLGCCIEKDER-------LLIYEY-------------------MPNKSLDCFLFD 197
             +V+LL   +E  E         L++EY                   +P K++  F++ 
Sbjct: 61  IYIVRLL--DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMY- 117

Query: 198 PTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNS-KISDFGM 256
                        Q++KGVA    + H++    ++HRDLK  N+L+DK     KI+D G+
Sbjct: 118 -------------QLLKGVA----HCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGL 157

Query: 257 ARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSG 312
            R          ++  T  I  T  Y +PE  L    +S   D++S G +  E+   
Sbjct: 158 GR-----AFSIPVKSYTHEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 57.0 bits (137), Expect = 5e-09
 Identities = 58/212 (27%), Positives = 101/212 (47%), Gaps = 34/212 (16%)

Query: 115 NKLGEGGFGTVYKG--VIGQGEIAVK--RLLGKSGQEIKELKNEASVIAQVQHKNLVKLL 170
           +KLGEG + TV+KG   + +  +A+K  RL  + G     ++ E S++  ++H N+V L 
Sbjct: 11  DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLH 69

Query: 171 GCCIEKDERL-LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVA-------QGLLY 222
              I  +  L L++EY+          D   ++ LD    +  +  V        +GL Y
Sbjct: 70  DI-IHTERCLTLVFEYL----------DSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSY 118

Query: 223 LHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGY 282
            H   + +I+HRDLK  N+L+++    K++DFG+AR       +       S    T  Y
Sbjct: 119 CH---KRKILHRDLKPQNLLINEKGELKLADFGLARA------KSVPTKTYSNEVVTLWY 169

Query: 283 MSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
             P+  L    +S   D++  G +L E+ +G+
Sbjct: 170 RPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 56.8 bits (137), Expect = 6e-09
 Identities = 60/212 (28%), Positives = 104/212 (49%), Gaps = 25/212 (11%)

Query: 111 FSAANKLGEGGFGTVYKGV-IGQGE-IAVKRLLGKSGQEI--KELKNEASVIAQVQHKNL 166
           +++  ++G G +G+V   +    GE +A+K+L      EI  K    E +++  +QH+N+
Sbjct: 17  YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENV 76

Query: 167 VKLLGCCIEK---DERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQ-IIKGVAQGLLY 222
           + LL         DE    Y  MP    D  L       + +   +VQ ++  +  GL Y
Sbjct: 77  IGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKIMGHPLSE--DKVQYLVYQMLCGLKY 132

Query: 223 LHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGY 282
           +H      IIHRDLK  N+ +++D   KI DFG+AR     + + E+ G       T  Y
Sbjct: 133 IHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVV----TRWY 180

Query: 283 MSPEYALEGIFSIKS-DVFSFGVLLLEIVSGK 313
            +PE  L  +   ++ D++S G ++ E+++GK
Sbjct: 181 RAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 56.7 bits (137), Expect = 7e-09
 Identities = 34/105 (32%), Positives = 56/105 (53%), Gaps = 15/105 (14%)

Query: 211 QIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQ 270
           QI++G    L YLH      I+HRD+K  N+L++ +   KI DFG+AR+     + DE +
Sbjct: 111 QILRG----LKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARV----EEPDESK 159

Query: 271 GNTSRISGTYGYMSPEYALEGI--FSIKSDVFSFGVLLLEIVSGK 313
             T  +   Y Y +PE  L G   ++   D++S G +  E++  +
Sbjct: 160 HMTQEVVTQY-YRAPEI-LMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 56.5 bits (136), Expect = 8e-09
 Identities = 53/219 (24%), Positives = 100/219 (45%), Gaps = 32/219 (14%)

Query: 110 NFSAANKLGEGGFGTVY---------KGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQ 160
           NF     LG G +G V+          G +   ++  K  L +  + ++  + E +V+  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 161 VQHKNLVKLLGCCIEKDERL-LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQG 219
           V+    +  L    + + +L LI +Y+    +   L+   +R+       V+   G  + 
Sbjct: 61  VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY---QRDNFS-EDEVRFYSG--EI 114

Query: 220 LLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGT 279
           +L L    ++ I++RD+K  NILLD + +  ++DFG+++     ++E E    T    GT
Sbjct: 115 ILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL--SEEKE---RTYSFCGT 169

Query: 280 YGYMSPEYALEGIFSIKS------DVFSFGVLLLEIVSG 312
             YM+PE     I   K       D +S G+L+ E+++G
Sbjct: 170 IEYMAPE-----IIRGKGGHGKAVDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 57.0 bits (137), Expect = 8e-09
 Identities = 33/96 (34%), Positives = 57/96 (59%), Gaps = 7/96 (7%)

Query: 216 VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR 275
           VA+G+ +L   +    +HRDL A N+LL +    KI DFG+AR +   +D + +   ++ 
Sbjct: 246 VARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIM--HDSNYVSKGSTF 300

Query: 276 ISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
           +     +M+PE   + +++  SDV+S+G+LL EI S
Sbjct: 301 LP--VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 56.4 bits (136), Expect = 8e-09
 Identities = 44/178 (24%), Positives = 84/178 (47%), Gaps = 13/178 (7%)

Query: 137 VKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERL-LIYEYMPNKSLDCFL 195
           +K+ L    ++I  ++ E  V     +   +  L  C + + RL  + E++     D   
Sbjct: 28  IKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGG--DLMF 85

Query: 196 FDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFG 255
               +R++ +   R    + ++  L +LH+     II+RDLK  N+LLD + + K++D+G
Sbjct: 86  HMQRQRKLPEEHARFYSAE-ISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYG 141

Query: 256 MARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           M +      D       TS   GT  Y++PE      +    D ++ GVL+ E+++G+
Sbjct: 142 MCKEGIRPGD------TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 56.2 bits (135), Expect = 1e-08
 Identities = 62/217 (28%), Positives = 109/217 (50%), Gaps = 46/217 (21%)

Query: 117 LGEGGFGTV---YKGVIGQGEIAVKRL------LGKSGQEIKELKNEASVIAQVQHKNLV 167
           +G G +G+V   Y   + Q ++AVK+L      L  + +  +EL+    ++  ++H+N++
Sbjct: 23  VGSGAYGSVCSAYDTRLRQ-KVAVKKLSRPFQSLIHARRTYRELR----LLKHMKHENVI 77

Query: 168 KLL-----GCCIEK-DERLLIYEYMP---NKSLDCFLFDPTKREILDWRTRVQ-IIKGVA 217
            LL        IE  +E  L+   M    N  + C       +++ D    VQ +I  + 
Sbjct: 78  GLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKC-------QKLSD--EHVQFLIYQLL 128

Query: 218 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRIS 277
           +GL Y+H      IIHRDLK SN+ +++D   +I DFG+AR       +DE+ G  +   
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR-----QADDEMTGYVA--- 177

Query: 278 GTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
            T  Y +PE  L  + ++   D++S G ++ E++ GK
Sbjct: 178 -TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 78/305 (25%), Positives = 133/305 (43%), Gaps = 43/305 (14%)

Query: 96  FPLFS----FSSVSSATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSGQEIK 149
           FPL      F S    +  +     +G+G +G V+K V+ +  G  A  ++L       +
Sbjct: 1   FPLSGKTIIFDSFPDPSDTWEIIETIGKGTYGKVFK-VLNKKNGSKAAVKILDPIHDIDE 59

Query: 150 ELKNEASVI-AQVQHKNLVKLLGCCIEKDER-----LLIYEYMPNKSLDCFLFDPTKR-E 202
           E++ E +++ A   H N+VK  G   +KD +      L+ E     S+   +    KR E
Sbjct: 60  EIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGE 119

Query: 203 ILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFG 262
            ++      I+     GL +LH     + IHRD+K +NILL  +   K+ DFG++  +  
Sbjct: 120 RMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQL-- 174

Query: 263 GNDEDELQGNTSRISGTYGYMSPEY-----ALEGIFSIKSDVFSFGVLLLEIVSGKKNTG 317
                 L+ NTS   GT  +M+PE       L+  +  + DV+S G+  +E+  G     
Sbjct: 175 --TSTRLRRNTS--VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLA 230

Query: 318 -FYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPT 376
             +  ++L  I         N    L    L    FN+ + +       C+ +  E RPT
Sbjct: 231 DLHPMRALFKIP-------RNPPPTLHQPELWSNEFNDFIRK-------CLTKDYEKRPT 276

Query: 377 MSDVV 381
           +SD++
Sbjct: 277 VSDLL 281

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 55.7 bits (134), Expect = 2e-08
 Identities = 33/94 (35%), Positives = 50/94 (53%), Gaps = 10/94 (10%)

Query: 220 LLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGT 279
           L +LH+Y    I++RDLK  NILLD   +  + DFG+++     N        T+   GT
Sbjct: 109 LEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK------TTNTFCGT 159

Query: 280 YGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSG 312
             Y++PE  L E  ++   D +S GVL+ E+  G
Sbjct: 160 TEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 34/100 (34%), Positives = 58/100 (58%), Gaps = 10/100 (10%)

Query: 224 HQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYM 283
           H ++R  +++RDLK +NILLD+  + +ISD G+A       D  + + + S   GT+GYM
Sbjct: 112 HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLA------CDFSKKKPHAS--VGTHGYM 162

Query: 284 SPEYALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGFYRTK 322
           +PE   +G  +   +D FS G +L +++ G      ++TK
Sbjct: 163 APEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 202

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 55.4 bits (134), Expect = 2e-08
 Identities = 31/93 (33%), Positives = 50/93 (53%), Gaps = 6/93 (6%)

Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
           GL Y+H      +IHRDLK SN+L+++D   +I DFGMAR +   +   E +   +    
Sbjct: 119 GLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGL--SSSPTEHKYFMTEYVA 173

Query: 279 TYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIV 310
           T  Y +PE  L    ++   D++S G +  E++
Sbjct: 174 TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 75/289 (25%), Positives = 117/289 (40%), Gaps = 67/289 (23%)

Query: 101 FSSVSSATGNFSAANK------LGEGGFGTV---YKGVIGQGEIAVKRLLG--KSGQEIK 149
           F SV  A   F+   +      +G G  G V   +  V+G   +AVK+L    ++    K
Sbjct: 7   FYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGI-NVAVKKLSRPFQNQTHAK 65

Query: 150 ELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCF--------LFDPTKR 201
               E  ++  V HKN++ LL              + P KSL+ F        L D    
Sbjct: 66  RAYRELVLLKCVNHKNIISLLNV------------FTPQKSLEEFQDVYLVMELMDANLC 113

Query: 202 EI----LDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMA 257
           ++    LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+A
Sbjct: 114 QVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 170

Query: 258 RIVFGGNDEDELQGNTSRISGTY----GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           R              T+ +   Y     Y +PE  L   +    D++S G ++ E+V G 
Sbjct: 171 R-----------TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG- 218

Query: 314 KNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEE--ASFNESLSRYV 360
            +  F  T  +       D W  NK+I+ + +   E       ++  YV
Sbjct: 219 -SVIFQGTDHI-------DQW--NKVIEQLGTPSAEFMNRLQPTVRNYV 257

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 54.0 bits (130), Expect = 4e-08
 Identities = 52/200 (26%), Positives = 92/200 (46%), Gaps = 27/200 (13%)

Query: 125 VYKGVIGQGEIAVKRLLGKSGQEIKEL----KNEASVIAQVQHKNLVKLLGCCIEKDERL 180
           +YKG+    E+ + R   K  +  K L    +NE   + ++   N++K+ G  I+  + L
Sbjct: 36  IYKGIFNNKEVII-RTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94

Query: 181 ----LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDL 236
               LI EY     L   L    K + L ++T++ +     +GL  L++Y+     +++L
Sbjct: 95  PRLSLILEYCTRGYLREVL---DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNL 149

Query: 237 KASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFS-- 294
            + + L+ ++   KI   G+ +I         L     +      Y S +  L  IFS  
Sbjct: 150 TSVSFLVTENYKLKIICHGLEKI---------LSSPPFKNVNFMVYFSYKM-LNDIFSEY 199

Query: 295 -IKSDVFSFGVLLLEIVSGK 313
            IK D++S GV+L EI +GK
Sbjct: 200 TIKDDIYSLGVVLWEIFTGK 219

Length = 283

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 54.2 bits (130), Expect = 4e-08
 Identities = 53/209 (25%), Positives = 88/209 (42%), Gaps = 31/209 (14%)

Query: 117 LGEGGFGTV-----------YKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKN 165
           LG+G FG V           Y   I + E+ + +       E+     E+ V+   +H  
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKILRKEVIIAK------DEVAHTVTESRVLQNTRHPF 56

Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ 225
           L  L       D    + EY     L  F     +R   + R R    + +   L YLH 
Sbjct: 57  LTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAE-IVSALEYLHS 113

Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR-ISGTYGYMS 284
                +++RD+K  N++LDKD + KI+DFG+ +       E    G T +   GT  Y++
Sbjct: 114 RD---VVYRDIKLENLMLDKDGHIKITDFGLCK-------EGISDGATMKTFCGTPEYLA 163

Query: 285 PEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           PE   +  +    D +  GV++ E++ G+
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 54.6 bits (131), Expect = 5e-08
 Identities = 45/173 (26%), Positives = 74/173 (42%), Gaps = 17/173 (9%)

Query: 143 KSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLD--CFLFDPTK 200
           K+GQ       EA ++  + H ++++L G         LI   +P    D  C+L     
Sbjct: 123 KAGQR-GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRN 178

Query: 201 REILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIV 260
             I D    + I + V + + YLH+    RIIHRD+KA NI ++   +  + DFG A   
Sbjct: 179 IAICDI---LAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFP 232

Query: 261 FGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
                 D         +GT    +PE      +    D++S G++L E+ +  
Sbjct: 233 V-----DINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 54.2 bits (130), Expect = 5e-08
 Identities = 31/97 (31%), Positives = 52/97 (53%), Gaps = 6/97 (6%)

Query: 216 VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR 275
            A+ L  L    +  +I+RDLK  NILLD   +  + DFG+ ++    +D+      T+ 
Sbjct: 99  TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK------TNT 152

Query: 276 ISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
             GT  Y++PE  L   ++   D ++ GVLL E+++G
Sbjct: 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 54.3 bits (130), Expect = 5e-08
 Identities = 63/284 (22%), Positives = 120/284 (42%), Gaps = 57/284 (20%)

Query: 54  RNTTNKGEDLMKFDLGMNLKVDVELTEGNNKCKKGCEKEVDQFPLFSFSSVSSATGNFSA 113
           +N         KF++      + E +  NN  +   E+++    +    + S   GN   
Sbjct: 16  KNHKANKGGSGKFEMNDKKLDEEERSHNNNAGEDEDEEKMIDNDINRSPNKSYKLGNI-- 73

Query: 114 ANKLGEGGFGTVYKGVI--GQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLG 171
              +G G FG VY+ +      ++A+K++L    Q+ +    E  ++  + H N++ L  
Sbjct: 74  ---IGNGSFGVVYEAICIDTSEKVAIKKVL----QDPQYKNRELLIMKNLNHINIIFLKD 126

Query: 172 C----CIEKDERLL----IYEYMP-------------NKSLDCFLFDPTKREILDWRTRV 210
                C +K+E+ +    + E++P             N +L  FL      ++       
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQL------- 179

Query: 211 QIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNS-KISDFGMARIVFGGNDEDEL 269
                  + L Y+H      I HRDLK  N+L+D + ++ K+ DFG A+ +  G      
Sbjct: 180 ------CRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG------ 224

Query: 270 QGNTSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSG 312
           Q + S I   + Y +PE  L    ++   D++S G ++ E++ G
Sbjct: 225 QRSVSYICSRF-YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 51.3 bits (123), Expect = 6e-08
 Identities = 31/146 (21%), Positives = 56/146 (38%), Gaps = 14/146 (9%)

Query: 116 KLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLV--KLLGCC 173
            L  G    VY       +  +K     S ++  + + E +++  +  K L   K+L   
Sbjct: 5   LLKGGLTNRVYLLGTKDEDYVLKI--NPSREKGADREREVAILQLLARKGLPVPKVLASG 62

Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
                  L+ E++  ++LD           +    +  I + +A+ L  LHQ   + + H
Sbjct: 63  ESDGWSYLLMEWIEGETLD----------EVSEEEKEDIAEQLAELLAKLHQLPLLVLCH 112

Query: 234 RDLKASNILLDKDMNSKISDFGMARI 259
            DL   NIL+D      I D+  A  
Sbjct: 113 GDLHPGNILVDDGKILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 53.3 bits (128), Expect = 7e-08
 Identities = 55/219 (25%), Positives = 95/219 (43%), Gaps = 44/219 (20%)

Query: 116 KLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQ------------VQH 163
           ++G G FG V    I      V R++      +KELK  AS   Q            +QH
Sbjct: 2   EIGNGWFGKVLLSEIYTDT-GVARVV------VKELKANASSKEQNEFLQQGDPYRILQH 54

Query: 164 KNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIK------GVA 217
            N+++ LG C+E    LL++EY     L  +L      +    R   Q++        +A
Sbjct: 55  PNILQCLGQCVEAIPYLLVFEYCELGDLKSYL-----SQEQWHRRNSQLLLLQRMACEIA 109

Query: 218 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRIS 277
            G+ ++H+++    +H DL   N  L  D+  K+ D+G   I      ED ++    +  
Sbjct: 110 AGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYG---IGPSRYKEDYIETEDDKCV 163

Query: 278 GTYGYMSPEYALE---GIFSIK----SDVFSFGVLLLEI 309
               +++PE   E   G+ + +    S+V++ GV L E+
Sbjct: 164 -PLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWEL 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 53.5 bits (128), Expect = 7e-08
 Identities = 56/209 (26%), Positives = 88/209 (42%), Gaps = 30/209 (14%)

Query: 117 LGEGGFGTV-----------YKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKN 165
           LG+G FG V           Y   I + E+ V +       E+     E  V+   +H  
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAK------DEVAHTLTENRVLQNSRHPF 56

Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ 225
           L  L       D    + EY     L  F     +R   + R R    + +   L YLH 
Sbjct: 57  LTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAE-IVSALDYLH- 112

Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR-ISGTYGYMS 284
            S   +++RDLK  N++LDKD + KI+DFG+ +       E    G T +   GT  Y++
Sbjct: 113 -SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK-------EGIKDGATMKTFCGTPEYLA 164

Query: 285 PEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           PE   +  +    D +  GV++ E++ G+
Sbjct: 165 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 32/96 (33%), Positives = 54/96 (56%), Gaps = 7/96 (7%)

Query: 216 VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR 275
           VA G+ +L   +    +HRDL A N+L+ +    KI DFG+AR +    D + +   ++ 
Sbjct: 248 VANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIM--RDSNYISKGSTF 302

Query: 276 ISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
           +     +M+PE     +++  SDV+SFG+LL EI +
Sbjct: 303 LP--LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 51/214 (23%), Positives = 102/214 (47%), Gaps = 24/214 (11%)

Query: 116 KLGEGGFGTVYKGVIGQG----EIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLG 171
           K+G G +G VYK     G    + A+K++ G +G  +   + E +++ +++H N++ L  
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALKQIEG-TGISMSACR-EIALLRELKHPNVISLQK 65

Query: 172 CCIEKDER--LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLY-----LH 224
             +   +R   L+++Y  +       F    +     +  VQ+ +G+ + LLY     +H
Sbjct: 66  VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPVQLPRGMVKSLLYQILDGIH 122

Query: 225 QYSRVRIIHRDLKASNILL----DKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY 280
                 ++HRDLK +NIL+     +    KI+D G AR+    N   +   +   +  T+
Sbjct: 123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF---NSPLKPLADLDPVVVTF 179

Query: 281 GYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGK 313
            Y +PE  L      K+ D+++ G +  E+++ +
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 53.1 bits (128), Expect = 1e-07
 Identities = 63/236 (26%), Positives = 103/236 (43%), Gaps = 49/236 (20%)

Query: 117 LGEGGFGTVYKGV-IGQGEI-AVKRLLGKSGQEIKE----LKNEASVIAQVQHKNLVKLL 170
           +G G FG V        G I A+K+L  KS    KE    ++ E  ++A+  +  +VKL 
Sbjct: 9   IGRGAFGEVRLVQKKDTGHIYAMKKLR-KSEMLEKEQVAHVRAERDILAEADNPWVVKLY 67

Query: 171 GCCIEKDERL-LIYEYMPNKSLDCFLFDPTKREIL-DWRTRVQIIKGVAQGLLYLHQYSR 228
               + +  L LI EY+P   +   L    K++   +  TR  I    A+ +L +    +
Sbjct: 68  -YSFQDENYLYLIMEYLPGGDMMTLLM---KKDTFTEEETRFYI----AETILAIDSIHK 119

Query: 229 VRIIHRDLKASNILLDKDMNSKISDFGM------------ARIVF---GGNDEDELQGNT 273
           +  IHRD+K  N+LLD   + K+SDFG+             RI+      N  D +    
Sbjct: 120 LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPM 179

Query: 274 SR-----------------ISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           S                    GT  Y++PE  L+  ++ + D +S GV++ E++ G
Sbjct: 180 SSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 61/240 (25%), Positives = 100/240 (41%), Gaps = 52/240 (21%)

Query: 100 SFSSVSSATGNFSAANK------LGEGGFGTV---YKGVIGQGEIAVKRLLG--KSGQEI 148
           +F SV      F+   +      +G G  G V   Y  ++ +  +A+K+L    ++    
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAIL-ERNVAIKKLSRPFQNQTHA 67

Query: 149 KELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCF--------LFDPTK 200
           K    E  ++  V HKN++ LL              + P KSL+ F        L D   
Sbjct: 68  KRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANL 115

Query: 201 REI----LDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGM 256
            ++    LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+
Sbjct: 116 CQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172

Query: 257 ARIVFGGNDEDELQGNTSRISG---TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           AR            G +  ++    T  Y +PE  L   +    D++S G ++ E++ G 
Sbjct: 173 ARTA----------GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 52.5 bits (126), Expect = 1e-07
 Identities = 32/102 (31%), Positives = 55/102 (53%), Gaps = 12/102 (11%)

Query: 220 LLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARI--------VFGGNDE-DELQ 270
           L YLH Y    I+HRDLK  N+L+    + K++DFG+++I        ++ G+ E D  +
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170

Query: 271 GNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
               ++ GT  Y++PE  L   +    D ++ G++L E + G
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 35/109 (32%), Positives = 61/109 (55%), Gaps = 12/109 (11%)

Query: 216 VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR 275
           +A+ +L +H   ++  +HRD+K  N+LLD + + +++DFG        N +  +Q  +S 
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSC---LKMNQDGTVQ--SSV 162

Query: 276 ISGTYGYMSPEY--ALE---GIFSIKSDVFSFGVLLLEIVSGKKNTGFY 319
             GT  Y+SPE   A+E   G +  + D +S GV + E++ G+  T FY
Sbjct: 163 AVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE--TPFY 209

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 52.4 bits (125), Expect = 2e-07
 Identities = 64/240 (26%), Positives = 98/240 (40%), Gaps = 54/240 (22%)

Query: 101 FSSVSSATGNFSAANK------LGEGGFGTV---YKGVIGQGEIAVKRLLG--KSGQEIK 149
           F SV      F+   +      +G G  G V   Y  V+ +  +A+K+L    ++    K
Sbjct: 3   FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDR-NVAIKKLSRPFQNQTHAK 61

Query: 150 ELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCF--------LFDPTKR 201
               E  ++  V HKN++ LL              + P KSL+ F        L D    
Sbjct: 62  RAYRELVLMKCVNHKNIISLLNV------------FTPQKSLEEFQDVYLVMELMDANLC 109

Query: 202 EI----LDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMA 257
           ++    LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+A
Sbjct: 110 QVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 166

Query: 258 RIVFGGNDEDELQGNTSRISGTY----GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           R              TS +   Y     Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 167 R-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 57/215 (26%), Positives = 97/215 (45%), Gaps = 37/215 (17%)

Query: 117 LGEGGFGTVYKGVI----------GQGEIAVK---RLLGKSGQEIK-ELKNEASVIAQVQ 162
           LG G    +Y G++             E  +K   ++L  S ++I       AS++ QV 
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLY 222
           HK++V L G C+   E +++ E++    LD  LF   K ++L    + ++ K +A  L Y
Sbjct: 63  HKHIVLLYGVCVRDVENIMVEEFVEFGPLD--LFMHRKSDVLTTPWKFKVAKQLASALSY 120

Query: 223 LHQYSRVRIIHRDLKASNILLDKD-MNS------KISDFGMARIVFGGNDEDELQGNTSR 275
           L       ++H ++   NILL ++ ++       K+SD G+   V         Q    R
Sbjct: 121 LEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVL------SRQECVER 171

Query: 276 ISGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEI 309
           I     +++PE   +    SI +D +SFG  L EI
Sbjct: 172 IP----WIAPECVEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 52.1 bits (125), Expect = 2e-07
 Identities = 53/245 (21%), Positives = 95/245 (38%), Gaps = 48/245 (19%)

Query: 111 FSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKS---GQEIKELKNEASVIAQVQHKN 165
           F     +G G FG V   + V      A+K L         +   +K E  ++A+  ++ 
Sbjct: 3   FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62

Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ 225
           +VKL     +KD    + +Y+P   +   L    +  I +       I  +   +  +H 
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI---RLGIFEEDLARFYIAELTCAIESVH- 118

Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMA--------RIVFGGNDE---------DE 268
             ++  IHRD+K  NIL+D+D + K++DFG+            +   D          +E
Sbjct: 119 --KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEE 176

Query: 269 LQGNTSR--------------------ISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLE 308
                                      + GT  Y++PE  L   ++   D +S GV+L E
Sbjct: 177 WSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236

Query: 309 IVSGK 313
           ++ G+
Sbjct: 237 MLVGQ 241

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 51.7 bits (124), Expect = 3e-07
 Identities = 37/100 (37%), Positives = 53/100 (53%), Gaps = 12/100 (12%)

Query: 218 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRIS 277
           + L Y+H  +   + HRDLK  NIL + D   KI DFG+AR+ F  ND       T  ++
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAF--NDTPTAIFWTDYVA 168

Query: 278 GTYGYMSPEYALEGIFSIKS----DVFSFGVLLLEIVSGK 313
            T  Y +PE  L G F  K     D++S G +  E+++GK
Sbjct: 169 -TRWYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 51.6 bits (124), Expect = 3e-07
 Identities = 36/98 (36%), Positives = 51/98 (52%), Gaps = 10/98 (10%)

Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDED--ELQGNTSRI 276
           GL Y+H      ++HRDLK  N+L++ D   KI DFG+AR    G  E+  E  G  +  
Sbjct: 117 GLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLAR----GFSENPGENAGFMTEY 169

Query: 277 SGTYGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGK 313
             T  Y +PE  L      K+ DV+S G +L E++  K
Sbjct: 170 VATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 51.4 bits (123), Expect = 4e-07
 Identities = 58/257 (22%), Positives = 114/257 (44%), Gaps = 29/257 (11%)

Query: 110 NFSAANKLGEGGFGTVYKGVIGQ-GEIAVKRLLGKSGQEIKE----LKNEASVIAQVQHK 164
           +F   + +G G FG V        G+I   +++ KS    +E     + E  +++     
Sbjct: 2   DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSP 61

Query: 165 NLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLH 224
            + +L     +KD   L+ EY P   L   L      +  D     Q    +A+ +L +H
Sbjct: 62  WIPQLQYAFQDKDNLYLVMEYQPGGDLLSLL--NRYEDQFD-EDMAQFY--LAELVLAIH 116

Query: 225 QYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMS 284
              ++  +HRD+K  N+L+D+  + K++DFG A  +      +++  +   + GT  Y++
Sbjct: 117 SVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARL----TANKMVNSKLPV-GTPDYIA 171

Query: 285 PEY------ALEGIFSIKSDVFSFGVLLLEIVSGKK-----NTGFYRTKSLN---LIGYA 330
           PE         +G + ++ D +S GV+  E++ G+       +       +N    + + 
Sbjct: 172 PEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFP 231

Query: 331 WDLWISNKIIDLIDSVL 347
            D  +S+  +DLI S+L
Sbjct: 232 EDPKVSSDFLDLIQSLL 248

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 50.8 bits (121), Expect = 5e-07
 Identities = 55/202 (27%), Positives = 93/202 (46%), Gaps = 18/202 (8%)

Query: 117 LGEGGFGTVY--KGVIGQGEIAVKRLLGK---SGQEIKELKNEASVIAQ-VQHKNLVKLL 170
           +G+G FG V   K  +     AVK L  K   + +E K +  E +V+ + V+H  LV L 
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVR 230
                 ++   + +++    L  F     +R   + R R    + +A  L YLH    + 
Sbjct: 63  YSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFPEPRARFYAAE-IASALGYLHS---IN 116

Query: 231 IIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE 290
           I++RDLK  NILLD   +  ++DFG+ +     +D       T+   GT  Y++PE   +
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD------TTTTFCGTPEYLAPEVIRK 170

Query: 291 GIFSIKSDVFSFGVLLLEIVSG 312
             +    D +  G +L E++ G
Sbjct: 171 QPYDNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 50.8 bits (121), Expect = 6e-07
 Identities = 50/214 (23%), Positives = 101/214 (47%), Gaps = 24/214 (11%)

Query: 116 KLGEGGFGTVYKGVIGQG----EIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLG 171
           K+G G +G VYK     G    E A+K++ G +G  +   + E +++ +++H N++ L  
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYALKQIEG-TGISMSACR-EIALLRELKHPNVIALQK 65

Query: 172 CCIEKDER--LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLY-----LH 224
             +   +R   L+++Y  +       F    +     +  +Q+ + + + LLY     +H
Sbjct: 66  VFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPMQLPRSMVKSLLYQILDGIH 122

Query: 225 QYSRVRIIHRDLKASNILL----DKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY 280
                 ++HRDLK +NIL+     +    KI+D G AR+    N   +   +   +  T+
Sbjct: 123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF---NSPLKPLADLDPVVVTF 179

Query: 281 GYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGK 313
            Y +PE  L      K+ D+++ G +  E+++ +
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 50.4 bits (121), Expect = 7e-07
 Identities = 34/98 (34%), Positives = 49/98 (50%), Gaps = 14/98 (14%)

Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
           GL Y+H      ++HRDLK SN+LL+ + + KI DFG+AR         E     +    
Sbjct: 120 GLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLART------TSEKGDFMTEYVV 170

Query: 279 TYGYMSPEYAL---EGIFSIKSDVFSFGVLLLEIVSGK 313
           T  Y +PE  L   E   +I  DV+S G +  E++  K
Sbjct: 171 TRWYRAPELLLNCSEYTTAI--DVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 49.9 bits (119), Expect = 9e-07
 Identities = 47/164 (28%), Positives = 80/164 (48%), Gaps = 25/164 (15%)

Query: 155 ASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIK 214
           AS+++QV H +L  + G C+   E +++ E++ +  LD  L     R  + W+  V   +
Sbjct: 67  ASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVA--Q 124

Query: 215 GVAQGLLYLHQYSRVRIIHRDLKASNILLDK----DMNS---KISDFGMARIVFGGNDED 267
            +A  L YL   +   ++H ++ A NILL +    +  S   K+SD G++   F     +
Sbjct: 125 QLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS---FTALSRE 178

Query: 268 ELQGNTSRISGTYGYMSPEYALEGI--FSIKSDVFSFGVLLLEI 309
           E      RI     +++PE  + G    S  +D +SFG  LLEI
Sbjct: 179 E---RVERIP----WIAPE-CVPGGNSLSTAADKWSFGTTLLEI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 50.2 bits (120), Expect = 9e-07
 Identities = 35/110 (31%), Positives = 62/110 (56%), Gaps = 14/110 (12%)

Query: 216 VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMA-RIVFGGNDEDELQGNTS 274
           +A+ +L +    ++  +HRD+K  N+LLDK+ + +++DFG   R+      +  +Q N +
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRL----LADGTVQSNVA 163

Query: 275 RISGTYGYMSPEY--ALE---GIFSIKSDVFSFGVLLLEIVSGKKNTGFY 319
              GT  Y+SPE   A+E   G +  + D +S GV + E++ G+  T FY
Sbjct: 164 --VGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE--TPFY 209

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 49.7 bits (118), Expect = 1e-06
 Identities = 54/237 (22%), Positives = 101/237 (42%), Gaps = 40/237 (16%)

Query: 110 NFSAANKLGEGGFGTV-YKGVIGQGEIAVKRLLGKSG----QEIKELKNEASVIAQVQHK 164
           +F +   +G G FG V        G +   ++L K+     +++  ++ E  ++ +    
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61

Query: 165 NLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLH 224
            +VK+     +K    LI E++P   +   L    K  + +  T+  I    A+ +L + 
Sbjct: 62  WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM--KKDTLTEEETQFYI----AETVLAID 115

Query: 225 QYSRVRIIHRDLKASNILLDKDMNSKISDFGMA-------RIVFGGNDEDELQG------ 271
              ++  IHRD+K  N+LLD   + K+SDFG+        R  F  N    L        
Sbjct: 116 SIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQN 175

Query: 272 -NTSRIS---------------GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
            N+ R +               GT  Y++PE  ++  ++   D +S GV++ E++ G
Sbjct: 176 MNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 59/214 (27%), Positives = 96/214 (44%), Gaps = 38/214 (17%)

Query: 129 VIGQGEIA-VKRLLGKSGQEIKELK-----------------NEASVIAQVQHKNLVKLL 170
           VIG+G    V+ +  KS Q++  +K                  E  ++A      +V+L 
Sbjct: 50  VIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109

Query: 171 GCCIEKDERL-LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRV 229
            C  + D+ L ++ EYMP   L   + +    E   W          A+ +L L     +
Sbjct: 110 -CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE--KWAKFY-----TAEVVLALDAIHSM 161

Query: 230 RIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEY-- 287
            +IHRD+K  N+LLDK  + K++DFG    +    DE  +    + + GT  Y+SPE   
Sbjct: 162 GLIHRDVKPDNMLLDKHGHLKLADFGTCMKM----DETGMVRCDTAV-GTPDYISPEVLK 216

Query: 288 --ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFY 319
               +G +  + D +S GV L E++ G  +T FY
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLFEMLVG--DTPFY 248

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 45/160 (28%), Positives = 77/160 (48%), Gaps = 6/160 (3%)

Query: 152 KNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQ 211
           ++E   +A   H  +VK        D+ LLI EY     L+  +    K  +      V 
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172

Query: 212 IIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQG 271
           ++    Q +L L +    +++HRDLK++NI L      K+ DFG ++     +D   L  
Sbjct: 173 LL--FYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQY---SDSVSLDV 227

Query: 272 NTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
            +S   GT  Y++PE      +S K+D++S GV+L E+++
Sbjct: 228 ASS-FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266

Length = 478

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 49.3 bits (117), Expect = 2e-06
 Identities = 55/237 (23%), Positives = 101/237 (42%), Gaps = 40/237 (16%)

Query: 110 NFSAANKLGEGGFGTV-YKGVIGQGEIAVKRLLGKSG----QEIKELKNEASVIAQVQHK 164
           +F +   +G G FG V        G I   ++L K+     +++  ++ E  ++ +    
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGA 61

Query: 165 NLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLH 224
            +VK+     +K    LI E++P   +   L    K  + +  T+  I    A+ +L + 
Sbjct: 62  WVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM--KKDTLSEEATQFYI----AETVLAID 115

Query: 225 QYSRVRIIHRDLKASNILLDKDMNSKISDFGMA-------RIVFGGN-------DEDELQ 270
              ++  IHRD+K  N+LLD   + K+SDFG+        R  F  N       D     
Sbjct: 116 AIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQN 175

Query: 271 GNTSRIS---------------GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
            N+ R +               GT  Y++PE  ++  ++   D +S GV++ E++ G
Sbjct: 176 MNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 48.6 bits (116), Expect = 3e-06
 Identities = 49/172 (28%), Positives = 81/172 (47%), Gaps = 22/172 (12%)

Query: 154 EASVIAQVQHKNLVKLLGCCIEKDERLL--IYEYMPNKSLDCFLFDPTKREILDWRTRVQ 211
           E  ++A    + +V+L      +D++ L  + EYMP   L   + +    E   W  R  
Sbjct: 93  ERDIMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE--KW-ARFY 147

Query: 212 IIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQG 271
             + V   L  +H       IHRD+K  N+LLDK  + K++DFG    +   +    ++ 
Sbjct: 148 TAE-VVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKM---DANGMVRC 200

Query: 272 NTSRISGTYGYMSPEYAL----EGIFSIKSDVFSFGVLLLEIVSGKKNTGFY 319
           +T+   GT  Y+SPE       +G +  + D +S GV L E++ G  +T FY
Sbjct: 201 DTA--VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG--DTPFY 248

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 46/150 (30%), Positives = 75/150 (50%), Gaps = 20/150 (13%)

Query: 176 KDERLL--IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
           +D+R L  + EYMP   L   +   +  ++ +   R       A+ +L L     +  IH
Sbjct: 113 QDDRYLYMVMEYMPGGDLVNLM---SNYDVPEKWARFY----TAEVVLALDAIHSMGFIH 165

Query: 234 RDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEY----AL 289
           RD+K  N+LLDK  + K++DFG    +   N E  ++ +T+   GT  Y+SPE       
Sbjct: 166 RDVKPDNMLLDKSGHLKLADFGTCMKM---NKEGMVRCDTA--VGTPDYISPEVLKSQGG 220

Query: 290 EGIFSIKSDVFSFGVLLLEIVSGKKNTGFY 319
           +G +  + D +S GV L E++ G  +T FY
Sbjct: 221 DGYYGRECDWWSVGVFLYEMLVG--DTPFY 248

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 49.0 bits (116), Expect = 4e-06
 Identities = 64/255 (25%), Positives = 111/255 (43%), Gaps = 49/255 (19%)

Query: 106 SATGNFSAANKLGEGGFGTVY--KGVIGQGEIAVKRL--LGKSGQEIKELKNEASVIAQV 161
           S    +    K+G G FG V+  K    Q     K +   G   +E  +L  E +V+ ++
Sbjct: 10  SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMREL 69

Query: 162 QHKNLVKLLGCCIEK-DERLLI-YEYMPNKSLD-----CF-LFDPTKREILDWRTRVQII 213
           +HKN+V+ +   + K +++L I  E+     L      C+ +F   +   +     V I 
Sbjct: 70  KHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAI-----VDIT 124

Query: 214 KGVAQGLLYLHQY----SRVRIIHRDLKASNILLD-------------KDMN----SKIS 252
           + +   L Y H      +  R++HRDLK  NI L               ++N    +KI 
Sbjct: 125 RQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIG 184

Query: 253 DFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSI--KSDVFSFGVLLLEIV 310
           DFG+++ +        ++       GT  Y SPE  L    S   KSD+++ G ++ E+ 
Sbjct: 185 DFGLSKNI-------GIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237

Query: 311 SGKKNTGFYRTKSLN 325
           SGK  T F++  + +
Sbjct: 238 SGK--TPFHKANNFS 250

Length = 1021

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 48.5 bits (115), Expect = 4e-06
 Identities = 58/250 (23%), Positives = 100/250 (40%), Gaps = 54/250 (21%)

Query: 111 FSAANKLGEGGFGTV--YKGVIGQGEIAVKRLLGK---SGQEIKELKNEASVIAQVQHKN 165
           F     LG G FG V     V      A+K L  K   +  ++  +K E  ++A+  ++ 
Sbjct: 3   FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62

Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWR-TRVQIIKGVAQGLLYLH 224
           +VKL     +KD    + +Y+P   +   L    + E+      R  I    A+  L + 
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI---RMEVFPEVLARFYI----AELTLAIE 115

Query: 225 QYSRVRIIHRDLKASNILLDKDMNSKISDFGMAR-IVFGGNDEDELQGNTSR-------- 275
              ++  IHRD+K  NIL+D D + K++DFG+     +  N +   +G+  R        
Sbjct: 116 SVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSD 175

Query: 276 --------------------------------ISGTYGYMSPEYALEGIFSIKSDVFSFG 303
                                           + GT  Y++PE  L   ++   D +S G
Sbjct: 176 LWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235

Query: 304 VLLLEIVSGK 313
           V+L E++ G+
Sbjct: 236 VILFEMLVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 48.7 bits (116), Expect = 4e-06
 Identities = 22/55 (40%), Positives = 35/55 (63%), Gaps = 3/55 (5%)

Query: 205 DWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARI 259
           D    V+ I  VA  L YLH++    IIHRDLK  N+L+  + + K++DFG++++
Sbjct: 102 DEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 47.5 bits (113), Expect = 7e-06
 Identities = 43/156 (27%), Positives = 74/156 (47%), Gaps = 17/156 (10%)

Query: 110 NFSAANKLGEGGFGTVYKGV--IGQGEIAVKRLLGKS----GQEIKELKNEASVIAQVQH 163
           +F     +G+G FG V + V     G+I   + L KS      ++  +K E  V+A+   
Sbjct: 2   DFHTVKVIGKGAFGEV-RLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60

Query: 164 KNLVKLLGCCIEKDERLLIYEYMPNKSLDCFL--FDPTKREILDWRTRVQIIKGVAQGLL 221
             +V L     +     LI E++P   L   L  +D    ++    TR  +    A+ +L
Sbjct: 61  PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDV----TRFYM----AECVL 112

Query: 222 YLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMA 257
            +    ++  IHRD+K  NIL+D+  + K+SDFG++
Sbjct: 113 AIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 47.7 bits (113), Expect = 7e-06
 Identities = 56/255 (21%), Positives = 100/255 (39%), Gaps = 64/255 (25%)

Query: 111 FSAANKLGEGGFGTV--YKGVIGQGEIAVKRLLGKS---GQEIKELKNEASVIAQVQHKN 165
           F     LG G FG V   + V  +   A+K L  K      ++  +K E  ++A+  ++ 
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62

Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKG------VAQG 219
           +V+L     +KD    + +Y+P   +   L             R+ I         +A+ 
Sbjct: 63  VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLI------------RMGIFPEDLARFYIAEL 110

Query: 220 LLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMA---------------------R 258
              +    ++  IHRD+K  NIL+D+D + K++DFG+                       
Sbjct: 111 TCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDS 170

Query: 259 IVFGGNDEDE-----------LQGNTSR---------ISGTYGYMSPEYALEGIFSIKSD 298
           + F     D            L+   +R         + GT  Y++PE  L   ++   D
Sbjct: 171 MDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD 230

Query: 299 VFSFGVLLLEIVSGK 313
            +S GV+L E++ G+
Sbjct: 231 WWSVGVILYEMLVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 45.9 bits (109), Expect = 3e-05
 Identities = 41/175 (23%), Positives = 72/175 (41%), Gaps = 31/175 (17%)

Query: 110 NFSAANKLGEGGFGTVYKGVI------GQGEIAVKRLLGKSGQEIKELKNE------ASV 157
           +F    KLGEG FG VYK  +       +G+  +K+        ++   NE       + 
Sbjct: 133 DFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKK--ATEYGAVEIWMNERVRRACPNS 190

Query: 158 IAQVQHKNLVKLLGCCIEKDERLLIYEY---------MPNK----SLDCFLFDPTKREIL 204
            A   +  L  +     ++DE  L++ Y         M +K    +++ +L    +    
Sbjct: 191 CADFVYGFLEPVSS--KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPK 248

Query: 205 DWRTRVQIIKGVAQGLLY-LHQYSRVRIIHRDLKASNILLDKDMNS-KISDFGMA 257
                 +II+ + + +L+ L       I+HRD+K  NI+  +   S KI D G A
Sbjct: 249 GLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303

Length = 566

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 44.2 bits (104), Expect = 1e-04
 Identities = 39/128 (30%), Positives = 56/128 (43%), Gaps = 20/128 (15%)

Query: 203 ILDW---------RTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILL-------DKD 246
           +LDW         R   QII      L Y H  + + ++H DLK  NIL+       D  
Sbjct: 218 LLDWIMKHGPFSHRHLAQIIFQTGVALDYFH--TELHLMHTDLKPENILMETSDTVVDPV 275

Query: 247 MNSKIS-DFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVL 305
            N  +  D    RI   G   DE    T+ +S T  Y SPE  L   +   +D++S G +
Sbjct: 276 TNRALPPDPCRVRICDLGGCCDERHSRTAIVS-TRHYRSPEVVLGLGWMYSTDMWSMGCI 334

Query: 306 LLEIVSGK 313
           + E+ +GK
Sbjct: 335 IYELYTGK 342

Length = 467

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 43.4 bits (102), Expect = 1e-04
 Identities = 58/235 (24%), Positives = 98/235 (41%), Gaps = 64/235 (27%)

Query: 212 IIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKD----------MNSKISDFGMARIVF 261
           I+ G  +GL YLHQ      IHR++KAS+IL+  D          + S + +   A++V+
Sbjct: 106 ILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162

Query: 262 GGNDEDELQGNTSRISGTYGYMSPEYALEGI--FSIKSDVFSFGVLLLEIVSGK-KNTGF 318
                D  Q +TS +     ++SPE   + +  +++KSD++S G+   E+ +G+      
Sbjct: 163 -----DFPQFSTSVLP----WLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM 213

Query: 319 YRTKSL--NLIG---YAWDLWI----------SNKIID--LIDSVLEEASFNESLSRYVH 361
            RT+ L   L G      D+            S   +D  + +SV+         S  + 
Sbjct: 214 LRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLR 273

Query: 362 -------------IALLCVQERAEDRPTMSDVVSML---------TNEASSLLPP 394
                        +  LC+Q+  E RP+ S ++S                SLLPP
Sbjct: 274 TPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQTQGSILSLLPP 328

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 32/109 (29%), Positives = 61/109 (55%), Gaps = 12/109 (11%)

Query: 216 VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR 275
           +A+ ++ +    ++  +HRD+K  NIL+D + + +++DFG    +    ++  +Q  +S 
Sbjct: 108 LAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLM---EDGTVQ--SSV 162

Query: 276 ISGTYGYMSPEY--ALE---GIFSIKSDVFSFGVLLLEIVSGKKNTGFY 319
             GT  Y+SPE   A+E   G +  + D +S GV + E++ G+  T FY
Sbjct: 163 AVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGE--TPFY 209

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 42.8 bits (100), Expect = 3e-04
 Identities = 28/80 (35%), Positives = 41/80 (51%), Gaps = 11/80 (13%)

Query: 210 VQIIKGVA-QGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDE 268
           + +IKGV  Q L  L +  R+ I+HRD+K  N+L+  D   KI DFG A  +  G + + 
Sbjct: 308 INVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNP 367

Query: 269 LQGNTSRISGTYGYMSPEYA 288
           L          YG + P Y+
Sbjct: 368 L----------YGMLDPRYS 377

Length = 507

>gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated

 Score = 41.4 bits (98), Expect = 8e-04
 Identities = 34/169 (20%), Positives = 70/169 (41%), Gaps = 41/169 (24%)

Query: 115 NKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKEL---------KNEASVIAQVQHKN 165
           + +G+G    + KG     +  +K  + K G    EL         + EA ++++     
Sbjct: 339 HLIGKGAEADIKKGEYLGRDAVIKERVPK-GYRHPELDERLRTERTRAEARLLSEA---- 393

Query: 166 LVKLLGCC------IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQG 219
             +  G        ++ +E+ ++ EY+  K L         +++L+      +++ V + 
Sbjct: 394 --RRAGVPTPVIYDVDPEEKTIVMEYIGGKDL---------KDVLEGNPE--LVRKVGEI 440

Query: 220 LLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDE 268
           +  LH   +  I+H DL  SN ++  D    I DFG+ +     +D  E
Sbjct: 441 VAKLH---KAGIVHGDLTTSNFIVRDDRLYLI-DFGLGKY----SDLIE 481

Length = 535

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 40.6 bits (95), Expect = 0.001
 Identities = 29/100 (29%), Positives = 47/100 (47%), Gaps = 11/100 (11%)

Query: 213 IKGVAQGLL----YLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDE 268
           +  VA+ LL    Y+H      IIHRD+K  N+L++   +  + DFG A    G      
Sbjct: 262 VTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318

Query: 269 LQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLE 308
             G    I+GT    +PE      ++   D++S G+++ E
Sbjct: 319 HYG----IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 39.1 bits (91), Expect = 0.003
 Identities = 31/88 (35%), Positives = 44/88 (50%), Gaps = 9/88 (10%)

Query: 117 LGEGGFGTVYKGV-IGQGE------IAVKRLLGKSGQEIKE-LKNEASVIAQV-QHKNLV 167
           LG G FG V +    G G+      +AVK L   +  + +E L +E  +++ + QHKN+V
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIV 105

Query: 168 KLLGCCIEKDERLLIYEYMPNKSLDCFL 195
            LLG C      L+I EY     L  FL
Sbjct: 106 NLLGACTHGGPVLVITEYCCYGDLLNFL 133

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 38.8 bits (90), Expect = 0.004
 Identities = 45/180 (25%), Positives = 73/180 (40%), Gaps = 37/180 (20%)

Query: 151 LKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYM---PNKSLDCFLFDPTKREILDWR 207
           L+ E  V     H N+V      I  +E  ++  +M     K L C  F     E+    
Sbjct: 46  LQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSEL---- 101

Query: 208 TRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKD----MNSKISDFGMARIVFGG 263
               I++GV + L Y+H    V   HR +KAS+IL+  D    ++   S+  M       
Sbjct: 102 AIAYILQGVLKALDYIHHMGYV---HRSVKASHILISVDGKVYLSGLRSNLSMIN----- 153

Query: 264 NDEDELQGNTSRISGTY--------GYMSPEYA---LEGIFSIKSDVFSFGVLLLEIVSG 312
                  G   R+   +         ++SPE     L+G +  KSD++S G+   E+ +G
Sbjct: 154 ------HGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQG-YDAKSDIYSVGITACELANG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	432
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
PTZ00284	467	protein kinase; Provisional	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.98
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.96
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.96
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.96
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.96
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.95
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.95
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.92
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.92
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.91
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.91
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.9
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.89
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.89
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.86
PRK12274	218	serine/threonine protein kinase; Provisional	99.86
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.85
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.85
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.84
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.83
PRK10345	210	hypothetical protein; Provisional	99.82
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.82
PRK14879	211	serine/threonine protein kinase; Provisional	99.79
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.78
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.78
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.78
smart00090	237	RIO RIO-like kinase.	99.77
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.77
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.74
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.72
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.72
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.68
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.65
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.63
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.48
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.47
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.45
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.43
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.36
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.35
KOG1243	690	consensus Protein kinase [General function predict	99.33
KOG3087	229	consensus Serine/threonine protein kinase [General	99.32
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.28
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.22
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.17
COG4248	637	Uncharacterized protein with protein kinase and he	99.15
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.13
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.1
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.06
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.96
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.89
PRK09902	216	hypothetical protein; Provisional	98.81
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.8
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.78
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.64
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.63
PF01636	239	APH: Phosphotransferase enzyme family This family	98.51
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.42
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.35
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.29
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.28
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.27
PRK10593	297	hypothetical protein; Provisional	98.22
PLN02876	822	acyl-CoA dehydrogenase	98.19
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.19
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.16
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.12
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.09
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.08
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	98.04
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.94
PRK05231	319	homoserine kinase; Provisional	97.92
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.86
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.85
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.82
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.8
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.6
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.53
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.47
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.4
PLN02756	418	S-methyl-5-thioribose kinase	97.2
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	97.19
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.15
PLN02236	344	choline kinase	97.13
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.01
KOG2270	520	consensus Serine/threonine protein kinase involved	96.91
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.81
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	96.77
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.66
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.54
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.45
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.4
COG2334	331	Putative homoserine kinase type II (protein kinase	96.36
PRK12396	409	5-methylribose kinase; Reviewed	96.29
PTZ00384	383	choline kinase; Provisional	95.76
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.71
PRK11768	325	serine/threonine protein kinase; Provisional	95.61
KOG1093	725	consensus Predicted protein kinase (contains TBC a	95.34
PF11883	48	DUF3403: Domain of unknown function (DUF3403); Int	94.92
PTZ00296	442	choline kinase; Provisional	94.44

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-55  Score=421.73  Aligned_cols=288  Identities=45%  Similarity=0.756  Sum_probs=250.6

Q ss_pred             CCCccchhhHhhhhCCCCcCceeccCCcEEEEEEEECC-ceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEE
Q 014024           95 QFPLFSFSSVSSATGNFSAANKLGEGGFGTVYKGVIGQ-GEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCC  173 (432)
Q Consensus        95 ~~~~~~~~~~~~~~~~y~~~~~ig~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~  173 (432)
                      ....|++.++..+|++|.-.+.||+|+||.||+|...+ ..||||++.........+|.+|+.++.+++|||+|+++|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            56779999999999999999999999999999999988 58999988665543134599999999999999999999999


Q ss_pred             EeCC-eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEe
Q 014024          174 IEKD-ERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKIS  252 (432)
Q Consensus       174 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  252 (432)
                      .+.+ +.+|||||+++|+|.++|+..... +++|..+++||.++|+||+|||+...++|+||||||+|||||+++++||+
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence            9998 599999999999999999875543 79999999999999999999999988889999999999999999999999


Q ss_pred             ecccceeccCCCCccccccccccc-cccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCcc-ccccchhhhh
Q 014024          253 DFGMARIVFGGNDEDELQGNTSRI-SGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYR-TKSLNLIGYA  330 (432)
Q Consensus       253 Dfg~a~~~~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~-~~~~~~~~~~  330 (432)
                      |||+|+.....      ....... .||.+|+|||++..+..|.|+||||||++|+||+||+++.+... .....+..|.
T Consensus       220 DFGLa~~~~~~------~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~  293 (361)
T KOG1187|consen  220 DFGLAKLGPEG------DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWA  293 (361)
T ss_pred             CccCcccCCcc------ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHH
Confidence            99999653110      0011111 79999999999999999999999999999999999999887654 3445688888


Q ss_pred             HHhhhccchhhhhhhhhh-hcccH-HHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccc
Q 014024          331 WDLWISNKIIDLIDSVLE-EASFN-ESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS  389 (432)
Q Consensus       331 ~~~~~~~~~~~~i~~~l~-~~~~~-~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~  389 (432)
                      +.......+.+++|+.+. ..... .+...+..++..|++.+|.+||+|.||++.|+.+..
T Consensus       294 ~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  294 KPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             HHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence            888888899999999887 44443 688889999999999999999999999999966544

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-49  Score=378.14  Aligned_cols=260  Identities=30%  Similarity=0.509  Sum_probs=215.6

Q ss_pred             CCCcCceeccCCcEEEEEEEECCce-EEEEEEcCCC--hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC-eeEEEEec
Q 014024          110 NFSAANKLGEGGFGTVYKGVIGQGE-IAVKRLLGKS--GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKD-ERLLIYEY  185 (432)
Q Consensus       110 ~y~~~~~ig~G~~g~Vy~~~~~~~~-vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~  185 (432)
                      ...+.+.||.|+||+||+|.+.+.. ||+|++....  ....+.|.+|+.+|.+++|||||+++|+|.+.. ..++||||
T Consensus        42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy  121 (362)
T KOG0192|consen   42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY  121 (362)
T ss_pred             HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence            3444566999999999999999997 9999996543  223668999999999999999999999999988 79999999


Q ss_pred             CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCC-CEEEeecccceeccCCC
Q 014024          186 MPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDM-NSKISDFGMARIVFGGN  264 (432)
Q Consensus       186 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~  264 (432)
                      +++|+|.++++.. .+..+++..+++++.|||+||.|||+.+.  ||||||||+|||++.++ ++||+|||+++......
T Consensus       122 ~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~  198 (362)
T KOG0192|consen  122 MPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK  198 (362)
T ss_pred             CCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence            9999999999764 35569999999999999999999999874  99999999999999998 99999999998752211


Q ss_pred             CccccccccccccccCCccChhhhc--cCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhh
Q 014024          265 DEDELQGNTSRISGTYGYMSPEYAL--EGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDL  342 (432)
Q Consensus       265 ~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                            .......||+.|||||++.  ...|+.|+||||||+++|||+||+.||.....     .         .-....
T Consensus       199 ------~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-----~---------~~~~~v  258 (362)
T KOG0192|consen  199 ------TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-----V---------QVASAV  258 (362)
T ss_pred             ------ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-----H---------HHHHHH
Confidence                  2233468999999999999  56899999999999999999999999864332     0         111222


Q ss_pred             hhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccccCCC
Q 014024          343 IDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLL  392 (432)
Q Consensus       343 i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~  392 (432)
                      +....+...+..++..+..++..||+.||+.||++.+++..|+.+.....
T Consensus       259 ~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~  308 (362)
T KOG0192|consen  259 VVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS  308 (362)
T ss_pred             HhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence            22333444445578889999999999999999999999999997765443

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-49  Score=360.66  Aligned_cols=249  Identities=28%  Similarity=0.400  Sum_probs=211.3

Q ss_pred             CCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCe-eEEEEe
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDE-RLLIYE  184 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~lv~e  184 (432)
                      ++.+.++.||+|..|+||++.+..+  -+|+|.+... .....+++.+|+++++.++|||||.+||.|..+.. ..|+||
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE  158 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME  158 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence            4667789999999999999999755  6899998433 56677899999999999999999999999999984 999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCC
Q 014024          185 YMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ-YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGG  263 (432)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  263 (432)
                      ||++|+|++++...   +.+++...-+|+.++++||.|||+ .+   ||||||||+|||++.+|++||+|||.+..+.. 
T Consensus       159 YMDgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn-  231 (364)
T KOG0581|consen  159 YMDGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVN-  231 (364)
T ss_pred             hcCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhh-
Confidence            99999999998543   459999999999999999999996 66   99999999999999999999999999987632 


Q ss_pred             CCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhh
Q 014024          264 NDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLI  343 (432)
Q Consensus       264 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i  343 (432)
                             ......+||..|||||.+.+..|+.++||||||+.++|+.+|+.|+.....             ....+.+++
T Consensus       232 -------S~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~-------------~~~~~~~Ll  291 (364)
T KOG0581|consen  232 -------SIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP-------------PYLDIFELL  291 (364)
T ss_pred             -------hhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC-------------CCCCHHHHH
Confidence                   245678999999999999999999999999999999999999999754311             112344445


Q ss_pred             hhhhhhcc---cH-HHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          344 DSVLEEAS---FN-ESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       344 ~~~l~~~~---~~-~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                      +....+..   +. ....++.+++..||++||.+||+++|+++|-
T Consensus       292 ~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hp  336 (364)
T KOG0581|consen  292 CAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHP  336 (364)
T ss_pred             HHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence            54444222   23 3677899999999999999999999999854

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.1e-49  Score=378.31  Aligned_cols=245  Identities=23%  Similarity=0.376  Sum_probs=210.4

Q ss_pred             CCCCcCceeccCCcEEEEEEEE-C-CceEEEEEEcCC---ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEE
Q 014024          109 GNFSAANKLGEGGFGTVYKGVI-G-QGEIAVKRLLGK---SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~-~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  183 (432)
                      .+|...+.||+|||+.||.+++ . +..||+|++.+.   .....+.+.+|+++.++++|||||+++++|++.++.|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            6799999999999999999998 3 338999998653   4456778999999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCC
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGG  263 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  263 (432)
                      |+|.+++|..++.   .++++++.+++.++.||+.||.|||+++   |+|||||..|+|++++.++||+|||+|..+...
T Consensus        98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~  171 (592)
T KOG0575|consen   98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD  171 (592)
T ss_pred             EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence            9999999999983   5677999999999999999999999999   999999999999999999999999999987322


Q ss_pred             CCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhh
Q 014024          264 NDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLI  343 (432)
Q Consensus       264 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i  343 (432)
                            .......+|||.|+|||++....++..+||||+||++|.|+.|++||+..                  .+.+..
T Consensus       172 ------~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk------------------~vkety  227 (592)
T KOG0575|consen  172 ------GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK------------------TVKETY  227 (592)
T ss_pred             ------ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc------------------hHHHHH
Confidence                  23456789999999999999999999999999999999999999998532                  122222


Q ss_pred             hhhhhhcc--cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          344 DSVLEEAS--FNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       344 ~~~l~~~~--~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      +.....++  +.....+..+|+..+|+.||.+|||+.+|+.+
T Consensus       228 ~~Ik~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  228 NKIKLNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             HHHHhcCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            22222222  33445667889999999999999999999974

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-47  Score=354.30  Aligned_cols=199  Identities=31%  Similarity=0.535  Sum_probs=180.2

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLI  182 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  182 (432)
                      ..++|.+.+.||.|+|++||+|++...  .||||.+...  .....+.+..|+.+|+.++|||||++++++..++..|+|
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV   87 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV   87 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence            357899999999999999999998654  8999999766  667778899999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCC------CCEEEeeccc
Q 014024          183 YEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKD------MNSKISDFGM  256 (432)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~------~~~kl~Dfg~  256 (432)
                      ||||+||+|.+|++.   ++.+++..+..++.|++.||++||+++   ||||||||+||||+..      -.+||+|||+
T Consensus        88 MEyC~gGDLs~yi~~---~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf  161 (429)
T KOG0595|consen   88 MEYCNGGDLSDYIRR---RGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGF  161 (429)
T ss_pred             EEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccch
Confidence            999999999999954   345999999999999999999999999   9999999999999765      4589999999


Q ss_pred             ceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 014024          257 ARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGF  318 (432)
Q Consensus       257 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~  318 (432)
                      |+.+..       .......+|++.|||||++..++|+.|+|+||+|+|+|+|++|+.||+.
T Consensus       162 AR~L~~-------~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a  216 (429)
T KOG0595|consen  162 ARFLQP-------GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA  216 (429)
T ss_pred             hhhCCc-------hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence            998732       2345678999999999999999999999999999999999999999863

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-48  Score=371.06  Aligned_cols=255  Identities=31%  Similarity=0.477  Sum_probs=219.7

Q ss_pred             CCcCceeccCCcEEEEEEEECCc-eEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecCCCC
Q 014024          111 FSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNK  189 (432)
Q Consensus       111 y~~~~~ig~G~~g~Vy~~~~~~~-~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  189 (432)
                      +..++.||+|-||.||.|.+++. +||+|.+.... ...+.|.+|+++|++++|+|||+++++|..++..+|||||++.|
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G  286 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG  286 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence            45578999999999999999887 99999987653 33467889999999999999999999999999999999999999


Q ss_pred             ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCcccc
Q 014024          190 SLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDEL  269 (432)
Q Consensus       190 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  269 (432)
                      +|.++|+.. .+..+...+.+.++.|||+||+||++++   +|||||..+||||+++..+||+|||+|+...+..     
T Consensus       287 sLl~yLr~~-~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~-----  357 (468)
T KOG0197|consen  287 SLLDYLRTR-EGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDE-----  357 (468)
T ss_pred             cHHHHhhhc-CCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCc-----
Confidence            999999863 3445999999999999999999999999   9999999999999999999999999999531111     


Q ss_pred             ccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchhhhhhhhhh
Q 014024          270 QGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLE  348 (432)
Q Consensus       270 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  348 (432)
                      ........-...|.|||.+..+.++.||||||||++||||+| |+.|++.               ..+.++.+.++...+
T Consensus       358 Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~---------------msn~ev~~~le~GyR  422 (468)
T KOG0197|consen  358 YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPG---------------MSNEEVLELLERGYR  422 (468)
T ss_pred             eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCC---------------CCHHHHHHHHhccCc
Confidence            111222233457999999999999999999999999999999 7777543               334566778888888


Q ss_pred             hcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccccC
Q 014024          349 EASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASS  390 (432)
Q Consensus       349 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~  390 (432)
                      -+.+..|+..+.++|..||+.+|++|||++.+...|++....
T Consensus       423 lp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  423 LPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             CCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence            889999999999999999999999999999999999887653

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-48  Score=359.20  Aligned_cols=253  Identities=22%  Similarity=0.320  Sum_probs=203.0

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCCCh-------HhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSG-------QEIKELKNEASVIAQVQHKNLVKLLGCCIEKD  177 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  177 (432)
                      ..+.|.+.+.||+|+||.|-+|....+  .||||++.....       .....+.+|+++|++++|||||+++++|.+.+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            456788999999999999999997544  899999854421       12233679999999999999999999999999


Q ss_pred             eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCC---CCEEEeec
Q 014024          178 ERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKD---MNSKISDF  254 (432)
Q Consensus       178 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Df  254 (432)
                      ..|+||||++||.|.+++-   .++.+.+.....+++|++.|+.|||++|   |+||||||+|||+..+   ..+||+||
T Consensus       250 s~YmVlE~v~GGeLfd~vv---~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF  323 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVV---ANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF  323 (475)
T ss_pred             ceEEEEEEecCccHHHHHH---hccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence            9999999999999999994   4555888888999999999999999999   9999999999999766   77999999


Q ss_pred             ccceeccCCCCccccccccccccccCCccChhhhccCC---CCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhH
Q 014024          255 GMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGI---FSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAW  331 (432)
Q Consensus       255 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~  331 (432)
                      |+|+...       ........+|||.|.|||++.++.   +..++|+||+||+||-+++|.+||......         
T Consensus       324 GlAK~~g-------~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~---------  387 (475)
T KOG0615|consen  324 GLAKVSG-------EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD---------  387 (475)
T ss_pred             chhhccc-------cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC---------
Confidence            9999741       133456789999999999998654   345889999999999999999998532211         


Q ss_pred             Hhhhccchhhhhhhhhh---hcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014024          332 DLWISNKIIDLIDSVLE---EASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN  386 (432)
Q Consensus       332 ~~~~~~~~~~~i~~~l~---~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~  386 (432)
                           ..+.+.|...-.   .........+..+|+.+||..||++|||+.|++++-+-
T Consensus       388 -----~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~  440 (475)
T KOG0615|consen  388 -----PSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWF  440 (475)
T ss_pred             -----ccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhh
Confidence                 111111111111   11123445678899999999999999999999987553

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-48  Score=342.80  Aligned_cols=255  Identities=23%  Similarity=0.344  Sum_probs=206.2

Q ss_pred             hCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcC--CChHhHHHHHHHHHHHHhcCCCceeeeEe-EEEeCCe-eEE
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLG--KSGQEIKELKNEASVIAQVQHKNLVKLLG-CCIEKDE-RLL  181 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~-~~~~~~~-~~l  181 (432)
                      ..+|++.++||+|.||.||++...  +..+|.|.+.-  -+....+.+..|+.+|++++|||||++++ -+.++.. .+|
T Consensus        18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni   97 (375)
T KOG0591|consen   18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI   97 (375)
T ss_pred             HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence            457899999999999999999863  34788887742  25667788999999999999999999999 4444444 899


Q ss_pred             EEecCCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcC-CCCeEeccCCCCCEEEcCCCCEEEeeccccee
Q 014024          182 IYEYMPNKSLDCFLFDP-TKREILDWRTRVQIIKGVAQGLLYLHQYS-RVRIIHRDLKASNILLDKDMNSKISDFGMARI  259 (432)
Q Consensus       182 v~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  259 (432)
                      |||||.+|+|...++.. ..++.+++..+|+++.|++.||..+|+.- +..|+||||||.||+++.+|.+||+|||+++.
T Consensus        98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~  177 (375)
T KOG0591|consen   98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF  177 (375)
T ss_pred             HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence            99999999999998653 34556999999999999999999999832 12499999999999999999999999999998


Q ss_pred             ccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccch
Q 014024          260 VFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKI  339 (432)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  339 (432)
                      +..      ......+.+|||.||+||.+.+..|+.+|||||+||++|||+.-+.||...                  ..
T Consensus       178 l~s------~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------------------n~  233 (375)
T KOG0591|consen  178 LSS------KTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------------------NL  233 (375)
T ss_pred             hcc------hhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------------------cH
Confidence            622      233456789999999999999999999999999999999999999998421                  11


Q ss_pred             hhhhhhhhhhc---cc-HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014024          340 IDLIDSVLEEA---SF-NESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN  386 (432)
Q Consensus       340 ~~~i~~~l~~~---~~-~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~  386 (432)
                      ..+-.+.-..+   .+ .....++.+|+..|+..||+.||+...+++.+..
T Consensus       234 ~~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  234 LSLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             HHHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence            11112222222   22 4567889999999999999999996666655544

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-46  Score=344.89  Aligned_cols=246  Identities=24%  Similarity=0.361  Sum_probs=206.2

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCC---ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGK---SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLL  181 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  181 (432)
                      ..++|+++++||+|+||+||.++..++  -+|+|++.+.   .....+....|..+|.+++||.||+++..|++.+.+|+
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl  102 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL  102 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence            457899999999999999999987654  6899988554   23456778899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceecc
Q 014024          182 IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVF  261 (432)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  261 (432)
                      |+||+.||.|..+|+   .++.+++..+..++.+|+.||.|||+.|   |+||||||+|||+|.+|+++|+|||+++...
T Consensus       103 Vld~~~GGeLf~hL~---~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~  176 (357)
T KOG0598|consen  103 VLDYLNGGELFYHLQ---REGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDL  176 (357)
T ss_pred             EEeccCCccHHHHHH---hcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence            999999999999994   4455999999999999999999999999   9999999999999999999999999998632


Q ss_pred             CCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhh
Q 014024          262 GGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIID  341 (432)
Q Consensus       262 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (432)
                      ..      ...+...+||+.|||||++.+..|+.++|.||||+++|||++|.+||..                  ++..+
T Consensus       177 ~~------~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~------------------~~~~~  232 (357)
T KOG0598|consen  177 KD------GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA------------------EDVKK  232 (357)
T ss_pred             cC------CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC------------------ccHHH
Confidence            21      2345568999999999999999999999999999999999999999842                  22223


Q ss_pred             hhhhhhhhc---ccHHHHHHHHHHHHHhhccCCCCCC----CHHHHHH
Q 014024          342 LIDSVLEEA---SFNESLSRYVHIALLCVQERAEDRP----TMSDVVS  382 (432)
Q Consensus       342 ~i~~~l~~~---~~~~~~~~l~~l~~~cl~~dp~~RP----t~~evl~  382 (432)
                      .++..+...   .+.-...+..+++...|+.||++|.    .+.+|-+
T Consensus       233 ~~~~I~~~k~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~  280 (357)
T KOG0598|consen  233 MYDKILKGKLPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKR  280 (357)
T ss_pred             HHHHHhcCcCCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhc
Confidence            333333222   2233567788999999999999996    4555544

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.6e-45  Score=368.73  Aligned_cols=260  Identities=30%  Similarity=0.461  Sum_probs=220.1

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC-------ceEEEEEEcCCChH-hHHHHHHHHHHHHhcCCCceeeeEeEEEeCCee
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ-------GEIAVKRLLGKSGQ-EIKELKNEASVIAQVQHKNLVKLLGCCIEKDER  179 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  179 (432)
                      ..+....+.||+|.||+||+|+..+       .-||||.++..... ..++|++|++++..++|||||+++|+|.+++..
T Consensus       485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~  564 (774)
T KOG1026|consen  485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL  564 (774)
T ss_pred             hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence            4566677899999999999998532       25999999877665 788999999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhhhcCCC-------C----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCC
Q 014024          180 LLIYEYMPNKSLDCFLFDPT-------K----REILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN  248 (432)
Q Consensus       180 ~lv~e~~~~gsL~~~l~~~~-------~----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~  248 (432)
                      ++|+|||..|+|.+||....       .    ..+++..+.+.||.|||.||+||-++.   +|||||..+|+||.++..
T Consensus       565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~  641 (774)
T KOG1026|consen  565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLV  641 (774)
T ss_pred             EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceE
Confidence            99999999999999995321       1    234889999999999999999999998   999999999999999999


Q ss_pred             EEEeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchh
Q 014024          249 SKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLI  327 (432)
Q Consensus       249 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~  327 (432)
                      +||+|||+++.....+.    ........-..+|||||.+..+++|.+||||||||+|||+++ |+.|+..         
T Consensus       642 VKIsDfGLsRdiYssDY----Yk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~g---------  708 (774)
T KOG1026|consen  642 VKISDFGLSRDIYSSDY----YKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYG---------  708 (774)
T ss_pred             EEecccccchhhhhhhh----hcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccc---------
Confidence            99999999997644321    112223445678999999999999999999999999999999 8888632         


Q ss_pred             hhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccc
Q 014024          328 GYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS  389 (432)
Q Consensus       328 ~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~  389 (432)
                            ..++++.+.+...-.-.++..++.++++||..||+.+|.+||+++||-..|+....
T Consensus       709 ------lSn~EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~  764 (774)
T KOG1026|consen  709 ------LSNQEVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ  764 (774)
T ss_pred             ------cchHHHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence                  23344555555444467888999999999999999999999999999999988543

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-45  Score=347.31  Aligned_cols=256  Identities=26%  Similarity=0.335  Sum_probs=211.4

Q ss_pred             hhhhCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCC---ChHhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCe
Q 014024          105 SSATGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGK---SGQEIKELKNEASVIAQV-QHKNLVKLLGCCIEKDE  178 (432)
Q Consensus       105 ~~~~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  178 (432)
                      .....+|..++.||+|+|++|++|+....  .+|+|++.+.   .+...+.+..|-++|.+| .||.|++++.-|.+...
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            44567899999999999999999998654  8999988543   233445678899999999 89999999999999999


Q ss_pred             eEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccce
Q 014024          179 RLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMAR  258 (432)
Q Consensus       179 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  258 (432)
                      +|+|+||+++|+|.+++.   +-+.|++...+.++.||+.||+|||++|   ||||||||+|||||+++++||+|||.|+
T Consensus       149 LYFvLe~A~nGdll~~i~---K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK  222 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIK---KYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAK  222 (604)
T ss_pred             eEEEEEecCCCcHHHHHH---HhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccc
Confidence            999999999999999995   4456999999999999999999999999   9999999999999999999999999999


Q ss_pred             eccCCCCc-----cc--cccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhH
Q 014024          259 IVFGGNDE-----DE--LQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAW  331 (432)
Q Consensus       259 ~~~~~~~~-----~~--~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~  331 (432)
                      .+.+....     ..  .......++||..|.+||++..+..+..+|+|+||||||+|+.|++||.....          
T Consensus       223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne----------  292 (604)
T KOG0592|consen  223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE----------  292 (604)
T ss_pred             cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH----------
Confidence            87543322     11  11222568999999999999999999999999999999999999999852211          


Q ss_pred             Hhhhccchhhhhhhhh--hhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          332 DLWISNKIIDLIDSVL--EEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       332 ~~~~~~~~~~~i~~~l--~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                              .-++++.+  .-..+...+....+|+...|..||.+|+|.++|-+|.
T Consensus       293 --------yliFqkI~~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp  339 (604)
T KOG0592|consen  293 --------YLIFQKIQALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP  339 (604)
T ss_pred             --------HHHHHHHHHhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence                    11111111  1223444457788899999999999999999998854

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-45  Score=339.73  Aligned_cols=261  Identities=24%  Similarity=0.365  Sum_probs=207.2

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC--eeEEEE
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKD--ERLLIY  183 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~  183 (432)
                      ..+|...+.||+|+||.||++.+.+  ...|||.....+....+.+.+|+.+|++++|||||+++|......  .++++|
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m   95 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM   95 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence            4567888999999999999999875  589999886654444778999999999999999999999854444  689999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcC-CCCEEEeecccceeccC
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDK-DMNSKISDFGMARIVFG  262 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~~  262 (432)
                      ||+++|+|.+++.+.+.  .+++..+..+..|+++||+|||++|   |+||||||+|||++. ++.+||+|||++.....
T Consensus        96 Ey~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~  170 (313)
T KOG0198|consen   96 EYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES  170 (313)
T ss_pred             eccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence            99999999999976543  5999999999999999999999999   999999999999999 79999999999987532


Q ss_pred             CCCccccccccccccccCCccChhhhccCC-CCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhh
Q 014024          263 GNDEDELQGNTSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIID  341 (432)
Q Consensus       263 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (432)
                         ............||+.|||||++..+. ...++|||||||++.||+||+.||...    .....+........    
T Consensus       171 ---~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~----~~~~~~~~~ig~~~----  239 (313)
T KOG0198|consen  171 ---KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF----FEEAEALLLIGRED----  239 (313)
T ss_pred             ---ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh----cchHHHHHHHhccC----
Confidence               111122344678999999999999643 345999999999999999999998643    11111111111111    


Q ss_pred             hhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccc
Q 014024          342 LIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS  389 (432)
Q Consensus       342 ~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~  389 (432)
                           .....+...+.+..+++..|++.||++|||+.+++++.-....
T Consensus       240 -----~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~  282 (313)
T KOG0198|consen  240 -----SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN  282 (313)
T ss_pred             -----CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence                 1112334456678899999999999999999999997765443

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.8e-45  Score=325.77  Aligned_cols=262  Identities=21%  Similarity=0.318  Sum_probs=202.0

Q ss_pred             CCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCCC--hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEe
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKS--GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYE  184 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  184 (432)
                      +.|+.+.++|+|+||+||++++.++  -||||++....  ....+-..+|+++|++++|+|+|.++++|.....+++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            4688899999999999999998765  79999996543  3445567899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCC
Q 014024          185 YMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGN  264 (432)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  264 (432)
                      ||+..-|.++-...  ++ ++...+.++++|++.|+.|+|+++   ++||||||+|||++.+|.+||||||+|+.+... 
T Consensus        82 ~~dhTvL~eLe~~p--~G-~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p-  154 (396)
T KOG0593|consen   82 YCDHTVLHELERYP--NG-VPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAP-  154 (396)
T ss_pred             ecchHHHHHHHhcc--CC-CCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCC-
Confidence            99887776654322  22 889999999999999999999999   999999999999999999999999999987432 


Q ss_pred             CccccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCcccccc---------chhhhhHHhh
Q 014024          265 DEDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSL---------NLIGYAWDLW  334 (432)
Q Consensus       265 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~---------~~~~~~~~~~  334 (432)
                           ....+..+.|.+|+|||.+.+ -+|...+||||+||++.||++|.+-|.....-+.         ++.......+
T Consensus       155 -----gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF  229 (396)
T KOG0593|consen  155 -----GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIF  229 (396)
T ss_pred             -----cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHh
Confidence                 234566788999999999887 7899999999999999999999987754332110         0111111111


Q ss_pred             hccc------hhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014024          335 ISNK------IIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVS  382 (432)
Q Consensus       335 ~~~~------~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~  382 (432)
                      ..+.      +.+.-+..-.+...+....-+.+++..||+.||++|++-++++.
T Consensus       230 ~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  230 SSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             ccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            1110      00000000011111223346789999999999999999999985

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-44  Score=333.69  Aligned_cols=264  Identities=24%  Similarity=0.385  Sum_probs=210.8

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  183 (432)
                      ..+.|++.+.||.|..++||+|+..  +..||||++... .....+.+.+|+..|+.++||||++++..|..+..+|+||
T Consensus        24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm  103 (516)
T KOG0582|consen   24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM  103 (516)
T ss_pred             CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence            4678999999999999999999874  348999999543 3344789999999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCC
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGG  263 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  263 (432)
                      .||.+|++.+++...-..+ +++..+..|++++++||.|||++|   .||||||+.||||+++|.+||+|||.+..+...
T Consensus       104 pfMa~GS~ldIik~~~~~G-l~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~  179 (516)
T KOG0582|consen  104 PFMAGGSLLDIIKTYYPDG-LEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDS  179 (516)
T ss_pred             hhhcCCcHHHHHHHHcccc-ccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence            9999999999997654444 999999999999999999999999   999999999999999999999999988776553


Q ss_pred             CCccccccccccccccCCccChhhhcc--CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhh
Q 014024          264 NDEDELQGNTSRISGTYGYMSPEYALE--GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIID  341 (432)
Q Consensus       264 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (432)
                      ...  ........+||++|||||++..  ..|+.|+||||||++..||.+|..||..+..-+.-+...      .+....
T Consensus       180 G~R--~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tL------qn~pp~  251 (516)
T KOG0582|consen  180 GDR--QVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTL------QNDPPT  251 (516)
T ss_pred             Cce--eeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHh------cCCCCC
Confidence            321  1122267899999999999543  469999999999999999999999998766432211111      111110


Q ss_pred             hhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014024          342 LIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVS  382 (432)
Q Consensus       342 ~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~  382 (432)
                      ..-..+..+........+.+++..||+.||.+|||+++++.
T Consensus       252 ~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  252 LLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             cccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            00111111112233457889999999999999999999995

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-44  Score=317.02  Aligned_cols=235  Identities=28%  Similarity=0.358  Sum_probs=201.5

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCCC---hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKS---GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLL  181 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  181 (432)
                      ..++|++.+.||.|+||.|.+++.+.+  -+|+|++....   ....+...+|.++|+.+.||.++++++.|.+.++.|+
T Consensus        42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym  121 (355)
T KOG0616|consen   42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM  121 (355)
T ss_pred             chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence            357899999999999999999997654  78999986553   3445667899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceecc
Q 014024          182 IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVF  261 (432)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  261 (432)
                      ||||++||-|..+++.   .+.+++..++.++.||+.||+|||+.+   |++|||||+|||+|.+|.+||+|||+|+.+ 
T Consensus       122 vmeyv~GGElFS~Lrk---~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v-  194 (355)
T KOG0616|consen  122 VMEYVPGGELFSYLRK---SGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRV-  194 (355)
T ss_pred             EEeccCCccHHHHHHh---cCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEe-
Confidence            9999999999999953   344999999999999999999999999   999999999999999999999999999986 


Q ss_pred             CCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhh
Q 014024          262 GGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIID  341 (432)
Q Consensus       262 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (432)
                              ...+...+|||.|+|||.++...++.++|.||||+++|||+.|..||.....                  .+
T Consensus       195 --------~~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~------------------~~  248 (355)
T KOG0616|consen  195 --------SGRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP------------------IQ  248 (355)
T ss_pred             --------cCcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh------------------HH
Confidence                    4457789999999999999999999999999999999999999999843221                  22


Q ss_pred             hhhhhhhhc--ccHHHHHHHHHHHHHhhccCCCCC
Q 014024          342 LIDSVLEEA--SFNESLSRYVHIALLCVQERAEDR  374 (432)
Q Consensus       342 ~i~~~l~~~--~~~~~~~~l~~l~~~cl~~dp~~R  374 (432)
                      +.++.+...  .+.....++.+|+...|+.|-.+|
T Consensus       249 iY~KI~~~~v~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  249 IYEKILEGKVKFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             HHHHHHhCcccCCcccCHHHHHHHHHHHhhhhHhh
Confidence            223333221  244445677888999999998888

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=3.8e-44  Score=341.57  Aligned_cols=244  Identities=28%  Similarity=0.426  Sum_probs=211.5

Q ss_pred             CCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEe
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYE  184 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  184 (432)
                      ++|.+.+.||+|.||.||+|+.+++  .||+|.+.+.  .+.+.+.+.+|+++++.++||||+.++++|+...+.++|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            5789999999999999999998766  7899988543  45567789999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCC
Q 014024          185 YMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGN  264 (432)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  264 (432)
                      |+.| +|..++.   ..+.+++..+..++.|++.||.|||+++   |+|||+||.|||++.++.+|++|||+|+.+..  
T Consensus        82 ~a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--  152 (808)
T KOG0597|consen   82 YAVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMST--  152 (808)
T ss_pred             hhhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhccc--
Confidence            9977 9999994   4555999999999999999999999998   99999999999999999999999999997522  


Q ss_pred             CccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhh
Q 014024          265 DEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLID  344 (432)
Q Consensus       265 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  344 (432)
                          .........|||.|||||++.++.|+..+|+||+|||+||+++|++||-                  .+.+..++.
T Consensus       153 ----~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~------------------a~si~~Lv~  210 (808)
T KOG0597|consen  153 ----NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFY------------------ARSITQLVK  210 (808)
T ss_pred             ----CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCch------------------HHHHHHHHH
Confidence                2334566789999999999999999999999999999999999999972                  233445555


Q ss_pred             hhhhhc--ccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          345 SVLEEA--SFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       345 ~~l~~~--~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      ..+..+  .+......+.+++...|.+||.+|.|-.+++.|
T Consensus       211 ~I~~d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  211 SILKDPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             HHhcCCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence            544433  244667789999999999999999999999874

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.4e-43  Score=343.31  Aligned_cols=262  Identities=29%  Similarity=0.418  Sum_probs=203.1

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEEC-------CceEEEEEEcCCC-hHhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCC
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIG-------QGEIAVKRLLGKS-GQEIKELKNEASVIAQV-QHKNLVKLLGCCIEKD  177 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  177 (432)
                      ..++|++.+.||+|+||.||+|.+.       +..||+|++.... ....+.+.+|+.+++.+ +||||++++++|...+
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            3578999999999999999999742       1369999886543 34456789999999999 8999999999987654


Q ss_pred             -eeEEEEecCCCCChhhhhcCCCC--------------------------------------------------------
Q 014024          178 -ERLLIYEYMPNKSLDCFLFDPTK--------------------------------------------------------  200 (432)
Q Consensus       178 -~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------  200 (432)
                       ..+++|||+++|+|.+++.....                                                        
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence             57899999999999999864211                                                        


Q ss_pred             ---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCcccccccccccc
Q 014024          201 ---REILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRIS  277 (432)
Q Consensus       201 ---~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~  277 (432)
                         ...+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++.......    ........
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~----~~~~~~~~  237 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPD----YVRKGSAR  237 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcc----hhcccCCC
Confidence               234788899999999999999999998   99999999999999999999999999986422111    11122334


Q ss_pred             ccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchhhhhhhhhhhcccHHHH
Q 014024          278 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESL  356 (432)
Q Consensus       278 gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~  356 (432)
                      ++..|+|||++.+..++.++|||||||++|||++ |..||....... .    ........         .....+...+
T Consensus       238 ~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-~----~~~~~~~~---------~~~~~~~~~~  303 (338)
T cd05102         238 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-E----FCQRLKDG---------TRMRAPENAT  303 (338)
T ss_pred             CCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-H----HHHHHhcC---------CCCCCCCCCC
Confidence            5678999999999999999999999999999997 999985432110 0    00000000         0011122345


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHHhccccc
Q 014024          357 SRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS  389 (432)
Q Consensus       357 ~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~  389 (432)
                      ..+.+++.+||+.||++|||+.|+++.|++...
T Consensus       304 ~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         304 PEIYRIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            678899999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-44  Score=344.80  Aligned_cols=250  Identities=26%  Similarity=0.373  Sum_probs=209.5

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEec
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEY  185 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  185 (432)
                      ...|....+||+|+.|.||.|.....  .||+|++........+-+.+|+.+|+..+|+|||++++.|...+.+++||||
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy  351 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY  351 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence            45688889999999999999987544  7999999887777788899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCC
Q 014024          186 MPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGND  265 (432)
Q Consensus       186 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  265 (432)
                      ++||+|.+.+.    ...+++.++..|++++++||+|||.++   |+|||||.+|||++.+|.+||+|||++..+...  
T Consensus       352 m~ggsLTDvVt----~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~--  422 (550)
T KOG0578|consen  352 MEGGSLTDVVT----KTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE--  422 (550)
T ss_pred             cCCCchhhhhh----cccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccc--
Confidence            99999999983    344999999999999999999999999   999999999999999999999999999876322  


Q ss_pred             ccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhh
Q 014024          266 EDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDS  345 (432)
Q Consensus       266 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  345 (432)
                          .......+|||.|||||++....|.+++||||||++++||+-|.+||-..     +.....+-...++.       
T Consensus       423 ----~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE-----~PlrAlyLIa~ng~-------  486 (550)
T KOG0578|consen  423 ----QSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNE-----NPLRALYLIATNGT-------  486 (550)
T ss_pred             ----cCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCC-----ChHHHHHHHhhcCC-------
Confidence                23566789999999999999999999999999999999999999997321     11111111111110       


Q ss_pred             hhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          346 VLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       346 ~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                       .....+......+.+++.+||+.|+++||++.|+|+|
T Consensus       487 -P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  487 -PKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             -CCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence             1111233445778899999999999999999999984

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-43  Score=340.73  Aligned_cols=265  Identities=28%  Similarity=0.461  Sum_probs=211.7

Q ss_pred             hhhCCCCcCceeccCCcEEEEEEEECCceEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEE
Q 014024          106 SATGNFSAANKLGEGGFGTVYKGVIGQGEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       106 ~~~~~y~~~~~ig~G~~g~Vy~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  183 (432)
                      ...+...+...||+|.||+||+|.+.+ .||||++...  ..+..+.|++|+.++++.+|.||+-+.|+|.++.. .||+
T Consensus       389 Ip~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiT  466 (678)
T KOG0193|consen  389 IPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIIT  466 (678)
T ss_pred             cCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeee
Confidence            334566778999999999999999865 4999998544  56678899999999999999999999999999887 9999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCC
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGG  263 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  263 (432)
                      .||+|.+|+.+++-..  ..|+..+.+.|+.|+++|+.|||.++   |||||||..||++.+++.+||+|||++..-...
T Consensus       467 qwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w  541 (678)
T KOG0193|consen  467 QWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRW  541 (678)
T ss_pred             hhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeeeeee
Confidence            9999999999997544  44999999999999999999999999   999999999999999999999999999864333


Q ss_pred             CCccccccccccccccCCccChhhhcc---CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchh
Q 014024          264 NDEDELQGNTSRISGTYGYMSPEYALE---GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKII  340 (432)
Q Consensus       264 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                      .+.    .......|...|||||++..   .+|+..+||||||+|+|||+||..|+. ....+.-+  |     ...+-.
T Consensus       542 ~g~----~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIi--f-----mVGrG~  609 (678)
T KOG0193|consen  542 SGE----QQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQII--F-----MVGRGY  609 (678)
T ss_pred             ccc----cccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheE--E-----Eecccc
Confidence            221    12233457788999999974   469999999999999999999999986 22211110  0     000000


Q ss_pred             hhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccccCCC
Q 014024          341 DLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLL  392 (432)
Q Consensus       341 ~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~  392 (432)
                      -..|..   .....++.++.+|+..||..++++||.+.+|+..|+.+..+.+
T Consensus       610 l~pd~s---~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~p  658 (678)
T KOG0193|consen  610 LMPDLS---KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLP  658 (678)
T ss_pred             cCccch---hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhccc
Confidence            000100   0123567789999999999999999999999999998877543

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=4e-43  Score=331.62  Aligned_cols=245  Identities=22%  Similarity=0.322  Sum_probs=198.5

Q ss_pred             ceeccCCcEEEEEEEECCceEEEEEEcCCCh---HhHHHHHHHHHHHHhcCCCceeeeEeEEEe----CCeeEEEEecCC
Q 014024          115 NKLGEGGFGTVYKGVIGQGEIAVKRLLGKSG---QEIKELKNEASVIAQVQHKNLVKLLGCCIE----KDERLLIYEYMP  187 (432)
Q Consensus       115 ~~ig~G~~g~Vy~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~  187 (432)
                      ..||+|++|.||+|..++..||+|.+.....   ...+.+.+|+.+|++++||||+++++++.+    ....++||||++
T Consensus        26 ~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~  105 (283)
T PHA02988         26 VLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCT  105 (283)
T ss_pred             eEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCC
Confidence            6799999999999999988999999865432   225778899999999999999999999877    346789999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCc
Q 014024          188 NKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQY-SRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDE  266 (432)
Q Consensus       188 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  266 (432)
                      +|+|.+++..   +..+++.....++.|++.||.|||+. +   ++||||||+||++++++.+||+|||++..+..    
T Consensus       106 ~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~----  175 (283)
T PHA02988        106 RGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSS----  175 (283)
T ss_pred             CCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcc----
Confidence            9999999954   34589999999999999999999985 6   88999999999999999999999999976421    


Q ss_pred             cccccccccccccCCccChhhhcc--CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhh
Q 014024          267 DELQGNTSRISGTYGYMSPEYALE--GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLID  344 (432)
Q Consensus       267 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  344 (432)
                           ......|+..|+|||++.+  ..++.++|||||||++|||++|+.||.......  .    ...        ++.
T Consensus       176 -----~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~--~----~~~--------i~~  236 (283)
T PHA02988        176 -----PPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE--I----YDL--------IIN  236 (283)
T ss_pred             -----ccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH--H----HHH--------HHh
Confidence                 1123467889999999976  689999999999999999999999986332110  0    000        001


Q ss_pred             hhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014024          345 SVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEA  388 (432)
Q Consensus       345 ~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~  388 (432)
                      .......+..++..+.+++.+||+.||++|||++|+++.|+...
T Consensus       237 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        237 KNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             cCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            11111122345678899999999999999999999999998753

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-43  Score=337.43  Aligned_cols=251  Identities=23%  Similarity=0.321  Sum_probs=206.5

Q ss_pred             hhhCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCC----Ch-HhHHHHHHHHHHHHhcC-CCceeeeEeEEEeCC
Q 014024          106 SATGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGK----SG-QEIKELKNEASVIAQVQ-HKNLVKLLGCCIEKD  177 (432)
Q Consensus       106 ~~~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~  177 (432)
                      ...++|.+.+.||+|+||+|+.|.+.  +..||+|.+...    .. ...+.+.+|+.++++++ ||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            45689999999999999999999874  348999966442    12 34556778999999999 999999999999999


Q ss_pred             eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCC-CCEEEeeccc
Q 014024          178 ERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKD-MNSKISDFGM  256 (432)
Q Consensus       178 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~  256 (432)
                      ..++||||+.+|.|.+++.+   .+.+.+..+..++.|++.|++|||+.|   |+||||||+|||++.+ +++||+|||+
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~  167 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL  167 (370)
T ss_pred             eEEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence            99999999999999999965   445899999999999999999999999   9999999999999999 9999999999


Q ss_pred             ceeccCCCCccccccccccccccCCccChhhhccCC-CC-chhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhh
Q 014024          257 ARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGI-FS-IKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLW  334 (432)
Q Consensus       257 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~t-~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  334 (432)
                      +....      .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+....             
T Consensus       168 s~~~~------~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~-------------  228 (370)
T KOG0583|consen  168 SAISP------GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV-------------  228 (370)
T ss_pred             ccccC------CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH-------------
Confidence            98742      1123456789999999999999877 75 889999999999999999999864111             


Q ss_pred             hccchhhhhhhhhhh--cccHHH-HHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014024          335 ISNKIIDLIDSVLEE--ASFNES-LSRYVHIALLCVQERAEDRPTMSDVVSMLTN  386 (432)
Q Consensus       335 ~~~~~~~~i~~~l~~--~~~~~~-~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~  386 (432)
                           ..+.......  ..+... ..++..|+.+||..||.+|+|+.+++++=+-
T Consensus       229 -----~~l~~ki~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~  278 (370)
T KOG0583|consen  229 -----PNLYRKIRKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWF  278 (370)
T ss_pred             -----HHHHHHHhcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhh
Confidence                 1111111111  112222 6788999999999999999999999965443

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-44  Score=355.18  Aligned_cols=258  Identities=27%  Similarity=0.439  Sum_probs=223.7

Q ss_pred             CCCCcCceeccCCcEEEEEEEECC-----ceEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEE
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQ-----GEIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLI  182 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  182 (432)
                      ....|.++||.|.||.|++|.++-     ..||||.++.. .+.....|..|+.+|.+++||||+++.|+....+..+||
T Consensus       629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi  708 (996)
T KOG0196|consen  629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII  708 (996)
T ss_pred             hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence            455778999999999999999742     27999999655 455677899999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccC
Q 014024          183 YEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFG  262 (432)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  262 (432)
                      .|||++|+|+.||+...++  |++.+...++++|+.|+.||.+.+   +|||||..+||||+.+...|++|||+++.+.+
T Consensus       709 TEyMENGsLDsFLR~~DGq--ftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvled  783 (996)
T KOG0196|consen  709 TEYMENGSLDSFLRQNDGQ--FTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED  783 (996)
T ss_pred             hhhhhCCcHHHHHhhcCCc--eEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeeccc
Confidence            9999999999999865544  999999999999999999999999   99999999999999999999999999997633


Q ss_pred             CCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchhh
Q 014024          263 GNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIID  341 (432)
Q Consensus       263 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (432)
                      ..+   ....+....-..+|.|||.+...++|.++||||||+++||.++ |.+|+-               .+.++++.+
T Consensus       784 d~~---~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYW---------------dmSNQdVIk  845 (996)
T KOG0196|consen  784 DPE---AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW---------------DMSNQDVIK  845 (996)
T ss_pred             CCC---ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccc---------------ccchHHHHH
Confidence            221   1122222233568999999999999999999999999999887 888852               245567778


Q ss_pred             hhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccc
Q 014024          342 LIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS  389 (432)
Q Consensus       342 ~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~  389 (432)
                      .|+...+-+.+.+|+..|.+|+..||++|-.+||.+.+|+.+|.+...
T Consensus       846 aIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr  893 (996)
T KOG0196|consen  846 AIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR  893 (996)
T ss_pred             HHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence            888888889999999999999999999999999999999999988654

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2e-42  Score=330.31  Aligned_cols=264  Identities=27%  Similarity=0.435  Sum_probs=201.5

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC------------------ceEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceee
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ------------------GEIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVK  168 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~------------------~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~  168 (432)
                      .++|.+.++||+|+||.||++.+.+                  ..+|+|.+... .......+.+|++++.+++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            4678999999999999999997532                  15899988654 3445567899999999999999999


Q ss_pred             eEeEEEeCCeeEEEEecCCCCChhhhhcCCC----------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 014024          169 LLGCCIEKDERLLIYEYMPNKSLDCFLFDPT----------------KREILDWRTRVQIIKGVAQGLLYLHQYSRVRII  232 (432)
Q Consensus       169 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iv  232 (432)
                      +++++.+.+..++||||+++|+|.+++....                ....+++..++.++.|++.||.|||+.+   |+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv  160 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV  160 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence            9999999999999999999999999885321                1134788899999999999999999998   99


Q ss_pred             eccCCCCCEEEcCCCCEEEeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhC
Q 014024          233 HRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG  312 (432)
Q Consensus       233 H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg  312 (432)
                      ||||||+|||+++++.+||+|||++..+.....    ........++..|+|||++.++.++.++||||||+++|||+++
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~  236 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDY----YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILML  236 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCce----eEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHc
Confidence            999999999999999999999999986422211    1112234557889999999988999999999999999999975


Q ss_pred             --CCCCCCccccccchhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014024          313 --KKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN  386 (432)
Q Consensus       313 --~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~  386 (432)
                        ..|+.....  ...............      .......+..++..+.+++.+||+.||++|||+.+|.+.|++
T Consensus       237 ~~~~p~~~~~~--~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         237 CKEQPYGELTD--EQVIENAGEFFRDQG------RQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             cCCCCCCcCCH--HHHHHHHHHHhhhcc------ccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence              445532221  111111000000000      000011123455788999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.1e-43  Score=341.48  Aligned_cols=248  Identities=25%  Similarity=0.356  Sum_probs=212.2

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC---ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEE
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK---SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLI  182 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  182 (432)
                      .+-|++++.||.|+.|.|-+|++..  +.+|||++.+.   .......+.+|+-+|+.+.|||++++|+++++..++|+|
T Consensus        11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv   90 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV   90 (786)
T ss_pred             ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence            4678899999999999999999854  47899988655   233456688999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccC
Q 014024          183 YEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFG  262 (432)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  262 (432)
                      .||+++|-|.+++.   .++++++.++.+++.||+.|+.|+|..+   |+||||||+|+|||.++++||+|||+|.+-..
T Consensus        91 lEyv~gGELFdylv---~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~  164 (786)
T KOG0588|consen   91 LEYVPGGELFDYLV---RKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVP  164 (786)
T ss_pred             EEecCCchhHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccC
Confidence            99999999999994   4566999999999999999999999999   99999999999999999999999999987422


Q ss_pred             CCCccccccccccccccCCccChhhhccCCC-CchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhh
Q 014024          263 GNDEDELQGNTSRISGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIID  341 (432)
Q Consensus       263 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (432)
                             .......||.|.|.|||++.+..| ..++||||.|||||.|+||+.||+.                  ++++.
T Consensus       165 -------gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD------------------dNir~  219 (786)
T KOG0588|consen  165 -------GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD------------------DNIRV  219 (786)
T ss_pred             -------CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC------------------ccHHH
Confidence                   233456799999999999999988 5799999999999999999999862                  33344


Q ss_pred             hhhhhhhhc--ccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014024          342 LIDSVLEEA--SFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN  386 (432)
Q Consensus       342 ~i~~~l~~~--~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~  386 (432)
                      ++.+..++.  .+...+.+.++|+..|+..||++|.|++||++|..-
T Consensus       220 LLlKV~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l  266 (786)
T KOG0588|consen  220 LLLKVQRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFL  266 (786)
T ss_pred             HHHHHHcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchh
Confidence            444433332  245567889999999999999999999999997643

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.7e-43  Score=331.04  Aligned_cols=264  Identities=25%  Similarity=0.330  Sum_probs=201.4

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCCC--hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeC--CeeE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKS--GQEIKELKNEASVIAQVQHKNLVKLLGCCIEK--DERL  180 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~  180 (432)
                      ..+.|+.+++||+|.||.||+|++..+  -||+|++....  .....-..+|+.+|++++||||+++.+...+.  ...|
T Consensus       115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY  194 (560)
T KOG0600|consen  115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY  194 (560)
T ss_pred             chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence            346788899999999999999998655  69999985543  34445567899999999999999999999877  6899


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceec
Q 014024          181 LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIV  260 (432)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  260 (432)
                      +|+|||++ +|.-++....  -.|++.++.-++.|++.||+|+|++|   |+|||||.+|||||.+|.+||+|||+|+++
T Consensus       195 lVFeYMdh-DL~GLl~~p~--vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y  268 (560)
T KOG0600|consen  195 LVFEYMDH-DLSGLLSSPG--VKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFY  268 (560)
T ss_pred             EEEecccc-hhhhhhcCCC--cccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeec
Confidence            99999977 5555564332  24999999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCCccccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCccc-cccch--------hhhh
Q 014024          261 FGGNDEDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRT-KSLNL--------IGYA  330 (432)
Q Consensus       261 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~-~~~~~--------~~~~  330 (432)
                      .....     ...++.+.|.+|+|||++.+ ..|+.++|+||.||||.||++|++.+..... +....        ....
T Consensus       269 ~~~~~-----~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~  343 (560)
T KOG0600|consen  269 TPSGS-----APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDY  343 (560)
T ss_pred             cCCCC-----cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhc
Confidence            43322     23566788999999999887 5699999999999999999999988754221 10000        0011


Q ss_pred             HHhhhcc-----chhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014024          331 WDLWISN-----KIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVS  382 (432)
Q Consensus       331 ~~~~~~~-----~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~  382 (432)
                      |....-.     ....-....+++. ....+....+|+..+|..||.+|.|+.++++
T Consensus       344 W~~~kLP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  344 WPVSKLPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             cccccCCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            1100000     0001111122221 2233456789999999999999999999986

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-42  Score=328.54  Aligned_cols=245  Identities=22%  Similarity=0.250  Sum_probs=199.6

Q ss_pred             CCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCCC---hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEE
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGKS---GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  183 (432)
                      ++|++.+.||+|+||.||+|.+.  +..+|+|++....   ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            47899999999999999999986  4489999885432   234566889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCC
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGG  263 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  263 (432)
                      ||+++|+|.+++..   ++.+++.....++.|++.||+|||+++   ++||||||+|||+++++.+||+|||++..... 
T Consensus        81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~-  153 (291)
T cd05612          81 EYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-  153 (291)
T ss_pred             eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccC-
Confidence            99999999999853   345899999999999999999999999   99999999999999999999999999976421 


Q ss_pred             CCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhh
Q 014024          264 NDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLI  343 (432)
Q Consensus       264 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i  343 (432)
                              ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......  .    ....        +.
T Consensus       154 --------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~--~----~~~~--------i~  211 (291)
T cd05612         154 --------RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF--G----IYEK--------IL  211 (291)
T ss_pred             --------CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--H----HHHH--------HH
Confidence                    122356899999999999988999999999999999999999998532210  0    0000        00


Q ss_pred             hhhhhhcccHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHHh
Q 014024          344 DSVLEEASFNESLSRYVHIALLCVQERAEDRPT-----MSDVVSML  384 (432)
Q Consensus       344 ~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt-----~~evl~~L  384 (432)
                      ...  ...+......+.+++.+||+.||.+||+     +.+++++-
T Consensus       212 ~~~--~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~  255 (291)
T cd05612         212 AGK--LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHR  255 (291)
T ss_pred             hCC--cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCc
Confidence            000  0112223456789999999999999995     88888764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2e-42  Score=329.54  Aligned_cols=260  Identities=20%  Similarity=0.281  Sum_probs=204.5

Q ss_pred             hhhhCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCCC---hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCee
Q 014024          105 SSATGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKS---GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDER  179 (432)
Q Consensus       105 ~~~~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  179 (432)
                      ....++|+++++||+|+||.||+|+-.++  -+|+|++.+..   ....+.+..|-.+|....+++||+++..|.+.+++
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L  216 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL  216 (550)
T ss_pred             cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence            34678999999999999999999997554  78999986653   34566788899999999999999999999999999


Q ss_pred             EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeeccccee
Q 014024          180 LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARI  259 (432)
Q Consensus       180 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  259 (432)
                      ||||||++||++..+|.   ..+.|++..+..++.+++.|+..||+.|   +|||||||+|+|||..|++||+|||++.-
T Consensus       217 YLiMEylPGGD~mTLL~---~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~g  290 (550)
T KOG0605|consen  217 YLIMEYLPGGDMMTLLM---RKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTG  290 (550)
T ss_pred             EEEEEecCCccHHHHHH---hcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccch
Confidence            99999999999999994   4566999999999999999999999999   99999999999999999999999999865


Q ss_pred             ccCCCCc------------------cccc-----------------------cccccccccCCccChhhhccCCCCchhh
Q 014024          260 VFGGNDE------------------DELQ-----------------------GNTSRISGTYGYMSPEYALEGIFSIKSD  298 (432)
Q Consensus       260 ~~~~~~~------------------~~~~-----------------------~~~~~~~gt~~y~aPE~~~~~~~t~~~D  298 (432)
                      +......                  ....                       ......+|||.|+|||++.+..|+..+|
T Consensus       291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cD  370 (550)
T KOG0605|consen  291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECD  370 (550)
T ss_pred             hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcccc
Confidence            4221000                  0000                       1112357999999999999999999999


Q ss_pred             hHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCC--
Q 014024          299 VFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPT--  376 (432)
Q Consensus       299 vwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt--  376 (432)
                      .||||||+|||+.|-+||.......      .+....+.      +..+..+.......+..+||.+|+. ||++|.-  
T Consensus       371 wWSLG~ImyEmLvGyPPF~s~tp~~------T~rkI~nw------r~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~  437 (550)
T KOG0605|consen  371 WWSLGCIMYEMLVGYPPFCSETPQE------TYRKIVNW------RETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSK  437 (550)
T ss_pred             HHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHHH------hhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcc
Confidence            9999999999999999985333211      11111100      0112222222334677889999999 9999975  


Q ss_pred             -HHHHHHH
Q 014024          377 -MSDVVSM  383 (432)
Q Consensus       377 -~~evl~~  383 (432)
                       ++||-+|
T Consensus       438 G~~EIK~H  445 (550)
T KOG0605|consen  438 GAEEIKKH  445 (550)
T ss_pred             cHHHHhcC
Confidence             6666653

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2.4e-42  Score=302.08  Aligned_cols=262  Identities=22%  Similarity=0.321  Sum_probs=201.9

Q ss_pred             CCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCCChH--hHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEe
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQ--EIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYE  184 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  184 (432)
                      .+|...+.||+|.||.||+|++..+  .||+|++......  ......+|++.|+.++|+||+.++++|...+...||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            4788899999999999999998554  8999998654322  23456789999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCC
Q 014024          185 YMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGN  264 (432)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  264 (432)
                      |++ .+|...+.+.  ...++..++..++.++++|++|||++.   |+||||||.|+|++++|.+||+|||+|+.+...+
T Consensus        82 fm~-tdLe~vIkd~--~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~  155 (318)
T KOG0659|consen   82 FMP-TDLEVVIKDK--NIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN  155 (318)
T ss_pred             ecc-ccHHHHhccc--ccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence            995 4888888653  455999999999999999999999999   9999999999999999999999999999863322


Q ss_pred             CccccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHh---hhccc--
Q 014024          265 DEDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDL---WISNK--  338 (432)
Q Consensus       265 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~---~~~~~--  338 (432)
                      .      .....+.|.+|+|||.+.+ ..|+..+|+||.|||+.||+-|.+-|....  +.+........   ...+.  
T Consensus       156 ~------~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~s--DidQL~~If~~LGTP~~~~WP  227 (318)
T KOG0659|consen  156 R------IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDS--DIDQLSKIFRALGTPTPDQWP  227 (318)
T ss_pred             c------ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCc--hHHHHHHHHHHcCCCCcccCc
Confidence            2      2222378999999998876 679999999999999999998876543221  11111111111   11111  


Q ss_pred             ----hhhhhhhh-----hhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          339 ----IIDLIDSV-----LEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       339 ----~~~~i~~~-----l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                          +.++.+-.     ...........+..+|+..++..||.+|+|++|.+++=
T Consensus       228 ~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~  282 (318)
T KOG0659|consen  228 EMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHP  282 (318)
T ss_pred             cccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcch
Confidence                11111111     11113344556779999999999999999999999764

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.2e-41  Score=328.82  Aligned_cols=263  Identities=23%  Similarity=0.309  Sum_probs=205.0

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEe
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYE  184 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  184 (432)
                      .++|++.+.||+|+||.||++.+...  .+|+|.+... .....+.+.+|++++++++|+||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            47899999999999999999998644  7888887654 33455679999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCC
Q 014024          185 YMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGN  264 (432)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  264 (432)
                      |+++++|.+++..   ...+++..+..++.|++.||.|||+.+  +|+||||||+||++++++.+||+|||++.....  
T Consensus        84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--  156 (331)
T cd06649          84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--  156 (331)
T ss_pred             cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccc--
Confidence            9999999999853   334899999999999999999999853  399999999999999999999999999875421  


Q ss_pred             CccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHH------------
Q 014024          265 DEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWD------------  332 (432)
Q Consensus       265 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~------------  332 (432)
                            .......|++.|+|||++.+..++.++|||||||++|||++|+.||........  ......            
T Consensus       157 ------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~  228 (331)
T cd06649         157 ------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKEL--EAIFGRPVVDGEEGEPHS  228 (331)
T ss_pred             ------cccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHhcccccccccCCccc
Confidence                  122345689999999999999999999999999999999999999854322110  000000            


Q ss_pred             ------------------hhhccchhhhhhhhhhhcc----cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014024          333 ------------------LWISNKIIDLIDSVLEEAS----FNESLSRYVHIALLCVQERAEDRPTMSDVVSMLT  385 (432)
Q Consensus       333 ------------------~~~~~~~~~~i~~~l~~~~----~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~  385 (432)
                                        ........+..+.......    ......++.+++.+||+.||++|||+.|++++..
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~  303 (331)
T cd06649         229 ISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTF  303 (331)
T ss_pred             cCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChH
Confidence                              0000001111111111111    1124567899999999999999999999998754

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=3.9e-42  Score=331.93  Aligned_cols=246  Identities=23%  Similarity=0.279  Sum_probs=199.6

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC---ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEE
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK---SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLI  182 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  182 (432)
                      .++|++.+.||+|+||.||+|.+..  ..+|+|.+...   .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            4689999999999999999999854  37999988543   223456788999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccC
Q 014024          183 YEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFG  262 (432)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  262 (432)
                      |||+++|+|.+++..   .+.+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++.....
T Consensus        97 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  170 (329)
T PTZ00263         97 LEFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD  170 (329)
T ss_pred             EcCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence            999999999999854   345889999999999999999999999   99999999999999999999999999986421


Q ss_pred             CCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhh
Q 014024          263 GNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDL  342 (432)
Q Consensus       263 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                               ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......  .    ....        +
T Consensus       171 ---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--~----~~~~--------i  227 (329)
T PTZ00263        171 ---------RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF--R----IYEK--------I  227 (329)
T ss_pred             ---------CcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH--H----HHHH--------H
Confidence                     122357899999999999999999999999999999999999998432110  0    0000        0


Q ss_pred             hhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHHh
Q 014024          343 IDSVLEEASFNESLSRYVHIALLCVQERAEDRPT-----MSDVVSML  384 (432)
Q Consensus       343 i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt-----~~evl~~L  384 (432)
                      ....+  ..+......+.+++..||+.||.+||+     +++++++-
T Consensus       228 ~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp  272 (329)
T PTZ00263        228 LAGRL--KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHP  272 (329)
T ss_pred             hcCCc--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCC
Confidence            00000  111123356789999999999999997     68888663

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=6.6e-42  Score=320.38  Aligned_cols=255  Identities=25%  Similarity=0.381  Sum_probs=202.7

Q ss_pred             hCCCCcCceeccCCcEEEEEEEEC-----CceEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEE
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIG-----QGEIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLL  181 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  181 (432)
                      ..+|++.+.||+|+||.||+|.+.     ...+|+|.+... .......+.+|+..+++++||||+++++++...+..++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            357889999999999999999763     227899988654 33445678999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceecc
Q 014024          182 IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVF  261 (432)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  261 (432)
                      ||||+++|+|.+++...  ...+++..++.++.|++.||+|||+.+   ++||||||+||++++++.++++|||.+....
T Consensus        84 v~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~  158 (266)
T cd05064          84 VTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK  158 (266)
T ss_pred             EEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence            99999999999998643  235899999999999999999999998   9999999999999999999999999876421


Q ss_pred             CCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchh
Q 014024          262 GGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKII  340 (432)
Q Consensus       262 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                      ...     ........++..|+|||.+.+..++.++|||||||++||+++ |..||.......               ..
T Consensus       159 ~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~---------------~~  218 (266)
T cd05064         159 SEA-----IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD---------------VI  218 (266)
T ss_pred             ccc-----hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---------------HH
Confidence            110     111122345678999999999999999999999999999875 999975322110               01


Q ss_pred             hhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014024          341 DLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNE  387 (432)
Q Consensus       341 ~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~  387 (432)
                      +.+........+..++..+.+++..||+.+|++||++.+|.+.|++.
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         219 KAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             HHHHCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            11111111122344567889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=9.2e-42  Score=322.09  Aligned_cols=256  Identities=30%  Similarity=0.514  Sum_probs=206.1

Q ss_pred             CCCCcCceeccCCcEEEEEEEECC-------ceEEEEEEcCCC-hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeE
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQ-------GEIAVKRLLGKS-GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERL  180 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~-------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  180 (432)
                      ++|++.+.||+|+||.||+|...+       ..+++|.+.... ....+.+.+|++.+++++|+||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            578899999999999999998643       258899885443 344567899999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCC
Q 014024          181 LIYEYMPNKSLDCFLFDPTK-------------REILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDM  247 (432)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~  247 (432)
                      ++|||+++++|.+++.....             ...+++..++.++.|++.||.|||+.+   ++|+||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence            99999999999999854321             145889999999999999999999998   99999999999999999


Q ss_pred             CEEEeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccch
Q 014024          248 NSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNL  326 (432)
Q Consensus       248 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~  326 (432)
                      .++|+|||++......+.    ........+++.|+|||.+.++.++.++|||||||++|||++ |..||.....     
T Consensus       162 ~~~L~dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~-----  232 (283)
T cd05048         162 TVKISDFGLSRDIYSADY----YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN-----  232 (283)
T ss_pred             cEEECCCcceeecccccc----ccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH-----
Confidence            999999999976422211    112233456788999999998999999999999999999998 9988743221     


Q ss_pred             hhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014024          327 IGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN  386 (432)
Q Consensus       327 ~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~  386 (432)
                                .+....+........+..++.++.+++.+||+.||++||+++||+++|+.
T Consensus       233 ----------~~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         233 ----------QEVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             ----------HHHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence                      11111122111222344567889999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=5.1e-42  Score=336.71  Aligned_cols=259  Identities=29%  Similarity=0.396  Sum_probs=202.4

Q ss_pred             hCCCCcCceeccCCcEEEEEEEEC-------CceEEEEEEcCCC-hHhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCe
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIG-------QGEIAVKRLLGKS-GQEIKELKNEASVIAQV-QHKNLVKLLGCCIEKDE  178 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  178 (432)
                      .++|++.+.||+|+||.||+|...       ...||+|++.... ....+.+.+|+.+++.+ +||||++++++|.+.+.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            458999999999999999999741       2279999885432 34456788999999999 89999999999999999


Q ss_pred             eEEEEecCCCCChhhhhcCCCC----------------------------------------------------------
Q 014024          179 RLLIYEYMPNKSLDCFLFDPTK----------------------------------------------------------  200 (432)
Q Consensus       179 ~~lv~e~~~~gsL~~~l~~~~~----------------------------------------------------------  200 (432)
                      .++||||+++|+|.+++.....                                                          
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            9999999999999998854211                                                          


Q ss_pred             --------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCc
Q 014024          201 --------------REILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDE  266 (432)
Q Consensus       201 --------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  266 (432)
                                    ...+++..+..++.|++.||+|||+.+   ++||||||+|||+++++.+||+|||++........ 
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-  269 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSN-  269 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCccc-
Confidence                          124788999999999999999999998   99999999999999999999999999986522111 


Q ss_pred             cccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchhhhhhh
Q 014024          267 DELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDS  345 (432)
Q Consensus       267 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  345 (432)
                         ........++..|+|||++.+..++.++|||||||++|||++ |..||....... ..             ...+..
T Consensus       270 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-~~-------------~~~~~~  332 (375)
T cd05104         270 ---YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-KF-------------YKMIKE  332 (375)
T ss_pred             ---ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-HH-------------HHHHHh
Confidence               111122345667999999999999999999999999999998 888875322110 00             111111


Q ss_pred             hhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014024          346 VLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNE  387 (432)
Q Consensus       346 ~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~  387 (432)
                      ......+...+.++.+++.+||+.||++||++.||++.|+..
T Consensus       333 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         333 GYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             CccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            111111222346789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-43  Score=304.19  Aligned_cols=269  Identities=20%  Similarity=0.212  Sum_probs=212.4

Q ss_pred             hhhCCCCcCceeccCCcEEEEEEEE--CCceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC-----e
Q 014024          106 SATGNFSAANKLGEGGFGTVYKGVI--GQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKD-----E  178 (432)
Q Consensus       106 ~~~~~y~~~~~ig~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~  178 (432)
                      -..++|.+.+.||+|||+.||+++.  .+..+|+|++.....+..+...+|++..++++|||+++++++...+.     .
T Consensus        18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~   97 (302)
T KOG2345|consen   18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE   97 (302)
T ss_pred             EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence            4568999999999999999999985  44589999998888888899999999999999999999999875433     4


Q ss_pred             eEEEEecCCCCChhhhhcCCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccc
Q 014024          179 RLLIYEYMPNKSLDCFLFDPTK-REILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMA  257 (432)
Q Consensus       179 ~~lv~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  257 (432)
                      .|++++|+..|+|.+.+..... +..+++.+.+.|+.++++||++||+.. +++.||||||.|||+.+.+.+++.|||.+
T Consensus        98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~  176 (302)
T KOG2345|consen   98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSA  176 (302)
T ss_pred             EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCc
Confidence            7999999999999999875433 347999999999999999999999986 46999999999999999999999999998


Q ss_pred             eeccCC---CCccccccccccccccCCccChhhhc---cCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhH
Q 014024          258 RIVFGG---NDEDELQGNTSRISGTYGYMSPEYAL---EGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAW  331 (432)
Q Consensus       258 ~~~~~~---~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~  331 (432)
                      ....-.   +..............|..|+|||.+.   +...++++|||||||+||+|+.|..||+..-....++.-.+.
T Consensus       177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~  256 (302)
T KOG2345|consen  177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQ  256 (302)
T ss_pred             cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeee
Confidence            764211   11101111223345788999999986   456899999999999999999999998653332222211111


Q ss_pred             HhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014024          332 DLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNE  387 (432)
Q Consensus       332 ~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~  387 (432)
                      .            ..+.-+.....++.+.+++++|++.||.+||++.+++..++++
T Consensus       257 n------------~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  257 N------------AQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             c------------cccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence            0            1111111222567889999999999999999999999998875

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=7.9e-42  Score=323.16  Aligned_cols=248  Identities=24%  Similarity=0.317  Sum_probs=198.4

Q ss_pred             CCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCCC---hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEe
Q 014024          110 NFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGKS---GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYE  184 (432)
Q Consensus       110 ~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  184 (432)
                      .|+..+.||+|+||.||++.+.  +..+|+|.+....   ......+.+|++++++++|+|++++++++.+.+..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            3778899999999999999874  3489999885432   2233457889999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCC
Q 014024          185 YMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGN  264 (432)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  264 (432)
                      |+++|+|.+++.... ...+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++...... 
T Consensus        81 ~~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~-  155 (285)
T cd05631          81 IMNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEG-  155 (285)
T ss_pred             ecCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC-
Confidence            999999988875432 234899999999999999999999998   999999999999999999999999999864211 


Q ss_pred             CccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhh
Q 014024          265 DEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLID  344 (432)
Q Consensus       265 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  344 (432)
                            .......||..|+|||++.+..++.++|||||||++|+|++|+.||........               .+.++
T Consensus       156 ------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~---------------~~~~~  214 (285)
T cd05631         156 ------ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK---------------REEVD  214 (285)
T ss_pred             ------CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh---------------HHHHH
Confidence                  112345689999999999999999999999999999999999999863321100               00011


Q ss_pred             hhh---hhcccHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 014024          345 SVL---EEASFNESLSRYVHIALLCVQERAEDRPT-----MSDVVSM  383 (432)
Q Consensus       345 ~~l---~~~~~~~~~~~l~~l~~~cl~~dp~~RPt-----~~evl~~  383 (432)
                      ..+   ....+......+.+|+..||+.||.+||+     +++++++
T Consensus       215 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         215 RRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             HHhhcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence            100   01122234567889999999999999997     7888875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-43  Score=329.41  Aligned_cols=265  Identities=23%  Similarity=0.293  Sum_probs=204.0

Q ss_pred             hhhCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCCChHhHHH--HHHHHHHHHhcC-CCceeeeEeEEEeCC-ee
Q 014024          106 SATGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEIKE--LKNEASVIAQVQ-HKNLVKLLGCCIEKD-ER  179 (432)
Q Consensus       106 ~~~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~~~~~~~--~~~E~~~l~~l~-h~niv~~~~~~~~~~-~~  179 (432)
                      ...++|.+.++||.|.||.||+|+....  .||||+++.+-.. +++  -.+|+..|++++ ||||+++.+++.+.+ .+
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L   85 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL   85 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence            3467899999999999999999997543  7999988655322 333  357999999999 999999999999888 99


Q ss_pred             EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeeccccee
Q 014024          180 LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARI  259 (432)
Q Consensus       180 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  259 (432)
                      ++|||||+. +|.+++.+.  ++.|++..+..|++||++||+|+|.+|   +.|||+||+|||+..+..+||+|||+|+.
T Consensus        86 ~fVfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARe  159 (538)
T KOG0661|consen   86 YFVFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLARE  159 (538)
T ss_pred             eeeHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccc
Confidence            999999954 888888764  667999999999999999999999999   99999999999999999999999999997


Q ss_pred             ccCCCCccccccccccccccCCccChhhhc-cCCCCchhhhHHHHHHHHHHHhCCCCCCCcccccc-chhhhhHHhhhcc
Q 014024          260 VFGGNDEDELQGNTSRISGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSL-NLIGYAWDLWISN  337 (432)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~  337 (432)
                      ...       ....+..+.|.+|+|||++. .+.|+.+.|+|++|||++|+.+-++-|.....-++ .-.-.+.......
T Consensus       160 v~S-------kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~  232 (538)
T KOG0661|consen  160 VRS-------KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKD  232 (538)
T ss_pred             ccc-------CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccc
Confidence            522       33566788999999999876 57799999999999999999999887754322110 0000000000000


Q ss_pred             chhh--hhhhhhh-----------hcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          338 KIID--LIDSVLE-----------EASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       338 ~~~~--~i~~~l~-----------~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                      .+.+  .+...+.           ....+.+..+..+++..|+.-||.+|||++|.+++-
T Consensus       233 ~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p  292 (538)
T KOG0661|consen  233 SWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP  292 (538)
T ss_pred             cchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence            0000  0000000           001123567889999999999999999999999854

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-42  Score=335.02  Aligned_cols=263  Identities=31%  Similarity=0.434  Sum_probs=214.6

Q ss_pred             hhhhCCCCcCceeccCCcEEEEEEEECCc-----e-EEEEEEcC---CChHhHHHHHHHHHHHHhcCCCceeeeEeEEEe
Q 014024          105 SSATGNFSAANKLGEGGFGTVYKGVIGQG-----E-IAVKRLLG---KSGQEIKELKNEASVIAQVQHKNLVKLLGCCIE  175 (432)
Q Consensus       105 ~~~~~~y~~~~~ig~G~~g~Vy~~~~~~~-----~-vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  175 (432)
                      .-..++-.+.++||+|+||.||+|.....     . ||+|....   .......++.+|+++|++++|||||+++|++..
T Consensus       153 el~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~  232 (474)
T KOG0194|consen  153 ELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL  232 (474)
T ss_pred             EEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC
Confidence            34567777789999999999999986432     3 89998875   346778899999999999999999999999999


Q ss_pred             CCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecc
Q 014024          176 KDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFG  255 (432)
Q Consensus       176 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  255 (432)
                      ....++|||+|.||+|.++|.....  .++..+...++.+.|.||+|||+++   ++||||..+|+|++.++.+||+|||
T Consensus       233 ~~Pl~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFG  307 (474)
T KOG0194|consen  233 EEPLMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFG  307 (474)
T ss_pred             CCccEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccc
Confidence            9999999999999999999965433  4999999999999999999999999   9999999999999999999999999


Q ss_pred             cceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhh
Q 014024          256 MARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLW  334 (432)
Q Consensus       256 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~  334 (432)
                      +++.-.      ..........-...|+|||.+..+.++.++|||||||++||+++ |..|+.....             
T Consensus       308 Ls~~~~------~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~-------------  368 (474)
T KOG0194|consen  308 LSRAGS------QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN-------------  368 (474)
T ss_pred             cccCCc------ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH-------------
Confidence            987521      01111111234568999999999999999999999999999999 7888643221             


Q ss_pred             hccchhhhh-hhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccccCCCC
Q 014024          335 ISNKIIDLI-DSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLP  393 (432)
Q Consensus       335 ~~~~~~~~i-~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~~  393 (432)
                        .++...+ ....+...+...+..+..++..||..+|++||+|.++.+.|+.+.....+
T Consensus       369 --~~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~  426 (474)
T KOG0194|consen  369 --YEVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA  426 (474)
T ss_pred             --HHHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence              1222222 33334444556778889999999999999999999999999987765443

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-43  Score=333.73  Aligned_cols=248  Identities=26%  Similarity=0.416  Sum_probs=207.7

Q ss_pred             CceeccCCcEEEEEEEECCceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecCCCCChhh
Q 014024          114 ANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDC  193 (432)
Q Consensus       114 ~~~ig~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~  193 (432)
                      ++-||.|+.|-||+|++.+..||||++..-.       ..+++-|++++|+||+.|.|+|.....+|||||||..|-|.+
T Consensus       129 LeWlGSGaQGAVF~Grl~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~  201 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLHNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYE  201 (904)
T ss_pred             hhhhccCcccceeeeeccCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHH
Confidence            5679999999999999999999999875332       347888999999999999999999999999999999999999


Q ss_pred             hhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCcccccccc
Q 014024          194 FLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNT  273 (432)
Q Consensus       194 ~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  273 (432)
                      .|.   .+.++.......|..+||.|+.|||.+.   |||||||.-||||..+..+||+|||.++.+..       ....
T Consensus       202 VLk---a~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~-------~STk  268 (904)
T KOG4721|consen  202 VLK---AGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSD-------KSTK  268 (904)
T ss_pred             HHh---ccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhh-------hhhh
Confidence            994   4556889999999999999999999998   99999999999999999999999999987521       2345


Q ss_pred             ccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhhhhhcccH
Q 014024          274 SRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFN  353 (432)
Q Consensus       274 ~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~  353 (432)
                      ..+.||..|||||++.+...++|+||||||||||||+||..|+...+...     .+|..         =...+.-..+.
T Consensus       269 MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA-----IIwGV---------GsNsL~LpvPs  334 (904)
T KOG4721|consen  269 MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA-----IIWGV---------GSNSLHLPVPS  334 (904)
T ss_pred             hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe-----eEEec---------cCCcccccCcc
Confidence            56899999999999999999999999999999999999999975433211     11111         01122233455


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccccCCCCCC
Q 014024          354 ESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPK  395 (432)
Q Consensus       354 ~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~~~~  395 (432)
                      .++.-+.-|+++||+..|.+||++++++.+|+=..+.+...+
T Consensus       335 tcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pell~~t  376 (904)
T KOG4721|consen  335 TCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPELLSTT  376 (904)
T ss_pred             cCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHhccc
Confidence            778888999999999999999999999999986665544433

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-42  Score=320.45  Aligned_cols=259  Identities=26%  Similarity=0.349  Sum_probs=206.7

Q ss_pred             hhhhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCCh--------------HhHHHHHHHHHHHHhcCCCceee
Q 014024          105 SSATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSG--------------QEIKELKNEASVIAQVQHKNLVK  168 (432)
Q Consensus       105 ~~~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~  168 (432)
                      ....++|++.+.||+|.||.|-+|++..  .-||+|++.+...              ...+.+.+|+.+|++++|+|||+
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~  172 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK  172 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence            3456899999999999999999999854  3799998854321              13467899999999999999999


Q ss_pred             eEeEEEeC--CeeEEEEecCCCCChhhhhcCCCCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcC
Q 014024          169 LLGCCIEK--DERLLIYEYMPNKSLDCFLFDPTKREI-LDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDK  245 (432)
Q Consensus       169 ~~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~-l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~  245 (432)
                      ++++..+.  +..|||+|||..|.+..-    ...++ ++..++++++.+++.||+|||.+|   |+||||||+|+||++
T Consensus       173 LiEvLDDP~s~~~YlVley~s~G~v~w~----p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~  245 (576)
T KOG0585|consen  173 LIEVLDDPESDKLYLVLEYCSKGEVKWC----PPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSS  245 (576)
T ss_pred             EEEeecCcccCceEEEEEeccCCccccC----CCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcC
Confidence            99999765  578999999999886433    23334 999999999999999999999999   999999999999999


Q ss_pred             CCCEEEeecccceeccCCCCccccccccccccccCCccChhhhccCC----CCchhhhHHHHHHHHHHHhCCCCCCCccc
Q 014024          246 DMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGI----FSIKSDVFSFGVLLLEIVSGKKNTGFYRT  321 (432)
Q Consensus       246 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~t~~~DvwSlG~il~elltg~~p~~~~~~  321 (432)
                      +|++||+|||.+.....+... .........+|||.|+|||...++.    .+.+.||||+||+||.|+.|+.||-.   
T Consensus       246 ~g~VKIsDFGVs~~~~~~~~~-~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~---  321 (576)
T KOG0585|consen  246 DGTVKISDFGVSNEFPQGSDE-GSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD---  321 (576)
T ss_pred             CCcEEeeccceeeecccCCcc-ccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc---
Confidence            999999999999875444222 2223344589999999999988633    36789999999999999999999731   


Q ss_pred             cccchhhhhHHhhhccchhhhhhhh----hhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccc
Q 014024          322 KSLNLIGYAWDLWISNKIIDLIDSV----LEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS  389 (432)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~i~~~----l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~  389 (432)
                                     +...++.++.    +..+..++.-..+.+|+..+|++||++|.++.+|..+..-...
T Consensus       322 ---------------~~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  322 ---------------DFELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             ---------------chHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence                           2222233332    2222333556788899999999999999999999998876543

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=5.8e-42  Score=319.52  Aligned_cols=249  Identities=34%  Similarity=0.544  Sum_probs=193.9

Q ss_pred             cCceeccCCcEEEEEEEEC------CceEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEec
Q 014024          113 AANKLGEGGFGTVYKGVIG------QGEIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEY  185 (432)
Q Consensus       113 ~~~~ig~G~~g~Vy~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  185 (432)
                      +.+.||.|.||.||+|...      +..|+||.+... .....+.+.+|++.+++++||||++++|++.+.+..++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            4578999999999999987      347999999554 344578899999999999999999999999988889999999


Q ss_pred             CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCC
Q 014024          186 MPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGND  265 (432)
Q Consensus       186 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  265 (432)
                      +++|+|.+++... ....+++..+..|+.|++.||+|||+.+   ++|+||+++||++++++.+||+|||++........
T Consensus        83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred             ccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence            9999999999764 2244999999999999999999999998   99999999999999999999999999987521111


Q ss_pred             ccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchhhhhh
Q 014024          266 EDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIIDLID  344 (432)
Q Consensus       266 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  344 (432)
                          ............|+|||.+.+..++.++||||||+++|||++ |+.|+......               ...+.+.
T Consensus       159 ----~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~---------------~~~~~~~  219 (259)
T PF07714_consen  159 ----YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE---------------EIIEKLK  219 (259)
T ss_dssp             ----EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH---------------HHHHHHH
T ss_pred             ----cccccccccccccccccccccccccccccccccccccccccccccccccccccc---------------ccccccc
Confidence                112233456678999999999999999999999999999999 67776433211               1111111


Q ss_pred             hhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          345 SVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       345 ~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                      .......+..++..+.+++..||+.||++|||++++++.|
T Consensus       220 ~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  220 QGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             TTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            1122223334567789999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=6.1e-42  Score=331.61  Aligned_cols=247  Identities=21%  Similarity=0.291  Sum_probs=200.4

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECC---ceEEEEEEcCC---ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQ---GEIAVKRLLGK---SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERL  180 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~---~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  180 (432)
                      ..++|++.+.||+|+||.||+|.+.+   ..+|+|++...   .....+.+.+|+++++.++||||+++++++.+.+..+
T Consensus        28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~  107 (340)
T PTZ00426         28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY  107 (340)
T ss_pred             ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence            35689999999999999999998643   26899988533   2334567889999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceec
Q 014024          181 LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIV  260 (432)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  260 (432)
                      +||||+++|+|.+++..   +..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus       108 lv~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~  181 (340)
T PTZ00426        108 LVLEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVV  181 (340)
T ss_pred             EEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence            99999999999999853   345899999999999999999999999   999999999999999999999999999864


Q ss_pred             cCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchh
Q 014024          261 FGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKII  340 (432)
Q Consensus       261 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                      .         .......||+.|+|||++.+..++.++|||||||++|||++|..||......      .....       
T Consensus       182 ~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~------~~~~~-------  239 (340)
T PTZ00426        182 D---------TRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL------LIYQK-------  239 (340)
T ss_pred             C---------CCcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH------HHHHH-------
Confidence            1         1123457899999999999888999999999999999999999998532210      00000       


Q ss_pred             hhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHHh
Q 014024          341 DLIDSVLEEASFNESLSRYVHIALLCVQERAEDRP-----TMSDVVSML  384 (432)
Q Consensus       341 ~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~~L  384 (432)
                       +....  ...+......+.+++..||+.||++|+     ++++++++-
T Consensus       240 -i~~~~--~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp  285 (340)
T PTZ00426        240 -ILEGI--IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHP  285 (340)
T ss_pred             -HhcCC--CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCC
Confidence             00000  011222345678999999999999995     899998863

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-43  Score=326.50  Aligned_cols=248  Identities=26%  Similarity=0.402  Sum_probs=205.8

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEe
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYE  184 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  184 (432)
                      ...|+..+.||+|.||.||+|.+...  .||+|++... .....+.+++|+.+|.+++++||.++|+.+..+..++++||
T Consensus        12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe   91 (467)
T KOG0201|consen   12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME   91 (467)
T ss_pred             ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence            34567779999999999999998765  7999998544 45567889999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCC
Q 014024          185 YMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGN  264 (432)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  264 (432)
                      ||.||++.+.+.   ....+++....-++.+++.|+.|||+.+   .+|||||+.|||+..+|.+||+|||.+..+..  
T Consensus        92 y~~gGsv~~lL~---~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~--  163 (467)
T KOG0201|consen   92 YCGGGSVLDLLK---SGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTN--  163 (467)
T ss_pred             HhcCcchhhhhc---cCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeec--
Confidence            999999999984   3344578888889999999999999999   99999999999999999999999999987632  


Q ss_pred             CccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhh
Q 014024          265 DEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLID  344 (432)
Q Consensus       265 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  344 (432)
                          .......++||+.|||||++.+..|+.|+||||||++.+||.+|.+|+.......               ..-+|.
T Consensus       164 ----~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr---------------vlflIp  224 (467)
T KOG0201|consen  164 ----TVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR---------------VLFLIP  224 (467)
T ss_pred             ----hhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce---------------EEEecc
Confidence                1233467899999999999998899999999999999999999999986544311               111111


Q ss_pred             hhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014024          345 SVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVS  382 (432)
Q Consensus       345 ~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~  382 (432)
                      +.............+.+++..||+.||+.||++.+++.
T Consensus       225 k~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  225 KSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             CCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            11111112244567889999999999999999999996

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=8.2e-42  Score=335.02  Aligned_cols=260  Identities=29%  Similarity=0.431  Sum_probs=203.9

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECC-------ceEEEEEEcCC-ChHhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCC
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQ-------GEIAVKRLLGK-SGQEIKELKNEASVIAQV-QHKNLVKLLGCCIEKD  177 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~-------~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  177 (432)
                      ..++|++.+.||+|+||.||+|....       ..||+|++... .....+.+.+|+++++.+ +|+||++++++|.+.+
T Consensus        36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~  115 (374)
T cd05106          36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG  115 (374)
T ss_pred             cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence            34689999999999999999988521       26999998654 334456788999999999 8999999999999999


Q ss_pred             eeEEEEecCCCCChhhhhcCCC----------------------------------------------------------
Q 014024          178 ERLLIYEYMPNKSLDCFLFDPT----------------------------------------------------------  199 (432)
Q Consensus       178 ~~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------  199 (432)
                      ..++||||+++|+|.+++....                                                          
T Consensus       116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (374)
T cd05106         116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS  195 (374)
T ss_pred             CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence            9999999999999999885321                                                          


Q ss_pred             ---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCccccc
Q 014024          200 ---------KREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQ  270 (432)
Q Consensus       200 ---------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  270 (432)
                               ....+++..+++++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++........    .
T Consensus       196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~----~  268 (374)
T cd05106         196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN----Y  268 (374)
T ss_pred             cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcc----e
Confidence                     1124788899999999999999999998   99999999999999999999999999976422111    1


Q ss_pred             cccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchhhhhhhhhhh
Q 014024          271 GNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEE  349 (432)
Q Consensus       271 ~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  349 (432)
                      .......++..|+|||++.+..++.++|||||||++|||++ |+.||.......              .....+......
T Consensus       269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--------------~~~~~~~~~~~~  334 (374)
T cd05106         269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--------------KFYKMVKRGYQM  334 (374)
T ss_pred             eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--------------HHHHHHHcccCc
Confidence            11122335668999999998999999999999999999997 999975322111              011111111111


Q ss_pred             cccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014024          350 ASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNE  387 (432)
Q Consensus       350 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~  387 (432)
                      ..+...+.++.+++..||+.||++|||+.+|++.|+++
T Consensus       335 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         335 SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            11222356789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.7e-42  Score=330.51  Aligned_cols=253  Identities=20%  Similarity=0.319  Sum_probs=201.7

Q ss_pred             CCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCC---hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEE
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS---GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  183 (432)
                      ++|++.+.||+|+||.||+|.+..  ..||+|++....   ......+.+|++++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            478999999999999999999854  489999985432   234566888999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCC
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGG  263 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  263 (432)
                      ||+++|+|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++..... 
T Consensus        81 e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-  153 (333)
T cd05600          81 EYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-  153 (333)
T ss_pred             eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence            99999999999943   345899999999999999999999999   99999999999999999999999999976421 


Q ss_pred             CCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhh
Q 014024          264 NDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLI  343 (432)
Q Consensus       264 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i  343 (432)
                              ......||+.|+|||++.+..++.++|||||||++|||++|..||........      ......  ....+
T Consensus       154 --------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~------~~~i~~--~~~~~  217 (333)
T cd05600         154 --------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET------WENLKY--WKETL  217 (333)
T ss_pred             --------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH------HHHHHh--ccccc
Confidence                    23445789999999999999999999999999999999999999854322110      000000  00000


Q ss_pred             hhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          344 DSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       344 ~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                      ..............++.+++..||+.+|.+||++.+++++-
T Consensus       218 ~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~  258 (333)
T cd05600         218 QRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHP  258 (333)
T ss_pred             cCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCc
Confidence            00000000012356788999999999999999999999863

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.3e-41  Score=317.05  Aligned_cols=255  Identities=31%  Similarity=0.489  Sum_probs=209.1

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECCc-eEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEec
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEY  185 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~~-~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  185 (432)
                      ...+|++.++||.|+||.||+|.+.++ .+++|.+........+.+..|+.+++.++|+|++++++++.+.+..++||||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL   83 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence            346789999999999999999998665 7899988776665677899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCC
Q 014024          186 MPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGND  265 (432)
Q Consensus       186 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  265 (432)
                      +++++|.+++.... ...+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||.+......  
T Consensus        84 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~--  157 (261)
T cd05148          84 MEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKED--  157 (261)
T ss_pred             cccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCc--
Confidence            99999999997543 345899999999999999999999998   999999999999999999999999999764211  


Q ss_pred             ccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchhhhhh
Q 014024          266 EDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIIDLID  344 (432)
Q Consensus       266 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  344 (432)
                          ........++..|+|||...+..++.++||||||+++|+|++ |+.||......               .....+.
T Consensus       158 ----~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~---------------~~~~~~~  218 (261)
T cd05148         158 ----VYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH---------------EVYDQIT  218 (261)
T ss_pred             ----cccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH---------------HHHHHHH
Confidence                111123345678999999998899999999999999999998 88887432210               0111111


Q ss_pred             hhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014024          345 SVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN  386 (432)
Q Consensus       345 ~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~  386 (432)
                      .......+..++..+.+++.+||+.||.+|||+.++++.|+.
T Consensus       219 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         219 AGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             hCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence            111222334556778999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.7e-41  Score=319.09  Aligned_cols=270  Identities=29%  Similarity=0.402  Sum_probs=203.1

Q ss_pred             CCC-CcCceeccCCcEEEEEEEE------CCceEEEEEEcCCC-hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeC--Ce
Q 014024          109 GNF-SAANKLGEGGFGTVYKGVI------GQGEIAVKRLLGKS-GQEIKELKNEASVIAQVQHKNLVKLLGCCIEK--DE  178 (432)
Q Consensus       109 ~~y-~~~~~ig~G~~g~Vy~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~  178 (432)
                      ++| ++.+.||+|+||+||++..      .+..+|+|.+.... ......+.+|+++++.++|+||+++++++...  ..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG   82 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence            345 8899999999999988653      23378999886543 33456788999999999999999999988654  35


Q ss_pred             eEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccce
Q 014024          179 RLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMAR  258 (432)
Q Consensus       179 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  258 (432)
                      .+++|||+++++|.+++..    ..+++..++.++.|++.||.|||+.+   ++||||||+||++++++.++|+|||++.
T Consensus        83 ~~lv~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~  155 (283)
T cd05080          83 LQLIMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAK  155 (283)
T ss_pred             EEEEecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeeccccc
Confidence            7899999999999999843    24999999999999999999999998   9999999999999999999999999998


Q ss_pred             eccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccc
Q 014024          259 IVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNK  338 (432)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  338 (432)
                      ........   ........++..|+|||.+.+..++.++||||||+++|+|+||..|+......-...............
T Consensus       156 ~~~~~~~~---~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd05080         156 AVPEGHEY---YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVR  232 (283)
T ss_pred             ccCCcchh---hccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhh
Confidence            65221110   011122335567999999998899999999999999999999999975432211111111100011111


Q ss_pred             hhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014024          339 IIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEA  388 (432)
Q Consensus       339 ~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~  388 (432)
                      ..+.++.......+...+..+.+++..||+.+|++|||++++++.|+.+.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         233 LIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            22222222222233445678999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.6e-41  Score=321.20  Aligned_cols=264  Identities=20%  Similarity=0.267  Sum_probs=199.5

Q ss_pred             CCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCCC--hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEe
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKS--GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYE  184 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  184 (432)
                      ++|++.+.||+|+||.||++.+..+  .+|+|++....  ....+.+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            4799999999999999999998643  78999885432  3345678889999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCC
Q 014024          185 YMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGN  264 (432)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  264 (432)
                      |++++++..+..   ....+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  154 (287)
T cd07848          81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS  154 (287)
T ss_pred             cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence            999987765542   2234899999999999999999999998   9999999999999999999999999998642211


Q ss_pred             CccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccc-hhhhh--------HHhh-
Q 014024          265 DEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLN-LIGYA--------WDLW-  334 (432)
Q Consensus       265 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~-~~~~~--------~~~~-  334 (432)
                           ........|++.|+|||++.+..++.++|||||||++|||++|+.||......+.. .....        .... 
T Consensus       155 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (287)
T cd07848         155 -----NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFY  229 (287)
T ss_pred             -----cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhh
Confidence                 11223456899999999999888999999999999999999999998643221100 00000        0000 


Q ss_pred             hccchhhhhhhhh------hhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          335 ISNKIIDLIDSVL------EEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       335 ~~~~~~~~i~~~l------~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      ..........+..      ........+..+.+++.+||+.||++|||+++++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         230 SNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             ccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            0000000000000      000111234578999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=9.8e-42  Score=328.31  Aligned_cols=241  Identities=22%  Similarity=0.275  Sum_probs=194.5

Q ss_pred             ceeccCCcEEEEEEEECC--ceEEEEEEcCC---ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecCCCC
Q 014024          115 NKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK---SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNK  189 (432)
Q Consensus       115 ~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  189 (432)
                      +.||+|+||.||++.+..  ..+|+|++...   .......+.+|+.++++++||||+++++++.+.+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            469999999999998754  37999988643   2334456788999999999999999999999999999999999999


Q ss_pred             ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCcccc
Q 014024          190 SLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDEL  269 (432)
Q Consensus       190 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  269 (432)
                      +|.+++..   +..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.....      
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~------  148 (323)
T cd05571          81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD------  148 (323)
T ss_pred             cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC------
Confidence            99998843   345899999999999999999999999   999999999999999999999999998753111      


Q ss_pred             ccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhhhhh
Q 014024          270 QGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEE  349 (432)
Q Consensus       270 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  349 (432)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.||.......  ..    ......          ..
T Consensus       149 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~--~~----~~~~~~----------~~  212 (323)
T cd05571         149 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LF----ELILME----------EI  212 (323)
T ss_pred             CCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH--HH----HHHHcC----------CC
Confidence            112334679999999999999999999999999999999999999984322100  00    000000          01


Q ss_pred             cccHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 014024          350 ASFNESLSRYVHIALLCVQERAEDRP-----TMSDVVSM  383 (432)
Q Consensus       350 ~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~~  383 (432)
                      ..+.....++.+++..||+.||++||     ++.+++++
T Consensus       213 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         213 RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence            11223456788999999999999999     89999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2.6e-41  Score=315.21  Aligned_cols=254  Identities=29%  Similarity=0.465  Sum_probs=203.4

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECCc-eEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecC
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYM  186 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~~-~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  186 (432)
                      .++|++.++||+|++|.||+|...++ .+++|.+.... ...+.+.+|+.+++.++|+||+++++++.+.+..+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            46789999999999999999997655 78999875433 34578899999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCc
Q 014024          187 PNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDE  266 (432)
Q Consensus       187 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  266 (432)
                      ++++|.+++.... ...+++..++.++.|++.||+|||+.+   ++||||||+||++++++.++|+|||++.......  
T Consensus        84 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~--  157 (261)
T cd05072          84 AKGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNE--  157 (261)
T ss_pred             CCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCc--
Confidence            9999999986432 334889999999999999999999998   9999999999999999999999999998642211  


Q ss_pred             cccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchhhhhhh
Q 014024          267 DELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDS  345 (432)
Q Consensus       267 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  345 (432)
                         ........++..|+|||++..+.++.++|||||||++|+|+| |..||.......  ..             ..+..
T Consensus       158 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--~~-------------~~~~~  219 (261)
T cd05072         158 ---YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD--VM-------------SALQR  219 (261)
T ss_pred             ---eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH--HH-------------HHHHc
Confidence               111122345678999999998899999999999999999998 888875322110  00             00011


Q ss_pred             hhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014024          346 VLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN  386 (432)
Q Consensus       346 ~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~  386 (432)
                      ..........+.++.+++.+||+.+|++||+++++.+.|++
T Consensus       220 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         220 GYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            11111122345678899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-41  Score=333.04  Aligned_cols=242  Identities=25%  Similarity=0.360  Sum_probs=206.8

Q ss_pred             hhhhCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCCC---hHhHHHHHHHHHHHHhcC-CCceeeeEeEEEeCCe
Q 014024          105 SSATGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKS---GQEIKELKNEASVIAQVQ-HKNLVKLLGCCIEKDE  178 (432)
Q Consensus       105 ~~~~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~  178 (432)
                      ....++|.++++||+|.||+|+++...++  .+|||.+++..   ..+.+....|.+++.... ||.+++++.+|...++
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            44568999999999999999999998665  78999987653   456778888999998885 9999999999999999


Q ss_pred             eEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccce
Q 014024          179 RLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMAR  258 (432)
Q Consensus       179 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  258 (432)
                      +|.||||+.||++..+.    ..+.|++..+..++..++.||.|||+++   |||||||.+|||||.+|++||+|||+++
T Consensus       444 l~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcK  516 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCK  516 (694)
T ss_pred             EEEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccc
Confidence            99999999999965544    3345999999999999999999999999   9999999999999999999999999998


Q ss_pred             eccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccc
Q 014024          259 IVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNK  338 (432)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  338 (432)
                      .-.      .....++..+|||.|+|||++.+..|+.++|.|||||+||||+.|..||...                  +
T Consensus       517 e~m------~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gd------------------d  572 (694)
T KOG0694|consen  517 EGM------GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGD------------------D  572 (694)
T ss_pred             ccC------CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCC------------------C
Confidence            632      1234677899999999999999999999999999999999999999998532                  2


Q ss_pred             hhhhhhhhhhh--cccHHHHHHHHHHHHHhhccCCCCCCCH
Q 014024          339 IIDLIDSVLEE--ASFNESLSRYVHIALLCVQERAEDRPTM  377 (432)
Q Consensus       339 ~~~~i~~~l~~--~~~~~~~~~l~~l~~~cl~~dp~~RPt~  377 (432)
                      ..++.|.++..  .++.....+..+++.++|.++|++|.-+
T Consensus       573 Eee~FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  573 EEEVFDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             HHHHHHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence            23344444432  2455667888999999999999999876

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-41  Score=342.42  Aligned_cols=263  Identities=25%  Similarity=0.341  Sum_probs=212.0

Q ss_pred             hhhCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCCChHhHHHHHHHHHHHHhcC-CCceeeeEe-EEEeC-----
Q 014024          106 SATGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEIKELKNEASVIAQVQ-HKNLVKLLG-CCIEK-----  176 (432)
Q Consensus       106 ~~~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~-~~~~~-----  176 (432)
                      ....++++.+.|.+|||+.||+|.+.+.  ++|+|++...++...+.+.+|+++|++|+ |+|||.+++ .....     
T Consensus        34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~  113 (738)
T KOG1989|consen   34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG  113 (738)
T ss_pred             ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence            3456778899999999999999998554  89999998889999999999999999997 999999999 33211     


Q ss_pred             -CeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecc
Q 014024          177 -DERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFG  255 (432)
Q Consensus       177 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  255 (432)
                       -..+|.||||.||.|-|++......+ |++.++++|++|+++|+++||... ++|||||||-+||||..+|+.||||||
T Consensus       114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFG  191 (738)
T KOG1989|consen  114 VWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFG  191 (738)
T ss_pred             eeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccc
Confidence             24578899999999999996554444 999999999999999999999985 679999999999999999999999999


Q ss_pred             cceeccCCCCc-cccc--cccccccccCCccChhhhc---cCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhh
Q 014024          256 MARIVFGGNDE-DELQ--GNTSRISGTYGYMSPEYAL---EGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGY  329 (432)
Q Consensus       256 ~a~~~~~~~~~-~~~~--~~~~~~~gt~~y~aPE~~~---~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~  329 (432)
                      .+......... ....  ...-....|+.|+|||++.   +..+++|+|||+|||+||-|+....||+....        
T Consensus       192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~--------  263 (738)
T KOG1989|consen  192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK--------  263 (738)
T ss_pred             ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc--------
Confidence            99764322211 0000  0111234689999999875   67799999999999999999999999964322        


Q ss_pred             hHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014024          330 AWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEA  388 (432)
Q Consensus       330 ~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~  388 (432)
                                ..++......+..+.....+..||..||+.||++||++-+|+..+-.+.
T Consensus       264 ----------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~  312 (738)
T KOG1989|consen  264 ----------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELA  312 (738)
T ss_pred             ----------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHh
Confidence                      1223333333344567788999999999999999999999999886654

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.3e-42  Score=329.51  Aligned_cols=248  Identities=22%  Similarity=0.329  Sum_probs=211.4

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCe-eEEE
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDE-RLLI  182 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~lv  182 (432)
                      .++|..++++|+|+||.+++.+.+.  ..+++|++...  .....+...+|+.++++++|||||.+.+.|.+++. .+||
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            4689999999999999999887654  47999988544  33344567899999999999999999999999888 8999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccC
Q 014024          183 YEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFG  262 (432)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  262 (432)
                      |+||+||++.+.+.... ...+++..++.|+.|++.|+.|||++.   |+|||||+.||+++.++.+||+|||+|+.+..
T Consensus        83 m~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~  158 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNP  158 (426)
T ss_pred             EeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCC
Confidence            99999999999997644 355999999999999999999999888   99999999999999999999999999998632


Q ss_pred             CCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhh
Q 014024          263 GNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDL  342 (432)
Q Consensus       263 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                      .      ........||+.|+.||.+.+.+|+.|+|||||||++|||++-+++|..                  .+...+
T Consensus       159 ~------~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a------------------~~m~~L  214 (426)
T KOG0589|consen  159 E------DSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKA------------------SNMSEL  214 (426)
T ss_pred             c------hhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCc------------------cchHHH
Confidence            1      2245668999999999999999999999999999999999999998742                  223333


Q ss_pred             hhhhh---hhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          343 IDSVL---EEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       343 i~~~l---~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      +.+..   ..+.+.....++..++..||+.+|+.||++.+++.+
T Consensus       215 i~ki~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  215 ILKINRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             HHHHhhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            33333   233456677899999999999999999999999975

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=6.4e-41  Score=323.94  Aligned_cols=262  Identities=24%  Similarity=0.349  Sum_probs=201.4

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEe
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYE  184 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  184 (432)
                      .++|++.+.||+|+||.||++.+...  .+++|.+... .......+.+|+++++.++|+||++++++|.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            47899999999999999999998643  6788877544 33455678999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCC
Q 014024          185 YMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQY-SRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGG  263 (432)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  263 (432)
                      |+++++|.+++..   .+.+++..+..++.|++.||.|||+. +   ++|+||||+|||+++++.+||+|||++..... 
T Consensus        84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~-  156 (333)
T cd06650          84 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-  156 (333)
T ss_pred             cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhh-
Confidence            9999999999853   34588999999999999999999975 5   99999999999999999999999999875421 


Q ss_pred             CCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchh-------h--------
Q 014024          264 NDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLI-------G--------  328 (432)
Q Consensus       264 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~-------~--------  328 (432)
                             .......|+..|+|||++.+..++.++|+|||||++|+|++|+.||...........       .        
T Consensus       157 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (333)
T cd06650         157 -------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSP  229 (333)
T ss_pred             -------hccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCc
Confidence                   112334688999999999988899999999999999999999999864322110000       0        


Q ss_pred             -----------hhHHhhhccchhhhhhhhhhhccc----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          329 -----------YAWDLWISNKIIDLIDSVLEEASF----NESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       329 -----------~~~~~~~~~~~~~~i~~~l~~~~~----~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                                 +............+.+.......+    .....++.+++.+||+.||++|||+.|++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h  299 (333)
T cd06650         230 RPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH  299 (333)
T ss_pred             ccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence                       000000000011111111111110    0123568899999999999999999999874

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.7e-41  Score=320.01  Aligned_cols=264  Identities=21%  Similarity=0.282  Sum_probs=196.8

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCC-hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEe
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS-GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYE  184 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  184 (432)
                      .++|++.+.||.|+||.||+|.+..  ..||+|.+.... ......+.+|++++++++|+||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE   83 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence            4679999999999999999998754  389999885432 2234567789999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCC
Q 014024          185 YMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGN  264 (432)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  264 (432)
                      |+++ +|.+++...  ...+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++...... 
T Consensus        84 ~~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~-  156 (288)
T cd07871          84 YLDS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVP-  156 (288)
T ss_pred             CCCc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCC-
Confidence            9975 888887532  234789999999999999999999998   999999999999999999999999999763211 


Q ss_pred             CccccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCcccccc-chhh--------hhHHhh
Q 014024          265 DEDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSL-NLIG--------YAWDLW  334 (432)
Q Consensus       265 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~-~~~~--------~~~~~~  334 (432)
                           ........+++.|+|||++.+ ..++.++||||+||++|+|+||+.||......+. ....        ..+...
T Consensus       157 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (288)
T cd07871         157 -----TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGI  231 (288)
T ss_pred             -----CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhcc
Confidence                 112234567899999998875 5689999999999999999999999854332110 0000        000000


Q ss_pred             h-ccchhhhhhhhhhh----cccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          335 I-SNKIIDLIDSVLEE----ASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       335 ~-~~~~~~~i~~~l~~----~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      . .........+....    ........+..+++.+||+.||.+|||+.|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         232 TSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             ccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            0 00000000000000    0011223567899999999999999999999865

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=3.8e-41  Score=313.28  Aligned_cols=251  Identities=27%  Similarity=0.406  Sum_probs=199.0

Q ss_pred             CCCCcCceeccCCcEEEEEEEECCc-eEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecCC
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMP  187 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~~-~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  187 (432)
                      ++|++.+.||+|+||.||++...++ .+++|.+.... ...+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            4688889999999999999998765 78999875432 334678899999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCcc
Q 014024          188 NKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDED  267 (432)
Q Consensus       188 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  267 (432)
                      +|+|.+++....  ..+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||.+.......   
T Consensus        83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~---  154 (256)
T cd05114          83 NGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE---  154 (256)
T ss_pred             CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCc---
Confidence            999999986432  34899999999999999999999998   9999999999999999999999999987642111   


Q ss_pred             ccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchhhhhhhh
Q 014024          268 ELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSV  346 (432)
Q Consensus       268 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  346 (432)
                        ........++..|+|||.+.+..++.++|+||||+++|+|++ |+.||......  ......             ...
T Consensus       155 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~--~~~~~i-------------~~~  217 (256)
T cd05114         155 --YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY--EVVEMI-------------SRG  217 (256)
T ss_pred             --eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHH-------------HCC
Confidence              011122335568999999998889999999999999999999 88887432210  011000             000


Q ss_pred             hhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014024          347 LEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLT  385 (432)
Q Consensus       347 l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~  385 (432)
                      .....+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus       218 ~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         218 FRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            001111223457899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=4.8e-41  Score=339.65  Aligned_cols=249  Identities=20%  Similarity=0.224  Sum_probs=202.7

Q ss_pred             CCCCcCceeccCCcEEEEEEEECC---ceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEec
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQ---GEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEY  185 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~---~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  185 (432)
                      ..|.+.+.||+|++|.||+|....   ..+++|............+.+|+.+++.++||||+++++++..++..++||||
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~  146 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY  146 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence            348999999999999999998643   36888877666666666788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCC
Q 014024          186 MPNKSLDCFLFDP-TKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGN  264 (432)
Q Consensus       186 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  264 (432)
                      +++|+|.+++... ..+.++++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++..+....
T Consensus       147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~  223 (478)
T PTZ00267        147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV  223 (478)
T ss_pred             CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence            9999999888542 23446899999999999999999999998   9999999999999999999999999998753211


Q ss_pred             CccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhh
Q 014024          265 DEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLID  344 (432)
Q Consensus       265 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  344 (432)
                      .    ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.....                  .+++.
T Consensus       224 ~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~------------------~~~~~  281 (478)
T PTZ00267        224 S----LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ------------------REIMQ  281 (478)
T ss_pred             c----cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------------------HHHHH
Confidence            1    1123345799999999999999999999999999999999999999743211                  11111


Q ss_pred             hhhhh---cccHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014024          345 SVLEE---ASFNESLSRYVHIALLCVQERAEDRPTMSDVVS  382 (432)
Q Consensus       345 ~~l~~---~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~  382 (432)
                      ..+..   ..+......+.+++..||+.||++||++.+++.
T Consensus       282 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        282 QVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             HHHhCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            11111   112234467899999999999999999999875

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=3.8e-41  Score=332.01  Aligned_cols=263  Identities=27%  Similarity=0.381  Sum_probs=206.5

Q ss_pred             hhhCCCCcCceeccCCcEEEEEEEECC-------ceEEEEEEcCCC-hHhHHHHHHHHHHHHhcC-CCceeeeEeEEEeC
Q 014024          106 SATGNFSAANKLGEGGFGTVYKGVIGQ-------GEIAVKRLLGKS-GQEIKELKNEASVIAQVQ-HKNLVKLLGCCIEK  176 (432)
Q Consensus       106 ~~~~~y~~~~~ig~G~~g~Vy~~~~~~-------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~  176 (432)
                      ...++|.+.++||+|+||.||+|.+..       ..||+|++.... ....+.+.+|+++++++. ||||+++++++.+.
T Consensus        34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~  113 (400)
T cd05105          34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS  113 (400)
T ss_pred             ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence            346789999999999999999998632       259999986443 344567899999999996 99999999999999


Q ss_pred             CeeEEEEecCCCCChhhhhcCCC---------------------------------------------------------
Q 014024          177 DERLLIYEYMPNKSLDCFLFDPT---------------------------------------------------------  199 (432)
Q Consensus       177 ~~~~lv~e~~~~gsL~~~l~~~~---------------------------------------------------------  199 (432)
                      +..++||||+++|+|.+++....                                                         
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (400)
T cd05105         114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE  193 (400)
T ss_pred             CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence            99999999999999998875321                                                         


Q ss_pred             ------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEE
Q 014024          200 ------------------------------------KREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILL  243 (432)
Q Consensus       200 ------------------------------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll  243 (432)
                                                          ....+++..+..++.|++.||+|||+.+   ++||||||+||++
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill  270 (400)
T cd05105         194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLL  270 (400)
T ss_pred             hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEE
Confidence                                                0124788889999999999999999998   9999999999999


Q ss_pred             cCCCCEEEeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCcccc
Q 014024          244 DKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTK  322 (432)
Q Consensus       244 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~  322 (432)
                      ++++.+||+|||++........    ........++..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus       271 ~~~~~~kL~DfGla~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~  346 (400)
T cd05105         271 AQGKIVKICDFGLARDIMHDSN----YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD  346 (400)
T ss_pred             eCCCEEEEEeCCcceecccccc----ccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence            9999999999999986422111    111223456788999999998899999999999999999997 88887532111


Q ss_pred             ccchhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccc
Q 014024          323 SLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS  389 (432)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~  389 (432)
                      .              .....+........+...+..+.+++.+||+.||++||++.+|.+.|+...+
T Consensus       347 ~--------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         347 S--------------TFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             H--------------HHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence            0              0001111111111223456778999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=6e-41  Score=319.96  Aligned_cols=264  Identities=23%  Similarity=0.255  Sum_probs=195.3

Q ss_pred             hCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCCCh-HhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEe
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGKSG-QEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYE  184 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  184 (432)
                      .++|++.+.||+|+||.||+|.+.  +..+|+|++..... .....+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            578999999999999999999985  34899998854432 223456789999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCC
Q 014024          185 YMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGN  264 (432)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  264 (432)
                      |++ ++|.+++...  ...+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++...... 
T Consensus        84 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-  156 (303)
T cd07869          84 YVH-TDLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVP-  156 (303)
T ss_pred             CCC-cCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCC-
Confidence            996 5677666432  234889999999999999999999999   999999999999999999999999998753111 


Q ss_pred             CccccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHH--hhhccch--
Q 014024          265 DEDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWD--LWISNKI--  339 (432)
Q Consensus       265 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~--~~~~~~~--  339 (432)
                           ........+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.........+......  .......  
T Consensus       157 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (303)
T cd07869         157 -----SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPG  231 (303)
T ss_pred             -----CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccc
Confidence                 112234567899999998875 458999999999999999999999986432211111000000  0000000  


Q ss_pred             ----hhhhhhh--------hhhc-ccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          340 ----IDLIDSV--------LEEA-SFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       340 ----~~~i~~~--------l~~~-~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                          .......        +... ........+.+++..||+.||++|||+.|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h  288 (303)
T cd07869         232 VHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH  288 (303)
T ss_pred             hhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence                0000000        0000 000112457789999999999999999999974

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=6.4e-41  Score=313.53  Aligned_cols=256  Identities=29%  Similarity=0.455  Sum_probs=204.7

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC-----ceEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEE
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ-----GEIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLL  181 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  181 (432)
                      .++|++.+.||+|+||.||+|.+..     ..+++|.+... .......+.+|+.++++++|+||+++++++.+.+..++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            3678999999999999999998742     26899987544 34455678899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceecc
Q 014024          182 IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVF  261 (432)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  261 (432)
                      +|||+++++|.+++....  ..+++..++.++.|++.|++|||+.+   |+|+||||+||++++++.++|+|||++....
T Consensus        83 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~  157 (266)
T cd05033          83 ITEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE  157 (266)
T ss_pred             EEEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence            999999999999986533  35899999999999999999999998   9999999999999999999999999998753


Q ss_pred             CCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchh
Q 014024          262 GGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKII  340 (432)
Q Consensus       262 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                      ....    ........++..|+|||.+.+..++.++||||||+++|+|++ |..||.......               ..
T Consensus       158 ~~~~----~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~---------------~~  218 (266)
T cd05033         158 DSEA----TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD---------------VI  218 (266)
T ss_pred             cccc----ceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH---------------HH
Confidence            1111    111122345678999999998999999999999999999998 988874322110               01


Q ss_pred             hhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014024          341 DLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNE  387 (432)
Q Consensus       341 ~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~  387 (432)
                      +.+........+...+..+.+++.+||+.+|++||++.+|+++|+.+
T Consensus       219 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         219 KAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             HHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            11111111112234456789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=4.3e-41  Score=316.93  Aligned_cols=257  Identities=30%  Similarity=0.444  Sum_probs=205.0

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC-------ceEEEEEEcCCChH-hHHHHHHHHHHHHhcCCCceeeeEeEEEeCCee
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ-------GEIAVKRLLGKSGQ-EIKELKNEASVIAQVQHKNLVKLLGCCIEKDER  179 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  179 (432)
                      .++|.+.+.||+|+||.||+|...+       ..+++|.+...... ..+.+.+|+++++.++|+|++++++++......
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            4578889999999999999998632       36899988655433 567899999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCC
Q 014024          180 LLIYEYMPNKSLDCFLFDPT-----------KREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN  248 (432)
Q Consensus       180 ~lv~e~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~  248 (432)
                      ++||||+++++|.+++....           ....+++..+..++.|++.|+.|||+.+   ++||||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence            99999999999999986432           2345889999999999999999999998   999999999999999999


Q ss_pred             EEEeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchh
Q 014024          249 SKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLI  327 (432)
Q Consensus       249 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~  327 (432)
                      +||+|||++........    ........+++.|+|||++.+..++.++||||||+++|||++ |..||.......  . 
T Consensus       161 ~kl~d~g~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~--~-  233 (280)
T cd05049         161 VKIGDFGMSRDVYTTDY----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE--V-  233 (280)
T ss_pred             EEECCcccceecccCcc----eecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--H-
Confidence            99999999976422111    111223345778999999999999999999999999999998 999874322211  0 


Q ss_pred             hhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014024          328 GYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN  386 (432)
Q Consensus       328 ~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~  386 (432)
                                  .+.+........+...+..+.+++.+||+.||++||++.||++.|++
T Consensus       234 ------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         234 ------------IECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             ------------HHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence                        11111111111122345778999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-42  Score=353.21  Aligned_cols=261  Identities=31%  Similarity=0.477  Sum_probs=213.0

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECCc-------eEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCee
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQG-------EIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDER  179 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~~-------~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  179 (432)
                      ..+.+..+.||+|.||.||.|...+.       .||+|.+... +.+...+|.+|+.+|+.++|||||+++|+|.+....
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            34556778999999999999986432       4899988554 567788999999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhhhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecc
Q 014024          180 LLIYEYMPNKSLDCFLFDPT----KREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFG  255 (432)
Q Consensus       180 ~lv~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  255 (432)
                      +|++|||++|+|..||++..    ....++..+.+.++.|||+|+.||++++   +|||||..+|+||+....+||+|||
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence            99999999999999997641    1345899999999999999999999999   9999999999999999999999999


Q ss_pred             cceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhh
Q 014024          256 MARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLW  334 (432)
Q Consensus       256 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~  334 (432)
                      +|+.+...+.   .. ......-...|||||.+..+.+|.|+|||||||+|||++| |..|++....             
T Consensus       848 lArDiy~~~y---yr-~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n-------------  910 (1025)
T KOG1095|consen  848 LARDIYDKDY---YR-KHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN-------------  910 (1025)
T ss_pred             hhHhhhhchh---ee-ccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch-------------
Confidence            9995432211   11 1111233457999999999999999999999999999999 7778643221             


Q ss_pred             hccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccccC
Q 014024          335 ISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASS  390 (432)
Q Consensus       335 ~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~  390 (432)
                        .++...+...-+-..+..|+..+.++|..||+.+|++||++..+++.+..+...
T Consensus       911 --~~v~~~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~  964 (1025)
T KOG1095|consen  911 --FEVLLDVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA  964 (1025)
T ss_pred             --HHHHHHHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence              222222222225566778999999999999999999999999999988776543

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=5.4e-41  Score=313.58  Aligned_cols=254  Identities=28%  Similarity=0.446  Sum_probs=203.4

Q ss_pred             CCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecC
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYM  186 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  186 (432)
                      .+|.+.+.||+|++|.||+|.+.+  ..+++|.+... ......+.+|+++++.++|+|++++++++...+..+++|||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            457888999999999999999754  47899987644 334567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCc
Q 014024          187 PNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDE  266 (432)
Q Consensus       187 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  266 (432)
                      ++++|.+++.... ...+++..++.++.|++.||+|||+.+   ++||||||+||++++++.+||+|||++.......  
T Consensus        85 ~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~--  158 (263)
T cd05052          85 TYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--  158 (263)
T ss_pred             CCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccce--
Confidence            9999999985432 334899999999999999999999998   9999999999999999999999999997642211  


Q ss_pred             cccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchhhhhhh
Q 014024          267 DELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDS  345 (432)
Q Consensus       267 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  345 (432)
                         ........++..|+|||.+.+..++.++|||||||++|||++ |..|+......+               ....+..
T Consensus       159 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---------------~~~~~~~  220 (263)
T cd05052         159 ---YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---------------VYELLEK  220 (263)
T ss_pred             ---eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---------------HHHHHHC
Confidence               111112334567999999999999999999999999999998 888875322110               0111111


Q ss_pred             hhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014024          346 VLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNE  387 (432)
Q Consensus       346 ~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~  387 (432)
                      ......+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus       221 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         221 GYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            111222334457789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=5.1e-41  Score=316.16  Aligned_cols=258  Identities=27%  Similarity=0.445  Sum_probs=201.7

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECC-------ceEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCe
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQ-------GEIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDE  178 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~-------~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  178 (432)
                      ..++|++.+.||+|+||.||+|.+.+       ..+|+|.+... .......+.+|+.+++.++|+||+++++++.+...
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            46789999999999999999998642       36899987543 23445678899999999999999999999999999


Q ss_pred             eEEEEecCCCCChhhhhcCCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEE
Q 014024          179 RLLIYEYMPNKSLDCFLFDPTK-------REILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKI  251 (432)
Q Consensus       179 ~~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  251 (432)
                      .++||||+++++|.+++.....       ...+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.++|
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence            9999999999999999854221       234678899999999999999999998   999999999999999999999


Q ss_pred             eecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhh
Q 014024          252 SDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYA  330 (432)
Q Consensus       252 ~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~  330 (432)
                      +|||++........    ........+++.|+|||++.++.++.++|||||||++|||++ |..||......  ..... 
T Consensus       161 ~dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~--~~~~~-  233 (277)
T cd05062         161 GDFGMTRDIYETDY----YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE--QVLRF-  233 (277)
T ss_pred             CCCCCccccCCcce----eecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHH-
Confidence            99999875422111    111122345678999999998899999999999999999999 67787432211  00000 


Q ss_pred             HHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014024          331 WDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN  386 (432)
Q Consensus       331 ~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~  386 (432)
                         .....         ....+...+..+.+++.+||+.+|++|||+.|+++.|++
T Consensus       234 ---~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         234 ---VMEGG---------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             ---HHcCC---------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence               00000         011122345678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.3e-41  Score=311.86  Aligned_cols=254  Identities=29%  Similarity=0.443  Sum_probs=203.6

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECCc-eEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecC
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYM  186 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~~-~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  186 (432)
                      .++|++.+.||+|++|.||+|.+.++ .+++|.+.... ...+.+.+|++++++++|+|++++++++...+..+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            46789999999999999999997555 78999886543 33567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCc
Q 014024          187 PNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDE  266 (432)
Q Consensus       187 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  266 (432)
                      ++++|.+++.... ...+++..+..++.|++.|+.+||+.+   ++||||||+||++++++.++|+|||++.......  
T Consensus        84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--  157 (261)
T cd05068          84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDI--  157 (261)
T ss_pred             cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCc--
Confidence            9999999986533 235899999999999999999999998   9999999999999999999999999998753111  


Q ss_pred             cccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchhhhhhh
Q 014024          267 DELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDS  345 (432)
Q Consensus       267 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  345 (432)
                         .........+..|+|||+..+..++.++|+||||+++|+|++ |+.||......               .....++.
T Consensus       158 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---------------~~~~~~~~  219 (261)
T cd05068         158 ---YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA---------------EVLQQVDQ  219 (261)
T ss_pred             ---ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH---------------HHHHHHHc
Confidence               111111223457999999998899999999999999999999 88887432110               00111111


Q ss_pred             hhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014024          346 VLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN  386 (432)
Q Consensus       346 ~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~  386 (432)
                      ......+...+..+.+++.+|++.+|++||++.++.+.|++
T Consensus       220 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         220 GYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             CCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            11111223445778999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=5.6e-41  Score=323.01  Aligned_cols=241  Identities=21%  Similarity=0.268  Sum_probs=193.5

Q ss_pred             ceeccCCcEEEEEEEECC--ceEEEEEEcCC---ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecCCCC
Q 014024          115 NKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK---SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNK  189 (432)
Q Consensus       115 ~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  189 (432)
                      +.||+|+||.||++.+..  ..+|+|.+...   .......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            469999999999999754  48999988543   2334556778999999999999999999999999999999999999


Q ss_pred             ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCcccc
Q 014024          190 SLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDEL  269 (432)
Q Consensus       190 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  269 (432)
                      +|..++..   ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++......      
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~------  148 (323)
T cd05595          81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD------  148 (323)
T ss_pred             cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCC------
Confidence            99988843   345899999999999999999999998   999999999999999999999999998753111      


Q ss_pred             ccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhhhhh
Q 014024          270 QGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEE  349 (432)
Q Consensus       270 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  349 (432)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.||.......      .........          .
T Consensus       149 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~------~~~~~~~~~----------~  212 (323)
T cd05595         149 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER------LFELILMEE----------I  212 (323)
T ss_pred             CCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH------HHHHHhcCC----------C
Confidence            112234578999999999999999999999999999999999999985322110      000000000          0


Q ss_pred             cccHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 014024          350 ASFNESLSRYVHIALLCVQERAEDRP-----TMSDVVSM  383 (432)
Q Consensus       350 ~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~~  383 (432)
                      ..+......+.+++..||+.||++||     ++.+++++
T Consensus       213 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         213 RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence            11223456788999999999999998     89998875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=5.4e-41  Score=318.36  Aligned_cols=260  Identities=27%  Similarity=0.413  Sum_probs=207.8

Q ss_pred             CCCCcCceeccCCcEEEEEEEECC-------ceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEE
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQ-------GEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLL  181 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  181 (432)
                      ++|.+.+.||+|+||.||+|...+       ..+++|.+........+.+.+|++.+++++|+||+++++++.+.+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            468888999999999999998532       2588888877666666789999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCC
Q 014024          182 IYEYMPNKSLDCFLFDPT-------------KREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN  248 (432)
Q Consensus       182 v~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~  248 (432)
                      ||||+++++|.+++....             ....+++..++.++.|++.|++|||+++   ++||||||+||++++++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence            999999999999986432             1234899999999999999999999999   999999999999999999


Q ss_pred             EEEeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchh
Q 014024          249 SKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLI  327 (432)
Q Consensus       249 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~  327 (432)
                      ++|+|||++........    ........++..|+|||.+.+..++.++||||||+++|||+| |+.||.......    
T Consensus       162 ~~l~dfg~a~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~----  233 (291)
T cd05094         162 VKIGDFGMSRDVYSTDY----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE----  233 (291)
T ss_pred             EEECCCCcccccCCCce----eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH----
Confidence            99999999976422111    111233456788999999999999999999999999999999 998874322210    


Q ss_pred             hhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccccC
Q 014024          328 GYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASS  390 (432)
Q Consensus       328 ~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~  390 (432)
                        .........         ........+..+.+++.+||+.+|++|||+.+|++.|+++...
T Consensus       234 --~~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         234 --VIECITQGR---------VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             --HHHHHhCCC---------CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence              001011110         0111223456788999999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=6.6e-41  Score=317.29  Aligned_cols=261  Identities=28%  Similarity=0.436  Sum_probs=207.0

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC-------ceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeE
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ-------GEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERL  180 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  180 (432)
                      ..+|.+.+.||+|+||.||++....       ..+++|.+........+.+.+|++++++++|+|++++++++...+..+
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            3578899999999999999998521       258889887766667778999999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhcCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEE
Q 014024          181 LIYEYMPNKSLDCFLFDPT----------KREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSK  250 (432)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  250 (432)
                      +||||+++++|.+++....          ....+++..++.++.|++.||+|||+.+   ++||||||+||++++++.+|
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence            9999999999999985432          1234899999999999999999999998   99999999999999999999


Q ss_pred             EeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhh
Q 014024          251 ISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGY  329 (432)
Q Consensus       251 l~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~  329 (432)
                      |+|||++........    ........++..|+|||.+.+..++.++|+|||||++|+|++ |..||.......      
T Consensus       161 l~dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~------  230 (288)
T cd05093         161 IGDFGMSRDVYSTDY----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE------  230 (288)
T ss_pred             eccCCccccccCCce----eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH------
Confidence            999999976422110    111223345778999999998999999999999999999999 888874322110      


Q ss_pred             hHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccccC
Q 014024          330 AWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASS  390 (432)
Q Consensus       330 ~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~  390 (432)
                      ..........         ...+...+.++.+++.+||+.||.+|||+.++++.|+++...
T Consensus       231 ~~~~i~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         231 VIECITQGRV---------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             HHHHHHcCCc---------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence            0000000000         011122346789999999999999999999999999887643

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=5.8e-41  Score=312.19  Aligned_cols=251  Identities=29%  Similarity=0.453  Sum_probs=200.5

Q ss_pred             CCCCcCceeccCCcEEEEEEEECCc-eEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecCC
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMP  187 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~~-~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  187 (432)
                      ++|.+.+.||+|+||.||+|...++ .+|+|.+.... ...+.+.+|+.++++++||||+++++++.+.+..+++|||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            4688899999999999999987665 69999876443 234678999999999999999999999999889999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCcc
Q 014024          188 NKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDED  267 (432)
Q Consensus       188 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  267 (432)
                      +++|.+++....  ..+++..++.++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||.+........  
T Consensus        83 ~~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~--  155 (256)
T cd05113          83 NGCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY--  155 (256)
T ss_pred             CCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCce--
Confidence            999999986432  24899999999999999999999998   99999999999999999999999999876422111  


Q ss_pred             ccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchhhhhhhh
Q 014024          268 ELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSV  346 (432)
Q Consensus       268 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  346 (432)
                         .......++..|+|||...+..++.++||||||+++|+|++ |..||.......               ..+.+...
T Consensus       156 ---~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---------------~~~~~~~~  217 (256)
T cd05113         156 ---TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE---------------TVEKVSQG  217 (256)
T ss_pred             ---eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---------------HHHHHhcC
Confidence               11122345678999999998889999999999999999999 888875322110               00001111


Q ss_pred             hhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014024          347 LEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLT  385 (432)
Q Consensus       347 l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~  385 (432)
                      .....+......+.+++.+||+.+|.+||++.++++.|+
T Consensus       218 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         218 LRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            111111223567899999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=6.9e-41  Score=324.33  Aligned_cols=264  Identities=20%  Similarity=0.314  Sum_probs=194.9

Q ss_pred             CCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeC-----CeeE
Q 014024          110 NFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEK-----DERL  180 (432)
Q Consensus       110 ~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~  180 (432)
                      +|++.+.||+|+||.||+|.+..  ..||+|++...  .......+.+|+++++.++||||+++++++...     ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            58889999999999999999754  48999988532  223445688999999999999999999988643     2479


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceec
Q 014024          181 LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIV  260 (432)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  260 (432)
                      +||||+. ++|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus        81 lv~e~~~-~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~  153 (338)
T cd07859          81 VVFELME-SDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA  153 (338)
T ss_pred             EEEecCC-CCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence            9999995 688888743   345899999999999999999999999   999999999999999999999999999764


Q ss_pred             cCCCCccccccccccccccCCccChhhhcc--CCCCchhhhHHHHHHHHHHHhCCCCCCCcccccc-chhhh--------
Q 014024          261 FGGNDEDELQGNTSRISGTYGYMSPEYALE--GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSL-NLIGY--------  329 (432)
Q Consensus       261 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~-~~~~~--------  329 (432)
                      ......   ........||+.|+|||++.+  ..++.++|||||||++|||++|+.||........ .....        
T Consensus       154 ~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  230 (338)
T cd07859         154 FNDTPT---AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPE  230 (338)
T ss_pred             ccccCc---cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            221111   112234578999999999876  6789999999999999999999999854322100 00000        


Q ss_pred             hHHhhhccchhhhhhhhhhhcc------cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          330 AWDLWISNKIIDLIDSVLEEAS------FNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       330 ~~~~~~~~~~~~~i~~~l~~~~------~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      .............+........      .......+.+++..||+.||++|||+.|++++
T Consensus       231 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         231 TISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             HHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            0000001111111111110000      01123567899999999999999999999975

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-40  Score=309.70  Aligned_cols=251  Identities=28%  Similarity=0.427  Sum_probs=206.0

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECCceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecCC
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMP  187 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  187 (432)
                      .++|++.+.||.|++|.||+|...++.+++|.+..... ..+.+.+|+.+++.++|+|++++++++.+.+..++||||++
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   83 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA   83 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence            46789999999999999999999988999999976654 56788999999999999999999999999899999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCcc
Q 014024          188 NKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDED  267 (432)
Q Consensus       188 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  267 (432)
                      +++|.+++..... ..+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||.++.....    
T Consensus        84 ~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~----  155 (256)
T cd05039          84 KGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG----  155 (256)
T ss_pred             CCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccc----
Confidence            9999999864332 35899999999999999999999999   999999999999999999999999999864111    


Q ss_pred             ccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchhhhhhhh
Q 014024          268 ELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSV  346 (432)
Q Consensus       268 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  346 (432)
                           ......+..|+|||++.++.++.++|+||||+++|+|++ |..||.......               ..+.+...
T Consensus       156 -----~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---------------~~~~~~~~  215 (256)
T cd05039         156 -----QDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---------------VVPHVEKG  215 (256)
T ss_pred             -----cccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH---------------HHHHHhcC
Confidence                 112234567999999998899999999999999999997 888874322110               00111111


Q ss_pred             hhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014024          347 LEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNE  387 (432)
Q Consensus       347 l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~  387 (432)
                      .....+...+..+.+++.+||..+|++||++.++++.|+.+
T Consensus       216 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         216 YRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             CCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence            11111223457788999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=7.5e-41  Score=321.20  Aligned_cols=257  Identities=26%  Similarity=0.406  Sum_probs=202.3

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC--c----eEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeE
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ--G----EIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERL  180 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~--~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  180 (432)
                      ..+|++.+.||+|+||.||+|.+..  .    .+|+|.+... .....+.+.+|+.+++.++|+||++++++|... ..+
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~   84 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ   84 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence            3579999999999999999998632  2    3899988644 345567789999999999999999999999764 567


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceec
Q 014024          181 LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIV  260 (432)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  260 (432)
                      +++||+++|+|.+++....  ..+++..++.++.|++.||+|||+.+   ++||||||+||++++++.+||+|||++..+
T Consensus        85 ~v~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~  159 (316)
T cd05108          85 LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (316)
T ss_pred             eeeecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccc
Confidence            9999999999999986432  34889999999999999999999998   999999999999999999999999999875


Q ss_pred             cCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccch
Q 014024          261 FGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKI  339 (432)
Q Consensus       261 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  339 (432)
                      .....    ........++..|+|||++.+..++.++||||||+++|||++ |..|+.......               .
T Consensus       160 ~~~~~----~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~---------------~  220 (316)
T cd05108         160 GADEK----EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---------------I  220 (316)
T ss_pred             cCCCc----ceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---------------H
Confidence            32211    111122334678999999999999999999999999999998 999875322110               0


Q ss_pred             hhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccc
Q 014024          340 IDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS  389 (432)
Q Consensus       340 ~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~  389 (432)
                      ...+........+..+..++.+++..||+.+|++||++.+++..|.....
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~  270 (316)
T cd05108         221 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  270 (316)
T ss_pred             HHHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence            11111111111222345678899999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-41  Score=321.96  Aligned_cols=239  Identities=21%  Similarity=0.266  Sum_probs=191.5

Q ss_pred             eccCCcEEEEEEEECCc--eEEEEEEcCC---ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecCCCCCh
Q 014024          117 LGEGGFGTVYKGVIGQG--EIAVKRLLGK---SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSL  191 (432)
Q Consensus       117 ig~G~~g~Vy~~~~~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  191 (432)
                      ||+|+||.||++.+...  .+|+|++...   .......+..|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            79999999999998643  7999988542   234456778899999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCcccccc
Q 014024          192 DCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQG  271 (432)
Q Consensus       192 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  271 (432)
                      .+++..   +..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++......      ..
T Consensus        81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~------~~  148 (312)
T cd05585          81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKD------DD  148 (312)
T ss_pred             HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccC------CC
Confidence            999853   345899999999999999999999999   999999999999999999999999998753211      11


Q ss_pred             ccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhhhhhcc
Q 014024          272 NTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEAS  351 (432)
Q Consensus       272 ~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~  351 (432)
                      ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......     ... .        .+...  ....
T Consensus       149 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~-----~~~-~--------~~~~~--~~~~  212 (312)
T cd05585         149 KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN-----EMY-R--------KILQE--PLRF  212 (312)
T ss_pred             ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH-----HHH-H--------HHHcC--CCCC
Confidence            233457899999999999999999999999999999999999998532210     000 0        00000  0011


Q ss_pred             cHHHHHHHHHHHHHhhccCCCCCCC---HHHHHHH
Q 014024          352 FNESLSRYVHIALLCVQERAEDRPT---MSDVVSM  383 (432)
Q Consensus       352 ~~~~~~~l~~l~~~cl~~dp~~RPt---~~evl~~  383 (432)
                      +......+.+++..||+.||.+||+   +.+++.+
T Consensus       213 ~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h  247 (312)
T cd05585         213 PDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH  247 (312)
T ss_pred             CCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence            2234567889999999999999985   5666654

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.4e-40  Score=320.35  Aligned_cols=245  Identities=26%  Similarity=0.368  Sum_probs=193.2

Q ss_pred             CCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCC---hHhHHHHHHHHHHH---HhcCCCceeeeEeEEEeCCeeEEE
Q 014024          111 FSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS---GQEIKELKNEASVI---AQVQHKNLVKLLGCCIEKDERLLI  182 (432)
Q Consensus       111 y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~~~~~~~~~~~~~lv  182 (432)
                      |++.+.||+|+||.||+|.+..  ..+|+|.+....   ....+.+..|++++   +.++||||+++++++.+.+..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            6778999999999999999754  489999986432   23345666776665   456799999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccC
Q 014024          183 YEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFG  262 (432)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  262 (432)
                      |||+++++|..++..    ..+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||++.....
T Consensus        81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05589          81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG  153 (324)
T ss_pred             EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence            999999999888742    35999999999999999999999998   99999999999999999999999999864311


Q ss_pred             CCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhh
Q 014024          263 GNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDL  342 (432)
Q Consensus       263 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                      .      ........|++.|+|||.+.+..++.++|||||||++|+|++|+.||.......  .    ..        .+
T Consensus       154 ~------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~--~----~~--------~i  213 (324)
T cd05589         154 F------GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE--V----FD--------SI  213 (324)
T ss_pred             C------CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH--H----HH--------HH
Confidence            1      112334678999999999999999999999999999999999999985322110  0    00        00


Q ss_pred             hhhhhhhcccHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHHh
Q 014024          343 IDSVLEEASFNESLSRYVHIALLCVQERAEDRP-----TMSDVVSML  384 (432)
Q Consensus       343 i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~~L  384 (432)
                      ...  ....+...+..+.+++.+||+.||.+||     ++.+++++-
T Consensus       214 ~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~  258 (324)
T cd05589         214 VND--EVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQP  258 (324)
T ss_pred             HhC--CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCC
Confidence            000  0012223456778999999999999999     577777653

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.4e-40  Score=314.21  Aligned_cols=256  Identities=29%  Similarity=0.470  Sum_probs=201.4

Q ss_pred             CCCCcCceeccCCcEEEEEEEE------CCceEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEE
Q 014024          109 GNFSAANKLGEGGFGTVYKGVI------GQGEIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLL  181 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  181 (432)
                      ++|++.+.||+|+||.||+|..      ....+++|.+... .......+.+|+++++.++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            5678889999999999999985      2237899988643 34455678999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCC
Q 014024          182 IYEYMPNKSLDCFLFDPT--------------KREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDM  247 (432)
Q Consensus       182 v~e~~~~gsL~~~l~~~~--------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~  247 (432)
                      +|||+++++|.+++....              ....+++.....++.|++.||+|||+++   ++||||||+||++++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence            999999999999984321              1234788999999999999999999998   99999999999999999


Q ss_pred             CEEEeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccch
Q 014024          248 NSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNL  326 (432)
Q Consensus       248 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~  326 (432)
                      .+||+|||++........    ........++..|+|||++.+..++.++||||||+++|||++ |..||.....     
T Consensus       162 ~~kl~dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~-----  232 (283)
T cd05090         162 HVKISDLGLSREIYSADY----YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-----  232 (283)
T ss_pred             cEEeccccccccccCCcc----eecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-----
Confidence            999999999976432211    111223345678999999988889999999999999999998 8888642211     


Q ss_pred             hhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014024          327 IGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN  386 (432)
Q Consensus       327 ~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~  386 (432)
                                ....+.+........+...+..+.+++.+||+.||++||++.+|+++|..
T Consensus       233 ----------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         233 ----------QEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             ----------HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence                      01111111111111222345678899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.5e-40  Score=315.07  Aligned_cols=258  Identities=29%  Similarity=0.479  Sum_probs=203.8

Q ss_pred             CCCcCceeccCCcEEEEEEEECC-------ceEEEEEEcCCC-hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEE
Q 014024          110 NFSAANKLGEGGFGTVYKGVIGQ-------GEIAVKRLLGKS-GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLL  181 (432)
Q Consensus       110 ~y~~~~~ig~G~~g~Vy~~~~~~-------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  181 (432)
                      +|++.+.||+|+||.||+|....       ..+++|.+.... ....+.+.+|+.+++.++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            57888999999999999998642       257888775443 3456778999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCC
Q 014024          182 IYEYMPNKSLDCFLFDPT---------------------KREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASN  240 (432)
Q Consensus       182 v~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~N  240 (432)
                      ++||+.+++|.+++....                     ....+++..++.++.|++.||+|||+.+   ++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence            999999999999875321                     1235889999999999999999999998   9999999999


Q ss_pred             EEEcCCCCEEEeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCc
Q 014024          241 ILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFY  319 (432)
Q Consensus       241 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~  319 (432)
                      |++++++.+||+|||+++........    .......++..|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~  233 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSY----VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI  233 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccch----hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC
Confidence            99999999999999999764222110    11122345678999999988889999999999999999999 88887432


Q ss_pred             cccccchhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccc
Q 014024          320 RTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS  389 (432)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~  389 (432)
                      ...               .+.+.+........+.....++.+++..||+.+|++||++.++++.|++...
T Consensus       234 ~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         234 APE---------------RLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             CHH---------------HHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence            211               1111111111122233345678899999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=6.1e-41  Score=323.39  Aligned_cols=241  Identities=22%  Similarity=0.260  Sum_probs=194.1

Q ss_pred             ceeccCCcEEEEEEEECC--ceEEEEEEcCC---ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecCCCC
Q 014024          115 NKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK---SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNK  189 (432)
Q Consensus       115 ~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  189 (432)
                      +.||+|+||.||++.+..  ..+|+|++...   .......+.+|+++++.++||||+++++++.+.+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            469999999999999754  48999988643   2334567788999999999999999999999999999999999999


Q ss_pred             ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCcccc
Q 014024          190 SLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDEL  269 (432)
Q Consensus       190 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  269 (432)
                      +|.+++..   ...+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++......      
T Consensus        81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~------  148 (328)
T cd05593          81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD------  148 (328)
T ss_pred             CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc------
Confidence            99988843   345899999999999999999999998   999999999999999999999999998753111      


Q ss_pred             ccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhhhhh
Q 014024          270 QGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEE  349 (432)
Q Consensus       270 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  349 (432)
                      ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.......     .. ......          ..
T Consensus       149 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~-----~~-~~~~~~----------~~  212 (328)
T cd05593         149 AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-----LF-ELILME----------DI  212 (328)
T ss_pred             ccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH-----HH-HHhccC----------Cc
Confidence            112234578999999999999999999999999999999999999985322110     00 000000          00


Q ss_pred             cccHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 014024          350 ASFNESLSRYVHIALLCVQERAEDRP-----TMSDVVSM  383 (432)
Q Consensus       350 ~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~~  383 (432)
                      ..+.....++.+++.+||+.||++||     ++.+++++
T Consensus       213 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         213 KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            11223346788999999999999997     89999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.7e-40  Score=308.85  Aligned_cols=250  Identities=28%  Similarity=0.404  Sum_probs=201.0

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECCceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEE-eCCeeEEEEecC
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCI-EKDERLLIYEYM  186 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~  186 (432)
                      ..+|++.+.||+|+||.||++...+..+++|......  ..+.+.+|+.++++++|+|++++++++. +.+..+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            3578899999999999999999988899999886443  3467889999999999999999999764 456789999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCc
Q 014024          187 PNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDE  266 (432)
Q Consensus       187 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  266 (432)
                      ++++|.+++.... ...+++..++.++.|++.||+|||+++   ++||||||+||++++++.+||+|||++.....    
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~----  154 (256)
T cd05082          83 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS----  154 (256)
T ss_pred             CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccc----
Confidence            9999999986432 234889999999999999999999998   99999999999999999999999999875421    


Q ss_pred             cccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchhhhhhh
Q 014024          267 DELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDS  345 (432)
Q Consensus       267 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  345 (432)
                           ......++..|+|||++.+..++.++|||||||++|+|++ |+.|+.......     .          ...+..
T Consensus       155 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~-----~----------~~~~~~  214 (256)
T cd05082         155 -----TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-----V----------VPRVEK  214 (256)
T ss_pred             -----cCCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH-----H----------HHHHhc
Confidence                 1122334567999999998899999999999999999998 888874321100     0          000111


Q ss_pred             hhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014024          346 VLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNE  387 (432)
Q Consensus       346 ~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~  387 (432)
                      ..........+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       215 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         215 GYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence            111112234467788999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.5e-42  Score=313.96  Aligned_cols=250  Identities=24%  Similarity=0.367  Sum_probs=213.3

Q ss_pred             hCCCCcCceeccCCcEEEEEEEE--CCceEEEEEEcCC---ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEE
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVI--GQGEIAVKRLLGK---SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLI  182 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  182 (432)
                      ..+|++.+.||+|.||+|-+|..  .++.||||.+.+.   ++++.-.+.+|+++|+.++||||+.++++|++.+...||
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            46899999999999999999986  3458999987544   455666789999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccC
Q 014024          183 YEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFG  262 (432)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  262 (432)
                      |||..+|.|.+|+   ..++.+++.++..++.||..|+.|+|.++   ++|||||.+|||+|+|+++||+|||++.++..
T Consensus       132 MEYaS~GeLYDYi---Ser~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~  205 (668)
T KOG0611|consen  132 MEYASGGELYDYI---SERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD  205 (668)
T ss_pred             EEecCCccHHHHH---HHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc
Confidence            9999999999999   45566999999999999999999999998   99999999999999999999999999987632


Q ss_pred             CCCccccccccccccccCCccChhhhccCCC-CchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhh
Q 014024          263 GNDEDELQGNTSRISGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIID  341 (432)
Q Consensus       263 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (432)
                             ....+.++|++-|.+||++.+..| .+.+|-||||++||.|+.|..||+..+                  -..
T Consensus       206 -------~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D------------------hk~  260 (668)
T KOG0611|consen  206 -------KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD------------------HKR  260 (668)
T ss_pred             -------ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch------------------HHH
Confidence                   224567899999999999999888 588999999999999999999986332                  122


Q ss_pred             hhhhhhhhcc-cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014024          342 LIDSVLEEAS-FNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEA  388 (432)
Q Consensus       342 ~i~~~l~~~~-~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~  388 (432)
                      ++.+.-+..+ .++.+.+..-|+.|||..+|++|.|+.+|..+.+--+
T Consensus       261 lvrQIs~GaYrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvNw  308 (668)
T KOG0611|consen  261 LVRQISRGAYREPETPSDASGLIRWMLMVNPERRATIEDIASHWWVNW  308 (668)
T ss_pred             HHHHhhcccccCCCCCchHHHHHHHHHhcCcccchhHHHHhhhheeec
Confidence            3333333332 2345567788999999999999999999999987544

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=8.5e-41  Score=325.76  Aligned_cols=249  Identities=26%  Similarity=0.378  Sum_probs=194.9

Q ss_pred             hCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEe
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYE  184 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  184 (432)
                      .++|+..+.||+|+||.||+|.+.  +..||+|.+... .....+.+.+|+++++.++|+||+++++++.+.+..++|||
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  152 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE  152 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence            467888899999999999999975  348999998554 33445678999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCC
Q 014024          185 YMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGN  264 (432)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  264 (432)
                      |+++++|.+..       ..++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++..+... 
T Consensus       153 ~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~-  221 (353)
T PLN00034        153 FMDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQT-  221 (353)
T ss_pred             cCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccc-
Confidence            99999986432       2567788899999999999999998   999999999999999999999999999865211 


Q ss_pred             CccccccccccccccCCccChhhhcc-----CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccch
Q 014024          265 DEDELQGNTSRISGTYGYMSPEYALE-----GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKI  339 (432)
Q Consensus       265 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  339 (432)
                           ........||..|+|||++..     ...+.++|||||||++|||++|+.||.......  .......       
T Consensus       222 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~--~~~~~~~-------  287 (353)
T PLN00034        222 -----MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD--WASLMCA-------  287 (353)
T ss_pred             -----cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc--HHHHHHH-------
Confidence                 111234578999999998743     234568999999999999999999986322111  0000000       


Q ss_pred             hhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          340 IDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       340 ~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                         +..............++.+++.+||+.||++|||+.|++++-
T Consensus       288 ---~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp  329 (353)
T PLN00034        288 ---ICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHP  329 (353)
T ss_pred             ---HhccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence               000001111223456789999999999999999999999864

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.4e-42  Score=294.58  Aligned_cols=251  Identities=24%  Similarity=0.332  Sum_probs=209.2

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCCC---hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKS---GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLL  181 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  181 (432)
                      +.++|++++.||+|-||.||+|+.+.+  -||+|++.+..   .....++.+|+++.+.++||||+++|++|.+....|+
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL   99 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL   99 (281)
T ss_pred             chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence            457899999999999999999998766  68999885442   2334678999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceecc
Q 014024          182 IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVF  261 (432)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  261 (432)
                      ++||..+|.+...|++.. ...+++.....+..|+|.|+.|+|..+   ++||||||+|+|++.++.+|++|||-+..-.
T Consensus       100 ilEya~~gel~k~L~~~~-~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p  175 (281)
T KOG0580|consen  100 ILEYAPRGELYKDLQEGR-MKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP  175 (281)
T ss_pred             EEEecCCchHHHHHHhcc-cccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence            999999999999997543 334899999999999999999999998   9999999999999999999999999987521


Q ss_pred             CCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhh
Q 014024          262 GGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIID  341 (432)
Q Consensus       262 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (432)
                              .......+||..|.+||...+..++..+|+|++|++.||++.|.+||.....              .+....
T Consensus       176 --------~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~--------------~etYkr  233 (281)
T KOG0580|consen  176 --------SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH--------------SETYKR  233 (281)
T ss_pred             --------CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh--------------HHHHHH
Confidence                    3345678999999999999999999999999999999999999999842110              001111


Q ss_pred             hhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014024          342 LIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLT  385 (432)
Q Consensus       342 ~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~  385 (432)
                      +..  .+-..+........+++..|+..+|.+|.+..|++++-.
T Consensus       234 I~k--~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpw  275 (281)
T KOG0580|consen  234 IRK--VDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPW  275 (281)
T ss_pred             HHH--ccccCCcccChhHHHHHHHHhccCccccccHHHHhhhHH
Confidence            111  111223455677889999999999999999999998753

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=3.7e-40  Score=361.07  Aligned_cols=261  Identities=23%  Similarity=0.383  Sum_probs=206.7

Q ss_pred             hCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEec
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEY  185 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  185 (432)
                      ...|...+.||+|+||.||+|...  +..||+|++......    ...|++.+++++||||++++++|.+.+..++||||
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey  764 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY  764 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence            355777889999999999999974  348999988543321    23468899999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCC
Q 014024          186 MPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGND  265 (432)
Q Consensus       186 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  265 (432)
                      +++|+|.+++.      .++|..+.+++.|+++||+|||+....+++||||||+||++++++..++. ||.+....    
T Consensus       765 ~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~----  833 (968)
T PLN00113        765 IEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC----  833 (968)
T ss_pred             CCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc----
Confidence            99999999983      28999999999999999999996544559999999999999999888875 55554321    


Q ss_pred             ccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhh
Q 014024          266 EDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDS  345 (432)
Q Consensus       266 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  345 (432)
                            ......+|+.|+|||++.+..++.++|||||||++|||+||+.|++...........|.............+++
T Consensus       834 ------~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  907 (968)
T PLN00113        834 ------TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDP  907 (968)
T ss_pred             ------cCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCc
Confidence                  11223678999999999999999999999999999999999999854433334445554433333334444555


Q ss_pred             hhhhc--ccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccc
Q 014024          346 VLEEA--SFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS  389 (432)
Q Consensus       346 ~l~~~--~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~  389 (432)
                      .+...  ...+...++.+++.+||+.||++||||+||++.|+....
T Consensus       908 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        908 SIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             cccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            44332  234566778899999999999999999999999998754

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.1e-40  Score=313.11  Aligned_cols=269  Identities=25%  Similarity=0.384  Sum_probs=202.4

Q ss_pred             hCCCCcCceeccCCcEEEEEEEEC------CceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeC--Cee
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIG------QGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEK--DER  179 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~  179 (432)
                      ..+|++.+.||+|+||.||++...      +..+++|.+........+.+.+|++++++++|+||+++++++...  ...
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   82 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   82 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence            357889999999999999999742      337999998777767778899999999999999999999987543  467


Q ss_pred             EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeeccccee
Q 014024          180 LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARI  259 (432)
Q Consensus       180 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  259 (432)
                      ++||||+++++|.+++...  ...+++..++.++.|++.||+|||+.+   ++||||||+||++++++.+||+|||++..
T Consensus        83 ~lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~  157 (284)
T cd05081          83 RLVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKV  157 (284)
T ss_pred             EEEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccccc
Confidence            8999999999999998543  234899999999999999999999998   99999999999999999999999999986


Q ss_pred             ccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhh----
Q 014024          260 VFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWI----  335 (432)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~----  335 (432)
                      .......   ........++..|+|||+..+..++.++|+||||+++|||++|..|+......   ..........    
T Consensus       158 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~~~~~~~~~  231 (284)
T cd05081         158 LPQDKEY---YKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE---FMRMMGNDKQGQMI  231 (284)
T ss_pred             ccCCCcc---eeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh---hhhhcccccccccc
Confidence            5322110   00111122344699999999889999999999999999999988765322110   0000000000    


Q ss_pred             ccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014024          336 SNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNE  387 (432)
Q Consensus       336 ~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~  387 (432)
                      .....+.+............+..+.+++.+||+.+|++|||+.||++.|+.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         232 VYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             hHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            0001111111111112233456799999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2e-40  Score=312.20  Aligned_cols=258  Identities=30%  Similarity=0.457  Sum_probs=202.0

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECC-------ceEEEEEEcCCC-hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCe
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQ-------GEIAVKRLLGKS-GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDE  178 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~-------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  178 (432)
                      .+++|.+.+.||+|++|.||+|.+.+       ..+++|...... ......+.+|+.+++.++|+||+++++++.+.+.
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            35789999999999999999999854       368888775443 3445678899999999999999999999999999


Q ss_pred             eEEEEecCCCCChhhhhcCCCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCC---CEEE
Q 014024          179 RLLIYEYMPNKSLDCFLFDPTK----REILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDM---NSKI  251 (432)
Q Consensus       179 ~~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl  251 (432)
                      .++||||+++++|.+++.....    ...+++..+..++.|++.||+|||+.+   ++||||||+||++++++   .+||
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence            9999999999999999854321    125899999999999999999999998   99999999999998765   5999


Q ss_pred             eecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhh
Q 014024          252 SDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYA  330 (432)
Q Consensus       252 ~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~  330 (432)
                      +|||+++.......    .........+..|+|||++.+..++.++|||||||++|||++ |..||.......       
T Consensus       161 ~dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~-------  229 (277)
T cd05036         161 ADFGMARDIYRASY----YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE-------  229 (277)
T ss_pred             ccCccccccCCccc----eecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-------
Confidence            99999986521110    111112233567999999999999999999999999999997 888875322111       


Q ss_pred             HHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014024          331 WDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN  386 (432)
Q Consensus       331 ~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~  386 (432)
                              ..+.+........+...+..+.+++.+||+.+|++||++.+|+++|+.
T Consensus       230 --------~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~  277 (277)
T cd05036         230 --------VMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY  277 (277)
T ss_pred             --------HHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence                    111111111112233445678899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=3.4e-40  Score=308.61  Aligned_cols=257  Identities=21%  Similarity=0.338  Sum_probs=204.8

Q ss_pred             CCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcC---CChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEE
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLG---KSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  183 (432)
                      ++|++.+.||+|+||.||+|...  +..+++|.+..   ........+.+|+++++.++|||++++++++.+.+..++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            68999999999999999999974  44899997743   23445567889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccC
Q 014024          184 EYMPNKSLDCFLFDPT-KREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFG  262 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  262 (432)
                      ||+++++|.+++.... ....+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            9999999998885322 2345889999999999999999999998   99999999999999999999999999886421


Q ss_pred             CCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhh
Q 014024          263 GNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDL  342 (432)
Q Consensus       263 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                      .      ........+++.|+|||.+.+..++.++|+||||+++|+|++|+.|+.......   ..+.          +.
T Consensus       159 ~------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~---~~~~----------~~  219 (267)
T cd08228         159 K------TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL---FSLC----------QK  219 (267)
T ss_pred             h------hHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH---HHHH----------HH
Confidence            1      111223467889999999998889999999999999999999999974221110   0000          11


Q ss_pred             hhhhhhh-cccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014024          343 IDSVLEE-ASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNE  387 (432)
Q Consensus       343 i~~~l~~-~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~  387 (432)
                      +...... ......+..+.+++.+||+.+|++||++.+|++.|+..
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         220 IEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             HhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence            1110001 11123456789999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-41  Score=329.75  Aligned_cols=255  Identities=23%  Similarity=0.332  Sum_probs=202.9

Q ss_pred             CCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCCC---hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEE
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGKS---GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  183 (432)
                      ++|++.+.||+|+||.||+|.+.  +..+|+|++....   ......+.+|++++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            47899999999999999999986  4589999986432   234567889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCC
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGG  263 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  263 (432)
                      ||+++++|.+++...   ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++......
T Consensus        81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence            999999999999543   45899999999999999999999998   999999999999999999999999999865322


Q ss_pred             CCc-----------------------cccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCcc
Q 014024          264 NDE-----------------------DELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYR  320 (432)
Q Consensus       264 ~~~-----------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~  320 (432)
                      ...                       ...........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~  234 (350)
T cd05573         155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT  234 (350)
T ss_pred             CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence            200                       000112334578999999999999999999999999999999999999985432


Q ss_pred             ccccchhhhhHHhhhccchhhhhh--hhhhhcccHHHHHHHHHHHHHhhccCCCCCCC-HHHHHHHh
Q 014024          321 TKSLNLIGYAWDLWISNKIIDLID--SVLEEASFNESLSRYVHIALLCVQERAEDRPT-MSDVVSML  384 (432)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~i~--~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt-~~evl~~L  384 (432)
                      ...      .        ...+..  ..+........+..+.+++..|++ ||.+||+ +.+++++.
T Consensus       235 ~~~------~--------~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp  286 (350)
T cd05573         235 LQE------T--------YNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHP  286 (350)
T ss_pred             HHH------H--------HHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence            110      0        000111  001111111235678899999997 9999999 99999864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.5e-40  Score=315.05  Aligned_cols=261  Identities=22%  Similarity=0.301  Sum_probs=191.7

Q ss_pred             CCCCcCceeccCCcEEEEEEEEC---CceEEEEEEcCCC--hHhHHHHHHHHHHHHhc---CCCceeeeEeEEEe-----
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIG---QGEIAVKRLLGKS--GQEIKELKNEASVIAQV---QHKNLVKLLGCCIE-----  175 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~---~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~-----  175 (432)
                      .+|++.+.||+|+||.||+|.+.   +..+|+|.+....  ......+.+|+.+++.+   +||||+++++++..     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            47899999999999999999873   2368999875432  22234456677777765   69999999999852     


Q ss_pred             CCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecc
Q 014024          176 KDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFG  255 (432)
Q Consensus       176 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  255 (432)
                      ....++||||++ ++|.+++.... ...+++..+..++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG  155 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence            346899999996 58888885432 234899999999999999999999998   9999999999999999999999999


Q ss_pred             cceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhh-
Q 014024          256 MARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLW-  334 (432)
Q Consensus       256 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-  334 (432)
                      ++......       .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+  ......... 
T Consensus       156 ~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~--~~~~i~~~~~  226 (290)
T cd07862         156 LARIYSFQ-------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD--QLGKILDVIG  226 (290)
T ss_pred             ceEeccCC-------cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH--HHHHHHHHhC
Confidence            99864211       12334568999999999998899999999999999999999999986432211  110000000 


Q ss_pred             --hccchh---hhhhhhh-------hhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          335 --ISNKII---DLIDSVL-------EEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       335 --~~~~~~---~~i~~~l-------~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                        ......   .+....+       ...........+.+++.+||+.||++|||+.|++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h  287 (290)
T cd07862         227 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  287 (290)
T ss_pred             CCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence              000000   0000000       000111234567899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=6.2e-41  Score=329.55  Aligned_cols=256  Identities=23%  Similarity=0.305  Sum_probs=195.6

Q ss_pred             CCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCC---hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEE
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS---GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  183 (432)
                      ++|++.+.||+|+||.||++.+..  ..+|+|.+....   ......+.+|++++++++|+||+++++.+.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            479999999999999999999754  379999885432   223456889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCC
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGG  263 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  263 (432)
                      ||+++|+|.+++..   .+.+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 E~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~  154 (376)
T cd05598          81 DYIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (376)
T ss_pred             eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence            99999999999853   345889999999999999999999999   999999999999999999999999997532100


Q ss_pred             CCc-------------------------------------cccccccccccccCCccChhhhccCCCCchhhhHHHHHHH
Q 014024          264 NDE-------------------------------------DELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLL  306 (432)
Q Consensus       264 ~~~-------------------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il  306 (432)
                      ...                                     ...........||+.|+|||++.+..++.++|||||||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil  234 (376)
T cd05598         155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL  234 (376)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence            000                                     0000111235799999999999999999999999999999


Q ss_pred             HHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCC---CHHHHHHH
Q 014024          307 LEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRP---TMSDVVSM  383 (432)
Q Consensus       307 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RP---t~~evl~~  383 (432)
                      |||++|+.||........     ... ....      ...+...........+.+++..|+ .+|.+|+   ++.+++++
T Consensus       235 yell~G~~Pf~~~~~~~~-----~~~-i~~~------~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         235 YEMLVGQPPFLADTPAET-----QLK-VINW------ETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             eehhhCCCCCCCCCHHHH-----HHH-Hhcc------CccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            999999999864332110     000 0000      000000111123345667777766 5999999   89999976

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.8e-40  Score=309.49  Aligned_cols=257  Identities=27%  Similarity=0.481  Sum_probs=203.5

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC--c---eEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEE
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ--G---EIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLL  181 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~--~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  181 (432)
                      .++|+..+.||+|+||.||+|.+..  +   .+++|..... .....+.+.+|++++++++|+|++++.+++.+.+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            3578888999999999999998742  2   5888887544 34456778999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceecc
Q 014024          182 IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVF  261 (432)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  261 (432)
                      ||||+++++|.+++...  .+.+++..+..++.|++.|++|||+.+   ++|+||||+||++++++.+||+|||++....
T Consensus        84 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  158 (268)
T cd05063          84 ITEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE  158 (268)
T ss_pred             EEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence            99999999999998643  245899999999999999999999998   9999999999999999999999999997653


Q ss_pred             CCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchh
Q 014024          262 GGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKII  340 (432)
Q Consensus       262 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                      .....   .........+..|+|||++.+..++.++|||||||++|||++ |+.||......               ...
T Consensus       159 ~~~~~---~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~---------------~~~  220 (268)
T cd05063         159 DDPEG---TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH---------------EVM  220 (268)
T ss_pred             ccccc---ceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH---------------HHH
Confidence            22111   111112223457999999998899999999999999999998 99997432110               011


Q ss_pred             hhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014024          341 DLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNE  387 (432)
Q Consensus       341 ~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~  387 (432)
                      ..+............+..+.+++.+||+.+|++||++.+|++.|+++
T Consensus       221 ~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         221 KAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             HHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            11111111122234567789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.8e-40  Score=315.78  Aligned_cols=258  Identities=27%  Similarity=0.400  Sum_probs=202.2

Q ss_pred             CCCCcCceeccCCcEEEEEEEECCc----eEEEEEEcCC-ChHhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeeEEE
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQG----EIAVKRLLGK-SGQEIKELKNEASVIAQV-QHKNLVKLLGCCIEKDERLLI  182 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv  182 (432)
                      ++|++.+.||+|+||.||+|...+.    .+++|.+... .....+.+.+|+++++++ +||||+++++++.+.+..+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            5789999999999999999987543    4678877643 344556789999999999 799999999999999999999


Q ss_pred             EecCCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCE
Q 014024          183 YEYMPNKSLDCFLFDPT-------------KREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNS  249 (432)
Q Consensus       183 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  249 (432)
                      +||+++++|.+++....             ....+++..++.++.|++.||+|||+.+   ++||||||+||++++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence            99999999999985422             1134889999999999999999999998   9999999999999999999


Q ss_pred             EEeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhh
Q 014024          250 KISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIG  328 (432)
Q Consensus       250 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~  328 (432)
                      ||+|||++.....       .........+..|+|||+..+..++.++|||||||++|||++ |..||.......     
T Consensus       159 kl~dfg~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~-----  226 (297)
T cd05089         159 KIADFGLSRGEEV-------YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE-----  226 (297)
T ss_pred             EECCcCCCccccc-------eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-----
Confidence            9999999863210       001111223457999999998899999999999999999998 999974322110     


Q ss_pred             hhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccccCC
Q 014024          329 YAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSL  391 (432)
Q Consensus       329 ~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~  391 (432)
                                ..+.+........+...+..+.+++.+||+.+|.+||++.++++.|+......
T Consensus       227 ----------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~  279 (297)
T cd05089         227 ----------LYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR  279 (297)
T ss_pred             ----------HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence                      00111111111122234567889999999999999999999999998876544

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.2e-40  Score=318.97  Aligned_cols=243  Identities=24%  Similarity=0.287  Sum_probs=193.6

Q ss_pred             CceeccCCcEEEEEEEEC-----CceEEEEEEcCC----ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEe
Q 014024          114 ANKLGEGGFGTVYKGVIG-----QGEIAVKRLLGK----SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYE  184 (432)
Q Consensus       114 ~~~ig~G~~g~Vy~~~~~-----~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  184 (432)
                      ++.||+|+||.||++...     +..+|+|.+...    .......+.+|+++++.++||||+++++++.+++..++|||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            367999999999999862     347999988542    22334567889999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCC
Q 014024          185 YMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGN  264 (432)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  264 (432)
                      |+++++|.+++..   .+.+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++...... 
T Consensus        81 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  153 (323)
T cd05584          81 YLSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHE-  153 (323)
T ss_pred             CCCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccC-
Confidence            9999999999843   345888999999999999999999999   999999999999999999999999998753211 


Q ss_pred             CccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhh
Q 014024          265 DEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLID  344 (432)
Q Consensus       265 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  344 (432)
                           ........||+.|+|||++.+..++.++|||||||++|||++|+.||......     ...         ..+..
T Consensus       154 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~-----~~~---------~~~~~  214 (323)
T cd05584         154 -----GTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK-----KTI---------DKILK  214 (323)
T ss_pred             -----CCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH-----HHH---------HHHHc
Confidence                 11223457899999999999888999999999999999999999998532210     000         00101


Q ss_pred             hhhhhcccHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHHh
Q 014024          345 SVLEEASFNESLSRYVHIALLCVQERAEDRP-----TMSDVVSML  384 (432)
Q Consensus       345 ~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~~L  384 (432)
                      .  ....+......+.+++..||+.||++||     ++.+++++-
T Consensus       215 ~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~  257 (323)
T cd05584         215 G--KLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHP  257 (323)
T ss_pred             C--CCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCC
Confidence            0  0111223456788999999999999999     888888753

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7e-40  Score=322.64  Aligned_cols=259  Identities=19%  Similarity=0.246  Sum_probs=195.3

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEec
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEY  185 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  185 (432)
                      .++|++.+.||+|+||.||++.+...  .||+|...      .+.+.+|++++++++||||+++++++......++|+|+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            46899999999999999999998544  78998642      23567899999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCC
Q 014024          186 MPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGND  265 (432)
Q Consensus       186 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  265 (432)
                      +. ++|.+++..   ...+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++....... 
T Consensus       165 ~~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-  236 (391)
T PHA03212        165 YK-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-  236 (391)
T ss_pred             CC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc-
Confidence            95 678777743   334899999999999999999999998   9999999999999999999999999997532111 


Q ss_pred             ccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccc-----cchhhhhHHhh------
Q 014024          266 EDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKS-----LNLIGYAWDLW------  334 (432)
Q Consensus       266 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~-----~~~~~~~~~~~------  334 (432)
                          ........||+.|+|||++.+..++.++|||||||++|||++|+.|+-......     ...........      
T Consensus       237 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~  312 (391)
T PHA03212        237 ----ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNE  312 (391)
T ss_pred             ----ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhh
Confidence                112334579999999999999999999999999999999999998753221100     00000000000      


Q ss_pred             -h---ccchhhhhhhhhhh-----------cccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          335 -I---SNKIIDLIDSVLEE-----------ASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       335 -~---~~~~~~~i~~~l~~-----------~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                       .   ..............           ......+.++.+++.+||+.||++|||+.|++++-
T Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp  377 (391)
T PHA03212        313 FPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFA  377 (391)
T ss_pred             cCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcCh
Confidence             0   00000000000000           00113456788999999999999999999999743

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=3.3e-40  Score=307.69  Aligned_cols=253  Identities=29%  Similarity=0.478  Sum_probs=200.7

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECCc-eEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecC
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYM  186 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~~-~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  186 (432)
                      .++|++.+.||+|+||.||+|...++ .+++|.+..... ..+.+.+|+.++++++|+|++++++++. ....+++|||+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM   82 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence            45789999999999999999987655 788888865432 3467899999999999999999999875 45678999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCc
Q 014024          187 PNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDE  266 (432)
Q Consensus       187 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  266 (432)
                      ++++|.+++.... ...+++..++.++.|++.||+|||+.+   ++|+||||+||++++++.++|+|||++..+....  
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~--  156 (260)
T cd05070          83 SKGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNE--  156 (260)
T ss_pred             CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcc--
Confidence            9999999986532 234899999999999999999999998   9999999999999999999999999998642211  


Q ss_pred             cccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchhhhhhh
Q 014024          267 DELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDS  345 (432)
Q Consensus       267 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  345 (432)
                         ........++..|+|||...+..++.++|+||||+++|+|++ |..||......               ...+.+..
T Consensus       157 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---------------~~~~~~~~  218 (260)
T cd05070         157 ---YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR---------------EVLEQVER  218 (260)
T ss_pred             ---cccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH---------------HHHHHHHc
Confidence               111122335567999999988899999999999999999999 88887432110               01111111


Q ss_pred             hhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014024          346 VLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN  386 (432)
Q Consensus       346 ~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~  386 (432)
                      ......+...+..+.+++.+||+.+|++|||++++.+.|++
T Consensus       219 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         219 GYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            11112233445678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.2e-40  Score=314.48  Aligned_cols=256  Identities=30%  Similarity=0.465  Sum_probs=202.4

Q ss_pred             CCCCcCceeccCCcEEEEEEEECC-------ceEEEEEEcCCC-hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeE
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQ-------GEIAVKRLLGKS-GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERL  180 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~-------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  180 (432)
                      .+|++.+.||+|+||.||+|.+.+       ..+|+|++.... ....+.+.+|+.+++.++|+||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            457788999999999999998642       368999986553 334567889999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhcCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCC
Q 014024          181 LIYEYMPNKSLDCFLFDP-------------TKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDM  247 (432)
Q Consensus       181 lv~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~  247 (432)
                      +++||+++++|.+++...             ..+..+++..+..++.|++.||+|||+.+   ++||||||+||++++++
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~  161 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL  161 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence            999999999999998421             11234888999999999999999999998   99999999999999999


Q ss_pred             CEEEeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccch
Q 014024          248 NSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNL  326 (432)
Q Consensus       248 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~  326 (432)
                      .+||+|||+++.......    ........+++.|+|||.+.++.++.++|||||||++|||++ |..|+......    
T Consensus       162 ~~kl~Dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~----  233 (283)
T cd05091         162 NVKISDLGLFREVYAADY----YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ----  233 (283)
T ss_pred             ceEecccccccccccchh----eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH----
Confidence            999999999876422211    111223445778999999998899999999999999999998 77776432210    


Q ss_pred             hhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014024          327 IGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN  386 (432)
Q Consensus       327 ~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~  386 (432)
                                 ...+.+........+..++..+.+++..||+.+|++||++++|++.|+.
T Consensus       234 -----------~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         234 -----------DVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             -----------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence                       1111111111112234556778999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-41  Score=329.31  Aligned_cols=256  Identities=21%  Similarity=0.281  Sum_probs=198.0

Q ss_pred             CCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC---ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEE
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK---SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  183 (432)
                      ++|++.+.||+|+||.||+|.+..  ..+|+|++...   .......+.+|+++++.++|+||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            478999999999999999999854  48999998543   2234456788999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCC
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGG  263 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  263 (432)
                      ||+++|+|.+++..   ++.+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  154 (364)
T cd05599          81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS  154 (364)
T ss_pred             CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence            99999999999853   345999999999999999999999999   999999999999999999999999998764221


Q ss_pred             CCcccc--------------------------------ccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh
Q 014024          264 NDEDEL--------------------------------QGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS  311 (432)
Q Consensus       264 ~~~~~~--------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt  311 (432)
                      ......                                ........||+.|+|||++.+..++.++|||||||++|||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~  234 (364)
T cd05599         155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV  234 (364)
T ss_pred             ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence            110000                                001113469999999999999999999999999999999999


Q ss_pred             CCCCCCCccccccchhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCC---HHHHHHH
Q 014024          312 GKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPT---MSDVVSM  383 (432)
Q Consensus       312 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt---~~evl~~  383 (432)
                      |..||.......     .........       ..+...........+.+++..|+. +|.+|++   +.+++++
T Consensus       235 G~~Pf~~~~~~~-----~~~~i~~~~-------~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h  296 (364)
T cd05599         235 GYPPFCSDNPQE-----TYRKIINWK-------ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH  296 (364)
T ss_pred             CCCCCCCCCHHH-----HHHHHHcCC-------CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence            999985332110     000000000       000000011224567788889986 9999998   9998875

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.7e-40  Score=335.97  Aligned_cols=255  Identities=22%  Similarity=0.249  Sum_probs=203.9

Q ss_pred             HhhhhCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC--
Q 014024          104 VSSATGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKD--  177 (432)
Q Consensus       104 ~~~~~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--  177 (432)
                      .....++|++.+.||+|+||.||+|.+.  +..||+|.+...  .......+.+|+..+..++|+|++++++.+...+  
T Consensus        27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~  106 (496)
T PTZ00283         27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR  106 (496)
T ss_pred             ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence            3445679999999999999999999874  448999998543  3455667889999999999999999988775432  


Q ss_pred             ------eeEEEEecCCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEE
Q 014024          178 ------ERLLIYEYMPNKSLDCFLFDPT-KREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSK  250 (432)
Q Consensus       178 ------~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  250 (432)
                            ..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.+|
T Consensus       107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vk  183 (496)
T PTZ00283        107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVK  183 (496)
T ss_pred             CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEE
Confidence                  3579999999999999986432 2346899999999999999999999998   99999999999999999999


Q ss_pred             EeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhh
Q 014024          251 ISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYA  330 (432)
Q Consensus       251 l~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~  330 (432)
                      |+|||+++.+.....    ........||+.|+|||++.+..++.++|||||||++|||++|+.||.....         
T Consensus       184 L~DFGls~~~~~~~~----~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~---------  250 (496)
T PTZ00283        184 LGDFGFSKMYAATVS----DDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM---------  250 (496)
T ss_pred             EEecccCeecccccc----ccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH---------
Confidence            999999986522111    1123346799999999999999999999999999999999999999853211         


Q ss_pred             HHhhhccchhhhhhhhh---hhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          331 WDLWISNKIIDLIDSVL---EEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       331 ~~~~~~~~~~~~i~~~l---~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                               .+.++..+   ....+...+.++.+++..||+.||.+||++.+++++
T Consensus       251 ---------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        251 ---------EEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             ---------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence                     11111111   111223445678999999999999999999999875

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=9.8e-41  Score=323.00  Aligned_cols=261  Identities=30%  Similarity=0.435  Sum_probs=202.3

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC-------ceEEEEEEcCCC-hHhHHHHHHHHHHHHhc-CCCceeeeEeEEEeC-C
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ-------GEIAVKRLLGKS-GQEIKELKNEASVIAQV-QHKNLVKLLGCCIEK-D  177 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~-------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-~  177 (432)
                      .++|++.+.||+|+||.||+|...+       ..||+|++.... ....+.+..|+.++.++ +|+||++++++|... .
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            4689999999999999999997432       369999886442 33456788899999999 899999999988654 5


Q ss_pred             eeEEEEecCCCCChhhhhcCCCC---------------------------------------------------------
Q 014024          178 ERLLIYEYMPNKSLDCFLFDPTK---------------------------------------------------------  200 (432)
Q Consensus       178 ~~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------  200 (432)
                      ..+++|||+++++|.+++.....                                                         
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            67899999999999998853211                                                         


Q ss_pred             -CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCcccccccccccccc
Q 014024          201 -REILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGT  279 (432)
Q Consensus       201 -~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt  279 (432)
                       ...+++..+..++.|++.||+|||+.+   |+||||||+||++++++.++|+|||++..+.....    ........++
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~----~~~~~~~~~~  238 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPD----YVRKGDARLP  238 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcc----hhhccCCCCC
Confidence             135899999999999999999999998   99999999999999999999999999986522111    1112234556


Q ss_pred             CCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchhhhhhhhhhhcccHHHHHH
Q 014024          280 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSR  358 (432)
Q Consensus       280 ~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~  358 (432)
                      ..|+|||++.+..++.++|||||||++|||++ |..||......+ .             ....+........+.....+
T Consensus       239 ~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~-------------~~~~~~~~~~~~~~~~~~~~  304 (337)
T cd05054         239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-E-------------FCRRLKEGTRMRAPEYATPE  304 (337)
T ss_pred             ccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-H-------------HHHHHhccCCCCCCccCCHH
Confidence            78999999999999999999999999999998 998874321110 0             00111111111112234567


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHHHhccccc
Q 014024          359 YVHIALLCVQERAEDRPTMSDVVSMLTNEAS  389 (432)
Q Consensus       359 l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~  389 (432)
                      +.+++.+||+.+|++||++.|++++|+.+..
T Consensus       305 ~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         305 IYSIMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            8999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.1e-40  Score=328.35  Aligned_cols=256  Identities=23%  Similarity=0.329  Sum_probs=196.5

Q ss_pred             CCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCC---ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEE
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGK---SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  183 (432)
                      .+|++++.||+|+||+||+|.+...  .+|+|++...   .....+.+.+|++++++++|+||+++++++.+.+..++||
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~   80 (381)
T cd05626           1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (381)
T ss_pred             CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence            3688899999999999999998544  7999998543   2344567889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCC
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGG  263 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  263 (432)
                      ||+++|+|.+++..   ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 E~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~  154 (381)
T cd05626          81 DYIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT  154 (381)
T ss_pred             ecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence            99999999999853   345899999999999999999999998   999999999999999999999999997643110


Q ss_pred             CCcc-----------------------------------------ccccccccccccCCccChhhhccCCCCchhhhHHH
Q 014024          264 NDED-----------------------------------------ELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSF  302 (432)
Q Consensus       264 ~~~~-----------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSl  302 (432)
                      ....                                         ..........||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  234 (381)
T cd05626         155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV  234 (381)
T ss_pred             cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence            0000                                         00001123579999999999998899999999999


Q ss_pred             HHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhh--hhhhhcccHHHHHHHHHHHHH--hhccCCCCCCCHH
Q 014024          303 GVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLID--SVLEEASFNESLSRYVHIALL--CVQERAEDRPTMS  378 (432)
Q Consensus       303 G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~--~~l~~~~~~~~~~~l~~l~~~--cl~~dp~~RPt~~  378 (432)
                      ||++|||++|..||........              ...++.  ..+..........++.+++.+  |+..++..||++.
T Consensus       235 G~il~elltG~~Pf~~~~~~~~--------------~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~  300 (381)
T cd05626         235 GVILFEMLVGQPPFLAPTPTET--------------QLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGAD  300 (381)
T ss_pred             hhHHHHHHhCCCCCcCCCHHHH--------------HHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHH
Confidence            9999999999999854321110              000000  000011111234566777777  5566777799999


Q ss_pred             HHHHHh
Q 014024          379 DVVSML  384 (432)
Q Consensus       379 evl~~L  384 (432)
                      +++++-
T Consensus       301 ~~l~hp  306 (381)
T cd05626         301 DIKAHP  306 (381)
T ss_pred             HHhcCc
Confidence            999863

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.9e-40  Score=320.60  Aligned_cols=252  Identities=21%  Similarity=0.260  Sum_probs=196.8

Q ss_pred             CCCcCceeccCCcEEEEEEEEC-----CceEEEEEEcCC----ChHhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCee
Q 014024          110 NFSAANKLGEGGFGTVYKGVIG-----QGEIAVKRLLGK----SGQEIKELKNEASVIAQV-QHKNLVKLLGCCIEKDER  179 (432)
Q Consensus       110 ~y~~~~~ig~G~~g~Vy~~~~~-----~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  179 (432)
                      +|++.+.||+|+||.||++...     +..+|+|++...    .....+.+..|+++++.+ +|+||+++++++.+.+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            5888999999999999998863     347999988532    223345678899999999 589999999999999999


Q ss_pred             EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeeccccee
Q 014024          180 LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARI  259 (432)
Q Consensus       180 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  259 (432)
                      ++||||+++|+|.+++..   +..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus        81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            999999999999999853   345899999999999999999999998   99999999999999999999999999976


Q ss_pred             ccCCCCccccccccccccccCCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccc
Q 014024          260 VFGGNDEDELQGNTSRISGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNK  338 (432)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  338 (432)
                      ......     .......||+.|+|||++.+. .++.++|||||||++|||++|+.||........  ........    
T Consensus       155 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--~~~~~~~~----  223 (332)
T cd05614         155 FLSEEK-----ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT--QSEVSRRI----  223 (332)
T ss_pred             ccccCC-----CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC--HHHHHHHH----
Confidence            422211     122345789999999998865 478999999999999999999999853322110  00000000    


Q ss_pred             hhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHHh
Q 014024          339 IIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRP-----TMSDVVSML  384 (432)
Q Consensus       339 ~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~~L  384 (432)
                          ..  .....+......+.+++.+||+.||++||     ++++++++-
T Consensus       224 ----~~--~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~  268 (332)
T cd05614         224 ----LK--CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHP  268 (332)
T ss_pred             ----hc--CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCC
Confidence                00  00111223456678999999999999999     777888753

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=3.1e-40  Score=306.29  Aligned_cols=247  Identities=27%  Similarity=0.394  Sum_probs=194.9

Q ss_pred             ceeccCCcEEEEEEEEC--CceEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecCCCCCh
Q 014024          115 NKLGEGGFGTVYKGVIG--QGEIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSL  191 (432)
Q Consensus       115 ~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  191 (432)
                      +.||+|+||.||+|.+.  ++.+++|..... .......+.+|++++++++|+||+++++++...+..++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            46999999999999874  447999987543 344556789999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCcccccc
Q 014024          192 DCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQG  271 (432)
Q Consensus       192 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  271 (432)
                      .+++...  ...+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.......    ...
T Consensus        81 ~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~----~~~  151 (252)
T cd05084          81 LTFLRTE--GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGV----YAS  151 (252)
T ss_pred             HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCccccccc----ccc
Confidence            9998543  234899999999999999999999998   9999999999999999999999999987532110    000


Q ss_pred             ccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchhhhhhhhhhhc
Q 014024          272 NTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEA  350 (432)
Q Consensus       272 ~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  350 (432)
                      .......+..|+|||.+.++.++.++||||||+++|+|++ |..|+......               .....+.......
T Consensus       152 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~---------------~~~~~~~~~~~~~  216 (252)
T cd05084         152 TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ---------------QTREAIEQGVRLP  216 (252)
T ss_pred             cCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH---------------HHHHHHHcCCCCC
Confidence            1111123457999999999999999999999999999998 88876432211               1111111111122


Q ss_pred             ccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014024          351 SFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLT  385 (432)
Q Consensus       351 ~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~  385 (432)
                      .+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus       217 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         217 CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            23344567899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=3.9e-40  Score=306.67  Aligned_cols=246  Identities=29%  Similarity=0.420  Sum_probs=193.9

Q ss_pred             eeccCCcEEEEEEEEC----CceEEEEEEcCCC--hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecCCCC
Q 014024          116 KLGEGGFGTVYKGVIG----QGEIAVKRLLGKS--GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNK  189 (432)
Q Consensus       116 ~ig~G~~g~Vy~~~~~----~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  189 (432)
                      .||+|+||.||+|.+.    +..+++|++....  ....+.+.+|+.+++.++|+||+++++++. .+..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            5899999999999752    3378999875432  345677899999999999999999999875 45678999999999


Q ss_pred             ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCcccc
Q 014024          190 SLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDEL  269 (432)
Q Consensus       190 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  269 (432)
                      +|.+++..   ...+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||++..+......   
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~---  151 (257)
T cd05116          81 PLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY---  151 (257)
T ss_pred             cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCe---
Confidence            99999843   345899999999999999999999998   999999999999999999999999999865222111   


Q ss_pred             ccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchhhhhhhhhh
Q 014024          270 QGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLE  348 (432)
Q Consensus       270 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  348 (432)
                      ........++..|+|||.+....++.++|+|||||++|||++ |+.||......               .....++....
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---------------~~~~~i~~~~~  216 (257)
T cd05116         152 YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN---------------EVTQMIESGER  216 (257)
T ss_pred             eeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---------------HHHHHHHCCCC
Confidence            011122234578999999988889999999999999999998 99998533211               01111111111


Q ss_pred             hcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014024          349 EASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN  386 (432)
Q Consensus       349 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~  386 (432)
                      ...+...+.++.+++.+||+.||++||++++|.+.|++
T Consensus       217 ~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         217 MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence            12233455778899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=3.6e-40  Score=310.97  Aligned_cols=256  Identities=29%  Similarity=0.428  Sum_probs=203.2

Q ss_pred             CCCCcCceeccCCcEEEEEEEEC-------CceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEE
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIG-------QGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLL  181 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  181 (432)
                      .+|...++||+|+||.||++...       +..+++|.+........+.+.+|+++++.++|+||+++++++.+.+..++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            46788899999999999999742       22688888877777777889999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCE
Q 014024          182 IYEYMPNKSLDCFLFDPTK------------REILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNS  249 (432)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  249 (432)
                      +|||+++++|.+++.....            ...+++..++.++.|++.|++|||+.+   ++||||||+||++++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence            9999999999999864321            134889999999999999999999998   9999999999999999999


Q ss_pred             EEeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhh
Q 014024          250 KISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIG  328 (432)
Q Consensus       250 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~  328 (432)
                      ||+|||++........    ........+++.|+|||.+.+..++.++|||||||++|||++ |+.||.......  .  
T Consensus       162 kL~dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~--  233 (280)
T cd05092         162 KIGDFGMSRDIYSTDY----YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE--A--  233 (280)
T ss_pred             EECCCCceeEcCCCce----eecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH--H--
Confidence            9999999976422110    111223345678999999999999999999999999999998 888874322110  0  


Q ss_pred             hhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014024          329 YAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN  386 (432)
Q Consensus       329 ~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~  386 (432)
                                 ...+........+...+..+.+++.+||+.||++||++.+|.+.|+.
T Consensus       234 -----------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         234 -----------IECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             -----------HHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence                       00011101111122345678899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=5.1e-40  Score=305.28  Aligned_cols=249  Identities=27%  Similarity=0.383  Sum_probs=202.1

Q ss_pred             CCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEec
Q 014024          110 NFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEY  185 (432)
Q Consensus       110 ~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  185 (432)
                      +|++.+.||+|++|.||+|....  ..+++|.+...  .....+.+.+|+++++.++|+|++++++++.+.+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            47888999999999999999854  48999987532  345667889999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCC
Q 014024          186 MPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGND  265 (432)
Q Consensus       186 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  265 (432)
                      +++++|.+++.... ...+++..++.++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++......  
T Consensus        81 ~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~--  154 (256)
T cd08529          81 AENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN--  154 (256)
T ss_pred             CCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCc--
Confidence            99999999986532 345899999999999999999999998   999999999999999999999999998865221  


Q ss_pred             ccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhh
Q 014024          266 EDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDS  345 (432)
Q Consensus       266 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  345 (432)
                          ........|++.|+|||+..+..++.++|+||||+++++|++|+.||.......  .            ..... .
T Consensus       155 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~------------~~~~~-~  215 (256)
T cd08529         155 ----TNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA--L------------ILKII-R  215 (256)
T ss_pred             ----cchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH--H------------HHHHH-c
Confidence                111233467889999999999999999999999999999999999985332100  0            00000 0


Q ss_pred             hhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          346 VLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       346 ~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      ......+...+..+.+++.+||+.+|++||++.+++++
T Consensus       216 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         216 GVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             CCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            01111222445678999999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=4e-40  Score=307.59  Aligned_cols=254  Identities=28%  Similarity=0.452  Sum_probs=201.1

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECCc-eEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecC
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYM  186 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~~-~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  186 (432)
                      .++|++.++||+|+||.||+|.+.++ .+++|++..... ..+.+.+|+++++.++|+||+++++.+.+ ...++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~   82 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   82 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence            46799999999999999999988665 789998864332 34578899999999999999999998754 5679999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCc
Q 014024          187 PNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDE  266 (432)
Q Consensus       187 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  266 (432)
                      ++++|.+++.... ...+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.++|+|||.+..+..... 
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~-  157 (262)
T cd05071          83 SKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-  157 (262)
T ss_pred             CCCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccc-
Confidence            9999999996432 234789999999999999999999998   99999999999999999999999999976522111 


Q ss_pred             cccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchhhhhhh
Q 014024          267 DELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDS  345 (432)
Q Consensus       267 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  345 (432)
                          .......++..|+|||+..+..++.++||||||+++|+|+| |..||.......               ....+..
T Consensus       158 ----~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~---------------~~~~~~~  218 (262)
T cd05071         158 ----TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------------VLDQVER  218 (262)
T ss_pred             ----ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH---------------HHHHHhc
Confidence                11123345678999999988899999999999999999999 777764322110               0000111


Q ss_pred             hhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014024          346 VLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNE  387 (432)
Q Consensus       346 ~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~  387 (432)
                      ..........+..+.+++.+|++.+|++||++.++++.|++.
T Consensus       219 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         219 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence            111112334567789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=4.9e-40  Score=315.47  Aligned_cols=240  Identities=26%  Similarity=0.323  Sum_probs=188.5

Q ss_pred             ceeccCCcEEEEEEEECCc--eEEEEEEcCCC---hHhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeeEEEEecCCC
Q 014024          115 NKLGEGGFGTVYKGVIGQG--EIAVKRLLGKS---GQEIKELKNEASVIAQV-QHKNLVKLLGCCIEKDERLLIYEYMPN  188 (432)
Q Consensus       115 ~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  188 (432)
                      ++||+|+||.||+|.+.++  .||+|.+....   ....+.+..|..++... +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999998654  79999885431   23344556677777654 899999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCccc
Q 014024          189 KSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDE  268 (432)
Q Consensus       189 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  268 (432)
                      |+|.+++..   ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++......     
T Consensus        81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~-----  149 (316)
T cd05592          81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG-----  149 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCC-----
Confidence            999998853   335899999999999999999999998   999999999999999999999999999764221     


Q ss_pred             cccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhhhh
Q 014024          269 LQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLE  348 (432)
Q Consensus       269 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  348 (432)
                       ........||+.|+|||++.+..++.++|||||||++|||++|+.||.......     .. ..         +.. ..
T Consensus       150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~-----~~-~~---------i~~-~~  212 (316)
T cd05592         150 -EGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE-----LF-DS---------ILN-DR  212 (316)
T ss_pred             -CCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH-----HH-HH---------HHc-CC
Confidence             122334578999999999999899999999999999999999999985322100     00 00         000 00


Q ss_pred             hcccHHHHHHHHHHHHHhhccCCCCCCCHH-HHHH
Q 014024          349 EASFNESLSRYVHIALLCVQERAEDRPTMS-DVVS  382 (432)
Q Consensus       349 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~-evl~  382 (432)
                      ...+.....++.+++..||+.||.+||++. ++++
T Consensus       213 ~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         213 PHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence            111223345678999999999999999875 5654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-40  Score=310.44  Aligned_cols=273  Identities=25%  Similarity=0.375  Sum_probs=206.7

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECCceEEEEEEcCCChHhHHHHHHHHHHHHh--cCCCceeeeEeEEEeCC----eeEE
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQ--VQHKNLVKLLGCCIEKD----ERLL  181 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~----~~~l  181 (432)
                      ..+.++.++||+|.||.||+|.+.++.||||++..   +..+.|.+|-++.+.  ++|+||++++++-....    .++|
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL  285 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL  285 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhccCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence            34566779999999999999999999999999864   556778888888776  58999999999876554    7899


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc------CCCCeEeccCCCCCEEEcCCCCEEEeecc
Q 014024          182 IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQY------SRVRIIHRDLKASNILLDKDMNSKISDFG  255 (432)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~------~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  255 (432)
                      |+||.+.|+|.+||.    ...++|....+++..+++||+|||+.      .+++|+|||||+.||||.+|++..|+|||
T Consensus       286 Vt~fh~kGsL~dyL~----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG  361 (534)
T KOG3653|consen  286 VTEFHPKGSLCDYLK----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG  361 (534)
T ss_pred             EeeeccCCcHHHHHH----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence            999999999999993    44599999999999999999999964      35789999999999999999999999999


Q ss_pred             cceeccCCCCccccccccccccccCCccChhhhccCC-CC-----chhhhHHHHHHHHHHHhCCCCCCCccccc--cchh
Q 014024          256 MARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGI-FS-----IKSDVFSFGVLLLEIVSGKKNTGFYRTKS--LNLI  327 (432)
Q Consensus       256 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~t-----~~~DvwSlG~il~elltg~~p~~~~~~~~--~~~~  327 (432)
                      +|..+..+...    ......+||.+|||||++.+.- +.     .+.||||+|.|||||++...-.......+  ..+.
T Consensus       362 LAl~~~p~~~~----~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe  437 (534)
T KOG3653|consen  362 LALRLEPGKPQ----GDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE  437 (534)
T ss_pred             eeEEecCCCCC----cchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh
Confidence            99998644333    3444579999999999987532 22     46899999999999999876542211111  1111


Q ss_pred             hhhHHhhhccchhhhhhhhhhhcc-cH-----HHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccccCC
Q 014024          328 GYAWDLWISNKIIDLIDSVLEEAS-FN-----ESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSL  391 (432)
Q Consensus       328 ~~~~~~~~~~~~~~~i~~~l~~~~-~~-----~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~  391 (432)
                      ..+-.....+++.+++-....++. +.     .....+.+.+..||+.||+-|.|+.=+.+.+..+....
T Consensus       438 ~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~  507 (534)
T KOG3653|consen  438 AEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW  507 (534)
T ss_pred             HHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence            111111222223332222111221 11     23456889999999999999999999999888876533

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.5e-40  Score=306.87  Aligned_cols=251  Identities=29%  Similarity=0.440  Sum_probs=199.5

Q ss_pred             CCCCcCceeccCCcEEEEEEEECCc-eEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecCC
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMP  187 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~~-~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  187 (432)
                      .+|++.+.||+|+||.||++.+..+ .+++|.+.... ...+.+.+|+++++.++|+||+++++++.+.+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            4578899999999999999988655 78999875432 233567889999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCcc
Q 014024          188 NKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDED  267 (432)
Q Consensus       188 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  267 (432)
                      +++|.+++....  ..+++..++.++.|++.|++|||+.+   ++||||||+||++++++.+||+|||+++......   
T Consensus        83 ~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~---  154 (256)
T cd05059          83 NGCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ---  154 (256)
T ss_pred             CCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccc---
Confidence            999999986432  25899999999999999999999999   9999999999999999999999999997642110   


Q ss_pred             ccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchhhhhhhh
Q 014024          268 ELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSV  346 (432)
Q Consensus       268 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  346 (432)
                        ........++..|+|||.+.+..++.++|+||||+++|+|++ |+.||.......               ....+...
T Consensus       155 --~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---------------~~~~~~~~  217 (256)
T cd05059         155 --YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---------------VVESVSAG  217 (256)
T ss_pred             --ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---------------HHHHHHcC
Confidence              011112233457999999999999999999999999999999 788875322110               00111111


Q ss_pred             hhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014024          347 LEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLT  385 (432)
Q Consensus       347 l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~  385 (432)
                      .....+...+..+.+++.+||+.+|++|||+.|+++.|.
T Consensus       218 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~  256 (256)
T cd05059         218 YRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT  256 (256)
T ss_pred             CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence            111222334668999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=4.4e-40  Score=310.24  Aligned_cols=256  Identities=27%  Similarity=0.394  Sum_probs=199.5

Q ss_pred             CCCCcCceeccCCcEEEEEEEECC--c----eEEEEEEcCCC-hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEE
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQ--G----EIAVKRLLGKS-GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLL  181 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~--~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  181 (432)
                      ++|++.+.||+|+||.||+|.+..  .    .+++|...... ......+..|+..+++++|+||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            578889999999999999998732  2    47778775433 2344678888889999999999999998754 45788


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceecc
Q 014024          182 IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVF  261 (432)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  261 (432)
                      ++||+++|+|.+++...  ...+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++...
T Consensus        86 i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          86 VTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             EEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            99999999999999643  235899999999999999999999998   9999999999999999999999999998653


Q ss_pred             CCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchh
Q 014024          262 GGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKII  340 (432)
Q Consensus       262 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                      ....    ........++..|+|||.+.++.++.++||||||+++|||++ |..||.......               ..
T Consensus       161 ~~~~----~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---------------~~  221 (279)
T cd05111         161 PDDK----KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE---------------VP  221 (279)
T ss_pred             CCCc----ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---------------HH
Confidence            2211    112233456778999999998999999999999999999998 998875322110               01


Q ss_pred             hhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccc
Q 014024          341 DLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS  389 (432)
Q Consensus       341 ~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~  389 (432)
                      +++........+..+...+.+++..||..||++|||+.|+++.|.....
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         222 DLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             HHHHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence            1111111111112234567889999999999999999999999988553

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=3.2e-40  Score=308.93  Aligned_cols=254  Identities=22%  Similarity=0.333  Sum_probs=200.3

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEec
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEY  185 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  185 (432)
                      .++|++.+.||+|+||.||+|.+..  ..+++|++..........+.+|+.++++++|+|++++++++...+..++||||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            4689999999999999999999743  37899988765555556788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCC
Q 014024          186 MPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGND  265 (432)
Q Consensus       186 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  265 (432)
                      +++++|.+++..   +..+++..+..++.|++.||.|||+.+   |+||||+|+||++++++.++|+|||++......  
T Consensus        88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~--  159 (267)
T cd06646          88 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITAT--  159 (267)
T ss_pred             CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccc--
Confidence            999999998843   345899999999999999999999998   999999999999999999999999999865211  


Q ss_pred             ccccccccccccccCCccChhhhc---cCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhh
Q 014024          266 EDELQGNTSRISGTYGYMSPEYAL---EGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDL  342 (432)
Q Consensus       266 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                          ........++..|+|||.+.   ...++.++|+|||||++|||++|+.|+......... ...     ...   ..
T Consensus       160 ----~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~-~~~-----~~~---~~  226 (267)
T cd06646         160 ----IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-FLM-----SKS---NF  226 (267)
T ss_pred             ----ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh-eee-----ecC---CC
Confidence                11123346888999999874   445788999999999999999999997432211000 000     000   00


Q ss_pred             hhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          343 IDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       343 i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                      ..+..  ......+..+.+++.+||+.+|++|||+++++++|
T Consensus       227 ~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         227 QPPKL--KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             CCCCC--ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            00000  00112346788999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=3.8e-40  Score=322.38  Aligned_cols=203  Identities=23%  Similarity=0.353  Sum_probs=172.6

Q ss_pred             CCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCC---hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEE
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS---GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  183 (432)
                      ++|++.+.||+|+||+||++.+..  ..+|+|++....   ......+..|+.++.+++|+||+++++.+.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            478999999999999999998754  489999985432   234456888999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCC
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGG  263 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  263 (432)
                      ||+++|+|.+++..   ++.+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~  154 (363)
T cd05628          81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA  154 (363)
T ss_pred             cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence            99999999999853   345999999999999999999999999   999999999999999999999999998754221


Q ss_pred             CCccc-----------------------------cccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCC
Q 014024          264 NDEDE-----------------------------LQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK  314 (432)
Q Consensus       264 ~~~~~-----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~  314 (432)
                      .....                             ........+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~  234 (363)
T cd05628         155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (363)
T ss_pred             ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence            10000                             0001124579999999999999999999999999999999999999


Q ss_pred             CCC
Q 014024          315 NTG  317 (432)
Q Consensus       315 p~~  317 (432)
                      ||.
T Consensus       235 Pf~  237 (363)
T cd05628         235 PFC  237 (363)
T ss_pred             CCC
Confidence            985

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.9e-40  Score=298.73  Aligned_cols=265  Identities=21%  Similarity=0.249  Sum_probs=199.0

Q ss_pred             hhhCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCCChH--hHHHHHHHHHHHHhcCCCceeeeEeEEEeC--Cee
Q 014024          106 SATGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQ--EIKELKNEASVIAQVQHKNLVKLLGCCIEK--DER  179 (432)
Q Consensus       106 ~~~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~  179 (432)
                      ...++|++++.|++|.||.||+|++..+  -||+|+++...+.  .--.-.+|+.+|.+++|||||.+-.+....  +..
T Consensus        73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i  152 (419)
T KOG0663|consen   73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI  152 (419)
T ss_pred             ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence            4567899999999999999999998665  6899998544321  122346899999999999999999987643  578


Q ss_pred             EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeeccccee
Q 014024          180 LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARI  259 (432)
Q Consensus       180 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  259 (432)
                      |+|||||+. +|..++..-.  .+|...++.-+..|++.|++|||.+.   |+||||||+|+|+...|.+||+|||+|+.
T Consensus       153 y~VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~  226 (419)
T KOG0663|consen  153 YIVMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLARE  226 (419)
T ss_pred             eeeHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhh
Confidence            999999966 7777775433  45999999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCccccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhh---h
Q 014024          260 VFGGNDEDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLW---I  335 (432)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~---~  335 (432)
                      +.      ......+..+.|.+|+|||.+.+ ..|+.+.|+||+|||+.||+++++-|.....  .+...-+....   .
T Consensus       227 yg------sp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE--~dQl~~If~llGtPt  298 (419)
T KOG0663|consen  227 YG------SPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSE--IDQLDKIFKLLGTPS  298 (419)
T ss_pred             hc------CCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCch--HHHHHHHHHHhCCCc
Confidence            62      22344667889999999999886 5699999999999999999999987643221  11111110000   0


Q ss_pred             cc-----chhhhh---------hhhhhhcccHH-HHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          336 SN-----KIIDLI---------DSVLEEASFNE-SLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       336 ~~-----~~~~~i---------~~~l~~~~~~~-~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                      ..     .....+         -..++..+... ....-.+|+...|..||.+|.|+.|.+++=
T Consensus       299 e~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~  362 (419)
T KOG0663|consen  299 EAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHE  362 (419)
T ss_pred             cccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccc
Confidence            00     000000         01111111111 234557899999999999999999999753

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=8.4e-41  Score=322.14  Aligned_cols=242  Identities=22%  Similarity=0.257  Sum_probs=192.9

Q ss_pred             ceeccCCcEEEEEEEECC--ceEEEEEEcCC---ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecCCCC
Q 014024          115 NKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK---SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNK  189 (432)
Q Consensus       115 ~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  189 (432)
                      +.||+|+||.||++.+..  ..+|+|.+...   .......+.+|+++++.++|+||+++++++.+.+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            469999999999998743  48999988643   2334556788999999999999999999999999999999999999


Q ss_pred             ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCccc
Q 014024          190 SLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ-YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDE  268 (432)
Q Consensus       190 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  268 (432)
                      +|.+++..   ...+++..+..++.|++.||+|||+ .+   |+||||||+|||+++++.+||+|||++......     
T Consensus        81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~-----  149 (325)
T cd05594          81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-----  149 (325)
T ss_pred             cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCC-----
Confidence            99988843   3458999999999999999999997 67   999999999999999999999999998753211     


Q ss_pred             cccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhhhh
Q 014024          269 LQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLE  348 (432)
Q Consensus       269 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  348 (432)
                       ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.......  .             ...+.. ..
T Consensus       150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~--~-------------~~~i~~-~~  212 (325)
T cd05594         150 -GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--L-------------FELILM-EE  212 (325)
T ss_pred             -CcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH--H-------------HHHHhc-CC
Confidence             112234568999999999999999999999999999999999999985322110  0             000000 00


Q ss_pred             hcccHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHHh
Q 014024          349 EASFNESLSRYVHIALLCVQERAEDRP-----TMSDVVSML  384 (432)
Q Consensus       349 ~~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~~L  384 (432)
                      ...+.....++.+++.+||+.||++|+     ++.+++++-
T Consensus       213 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~  253 (325)
T cd05594         213 IRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHK  253 (325)
T ss_pred             CCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCC
Confidence            011222346788999999999999996     899998763

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2.3e-40  Score=314.15  Aligned_cols=261  Identities=28%  Similarity=0.435  Sum_probs=205.3

Q ss_pred             hhhCCCCcCceeccCCcEEEEEEEECC-------ceEEEEEEcCC-ChHhHHHHHHHHHHHHhc-CCCceeeeEeEEEeC
Q 014024          106 SATGNFSAANKLGEGGFGTVYKGVIGQ-------GEIAVKRLLGK-SGQEIKELKNEASVIAQV-QHKNLVKLLGCCIEK  176 (432)
Q Consensus       106 ~~~~~y~~~~~ig~G~~g~Vy~~~~~~-------~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  176 (432)
                      ...++|++.+.||+|+||.||++...+       ..+++|.+... .......+.+|+++++++ +|+||+++++++...
T Consensus         9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   88 (293)
T cd05053           9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE   88 (293)
T ss_pred             cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence            345678999999999999999998642       36899988653 334456788999999999 799999999999999


Q ss_pred             CeeEEEEecCCCCChhhhhcCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEE
Q 014024          177 DERLLIYEYMPNKSLDCFLFDP-------------TKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILL  243 (432)
Q Consensus       177 ~~~~lv~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll  243 (432)
                      +..+++|||+++|+|.+++...             .....+++..++.++.|++.||+|||+.+   |+||||||+||++
T Consensus        89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~  165 (293)
T cd05053          89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLV  165 (293)
T ss_pred             CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEE
Confidence            9999999999999999998532             12345899999999999999999999998   9999999999999


Q ss_pred             cCCCCEEEeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCcccc
Q 014024          244 DKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTK  322 (432)
Q Consensus       244 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~  322 (432)
                      ++++.+||+|||+++.+.....    ........++..|+|||.+.+..++.++|||||||++|||++ |..|+......
T Consensus       166 ~~~~~~kL~Dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~  241 (293)
T cd05053         166 TEDHVMKIADFGLARDIHHIDY----YRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE  241 (293)
T ss_pred             cCCCeEEeCccccccccccccc----eeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH
Confidence            9999999999999986422111    111122334567999999998999999999999999999998 88887432211


Q ss_pred             ccchhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014024          323 SLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEA  388 (432)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~  388 (432)
                      .               ..+.+........+......+.+++.+||+.||++|||+.++++.|+++.
T Consensus       242 ~---------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         242 E---------------LFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             H---------------HHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            0               11111111111122334567889999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2.8e-40  Score=318.89  Aligned_cols=247  Identities=21%  Similarity=0.332  Sum_probs=193.6

Q ss_pred             ceeccCCcEEEEEEEECCc--eEEEEEEcCC---ChHhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeeEEEEecCCC
Q 014024          115 NKLGEGGFGTVYKGVIGQG--EIAVKRLLGK---SGQEIKELKNEASVIAQV-QHKNLVKLLGCCIEKDERLLIYEYMPN  188 (432)
Q Consensus       115 ~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  188 (432)
                      +.||+|+||.||++.+...  .+|+|.+...   .....+.+..|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            4699999999999998544  7999988643   334455678899888877 799999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCccc
Q 014024          189 KSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDE  268 (432)
Q Consensus       189 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  268 (432)
                      |+|..++..   ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++......     
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~-----  149 (329)
T cd05618          81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-----  149 (329)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCC-----
Confidence            999988843   345999999999999999999999998   999999999999999999999999998753111     


Q ss_pred             cccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccc---cchhhhhHHhhhccchhhhhhh
Q 014024          269 LQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKS---LNLIGYAWDLWISNKIIDLIDS  345 (432)
Q Consensus       269 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~i~~  345 (432)
                       ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.......   .....+.........       
T Consensus       150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~-------  221 (329)
T cd05618         150 -GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-------  221 (329)
T ss_pred             -CCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC-------
Confidence             112234578999999999999999999999999999999999999986432211   111111111111100       


Q ss_pred             hhhhcccHHHHHHHHHHHHHhhccCCCCCCC------HHHHHHH
Q 014024          346 VLEEASFNESLSRYVHIALLCVQERAEDRPT------MSDVVSM  383 (432)
Q Consensus       346 ~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt------~~evl~~  383 (432)
                         ...+......+.+++.+||+.||++||+      +.+++++
T Consensus       222 ---~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         222 ---IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             ---CCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence               1122334466789999999999999998      4677654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.1e-40  Score=312.04  Aligned_cols=271  Identities=24%  Similarity=0.393  Sum_probs=201.4

Q ss_pred             CCCCcCceeccCCcEEEEEEEEC------CceEEEEEEcCCC-hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeC--Cee
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIG------QGEIAVKRLLGKS-GQEIKELKNEASVIAQVQHKNLVKLLGCCIEK--DER  179 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~  179 (432)
                      ..|++.+.||+|+||.||++...      +..+++|.+.... ......+.+|+++++.++|+|++++++++.+.  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            45788999999999999999742      3379999886443 44456799999999999999999999998775  567


Q ss_pred             EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeeccccee
Q 014024          180 LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARI  259 (432)
Q Consensus       180 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  259 (432)
                      ++||||+++++|.+++....  ..+++..+..++.|++.||+|||+.+   ++||||||+||++++++.++|+|||++..
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA  158 (284)
T ss_pred             EEEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence            89999999999999985432  34899999999999999999999998   99999999999999999999999999986


Q ss_pred             ccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccch
Q 014024          260 VFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKI  339 (432)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  339 (432)
                      +......   ........++..|+|||.+.+..++.++||||||+++|+|++++.|........................
T Consensus       159 ~~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd05079         159 IETDKEY---YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL  235 (284)
T ss_pred             cccCccc---eeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH
Confidence            5322111   1112234567789999999888899999999999999999998776422110000000000000000000


Q ss_pred             hhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014024          340 IDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNE  387 (432)
Q Consensus       340 ~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~  387 (432)
                      ...+........+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         236 VRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            011111111111233457899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=4.2e-40  Score=308.50  Aligned_cols=258  Identities=26%  Similarity=0.437  Sum_probs=202.4

Q ss_pred             CCCCcCceeccCCcEEEEEEEECCc-----eEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEE
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQG-----EIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLI  182 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~~-----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  182 (432)
                      ++|++.+.||+|+||.||+|.....     .+++|.+... .......+..|+.++++++||||+++++++.+....++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            4578899999999999999987432     5899988654 455567899999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccC
Q 014024          183 YEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFG  262 (432)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  262 (432)
                      |||+++++|.+++....  +.+++.+++.++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||++.....
T Consensus        84 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          84 TEFMENGALDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             EecCCCCcHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence            99999999999986432  34899999999999999999999998   99999999999999999999999999876432


Q ss_pred             CCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchhh
Q 014024          263 GNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIID  341 (432)
Q Consensus       263 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (432)
                      ...... .........+..|+|||.+.+..++.++|||||||++|||++ |..||......  ..             .+
T Consensus       159 ~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--~~-------------~~  222 (269)
T cd05065         159 DTSDPT-YTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--DV-------------IN  222 (269)
T ss_pred             Cccccc-cccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--HH-------------HH
Confidence            211100 000011112457999999999999999999999999999886 99887432211  01             11


Q ss_pred             hhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014024          342 LIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNE  387 (432)
Q Consensus       342 ~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~  387 (432)
                      .+........+.+.+..+.+++..||+.+|.+||++.+++..|+..
T Consensus       223 ~i~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         223 AIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             HHHcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            1111111122234456788999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=4.8e-40  Score=307.83  Aligned_cols=257  Identities=26%  Similarity=0.444  Sum_probs=202.7

Q ss_pred             hCCCCcCceeccCCcEEEEEEEEC--C---ceEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEE
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIG--Q---GEIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLL  181 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~--~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  181 (432)
                      .++|++.+.||+|+||.||+|.+.  +   ..+++|.+... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI   82 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            357889999999999999999863  1   15888887543 23455688999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceecc
Q 014024          182 IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVF  261 (432)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  261 (432)
                      ||||+++++|.+++....  ..+++.+++.++.|++.||+|||+.+   ++||||||+||++++++.++|+|||++..+.
T Consensus        83 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd05066          83 VTEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  157 (267)
T ss_pred             EEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence            999999999999996432  34899999999999999999999998   9999999999999999999999999998653


Q ss_pred             CCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchh
Q 014024          262 GGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKII  340 (432)
Q Consensus       262 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                      .....   ........++..|+|||.+.+..++.++|+||||+++|++++ |..||.......  ....           
T Consensus       158 ~~~~~---~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~--~~~~-----------  221 (267)
T cd05066         158 DDPEA---AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD--VIKA-----------  221 (267)
T ss_pred             cccce---eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH--HHHH-----------
Confidence            21111   111122233567999999998899999999999999999887 999975332110  0000           


Q ss_pred             hhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014024          341 DLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNE  387 (432)
Q Consensus       341 ~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~  387 (432)
                        +........+...+..+.+++.+|++.+|.+||++.++++.|+..
T Consensus       222 --~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         222 --IEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             --HhCCCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence              001011111223456788999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.5e-40  Score=307.06  Aligned_cols=255  Identities=27%  Similarity=0.470  Sum_probs=199.2

Q ss_pred             CCcCceeccCCcEEEEEEEECC-----ceEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCe-----
Q 014024          111 FSAANKLGEGGFGTVYKGVIGQ-----GEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDE-----  178 (432)
Q Consensus       111 y~~~~~ig~G~~g~Vy~~~~~~-----~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-----  178 (432)
                      |.+.+.||+|+||.||+|....     ..+|+|++...  .....+.+.+|++.++.++|+|++++++++.+.+.     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5678999999999999998643     36999988643  34456788999999999999999999999876554     


Q ss_pred             -eEEEEecCCCCChhhhhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeec
Q 014024          179 -RLLIYEYMPNKSLDCFLFDPT---KREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDF  254 (432)
Q Consensus       179 -~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  254 (432)
                       .++++||+++++|..++....   ....+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence             789999999999998885421   2235899999999999999999999998   999999999999999999999999


Q ss_pred             ccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHh
Q 014024          255 GMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDL  333 (432)
Q Consensus       255 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~  333 (432)
                      |+++.......    ........++..|+|||.+.+..++.++|||||||++|||++ |..||.....  .......   
T Consensus       158 g~~~~~~~~~~----~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~--~~~~~~~---  228 (273)
T cd05035         158 GLSKKIYSGDY----YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN--HEIYDYL---  228 (273)
T ss_pred             cceeecccccc----ccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHH---
Confidence            99986532211    111122334668999999988889999999999999999999 8888743221  1111111   


Q ss_pred             hhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014024          334 WISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNE  387 (432)
Q Consensus       334 ~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~  387 (432)
                                ........+...+..+.+++.+||+.||++|||+.|+++.|+++
T Consensus       229 ----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         229 ----------RHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             ----------HcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                      00001112234456789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-41  Score=319.31  Aligned_cols=261  Identities=27%  Similarity=0.434  Sum_probs=210.6

Q ss_pred             CCCCcCceeccCCcEEEEEEEECC-ceEEEEEEcCCChH-hHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecC
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQ-GEIAVKRLLGKSGQ-EIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYM  186 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~-~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  186 (432)
                      +...+.++||+|-||.|.+++..+ ..||||++...... ....|.+|+++|.+++||||++++|+|..++..++|+||+
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm  617 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM  617 (807)
T ss_pred             hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence            445678999999999999999887 59999999877544 4588999999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCc
Q 014024          187 PNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDE  266 (432)
Q Consensus       187 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  266 (432)
                      ++|+|.+|+..+.... +......+|+.||+.||+||.+.+   +|||||.+.|+|+|.++++||+|||+++-+..++. 
T Consensus       618 EnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y-  692 (807)
T KOG1094|consen  618 ENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY-  692 (807)
T ss_pred             hcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCc-
Confidence            9999999996543222 455666789999999999999999   99999999999999999999999999997654432 


Q ss_pred             cccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh--CCCCCCCccccccchhhhhHHhhhccchhhhhh
Q 014024          267 DELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS--GKKNTGFYRTKSLNLIGYAWDLWISNKIIDLID  344 (432)
Q Consensus       267 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  344 (432)
                         .......+-..+|||||.+.-+++|.++|+|+||+++||+++  ...|++....+.           ..++...+.+
T Consensus       693 ---y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~-----------vven~~~~~~  758 (807)
T KOG1094|consen  693 ---YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ-----------VVENAGEFFR  758 (807)
T ss_pred             ---eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH-----------HHHhhhhhcC
Confidence               122233455679999999999999999999999999999865  566764332211           0011111111


Q ss_pred             h---hhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014024          345 S---VLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEA  388 (432)
Q Consensus       345 ~---~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~  388 (432)
                      .   ......+..++..+.+++..||..|.++||+++++..+|.+..
T Consensus       759 ~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~  805 (807)
T KOG1094|consen  759 DQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA  805 (807)
T ss_pred             CCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence            1   1122335677889999999999999999999999999998753

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=3.1e-40  Score=318.06  Aligned_cols=246  Identities=25%  Similarity=0.321  Sum_probs=195.3

Q ss_pred             CCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCC---ChHhHHHHHHHHHHHHhcCC-CceeeeEeEEEeCCeeEEEE
Q 014024          110 NFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGK---SGQEIKELKNEASVIAQVQH-KNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       110 ~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~  183 (432)
                      +|++.+.||+|+||.||+|.+.+.  .+|+|++...   .....+.+..|.+++..++| ++|+++++++.+.+..|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            588899999999999999998654  7999988543   23445667889999999976 56888999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCC
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGG  263 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  263 (432)
                      ||+++|+|.+++..   ...+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++......
T Consensus        81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05587          81 EYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG  154 (324)
T ss_pred             cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence            99999999998843   345899999999999999999999998   999999999999999999999999998743111


Q ss_pred             CCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhh
Q 014024          264 NDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLI  343 (432)
Q Consensus       264 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i  343 (432)
                            ........||+.|+|||++.+..++.++|||||||++|+|+||+.||.......  ...            .+.
T Consensus       155 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~--~~~------------~i~  214 (324)
T cd05587         155 ------GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE--LFQ------------SIM  214 (324)
T ss_pred             ------CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH--HHH------------HHH
Confidence                  112234578999999999999999999999999999999999999985322110  000            000


Q ss_pred             hhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHHH
Q 014024          344 DSVLEEASFNESLSRYVHIALLCVQERAEDRPTM-----SDVVSM  383 (432)
Q Consensus       344 ~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~-----~evl~~  383 (432)
                      ..  ....+.....++.+++.+||+.||.+|++.     .+++++
T Consensus       215 ~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  257 (324)
T cd05587         215 EH--NVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH  257 (324)
T ss_pred             cC--CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            00  011122334677899999999999999986     566654

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-40  Score=312.00  Aligned_cols=251  Identities=25%  Similarity=0.295  Sum_probs=199.2

Q ss_pred             CCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCC---hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEe
Q 014024          110 NFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS---GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYE  184 (432)
Q Consensus       110 ~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  184 (432)
                      +|++.++||+|+||.||++.+..  ..+|+|++....   ......+.+|+.+++.++|+||+++++++.+++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            58889999999999999999753  489999885432   2223457789999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCC
Q 014024          185 YMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGN  264 (432)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  264 (432)
                      |+++|+|.+++.... ...+++..+..++.|++.||.|||+.+   ++||||||+||++++++.++|+|||++...... 
T Consensus        81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-  155 (285)
T cd05605          81 LMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEG-  155 (285)
T ss_pred             ccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCC-
Confidence            999999998885432 345899999999999999999999998   999999999999999999999999999764211 


Q ss_pred             CccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhh
Q 014024          265 DEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLID  344 (432)
Q Consensus       265 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  344 (432)
                            .......|++.|+|||++.+..++.++||||+||++|||++|+.||.......  ...         .....+.
T Consensus       156 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~--~~~---------~~~~~~~  218 (285)
T cd05605         156 ------ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV--KRE---------EVERRVK  218 (285)
T ss_pred             ------CccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh--HHH---------HHHHHhh
Confidence                  11223468999999999998899999999999999999999999985322110  000         0000011


Q ss_pred             hhhhhcccHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 014024          345 SVLEEASFNESLSRYVHIALLCVQERAEDRP-----TMSDVVSM  383 (432)
Q Consensus       345 ~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~~  383 (432)
                      . .....+...+..+.+++..||+.||++||     ++.+++++
T Consensus       219 ~-~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         219 E-DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             h-cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            0 01112233456788999999999999999     88898775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-41  Score=306.23  Aligned_cols=268  Identities=24%  Similarity=0.319  Sum_probs=206.9

Q ss_pred             hhhCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEc--CCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEe-----C
Q 014024          106 SATGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLL--GKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIE-----K  176 (432)
Q Consensus       106 ~~~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~  176 (432)
                      .....|...+.||+|+||.|+.+.+..+  .||+|++.  -......+.-.+|+++|+.++|+||+.+.+++..     -
T Consensus        19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f   98 (359)
T KOG0660|consen   19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF   98 (359)
T ss_pred             eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence            3456677789999999999999998554  89999986  4455667778899999999999999999999865     3


Q ss_pred             CeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeeccc
Q 014024          177 DERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGM  256 (432)
Q Consensus       177 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  256 (432)
                      +..|+|+|+| +.+|...+.   .+..++...+..+++|+++||.|+|+.+   ++||||||+|++++.+..+||+|||+
T Consensus        99 ~DvYiV~elM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGL  171 (359)
T KOG0660|consen   99 NDVYLVFELM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGL  171 (359)
T ss_pred             ceeEEehhHH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccc
Confidence            4679999999 678888883   3444999999999999999999999999   99999999999999999999999999


Q ss_pred             ceeccCCCCccccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCccc-cccchhhhh----
Q 014024          257 ARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRT-KSLNLIGYA----  330 (432)
Q Consensus       257 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~-~~~~~~~~~----  330 (432)
                      |+.....    ......+..+.|.+|+|||+... ..||.+.||||.|||+.||++|+.-|...+. ....+....    
T Consensus       172 AR~~~~~----~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP  247 (359)
T KOG0660|consen  172 ARYLDKF----FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTP  247 (359)
T ss_pred             eeecccc----CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCC
Confidence            9985322    22334466788999999998764 6799999999999999999999988765433 111221111    


Q ss_pred             ----HHhhhccchhhhhhhhhhhcc------cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          331 ----WDLWISNKIIDLIDSVLEEAS------FNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       331 ----~~~~~~~~~~~~i~~~l~~~~------~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                          .....++.....+...-....      .+.......+|+.+||..||.+|+|++|.+++-
T Consensus       248 ~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hP  311 (359)
T KOG0660|consen  248 SEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHP  311 (359)
T ss_pred             CHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcCh
Confidence                111222223333332211111      112335667999999999999999999999864

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=7.4e-40  Score=316.04  Aligned_cols=247  Identities=21%  Similarity=0.321  Sum_probs=194.3

Q ss_pred             ceeccCCcEEEEEEEECCc--eEEEEEEcCC---ChHhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeeEEEEecCCC
Q 014024          115 NKLGEGGFGTVYKGVIGQG--EIAVKRLLGK---SGQEIKELKNEASVIAQV-QHKNLVKLLGCCIEKDERLLIYEYMPN  188 (432)
Q Consensus       115 ~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  188 (432)
                      ++||+|+||.||++.+...  .+|+|.+...   .....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            4699999999999998543  7999998643   233455688899999998 799999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCccc
Q 014024          189 KSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDE  268 (432)
Q Consensus       189 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  268 (432)
                      |+|.+++..   .+.+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++......     
T Consensus        81 g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-----  149 (329)
T cd05588          81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-----  149 (329)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC-----
Confidence            999988843   345999999999999999999999999   999999999999999999999999998642111     


Q ss_pred             cccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccc---cchhhhhHHhhhccchhhhhhh
Q 014024          269 LQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKS---LNLIGYAWDLWISNKIIDLIDS  345 (432)
Q Consensus       269 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~i~~  345 (432)
                       ........||+.|+|||++.+..++.++|+|||||++|+|++|+.||.......   .....+.....        ...
T Consensus       150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~--------~~~  220 (329)
T cd05588         150 -GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI--------LEK  220 (329)
T ss_pred             -CCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHH--------HcC
Confidence             112334578999999999999999999999999999999999999986432211   11111111111        011


Q ss_pred             hhhhcccHHHHHHHHHHHHHhhccCCCCCCC------HHHHHHH
Q 014024          346 VLEEASFNESLSRYVHIALLCVQERAEDRPT------MSDVVSM  383 (432)
Q Consensus       346 ~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt------~~evl~~  383 (432)
                      ..  ..+......+.+++..||+.||.+||+      +.+++++
T Consensus       221 ~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05588         221 QI--RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH  262 (329)
T ss_pred             CC--CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence            00  112233456889999999999999997      6788764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.8e-40  Score=310.92  Aligned_cols=271  Identities=26%  Similarity=0.394  Sum_probs=205.7

Q ss_pred             CCCCcCceeccCCcEEEEEEEEC------CceEEEEEEcCCChH-hHHHHHHHHHHHHhcCCCceeeeEeEEEe--CCee
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIG------QGEIAVKRLLGKSGQ-EIKELKNEASVIAQVQHKNLVKLLGCCIE--KDER  179 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~  179 (432)
                      ++|++.+.||+|+||.||++...      +..+|+|.+...... ..+.+.+|++.++.++|+||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            46788899999999999999864      237999988655443 56789999999999999999999999877  5578


Q ss_pred             EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeeccccee
Q 014024          180 LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARI  259 (432)
Q Consensus       180 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  259 (432)
                      +++|||+++++|.+++....  ..+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++..
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence            99999999999999996432  24899999999999999999999998   99999999999999999999999999987


Q ss_pred             ccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccch
Q 014024          260 VFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKI  339 (432)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  339 (432)
                      .......   ........++..|+|||...+..++.++||||||++++||++|+.|+.......................
T Consensus       159 ~~~~~~~---~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd05038         159 LPEDKDY---YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRL  235 (284)
T ss_pred             cccCCcc---eeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHH
Confidence            5311111   1111123345679999999988999999999999999999999988743222111100000000000111


Q ss_pred             hhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014024          340 IDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNE  387 (432)
Q Consensus       340 ~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~  387 (432)
                      .+.+........+..++.++.+++.+||+.+|++|||+.||+++|+.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         236 LELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            122222122222334457899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4e-40  Score=309.80  Aligned_cols=257  Identities=26%  Similarity=0.430  Sum_probs=203.8

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC-------ceEEEEEEcCCC-hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCee
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ-------GEIAVKRLLGKS-GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDER  179 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~-------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  179 (432)
                      .++|++.+.||+|+||.||+|...+       ..+++|.+.... ......+.+|+.+++.++|+|++++++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            4678899999999999999998743       369999886443 34456788999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhhhcCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEe
Q 014024          180 LLIYEYMPNKSLDCFLFDPT-------KREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKIS  252 (432)
Q Consensus       180 ~lv~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  252 (432)
                      ++||||+++++|.+++....       ....+++..++.++.|++.||.|||+.+   ++||||||+||++++++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence            99999999999999986432       1234788999999999999999999998   9999999999999999999999


Q ss_pred             ecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhH
Q 014024          253 DFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAW  331 (432)
Q Consensus       253 Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~  331 (432)
                      |||+++.......    ........++..|+|||.+.++.++.++|||||||++|||+| |..||......  ....   
T Consensus       162 dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~~~~---  232 (277)
T cd05032         162 DFGMTRDIYETDY----YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE--EVLK---  232 (277)
T ss_pred             CcccchhhccCcc----cccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH--HHHH---
Confidence            9999876422111    111223456788999999998889999999999999999998 88887432211  1111   


Q ss_pred             HhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014024          332 DLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN  386 (432)
Q Consensus       332 ~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~  386 (432)
                                .+........+...+..+.+++..||+.+|++|||+.++++.|++
T Consensus       233 ----------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         233 ----------FVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             ----------HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence                      111100111222346788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=5.5e-40  Score=316.20  Aligned_cols=236  Identities=25%  Similarity=0.296  Sum_probs=185.1

Q ss_pred             ceeccCCcEEEEEEEECC--ceEEEEEEcCCC---hHhHHHHHHHHH-HHHhcCCCceeeeEeEEEeCCeeEEEEecCCC
Q 014024          115 NKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS---GQEIKELKNEAS-VIAQVQHKNLVKLLGCCIEKDERLLIYEYMPN  188 (432)
Q Consensus       115 ~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  188 (432)
                      +.||+|+||.||+|.+..  ..+|+|++....   ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            469999999999999854  489999985432   122334444544 56789999999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCccc
Q 014024          189 KSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDE  268 (432)
Q Consensus       189 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  268 (432)
                      |+|.+++..   +..+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||++......     
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-----  149 (323)
T cd05575          81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-----  149 (323)
T ss_pred             CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC-----
Confidence            999998853   345899999999999999999999998   999999999999999999999999998753111     


Q ss_pred             cccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhhhh
Q 014024          269 LQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLE  348 (432)
Q Consensus       269 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  348 (432)
                       ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.......      ...        .+..... 
T Consensus       150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~------~~~--------~i~~~~~-  213 (323)
T cd05575         150 -SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE------MYD--------NILNKPL-  213 (323)
T ss_pred             -CCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH------HHH--------HHHcCCC-
Confidence             112334578999999999999999999999999999999999999985322100      000        0000000 


Q ss_pred             hcccHHHHHHHHHHHHHhhccCCCCCCCHH
Q 014024          349 EASFNESLSRYVHIALLCVQERAEDRPTMS  378 (432)
Q Consensus       349 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~  378 (432)
                       ......+..+.+++.+||+.||.+||++.
T Consensus       214 -~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         214 -RLKPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             -CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence             11122356788999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.4e-39  Score=304.32  Aligned_cols=258  Identities=24%  Similarity=0.349  Sum_probs=206.1

Q ss_pred             CCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCC---ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEE
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGK---SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  183 (432)
                      ++|++.+.||+|++|.||+|...  +..+++|.+...   .....+.+.+|++++++++|+|++++++++.+.+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            68999999999999999999986  448999977432   2344667899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccC
Q 014024          184 EYMPNKSLDCFLFDP-TKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFG  262 (432)
Q Consensus       184 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  262 (432)
                      ||+++++|.+++... .....+++..++.++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            999999999988543 22345899999999999999999999998   99999999999999999999999999876422


Q ss_pred             CCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhh
Q 014024          263 GNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDL  342 (432)
Q Consensus       263 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                      ..      .......++..|+|||.+.+..++.++|+||||+++|+|++|+.|+......   ....          .+.
T Consensus       159 ~~------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~----------~~~  219 (267)
T cd08224         159 KT------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSL----------CKK  219 (267)
T ss_pred             CC------cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc---HHHH----------Hhh
Confidence            11      1122346788999999999888999999999999999999999997432211   1000          000


Q ss_pred             hhhhhhhcccH-HHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014024          343 IDSVLEEASFN-ESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEA  388 (432)
Q Consensus       343 i~~~l~~~~~~-~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~  388 (432)
                      +........+. ..+..+.+++.+||+.+|++|||+.+|++.|+++.
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         220 IEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             hhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            00101111111 34567889999999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.6e-40  Score=305.74  Aligned_cols=267  Identities=20%  Similarity=0.247  Sum_probs=216.1

Q ss_pred             hhhCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCCC---hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeE
Q 014024          106 SATGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKS---GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERL  180 (432)
Q Consensus       106 ~~~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  180 (432)
                      -..++|++++.||+|.-|+||++++.+.  .+|+|++.+..   .....+.+.|-+||+.++||.++.+|..|+.++..|
T Consensus        74 l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~c  153 (459)
T KOG0610|consen   74 LGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSC  153 (459)
T ss_pred             cCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeE
Confidence            3456789999999999999999999775  78999996553   334556778999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceec
Q 014024          181 LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIV  260 (432)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  260 (432)
                      ++||||+||+|....+... .+.+++..++.++.+++-||+|||-.|   ||+|||||+||||.++|++-|+||.++...
T Consensus       154 l~meyCpGGdL~~LrqkQp-~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~  229 (459)
T KOG0610|consen  154 LVMEYCPGGDLHSLRQKQP-GKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRC  229 (459)
T ss_pred             EEEecCCCccHHHHHhhCC-CCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccC
Confidence            9999999999999887644 445999999999999999999999999   999999999999999999999999998764


Q ss_pred             cCCC-------------------------------C-c------------------cccccccccccccCCccChhhhcc
Q 014024          261 FGGN-------------------------------D-E------------------DELQGNTSRISGTYGYMSPEYALE  290 (432)
Q Consensus       261 ~~~~-------------------------------~-~------------------~~~~~~~~~~~gt~~y~aPE~~~~  290 (432)
                      ....                               . .                  ..........+||-.|.|||++.+
T Consensus       230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G  309 (459)
T KOG0610|consen  230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG  309 (459)
T ss_pred             CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence            1100                               0 0                  001123345789999999999999


Q ss_pred             CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccC
Q 014024          291 GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQER  370 (432)
Q Consensus       291 ~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~d  370 (432)
                      ...+.++|.|+||+++|||+.|..||.....              ......++.+.+.-...+.....+.+||...|.+|
T Consensus       310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~--------------~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKd  375 (459)
T KOG0610|consen  310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNN--------------KETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKD  375 (459)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCcCCCCc--------------hhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccC
Confidence            9999999999999999999999999853322              22334444444433333355678899999999999


Q ss_pred             CCCCCC----HHHHHHH--hcccccC
Q 014024          371 AEDRPT----MSDVVSM--LTNEASS  390 (432)
Q Consensus       371 p~~RPt----~~evl~~--L~~~~~~  390 (432)
                      |.+|..    +.||-+|  +++...+
T Consensus       376 P~kRlg~~rGA~eIK~HpFF~gVnWa  401 (459)
T KOG0610|consen  376 PSKRLGSKRGAAEIKRHPFFEGVNWA  401 (459)
T ss_pred             hhhhhccccchHHhhcCccccCCChh
Confidence            999998    8888873  4555444

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1e-39  Score=303.97  Aligned_cols=248  Identities=26%  Similarity=0.408  Sum_probs=194.6

Q ss_pred             eeccCCcEEEEEEEEC--C--ceEEEEEEcCCC-hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecCCCCC
Q 014024          116 KLGEGGFGTVYKGVIG--Q--GEIAVKRLLGKS-GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKS  190 (432)
Q Consensus       116 ~ig~G~~g~Vy~~~~~--~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  190 (432)
                      .||+|+||.||+|.+.  +  ..+|+|.+.... ....+.+.+|+.++++++|+||+++++++. .+..++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            3899999999999764  2  258999886553 334567899999999999999999999885 457899999999999


Q ss_pred             hhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCccccc
Q 014024          191 LDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQ  270 (432)
Q Consensus       191 L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  270 (432)
                      |.+++...  ...+++..++.++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++.........   .
T Consensus        81 L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~---~  152 (257)
T cd05115          81 LNKFLSGK--KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY---Y  152 (257)
T ss_pred             HHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccc---e
Confidence            99998542  335899999999999999999999998   999999999999999999999999999754221111   1


Q ss_pred             cccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchhhhhhhhhhh
Q 014024          271 GNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEE  349 (432)
Q Consensus       271 ~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  349 (432)
                      .......++..|+|||.+.+..++.++||||||+++|+|++ |..||......               .....+......
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---------------~~~~~~~~~~~~  217 (257)
T cd05115         153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP---------------EVMSFIEQGKRL  217 (257)
T ss_pred             eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH---------------HHHHHHHCCCCC
Confidence            11112233578999999988889999999999999999996 99997532211               111111111222


Q ss_pred             cccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014024          350 ASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNE  387 (432)
Q Consensus       350 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~  387 (432)
                      ..+..++.++.+++..||..+|++||++.+|.+.|+..
T Consensus       218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            23344567888999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=7.9e-40  Score=305.11  Aligned_cols=253  Identities=30%  Similarity=0.473  Sum_probs=201.5

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECCc-eEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecC
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYM  186 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~~-~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  186 (432)
                      .++|++.++||+|+||.||+|...++ .+++|.+..... ..+.+.+|+.++++++|+|++++++++. .+..+++|||+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM   82 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence            46789999999999999999998654 899998865433 3467889999999999999999999874 45689999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCc
Q 014024          187 PNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDE  266 (432)
Q Consensus       187 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  266 (432)
                      ++++|.+++.... ...+++.++..++.|++.||+|||+.+   ++||||||+||++++++.++|+|||++.......  
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--  156 (260)
T cd05067          83 ENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNE--  156 (260)
T ss_pred             CCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCC--
Confidence            9999999986533 345899999999999999999999998   9999999999999999999999999997642111  


Q ss_pred             cccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchhhhhhh
Q 014024          267 DELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDS  345 (432)
Q Consensus       267 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  345 (432)
                         ........++..|+|||++.+..++.++||||||+++|||++ |+.||......               .....+..
T Consensus       157 ---~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---------------~~~~~~~~  218 (260)
T cd05067         157 ---YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP---------------EVIQNLER  218 (260)
T ss_pred             ---cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH---------------HHHHHHHc
Confidence               111123345678999999998899999999999999999999 99997532211               00111111


Q ss_pred             hhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014024          346 VLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN  386 (432)
Q Consensus       346 ~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~  386 (432)
                      ......+...+.++.+++.+||..+|++||+++++++.|+.
T Consensus       219 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         219 GYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            11112223345679999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-40  Score=325.51  Aligned_cols=257  Identities=21%  Similarity=0.263  Sum_probs=195.7

Q ss_pred             CCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC---ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEE
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK---SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  183 (432)
                      ++|++.+.||+|+||.||++....  ..+|+|++...   .....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            478999999999999999998754  37999988543   2234567888999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCC
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGG  263 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  263 (432)
                      ||+++|+|.+++..   .+.+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  154 (377)
T cd05629          81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ  154 (377)
T ss_pred             eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence            99999999999853   345899999999999999999999999   999999999999999999999999999643211


Q ss_pred             CCcc----------cc-------------------------------ccccccccccCCccChhhhccCCCCchhhhHHH
Q 014024          264 NDED----------EL-------------------------------QGNTSRISGTYGYMSPEYALEGIFSIKSDVFSF  302 (432)
Q Consensus       264 ~~~~----------~~-------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSl  302 (432)
                      ....          ..                               ........||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  234 (377)
T cd05629         155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL  234 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence            0000          00                               000012469999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCC---CCHHH
Q 014024          303 GVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDR---PTMSD  379 (432)
Q Consensus       303 G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~R---Pt~~e  379 (432)
                      ||++|||++|..||.......  ..    ......      ...+..........++.+++..|++ +|.+|   +++.|
T Consensus       235 Gvil~elltG~~Pf~~~~~~~--~~----~~i~~~------~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~  301 (377)
T cd05629         235 GAIMFECLIGWPPFCSENSHE--TY----RKIINW------RETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHE  301 (377)
T ss_pred             chhhhhhhcCCCCCCCCCHHH--HH----HHHHcc------CCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHH
Confidence            999999999999985322110  00    000000      0000000011234567889999997 66665   59999


Q ss_pred             HHHHh
Q 014024          380 VVSML  384 (432)
Q Consensus       380 vl~~L  384 (432)
                      ++++-
T Consensus       302 ~l~hp  306 (377)
T cd05629         302 IKSHP  306 (377)
T ss_pred             HhcCC
Confidence            99864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-39  Score=303.86  Aligned_cols=249  Identities=35%  Similarity=0.481  Sum_probs=195.6

Q ss_pred             ceeccCCcEEEEEEEECC-----ceEEEEEEcCCCh-HhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecCCC
Q 014024          115 NKLGEGGFGTVYKGVIGQ-----GEIAVKRLLGKSG-QEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPN  188 (432)
Q Consensus       115 ~~ig~G~~g~Vy~~~~~~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  188 (432)
                      ++||+|+||.||+|....     ..+++|.+..... ...+.+.+|+++++.++|+|++++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            469999999999997532     3689998865543 35567899999999999999999999875 4567999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCccc
Q 014024          189 KSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDE  268 (432)
Q Consensus       189 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  268 (432)
                      ++|.+++...   ..+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||++.........  
T Consensus        80 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~--  151 (257)
T cd05060          80 GPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY--  151 (257)
T ss_pred             CcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcc--
Confidence            9999999543   35899999999999999999999998   999999999999999999999999999865322111  


Q ss_pred             cccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchhhhhhhhh
Q 014024          269 LQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVL  347 (432)
Q Consensus       269 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  347 (432)
                       ........++..|+|||.+.+..++.++||||||+++|+|++ |..||......  ....             .+....
T Consensus       152 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~--~~~~-------------~~~~~~  215 (257)
T cd05060         152 -YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA--EVIA-------------MLESGE  215 (257)
T ss_pred             -cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH--HHHH-------------HHHcCC
Confidence             111112233567999999998999999999999999999998 99997543221  1111             111111


Q ss_pred             hhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014024          348 EEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEA  388 (432)
Q Consensus       348 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~  388 (432)
                      ....+...+..+.+++.+||+.+|++||++.++++.|+++.
T Consensus       216 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         216 RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence            11222334567889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=5.5e-40  Score=313.91  Aligned_cols=261  Identities=28%  Similarity=0.411  Sum_probs=204.7

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC---------ceEEEEEEcCC-ChHhHHHHHHHHHHHHhc-CCCceeeeEeEEEeC
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ---------GEIAVKRLLGK-SGQEIKELKNEASVIAQV-QHKNLVKLLGCCIEK  176 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~---------~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  176 (432)
                      .++|.+.+.||+|+||.||++...+         ..+|+|.+... .......+.+|+++++.+ +|+||+++++++.+.
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            4689999999999999999998532         25899988654 344556788899999999 799999999999999


Q ss_pred             CeeEEEEecCCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEE
Q 014024          177 DERLLIYEYMPNKSLDCFLFDPTK-------------REILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILL  243 (432)
Q Consensus       177 ~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll  243 (432)
                      +..++||||+++|+|.+++.....             ...+++.+++.++.|++.||+|||+.+   ++||||||+||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence            999999999999999999964321             234889999999999999999999998   9999999999999


Q ss_pred             cCCCCEEEeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCcccc
Q 014024          244 DKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTK  322 (432)
Q Consensus       244 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~  322 (432)
                      ++++.+||+|||++........    ........+++.|+|||.+.+..++.++|+|||||++|+|++ |+.||......
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~  249 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDY----YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE  249 (307)
T ss_pred             cCCCcEEECCCcccccccccch----hhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence            9999999999999875421110    011112234568999999998889999999999999999998 78886422110


Q ss_pred             ccchhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccccC
Q 014024          323 SLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASS  390 (432)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~  390 (432)
                                     ...+.+........+.....++.+++..||+.+|++|||+.++++.|+.+...
T Consensus       250 ---------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~  302 (307)
T cd05098         250 ---------------ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL  302 (307)
T ss_pred             ---------------HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence                           01111111111122234456888999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=3.9e-40  Score=314.34  Aligned_cols=257  Identities=27%  Similarity=0.394  Sum_probs=200.4

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECCc----eEEEEEEcCC-ChHhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeeEE
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQG----EIAVKRLLGK-SGQEIKELKNEASVIAQV-QHKNLVKLLGCCIEKDERLL  181 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l  181 (432)
                      .++|++.+.||+|+||.||+|.+...    .+++|.+... .......+.+|++++.++ +|+||+++++++.+.+..++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            35788999999999999999987432    4577776543 344556788999999999 89999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCC
Q 014024          182 IYEYMPNKSLDCFLFDPT-------------KREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN  248 (432)
Q Consensus       182 v~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~  248 (432)
                      ||||+++++|.+++....             ....+++..++.++.|++.||+|||+.+   ++||||||+|||+++++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence            999999999999986432             1235889999999999999999999998   999999999999999999


Q ss_pred             EEEeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchh
Q 014024          249 SKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLI  327 (432)
Q Consensus       249 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~  327 (432)
                      +||+|||++.....       ........++..|+|||++.+..++.++|||||||++|||+| |..||......+  . 
T Consensus       163 ~kl~dfg~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~-  232 (303)
T cd05088         163 AKIADFGLSRGQEV-------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--L-  232 (303)
T ss_pred             EEeCccccCcccch-------hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH--H-
Confidence            99999999863210       001111234567999999988889999999999999999998 998874322110  0 


Q ss_pred             hhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccc
Q 014024          328 GYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS  389 (432)
Q Consensus       328 ~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~  389 (432)
                        .          +.+........+...+..+.+++.+||+.+|++||++.++++.|+.+..
T Consensus       233 --~----------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~  282 (303)
T cd05088         233 --Y----------EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  282 (303)
T ss_pred             --H----------HHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence              0          0000001111112234578899999999999999999999999987644

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1e-39  Score=306.19  Aligned_cols=255  Identities=25%  Similarity=0.466  Sum_probs=196.4

Q ss_pred             CCcCceeccCCcEEEEEEEECCc----eEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeC------Ce
Q 014024          111 FSAANKLGEGGFGTVYKGVIGQG----EIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEK------DE  178 (432)
Q Consensus       111 y~~~~~ig~G~~g~Vy~~~~~~~----~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~  178 (432)
                      |.+.+.||+|+||.||+|.+...    .+|+|.+...  .....+.+.+|+++++.++|+||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            35678999999999999997543    5888877543  345567889999999999999999999987532      24


Q ss_pred             eEEEEecCCCCChhhhhcCC---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecc
Q 014024          179 RLLIYEYMPNKSLDCFLFDP---TKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFG  255 (432)
Q Consensus       179 ~~lv~e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  255 (432)
                      .+++|||+++|+|.+++...   .....+++.....++.|++.||+|||+.+   |+||||||+||++++++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence            68999999999999887422   12334899999999999999999999998   9999999999999999999999999


Q ss_pred             cceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhh
Q 014024          256 MARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLW  334 (432)
Q Consensus       256 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~  334 (432)
                      ++........    ........+++.|+|||...+..++.++||||||+++|||++ |+.||......  ..    ....
T Consensus       158 ~~~~~~~~~~----~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~----~~~~  227 (272)
T cd05075         158 LSKKIYNGDY----YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS--EI----YDYL  227 (272)
T ss_pred             cccccCcccc----eecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH--HH----HHHH
Confidence            9986522111    011122345678999999999999999999999999999999 78887532211  11    1111


Q ss_pred             hccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014024          335 ISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNE  387 (432)
Q Consensus       335 ~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~  387 (432)
                      .....         ...+...+..+.+++.+||+.||++|||+.++++.|+++
T Consensus       228 ~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         228 RQGNR---------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             HcCCC---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            11100         011223456688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.4e-39  Score=303.58  Aligned_cols=252  Identities=28%  Similarity=0.459  Sum_probs=199.6

Q ss_pred             CCCCcCceeccCCcEEEEEEEECCc-eEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecCC
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMP  187 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~~-~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  187 (432)
                      ++|++.+.||+|++|.||+|.+.++ .+++|.+.... ...+.+.+|+++++.++|+|++++++++. .+..+++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence            5688899999999999999998665 78999875433 23467889999999999999999999875 456789999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCcc
Q 014024          188 NKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDED  267 (432)
Q Consensus       188 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  267 (432)
                      +++|.+++.... ...+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||++........  
T Consensus        84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~--  157 (260)
T cd05069          84 KGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY--  157 (260)
T ss_pred             CCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcc--
Confidence            999999996532 234899999999999999999999998   99999999999999999999999999976422111  


Q ss_pred             ccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchhhhhhhh
Q 014024          268 ELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSV  346 (432)
Q Consensus       268 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  346 (432)
                         .......++..|+|||...+..++.++|+||||+++|+|++ |..||......  ...             ..+...
T Consensus       158 ---~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~-------------~~~~~~  219 (260)
T cd05069         158 ---TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR--EVL-------------EQVERG  219 (260)
T ss_pred             ---cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHH-------------HHHHcC
Confidence               11122345678999999998999999999999999999999 88887432110  000             001111


Q ss_pred             hhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014024          347 LEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN  386 (432)
Q Consensus       347 l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~  386 (432)
                      .....+...+..+.+++.+||+.||++||++++|++.|++
T Consensus       220 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         220 YRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            1111223445778999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.4e-40  Score=305.17  Aligned_cols=253  Identities=25%  Similarity=0.365  Sum_probs=200.6

Q ss_pred             CCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCC-----hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEE
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS-----GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLL  181 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  181 (432)
                      ++|.+.+.||+|++|.||.+.+..  ..+++|.+....     ....+.+.+|++++++++|+||+++++++.+.+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            579999999999999999998743  489999875432     2234578899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceecc
Q 014024          182 IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVF  261 (432)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  261 (432)
                      |+||+++++|.+++..   ...+++.....++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++....
T Consensus        82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            9999999999998843   345889999999999999999999998   9999999999999999999999999987642


Q ss_pred             CCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhh
Q 014024          262 GGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIID  341 (432)
Q Consensus       262 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (432)
                      .....   ........++..|+|||++.+..++.++||||||+++|+|++|+.||......     ....         .
T Consensus       156 ~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~---------~  218 (263)
T cd06625         156 TICSS---GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM-----AAIF---------K  218 (263)
T ss_pred             ccccc---cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH-----HHHH---------H
Confidence            21110   11112345788999999999988999999999999999999999997432110     0000         0


Q ss_pred             hhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          342 LIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       342 ~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                      ..........+......+.+++.+||..+|++|||+.+++++.
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~  261 (263)
T cd06625         219 IATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHF  261 (263)
T ss_pred             HhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence            0000011112233456788999999999999999999999764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=3.5e-40  Score=317.28  Aligned_cols=240  Identities=25%  Similarity=0.330  Sum_probs=192.7

Q ss_pred             ceeccCCcEEEEEEEECCc--eEEEEEEcCC---ChHhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeeEEEEecCCC
Q 014024          115 NKLGEGGFGTVYKGVIGQG--EIAVKRLLGK---SGQEIKELKNEASVIAQV-QHKNLVKLLGCCIEKDERLLIYEYMPN  188 (432)
Q Consensus       115 ~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  188 (432)
                      ++||+|+||.||+|.+.+.  .+|+|.+...   .....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            4699999999999998653  7999988543   233445677888988876 799999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCccc
Q 014024          189 KSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDE  268 (432)
Q Consensus       189 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  268 (432)
                      ++|..++..   ...+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++......     
T Consensus        81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~-----  149 (321)
T cd05591          81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILN-----  149 (321)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccC-----
Confidence            999988843   345899999999999999999999999   999999999999999999999999998753211     


Q ss_pred             cccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhhhh
Q 014024          269 LQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLE  348 (432)
Q Consensus       269 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  348 (432)
                       ........||+.|+|||++.+..++.++|||||||++|+|++|+.||......                  +.+.....
T Consensus       150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~------------------~~~~~i~~  210 (321)
T cd05591         150 -GVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED------------------DLFESILH  210 (321)
T ss_pred             -CccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH------------------HHHHHHHc
Confidence             11223456899999999999999999999999999999999999998532211                  01111110


Q ss_pred             h--cccHHHHHHHHHHHHHhhccCCCCCC-------CHHHHHHHh
Q 014024          349 E--ASFNESLSRYVHIALLCVQERAEDRP-------TMSDVVSML  384 (432)
Q Consensus       349 ~--~~~~~~~~~l~~l~~~cl~~dp~~RP-------t~~evl~~L  384 (432)
                      .  ..+.....++.+++..||+.||++||       ++.+++++-
T Consensus       211 ~~~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp  255 (321)
T cd05591         211 DDVLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHP  255 (321)
T ss_pred             CCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCC
Confidence            0  01122346788999999999999999       888888653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=5.2e-40  Score=316.37  Aligned_cols=246  Identities=25%  Similarity=0.311  Sum_probs=194.8

Q ss_pred             CCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCCC---hHhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeeEEEE
Q 014024          110 NFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKS---GQEIKELKNEASVIAQV-QHKNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       110 ~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  183 (432)
                      +|++.+.||+|+||.||+|.+.+.  .+|+|.+....   ....+.+..|..++..+ +|++|+++++++.+.+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            588899999999999999998654  79999886432   23344567788888877 5899999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCC
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGG  263 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  263 (432)
                      ||+++|+|.+++..   ...+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++......
T Consensus        81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~  154 (323)
T cd05616          81 EYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD  154 (323)
T ss_pred             cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence            99999999988843   345899999999999999999999998   999999999999999999999999998753111


Q ss_pred             CCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhh
Q 014024          264 NDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLI  343 (432)
Q Consensus       264 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i  343 (432)
                            ........||+.|+|||++.+..++.++|||||||++|||+||+.||......  ....            .+.
T Consensus       155 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~--~~~~------------~i~  214 (323)
T cd05616         155 ------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--ELFQ------------SIM  214 (323)
T ss_pred             ------CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH--HHHH------------HHH
Confidence                  11233457899999999999999999999999999999999999998533211  0000            000


Q ss_pred             hhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHHH
Q 014024          344 DSVLEEASFNESLSRYVHIALLCVQERAEDRPTM-----SDVVSM  383 (432)
Q Consensus       344 ~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~-----~evl~~  383 (432)
                      ..  ....+.....++.+++.+||+.||++|++.     .++.++
T Consensus       215 ~~--~~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05616         215 EH--NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  257 (323)
T ss_pred             hC--CCCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence            00  011122345678899999999999999985     566543

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=5e-40  Score=328.61  Aligned_cols=261  Identities=19%  Similarity=0.298  Sum_probs=190.5

Q ss_pred             hhhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeC-------
Q 014024          106 SATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEK-------  176 (432)
Q Consensus       106 ~~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-------  176 (432)
                      ...++|++.+.||+|+||.||+|....  ..||+|++....    ....+|+.+++.++|+||+++++++...       
T Consensus        63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~  138 (440)
T PTZ00036         63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK  138 (440)
T ss_pred             CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence            345789999999999999999999754  489999885432    2345799999999999999999887432       


Q ss_pred             -CeeEEEEecCCCCChhhhhcC-CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCC-CEEEee
Q 014024          177 -DERLLIYEYMPNKSLDCFLFD-PTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDM-NSKISD  253 (432)
Q Consensus       177 -~~~~lv~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~D  253 (432)
                       ...++||||+++ +|.+++.. ......+++..+..++.|++.||+|||+.+   |+||||||+|||++.++ .+||+|
T Consensus       139 ~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~D  214 (440)
T PTZ00036        139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCD  214 (440)
T ss_pred             ceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeec
Confidence             246789999975 56555532 123445999999999999999999999999   99999999999998665 699999


Q ss_pred             cccceeccCCCCccccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHH
Q 014024          254 FGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWD  332 (432)
Q Consensus       254 fg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~  332 (432)
                      ||+++.+....       ......||+.|+|||++.+ ..++.++|||||||++|||++|..||......+ .+.. ...
T Consensus       215 FGla~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~-~~~~-i~~  285 (440)
T PTZ00036        215 FGSAKNLLAGQ-------RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD-QLVR-IIQ  285 (440)
T ss_pred             cccchhccCCC-------CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHH-HHH
Confidence            99998653211       1233567999999998875 468999999999999999999999985432211 0000 000


Q ss_pred             hhhcc----------chh-----hhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          333 LWISN----------KII-----DLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       333 ~~~~~----------~~~-----~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      .....          ...     ......+....+...+.++.+|+.+||+.||.+|||+.|++++
T Consensus       286 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        286 VLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             HhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence            00000          000     0000111111122234678899999999999999999999975

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=7e-40  Score=312.70  Aligned_cols=261  Identities=27%  Similarity=0.405  Sum_probs=204.5

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEEC---------CceEEEEEEcCC-ChHhHHHHHHHHHHHHhc-CCCceeeeEeEEEe
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIG---------QGEIAVKRLLGK-SGQEIKELKNEASVIAQV-QHKNLVKLLGCCIE  175 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~---------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~  175 (432)
                      ..++|.+.+.||+|+||.||+|...         ...+++|..... .....+.+.+|+.+++.+ +|+||+++++++..
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   92 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   92 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence            4678899999999999999999742         125888887643 234567789999999999 89999999999999


Q ss_pred             CCeeEEEEecCCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEE
Q 014024          176 KDERLLIYEYMPNKSLDCFLFDPTK-------------REILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNIL  242 (432)
Q Consensus       176 ~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIl  242 (432)
                      ....+++|||+++|+|.+++.....             ...+++..+..++.|++.||.|||+.+   ++||||||+||+
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil  169 (304)
T cd05101          93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVL  169 (304)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEE
Confidence            9999999999999999999864321             234788999999999999999999998   999999999999


Q ss_pred             EcCCCCEEEeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccc
Q 014024          243 LDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRT  321 (432)
Q Consensus       243 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~  321 (432)
                      +++++.+||+|||++........    ........++..|+|||++.+..++.++||||||+++|+|++ |..|+.....
T Consensus       170 i~~~~~~kl~D~g~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~  245 (304)
T cd05101         170 VTENNVMKIADFGLARDVNNIDY----YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV  245 (304)
T ss_pred             EcCCCcEEECCCccceecccccc----cccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence            99999999999999986522111    111222345678999999998889999999999999999998 7777642211


Q ss_pred             cccchhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccc
Q 014024          322 KSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS  389 (432)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~  389 (432)
                      .               ...+.+........+..++..+.+++.+||+.+|.+|||+.|+++.|+++..
T Consensus       246 ~---------------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~  298 (304)
T cd05101         246 E---------------ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT  298 (304)
T ss_pred             H---------------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence            0               0011111111111223455778899999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=3.9e-40  Score=316.75  Aligned_cols=241  Identities=23%  Similarity=0.334  Sum_probs=191.0

Q ss_pred             ceeccCCcEEEEEEEECC--ceEEEEEEcCC---ChHhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeeEEEEecCCC
Q 014024          115 NKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK---SGQEIKELKNEASVIAQV-QHKNLVKLLGCCIEKDERLLIYEYMPN  188 (432)
Q Consensus       115 ~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  188 (432)
                      +.||+|+||.||+|.+..  ..+|+|++...   .....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            469999999999999854  37999988543   223455677888888876 699999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCccc
Q 014024          189 KSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDE  268 (432)
Q Consensus       189 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  268 (432)
                      |+|.+++..   ...+++..+..++.|++.||+|||+.+   ++||||||+|||+++++.+||+|||++......     
T Consensus        81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~-----  149 (320)
T cd05590          81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN-----  149 (320)
T ss_pred             chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC-----
Confidence            999988843   345899999999999999999999998   999999999999999999999999998753111     


Q ss_pred             cccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhhhh
Q 014024          269 LQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLE  348 (432)
Q Consensus       269 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  348 (432)
                       ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.......  .    ........          
T Consensus       150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~--~----~~~i~~~~----------  212 (320)
T cd05590         150 -GKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD--L----FEAILNDE----------  212 (320)
T ss_pred             -CCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH--H----HHHHhcCC----------
Confidence             112334578999999999999999999999999999999999999985322110  0    00000000          


Q ss_pred             hcccHHHHHHHHHHHHHhhccCCCCCCCH------HHHHHH
Q 014024          349 EASFNESLSRYVHIALLCVQERAEDRPTM------SDVVSM  383 (432)
Q Consensus       349 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt~------~evl~~  383 (432)
                      ...+.....++.+++..||+.||++||++      .+++++
T Consensus       213 ~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h  253 (320)
T cd05590         213 VVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH  253 (320)
T ss_pred             CCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence            01122234678899999999999999998      666654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.2e-39  Score=308.78  Aligned_cols=260  Identities=27%  Similarity=0.431  Sum_probs=202.0

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECC-------ceEEEEEEcCCC-hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCe
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQ-------GEIAVKRLLGKS-GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDE  178 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~-------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  178 (432)
                      ..++|++.+.||+|+||.||+|...+       ..+|+|.+.... ......+.+|+.+++.++|+||+++++++.+.+.
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            46789999999999999999997532       268999875443 3344567889999999999999999999999999


Q ss_pred             eEEEEecCCCCChhhhhcCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEE
Q 014024          179 RLLIYEYMPNKSLDCFLFDPT-------KREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKI  251 (432)
Q Consensus       179 ~~lv~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  251 (432)
                      .++||||+++|+|.+++....       ....+++..+..++.|++.||.|||+++   ++||||||+||++++++.++|
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence            999999999999999996422       1234577888999999999999999998   999999999999999999999


Q ss_pred             eecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhh
Q 014024          252 SDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYA  330 (432)
Q Consensus       252 ~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~  330 (432)
                      +|||+++.......    ........++..|+|||.+.++.++.++|+|||||++|||++ |..||......  ..    
T Consensus       161 ~Dfg~~~~~~~~~~----~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~--~~----  230 (288)
T cd05061         161 GDFGMTRDIYETDY----YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE--QV----  230 (288)
T ss_pred             CcCCcccccccccc----ccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH--HH----
Confidence            99999876422111    111122345678999999999999999999999999999999 67776432111  00    


Q ss_pred             HHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014024          331 WDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEA  388 (432)
Q Consensus       331 ~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~  388 (432)
                               .+.+...-....+...+..+.+++.+||+.||++|||+.++++.|++..
T Consensus       231 ---------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         231 ---------LKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             ---------HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence                     0100000000112233567899999999999999999999999998854

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-39  Score=302.93  Aligned_cols=249  Identities=35%  Similarity=0.542  Sum_probs=201.5

Q ss_pred             ceeccCCcEEEEEEEEC-----CceEEEEEEcCCChH-hHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecCCC
Q 014024          115 NKLGEGGFGTVYKGVIG-----QGEIAVKRLLGKSGQ-EIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPN  188 (432)
Q Consensus       115 ~~ig~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  188 (432)
                      +.||+|+||.||+|...     +..+++|.+...... ..+.+.+|++.++.++|+|++++++++.+....+++|||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            46999999999999986     448999998665433 367889999999999999999999999999999999999999


Q ss_pred             CChhhhhcCCCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccC
Q 014024          189 KSLDCFLFDPTK------REILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFG  262 (432)
Q Consensus       189 gsL~~~l~~~~~------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  262 (432)
                      ++|.+++.....      ...+++..++.++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence            999999965421      256999999999999999999999998   99999999999999999999999999987532


Q ss_pred             CCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchhh
Q 014024          263 GNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIID  341 (432)
Q Consensus       263 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (432)
                      ...    ........++..|+|||.+....++.++||||||+++|+|++ |..||.......               ..+
T Consensus       158 ~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---------------~~~  218 (262)
T cd00192         158 DDY----YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE---------------VLE  218 (262)
T ss_pred             ccc----cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH---------------HHH
Confidence            211    112334567889999999998899999999999999999999 588875432110               001


Q ss_pred             hhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014024          342 LIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLT  385 (432)
Q Consensus       342 ~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~  385 (432)
                      .+........+...+.++.+++.+||+.+|.+|||+.|++++|+
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         219 YLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             HHHcCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            11111111223344678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.4e-39  Score=302.47  Aligned_cols=249  Identities=20%  Similarity=0.277  Sum_probs=200.0

Q ss_pred             CCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecC
Q 014024          110 NFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYM  186 (432)
Q Consensus       110 ~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  186 (432)
                      +|++.+.||+|+||.||++.+..  ..+++|.+... .....+.+.+|+.+++.++|+|++++++.+.+.+..+++|||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            57889999999999999998754  48999987533 3445677889999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCc
Q 014024          187 PNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDE  266 (432)
Q Consensus       187 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  266 (432)
                      ++++|.+++... ....+++.....++.|++.||.|||+.+   ++|+||||+||++++++.++++|||++......   
T Consensus        81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~---  153 (255)
T cd08219          81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP---  153 (255)
T ss_pred             CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccc---
Confidence            999999988542 2334889999999999999999999998   999999999999999999999999999764221   


Q ss_pred             cccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhh
Q 014024          267 DELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSV  346 (432)
Q Consensus       267 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  346 (432)
                         ........|++.|+|||++.+..++.++|+||||+++|+|++|..||......     ......          ...
T Consensus       154 ---~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-----~~~~~~----------~~~  215 (255)
T cd08219         154 ---GAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK-----NLILKV----------CQG  215 (255)
T ss_pred             ---ccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH-----HHHHHH----------hcC
Confidence               11123356888999999999889999999999999999999999998532110     000000          000


Q ss_pred             hhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          347 LEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       347 l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      .....+......+.+++.+||+.||++||++.++++.
T Consensus       216 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         216 SYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             CCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            0111122344568899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.2e-39  Score=304.96  Aligned_cols=253  Identities=25%  Similarity=0.418  Sum_probs=200.4

Q ss_pred             CCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCCh---------HhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCe
Q 014024          110 NFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSG---------QEIKELKNEASVIAQVQHKNLVKLLGCCIEKDE  178 (432)
Q Consensus       110 ~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  178 (432)
                      +|.+.+.||+|++|.||+|.+..  ..+++|.+.....         ...+.+.+|+.++++++|+||+++++++.+.+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            47888999999999999998744  4899998854321         233568899999999999999999999999999


Q ss_pred             eEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccce
Q 014024          179 RLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMAR  258 (432)
Q Consensus       179 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  258 (432)
                      .+++|||+++++|.+++..   .+.+++..+..++.|++.||+|||+.+   ++||||+|+||++++++.++|+|||.+.
T Consensus        81 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~  154 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK  154 (267)
T ss_pred             cEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence            9999999999999999943   345889999999999999999999998   9999999999999999999999999998


Q ss_pred             eccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccc
Q 014024          259 IVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNK  338 (432)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  338 (432)
                      ...................|+..|+|||.+.+..++.++|+||||+++|+|++|+.||.......     ..        
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~--------  221 (267)
T cd06628         155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ-----AI--------  221 (267)
T ss_pred             ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH-----HH--------
Confidence            75322111111112223468889999999998889999999999999999999999985322100     00        


Q ss_pred             hhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          339 IIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       339 ~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                       ..... ......+...+..+.+++.+||+.||.+||++.+++++
T Consensus       222 -~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         222 -FKIGE-NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             -HHHhc-cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence             00000 11112223445778899999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=9.5e-40  Score=307.95  Aligned_cols=261  Identities=25%  Similarity=0.399  Sum_probs=205.5

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECC------ceEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEe-CCe
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQ------GEIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIE-KDE  178 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~------~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~  178 (432)
                      ..++|++.+.||+|+||.||+|.+.+      ..+++|.+... .....+.+.+|+.+++.++|+|++++++++.+ ...
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            35789999999999999999999765      37888887544 34556778999999999999999999998876 467


Q ss_pred             eEEEEecCCCCChhhhhcCCCCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEee
Q 014024          179 RLLIYEYMPNKSLDCFLFDPTKR-----EILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISD  253 (432)
Q Consensus       179 ~~lv~e~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  253 (432)
                      .++++||+++++|.+++......     ..+++..++.++.|++.||+|||+.+   ++|+||||+||++++++.+||+|
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence            89999999999999998543222     45899999999999999999999998   99999999999999999999999


Q ss_pred             cccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHH
Q 014024          254 FGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWD  332 (432)
Q Consensus       254 fg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  332 (432)
                      ||+++.+.....    ........++..|+|||++.+..++.++||||||+++||+++ |+.||......  ....    
T Consensus       161 ~g~~~~~~~~~~----~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~----  230 (280)
T cd05043         161 NALSRDLFPMDY----HCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF--EMAA----  230 (280)
T ss_pred             CCCcccccCCce----EEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH--HHHH----
Confidence            999986532211    111122345678999999998889999999999999999999 99987532211  1111    


Q ss_pred             hhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccc
Q 014024          333 LWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS  389 (432)
Q Consensus       333 ~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~  389 (432)
                               .+...........++.++.+++.+||..||++|||+.++++.|+++..
T Consensus       231 ---------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         231 ---------YLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             ---------HHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                     111111111122335678899999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=8.7e-40  Score=308.40  Aligned_cols=244  Identities=25%  Similarity=0.314  Sum_probs=193.4

Q ss_pred             eccCCcEEEEEEEECC--ceEEEEEEcCCC---hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecCCCCCh
Q 014024          117 LGEGGFGTVYKGVIGQ--GEIAVKRLLGKS---GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSL  191 (432)
Q Consensus       117 ig~G~~g~Vy~~~~~~--~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  191 (432)
                      ||+|+||+||++.+..  ..+|+|.+....   ....+.+..|+++++.++|+||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            6999999999998753  489999885432   22345677899999999999999999999999999999999999999


Q ss_pred             hhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCccccc
Q 014024          192 DCFLFDPT-KREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQ  270 (432)
Q Consensus       192 ~~~l~~~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  270 (432)
                      .+++.... ....+++..++.++.|++.||.|||+.+   |+||||||+||++++++.++|+|||++.......      
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~------  151 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ------  151 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCC------
Confidence            88875422 3345899999999999999999999998   9999999999999999999999999997642211      


Q ss_pred             cccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhhhh--
Q 014024          271 GNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLE--  348 (432)
Q Consensus       271 ~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~--  348 (432)
                      .......||+.|+|||.+.+..++.++|||||||++|+|++|+.||........              ..........  
T Consensus       152 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--------------~~~~~~~~~~~~  217 (280)
T cd05608         152 SKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--------------NKELKQRILNDS  217 (280)
T ss_pred             ccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--------------HHHHHHhhcccC
Confidence            122345789999999999999999999999999999999999999854322100              0000001000  


Q ss_pred             hcccHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 014024          349 EASFNESLSRYVHIALLCVQERAEDRP-----TMSDVVSM  383 (432)
Q Consensus       349 ~~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~~  383 (432)
                      ...+...+..+.+++..||+.||++||     ++.+++++
T Consensus       218 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         218 VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence            011223456788999999999999999     77788865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=7.2e-40  Score=322.82  Aligned_cols=261  Identities=27%  Similarity=0.395  Sum_probs=204.4

Q ss_pred             hhhCCCCcCceeccCCcEEEEEEEECC-------ceEEEEEEcCCC-hHhHHHHHHHHHHHHhcC-CCceeeeEeEEEeC
Q 014024          106 SATGNFSAANKLGEGGFGTVYKGVIGQ-------GEIAVKRLLGKS-GQEIKELKNEASVIAQVQ-HKNLVKLLGCCIEK  176 (432)
Q Consensus       106 ~~~~~y~~~~~ig~G~~g~Vy~~~~~~-------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~  176 (432)
                      ...++|.+.+.||+|+||.||+|.+.+       ..||+|++.... ....+.+.+|+++|.++. |+||+++++++...
T Consensus        34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~  113 (401)
T cd05107          34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG  113 (401)
T ss_pred             ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence            345678889999999999999998642       269999996543 333457889999999997 99999999999999


Q ss_pred             CeeEEEEecCCCCChhhhhcCCC---------------------------------------------------------
Q 014024          177 DERLLIYEYMPNKSLDCFLFDPT---------------------------------------------------------  199 (432)
Q Consensus       177 ~~~~lv~e~~~~gsL~~~l~~~~---------------------------------------------------------  199 (432)
                      +..++||||+++|+|.++++...                                                         
T Consensus       114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (401)
T cd05107         114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ  193 (401)
T ss_pred             CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence            99999999999999999985421                                                         


Q ss_pred             --------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCE
Q 014024          200 --------------------------------------KREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNI  241 (432)
Q Consensus       200 --------------------------------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NI  241 (432)
                                                            ....+++..+..++.|++.||+|||+.+   ++||||||+||
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~Ni  270 (401)
T cd05107         194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNV  270 (401)
T ss_pred             cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceE
Confidence                                                  1124678888999999999999999998   99999999999


Q ss_pred             EEcCCCCEEEeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCcc
Q 014024          242 LLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYR  320 (432)
Q Consensus       242 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~  320 (432)
                      |+++++.+||+|||+++.......    ........++..|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus       271 Ll~~~~~~kL~DfGla~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~  346 (401)
T cd05107         271 LICEGKLVKICDFGLARDIMRDSN----YISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP  346 (401)
T ss_pred             EEeCCCEEEEEecCcceecccccc----cccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence            999999999999999986422111    011223356788999999998889999999999999999998 888874322


Q ss_pred             ccccchhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014024          321 TKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNE  387 (432)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~  387 (432)
                      ..+.              ....+....+...+......+.+++..||+.+|++||++++|++.|+.+
T Consensus       347 ~~~~--------------~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         347 MNEQ--------------FYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             chHH--------------HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            1110              0011111111112223456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.7e-39  Score=308.58  Aligned_cols=264  Identities=27%  Similarity=0.418  Sum_probs=203.2

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC------------------ceEEEEEEcCCC-hHhHHHHHHHHHHHHhcCCCceee
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ------------------GEIAVKRLLGKS-GQEIKELKNEASVIAQVQHKNLVK  168 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~------------------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~  168 (432)
                      .++|++.+.||+|+||.||+|.+.+                  ..+++|.+.... ....+.+.+|++++++++|+|+++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            4689999999999999999998653                  247889886543 445678899999999999999999


Q ss_pred             eEeEEEeCCeeEEEEecCCCCChhhhhcCCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCC
Q 014024          169 LLGCCIEKDERLLIYEYMPNKSLDCFLFDPT--------KREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASN  240 (432)
Q Consensus       169 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~N  240 (432)
                      +++++..++..+++|||+++++|.+++....        ....+++..++.++.|++.||+|||+.+   ++|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence            9999999999999999999999999986432        1225899999999999999999999998   9999999999


Q ss_pred             EEEcCCCCEEEeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh--CCCCCCC
Q 014024          241 ILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS--GKKNTGF  318 (432)
Q Consensus       241 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt--g~~p~~~  318 (432)
                      |++++++.++|+|||++........    ........++..|+|||++.++.++.++|||||||++|||++  |..|+..
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~  236 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDY----YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH  236 (296)
T ss_pred             eeecCCCceEEccccceeecccCcc----eeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence            9999999999999999876422211    112233456778999999998899999999999999999998  5566542


Q ss_pred             ccccccchhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014024          319 YRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN  386 (432)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~  386 (432)
                      ...  ...............      .......+...+.++.+++.+||+.||++|||+.+|++.|+.
T Consensus       237 ~~~--~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         237 LTD--QQVIENAGHFFRDDG------RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             cCh--HHHHHHHHhcccccc------ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence            221  111110000000000      000011122334678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.6e-40  Score=310.43  Aligned_cols=264  Identities=25%  Similarity=0.400  Sum_probs=200.1

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECCc----------------eEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeE
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQG----------------EIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLL  170 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~~----------------~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~  170 (432)
                      .++|++.+.||+|+||.||++...+.                .+|+|.+... .....+.+.+|++++++++|+|+++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            35799999999999999999876421                4889988654 344556799999999999999999999


Q ss_pred             eEEEeCCeeEEEEecCCCCChhhhhcCCCC---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCE
Q 014024          171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTK---------REILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNI  241 (432)
Q Consensus       171 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NI  241 (432)
                      +++...+..++||||+++++|.+++.....         ...+++..++.++.|++.||+|||+.+   ++|+||||+||
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni  160 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC  160 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence            999999999999999999999999854221         123788999999999999999999998   99999999999


Q ss_pred             EEcCCCCEEEeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhC--CCCCCCc
Q 014024          242 LLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG--KKNTGFY  319 (432)
Q Consensus       242 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg--~~p~~~~  319 (432)
                      ++++++.+||+|||++........    ........++..|+|||...++.++.++|+||||+++|+|+++  ..||...
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~  236 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDY----YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLL  236 (295)
T ss_pred             EEcCCCcEEecccccccccccCcc----eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCccc
Confidence            999999999999999976422111    1112233456789999999988999999999999999999984  4454322


Q ss_pred             cccccchhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014024          320 RTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN  386 (432)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~  386 (432)
                      ...  ..............      .......+...+..+.+++.+||+.||++||++.+|++.|+.
T Consensus       237 ~~~--~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         237 SDE--QVIENTGEFFRNQG------RQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             ChH--HHHHHHHHhhhhcc------ccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence            111  11000000000000      000011122235689999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.4e-39  Score=306.74  Aligned_cols=257  Identities=27%  Similarity=0.396  Sum_probs=201.3

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC--c----eEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeE
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ--G----EIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERL  180 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~--~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  180 (432)
                      ..+|++.+.||+|+||.||+|.+..  .    .||+|.+... .....+.+.+|+.+++.++|+|++++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence            4678889999999999999998532  2    4799988654 344566788999999999999999999998754 568


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceec
Q 014024          181 LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIV  260 (432)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  260 (432)
                      +++||+++|+|.+++...  ...+++..++.++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++..
T Consensus        85 l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~  159 (279)
T cd05109          85 LVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (279)
T ss_pred             EEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence            899999999999998643  234899999999999999999999998   999999999999999999999999999875


Q ss_pred             cCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccch
Q 014024          261 FGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKI  339 (432)
Q Consensus       261 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  339 (432)
                      .....    ........++..|+|||...+..++.++|||||||++|||++ |..||.......               .
T Consensus       160 ~~~~~----~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---------------~  220 (279)
T cd05109         160 DIDET----EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---------------I  220 (279)
T ss_pred             ccccc----eeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---------------H
Confidence            22111    011122344678999999998899999999999999999998 888875322110               1


Q ss_pred             hhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccc
Q 014024          340 IDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS  389 (432)
Q Consensus       340 ~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~  389 (432)
                      ...+........+...+.++.+++..||+.||++||++.++++.|+....
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05109         221 PDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR  270 (279)
T ss_pred             HHHHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            11111111111122345678899999999999999999999999887643

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-39  Score=303.10  Aligned_cols=255  Identities=30%  Similarity=0.474  Sum_probs=203.7

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECCc-eEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEec
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEY  185 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~~-~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  185 (432)
                      ..++|++.+.||+|+||.||+|.+.+. .+++|.+.... ...+.+.+|+.++++++|+|++++++++.+....+++|||
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY   82 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence            357899999999999999999997655 78999886543 3346789999999999999999999999988899999999


Q ss_pred             CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCC
Q 014024          186 MPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGND  265 (432)
Q Consensus       186 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  265 (432)
                      +++++|.+++.... ...+++..+..++.|++.|+.|||+++   ++|+||||+||++++++.+||+|||++....... 
T Consensus        83 ~~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~-  157 (261)
T cd05034          83 MSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDE-  157 (261)
T ss_pred             cCCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchh-
Confidence            99999999996533 234899999999999999999999998   9999999999999999999999999987642110 


Q ss_pred             ccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchhhhhh
Q 014024          266 EDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIIDLID  344 (432)
Q Consensus       266 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  344 (432)
                          ........++..|+|||.+.+..++.++|+||||+++|+|++ |+.||......  ...             +.+.
T Consensus       158 ----~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--~~~-------------~~~~  218 (261)
T cd05034         158 ----YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR--EVL-------------EQVE  218 (261)
T ss_pred             ----hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHH-------------HHHH
Confidence                111112234568999999998899999999999999999999 89887432110  000             0011


Q ss_pred             hhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014024          345 SVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN  386 (432)
Q Consensus       345 ~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~  386 (432)
                      .......+...+..+.+++.+|++.+|++||++.++.+.|+.
T Consensus       219 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         219 RGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            111111222335678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.5e-40  Score=325.88  Aligned_cols=254  Identities=22%  Similarity=0.323  Sum_probs=193.4

Q ss_pred             CCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCCC---hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEE
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKS---GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  183 (432)
                      .+|++++.||+|+||.||+|.+...  .+|+|++....   ....+.+.+|++++++++|+||+++++.+.+.+..++||
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~   80 (382)
T cd05625           1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM   80 (382)
T ss_pred             CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence            3688999999999999999998543  79999885432   234567889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCC
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGG  263 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  263 (432)
                      ||+++|+|.+++..   .+.+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 E~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~  154 (382)
T cd05625          81 DYIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (382)
T ss_pred             eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence            99999999999853   345889999999999999999999998   999999999999999999999999997532110


Q ss_pred             CCcc-----------------------------------------ccccccccccccCCccChhhhccCCCCchhhhHHH
Q 014024          264 NDED-----------------------------------------ELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSF  302 (432)
Q Consensus       264 ~~~~-----------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSl  302 (432)
                      ....                                         ..........||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  234 (382)
T cd05625         155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV  234 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence            0000                                         00001123578999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhh--hhhhhcccHHHHHHHHHHHHHhhccCCCCCCC---H
Q 014024          303 GVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLID--SVLEEASFNESLSRYVHIALLCVQERAEDRPT---M  377 (432)
Q Consensus       303 G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~--~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt---~  377 (432)
                      ||++|||++|+.||........              ...++.  ..+..........+..+++..|+ .+|++|++   +
T Consensus       235 Gvil~elltG~~Pf~~~~~~~~--------------~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~  299 (382)
T cd05625         235 GVILYEMLVGQPPFLAQTPLET--------------QMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGA  299 (382)
T ss_pred             hHHHHHHHhCCCCCCCCCHHHH--------------HHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCH
Confidence            9999999999999853321100              000000  00000111122345666676665 49999997   8


Q ss_pred             HHHHHH
Q 014024          378 SDVVSM  383 (432)
Q Consensus       378 ~evl~~  383 (432)
                      .+++++
T Consensus       300 ~ei~~h  305 (382)
T cd05625         300 DEIKAH  305 (382)
T ss_pred             HHHhcC
Confidence            888764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.9e-40  Score=325.00  Aligned_cols=253  Identities=22%  Similarity=0.251  Sum_probs=199.3

Q ss_pred             hhhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC---ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeE
Q 014024          106 SATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK---SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERL  180 (432)
Q Consensus       106 ~~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  180 (432)
                      ...++|++.+.||+|+||.||++.+..  ..+|+|.+...   .....+.+.+|+.+++.++||||+++++++.+++..+
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~  119 (370)
T cd05596          40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY  119 (370)
T ss_pred             CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            356789999999999999999999854  37999988532   2233455788999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceec
Q 014024          181 LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIV  260 (432)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  260 (432)
                      +||||+++|+|.+++..    ..+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++...
T Consensus       120 lv~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~  192 (370)
T cd05596         120 MVMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKM  192 (370)
T ss_pred             EEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence            99999999999998843    24888999999999999999999998   999999999999999999999999999764


Q ss_pred             cCCCCccccccccccccccCCccChhhhccC----CCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhc
Q 014024          261 FGGNDEDELQGNTSRISGTYGYMSPEYALEG----IFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWIS  336 (432)
Q Consensus       261 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  336 (432)
                      ....     ........||+.|+|||++.+.    .++.++|||||||++|||++|+.||......     .. .     
T Consensus       193 ~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-----~~-~-----  256 (370)
T cd05596         193 DANG-----MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-----GT-Y-----  256 (370)
T ss_pred             cCCC-----cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH-----HH-H-----
Confidence            2111     1122345799999999998653    4789999999999999999999998532210     00 0     


Q ss_pred             cchhhhhhhh--hhhcccHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHHh
Q 014024          337 NKIIDLIDSV--LEEASFNESLSRYVHIALLCVQERAED--RPTMSDVVSML  384 (432)
Q Consensus       337 ~~~~~~i~~~--l~~~~~~~~~~~l~~l~~~cl~~dp~~--RPt~~evl~~L  384 (432)
                         ..+....  +...........+.+++..||+.+|.+  ||++.+++++-
T Consensus       257 ---~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~  305 (370)
T cd05596         257 ---SKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHP  305 (370)
T ss_pred             ---HHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence               0111100  000111123567889999999999988  99999998864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.3e-39  Score=304.59  Aligned_cols=257  Identities=21%  Similarity=0.333  Sum_probs=204.1

Q ss_pred             CCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCC---ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEE
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGK---SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  183 (432)
                      ++|++.+.||+|++|.||++...  +..+++|.+...   .....+.+.+|+.+++.++|+|++++++++.+++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            57889999999999999999963  448999977542   2334567889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccC
Q 014024          184 EYMPNKSLDCFLFDP-TKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFG  262 (432)
Q Consensus       184 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  262 (432)
                      ||+++++|.+++... .....+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            999999999988532 22345899999999999999999999998   99999999999999999999999999876421


Q ss_pred             CCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhh
Q 014024          263 GNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDL  342 (432)
Q Consensus       263 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                      .      ........++..|+|||++.+..++.++|+||||+++|+|++|..||...........             ..
T Consensus       159 ~------~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-------------~~  219 (267)
T cd08229         159 K------TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLC-------------KK  219 (267)
T ss_pred             C------CcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHh-------------hh
Confidence            1      1112234688899999999988899999999999999999999999742211100000             00


Q ss_pred             hhhhh-hhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014024          343 IDSVL-EEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNE  387 (432)
Q Consensus       343 i~~~l-~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~  387 (432)
                      +.... ...........+.+++.+||+.||++|||+.+|.+.+++.
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         220 IEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             hhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence            00000 0001123456788999999999999999999999988764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=7.3e-40  Score=314.21  Aligned_cols=240  Identities=26%  Similarity=0.348  Sum_probs=189.5

Q ss_pred             ceeccCCcEEEEEEEECCc--eEEEEEEcCCC---hHhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeeEEEEecCCC
Q 014024          115 NKLGEGGFGTVYKGVIGQG--EIAVKRLLGKS---GQEIKELKNEASVIAQV-QHKNLVKLLGCCIEKDERLLIYEYMPN  188 (432)
Q Consensus       115 ~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  188 (432)
                      +.||+|+||.||+|.+.++  .+|+|.+....   ....+....|..++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            4699999999999998654  79999886431   22344566778888764 899999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCccc
Q 014024          189 KSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDE  268 (432)
Q Consensus       189 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  268 (432)
                      |+|.+++..   ...+++..+..++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||++......     
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~-----  149 (316)
T cd05619          81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG-----  149 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCC-----
Confidence            999999853   345899999999999999999999998   999999999999999999999999998753211     


Q ss_pred             cccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhhhh
Q 014024          269 LQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLE  348 (432)
Q Consensus       269 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  348 (432)
                       ........||+.|+|||++.+..++.++|||||||++|||++|+.||......  ...             ..+.. ..
T Consensus       150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--~~~-------------~~i~~-~~  212 (316)
T cd05619         150 -DAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE--ELF-------------QSIRM-DN  212 (316)
T ss_pred             -CCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH--HHH-------------HHHHh-CC
Confidence             11223457899999999999999999999999999999999999998532211  000             00000 00


Q ss_pred             hcccHHHHHHHHHHHHHhhccCCCCCCCHH-HHHH
Q 014024          349 EASFNESLSRYVHIALLCVQERAEDRPTMS-DVVS  382 (432)
Q Consensus       349 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~-evl~  382 (432)
                      ...+......+.+++..||+.||++||++. ++.+
T Consensus       213 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         213 PCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             CCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            011122345678999999999999999997 6665

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.1e-39  Score=311.02  Aligned_cols=259  Identities=29%  Similarity=0.425  Sum_probs=203.6

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEEC-------CceEEEEEEcCCC-hHhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCC
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIG-------QGEIAVKRLLGKS-GQEIKELKNEASVIAQV-QHKNLVKLLGCCIEKD  177 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  177 (432)
                      ..++|.+.+.||+|+||.||++...       ...+|+|++.... ....+.+.+|+.+++++ +|+||+++++++...+
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  112 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG  112 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence            3467999999999999999999752       1268999876543 34456789999999999 7999999999999999


Q ss_pred             eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccc
Q 014024          178 ERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMA  257 (432)
Q Consensus       178 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  257 (432)
                      ..+++|||+++|+|.+++.... ...+++.++..++.|++.||+|||+.+   ++|+||||+||++++++.++++|||++
T Consensus       113 ~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~  188 (302)
T cd05055         113 PILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLA  188 (302)
T ss_pred             ceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccc
Confidence            9999999999999999986432 233899999999999999999999998   999999999999999999999999999


Q ss_pred             eeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhc
Q 014024          258 RIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWIS  336 (432)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  336 (432)
                      ........    ........++..|+|||.+.+..++.++|||||||++|+|++ |..||.......             
T Consensus       189 ~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~-------------  251 (302)
T cd05055         189 RDIMNDSN----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS-------------  251 (302)
T ss_pred             ccccCCCc----eeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH-------------
Confidence            76422111    011122345778999999999999999999999999999998 888874322100             


Q ss_pred             cchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014024          337 NKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNE  387 (432)
Q Consensus       337 ~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~  387 (432)
                       .....++.......+...+..+.+++.+||+.+|++|||+.|+++.|++.
T Consensus       252 -~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         252 -KFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             -HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence             00111111111111122346788999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=9.2e-40  Score=310.73  Aligned_cols=252  Identities=23%  Similarity=0.355  Sum_probs=202.8

Q ss_pred             hhhCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEE
Q 014024          106 SATGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       106 ~~~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  183 (432)
                      ....+|++.+.||+|++|.||+|.+.  +..+++|.+........+.+.+|+.+++.++|+|++++++.+..+...++||
T Consensus        17 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~   96 (296)
T cd06654          17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (296)
T ss_pred             CcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence            34568999999999999999999874  3489999887665555678899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCC
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGG  263 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  263 (432)
                      ||+++++|.+++..    ..+++.++..++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++......
T Consensus        97 e~~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~  169 (296)
T cd06654          97 EYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (296)
T ss_pred             cccCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence            99999999999842    34889999999999999999999998   999999999999999999999999998754221


Q ss_pred             CCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhh
Q 014024          264 NDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLI  343 (432)
Q Consensus       264 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i  343 (432)
                      .      .......+++.|+|||.+.+..++.++|||||||++|+|++|+.||........ .   . .......     
T Consensus       170 ~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~-~---~-~~~~~~~-----  233 (296)
T cd06654         170 Q------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-L---Y-LIATNGT-----  233 (296)
T ss_pred             c------cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh-H---H-HHhcCCC-----
Confidence            1      112234688899999999988899999999999999999999999853221100 0   0 0000000     


Q ss_pred             hhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          344 DSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       344 ~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                       +  ....+......+.+++.+||..+|++||++.+++++
T Consensus       234 -~--~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         234 -P--ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             -C--CCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence             0  001122334568899999999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.9e-39  Score=313.86  Aligned_cols=260  Identities=28%  Similarity=0.411  Sum_probs=203.1

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC---------ceEEEEEEcCC-ChHhHHHHHHHHHHHHhc-CCCceeeeEeEEEeC
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ---------GEIAVKRLLGK-SGQEIKELKNEASVIAQV-QHKNLVKLLGCCIEK  176 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~---------~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  176 (432)
                      ..+|++.+.||+|+||.||++...+         ..+++|.+... .....+.+.+|+++++++ +|+||+++++++.+.
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   90 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence            3578999999999999999997521         15788977643 344567889999999999 799999999999999


Q ss_pred             CeeEEEEecCCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEE
Q 014024          177 DERLLIYEYMPNKSLDCFLFDPT-------------KREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILL  243 (432)
Q Consensus       177 ~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll  243 (432)
                      +..+++|||+++|+|.+++....             ....+++..+..++.|++.||+|||+.+   ++||||||+||++
T Consensus        91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill  167 (334)
T cd05100          91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLV  167 (334)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEE
Confidence            99999999999999999986421             1234888999999999999999999998   9999999999999


Q ss_pred             cCCCCEEEeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCcccc
Q 014024          244 DKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTK  322 (432)
Q Consensus       244 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~  322 (432)
                      ++++.+||+|||+++.......    ........++..|+|||++.+..++.++||||||+++|||++ |..||......
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~  243 (334)
T cd05100         168 TEDNVMKIADFGLARDVHNIDY----YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE  243 (334)
T ss_pred             cCCCcEEECCcccceecccccc----cccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence            9999999999999976421110    111122334567999999999999999999999999999998 77876432211


Q ss_pred             ccchhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccc
Q 014024          323 SLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS  389 (432)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~  389 (432)
                      .     .          ...+........+...+..+.+++.+||+.+|++||++.|+++.|+.+..
T Consensus       244 ~-----~----------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~  295 (334)
T cd05100         244 E-----L----------FKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT  295 (334)
T ss_pred             H-----H----------HHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence            0     0          01111111111222345678899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2.6e-39  Score=299.59  Aligned_cols=246  Identities=28%  Similarity=0.411  Sum_probs=195.4

Q ss_pred             ceeccCCcEEEEEEEECCc-eEEEEEEcCCC-hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecCCCCChh
Q 014024          115 NKLGEGGFGTVYKGVIGQG-EIAVKRLLGKS-GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLD  192 (432)
Q Consensus       115 ~~ig~G~~g~Vy~~~~~~~-~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~  192 (432)
                      ++||+|+||.||+|...++ .+++|.+.... ......+.+|+++++.++|+||+++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            4699999999999987655 78999876543 334456889999999999999999999999999999999999999999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCccccccc
Q 014024          193 CFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN  272 (432)
Q Consensus       193 ~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  272 (432)
                      +++....  ..+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.+||+|||++.......     ...
T Consensus        81 ~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-----~~~  150 (250)
T cd05085          81 SFLRKKK--DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI-----YSS  150 (250)
T ss_pred             HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccc-----ccc
Confidence            9885432  34889999999999999999999998   9999999999999999999999999987532111     111


Q ss_pred             cccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchhhhhhhhhhhcc
Q 014024          273 TSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEAS  351 (432)
Q Consensus       273 ~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~  351 (432)
                      .....++..|+|||++.++.++.++||||||+++|++++ |..||.......               ....+........
T Consensus       151 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~---------------~~~~~~~~~~~~~  215 (250)
T cd05085         151 SGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ---------------AREQVEKGYRMSC  215 (250)
T ss_pred             CCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH---------------HHHHHHcCCCCCC
Confidence            112234567999999998999999999999999999998 888875322110               0001111111122


Q ss_pred             cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014024          352 FNESLSRYVHIALLCVQERAEDRPTMSDVVSMLT  385 (432)
Q Consensus       352 ~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~  385 (432)
                      +...+..+.+++.+||..+|++||++.|+++.|.
T Consensus       216 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         216 PQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            2334578899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.9e-39  Score=305.87  Aligned_cols=250  Identities=23%  Similarity=0.367  Sum_probs=197.2

Q ss_pred             CCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEec
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEY  185 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  185 (432)
                      ++|++.++||+|+||.||+|.+..  ..+++|.+... .....+.+.+|++++++++|||++++++++...+..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            468889999999999999998743  37999988544 344556788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCC
Q 014024          186 MPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGND  265 (432)
Q Consensus       186 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  265 (432)
                      +++++|..+.       .+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.....   
T Consensus        81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~---  147 (279)
T cd06619          81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN---  147 (279)
T ss_pred             CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccc---
Confidence            9999986542       2788889999999999999999998   99999999999999999999999999976421   


Q ss_pred             ccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhh-hHHhhhccchhhhhh
Q 014024          266 EDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGY-AWDLWISNKIIDLID  344 (432)
Q Consensus       266 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~  344 (432)
                           .......++..|+|||++.+..++.++|+||||+++|+|++|+.||............. .........     .
T Consensus       148 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~  217 (279)
T cd06619         148 -----SIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-----P  217 (279)
T ss_pred             -----ccccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-----C
Confidence                 12233578899999999999899999999999999999999999985432211110000 000000000     0


Q ss_pred             hhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          345 SVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       345 ~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                      .   .........++.+++.+||+.+|++||++.|++++.
T Consensus       218 ~---~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~  254 (279)
T cd06619         218 P---VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHP  254 (279)
T ss_pred             C---CCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence            0   000112345688999999999999999999999863

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.6e-39  Score=312.01  Aligned_cols=240  Identities=25%  Similarity=0.321  Sum_probs=189.1

Q ss_pred             ceeccCCcEEEEEEEECCc--eEEEEEEcCCC---hHhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeeEEEEecCCC
Q 014024          115 NKLGEGGFGTVYKGVIGQG--EIAVKRLLGKS---GQEIKELKNEASVIAQV-QHKNLVKLLGCCIEKDERLLIYEYMPN  188 (432)
Q Consensus       115 ~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  188 (432)
                      ++||+|+||.||+|.+...  .+|+|.+....   ....+....|..++... +|+||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            4699999999999998643  79999885431   23345567788888765 899999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCccc
Q 014024          189 KSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDE  268 (432)
Q Consensus       189 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  268 (432)
                      |+|.+++..   +..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++......     
T Consensus        81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-----  149 (316)
T cd05620          81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-----  149 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC-----
Confidence            999988853   345899999999999999999999998   999999999999999999999999998742111     


Q ss_pred             cccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhhhh
Q 014024          269 LQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLE  348 (432)
Q Consensus       269 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  348 (432)
                       ........||+.|+|||++.+..++.++|||||||++|||++|+.||......  ...             +.+... .
T Consensus       150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~--~~~-------------~~~~~~-~  212 (316)
T cd05620         150 -DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED--ELF-------------ESIRVD-T  212 (316)
T ss_pred             -CCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HHH-------------HHHHhC-C
Confidence             11233457899999999999999999999999999999999999998532211  000             000000 0


Q ss_pred             hcccHHHHHHHHHHHHHhhccCCCCCCCHH-HHHH
Q 014024          349 EASFNESLSRYVHIALLCVQERAEDRPTMS-DVVS  382 (432)
Q Consensus       349 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~-evl~  382 (432)
                      ...+.....++.+++..||+.||++||++. ++++
T Consensus       213 ~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~  247 (316)
T cd05620         213 PHYPRWITKESKDILEKLFERDPTRRLGVVGNIRG  247 (316)
T ss_pred             CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence            111122345678999999999999999984 6664

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=9.9e-40  Score=303.91  Aligned_cols=250  Identities=29%  Similarity=0.451  Sum_probs=200.0

Q ss_pred             CCcCceeccCCcEEEEEEEECCc--eEEEEEEcCCChHhHH--HHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecC
Q 014024          111 FSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEIK--ELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYM  186 (432)
Q Consensus       111 y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  186 (432)
                      |++.+.||+|+||+||++.+.+.  .+|+|.+.........  ...+|+.++++++|+||+++++++.+....++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            67789999999999999998665  6999999777554433  3456999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCc
Q 014024          187 PNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDE  266 (432)
Q Consensus       187 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  266 (432)
                      ++++|.+++.   ....+++..++.++.|+++||++||+.+   ++|+||||+||++++++.++|+|||.+....     
T Consensus        81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-----  149 (260)
T PF00069_consen   81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS-----  149 (260)
T ss_dssp             TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST-----
T ss_pred             cccccccccc---cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc-----
Confidence            9999999995   3455899999999999999999999998   9999999999999999999999999997641     


Q ss_pred             cccccccccccccCCccChhhhc-cCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhh
Q 014024          267 DELQGNTSRISGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDS  345 (432)
Q Consensus       267 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  345 (432)
                       ..........++..|+|||++. +..++.++|+||+|+++|+|++|..|+......+  ..         .........
T Consensus       150 -~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~--~~---------~~~~~~~~~  217 (260)
T PF00069_consen  150 -ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDD--QL---------EIIEKILKR  217 (260)
T ss_dssp             -STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHH--HH---------HHHHHHHHT
T ss_pred             -ccccccccccccccccccccccccccccccccccccccccccccccccccccccchh--hh---------hhhhhcccc
Confidence             1122344567889999999998 8889999999999999999999999986431100  00         000001110


Q ss_pred             hhhhccc--HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          346 VLEEASF--NESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       346 ~l~~~~~--~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      .......  ......+.+++..||+.||++||++.+++++
T Consensus       218 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  218 PLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH  257 (260)
T ss_dssp             HHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred             cccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0100000  0113789999999999999999999999875

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.1e-39  Score=303.06  Aligned_cols=247  Identities=28%  Similarity=0.434  Sum_probs=199.2

Q ss_pred             CCCCcCceeccCCcEEEEEEEECCceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecCCC
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPN  188 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  188 (432)
                      ++|++.+.||+|+||.||++...+..+++|......  ..+.+.+|+.+++.++|+|++++++++... ..+++|||+++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~   82 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSK   82 (254)
T ss_pred             HHceeeeeeccCCCCceEecccCCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCC
Confidence            568899999999999999999888899999886543  346788999999999999999999998664 47999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCccc
Q 014024          189 KSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDE  268 (432)
Q Consensus       189 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  268 (432)
                      ++|.+++.... ...+++..++.++.|++.|+.|||+.+   ++||||||+||+++.++.+||+|||++......     
T Consensus        83 ~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-----  153 (254)
T cd05083          83 GNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-----  153 (254)
T ss_pred             CCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc-----
Confidence            99999986533 234899999999999999999999998   999999999999999999999999998753111     


Q ss_pred             cccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchhhhhhhhh
Q 014024          269 LQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVL  347 (432)
Q Consensus       269 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  347 (432)
                          ......+..|+|||.+.++.++.++|+||||+++|+|++ |+.||.......               ..+.+....
T Consensus       154 ----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---------------~~~~~~~~~  214 (254)
T cd05083         154 ----VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE---------------VKECVEKGY  214 (254)
T ss_pred             ----CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH---------------HHHHHhCCC
Confidence                112233567999999998899999999999999999998 888875322110               011111111


Q ss_pred             hhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014024          348 EEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN  386 (432)
Q Consensus       348 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~  386 (432)
                      ........+..+.+++.+||+.+|++||+++++++.|++
T Consensus       215 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         215 RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            111223345678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=3.4e-40  Score=318.56  Aligned_cols=252  Identities=19%  Similarity=0.268  Sum_probs=198.4

Q ss_pred             CCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCC---hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEE
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS---GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  183 (432)
                      ++|++.+.||+|+||.||++.+..  ..+|+|++....   ....+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            478999999999999999999754  389999886432   234566889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCC
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGG  263 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  263 (432)
                      ||+++|+|.+++...  ...+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++..+...
T Consensus        81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            999999999998643  235999999999999999999999999   999999999999999999999999999865221


Q ss_pred             CCccccccccccccccCCccChhhhc------cCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhcc
Q 014024          264 NDEDELQGNTSRISGTYGYMSPEYAL------EGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISN  337 (432)
Q Consensus       264 ~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  337 (432)
                      .     ........||+.|+|||++.      ...++.++|||||||++|+|++|+.||.......     .........
T Consensus       156 ~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-----~~~~i~~~~  225 (330)
T cd05601         156 K-----MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK-----TYNNIMNFQ  225 (330)
T ss_pred             C-----ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH-----HHHHHHcCC
Confidence            1     11223346899999999986      4567899999999999999999999985322110     000000000


Q ss_pred             chhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          338 KIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       338 ~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                             ..+...........+.+++..|++ +|.+|||+.+++++
T Consensus       226 -------~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         226 -------RFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             -------CccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence                   000011111235668889999998 99999999999975

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.1e-40  Score=316.40  Aligned_cols=237  Identities=24%  Similarity=0.275  Sum_probs=189.0

Q ss_pred             ceeccCCcEEEEEEEE-----CCceEEEEEEcCCC--hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecCC
Q 014024          115 NKLGEGGFGTVYKGVI-----GQGEIAVKRLLGKS--GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMP  187 (432)
Q Consensus       115 ~~ig~G~~g~Vy~~~~-----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  187 (432)
                      +.||+|+||.||++..     .+..+|+|++....  ......+.+|++++++++|+||+++++++.+++..|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            6799999999999875     23479999886432  2234457789999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCcc
Q 014024          188 NKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDED  267 (432)
Q Consensus       188 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  267 (432)
                      +|+|.+++..   ...+++..+..++.|++.||+|||+.+   |+||||||+||++++++.+||+|||++......    
T Consensus        82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~----  151 (318)
T cd05582          82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH----  151 (318)
T ss_pred             CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCC----
Confidence            9999999843   345899999999999999999999999   999999999999999999999999998764211    


Q ss_pred             ccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhhh
Q 014024          268 ELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVL  347 (432)
Q Consensus       268 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  347 (432)
                        ........||+.|+|||.+.+..++.++|||||||++|||++|+.||.......  .   .         ..+.... 
T Consensus       152 --~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~--~---~---------~~i~~~~-  214 (318)
T cd05582         152 --EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE--T---M---------TMILKAK-  214 (318)
T ss_pred             --CCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH--H---H---------HHHHcCC-
Confidence              112234578999999999998889999999999999999999999985322100  0   0         0000000 


Q ss_pred             hhcccHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 014024          348 EEASFNESLSRYVHIALLCVQERAEDRPTMSD  379 (432)
Q Consensus       348 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~e  379 (432)
                       ...+......+.+++..||+.||++||++.+
T Consensus       215 -~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         215 -LGMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             -CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence             0112233567789999999999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.9e-39  Score=307.26  Aligned_cols=257  Identities=26%  Similarity=0.428  Sum_probs=201.2

Q ss_pred             hCCCCcCceeccCCcEEEEEEEEC-------CceEEEEEEcCCC-hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCee
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIG-------QGEIAVKRLLGKS-GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDER  179 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  179 (432)
                      .++|++.+.||+|+||.||++.+.       ...+++|.+.... ......+.+|+.++++++|+|++++++++.+.+..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            467899999999999999999863       2378999886543 34456789999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhhhcCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCC
Q 014024          180 LLIYEYMPNKSLDCFLFDPT-------------------KREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASN  240 (432)
Q Consensus       180 ~lv~e~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~N  240 (432)
                      +++|||+++++|.+++....                   ....+++..++.++.|++.||+|||+.+   ++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence            99999999999999986321                   1134788999999999999999999998   9999999999


Q ss_pred             EEEcCCCCEEEeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCc
Q 014024          241 ILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFY  319 (432)
Q Consensus       241 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~  319 (432)
                      |++++++.++|+|||++..+.....    .........+..|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~  236 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADY----YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM  236 (288)
T ss_pred             eEecCCCceEECccccceecccCcc----ccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999876422211    011112234567999999998999999999999999999998 77776321


Q ss_pred             cccccchhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014024          320 RTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN  386 (432)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~  386 (432)
                      ...     ...          ..+...-....+...+.++.+++.+||+.+|++|||+.|+++.|++
T Consensus       237 ~~~-----~~~----------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         237 AHE-----EVI----------YYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             CHH-----HHH----------HHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            110     000          0000000011122345678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=3.5e-39  Score=311.04  Aligned_cols=247  Identities=23%  Similarity=0.340  Sum_probs=193.3

Q ss_pred             ceeccCCcEEEEEEEECCc--eEEEEEEcCC---ChHhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeeEEEEecCCC
Q 014024          115 NKLGEGGFGTVYKGVIGQG--EIAVKRLLGK---SGQEIKELKNEASVIAQV-QHKNLVKLLGCCIEKDERLLIYEYMPN  188 (432)
Q Consensus       115 ~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  188 (432)
                      ++||+|+||.||++.+...  .+|+|++...   .....+.+.+|+.++.++ +|+||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            4699999999999997544  7999998643   233456688899999888 699999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCccc
Q 014024          189 KSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDE  268 (432)
Q Consensus       189 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  268 (432)
                      |+|..++..   .+.+++..+..++.|++.||+|||+.+   ++||||||+|||++.++.+||+|||++......     
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-----  149 (327)
T cd05617          81 GDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-----  149 (327)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCC-----
Confidence            999988843   345999999999999999999999998   999999999999999999999999998753111     


Q ss_pred             cccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCcccc-ccchhhhhHHhhhccchhhhhhhhh
Q 014024          269 LQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTK-SLNLIGYAWDLWISNKIIDLIDSVL  347 (432)
Q Consensus       269 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~l  347 (432)
                       ........||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ......+.......        .  
T Consensus       150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--------~--  218 (327)
T cd05617         150 -GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE--------K--  218 (327)
T ss_pred             -CCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh--------C--
Confidence             11223457899999999999999999999999999999999999998543221 11111111111100        0  


Q ss_pred             hhcccHHHHHHHHHHHHHhhccCCCCCCCH------HHHHHH
Q 014024          348 EEASFNESLSRYVHIALLCVQERAEDRPTM------SDVVSM  383 (432)
Q Consensus       348 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~------~evl~~  383 (432)
                      ....+......+.+++.+||+.||.+||++      .++.++
T Consensus       219 ~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  260 (327)
T cd05617         219 PIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH  260 (327)
T ss_pred             CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence            011122334567899999999999999985      577654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.3e-39  Score=304.99  Aligned_cols=248  Identities=24%  Similarity=0.326  Sum_probs=191.4

Q ss_pred             eccCCcEEEEEEEECC--ceEEEEEEcCCC---hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecCCCCCh
Q 014024          117 LGEGGFGTVYKGVIGQ--GEIAVKRLLGKS---GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSL  191 (432)
Q Consensus       117 ig~G~~g~Vy~~~~~~--~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  191 (432)
                      ||+|+||.||++....  ..+|+|.+....   ......+..|++++++++||||+++++++.++...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            7999999999998754  489999885321   12234456799999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCcccccc
Q 014024          192 DCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQG  271 (432)
Q Consensus       192 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  271 (432)
                      .+++.... ...+++..+..++.|++.||+|||+.+   ++||||||+||++++++.++|+|||++......       .
T Consensus        81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~-------~  149 (277)
T cd05607          81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG-------K  149 (277)
T ss_pred             HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCC-------c
Confidence            98885433 334889999999999999999999998   999999999999999999999999998764221       1


Q ss_pred             ccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhhhhhcc
Q 014024          272 NTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEAS  351 (432)
Q Consensus       272 ~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~  351 (432)
                      ......|+..|+|||++.+..++.++|||||||++|||++|+.||........ ..... .        ........ ..
T Consensus       150 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~-~~~~~-~--------~~~~~~~~-~~  218 (277)
T cd05607         150 TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA-KEELK-R--------RTLEDEVK-FE  218 (277)
T ss_pred             eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh-HHHHH-H--------Hhhccccc-cc
Confidence            12234688999999999988899999999999999999999999853321100 00000 0        00000000 00


Q ss_pred             cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014024          352 FNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN  386 (432)
Q Consensus       352 ~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~  386 (432)
                      ......++.+++..||+.||++||+++|+++.+..
T Consensus       219 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~  253 (277)
T cd05607         219 HQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRK  253 (277)
T ss_pred             cccCCHHHHHHHHHHhccCHhhCCCCccchhhhhc
Confidence            11235568899999999999999999877654443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2.9e-39  Score=307.31  Aligned_cols=264  Identities=27%  Similarity=0.410  Sum_probs=200.7

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC------------------ceEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceee
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ------------------GEIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVK  168 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~------------------~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~  168 (432)
                      .++|++.+.||+|+||.||++...+                  ..+|+|.+... .....+.+.+|+++++.++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            3579999999999999999986432                  15888888654 3445678999999999999999999


Q ss_pred             eEeEEEeCCeeEEEEecCCCCChhhhhcCCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCC
Q 014024          169 LLGCCIEKDERLLIYEYMPNKSLDCFLFDPTK--------REILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASN  240 (432)
Q Consensus       169 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~N  240 (432)
                      +++++.+.+..+++|||+++++|.+++.....        ...+++..+..++.|++.||+|||+.+   ++|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N  160 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence            99999999999999999999999999864321        124778899999999999999999998   9999999999


Q ss_pred             EEEcCCCCEEEeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh--CCCCCCC
Q 014024          241 ILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS--GKKNTGF  318 (432)
Q Consensus       241 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt--g~~p~~~  318 (432)
                      |++++++.++|+|||++..+.....    ........++..|+|||...++.++.++|+|||||++|||++  |..|+..
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~  236 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDY----YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ  236 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcc----eeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence            9999999999999999976422211    111222344678999999888899999999999999999998  5666643


Q ss_pred             ccccccchhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014024          319 YRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN  386 (432)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~  386 (432)
                      .....  ..............      ......+..++..+.+++.+||+.||++||++.+|.+.|++
T Consensus       237 ~~~~~--~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         237 LSDEQ--VIENTGEFFRDQGR------QVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             cChHH--HHHHHHHHHhhccc------cccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            22111  00000000000000      00011122345788999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=5.1e-40  Score=321.74  Aligned_cols=255  Identities=21%  Similarity=0.244  Sum_probs=198.1

Q ss_pred             HhhhhCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCC---ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCe
Q 014024          104 VSSATGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGK---SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDE  178 (432)
Q Consensus       104 ~~~~~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  178 (432)
                      +....++|++.+.||+|+||.||++.+..+  .+|+|.+...   .....+.+.+|+.+++.++||||+++++++.+++.
T Consensus        38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (370)
T cd05621          38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY  117 (370)
T ss_pred             cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence            344568899999999999999999998643  7899988532   22334567889999999999999999999999999


Q ss_pred             eEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccce
Q 014024          179 RLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMAR  258 (432)
Q Consensus       179 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  258 (432)
                      .++||||+++|+|.+++..    ..+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++.
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~  190 (370)
T cd05621         118 LYMVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCM  190 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccce
Confidence            9999999999999999843    23889999999999999999999998   9999999999999999999999999998


Q ss_pred             eccCCCCccccccccccccccCCccChhhhccC----CCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhh
Q 014024          259 IVFGGNDEDELQGNTSRISGTYGYMSPEYALEG----IFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLW  334 (432)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  334 (432)
                      ......     ........||+.|+|||++.+.    .++.++|+|||||++|+|++|+.||......     ..     
T Consensus       191 ~~~~~~-----~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~-----~~-----  255 (370)
T cd05621         191 KMDETG-----MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV-----GT-----  255 (370)
T ss_pred             ecccCC-----ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH-----HH-----
Confidence            642111     1122345799999999998753    3789999999999999999999998532210     00     


Q ss_pred             hccchhhhhhhh--hhhcccHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHHh
Q 014024          335 ISNKIIDLIDSV--LEEASFNESLSRYVHIALLCVQERAED--RPTMSDVVSML  384 (432)
Q Consensus       335 ~~~~~~~~i~~~--l~~~~~~~~~~~l~~l~~~cl~~dp~~--RPt~~evl~~L  384 (432)
                          ...+.+..  +...........+.+++..|++.++.+  ||++.|++++-
T Consensus       256 ----~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp  305 (370)
T cd05621         256 ----YSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHP  305 (370)
T ss_pred             ----HHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCc
Confidence                01111100  000111123456778889999855543  89999999873

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.9e-39  Score=311.24  Aligned_cols=260  Identities=28%  Similarity=0.427  Sum_probs=202.8

Q ss_pred             hCCCCcCceeccCCcEEEEEEEEC---------CceEEEEEEcCC-ChHhHHHHHHHHHHHHhc-CCCceeeeEeEEEeC
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIG---------QGEIAVKRLLGK-SGQEIKELKNEASVIAQV-QHKNLVKLLGCCIEK  176 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~---------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  176 (432)
                      .++|.+.+.||+|+||.||++...         ...+++|.+... .......+.+|+++++++ +|+||+++++++.+.
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            468889999999999999999752         125888887644 334566788999999999 699999999999999


Q ss_pred             CeeEEEEecCCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEE
Q 014024          177 DERLLIYEYMPNKSLDCFLFDPT-------------KREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILL  243 (432)
Q Consensus       177 ~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll  243 (432)
                      +..+++|||+++|+|.+++....             ....+++..+..++.|++.||.|||+.+   ++||||||+||++
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  167 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV  167 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence            99999999999999999986432             1235899999999999999999999998   9999999999999


Q ss_pred             cCCCCEEEeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCcccc
Q 014024          244 DKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTK  322 (432)
Q Consensus       244 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~  322 (432)
                      ++++.+||+|||+++.......    ........++..|+|||.+.++.++.++||||||+++|+|++ |..||......
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~  243 (314)
T cd05099         168 TEDNVMKIADFGLARGVHDIDY----YKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE  243 (314)
T ss_pred             cCCCcEEEcccccccccccccc----ccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999976421111    011112234467999999998899999999999999999999 88887432211


Q ss_pred             ccchhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccc
Q 014024          323 SLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS  389 (432)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~  389 (432)
                        ...             +.+........+...+.++.+++.+||+.+|++|||+.++++.|+....
T Consensus       244 --~~~-------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~  295 (314)
T cd05099         244 --ELF-------------KLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA  295 (314)
T ss_pred             --HHH-------------HHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence              000             1111100111223345678899999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-40  Score=322.94  Aligned_cols=243  Identities=28%  Similarity=0.448  Sum_probs=203.8

Q ss_pred             eeccCCcEEEEEEEECCc--eEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecCCCCChhh
Q 014024          116 KLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDC  193 (432)
Q Consensus       116 ~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~  193 (432)
                      +||+|.||+||-|++.++  .+|||.+..+.....+-+..|+...++++|.|||+++|.+.+++..-|+||-++||+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            699999999999999776  679999988888888889999999999999999999999999999999999999999999


Q ss_pred             hhcCCCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEc-CCCCEEEeecccceeccCCCCccccc
Q 014024          194 FLFDPTKREIL--DWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLD-KDMNSKISDFGMARIVFGGNDEDELQ  270 (432)
Q Consensus       194 ~l~~~~~~~~l--~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~  270 (432)
                      +|...  =+++  ++...-.+.+||++||.|||++.   |||||||-+|+|++ -.|.+||+|||.++.+.+      ..
T Consensus       662 LLrsk--WGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg------in  730 (1226)
T KOG4279|consen  662 LLRSK--WGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG------IN  730 (1226)
T ss_pred             HHHhc--cCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc------CC
Confidence            99642  2345  78888899999999999999998   99999999999995 578899999999988632      24


Q ss_pred             cccccccccCCccChhhhccCC--CCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhhhh
Q 014024          271 GNTSRISGTYGYMSPEYALEGI--FSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLE  348 (432)
Q Consensus       271 ~~~~~~~gt~~y~aPE~~~~~~--~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  348 (432)
                      ..+..+.||..|||||++..+.  |..++|||||||++.||.||++||-..+.........       +    +  -..-
T Consensus       731 P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkV-------G----m--yKvH  797 (1226)
T KOG4279|consen  731 PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKV-------G----M--YKVH  797 (1226)
T ss_pred             ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhh-------c----c--eecC
Confidence            4567789999999999998754  8999999999999999999999985433211110000       0    0  0112


Q ss_pred             hcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014024          349 EASFNESLSRYVHIALLCVQERAEDRPTMSDVVS  382 (432)
Q Consensus       349 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~  382 (432)
                      .+.+.+...+...++.+|+.+||.+||+++++++
T Consensus       798 P~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  798 PPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             CCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            3345566778889999999999999999999997

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.1e-39  Score=313.45  Aligned_cols=241  Identities=26%  Similarity=0.324  Sum_probs=192.8

Q ss_pred             ceeccCCcEEEEEEEECCc--eEEEEEEcCC---ChHhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeeEEEEecCCC
Q 014024          115 NKLGEGGFGTVYKGVIGQG--EIAVKRLLGK---SGQEIKELKNEASVIAQV-QHKNLVKLLGCCIEKDERLLIYEYMPN  188 (432)
Q Consensus       115 ~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  188 (432)
                      +.||+|+||.||++.+..+  .+|+|.+...   .....+.+..|.++++.+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999998543  7999988643   223455677888999888 699999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCccc
Q 014024          189 KSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDE  268 (432)
Q Consensus       189 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  268 (432)
                      |+|.+++..   ...+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||++......     
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-----  149 (318)
T cd05570          81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG-----  149 (318)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcC-----
Confidence            999988853   335999999999999999999999998   999999999999999999999999998642111     


Q ss_pred             cccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhhhh
Q 014024          269 LQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLE  348 (432)
Q Consensus       269 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  348 (432)
                       ........|++.|+|||++.+..++.++|+|||||++|+|++|+.||.......      .........          
T Consensus       150 -~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~------~~~~i~~~~----------  212 (318)
T cd05570         150 -GVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE------LFQSILEDE----------  212 (318)
T ss_pred             -CCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH------HHHHHHcCC----------
Confidence             112234568999999999999999999999999999999999999985322110      000000000          


Q ss_pred             hcccHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHHH
Q 014024          349 EASFNESLSRYVHIALLCVQERAEDRPTM-----SDVVSM  383 (432)
Q Consensus       349 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt~-----~evl~~  383 (432)
                      ...+...+..+.+++.+||+.||.+||++     .+++++
T Consensus       213 ~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         213 VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence            01122345678899999999999999999     888865

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.6e-39  Score=302.33  Aligned_cols=255  Identities=25%  Similarity=0.401  Sum_probs=199.8

Q ss_pred             CCCcCceeccCCcEEEEEEEECCc-eEEEEEEcCCC------hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEE
Q 014024          110 NFSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKS------GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLI  182 (432)
Q Consensus       110 ~y~~~~~ig~G~~g~Vy~~~~~~~-~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  182 (432)
                      +|.+.+.||+|+||.||+|...++ .+|+|.+....      ....+.+.+|++++++++|+||+++++++.+.+..+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            478889999999999999987544 78999875332      23345688999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccC
Q 014024          183 YEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFG  262 (432)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  262 (432)
                      |||+++++|.+++..   ...+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          81 MEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            999999999999853   235889999999999999999999998   99999999999999999999999999876422


Q ss_pred             CCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhh
Q 014024          263 GNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDL  342 (432)
Q Consensus       263 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                      ...............++..|+|||++.+..++.++|+||||+++|+|++|+.||........     ........     
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-----~~~~~~~~-----  224 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA-----MFYIGAHR-----  224 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH-----HHHhhhcc-----
Confidence            11111112222345688999999999988899999999999999999999999853221100     00000000     


Q ss_pred             hhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          343 IDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       343 i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                         ......+......+.+++.+||+.+|++||++.+++++
T Consensus       225 ---~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  262 (265)
T cd06631         225 ---GLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH  262 (265)
T ss_pred             ---CCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence               00011222345678899999999999999999999863

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=3e-39  Score=303.01  Aligned_cols=249  Identities=28%  Similarity=0.410  Sum_probs=193.7

Q ss_pred             ceeccCCcEEEEEEEECCc----eEEEEEEcCC-ChHhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeeEEEEecCCC
Q 014024          115 NKLGEGGFGTVYKGVIGQG----EIAVKRLLGK-SGQEIKELKNEASVIAQV-QHKNLVKLLGCCIEKDERLLIYEYMPN  188 (432)
Q Consensus       115 ~~ig~G~~g~Vy~~~~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  188 (432)
                      +.||+|+||.||+|.+.+.    .+++|.+... .....+.+.+|+++++++ +||||+++++++...+..+++|||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            3689999999999997543    4677877643 344556788999999999 799999999999999999999999999


Q ss_pred             CChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecc
Q 014024          189 KSLDCFLFDPT-------------KREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFG  255 (432)
Q Consensus       189 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  255 (432)
                      |+|.+++....             ....+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence            99999985422             1224789999999999999999999998   9999999999999999999999999


Q ss_pred             cceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhh
Q 014024          256 MARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLW  334 (432)
Q Consensus       256 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~  334 (432)
                      ++.....       .........+..|+|||++.+..++.++||||||+++|||++ |..||......+  .   .    
T Consensus       158 l~~~~~~-------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--~---~----  221 (270)
T cd05047         158 LSRGQEV-------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--L---Y----  221 (270)
T ss_pred             Cccccch-------hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH--H---H----
Confidence            9853210       001111233567999999988889999999999999999997 999874321100  0   0    


Q ss_pred             hccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014024          335 ISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEA  388 (432)
Q Consensus       335 ~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~  388 (432)
                            ..+........+......+.+++.+||+.+|.+|||+.++++.|+.+.
T Consensus       222 ------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         222 ------EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             ------HHHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence                  001110111112233457889999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.8e-40  Score=291.22  Aligned_cols=252  Identities=24%  Similarity=0.353  Sum_probs=203.0

Q ss_pred             hhhhCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCC--------ChHhHHHHHHHHHHHHhc-CCCceeeeEeEE
Q 014024          105 SSATGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGK--------SGQEIKELKNEASVIAQV-QHKNLVKLLGCC  173 (432)
Q Consensus       105 ~~~~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~--------~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~  173 (432)
                      ...-.+|.-.+.||.|..++|-++....+  +.|+|++...        .....+.-.+|+.+|+++ .||||+.+.+.+
T Consensus        13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y   92 (411)
T KOG0599|consen   13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY   92 (411)
T ss_pred             hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence            34456788889999999999999887544  7899887322        123345567899999998 599999999999


Q ss_pred             EeCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEee
Q 014024          174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISD  253 (432)
Q Consensus       174 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  253 (432)
                      +.+...++|+|.|+.|.|.|+|.   ..-.+++....+|+.|+.+|++|||..+   |+||||||+|||+|++.++||+|
T Consensus        93 es~sF~FlVFdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isD  166 (411)
T KOG0599|consen   93 ESDAFVFLVFDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISD  166 (411)
T ss_pred             cCcchhhhhhhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEec
Confidence            99999999999999999999994   4455999999999999999999999999   99999999999999999999999


Q ss_pred             cccceeccCCCCccccccccccccccCCccChhhhcc------CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchh
Q 014024          254 FGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE------GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLI  327 (432)
Q Consensus       254 fg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~  327 (432)
                      ||++..+..+       ......+|||+|+|||.+..      ..|+..+|+|++|||+|.|+.|.+||           
T Consensus       167 FGFa~~l~~G-------ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPF-----------  228 (411)
T KOG0599|consen  167 FGFACQLEPG-------EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPF-----------  228 (411)
T ss_pred             cceeeccCCc-------hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCch-----------
Confidence            9999986433       24456899999999998863      45889999999999999999999997           


Q ss_pred             hhhHHhhhccchhhhhhh---hhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          328 GYAWDLWISNKIIDLIDS---VLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       328 ~~~~~~~~~~~~~~~i~~---~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                       |.....   -+..+|..   ....+...+......+|+.+||+.||.+|.|++|++++-
T Consensus       229 -wHRkQm---lMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHp  284 (411)
T KOG0599|consen  229 -WHRKQM---LMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHP  284 (411)
T ss_pred             -hHHHHH---HHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcCh
Confidence             211111   01111111   112222334556778999999999999999999999753

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.6e-39  Score=311.02  Aligned_cols=263  Identities=22%  Similarity=0.318  Sum_probs=196.2

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCC-hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEe
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS-GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYE  184 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  184 (432)
                      .++|.+.+.||+|+||.||+|.+..  ..+|+|.+.... ......+.+|++++++++|+||+++++++..++..++|||
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   84 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE   84 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence            3679999999999999999998754  379999885432 2233457789999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCC
Q 014024          185 YMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGN  264 (432)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  264 (432)
                      |+++ +|.+++...  ...+++..+..++.|++.||+|||+.+   |+||||||+||++++++.+||+|||++...... 
T Consensus        85 ~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-  157 (309)
T cd07872          85 YLDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVP-  157 (309)
T ss_pred             CCCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCC-
Confidence            9975 777777433  234889999999999999999999998   999999999999999999999999999753211 


Q ss_pred             CccccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCcccccc-chhh--------hhHHhh
Q 014024          265 DEDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSL-NLIG--------YAWDLW  334 (432)
Q Consensus       265 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~-~~~~--------~~~~~~  334 (432)
                           ........+++.|+|||.+.+ ..++.++|||||||++|+|+||+.||......+. ....        ..+...
T Consensus       158 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (309)
T cd07872         158 -----TKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGI  232 (309)
T ss_pred             -----ccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhh
Confidence                 111223467899999998865 5689999999999999999999999864332110 0000        000000


Q ss_pred             hccchhhhhhhhhhh-------cccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          335 ISNKIIDLIDSVLEE-------ASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       335 ~~~~~~~~i~~~l~~-------~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                      ....  +..+.....       ........++.+++.+||+.||.+|||+.|++++-
T Consensus       233 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~  287 (309)
T cd07872         233 SSND--EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHA  287 (309)
T ss_pred             cchh--hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcCh
Confidence            0000  000000000       00112345678999999999999999999999743

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2e-39  Score=306.80  Aligned_cols=251  Identities=25%  Similarity=0.331  Sum_probs=197.9

Q ss_pred             CCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCCC---hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEe
Q 014024          110 NFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKS---GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYE  184 (432)
Q Consensus       110 ~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  184 (432)
                      .|+..+.||+|+||.||++.+...  .+|+|.+....   ......+.+|+.++++++|+|++++++.+.+.+..++|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            367789999999999999998644  89999875432   2233557789999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCC
Q 014024          185 YMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGN  264 (432)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  264 (432)
                      |+++++|.+++.... ...+++..+..++.|++.||.|||+.+   ++||||||+||++++++.++|+|||++.......
T Consensus        81 ~~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05630          81 LMNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  156 (285)
T ss_pred             ecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence            999999999885432 234899999999999999999999998   9999999999999999999999999987542111


Q ss_pred             CccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhh
Q 014024          265 DEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLID  344 (432)
Q Consensus       265 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  344 (432)
                             ......|+..|+|||++.+..++.++||||||+++|+|++|+.||........ .          .......+
T Consensus       157 -------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~-~----------~~~~~~~~  218 (285)
T cd05630         157 -------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-R----------EEVERLVK  218 (285)
T ss_pred             -------cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch-H----------HHHHhhhh
Confidence                   11234689999999999999999999999999999999999999854221100 0          00000111


Q ss_pred             hhhhhcccHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 014024          345 SVLEEASFNESLSRYVHIALLCVQERAEDRPT-----MSDVVSM  383 (432)
Q Consensus       345 ~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt-----~~evl~~  383 (432)
                      . .....+......+.+++..||+.||++|||     +.|++++
T Consensus       219 ~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h  261 (285)
T cd05630         219 E-VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH  261 (285)
T ss_pred             h-hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence            0 011122234456889999999999999999     8888874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=3.3e-39  Score=310.66  Aligned_cols=240  Identities=24%  Similarity=0.309  Sum_probs=190.1

Q ss_pred             CCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC---ChHhHHHHHHHHHHHHhcC-CCceeeeEeEEEeCCeeEEEE
Q 014024          110 NFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK---SGQEIKELKNEASVIAQVQ-HKNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       110 ~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~  183 (432)
                      +|+..+.||+|+||.||+|.+..  ..||+|++...   .....+.+..|..+++.+. |++|+++++++.+.+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            47788999999999999999754  37999988643   2234456778888988886 577888999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCC
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGG  263 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  263 (432)
                      ||+++|+|.+++..   ...+++..+..++.|++.||+|||+.+   ++||||||+|||+++++.+||+|||++......
T Consensus        81 Ey~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~  154 (323)
T cd05615          81 EYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD  154 (323)
T ss_pred             cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence            99999999998843   345999999999999999999999998   999999999999999999999999998753111


Q ss_pred             CCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhh
Q 014024          264 NDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLI  343 (432)
Q Consensus       264 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i  343 (432)
                            ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.......  ..            ..+.
T Consensus       155 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~--~~------------~~i~  214 (323)
T cd05615         155 ------GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE--LF------------QSIM  214 (323)
T ss_pred             ------CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH--HH------------HHHH
Confidence                  112234568999999999999999999999999999999999999985322100  00            0011


Q ss_pred             hhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCH
Q 014024          344 DSVLEEASFNESLSRYVHIALLCVQERAEDRPTM  377 (432)
Q Consensus       344 ~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~  377 (432)
                      ...  ...+.....++.+++.+||+.+|.+|++.
T Consensus       215 ~~~--~~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         215 EHN--VSYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             hCC--CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence            100  01122334677899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=3.6e-39  Score=308.46  Aligned_cols=261  Identities=23%  Similarity=0.314  Sum_probs=200.7

Q ss_pred             CCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEec
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEY  185 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  185 (432)
                      ++|++.+.||+|+||.||++.+...  .+++|.+... .......+.+|++++++++||||+++++++.+++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            4789999999999999999997643  6777877544 344456788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCC
Q 014024          186 MPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ-YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGN  264 (432)
Q Consensus       186 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  264 (432)
                      +++++|.+++..   ...+++..+..++.|++.||.|||+ .+   ++|+||||+||++++++.+||+|||++...... 
T Consensus        81 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-  153 (308)
T cd06615          81 MDGGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  153 (308)
T ss_pred             cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence            999999999853   3458999999999999999999998 46   999999999999999999999999998754211 


Q ss_pred             CccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHh---hh------
Q 014024          265 DEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDL---WI------  335 (432)
Q Consensus       265 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~---~~------  335 (432)
                             ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||........  .......   ..      
T Consensus       154 -------~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~  224 (308)
T cd06615         154 -------MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL--EAMFGRPVSEGEAKESHR  224 (308)
T ss_pred             -------ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhH--HHhhcCccccccccCCcc
Confidence                   12335688999999999888899999999999999999999999853321110  0000000   00      


Q ss_pred             -----------ccchhhhhhhhhhhcc----cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014024          336 -----------SNKIIDLIDSVLEEAS----FNESLSRYVHIALLCVQERAEDRPTMSDVVSMLT  385 (432)
Q Consensus       336 -----------~~~~~~~i~~~l~~~~----~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~  385 (432)
                                 .....+..+.......    ......++.+++.+||+.+|++|||+.+++++..
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~  289 (308)
T cd06615         225 PVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF  289 (308)
T ss_pred             cccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence                       0000111111111100    0113456889999999999999999999998754

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2.5e-39  Score=300.98  Aligned_cols=249  Identities=27%  Similarity=0.385  Sum_probs=198.4

Q ss_pred             ceeccCCcEEEEEEEECC---c--eEEEEEEcCCCh-HhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecCCC
Q 014024          115 NKLGEGGFGTVYKGVIGQ---G--EIAVKRLLGKSG-QEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPN  188 (432)
Q Consensus       115 ~~ig~G~~g~Vy~~~~~~---~--~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  188 (432)
                      ++||+|++|.||+|.+..   .  .+++|.+..... ...+.+.+|++.+++++|+||+++++.+.+ ...+++|||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998743   2  589998876655 567789999999999999999999999988 888999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCccc
Q 014024          189 KSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDE  268 (432)
Q Consensus       189 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  268 (432)
                      ++|.+++..... ..+++...+.++.|++.||+|||+.+   ++|+||+|+||+++.++.+||+|||++..+......  
T Consensus        80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~--  153 (257)
T cd05040          80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH--  153 (257)
T ss_pred             CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccc--
Confidence            999999865432 45899999999999999999999998   999999999999999999999999999875322111  


Q ss_pred             cccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchhhhhhhhh
Q 014024          269 LQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVL  347 (432)
Q Consensus       269 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  347 (432)
                       ........++..|+|||.+.+..++.++|||||||++|+|++ |+.||.......  ...   ...         ....
T Consensus       154 -~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~---~~~---------~~~~  218 (257)
T cd05040         154 -YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ--ILK---KID---------KEGE  218 (257)
T ss_pred             -eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--HHH---HHH---------hcCC
Confidence             111123456788999999998999999999999999999999 999974322110  000   000         0000


Q ss_pred             hhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014024          348 EEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLT  385 (432)
Q Consensus       348 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~  385 (432)
                      ....+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus       219 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         219 RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            01112234567899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=4.7e-39  Score=301.21  Aligned_cols=256  Identities=24%  Similarity=0.351  Sum_probs=199.9

Q ss_pred             hhhCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEE
Q 014024          106 SATGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       106 ~~~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  183 (432)
                      .+++++.....||+|+||.||+|.+.++  .+++|.+........+.+.+|+.++++++|+||+++++++..++..++++
T Consensus         5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   84 (268)
T cd06624           5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM   84 (268)
T ss_pred             cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence            4556666678899999999999987543  79999887776667788999999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcC-CCCEEEeecccceeccC
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDK-DMNSKISDFGMARIVFG  262 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~~  262 (432)
                      ||+++++|.+++.........++..+..++.|++.||+|||+.+   |+||||||+||+++. ++.++|+|||++.....
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~  161 (268)
T cd06624          85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG  161 (268)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence            99999999999864322211278888999999999999999998   999999999999976 67999999999876422


Q ss_pred             CCCccccccccccccccCCccChhhhccCC--CCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchh
Q 014024          263 GNDEDELQGNTSRISGTYGYMSPEYALEGI--FSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKII  340 (432)
Q Consensus       263 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                      ..      .......+++.|+|||++.+..  ++.++|+||||+++|+|++|+.|+..........    +..       
T Consensus       162 ~~------~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~----~~~-------  224 (268)
T cd06624         162 IN------PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM----FKV-------  224 (268)
T ss_pred             CC------CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH----hhh-------
Confidence            11      1122345788999999987643  7899999999999999999999975322111000    000       


Q ss_pred             hhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          341 DLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       341 ~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                        .........+.....++.+++.+||+.+|.+|||+.+++++
T Consensus       225 --~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         225 --GMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             --hhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence              00000111222345678899999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=3.4e-39  Score=336.38  Aligned_cols=263  Identities=21%  Similarity=0.314  Sum_probs=201.8

Q ss_pred             CCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC---ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEE
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK---SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  183 (432)
                      ++|++.++||+|+||.||+|.+..  ..||+|++...   .....+.+.+|++++++++||||+++++++.+.+..+++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            689999999999999999999854  48999998543   2334567899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecc
Q 014024          184 EYMPNKSLDCFLFDPT--------KREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFG  255 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  255 (432)
                      ||+++++|.+++....        ....+++..++.++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence            9999999999885321        1233667788999999999999999998   9999999999999999999999999


Q ss_pred             cceeccCCCCcc-c-----------cccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccc
Q 014024          256 MARIVFGGNDED-E-----------LQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKS  323 (432)
Q Consensus       256 ~a~~~~~~~~~~-~-----------~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~  323 (432)
                      ++.......... .           .........||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            998652111000 0           0011123569999999999999999999999999999999999999985422111


Q ss_pred             cchhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHhccc
Q 014024          324 LNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRP-TMSDVVSMLTNE  387 (432)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RP-t~~evl~~L~~~  387 (432)
                      ..     ..    ..   ..++. ........+..+.+++.+|++.||++|| +++++.+.|+..
T Consensus       239 i~-----~~----~~---i~~P~-~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~  290 (932)
T PRK13184        239 IS-----YR----DV---ILSPI-EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH  290 (932)
T ss_pred             hh-----hh----hh---ccChh-hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            00     00    00   00000 0001123446688999999999999996 566677776654

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.6e-39  Score=319.02  Aligned_cols=261  Identities=20%  Similarity=0.258  Sum_probs=195.0

Q ss_pred             CCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC-----eeE
Q 014024          110 NFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKD-----ERL  180 (432)
Q Consensus       110 ~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~  180 (432)
                      +|++.+.||+|+||.||++.+.  +..||+|++...  .....+.+.+|+++++.++|+||+++++++...+     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4788999999999999999974  448999988543  2344567889999999999999999999998776     789


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceec
Q 014024          181 LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIV  260 (432)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  260 (432)
                      +||||+. ++|.+++.   ....+++..+..++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||++...
T Consensus        81 lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~  153 (372)
T cd07853          81 VVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE  153 (372)
T ss_pred             EEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence            9999996 56777763   2345999999999999999999999998   999999999999999999999999999864


Q ss_pred             cCCCCccccccccccccccCCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccc-
Q 014024          261 FGGNDEDELQGNTSRISGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNK-  338 (432)
Q Consensus       261 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-  338 (432)
                      ....     ........+++.|+|||++.+. .++.++|||||||++|||++|+.||.......  ............. 
T Consensus       154 ~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i~~~~g~~~~  226 (372)
T cd07853         154 EPDE-----SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ--QLDLITDLLGTPSL  226 (372)
T ss_pred             ccCc-----cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH--HHHHHHHHcCCCCH
Confidence            2111     1122334678899999998864 57999999999999999999999986433211  0000000000000 


Q ss_pred             ---------hhhhhhhhh-hh-------cccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          339 ---------IIDLIDSVL-EE-------ASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       339 ---------~~~~i~~~l-~~-------~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                               ....+.... ..       ........++.+++.+||+.||++|||+.|++++-
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp  289 (372)
T cd07853         227 EAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHP  289 (372)
T ss_pred             HHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCH
Confidence                     000000000 00       01112245678999999999999999999999863

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=3.2e-39  Score=302.74  Aligned_cols=256  Identities=25%  Similarity=0.348  Sum_probs=202.3

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECCc-----eEEEEEEcCCC-hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEE
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQG-----EIAVKRLLGKS-GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLL  181 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~~-----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  181 (432)
                      ..+|.+.+.||+|+||.||+|.+.+.     .+++|...... ....+.+.+|+.++++++|+|++++++++.+ +..++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l   83 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI   83 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence            35688899999999999999986432     68889886554 5566789999999999999999999999875 45789


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceecc
Q 014024          182 IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVF  261 (432)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  261 (432)
                      ||||+++++|.+++....  ..+++..++.++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++....
T Consensus        84 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~  158 (270)
T cd05056          84 VMELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE  158 (270)
T ss_pred             EEEcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecc
Confidence            999999999999995432  34899999999999999999999998   9999999999999999999999999998652


Q ss_pred             CCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchh
Q 014024          262 GGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKII  340 (432)
Q Consensus       262 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                      ...     ........++..|+|||.+....++.++||||||+++|||++ |..||.......  ....           
T Consensus       159 ~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--~~~~-----------  220 (270)
T cd05056         159 DES-----YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND--VIGR-----------  220 (270)
T ss_pred             ccc-----ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH--HHHH-----------
Confidence            221     111112334567999999988889999999999999999986 999975332210  0000           


Q ss_pred             hhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccc
Q 014024          341 DLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS  389 (432)
Q Consensus       341 ~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~  389 (432)
                        +........+...+..+.+++.+|+..+|++|||+.++++.|+++..
T Consensus       221 --~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~  267 (270)
T cd05056         221 --IENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ  267 (270)
T ss_pred             --HHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence              00000111223445688999999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.7e-39  Score=304.81  Aligned_cols=253  Identities=24%  Similarity=0.387  Sum_probs=197.4

Q ss_pred             hhhCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCCChHhHHHHHHHHHHHHhc-CCCceeeeEeEEEeC------
Q 014024          106 SATGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEIKELKNEASVIAQV-QHKNLVKLLGCCIEK------  176 (432)
Q Consensus       106 ~~~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~------  176 (432)
                      .+++.|++.+.||+|+||.||+|...+.  .+++|.+.... .....+.+|+.+++++ +|+|++++++++...      
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            4578899999999999999999987543  78999885443 3345788899999998 699999999998753      


Q ss_pred             CeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeeccc
Q 014024          177 DERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGM  256 (432)
Q Consensus       177 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  256 (432)
                      ...+++|||+++++|.+++... ....+++..+..++.|++.|++|||+.+   ++|+||||+||++++++.++|+|||+
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~  157 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV  157 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence            4578999999999999998643 2345899999999999999999999998   99999999999999999999999999


Q ss_pred             ceeccCCCCccccccccccccccCCccChhhhc-----cCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhH
Q 014024          257 ARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAW  331 (432)
Q Consensus       257 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~  331 (432)
                      +......      ........|+..|+|||++.     +..++.++|+|||||++|||++|+.||........    . .
T Consensus       158 ~~~~~~~------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~----~-~  226 (272)
T cd06637         158 SAQLDRT------VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA----L-F  226 (272)
T ss_pred             ceecccc------cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH----H-H
Confidence            9764211      11233456889999999986     34588899999999999999999999853321100    0 0


Q ss_pred             HhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          332 DLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       332 ~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      ...         ............+..+.+++.+||..+|.+|||+.+++.+
T Consensus       227 ~~~---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         227 LIP---------RNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             HHh---------cCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence            000         0000001111234578899999999999999999999864

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=4e-39  Score=300.88  Aligned_cols=239  Identities=23%  Similarity=0.355  Sum_probs=187.6

Q ss_pred             ceeccCCcEEEEEEEECC--------------ceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeE
Q 014024          115 NKLGEGGFGTVYKGVIGQ--------------GEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERL  180 (432)
Q Consensus       115 ~~ig~G~~g~Vy~~~~~~--------------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  180 (432)
                      +.||+|+||.||+|....              ..+++|.+..........+.+|+.+++.++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999998432              147888876655556667889999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCC-------EEEee
Q 014024          181 LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN-------SKISD  253 (432)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~-------~kl~D  253 (432)
                      ++|||+++++|..++...  ...+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.       ++++|
T Consensus        81 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             EEEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            999999999999888532  345899999999999999999999998   999999999999987664       89999


Q ss_pred             cccceeccCCCCccccccccccccccCCccChhhhc-cCCCCchhhhHHHHHHHHHHH-hCCCCCCCccccccchhhhhH
Q 014024          254 FGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIV-SGKKNTGFYRTKSLNLIGYAW  331 (432)
Q Consensus       254 fg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~~~DvwSlG~il~ell-tg~~p~~~~~~~~~~~~~~~~  331 (432)
                      ||++....          ......++..|+|||.+. +..++.++|||||||++|||+ +|..|+........       
T Consensus       156 ~g~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-------  218 (262)
T cd05077         156 PGIPITVL----------SRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-------  218 (262)
T ss_pred             CCCCcccc----------CcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-------
Confidence            99987541          112345778899999887 467899999999999999998 47777542211000       


Q ss_pred             HhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014024          332 DLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLT  385 (432)
Q Consensus       332 ~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~  385 (432)
                              ..+......  .......++.+++..||+.||++||++.+|++.++
T Consensus       219 --------~~~~~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         219 --------ERFYEGQCM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             --------HHHHhcCcc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence                    000000000  01122356889999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=3.3e-39  Score=304.90  Aligned_cols=262  Identities=23%  Similarity=0.324  Sum_probs=196.0

Q ss_pred             CCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCC--hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEec
Q 014024          110 NFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS--GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEY  185 (432)
Q Consensus       110 ~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  185 (432)
                      +|++.+.||+|++|.||+|....  ..+++|++....  ......+.+|+.++++++|+|++++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            57889999999999999999753  489999885432  23346788899999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCC
Q 014024          186 MPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGND  265 (432)
Q Consensus       186 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  265 (432)
                      ++ ++|.+++........+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++......  
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--  154 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP--  154 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCC--
Confidence            97 688888765444456999999999999999999999998   999999999999999999999999999754211  


Q ss_pred             ccccccccccccccCCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhh-------HHhhhcc
Q 014024          266 EDELQGNTSRISGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYA-------WDLWISN  337 (432)
Q Consensus       266 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~-------~~~~~~~  337 (432)
                          ........+++.|+|||.+.+. .++.++||||||+++|+|+||+.||........ .....       ...+...
T Consensus       155 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  229 (285)
T cd07861         155 ----VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ-LFRIFRILGTPTEDVWPGV  229 (285)
T ss_pred             ----cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHHhCCCChhhhhcc
Confidence                1112234568899999988654 578999999999999999999999853321100 00000       0000000


Q ss_pred             -chhh---hh----hhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          338 -KIID---LI----DSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       338 -~~~~---~i----~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                       ...+   ..    .... .........++.+++.+||+.||++|||+.+++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         230 TSLPDYKNTFPKWKKGSL-RSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             hhhHHHHhhccccCcchh-HHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence             0000   00    0000 00011234567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=7.9e-39  Score=301.30  Aligned_cols=248  Identities=25%  Similarity=0.394  Sum_probs=201.8

Q ss_pred             CCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEec
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEY  185 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  185 (432)
                      ..|+..+.||.|+||.||+|.+..  ..+++|.+... .....+.+.+|+.+++.++|+|++++++++.+....++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            457788999999999999999754  48899987644 345567889999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCC
Q 014024          186 MPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGND  265 (432)
Q Consensus       186 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  265 (432)
                      +++++|.+++..    ..+++.....++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++....... 
T Consensus        84 ~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-  155 (277)
T cd06640          84 LGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-  155 (277)
T ss_pred             CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc-
Confidence            999999998842    34889999999999999999999998   9999999999999999999999999997652211 


Q ss_pred             ccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhh
Q 014024          266 EDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDS  345 (432)
Q Consensus       266 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  345 (432)
                           .......++..|+|||++.+..++.++|+||||+++|||++|..|+........               ...+..
T Consensus       156 -----~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---------------~~~~~~  215 (277)
T cd06640         156 -----IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV---------------LFLIPK  215 (277)
T ss_pred             -----cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH---------------hhhhhc
Confidence                 112234678889999999988899999999999999999999999753321100               000111


Q ss_pred             hhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          346 VLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       346 ~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                      ..........+..+.+++..||+.+|++||++.+++++-
T Consensus       216 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  254 (277)
T cd06640         216 NNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHK  254 (277)
T ss_pred             CCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhCh
Confidence            111122334567788999999999999999999998763

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.6e-39  Score=304.24  Aligned_cols=253  Identities=22%  Similarity=0.348  Sum_probs=199.7

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEec
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEY  185 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  185 (432)
                      .++|++.+.||+|+||.||+|.+..  ..+++|.+..........+.+|+.+++.++|||++++++.+.+.+..++||||
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~   87 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF   87 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence            4688999999999999999998754  48899988766555566788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCC
Q 014024          186 MPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGND  265 (432)
Q Consensus       186 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  265 (432)
                      +++++|.+++..   .+.+++.++..++.|++.|+.|||+.+   ++|+||||+||+++.++.++|+|||++......  
T Consensus        88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--  159 (267)
T cd06645          88 CGGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITAT--  159 (267)
T ss_pred             cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCc--
Confidence            999999998843   345899999999999999999999998   999999999999999999999999998764211  


Q ss_pred             ccccccccccccccCCccChhhhc---cCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhh
Q 014024          266 EDELQGNTSRISGTYGYMSPEYAL---EGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDL  342 (432)
Q Consensus       266 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                          ........|+..|+|||++.   .+.++.++|+|||||++|+|++|..|+........ .....    .....   
T Consensus       160 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~-~~~~~----~~~~~---  227 (267)
T cd06645         160 ----IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFLMT----KSNFQ---  227 (267)
T ss_pred             ----ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-HHhhh----ccCCC---
Confidence                11223456889999999874   45688999999999999999999999743221100 00000    00000   


Q ss_pred             hhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          343 IDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       343 i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                       .+...  .....+..+.+++.+||+.+|++||++.+++++
T Consensus       228 -~~~~~--~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         228 -PPKLK--DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             -CCccc--ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence             00000  001223567899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-39  Score=302.43  Aligned_cols=247  Identities=25%  Similarity=0.377  Sum_probs=200.5

Q ss_pred             CCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCC-hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEec
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS-GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEY  185 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  185 (432)
                      ++|++.+.||.|++|.||+|.+..  ..+++|.+.... ......+.+|+++++.++|+|++++++++.++...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            478889999999999999999754  389999885443 44556788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCC
Q 014024          186 MPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGND  265 (432)
Q Consensus       186 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  265 (432)
                      +++++|.+++...    .+++..+..++.|++.|+.|||+.+   ++|+||+|+||++++++.++|+|||++....... 
T Consensus        81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-  152 (274)
T cd06609          81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-  152 (274)
T ss_pred             eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence            9999999998532    5899999999999999999999998   9999999999999999999999999998753211 


Q ss_pred             ccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhh
Q 014024          266 EDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDS  345 (432)
Q Consensus       266 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  345 (432)
                           .......+++.|+|||++.+..++.++||||||+++|+|+||+.||.......     ..          ..+..
T Consensus       153 -----~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~-----~~----------~~~~~  212 (274)
T cd06609         153 -----SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR-----VL----------FLIPK  212 (274)
T ss_pred             -----cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH-----HH----------HHhhh
Confidence                 12233567889999999998889999999999999999999999985322100     00          00000


Q ss_pred             hhhhcccHH-HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          346 VLEEASFNE-SLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       346 ~l~~~~~~~-~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      ......... .+..+.+++.+||..+|++|||+++++++
T Consensus       213 ~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         213 NNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             cCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            000011111 34568899999999999999999999874

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=3.2e-39  Score=304.72  Aligned_cols=252  Identities=25%  Similarity=0.355  Sum_probs=199.8

Q ss_pred             CCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecCC
Q 014024          110 NFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMP  187 (432)
Q Consensus       110 ~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  187 (432)
                      .|++.+.||+|+||.||+|.+...  .+++|.+........+.+.+|+++++.++|+|++++++++...+..++||||++
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~   85 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   85 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence            367889999999999999998654  678888876666677788999999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCcc
Q 014024          188 NKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDED  267 (432)
Q Consensus       188 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  267 (432)
                      +++|..++...  ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++......    
T Consensus        86 ~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~----  156 (282)
T cd06643          86 GGAVDAVMLEL--ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT----  156 (282)
T ss_pred             CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccc----
Confidence            99998887532  345899999999999999999999998   999999999999999999999999998754211    


Q ss_pred             ccccccccccccCCccChhhhc-----cCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhh
Q 014024          268 ELQGNTSRISGTYGYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDL  342 (432)
Q Consensus       268 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                        ........++..|+|||++.     +..++.++|+|||||++|+|++|+.||.......     ..........    
T Consensus       157 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-----~~~~~~~~~~----  225 (282)
T cd06643         157 --IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR-----VLLKIAKSEP----  225 (282)
T ss_pred             --ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH-----HHHHHhhcCC----
Confidence              11223356889999999874     3457889999999999999999999975322100     0000000000    


Q ss_pred             hhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014024          343 IDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLT  385 (432)
Q Consensus       343 i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~  385 (432)
                        .  ....+...+.++.+++..||+.||++||++.+++++-.
T Consensus       226 --~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  264 (282)
T cd06643         226 --P--TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPF  264 (282)
T ss_pred             --C--CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCC
Confidence              0  00112233467889999999999999999999987654

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.8e-39  Score=312.85  Aligned_cols=235  Identities=23%  Similarity=0.292  Sum_probs=185.3

Q ss_pred             ceeccCCcEEEEEEEECC--ceEEEEEEcCC---ChHhHHHHHHHHH-HHHhcCCCceeeeEeEEEeCCeeEEEEecCCC
Q 014024          115 NKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK---SGQEIKELKNEAS-VIAQVQHKNLVKLLGCCIEKDERLLIYEYMPN  188 (432)
Q Consensus       115 ~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~---~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  188 (432)
                      +.||+|+||.||+|.+..  ..+|+|++...   .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            469999999999999753  48999988543   1223344555554 56778999999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCccc
Q 014024          189 KSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDE  268 (432)
Q Consensus       189 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  268 (432)
                      |+|..++.   ....+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++......     
T Consensus        81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-----  149 (325)
T cd05604          81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-----  149 (325)
T ss_pred             CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC-----
Confidence            99998884   3345899999999999999999999998   999999999999999999999999998753111     


Q ss_pred             cccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhhhh
Q 014024          269 LQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLE  348 (432)
Q Consensus       269 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  348 (432)
                       ........||+.|+|||++.+..++.++|||||||++|+|++|+.||......                  +..+..+.
T Consensus       150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~------------------~~~~~~~~  210 (325)
T cd05604         150 -SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA------------------EMYDNILH  210 (325)
T ss_pred             -CCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH------------------HHHHHHHc
Confidence             11233457899999999999999999999999999999999999998532211                  01111110


Q ss_pred             h--cccHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 014024          349 E--ASFNESLSRYVHIALLCVQERAEDRPTMSD  379 (432)
Q Consensus       349 ~--~~~~~~~~~l~~l~~~cl~~dp~~RPt~~e  379 (432)
                      .  .........+.+++..|++.+|.+||++++
T Consensus       211 ~~~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~  243 (325)
T cd05604         211 KPLVLRPGASLTAWSILEELLEKDRQRRLGAKE  243 (325)
T ss_pred             CCccCCCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence            0  011123456788999999999999998863

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=3e-39  Score=315.61  Aligned_cols=261  Identities=21%  Similarity=0.237  Sum_probs=195.2

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC-----
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKD-----  177 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----  177 (432)
                      ..++|++.+.||+|+||.||++.+..  ..+|+|++...  .......+.+|+.+++.++||||+++++++...+     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            46899999999999999999998754  48999998543  3344567889999999999999999999986543     


Q ss_pred             -eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeeccc
Q 014024          178 -ERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGM  256 (432)
Q Consensus       178 -~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  256 (432)
                       ..++||||+++ +|.+.+.     ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~  169 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  169 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence             46999999976 4555542     23788899999999999999999999   99999999999999999999999999


Q ss_pred             ceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhc
Q 014024          257 ARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWIS  336 (432)
Q Consensus       257 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  336 (432)
                      +.....       ........||+.|+|||++.+..++.++|||||||++|+|++|+.||...+....  ..........
T Consensus       170 a~~~~~-------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~--~~~~~~~~~~  240 (359)
T cd07876         170 ARTACT-------NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQ--WNKVIEQLGT  240 (359)
T ss_pred             cccccc-------CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCC
Confidence            975311       1122345789999999999999999999999999999999999999864332110  0000000000


Q ss_pred             ----------cchhhhhhhhhh------------------hcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014024          337 ----------NKIIDLIDSVLE------------------EASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLT  385 (432)
Q Consensus       337 ----------~~~~~~i~~~l~------------------~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~  385 (432)
                                ............                  ..........+.+++.+||+.||++|||+.|++++-.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~  317 (359)
T cd07876         241 PSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPY  317 (359)
T ss_pred             CcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCch
Confidence                      000000000000                  0000112356789999999999999999999998653

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=7.3e-39  Score=303.87  Aligned_cols=252  Identities=24%  Similarity=0.370  Sum_probs=200.9

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEec
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEY  185 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  185 (432)
                      .++|++.+.||.|+||.||+|.+..  ..+++|.+........+.+.+|+.+++.++|+|++++++.+..+...++||||
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF   90 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence            4779999999999999999999855  37899998777777778899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCC
Q 014024          186 MPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGND  265 (432)
Q Consensus       186 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  265 (432)
                      +++++|..++....  ..+++..+..++.|++.|+.|||+.+   ++||||||+||+++.++.++|+|||++......  
T Consensus        91 ~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--  163 (292)
T cd06644          91 CPGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--  163 (292)
T ss_pred             CCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc--
Confidence            99999988875432  34899999999999999999999998   999999999999999999999999998753211  


Q ss_pred             ccccccccccccccCCccChhhhc-----cCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchh
Q 014024          266 EDELQGNTSRISGTYGYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKII  340 (432)
Q Consensus       266 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                          ........+++.|+|||++.     ...++.++|+|||||++|+|++|..|+.......     .... ...... 
T Consensus       164 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-----~~~~-~~~~~~-  232 (292)
T cd06644         164 ----LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-----VLLK-IAKSEP-  232 (292)
T ss_pred             ----ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH-----HHHH-HhcCCC-
Confidence                11223456788999999885     3457889999999999999999999975322100     0000 000000 


Q ss_pred             hhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          341 DLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       341 ~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                          +  ....+.....++.+++.+||+.+|++||++.+++++
T Consensus       233 ----~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         233 ----P--TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             ----c--cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence                0  001122334568899999999999999999999874

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=8.3e-39  Score=297.40  Aligned_cols=249  Identities=23%  Similarity=0.332  Sum_probs=198.6

Q ss_pred             CCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeC-CeeEEEEe
Q 014024          110 NFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEK-DERLLIYE  184 (432)
Q Consensus       110 ~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e  184 (432)
                      +|++.+.||+|++|.||++.+..  ..+++|++...  .....+.+.+|++++++++|+|++++++.+... ...+++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            58899999999999999999754  37999988543  234556788999999999999999999987644 46789999


Q ss_pred             cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCC
Q 014024          185 YMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGN  264 (432)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  264 (432)
                      |+++++|.+++.... ...+++.++..++.|++.|+++||+.+   ++||||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~  156 (257)
T cd08223          81 FCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC  156 (257)
T ss_pred             ccCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence            999999999986532 345899999999999999999999998   9999999999999999999999999998652211


Q ss_pred             CccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhh
Q 014024          265 DEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLID  344 (432)
Q Consensus       265 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  344 (432)
                            .......+++.|+|||+..+..++.++|+||||+++++|++|+.||......     ....         ....
T Consensus       157 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~-----~~~~---------~~~~  216 (257)
T cd08223         157 ------DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN-----SLVY---------RIIE  216 (257)
T ss_pred             ------CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH-----HHHH---------HHHh
Confidence                  1223456789999999999999999999999999999999999997532210     0000         0000


Q ss_pred             hhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          345 SVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       345 ~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      . .....+......+.+++.+|++.+|++||++.+++++
T Consensus       217 ~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         217 G-KLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             c-CCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            0 0111223445678899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=6.2e-39  Score=299.14  Aligned_cols=253  Identities=29%  Similarity=0.452  Sum_probs=201.0

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECCc-eEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecC
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYM  186 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~~-~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  186 (432)
                      .++|++.+.||+|+||.||++.+.+. .+++|.+... ....+.+.+|+++++.++|+|++++++++.+ ...+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            46789999999999999999987554 7888877543 3345678899999999999999999999887 7789999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCc
Q 014024          187 PNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDE  266 (432)
Q Consensus       187 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  266 (432)
                      ++++|.+++.... ...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||.+.......  
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~--  156 (260)
T cd05073          83 AKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE--  156 (260)
T ss_pred             CCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCC--
Confidence            9999999996532 334889999999999999999999998   9999999999999999999999999997642211  


Q ss_pred             cccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchhhhhhh
Q 014024          267 DELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDS  345 (432)
Q Consensus       267 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  345 (432)
                         ........++..|+|||++..+.++.++|+||||+++|++++ |+.||......  ...             ..+..
T Consensus       157 ---~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~-------------~~~~~  218 (260)
T cd05073         157 ---YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVI-------------RALER  218 (260)
T ss_pred             ---cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH--HHH-------------HHHhC
Confidence               111122345677999999998889999999999999999999 88887532211  000             00011


Q ss_pred             hhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014024          346 VLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN  386 (432)
Q Consensus       346 ~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~  386 (432)
                      ..........+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus       219 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         219 GYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             CCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            11111122345678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=3e-39  Score=310.81  Aligned_cols=234  Identities=23%  Similarity=0.276  Sum_probs=184.2

Q ss_pred             ceeccCCcEEEEEEEECC--ceEEEEEEcCCC---hHhHHHHHHHH-HHHHhcCCCceeeeEeEEEeCCeeEEEEecCCC
Q 014024          115 NKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS---GQEIKELKNEA-SVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPN  188 (432)
Q Consensus       115 ~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  188 (432)
                      ++||+|+||.||+|.+..  ..+|+|++....   ......+..|. .+++.++|+||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            469999999999999854  379999885432   12233444554 467889999999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCccc
Q 014024          189 KSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDE  268 (432)
Q Consensus       189 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  268 (432)
                      ++|..++..   ...+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++......     
T Consensus        81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-----  149 (321)
T cd05603          81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-----  149 (321)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC-----
Confidence            999888843   345889999999999999999999998   999999999999999999999999998742111     


Q ss_pred             cccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhhhh
Q 014024          269 LQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLE  348 (432)
Q Consensus       269 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  348 (432)
                       ........||+.|+|||++.+..++.++|||||||++|||++|..||......                  ...+....
T Consensus       150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------------------~~~~~i~~  210 (321)
T cd05603         150 -EETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS------------------QMYDNILH  210 (321)
T ss_pred             -CCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH------------------HHHHHHhc
Confidence             11233457899999999999889999999999999999999999998532110                  01111110


Q ss_pred             --hcccHHHHHHHHHHHHHhhccCCCCCCCHH
Q 014024          349 --EASFNESLSRYVHIALLCVQERAEDRPTMS  378 (432)
Q Consensus       349 --~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~  378 (432)
                        ...+......+.+++.+||+.||.+||+..
T Consensus       211 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         211 KPLQLPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence              111223446788999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.5e-39  Score=313.51  Aligned_cols=239  Identities=25%  Similarity=0.289  Sum_probs=185.7

Q ss_pred             ceeccCCcEEEEEEEECCc--eEEEEEEcCCC---hHhHHHHHHH-HHHHHhcCCCceeeeEeEEEeCCeeEEEEecCCC
Q 014024          115 NKLGEGGFGTVYKGVIGQG--EIAVKRLLGKS---GQEIKELKNE-ASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPN  188 (432)
Q Consensus       115 ~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~---~~~~~~~~~E-~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  188 (432)
                      +.||+|+||.||+|.+...  .+|+|++....   ......+..| ..+++.++|+||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            4699999999999998644  79999885432   1222233444 3456788999999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCccc
Q 014024          189 KSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDE  268 (432)
Q Consensus       189 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  268 (432)
                      ++|.+++..   ...+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++......     
T Consensus        81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~-----  149 (325)
T cd05602          81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-----  149 (325)
T ss_pred             CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccC-----
Confidence            999998853   344888899999999999999999999   999999999999999999999999998753211     


Q ss_pred             cccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhhhh
Q 014024          269 LQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLE  348 (432)
Q Consensus       269 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  348 (432)
                       ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.......     .. .        .+....  
T Consensus       150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----~~-~--------~i~~~~--  212 (325)
T cd05602         150 -NGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-----MY-D--------NILNKP--  212 (325)
T ss_pred             -CCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH-----HH-H--------HHHhCC--
Confidence             112334579999999999999999999999999999999999999985322110     00 0        000000  


Q ss_pred             hcccHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 014024          349 EASFNESLSRYVHIALLCVQERAEDRPTMSDVV  381 (432)
Q Consensus       349 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl  381 (432)
                      ..........+.+++..||+.||.+||++.+.+
T Consensus       213 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         213 LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence            011223456788999999999999999987433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.6e-39  Score=314.05  Aligned_cols=261  Identities=28%  Similarity=0.409  Sum_probs=199.3

Q ss_pred             hCCCCcCceeccCCcEEEEEEEEC-------CceEEEEEEcCCC-hHhHHHHHHHHHHHHhc-CCCceeeeEeEEEeC-C
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIG-------QGEIAVKRLLGKS-GQEIKELKNEASVIAQV-QHKNLVKLLGCCIEK-D  177 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-~  177 (432)
                      .++|++.+.||+|+||.||+|.+.       +..||+|++.... ......+.+|+.++.++ +|+||+++++++... .
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            468999999999999999999742       2379999986543 33456788999999999 689999999988654 4


Q ss_pred             eeEEEEecCCCCChhhhhcCCCC---------------------------------------------------------
Q 014024          178 ERLLIYEYMPNKSLDCFLFDPTK---------------------------------------------------------  200 (432)
Q Consensus       178 ~~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------  200 (432)
                      ..+++|||+++|+|.+++.....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            67899999999999998853210                                                         


Q ss_pred             -------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCcccccccc
Q 014024          201 -------REILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNT  273 (432)
Q Consensus       201 -------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  273 (432)
                             ...+++..+..++.|++.||+|||+.+   |+||||||+||++++++.+||+|||++........    ....
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~----~~~~  238 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPD----YVRK  238 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcc----hhhc
Confidence                   123788889999999999999999998   99999999999999999999999999976422111    0111


Q ss_pred             ccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchhhhhhhhhhhccc
Q 014024          274 SRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASF  352 (432)
Q Consensus       274 ~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~  352 (432)
                      ....++..|+|||.+.+..++.++||||||+++|+|++ |..|+....... .    ...         .+........+
T Consensus       239 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~----~~~---------~~~~~~~~~~~  304 (343)
T cd05103         239 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-E----FCR---------RLKEGTRMRAP  304 (343)
T ss_pred             CCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-H----HHH---------HHhccCCCCCC
Confidence            22345677999999998899999999999999999997 888875322110 0    000         00000001111


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccc
Q 014024          353 NESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS  389 (432)
Q Consensus       353 ~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~  389 (432)
                      .....++.+++..||+.||++|||+.||+++|+.+..
T Consensus       305 ~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         305 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            1123568899999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=4.5e-39  Score=300.17  Aligned_cols=252  Identities=27%  Similarity=0.398  Sum_probs=191.2

Q ss_pred             ceeccCCcEEEEEEEECC-----ceEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEE-eCCeeEEEEecCC
Q 014024          115 NKLGEGGFGTVYKGVIGQ-----GEIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCI-EKDERLLIYEYMP  187 (432)
Q Consensus       115 ~~ig~G~~g~Vy~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~  187 (432)
                      +.||+|+||.||+|.+.+     ..+++|.+... .....+.+.+|+.+++.++|||++++++++. .++..+++|||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            468999999999998632     26899987543 3455678889999999999999999999876 4556789999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCcc
Q 014024          188 NKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDED  267 (432)
Q Consensus       188 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  267 (432)
                      +++|.+++....  ..+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||++......... 
T Consensus        81 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~-  154 (262)
T cd05058          81 HGDLRNFIRSET--HNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY-  154 (262)
T ss_pred             CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcce-
Confidence            999999986432  23678888999999999999999998   999999999999999999999999999754221100 


Q ss_pred             ccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCC-CCCCccccccchhhhhHHhhhccchhhhhhhh
Q 014024          268 ELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK-NTGFYRTKSLNLIGYAWDLWISNKIIDLIDSV  346 (432)
Q Consensus       268 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  346 (432)
                       .........++..|+|||.+.+..++.++||||||+++|||++|.. |+.....  .......             ...
T Consensus       155 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--~~~~~~~-------------~~~  218 (262)
T cd05058         155 -SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS--FDITVYL-------------LQG  218 (262)
T ss_pred             -eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHH-------------hcC
Confidence             0111123345678999999988899999999999999999999654 4432111  0111100             000


Q ss_pred             hhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014024          347 LEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEA  388 (432)
Q Consensus       347 l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~  388 (432)
                      .....+...+..+.+++..||+.+|++||++.++++.|++..
T Consensus       219 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         219 RRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence            000111123457889999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.5e-39  Score=302.59  Aligned_cols=238  Identities=22%  Similarity=0.319  Sum_probs=185.7

Q ss_pred             eeccCCcEEEEEEEECC--------------------------ceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeee
Q 014024          116 KLGEGGFGTVYKGVIGQ--------------------------GEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKL  169 (432)
Q Consensus       116 ~ig~G~~g~Vy~~~~~~--------------------------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~  169 (432)
                      .||+|+||.||+|....                          ..+++|.+..........+.+|+.+++.++|+||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            59999999999987411                          1478888765555555678889999999999999999


Q ss_pred             EeEEEeCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCC--
Q 014024          170 LGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDM--  247 (432)
Q Consensus       170 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~--  247 (432)
                      ++++.+....++||||+++|+|..++...  ++.+++..+..++.|++.||+|||+.+   |+||||||+||++++.+  
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence            99999999999999999999999988543  334899999999999999999999998   99999999999997644  


Q ss_pred             -----CEEEeecccceeccCCCCccccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHH-hCCCCCCCcc
Q 014024          248 -----NSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIV-SGKKNTGFYR  320 (432)
Q Consensus       248 -----~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~ell-tg~~p~~~~~  320 (432)
                           .+|++|||++.....          .....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+....
T Consensus       157 ~~~~~~~kl~d~g~~~~~~~----------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~  226 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTALS----------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT  226 (274)
T ss_pred             cCccceeeecCCcccccccc----------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccC
Confidence                 379999998864311          112346778999998875 56899999999999999995 6888874322


Q ss_pred             ccccchhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014024          321 TKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLT  385 (432)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~  385 (432)
                      ...  .             ........  ..+......+.+++.+||+.+|++|||+.+|++.|.
T Consensus       227 ~~~--~-------------~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         227 PSE--K-------------ERFYEKKH--RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             hHH--H-------------HHHHHhcc--CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            111  0             00111100  011112346889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-38  Score=297.11  Aligned_cols=254  Identities=22%  Similarity=0.348  Sum_probs=203.0

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEec
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEY  185 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  185 (432)
                      .++|++.+.||.|+||.||+|....  ..+++|.+........+.+.+|++++++++|+|++++++++.+.+..+++|||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            3678999999999999999999754  47999998766666778899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCC
Q 014024          186 MPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGND  265 (432)
Q Consensus       186 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  265 (432)
                      +++++|.+++...  ...+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.+||+|||++......  
T Consensus        82 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~--  154 (262)
T cd06613          82 CGGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTAT--  154 (262)
T ss_pred             CCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhh--
Confidence            9999999988542  245899999999999999999999998   999999999999999999999999998764211  


Q ss_pred             ccccccccccccccCCccChhhhccC---CCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhh
Q 014024          266 EDELQGNTSRISGTYGYMSPEYALEG---IFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDL  342 (432)
Q Consensus       266 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                          ........++..|+|||.+.+.   .++.++|+||||+++|+|++|+.|+........ ..    . .....   +
T Consensus       155 ----~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~-~~----~-~~~~~---~  221 (262)
T cd06613         155 ----IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA-LF----L-ISKSN---F  221 (262)
T ss_pred             ----hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HH----H-HHhcc---C
Confidence                1112334678889999998776   889999999999999999999999753322110 00    0 00000   0


Q ss_pred             hhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          343 IDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       343 i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      ....  .......+.++.+++.+||+.+|.+|||+.+|+.+
T Consensus       222 ~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         222 PPPK--LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             CCcc--ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0000  00122345678999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=5.5e-39  Score=298.32  Aligned_cols=250  Identities=25%  Similarity=0.385  Sum_probs=201.4

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEec
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEY  185 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  185 (432)
                      .++|++.+.||+|+||.||+|....  ..+++|.+.....  .+.+.+|++++++++|+|++++++++.+....++++||
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            3689999999999999999999865  4789998865432  67899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCC
Q 014024          186 MPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGND  265 (432)
Q Consensus       186 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  265 (432)
                      +++++|.+++...  ...+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++....... 
T Consensus        80 ~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~-  153 (256)
T cd06612          80 CGAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM-  153 (256)
T ss_pred             CCCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCc-
Confidence            9999999998542  345899999999999999999999998   9999999999999999999999999998652211 


Q ss_pred             ccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhh
Q 014024          266 EDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDS  345 (432)
Q Consensus       266 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  345 (432)
                           .......++..|+|||++.+..++.++||||||+++|+|++|+.|+.........     .. . .....    .
T Consensus       154 -----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~-----~~-~-~~~~~----~  217 (256)
T cd06612         154 -----AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI-----FM-I-PNKPP----P  217 (256)
T ss_pred             -----cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh-----hh-h-ccCCC----C
Confidence                 1223345788999999999889999999999999999999999998543221100     00 0 00000    0


Q ss_pred             hhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          346 VLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       346 ~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                        ....+......+.+++.+||+.||++|||+.|++++
T Consensus       218 --~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         218 --TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             --CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence              000112234578899999999999999999999874

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=4.1e-39  Score=306.44  Aligned_cols=252  Identities=23%  Similarity=0.350  Sum_probs=202.6

Q ss_pred             hhhCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEE
Q 014024          106 SATGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       106 ~~~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  183 (432)
                      ....+|++.+.||+|++|.||++.+.  +..+++|.+........+.+.+|+.+++.++|+|++++++++...+..++||
T Consensus        16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   95 (297)
T cd06656          16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   95 (297)
T ss_pred             ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence            34578999999999999999999974  4489999987665555677889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCC
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGG  263 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  263 (432)
                      ||+++++|.+++..    ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++......
T Consensus        96 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~  168 (297)
T cd06656          96 EYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  168 (297)
T ss_pred             cccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence            99999999999842    34889999999999999999999998   999999999999999999999999998764221


Q ss_pred             CCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhh
Q 014024          264 NDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLI  343 (432)
Q Consensus       264 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i  343 (432)
                      .      .......+++.|+|||.+.+..++.++|+|||||++|+|++|..||...........  .   .... .    
T Consensus       169 ~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~--~---~~~~-~----  232 (297)
T cd06656         169 Q------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL--I---ATNG-T----  232 (297)
T ss_pred             c------cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee--e---ccCC-C----
Confidence            1      112234678899999999998899999999999999999999999853221110000  0   0000 0    


Q ss_pred             hhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          344 DSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       344 ~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                       +  ....+...+..+.+++.+||+.+|++||++.+++++
T Consensus       233 -~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (297)
T cd06656         233 -P--ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH  269 (297)
T ss_pred             -C--CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             0  000112234567889999999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=5.8e-39  Score=298.38  Aligned_cols=251  Identities=28%  Similarity=0.440  Sum_probs=198.3

Q ss_pred             CCCCcCceeccCCcEEEEEEEEC-CceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecCC
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIG-QGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMP  187 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  187 (432)
                      .+|++.+.||+|+||.||++.+. +..+++|.+..... ....+.+|++++++++|+|++++++++......+++|||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            57888899999999999999876 45889998754332 34578899999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCcc
Q 014024          188 NKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDED  267 (432)
Q Consensus       188 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  267 (432)
                      +++|.+++....  ..+++..+..++.|++.|+++||+.+   ++|+||||+||+++.++.++|+|||++.......   
T Consensus        83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~---  154 (256)
T cd05112          83 HGCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ---  154 (256)
T ss_pred             CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCc---
Confidence            999999986432  34889999999999999999999998   9999999999999999999999999987642111   


Q ss_pred             ccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchhhhhhhh
Q 014024          268 ELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSV  346 (432)
Q Consensus       268 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  346 (432)
                        ........++..|+|||.+.++.++.++||||||+++|||++ |..||.......  .   ...          +...
T Consensus       155 --~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~---~~~----------~~~~  217 (256)
T cd05112         155 --YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE--V---VET----------INAG  217 (256)
T ss_pred             --ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH--H---HHH----------HhCC
Confidence              011122334568999999998899999999999999999998 888875322110  0   000          0000


Q ss_pred             hhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014024          347 LEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLT  385 (432)
Q Consensus       347 l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~  385 (432)
                      .....+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus       218 ~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         218 FRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             CCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence            000111123467899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=3.2e-39  Score=303.89  Aligned_cols=247  Identities=25%  Similarity=0.410  Sum_probs=198.5

Q ss_pred             CCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecC
Q 014024          110 NFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYM  186 (432)
Q Consensus       110 ~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  186 (432)
                      .|+..+.||+|+||.||+|.+..  ..+++|.+... .....+.+.+|+++++.++|+||+++++++..++..++||||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            46677889999999999998754  37899987644 2445667899999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCc
Q 014024          187 PNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDE  266 (432)
Q Consensus       187 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  266 (432)
                      ++++|.+++..    ..+++..+..++.|++.|+.|||+.+   ++|+||+|+||++++++.++|+|||++..+...   
T Consensus        85 ~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~---  154 (277)
T cd06642          85 GGGSALDLLKP----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT---  154 (277)
T ss_pred             CCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCc---
Confidence            99999998842    34899999999999999999999998   999999999999999999999999999764221   


Q ss_pred             cccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhh
Q 014024          267 DELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSV  346 (432)
Q Consensus       267 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  346 (432)
                         ........++..|+|||++.+..++.++|+||||+++|||++|+.|+.......  ..             ..+...
T Consensus       155 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~-------------~~~~~~  216 (277)
T cd06642         155 ---QIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR--VL-------------FLIPKN  216 (277)
T ss_pred             ---chhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh--HH-------------hhhhcC
Confidence               111223467889999999999899999999999999999999999975322110  00             000000


Q ss_pred             hhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          347 LEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       347 l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                      .........+..+.+++.+||+.+|++||++.+++++-
T Consensus       217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  254 (277)
T cd06642         217 SPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHK  254 (277)
T ss_pred             CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhH
Confidence            01111223456788999999999999999999999853

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=8.2e-39  Score=308.58  Aligned_cols=261  Identities=19%  Similarity=0.266  Sum_probs=193.8

Q ss_pred             cCceeccC--CcEEEEEEEECCc--eEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecC
Q 014024          113 AANKLGEG--GFGTVYKGVIGQG--EIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYM  186 (432)
Q Consensus       113 ~~~~ig~G--~~g~Vy~~~~~~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  186 (432)
                      ++++||+|  +|++||++....+  .||+|++...  .....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            56789999  7899999987543  7999988543  2344567888999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCc
Q 014024          187 PNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDE  266 (432)
Q Consensus       187 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  266 (432)
                      ++|+|.+++.... ...+++..++.++.|++.||+|||+.+   |+||||||+||+++.++.++++||+...........
T Consensus        82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~  157 (327)
T cd08227          82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR  157 (327)
T ss_pred             CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence            9999999985432 234899999999999999999999998   999999999999999999999999876543221111


Q ss_pred             -cccccccccccccCCccChhhhcc--CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhh
Q 014024          267 -DELQGNTSRISGTYGYMSPEYALE--GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLI  343 (432)
Q Consensus       267 -~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i  343 (432)
                       ...........++..|+|||++.+  ..++.++|||||||++|||++|+.||......... .    .. ........+
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~----~~-~~~~~~~~~  231 (327)
T cd08227         158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML-L----EK-LNGTVPCLL  231 (327)
T ss_pred             ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHH-H----HH-hcCCccccc
Confidence             000111223356778999999876  46899999999999999999999998643221100 0    00 000000000


Q ss_pred             h------------------------------------hhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          344 D------------------------------------SVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       344 ~------------------------------------~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      +                                    ..............+.+++.+||+.||++|||++|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~  307 (327)
T cd08227         232 DTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  307 (327)
T ss_pred             cccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence            0                                    000000112234578899999999999999999999974

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.8e-39  Score=295.97  Aligned_cols=248  Identities=31%  Similarity=0.449  Sum_probs=196.6

Q ss_pred             ceeccCCcEEEEEEEEC-CceEEEEEEcCCCh-HhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecCCCCChh
Q 014024          115 NKLGEGGFGTVYKGVIG-QGEIAVKRLLGKSG-QEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLD  192 (432)
Q Consensus       115 ~~ig~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~  192 (432)
                      ++||+|++|.||++.+. +..+++|....... .....+.+|++++++++|+||+++++++.+....++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            46999999999999986 45899998765433 35678899999999999999999999999999999999999999999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCccccccc
Q 014024          193 CFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN  272 (432)
Q Consensus       193 ~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  272 (432)
                      +++....  ..+++..+..++.+++.||+|||+++   ++||||+|+||++++++.+||+|||++........    ...
T Consensus        81 ~~l~~~~--~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~----~~~  151 (251)
T cd05041          81 TFLRKKK--NRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIY----TVS  151 (251)
T ss_pred             HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcc----eec
Confidence            9985432  34889999999999999999999998   99999999999999999999999999976421110    111


Q ss_pred             cccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchhhhhhhhhhhcc
Q 014024          273 TSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEAS  351 (432)
Q Consensus       273 ~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~  351 (432)
                      .....++..|+|||.+.++.++.++|+||||+++|+|+| |..||......               .....+........
T Consensus       152 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~---------------~~~~~~~~~~~~~~  216 (251)
T cd05041         152 DGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ---------------QTRERIESGYRMPA  216 (251)
T ss_pred             cccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH---------------HHHHHHhcCCCCCC
Confidence            112233567999999998899999999999999999999 77776432211               01111111111122


Q ss_pred             cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014024          352 FNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN  386 (432)
Q Consensus       352 ~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~  386 (432)
                      +...+..+.+++.+||+.+|.+|||+.|+++.|+.
T Consensus       217 ~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~  251 (251)
T cd05041         217 PQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI  251 (251)
T ss_pred             CccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence            33445688999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.2e-38  Score=296.19  Aligned_cols=250  Identities=22%  Similarity=0.331  Sum_probs=201.3

Q ss_pred             CCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEec
Q 014024          110 NFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEY  185 (432)
Q Consensus       110 ~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  185 (432)
                      +|+..+.||.|+||.||.+....  ..+++|.+...  .......+.+|++++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            58889999999999999888644  47899987543  345567788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCC
Q 014024          186 MPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGND  265 (432)
Q Consensus       186 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  265 (432)
                      +++++|.+++.... ...+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++....... 
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~-  155 (256)
T cd08221          81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY-  155 (256)
T ss_pred             cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEccccc-
Confidence            99999999986432 345899999999999999999999998   9999999999999999999999999998652211 


Q ss_pred             ccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhh
Q 014024          266 EDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDS  345 (432)
Q Consensus       266 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  345 (432)
                           .......+++.|+|||...+..++.++|+||||+++|+|++|..||......     ....         .+...
T Consensus       156 -----~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-----~~~~---------~~~~~  216 (256)
T cd08221         156 -----SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL-----NLVV---------KIVQG  216 (256)
T ss_pred             -----ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH-----HHHH---------HHHcC
Confidence                 1223456889999999998888999999999999999999999997532110     0000         00000


Q ss_pred             hhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          346 VLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       346 ~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                      . ........+..+.+++.+||+.+|++||++.++++++
T Consensus       217 ~-~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         217 N-YTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             C-CCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence            0 0111123456788999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=3.3e-39  Score=306.96  Aligned_cols=251  Identities=22%  Similarity=0.366  Sum_probs=201.9

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEe
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYE  184 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  184 (432)
                      ...+|++.+.||.|++|.||+|.+.  +..+++|.+........+.+.+|+..++.++|+|++++++++.+.+..++|+|
T Consensus        17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   96 (296)
T cd06655          17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME   96 (296)
T ss_pred             CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence            3457999999999999999999864  34899998866655556778999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCC
Q 014024          185 YMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGN  264 (432)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  264 (432)
                      |+++++|.+++..    ..+++.++..++.|++.|++|||+.+   ++||||+|+||+++.++.+||+|||++.......
T Consensus        97 ~~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~  169 (296)
T cd06655          97 YLAGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ  169 (296)
T ss_pred             ecCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence            9999999998842    34899999999999999999999998   9999999999999999999999999987642211


Q ss_pred             CccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhh
Q 014024          265 DEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLID  344 (432)
Q Consensus       265 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  344 (432)
                            .......++..|+|||.+.+..++.++|+|||||++|+|++|+.||........     ........ .     
T Consensus       170 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~-----~~~~~~~~-~-----  232 (296)
T cd06655         170 ------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-----LYLIATNG-T-----  232 (296)
T ss_pred             ------ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHhcC-C-----
Confidence                  112334688899999999988899999999999999999999999854322100     00000000 0     


Q ss_pred             hhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          345 SVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       345 ~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      +  ....+......+.+++.+||..||++||++.+++.+
T Consensus       233 ~--~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         233 P--ELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             c--ccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence            0  000112234568889999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.8e-39  Score=318.10  Aligned_cols=260  Identities=20%  Similarity=0.229  Sum_probs=199.5

Q ss_pred             hhhHhhhhCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCC---ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEe
Q 014024          101 FSSVSSATGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGK---SGQEIKELKNEASVIAQVQHKNLVKLLGCCIE  175 (432)
Q Consensus       101 ~~~~~~~~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  175 (432)
                      ........++|++.+.||+|+||.||++.+..+  .+|+|.+...   .....+.+.+|+.+++.++||||+++++.+.+
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  114 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            334455678999999999999999999998654  7899987532   22334567889999999999999999999999


Q ss_pred             CCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecc
Q 014024          176 KDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFG  255 (432)
Q Consensus       176 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  255 (432)
                      .+..++||||+++|+|.+++..    ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG  187 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG  187 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCC
Confidence            9999999999999999999843    23888999999999999999999999   9999999999999999999999999


Q ss_pred             cceeccCCCCccccccccccccccCCccChhhhccC----CCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhH
Q 014024          256 MARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEG----IFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAW  331 (432)
Q Consensus       256 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~  331 (432)
                      ++.......     ........||+.|+|||++.+.    .++.++|||||||++|||++|+.||......     ....
T Consensus       188 ~a~~~~~~~-----~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-----~~~~  257 (371)
T cd05622         188 TCMKMNKEG-----MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-----GTYS  257 (371)
T ss_pred             ceeEcCcCC-----cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH-----HHHH
Confidence            998652211     1122345799999999998753    3789999999999999999999998532210     0000


Q ss_pred             HhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHHh
Q 014024          332 DLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAED--RPTMSDVVSML  384 (432)
Q Consensus       332 ~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~--RPt~~evl~~L  384 (432)
                      .......       .+...........+.+++..||..++.+  ||++.+++++.
T Consensus       258 ~i~~~~~-------~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         258 KIMNHKN-------SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             HHHcCCC-------cccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence            0000000       0001111234566788999999844433  78999999875

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.1e-39  Score=301.98  Aligned_cols=239  Identities=24%  Similarity=0.404  Sum_probs=188.6

Q ss_pred             ceeccCCcEEEEEEEECCc---------eEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEec
Q 014024          115 NKLGEGGFGTVYKGVIGQG---------EIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEY  185 (432)
Q Consensus       115 ~~ig~G~~g~Vy~~~~~~~---------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  185 (432)
                      +.||+|+||.||+|.....         .+++|.+........+.+.+|+.+++.++|+|++++++++..++..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            4699999999999986431         4778877655555667889999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCC--------EEEeecccc
Q 014024          186 MPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN--------SKISDFGMA  257 (432)
Q Consensus       186 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~--------~kl~Dfg~a  257 (432)
                      +++|+|.+++....  ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.        ++++|||++
T Consensus        81 ~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          81 VKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             CCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence            99999999986433  24899999999999999999999998   999999999999987765        599999988


Q ss_pred             eeccCCCCccccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCC-CCCCCccccccchhhhhHHhhh
Q 014024          258 RIVFGGNDEDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGK-KNTGFYRTKSLNLIGYAWDLWI  335 (432)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~-~p~~~~~~~~~~~~~~~~~~~~  335 (432)
                      ....          ......++..|+|||++.+ ..++.++||||||+++|+|++|. .|+.......            
T Consensus       156 ~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~------------  213 (258)
T cd05078         156 ITVL----------PKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK------------  213 (258)
T ss_pred             cccC----------CchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH------------
Confidence            6531          1223457888999999986 45899999999999999999995 4432211100            


Q ss_pred             ccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014024          336 SNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLT  385 (432)
Q Consensus       336 ~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~  385 (432)
                         .......  ....+.....++.+++..||+.||++|||++++++.|+
T Consensus       214 ---~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         214 ---KLQFYED--RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             ---HHHHHHc--cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence               0000000  01112223356889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.4e-39  Score=313.34  Aligned_cols=258  Identities=22%  Similarity=0.304  Sum_probs=193.4

Q ss_pred             hhhCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCCC--hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeC-----
Q 014024          106 SATGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKS--GQEIKELKNEASVIAQVQHKNLVKLLGCCIEK-----  176 (432)
Q Consensus       106 ~~~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----  176 (432)
                      ...++|++.+.||+|+||.||+|.+...  .||+|++....  ....+.+.+|++++++++|+||+++++++...     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            3457899999999999999999987543  79999886432  23345677899999999999999999988543     


Q ss_pred             -CeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecc
Q 014024          177 -DERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFG  255 (432)
Q Consensus       177 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  255 (432)
                       ...++++|++ +++|.+++.    ...+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg  163 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG  163 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence             3468999988 778888773    234999999999999999999999999   9999999999999999999999999


Q ss_pred             cceeccCCCCccccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHH--
Q 014024          256 MARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWD--  332 (432)
Q Consensus       256 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~--  332 (432)
                      ++....         .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......  .......  
T Consensus       164 ~~~~~~---------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~  232 (343)
T cd07878         164 LARQAD---------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID--QLKRIMEVV  232 (343)
T ss_pred             cceecC---------CCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHh
Confidence            998641         12234568999999999876 568999999999999999999999985432110  0000000  


Q ss_pred             ---------hhhccchhhhhhhhhhhcc-------cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          333 ---------LWISNKIIDLIDSVLEEAS-------FNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       333 ---------~~~~~~~~~~i~~~l~~~~-------~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                               ..........+.. +....       .......+.+++.+||+.||++|||+.|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         233 GTPSPEVLKKISSEHARKYIQS-LPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             CCCCHHHHHhcchhhHHHHhhc-cccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                     0000000000000 00000       00112356799999999999999999999976

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.1e-38  Score=298.45  Aligned_cols=251  Identities=25%  Similarity=0.379  Sum_probs=193.2

Q ss_pred             CCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC-----ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeC--Cee
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK-----SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEK--DER  179 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~  179 (432)
                      .+|+..+.||+|+||.||+|.+..  ..+++|++...     .......+.+|+.++++++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            478999999999999999999754  48999987532     223456788999999999999999999998753  567


Q ss_pred             EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeeccccee
Q 014024          180 LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARI  259 (432)
Q Consensus       180 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  259 (432)
                      ++++||+++++|.+++..   ...+++...+.++.|++.||+|||+.+   ++||||+|+||++++++.+||+|||++..
T Consensus        82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~  155 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (266)
T ss_pred             EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence            899999999999999853   334889999999999999999999998   99999999999999999999999999876


Q ss_pred             ccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccch
Q 014024          260 VFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKI  339 (432)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  339 (432)
                      .......   ........++..|+|||++.+..++.++|+|||||++|+|++|+.||.......              ..
T Consensus       156 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~--------------~~  218 (266)
T cd06651         156 LQTICMS---GTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA--------------AI  218 (266)
T ss_pred             ccccccc---CCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH--------------HH
Confidence            4211100   111223457889999999998889999999999999999999999985322100              00


Q ss_pred             hhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          340 IDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       340 ~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      ............+......+..++ .||..+|++||+++||+++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h  261 (266)
T cd06651         219 FKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH  261 (266)
T ss_pred             HHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence            000000001111222334556666 7888999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=6e-39  Score=301.60  Aligned_cols=256  Identities=27%  Similarity=0.404  Sum_probs=201.7

Q ss_pred             CCCCcCceeccCCcEEEEEEEEC-------CceEEEEEEcCCChH-hHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeE
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIG-------QGEIAVKRLLGKSGQ-EIKELKNEASVIAQVQHKNLVKLLGCCIEKDERL  180 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  180 (432)
                      ++|++.+.||+|+||.||+|...       ...+++|.+...... ..+.+.+|++++++++|+|++++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            57889999999999999999863       236888887654433 5678999999999999999999999999989999


Q ss_pred             EEEecCCCCChhhhhcCCCCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeec
Q 014024          181 LIYEYMPNKSLDCFLFDPTKR------EILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDF  254 (432)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  254 (432)
                      +||||+++++|.+++......      ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.++++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence            999999999999999654322      15899999999999999999999998   999999999999999999999999


Q ss_pred             ccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHh
Q 014024          255 GMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDL  333 (432)
Q Consensus       255 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~  333 (432)
                      |++.......     ........++..|+|||.+.+..++.++||||||+++|+|++ |..||......  ....    .
T Consensus       162 ~~~~~~~~~~-----~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~--~~~~----~  230 (275)
T cd05046         162 SLSKDVYNSE-----YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE--EVLN----R  230 (275)
T ss_pred             ccccccCccc-----ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH--HHHH----H
Confidence            9987532111     112233456778999999988889999999999999999999 77776422111  0000    0


Q ss_pred             hhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014024          334 WISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN  386 (432)
Q Consensus       334 ~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~  386 (432)
                      ...        ...........+..+.+++.+||+.+|++||++.++++.|++
T Consensus       231 ~~~--------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         231 LQA--------GKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             HHc--------CCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence            000        000011122345678999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=4.8e-39  Score=313.71  Aligned_cols=260  Identities=22%  Similarity=0.241  Sum_probs=195.0

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeC------
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEK------  176 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------  176 (432)
                      ..++|++.+.||+|+||.||++.+..  ..+|+|++...  .......+.+|+.+++.++|+||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            46799999999999999999998753  48999988643  334456778899999999999999999988643      


Q ss_pred             CeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeeccc
Q 014024          177 DERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGM  256 (432)
Q Consensus       177 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  256 (432)
                      ...++||||+++ ++.+.+.     ..+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~  165 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence            346999999976 5555552     23889999999999999999999998   99999999999999999999999999


Q ss_pred             ceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhh--
Q 014024          257 ARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLW--  334 (432)
Q Consensus       257 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~--  334 (432)
                      ++....       ........||+.|+|||++.+..++.++|||||||++|+|++|+.||........  ........  
T Consensus       166 ~~~~~~-------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~  236 (355)
T cd07874         166 ARTAGT-------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ--WNKVIEQLGT  236 (355)
T ss_pred             cccCCC-------ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCC
Confidence            975311       1122345789999999999999999999999999999999999999864321100  00000000  


Q ss_pred             --------hccchhhhhhhh---------------h---hhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          335 --------ISNKIIDLIDSV---------------L---EEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       335 --------~~~~~~~~i~~~---------------l---~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                              ........++..               +   ...........+.+++.+||+.||++|||+.|++++-
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp  312 (355)
T cd07874         237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHP  312 (355)
T ss_pred             CCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCc
Confidence                    000001111000               0   0000111235678999999999999999999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.3e-39  Score=303.80  Aligned_cols=253  Identities=22%  Similarity=0.355  Sum_probs=200.2

Q ss_pred             CCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEec
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEY  185 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  185 (432)
                      ++|++.+.||+|+||.||++.+.  +..+++|.+... .......+.+|++++++++|+||+++++.+...+..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            46889999999999999999986  448999987543 344567889999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCC
Q 014024          186 MPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQY-SRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGN  264 (432)
Q Consensus       186 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  264 (432)
                      +++++|..++........+++..+..++.|++.||.|||+. +   ++|+||||+||+++.++.++|+|||++..+..  
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--  155 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA--  155 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccC--
Confidence            99999999886543334699999999999999999999974 6   99999999999999999999999999875421  


Q ss_pred             CccccccccccccccCCccChhhhccC------CCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccc
Q 014024          265 DEDELQGNTSRISGTYGYMSPEYALEG------IFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNK  338 (432)
Q Consensus       265 ~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  338 (432)
                            .......+++.|+|||.+.+.      .++.++|+|||||++|+|++|+.||.......  ...         .
T Consensus       156 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~---------~  218 (286)
T cd06622         156 ------SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN--IFA---------Q  218 (286)
T ss_pred             ------CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh--HHH---------H
Confidence                  112234578899999988543      35889999999999999999999985321100  000         0


Q ss_pred             hhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          339 IIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       339 ~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                      .....+ ......+.....++.+++.+||+.+|++||++.+++++-
T Consensus       219 ~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~  263 (286)
T cd06622         219 LSAIVD-GDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHP  263 (286)
T ss_pred             HHHHhh-cCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcCh
Confidence            001111 011122334567788999999999999999999999853

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=5.9e-39  Score=310.00  Aligned_cols=254  Identities=19%  Similarity=0.219  Sum_probs=194.2

Q ss_pred             CCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCC---ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEE
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGK---SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  183 (432)
                      ++|++.+.||+|+||.||++.+...  .+|+|.+...   .......+.+|..++..++|+||+++++++.+.+..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            4799999999999999999997543  7899988542   2233455788999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCC
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGG  263 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  263 (432)
                      ||+++|+|.+++...  ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            999999999999642  234899999999999999999999999   999999999999999999999999999764221


Q ss_pred             CCccccccccccccccCCccChhhhcc-----CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccc
Q 014024          264 NDEDELQGNTSRISGTYGYMSPEYALE-----GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNK  338 (432)
Q Consensus       264 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  338 (432)
                      .     ........||+.|+|||++.+     +.++.++|||||||++|+|++|+.||......     ...........
T Consensus       156 ~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-----~~~~~i~~~~~  225 (331)
T cd05624         156 G-----TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-----ETYGKIMNHEE  225 (331)
T ss_pred             C-----ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH-----HHHHHHHcCCC
Confidence            1     112233569999999999875     56889999999999999999999998532210     00000000000


Q ss_pred             hhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 014024          339 IIDLIDSVLEEASFNESLSRYVHIALLCVQERAED--RPTMSDVVSM  383 (432)
Q Consensus       339 ~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~--RPt~~evl~~  383 (432)
                      ...      ..........++.+++.+|+..++.+  |+++++++++
T Consensus       226 ~~~------~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         226 RFQ------FPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             ccc------CCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            000      00011123467788899988865544  5688888875

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.8e-39  Score=317.01  Aligned_cols=261  Identities=22%  Similarity=0.254  Sum_probs=195.9

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC----ceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEE
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ----GEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~----~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  183 (432)
                      ..+|++.+.||+|+||.||++...+    ..+++|.+...     ....+|++++++++|+||+++++++......+++|
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            4679999999999999999997643    36888877543     23467999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCC
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGG  263 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  263 (432)
                      |++. ++|.+++.   ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.++|+|||++......
T Consensus       166 e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        166 PKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH  238 (392)
T ss_pred             hhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence            9995 57877772   3345999999999999999999999998   999999999999999999999999999764221


Q ss_pred             CCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCcccccc-chhhhhHHhh-------h
Q 014024          264 NDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSL-NLIGYAWDLW-------I  335 (432)
Q Consensus       264 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~-~~~~~~~~~~-------~  335 (432)
                      ..    ........||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..........       .
T Consensus       239 ~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~  314 (392)
T PHA03207        239 PD----TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFP  314 (392)
T ss_pred             cc----cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccC
Confidence            11    1122346799999999999999999999999999999999999999854332110 0000000000       0


Q ss_pred             ccc---hhhhhhh---hhhhccc-------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          336 SNK---IIDLIDS---VLEEASF-------NESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       336 ~~~---~~~~i~~---~l~~~~~-------~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                      .+.   .......   ..+....       .....++.+++..||+.||++|||+.|++.+-
T Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p  376 (392)
T PHA03207        315 QNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLP  376 (392)
T ss_pred             CccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCc
Confidence            000   0000000   0000000       01234677899999999999999999999873

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=5.4e-39  Score=303.98  Aligned_cols=260  Identities=22%  Similarity=0.309  Sum_probs=189.4

Q ss_pred             CCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCCC--hHhHHHHHHHHHHHHhc---CCCceeeeEeEEEeC-----C
Q 014024          110 NFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKS--GQEIKELKNEASVIAQV---QHKNLVKLLGCCIEK-----D  177 (432)
Q Consensus       110 ~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~-----~  177 (432)
                      +|++.+.||+|+||.||+|.+..+  .+|+|.+....  ......+.+|+.+++.+   +|+||+++++++...     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            588899999999999999998643  79999885432  11223455677776665   799999999988642     4


Q ss_pred             eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccc
Q 014024          178 ERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMA  257 (432)
Q Consensus       178 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  257 (432)
                      ..+++|||+++ +|.+++.... ...+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||++
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~  155 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA  155 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence            57899999975 7888775432 234899999999999999999999999   999999999999999999999999999


Q ss_pred             eeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhh--
Q 014024          258 RIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWI--  335 (432)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~--  335 (432)
                      ......       .......+|..|+|||++.+..++.++|||||||++|+|++|+.||.......  ..........  
T Consensus       156 ~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~--~~~~~~~~~~~~  226 (288)
T cd07863         156 RIYSCQ-------MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD--QLGKIFDLIGLP  226 (288)
T ss_pred             ccccCc-------ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH--HHHHHHHHhCCC
Confidence            764211       11233567899999999998899999999999999999999999875332210  0000000000  


Q ss_pred             -ccchhh-------hhhhh---hhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          336 -SNKIID-------LIDSV---LEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       336 -~~~~~~-------~i~~~---l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                       ......       ...+.   ............+.+++.+||+.||++|||+.|++.+
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         227 PEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             ChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence             000000       00000   0001112234567899999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=9.9e-39  Score=296.81  Aligned_cols=246  Identities=22%  Similarity=0.325  Sum_probs=200.1

Q ss_pred             CCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEec
Q 014024          110 NFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEY  185 (432)
Q Consensus       110 ~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  185 (432)
                      +|++.+.||+|+||.+|++....  ..+++|.+...  .....+.+.+|+.++++++|+|++++++++.+.+..++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            58889999999999999998743  48999988543  334556789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCC
Q 014024          186 MPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGND  265 (432)
Q Consensus       186 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  265 (432)
                      +++++|.+++.... ...+++..+..++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||++......  
T Consensus        81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~--  154 (256)
T cd08218          81 CEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST--  154 (256)
T ss_pred             CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcc--
Confidence            99999999885432 224789999999999999999999998   999999999999999999999999999764221  


Q ss_pred             ccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhh
Q 014024          266 EDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDS  345 (432)
Q Consensus       266 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  345 (432)
                          ........|++.|+|||+..+..++.++|+||||+++++|++|+.|+.....                  .+.++.
T Consensus       155 ----~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------------------~~~~~~  212 (256)
T cd08218         155 ----VELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM------------------KNLVLK  212 (256)
T ss_pred             ----hhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH------------------HHHHHH
Confidence                1112234578889999999988899999999999999999999999753211                  111111


Q ss_pred             hhh---hcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          346 VLE---EASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       346 ~l~---~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      .+.   ...+.....++.+++.+||+.+|++||++.+|+++
T Consensus       213 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         213 IIRGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             HhcCCCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            111   11223345678999999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-39  Score=301.92  Aligned_cols=252  Identities=23%  Similarity=0.361  Sum_probs=202.0

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEec
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEY  185 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  185 (432)
                      .++|++.+.||.|++|.||++.+..  ..+++|..........+.+..|++++++++|+|++++++.+.+....++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            4679999999999999999999753  48999998777777778899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCC
Q 014024          186 MPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGND  265 (432)
Q Consensus       186 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  265 (432)
                      +++++|.+++...  ...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++......  
T Consensus        84 ~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~--  156 (280)
T cd06611          84 CDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKST--  156 (280)
T ss_pred             cCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccc--
Confidence            9999999998543  235999999999999999999999999   999999999999999999999999988753211  


Q ss_pred             ccccccccccccccCCccChhhhc-----cCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchh
Q 014024          266 EDELQGNTSRISGTYGYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKII  340 (432)
Q Consensus       266 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                          ........+++.|+|||.+.     ...++.++|+||||+++|+|++|+.||.......     .... ...... 
T Consensus       157 ----~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~-----~~~~-~~~~~~-  225 (280)
T cd06611         157 ----LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR-----VLLK-ILKSEP-  225 (280)
T ss_pred             ----ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH-----HHHH-HhcCCC-
Confidence                11223456889999999875     3457889999999999999999999975332110     0000 000000 


Q ss_pred             hhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          341 DLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       341 ~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                          +.  ...+......+.+++..||+.+|.+||++.+++++
T Consensus       226 ----~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         226 ----PT--LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             ----CC--cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence                00  00122344678899999999999999999999875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=8.4e-39  Score=302.49  Aligned_cols=251  Identities=24%  Similarity=0.305  Sum_probs=196.7

Q ss_pred             CCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCC---hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEe
Q 014024          110 NFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS---GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYE  184 (432)
Q Consensus       110 ~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  184 (432)
                      .|+..+.||+|+||+||+|.+..  ..+|+|.+....   ......+.+|+++++.++|+|++++.+.+.+++..+++||
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            36778899999999999999854  379999885432   2233457889999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCC
Q 014024          185 YMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGN  264 (432)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  264 (432)
                      |+++++|.+++.... ...+++..+..++.|++.||.|||+.+   |+||||||+||++++++.++|+|||++...... 
T Consensus        81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~-  155 (285)
T cd05632          81 IMNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEG-  155 (285)
T ss_pred             eccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCC-
Confidence            999999998886432 235999999999999999999999998   999999999999999999999999998764211 


Q ss_pred             CccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhh
Q 014024          265 DEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLID  344 (432)
Q Consensus       265 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  344 (432)
                            .......|+..|+|||++.+..++.++|+||||+++|+|++|..||........  .....     ......  
T Consensus       156 ------~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~--~~~~~-----~~~~~~--  220 (285)
T cd05632         156 ------ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK--REEVD-----RRVLET--  220 (285)
T ss_pred             ------CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHH-----Hhhhcc--
Confidence                  112234689999999999988999999999999999999999999853221000  00000     000000  


Q ss_pred             hhhhhcccHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 014024          345 SVLEEASFNESLSRYVHIALLCVQERAEDRPT-----MSDVVSM  383 (432)
Q Consensus       345 ~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt-----~~evl~~  383 (432)
                         ...........+.+++..||+.||++||+     +.+++++
T Consensus       221 ---~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         221 ---EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             ---ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence               00112233456789999999999999999     6677764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-39  Score=302.26  Aligned_cols=276  Identities=22%  Similarity=0.316  Sum_probs=208.0

Q ss_pred             hhhhCCCCcCceeccCCcEEEEEEEECCceEEEEEEcCCChHhHHHHHHHHHHHHh--cCCCceeeeEeEEEeC----Ce
Q 014024          105 SSATGNFSAANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQ--VQHKNLVKLLGCCIEK----DE  178 (432)
Q Consensus       105 ~~~~~~y~~~~~ig~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~----~~  178 (432)
                      .....+..+.+.||+|.||.||+|.+.+..||||++...++   +.+.+|.++.+.  ++|+||+.+++.=..+    .+
T Consensus       207 RTiarqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ  283 (513)
T KOG2052|consen  207 RTIARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ  283 (513)
T ss_pred             HhhhheeEEEEEecCccccceeeccccCCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence            34557788899999999999999999999999999976543   467788888876  4999999999875433    25


Q ss_pred             eEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCCeEeccCCCCCEEEcCCCCEEEee
Q 014024          179 RLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ-----YSRVRIIHRDLKASNILLDKDMNSKISD  253 (432)
Q Consensus       179 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-----~~~~~ivH~Dlkp~NIll~~~~~~kl~D  253 (432)
                      ++||.+|.+.|||.|||.    +..++....++++..+|.||++||.     +|++.|.|||||+.||||..++...|+|
T Consensus       284 LwLvTdYHe~GSL~DyL~----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD  359 (513)
T KOG2052|consen  284 LWLVTDYHEHGSLYDYLN----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD  359 (513)
T ss_pred             EEEeeecccCCcHHHHHh----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence            799999999999999994    3559999999999999999999994     6788899999999999999999999999


Q ss_pred             cccceeccCCCCccccccccccccccCCccChhhhccCC----C--CchhhhHHHHHHHHHHHhCCCCCCCccccccchh
Q 014024          254 FGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGI----F--SIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLI  327 (432)
Q Consensus       254 fg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~--t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~  327 (432)
                      +|+|.......  +...-.....+||.+|||||++...-    +  -..+||||||.|+||+.-....-+........+.
T Consensus       360 LGLAv~h~~~t--~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyy  437 (513)
T KOG2052|consen  360 LGLAVRHDSDT--DTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYY  437 (513)
T ss_pred             ceeeEEecccC--CcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcc
Confidence            99998753332  33344556679999999999986421    2  2469999999999999765332111111111111


Q ss_pred             hhhHHhhhccchhhhhh-hhhhhcc-----cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccc
Q 014024          328 GYAWDLWISNKIIDLID-SVLEEAS-----FNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS  389 (432)
Q Consensus       328 ~~~~~~~~~~~~~~~i~-~~l~~~~-----~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~  389 (432)
                      .++...+.-+++.+.+- +.++...     ..+....+.++++.||..+|.-|-|+--+-..|.++..
T Consensus       438 d~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  438 DVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             cCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            11222222223333222 2333332     34667889999999999999999999999988887653

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.4e-39  Score=318.05  Aligned_cols=256  Identities=21%  Similarity=0.294  Sum_probs=194.3

Q ss_pred             CCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC---ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEE
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK---SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  183 (432)
                      ++|++.+.||+|+||.||++....  ..+|+|++...   .......+.+|+.++.+++|+|++++++.+.+.+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            478899999999999999999854  37999988543   2334567888999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCC
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGG  263 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  263 (432)
                      ||+++|+|.+++..   +..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~  154 (360)
T cd05627          81 EFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA  154 (360)
T ss_pred             eCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence            99999999999843   345899999999999999999999999   999999999999999999999999998754211


Q ss_pred             CCccc-----------------------------cccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCC
Q 014024          264 NDEDE-----------------------------LQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK  314 (432)
Q Consensus       264 ~~~~~-----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~  314 (432)
                      .....                             .........||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~  234 (360)
T cd05627         155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (360)
T ss_pred             cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence            10000                             0001123579999999999999999999999999999999999999


Q ss_pred             CCCCccccccchhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCC---HHHHHHH
Q 014024          315 NTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPT---MSDVVSM  383 (432)
Q Consensus       315 p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt---~~evl~~  383 (432)
                      ||.......      .........      ..+..........++.+++.+|+. ||.+|++   +.+++++
T Consensus       235 Pf~~~~~~~------~~~~i~~~~------~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h  293 (360)
T cd05627         235 PFCSETPQE------TYRKVMNWK------ETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH  293 (360)
T ss_pred             CCCCCCHHH------HHHHHHcCC------CceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence            985322110      000000000      000000001123466777777664 9999985   6677665

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-38  Score=300.12  Aligned_cols=257  Identities=29%  Similarity=0.422  Sum_probs=202.3

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECCc------eEEEEEEcCCC-hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeE
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQG------EIAVKRLLGKS-GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERL  180 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~~------~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  180 (432)
                      .++|++.+.||+|+||.||+|.+...      .+++|...... ......+.+|+..+++++|+|++++++++.. ...+
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   84 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ   84 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence            36788899999999999999986421      47888876553 3455778999999999999999999999987 7889


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceec
Q 014024          181 LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIV  260 (432)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  260 (432)
                      +||||+++|+|.+++....  ..+++..++.++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||++...
T Consensus        85 ~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~  159 (279)
T cd05057          85 LITQLMPLGCLLDYVRNHK--DNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (279)
T ss_pred             EEEecCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccc
Confidence            9999999999999986432  34899999999999999999999988   999999999999999999999999999875


Q ss_pred             cCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccch
Q 014024          261 FGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKI  339 (432)
Q Consensus       261 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  339 (432)
                      ......    .......++..|+|||.+....++.++|+||||+++||+++ |+.||......+               .
T Consensus       160 ~~~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---------------~  220 (279)
T cd05057         160 DVDEKE----YHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE---------------I  220 (279)
T ss_pred             cCcccc----eecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH---------------H
Confidence            321111    11112223567999999988899999999999999999999 999975322110               1


Q ss_pred             hhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccc
Q 014024          340 IDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS  389 (432)
Q Consensus       340 ~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~  389 (432)
                      .+.+........+..+...+.+++.+||..+|.+||++.++++.|++...
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         221 PDLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             HHHHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            11111111111122234568899999999999999999999999988643

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.5e-39  Score=296.39  Aligned_cols=264  Identities=21%  Similarity=0.284  Sum_probs=197.1

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCCh--HhHHHHHHHHHHHHhcCCCc-eeeeEeEEEeCC-----
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSG--QEIKELKNEASVIAQVQHKN-LVKLLGCCIEKD-----  177 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~-----  177 (432)
                      ...|+.+++||+|.||+||+|+...  ..||+|++.....  ..-....+|+.+|+.++|+| |+.+++++...+     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            4567778889999999999999744  4899999865533  23345678999999999999 999999998877     


Q ss_pred             -eeEEEEecCCCCChhhhhcCCCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecc
Q 014024          178 -ERLLIYEYMPNKSLDCFLFDPTKR-EILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFG  255 (432)
Q Consensus       178 -~~~lv~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  255 (432)
                       ..++|+||+ ..+|..++...... ..++...+..++.|++.||+|||+++   |+||||||+|||++++|.+||+|||
T Consensus        90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence             789999999 55888888553321 23777899999999999999999999   9999999999999999999999999


Q ss_pred             cceeccCCCCccccccccccccccCCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHh-
Q 014024          256 MARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDL-  333 (432)
Q Consensus       256 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~-  333 (432)
                      +|+...      .........++|.+|+|||++.+. .|+...||||+|||+.||++++.-|.....  .+........ 
T Consensus       166 lAra~~------ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se--~~ql~~If~~l  237 (323)
T KOG0594|consen  166 LARAFS------IPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE--IDQLFRIFRLL  237 (323)
T ss_pred             hHHHhc------CCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH--HHHHHHHHHHc
Confidence            998642      112235667899999999999876 699999999999999999998877654332  1111111110 


Q ss_pred             --hhccchhhhh---h--hhhhhcc-c-------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          334 --WISNKIIDLI---D--SVLEEAS-F-------NESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       334 --~~~~~~~~~i---~--~~l~~~~-~-------~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                        .....+....   +  ....... +       +....+..+++.+||+.+|.+|.|++..+++
T Consensus       238 GtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  238 GTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence              0000100000   0  0000000 0       0111467899999999999999999999987

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=6.6e-39  Score=313.79  Aligned_cols=260  Identities=22%  Similarity=0.243  Sum_probs=194.8

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeC------
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEK------  176 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------  176 (432)
                      ..++|++.+.||+|+||.||++.+..  ..+|+|++...  .......+.+|+.+++.++|+||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            45789999999999999999999754  47999988543  334456778899999999999999999987543      


Q ss_pred             CeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeeccc
Q 014024          177 DERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGM  256 (432)
Q Consensus       177 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  256 (432)
                      ...|+||||+++ +|.+++.     ..+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+|||+
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~  172 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  172 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence            357999999975 5666652     23788999999999999999999998   99999999999999999999999999


Q ss_pred             ceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhh--
Q 014024          257 ARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLW--  334 (432)
Q Consensus       257 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~--  334 (432)
                      ++....       ........+|..|+|||++.+..++.++|||||||++|+|++|+.||.......  .........  
T Consensus       173 a~~~~~-------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~  243 (364)
T cd07875         173 ARTAGT-------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID--QWNKVIEQLGT  243 (364)
T ss_pred             ccccCC-------CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCC
Confidence            976311       112234568999999999999999999999999999999999999986433211  000000000  


Q ss_pred             --------hccchhhhhhh---------------hhh---hcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          335 --------ISNKIIDLIDS---------------VLE---EASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       335 --------~~~~~~~~i~~---------------~l~---~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                              ...........               ...   ..........+.+++.+||+.||.+|||+.|++++-
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp  319 (364)
T cd07875         244 PCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP  319 (364)
T ss_pred             CCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence                    00000000000               000   000011234678999999999999999999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.9e-40  Score=301.25  Aligned_cols=256  Identities=22%  Similarity=0.329  Sum_probs=191.5

Q ss_pred             CCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC-----eeEEE
Q 014024          110 NFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKD-----ERLLI  182 (432)
Q Consensus       110 ~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~lv  182 (432)
                      .|...+++|.|+||.||.|.....  .+|||+.......    -.+|+++|+.+.|||||++..+|....     ...+|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            466679999999999999997544  8999998665432    356899999999999999998886432     23579


Q ss_pred             EecCCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCC-CCEEEeecccceec
Q 014024          183 YEYMPNKSLDCFLFDP-TKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKD-MNSKISDFGMARIV  260 (432)
Q Consensus       183 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~  260 (432)
                      |||++. +|.+++... ..+..++...+.-+..||++||+|||+.+   |+||||||.|+|+|.+ |.+||+|||.|+.+
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            999966 777777532 12344888888999999999999999998   9999999999999976 89999999999997


Q ss_pred             cCCCCccccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhcc--
Q 014024          261 FGGNDEDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISN--  337 (432)
Q Consensus       261 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--  337 (432)
                      ..++.+       .+...|..|+|||.+.+ ..|+.+.||||.|||+.||+-|++-|...+.  .+.+..........  
T Consensus       177 ~~~epn-------iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~--~dQL~eIik~lG~Pt~  247 (364)
T KOG0658|consen  177 VKGEPN-------ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS--VDQLVEIIKVLGTPTR  247 (364)
T ss_pred             ccCCCc-------eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH--HHHHHHHHHHhCCCCH
Confidence            554332       34556788999999886 5699999999999999999999988754222  11111111111000  


Q ss_pred             -chh-------hhhhhhhhhc-----ccHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014024          338 -KII-------DLIDSVLEEA-----SFNESLSRYVHIALLCVQERAEDRPTMSDVVS  382 (432)
Q Consensus       338 -~~~-------~~i~~~l~~~-----~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~  382 (432)
                       ++.       +.-.+.+...     .....+.+..+++.++|+.+|.+|.++.|++.
T Consensus       248 e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  248 EDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             HHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence             000       0001111111     22345578899999999999999999999996

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.4e-38  Score=298.20  Aligned_cols=253  Identities=27%  Similarity=0.415  Sum_probs=189.3

Q ss_pred             ceeccCCcEEEEEEEECCc----eEEEEEEcCCC-hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecCCCC
Q 014024          115 NKLGEGGFGTVYKGVIGQG----EIAVKRLLGKS-GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNK  189 (432)
Q Consensus       115 ~~ig~G~~g~Vy~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  189 (432)
                      +.||+|+||.||+|...++    .+++|.+.... ......+.+|+.++++++|+||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            3699999999999986432    68888875543 334457888999999999999999999999999999999999999


Q ss_pred             ChhhhhcCCCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCcc
Q 014024          190 SLDCFLFDPTK--REILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDED  267 (432)
Q Consensus       190 sL~~~l~~~~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  267 (432)
                      +|.+++.....  ....++..+..++.|++.|++|||+.+   ++|+||||+||+++.++++||+|||++.......   
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~---  154 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED---  154 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcc---
Confidence            99999864321  234677788899999999999999998   9999999999999999999999999987531111   


Q ss_pred             ccccccccccccCCccChhhhccC-------CCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccch
Q 014024          268 ELQGNTSRISGTYGYMSPEYALEG-------IFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKI  339 (432)
Q Consensus       268 ~~~~~~~~~~gt~~y~aPE~~~~~-------~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  339 (432)
                       .........++..|+|||++.+.       .++.++|+||||+++|||++ |+.||.......  ...+.    ..+..
T Consensus       155 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~--~~~~~----~~~~~  227 (269)
T cd05087         155 -YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ--VLTYT----VREQQ  227 (269)
T ss_pred             -eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH--HHHHH----hhccc
Confidence             01112234567889999988642       35789999999999999996 999985433211  11110    00111


Q ss_pred             hhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014024          340 IDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLT  385 (432)
Q Consensus       340 ~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~  385 (432)
                      ....++.+    .......+.+++..|+ .+|++|||+.||+..|+
T Consensus       228 ~~~~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         228 LKLPKPRL----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCCCCcc----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            11111111    1122345778999999 68999999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=7.7e-39  Score=299.78  Aligned_cols=250  Identities=32%  Similarity=0.505  Sum_probs=196.0

Q ss_pred             ceeccCCcEEEEEEEECC--------ceEEEEEEcCCC-hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEec
Q 014024          115 NKLGEGGFGTVYKGVIGQ--------GEIAVKRLLGKS-GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEY  185 (432)
Q Consensus       115 ~~ig~G~~g~Vy~~~~~~--------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  185 (432)
                      +.||+|+||.||+|...+        ..+++|.+.... ......+.+|+.+++.++|+||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            369999999999998743        257888775442 24466788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCC-----CEEEeeccc
Q 014024          186 MPNKSLDCFLFDPT----KREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDM-----NSKISDFGM  256 (432)
Q Consensus       186 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-----~~kl~Dfg~  256 (432)
                      +++++|.+++....    ....+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++     .++|+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence            99999999996432    2234789999999999999999999998   99999999999999887     899999999


Q ss_pred             ceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhh
Q 014024          257 ARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWI  335 (432)
Q Consensus       257 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  335 (432)
                      +........    ........++..|+|||++.++.++.++||||||+++|+|++ |+.||......  ...        
T Consensus       158 ~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~--~~~--------  223 (269)
T cd05044         158 ARDIYKSDY----YRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ--EVL--------  223 (269)
T ss_pred             ccccccccc----cccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH--HHH--------
Confidence            976422211    111223345678999999999999999999999999999998 99887532210  010        


Q ss_pred             ccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014024          336 SNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN  386 (432)
Q Consensus       336 ~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~  386 (432)
                           ..+........+...+..+.+++.+||..+|.+||++.+|++.|++
T Consensus       224 -----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         224 -----QHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             -----HHHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence                 1111111111223445778899999999999999999999999864

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=6e-39  Score=305.86  Aligned_cols=263  Identities=21%  Similarity=0.291  Sum_probs=196.5

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCC-hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEe
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS-GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYE  184 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  184 (432)
                      .++|++.+.||+|+||.||+|.+..  ..+|+|.+.... ......+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e   84 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   84 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence            4679999999999999999998753  479999885432 2233467789999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCC
Q 014024          185 YMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGN  264 (432)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  264 (432)
                      |++ ++|.+++...  ...+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||++...... 
T Consensus        85 ~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~-  157 (301)
T cd07873          85 YLD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP-  157 (301)
T ss_pred             ccc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCC-
Confidence            997 5888887543  234889999999999999999999998   999999999999999999999999998753211 


Q ss_pred             CccccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhh---hccchh
Q 014024          265 DEDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLW---ISNKII  340 (432)
Q Consensus       265 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~  340 (432)
                           ........+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||......+  .........   ......
T Consensus       158 -----~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~--~~~~~~~~~~~~~~~~~~  230 (301)
T cd07873         158 -----TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE--QLHFIFRILGTPTEETWP  230 (301)
T ss_pred             -----CCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHcCCCChhhch
Confidence                 111223456889999998865 458899999999999999999999986433211  000000000   000000


Q ss_pred             hhhh---------hhhhh----cccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          341 DLID---------SVLEE----ASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       341 ~~i~---------~~l~~----~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                      ....         +....    .........+.+++.+||+.||.+|||+.|++++-
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~  287 (301)
T cd07873         231 GILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHP  287 (301)
T ss_pred             hhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            0000         00000    00112345678999999999999999999999843

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=8.8e-39  Score=302.10  Aligned_cols=258  Identities=24%  Similarity=0.341  Sum_probs=203.5

Q ss_pred             hCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEe
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYE  184 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  184 (432)
                      .++|++.+.||+|+||.||++...  +..+++|..... .....+.+.+|+++++.++|+||+++++++...+..++|||
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME   83 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence            367889999999999999999986  347888877544 33456788999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCC
Q 014024          185 YMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ-YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGG  263 (432)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  263 (432)
                      |+++++|.+++..   .+.+++..+..++.+++.||.|||+ .+   ++||||+|+||++++++.++|+|||++..... 
T Consensus        84 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~-  156 (284)
T cd06620          84 FMDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELIN-  156 (284)
T ss_pred             cCCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhh-
Confidence            9999999998843   3458999999999999999999997 46   99999999999999999999999999865311 


Q ss_pred             CCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhh
Q 014024          264 NDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLI  343 (432)
Q Consensus       264 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i  343 (432)
                             .......|+..|+|||++.+..++.++|+|||||++|+|++|+.||......+...       .......+.+
T Consensus       157 -------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~-------~~~~~~~~~~  222 (284)
T cd06620         157 -------SIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQ-------DDPMGILDLL  222 (284)
T ss_pred             -------hccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhh-------hhhhHHHHHH
Confidence                   11223568899999999988899999999999999999999999986433211000       0000111111


Q ss_pred             hhhhhh---cc-cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014024          344 DSVLEE---AS-FNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN  386 (432)
Q Consensus       344 ~~~l~~---~~-~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~  386 (432)
                      ......   .. ....+..+.+++.+||+.||++|||+.|++++..-
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~  269 (284)
T cd06620         223 QQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF  269 (284)
T ss_pred             HHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence            111111   01 11245678899999999999999999999987544

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.7e-38  Score=320.77  Aligned_cols=264  Identities=20%  Similarity=0.246  Sum_probs=191.3

Q ss_pred             HhhhhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCChHhHHHHHHHHHHHHhcCC------CceeeeEeEEEe
Q 014024          104 VSSATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSGQEIKELKNEASVIAQVQH------KNLVKLLGCCIE  175 (432)
Q Consensus       104 ~~~~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~~~~~~~~  175 (432)
                      +....++|++.++||+|+||+||+|.+..  ..||||++.... ........|+.+++.++|      .+++++++++..
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~  202 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN  202 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence            33456889999999999999999998754  379999985432 233456678888877754      458899998876


Q ss_pred             C-CeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCCCCCEEEcCCC------
Q 014024          176 K-DERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ-YSRVRIIHRDLKASNILLDKDM------  247 (432)
Q Consensus       176 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~------  247 (432)
                      . .+.++|||++ +++|.+++..   ++.+++..+..++.|++.||.|||+ .+   |+||||||+|||++.++      
T Consensus       203 ~~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~  275 (467)
T PTZ00284        203 ETGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPV  275 (467)
T ss_pred             CCceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccc
Confidence            5 5788999988 7788888743   3459999999999999999999998 47   99999999999998765      


Q ss_pred             ----------CEEEeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 014024          248 ----------NSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTG  317 (432)
Q Consensus       248 ----------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~  317 (432)
                                .+||+|||.+...         ........||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       276 ~~~~~~~~~~~vkl~DfG~~~~~---------~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~  346 (467)
T PTZ00284        276 TNRALPPDPCRVRICDLGGCCDE---------RHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYD  346 (467)
T ss_pred             cccccCCCCceEEECCCCccccC---------ccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence                      4999999987542         112334679999999999999999999999999999999999999986


Q ss_pred             Cccccc-cchhhhh----HHhhh----ccchhhhhhh---------------hhhhcc--cHHHHHHHHHHHHHhhccCC
Q 014024          318 FYRTKS-LNLIGYA----WDLWI----SNKIIDLIDS---------------VLEEAS--FNESLSRYVHIALLCVQERA  371 (432)
Q Consensus       318 ~~~~~~-~~~~~~~----~~~~~----~~~~~~~i~~---------------~l~~~~--~~~~~~~l~~l~~~cl~~dp  371 (432)
                      .....+ .......    ...+.    .....++.+.               ......  .......+.+|+..||+.||
T Consensus       347 ~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP  426 (467)
T PTZ00284        347 THDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDR  426 (467)
T ss_pred             CCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcCh
Confidence            433211 0000000    00000    0000011100               000000  00113457799999999999


Q ss_pred             CCCCCHHHHHHHh
Q 014024          372 EDRPTMSDVVSML  384 (432)
Q Consensus       372 ~~RPt~~evl~~L  384 (432)
                      ++|||+.|+++|-
T Consensus       427 ~~R~ta~e~L~Hp  439 (467)
T PTZ00284        427 QKRLNARQMTTHP  439 (467)
T ss_pred             hhCCCHHHHhcCc
Confidence            9999999999853

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2e-38  Score=331.87  Aligned_cols=256  Identities=22%  Similarity=0.316  Sum_probs=196.8

Q ss_pred             hhhhCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeC--Ce
Q 014024          105 SSATGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEK--DE  178 (432)
Q Consensus       105 ~~~~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~  178 (432)
                      ....++|++.+.||+|+||.||++.+...  .+++|.+...  .......+..|+.++++++||||++++++|.+.  ..
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~   88 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK   88 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence            34567899999999999999999998654  6888887533  344567789999999999999999999988654  56


Q ss_pred             eEEEEecCCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCC----CCeEeccCCCCCEEEcC--------
Q 014024          179 RLLIYEYMPNKSLDCFLFDP-TKREILDWRTRVQIIKGVAQGLLYLHQYSR----VRIIHRDLKASNILLDK--------  245 (432)
Q Consensus       179 ~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~----~~ivH~Dlkp~NIll~~--------  245 (432)
                      .|+||||+++++|.++|... .....+++..++.|+.||+.||+|||+.+.    .+|+||||||+||||+.        
T Consensus        89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i  168 (1021)
T PTZ00266         89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI  168 (1021)
T ss_pred             EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence            89999999999999998542 123459999999999999999999998542    23999999999999964        


Q ss_pred             ---------CCCEEEeecccceeccCCCCccccccccccccccCCccChhhhcc--CCCCchhhhHHHHHHHHHHHhCCC
Q 014024          246 ---------DMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE--GIFSIKSDVFSFGVLLLEIVSGKK  314 (432)
Q Consensus       246 ---------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~~~DvwSlG~il~elltg~~  314 (432)
                               .+.+||+|||++..+...       .......||+.|+|||++.+  ..++.++|||||||+||+|+||+.
T Consensus       169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~-------s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~  241 (1021)
T PTZ00266        169 TAQANNLNGRPIAKIGDFGLSKNIGIE-------SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT  241 (1021)
T ss_pred             cccccccCCCCceEEccCCcccccccc-------ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCC
Confidence                     345899999999764211       12234578999999999864  458999999999999999999999


Q ss_pred             CCCCccccccchhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014024          315 NTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVS  382 (432)
Q Consensus       315 p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~  382 (432)
                      ||.....    .....          ..+.... .......+.++.+|+..||+.+|.+||++.|++.
T Consensus       242 PF~~~~~----~~qli----------~~lk~~p-~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        242 PFHKANN----FSQLI----------SELKRGP-DLPIKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             CCCcCCc----HHHHH----------HHHhcCC-CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            9853221    00000          0000000 0001123467889999999999999999999995

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=7.6e-39  Score=302.63  Aligned_cols=263  Identities=24%  Similarity=0.334  Sum_probs=201.7

Q ss_pred             cchhhHhhhhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCChHhHHHHHHHHHHHHhc-CCCceeeeEeEEE-
Q 014024           99 FSFSSVSSATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSGQEIKELKNEASVIAQV-QHKNLVKLLGCCI-  174 (432)
Q Consensus        99 ~~~~~~~~~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~-  174 (432)
                      +.+..+....++|++.+.||+|+||.||++.+..  ..+++|.+.... .....+.+|+.+++.+ +|+|++++++++. 
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            4455667788999999999999999999998854  378999875432 2235678899999999 6999999999884 


Q ss_pred             ----eCCeeEEEEecCCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCE
Q 014024          175 ----EKDERLLIYEYMPNKSLDCFLFDP-TKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNS  249 (432)
Q Consensus       175 ----~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  249 (432)
                          .++..++||||+++++|.+++... .....+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~  163 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGV  163 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCE
Confidence                345689999999999999887532 22345889999999999999999999998   9999999999999999999


Q ss_pred             EEeecccceeccCCCCccccccccccccccCCccChhhhcc-----CCCCchhhhHHHHHHHHHHHhCCCCCCCcccccc
Q 014024          250 KISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE-----GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSL  324 (432)
Q Consensus       250 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~  324 (432)
                      +|+|||++......      ........|++.|+|||++..     ..++.++|||||||++|+|++|+.|+....... 
T Consensus       164 kl~dfg~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~-  236 (286)
T cd06638         164 KLVDFGVSAQLTST------RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR-  236 (286)
T ss_pred             EEccCCceeecccC------CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH-
Confidence            99999999865221      112233468899999998753     457899999999999999999999975332110 


Q ss_pred             chhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          325 NLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                      ...    . .........       ..+......+.+++.+||+.||++|||+.|+++++
T Consensus       237 ~~~----~-~~~~~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         237 ALF----K-IPRNPPPTL-------HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             HHh----h-ccccCCCcc-------cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence            000    0 000000000       01111245688999999999999999999999865

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.7e-38  Score=308.51  Aligned_cols=192  Identities=22%  Similarity=0.306  Sum_probs=163.0

Q ss_pred             hhhCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEE
Q 014024          106 SATGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       106 ~~~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  183 (432)
                      ....+|++.+.||+|+||.||+|...+.  .+|+|.....      ....|+.++++++|+||+++++++.+....++||
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  136 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL  136 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence            3456899999999999999999998654  7888864332      2346899999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCC
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGG  263 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  263 (432)
                      |++. ++|.+++...  ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++..... 
T Consensus       137 e~~~-~~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~-  209 (357)
T PHA03209        137 PHYS-SDLYTYLTKR--SRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVV-  209 (357)
T ss_pred             EccC-CcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCcccccccc-
Confidence            9995 5777777542  345899999999999999999999998   99999999999999999999999999975211 


Q ss_pred             CCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCC
Q 014024          264 NDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNT  316 (432)
Q Consensus       264 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~  316 (432)
                            ........||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus       210 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        210 ------APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             ------CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence                  11223456899999999999999999999999999999999976554

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.9e-38  Score=316.73  Aligned_cols=260  Identities=17%  Similarity=0.206  Sum_probs=192.9

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEec
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEY  185 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  185 (432)
                      ..+|.+.+.||+|+||.||+|.+...  .|++|...      ...+.+|+++|++++|+||+++++++...+..++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            45799999999999999999998654  78998542      23456899999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCC
Q 014024          186 MPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGND  265 (432)
Q Consensus       186 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  265 (432)
                      +. ++|.+++...  ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus       242 ~~-~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~  315 (461)
T PHA03211        242 YR-SDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS  315 (461)
T ss_pred             cC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence            95 6787777432  235999999999999999999999998   99999999999999999999999999986522111


Q ss_pred             ccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCcc-ccc-----cchhhhhHHhhh-ccc
Q 014024          266 EDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYR-TKS-----LNLIGYAWDLWI-SNK  338 (432)
Q Consensus       266 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~-~~~-----~~~~~~~~~~~~-~~~  338 (432)
                          ........||..|+|||++.+..++.++|||||||++|||++|..|+-... ...     ..+......... ...
T Consensus       316 ----~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~  391 (461)
T PHA03211        316 ----TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDE  391 (461)
T ss_pred             ----cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccccc
Confidence                111224579999999999999999999999999999999999886642111 100     001111100000 000


Q ss_pred             h-----hhhhhhhh-------hhccc-------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          339 I-----IDLIDSVL-------EEASF-------NESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       339 ~-----~~~i~~~l-------~~~~~-------~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      .     ..+.....       .....       ......+.+|+.+||+.||.+|||+.|++++
T Consensus       392 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        392 FPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             CCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            0     00000000       00000       0112367889999999999999999999986

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.8e-38  Score=297.40  Aligned_cols=253  Identities=25%  Similarity=0.364  Sum_probs=187.0

Q ss_pred             ceeccCCcEEEEEEEECC----ceEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecCCCC
Q 014024          115 NKLGEGGFGTVYKGVIGQ----GEIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNK  189 (432)
Q Consensus       115 ~~ig~G~~g~Vy~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  189 (432)
                      +.||+|+||.||+|....    ..+++|.+... .......+.+|+..++.++|+||+++++.+.+....++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            359999999999997533    26788876543 3344567889999999999999999999999999999999999999


Q ss_pred             ChhhhhcCCCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCcc
Q 014024          190 SLDCFLFDPTK--REILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDED  267 (432)
Q Consensus       190 sL~~~l~~~~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  267 (432)
                      +|.+++.....  ....++.....++.|++.||+|||+.+   |+||||||+||++++++.+||+|||++........  
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~--  155 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY--  155 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchh--
Confidence            99999865332  233567888999999999999999998   99999999999999999999999999865321110  


Q ss_pred             ccccccccccccCCccChhhhcc-------CCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccch
Q 014024          268 ELQGNTSRISGTYGYMSPEYALE-------GIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKI  339 (432)
Q Consensus       268 ~~~~~~~~~~gt~~y~aPE~~~~-------~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  339 (432)
                        ........++..|+|||++..       ..++.++|||||||++|||++ |..||.......  ..   ... .....
T Consensus       156 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--~~---~~~-~~~~~  227 (269)
T cd05042         156 --YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ--VL---KQV-VREQD  227 (269)
T ss_pred             --eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH--HH---HHH-hhccC
Confidence              111123345678999998753       457889999999999999999 777764322110  00   000 00111


Q ss_pred             hhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014024          340 IDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLT  385 (432)
Q Consensus       340 ~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~  385 (432)
                      .+...+    ..+......+.+++..|+ .||++|||+++|++.|.
T Consensus       228 ~~~~~~----~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         228 IKLPKP----QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             ccCCCC----cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            111111    112234456677888898 59999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.1e-38  Score=304.33  Aligned_cols=256  Identities=27%  Similarity=0.434  Sum_probs=198.9

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC--c----eEEEEEEcCCC-hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeE
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ--G----EIAVKRLLGKS-GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERL  180 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~--~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  180 (432)
                      .++|+..+.||+|+||.||+|.+..  .    .+++|.+.... ......+.+|+.+++.++|+||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~   84 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ   84 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence            4678888999999999999998632  2    46888775543 33345688999999999999999999998754 467


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceec
Q 014024          181 LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIV  260 (432)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  260 (432)
                      +++||+++|+|.+++...  ...+++..++.++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||+++..
T Consensus        85 ~v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~  159 (303)
T cd05110          85 LVTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (303)
T ss_pred             eeehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence            899999999999998543  234889999999999999999999998   999999999999999999999999999865


Q ss_pred             cCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccch
Q 014024          261 FGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKI  339 (432)
Q Consensus       261 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  339 (432)
                      .....    ........++..|+|||.+.+..++.++||||||+++|||++ |+.||.......               .
T Consensus       160 ~~~~~----~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~---------------~  220 (303)
T cd05110         160 EGDEK----EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---------------I  220 (303)
T ss_pred             cCccc----ccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---------------H
Confidence            32211    111223345678999999998999999999999999999997 888874321100               0


Q ss_pred             hhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014024          340 IDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEA  388 (432)
Q Consensus       340 ~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~  388 (432)
                      .+.+........+..+...+.+++..||..+|++||++.++++.|+.+.
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~  269 (303)
T cd05110         221 PDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA  269 (303)
T ss_pred             HHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            1111111111112223457889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-38  Score=307.34  Aligned_cols=255  Identities=18%  Similarity=0.238  Sum_probs=193.8

Q ss_pred             CCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC---ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEE
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK---SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  183 (432)
                      ++|++.+.||+|+||.||++....  ..+|+|.+...   .....+.+.+|..++..++|+||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            479999999999999999999754  48999998532   2234556888999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCC
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGG  263 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  263 (432)
                      ||+++|+|.+++...  ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (331)
T cd05597          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD  155 (331)
T ss_pred             ecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence            999999999998542  234899999999999999999999999   999999999999999999999999998764221


Q ss_pred             CCccccccccccccccCCccChhhhcc-----CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccc
Q 014024          264 NDEDELQGNTSRISGTYGYMSPEYALE-----GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNK  338 (432)
Q Consensus       264 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  338 (432)
                      .     ........||+.|+|||++..     +.++.++|||||||++|+|++|+.||.....     ............
T Consensus       156 ~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~-----~~~~~~i~~~~~  225 (331)
T cd05597         156 G-----TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL-----VETYGKIMNHKE  225 (331)
T ss_pred             C-----CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH-----HHHHHHHHcCCC
Confidence            1     111223468999999999863     4578899999999999999999999853211     000000000000


Q ss_pred             hhhhhhhhhhhcccHHHHHHHHHHHHHhhcc--CCCCCCCHHHHHHHh
Q 014024          339 IIDLIDSVLEEASFNESLSRYVHIALLCVQE--RAEDRPTMSDVVSML  384 (432)
Q Consensus       339 ~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~--dp~~RPt~~evl~~L  384 (432)
                      ...+      .......+..+.+++.+|+..  ++..||++.+++++-
T Consensus       226 ~~~~------~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp  267 (331)
T cd05597         226 HFQF------PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHP  267 (331)
T ss_pred             cccC------CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCC
Confidence            0000      001112345677888887754  333488999999873

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-39  Score=309.53  Aligned_cols=252  Identities=22%  Similarity=0.317  Sum_probs=209.2

Q ss_pred             hhhCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCCCh---HhHHHHHHHHHHHHhcC-CCceeeeEeEEEeCCee
Q 014024          106 SATGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSG---QEIKELKNEASVIAQVQ-HKNLVKLLGCCIEKDER  179 (432)
Q Consensus       106 ~~~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~  179 (432)
                      .....|++.+.||+|.||.||++....+  .+|+|.+.+...   ...+.+.+|+.+|+++. |||||.+++.|++....
T Consensus        32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~  111 (382)
T KOG0032|consen   32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV  111 (382)
T ss_pred             cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence            4567899999999999999999998653  899998865533   24568999999999998 99999999999999999


Q ss_pred             EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCC----CCEEEeecc
Q 014024          180 LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKD----MNSKISDFG  255 (432)
Q Consensus       180 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~Dfg  255 (432)
                      ++|||++.||.|.+.+...    .+++..+..++.|++.++.|||+.|   ++||||||+|+|+...    +.+|++|||
T Consensus       112 ~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFG  184 (382)
T KOG0032|consen  112 YLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFG  184 (382)
T ss_pred             EEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence            9999999999999999654    2999999999999999999999999   9999999999999543    579999999


Q ss_pred             cceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhh
Q 014024          256 MARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWI  335 (432)
Q Consensus       256 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  335 (432)
                      ++.....       .......+||+.|+|||++....|+..+||||+|+++|.|++|..||..........         
T Consensus       185 la~~~~~-------~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~---------  248 (382)
T KOG0032|consen  185 LAKFIKP-------GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL---------  248 (382)
T ss_pred             CceEccC-------CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH---------
Confidence            9998522       234567899999999999999999999999999999999999999985332211100         


Q ss_pred             ccchhhhhhh--hhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014024          336 SNKIIDLIDS--VLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLT  385 (432)
Q Consensus       336 ~~~~~~~i~~--~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~  385 (432)
                           .+...  .......+.......+++..|+..||.+|+|+.++++|-+
T Consensus       249 -----~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpW  295 (382)
T KOG0032|consen  249 -----AILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPW  295 (382)
T ss_pred             -----HHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence                 11111  1222333455677889999999999999999999999743

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.9e-38  Score=304.59  Aligned_cols=196  Identities=23%  Similarity=0.381  Sum_probs=157.5

Q ss_pred             CceeccCCcEEEEEEEECC----ceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEe--CCeeEEEEecCC
Q 014024          114 ANKLGEGGFGTVYKGVIGQ----GEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIE--KDERLLIYEYMP  187 (432)
Q Consensus       114 ~~~ig~G~~g~Vy~~~~~~----~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~  187 (432)
                      .++||+|+||.||+|...+    ..+|+|.+....  ....+.+|++++++++||||+++++++..  ....+++|||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            4689999999999998643    378999886442  23456789999999999999999999854  456789999986


Q ss_pred             CCChhhhhcCC------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEE----cCCCCEEEeecccc
Q 014024          188 NKSLDCFLFDP------TKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILL----DKDMNSKISDFGMA  257 (432)
Q Consensus       188 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~Dfg~a  257 (432)
                      + +|.+++...      .....+++..+..++.|++.||.|||+.+   |+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            4 777666321      11234889999999999999999999999   9999999999999    46678999999999


Q ss_pred             eeccCCCCccccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 014024          258 RIVFGGNDEDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGF  318 (432)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~  318 (432)
                      ........   .........||+.|+|||++.+ ..++.++||||+||++|+|++|+.||..
T Consensus       160 ~~~~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~  218 (317)
T cd07868         160 RLFNSPLK---PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             eccCCCCc---cccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence            86522111   1122334678999999999876 4589999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.7e-38  Score=295.57  Aligned_cols=251  Identities=24%  Similarity=0.338  Sum_probs=195.4

Q ss_pred             CCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC-----ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeC--Cee
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK-----SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEK--DER  179 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~  179 (432)
                      .+|++.+.||+|+||.||.|.+..  ..+++|.+...     .....+.+.+|+.++++++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            578999999999999999999754  37999987432     223456788999999999999999999998764  467


Q ss_pred             EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeeccccee
Q 014024          180 LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARI  259 (432)
Q Consensus       180 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  259 (432)
                      +++|||+++++|.+++..   ...+++.....++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++..
T Consensus        82 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~  155 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR  155 (265)
T ss_pred             EEEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence            899999999999999853   234888999999999999999999998   99999999999999999999999999876


Q ss_pred             ccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccch
Q 014024          260 VFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKI  339 (432)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  339 (432)
                      ......   .........++..|+|||.+.+..++.++|+||||+++|+|++|+.||.......    .          .
T Consensus       156 ~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~----~----------~  218 (265)
T cd06652         156 LQTICL---SGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA----A----------I  218 (265)
T ss_pred             cccccc---cccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH----H----------H
Confidence            421110   0111223468889999999988889999999999999999999999985321100    0          0


Q ss_pred             hhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          340 IDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       340 ~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      ............+......+.+++..|+. +|++||++++|+++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         219 FKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             HHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence            00000001111233445667888999985 99999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-38  Score=304.59  Aligned_cols=257  Identities=20%  Similarity=0.224  Sum_probs=201.8

Q ss_pred             CCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCCh---HhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEE
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSG---QEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  183 (432)
                      ++|+..+.||+|++|.||+|...+  ..+++|.+.....   ...+.+.+|++.++.++|+||+++++.+.+....++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            468889999999999999999865  4899998865432   24567889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCC
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGG  263 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  263 (432)
                      ||+.+++|.+++... ....+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++......
T Consensus        81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence            999999999998543 2345899999999999999999999998   999999999999999999999999998764221


Q ss_pred             CCccc-----------------------cccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCcc
Q 014024          264 NDEDE-----------------------LQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYR  320 (432)
Q Consensus       264 ~~~~~-----------------------~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~  320 (432)
                      .....                       .........|+..|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  236 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN  236 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            11000                       0011123468889999999998889999999999999999999999985332


Q ss_pred             ccccchhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCC----HHHHHHH
Q 014024          321 TKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPT----MSDVVSM  383 (432)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt----~~evl~~  383 (432)
                      ...              ..................+..+.+++.+||+.||++||+    +.+++++
T Consensus       237 ~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~  289 (316)
T cd05574         237 RDE--------------TFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH  289 (316)
T ss_pred             hHH--------------HHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence            110              001111111111111124678899999999999999999    7777774

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=3.4e-38  Score=294.74  Aligned_cols=259  Identities=27%  Similarity=0.432  Sum_probs=203.6

Q ss_pred             CCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCC-hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEec
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS-GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEY  185 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  185 (432)
                      ++|++.+.||.|++|.||+|...+  ..+++|++.... ....+.+.+|++.++.++|+|++++++.+...+..+++||+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            478999999999999999998743  378999885432 33567889999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCC
Q 014024          186 MPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGND  265 (432)
Q Consensus       186 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  265 (432)
                      +++++|.+++........+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++..+.....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            999999999965433345899999999999999999999998   99999999999999999999999999887543222


Q ss_pred             ccccccccccccccCCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhh
Q 014024          266 EDELQGNTSRISGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLID  344 (432)
Q Consensus       266 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  344 (432)
                      ..  ........|+..|+|||.+... .++.++|+||||+++|+|++|+.||.......     .........      .
T Consensus       158 ~~--~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-----~~~~~~~~~------~  224 (267)
T cd06610         158 RT--RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-----VLMLTLQND------P  224 (267)
T ss_pred             cc--ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-----hHHHHhcCC------C
Confidence            11  1122344688999999998876 78999999999999999999999985332211     000000000      0


Q ss_pred             hhhhhcc-cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          345 SVLEEAS-FNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       345 ~~l~~~~-~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      ..+.... ....+..+.+++..||+.||++||++.+++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         225 PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            0000000 12345678899999999999999999999875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.8e-38  Score=298.61  Aligned_cols=263  Identities=23%  Similarity=0.317  Sum_probs=197.3

Q ss_pred             CCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCC--hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEe
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS--GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYE  184 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  184 (432)
                      ++|++.+.||+|++|.||+|.+..  ..+++|++....  ....+.+.+|++++++++|+|++++++++...+..++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            478999999999999999999853  489999875432  2234567899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCC
Q 014024          185 YMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGN  264 (432)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  264 (432)
                      |+++++|..+...   ...+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07847          81 YCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG  154 (286)
T ss_pred             ccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence            9999998887633   234899999999999999999999998   9999999999999999999999999998753221


Q ss_pred             CccccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccch--hhhh-------HHhh
Q 014024          265 DEDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNL--IGYA-------WDLW  334 (432)
Q Consensus       265 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~--~~~~-------~~~~  334 (432)
                      .      ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||......+...  ....       ...+
T Consensus       155 ~------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (286)
T cd07847         155 D------DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIF  228 (286)
T ss_pred             c------cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence            1      1223457788999999876 558899999999999999999999986433211000  0000       0000


Q ss_pred             hccch-hhhhhhhhhh-----cccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          335 ISNKI-IDLIDSVLEE-----ASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       335 ~~~~~-~~~i~~~l~~-----~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      ..... .....+....     .........+.+++.+||+.+|++||++.|++.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         229 STNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             ccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence            00000 0000000000     0011224678899999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.9e-38  Score=294.60  Aligned_cols=250  Identities=22%  Similarity=0.325  Sum_probs=199.3

Q ss_pred             CCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEe--CCeeEEEE
Q 014024          110 NFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIE--KDERLLIY  183 (432)
Q Consensus       110 ~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~  183 (432)
                      +|++.+.||.|+||.||++.+..  ..+++|.+...  .....+.+.+|+++++.++|+|++++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            58889999999999999998754  37888987533  34556778899999999999999999998764  35678999


Q ss_pred             ecCCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHH-----hcCCCCeEeccCCCCCEEEcCCCCEEEeecccc
Q 014024          184 EYMPNKSLDCFLFDP-TKREILDWRTRVQIIKGVAQGLLYLH-----QYSRVRIIHRDLKASNILLDKDMNSKISDFGMA  257 (432)
Q Consensus       184 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~l~~LH-----~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  257 (432)
                      ||+++++|.+++... .....+++..++.++.|++.||.|||     +.+   ++|+||+|+||++++++.+||+|||++
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~  157 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA  157 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence            999999999998543 22456899999999999999999999     666   999999999999999999999999999


Q ss_pred             eeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhcc
Q 014024          258 RIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISN  337 (432)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  337 (432)
                      .......      .......+++.|+|||.+.+..++.++|+||||+++++|++|+.|+......  .            
T Consensus       158 ~~~~~~~------~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~------------  217 (265)
T cd08217         158 KILGHDS------SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL--Q------------  217 (265)
T ss_pred             ccccCCc------ccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH--H------------
Confidence            8752211      1122346889999999999888999999999999999999999998543210  0            


Q ss_pred             chhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          338 KIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       338 ~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                       ..+.+........+...+..+.+++.+|++.+|++||++.+|+++
T Consensus       218 -~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         218 -LASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             -HHHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence             011111111112233445778999999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2.6e-38  Score=293.77  Aligned_cols=248  Identities=24%  Similarity=0.365  Sum_probs=198.7

Q ss_pred             CCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEec
Q 014024          110 NFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEY  185 (432)
Q Consensus       110 ~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  185 (432)
                      +|++.+.||+|++|.||++....  ..+++|.+...  .....+.+.+|++++++++|+|++++++.+...+..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            58889999999999999998754  37999988543  334567889999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCC-CEEEeecccceeccCCC
Q 014024          186 MPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDM-NSKISDFGMARIVFGGN  264 (432)
Q Consensus       186 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~  264 (432)
                      +++++|.+++.... ...+++..+..++.|++.||+|||+++   ++|+||+|+||++++++ .+||+|||++...... 
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~-  155 (256)
T cd08220          81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK-  155 (256)
T ss_pred             CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCC-
Confidence            99999999996432 334899999999999999999999998   99999999999998654 5799999999865221 


Q ss_pred             CccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhh
Q 014024          265 DEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLID  344 (432)
Q Consensus       265 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  344 (432)
                            .......++..|+|||.+.+..++.++||||||+++|+|++|+.|+.......  .   ...         . .
T Consensus       156 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~--~---~~~---------~-~  214 (256)
T cd08220         156 ------SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA--L---VLK---------I-M  214 (256)
T ss_pred             ------ccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH--H---HHH---------H-H
Confidence                  11223467889999999998889999999999999999999999975332110  0   000         0 0


Q ss_pred             hhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          345 SVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       345 ~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      .......+......+.+++.+||+.+|++|||+.|++++
T Consensus       215 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         215 SGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             hcCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            000011122345678899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.8e-38  Score=295.72  Aligned_cols=255  Identities=22%  Similarity=0.381  Sum_probs=199.9

Q ss_pred             CCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCCC------hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEE
Q 014024          110 NFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGKS------GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLL  181 (432)
Q Consensus       110 ~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  181 (432)
                      +|+..+.||+|++|.||++.+.  +..+++|.+....      ....+.+.+|++.+++++|+|++++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            5888899999999999999874  3489999885432      2245678999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCC-CEEEeecccceec
Q 014024          182 IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDM-NSKISDFGMARIV  260 (432)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~  260 (432)
                      ||||+++++|.+++..   .+.+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++ .++|+|||++...
T Consensus        81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            9999999999999853   345899999999999999999999998   99999999999998776 5999999998765


Q ss_pred             cCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchh
Q 014024          261 FGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKII  340 (432)
Q Consensus       261 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                      ......  .........++..|+|||.+.+..++.++|+||+|+++++|++|..||........  ....         .
T Consensus       155 ~~~~~~--~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~~~---------~  221 (268)
T cd06630         155 AAKGTG--AGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH--LALI---------F  221 (268)
T ss_pred             cccccc--CCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch--HHHH---------H
Confidence            322110  01112334678899999999888899999999999999999999999853322110  0000         0


Q ss_pred             hhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          341 DLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       341 ~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      ...........+.....++.+++.+||+.+|++||++.+++++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~  264 (268)
T cd06630         222 KIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH  264 (268)
T ss_pred             HHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence            0000011112233455778899999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=3.1e-38  Score=293.31  Aligned_cols=250  Identities=33%  Similarity=0.546  Sum_probs=198.6

Q ss_pred             CCcCceeccCCcEEEEEEEECC------ceEEEEEEcCCChH-hHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEE
Q 014024          111 FSAANKLGEGGFGTVYKGVIGQ------GEIAVKRLLGKSGQ-EIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       111 y~~~~~ig~G~~g~Vy~~~~~~------~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  183 (432)
                      +++.+.||.|+||.||++.+.+      ..+++|.+...... ..+.+.+|++.++.++|+|++++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            4567899999999999999865      47999998655433 5678999999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCC
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGG  263 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  263 (432)
                      ||+++++|.+++...... .+++..+..++.|++.||++||+.+   ++|+||+|+||++++++.++|+|||++......
T Consensus        81 e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPK-ELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             eccCCCCHHHHHHhhhhc-cCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence            999999999998543221 1899999999999999999999998   999999999999999999999999999875322


Q ss_pred             CCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchhhh
Q 014024          264 NDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIIDL  342 (432)
Q Consensus       264 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                      ..     .......+++.|+|||.+.+..++.++|+||||+++++|++ |..|+......  ..             ...
T Consensus       157 ~~-----~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~--~~-------------~~~  216 (258)
T smart00219      157 DY-----YKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE--EV-------------LEY  216 (258)
T ss_pred             cc-----cccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH--HH-------------HHH
Confidence            11     01112336789999999988889999999999999999998 77776431110  00             001


Q ss_pred             hhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          343 IDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       343 i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                      +........+...+.++.+++.+|+..+|++|||+.++++.|
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      217 LKKGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             HhcCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            111111111223456788999999999999999999999865

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.7e-38  Score=294.21  Aligned_cols=237  Identities=25%  Similarity=0.416  Sum_probs=186.6

Q ss_pred             ceeccCCcEEEEEEEECCce------------EEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEE
Q 014024          115 NKLGEGGFGTVYKGVIGQGE------------IAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLI  182 (432)
Q Consensus       115 ~~ig~G~~g~Vy~~~~~~~~------------vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  182 (432)
                      +.||+|+||.||+|.+.+..            +++|.+...... ...+.+|+.+++.++|+|++++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            46999999999999985433            677766544333 6788899999999999999999999988 778999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCC-------CEEEeecc
Q 014024          183 YEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDM-------NSKISDFG  255 (432)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-------~~kl~Dfg  255 (432)
                      |||+++|+|.+++.....  .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++       .+||+|||
T Consensus        79 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          79 EEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             EEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence            999999999999864322  5899999999999999999999998   99999999999999888       79999999


Q ss_pred             cceeccCCCCccccccccccccccCCccChhhhccC--CCCchhhhHHHHHHHHHHHhC-CCCCCCccccccchhhhhHH
Q 014024          256 MARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEG--IFSIKSDVFSFGVLLLEIVSG-KKNTGFYRTKSLNLIGYAWD  332 (432)
Q Consensus       256 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~~~DvwSlG~il~elltg-~~p~~~~~~~~~~~~~~~~~  332 (432)
                      ++.....          .....++..|+|||++.+.  .++.++||||||+++|+|++| ..|+.......  ...+.  
T Consensus       154 ~a~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~--~~~~~--  219 (259)
T cd05037         154 IPITVLS----------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE--KERFY--  219 (259)
T ss_pred             ccccccc----------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh--HHHHH--
Confidence            9976421          2233466789999998876  789999999999999999994 66654322110  00000  


Q ss_pred             hhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014024          333 LWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLT  385 (432)
Q Consensus       333 ~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~  385 (432)
                        ....           ..+......+.+++.+||..+|.+|||+.++++.|+
T Consensus       220 --~~~~-----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         220 --QDQH-----------RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             --hcCC-----------CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence              0000           001111267889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.3e-39  Score=308.57  Aligned_cols=255  Identities=22%  Similarity=0.294  Sum_probs=200.2

Q ss_pred             hhhCCCCcCceeccCCcEEEEEEEECCc-eEEEEEE--cCCChHhHHHHHHHHHHHHhcC-CCceeeeEeEEEeCCeeEE
Q 014024          106 SATGNFSAANKLGEGGFGTVYKGVIGQG-EIAVKRL--LGKSGQEIKELKNEASVIAQVQ-HKNLVKLLGCCIEKDERLL  181 (432)
Q Consensus       106 ~~~~~y~~~~~ig~G~~g~Vy~~~~~~~-~vavK~~--~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~l  181 (432)
                      .....|+++++||+||.+.||++...+. -+|+|++  ...+.+....|.+|+..|.+++ |.+|+++++|-..++.+|+
T Consensus       358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm  437 (677)
T KOG0596|consen  358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM  437 (677)
T ss_pred             ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence            4567799999999999999999998766 6777766  3446677889999999999995 8999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceecc
Q 014024          182 IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVF  261 (432)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  261 (432)
                      ||||- ..+|..+|......  ++.-.+..+..|++.|+.++|+.|   |||.||||.|+|+- .|.+||+|||.|..+.
T Consensus       438 vmE~G-d~DL~kiL~k~~~~--~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~  510 (677)
T KOG0596|consen  438 VMECG-DIDLNKILKKKKSI--DPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQ  510 (677)
T ss_pred             Eeecc-cccHHHHHHhccCC--CchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccC
Confidence            99976 56899988653332  332378889999999999999999   99999999999984 5789999999998752


Q ss_pred             CCCCccccccccccccccCCccChhhhccC-----------CCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhh
Q 014024          262 GGNDEDELQGNTSRISGTYGYMSPEYALEG-----------IFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYA  330 (432)
Q Consensus       262 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~  330 (432)
                      .    +...-.....+||+.||+||.+...           +.++++||||||||||+|+.|+.||+.+..         
T Consensus       511 ~----DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n---------  577 (677)
T KOG0596|consen  511 P----DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN---------  577 (677)
T ss_pred             c----cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH---------
Confidence            2    2223344567899999999988632           256899999999999999999999864332         


Q ss_pred             HHhhhccchhhhhhhhhhhcccHHHH-HHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          331 WDLWISNKIIDLIDSVLEEASFNESL-SRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       331 ~~~~~~~~~~~~i~~~l~~~~~~~~~-~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                          .-.++..+.++....+++.... .+++++++.||+.||.+|||+.++|++-
T Consensus       578 ----~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhp  628 (677)
T KOG0596|consen  578 ----QIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHP  628 (677)
T ss_pred             ----HHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCc
Confidence                0122333444433223322111 2389999999999999999999999853

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=6.3e-38  Score=295.15  Aligned_cols=246  Identities=26%  Similarity=0.394  Sum_probs=197.9

Q ss_pred             CCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecC
Q 014024          110 NFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYM  186 (432)
Q Consensus       110 ~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  186 (432)
                      -|+..+.||.|+||.||+|.+..  ..+|+|..... .......+.+|+..+++++|+|++++++++.+++..++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            36778899999999999998743  47999987543 2344567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCc
Q 014024          187 PNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDE  266 (432)
Q Consensus       187 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  266 (432)
                      ++++|.+++..    ..+++..+..++.|++.|+.+||+.+   ++|+||+|+||++++++.++|+|||++......   
T Consensus        85 ~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~---  154 (277)
T cd06641          85 GGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT---  154 (277)
T ss_pred             CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccc---
Confidence            99999998842    34899999999999999999999998   999999999999999999999999998764221   


Q ss_pred             cccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhh
Q 014024          267 DELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSV  346 (432)
Q Consensus       267 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  346 (432)
                         ........++..|+|||.+.+..++.++|+|||||++|+|++|..|+.......     ..          ..+...
T Consensus       155 ---~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-----~~----------~~~~~~  216 (277)
T cd06641         155 ---QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK-----VL----------FLIPKN  216 (277)
T ss_pred             ---hhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH-----HH----------HHHhcC
Confidence               111223467889999999988889999999999999999999999975322100     00          000000


Q ss_pred             hhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          347 LEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       347 l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      .........+..+.+++.+||+.+|.+||++.+++++
T Consensus       217 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         217 NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             CCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            0111122345678899999999999999999999995

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.6e-38  Score=301.54  Aligned_cols=250  Identities=22%  Similarity=0.325  Sum_probs=198.8

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEec
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEY  185 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  185 (432)
                      .+.|.....||+|+||.||++.+..  ..+++|++........+.+.+|+..++.++|+|++++++.+...+..++||||
T Consensus        21 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~  100 (292)
T cd06658          21 REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF  100 (292)
T ss_pred             HHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence            3445556779999999999998753  48999998766666677889999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCC
Q 014024          186 MPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGND  265 (432)
Q Consensus       186 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  265 (432)
                      +++++|.+++..    ..+++..+..++.|++.||+|||+.+   ++||||||+||++++++.++|+|||++......  
T Consensus       101 ~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~--  171 (292)
T cd06658         101 LEGGALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE--  171 (292)
T ss_pred             CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccc--
Confidence            999999998832    34899999999999999999999998   999999999999999999999999998754211  


Q ss_pred             ccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhh
Q 014024          266 EDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDS  345 (432)
Q Consensus       266 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  345 (432)
                          ........|+..|+|||.+.+..++.++|+||||+++|||++|+.||.......  ...         .....+..
T Consensus       172 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~~~---------~~~~~~~~  236 (292)
T cd06658         172 ----VPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ--AMR---------RIRDNLPP  236 (292)
T ss_pred             ----cccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHH---------HHHhcCCC
Confidence                111233568899999999988889999999999999999999999975322100  000         00000011


Q ss_pred             hhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          346 VLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       346 ~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      .+.  ........+.+++..||..||.+|||+.+++++
T Consensus       237 ~~~--~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         237 RVK--DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             ccc--cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            100  011234567889999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2.3e-38  Score=298.85  Aligned_cols=259  Identities=22%  Similarity=0.369  Sum_probs=200.1

Q ss_pred             chhhHhhhhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCChHhHHHHHHHHHHHHhc-CCCceeeeEeEEEe-
Q 014024          100 SFSSVSSATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSGQEIKELKNEASVIAQV-QHKNLVKLLGCCIE-  175 (432)
Q Consensus       100 ~~~~~~~~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~-  175 (432)
                      ++.++....++|++.+.||.|+||.||+|.+..  ..+++|...... .....+..|+.+++++ +|+|++++++++.. 
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   85 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK   85 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence            444555677899999999999999999999854  378888875443 3446788899999998 69999999999853 


Q ss_pred             -----CCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEE
Q 014024          176 -----KDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSK  250 (432)
Q Consensus       176 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  250 (432)
                           .+..+++|||+++|+|.+++.... ...+++..+..++.|++.|+.|||+.+   ++|+||+|+||++++++.++
T Consensus        86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~  161 (282)
T cd06636          86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK  161 (282)
T ss_pred             cccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence                 457799999999999999886432 234888889999999999999999998   99999999999999999999


Q ss_pred             EeecccceeccCCCCccccccccccccccCCccChhhhc-----cCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccc
Q 014024          251 ISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLN  325 (432)
Q Consensus       251 l~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~  325 (432)
                      |+|||++......      ........|+..|+|||.+.     ...++.++|+|||||++|+|++|+.||........ 
T Consensus       162 l~dfg~~~~~~~~------~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~-  234 (282)
T cd06636         162 LVDFGVSAQLDRT------VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA-  234 (282)
T ss_pred             EeeCcchhhhhcc------ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh-
Confidence            9999998754211      11223456889999999875     34688899999999999999999999853221000 


Q ss_pred             hhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          326 LIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       326 ~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                                   .................+..+.+++.+||+.||.+||++.|++++
T Consensus       235 -------------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         235 -------------LFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             -------------hhhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence                         000000000001112345678999999999999999999999764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.8e-38  Score=292.88  Aligned_cols=247  Identities=26%  Similarity=0.396  Sum_probs=198.7

Q ss_pred             CCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCCC-----hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEE
Q 014024          110 NFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGKS-----GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLI  182 (432)
Q Consensus       110 ~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  182 (432)
                      +|+..+.||+|++|.||+|...  +..+++|.+....     ....+.+.+|+.+++.++|+|++++++++.+....+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4777899999999999999985  4489999875432     34567789999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccC
Q 014024          183 YEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFG  262 (432)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  262 (432)
                      +||+++++|.+++..   ...+++..+..++.|++.|++|||+.+   ++|+||+|+||+++.++.+||+|||++.....
T Consensus        81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            999999999999853   234889999999999999999999998   99999999999999999999999999876422


Q ss_pred             CCCccccccccccccccCCccChhhhccCC-CCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhh
Q 014024          263 GNDEDELQGNTSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIID  341 (432)
Q Consensus       263 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (432)
                      ..       ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||......     .......       
T Consensus       155 ~~-------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~-----~~~~~~~-------  215 (258)
T cd06632         155 FS-------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV-----AAVFKIG-------  215 (258)
T ss_pred             cc-------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH-----HHHHHHH-------
Confidence            11       123456788999999988776 899999999999999999999998543210     0000000       


Q ss_pred             hhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          342 LIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       342 ~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                        ........+......+.+++.+||+.+|++||++.+++.+
T Consensus       216 --~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         216 --RSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             --hcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence              0000011122345678899999999999999999999864

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.5e-38  Score=305.78  Aligned_cols=254  Identities=19%  Similarity=0.238  Sum_probs=193.7

Q ss_pred             CCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCC---ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEE
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGK---SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  183 (432)
                      ++|++.+.||+|+||.||++...+.  .+|+|.+...   .......+.+|..++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            4789999999999999999998654  7899988532   2233445788999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCC
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGG  263 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  263 (432)
                      ||+++|+|.+++...  ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~  155 (332)
T cd05623          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  155 (332)
T ss_pred             eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence            999999999999642  234899999999999999999999999   999999999999999999999999998764221


Q ss_pred             CCccccccccccccccCCccChhhhc-----cCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccc
Q 014024          264 NDEDELQGNTSRISGTYGYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNK  338 (432)
Q Consensus       264 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  338 (432)
                      .     ........||+.|+|||++.     ...++.++|||||||++|||++|+.||.....     ............
T Consensus       156 ~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~-----~~~~~~i~~~~~  225 (332)
T cd05623         156 G-----TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL-----VETYGKIMNHKE  225 (332)
T ss_pred             C-----cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH-----HHHHHHHhCCCc
Confidence            1     11223357999999999986     34688999999999999999999999853221     000000000000


Q ss_pred             hhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCC--CCCCHHHHHHH
Q 014024          339 IIDLIDSVLEEASFNESLSRYVHIALLCVQERAE--DRPTMSDVVSM  383 (432)
Q Consensus       339 ~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~--~RPt~~evl~~  383 (432)
                      ...      ...........+.+++.+|+..+++  .|+++.+++++
T Consensus       226 ~~~------~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         226 RFQ------FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             ccc------CCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            000      0011122346677888888865444  47899999887

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-40  Score=313.32  Aligned_cols=243  Identities=29%  Similarity=0.455  Sum_probs=198.0

Q ss_pred             CCcCceeccCCcEEEEEEEECCc--eEEEEEEcCC---ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEec
Q 014024          111 FSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGK---SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEY  185 (432)
Q Consensus       111 y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  185 (432)
                      |.-++.||.|+||-||.|++..+  .||||++...   +.+.++.+..|+++|++++|||.+.+-|||..+...+|||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            55578899999999999998654  7999998543   456678899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCC
Q 014024          186 MPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGND  265 (432)
Q Consensus       186 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  265 (432)
                      | -|+-.|++.  -.++++.+.++..|+.+.+.||+|||+.+   .||||||..|||+++.|.+||+|||.|...     
T Consensus       108 C-lGSAsDlle--VhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~-----  176 (948)
T KOG0577|consen  108 C-LGSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIM-----  176 (948)
T ss_pred             H-hccHHHHHH--HHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhc-----
Confidence            9 456566653  23456999999999999999999999999   999999999999999999999999999874     


Q ss_pred             ccccccccccccccCCccChhhhc---cCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhh
Q 014024          266 EDELQGNTSRISGTYGYMSPEYAL---EGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDL  342 (432)
Q Consensus       266 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                           ....+++|||.|||||++.   .++|+-++||||||+++.||...++|.-     .++.....+....++ .   
T Consensus       177 -----~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlF-----nMNAMSALYHIAQNe-s---  242 (948)
T KOG0577|consen  177 -----APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF-----NMNAMSALYHIAQNE-S---  242 (948)
T ss_pred             -----CchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCcc-----CchHHHHHHHHHhcC-C---
Confidence                 3455689999999999986   5889999999999999999999998852     111111111111110 0   


Q ss_pred             hhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          343 IDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       343 i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                        +.+   ...++...+++++..||++-|.+|||..+++.+
T Consensus       243 --PtL---qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  243 --PTL---QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             --CCC---CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence              111   134677788999999999999999999998854

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=7.3e-38  Score=300.43  Aligned_cols=196  Identities=23%  Similarity=0.382  Sum_probs=156.9

Q ss_pred             CceeccCCcEEEEEEEECC----ceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEe--CCeeEEEEecCC
Q 014024          114 ANKLGEGGFGTVYKGVIGQ----GEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIE--KDERLLIYEYMP  187 (432)
Q Consensus       114 ~~~ig~G~~g~Vy~~~~~~----~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~  187 (432)
                      ..+||+|+||.||+|...+    ..+|+|.+....  ....+.+|+++++.++||||+++++++..  ....++||||++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            3679999999999999643    378999886443  23457789999999999999999999854  456789999987


Q ss_pred             CCChhhhhcCC------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEE----cCCCCEEEeecccc
Q 014024          188 NKSLDCFLFDP------TKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILL----DKDMNSKISDFGMA  257 (432)
Q Consensus       188 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~Dfg~a  257 (432)
                      + +|.+++...      .....+++..+..++.|++.||.|||+.+   |+||||||+||++    ++++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            5 666665321      12234889999999999999999999998   9999999999999    56778999999999


Q ss_pred             eeccCCCCccccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 014024          258 RIVFGGNDEDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGF  318 (432)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~  318 (432)
                      +.......   .........+|+.|+|||++.+ ..++.++|||||||++|||+||+.||..
T Consensus       160 ~~~~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~  218 (317)
T cd07867         160 RLFNSPLK---PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             eccCCCcc---cccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence            86522111   1112334578999999999876 4589999999999999999999999864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=5.7e-38  Score=292.71  Aligned_cols=251  Identities=25%  Similarity=0.358  Sum_probs=203.8

Q ss_pred             CCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCCh-HhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEec
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSG-QEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEY  185 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  185 (432)
                      ++|++.+.||+|++|.||+|.+..  ..+++|++..... ...+.+.+|++.+.+++|+|++++++++...+..++||||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            478899999999999999999864  4899998866543 4567899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCC
Q 014024          186 MPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ-YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGN  264 (432)
Q Consensus       186 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  264 (432)
                      +++++|.+++...   ..+++..++.++.|+++|++|||+ .+   ++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~  154 (264)
T cd06623          81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL  154 (264)
T ss_pred             cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence            9999999999543   558999999999999999999999 88   9999999999999999999999999998652211


Q ss_pred             CccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhh
Q 014024          265 DEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLID  344 (432)
Q Consensus       265 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  344 (432)
                            .......++..|+|||.+.+..++.++|+||||+++|+|++|+.|+......  ......         ..+..
T Consensus       155 ------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~~---------~~~~~  217 (264)
T cd06623         155 ------DQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP--SFFELM---------QAICD  217 (264)
T ss_pred             ------CcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc--CHHHHH---------HHHhc
Confidence                  1112456788999999999999999999999999999999999998543310  000000         00010


Q ss_pred             hhhhhcccHH-HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          345 SVLEEASFNE-SLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       345 ~~l~~~~~~~-~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      . .....+.. .+..+.+++..||+.+|++||++.+++++
T Consensus       218 ~-~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         218 G-PPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             C-CCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            0 01111222 45789999999999999999999999984

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=9.1e-38  Score=298.29  Aligned_cols=259  Identities=19%  Similarity=0.268  Sum_probs=198.7

Q ss_pred             CCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCCC---hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEE
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKS---GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  183 (432)
                      ++|++.+.||+|+||.||++.+...  .|++|.+....   ....+.+.+|+++++.++|+||+++++.+.+++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            4788999999999999999998654  79999886543   234557889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCC
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGG  263 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  263 (432)
                      ||+++++|.+++..   .+.+++..+..++.|++.||.|||+.+   ++||||||+||++++++.++|+|||+++.....
T Consensus        81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~  154 (305)
T cd05609          81 EYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS  154 (305)
T ss_pred             ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence            99999999999943   345899999999999999999999998   999999999999999999999999998642110


Q ss_pred             CCc---------cccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhh
Q 014024          264 NDE---------DELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLW  334 (432)
Q Consensus       264 ~~~---------~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  334 (432)
                      ...         ...........++..|+|||.+.+..++.++|+||||+++|||++|..||......  ..   . ...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~--~~---~-~~~  228 (305)
T cd05609         155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE--EL---F-GQV  228 (305)
T ss_pred             ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HH---H-HHH
Confidence            000         00001112245788999999998888999999999999999999999997421110  00   0 000


Q ss_pred             hccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014024          335 ISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN  386 (432)
Q Consensus       335 ~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~  386 (432)
                      .....       .........+..+.+++.+||+.||++||+..++.+.|+.
T Consensus       229 ~~~~~-------~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         229 ISDDI-------EWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             Hhccc-------CCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            00000       0000011235668899999999999999997666666665

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-38  Score=295.93  Aligned_cols=254  Identities=26%  Similarity=0.397  Sum_probs=198.8

Q ss_pred             hhhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCChHhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCC-----
Q 014024          106 SATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSGQEIKELKNEASVIAQV-QHKNLVKLLGCCIEKD-----  177 (432)
Q Consensus       106 ~~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~-----  177 (432)
                      ..+++|++.+.||+|++|.||+|.+..  ..+++|.+..... ..+.+.+|+++++++ +|+|++++++++.+..     
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            357899999999999999999999854  3789998765543 346789999999999 6999999999997644     


Q ss_pred             -eeEEEEecCCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecc
Q 014024          178 -ERLLIYEYMPNKSLDCFLFDPT-KREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFG  255 (432)
Q Consensus       178 -~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  255 (432)
                       ..++||||+++++|.+++.... .+..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence             4799999999999999885422 2346899999999999999999999998   9999999999999999999999999


Q ss_pred             cceeccCCCCccccccccccccccCCccChhhhcc-----CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhh
Q 014024          256 MARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE-----GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYA  330 (432)
Q Consensus       256 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~  330 (432)
                      ++......      ........++..|+|||.+..     ..++.++||||||+++|+|++|+.||....... ..    
T Consensus       159 ~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~----  227 (275)
T cd06608         159 VSAQLDST------LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR-AL----  227 (275)
T ss_pred             cceecccc------hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH-HH----
Confidence            98764211      112234568889999998753     347889999999999999999999985321100 00    


Q ss_pred             HHhhhccchhhhhhhhh-hhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          331 WDLWISNKIIDLIDSVL-EEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       331 ~~~~~~~~~~~~i~~~l-~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                               ..+..... ...........+.+++.+||..||++|||+.+++++
T Consensus       228 ---------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         228 ---------FKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             ---------HHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence                     00000000 001112345678899999999999999999999874

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=5.8e-38  Score=293.92  Aligned_cols=253  Identities=24%  Similarity=0.400  Sum_probs=198.5

Q ss_pred             CCCcCceeccCCcEEEEEEEECC---ceEEEEEEcCC----------ChHhHHHHHHHHHHHHh-cCCCceeeeEeEEEe
Q 014024          110 NFSAANKLGEGGFGTVYKGVIGQ---GEIAVKRLLGK----------SGQEIKELKNEASVIAQ-VQHKNLVKLLGCCIE  175 (432)
Q Consensus       110 ~y~~~~~ig~G~~g~Vy~~~~~~---~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~  175 (432)
                      +|++.+.||+|+||.||+|.+..   ..+++|.+...          .......+.+|+.++.. ++|+|++++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            48889999999999999999865   37899987422          23344567788888875 799999999999999


Q ss_pred             CCeeEEEEecCCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCCCCCEEEcCCCCEEEee
Q 014024          176 KDERLLIYEYMPNKSLDCFLFDP-TKREILDWRTRVQIIKGVAQGLLYLHQ-YSRVRIIHRDLKASNILLDKDMNSKISD  253 (432)
Q Consensus       176 ~~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~D  253 (432)
                      .+..+++|||+++++|.+++... .....+++..++.++.|++.||.|||+ .+   ++|+||+|+||++++++.++|+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence            99999999999999999887432 223458999999999999999999996 56   99999999999999999999999


Q ss_pred             cccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHh
Q 014024          254 FGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDL  333 (432)
Q Consensus       254 fg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~  333 (432)
                      ||.+.......       ......++..|+|||.+.++.++.++|+||||+++|+|++|+.||......  ...      
T Consensus       158 fg~~~~~~~~~-------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~--~~~------  222 (269)
T cd08528         158 FGLAKQKQPES-------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML--SLA------  222 (269)
T ss_pred             ccceeeccccc-------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH--HHH------
Confidence            99998642211       223456888999999999888999999999999999999999997432110  000      


Q ss_pred             hhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014024          334 WISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN  386 (432)
Q Consensus       334 ~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~  386 (432)
                            ....+..............+.+++.+||+.||++||++.|+.+++++
T Consensus       223 ------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~  269 (269)
T cd08528         223 ------TKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD  269 (269)
T ss_pred             ------HHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence                  00001100000111234678899999999999999999999998864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-39  Score=310.49  Aligned_cols=240  Identities=23%  Similarity=0.297  Sum_probs=183.5

Q ss_pred             eccCCcEEEEEEEECC--ceEEEEEEcCCC---hHhHHHHHHHHHHHHhc---CCCceeeeEeEEEeCCeeEEEEecCCC
Q 014024          117 LGEGGFGTVYKGVIGQ--GEIAVKRLLGKS---GQEIKELKNEASVIAQV---QHKNLVKLLGCCIEKDERLLIYEYMPN  188 (432)
Q Consensus       117 ig~G~~g~Vy~~~~~~--~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~  188 (432)
                      ||+|+||.||+|.+..  ..+|+|++....   .........|..++...   +||||+++++++.+.+..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            7999999999999854  489999985432   12233445566777665   699999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCccc
Q 014024          189 KSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDE  268 (432)
Q Consensus       189 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  268 (432)
                      |+|.+++..   ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++......     
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~-----  149 (330)
T cd05586          81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTD-----  149 (330)
T ss_pred             ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCC-----
Confidence            999988853   345899999999999999999999999   999999999999999999999999998753211     


Q ss_pred             cccccccccccCCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhhh
Q 014024          269 LQGNTSRISGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVL  347 (432)
Q Consensus       269 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  347 (432)
                       ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.......      .......... .+     
T Consensus       150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~------~~~~i~~~~~-~~-----  216 (330)
T cd05586         150 -NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ------MYRNIAFGKV-RF-----  216 (330)
T ss_pred             -CCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH------HHHHHHcCCC-CC-----
Confidence             1122345789999999998754 48999999999999999999999984322100      0000000000 00     


Q ss_pred             hhcccHHHHHHHHHHHHHhhccCCCCCC----CHHHHHHH
Q 014024          348 EEASFNESLSRYVHIALLCVQERAEDRP----TMSDVVSM  383 (432)
Q Consensus       348 ~~~~~~~~~~~l~~l~~~cl~~dp~~RP----t~~evl~~  383 (432)
                         ........+.+++.+||+.||.+||    ++.+++++
T Consensus       217 ---~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h  253 (330)
T cd05586         217 ---PKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH  253 (330)
T ss_pred             ---CCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence               0012345678899999999999998    56666664

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.4e-38  Score=300.65  Aligned_cols=261  Identities=23%  Similarity=0.340  Sum_probs=196.9

Q ss_pred             CCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCC--hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEe
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS--GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYE  184 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  184 (432)
                      ++|++.+.||+|+||.||+|.+.+  ..+++|++....  ....+.+.+|+++++.++|+|++++++++..++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            478899999999999999999854  489999875432  2235568899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCC
Q 014024          185 YMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGN  264 (432)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  264 (432)
                      |+++++|.++...   ...+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07846          81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  154 (286)
T ss_pred             cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence            9999999887643   234899999999999999999999998   9999999999999999999999999987642221


Q ss_pred             CccccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCcccccc--chhhhhHHhhhccchhh
Q 014024          265 DEDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSL--NLIGYAWDLWISNKIID  341 (432)
Q Consensus       265 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~  341 (432)
                            .......++..|+|||++.+ ..++.++||||||+++|||++|+.||......+.  .........  ......
T Consensus       155 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  226 (286)
T cd07846         155 ------EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNL--IPRHQE  226 (286)
T ss_pred             ------cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCC--chhhHH
Confidence                  11223457889999998875 4578899999999999999999988753221000  000000000  000000


Q ss_pred             hhh------hhh---------hhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          342 LID------SVL---------EEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       342 ~i~------~~l---------~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      ..+      ...         ........+..+.+++.+||+.+|++||++.+++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         227 IFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             HhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence            000      000         000112335678899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=4.1e-38  Score=298.48  Aligned_cols=244  Identities=25%  Similarity=0.324  Sum_probs=198.7

Q ss_pred             CCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCC---hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEE
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS---GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  183 (432)
                      ++|++.+.||+|++|.||++.+..  ..+++|.+....   ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            478999999999999999999854  489999885432   234567889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCC
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGG  263 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  263 (432)
                      ||+++++|.+++..   ...+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++..... 
T Consensus        81 e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~-  153 (290)
T cd05580          81 EYVPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKG-  153 (290)
T ss_pred             ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCC-
Confidence            99999999999854   345899999999999999999999998   99999999999999999999999999876421 


Q ss_pred             CCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhh
Q 014024          264 NDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLI  343 (432)
Q Consensus       264 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i  343 (432)
                              ......+++.|+|||.+.+...+.++|+||||+++|+|++|+.||......      ....        ...
T Consensus       154 --------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~--------~~~  211 (290)
T cd05580         154 --------RTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI------QIYE--------KIL  211 (290)
T ss_pred             --------CCCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH------HHHH--------HHh
Confidence                    123446889999999998888999999999999999999999997532210      0000        000


Q ss_pred             hhhhhhcccHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 014024          344 DSVLEEASFNESLSRYVHIALLCVQERAEDRP-----TMSDVVSM  383 (432)
Q Consensus       344 ~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~~  383 (432)
                      ..  ....+......+.+++.+||+.||.+||     +++|++++
T Consensus       212 ~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~  254 (290)
T cd05580         212 EG--KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH  254 (290)
T ss_pred             cC--CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence            00  0011223356788999999999999999     77888765

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=4.2e-38  Score=298.48  Aligned_cols=262  Identities=24%  Similarity=0.322  Sum_probs=200.8

Q ss_pred             cchhhHhhhhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCChHhHHHHHHHHHHHHhc-CCCceeeeEeEEEe
Q 014024           99 FSFSSVSSATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSGQEIKELKNEASVIAQV-QHKNLVKLLGCCIE  175 (432)
Q Consensus        99 ~~~~~~~~~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~  175 (432)
                      +.+.++....++|++.+.||+|+||.||++...+  ..+++|.+.... .....+.+|+.+++++ +|+|++++++++..
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            4445666778999999999999999999999854  378899875432 2345678899999998 79999999999875


Q ss_pred             C-----CeeEEEEecCCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCE
Q 014024          176 K-----DERLLIYEYMPNKSLDCFLFDPT-KREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNS  249 (432)
Q Consensus       176 ~-----~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  249 (432)
                      .     +..++||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+   ++|+||||+||++++++.+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~  167 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV  167 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence            4     35799999999999999885321 2345899999999999999999999998   9999999999999999999


Q ss_pred             EEeecccceeccCCCCccccccccccccccCCccChhhhccC-----CCCchhhhHHHHHHHHHHHhCCCCCCCcccccc
Q 014024          250 KISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEG-----IFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSL  324 (432)
Q Consensus       250 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~  324 (432)
                      ||+|||++.......      .......|+..|+|||.+...     .++.++|+|||||++|+|++|+.|+....... 
T Consensus       168 kl~dfg~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~-  240 (291)
T cd06639         168 KLVDFGVSAQLTSTR------LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK-  240 (291)
T ss_pred             EEeecccchhccccc------ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH-
Confidence            999999987642211      112234678899999987643     36899999999999999999999975332110 


Q ss_pred             chhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          325 NLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      .    ... ........+       ..+......+.+++.+||+.+|++||++.|++++
T Consensus       241 ~----~~~-~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         241 T----LFK-IPRNPPPTL-------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             H----HHH-HhcCCCCCC-------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            0    000 000000000       0112234568899999999999999999999875

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.2e-38  Score=299.15  Aligned_cols=261  Identities=20%  Similarity=0.251  Sum_probs=192.8

Q ss_pred             CCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCC--hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEec
Q 014024          110 NFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS--GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEY  185 (432)
Q Consensus       110 ~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  185 (432)
                      +|++.+.||+|+||.||+|.+..  ..+++|.+....  ......+.+|++++++++|+|++++++++.+....++++||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            58889999999999999999853  478999885432  22335677899999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCC
Q 014024          186 MPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGND  265 (432)
Q Consensus       186 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  265 (432)
                      +++ +|.+++...  ...+++..++.++.|+++||.|||+.+   ++||||||+||+++.++.+||+|||++......  
T Consensus        81 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~--  152 (284)
T cd07839          81 CDQ-DLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIP--  152 (284)
T ss_pred             CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCC--
Confidence            974 677766432  344899999999999999999999998   999999999999999999999999999764211  


Q ss_pred             ccccccccccccccCCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhcc------c
Q 014024          266 EDELQGNTSRISGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISN------K  338 (432)
Q Consensus       266 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------~  338 (432)
                          ........++..|+|||++.+. .++.++|||||||++|+|+||+.|+........ ............      .
T Consensus       153 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  227 (284)
T cd07839         153 ----VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKRIFRLLGTPTEESWPG  227 (284)
T ss_pred             ----CCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH-HHHHHHHHhCCCChHHhHH
Confidence                1112234578899999988764 479999999999999999999988632222110 000000000000      0


Q ss_pred             hhhhhhhhh---------hhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          339 IIDLIDSVL---------EEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       339 ~~~~i~~~l---------~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      .....+...         ..........++.+++.+||+.||.+|||+.+++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h  281 (284)
T cd07839         228 VSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH  281 (284)
T ss_pred             hhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence            000000000         000111234677899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=7.7e-38  Score=293.65  Aligned_cols=255  Identities=24%  Similarity=0.433  Sum_probs=195.9

Q ss_pred             CCcCceeccCCcEEEEEEEEC-----CceEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC------
Q 014024          111 FSAANKLGEGGFGTVYKGVIG-----QGEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKD------  177 (432)
Q Consensus       111 y~~~~~ig~G~~g~Vy~~~~~-----~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------  177 (432)
                      |.+.++||+|+||.||+|.+.     +..+|+|.+...  .....+.+.+|++++++++|||++++++++...+      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567889999999999999853     237999988644  3455677899999999999999999999886542      


Q ss_pred             eeEEEEecCCCCChhhhhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeec
Q 014024          178 ERLLIYEYMPNKSLDCFLFDPT---KREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDF  254 (432)
Q Consensus       178 ~~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  254 (432)
                      ..++++||+++|+|.+++....   ....+++.....++.|++.||+|||+.+   |+||||||+||++++++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence            2478899999999988874321   1224789999999999999999999998   999999999999999999999999


Q ss_pred             ccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHh
Q 014024          255 GMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDL  333 (432)
Q Consensus       255 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~  333 (432)
                      |+++.......    ........+++.|++||...+..++.++||||||+++|+|++ |+.|+.....  .....+..  
T Consensus       158 g~~~~~~~~~~----~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--~~~~~~~~--  229 (273)
T cd05074         158 GLSKKIYSGDY----YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--SEIYNYLI--  229 (273)
T ss_pred             cccccccCCcc----eecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--HHHHHHHH--
Confidence            99986422111    111122345577999999998889999999999999999999 7888643221  11111110  


Q ss_pred             hhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014024          334 WISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNE  387 (432)
Q Consensus       334 ~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~  387 (432)
                        ...         ....+...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus       230 --~~~---------~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         230 --KGN---------RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             --cCC---------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence              000         0011123456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.7e-37  Score=295.28  Aligned_cols=260  Identities=22%  Similarity=0.287  Sum_probs=195.9

Q ss_pred             CCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCCh-----HhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEE
Q 014024          110 NFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSG-----QEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLI  182 (432)
Q Consensus       110 ~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  182 (432)
                      +|++.+.||+|++|.||+|.+..  ..+++|.+.....     .....+..|++++++++|+|++++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            57888999999999999999753  4899999865432     2345577899999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccC
Q 014024          183 YEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFG  262 (432)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  262 (432)
                      |||+ +++|.+++....  ..+++..+..++.|+++||+|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            9999 999999985432  35999999999999999999999999   99999999999999999999999999986522


Q ss_pred             CCCccccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhc-----
Q 014024          263 GNDEDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWIS-----  336 (432)
Q Consensus       263 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----  336 (432)
                      ..      .......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||......  ............     
T Consensus       155 ~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~  226 (298)
T cd07841         155 PN------RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI--DQLGKIFEALGTPTEEN  226 (298)
T ss_pred             CC------ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH--HHHHHHHHHcCCCchhh
Confidence            11      11223356788999998864 56799999999999999999997766432211  000000000000     


Q ss_pred             ----cchhhhhhhhhhh-----cccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          337 ----NKIIDLIDSVLEE-----ASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       337 ----~~~~~~i~~~l~~-----~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                          .............     .........+.+++..||+.||++|||+.|++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         227 WPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             hhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence                0000000000000     0112234678899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=4.6e-38  Score=307.34  Aligned_cols=193  Identities=25%  Similarity=0.382  Sum_probs=167.5

Q ss_pred             CCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCCChHhHHHHHHHHHHHHhcC-C-----CceeeeEeEEEeCCeeEE
Q 014024          110 NFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEIKELKNEASVIAQVQ-H-----KNLVKLLGCCIEKDERLL  181 (432)
Q Consensus       110 ~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~~~~~~~~~~~~~l  181 (432)
                      +|++.+.||+|.||.|-+|.+..+  .||||+++... ....+-..|+.+|..++ |     -|+|+++++|...++.||
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            789999999999999999998664  79999986654 44566778999999997 4     479999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCC--CCEEEeeccccee
Q 014024          182 IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKD--MNSKISDFGMARI  259 (432)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~Dfg~a~~  259 (432)
                      |+|.+ .-+|.+++.....++ ++...++.++.||+.||.+||+.+   |||+||||+||||.+.  ..+||+|||++..
T Consensus       266 VfELL-~~NLYellK~n~f~G-lsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~  340 (586)
T KOG0667|consen  266 VFELL-STNLYELLKNNKFRG-LSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF  340 (586)
T ss_pred             eehhh-hhhHHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence            99999 669999997765554 999999999999999999999999   9999999999999754  4699999999987


Q ss_pred             ccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 014024          260 VFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTG  317 (432)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~  317 (432)
                      ..         ........+..|+|||++.+.+|+.+.||||||||+.||++|.+-|.
T Consensus       341 ~~---------q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfp  389 (586)
T KOG0667|consen  341 ES---------QRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFP  389 (586)
T ss_pred             cC---------CcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccC
Confidence            41         12225566778999999999999999999999999999999965553

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-40  Score=285.11  Aligned_cols=247  Identities=25%  Similarity=0.355  Sum_probs=199.7

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLI  182 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  182 (432)
                      .+++|++.+.||+|.|+.||++....+  ++++|.+.-+  +....+.+.+|+++-+.++||||+++.+-+.+....|+|
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            467899999999999999999887543  6777766322  334667899999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCC---CCEEEeeccccee
Q 014024          183 YEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKD---MNSKISDFGMARI  259 (432)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Dfg~a~~  259 (432)
                      +|++.|+.|..-+-   .+..+++..+-....||+++|.|+|.++   |+|||+||+|+++-+.   .-+||+|||+|..
T Consensus        89 Fe~m~G~dl~~eIV---~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~  162 (355)
T KOG0033|consen   89 FDLVTGGELFEDIV---AREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIE  162 (355)
T ss_pred             EecccchHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEE
Confidence            99999999865552   3355788888899999999999999999   9999999999999543   3489999999998


Q ss_pred             ccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccch
Q 014024          260 VFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKI  339 (432)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  339 (432)
                      +.+       ........|||+|||||++...+|+..+|||+.|||||-|+.|..||-..+.                  
T Consensus       163 l~~-------g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~------------------  217 (355)
T KOG0033|consen  163 VND-------GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ------------------  217 (355)
T ss_pred             eCC-------ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH------------------
Confidence            631       2345567899999999999999999999999999999999999999742111                  


Q ss_pred             hhhhhhhhhhc------ccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          340 IDLIDSVLEEA------SFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       340 ~~~i~~~l~~~------~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                      .++.+......      ..+...++..+|+.+||..||.+|.|+.|.+++-
T Consensus       218 ~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~Hp  268 (355)
T KOG0033|consen  218 HRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHP  268 (355)
T ss_pred             HHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCc
Confidence            11222222111      1223346678899999999999999999998654

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=6.7e-38  Score=292.67  Aligned_cols=249  Identities=25%  Similarity=0.385  Sum_probs=201.3

Q ss_pred             CCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCC-hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEec
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS-GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEY  185 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  185 (432)
                      ++|+..+.||.|++|.||++.+..  ..+++|.+.... ....+.+.+|++++++++|+||+++++.+...+..++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            468888999999999999999863  478999886543 34556788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCC
Q 014024          186 MPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ-YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGN  264 (432)
Q Consensus       186 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  264 (432)
                      +++++|.+++....  ..+++.....++.|++.|++|||+ .+   ++|+||+|+||++++++.++|+|||.+...... 
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~-  154 (265)
T cd06605          81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS-  154 (265)
T ss_pred             cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHH-
Confidence            99999999985432  458999999999999999999999 87   999999999999999999999999998754211 


Q ss_pred             CccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhh
Q 014024          265 DEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLID  344 (432)
Q Consensus       265 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  344 (432)
                             ......++..|+|||.+.+..++.++|+||||+++|+|++|+.|+...........             +.++
T Consensus       155 -------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~-------------~~~~  214 (265)
T cd06605         155 -------LAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIF-------------ELLQ  214 (265)
T ss_pred             -------HhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHH-------------HHHH
Confidence                   11125678899999999999999999999999999999999999854322111111             1111


Q ss_pred             hhhhh---cccHH-HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          345 SVLEE---ASFNE-SLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       345 ~~l~~---~~~~~-~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      .....   ..+.. ....+.+++..||..+|++|||+.+++.+
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         215 YIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             HHhcCCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence            11111   11111 45678899999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=9.1e-38  Score=293.08  Aligned_cols=254  Identities=24%  Similarity=0.350  Sum_probs=196.4

Q ss_pred             CCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCCC----------hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC
Q 014024          110 NFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGKS----------GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKD  177 (432)
Q Consensus       110 ~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  177 (432)
                      +|.+.+.||.|++|.||+|...  +..+++|.+....          ....+.+.+|+.+++.++|+|++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            5778899999999999999864  3479999874321          112356788999999999999999999999999


Q ss_pred             eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccc
Q 014024          178 ERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMA  257 (432)
Q Consensus       178 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  257 (432)
                      ..++||||+++++|.+++...   ..+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.++|+|||++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~  155 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS  155 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence            999999999999999998543   45899999999999999999999998   999999999999999999999999999


Q ss_pred             eeccCCCCccccccccccccccCCccChhhhccCC--CCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhh
Q 014024          258 RIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGI--FSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWI  335 (432)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  335 (432)
                      .......    .........++..|+|||.+....  ++.++|+||||+++|++++|..|+......     ........
T Consensus       156 ~~~~~~~----~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~  226 (272)
T cd06629         156 KKSDDIY----DNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI-----AAMFKLGN  226 (272)
T ss_pred             ccccccc----cccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH-----HHHHHhhc
Confidence            7532111    011223456888999999987654  899999999999999999999997432210     00000000


Q ss_pred             ccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          336 SNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       336 ~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      .. ....+.    .......+..+.+++..||+.+|++||++.+|+++
T Consensus       227 ~~-~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         227 KR-SAPPIP----PDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             cc-cCCcCC----ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            00 000000    11112335678899999999999999999999876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=7e-38  Score=297.40  Aligned_cols=250  Identities=24%  Similarity=0.360  Sum_probs=201.2

Q ss_pred             hCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEec
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEY  185 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  185 (432)
                      .++|.+.+.||+|+||.||++...  +..+++|.+........+.+.+|+.+++.++|||++++++.+...+..++|+||
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   97 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY   97 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence            478999999999999999999864  347999988655555567789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCC
Q 014024          186 MPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGND  265 (432)
Q Consensus       186 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  265 (432)
                      +++++|.+++..    ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++....... 
T Consensus        98 ~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~-  169 (293)
T cd06647          98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-  169 (293)
T ss_pred             CCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccc-
Confidence            999999999843    34889999999999999999999998   9999999999999999999999999887542211 


Q ss_pred             ccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhh
Q 014024          266 EDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDS  345 (432)
Q Consensus       266 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  345 (432)
                           .......+++.|+|||.+..+.++.++|+||||+++|++++|+.||......... .    .......      +
T Consensus       170 -----~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~-~----~~~~~~~------~  233 (293)
T cd06647         170 -----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-Y----LIATNGT------P  233 (293)
T ss_pred             -----cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe-e----ehhcCCC------C
Confidence                 1223346888999999998888999999999999999999999998533221100 0    0000000      0


Q ss_pred             hhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          346 VLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       346 ~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                        ...........+.+++.+||+.+|++||++.+++.+
T Consensus       234 --~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         234 --ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             --CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              000112234568899999999999999999999976

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.4e-37  Score=292.77  Aligned_cols=261  Identities=25%  Similarity=0.329  Sum_probs=198.9

Q ss_pred             CCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCC-hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeC--CeeEEEE
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS-GQEIKELKNEASVIAQVQHKNLVKLLGCCIEK--DERLLIY  183 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~  183 (432)
                      ++|+..+.||.|++|.||++.+..  ..+++|.+.... ......+.+|++++++++|+||+++++++.+.  +..++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            468889999999999999999854  478999886442 34556789999999999999999999998654  4689999


Q ss_pred             ecCCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccC
Q 014024          184 EYMPNKSLDCFLFDP-TKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFG  262 (432)
Q Consensus       184 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  262 (432)
                      ||+++++|.+++... .....+++.....++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            999999998887432 12345889999999999999999999998   99999999999999999999999999875421


Q ss_pred             CCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhh
Q 014024          263 GNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDL  342 (432)
Q Consensus       263 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                      .        ......++..|+|||.+.+..++.++|+||||+++|+|++|+.|+.............. ..........+
T Consensus       158 ~--------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~  228 (287)
T cd06621         158 S--------LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELL-SYIVNMPNPEL  228 (287)
T ss_pred             c--------ccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHH-HHHhcCCchhh
Confidence            1        11234567889999999999999999999999999999999999864422111111100 00000000000


Q ss_pred             hhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          343 IDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       343 i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                      .+.   ..........+.+++.+||+.+|++|||+.|++++-
T Consensus       229 ~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~  267 (287)
T cd06621         229 KDE---PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHP  267 (287)
T ss_pred             ccC---CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCc
Confidence            000   000012356788999999999999999999999854

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=9.6e-38  Score=295.93  Aligned_cols=263  Identities=22%  Similarity=0.297  Sum_probs=194.0

Q ss_pred             hCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCCCh-HhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEe
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGKSG-QEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYE  184 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  184 (432)
                      .++|++.+.||+|++|.||+|.+.  +..+++|.+..... .....+.+|++++++++|+||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE   83 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence            468999999999999999999975  34899998854422 223456789999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCC
Q 014024          185 YMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGN  264 (432)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  264 (432)
                      |+++ +|.+++....  ..+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||++...... 
T Consensus        84 ~~~~-~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-  156 (291)
T cd07844          84 YLDT-DLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVP-  156 (291)
T ss_pred             cCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCC-
Confidence            9975 8888875432  35899999999999999999999998   999999999999999999999999998653111 


Q ss_pred             CccccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhc---cchh
Q 014024          265 DEDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWIS---NKII  340 (432)
Q Consensus       265 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~  340 (432)
                           ........++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||....... ......+.....   ....
T Consensus       157 -----~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  230 (291)
T cd07844         157 -----SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE-DQLHKIFRVLGTPTEETWP  230 (291)
T ss_pred             -----CccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH-HHHHHHHHhcCCCChhhhh
Confidence                 111122346788999998875 558999999999999999999999985433110 000000000000   0000


Q ss_pred             hh-------------h-hhhhhhcc-cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          341 DL-------------I-DSVLEEAS-FNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       341 ~~-------------i-~~~l~~~~-~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      ..             . ...+.... .......+.+++.+||+.+|++|||+.+++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~  288 (291)
T cd07844         231 GVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH  288 (291)
T ss_pred             hhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence            00             0 00000000 00112567899999999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.3e-37  Score=290.50  Aligned_cols=254  Identities=27%  Similarity=0.427  Sum_probs=199.2

Q ss_pred             CCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCCCh--HhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEec
Q 014024          110 NFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGKSG--QEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEY  185 (432)
Q Consensus       110 ~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  185 (432)
                      +|++.+.||+|+||.||+|...  +..+++|.+.....  ...+.+.+|+++++.++|+||+++++++.+.+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            5888999999999999999874  34899998865543  3677899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCC
Q 014024          186 MPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGND  265 (432)
Q Consensus       186 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  265 (432)
                      +++++|.+++..   ...+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++........
T Consensus        81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~  154 (264)
T cd06626          81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT  154 (264)
T ss_pred             CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence            999999999854   334889999999999999999999998   99999999999999999999999999987532221


Q ss_pred             ccccccccccccccCCccChhhhccCC---CCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhh
Q 014024          266 EDELQGNTSRISGTYGYMSPEYALEGI---FSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDL  342 (432)
Q Consensus       266 ~~~~~~~~~~~~gt~~y~aPE~~~~~~---~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                      .  .........++..|+|||++.+..   ++.++||||||+++++|++|+.||.......    ....... ...    
T Consensus       155 ~--~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~----~~~~~~~-~~~----  223 (264)
T cd06626         155 T--MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF----QIMFHVG-AGH----  223 (264)
T ss_pred             c--ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH----HHHHHHh-cCC----
Confidence            1  011022356788999999998766   8999999999999999999999985332110    0000000 000    


Q ss_pred             hhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          343 IDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       343 i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                       .+.+  .........+.+++.+||+.+|.+|||+.+++.+
T Consensus       224 -~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~  261 (264)
T cd06626         224 -KPPI--PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQH  261 (264)
T ss_pred             -CCCC--CcccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence             0000  0011224567899999999999999999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-39  Score=312.49  Aligned_cols=252  Identities=27%  Similarity=0.363  Sum_probs=211.1

Q ss_pred             CCCCcCceeccCCcEEEEEEEECC---c--eEEEEEEcCCChH-hHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEE
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQ---G--EIAVKRLLGKSGQ-EIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLI  182 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~---~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  182 (432)
                      +...+.++||+|.||.|++|.+..   +  .||||.+...... ....|.+|+.+|.+++|+|++++||+..+ ....+|
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV  188 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV  188 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence            445667899999999999999853   2  6999999766544 67889999999999999999999999988 677899


Q ss_pred             EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccC
Q 014024          183 YEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFG  262 (432)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  262 (432)
                      ||.++.|+|.+.|+. ..+..|.......++.|||.||.||.+++   +|||||...|+||-....+||+|||+.+-+..
T Consensus       189 ~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~  264 (1039)
T KOG0199|consen  189 FELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGE  264 (1039)
T ss_pred             hhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCC
Confidence            999999999999987 55667889999999999999999999998   99999999999999999999999999998633


Q ss_pred             CCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchhh
Q 014024          263 GNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIID  341 (432)
Q Consensus       263 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (432)
                      +++.   ........-...|+|||.+....++.++|||+|||++|||+| |..||..               ...-.+.+
T Consensus       265 ned~---Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G---------------~~g~qIL~  326 (1039)
T KOG0199|consen  265 NEDM---YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVG---------------CRGIQILK  326 (1039)
T ss_pred             CCcc---eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCC---------------CCHHHHHH
Confidence            3221   112223344568999999999999999999999999999999 6667531               12234556


Q ss_pred             hhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          342 LIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       342 ~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      .+|..-+-..+..|+++++++++.||..+|++|||+..|.+.
T Consensus       327 ~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~  368 (1039)
T KOG0199|consen  327 NIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED  368 (1039)
T ss_pred             hccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence            666655666778899999999999999999999999999743

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.8e-37  Score=290.71  Aligned_cols=252  Identities=23%  Similarity=0.356  Sum_probs=185.8

Q ss_pred             eeccCCcEEEEEEEECCc----eEEEEEEcCCC-hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecCCCCC
Q 014024          116 KLGEGGFGTVYKGVIGQG----EIAVKRLLGKS-GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKS  190 (432)
Q Consensus       116 ~ig~G~~g~Vy~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  190 (432)
                      .||+|+||.||+|...+.    .+++|.+.... ....+.+.+|+..++.++||||+++++.+.+....++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            599999999999975332    45667665433 3456788999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCcccc
Q 014024          191 LDCFLFDPTK-REILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDEL  269 (432)
Q Consensus       191 L~~~l~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  269 (432)
                      |.+++..... ...+++.....++.|++.||+|||+.+   ++||||||+|||++.++.++|+|||++.......    .
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~----~  154 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKED----Y  154 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcch----h
Confidence            9999965322 234677788899999999999999998   9999999999999999999999999986421110    0


Q ss_pred             ccccccccccCCccChhhhcc-------CCCCchhhhHHHHHHHHHHHhC-CCCCCCccccccchhhhhHHhhhccchhh
Q 014024          270 QGNTSRISGTYGYMSPEYALE-------GIFSIKSDVFSFGVLLLEIVSG-KKNTGFYRTKSLNLIGYAWDLWISNKIID  341 (432)
Q Consensus       270 ~~~~~~~~gt~~y~aPE~~~~-------~~~t~~~DvwSlG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (432)
                      ........++..|+|||++..       ..++.++||||||+++|||+++ ..|+......  .   .... ...+....
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~--~---~~~~-~~~~~~~~  228 (268)
T cd05086         155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR--E---VLNH-VIKDQQVK  228 (268)
T ss_pred             hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH--H---HHHH-HHhhcccc
Confidence            112234567889999998753       2457899999999999999975 5565322110  0   0000 01111111


Q ss_pred             hhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014024          342 LIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLT  385 (432)
Q Consensus       342 ~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~  385 (432)
                      ..++.+    .......+.+++..|| .+|++||++++|++.|.
T Consensus       229 ~~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         229 LFKPQL----ELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             cCCCcc----CCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            112111    1123456778899999 67999999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-37  Score=292.44  Aligned_cols=247  Identities=24%  Similarity=0.406  Sum_probs=196.4

Q ss_pred             CCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC-ChHhHHHHHHHHHHHHhcC---CCceeeeEeEEEeCCeeEEEE
Q 014024          110 NFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK-SGQEIKELKNEASVIAQVQ---HKNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       110 ~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~  183 (432)
                      .|+..+.||+|+||.||+|.+..  ..+++|.+... .......+.+|+.++++++   |+|++++++++.+....++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            57888999999999999999743  47999987544 3345567889999999997   999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCC
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGG  263 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  263 (432)
                      ||+++++|.+++..    ..+++..++.++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++......
T Consensus        82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06917          82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN  154 (277)
T ss_pred             ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence            99999999998843    25899999999999999999999998   999999999999999999999999999875322


Q ss_pred             CCccccccccccccccCCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhh
Q 014024          264 NDEDELQGNTSRISGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDL  342 (432)
Q Consensus       264 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                      .      .......|+..|+|||.+.++ .++.++|+||||+++|+|++|..||.......     ... .......   
T Consensus       155 ~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-----~~~-~~~~~~~---  219 (277)
T cd06917         155 S------SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR-----AMM-LIPKSKP---  219 (277)
T ss_pred             c------cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh-----hhh-ccccCCC---
Confidence            1      122334688899999988754 47899999999999999999999985322110     000 0000000   


Q ss_pred             hhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          343 IDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       343 i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                        +.+.   ....+.++.+++..||+.||++||++.+++.+
T Consensus       220 --~~~~---~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         220 --PRLE---DNGYSKLLREFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             --CCCC---cccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence              0000   01134678899999999999999999999874

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-38  Score=296.51  Aligned_cols=262  Identities=23%  Similarity=0.299  Sum_probs=200.0

Q ss_pred             CCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEe
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYE  184 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  184 (432)
                      ++|++.+.||+|++|.||+|.+.+  ..+++|++...  .....+.+.+|++++++++|+||+++++++.+.+..+++||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            478999999999999999999864  37999987543  23345678999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCC
Q 014024          185 YMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGN  264 (432)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  264 (432)
                      |++++++..+...   ...+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~  154 (288)
T cd07833          81 YVERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP  154 (288)
T ss_pred             cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence            9998877766532   334899999999999999999999998   9999999999999999999999999988753221


Q ss_pred             CccccccccccccccCCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHH-----------
Q 014024          265 DEDELQGNTSRISGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWD-----------  332 (432)
Q Consensus       265 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~-----------  332 (432)
                      .     .......++..|+|||++.+. .++.++|+||||+++|+|++|+.||......+  .......           
T Consensus       155 ~-----~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~  227 (288)
T cd07833         155 A-----SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID--QLYLIQKCLGPLPPSHQE  227 (288)
T ss_pred             c-----ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHHhh
Confidence            1     122345678899999999887 78999999999999999999999885432211  0000000           


Q ss_pred             hhhccc------hhhhhh-hhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          333 LWISNK------IIDLID-SVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       333 ~~~~~~------~~~~i~-~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      ....+.      ..+..+ .......+...+.++.+++.+||..+|++||++++++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         228 LFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             hcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence            000000      000000 001111222336788999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=2.1e-37  Score=292.42  Aligned_cols=262  Identities=23%  Similarity=0.322  Sum_probs=197.1

Q ss_pred             CCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCC-hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecC
Q 014024          110 NFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS-GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYM  186 (432)
Q Consensus       110 ~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  186 (432)
                      +|++.+.||.|++|.||+|.+..  ..+++|.+.... ......+.+|++++++++|+|++++++++.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            58889999999999999999854  379999886543 223456778999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCc
Q 014024          187 PNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDE  266 (432)
Q Consensus       187 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  266 (432)
                      ++ +|.+++........+++..+..++.|++.||+|||+.+   ++||||+|+||++++++.++|+|||++......   
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~---  153 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIP---  153 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCC---
Confidence            85 78888765444456999999999999999999999998   999999999999999999999999999754211   


Q ss_pred             cccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhh---hccchhhh
Q 014024          267 DELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLW---ISNKIIDL  342 (432)
Q Consensus       267 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~  342 (432)
                         ........++..|++||.+.+ ..++.++|+||||+++|+|++|+.||......+.  ........   .......+
T Consensus       154 ---~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  228 (284)
T cd07836         154 ---VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ--LLKIFRIMGTPTESTWPGI  228 (284)
T ss_pred             ---ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHHHHhCCCChhhHHHH
Confidence               111223456889999998865 4578999999999999999999999864332110  00000000   00000000


Q ss_pred             h------h------hhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          343 I------D------SVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       343 i------~------~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      .      .      ........+..+..+.+++..|++.||.+||++.+++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         229 SQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             hcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            0      0      000011112335678899999999999999999999864

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-38  Score=298.05  Aligned_cols=251  Identities=22%  Similarity=0.289  Sum_probs=209.4

Q ss_pred             hCCCCcCceeccCCcEEEEEEEE--CCceEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEE
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVI--GQGEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  183 (432)
                      .+=|.+.+.||+|-|.+|-+|++  .+.+||||++.+.  +......+.+|++-|+.++|||||++|++......+|||+
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL   96 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL   96 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence            45678889999999999999975  6679999999655  3344567889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEc-CCCCEEEeecccceeccC
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLD-KDMNSKISDFGMARIVFG  262 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~~  262 (432)
                      |.-++|+|.+|+..+...  +.+....+++.||+.|+.|+|+.+   +|||||||+|+.+- .-|-+||+|||++-.+.+
T Consensus        97 ELGD~GDl~DyImKHe~G--l~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P  171 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKHEEG--LNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP  171 (864)
T ss_pred             EecCCchHHHHHHhhhcc--ccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence            999999999999754433  999999999999999999999999   99999999999875 568899999999987643


Q ss_pred             CCCccccccccccccccCCccChhhhccCCCC-chhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhh
Q 014024          263 GNDEDELQGNTSRISGTYGYMSPEYALEGIFS-IKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIID  341 (432)
Q Consensus       263 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t-~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (432)
                      +       ......+|...|-|||++.+..|+ +++||||||||||-|++|+.||+...              .++.+..
T Consensus       172 G-------~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAN--------------DSETLTm  230 (864)
T KOG4717|consen  172 G-------KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAN--------------DSETLTM  230 (864)
T ss_pred             c-------chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccccc--------------chhhhhh
Confidence            3       234567899999999999998885 78999999999999999999985322              2233333


Q ss_pred             hhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014024          342 LIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN  386 (432)
Q Consensus       342 ~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~  386 (432)
                      ++|-.  -..+.....++.+||..||..||.+|.+.+||+..-+-
T Consensus       231 ImDCK--YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wl  273 (864)
T KOG4717|consen  231 IMDCK--YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWL  273 (864)
T ss_pred             hhccc--ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccc
Confidence            33321  23355667889999999999999999999999876543

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.3e-37  Score=293.77  Aligned_cols=251  Identities=24%  Similarity=0.380  Sum_probs=190.5

Q ss_pred             CCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCC-hHhHHHHHHHHHH-HHhcCCCceeeeEeEEEeCCeeEEEEe
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS-GQEIKELKNEASV-IAQVQHKNLVKLLGCCIEKDERLLIYE  184 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e  184 (432)
                      ++|++.+.||+|+||.||++.+..  ..||+|++.... ......+..|+.. ++..+|+|++++++++...+..+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            478999999999999999999854  489999886542 2233445556664 666789999999999999999999999


Q ss_pred             cCCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEeccCCCCCEEEcCCCCEEEeecccceeccC
Q 014024          185 YMPNKSLDCFLFDP-TKREILDWRTRVQIIKGVAQGLLYLHQY-SRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFG  262 (432)
Q Consensus       185 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  262 (432)
                      |++ |+|.+++... .....+++..++.++.|++.||+|||++ +   ++||||||+||+++.++.+||+|||++.....
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            996 6777776432 2334689999999999999999999987 7   99999999999999999999999999876421


Q ss_pred             CCCccccccccccccccCCccChhhhcc----CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccc
Q 014024          263 GNDEDELQGNTSRISGTYGYMSPEYALE----GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNK  338 (432)
Q Consensus       263 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  338 (432)
                      .       .......++..|+|||.+.+    ..++.++|+|||||++|+|++|+.||.........             
T Consensus       157 ~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-------------  216 (283)
T cd06617         157 S-------VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQ-------------  216 (283)
T ss_pred             c-------cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHH-------------
Confidence            1       11122457888999998864    45789999999999999999999998532211000             


Q ss_pred             hhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          339 IIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       339 ~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      ....+............+.++.+++..||..+|++||++.+++++
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  261 (283)
T cd06617         217 LKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH  261 (283)
T ss_pred             HHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            001111000000011234678899999999999999999999874

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=8.5e-38  Score=295.16  Aligned_cols=261  Identities=21%  Similarity=0.285  Sum_probs=193.9

Q ss_pred             CCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCC--hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEec
Q 014024          110 NFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS--GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEY  185 (432)
Q Consensus       110 ~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  185 (432)
                      +|++.+.||.|++|.||+|.+..  ..+++|++....  ....+.+.+|++++++++|+||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            58889999999999999999853  479999875432  22345788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCC
Q 014024          186 MPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGND  265 (432)
Q Consensus       186 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  265 (432)
                      +. ++|.+++.... ...+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.+||+|||++......  
T Consensus        81 ~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~--  153 (284)
T cd07860          81 LH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--  153 (284)
T ss_pred             cc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccC--
Confidence            96 57888875432 345899999999999999999999998   999999999999999999999999998754211  


Q ss_pred             ccccccccccccccCCccChhhhccCC-CCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhcc-c----h
Q 014024          266 EDELQGNTSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISN-K----I  339 (432)
Q Consensus       266 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~----~  339 (432)
                          ........++..|+|||.+.+.. ++.++||||||+++|+|+||+.||....... ............. .    .
T Consensus       154 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  228 (284)
T cd07860         154 ----VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLGTPDEVVWPGV  228 (284)
T ss_pred             ----ccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCChhhhhhh
Confidence                11122335678899999887644 6889999999999999999999985432111 1110000000000 0    0


Q ss_pred             hhh----------hhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          340 IDL----------IDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       340 ~~~----------i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      ...          ....+ ..........+.+++.+||+.||.+|||+++++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         229 TSLPDYKPSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             hHHHHHHhhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence            000          00000 00011223567889999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.8e-37  Score=293.04  Aligned_cols=261  Identities=21%  Similarity=0.294  Sum_probs=198.3

Q ss_pred             CCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCCC--hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEec
Q 014024          110 NFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGKS--GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEY  185 (432)
Q Consensus       110 ~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  185 (432)
                      +|++.+.||+|++|.||+|.+.  +..+++|++....  ....+.+.+|+.++++++|+|++++++++.+....++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            5888999999999999999974  3489999886543  34456789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCC
Q 014024          186 MPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGND  265 (432)
Q Consensus       186 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  265 (432)
                      + +++|.+++....  ..+++..++.++.|++.||+|||+.+   ++|+||||+||++++++.++|+|||++........
T Consensus        81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (286)
T cd07832          81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP  154 (286)
T ss_pred             c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence            9 999999886433  45999999999999999999999998   99999999999999999999999999986522211


Q ss_pred             ccccccccccccccCCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhcc-------
Q 014024          266 EDELQGNTSRISGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISN-------  337 (432)
Q Consensus       266 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-------  337 (432)
                           .......++..|+|||.+.+. .++.++||||+|+++|+|++|..||.....  ..............       
T Consensus       155 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  227 (286)
T cd07832         155 -----RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND--IEQLAIVFRTLGTPNEETWPG  227 (286)
T ss_pred             -----CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH--HHHHHHHHHHcCCCChHHHhh
Confidence                 122345688999999988654 468999999999999999999777643221  11111110000000       


Q ss_pred             -----chhhhhhh----hhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          338 -----KIIDLIDS----VLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       338 -----~~~~~i~~----~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                           ....+...    ........+....+.+++.+||+.+|++|||+++++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         228 LTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             ccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence                 00000000    00000112234788999999999999999999999876

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.4e-37  Score=294.07  Aligned_cols=255  Identities=24%  Similarity=0.361  Sum_probs=204.3

Q ss_pred             hhhhCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEE
Q 014024          105 SSATGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLI  182 (432)
Q Consensus       105 ~~~~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  182 (432)
                      ....++|+..+.||+|++|.||+|.+.  +..+++|.+..... ..+.+.+|++.++.++|+|++++++++...+..+++
T Consensus        15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   93 (286)
T cd06614          15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV   93 (286)
T ss_pred             CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence            345678999999999999999999986  45899999866544 566788999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccC
Q 014024          183 YEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFG  262 (432)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  262 (432)
                      +||+++++|.+++....  ..+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        94 ~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  168 (286)
T cd06614          94 MEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTK  168 (286)
T ss_pred             EeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence            99999999999996532  25999999999999999999999998   99999999999999999999999999875422


Q ss_pred             CCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhh
Q 014024          263 GNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDL  342 (432)
Q Consensus       263 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                      ..      .......++..|+|||.+.+..++.++|+||||+++|+|++|+.|+.......     .... .......  
T Consensus       169 ~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~-----~~~~-~~~~~~~--  234 (286)
T cd06614         169 EK------SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR-----ALFL-ITTKGIP--  234 (286)
T ss_pred             ch------hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH-----HHHH-HHhcCCC--
Confidence            11      11223457889999999988889999999999999999999999975322210     0000 0000000  


Q ss_pred             hhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          343 IDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       343 i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                           ........+..+.+++.+||+.+|.+||++.+++++.
T Consensus       235 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~  271 (286)
T cd06614         235 -----PLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHP  271 (286)
T ss_pred             -----CCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhCh
Confidence                 0001112456788999999999999999999998743

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=2.3e-37  Score=293.35  Aligned_cols=264  Identities=23%  Similarity=0.283  Sum_probs=193.8

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCCCh-HhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGKSG-QEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  183 (432)
                      ++++|.+.+.||+|+||.||+|...  +..+++|.+..... .....+.+|+.+++.++|+||+++++++.+++..++||
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            4678999999999999999999874  44899998854432 22345678999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCC
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGG  263 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  263 (432)
                      ||+. +++.+++...  ...+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++......
T Consensus        83 e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  156 (291)
T cd07870          83 EYMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP  156 (291)
T ss_pred             eccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence            9996 5666665432  234788889999999999999999998   999999999999999999999999998753111


Q ss_pred             CCccccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhh---cc--
Q 014024          264 NDEDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWI---SN--  337 (432)
Q Consensus       264 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~--  337 (432)
                            ........+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||.........+. ..+....   ..  
T Consensus       157 ------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~-~~~~~~~~~~~~~~  229 (291)
T cd07870         157 ------SQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLE-KIWTVLGVPTEDTW  229 (291)
T ss_pred             ------CCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHH-HHHHHcCCCChhhh
Confidence                  111223456889999998875 4588999999999999999999999864332111000 0000000   00  


Q ss_pred             ----chhhhhhhhhhhc---------ccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          338 ----KIIDLIDSVLEEA---------SFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       338 ----~~~~~i~~~l~~~---------~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                          .............         ........+.+++.+|++.||.+|||+.|++.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h  288 (291)
T cd07870         230 PGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH  288 (291)
T ss_pred             hhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence                0000000000000         000113567889999999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-39  Score=307.57  Aligned_cols=258  Identities=27%  Similarity=0.427  Sum_probs=219.5

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEe
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYE  184 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  184 (432)
                      ...+....++||-|-||.||.|.++.-  .||||.++... -..++|..|+.+|+.++|||+|+++|+|..+..+|||+|
T Consensus       265 eRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTE  343 (1157)
T KOG4278|consen  265 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITE  343 (1157)
T ss_pred             cchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEe
Confidence            344556678999999999999999765  89999886544 457899999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCC
Q 014024          185 YMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGN  264 (432)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  264 (432)
                      ||..|+|.+||++... ..++....+.++.||..|++||..++   +|||||...|+|+.++..+|++|||+++++.+..
T Consensus       344 fM~yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT  419 (1157)
T KOG4278|consen  344 FMCYGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT  419 (1157)
T ss_pred             cccCccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCc
Confidence            9999999999977543 44888888999999999999999999   9999999999999999999999999999874321


Q ss_pred             CccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchhhhh
Q 014024          265 DEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIIDLI  343 (432)
Q Consensus       265 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i  343 (432)
                      .     .......-..-|.|||-+....++.|+|||+|||+|||+.| |..|+...+               ...+.+++
T Consensus       420 Y-----TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid---------------lSqVY~LL  479 (1157)
T KOG4278|consen  420 Y-----TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID---------------LSQVYGLL  479 (1157)
T ss_pred             e-----ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc---------------HHHHHHHH
Confidence            1     11122233567999999999999999999999999999988 777764222               23456777


Q ss_pred             hhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccc
Q 014024          344 DSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS  389 (432)
Q Consensus       344 ~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~  389 (432)
                      +...+...+..|+..+++|+..||+-+|.+||+++|+-+.++....
T Consensus       480 EkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~  525 (1157)
T KOG4278|consen  480 EKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS  525 (1157)
T ss_pred             hccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence            8888888899999999999999999999999999999998876543

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=8.8e-38  Score=297.28  Aligned_cols=248  Identities=22%  Similarity=0.309  Sum_probs=196.5

Q ss_pred             CCcCceeccCCcEEEEEEEEC--CceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecCCC
Q 014024          111 FSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPN  188 (432)
Q Consensus       111 y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  188 (432)
                      |.....||+|+||.||++.+.  +..+++|.+........+.+.+|+.+++.++|||++++++++..++..+++|||+++
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~  102 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG  102 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence            334457999999999999874  448999998655555566788999999999999999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCccc
Q 014024          189 KSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDE  268 (432)
Q Consensus       189 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  268 (432)
                      ++|.+++..    ..+++..++.++.|++.||+|||+.+   ++|+||+|+||+++.++.+||+|||++......     
T Consensus       103 ~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~-----  170 (297)
T cd06659         103 GALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD-----  170 (297)
T ss_pred             CCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccc-----
Confidence            999988732    34899999999999999999999998   999999999999999999999999998753211     


Q ss_pred             cccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhhhh
Q 014024          269 LQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLE  348 (432)
Q Consensus       269 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  348 (432)
                       ........++..|+|||++.+..++.++|||||||++|||++|+.||.......  ......     ...    .... 
T Consensus       171 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--~~~~~~-----~~~----~~~~-  237 (297)
T cd06659         171 -VPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ--AMKRLR-----DSP----PPKL-  237 (297)
T ss_pred             -cccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHh-----ccC----CCCc-
Confidence             111233568899999999998889999999999999999999999975322110  000000     000    0000 


Q ss_pred             hcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          349 EASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       349 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                       .........+.+++..||+.+|++||++.+++++-
T Consensus       238 -~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~  272 (297)
T cd06659         238 -KNAHKISPVLRDFLERMLTREPQERATAQELLDHP  272 (297)
T ss_pred             -cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhCh
Confidence             00112245678899999999999999999999963

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-39  Score=311.49  Aligned_cols=247  Identities=24%  Similarity=0.406  Sum_probs=206.2

Q ss_pred             CCCCcCceeccCCcEEEEEEEECCce--EEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecC
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQGE--IAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYM  186 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~~~--vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  186 (432)
                      +.|+|+..||.|+||.||+|...+..  .|.|.+.-.+.+..+.+.-|+++|..+.||+||++++.|...+.+++..|||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC  111 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC  111 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence            55788899999999999999988763  4678887788888999999999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCc
Q 014024          187 PNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDE  266 (432)
Q Consensus       187 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  266 (432)
                      .||..+..+....  ..+.+.++.-+++|++.||.|||+++   |||||||..|||++-+|.++|+|||.+...      
T Consensus       112 ~GGAVDaimlEL~--r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn------  180 (1187)
T KOG0579|consen  112 GGGAVDAIMLELG--RVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKN------  180 (1187)
T ss_pred             CCchHhHHHHHhc--cccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccc------
Confidence            9999999886543  34999999999999999999999999   999999999999999999999999988653      


Q ss_pred             cccccccccccccCCccChhhhc-----cCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhh
Q 014024          267 DELQGNTSRISGTYGYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIID  341 (432)
Q Consensus       267 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (432)
                      .........+.|||.|||||+..     ..+|+.++||||||++|.||..+.+|....     +..             .
T Consensus       181 ~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel-----npM-------------R  242 (1187)
T KOG0579|consen  181 KSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL-----NPM-------------R  242 (1187)
T ss_pred             hhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc-----chH-------------H
Confidence            22234456789999999999875     467999999999999999999999884211     111             1


Q ss_pred             hhhhhhhhc-----ccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          342 LIDSVLEEA-----SFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       342 ~i~~~l~~~-----~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                      .+-..-...     .+..+...+.+++..||..||..||++++++++-
T Consensus       243 VllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hp  290 (1187)
T KOG0579|consen  243 VLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHP  290 (1187)
T ss_pred             HHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCc
Confidence            111111111     1345677889999999999999999999999754

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=3.1e-37  Score=291.79  Aligned_cols=248  Identities=23%  Similarity=0.326  Sum_probs=197.1

Q ss_pred             CCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecCC
Q 014024          110 NFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMP  187 (432)
Q Consensus       110 ~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  187 (432)
                      +|.-.+.||+|++|.||++....  ..+++|++........+.+.+|+.+++.++|+|++++++++...+..++++||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            34445789999999999998743  4799998866555556778899999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCcc
Q 014024          188 NKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDED  267 (432)
Q Consensus       188 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  267 (432)
                      +++|.+++..    ..+++..+..++.|++.||+|||+.+   ++||||+|+||++++++.++|+|||.+......    
T Consensus       100 ~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~----  168 (285)
T cd06648         100 GGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE----  168 (285)
T ss_pred             CCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccC----
Confidence            9999999854    34899999999999999999999998   999999999999999999999999988653211    


Q ss_pred             ccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhhh
Q 014024          268 ELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVL  347 (432)
Q Consensus       268 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  347 (432)
                        ........|++.|+|||...+..++.++|+||||+++|+|++|+.||.....     ......      ......+..
T Consensus       169 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~-----~~~~~~------~~~~~~~~~  235 (285)
T cd06648         169 --VPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP-----LQAMKR------IRDNLPPKL  235 (285)
T ss_pred             --CcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH-----HHHHHH------HHhcCCCCC
Confidence              1112234688999999999888899999999999999999999999743211     000000      000000000


Q ss_pred             hhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          348 EEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       348 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      .  .....+..+.+++.+||+.+|++||++.+++++
T Consensus       236 ~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  269 (285)
T cd06648         236 K--NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH  269 (285)
T ss_pred             c--ccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence            0  011234678999999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2.8e-37  Score=295.26  Aligned_cols=248  Identities=28%  Similarity=0.410  Sum_probs=194.4

Q ss_pred             hCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCC---ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEE
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGK---SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLI  182 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  182 (432)
                      ...|.+.+.||+|+||.||+|...  +..+++|.+...   .....+.+.+|+++++.++|+|++++.+++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv   93 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV   93 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence            456889999999999999999874  348999987533   234456788999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccC
Q 014024          183 YEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFG  262 (432)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  262 (432)
                      |||++ |++.+++...  ...+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++.... 
T Consensus        94 ~e~~~-g~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~-  166 (307)
T cd06607          94 MEYCL-GSASDILEVH--KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVS-  166 (307)
T ss_pred             HHhhC-CCHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecC-
Confidence            99997 5666665322  234899999999999999999999998   9999999999999999999999999987631 


Q ss_pred             CCCccccccccccccccCCccChhhhc---cCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccch
Q 014024          263 GNDEDELQGNTSRISGTYGYMSPEYAL---EGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKI  339 (432)
Q Consensus       263 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  339 (432)
                               ......++..|+|||++.   .+.++.++||||||+++|||++|+.|+.......     ...... ....
T Consensus       167 ---------~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~-----~~~~~~-~~~~  231 (307)
T cd06607         167 ---------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-----ALYHIA-QNDS  231 (307)
T ss_pred             ---------CCCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH-----HHHHHh-cCCC
Confidence                     112345788899999874   4568899999999999999999999974322100     000000 0000


Q ss_pred             hhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014024          340 IDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLT  385 (432)
Q Consensus       340 ~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~  385 (432)
                              ...........+.+++.+||+.+|++||++.+++.+..
T Consensus       232 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  269 (307)
T cd06607         232 --------PTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRF  269 (307)
T ss_pred             --------CCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence                    00011234567899999999999999999999998643

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-38  Score=305.05  Aligned_cols=252  Identities=27%  Similarity=0.411  Sum_probs=209.5

Q ss_pred             CCcCceeccCCcEEEEEEEECCc------eEEEEEEcC-CChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEE
Q 014024          111 FSAANKLGEGGFGTVYKGVIGQG------EIAVKRLLG-KSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       111 y~~~~~ig~G~~g~Vy~~~~~~~------~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  183 (432)
                      ....++||.|-||.||.|...+-      .||||..+. ......+.|..|+.+|+.++||||++++|+|.+. ..+|||
T Consensus       391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wivm  469 (974)
T KOG4257|consen  391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVM  469 (974)
T ss_pred             ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEE
Confidence            34567899999999999986321      588888765 3456678899999999999999999999999875 568999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCC
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGG  263 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  263 (432)
                      |.++-|-|..||+...  ..++......+++||+.||+|||+..   +|||||..+|||+.+...+||+|||+++.+.+.
T Consensus       470 EL~~~GELr~yLq~nk--~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~  544 (974)
T KOG4257|consen  470 ELAPLGELREYLQQNK--DSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLEDD  544 (974)
T ss_pred             ecccchhHHHHHHhcc--ccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence            9999999999997543  34889999999999999999999998   999999999999999999999999999986322


Q ss_pred             CCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchhhh
Q 014024          264 NDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIIDL  342 (432)
Q Consensus       264 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                      .     -+..+...-..-|||||-+.-..+|.++|||.|||.+||+++ |.+||..-.               +.++-..
T Consensus       545 ~-----yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvk---------------NsDVI~~  604 (974)
T KOG4257|consen  545 A-----YYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVK---------------NSDVIGH  604 (974)
T ss_pred             c-----hhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccc---------------ccceEEE
Confidence            1     222222333557999999999999999999999999999987 999985322               2344444


Q ss_pred             hhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014024          343 IDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEA  388 (432)
Q Consensus       343 i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~  388 (432)
                      ++..-+.++++.|+..++.|+.+||..+|.+||++.++...|.++.
T Consensus       605 iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~  650 (974)
T KOG4257|consen  605 IENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVL  650 (974)
T ss_pred             ecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHH
Confidence            5555667788999999999999999999999999999988776543

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=5.5e-37  Score=283.40  Aligned_cols=249  Identities=29%  Similarity=0.446  Sum_probs=201.6

Q ss_pred             CCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecCC
Q 014024          110 NFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMP  187 (432)
Q Consensus       110 ~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  187 (432)
                      +|+..+.||+|++|.||++.+.  +..+++|++........+.+.+|++.++.++|+|++++++++......++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            4778899999999999999986  44799999877665567789999999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCcc
Q 014024          188 NKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDED  267 (432)
Q Consensus       188 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  267 (432)
                      +++|.+++....  ..+++..+..++.|++.||.+||+.+   ++||||+|+||++++++.++|+|||.+........  
T Consensus        81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--  153 (253)
T cd05122          81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--  153 (253)
T ss_pred             CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence            999999985432  45899999999999999999999988   99999999999999999999999999876422110  


Q ss_pred             ccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhhh
Q 014024          268 ELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVL  347 (432)
Q Consensus       268 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  347 (432)
                           .....++..|+|||.+.+..++.++|+||||+++|+|++|+.|+.......     .... .........     
T Consensus       154 -----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~-~~~~~~~~~-----  217 (253)
T cd05122         154 -----RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK-----ALFK-IATNGPPGL-----  217 (253)
T ss_pred             -----ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH-----HHHH-HHhcCCCCc-----
Confidence                 234568889999999998889999999999999999999999975332100     0000 000000000     


Q ss_pred             hhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          348 EEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       348 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                        .........+.+++.+||+.||++|||+.+++++
T Consensus       218 --~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         218 --RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             --CcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence              0011124678999999999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-37  Score=301.01  Aligned_cols=270  Identities=20%  Similarity=0.289  Sum_probs=197.8

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC-----e
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKD-----E  178 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~  178 (432)
                      .+++|++.+.||+|+||.||+|.+..  ..||+|.+... .......+.+|+.++++++|+||+++++++....     .
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   82 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND   82 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence            35789999999999999999998753  48999988543 2334566788999999999999999999876543     5


Q ss_pred             eEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccce
Q 014024          179 RLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMAR  258 (432)
Q Consensus       179 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  258 (432)
                      .++++||+.+ +|.+++.    ...+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++.
T Consensus        83 ~~lv~e~~~~-~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~  154 (336)
T cd07849          83 VYIVQELMET-DLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLAR  154 (336)
T ss_pred             EEEEehhccc-CHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECccccee
Confidence            7999999965 7777663    234899999999999999999999998   9999999999999999999999999998


Q ss_pred             eccCCCCccccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhh--
Q 014024          259 IVFGGNDEDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWI--  335 (432)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~--  335 (432)
                      ........   ........|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.......  ..........  
T Consensus       155 ~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~--~~~~~~~~~~~~  229 (336)
T cd07849         155 IADPEHDH---TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH--QLNLILGVLGTP  229 (336)
T ss_pred             eccccccc---cCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHcCCC
Confidence            64322111   112233568899999998754 568999999999999999999999985432110  0000000000  


Q ss_pred             -ccchhhhhhhhh----h----------hcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--hccccc
Q 014024          336 -SNKIIDLIDSVL----E----------EASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM--LTNEAS  389 (432)
Q Consensus       336 -~~~~~~~i~~~l----~----------~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~--L~~~~~  389 (432)
                       .+....+.+...    .          ....+....++.+++.+||+.+|++|||+.+++++  ++....
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~  300 (336)
T cd07849         230 SQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD  300 (336)
T ss_pred             CHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence             000110010000    0          00011224568899999999999999999999997  555443

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.3e-37  Score=289.35  Aligned_cols=249  Identities=21%  Similarity=0.320  Sum_probs=197.6

Q ss_pred             CCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEec
Q 014024          110 NFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEY  185 (432)
Q Consensus       110 ~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  185 (432)
                      +|++.+.||+|+||.||++....  ..+++|.+...  .....+.+.+|+++++.++|+|++++++.+.+.+..++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            57889999999999999999854  47899987543  223456788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCC-EEEeecccceeccCCC
Q 014024          186 MPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN-SKISDFGMARIVFGGN  264 (432)
Q Consensus       186 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~-~kl~Dfg~a~~~~~~~  264 (432)
                      +++++|.+++.... ...+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++. +||+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          81 CDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence            99999999986432 234899999999999999999999998   999999999999998864 6999999987642111


Q ss_pred             CccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhh
Q 014024          265 DEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLID  344 (432)
Q Consensus       265 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  344 (432)
                            .......|++.|+|||+..+..++.++|+||||+++++|++|..|+.....     .....         ....
T Consensus       157 ------~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~---------~~~~  216 (257)
T cd08225         157 ------ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL-----HQLVL---------KICQ  216 (257)
T ss_pred             ------ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HHHHH---------HHhc
Confidence                  112234588899999999888899999999999999999999999753211     11111         1111


Q ss_pred             hhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          345 SVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       345 ~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      ... ..........+.+++.+||+.+|++|||+.+++++
T Consensus       217 ~~~-~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         217 GYF-APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             ccC-CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            100 11122334678899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-37  Score=295.52  Aligned_cols=267  Identities=19%  Similarity=0.273  Sum_probs=195.3

Q ss_pred             CCCcCceeccCCcEEEEEEEECC----ceEEEEEEcCCC---hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeC--CeeE
Q 014024          110 NFSAANKLGEGGFGTVYKGVIGQ----GEIAVKRLLGKS---GQEIKELKNEASVIAQVQHKNLVKLLGCCIEK--DERL  180 (432)
Q Consensus       110 ~y~~~~~ig~G~~g~Vy~~~~~~----~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~  180 (432)
                      +|++.+.||+|++|.||+|....    ..+|+|.+....   ....+.+.+|+.+++.++|||++++++++.+.  +..+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            47888999999999999999854    489999987632   33446678899999999999999999999988  7899


Q ss_pred             EEEecCCCCChhhhhcCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcC----CCCEEEeec
Q 014024          181 LIYEYMPNKSLDCFLFDPT--KREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDK----DMNSKISDF  254 (432)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~Df  254 (432)
                      +||||+++ ++.+++....  ....+++..++.++.|++.||.|||+.+   ++||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 5655553221  2235899999999999999999999998   999999999999999    999999999


Q ss_pred             ccceeccCCCCccccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhh----
Q 014024          255 GMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGY----  329 (432)
Q Consensus       255 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~----  329 (432)
                      |++.........   ........++..|+|||.+.+ ..++.++||||||+++++|++|+.||............+    
T Consensus       157 g~~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~  233 (316)
T cd07842         157 GLARLFNAPLKP---LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQ  233 (316)
T ss_pred             ccccccCCCccc---ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHH
Confidence            999864222111   112234567889999998876 458999999999999999999999986543322000000    


Q ss_pred             ---hHHhhh------------ccchhhhhhhhhhhccc---------H--HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          330 ---AWDLWI------------SNKIIDLIDSVLEEASF---------N--ESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       330 ---~~~~~~------------~~~~~~~i~~~l~~~~~---------~--~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                         ......            ........+........         .  .....+.+++.+||+.||++|||+.|++++
T Consensus       234 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         234 LERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             HHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence               000000            00000000000000000         0  233568899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=7.9e-38  Score=291.17  Aligned_cols=247  Identities=23%  Similarity=0.282  Sum_probs=199.9

Q ss_pred             CCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCCC---hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEe
Q 014024          110 NFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGKS---GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYE  184 (432)
Q Consensus       110 ~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  184 (432)
                      +|++.+.||.|+||.||++.+.  +..+++|.+....   ....+.+.+|++++++++||||+++++.+.+++..++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            5888999999999999999986  3489999886432   2456788999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCC
Q 014024          185 YMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGN  264 (432)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  264 (432)
                      |+++++|.+++..   ...+++..+..++.|+++||.|||+.+   ++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  154 (258)
T cd05578          81 LLLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT  154 (258)
T ss_pred             CCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence            9999999999843   245899999999999999999999998   9999999999999999999999999987642211


Q ss_pred             CccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhh
Q 014024          265 DEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLID  344 (432)
Q Consensus       265 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  344 (432)
                             ......|+..|+|||.+.+..++.++|+||||+++|+|++|..|+.......   ......         ...
T Consensus       155 -------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~---------~~~  215 (258)
T cd05578         155 -------LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI---RDQIRA---------KQE  215 (258)
T ss_pred             -------cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH---HHHHHH---------Hhc
Confidence                   2233567889999999998889999999999999999999999986433210   000000         000


Q ss_pred             hhhhhcccHHHHHHHHHHHHHhhccCCCCCCCH--HHHHH
Q 014024          345 SVLEEASFNESLSRYVHIALLCVQERAEDRPTM--SDVVS  382 (432)
Q Consensus       345 ~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~--~evl~  382 (432)
                      . .....+...+..+.+++.+||+.||.+||++  +|+++
T Consensus       216 ~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~  254 (258)
T cd05578         216 T-ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN  254 (258)
T ss_pred             c-ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence            0 1112233445788899999999999999999  66654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-38  Score=314.10  Aligned_cols=249  Identities=28%  Similarity=0.418  Sum_probs=211.2

Q ss_pred             cCceeccCCcEEEEEEEEC-Cc-----eEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEec
Q 014024          113 AANKLGEGGFGTVYKGVIG-QG-----EIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEY  185 (432)
Q Consensus       113 ~~~~ig~G~~g~Vy~~~~~-~~-----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  185 (432)
                      ..++||+|+||+||+|.+- .+     +||+|++... ..+..+++..|+.+|.+++|||+++++++|.... ..||++|
T Consensus       700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~  778 (1177)
T KOG1025|consen  700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL  778 (1177)
T ss_pred             hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence            3588999999999999862 11     7999998655 4456788999999999999999999999998766 7889999


Q ss_pred             CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCC
Q 014024          186 MPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGND  265 (432)
Q Consensus       186 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  265 (432)
                      ++.|+|.+|++.+  +..+..+..+.|++|||+||.|||.+.   ++||||..+||||.....+|+.|||+++.+...+ 
T Consensus       779 mP~G~LlDyvr~h--r~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~-  852 (1177)
T KOG1025|consen  779 MPLGCLLDYVREH--RDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE-  852 (1177)
T ss_pred             cccchHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccc-
Confidence            9999999999864  445999999999999999999999998   9999999999999999999999999999863322 


Q ss_pred             ccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchhhhhh
Q 014024          266 EDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIIDLID  344 (432)
Q Consensus       266 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  344 (432)
                         .........-.+-|||=|.+....|+.++|||||||++||++| |..|+...               ..+++.++++
T Consensus       853 ---~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi---------------~~~eI~dlle  914 (1177)
T KOG1025|consen  853 ---KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGI---------------PAEEIPDLLE  914 (1177)
T ss_pred             ---ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCC---------------CHHHhhHHHh
Confidence               1223333344567999999999999999999999999999999 88886432               2345667777


Q ss_pred             hhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014024          345 SVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN  386 (432)
Q Consensus       345 ~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~  386 (432)
                      ...+-..++.+..++..++.+||..|++.||+++++...+.+
T Consensus       915 ~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~  956 (1177)
T KOG1025|consen  915 KGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR  956 (1177)
T ss_pred             ccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence            666777888999999999999999999999999999987754

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=6.7e-37  Score=290.77  Aligned_cols=262  Identities=19%  Similarity=0.229  Sum_probs=184.7

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECCc-----eEEEEEEcCCChHh-H----------HHHHHHHHHHHhcCCCceeeeEe
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQG-----EIAVKRLLGKSGQE-I----------KELKNEASVIAQVQHKNLVKLLG  171 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~~-----~vavK~~~~~~~~~-~----------~~~~~E~~~l~~l~h~niv~~~~  171 (432)
                      .++|++.++||+|+||.||+|...+.     .+++|......... .          .....+...+..++|+|++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            46899999999999999999997543     45666432222111 0          11122334455678999999999


Q ss_pred             EEEeCC----eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCC
Q 014024          172 CCIEKD----ERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDM  247 (432)
Q Consensus       172 ~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~  247 (432)
                      ++....    ..++++|++.. ++.+.+..   ....++..+..++.|++.||+|||+.+   |+||||||+|||++.++
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~  163 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN  163 (294)
T ss_pred             eeeEecCCceEEEEEEehhcc-CHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence            876543    34678887743 55555522   223678888999999999999999998   99999999999999999


Q ss_pred             CEEEeecccceeccCCCCccc-cccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccch
Q 014024          248 NSKISDFGMARIVFGGNDEDE-LQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNL  326 (432)
Q Consensus       248 ~~kl~Dfg~a~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~  326 (432)
                      .++|+|||+++.+........ .........||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..
T Consensus       164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~-~~  242 (294)
T PHA02882        164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG-NL  242 (294)
T ss_pred             cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch-HH
Confidence            999999999987533221111 1112233569999999999999999999999999999999999999986442211 11


Q ss_pred             hhhhHHhhhccchhhhhhhhhhhc-ccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014024          327 IGYAWDLWISNKIIDLIDSVLEEA-SFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLT  385 (432)
Q Consensus       327 ~~~~~~~~~~~~~~~~i~~~l~~~-~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~  385 (432)
                      ....        ..+++....... ....++..+.+++..|++.+|++||++.++.+.|+
T Consensus       243 ~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        243 IHAA--------KCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HHHh--------HHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            1000        011111111110 12234577899999999999999999999998764

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-37  Score=286.72  Aligned_cols=251  Identities=25%  Similarity=0.347  Sum_probs=196.6

Q ss_pred             CCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC-----ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeC--Cee
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK-----SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEK--DER  179 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~  179 (432)
                      .+|++.+.||+|+||.||+|.+..  ..+++|.+...     .......+.+|++++++++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            478999999999999999999754  38999987422     234556788999999999999999999998764  457


Q ss_pred             EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeeccccee
Q 014024          180 LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARI  259 (432)
Q Consensus       180 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  259 (432)
                      ++++||+++++|.+++..   ...+++.....++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++..
T Consensus        82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence            899999999999999853   234889999999999999999999998   99999999999999999999999999976


Q ss_pred             ccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccch
Q 014024          260 VFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKI  339 (432)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  339 (432)
                      .......   ........++..|+|||++.+..++.++|+|||||++|+|++|+.||......              ...
T Consensus       156 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------------~~~  218 (264)
T cd06653         156 IQTICMS---GTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM--------------AAI  218 (264)
T ss_pred             ccccccc---CccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH--------------HHH
Confidence            4211100   11122346888999999999888999999999999999999999998532110              000


Q ss_pred             hhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          340 IDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       340 ~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      ............+......+.+++.+||+ +|..||++.+++.+
T Consensus       219 ~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~  261 (264)
T cd06653         219 FKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH  261 (264)
T ss_pred             HHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence            11111111122233455678899999999 57999999998875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=6.5e-37  Score=294.04  Aligned_cols=249  Identities=28%  Similarity=0.417  Sum_probs=195.3

Q ss_pred             CCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC---ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEe
Q 014024          110 NFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK---SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYE  184 (432)
Q Consensus       110 ~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  184 (432)
                      .|...+.||+|+||.||++.+..  ..+++|++...   .......+.+|+++++.++|+|++++++++.+.+..++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            37788999999999999999753  47999988533   23445678899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCC
Q 014024          185 YMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGN  264 (432)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  264 (432)
                      |+.+ +|.+.+...  ...+++..+..++.|++.|+.|||+.+   ++||||+|+||++++++.++|+|||++....   
T Consensus       106 ~~~g-~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~---  176 (317)
T cd06635         106 YCLG-SASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIAS---  176 (317)
T ss_pred             CCCC-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccC---
Confidence            9975 666666432  344899999999999999999999998   9999999999999999999999999986531   


Q ss_pred             CccccccccccccccCCccChhhhc---cCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhh
Q 014024          265 DEDELQGNTSRISGTYGYMSPEYAL---EGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIID  341 (432)
Q Consensus       265 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (432)
                             ......++..|+|||++.   .+.++.++|||||||++|+|++|+.|+.......              ....
T Consensus       177 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--------------~~~~  235 (317)
T cd06635         177 -------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------------ALYH  235 (317)
T ss_pred             -------CcccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH--------------HHHH
Confidence                   122346788999999874   4668999999999999999999999974321100              0000


Q ss_pred             hhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014024          342 LIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEA  388 (432)
Q Consensus       342 ~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~  388 (432)
                      .................+.+++.+||+.+|.+||++.++++++....
T Consensus       236 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  282 (317)
T cd06635         236 IAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR  282 (317)
T ss_pred             HHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence            11110011111234456889999999999999999999999776543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=4.8e-37  Score=285.04  Aligned_cols=250  Identities=22%  Similarity=0.321  Sum_probs=202.8

Q ss_pred             CCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCCC--hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEec
Q 014024          110 NFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGKS--GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEY  185 (432)
Q Consensus       110 ~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  185 (432)
                      +|.+.+.||.|++|.||++.+.  +..+++|++....  ....+.+.+|+++++.++|+|++++.+.+...+..++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            5888899999999999999986  4489999886543  35667789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCC
Q 014024          186 MPNKSLDCFLFDPT-KREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGN  264 (432)
Q Consensus       186 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  264 (432)
                      +++++|.+++.... ....+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999999986532 1356999999999999999999999998   9999999999999999999999999998642211


Q ss_pred             CccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhh
Q 014024          265 DEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLID  344 (432)
Q Consensus       265 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  344 (432)
                            .......|++.|+|||...+..++.++|+||+|+++++|++|+.|+.......     ....          ..
T Consensus       158 ------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-----~~~~----------~~  216 (258)
T cd08215         158 ------DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE-----LALK----------IL  216 (258)
T ss_pred             ------ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH-----HHHH----------Hh
Confidence                  12233568889999999998889999999999999999999999975332110     0000          00


Q ss_pred             hhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          345 SVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       345 ~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      .......+......+.+++.+||..+|++|||+.+++++
T Consensus       217 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         217 KGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            000111122345678899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=4e-37  Score=292.00  Aligned_cols=264  Identities=20%  Similarity=0.248  Sum_probs=195.6

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCC--hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeC--CeeEE
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS--GQEIKELKNEASVIAQVQHKNLVKLLGCCIEK--DERLL  181 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l  181 (432)
                      .++|++.+.||.|+||.||+|.+..  ..+++|.+....  ......+.+|+.++++++||||+++++++...  +..++
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l   83 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM   83 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence            3579999999999999999999864  378999885432  22234567899999999999999999999877  88999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceecc
Q 014024          182 IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVF  261 (432)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  261 (432)
                      ||||+++ +|.+++....  ..+++..++.++.|++.||+|||+.+   ++|+||||+||++++++.++|+|||++....
T Consensus        84 v~e~~~~-~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~  157 (293)
T cd07843          84 VMEYVEH-DLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYG  157 (293)
T ss_pred             EehhcCc-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence            9999974 8888875432  25899999999999999999999998   9999999999999999999999999998652


Q ss_pred             CCCCccccccccccccccCCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCCcccccc--chhh-------hhH
Q 014024          262 GGNDEDELQGNTSRISGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSL--NLIG-------YAW  331 (432)
Q Consensus       262 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~--~~~~-------~~~  331 (432)
                      ...      .......+++.|+|||.+.+. .++.++|+||||+++|+|++|..||........  ....       ..|
T Consensus       158 ~~~------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~  231 (293)
T cd07843         158 SPL------KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIW  231 (293)
T ss_pred             CCc------cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHH
Confidence            211      122334578899999988754 468999999999999999999999864322110  0000       000


Q ss_pred             Hhh------hccchhhhhhhhhhhcccHH-HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          332 DLW------ISNKIIDLIDSVLEEASFNE-SLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       332 ~~~------~~~~~~~~i~~~l~~~~~~~-~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      ..+      ............+....+.. ....+.+++..||+.+|++|||+.|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         232 PGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             HHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence            000      00000000001111111111 35667899999999999999999999874

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=8.5e-37  Score=283.30  Aligned_cols=251  Identities=24%  Similarity=0.373  Sum_probs=202.9

Q ss_pred             CCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCCC--hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeC--CeeEEEE
Q 014024          110 NFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGKS--GQEIKELKNEASVIAQVQHKNLVKLLGCCIEK--DERLLIY  183 (432)
Q Consensus       110 ~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~  183 (432)
                      +|...+.||+|++|.||+|.+.  +..+++|.+....  ....+.+.+|+..+++++|+|++++++.+.+.  ...++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4778899999999999999986  4489999886554  35567889999999999999999999999988  8899999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCC
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGG  263 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  263 (432)
                      ||+++++|.+++....   .+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||.+......
T Consensus        81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  154 (260)
T cd06606          81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI  154 (260)
T ss_pred             EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence            9999999999985432   6999999999999999999999998   999999999999999999999999999875322


Q ss_pred             CCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhh
Q 014024          264 NDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLI  343 (432)
Q Consensus       264 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i  343 (432)
                      ...    .......++..|+|||...+...+.++||||||+++++|++|..||.....    .....+...         
T Consensus       155 ~~~----~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~---------  217 (260)
T cd06606         155 ETG----EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN----PMAALYKIG---------  217 (260)
T ss_pred             ccc----ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc----hHHHHHhcc---------
Confidence            110    112345678899999999988899999999999999999999999864431    111111100         


Q ss_pred             hhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          344 DSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       344 ~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      ........+...+..+.+++.+|++.+|++||++.+++++
T Consensus       218 ~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         218 SSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             ccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence            0001111222335788999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.1e-37  Score=314.35  Aligned_cols=268  Identities=22%  Similarity=0.281  Sum_probs=187.4

Q ss_pred             hhhCCCCcCceeccCCcEEEEEEEECCc---eEEE------------------EEEcCCChHhHHHHHHHHHHHHhcCCC
Q 014024          106 SATGNFSAANKLGEGGFGTVYKGVIGQG---EIAV------------------KRLLGKSGQEIKELKNEASVIAQVQHK  164 (432)
Q Consensus       106 ~~~~~y~~~~~ig~G~~g~Vy~~~~~~~---~vav------------------K~~~~~~~~~~~~~~~E~~~l~~l~h~  164 (432)
                      ...++|++.+.||+|+||.||++.....   ..+.                  |.+ .........+.+|+.+|++++|+
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~-~~~~~~~~~~~~Ei~il~~l~Hp  223 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRV-KAGSRAAIQLENEILALGRLNHE  223 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHh-hcchHHHHHHHHHHHHHHhCCCC
Confidence            3457899999999999999999875322   1111                  111 11223456688999999999999


Q ss_pred             ceeeeEeEEEeCCeeEEEEecCCCCChhhhhcCCCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEE
Q 014024          165 NLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTK--REILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNIL  242 (432)
Q Consensus       165 niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIl  242 (432)
                      ||+++++++.+.+..|+++|++. ++|.+++.....  ...........++.|++.||+|||+.+   |+||||||+|||
T Consensus       224 nIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NIL  299 (501)
T PHA03210        224 NILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIF  299 (501)
T ss_pred             CcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEE
Confidence            99999999999999999999995 466666643211  222445677889999999999999998   999999999999


Q ss_pred             EcCCCCEEEeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCC-CCCccc
Q 014024          243 LDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKN-TGFYRT  321 (432)
Q Consensus       243 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p-~~~~~~  321 (432)
                      ++.++.+||+|||++..+....     ........||..|+|||++.+..++.++|||||||++|||++|..+ +.....
T Consensus       300 l~~~~~vkL~DFGla~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~  374 (501)
T PHA03210        300 LNCDGKIVLGDFGTAMPFEKER-----EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGG  374 (501)
T ss_pred             ECCCCCEEEEeCCCceecCccc-----ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCC
Confidence            9999999999999998652211     1122345789999999999999999999999999999999998754 332211


Q ss_pred             cc-cchhhhhHHh------hh--ccchhhhhhhhhhhc---c------cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          322 KS-LNLIGYAWDL------WI--SNKIIDLIDSVLEEA---S------FNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       322 ~~-~~~~~~~~~~------~~--~~~~~~~i~~~l~~~---~------~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      .. ..+.......      +.  .....+.++......   .      ....+.++.+++.+||+.||.+|||+.|++++
T Consensus       375 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        375 KPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             CHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            10 1111100000      00  000111111100000   0      00123456778999999999999999999975

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=5.3e-37  Score=291.35  Aligned_cols=263  Identities=20%  Similarity=0.235  Sum_probs=192.6

Q ss_pred             CCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCC--hHhHHHHHHHHHHHHhcC-CCceeeeEeEEEeCCe-----
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS--GQEIKELKNEASVIAQVQ-HKNLVKLLGCCIEKDE-----  178 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~-----  178 (432)
                      ++|++.+.||+|+||.||+|.+..  ..|++|......  ......+.+|+.+++.++ |+|++++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            478999999999999999999854  389999875432  223456788999999995 6999999999987665     


Q ss_pred             eEEEEecCCCCChhhhhcCCCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcC-CCCEEEeecc
Q 014024          179 RLLIYEYMPNKSLDCFLFDPTK--REILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDK-DMNSKISDFG  255 (432)
Q Consensus       179 ~~lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg  255 (432)
                      .++||||+++ +|.+++.....  ...+++..++.++.|++.||.|||+.+   ++||||+|+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence            7999999986 78887754322  345899999999999999999999998   999999999999998 8999999999


Q ss_pred             cceeccCCCCccccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhh
Q 014024          256 MARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLW  334 (432)
Q Consensus       256 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  334 (432)
                      ++..+...      ........+++.|+|||++.+ ..++.++|+||||+++|+|++|..||........ ..... ...
T Consensus       157 ~~~~~~~~------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~-~~~~~-~~~  228 (295)
T cd07837         157 LGRAFSIP------VKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ-LLHIF-KLL  228 (295)
T ss_pred             cceecCCC------ccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHH-HHh
Confidence            98764211      111223356888999998865 4579999999999999999999999854322110 00000 000


Q ss_pred             hcc------chhhhhh--------hhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          335 ISN------KIIDLID--------SVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       335 ~~~------~~~~~i~--------~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      ...      ......+        +.............+.+++..||+.||.+||++.|++.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         229 GTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             CCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            000      0000000        000000112245668899999999999999999999865

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=6.6e-37  Score=290.53  Aligned_cols=242  Identities=23%  Similarity=0.321  Sum_probs=194.8

Q ss_pred             CceeccCCcEEEEEEEECC--ceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecCCCCCh
Q 014024          114 ANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSL  191 (432)
Q Consensus       114 ~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  191 (432)
                      ..+||+|+||.||++....  ..+++|++..........+.+|+.+++.++|+|++++++++...+..+++|||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            4679999999999998743  48999988665555667789999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCcccccc
Q 014024          192 DCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQG  271 (432)
Q Consensus       192 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  271 (432)
                      .+++..    ..+++.....++.|++.|++|||+.+   ++|+||+|+||+++.++.++|+|||++.......      .
T Consensus       105 ~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~------~  171 (292)
T cd06657         105 TDIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV------P  171 (292)
T ss_pred             HHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc------c
Confidence            998732    34899999999999999999999998   9999999999999999999999999987542211      1


Q ss_pred             ccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhhhhhc-
Q 014024          272 NTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEA-  350 (432)
Q Consensus       272 ~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~-  350 (432)
                      ......+++.|+|||.+.+..++.++|+||+|+++|+|++|..||......  ...             ..+...+... 
T Consensus       172 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~--~~~-------------~~~~~~~~~~~  236 (292)
T cd06657         172 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAM-------------KMIRDNLPPKL  236 (292)
T ss_pred             cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHH-------------HHHHhhCCccc
Confidence            123346788999999998888999999999999999999999997532110  000             0000000000 


Q ss_pred             -ccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          351 -SFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       351 -~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                       .....+..+.+++.+||+.+|.+||++.+++++
T Consensus       237 ~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         237 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             CCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence             111234567889999999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-39  Score=332.19  Aligned_cols=258  Identities=27%  Similarity=0.359  Sum_probs=204.1

Q ss_pred             hhhCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCCC--hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEE
Q 014024          106 SATGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKS--GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLL  181 (432)
Q Consensus       106 ~~~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  181 (432)
                      .-+-+++....||.|.||.||-|.+.++  -.|+|.+....  ......+.+|+.++..++|||+|+++|+-.+.+..+|
T Consensus      1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred             cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence            3456788889999999999999998655  56888764332  3345568899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceecc
Q 014024          182 IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVF  261 (432)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  261 (432)
                      .||||++|+|.+.+..   .+..++.....+..|++.|++|||++|   ||||||||.||+++.+|.+|++|||.|..+.
T Consensus      1312 FMEyC~~GsLa~ll~~---gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEH---GRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred             HHHHhccCcHHHHHHh---cchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEec
Confidence            9999999999999843   333667777788899999999999999   9999999999999999999999999999864


Q ss_pred             CCCCccccccccccccccCCccChhhhccC---CCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccc
Q 014024          262 GGNDEDELQGNTSRISGTYGYMSPEYALEG---IFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNK  338 (432)
Q Consensus       262 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  338 (432)
                      ..  ....++......||+.|||||++.+.   ....++||||+|||++||+||++||..++.+      |.        
T Consensus      1386 ~~--~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne------~a-------- 1449 (1509)
T KOG4645|consen 1386 NN--AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE------WA-------- 1449 (1509)
T ss_pred             Cc--hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch------hH--------
Confidence            33  22234455678999999999999853   3567999999999999999999998654431      10        


Q ss_pred             hhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014024          339 IIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLT  385 (432)
Q Consensus       339 ~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~  385 (432)
                      +.--+...-....+.....+=.+++..||+.||.+|.++.|++++=-
T Consensus      1450 IMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f 1496 (1509)
T KOG4645|consen 1450 IMYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAF 1496 (1509)
T ss_pred             HHhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhc
Confidence            00111111112223334556678999999999999999999888643

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.7e-36  Score=283.96  Aligned_cols=248  Identities=22%  Similarity=0.254  Sum_probs=190.3

Q ss_pred             hHhhhhCCCCcCcee--ccCCcEEEEEEEECCc--eEEEEEEcCCChHhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCC
Q 014024          103 SVSSATGNFSAANKL--GEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEIKELKNEASVIAQV-QHKNLVKLLGCCIEKD  177 (432)
Q Consensus       103 ~~~~~~~~y~~~~~i--g~G~~g~Vy~~~~~~~--~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  177 (432)
                      +.....++|.+.+.+  |+|+||.||++.....  .+++|.........     .|+.....+ +|+|++++++.+...+
T Consensus         8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~   82 (267)
T PHA03390          8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLK   82 (267)
T ss_pred             HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCC
Confidence            344456788887877  9999999999997543  78888875432111     122222222 7999999999999999


Q ss_pred             eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCC-CEEEeeccc
Q 014024          178 ERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDM-NSKISDFGM  256 (432)
Q Consensus       178 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~  256 (432)
                      ..++||||+++++|.+++...   ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++ .++|+|||+
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~  156 (267)
T PHA03390         83 GHVLIMDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGL  156 (267)
T ss_pred             eeEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCcc
Confidence            999999999999999998532   36999999999999999999999998   99999999999999998 999999999


Q ss_pred             ceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhc
Q 014024          257 ARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWIS  336 (432)
Q Consensus       257 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  336 (432)
                      +....          ......++..|+|||++.+..++.++|+||||+++|+|++|+.||............+...    
T Consensus       157 ~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~----  222 (267)
T PHA03390        157 CKIIG----------TPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKR----  222 (267)
T ss_pred             ceecC----------CCccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHh----
Confidence            87641          1123457889999999999899999999999999999999999986332222111111100    


Q ss_pred             cchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCC-HHHHHHH
Q 014024          337 NKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPT-MSDVVSM  383 (432)
Q Consensus       337 ~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt-~~evl~~  383 (432)
                            ...  ...........+.+++..||+.+|.+||+ +++++++
T Consensus       223 ------~~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h  262 (267)
T PHA03390        223 ------QQK--KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH  262 (267)
T ss_pred             ------hcc--cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence                  000  01112235567889999999999999996 6988854

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=7.8e-37  Score=285.13  Aligned_cols=242  Identities=26%  Similarity=0.359  Sum_probs=194.1

Q ss_pred             eccCCcEEEEEEEEC--CceEEEEEEcCCC---hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecCCCCCh
Q 014024          117 LGEGGFGTVYKGVIG--QGEIAVKRLLGKS---GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSL  191 (432)
Q Consensus       117 ig~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  191 (432)
                      ||.|++|.||++.+.  +..+++|.+....   ....+.+.+|+.+++.++|+||+++++.+.++...++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            699999999999987  4589999885432   23456789999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCcccccc
Q 014024          192 DCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQG  271 (432)
Q Consensus       192 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  271 (432)
                      .+++..   ...+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++.......       
T Consensus        81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-------  147 (262)
T cd05572          81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-------  147 (262)
T ss_pred             HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-------
Confidence            999953   334899999999999999999999998   9999999999999999999999999998652211       


Q ss_pred             ccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhhhhhcc
Q 014024          272 NTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEAS  351 (432)
Q Consensus       272 ~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~  351 (432)
                      ......++..|+|||.+.+..++.++|+||||+++|+|++|..|+...........            ....+.......
T Consensus       148 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~------------~~~~~~~~~~~~  215 (262)
T cd05572         148 KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIY------------NDILKGNGKLEF  215 (262)
T ss_pred             ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHH------------HHHhccCCCCCC
Confidence            12234678899999999888899999999999999999999999854331110000            011100111122


Q ss_pred             cHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 014024          352 FNESLSRYVHIALLCVQERAEDRPT-----MSDVVSM  383 (432)
Q Consensus       352 ~~~~~~~l~~l~~~cl~~dp~~RPt-----~~evl~~  383 (432)
                      +.....++.+++.+||+.+|++||+     +.|++++
T Consensus       216 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~  252 (262)
T cd05572         216 PNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH  252 (262)
T ss_pred             CcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence            3333578899999999999999999     7777763

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=8.9e-37  Score=294.51  Aligned_cols=266  Identities=21%  Similarity=0.257  Sum_probs=193.2

Q ss_pred             ceeccC--CcEEEEEEEEC--CceEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecCCC
Q 014024          115 NKLGEG--GFGTVYKGVIG--QGEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPN  188 (432)
Q Consensus       115 ~~ig~G--~~g~Vy~~~~~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  188 (432)
                      ..||+|  +||+||++.+.  +..||+|.+...  .....+.+.+|+.+++.++|+||+++++++..++..++|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            456666  99999999984  458999988543  344557889999999999999999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCccc
Q 014024          189 KSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDE  268 (432)
Q Consensus       189 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  268 (432)
                      +++.+++..... ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.++++||+.+...........
T Consensus        84 ~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~  159 (328)
T cd08226          84 GSANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK  159 (328)
T ss_pred             CCHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence            999998865332 34899999999999999999999998   99999999999999999999999986543321111100


Q ss_pred             -cccccccccccCCccChhhhccC--CCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhH--------------
Q 014024          269 -LQGNTSRISGTYGYMSPEYALEG--IFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAW--------------  331 (432)
Q Consensus       269 -~~~~~~~~~gt~~y~aPE~~~~~--~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~--------------  331 (432)
                       .........++..|+|||++.+.  .++.++|||||||++|+|++|+.||...............              
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (328)
T cd08226         160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE  239 (328)
T ss_pred             ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence             01111122356679999998763  4789999999999999999999998643321100000000              


Q ss_pred             -Hhhh----------------ccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          332 -DLWI----------------SNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       332 -~~~~----------------~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                       ....                ........+..+...........+.+++.+||+.||++|||+.|++++-
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~  309 (328)
T cd08226         240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHA  309 (328)
T ss_pred             hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCH
Confidence             0000                0000011111112222334567889999999999999999999998743

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.2e-37  Score=301.92  Aligned_cols=244  Identities=23%  Similarity=0.356  Sum_probs=191.6

Q ss_pred             CcCceeccCCcEEEEEEEECCceEEE-----EEE-cCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCe--eEEEE
Q 014024          112 SAANKLGEGGFGTVYKGVIGQGEIAV-----KRL-LGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDE--RLLIY  183 (432)
Q Consensus       112 ~~~~~ig~G~~g~Vy~~~~~~~~vav-----K~~-~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--~~lv~  183 (432)
                      ....+||+|+|-+||+|.+....+.|     |.- ........+.|..|+.+|+.|+|+||+++|+++.+..+  ..+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            44578999999999999997664322     211 22345567899999999999999999999999987765  67899


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcC-CCCEEEeecccceeccC
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDK-DMNSKISDFGMARIVFG  262 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~~  262 (432)
                      |.+..|+|..|+..   .+..+......|++||++||.|||++. +||+|||||-+||+|+. .|.+||+|+|+|..+. 
T Consensus       123 EL~TSGtLr~Y~kk---~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r-  197 (632)
T KOG0584|consen  123 ELFTSGTLREYRKK---HRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR-  197 (632)
T ss_pred             ecccCCcHHHHHHH---hccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhh-
Confidence            99999999999954   344889999999999999999999986 67999999999999975 5899999999999862 


Q ss_pred             CCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhh
Q 014024          263 GNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDL  342 (432)
Q Consensus       263 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                             ........|||.|||||++. ..|++.+||||||+.++||+|+..|+..-.    +.++.. ....++....-
T Consensus       198 -------~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~----n~AQIY-KKV~SGiKP~s  264 (632)
T KOG0584|consen  198 -------KSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT----NPAQIY-KKVTSGIKPAA  264 (632)
T ss_pred             -------ccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC----CHHHHH-HHHHcCCCHHH
Confidence                   22334578999999999887 889999999999999999999999974221    222211 11111111111


Q ss_pred             hhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014024          343 IDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVS  382 (432)
Q Consensus       343 i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~  382 (432)
                      +..        -...++.++|..|+.. ...|||+.|+|.
T Consensus       265 l~k--------V~dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  265 LSK--------VKDPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             hhc--------cCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence            111        1125678999999999 999999999997

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-36  Score=281.61  Aligned_cols=247  Identities=26%  Similarity=0.384  Sum_probs=200.4

Q ss_pred             CCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCCh--HhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEec
Q 014024          110 NFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSG--QEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEY  185 (432)
Q Consensus       110 ~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  185 (432)
                      +|++.+.||+|++|.||++.+..  ..+++|.+.....  ...+.+.+|++++++++|+|++++++++.+.+..+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            57889999999999999998754  3899999866543  5667899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCC
Q 014024          186 MPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGND  265 (432)
Q Consensus       186 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  265 (432)
                      +++++|.+++...   ..+++..+..++.|++.|+.+||+.+   ++||||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (254)
T cd06627          81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK  154 (254)
T ss_pred             CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence            9999999998543   45899999999999999999999998   99999999999999999999999999987532211


Q ss_pred             ccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhh
Q 014024          266 EDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDS  345 (432)
Q Consensus       266 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  345 (432)
                            ......++..|+|||...+..++.++|+||+|+++|+|++|..|+......     ...+... ..        
T Consensus       155 ------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~-----~~~~~~~-~~--------  214 (254)
T cd06627         155 ------DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM-----AALFRIV-QD--------  214 (254)
T ss_pred             ------cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH-----HHHHHHh-cc--------
Confidence                  123346788999999998888899999999999999999999997532210     0000000 00        


Q ss_pred             hhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          346 VLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       346 ~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                       .....+......+.+++.+||+.+|++|||+.+++.+
T Consensus       215 -~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  251 (254)
T cd06627         215 -DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH  251 (254)
T ss_pred             -CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence             0011122334678899999999999999999999853

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.1e-36  Score=287.13  Aligned_cols=242  Identities=23%  Similarity=0.254  Sum_probs=184.9

Q ss_pred             eeccCCcEEEEEEEECC--ceEEEEEEcCCC---hHhHHHHHHHHHHHH---hcCCCceeeeEeEEEeCCeeEEEEecCC
Q 014024          116 KLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS---GQEIKELKNEASVIA---QVQHKNLVKLLGCCIEKDERLLIYEYMP  187 (432)
Q Consensus       116 ~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~---~~~~~~~~~E~~~l~---~l~h~niv~~~~~~~~~~~~~lv~e~~~  187 (432)
                      .||+|+||.||++.+..  ..+|+|.+....   ......+.+|..+++   ..+|+|++.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            48999999999999854  479999875432   112223344444333   3479999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCcc
Q 014024          188 NKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDED  267 (432)
Q Consensus       188 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  267 (432)
                      +++|.+++..   ++.+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.++|+|||++......    
T Consensus        81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~----  150 (279)
T cd05633          81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK----  150 (279)
T ss_pred             CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceecccc----
Confidence            9999998843   345999999999999999999999999   999999999999999999999999998753211    


Q ss_pred             ccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhh
Q 014024          268 ELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSV  346 (432)
Q Consensus       268 ~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  346 (432)
                          ......|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||..........   ....          ...
T Consensus       151 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~---~~~~----------~~~  213 (279)
T cd05633         151 ----KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE---IDRM----------TLT  213 (279)
T ss_pred             ----CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH---HHHH----------hhc
Confidence                1223468999999998864 568999999999999999999999986433211100   0000          000


Q ss_pred             hhhcccHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHHh
Q 014024          347 LEEASFNESLSRYVHIALLCVQERAEDRP-----TMSDVVSML  384 (432)
Q Consensus       347 l~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~~L  384 (432)
                      .....+...+.++.+++..||+.||.+||     ++++++++.
T Consensus       214 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~  256 (279)
T cd05633         214 VNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHV  256 (279)
T ss_pred             CCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCc
Confidence            11112233456788999999999999999     699998863

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=7e-37  Score=284.02  Aligned_cols=248  Identities=25%  Similarity=0.322  Sum_probs=200.9

Q ss_pred             CCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEec
Q 014024          110 NFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEY  185 (432)
Q Consensus       110 ~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  185 (432)
                      +|++.+.||+|++|.||++....  ..+++|.+...  .......+.+|+++++.++|+||+++.+++.+....++||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            58889999999999999998753  37899988543  334456778899999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCC
Q 014024          186 MPNKSLDCFLFDPT-KREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGN  264 (432)
Q Consensus       186 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  264 (432)
                      +++++|.+++.... ....+++..++.++.|++.||+|||+.+   ++|+||+|+||++++++.+||+|||++...... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            99999999885421 2345899999999999999999999998   999999999999999999999999999875221 


Q ss_pred             CccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhh
Q 014024          265 DEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLID  344 (432)
Q Consensus       265 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  344 (432)
                             ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||.......               ....+.
T Consensus       157 -------~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---------------~~~~~~  214 (256)
T cd08530         157 -------MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD---------------LRYKVQ  214 (256)
T ss_pred             -------CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---------------HHHHHh
Confidence                   1223457889999999999899999999999999999999999985432211               000011


Q ss_pred             hhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          345 SVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       345 ~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      .......+.....++.+++.+||+.+|++||++.+++++
T Consensus       215 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         215 RGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             cCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            111111223455778999999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=8.7e-37  Score=297.58  Aligned_cols=260  Identities=23%  Similarity=0.248  Sum_probs=195.0

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeC------
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEK------  176 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------  176 (432)
                      ..++|++.+.||+|+||.||+|.+..  ..+|+|.+...  .......+.+|+.++++++|+|++++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            45789999999999999999999753  48999987532  334456677899999999999999999988643      


Q ss_pred             CeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeeccc
Q 014024          177 DERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGM  256 (432)
Q Consensus       177 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  256 (432)
                      ...++||||+.+ +|.+.+..   .  ++...+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+
T Consensus        94 ~~~~lv~e~~~~-~l~~~~~~---~--l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~  164 (353)
T cd07850          94 QDVYLVMELMDA-NLCQVIQM---D--LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  164 (353)
T ss_pred             CcEEEEEeccCC-CHHHHHhh---c--CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence            356999999964 77777632   1  888999999999999999999998   99999999999999999999999999


Q ss_pred             ceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhh--
Q 014024          257 ARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLW--  334 (432)
Q Consensus       257 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~--  334 (432)
                      +......       .......++..|+|||.+.+..++.++|||||||++|+|++|+.||...+...  .........  
T Consensus       165 ~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~  235 (353)
T cd07850         165 ARTAGTS-------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHID--QWNKIIEQLGT  235 (353)
T ss_pred             ceeCCCC-------CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHhcCC
Confidence            9864211       11223467889999999999999999999999999999999999986433210  000000000  


Q ss_pred             --------hccch---------------hhhhhhhhhh----cccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          335 --------ISNKI---------------IDLIDSVLEE----ASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       335 --------~~~~~---------------~~~i~~~l~~----~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                              .....               .+........    .........+.+++.+||+.||++|||+.|++++-
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~  312 (353)
T cd07850         236 PSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHP  312 (353)
T ss_pred             CCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcCh
Confidence                    00000               0000000000    00112355678999999999999999999999763

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-37  Score=289.42  Aligned_cols=261  Identities=21%  Similarity=0.278  Sum_probs=193.5

Q ss_pred             CCcCceeccCCcEEEEEEEEC--CceEEEEEEcCCC--hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecC
Q 014024          111 FSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGKS--GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYM  186 (432)
Q Consensus       111 y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  186 (432)
                      |++.+.||.|++|.||+|.+.  +..+++|++....  ......+.+|++.++.++|+|++++++++.+.+..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            677899999999999999874  4489999885443  223356788999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCc
Q 014024          187 PNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDE  266 (432)
Q Consensus       187 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  266 (432)
                      + ++|.+++..... ..+++..+..++.|++.||+|||+.+   ++||||+|+||++++++.++|+|||++......   
T Consensus        81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~---  152 (283)
T cd07835          81 D-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVP---  152 (283)
T ss_pred             C-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCC---
Confidence            5 689888854322 35899999999999999999999998   999999999999999999999999999754211   


Q ss_pred             cccccccccccccCCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhc--------c
Q 014024          267 DELQGNTSRISGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWIS--------N  337 (432)
Q Consensus       267 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------~  337 (432)
                         ........++..|+|||++.+. .++.++|+||||+++|+|++|+.||....... ............        .
T Consensus       153 ---~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  228 (283)
T cd07835         153 ---VRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID-QLFRIFRTLGTPDEDVWPGVT  228 (283)
T ss_pred             ---ccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChHHhhhhh
Confidence               1112223568889999987654 57899999999999999999999985432211 000000000000        0


Q ss_pred             chhhhhhhhh------hhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          338 KIIDLIDSVL------EEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       338 ~~~~~i~~~l------~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      ...+......      ...........+.+++.+||+.+|++|||+.|++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         229 SLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             hchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            0000000000      000111233578899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.4e-36  Score=291.27  Aligned_cols=268  Identities=20%  Similarity=0.224  Sum_probs=197.2

Q ss_pred             CcCceeccCCcEEEEEEEECCceEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecCCCC
Q 014024          112 SAANKLGEGGFGTVYKGVIGQGEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNK  189 (432)
Q Consensus       112 ~~~~~ig~G~~g~Vy~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  189 (432)
                      .+.+.+|.|+++.||++...+..+|+|++...  .....+.+.+|+++++.++|+||+++++++.+.+..+++|||++++
T Consensus         5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~   84 (314)
T cd08216           5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG   84 (314)
T ss_pred             hhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence            44556677777777777777779999998654  4556678999999999999999999999999999999999999999


Q ss_pred             ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCc-cc
Q 014024          190 SLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDE-DE  268 (432)
Q Consensus       190 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~  268 (432)
                      +|.+++..... ..+++.....++.|++.||+|||+.+   |+||||||+||++++++.+||+|||.+..+...... ..
T Consensus        85 ~l~~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~  160 (314)
T cd08216          85 SCEDLLKTHFP-EGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV  160 (314)
T ss_pred             CHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence            99999865322 34889999999999999999999998   999999999999999999999999998765332211 01


Q ss_pred             cccccccccccCCccChhhhcc--CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHh-----------hh
Q 014024          269 LQGNTSRISGTYGYMSPEYALE--GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDL-----------WI  335 (432)
Q Consensus       269 ~~~~~~~~~gt~~y~aPE~~~~--~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~-----------~~  335 (432)
                      .........++..|+|||++..  ..++.++|+|||||++|||++|+.||........ ........           ..
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  239 (314)
T cd08216         161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM-LLEKVRGTVPCLLDKSTYPLY  239 (314)
T ss_pred             cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhccCccccccCchhhh
Confidence            1112233457788999999876  3588999999999999999999999864322110 00000000           00


Q ss_pred             ccchhh----hhh----hhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          336 SNKIID----LID----SVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       336 ~~~~~~----~i~----~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                      ......    ..+    .............++.+++.+||+.||++|||+.+++++-
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p  296 (314)
T cd08216         240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS  296 (314)
T ss_pred             cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCc
Confidence            000000    000    0001111223345788999999999999999999999854

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=7.5e-37  Score=296.10  Aligned_cols=266  Identities=20%  Similarity=0.299  Sum_probs=197.5

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeC-----Ce
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEK-----DE  178 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~  178 (432)
                      ..+|.+.+.||+|+||.||+|.+..  ..+++|.+...  .......+.+|+.+++.++|+||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            4579999999999999999999754  48999987543  233345677899999999999999999988654     34


Q ss_pred             eEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccce
Q 014024          179 RLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMAR  258 (432)
Q Consensus       179 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  258 (432)
                      .++++||+. ++|.+++..   ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.
T Consensus        84 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~  156 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRS---SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR  156 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence            799999996 678888743   345999999999999999999999998   9999999999999999999999999998


Q ss_pred             eccCCCCccccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHH-----
Q 014024          259 IVFGGNDEDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWD-----  332 (432)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~-----  332 (432)
                      ......      .......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||......  ........     
T Consensus       157 ~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~  228 (337)
T cd07858         157 TTSEKG------DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV--HQLKLITELLGSP  228 (337)
T ss_pred             ccCCCc------ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH--HHHHHHHHHhCCC
Confidence            642211      11223457889999998865 56899999999999999999999998543210  00000000     


Q ss_pred             ------hhhccchhhhhhhhhh------hcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--hcccc
Q 014024          333 ------LWISNKIIDLIDSVLE------EASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM--LTNEA  388 (432)
Q Consensus       333 ------~~~~~~~~~~i~~~l~------~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~--L~~~~  388 (432)
                            ..........++....      .........++.+++.+||+.+|++|||+.+++++  +....
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~  298 (337)
T cd07858         229 SEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH  298 (337)
T ss_pred             ChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence                  0001111111110000      00112345678899999999999999999999987  55443

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.6e-36  Score=285.96  Aligned_cols=256  Identities=20%  Similarity=0.270  Sum_probs=188.8

Q ss_pred             CCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCC-hHhHHHHHHHHHHHHhcC-CCceeeeEeEEEeC--CeeEEEEe
Q 014024          111 FSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS-GQEIKELKNEASVIAQVQ-HKNLVKLLGCCIEK--DERLLIYE  184 (432)
Q Consensus       111 y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~e  184 (432)
                      |++.+.||+|+||.||+|.+..  ..+++|++.... ........+|+..+.++. |+|++++++++.+.  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            6778999999999999999743  478999875432 222233457888898885 99999999999887  88999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCC
Q 014024          185 YMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGN  264 (432)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  264 (432)
                      |++ ++|.+++...  ...+++..++.++.|++.||+|||+.+   ++||||+|+||++++ +.+||+|||++.......
T Consensus        81 ~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~  153 (282)
T cd07831          81 LMD-MNLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP  153 (282)
T ss_pred             cCC-ccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence            997 4777777542  245899999999999999999999998   999999999999999 999999999998652211


Q ss_pred             CccccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhh---------
Q 014024          265 DEDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLW---------  334 (432)
Q Consensus       265 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~---------  334 (432)
                             ......++..|+|||++.. +.++.++|||||||++|||++|..||......+  .........         
T Consensus       154 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~  224 (282)
T cd07831         154 -------PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD--QIAKIHDVLGTPDAEVLK  224 (282)
T ss_pred             -------CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH--HHHHHHHHcCCCCHHHHH
Confidence                   1123457889999997654 557899999999999999999999985432211  000000000         


Q ss_pred             --hccchhhh-----hhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          335 --ISNKIIDL-----IDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       335 --~~~~~~~~-----i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                        ........     ....+ .......+..+.+++.+||+.+|++||++.+++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         225 KFRKSRHMNYNFPSKKGTGL-RKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             hhcccccccccCcccccccH-HHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence              00000000     00000 00012345788999999999999999999999875

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-36  Score=286.06  Aligned_cols=260  Identities=23%  Similarity=0.297  Sum_probs=195.7

Q ss_pred             CCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCC--hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeC--CeeEEEEe
Q 014024          111 FSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS--GQEIKELKNEASVIAQVQHKNLVKLLGCCIEK--DERLLIYE  184 (432)
Q Consensus       111 y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e  184 (432)
                      |++.+.||.|++|.||+|...+  ..+++|.+....  ......+.+|++++++++|+|++++++++.+.  +..++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            6778999999999999999865  489999986552  33456688899999999999999999999888  88999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCC
Q 014024          185 YMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGN  264 (432)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  264 (432)
                      |+++ +|.+++....  ..+++..++.++.|++.||+|||+.+   ++|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~  154 (287)
T cd07840          81 YMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN  154 (287)
T ss_pred             cccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence            9975 8888775432  35899999999999999999999998   9999999999999999999999999998753322


Q ss_pred             CccccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhh---ccc--
Q 014024          265 DEDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWI---SNK--  338 (432)
Q Consensus       265 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~--  338 (432)
                      .     .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.......  ..........   ...  
T Consensus       155 ~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~  227 (287)
T cd07840         155 S-----ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE--QLEKIFELCGSPTDENWP  227 (287)
T ss_pred             c-----ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCchhhcc
Confidence            1     11223456788999997765 457999999999999999999999985433211  0000000000   000  


Q ss_pred             ------------hhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          339 ------------IIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       339 ------------~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                                  ........+.......++..+.+++..||+.+|++||++.+++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         228 GVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             ccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence                        000000111111111125678999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=6.4e-37  Score=289.82  Aligned_cols=253  Identities=26%  Similarity=0.420  Sum_probs=191.9

Q ss_pred             CCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCC-hHhHHHHHHHHHHHHhcC-CCceeeeEeEEEeCCeeEEEEe
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS-GQEIKELKNEASVIAQVQ-HKNLVKLLGCCIEKDERLLIYE  184 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e  184 (432)
                      ++|+..+.||+|+||.||++.+..  ..+|+|.+.... ......+.+|+.++.++. |+||+++++++..++..+++||
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e   83 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME   83 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence            356677899999999999999854  489999886432 345567889999999996 9999999999999999999999


Q ss_pred             cCCCCChhhhh---cCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEeccCCCCCEEEcCCCCEEEeecccceec
Q 014024          185 YMPNKSLDCFL---FDPTKREILDWRTRVQIIKGVAQGLLYLHQY-SRVRIIHRDLKASNILLDKDMNSKISDFGMARIV  260 (432)
Q Consensus       185 ~~~~gsL~~~l---~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  260 (432)
                      |+.. ++.++.   .. .....+++..+..++.|++.||+|||+. +   ++||||||+||++++++.+||+|||++...
T Consensus        84 ~~~~-~l~~l~~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  158 (288)
T cd06616          84 LMDI-SLDKFYKYVYE-VLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQL  158 (288)
T ss_pred             cccC-CHHHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence            9864 444332   22 1234589999999999999999999975 6   999999999999999999999999998754


Q ss_pred             cCCCCccccccccccccccCCccChhhhccC---CCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhcc
Q 014024          261 FGGNDEDELQGNTSRISGTYGYMSPEYALEG---IFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISN  337 (432)
Q Consensus       261 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  337 (432)
                      ...       .......|+..|+|||.+.+.   .++.++|||||||++|+|++|+.||.....    ......... ..
T Consensus       159 ~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~~~~-~~  226 (288)
T cd06616         159 VDS-------IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS----VFDQLTQVV-KG  226 (288)
T ss_pred             ccC-------CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch----HHHHHhhhc-CC
Confidence            211       111233578899999998866   689999999999999999999999854321    000000000 00


Q ss_pred             chhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          338 KIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       338 ~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      .     .+.+........+..+.+++.+||+.+|++|||+.+|+.+
T Consensus       227 ~-----~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         227 D-----PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             C-----CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0     0111111112345678999999999999999999999975

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2.1e-36  Score=289.07  Aligned_cols=266  Identities=21%  Similarity=0.311  Sum_probs=192.0

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCC--hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC-----
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS--GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKD-----  177 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----  177 (432)
                      ..++|++.+.||+|+||.||+|....  ..+|+|.+....  ......+.+|++++++++||||+++++++...+     
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence            45689999999999999999999854  489999885432  222345568999999999999999999987654     


Q ss_pred             ---eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeec
Q 014024          178 ---ERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDF  254 (432)
Q Consensus       178 ---~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  254 (432)
                         ..++||||+.+ +|.+++...  ...+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+||
T Consensus        90 ~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~df  163 (310)
T cd07865          90 YKGSFYLVFEFCEH-DLAGLLSNK--NVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADF  163 (310)
T ss_pred             CCceEEEEEcCCCc-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcC
Confidence               34999999965 777776432  234899999999999999999999998   999999999999999999999999


Q ss_pred             ccceeccCCCCccccccccccccccCCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCCccccc-cchhhhhHH
Q 014024          255 GMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKS-LNLIGYAWD  332 (432)
Q Consensus       255 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlG~il~elltg~~p~~~~~~~~-~~~~~~~~~  332 (432)
                      |++..........  ........++..|+|||.+.+. .++.++|+||||+++|+|++|+.|+....... .........
T Consensus       164 g~~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~  241 (310)
T cd07865         164 GLARAFSLSKNSK--PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCG  241 (310)
T ss_pred             CCcccccCCcccC--CCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            9998653222111  1122334578899999988664 47899999999999999999999875432210 000000000


Q ss_pred             h-----hh-------------ccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          333 L-----WI-------------SNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       333 ~-----~~-------------~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      .     +.             .......+...+.   .......+.+++.+||+.||++|||+++++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~---~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         242 SITPEVWPGVDKLELFKKMELPQGQKRKVKERLK---PYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             CCChhhcccccchhhhhhccCCCccchhhHHhcc---cccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence            0     00             0000000000000   00112456789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=8.1e-37  Score=295.52  Aligned_cols=269  Identities=20%  Similarity=0.291  Sum_probs=198.1

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCC--hHhHHHHHHHHHHHHhcCCCceeeeEeEEEe----CCee
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS--GQEIKELKNEASVIAQVQHKNLVKLLGCCIE----KDER  179 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~  179 (432)
                      .++|++.+.||.|++|.||+|....  ..+++|++....  ......+.+|+.++++++|+||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            4789999999999999999999754  489999886432  2345667889999999999999999998753    3467


Q ss_pred             EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeeccccee
Q 014024          180 LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARI  259 (432)
Q Consensus       180 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  259 (432)
                      ++||||+. ++|.+++..   ...+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||++..
T Consensus        84 ~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~  156 (334)
T cd07855          84 YVVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG  156 (334)
T ss_pred             EEEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence            99999995 688888843   344999999999999999999999998   99999999999999999999999999976


Q ss_pred             ccCCCCccccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCcccccc-chhh--------h
Q 014024          260 VFGGNDEDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSL-NLIG--------Y  329 (432)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~-~~~~--------~  329 (432)
                      .......  .........++..|+|||.+.+ ..++.++||||||+++|+|++|+.||........ ....        .
T Consensus       157 ~~~~~~~--~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~  234 (334)
T cd07855         157 LSSSPTE--HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEE  234 (334)
T ss_pred             ecccCcC--CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhH
Confidence            5322111  1111234578889999998865 5689999999999999999999999854322100 0000        0


Q ss_pred             hHHhhhccchhhhhhhhhhh------cccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014024          330 AWDLWISNKIIDLIDSVLEE------ASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLT  385 (432)
Q Consensus       330 ~~~~~~~~~~~~~i~~~l~~------~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~  385 (432)
                      .......+.....++..-..      ......+.++.+++..||+.+|++||++.+++.+..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~  296 (334)
T cd07855         235 VLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPF  296 (334)
T ss_pred             hhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChh
Confidence            00000001111111110000      001223577899999999999999999999998543

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-39  Score=285.48  Aligned_cols=249  Identities=26%  Similarity=0.398  Sum_probs=206.3

Q ss_pred             CCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecC
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYM  186 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  186 (432)
                      +-|.++.+||+|+||.||+|.+...  -+|+|++.-.  ...+++..|+.+|+++..+++|++||.+.....+++|||||
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC  110 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC  110 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence            4467789999999999999988654  6788887543  56788999999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCc
Q 014024          187 PNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDE  266 (432)
Q Consensus       187 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  266 (432)
                      ..|+..+.++.  .+++++++++..++...++||+|||...   -+|||||..|||++.+|.+||+|||.|..+.+    
T Consensus       111 GAGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD----  181 (502)
T KOG0574|consen  111 GAGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTD----  181 (502)
T ss_pred             CCCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhh----
Confidence            99999999864  4567999999999999999999999987   89999999999999999999999999987632    


Q ss_pred             cccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhh
Q 014024          267 DELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSV  346 (432)
Q Consensus       267 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  346 (432)
                        .-.......|||.|||||++..-.|+.++||||||+...||..|++|+........-+   .        +.....+.
T Consensus       182 --TMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF---M--------IPT~PPPT  248 (502)
T KOG0574|consen  182 --TMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF---M--------IPTKPPPT  248 (502)
T ss_pred             --hHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE---e--------ccCCCCCC
Confidence              2334456789999999999999999999999999999999999999986443311000   0        00000010


Q ss_pred             hhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          347 LEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       347 l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                        -..+.....++.++++.||-++|++|-|+.+++++
T Consensus       249 --F~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  249 --FKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             --CCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence              11244567788999999999999999999999875

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=2e-36  Score=289.47  Aligned_cols=266  Identities=23%  Similarity=0.277  Sum_probs=194.6

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCCh--HhHHHHHHHHHHHHhcCCCceeeeEeEEEeC--CeeE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSG--QEIKELKNEASVIAQVQHKNLVKLLGCCIEK--DERL  180 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~  180 (432)
                      ..++|++.+.||+|+||.||+|.+..  ..||+|.+.....  .....+.+|+.++++++|+|++++++++.+.  +..+
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF   84 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence            35789999999999999999999854  4899998854321  2223456799999999999999999998765  5689


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceec
Q 014024          181 LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIV  260 (432)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  260 (432)
                      +||||+.+ +|.+++...  ...+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||++...
T Consensus        85 lv~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~  158 (309)
T cd07845          85 LVMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY  158 (309)
T ss_pred             EEEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeec
Confidence            99999965 787777542  245899999999999999999999999   999999999999999999999999999875


Q ss_pred             cCCCCccccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhh---c
Q 014024          261 FGGNDEDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWI---S  336 (432)
Q Consensus       261 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~---~  336 (432)
                      ....      .......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||.......  ..........   .
T Consensus       159 ~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~--~~~~~~~~~~~~~~  230 (309)
T cd07845         159 GLPA------KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE--QLDLIIQLLGTPNE  230 (309)
T ss_pred             CCcc------CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCCh
Confidence            2211      11223345788999998865 558999999999999999999999985432211  1000000000   0


Q ss_pred             cchhhh-----hhhh-hh-------hcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014024          337 NKIIDL-----IDSV-LE-------EASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN  386 (432)
Q Consensus       337 ~~~~~~-----i~~~-l~-------~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~  386 (432)
                      ......     .... +.       ..........+.+++..||+.||++|||+.+++++-.-
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f  293 (309)
T cd07845         231 SIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYF  293 (309)
T ss_pred             hhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhh
Confidence            000000     0000 00       00001124567889999999999999999999986544

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.7e-36  Score=285.48  Aligned_cols=243  Identities=25%  Similarity=0.312  Sum_probs=189.6

Q ss_pred             eccCCcEEEEEEEECC--ceEEEEEEcCCC---hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecCCCCCh
Q 014024          117 LGEGGFGTVYKGVIGQ--GEIAVKRLLGKS---GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSL  191 (432)
Q Consensus       117 ig~G~~g~Vy~~~~~~--~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  191 (432)
                      ||+|+||+||++.+..  ..+++|.+....   ....+.+..|++++++++|||++++++.+...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            6999999999998753  489999885432   22344567899999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCcccccc
Q 014024          192 DCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQG  271 (432)
Q Consensus       192 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  271 (432)
                      .+++..... ..+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.++|+|||.+.....       ..
T Consensus        81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~-------~~  149 (277)
T cd05577          81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKG-------GK  149 (277)
T ss_pred             HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhcc-------CC
Confidence            999865332 35899999999999999999999998   99999999999999999999999999875421       11


Q ss_pred             ccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhhhhhcc
Q 014024          272 NTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEAS  351 (432)
Q Consensus       272 ~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~  351 (432)
                      ......++..|+|||.+.++.++.++|+||||+++|+|++|+.||.........  ...         ...+.. .....
T Consensus       150 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~~---------~~~~~~-~~~~~  217 (277)
T cd05577         150 KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK--EEL---------KRRTLE-MAVEY  217 (277)
T ss_pred             ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH--HHH---------Hhcccc-ccccC
Confidence            122345778999999998888999999999999999999999998543221000  000         000000 01112


Q ss_pred             cHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 014024          352 FNESLSRYVHIALLCVQERAEDRP-----TMSDVVS  382 (432)
Q Consensus       352 ~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~  382 (432)
                      +......+.+++.+||+.||++||     ++.++++
T Consensus       218 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         218 PDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             CccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            223356788999999999999999     6666765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=2.4e-36  Score=286.80  Aligned_cols=263  Identities=22%  Similarity=0.271  Sum_probs=192.0

Q ss_pred             CCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCC--hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEe
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS--GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYE  184 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  184 (432)
                      ++|++.+.||+|++|.||+|.+..  ..+++|.+....  ....+.+.+|++++++++|+|++++++++.+....++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            578999999999999999999753  379999875432  2334568889999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcC-CCCEEEeecccceeccCC
Q 014024          185 YMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDK-DMNSKISDFGMARIVFGG  263 (432)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~  263 (432)
                      |++ ++|.+++.... ...+++..+..++.|++.||+|||+.+   ++|+||+|+||+++. ++.+||+|||++......
T Consensus        82 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         82 YLD-LDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP  156 (294)
T ss_pred             ccc-ccHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence            996 47777764322 223688888999999999999999998   999999999999985 557999999999753111


Q ss_pred             CCccccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHH-------hhh
Q 014024          264 NDEDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWD-------LWI  335 (432)
Q Consensus       264 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~-------~~~  335 (432)
                            ........+++.|+|||++.+ ..++.++||||||+++|+|+||+.||......+. .......       .+.
T Consensus       157 ------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~  229 (294)
T PLN00009        157 ------VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE-LFKIFRILGTPNEETWP  229 (294)
T ss_pred             ------ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChhhcc
Confidence                  111223456889999998866 4579999999999999999999999864322110 0000000       000


Q ss_pred             -ccchhhhhhhhh------hhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          336 -SNKIIDLIDSVL------EEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       336 -~~~~~~~i~~~l------~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                       .....+......      ..........++.+++.+|++.+|++||++.+++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~  284 (294)
T PLN00009        230 GVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH  284 (294)
T ss_pred             ccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             000000000000      000011234567899999999999999999999974

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.2e-36  Score=292.55  Aligned_cols=266  Identities=22%  Similarity=0.282  Sum_probs=196.8

Q ss_pred             hhhHhhhhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCC--hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeC
Q 014024          101 FSSVSSATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS--GQEIKELKNEASVIAQVQHKNLVKLLGCCIEK  176 (432)
Q Consensus       101 ~~~~~~~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  176 (432)
                      ..++....++|++.+.||+|+||.||+|.+..  ..||+|++....  ....+.+.+|+.++++++|+||+++++++...
T Consensus         9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~   88 (345)
T cd07877           9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA   88 (345)
T ss_pred             HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence            34566778999999999999999999998743  379999886432  23345678899999999999999999988643


Q ss_pred             ------CeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEE
Q 014024          177 ------DERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSK  250 (432)
Q Consensus       177 ------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  250 (432)
                            ...+++++++ +++|.+++..    ..+++..+..++.|+++||+|||+.+   ++||||||+||++++++.+|
T Consensus        89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k  160 (345)
T cd07877          89 RSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK  160 (345)
T ss_pred             ccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEE
Confidence                  3467888877 7888887732    24899999999999999999999998   99999999999999999999


Q ss_pred             EeecccceeccCCCCccccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhh
Q 014024          251 ISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGY  329 (432)
Q Consensus       251 l~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~  329 (432)
                      |+|||++....         .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||....... .....
T Consensus       161 l~dfg~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~  230 (345)
T cd07877         161 ILDFGLARHTD---------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLI  230 (345)
T ss_pred             Eeccccccccc---------ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHH
Confidence            99999987531         12233567889999998866 568899999999999999999999985332211 00000


Q ss_pred             h----------HHhhhccchhhhhhhhhh--h-c---ccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          330 A----------WDLWISNKIIDLIDSVLE--E-A---SFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       330 ~----------~~~~~~~~~~~~i~~~l~--~-~---~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                      .          ............+...-.  . .   ........+.+++..|++.||.+||++.+++++-
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~  301 (345)
T cd07877         231 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA  301 (345)
T ss_pred             HHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence            0          000000000011000000  0 0   0001245688999999999999999999999864

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=2.4e-36  Score=292.63  Aligned_cols=266  Identities=24%  Similarity=0.340  Sum_probs=196.8

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC--ChHhHHHHHHHHHHHHhc-CCCceeeeEeEEEeC--Cee
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK--SGQEIKELKNEASVIAQV-QHKNLVKLLGCCIEK--DER  179 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~--~~~  179 (432)
                      ..++|++.+.||+|+||.||+|.+..  ..+++|++...  .......+.+|+.+++++ +|+||+++++++...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            45789999999999999999999753  47999988532  233445677899999999 999999999998654  467


Q ss_pred             EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeeccccee
Q 014024          180 LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARI  259 (432)
Q Consensus       180 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  259 (432)
                      ++||||++ ++|.+++...    .+++..+..++.|++.||+|||+.+   |+|+||||+||++++++.+||+|||++..
T Consensus        85 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~  156 (337)
T cd07852          85 YLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS  156 (337)
T ss_pred             EEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence            99999997 5888887432    5889999999999999999999998   99999999999999999999999999986


Q ss_pred             ccCCCCccccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHH------
Q 014024          260 VFGGNDEDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWD------  332 (432)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~------  332 (432)
                      ........ .........|+..|+|||.+.+ ..++.++|+||||+++|+|++|+.||........  ......      
T Consensus       157 ~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~--~~~~~~~~~~~~  233 (337)
T cd07852         157 LSELEENP-ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ--LEKIIEVIGPPS  233 (337)
T ss_pred             cccccccc-cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCC
Confidence            53322110 0112233568899999998765 5578999999999999999999999854332110  000000      


Q ss_pred             -----hhhccchhhhhhhhhhh------cccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          333 -----LWISNKIIDLIDSVLEE------ASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       333 -----~~~~~~~~~~i~~~l~~------~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                           ........++++.....      ......+..+.+++.+||+.||++|||+.+++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         234 AEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence                 00000011111100000      0011135678999999999999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=3.2e-36  Score=288.01  Aligned_cols=251  Identities=27%  Similarity=0.381  Sum_probs=195.4

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcC---CChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEE
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLG---KSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLI  182 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  182 (432)
                      ...|...+.||+|++|.||+|.+..  ..+++|.+..   ......+.+.+|+++++.++|+|++++.+++......++|
T Consensus        14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   93 (308)
T cd06634          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV   93 (308)
T ss_pred             HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence            3447778899999999999999854  3789998753   2334456788899999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccC
Q 014024          183 YEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFG  262 (432)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  262 (432)
                      |||+. |++.+++...  ...+++..+..++.|++.|+.|||+.+   ++||||+|+||++++++.++|+|||++.....
T Consensus        94 ~e~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  167 (308)
T cd06634          94 MEYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (308)
T ss_pred             EEccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence            99996 5777766432  234899999999999999999999998   99999999999999999999999999876421


Q ss_pred             CCCccccccccccccccCCccChhhhc---cCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccch
Q 014024          263 GNDEDELQGNTSRISGTYGYMSPEYAL---EGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKI  339 (432)
Q Consensus       263 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  339 (432)
                                .....++..|+|||.+.   .+.++.++|||||||++|+|++|+.|+.......     .         .
T Consensus       168 ----------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~---------~  223 (308)
T cd06634         168 ----------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-----A---------L  223 (308)
T ss_pred             ----------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH-----H---------H
Confidence                      12345788999999874   3568899999999999999999999974322100     0         0


Q ss_pred             hhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014024          340 IDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEA  388 (432)
Q Consensus       340 ~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~  388 (432)
                      ...................+.+++.+||+.+|++||++.+++++.....
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~  272 (308)
T cd06634         224 YHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (308)
T ss_pred             HHHhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence            0000000000011234567889999999999999999999998765543

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=5.1e-36  Score=287.27  Aligned_cols=243  Identities=28%  Similarity=0.434  Sum_probs=189.7

Q ss_pred             CCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC---ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEec
Q 014024          111 FSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK---SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEY  185 (432)
Q Consensus       111 y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  185 (432)
                      |...+.||+|+||.||+|.+..  ..+++|++...   .....+.+.+|+++++.++|+|++++++++.+.+..++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            6667889999999999998743  47899988533   233456788899999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCC
Q 014024          186 MPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGND  265 (432)
Q Consensus       186 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  265 (432)
                      +. +++.+++...  ...+++.++..++.|++.|+.|||+.+   ++|+||+|+||++++++.+||+|||++...     
T Consensus       103 ~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~-----  171 (313)
T cd06633         103 CL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKS-----  171 (313)
T ss_pred             CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCccc-----
Confidence            96 5666666432  335899999999999999999999998   999999999999999999999999988642     


Q ss_pred             ccccccccccccccCCccChhhhc---cCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhh
Q 014024          266 EDELQGNTSRISGTYGYMSPEYAL---EGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDL  342 (432)
Q Consensus       266 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                           .......|+..|+|||++.   .+.++.++||||||+++|+|++|..|+......     ........ ...   
T Consensus       172 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~-----~~~~~~~~-~~~---  237 (313)
T cd06633         172 -----SPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----SALYHIAQ-NDS---  237 (313)
T ss_pred             -----CCCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHh-cCC---
Confidence                 1122356888999999984   466889999999999999999999997432210     00000000 000   


Q ss_pred             hhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          343 IDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       343 i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                           ...........+.+++.+||+.+|.+||++.+++.+
T Consensus       238 -----~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         238 -----PTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             -----CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 000111233568889999999999999999999975

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-36  Score=284.76  Aligned_cols=259  Identities=22%  Similarity=0.274  Sum_probs=196.1

Q ss_pred             CCcCceeccCCcEEEEEEEEC--CceEEEEEEcCCCh--HhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecC
Q 014024          111 FSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGKSG--QEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYM  186 (432)
Q Consensus       111 y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  186 (432)
                      |++.+.||.|++|.||+|...  +..+++|.+.....  .....+.+|++++++++|+|++++++++..++..++++||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            567889999999999999975  33789998854432  34567888999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCc
Q 014024          187 PNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDE  266 (432)
Q Consensus       187 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  266 (432)
                      ++ ++.+++....  ..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||.+.......  
T Consensus        81 ~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--  152 (283)
T cd05118          81 DT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--  152 (283)
T ss_pred             CC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--
Confidence            75 7777775422  45899999999999999999999998   9999999999999999999999999997752221  


Q ss_pred             cccccccccccccCCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhh---ccchhhh
Q 014024          267 DELQGNTSRISGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWI---SNKIIDL  342 (432)
Q Consensus       267 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~  342 (432)
                          .......++..|+|||.+.+. .++.++|+||||+++|+|+||+.||......+  ..........   .......
T Consensus       153 ----~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  226 (283)
T cd05118         153 ----RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID--QLFKIFRTLGTPDPEVWPKF  226 (283)
T ss_pred             ----ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHcCCCchHhcccc
Confidence                112234577889999998876 78999999999999999999999885433211  0000000000   0000000


Q ss_pred             hh-------------hhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          343 ID-------------SVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       343 i~-------------~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      .+             .............++.+++..||+.||.+||++.+++.+
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         227 TSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             hhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            00             000001122345778999999999999999999999874

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.7e-37  Score=295.96  Aligned_cols=250  Identities=23%  Similarity=0.293  Sum_probs=206.9

Q ss_pred             hhhhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeE
Q 014024          105 SSATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERL  180 (432)
Q Consensus       105 ~~~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  180 (432)
                      ....+.|.+.+.||+|.|+.|.+|.+..  +.||+|.+.+.  +....+.+.+|+++|+.++|||||+++.+......+|
T Consensus        52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly  131 (596)
T KOG0586|consen   52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLY  131 (596)
T ss_pred             cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence            4457899999999999999999999754  48999988554  2344456889999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceec
Q 014024          181 LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIV  260 (432)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  260 (432)
                      +||||+.+|.+.+++...   +.+.+..+..++.|+..|++|||+++   |+|||||++||||+.+.++||+|||++..+
T Consensus       132 lV~eya~~ge~~~yl~~~---gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~  205 (596)
T KOG0586|consen  132 LVMEYASGGELFDYLVKH---GRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFF  205 (596)
T ss_pred             EEEEeccCchhHHHHHhc---ccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceee
Confidence            999999999999999543   33666888999999999999999999   999999999999999999999999999886


Q ss_pred             cCCCCccccccccccccccCCccChhhhccCCC-CchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccch
Q 014024          261 FGGNDEDELQGNTSRISGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKI  339 (432)
Q Consensus       261 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  339 (432)
                      ..       .......+|++.|.|||++.+..| ++.+|+||+|+++|.|++|..||+...                  +
T Consensus       206 ~~-------~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~------------------l  260 (596)
T KOG0586|consen  206 DY-------GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN------------------L  260 (596)
T ss_pred             cc-------cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc------------------c
Confidence            32       334567899999999999998776 689999999999999999999986322                  1


Q ss_pred             hhhhhhhhhhcc--cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014024          340 IDLIDSVLEEAS--FNESLSRYVHIALLCVQERAEDRPTMSDVVSMLT  385 (432)
Q Consensus       340 ~~~i~~~l~~~~--~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~  385 (432)
                      ..+-++.++..+  +.....++-++++.+|-.+|.+|++++++..+-+
T Consensus       261 k~Lr~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W  308 (596)
T KOG0586|consen  261 KELRPRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRW  308 (596)
T ss_pred             ccccchheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhhcc
Confidence            222222222211  2223356778999999999999999999987543

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.3e-36  Score=293.23  Aligned_cols=262  Identities=22%  Similarity=0.319  Sum_probs=193.0

Q ss_pred             hCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC------
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKD------  177 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------  177 (432)
                      .++|.+.+.||+|+||.||+|.+.  +..+|+|++...  .......+.+|+.+++.++|+||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            478999999999999999999974  348999988543  2233456788999999999999999999986543      


Q ss_pred             eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccc
Q 014024          178 ERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMA  257 (432)
Q Consensus       178 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  257 (432)
                      ..++|+||+.. +|..+.     ...+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++
T Consensus        94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~  164 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA  164 (342)
T ss_pred             eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence            45899999964 666654     124899999999999999999999998   999999999999999999999999998


Q ss_pred             eeccCCCCccccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHh---
Q 014024          258 RIVFGGNDEDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDL---  333 (432)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~---  333 (432)
                      ....         .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||......  .........   
T Consensus       165 ~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~--~~~~~~~~~~~~  233 (342)
T cd07879         165 RHAD---------AEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL--DQLTQILKVTGV  233 (342)
T ss_pred             cCCC---------CCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCC
Confidence            7531         11223467889999999876 46899999999999999999999998643211  000000000   


Q ss_pred             --------hhccchhhhhhhhh---hhc---ccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--hccccc
Q 014024          334 --------WISNKIIDLIDSVL---EEA---SFNESLSRYVHIALLCVQERAEDRPTMSDVVSM--LTNEAS  389 (432)
Q Consensus       334 --------~~~~~~~~~i~~~l---~~~---~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~--L~~~~~  389 (432)
                              .........+....   ...   ..+.....+.+++.+||+.||++||++.+++.+  ++...+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         234 PGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             CCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence                    00000000000000   000   001223567899999999999999999999975  555443

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.9e-36  Score=284.90  Aligned_cols=253  Identities=26%  Similarity=0.345  Sum_probs=201.4

Q ss_pred             CCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCC---ChHhHHHHHHHHHHHHhcC-CCceeeeEeEEEeCCeeEEE
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGK---SGQEIKELKNEASVIAQVQ-HKNLVKLLGCCIEKDERLLI  182 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv  182 (432)
                      ++|.+.+.||+|++|.||++...  +..+++|.+...   .....+.+..|.+++++++ |+||+++++++.+.+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            47899999999999999999985  348999988542   2344567888999999998 99999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccC
Q 014024          183 YEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFG  262 (432)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  262 (432)
                      |||+++++|.+++..   ...+++..++.++.|++.||.+||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          81 LEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            999999999999953   335999999999999999999999998   99999999999999999999999999986532


Q ss_pred             CCCccc--------------cccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhh
Q 014024          263 GNDEDE--------------LQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIG  328 (432)
Q Consensus       263 ~~~~~~--------------~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~  328 (432)
                      ......              .........++..|+|||...+..++.++|+||||++++++++|+.|+.....     ..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~  229 (280)
T cd05581         155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE-----YL  229 (280)
T ss_pred             ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH-----HH
Confidence            221100              01223345678899999999988899999999999999999999999753321     00


Q ss_pred             hhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCH----HHHHHH
Q 014024          329 YAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTM----SDVVSM  383 (432)
Q Consensus       329 ~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~----~evl~~  383 (432)
                      ..         ....  ......+...+..+.+++..||+.+|.+||++    .+++++
T Consensus       230 ~~---------~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~  277 (280)
T cd05581         230 TF---------QKIL--KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH  277 (280)
T ss_pred             HH---------HHHH--hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence            00         0000  01112223345678999999999999999999    887764

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-37  Score=285.87  Aligned_cols=249  Identities=25%  Similarity=0.316  Sum_probs=201.6

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCCC---hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEE
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKS---GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLI  182 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  182 (432)
                      .+.|..-++||+||||.||-++...+  -+|.|++.++.   ........+|-.+|.+++.+.||.+-..|+..+.+|+|
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV  263 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV  263 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence            35678889999999999998876544  57777664332   22334567899999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccC
Q 014024          183 YEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFG  262 (432)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  262 (432)
                      +..|+||+|.-+|.+.+. ..+++..+..++.+|+.||++||...   ||+|||||+|||+|+.|+++|+|+|+|..+..
T Consensus       264 LtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~  339 (591)
T KOG0986|consen  264 LTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPE  339 (591)
T ss_pred             EEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence            999999999999988665 44999999999999999999999998   99999999999999999999999999987633


Q ss_pred             CCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhh
Q 014024          263 GNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDL  342 (432)
Q Consensus       263 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                      +.       .....+||.+|||||++.++.|+...|.|||||++|||+.|+.||.....               ..-.+.
T Consensus       340 g~-------~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke---------------Kvk~eE  397 (591)
T KOG0986|consen  340 GK-------PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE---------------KVKREE  397 (591)
T ss_pred             CC-------ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh---------------hhhHHH
Confidence            22       22334899999999999999999999999999999999999999854332               111223


Q ss_pred             hhhhhhh---cccHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 014024          343 IDSVLEE---ASFNESLSRYVHIALLCVQERAEDRPT-----MSDVVS  382 (432)
Q Consensus       343 i~~~l~~---~~~~~~~~~l~~l~~~cl~~dp~~RPt-----~~evl~  382 (432)
                      +|.+...   .++..-..+..++....|+.||.+|..     +++|-+
T Consensus       398 vdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~  445 (591)
T KOG0986|consen  398 VDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKE  445 (591)
T ss_pred             HHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhh
Confidence            3333322   233445567788899999999999964     456655

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.2e-36  Score=291.98  Aligned_cols=262  Identities=23%  Similarity=0.324  Sum_probs=199.6

Q ss_pred             CCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCC--hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC-----eeE
Q 014024          110 NFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS--GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKD-----ERL  180 (432)
Q Consensus       110 ~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~  180 (432)
                      +|++.+.||.|++|.||+|....  ..+++|++....  ....+.+.+|+.+++.++|+||+++.+++...+     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            58889999999999999999854  489999886543  445567899999999999999999999998775     789


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceec
Q 014024          181 LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIV  260 (432)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  260 (432)
                      ++|||++ ++|.+++..   +..+++..++.++.|++.||+|||+.+   ++||||||+||++++++.++|+|||++...
T Consensus        81 lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~  153 (330)
T cd07834          81 IVTELME-TDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV  153 (330)
T ss_pred             EEecchh-hhHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence            9999997 478888743   336999999999999999999999998   999999999999999999999999999875


Q ss_pred             cCCCCccccccccccccccCCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHH-------
Q 014024          261 FGGNDEDELQGNTSRISGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWD-------  332 (432)
Q Consensus       261 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~-------  332 (432)
                      ......   ........++..|+|||.+.+. .++.++|+||||+++|+|++|+.||........  ......       
T Consensus       154 ~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~--~~~i~~~~~~~~~  228 (330)
T cd07834         154 DPDEDE---KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ--LNLIVEVLGTPSE  228 (330)
T ss_pred             cccccc---cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH--HHHHHHhcCCCCh
Confidence            332110   1123345678899999999887 789999999999999999999999854332110  000000       


Q ss_pred             ----hhhccchhhhhhhhhh------hcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          333 ----LWISNKIIDLIDSVLE------EASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       333 ----~~~~~~~~~~i~~~l~------~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                          ........+.+...-.      .......+..+.+++.+||+.+|++||++.+++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         229 EDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             hHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                0001111111111000      00111235678899999999999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=2e-36  Score=289.37  Aligned_cols=267  Identities=24%  Similarity=0.324  Sum_probs=192.6

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCCh--HhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC------
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSG--QEIKELKNEASVIAQVQHKNLVKLLGCCIEKD------  177 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------  177 (432)
                      .++|++.+.||+|+||.||+|.+..  ..+++|++.....  .....+.+|+++++.++|+||+++++++.+..      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            6899999999999999999999754  4799998854322  22345678999999999999999999875443      


Q ss_pred             --eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecc
Q 014024          178 --ERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFG  255 (432)
Q Consensus       178 --~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  255 (432)
                        ..++|+||+.+ ++...+...  ...+++..+..++.|+++||+|||+.+   ++|+||||+||++++++.++|+|||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg  160 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENP--SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG  160 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence              46999999965 566665432  335999999999999999999999998   9999999999999999999999999


Q ss_pred             cceeccCCCCccc-----cccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhh
Q 014024          256 MARIVFGGNDEDE-----LQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGY  329 (432)
Q Consensus       256 ~a~~~~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~  329 (432)
                      ++...........     .........+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||.......  ....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~--~~~~  238 (311)
T cd07866         161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID--QLHL  238 (311)
T ss_pred             cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH--HHHH
Confidence            9986532221111     1112234567889999998765 458999999999999999999999985332211  0000


Q ss_pred             hHHhhhc---------cchhhh--------hhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          330 AWDLWIS---------NKIIDL--------IDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       330 ~~~~~~~---------~~~~~~--------i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      .......         ......        ....+.. ........+.+++.+||+.||++|||+.|++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEE-RFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             HHHHhCCCChhhchhhhhcccccccccCCCCCccHHH-HcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence            0000000         000000        0000000 011223568899999999999999999999864

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4e-36  Score=291.65  Aligned_cols=261  Identities=22%  Similarity=0.310  Sum_probs=195.0

Q ss_pred             hhhhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC---
Q 014024          105 SSATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKD---  177 (432)
Q Consensus       105 ~~~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---  177 (432)
                      ....++|++.+.||+|+||.||++.+..  ..||+|++...  .......+.+|+++++.++|+||+++++++....   
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07880          11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD   90 (343)
T ss_pred             hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence            3457889999999999999999998753  48999988543  2334456889999999999999999999987553   


Q ss_pred             ---eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeec
Q 014024          178 ---ERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDF  254 (432)
Q Consensus       178 ---~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  254 (432)
                         ..++||||+ +++|.+++.    ...+++..+..++.|++.||+|||+.+   |+||||||+||++++++.++|+||
T Consensus        91 ~~~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~df  162 (343)
T cd07880          91 RFHDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDF  162 (343)
T ss_pred             ccceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeec
Confidence               358999999 778888873    234899999999999999999999998   999999999999999999999999


Q ss_pred             ccceeccCCCCccccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhh----
Q 014024          255 GMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGY----  329 (432)
Q Consensus       255 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~----  329 (432)
                      |++....         .......+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||........ ....    
T Consensus       163 g~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~-~~~~~~~~  232 (343)
T cd07880         163 GLARQTD---------SEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ-LMEIMKVT  232 (343)
T ss_pred             ccccccc---------cCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhc
Confidence            9997541         11223467889999998876 4588999999999999999999999864322100 0000    


Q ss_pred             ------hHHhhhccchhhhhhhhhh------hcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          330 ------AWDLWISNKIIDLIDSVLE------EASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       330 ------~~~~~~~~~~~~~i~~~l~------~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                            .............+...-.      ..........+.+++.+|++.||++|||+.+++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~  298 (343)
T cd07880         233 GTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH  298 (343)
T ss_pred             CCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                  0000000011111110000      00011234568899999999999999999999953

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=6.6e-36  Score=284.79  Aligned_cols=264  Identities=24%  Similarity=0.304  Sum_probs=194.2

Q ss_pred             hhhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCC--hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC----
Q 014024          106 SATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS--GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKD----  177 (432)
Q Consensus       106 ~~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----  177 (432)
                      ...++|++.+.||+|+||.||+|....  ..+++|.+....  ......+.+|++++++++|||++++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            356789999999999999999999854  478999885432  223356778999999999999999999987654    


Q ss_pred             ------eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEE
Q 014024          178 ------ERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKI  251 (432)
Q Consensus       178 ------~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  251 (432)
                            ..++|+||+++ ++...+...  ...+++..+..++.|++.||+|||+.+   |+|+||+|+||++++++.+||
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl  157 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL  157 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence                  78999999986 566666432  235899999999999999999999998   999999999999999999999


Q ss_pred             eecccceeccCCCCccccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhh
Q 014024          252 SDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYA  330 (432)
Q Consensus       252 ~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~  330 (432)
                      +|||++........     .......++..|+|||.+.+ ..++.++|||||||++++|++|+.||.....  .......
T Consensus       158 ~dfg~~~~~~~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~--~~~~~~~  230 (302)
T cd07864         158 ADFGLARLYNSEES-----RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE--LAQLELI  230 (302)
T ss_pred             CcccccccccCCcc-----cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHH
Confidence            99999986532211     11122345778999998865 4578999999999999999999999853221  1111000


Q ss_pred             HHhhh---ccchhhhhh--------------hhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          331 WDLWI---SNKIIDLID--------------SVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       331 ~~~~~---~~~~~~~i~--------------~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      .....   .....++..              ...+.. ....+..+.+++..||+.||.+||++.+++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         231 SRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             HHHhCCCChhhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            00000   000000000              000000 11134678999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=3.9e-36  Score=284.54  Aligned_cols=255  Identities=22%  Similarity=0.283  Sum_probs=198.0

Q ss_pred             CCCcCceeccCCcEEEEEEEEC-----CceEEEEEEcCCC----hHhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCee
Q 014024          110 NFSAANKLGEGGFGTVYKGVIG-----QGEIAVKRLLGKS----GQEIKELKNEASVIAQV-QHKNLVKLLGCCIEKDER  179 (432)
Q Consensus       110 ~y~~~~~ig~G~~g~Vy~~~~~-----~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  179 (432)
                      +|++.+.||+|++|.||++...     +..+++|.+....    ....+.+.+|+.++.++ +|+|++++++.+......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4788899999999999998853     2479999885432    23345678899999999 599999999999999999


Q ss_pred             EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeeccccee
Q 014024          180 LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARI  259 (432)
Q Consensus       180 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  259 (432)
                      ++||||+++++|.+++..   +..+++..+..++.|+++||.|||+.+   ++||||+|+||++++++.++|+|||++..
T Consensus        81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence            999999999999998843   345899999999999999999999998   99999999999999999999999999876


Q ss_pred             ccCCCCccccccccccccccCCccChhhhccCC--CCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhcc
Q 014024          260 VFGGNDEDELQGNTSRISGTYGYMSPEYALEGI--FSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISN  337 (432)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  337 (432)
                      .....     ........|+..|+|||.+.+..  .+.++|+||||+++|+|++|..||....... ......       
T Consensus       155 ~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-~~~~~~-------  221 (288)
T cd05583         155 FLAEE-----EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN-SQSEIS-------  221 (288)
T ss_pred             ccccc-----ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc-hHHHHH-------
Confidence            43221     11122346788999999987655  7889999999999999999999985322110 000000       


Q ss_pred             chhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014024          338 KIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNE  387 (432)
Q Consensus       338 ~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~  387 (432)
                        ......  ....+......+.+++.+||+.||++|||+.++.+.|+..
T Consensus       222 --~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~  267 (288)
T cd05583         222 --RRILKS--KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP  267 (288)
T ss_pred             --HHHHcc--CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence              000000  0112223446788999999999999999999888877764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=2.5e-36  Score=281.38  Aligned_cols=249  Identities=26%  Similarity=0.379  Sum_probs=193.4

Q ss_pred             CCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCC-----ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEE
Q 014024          110 NFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGK-----SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLI  182 (432)
Q Consensus       110 ~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  182 (432)
                      +|.+.+.||+|+||.||++.+...  .+++|.....     .......+..|+.+++.++|||++++++++.+.+..++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            588899999999999999987543  3445544321     222344567799999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceecc
Q 014024          183 YEYMPNKSLDCFLFDP-TKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVF  261 (432)
Q Consensus       183 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  261 (432)
                      |||+++++|.+++... .....+++..++.++.|++.||.|||+.+   ++|+||+|+||++++ +.++|+|||++....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence            9999999999888542 22345999999999999999999999998   999999999999975 569999999987753


Q ss_pred             CCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhh
Q 014024          262 GGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIID  341 (432)
Q Consensus       262 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (432)
                      ...      .......+++.|+|||.+.+..++.++|+||||+++|+|++|..|+.....     .....         .
T Consensus       157 ~~~------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-----~~~~~---------~  216 (260)
T cd08222         157 GSC------DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF-----LSVVL---------R  216 (260)
T ss_pred             CCc------ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HHHHH---------H
Confidence            221      122334678899999999888899999999999999999999999742211     00000         0


Q ss_pred             hhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          342 LIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       342 ~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      .. .......+...+.++.+++.+||+.+|++||++.+++++
T Consensus       217 ~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         217 IV-EGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             HH-cCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence            00 001111233455688899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8e-36  Score=277.98  Aligned_cols=244  Identities=24%  Similarity=0.284  Sum_probs=186.3

Q ss_pred             ceeccCCcEEEEEEEECC--ceEEEEEEcCCCh---HhHHHHHHHHHHH-HhcCCCceeeeEeEEEeCCeeEEEEecCCC
Q 014024          115 NKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSG---QEIKELKNEASVI-AQVQHKNLVKLLGCCIEKDERLLIYEYMPN  188 (432)
Q Consensus       115 ~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~---~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  188 (432)
                      +.||+|+||.||+|.+..  ..+|+|.+.....   .....+..|..++ ...+|+|++++++++.+.+..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            569999999999999843  4899998864432   2223344454444 445899999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCccc
Q 014024          189 KSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDE  268 (432)
Q Consensus       189 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  268 (432)
                      ++|.+++..   ...+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++.....      
T Consensus        82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------  149 (260)
T cd05611          82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------  149 (260)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence            999999853   345899999999999999999999998   99999999999999999999999999875311      


Q ss_pred             cccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhhhh
Q 014024          269 LQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLE  348 (432)
Q Consensus       269 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  348 (432)
                          .....++..|+|||.+.+..++.++||||||+++|+|++|..||.......      ..........      ...
T Consensus       150 ----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~------~~~  213 (260)
T cd05611         150 ----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA------VFDNILSRRI------NWP  213 (260)
T ss_pred             ----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHhccc------CCC
Confidence                223457889999999988889999999999999999999999985322110      0000000000      000


Q ss_pred             hcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014024          349 EASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN  386 (432)
Q Consensus       349 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~  386 (432)
                      .......+..+.+++.+||+.+|++||++.++.+.|..
T Consensus       214 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~  251 (260)
T cd05611         214 EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH  251 (260)
T ss_pred             CcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence            01112345778999999999999999987666555443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=5.8e-36  Score=283.63  Aligned_cols=249  Identities=23%  Similarity=0.294  Sum_probs=193.7

Q ss_pred             CCCcCceeccCCcEEEEEEEEC-----CceEEEEEEcCCC----hHhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCee
Q 014024          110 NFSAANKLGEGGFGTVYKGVIG-----QGEIAVKRLLGKS----GQEIKELKNEASVIAQV-QHKNLVKLLGCCIEKDER  179 (432)
Q Consensus       110 ~y~~~~~ig~G~~g~Vy~~~~~-----~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  179 (432)
                      +|++.+.||.|+||.||++...     +..+|+|.+....    ....+.+.+|+++++++ +|+||+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            5788999999999999999863     3479999885432    22346678899999999 589999999999999999


Q ss_pred             EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeeccccee
Q 014024          180 LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARI  259 (432)
Q Consensus       180 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  259 (432)
                      ++||||+++++|.+++..   +..+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.+||+|||++..
T Consensus        81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            999999999999999853   345889999999999999999999998   99999999999999999999999999976


Q ss_pred             ccCCCCccccccccccccccCCccChhhhccC--CCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhcc
Q 014024          260 VFGGNDEDELQGNTSRISGTYGYMSPEYALEG--IFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISN  337 (432)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  337 (432)
                      .....     ........|+..|+|||.+.+.  .++.++||||||+++|+|++|+.|+....... .            
T Consensus       155 ~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-~------------  216 (290)
T cd05613         155 FHEDE-----VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN-S------------  216 (290)
T ss_pred             ccccc-----ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc-c------------
Confidence            42211     1112235688899999998753  47889999999999999999999975321100 0            


Q ss_pred             chhhhhhhhh--hhcccHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 014024          338 KIIDLIDSVL--EEASFNESLSRYVHIALLCVQERAEDRP-----TMSDVVSM  383 (432)
Q Consensus       338 ~~~~~i~~~l--~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~~  383 (432)
                       ..++.+...  ....+......+.+++.+||+.||++||     ++.+++.+
T Consensus       217 -~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         217 -QAEISRRILKSEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             -HHHHHHHhhccCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence             011111111  0112223456788999999999999997     67777654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=8.6e-36  Score=287.53  Aligned_cols=263  Identities=20%  Similarity=0.310  Sum_probs=195.8

Q ss_pred             hhhhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEe-CCee
Q 014024          105 SSATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIE-KDER  179 (432)
Q Consensus       105 ~~~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~  179 (432)
                      ...+++|++.+.||.|+||.||++.+..  ..+++|++...  .....+.+.+|+++++.++|||++++.+++.. ....
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   85 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI   85 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence            3467899999999999999999998754  37999987532  22345677889999999999999999999865 4578


Q ss_pred             EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeeccccee
Q 014024          180 LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARI  259 (432)
Q Consensus       180 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  259 (432)
                      ++++||+ +++|.+++.    ...+++.....++.|++.||.|||+.+   ++||||+|+||++++++.++|+|||.+..
T Consensus        86 ~lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~  157 (328)
T cd07856          86 YFVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI  157 (328)
T ss_pred             EEEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence            9999998 568888773    234788888999999999999999998   99999999999999999999999999875


Q ss_pred             ccCCCCccccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCcccccc-c-hh-------hh
Q 014024          260 VFGGNDEDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSL-N-LI-------GY  329 (432)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~-~-~~-------~~  329 (432)
                      ..         .......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||........ . ..       ..
T Consensus       158 ~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~  228 (328)
T cd07856         158 QD---------PQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDD  228 (328)
T ss_pred             cC---------CCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            31         11223456888999998765 5689999999999999999999999854322100 0 00       00


Q ss_pred             hHHhhhccchhhhhhhhhhh-ccc-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          330 AWDLWISNKIIDLIDSVLEE-ASF-----NESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       330 ~~~~~~~~~~~~~i~~~l~~-~~~-----~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                      ...........+++...... ..+     ......+.+++.+||+.+|++|||+.+++.+-
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~  289 (328)
T cd07856         229 VINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHP  289 (328)
T ss_pred             HHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCC
Confidence            00000011111111111000 001     12346788999999999999999999998763

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=9.9e-36  Score=280.46  Aligned_cols=241  Identities=24%  Similarity=0.257  Sum_probs=184.4

Q ss_pred             eeccCCcEEEEEEEECC--ceEEEEEEcCCCh---HhHHHHHHHHH---HHHhcCCCceeeeEeEEEeCCeeEEEEecCC
Q 014024          116 KLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSG---QEIKELKNEAS---VIAQVQHKNLVKLLGCCIEKDERLLIYEYMP  187 (432)
Q Consensus       116 ~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~---~~~~~~~~E~~---~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  187 (432)
                      .||+|+||.||++.+..  ..||+|.+.....   .....+..|..   .++...|+|++++.+++.+.+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            48999999999998754  4899998854321   11122334433   3444579999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCcc
Q 014024          188 NKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDED  267 (432)
Q Consensus       188 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  267 (432)
                      +++|.+++..   .+.+++..+..++.|++.|+.|||+.+   ++||||||+||++++++.++|+|||++......    
T Consensus        81 g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~----  150 (278)
T cd05606          81 GGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK----  150 (278)
T ss_pred             CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCcc----
Confidence            9999998843   345999999999999999999999998   999999999999999999999999998754211    


Q ss_pred             ccccccccccccCCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhh
Q 014024          268 ELQGNTSRISGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSV  346 (432)
Q Consensus       268 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  346 (432)
                          ......|+..|+|||.+.++ .++.++||||+|+++|+|++|+.||...........   .         ... ..
T Consensus       151 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~---~---------~~~-~~  213 (278)
T cd05606         151 ----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI---D---------RMT-LT  213 (278)
T ss_pred             ----CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH---H---------HHh-hc
Confidence                11234688999999998754 689999999999999999999999864322111000   0         000 00


Q ss_pred             hhhcccHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 014024          347 LEEASFNESLSRYVHIALLCVQERAEDRP-----TMSDVVSM  383 (432)
Q Consensus       347 l~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~~  383 (432)
                      .....+......+.+++.+|+..+|.+||     ++.+++++
T Consensus       214 ~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         214 MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             cCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence            01111222356788999999999999999     99999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=2.5e-36  Score=293.03  Aligned_cols=264  Identities=23%  Similarity=0.314  Sum_probs=193.0

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeC---------
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEK---------  176 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---------  176 (432)
                      .++|.+.+.||.|+||.||+|.+..  ..+++|++........+.+.+|+++++.++|+||+++++++...         
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            4789999999999999999999854  38999988666656667889999999999999999999776543         


Q ss_pred             -----CeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEc-CCCCEE
Q 014024          177 -----DERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLD-KDMNSK  250 (432)
Q Consensus       177 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~k  250 (432)
                           ...++||||++ ++|.+++.    ...+++..++.++.|++.||.|||+.+   ++||||||+||+++ +++.+|
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k  155 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK  155 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence                 35789999997 58887773    234899999999999999999999998   99999999999997 456789


Q ss_pred             EeecccceeccCCCCccccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhh
Q 014024          251 ISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGY  329 (432)
Q Consensus       251 l~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~  329 (432)
                      |+|||++.........   ........++..|+|||.+.+ ..++.++|||||||++|+|++|+.||........ ....
T Consensus       156 l~dfg~~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~-~~~~  231 (342)
T cd07854         156 IGDFGLARIVDPHYSH---KGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ-MQLI  231 (342)
T ss_pred             ECCcccceecCCcccc---ccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHH
Confidence            9999999764221111   111223457889999998754 5688999999999999999999999854322100 0000


Q ss_pred             hHHhhh-----ccchhhhhhhhhh-----h-----cccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          330 AWDLWI-----SNKIIDLIDSVLE-----E-----ASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       330 ~~~~~~-----~~~~~~~i~~~l~-----~-----~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      ......     .......+.....     .     ........++.+++..||+.||++|||+.+++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  300 (342)
T cd07854         232 LESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH  300 (342)
T ss_pred             HHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence            000000     0000000000000     0     0011234568899999999999999999999975

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-35  Score=280.48  Aligned_cols=260  Identities=23%  Similarity=0.272  Sum_probs=191.2

Q ss_pred             CCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCC--hHhHHHHHHHHHHHHhc---CCCceeeeEeEEEeCCe-----
Q 014024          111 FSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS--GQEIKELKNEASVIAQV---QHKNLVKLLGCCIEKDE-----  178 (432)
Q Consensus       111 y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~-----  178 (432)
                      |++.+.||+|+||.||+|.+..  ..+++|++....  ......+.+|+.+++++   +|+|++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            6778999999999999999864  489999986432  22234566788777766   59999999999988776     


Q ss_pred             eEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccce
Q 014024          179 RLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMAR  258 (432)
Q Consensus       179 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  258 (432)
                      .+++|||+.+ +|.+++..... ..+++..++.++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++.
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~  155 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR  155 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence            8999999975 78887754322 34899999999999999999999998   9999999999999999999999999997


Q ss_pred             eccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhh----
Q 014024          259 IVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLW----  334 (432)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~----  334 (432)
                      .....       .......++..|+|||.+.+..++.++|+|||||++|+|++|+.||......+ ..........    
T Consensus       156 ~~~~~-------~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  227 (287)
T cd07838         156 IYSFE-------MALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD-QLDKIFDVIGLPSE  227 (287)
T ss_pred             eccCC-------cccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH-HHHHHHHHcCCCCh
Confidence            75211       11122347888999999999899999999999999999999988875322110 0000000000    


Q ss_pred             ---hccc--hhhhhhhhhh---hcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          335 ---ISNK--IIDLIDSVLE---EASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       335 ---~~~~--~~~~i~~~l~---~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                         ....  ..........   ..........+.+++.+||+.||.+||++.+++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         228 EEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             HhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence               0000  0000000000   11112334677899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=6e-36  Score=278.94  Aligned_cols=248  Identities=23%  Similarity=0.326  Sum_probs=194.2

Q ss_pred             eccCCcEEEEEEEECC--ceEEEEEEcCCCh---HhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecCCCCCh
Q 014024          117 LGEGGFGTVYKGVIGQ--GEIAVKRLLGKSG---QEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSL  191 (432)
Q Consensus       117 ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  191 (432)
                      ||.|+||.||++.+..  ..+++|.+.....   ...+.+.+|++++++++|+|++++++.+..++..+++|||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999999864  4899998865433   4566788999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCcc--cc
Q 014024          192 DCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDED--EL  269 (432)
Q Consensus       192 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~--~~  269 (432)
                      .+++...   ..+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++..........  ..
T Consensus        81 ~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  154 (265)
T cd05579          81 ASLLENV---GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD  154 (265)
T ss_pred             HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence            9998543   35899999999999999999999998   9999999999999999999999999987642211100  00


Q ss_pred             ccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhhhhh
Q 014024          270 QGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEE  349 (432)
Q Consensus       270 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  349 (432)
                      ........++..|+|||.......+.++|+||||+++|+|++|..||.......     ....         .....  .
T Consensus       155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-----~~~~---------~~~~~--~  218 (265)
T cd05579         155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE-----IFQN---------ILNGK--I  218 (265)
T ss_pred             cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-----HHHH---------HhcCC--c
Confidence            112234567889999999988889999999999999999999999975332110     0000         00000  0


Q ss_pred             cccHH--HHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014024          350 ASFNE--SLSRYVHIALLCVQERAEDRPTMSDVVSMLTN  386 (432)
Q Consensus       350 ~~~~~--~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~  386 (432)
                      ..+..  .+..+.+++.+||+.+|.+|||+.++.+.|+.
T Consensus       219 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~  257 (265)
T cd05579         219 EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH  257 (265)
T ss_pred             CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence            11111  25678899999999999999999666666654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=6.6e-36  Score=284.17  Aligned_cols=253  Identities=23%  Similarity=0.365  Sum_probs=191.7

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCCC-hHhHHHHHHHHHHHHhcC-CCceeeeEeEEEeCCeeEEE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGKS-GQEIKELKNEASVIAQVQ-HKNLVKLLGCCIEKDERLLI  182 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv  182 (432)
                      ..++|++.+.||+|++|.||+|.+.  +..+++|.+.... ......+..|+.++.... |+||+++++++.+....+++
T Consensus        13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v   92 (296)
T cd06618          13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC   92 (296)
T ss_pred             CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence            3477899999999999999999987  4589999986542 234455667777777765 99999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCCCCCEEEcCCCCEEEeecccceecc
Q 014024          183 YEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ-YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVF  261 (432)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  261 (432)
                      |||+. +++.++....  ...+++..+..++.|++.||+|||+ .+   ++||||+|+||++++++.+||+|||++..+.
T Consensus        93 ~e~~~-~~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~  166 (296)
T cd06618          93 MELMS-TCLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLV  166 (296)
T ss_pred             eeccC-cCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence            99985 4666665432  2358999999999999999999997 46   9999999999999999999999999987642


Q ss_pred             CCCCccccccccccccccCCccChhhhccCC----CCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhcc
Q 014024          262 GGNDEDELQGNTSRISGTYGYMSPEYALEGI----FSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISN  337 (432)
Q Consensus       262 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  337 (432)
                      ...       ......++..|+|||.+.+..    ++.++|+||||+++|+|++|+.||....... .....    ....
T Consensus       167 ~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~----~~~~  234 (296)
T cd06618         167 DSK-------AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-EVLTK----ILQE  234 (296)
T ss_pred             CCC-------cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH-HHHHH----HhcC
Confidence            111       112235778899999987553    8899999999999999999999985322110 00000    0000


Q ss_pred             chhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          338 KIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       338 ~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                      ....       .........++.+++.+||+.||++||++.+++++.
T Consensus       235 ~~~~-------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~  274 (296)
T cd06618         235 EPPS-------LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP  274 (296)
T ss_pred             CCCC-------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence            0000       000112346789999999999999999999999764

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-36  Score=281.70  Aligned_cols=261  Identities=23%  Similarity=0.284  Sum_probs=192.8

Q ss_pred             CCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCCh-HhHHHHHHHHHHHHhcC-CCceeeeEeEEEeCCeeEEEEecC
Q 014024          111 FSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSG-QEIKELKNEASVIAQVQ-HKNLVKLLGCCIEKDERLLIYEYM  186 (432)
Q Consensus       111 y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~  186 (432)
                      |++.+.||.|++|.||+|...+  ..+++|++..... .......+|+..+++++ |+|++++++++.+++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            6778999999999999999854  4799998855422 22234567899999999 999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCc
Q 014024          187 PNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDE  266 (432)
Q Consensus       187 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  266 (432)
                       +|+|.+++.... ...+++..+..++.|++.+|.|||+++   ++|+||+|+||++++++.++|+|||++......   
T Consensus        81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~---  152 (283)
T cd07830          81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSR---  152 (283)
T ss_pred             -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCC---
Confidence             788988885433 235899999999999999999999998   999999999999999999999999999764221   


Q ss_pred             cccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccc--hh---------hhhHHhh
Q 014024          267 DELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLN--LI---------GYAWDLW  334 (432)
Q Consensus       267 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~--~~---------~~~~~~~  334 (432)
                          .......++..|+|||++.+ ..++.++|+||||+++++|++|+.||......+..  ..         .|.....
T Consensus       153 ----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (283)
T cd07830         153 ----PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYK  228 (283)
T ss_pred             ----CCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhh
Confidence                11223457889999998754 55899999999999999999999888543221100  00         0000000


Q ss_pred             hccchhhhhhhhh---hhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          335 ISNKIIDLIDSVL---EEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       335 ~~~~~~~~i~~~l---~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      ........+....   ...........+.+++..||+.+|++|||+.|++.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         229 LASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             hhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            0000000000000   000011124678899999999999999999999865

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-36  Score=274.60  Aligned_cols=265  Identities=25%  Similarity=0.360  Sum_probs=216.8

Q ss_pred             hhhHhhhhCCCCcCceeccCCcEEEEEEEECCc-------eEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeE
Q 014024          101 FSSVSSATGNFSAANKLGEGGFGTVYKGVIGQG-------EIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGC  172 (432)
Q Consensus       101 ~~~~~~~~~~y~~~~~ig~G~~g~Vy~~~~~~~-------~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~  172 (432)
                      ..++.....+++...++-+|.||.||+|.+.+.       .+.+|.+... ++-....+..|.-.+..+.|||+..+.++
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V  355 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV  355 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence            344555667889999999999999999965332       4667766443 44556778889999999999999999999


Q ss_pred             EEeC-CeeEEEEecCCCCChhhhhc-----CCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCC
Q 014024          173 CIEK-DERLLIYEYMPNKSLDCFLF-----DPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKD  246 (432)
Q Consensus       173 ~~~~-~~~~lv~e~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~  246 (432)
                      +.+. ...+++|.++.-|+|..|+.     +......++..+...++.|++.|++|||..+   ++|.||..+|+++|+.
T Consensus       356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~  432 (563)
T KOG1024|consen  356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQ  432 (563)
T ss_pred             EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhh
Confidence            8654 57788999999999999997     5555556888899999999999999999999   9999999999999999


Q ss_pred             CCEEEeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccc
Q 014024          247 MNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLN  325 (432)
Q Consensus       247 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~  325 (432)
                      .++||+|=.+++.+.+.+..    .-..+-.....||+||.+....|+.++|||||||+||||+| |+.|+-..++    
T Consensus       433 LqVkltDsaLSRDLFP~DYh----cLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP----  504 (563)
T KOG1024|consen  433 LQVKLTDSALSRDLFPGDYH----CLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP----  504 (563)
T ss_pred             eeEEeccchhccccCccccc----ccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH----
Confidence            99999999999887554322    22223344567999999999999999999999999999999 8888643222    


Q ss_pred             hhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014024          326 LIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNE  387 (432)
Q Consensus       326 ~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~  387 (432)
                                 .++..++.+..+-..+..|+.++..++..||..+|++||++++++.-|.+.
T Consensus       505 -----------fEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF  555 (563)
T KOG1024|consen  505 -----------FEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF  555 (563)
T ss_pred             -----------HHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence                       234455566666667788999999999999999999999999999988764

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-37  Score=275.43  Aligned_cols=248  Identities=23%  Similarity=0.273  Sum_probs=201.4

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCCC---hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKS---GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLL  181 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  181 (432)
                      ..++|..+++||+|.||+|.+++.+..  .+|+|++.+..   ......-..|-++|+..+||.+..+...|...+.+|+
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF  245 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF  245 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence            457899999999999999999987544  78999886552   3334455678999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceecc
Q 014024          182 IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVF  261 (432)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  261 (432)
                      ||||..||.|.-+|.   ..+.+++...+.+-..|+.||.|||+++   ||+||||.+|.|+|.+|++||+|||+++-- 
T Consensus       246 VMeyanGGeLf~HLs---rer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~-  318 (516)
T KOG0690|consen  246 VMEYANGGELFFHLS---RERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEE-  318 (516)
T ss_pred             EEEEccCceEeeehh---hhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhc-
Confidence            999999999988883   4556999999999999999999999998   999999999999999999999999999752 


Q ss_pred             CCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhh
Q 014024          262 GGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIID  341 (432)
Q Consensus       262 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (432)
                           -.........+|||.|+|||++....|..++|.|.+||++|||++|+.||..-+.               +.+.+
T Consensus       319 -----I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh---------------~kLFe  378 (516)
T KOG0690|consen  319 -----IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH---------------EKLFE  378 (516)
T ss_pred             -----ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch---------------hHHHH
Confidence                 1223456778999999999999999999999999999999999999999742211               12222


Q ss_pred             hhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 014024          342 LIDSVLEEASFNESLSRYVHIALLCVQERAEDRP-----TMSDVVS  382 (432)
Q Consensus       342 ~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~  382 (432)
                      +|-- -....+.....+...|+...|.+||.+|.     .+.||.+
T Consensus       379 LIl~-ed~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~  423 (516)
T KOG0690|consen  379 LILM-EDLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR  423 (516)
T ss_pred             HHHh-hhccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence            2211 01123444556677888899999999996     3556554

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.4e-36  Score=312.35  Aligned_cols=256  Identities=25%  Similarity=0.390  Sum_probs=190.8

Q ss_pred             hhhCCCCcCceeccCCcEEEEEEEE--CCceEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEe-------
Q 014024          106 SATGNFSAANKLGEGGFGTVYKGVI--GQGEIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIE-------  175 (432)
Q Consensus       106 ~~~~~y~~~~~ig~G~~g~Vy~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-------  175 (432)
                      .-..+|+.++.||+||||.||++++  ++..+|||++... +......+.+|+..|++++|||||+++..+.+       
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            4467889999999999999999997  4569999999655 44456678899999999999999999852210       


Q ss_pred             --------------------------------------------------------------------------------
Q 014024          176 --------------------------------------------------------------------------------  175 (432)
Q Consensus       176 --------------------------------------------------------------------------------  175 (432)
                                                                                                      
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ------------------------C--------CeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 014024          176 ------------------------K--------DERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYL  223 (432)
Q Consensus       176 ------------------------~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~L  223 (432)
                                              +        ..+||=||||+..++.+++.+.....  .....++++.+|++||+|+
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYI  713 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYI  713 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHH
Confidence                                    0        12367799999988888885432211  4778899999999999999


Q ss_pred             HhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceecc------------CCCCccccccccccccccCCccChhhhccC
Q 014024          224 HQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVF------------GGNDEDELQGNTSRISGTYGYMSPEYALEG  291 (432)
Q Consensus       224 H~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~------------~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  291 (432)
                      |+.|   ||||||||.||++++++.+||+|||+|....            ............+...||.-|+|||++.+.
T Consensus       714 H~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~  790 (1351)
T KOG1035|consen  714 HDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT  790 (1351)
T ss_pred             HhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence            9999   9999999999999999999999999998721            111112223355678899999999999864


Q ss_pred             ---CCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhhhh--hcccHHHHHHHHHHHHHh
Q 014024          292 ---IFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLE--EASFNESLSRYVHIALLC  366 (432)
Q Consensus       292 ---~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~--~~~~~~~~~~l~~l~~~c  366 (432)
                         .|+.|+|+||||+|++||+.   ||+..    ++.+...         .++-+..+.  .....+....=..++.++
T Consensus       791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts----MERa~iL---------~~LR~g~iP~~~~f~~~~~~~e~slI~~L  854 (1351)
T KOG1035|consen  791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTS----MERASIL---------TNLRKGSIPEPADFFDPEHPEEASLIRWL  854 (1351)
T ss_pred             ccccccchhhhHHHHHHHHHHhc---cCCch----HHHHHHH---------HhcccCCCCCCcccccccchHHHHHHHHH
Confidence               49999999999999999996   34311    1111111         111111111  111233344556899999


Q ss_pred             hccCCCCCCCHHHHHH
Q 014024          367 VQERAEDRPTMSDVVS  382 (432)
Q Consensus       367 l~~dp~~RPt~~evl~  382 (432)
                      ++.||.+|||+.|+++
T Consensus       855 l~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  855 LSHDPSKRPTATELLN  870 (1351)
T ss_pred             hcCCCccCCCHHHHhh
Confidence            9999999999999985

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.8e-35  Score=286.18  Aligned_cols=269  Identities=20%  Similarity=0.246  Sum_probs=194.6

Q ss_pred             hCCCC-cCceeccCCcEEEEEEEECC--ceEEEEEEcCCChHh--------------HHHHHHHHHHHHhcCCCceeeeE
Q 014024          108 TGNFS-AANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSGQE--------------IKELKNEASVIAQVQHKNLVKLL  170 (432)
Q Consensus       108 ~~~y~-~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~~~  170 (432)
                      .++|. +.+.||.|+||.||+|.+..  ..+|+|.+.......              ...+.+|++++++++|+||++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            45665 45779999999999999753  489999885432211              12467899999999999999999


Q ss_pred             eEEEeCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEE
Q 014024          171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSK  250 (432)
Q Consensus       171 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  250 (432)
                      +++...+..++||||+. ++|.+++..   +..+++.....++.|++.||+|||+.+   ++|+||+|+||+++.++.++
T Consensus        87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~k  159 (335)
T PTZ00024         87 DVYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICK  159 (335)
T ss_pred             EEEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEE
Confidence            99999999999999996 588888843   344899999999999999999999998   99999999999999999999


Q ss_pred             EeecccceeccCCCCcc--------ccccccccccccCCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCCccc
Q 014024          251 ISDFGMARIVFGGNDED--------ELQGNTSRISGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGFYRT  321 (432)
Q Consensus       251 l~Dfg~a~~~~~~~~~~--------~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlG~il~elltg~~p~~~~~~  321 (432)
                      |+|||++..........        ..........+++.|+|||.+.+. .++.++|+|||||++|+|++|+.||.....
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~  239 (335)
T PTZ00024        160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE  239 (335)
T ss_pred             ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            99999998653110000        001112234568889999988764 479999999999999999999999864332


Q ss_pred             cccchhhhhHHhhhccc---hhhh------------hhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014024          322 KSLNLIGYAWDLWISNK---IIDL------------IDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN  386 (432)
Q Consensus       322 ~~~~~~~~~~~~~~~~~---~~~~------------i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~  386 (432)
                      ..  .............   ....            ..... ..........+.+++..||+.+|++|||+.|++.+-.-
T Consensus       240 ~~--~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~  316 (335)
T PTZ00024        240 ID--QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDL-KTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYF  316 (335)
T ss_pred             HH--HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccH-HHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCccc
Confidence            11  1111100000000   0000            00000 00011234568899999999999999999999985443

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.2e-35  Score=285.31  Aligned_cols=263  Identities=23%  Similarity=0.279  Sum_probs=191.1

Q ss_pred             CCCcCceeccCCcEEEEEEEECC----ceEEEEEEcCC--ChHhHHHHHHHHHHHHhc-CCCceeeeEeEEEeC----Ce
Q 014024          110 NFSAANKLGEGGFGTVYKGVIGQ----GEIAVKRLLGK--SGQEIKELKNEASVIAQV-QHKNLVKLLGCCIEK----DE  178 (432)
Q Consensus       110 ~y~~~~~ig~G~~g~Vy~~~~~~----~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~----~~  178 (432)
                      +|++.+.||+|+||.||++....    ..+|+|.+...  .....+.+.+|+++++++ +|+||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            57888999999999999999754    37999987542  223355678899999999 599999999875432    45


Q ss_pred             eEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccce
Q 014024          179 RLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMAR  258 (432)
Q Consensus       179 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  258 (432)
                      .++++||+. ++|.+++.   ....+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||++.
T Consensus        81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~  153 (332)
T cd07857          81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR  153 (332)
T ss_pred             EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence            688899885 68888874   3345899999999999999999999998   9999999999999999999999999998


Q ss_pred             eccCCCCccccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhh-------
Q 014024          259 IVFGGNDEDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYA-------  330 (432)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~-------  330 (432)
                      ........  .........|+..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.......  .....       
T Consensus       154 ~~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~  229 (332)
T cd07857         154 GFSENPGE--NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD--QLNQILQVLGTP  229 (332)
T ss_pred             eccccccc--ccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH--HHHHHHHHhCCC
Confidence            65322111  1112234578999999998765 568999999999999999999999986433210  00000       


Q ss_pred             ----HHhhhccchhhhhhhhhh------hcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          331 ----WDLWISNKIIDLIDSVLE------EASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       331 ----~~~~~~~~~~~~i~~~l~------~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                          ................-.      ..........+.+++.+||+.||++|||+.+++.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~  292 (332)
T cd07857         230 DEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH  292 (332)
T ss_pred             CHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                000000000000000000      00011124578899999999999999999999864

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-35  Score=288.14  Aligned_cols=259  Identities=22%  Similarity=0.309  Sum_probs=195.4

Q ss_pred             hhhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCe---
Q 014024          106 SATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDE---  178 (432)
Q Consensus       106 ~~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---  178 (432)
                      ...++|++.+.||+|++|.||+|.+..  ..+++|++...  .....+.+.+|+.+++.++|+|++++.+++...+.   
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            346789999999999999999999854  47999987543  23344667789999999999999999988765554   


Q ss_pred             ---eEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecc
Q 014024          179 ---RLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFG  255 (432)
Q Consensus       179 ---~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  255 (432)
                         .++|+||+ +++|.+++..    ..+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.++|+|||
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg  163 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFG  163 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccc
Confidence               89999998 6689888843    34999999999999999999999998   9999999999999999999999999


Q ss_pred             cceeccCCCCccccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhh----
Q 014024          256 MARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYA----  330 (432)
Q Consensus       256 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~----  330 (432)
                      ++.....         ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.......  .....    
T Consensus       164 ~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~--~~~~i~~~~  232 (343)
T cd07851         164 LARHTDD---------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID--QLKRIMNLV  232 (343)
T ss_pred             ccccccc---------cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHhc
Confidence            9976411         1233467888999998865 467899999999999999999999985332210  00000    


Q ss_pred             -------HHhhhccchhhhhhhhhhhc------ccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          331 -------WDLWISNKIIDLIDSVLEEA------SFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       331 -------~~~~~~~~~~~~i~~~l~~~------~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                             ...........++.......      ........+.+++.+||+.+|++|||+.+|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         233 GTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             CCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence                   00000111111111100000      001125678899999999999999999999875

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-35  Score=278.81  Aligned_cols=260  Identities=24%  Similarity=0.313  Sum_probs=195.2

Q ss_pred             CCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCC--hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecC
Q 014024          111 FSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS--GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYM  186 (432)
Q Consensus       111 y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  186 (432)
                      |+..+.||+|++|.||+|....  ..+++|.+....  ....+.+..|+.++++++|+|++++++++.+.+..++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            5667889999999999999864  489999886542  334466788999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCc
Q 014024          187 PNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDE  266 (432)
Q Consensus       187 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  266 (432)
                      + ++|.+++....  ..+++..+..++.|++.||+|||+.+   ++||||+|+||++++++.++|+|||.+.......  
T Consensus        81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~--  152 (282)
T cd07829          81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPL--  152 (282)
T ss_pred             C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCc--
Confidence            7 58999985432  35999999999999999999999998   9999999999999999999999999997642211  


Q ss_pred             cccccccccccccCCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCCcccccc--chhh-------hhHHhhh-
Q 014024          267 DELQGNTSRISGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSL--NLIG-------YAWDLWI-  335 (432)
Q Consensus       267 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~--~~~~-------~~~~~~~-  335 (432)
                          .......++..|+|||.+.+. .++.++|+||||+++|||++|+.||......+.  ....       ..+.... 
T Consensus       153 ----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (282)
T cd07829         153 ----RTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTK  228 (282)
T ss_pred             ----cccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcc
Confidence                112233457789999998776 789999999999999999999988754321100  0000       0000000 


Q ss_pred             ----ccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          336 ----SNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       336 ----~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                          ............ ....+.....+.+++..||+.+|++||++.+++.+
T Consensus       229 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         229 LPDYKPTFPKFPPKDL-EKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             cccccccccccCccch-HHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence                000000000000 00111225678999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-36  Score=267.10  Aligned_cols=264  Identities=24%  Similarity=0.267  Sum_probs=199.6

Q ss_pred             CceeccCCcEEEEEEEE--CCceEEEEEEcCCChHhHHHHHHHHHHHHhcC-CCceeeeEeEEEeCCeeEEEEecCCCCC
Q 014024          114 ANKLGEGGFGTVYKGVI--GQGEIAVKRLLGKSGQEIKELKNEASVIAQVQ-HKNLVKLLGCCIEKDERLLIYEYMPNKS  190 (432)
Q Consensus       114 ~~~ig~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gs  190 (432)
                      .+.||+|+|+.|--+..  .+.++|||++.+........+.+|++++.+++ |+||+.++++|+++..+|||||-+.||+
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp  162 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP  162 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence            46799999999998875  34489999998887788889999999999995 9999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCC---EEEeecccceeccCCCCc-
Q 014024          191 LDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN---SKISDFGMARIVFGGNDE-  266 (432)
Q Consensus       191 L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Dfg~a~~~~~~~~~-  266 (432)
                      |..+++   .+..|++.++.++..+|+.||.|||.+|   |.||||||+|||-.+...   +||+||.+..-..-..+- 
T Consensus       163 lLshI~---~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s  236 (463)
T KOG0607|consen  163 LLSHIQ---KRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS  236 (463)
T ss_pred             HHHHHH---HhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence            999995   4556999999999999999999999999   999999999999976554   799999887643222111 


Q ss_pred             cccccccccccccCCccChhhhc-----cCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhh
Q 014024          267 DELQGNTSRISGTYGYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIID  341 (432)
Q Consensus       267 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (432)
                      ..........+|+..|||||+..     ...|+.++|.||||||||-|++|..||......+-.+-.--.-..-.+.+.+
T Consensus       237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFe  316 (463)
T KOG0607|consen  237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFE  316 (463)
T ss_pred             CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHH
Confidence            11122334578999999999875     2458999999999999999999999997654432211000000000011112


Q ss_pred             hhhhhhhhcccHHH----HHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          342 LIDSVLEEASFNES----LSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       342 ~i~~~l~~~~~~~~----~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                      -|+.... ++++..    ..+-.+++...+..|+.+|.++.+++++-
T Consensus       317 sIQEGkY-eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhP  362 (463)
T KOG0607|consen  317 SIQEGKY-EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHP  362 (463)
T ss_pred             HHhccCC-cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCc
Confidence            2221111 123322    34456788889999999999999999843

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.2e-35  Score=265.29  Aligned_cols=279  Identities=20%  Similarity=0.271  Sum_probs=198.9

Q ss_pred             hhhCCCCcCceeccCCcEEEEEEEECCc------eEEEEEEcCCCh--HhHHHHHHHHHHHHhcCCCceeeeEeEEEe-C
Q 014024          106 SATGNFSAANKLGEGGFGTVYKGVIGQG------EIAVKRLLGKSG--QEIKELKNEASVIAQVQHKNLVKLLGCCIE-K  176 (432)
Q Consensus       106 ~~~~~y~~~~~ig~G~~g~Vy~~~~~~~------~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~  176 (432)
                      .....|+.+..||+|.||.||+|...++      .+|+|++.....  .......+|+..++.++|+|++.+..++.+ +
T Consensus        21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d  100 (438)
T KOG0666|consen   21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD  100 (438)
T ss_pred             HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence            4556899999999999999999964322      589998865422  223456789999999999999999999977 7


Q ss_pred             CeeEEEEecCCCCChhhhhcC--CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCC----CCEE
Q 014024          177 DERLLIYEYMPNKSLDCFLFD--PTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKD----MNSK  250 (432)
Q Consensus       177 ~~~~lv~e~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~k  250 (432)
                      ...++++||.+. +|...++.  ......++...+..|+.||+.|+.|||++-   |+||||||.|||+..+    |.+|
T Consensus       101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VK  176 (438)
T KOG0666|consen  101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVK  176 (438)
T ss_pred             ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeE
Confidence            788999999977 55555543  223346899999999999999999999998   9999999999999877    8999


Q ss_pred             EeecccceeccCCCCccccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCccc--cccchh
Q 014024          251 ISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRT--KSLNLI  327 (432)
Q Consensus       251 l~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~--~~~~~~  327 (432)
                      |+|+|+++.+...-   ..-......+.|.+|+|||.+.+ ..||++.|||+.|||+.||+|-.+-|.....  +..+..
T Consensus       177 IaDlGlaR~~~~pl---kpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pf  253 (438)
T KOG0666|consen  177 IADLGLARLFNNPL---KPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPF  253 (438)
T ss_pred             eecccHHHHhhccc---cccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCc
Confidence            99999999863221   11223456788999999999886 5699999999999999999998776533221  111000


Q ss_pred             -----hhhHHh---hhc---------cchhhhhhhhhhhcccHH-----------HHHHHHHHHHHhhccCCCCCCCHHH
Q 014024          328 -----GYAWDL---WIS---------NKIIDLIDSVLEEASFNE-----------SLSRYVHIALLCVQERAEDRPTMSD  379 (432)
Q Consensus       328 -----~~~~~~---~~~---------~~~~~~i~~~l~~~~~~~-----------~~~~l~~l~~~cl~~dp~~RPt~~e  379 (432)
                           ......   ...         ......+...-+.....-           -...-.+|+..+|+.||-+|.|+.+
T Consensus       254 q~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~q  333 (438)
T KOG0666|consen  254 QHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQ  333 (438)
T ss_pred             hHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHH
Confidence                 000000   000         011111111111111110           0122568999999999999999999


Q ss_pred             HHHHhcccccCC
Q 014024          380 VVSMLTNEASSL  391 (432)
Q Consensus       380 vl~~L~~~~~~~  391 (432)
                      .+++.--..+.+
T Consensus       334 Aleh~yF~~d~l  345 (438)
T KOG0666|consen  334 ALEHPYFTEDPL  345 (438)
T ss_pred             HhcccccccCCC
Confidence            998654433333

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-35  Score=270.13  Aligned_cols=235  Identities=26%  Similarity=0.314  Sum_probs=189.2

Q ss_pred             eccCCcEEEEEEEECC--ceEEEEEEcCCC---hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecCCCCCh
Q 014024          117 LGEGGFGTVYKGVIGQ--GEIAVKRLLGKS---GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSL  191 (432)
Q Consensus       117 ig~G~~g~Vy~~~~~~--~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  191 (432)
                      ||.|+||.||++...+  ..+++|.+....   ......+..|++++++++|+|++++++.+..++..+++|||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            6999999999999863  488999875442   23456788999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCcccccc
Q 014024          192 DCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQG  271 (432)
Q Consensus       192 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  271 (432)
                      .+++...   ..+++.....++.|++.|+.|||+.+   ++|+||+|+||++++++.++|+|||++.......      .
T Consensus        81 ~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~------~  148 (250)
T cd05123          81 FSHLSKE---GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG------S  148 (250)
T ss_pred             HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC------C
Confidence            9998532   35899999999999999999999998   9999999999999999999999999998642211      1


Q ss_pred             ccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhhhhhcc
Q 014024          272 NTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEAS  351 (432)
Q Consensus       272 ~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~  351 (432)
                      ......++..|+|||...+...+.++|+||||+++|+|++|..||...+..  ..   .         .....  .....
T Consensus       149 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--~~---~---------~~~~~--~~~~~  212 (250)
T cd05123         149 RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK--EI---Y---------EKILK--DPLRF  212 (250)
T ss_pred             cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--HH---H---------HHHhc--CCCCC
Confidence            233456788999999998888999999999999999999999998532210  00   0         00000  01112


Q ss_pred             cHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 014024          352 FNESLSRYVHIALLCVQERAEDRPTMSD  379 (432)
Q Consensus       352 ~~~~~~~l~~l~~~cl~~dp~~RPt~~e  379 (432)
                      +...+..+.+++.+||..||++||++.+
T Consensus       213 ~~~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         213 PEFLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence            2223567889999999999999999943

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-36  Score=307.30  Aligned_cols=258  Identities=21%  Similarity=0.235  Sum_probs=201.7

Q ss_pred             hhhHhhhhCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCC---ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEe
Q 014024          101 FSSVSSATGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGK---SGQEIKELKNEASVIAQVQHKNLVKLLGCCIE  175 (432)
Q Consensus       101 ~~~~~~~~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  175 (432)
                      ..++....++|.++++||+|+||.|...+...+  -+|+|++.+.   ......-|..|-.+|..-+.+-|+.++..|.+
T Consensus        67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD  146 (1317)
T KOG0612|consen   67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD  146 (1317)
T ss_pred             HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence            345566789999999999999999999998665  6799988552   23445668889999999999999999999999


Q ss_pred             CCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecc
Q 014024          176 KDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFG  255 (432)
Q Consensus       176 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  255 (432)
                      ++++|+||||++||+|-.++..   ...+++..+..++..|+.||..||+.|   +|||||||+|||+|.+|++||+|||
T Consensus       147 ~~~LYlVMdY~pGGDlltLlSk---~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFG  220 (1317)
T KOG0612|consen  147 ERYLYLVMDYMPGGDLLTLLSK---FDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFG  220 (1317)
T ss_pred             ccceEEEEecccCchHHHHHhh---cCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccch
Confidence            9999999999999999999843   335999999999999999999999999   9999999999999999999999999


Q ss_pred             cceeccCCCCccccccccccccccCCccChhhhc----c-CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhh
Q 014024          256 MARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL----E-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYA  330 (432)
Q Consensus       256 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~  330 (432)
                      .+..+...     -.......+|||.|++||++.    + +.|++.+|.||+||++|||+.|..||-...     ++   
T Consensus       221 sClkm~~d-----G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads-----lv---  287 (1317)
T KOG0612|consen  221 SCLKMDAD-----GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS-----LV---  287 (1317)
T ss_pred             hHHhcCCC-----CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH-----HH---
Confidence            99876311     133456689999999999986    3 679999999999999999999999983211     11   


Q ss_pred             HHhhhccchhhhhhh--hhhhcccHHHHHHHHHHHHHhhccCCCCCCC---HHHHHHHh
Q 014024          331 WDLWISNKIIDLIDS--VLEEASFNESLSRYVHIALLCVQERAEDRPT---MSDVVSML  384 (432)
Q Consensus       331 ~~~~~~~~~~~~i~~--~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt---~~evl~~L  384 (432)
                            +.-..+++.  .+.-+...+.+....+||...+. +|+.|..   +.++-.|.
T Consensus       288 ------eTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~Hp  339 (1317)
T KOG0612|consen  288 ------ETYGKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHP  339 (1317)
T ss_pred             ------HHHHHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCc
Confidence                  111111111  11111112234556666666553 6778887   88887754

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1e-35  Score=291.90  Aligned_cols=203  Identities=29%  Similarity=0.406  Sum_probs=173.3

Q ss_pred             CCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCCC-hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeC------Cee
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKS-GQEIKELKNEASVIAQVQHKNLVKLLGCCIEK------DER  179 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~  179 (432)
                      ..|...+.||+|+||.||+|+++..  .||||.+.... ....+....|+++|++++|+|||++++.=++.      +..
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~   92 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP   92 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence            4456678899999999999997543  89999886542 34456788999999999999999999986543      356


Q ss_pred             EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEc--CCCC--EEEeecc
Q 014024          180 LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLD--KDMN--SKISDFG  255 (432)
Q Consensus       180 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~--~~~~--~kl~Dfg  255 (432)
                      .+|||||.+|+|...+.......-+++.+.+.++.+++.||.|||+++   |+||||||.||++-  .+|+  .||+|||
T Consensus        93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG  169 (732)
T KOG4250|consen   93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFG  169 (732)
T ss_pred             eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccc
Confidence            899999999999999988776666999999999999999999999999   99999999999983  3343  6999999


Q ss_pred             cceeccCCCCccccccccccccccCCccChhhhc-cCCCCchhhhHHHHHHHHHHHhCCCCCCCccc
Q 014024          256 MARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRT  321 (432)
Q Consensus       256 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~~~DvwSlG~il~elltg~~p~~~~~~  321 (432)
                      .|+-+.++       ....+..||+.|.+||++. .+.|+..+|.|||||++|+++||..||.....
T Consensus       170 ~Arel~d~-------s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~  229 (732)
T KOG4250|consen  170 AARELDDN-------SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGG  229 (732)
T ss_pred             ccccCCCC-------CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCC
Confidence            99876322       2556789999999999999 48899999999999999999999999976554

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.8e-34  Score=301.74  Aligned_cols=145  Identities=28%  Similarity=0.423  Sum_probs=130.2

Q ss_pred             hCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCC---ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEE
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGK---SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLI  182 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  182 (432)
                      .++|.+.+.||+|+||.||+|.+.  +..||+|++...   .......+..|+.+++.++|+||+++++++......|+|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            468999999999999999999987  448999998543   234456788999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccce
Q 014024          183 YEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMAR  258 (432)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  258 (432)
                      |||+.+++|.+++..   .+.+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        83 mEy~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999999853   334889999999999999999999998   9999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-36  Score=261.82  Aligned_cols=251  Identities=23%  Similarity=0.376  Sum_probs=193.1

Q ss_pred             CCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC-ChHhHHHHHHHHHHHHhcC-CCceeeeEeEEEeCCeeEEEEe
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK-SGQEIKELKNEASVIAQVQ-HKNLVKLLGCCIEKDERLLIYE  184 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e  184 (432)
                      ++.+.+..||.|..|.||++....  .-.|||.+... +.+..+.+...++++...+ +|+||+.+|+|..+...++.||
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe  171 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME  171 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence            344567789999999999999876  46899988544 4566677888888877765 8999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCC
Q 014024          185 YMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGN  264 (432)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  264 (432)
                      .| ...++.++..  -.+++++..+-++...++.||.||.+++  +|+|||+||+|||+|+.|++|++|||.+-.+.++ 
T Consensus       172 lM-s~C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS-  245 (391)
T KOG0983|consen  172 LM-STCAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS-  245 (391)
T ss_pred             HH-HHHHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc-
Confidence            88 3345555543  2345888888899999999999999876  5999999999999999999999999999876432 


Q ss_pred             CccccccccccccccCCccChhhhcc---CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhh
Q 014024          265 DEDELQGNTSRISGTYGYMSPEYALE---GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIID  341 (432)
Q Consensus       265 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (432)
                            ...+...|-+.|||||.+.-   ..|+.++||||||+.++||.||+.||.....+ .+...-+    .+ +.. 
T Consensus       246 ------kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td-Fe~ltkv----ln-~eP-  312 (391)
T KOG0983|consen  246 ------KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD-FEVLTKV----LN-EEP-  312 (391)
T ss_pred             ------cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc-HHHHHHH----Hh-cCC-
Confidence                  23345678889999999873   46899999999999999999999998643221 1111111    01 000 


Q ss_pred             hhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          342 LIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       342 ~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                         +.+....  .....+.+++..||++|+.+||...+++++
T Consensus       313 ---P~L~~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  313 ---PLLPGHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             ---CCCCccc--CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence               1111111  134678899999999999999999999875

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-35  Score=301.85  Aligned_cols=261  Identities=29%  Similarity=0.448  Sum_probs=210.3

Q ss_pred             hhhCCCCcCceeccCCcEEEEEEEEC---------CceEEEEEEcCCC-hHhHHHHHHHHHHHHhc-CCCceeeeEeEEE
Q 014024          106 SATGNFSAANKLGEGGFGTVYKGVIG---------QGEIAVKRLLGKS-GQEIKELKNEASVIAQV-QHKNLVKLLGCCI  174 (432)
Q Consensus       106 ~~~~~y~~~~~ig~G~~g~Vy~~~~~---------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~  174 (432)
                      ...++..+.+.||+|.||.|++|...         ...||||.+.... ....+.+..|+++|+.+ +|+|++.++|+|.
T Consensus       293 ~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t  372 (609)
T KOG0200|consen  293 IPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACT  372 (609)
T ss_pred             echhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeec
Confidence            33455566779999999999999843         2279999986553 35677899999999999 5999999999999


Q ss_pred             eCCeeEEEEecCCCCChhhhhcCCC------C-----C--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCE
Q 014024          175 EKDERLLIYEYMPNKSLDCFLFDPT------K-----R--EILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNI  241 (432)
Q Consensus       175 ~~~~~~lv~e~~~~gsL~~~l~~~~------~-----~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NI  241 (432)
                      +.+..++|+||+..|+|.++++...      .     .  ..++..+.+.++.|||.|++||++..   ++||||..+||
T Consensus       373 ~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNV  449 (609)
T KOG0200|consen  373 QDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNV  449 (609)
T ss_pred             cCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhE
Confidence            9999999999999999999997544      0     0  23889999999999999999999998   99999999999


Q ss_pred             EEcCCCCEEEeecccceeccCCCCcccccccccccc--ccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCC
Q 014024          242 LLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRIS--GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGF  318 (432)
Q Consensus       242 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~  318 (432)
                      |++++..+||+|||+++.....+     ........  -...|||||.+....|+.++||||||++|||++| |..|+..
T Consensus       450 Li~~~~~~kIaDFGlar~~~~~~-----~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~  524 (609)
T KOG0200|consen  450 LITKNKVIKIADFGLARDHYNKD-----YYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG  524 (609)
T ss_pred             EecCCCEEEEccccceeccCCCC-----ceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC
Confidence            99999999999999998542211     11111112  2345999999999999999999999999999999 7777642


Q ss_pred             ccccccchhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014024          319 YRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEA  388 (432)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~  388 (432)
                      ..              ...++.+.+.+..+...+..+..++.+++..||+.+|++||++.++.+.++...
T Consensus       525 ~~--------------~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l  580 (609)
T KOG0200|consen  525 IP--------------PTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL  580 (609)
T ss_pred             CC--------------cHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence            11              012223345555555667778899999999999999999999999999998843

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=3.8e-35  Score=269.85  Aligned_cols=218  Identities=18%  Similarity=0.110  Sum_probs=172.7

Q ss_pred             CCcEEEEEEEECCc--eEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecCCCCChhhhhcC
Q 014024          120 GGFGTVYKGVIGQG--EIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFD  197 (432)
Q Consensus       120 G~~g~Vy~~~~~~~--~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~  197 (432)
                      |.+|.||++.+..+  .+|+|++....     .+..|...+....|||++++++++.+.+..+++|||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            88999999998543  79999986543     233455555566799999999999999999999999999999999853


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCcccccccccccc
Q 014024          198 PTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRIS  277 (432)
Q Consensus       198 ~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~  277 (432)
                         ...+++..+..++.|++.||.|||+.+   ++||||||+||++++++.++++|||.+.....         ......
T Consensus        79 ---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~---------~~~~~~  143 (237)
T cd05576          79 ---FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVED---------SCDGEA  143 (237)
T ss_pred             ---hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccc---------ccccCC
Confidence               234899999999999999999999998   99999999999999999999999998765421         112234


Q ss_pred             ccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhhhhhcccHHHHH
Q 014024          278 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLS  357 (432)
Q Consensus       278 gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~  357 (432)
                      ++..|+|||...+..++.++|+||+|+++|||++|..|+.......                    ........+.....
T Consensus       144 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~--------------------~~~~~~~~~~~~~~  203 (237)
T cd05576         144 VENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI--------------------NTHTTLNIPEWVSE  203 (237)
T ss_pred             cCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc--------------------ccccccCCcccCCH
Confidence            5677999999988889999999999999999999998753211100                    00000011122345


Q ss_pred             HHHHHHHHhhccCCCCCCCH
Q 014024          358 RYVHIALLCVQERAEDRPTM  377 (432)
Q Consensus       358 ~l~~l~~~cl~~dp~~RPt~  377 (432)
                      .+.+++.+||+.||++||++
T Consensus       204 ~~~~li~~~l~~dp~~R~~~  223 (237)
T cd05576         204 EARSLLQQLLQFNPTERLGA  223 (237)
T ss_pred             HHHHHHHHHccCCHHHhcCC
Confidence            67889999999999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-35  Score=287.44  Aligned_cols=243  Identities=21%  Similarity=0.226  Sum_probs=194.4

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCCChHhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeeEEEE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEIKELKNEASVIAQV-QHKNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  183 (432)
                      .++.|.+...+|.|+|+.|-++.+..+  ..++|++....    ....+|+.++... +|+|++++.+.+.+..+.|+||
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~  395 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM  395 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence            467889999999999999999987554  78999886552    2335566666555 7999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEE-cCCCCEEEeecccceeccC
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILL-DKDMNSKISDFGMARIVFG  262 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll-~~~~~~kl~Dfg~a~~~~~  262 (432)
                      |.+.++-+.+.+..   ...+. ..+..|+.+|+.|+.|||++|   ++||||||+|||+ ++.++++|+|||.++... 
T Consensus       396 e~l~g~ell~ri~~---~~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~-  467 (612)
T KOG0603|consen  396 ELLDGGELLRRIRS---KPEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELE-  467 (612)
T ss_pred             hhccccHHHHHHHh---cchhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCc-
Confidence            99999988877743   22233 777789999999999999999   9999999999999 699999999999998752 


Q ss_pred             CCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhh
Q 014024          263 GNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDL  342 (432)
Q Consensus       263 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                              ......+-|..|.|||+.....|++++|+||||++||+|++|+.|+......                 .++
T Consensus       468 --------~~~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-----------------~ei  522 (612)
T KOG0603|consen  468 --------RSCDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-----------------IEI  522 (612)
T ss_pred             --------hhhcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-----------------HHH
Confidence                    1233456788999999999999999999999999999999999997543321                 112


Q ss_pred             hhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014024          343 IDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN  386 (432)
Q Consensus       343 i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~  386 (432)
                      ..................+|+.+||+.||.+||+|.++..+-.-
T Consensus       523 ~~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  523 HTRIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             HHhhcCCccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence            22222222223344567789999999999999999999987655

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-36  Score=277.66  Aligned_cols=261  Identities=28%  Similarity=0.383  Sum_probs=199.0

Q ss_pred             hCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCCC-------hHhHHHHHHHHHHHHhcCCCceeeeEeEEE-eCC
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGKS-------GQEIKELKNEASVIAQVQHKNLVKLLGCCI-EKD  177 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~  177 (432)
                      .++|-++++||+|||+.||+|.+-  ++.||+|+-..+.       ....+...+|.++.+.+.||.||++|++|. +.+
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd  541 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD  541 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence            467888999999999999999974  3478898763332       122344668999999999999999999995 567


Q ss_pred             eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEc---CCCCEEEeec
Q 014024          178 ERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLD---KDMNSKISDF  254 (432)
Q Consensus       178 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Df  254 (432)
                      .+|-|+|||+|.+|+-||   ..++.+++.++..|+.||+.||.||.+.. ++|||-||||.|||+-   .-|.+||+||
T Consensus       542 sFCTVLEYceGNDLDFYL---KQhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDF  617 (775)
T KOG1151|consen  542 SFCTVLEYCEGNDLDFYL---KQHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDF  617 (775)
T ss_pred             cceeeeeecCCCchhHHH---HhhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeec
Confidence            889999999999999999   45667999999999999999999999875 6799999999999994   3577999999


Q ss_pred             ccceeccCCCCcc-ccccccccccccCCccChhhhccC----CCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhh
Q 014024          255 GMARIVFGGNDED-ELQGNTSRISGTYGYMSPEYALEG----IFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGY  329 (432)
Q Consensus       255 g~a~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~----~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~  329 (432)
                      |+++.+.+..... .-...++...||.+|++||.+.-+    +.+.++||||.|||+|..+.|++||+...... +.+. 
T Consensus       618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ-dILq-  695 (775)
T KOG1151|consen  618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ-DILQ-  695 (775)
T ss_pred             chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH-HHHh-
Confidence            9999975544332 222345567899999999988643    47899999999999999999999997433211 1110 


Q ss_pred             hHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014024          330 AWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVS  382 (432)
Q Consensus       330 ~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~  382 (432)
                            .+.+...  ..+.-+..+....+...++.+||+..-++|....++..
T Consensus       696 ------eNTIlkA--tEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  696 ------ENTILKA--TEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             ------hhchhcc--eeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence                  1111110  00111112233456678999999999999998887764

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-35  Score=260.91  Aligned_cols=253  Identities=23%  Similarity=0.260  Sum_probs=194.7

Q ss_pred             hhhCCCCcC-ceeccCCcEEEEEEEECCc--eEEEEEEcCCChHhHHHHHHHHHHHHhc-CCCceeeeEeEEEeC----C
Q 014024          106 SATGNFSAA-NKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEIKELKNEASVIAQV-QHKNLVKLLGCCIEK----D  177 (432)
Q Consensus       106 ~~~~~y~~~-~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~----~  177 (432)
                      ..+++|.+. ++||-|-.|.|-.+..+.+  ++|+|++...     ....+|++..-.. .|+|||.++++|.+.    +
T Consensus        58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk  132 (400)
T KOG0604|consen   58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRK  132 (400)
T ss_pred             cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence            357888764 5799999999999887554  7899987543     3345677765555 599999999998643    5


Q ss_pred             eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcC---CCCEEEeec
Q 014024          178 ERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDK---DMNSKISDF  254 (432)
Q Consensus       178 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Df  254 (432)
                      .+.+|||+++||.|...+++.+ ...+++.++-.|+.||+.|+.|||+.+   |.||||||+|+|...   |..+||+||
T Consensus       133 cLLiVmE~meGGeLfsriq~~g-~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDf  208 (400)
T KOG0604|consen  133 CLLIVMECMEGGELFSRIQDRG-DQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDF  208 (400)
T ss_pred             eeEeeeecccchHHHHHHHHcc-cccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccc
Confidence            6788999999999999997754 345999999999999999999999999   999999999999964   456899999


Q ss_pred             ccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhh
Q 014024          255 GMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLW  334 (432)
Q Consensus       255 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  334 (432)
                      |+|+.-       .........+.||.|.|||++...+|+..+|+||+||++|-|++|-+||--...  .         .
T Consensus       209 GFAK~t-------~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg--~---------a  270 (400)
T KOG0604|consen  209 GFAKET-------QEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG--L---------A  270 (400)
T ss_pred             cccccc-------CCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC--c---------c
Confidence            999863       113445667889999999999999999999999999999999999999732111  0         0


Q ss_pred             hccchhhhhhhhhhhcccH----HHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014024          335 ISNKIIDLIDSVLEEASFN----ESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN  386 (432)
Q Consensus       335 ~~~~~~~~i~~~l~~~~~~----~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~  386 (432)
                      .+..++.-|..... .++.    ...+...++++.+|..+|.+|.|+.+++++-+-
T Consensus       271 ispgMk~rI~~gqy-~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi  325 (400)
T KOG0604|consen  271 ISPGMKRRIRTGQY-EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWI  325 (400)
T ss_pred             CChhHHhHhhccCc-cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchh
Confidence            11111111111111 1122    233456689999999999999999999987553

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-35  Score=270.26  Aligned_cols=262  Identities=20%  Similarity=0.220  Sum_probs=200.1

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCCChHhHHHHHHHHHHHHhcCC--Cc----eeeeEeEEEeCCe
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEIKELKNEASVIAQVQH--KN----LVKLLGCCIEKDE  178 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~n----iv~~~~~~~~~~~  178 (432)
                      .+++|.+.+++|+|.||.|-.+.+...  .||+|++..- ....+...-|+++|+++.+  |+    +|.+.++|...++
T Consensus        87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh  165 (415)
T KOG0671|consen   87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH  165 (415)
T ss_pred             cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence            378999999999999999999998665  7899877543 3445666779999999942  32    7888899999999


Q ss_pred             eEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcC-------------
Q 014024          179 RLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDK-------------  245 (432)
Q Consensus       179 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-------------  245 (432)
                      .|||+|.+ |.|+.+++.+.+ ..+++...+..++.|+++++++||+.+   ++|-||||+|||+.+             
T Consensus       166 iCivfell-G~S~~dFlk~N~-y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~  240 (415)
T KOG0671|consen  166 ICIVFELL-GLSTFDFLKENN-YIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKV  240 (415)
T ss_pred             eEEEEecc-ChhHHHHhccCC-ccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCcc
Confidence            99999988 779999996643 345999999999999999999999998   999999999999932             


Q ss_pred             -------CCCEEEeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 014024          246 -------DMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGF  318 (432)
Q Consensus       246 -------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~  318 (432)
                             +..+|++|||.|...         .......+.|..|+|||++.+-.++..+||||+||||+|+.||..-|+.
T Consensus       241 ~~~r~~ks~~I~vIDFGsAtf~---------~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqt  311 (415)
T KOG0671|consen  241 CFIRPLKSTAIKVIDFGSATFD---------HEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQT  311 (415)
T ss_pred             ceeccCCCcceEEEecCCccee---------ccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceeccc
Confidence                   345899999999863         2233567889999999999999999999999999999999999988766


Q ss_pred             ccccc-cchhhhhHHhhhccch-------------------------h---hhhhhh-hhhcccHHHHHHHHHHHHHhhc
Q 014024          319 YRTKS-LNLIGYAWDLWISNKI-------------------------I---DLIDSV-LEEASFNESLSRYVHIALLCVQ  368 (432)
Q Consensus       319 ~~~~~-~~~~~~~~~~~~~~~~-------------------------~---~~i~~~-l~~~~~~~~~~~l~~l~~~cl~  368 (432)
                      .+..+ ..+.+.+........+                         .   +..++. ......+.+...+.+|+..||.
T Consensus       312 Hen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~  391 (415)
T KOG0671|consen  312 HENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLE  391 (415)
T ss_pred             CCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHc
Confidence            55311 1111111000000000                         0   000000 0011233556779999999999


Q ss_pred             cCCCCCCCHHHHHHH
Q 014024          369 ERAEDRPTMSDVVSM  383 (432)
Q Consensus       369 ~dp~~RPt~~evl~~  383 (432)
                      .||.+|+|+.|++.+
T Consensus       392 fDP~~RiTl~EAL~H  406 (415)
T KOG0671|consen  392 FDPARRITLREALSH  406 (415)
T ss_pred             cCccccccHHHHhcC
Confidence            999999999999875

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-34  Score=267.16  Aligned_cols=240  Identities=25%  Similarity=0.307  Sum_probs=194.2

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCCC---hHhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeeE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKS---GQEIKELKNEASVIAQV-QHKNLVKLLGCCIEKDERL  180 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  180 (432)
                      ...+|..+.+||+|+||+|.+|...++  -+|||++.+..   ....+--..|-++|..- +-|.++.+..+|..-+.+|
T Consensus       347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy  426 (683)
T KOG0696|consen  347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY  426 (683)
T ss_pred             eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence            346889999999999999999998766  68999886542   22233345577777766 4578999999999999999


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceec
Q 014024          181 LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIV  260 (432)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  260 (432)
                      +||||+.||+|-.+++..   +.+.+..+..++.+|+-||-+||++|   |++||||.+||++|.+|++||+|||+++.-
T Consensus       427 FVMEyvnGGDLMyhiQQ~---GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEn  500 (683)
T KOG0696|consen  427 FVMEYVNGGDLMYHIQQV---GKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN  500 (683)
T ss_pred             eEEEEecCchhhhHHHHh---cccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccc
Confidence            999999999998888543   34888889999999999999999999   999999999999999999999999999752


Q ss_pred             cCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchh
Q 014024          261 FGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKII  340 (432)
Q Consensus       261 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                            ......+...+|||.|+|||++..++|+.++|.|||||+||||+.|+.||+..+.                  .
T Consensus       501 ------i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE------------------~  556 (683)
T KOG0696|consen  501 ------IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE------------------D  556 (683)
T ss_pred             ------ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH------------------H
Confidence                  2223456678999999999999999999999999999999999999999864332                  1


Q ss_pred             hhhhhhhh--hcccHHHHHHHHHHHHHhhccCCCCCCC
Q 014024          341 DLIDSVLE--EASFNESLSRYVHIALLCVQERAEDRPT  376 (432)
Q Consensus       341 ~~i~~~l~--~~~~~~~~~~l~~l~~~cl~~dp~~RPt  376 (432)
                      ++......  -.++.....+.+.++...+.+.|.+|..
T Consensus       557 elF~aI~ehnvsyPKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  557 ELFQAIMEHNVSYPKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             HHHHHHHHccCcCcccccHHHHHHHHHHhhcCCccccC
Confidence            11111111  1234455667788999999999999964

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1.9e-33  Score=287.35  Aligned_cols=259  Identities=19%  Similarity=0.236  Sum_probs=167.1

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECC------ceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeE------EE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQ------GEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGC------CI  174 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~------~~  174 (432)
                      ..++|++.+.||+|+||.||+|.+.+      ..+|+|++......  +...+|  .++...+.++..+...      ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            56899999999999999999999743      47999987543221  111111  1122222222222211      24


Q ss_pred             eCCeeEEEEecCCCCChhhhhcCCCCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCC
Q 014024          175 EKDERLLIYEYMPNKSLDCFLFDPTKR-----------------EILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLK  237 (432)
Q Consensus       175 ~~~~~~lv~e~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlk  237 (432)
                      +....++||||+++++|.+++......                 .......+..++.|++.||+|||+.+   |+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence            556789999999999999988543210                 01123345679999999999999998   9999999


Q ss_pred             CCCEEEcC-CCCEEEeecccceeccCCCCccccccccccccccCCccChhhhccC----------------------CCC
Q 014024          238 ASNILLDK-DMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEG----------------------IFS  294 (432)
Q Consensus       238 p~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~t  294 (432)
                      |+|||+++ ++.+||+|||++..+..+.     ........+++.|+|||.+...                      .++
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~-----~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~  357 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGI-----NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLP  357 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCcccccccc-----ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCC
Confidence            99999985 6899999999997642211     1223446789999999966422                      234


Q ss_pred             chhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhcc----chhhhhhhhh----hh--cccHHHHHHHHHHHH
Q 014024          295 IKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISN----KIIDLIDSVL----EE--ASFNESLSRYVHIAL  364 (432)
Q Consensus       295 ~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~i~~~l----~~--~~~~~~~~~l~~l~~  364 (432)
                      .++|||||||+||||+++..|.+..      ...+.......+    .....+....    ..  ...+.......+|+.
T Consensus       358 ~k~DVwSlGviL~el~~~~~~~~~~------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~  431 (566)
T PLN03225        358 DRFDIYSAGLIFLQMAFPNLRSDSN------LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLK  431 (566)
T ss_pred             CCcccHHHHHHHHHHHhCcCCCchH------HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHH
Confidence            5679999999999999977664311      111100000000    0001111100    00  000111233458999


Q ss_pred             HhhccCCCCCCCHHHHHHH
Q 014024          365 LCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       365 ~cl~~dp~~RPt~~evl~~  383 (432)
                      +||+.||++|||+.+++++
T Consensus       432 ~mL~~dP~kR~ta~e~L~H  450 (566)
T PLN03225        432 SMMRFKGRQRISAKAALAH  450 (566)
T ss_pred             HHccCCcccCCCHHHHhCC
Confidence            9999999999999999986

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-33  Score=282.13  Aligned_cols=260  Identities=22%  Similarity=0.351  Sum_probs=207.8

Q ss_pred             chhhHhhhhCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCCChHhHHHHHHHHHHHHhc-CCCceeeeEeEEEe-
Q 014024          100 SFSSVSSATGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGKSGQEIKELKNEASVIAQV-QHKNLVKLLGCCIE-  175 (432)
Q Consensus       100 ~~~~~~~~~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~-  175 (432)
                      .+..+..-++-|++.++||.|.+|.||++...  ++..|+|+..... ..-++++.|.++|+.. .|||++.++|++.. 
T Consensus        10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~   88 (953)
T KOG0587|consen   10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKK   88 (953)
T ss_pred             chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence            34444556788999999999999999998864  4478888875543 3346778899999987 69999999999863 


Q ss_pred             ----CCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEE
Q 014024          176 ----KDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKI  251 (432)
Q Consensus       176 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  251 (432)
                          ++.++||||||.+||..|++.+.. ...+.|..+..|++.++.|+.+||.+.   ++|||||-.|||++.++.+||
T Consensus        89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKL  164 (953)
T KOG0587|consen   89 DPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKL  164 (953)
T ss_pred             cCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEE
Confidence                468999999999999999998766 455999999999999999999999998   999999999999999999999


Q ss_pred             eecccceeccCCCCccccccccccccccCCccChhhhcc-----CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccch
Q 014024          252 SDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE-----GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNL  326 (432)
Q Consensus       252 ~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~  326 (432)
                      +|||.+..+.      ..........||+.|||||++..     ..|+..+|+||||++..||--|.+|+-.+....   
T Consensus       165 vDFGvSaQld------sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr---  235 (953)
T KOG0587|consen  165 VDFGVSAQLD------STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR---  235 (953)
T ss_pred             eeeeeeeeee------cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh---
Confidence            9999998763      33455667899999999999874     347889999999999999999999975433210   


Q ss_pred             hhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          327 IGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       327 ~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                        ......  ..      +-.....+.....++.+++..||.+|.++||++.+++++
T Consensus       236 --aLF~Ip--RN------PPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  236 --ALFLIP--RN------PPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             --hhccCC--CC------CCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence              000000  00      101111244667889999999999999999999999864

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-34  Score=272.84  Aligned_cols=241  Identities=24%  Similarity=0.351  Sum_probs=189.4

Q ss_pred             CceeccCCcEEEEEEEECC--ceEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecCCCC
Q 014024          114 ANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNK  189 (432)
Q Consensus       114 ~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  189 (432)
                      .++||+|-||+||-|.+..  +.||||++.+.  ......++.+|+.+|+.++||.||.+...|+..+..++|||-+.| 
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G-  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG-  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence            4789999999999998754  48999988443  233447899999999999999999999999999999999999955 


Q ss_pred             ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcC---CCCEEEeecccceeccCCCCc
Q 014024          190 SLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDK---DMNSKISDFGMARIVFGGNDE  266 (432)
Q Consensus       190 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg~a~~~~~~~~~  266 (432)
                      +..+.+.... .+.+++.....++.||+.||.|||.++   |+|+||||+|||+.+   ..++||+|||+|+... .   
T Consensus       648 DMLEMILSsE-kgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIg-E---  719 (888)
T KOG4236|consen  648 DMLEMILSSE-KGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIG-E---  719 (888)
T ss_pred             hHHHHHHHhh-cccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecc-h---
Confidence            5444444322 334999999999999999999999999   999999999999954   4579999999999851 1   


Q ss_pred             cccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhh
Q 014024          267 DELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSV  346 (432)
Q Consensus       267 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  346 (432)
                         .......+|||.|+|||++.++.|+..-|+||.|||+|.-++|..||.....                 +.+.|+..
T Consensus       720 ---ksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd-----------------IndQIQNA  779 (888)
T KOG4236|consen  720 ---KSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED-----------------INDQIQNA  779 (888)
T ss_pred             ---hhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc-----------------hhHHhhcc
Confidence               2234567999999999999999999999999999999999999999853322                 22222210


Q ss_pred             ---hhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          347 ---LEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       347 ---l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                         .......+......+|+...|+..-.+|-|...-+.+
T Consensus       780 aFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh  819 (888)
T KOG4236|consen  780 AFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH  819 (888)
T ss_pred             ccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence               1111122334556788888888888888888766654

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=7.8e-33  Score=253.83  Aligned_cols=235  Identities=27%  Similarity=0.349  Sum_probs=190.0

Q ss_pred             CcEEEEEEEECC--ceEEEEEEcCCChHh-HHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecCCCCChhhhhcC
Q 014024          121 GFGTVYKGVIGQ--GEIAVKRLLGKSGQE-IKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFD  197 (432)
Q Consensus       121 ~~g~Vy~~~~~~--~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~  197 (432)
                      +||.||+|...+  ..+++|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            589999999865  489999987655444 67899999999999999999999999999999999999999999999854


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCcccccccccccc
Q 014024          198 PTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRIS  277 (432)
Q Consensus       198 ~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~  277 (432)
                      ..   .+++..++.++.+++.++.+||+.+   ++|+||+|+||++++++.++|+|||.+.......       ......
T Consensus        81 ~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-------~~~~~~  147 (244)
T smart00220       81 RG---RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-------LLTTFV  147 (244)
T ss_pred             cc---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc-------cccccc
Confidence            22   2889999999999999999999998   9999999999999999999999999998752211       233456


Q ss_pred             ccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhhhhhcccHH--H
Q 014024          278 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNE--S  355 (432)
Q Consensus       278 gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~--~  355 (432)
                      ++..|++||......++.++|+||||+++++|++|..|+.......              ...+.+...........  .
T Consensus       148 ~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~  213 (244)
T smart00220      148 GTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL--------------ELFKKIGKPKPPFPPPEWKI  213 (244)
T ss_pred             CCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH--------------HHHHHHhccCCCCccccccC
Confidence            7889999999998889999999999999999999999975321100              00111111000000000  4


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014024          356 LSRYVHIALLCVQERAEDRPTMSDVVS  382 (432)
Q Consensus       356 ~~~l~~l~~~cl~~dp~~RPt~~evl~  382 (432)
                      +.++.+++.+|+..+|++||++.++++
T Consensus       214 ~~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      214 SPEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             CHHHHHHHHHHccCCchhccCHHHHhh
Confidence            567889999999999999999999987

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=8.6e-33  Score=275.99  Aligned_cols=267  Identities=21%  Similarity=0.262  Sum_probs=180.8

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEE------------------CCceEEEEEEcCCChHhHHHH--------------HHH
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVI------------------GQGEIAVKRLLGKSGQEIKEL--------------KNE  154 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~------------------~~~~vavK~~~~~~~~~~~~~--------------~~E  154 (432)
                      ..++|.+.++||+|+||.||+|..                  .+..||||++........+.|              ..|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            467999999999999999999964                  123699999865443333333              346


Q ss_pred             HHHHHhcCCCce-----eeeEeEEEe--------CCeeEEEEecCCCCChhhhhcCCCC---------------------
Q 014024          155 ASVIAQVQHKNL-----VKLLGCCIE--------KDERLLIYEYMPNKSLDCFLFDPTK---------------------  200 (432)
Q Consensus       155 ~~~l~~l~h~ni-----v~~~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~---------------------  200 (432)
                      +.++.+++|.++     ++++++|..        .+..++||||+++++|.++++....                     
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777777776554     677777753        3567999999999999998864211                     


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCccccccccccccccC
Q 014024          201 REILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY  280 (432)
Q Consensus       201 ~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~  280 (432)
                      ...+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++.....+.     ........+|+
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~-----~~~~~~g~~tp  374 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI-----NFNPLYGMLDP  374 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCC-----ccCccccCCCc
Confidence            123567788999999999999999998   9999999999999999999999999997542211     11112234578


Q ss_pred             CccChhhhccCCC----------------------CchhhhHHHHHHHHHHHhCCC-CCCCccccccchhhhhHHhhhcc
Q 014024          281 GYMSPEYALEGIF----------------------SIKSDVFSFGVLLLEIVSGKK-NTGFYRTKSLNLIGYAWDLWISN  337 (432)
Q Consensus       281 ~y~aPE~~~~~~~----------------------t~~~DvwSlG~il~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~  337 (432)
                      .|+|||.+.....                      ..+.|+||+||++|+|++|.. |+............+..   ..+
T Consensus       375 ~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~---~~~  451 (507)
T PLN03224        375 RYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDN---DLN  451 (507)
T ss_pred             ceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccc---hHH
Confidence            9999998754321                      234799999999999999875 54321110000000000   000


Q ss_pred             chhhhhhhhhhhcccHHHHHHHHHHHHHhhccCC---CCCCCHHHHHHHh
Q 014024          338 KIIDLIDSVLEEASFNESLSRYVHIALLCVQERA---EDRPTMSDVVSML  384 (432)
Q Consensus       338 ~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp---~~RPt~~evl~~L  384 (432)
                      ...........-...+.......+++..+|..+|   .+|+|++|+++|-
T Consensus       452 ~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp  501 (507)
T PLN03224        452 RWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHR  501 (507)
T ss_pred             HHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCC
Confidence            0000000111111122334667889999999766   6899999999874

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-34  Score=273.14  Aligned_cols=250  Identities=22%  Similarity=0.272  Sum_probs=206.4

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECCce--EEEEEEcCC---ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQGE--IAVKRLLGK---SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLL  181 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~~~--vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  181 (432)
                      ...+++++..||.||||.|=+...+...  +|+|.+++.   +....+.+..|-++|..++.+.||++|.-|.+.+..|+
T Consensus       418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYm  497 (732)
T KOG0614|consen  418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYM  497 (732)
T ss_pred             chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhh
Confidence            3467788889999999999998877664  677766443   34456678899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceecc
Q 014024          182 IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVF  261 (432)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  261 (432)
                      .||-|-||.|-..+.   .++.|+......++..+++|++|||++|   ||+|||||+|.++|.+|.+||.|||+|+.+.
T Consensus       498 LmEaClGGElWTiLr---dRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~  571 (732)
T KOG0614|consen  498 LMEACLGGELWTILR---DRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIG  571 (732)
T ss_pred             hHHhhcCchhhhhhh---hcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhc
Confidence            999999999999984   5566999999999999999999999999   9999999999999999999999999999862


Q ss_pred             CCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhh
Q 014024          262 GGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIID  341 (432)
Q Consensus       262 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (432)
                      .       ...+..++|||.|.|||++.++..+.++|.||||+++|||++|++||...+...               ...
T Consensus       572 ~-------g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmk---------------tYn  629 (732)
T KOG0614|consen  572 S-------GRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMK---------------TYN  629 (732)
T ss_pred             c-------CCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHH---------------HHH
Confidence            2       346678999999999999999999999999999999999999999996544311               111


Q ss_pred             hhhh-hhhhcccHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHHh
Q 014024          342 LIDS-VLEEASFNESLSRYVHIALLCVQERAEDRPT-----MSDVVSML  384 (432)
Q Consensus       342 ~i~~-~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt-----~~evl~~L  384 (432)
                      +|-+ .-.-..+....+...+|++.....+|.+|..     +.+|-.|-
T Consensus       630 ~ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~  678 (732)
T KOG0614|consen  630 LILKGIDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHR  678 (732)
T ss_pred             HHHhhhhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhh
Confidence            1111 1112334445566778999999999999986     66777654

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.4e-35  Score=252.84  Aligned_cols=266  Identities=21%  Similarity=0.323  Sum_probs=192.0

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEe--------
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIE--------  175 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--------  175 (432)
                      .+.|+-..+||+|.||.||+|+..++  +||+|++.-.  ....-....+|+++|..+.|+|++.+++.|..        
T Consensus        16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~   95 (376)
T KOG0669|consen   16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD   95 (376)
T ss_pred             chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence            45677788999999999999987554  6788765321  12223345679999999999999999998853        


Q ss_pred             CCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecc
Q 014024          176 KDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFG  255 (432)
Q Consensus       176 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  255 (432)
                      ...+|+||++|+. +|.-+|.+...  .++..++.+++.++..||.|+|...   |+|||+||.|+|++.+|.+||+|||
T Consensus        96 r~t~ylVf~~ceh-DLaGlLsn~~v--r~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFG  169 (376)
T KOG0669|consen   96 RATFYLVFDFCEH-DLAGLLSNRKV--RFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFG  169 (376)
T ss_pred             cceeeeeHHHhhh-hHHHHhcCccc--cccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccc
Confidence            2347999999976 56666644333  3899999999999999999999998   9999999999999999999999999


Q ss_pred             cceeccCCCCccccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCcccc-ccchh------
Q 014024          256 MARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTK-SLNLI------  327 (432)
Q Consensus       256 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~~-~~~~~------  327 (432)
                      +++.+...+...  ....++.+.|.+|++||.+.+ .+|+++.|||.-|||+.||.||.+-++..... ...+.      
T Consensus       170 lar~fs~~~n~~--kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs  247 (376)
T KOG0669|consen  170 LARAFSTSKNVV--KPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGS  247 (376)
T ss_pred             cccceecccccC--CCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhcc
Confidence            998764433221  223566778999999998876 67999999999999999999998765432210 00000      


Q ss_pred             --hhhHHhhhc-------------cchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          328 --GYAWDLWIS-------------NKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       328 --~~~~~~~~~-------------~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                        ..+|+...+             +.....+...+..-   -...+..+|+..++..||.+|+++.+++++-
T Consensus       248 ~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~---~kd~~a~dLle~ll~~DP~kR~~ad~alnh~  316 (376)
T KOG0669|consen  248 ITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPY---VKDDEALDLLEKLLKLDPTKRIDADQALNHD  316 (376)
T ss_pred             CCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccc---cCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence              111111110             00111111111100   0113566899999999999999999999754

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-33  Score=276.55  Aligned_cols=246  Identities=27%  Similarity=0.392  Sum_probs=187.5

Q ss_pred             CcCceeccCCcEE-EEEEEECCceEEEEEEcCCChHhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeeEEEEecCCCC
Q 014024          112 SAANKLGEGGFGT-VYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQV-QHKNLVKLLGCCIEKDERLLIYEYMPNK  189 (432)
Q Consensus       112 ~~~~~ig~G~~g~-Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g  189 (432)
                      .-.+++|.|+.|+ ||+|...++.||||++...   ...-..+|+..|+.- +||||+++++.-.+....||..|.| .-
T Consensus       512 ~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~  587 (903)
T KOG1027|consen  512 SPKEILGYGSNGTVVFRGVYEGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-AC  587 (903)
T ss_pred             ccHHHcccCCCCcEEEEEeeCCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hh
Confidence            3456788888764 7999999999999998643   334567899999988 5999999999988999999999999 55


Q ss_pred             ChhhhhcCCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcC---C--CCEEEeecccceeccCC
Q 014024          190 SLDCFLFDPTK-REILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDK---D--MNSKISDFGMARIVFGG  263 (432)
Q Consensus       190 sL~~~l~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~--~~~kl~Dfg~a~~~~~~  263 (432)
                      +|.+++..... .........+.++.|++.||++||+.+   ||||||||.||||+.   +  ..++|+|||+++.+..+
T Consensus       588 sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~  664 (903)
T KOG1027|consen  588 SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG  664 (903)
T ss_pred             hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence            89999865311 111111445778999999999999998   999999999999975   3  46899999999997544


Q ss_pred             CCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhC-CCCCCCccccccchhhhhHHhhhccchhhh
Q 014024          264 NDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG-KKNTGFYRTKSLNLIGYAWDLWISNKIIDL  342 (432)
Q Consensus       264 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                      ...   -.......||-+|+|||++....-+.++||||+||++|+.++| .+||+..-..+.+...-       +.....
T Consensus       665 ~sS---~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~-------~~~L~~  734 (903)
T KOG1027|consen  665 KSS---FSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTG-------NYTLVH  734 (903)
T ss_pred             cch---hhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcC-------ccceee
Confidence            332   2335678899999999999988888899999999999999996 89987433222111110       000000


Q ss_pred             hhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014024          343 IDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVS  382 (432)
Q Consensus       343 i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~  382 (432)
                            -....++  +..+||.+|+..+|..||++.+|+.
T Consensus       735 ------L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  735 ------LEPLPDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             ------eccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence                  0111122  6678999999999999999999985

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-33  Score=228.92  Aligned_cols=261  Identities=20%  Similarity=0.247  Sum_probs=191.2

Q ss_pred             CCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEec
Q 014024          110 NFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEY  185 (432)
Q Consensus       110 ~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  185 (432)
                      +|.-.++||+|.||+||+|++.++  -||+|++...  ++..-....+|+-+|+.++|.|||++++....++...+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            456678899999999999998765  6899988543  333345678899999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCC
Q 014024          186 MPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGND  265 (432)
Q Consensus       186 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  265 (432)
                      |.. +|..+...  -++.++...+..++.|+++||.++|+++   +.||||||.|.|++.+|.+|++|||+++-+.    
T Consensus        83 cdq-dlkkyfds--lng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafg----  152 (292)
T KOG0662|consen   83 CDQ-DLKKYFDS--LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFG----  152 (292)
T ss_pred             hhH-HHHHHHHh--cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcC----
Confidence            954 66666543  3455999999999999999999999999   9999999999999999999999999998751    


Q ss_pred             ccccccccccccccCCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCC-CCCccccccchhhhhHH--hhhccc---
Q 014024          266 EDELQGNTSRISGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKN-TGFYRTKSLNLIGYAWD--LWISNK---  338 (432)
Q Consensus       266 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlG~il~elltg~~p-~~~~~~~~~~~~~~~~~--~~~~~~---  338 (432)
                        ..-...+..+.|.+|.+|.++.+. -|+...|+||-|||+.|+....+| |...+..+ .+...++.  ....+.   
T Consensus       153 --ipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvdd-qlkrif~~lg~p~ed~wps  229 (292)
T KOG0662|consen  153 --IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKRIFRLLGTPTEDQWPS  229 (292)
T ss_pred             --CceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHH-HHHHHHHHhCCCccccCCc
Confidence              112234455779999999998875 489999999999999999885555 43322211 11111111  111111   


Q ss_pred             hhhhhhhhhhhcccH---------HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          339 IIDLIDSVLEEASFN---------ESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       339 ~~~~i~~~l~~~~~~---------~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      +..+.|-.....++.         .....=++++...+.-+|..|.++++.+++
T Consensus       230 ~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  230 MTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             cccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence            112222111111111         111222478888888999999999988775

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-32  Score=248.52  Aligned_cols=247  Identities=21%  Similarity=0.335  Sum_probs=197.2

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCC---ChHhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeeE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGK---SGQEIKELKNEASVIAQV-QHKNLVKLLGCCIEKDERL  180 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  180 (432)
                      ...+|.++++||+|+|.+|.++++..+  -+|+|++++.   ..+.++-.+.|-.+..+. +||.+|.+..+|..+..++
T Consensus       248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf  327 (593)
T KOG0695|consen  248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF  327 (593)
T ss_pred             ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence            457899999999999999999998655  6788876433   445566677788888776 6899999999999999999


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceec
Q 014024          181 LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIV  260 (432)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  260 (432)
                      +|.||++||+|--+.+   .++.+++..+..+...|+.||.|||+.|   |++||||.+|+|+|..|++||+|+|+++.-
T Consensus       328 fvieyv~ggdlmfhmq---rqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~  401 (593)
T KOG0695|consen  328 FVIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG  401 (593)
T ss_pred             EEEEEecCcceeeehh---hhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcC
Confidence            9999999999976663   4455999999999999999999999999   999999999999999999999999999752


Q ss_pred             cCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccc--cccchhhhhHHhhhccc
Q 014024          261 FGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRT--KSLNLIGYAWDLWISNK  338 (432)
Q Consensus       261 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~  338 (432)
                      .      .....++..+|||.|.|||.+.+..|...+|.|+|||+++||+.|+.||+.-..  .+.+.-.|.....    
T Consensus       402 l------~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvi----  471 (593)
T KOG0695|consen  402 L------GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVI----  471 (593)
T ss_pred             C------CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHH----
Confidence            1      113356778999999999999999999999999999999999999999976443  3333333332221    


Q ss_pred             hhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCC
Q 014024          339 IIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRP  375 (432)
Q Consensus       339 ~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RP  375 (432)
                          +++.++.  +....-....+++.-|.+||.+|.
T Consensus       472 ----lekqiri--prslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  472 ----LEKQIRI--PRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             ----hhhcccc--cceeehhhHHHHHHhhcCCcHHhc
Confidence                1222221  222233445678888999999885

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-34  Score=252.72  Aligned_cols=247  Identities=27%  Similarity=0.391  Sum_probs=188.5

Q ss_pred             CCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCCCh-HhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeeEEEEe
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSG-QEIKELKNEASVIAQV-QHKNLVKLLGCCIEKDERLLIYE  184 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  184 (432)
                      ++.+-+..||.|+||+|++-.++..  ..|||++..... ...+++..|.+...+- +.||||++||.+..++..++.||
T Consensus        64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME  143 (361)
T KOG1006|consen   64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME  143 (361)
T ss_pred             chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence            4555678899999999999887654  789999966543 5667788888766554 68999999999999999999999


Q ss_pred             cCCCCChhhhh---cCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceecc
Q 014024          185 YMPNKSLDCFL---FDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVF  261 (432)
Q Consensus       185 ~~~~gsL~~~l---~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  261 (432)
                      .|+ .||+.+.   +.. .+..+++.-.-.|....+.||.||...-  .|+|||+||+|||++..|.+||+|||.+-.+.
T Consensus       144 LMd-~SlDklYk~vy~v-q~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv  219 (361)
T KOG1006|consen  144 LMD-ISLDKLYKRVYSV-QKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLV  219 (361)
T ss_pred             HHh-hhHHHHHHHHHHH-HhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHH
Confidence            994 4554432   322 2344888888888888999999998764  59999999999999999999999999987652


Q ss_pred             CCCCccccccccccccccCCccChhhhcc--CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccch
Q 014024          262 GGNDEDELQGNTSRISGTYGYMSPEYALE--GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKI  339 (432)
Q Consensus       262 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  339 (432)
                      .       ....+...|-..|||||.+..  ..|+.+|||||||++|||+.||+.|+..+..                 +
T Consensus       220 ~-------SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----------------v  275 (361)
T KOG1006|consen  220 D-------SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----------------V  275 (361)
T ss_pred             H-------HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----------------H
Confidence            1       112233456677999999874  3489999999999999999999999754332                 1


Q ss_pred             hhhhhhhhhhc--------ccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          340 IDLIDSVLEEA--------SFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       340 ~~~i~~~l~~~--------~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      .+.+......+        ...+....+..++.-||.+|-.+||...++..+
T Consensus       276 feql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  276 FEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             HHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            11111111111        112345678899999999999999999998863

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.98  E-value=3.7e-32  Score=262.56  Aligned_cols=208  Identities=24%  Similarity=0.361  Sum_probs=174.0

Q ss_pred             hhhCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCCCh---HhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeE
Q 014024          106 SATGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSG---QEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERL  180 (432)
Q Consensus       106 ~~~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  180 (432)
                      ....-|..++.||-|+||.|.++.-.++  -+|.|.+.+.+-   .....++.|-+||....++-||++|..|.+.+++|
T Consensus       626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLY  705 (1034)
T KOG0608|consen  626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLY  705 (1034)
T ss_pred             ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceE
Confidence            3455677889999999999999986655  688888765542   33445788999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceec
Q 014024          181 LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIV  260 (432)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  260 (432)
                      +||||++||++-.+|-   .-+.|.+..++.++.++..|+++.|..|   +|||||||+|||||.+|++||+|||++.-+
T Consensus       706 FVMdYIPGGDmMSLLI---rmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGf  779 (1034)
T KOG0608|consen  706 FVMDYIPGGDMMSLLI---RMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF  779 (1034)
T ss_pred             EEEeccCCccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccc
Confidence            9999999999998884   4455899999999999999999999999   999999999999999999999999998653


Q ss_pred             c--------C-CCCc---------------------------cccccccccccccCCccChhhhccCCCCchhhhHHHHH
Q 014024          261 F--------G-GNDE---------------------------DELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGV  304 (432)
Q Consensus       261 ~--------~-~~~~---------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~  304 (432)
                      .        . ++..                           ..........+||+.|+|||++....++..+|.||.||
T Consensus       780 RWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gv  859 (1034)
T KOG0608|consen  780 RWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGV  859 (1034)
T ss_pred             eeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhH
Confidence            1        0 0000                           00112223467999999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCc
Q 014024          305 LLLEIVSGKKNTGFY  319 (432)
Q Consensus       305 il~elltg~~p~~~~  319 (432)
                      |||||+.|+.||-..
T Consensus       860 il~em~~g~~pf~~~  874 (1034)
T KOG0608|consen  860 ILYEMLVGQPPFLAD  874 (1034)
T ss_pred             HHHHHhhCCCCccCC
Confidence            999999999998543

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=1.1e-29  Score=227.35  Aligned_cols=210  Identities=34%  Similarity=0.562  Sum_probs=182.1

Q ss_pred             eccCCcEEEEEEEEC--CceEEEEEEcCCChH-hHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecCCCCChhh
Q 014024          117 LGEGGFGTVYKGVIG--QGEIAVKRLLGKSGQ-EIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDC  193 (432)
Q Consensus       117 ig~G~~g~Vy~~~~~--~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~  193 (432)
                      ||+|++|.||++...  +..+++|.+...... ..+.+.+|++.++.++|++++++++++......++++||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            689999999999997  558999998665432 45678999999999999999999999999999999999999999999


Q ss_pred             hhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcC-CCCEEEeecccceeccCCCCccccccc
Q 014024          194 FLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDK-DMNSKISDFGMARIVFGGNDEDELQGN  272 (432)
Q Consensus       194 ~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~  272 (432)
                      ++....  ..+++..+..++.++++++.+||+.+   ++|+||+|.||+++. ++.++|+|||.+........      .
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~------~  149 (215)
T cd00180          81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS------L  149 (215)
T ss_pred             HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc------h
Confidence            985432  35899999999999999999999998   999999999999999 89999999999986522110      1


Q ss_pred             cccccccCCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhhhhhcc
Q 014024          273 TSRISGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEAS  351 (432)
Q Consensus       273 ~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~  351 (432)
                      .....+...|++||..... ..+.++|+|++|+++++|                                          
T Consensus       150 ~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------  187 (215)
T cd00180         150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------  187 (215)
T ss_pred             hhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------
Confidence            3335678889999999877 889999999999999998                                          


Q ss_pred             cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          352 FNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       352 ~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                           ..+.+++..|++.+|++||++.++++++
T Consensus       188 -----~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 -----PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             -----HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                 4577899999999999999999998754

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5.8e-30  Score=241.26  Aligned_cols=132  Identities=29%  Similarity=0.385  Sum_probs=111.7

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCCChHhHHHHHHHHHHHHhcC-----C---CceeeeEeEEEe-
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEIKELKNEASVIAQVQ-----H---KNLVKLLGCCIE-  175 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~~~~~~~~-  175 (432)
                      ..++|.+.++||-|-|++||++.+...  .||+|+.+. .....+....|+++|++++     |   .+||++++.|.. 
T Consensus        76 ~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs  154 (590)
T KOG1290|consen   76 NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS  154 (590)
T ss_pred             cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence            358999999999999999999998655  688888754 3445567788999999984     3   469999999964 


Q ss_pred             ---CCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEE
Q 014024          176 ---KDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILL  243 (432)
Q Consensus       176 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll  243 (432)
                         +.+.|+|+|++ |.+|..+|.....++ ++...+.+|++|++.||.|||...  +|||-||||+|||+
T Consensus       155 GpNG~HVCMVfEvL-GdnLLklI~~s~YrG-lpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  155 GPNGQHVCMVFEVL-GDNLLKLIKYSNYRG-LPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL  221 (590)
T ss_pred             CCCCcEEEEEehhh-hhHHHHHHHHhCCCC-CcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence               46889999999 667877776655555 999999999999999999999876  69999999999999

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=1e-30  Score=221.19  Aligned_cols=205  Identities=28%  Similarity=0.372  Sum_probs=163.0

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCC-ChHhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeeEEE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGK-SGQEIKELKNEASVIAQV-QHKNLVKLLGCCIEKDERLLI  182 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv  182 (432)
                      ..+...-+..||+|++|.|-+-++.  +.-.|+|++... ..+...+..+|+++..+. .+|.+|+++|.+.+....++.
T Consensus        44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIc  123 (282)
T KOG0984|consen   44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWIC  123 (282)
T ss_pred             chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEe
Confidence            3455556788999999999877764  346799988544 334556677888877665 689999999999999999999


Q ss_pred             EecCCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceecc
Q 014024          183 YEYMPNKSLDCFLFDP-TKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVF  261 (432)
Q Consensus       183 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  261 (432)
                      ||.|. .||+.+-... .....+++...-+|+..+..||.|||++-  .++|||+||+|||++.+|++|+||||.+-.+.
T Consensus       124 ME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~  200 (282)
T KOG0984|consen  124 MELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLV  200 (282)
T ss_pred             HHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeeh
Confidence            99994 4666554321 23455899999999999999999999875  59999999999999999999999999998762


Q ss_pred             CCCCccccccccccccccCCccChhhhcc----CCCCchhhhHHHHHHHHHHHhCCCCCCCccc
Q 014024          262 GGNDEDELQGNTSRISGTYGYMSPEYALE----GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRT  321 (432)
Q Consensus       262 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~t~~~DvwSlG~il~elltg~~p~~~~~~  321 (432)
                      ++       -..+...|-..|||||.+..    ..|+-++||||||+.++||.+++.|++.+.+
T Consensus       201 dS-------iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t  257 (282)
T KOG0984|consen  201 DS-------IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT  257 (282)
T ss_pred             hh-------hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence            21       11222456778999998763    4699999999999999999999999876554

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=8.3e-32  Score=236.74  Aligned_cols=264  Identities=20%  Similarity=0.258  Sum_probs=188.6

Q ss_pred             CCcCceeccCCcEEEEEEEEC--CceEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC-----eeEE
Q 014024          111 FSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKD-----ERLL  181 (432)
Q Consensus       111 y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~l  181 (432)
                      .+-.+.||.|+||.||-..+.  ++.++.|++..-  +-...+.+.+|+.+|.-++|.|++..+++..-..     ..|+
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            344678999999999998874  347899988543  2334567889999999999999999998875442     3578


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceecc
Q 014024          182 IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVF  261 (432)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  261 (432)
                      ++|.+ ..+|...+.   ....++...+.-+++||++||.|||+.+   |.||||||.|.|+++|..+||+|||+++...
T Consensus       135 ~TELm-QSDLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee  207 (449)
T KOG0664|consen  135 LTELM-QSDLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWD  207 (449)
T ss_pred             HHHHH-Hhhhhheec---cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccc
Confidence            88888 457777773   3345888888899999999999999999   9999999999999999999999999998742


Q ss_pred             CCCCccccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCccc-cccchhhhhHHhhhccch
Q 014024          262 GGNDEDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRT-KSLNLIGYAWDLWISNKI  339 (432)
Q Consensus       262 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~  339 (432)
                      ..     .....+..+.|..|+|||.+.+ ..|+.+.||||.|||+.||+..+--|..-.. +..++..........+.+
T Consensus       208 ~d-----~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaM  282 (449)
T KOG0664|consen  208 QR-----DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAM  282 (449)
T ss_pred             hh-----hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHH
Confidence            11     1223344567889999999987 5699999999999999999988766643222 111221111111111111


Q ss_pred             hhhhh----hhhhhc-------------ccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014024          340 IDLID----SVLEEA-------------SFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN  386 (432)
Q Consensus       340 ~~~i~----~~l~~~-------------~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~  386 (432)
                      +...+    ..++..             .+.....+-+.+...++..||++|.+..+.+.++..
T Consensus       283 r~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~  346 (449)
T KOG0664|consen  283 KYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL  346 (449)
T ss_pred             HHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence            10000    111111             011222345677888899999999999999887654

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=1e-30  Score=250.57  Aligned_cols=196  Identities=26%  Similarity=0.404  Sum_probs=167.9

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCCCh--------HhHHHHHHHHHHHHhcC---CCceeeeEeEE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSG--------QEIKELKNEASVIAQVQ---HKNLVKLLGCC  173 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---h~niv~~~~~~  173 (432)
                      ...+|...+.+|+|+||.|++|.++..  .|++|.+.+.+-        ...-.+..|+.+|..++   |+||++++++|
T Consensus       559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF  638 (772)
T KOG1152|consen  559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF  638 (772)
T ss_pred             ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence            345789999999999999999998765  788888754421        11122556999999997   99999999999


Q ss_pred             EeCCeeEEEEecC-CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEe
Q 014024          174 IEKDERLLIYEYM-PNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKIS  252 (432)
Q Consensus       174 ~~~~~~~lv~e~~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  252 (432)
                      ++++++||+||-. ++-+|.+++.   .+..+++.++..|+.|++.|+++||+++   |+|||||-+|+.++.+|-+||+
T Consensus       639 Eddd~yyl~te~hg~gIDLFd~IE---~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~kli  712 (772)
T KOG1152|consen  639 EDDDYYYLETEVHGEGIDLFDFIE---FKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLI  712 (772)
T ss_pred             ecCCeeEEEecCCCCCcchhhhhh---ccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEe
Confidence            9999999999976 4568888883   4455999999999999999999999999   9999999999999999999999


Q ss_pred             ecccceeccCCCCccccccccccccccCCccChhhhccCCC-CchhhhHHHHHHHHHHHhCCCCC
Q 014024          253 DFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIVSGKKNT  316 (432)
Q Consensus       253 Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~~DvwSlG~il~elltg~~p~  316 (432)
                      |||.+....        .+....++||..|.|||++.+..| ...-|||++|++||.++....|+
T Consensus       713 dfgsaa~~k--------sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy  769 (772)
T KOG1152|consen  713 DFGSAAYTK--------SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY  769 (772)
T ss_pred             eccchhhhc--------CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence            999997641        345667899999999999998886 67799999999999999888775

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=2.7e-30  Score=221.91  Aligned_cols=259  Identities=18%  Similarity=0.323  Sum_probs=191.7

Q ss_pred             hhhCCCCcCceeccCCcEEEEEEEE--CCceEEEEEEcCCChHhHHHHHHHHHHHHhcC-CCceeeeEeEEEeCC--eeE
Q 014024          106 SATGNFSAANKLGEGGFGTVYKGVI--GQGEIAVKRLLGKSGQEIKELKNEASVIAQVQ-HKNLVKLLGCCIEKD--ERL  180 (432)
Q Consensus       106 ~~~~~y~~~~~ig~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~--~~~  180 (432)
                      ...++|++.+++|+|.++.||.|..  ++.++++|++++   ...+.+.+|+.+|+.++ ||||+++++...++.  ...
T Consensus        35 g~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa  111 (338)
T KOG0668|consen   35 GNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS  111 (338)
T ss_pred             cccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence            3578999999999999999999984  455899998865   34467889999999997 999999999997764  568


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCC-CCEEEeeccccee
Q 014024          181 LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKD-MNSKISDFGMARI  259 (432)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~  259 (432)
                      +|+||+++.+...+.      ..++...+..++.+++.||.|+|+.|   |.|||+||.|+++|.. -.++|+|+|+|..
T Consensus       112 LiFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEF  182 (338)
T KOG0668|consen  112 LIFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEF  182 (338)
T ss_pred             hHhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhh
Confidence            999999998876654      23777888999999999999999999   9999999999999864 4689999999998


Q ss_pred             ccCCCCccccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchh-----------
Q 014024          260 VFGGNDEDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLI-----------  327 (432)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~-----------  327 (432)
                      +.++.       .....+.+..|.-||.+.. ..|+..-|+|||||++..|+..+.||-........++           
T Consensus       183 YHp~~-------eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el  255 (338)
T KOG0668|consen  183 YHPGK-------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDEL  255 (338)
T ss_pred             cCCCc-------eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHH
Confidence            74332       1223345566889998875 5688999999999999999999999844332111111           


Q ss_pred             -hhhHHh--hhccchhhhhhhhhhhc--------ccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          328 -GYAWDL--WISNKIIDLIDSVLEEA--------SFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       328 -~~~~~~--~~~~~~~~~i~~~l~~~--------~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                       .+....  .......+++....+..        ...-...+..+++...|..|-.+|||++|.+.+
T Consensus       256 ~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H  322 (338)
T KOG0668|consen  256 YAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH  322 (338)
T ss_pred             HHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence             111000  00111111111111100        000112567899999999999999999998865

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.96  E-value=5.1e-31  Score=256.43  Aligned_cols=253  Identities=21%  Similarity=0.318  Sum_probs=202.7

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEe
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYE  184 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  184 (432)
                      -.++|+....+|.|.||.||++++...  ..|+|+++.........+++|+-+++..+|+||+.+++.+...+..++.||
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME   92 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME   92 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence            457899999999999999999998654  789999988777788889999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCC
Q 014024          185 YMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGN  264 (432)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  264 (432)
                      ||.+|+|.+.-+   ..+++++.+...+++..++|++|||+.+   -+|||||-.||++++.|.+|++|||.+-.+    
T Consensus        93 ycgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqi----  162 (829)
T KOG0576|consen   93 YCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQI----  162 (829)
T ss_pred             ecCCCcccceee---ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhh----
Confidence            999999998763   4567999999999999999999999999   899999999999999999999999998764    


Q ss_pred             CccccccccccccccCCccChhhhc---cCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhh
Q 014024          265 DEDELQGNTSRISGTYGYMSPEYAL---EGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIID  341 (432)
Q Consensus       265 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (432)
                        ...-.....+.||+.|||||+..   .+.|...+|+|++|+...|+---+.|.-.....    ...+...   .   .
T Consensus       163 --tati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm----r~l~LmT---k---S  230 (829)
T KOG0576|consen  163 --TATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM----RALFLMT---K---S  230 (829)
T ss_pred             --hhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH----HHHHHhh---c---c
Confidence              22234556788999999999774   577999999999999999998777663111100    0000000   0   0


Q ss_pred             hhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014024          342 LIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVS  382 (432)
Q Consensus       342 ~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~  382 (432)
                      ..++-. ..........+.++++.|+.++|.+||++..+++
T Consensus       231 ~~qpp~-lkDk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  231 GFQPPT-LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             CCCCCc-ccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            000000 0112244566788999999999999999987764

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.96  E-value=1.6e-28  Score=222.94  Aligned_cols=197  Identities=30%  Similarity=0.461  Sum_probs=169.9

Q ss_pred             CCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCChH-hHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecCC
Q 014024          111 FSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSGQ-EIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMP  187 (432)
Q Consensus       111 y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  187 (432)
                      |.+.+.||.|++|.||++...+  ..+++|.+...... ..+.+.+|++.++.++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            5667899999999999999865  48999998765544 67789999999999999999999999999899999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCcc
Q 014024          188 NKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDED  267 (432)
Q Consensus       188 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  267 (432)
                      +++|.+++......  +++.....++.+++.++.+||+.+   ++|+||+|.||+++.++.++|+|||.+.......   
T Consensus        81 ~~~L~~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~---  152 (225)
T smart00221       81 GGDLFDYLRKKGGK--LSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDL---  152 (225)
T ss_pred             CCCHHHHHHhcccC--CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc---
Confidence            99999998543221  789999999999999999999998   9999999999999999999999999998753221   


Q ss_pred             ccccccccccccCCccChhhh-ccCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 014024          268 ELQGNTSRISGTYGYMSPEYA-LEGIFSIKSDVFSFGVLLLEIVSGKKNTG  317 (432)
Q Consensus       268 ~~~~~~~~~~gt~~y~aPE~~-~~~~~t~~~DvwSlG~il~elltg~~p~~  317 (432)
                        ........++..|++||.. ....++.++|+||||+++++|++|+.||.
T Consensus       153 --~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~  201 (225)
T smart00221      153 --AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS  201 (225)
T ss_pred             --cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence              0122345677889999998 66778889999999999999999999984

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2e-29  Score=221.56  Aligned_cols=251  Identities=19%  Similarity=0.312  Sum_probs=183.3

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCCChHhHHHHHHHHHHHHhc-CCCceeeeEeE-EEeCCeeEEE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEIKELKNEASVIAQV-QHKNLVKLLGC-CIEKDERLLI  182 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~-~~~~~~~~lv  182 (432)
                      ..+.|.+.+.+|+|.||.+.++++.+.  .+++|-+.. .......|.+|...--.+ .|.||+.-|+. |+..+.++++
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~-p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~  100 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR-PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV  100 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc-chhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence            457899999999999999999999766  677776643 345567888887765555 48999987765 5667778889


Q ss_pred             EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEc--CCCCEEEeecccceec
Q 014024          183 YEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLD--KDMNSKISDFGMARIV  260 (432)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~Dfg~a~~~  260 (432)
                      +||++.|+|..-+..    .-+.+....+++.|++.||.|+|+.+   +||||||.+||||-  +...+||+|||..+..
T Consensus       101 qE~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~  173 (378)
T KOG1345|consen  101 QEFAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKV  173 (378)
T ss_pred             eccCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeeccccccc
Confidence            999999999888733    22788889999999999999999999   99999999999993  3457999999999763


Q ss_pred             cCCCCccccccccccccccCCccChhhhcc---C--CCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhh
Q 014024          261 FGGNDEDELQGNTSRISGTYGYMSPEYALE---G--IFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWI  335 (432)
Q Consensus       261 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~--~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  335 (432)
                               .........+..|.+||....   +  ...+.+|+|.||+++|.++||+.||+.....+.....  |..|.
T Consensus       174 ---------g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~--~~~w~  242 (378)
T KOG1345|consen  174 ---------GTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWE--WEQWL  242 (378)
T ss_pred             ---------CceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHH--HHHHh
Confidence                     112222344567999997653   2  3578899999999999999999999854443333332  23333


Q ss_pred             ccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014024          336 SNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVS  382 (432)
Q Consensus       336 ~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~  382 (432)
                      ........+.      .....+....+.+.-|..++++|=-+.++..
T Consensus       243 ~rk~~~~P~~------F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk  283 (378)
T KOG1345|consen  243 KRKNPALPKK------FNPFSEKALRLFKKSLTPRFKDRCKIWTAKK  283 (378)
T ss_pred             cccCccCchh------hcccCHHHHHHHHHhcCCcccccchhHHHHH
Confidence            2222211111      1122345667788888999999944444433

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.96  E-value=8.2e-30  Score=241.58  Aligned_cols=199  Identities=21%  Similarity=0.245  Sum_probs=167.8

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCCChHhHHHHHHHHHHHHhcC------CCceeeeEeEEEeCCe
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEIKELKNEASVIAQVQ------HKNLVKLLGCCIEKDE  178 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~~~~~~~~~~  178 (432)
                      ..++|.+....|+|-|++|-+|.+...  .||||++..+. ...+.=..|+++|++|+      .-|+++++..|...++
T Consensus       430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH  508 (752)
T KOG0670|consen  430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH  508 (752)
T ss_pred             hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence            456788888899999999999998654  89999986553 33444567999999995      3579999999999999


Q ss_pred             eEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCC-CEEEeecccc
Q 014024          179 RLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDM-NSKISDFGMA  257 (432)
Q Consensus       179 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a  257 (432)
                      +|||+|-+ ..+|.+.|...+.+--|....+..++.|+.-||..|...|   |+|.||||+|||+++.. .+||||||.|
T Consensus       509 LClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA  584 (752)
T KOG0670|consen  509 LCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSA  584 (752)
T ss_pred             eEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCccc
Confidence            99999988 6689999987777667999999999999999999999998   99999999999998754 5799999999


Q ss_pred             eeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 014024          258 RIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGF  318 (432)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~  318 (432)
                      .....        ...+....+..|.|||++.+-.|+...|+||.||.||||.||+..|+.
T Consensus       585 ~~~~e--------neitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG  637 (752)
T KOG0670|consen  585 SFASE--------NEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPG  637 (752)
T ss_pred             ccccc--------ccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCC
Confidence            76421        122334455679999999999999999999999999999999987743

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.96  E-value=5e-29  Score=224.01  Aligned_cols=261  Identities=23%  Similarity=0.238  Sum_probs=188.3

Q ss_pred             hCCCCcCceeccCCcEEEEEEEE--CCceEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeC------C
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVI--GQGEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEK------D  177 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~  177 (432)
                      ..+|.-++.+|.|.- .|--+.+  .+.+|++|+....  .....+...+|...+..++|+|+++++.+|.-.      .
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            456777888999988 5666655  3458999987443  233456678899999999999999999998643      3


Q ss_pred             eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccc
Q 014024          178 ERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMA  257 (432)
Q Consensus       178 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  257 (432)
                      ..|+|||++ ..+|.+.++.     .++-.....|++|++.|+.+||+.+   |+||||||+||++..+..+||.|||+|
T Consensus        95 e~y~v~e~m-~~nl~~vi~~-----elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~a  165 (369)
T KOG0665|consen   95 EVYLVMELM-DANLCQVILM-----ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLA  165 (369)
T ss_pred             hHHHHHHhh-hhHHHHHHHH-----hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhh
Confidence            569999999 5678877752     2677788899999999999999999   999999999999999999999999999


Q ss_pred             eeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccc-------------ccc
Q 014024          258 RIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRT-------------KSL  324 (432)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~-------------~~~  324 (432)
                      +.-       ......+..+.|..|.|||++-+-.+.+.+||||+||++.||++|+.-|...+-             .+.
T Consensus       166 r~e-------~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~  238 (369)
T KOG0665|consen  166 RTE-------DTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDP  238 (369)
T ss_pred             ccc-------CcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCH
Confidence            863       112345567888999999999988899999999999999999999876642111             000


Q ss_pred             chhhh----hHHhhhcc--ch-----hhhhhhhhhhc--ccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014024          325 NLIGY----AWDLWISN--KI-----IDLIDSVLEEA--SFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLT  385 (432)
Q Consensus       325 ~~~~~----~~~~~~~~--~~-----~~~i~~~l~~~--~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~  385 (432)
                      .+..-    +.....+.  ..     ..+.|......  .+.-......+++.+||..||++|.+++++++|--
T Consensus       239 ~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY  312 (369)
T KOG0665|consen  239 SFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPY  312 (369)
T ss_pred             HHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCe
Confidence            00000    00000000  00     00000000000  01112344678999999999999999999999753

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.95  E-value=1.1e-28  Score=264.09  Aligned_cols=200  Identities=18%  Similarity=0.205  Sum_probs=137.0

Q ss_pred             cCC-CceeeeEeEE-------EeCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 014024          161 VQH-KNLVKLLGCC-------IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRII  232 (432)
Q Consensus       161 l~h-~niv~~~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iv  232 (432)
                      ++| .||++++++|       .+.+..+.++||+ +++|.+++...  ...+++..++.++.||++||+|||+++   |+
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---Iv  102 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---IV  102 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence            455 5777788877       2334567788987 66999999542  345999999999999999999999999   99


Q ss_pred             eccCCCCCEEEcCCCC-------------------EEEeecccceeccCCCCc---c--c-----cccccccccccCCcc
Q 014024          233 HRDLKASNILLDKDMN-------------------SKISDFGMARIVFGGNDE---D--E-----LQGNTSRISGTYGYM  283 (432)
Q Consensus       233 H~Dlkp~NIll~~~~~-------------------~kl~Dfg~a~~~~~~~~~---~--~-----~~~~~~~~~gt~~y~  283 (432)
                      ||||||+||||+..+.                   +|++|||+++........   .  .     .........||+.|+
T Consensus       103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~  182 (793)
T PLN00181        103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT  182 (793)
T ss_pred             eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence            9999999999965444                   455555555431100000   0  0     000111246889999


Q ss_pred             ChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHH
Q 014024          284 SPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIA  363 (432)
Q Consensus       284 aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~  363 (432)
                      |||++.+..++.++|||||||+||||++|..|+.....    .   .         ..+ ..................++
T Consensus       183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~---~---------~~~-~~~~~~~~~~~~~~~~~~~~  245 (793)
T PLN00181        183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----T---M---------SSL-RHRVLPPQILLNWPKEASFC  245 (793)
T ss_pred             ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----H---H---------HHH-HHhhcChhhhhcCHHHHHHH
Confidence            99999999999999999999999999998877531100    0   0         000 00000000111223456788


Q ss_pred             HHhhccCCCCCCCHHHHHHH
Q 014024          364 LLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       364 ~~cl~~dp~~RPt~~evl~~  383 (432)
                      .+||+.+|.+||++.|++++
T Consensus       246 ~~~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        246 LWLLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             HHhCCCChhhCcChHHHhhc
Confidence            99999999999999999874

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.95  E-value=5.3e-28  Score=225.05  Aligned_cols=267  Identities=24%  Similarity=0.369  Sum_probs=195.4

Q ss_pred             hhhCCCCcCceeccCCcEEEEEEEECC-----ceEEEEEEcCCChHhHHHHHHHHHHHHhcC-CCceeeeEeEEEeCCee
Q 014024          106 SATGNFSAANKLGEGGFGTVYKGVIGQ-----GEIAVKRLLGKSGQEIKELKNEASVIAQVQ-HKNLVKLLGCCIEKDER  179 (432)
Q Consensus       106 ~~~~~y~~~~~ig~G~~g~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~  179 (432)
                      ...+.|...++||+|.|++||++.+..     ..||+|.+...+.  -..+.+|++.|..+. +.||+++.+++..++..
T Consensus        33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v  110 (418)
T KOG1167|consen   33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQV  110 (418)
T ss_pred             hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence            345678999999999999999998643     3799998865433  346889999999995 89999999999999999


Q ss_pred             EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcC-CCCEEEeecccce
Q 014024          180 LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDK-DMNSKISDFGMAR  258 (432)
Q Consensus       180 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~  258 (432)
                      .+|+||++.....++...      ++...+..++..++.||+++|++|   |+||||||+|+|.+. .+.-.|.|||+|.
T Consensus       111 ~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~  181 (418)
T KOG1167|consen  111 AIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQ  181 (418)
T ss_pred             EEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHH
Confidence            999999999999888732      778889999999999999999999   999999999999975 4567999999998


Q ss_pred             eccCCC--------------C------------------------ccccccccccccccCCccChhhhcc-CCCCchhhh
Q 014024          259 IVFGGN--------------D------------------------EDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDV  299 (432)
Q Consensus       259 ~~~~~~--------------~------------------------~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv  299 (432)
                      ......              .                        .+.......+..||++|.|||++.. ...++++||
T Consensus       182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi  261 (418)
T KOG1167|consen  182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI  261 (418)
T ss_pred             HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence            311000              0                        0111122234569999999999875 567999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCccccccchhhhhHH-----------------hhh-cc--chhhhh--------hhhhh---
Q 014024          300 FSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWD-----------------LWI-SN--KIIDLI--------DSVLE---  348 (432)
Q Consensus       300 wSlG~il~elltg~~p~~~~~~~~~~~~~~~~~-----------------~~~-~~--~~~~~i--------~~~l~---  348 (432)
                      ||-|+|++.+++++.||-....+-..+...+.-                 .+. .+  ...++.        .....   
T Consensus       262 ws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q  341 (418)
T KOG1167|consen  262 WSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQ  341 (418)
T ss_pred             eeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccc
Confidence            999999999999999984433221111111000                 000 00  011110        00000   


Q ss_pred             -----hcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          349 -----EASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       349 -----~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                           ....+..+..+++++.+|+..||.+|.|+++.+.+
T Consensus       342 ~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  342 PNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             cceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence                 00011123467899999999999999999999875

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=8.1e-27  Score=204.26  Aligned_cols=168  Identities=17%  Similarity=0.127  Sum_probs=123.9

Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCccc
Q 014024          189 KSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDE  268 (432)
Q Consensus       189 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  268 (432)
                      |+|.+++...  +..+++..++.++.|++.||.|||+.+         ||+||++++++.+|+  ||++.....      
T Consensus         1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~------   61 (176)
T smart00750        1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTP------   61 (176)
T ss_pred             CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecc------
Confidence            6888888542  335999999999999999999999875         999999999999999  999886421      


Q ss_pred             cccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhhhh
Q 014024          269 LQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLE  348 (432)
Q Consensus       269 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  348 (432)
                           ....||+.|+|||++.+..++.++|||||||++|||+||+.||.............. .......      .. .
T Consensus        62 -----~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~-~~~~~~~------~~-~  128 (176)
T smart00750       62 -----EQSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILL-NGMPADD------PR-D  128 (176)
T ss_pred             -----ccCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHH-HHhccCC------cc-c
Confidence                 112588999999999999999999999999999999999999753221111110000 0000000      00 0


Q ss_pred             hcccHHHH--HHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014024          349 EASFNESL--SRYVHIALLCVQERAEDRPTMSDVVSMLTNEA  388 (432)
Q Consensus       349 ~~~~~~~~--~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~  388 (432)
                      ........  ..+.+++..||+.+|++||++.|+++++....
T Consensus       129 ~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      129 RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence            00111222  26899999999999999999999999987653

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=2.5e-25  Score=213.69  Aligned_cols=266  Identities=23%  Similarity=0.260  Sum_probs=197.4

Q ss_pred             CCCcCceeccCCcEEEEEEEECCc---eEEEEEEcCCChHhHHHHHHHHHHHHhcCC----CceeeeEeEE-EeCCeeEE
Q 014024          110 NFSAANKLGEGGFGTVYKGVIGQG---EIAVKRLLGKSGQEIKELKNEASVIAQVQH----KNLVKLLGCC-IEKDERLL  181 (432)
Q Consensus       110 ~y~~~~~ig~G~~g~Vy~~~~~~~---~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~~~~~~-~~~~~~~l  181 (432)
                      +|.+.++||+|+||.||.+.+...   .+|+|............+..|..++..+..    +++..+++.. ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            899999999999999999998664   577777654433322367889999998873    6889999988 47778899


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCC-----CCEEEeeccc
Q 014024          182 IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKD-----MNSKISDFGM  256 (432)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-----~~~kl~Dfg~  256 (432)
                      ||+.+ |.+|.++..... .+.++..+..+|+.|++.+|++||+.|   ++||||||+|++++..     ..+.|.|||+
T Consensus        99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl  173 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL  173 (322)
T ss_pred             EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence            99988 889998775444 456999999999999999999999999   9999999999999865     3589999999


Q ss_pred             ce--eccCCCCcc--ccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHH
Q 014024          257 AR--IVFGGNDED--ELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWD  332 (432)
Q Consensus       257 a~--~~~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~  332 (432)
                      ++  .+.......  ..........||..|+++..+.+...+.+.|+||++.++.+++.|..||........ .      
T Consensus       174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-~------  246 (322)
T KOG1164|consen  174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-K------  246 (322)
T ss_pred             CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-H------
Confidence            99  432222211  111112456699999999999999999999999999999999999999854332111 0      


Q ss_pred             hhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccccCC
Q 014024          333 LWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSL  391 (432)
Q Consensus       333 ~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~  391 (432)
                          ...................+..+.++...+-..+...+|....+...|+......
T Consensus       247 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~  301 (322)
T KOG1164|consen  247 ----SKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE  301 (322)
T ss_pred             ----HHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence                0000000000000011123455666666666789999999999999988766554

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=4.3e-25  Score=211.91  Aligned_cols=179  Identities=18%  Similarity=0.190  Sum_probs=134.4

Q ss_pred             hhhCCCCcCceeccCCcEEEEEEEECC---ceEEEEEEcCC-----ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC
Q 014024          106 SATGNFSAANKLGEGGFGTVYKGVIGQ---GEIAVKRLLGK-----SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKD  177 (432)
Q Consensus       106 ~~~~~y~~~~~ig~G~~g~Vy~~~~~~---~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  177 (432)
                      ...++|.+.+.||+|+||+||+|.+..   ..+|+|++...     .....+.+.+|+++|++++|+|+++.+..   .+
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~   91 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TG   91 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cC
Confidence            346789999999999999999998743   35799986532     23345678999999999999999853322   24


Q ss_pred             eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccC-CCCCEEEcCCCCEEEeeccc
Q 014024          178 ERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDL-KASNILLDKDMNSKISDFGM  256 (432)
Q Consensus       178 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~Dfg~  256 (432)
                      ..++||||+++++|....    ..   .   ...++.|+++||.|||+.+   |+|||| ||+|||++.++.+||+|||+
T Consensus        92 ~~~LVmE~~~G~~L~~~~----~~---~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGl  158 (365)
T PRK09188         92 KDGLVRGWTEGVPLHLAR----PH---G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQL  158 (365)
T ss_pred             CcEEEEEccCCCCHHHhC----cc---c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECcc
Confidence            579999999999996321    11   1   1467889999999999998   999999 99999999999999999999


Q ss_pred             ceeccCCCCcccc--ccccccccccCCccChhhhccCC------CCchhhhH
Q 014024          257 ARIVFGGNDEDEL--QGNTSRISGTYGYMSPEYALEGI------FSIKSDVF  300 (432)
Q Consensus       257 a~~~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~------~t~~~Dvw  300 (432)
                      ++.+.........  ........+++.|+|||.+...+      .+..+|-|
T Consensus       159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW  210 (365)
T ss_pred             ceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence            9986443222111  11223567888999999887432      33446766

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=2.4e-25  Score=192.88  Aligned_cols=282  Identities=20%  Similarity=0.230  Sum_probs=214.0

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCCChHhHHHHHHHHHHHHhcCC-CceeeeEeEEEeCCeeEEEE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGKSGQEIKELKNEASVIAQVQH-KNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~  183 (432)
                      ..++|.++++||+|+||.+|.|..-  +..||+|.-....  ...++..|.++.+.+++ ..|..+.-+..+...-.+||
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM   90 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM   90 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence            3578999999999999999999863  3489999865443  23467889999999986 67888888888999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCC---CCEEEeecccceec
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKD---MNSKISDFGMARIV  260 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Dfg~a~~~  260 (432)
                      |.. |.+|.++..-...  .++..+++.++-|++.-++|+|..+   ++||||||+|+|.+-+   ..+.++|||+|+.+
T Consensus        91 dLL-GPsLEdLfnfC~R--~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky  164 (341)
T KOG1163|consen   91 DLL-GPSLEDLFNFCSR--RFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY  164 (341)
T ss_pred             ecc-CccHHHHHHHHhh--hhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhh
Confidence            998 8899888754333  3999999999999999999999999   9999999999999643   45899999999998


Q ss_pred             cCCCCcccccccc-ccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccch
Q 014024          261 FGGNDEDELQGNT-SRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKI  339 (432)
Q Consensus       261 ~~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  339 (432)
                      .+.......+... ....||.+|.+--.+.+...+.+.|+-|+|.+|.++.-|..||+.........   -++.....++
T Consensus       165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~Q---KyEkI~EkK~  241 (341)
T KOG1163|consen  165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQ---KYEKISEKKM  241 (341)
T ss_pred             ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHH---HHHHHHHhhc
Confidence            6665554444443 45789999999888888888999999999999999999999987543311100   0011111111


Q ss_pred             hhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccccCCCCCCCCccccccC
Q 014024          340 IDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQPAFCNLRN  404 (432)
Q Consensus       340 ~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~~~~~~~~~~~~~  404 (432)
                      ...+ ..+..    ..+.++...+..|-....++-|...-+.+.+.-+...+.....-.++|...
T Consensus       242 s~~i-e~LC~----G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW~~l  301 (341)
T KOG1163|consen  242 STPI-EVLCK----GFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDWTML  301 (341)
T ss_pred             CCCH-HHHhC----CCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeHHHH
Confidence            1111 11222    235677888999999999999999988887777666665555566666553

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=6.4e-24  Score=192.03  Aligned_cols=264  Identities=20%  Similarity=0.258  Sum_probs=198.6

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEE--CCceEEEEEEcCCChHhHHHHHHHHHHHHhcC-CCceeeeEeEEEeCCeeEEEE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVI--GQGEIAVKRLLGKSGQEIKELKNEASVIAQVQ-HKNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~  183 (432)
                      -.-+|.++++||+|+||..+.|.+  ++..||||.-..+  ....++..|.+..+.+. .++|..++.+-.++.+-.||+
T Consensus        26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi  103 (449)
T KOG1165|consen   26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI  103 (449)
T ss_pred             ecccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence            356899999999999999999985  5668999965443  33467889999999985 689999998888888999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCC-----CEEEeecccce
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDM-----NSKISDFGMAR  258 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-----~~kl~Dfg~a~  258 (432)
                      |.+ |-+|.|+. +..++ .|+..+++.+|.|++.-++|+|++.   +|.|||||+|+||+..+     .+.++|||+|+
T Consensus       104 dLL-GPSLEDLF-D~CgR-~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK  177 (449)
T KOG1165|consen  104 DLL-GPSLEDLF-DLCGR-RFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK  177 (449)
T ss_pred             hhh-CcCHHHHH-HHhcC-cccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchh
Confidence            998 77888865 32333 3999999999999999999999999   99999999999997544     48999999999


Q ss_pred             eccCCCCccccccc-cccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhcc
Q 014024          259 IVFGGNDEDELQGN-TSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISN  337 (432)
Q Consensus       259 ~~~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  337 (432)
                      .+.+.......+.. ..+..||.+||+-..+.+.+.+.+.|+-|||-++++.+-|..||+........   .-++.....
T Consensus       178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK---~kYeKIGe~  254 (449)
T KOG1165|consen  178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNK---EKYEKIGET  254 (449)
T ss_pred             hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchH---HHHHHhccc
Confidence            98766655555444 35688999999999999999999999999999999999999999754332111   011111111


Q ss_pred             chhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014024          338 KIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN  386 (432)
Q Consensus       338 ~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~  386 (432)
                      +...-++. +..    ..+.++...+...-..+..+-|..+-+...+.+
T Consensus       255 Kr~T~i~~-Lc~----g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~d  298 (449)
T KOG1165|consen  255 KRSTPIEV-LCE----GFPEEFATYLRYVRRLDFFETPDYDYLRKLFDD  298 (449)
T ss_pred             cccCCHHH-HHh----cCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence            11111111 111    234455566666667777888887766554443

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.91  E-value=1.1e-22  Score=194.22  Aligned_cols=264  Identities=28%  Similarity=0.379  Sum_probs=195.5

Q ss_pred             CCcCceeccCCcEEEEEEEECCceEEEEEEcCCCh---HhHHHHHHHHHHHHhcCCC-ceeeeEeEEEeCCeeEEEEecC
Q 014024          111 FSAANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSG---QEIKELKNEASVIAQVQHK-NLVKLLGCCIEKDERLLIYEYM  186 (432)
Q Consensus       111 y~~~~~ig~G~~g~Vy~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e~~  186 (432)
                      |.+.+.||.|+||.||++.+. ..+++|.+.....   .....+.+|+.+++.+.|+ +++++.+.+......+++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~   80 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV   80 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence            677889999999999999988 6788888754432   2467899999999999988 7999999997777789999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCC-CEEEeecccceeccCCCC
Q 014024          187 PNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDM-NSKISDFGMARIVFGGND  265 (432)
Q Consensus       187 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~~  265 (432)
                      .++++.+++........+.......++.|++.++.|+|+.+   ++|||+||+||+++..+ .++++|||.+..+.....
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~  157 (384)
T COG0515          81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS  157 (384)
T ss_pred             CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence            99999977643221125889999999999999999999999   99999999999999998 799999999985422211


Q ss_pred             ccccccccccccccCCccChhhhcc---CCCCchhhhHHHHHHHHHHHhCCCCCCCcccc--ccchhhhhHHhhhccchh
Q 014024          266 EDELQGNTSRISGTYGYMSPEYALE---GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTK--SLNLIGYAWDLWISNKII  340 (432)
Q Consensus       266 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~t~~~DvwSlG~il~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~  340 (432)
                      ............|+..|+|||.+.+   ...+...|+||+|++++++++|..|+......  ..............    
T Consensus       158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~----  233 (384)
T COG0515         158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP----  233 (384)
T ss_pred             cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc----
Confidence            1000013456789999999999987   57899999999999999999999996433321  00111111110000    


Q ss_pred             hhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          341 DLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       341 ~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                       .................+.+++..|+..+|..|.+..+....
T Consensus       234 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         234 -SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             -ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence             000000000001223567889999999999999999987764

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.91  E-value=4.4e-25  Score=225.76  Aligned_cols=256  Identities=18%  Similarity=0.233  Sum_probs=190.0

Q ss_pred             CCCcCceeccCCcEEEEEEEECCceEEEEEEcCCC-hHhHHHHHHHHHH--HHhcCCCceeeeEeEEEeCCeeEEEEecC
Q 014024          110 NFSAANKLGEGGFGTVYKGVIGQGEIAVKRLLGKS-GQEIKELKNEASV--IAQVQHKNLVKLLGCCIEKDERLLIYEYM  186 (432)
Q Consensus       110 ~y~~~~~ig~G~~g~Vy~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~h~niv~~~~~~~~~~~~~lv~e~~  186 (432)
                      +|...+.||++.|=+|.+|++.++.|+||++.+.. ....+.+.++++-  ...++|||.+++.-+....+-.|+|-+|.
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyv  103 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYV  103 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHH
Confidence            67788999999999999999999999999996664 3334444443333  45568999999998888888889999998


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCC-CC
Q 014024          187 PNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGG-ND  265 (432)
Q Consensus       187 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-~~  265 (432)
                      .+ +|.|.+   ..+..+...+...|+.|++.||..+|..|   |+|||||.+||||+.-+-+.|+||..-+...-. ++
T Consensus       104 kh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN  176 (1431)
T KOG1240|consen  104 KH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN  176 (1431)
T ss_pred             hh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence            44 788888   56777888899999999999999999999   999999999999999999999999877654332 22


Q ss_pred             ccccccccccccccCCccChhhhccC-----------CCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHh
Q 014024          266 EDELQGNTSRISGTYGYMSPEYALEG-----------IFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDL  333 (432)
Q Consensus       266 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~  333 (432)
                      +.+..........-.+|+|||.+...           ..+++.||||+||++.||++ |+++|.....     ..|-   
T Consensus       177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL-----~aYr---  248 (1431)
T KOG1240|consen  177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQL-----LAYR---  248 (1431)
T ss_pred             cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHH-----HhHh---
Confidence            22223333334445679999987531           27889999999999999988 6777653221     1110   


Q ss_pred             hhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014024          334 WISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNE  387 (432)
Q Consensus       334 ~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~  387 (432)
                        ++. .......+..-    +...+++++..|++.||.+|.++++.++...+.
T Consensus       249 --~~~-~~~~e~~Le~I----ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~  295 (1431)
T KOG1240|consen  249 --SGN-ADDPEQLLEKI----EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL  295 (1431)
T ss_pred             --ccC-ccCHHHHHHhC----cCccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence              010 11111111111    113688999999999999999999999876553

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.90  E-value=1.7e-24  Score=190.81  Aligned_cols=251  Identities=20%  Similarity=0.311  Sum_probs=195.4

Q ss_pred             CCCcCceeccCCcEEEEEEEECCceEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecCC
Q 014024          110 NFSAANKLGEGGFGTVYKGVIGQGEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMP  187 (432)
Q Consensus       110 ~y~~~~~ig~G~~g~Vy~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  187 (432)
                      ...+..+|.+...|..|+|++++..+++|++.-.  .....+.|..|.-.|+.+.||||+.+++.|..+.+..++..|++
T Consensus       191 ~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp  270 (448)
T KOG0195|consen  191 SLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP  270 (448)
T ss_pred             hhhhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence            3455677899999999999999998888877433  23334568889999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCcc
Q 014024          188 NKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDED  267 (432)
Q Consensus       188 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  267 (432)
                      .|+|...+++.. .-..+..++.+++.++++|++|||+..+. |----|.+..+++|++.+++|+- +-+++.       
T Consensus       271 ~gslynvlhe~t-~vvvd~sqav~faldiargmaflhslep~-ipr~~lns~hvmidedltarism-ad~kfs-------  340 (448)
T KOG0195|consen  271 FGSLYNVLHEQT-SVVVDHSQAVRFALDIARGMAFLHSLEPM-IPRFYLNSKHVMIDEDLTARISM-ADTKFS-------  340 (448)
T ss_pred             chHHHHHHhcCc-cEEEecchHHHHHHHHHhhHHHHhhcchh-hhhhhcccceEEecchhhhheec-ccceee-------
Confidence            999999997643 33477889999999999999999998732 33446899999999999887642 112111       


Q ss_pred             ccccccccccccCCccChhhhccCCC---CchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhh
Q 014024          268 ELQGNTSRISGTYGYMSPEYALEGIF---SIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLID  344 (432)
Q Consensus       268 ~~~~~~~~~~gt~~y~aPE~~~~~~~---t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  344 (432)
                         .......-.|.|++||.++..+-   -.++|+|||++++|||.|...||......+..              .++.-
T Consensus       341 ---fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg--------------mkial  403 (448)
T KOG0195|consen  341 ---FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG--------------MKIAL  403 (448)
T ss_pred             ---eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh--------------hhhhh
Confidence               11122334678999999987653   35799999999999999999998654432211              22233


Q ss_pred             hhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014024          345 SVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNE  387 (432)
Q Consensus       345 ~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~  387 (432)
                      +.++...++.....+.+|+.-|+..||.+||.+..|+-.|++.
T Consensus       404 eglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm  446 (448)
T KOG0195|consen  404 EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM  446 (448)
T ss_pred             ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence            4555666777788899999999999999999999999888763

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.89  E-value=3.3e-23  Score=185.36  Aligned_cols=171  Identities=17%  Similarity=0.173  Sum_probs=133.7

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECCceEEEEEEcCCCh---HhHHH------HHHHHHHHHhcCCCceeeeEeEEEeC-
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSG---QEIKE------LKNEASVIAQVQHKNLVKLLGCCIEK-  176 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~~~vavK~~~~~~~---~~~~~------~~~E~~~l~~l~h~niv~~~~~~~~~-  176 (432)
                      ..++|...+++|.|+||.||+...+.+.+++|.+.+...   .....      +.+|++.+.+++|++|..+.+++... 
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~  108 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE  108 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence            478999999999999999999877666999999964432   22222      68899999999999999999886643 


Q ss_pred             -------CeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCE
Q 014024          177 -------DERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNS  249 (432)
Q Consensus       177 -------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  249 (432)
                             ...+++|||++|.+|.++..       ++.    ....+++.++..+|+.|   ++|||++|+||+++++| +
T Consensus       109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i  173 (232)
T PRK10359        109 RKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-L  173 (232)
T ss_pred             cccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-E
Confidence                   35789999999999987731       222    24569999999999999   99999999999999988 9


Q ss_pred             EEeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHH
Q 014024          250 KISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIV  310 (432)
Q Consensus       250 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ell  310 (432)
                      +|+|||.........                  ....++....+..++|+||||+.+..+.
T Consensus       174 ~liDfg~~~~~~e~~------------------a~d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        174 RIIDLSGKRCTAQRK------------------AKDRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEECCCcccccchh------------------hHHHHHHHhHhcccccccceeEeehHHH
Confidence            999999886531100                  0011344455677999999999987654

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.89  E-value=1e-23  Score=215.29  Aligned_cols=256  Identities=20%  Similarity=0.268  Sum_probs=184.4

Q ss_pred             CcCceeccCCcEEEEEEEECCc--eEEEEEEc-----CCChHhHH-HHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEE
Q 014024          112 SAANKLGEGGFGTVYKGVIGQG--EIAVKRLL-----GKSGQEIK-ELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       112 ~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~-----~~~~~~~~-~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  183 (432)
                      ....++|.|.+|.|+.......  ....|.+.     ........ .+..|+-+-..++|+|++..+..+.+.....-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            4567899999997777654221  22233221     11111111 2566777778889999988888777766655569


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCC
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGG  263 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  263 (432)
                      |||++ +|..++..   ...+...++..++.|++.|+.|+|+.|   |.|||+||+|++++.+|.+||+|||.+......
T Consensus       401 E~~~~-Dlf~~~~~---~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~  473 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMS---NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP  473 (601)
T ss_pred             hcccH-HHHHHHhc---ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence            99999 99998843   235888899999999999999999999   999999999999999999999999999875322


Q ss_pred             CCccccccccccccccCCccChhhhccCCCCc-hhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhh
Q 014024          264 NDEDELQGNTSRISGTYGYMSPEYALEGIFSI-KSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDL  342 (432)
Q Consensus       264 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~-~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                      -..  ........+|...|+|||.+.+..|.+ ..||||.|++++.|++|+.||......+..+.......+     ...
T Consensus       474 ~e~--~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~-----~~~  546 (601)
T KOG0590|consen  474 WEK--NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQ-----RNI  546 (601)
T ss_pred             cch--hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccc-----ccc
Confidence            111  123345678999999999999999865 599999999999999999999766554332211000000     000


Q ss_pred             hhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          343 IDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       343 i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      ...  ........+.....++.++|+.||.+|.|+++|++.
T Consensus       547 ~~~--~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d  585 (601)
T KOG0590|consen  547 FEG--PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND  585 (601)
T ss_pred             ccC--hHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence            000  011123445677889999999999999999999873

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.86  E-value=1.8e-21  Score=171.97  Aligned_cols=137  Identities=16%  Similarity=0.138  Sum_probs=105.1

Q ss_pred             CceeccCCcEEEEEEEEC-CceEEEEEEcCCChH--h------------------------HHHHHHHHHHHHhcCCCce
Q 014024          114 ANKLGEGGFGTVYKGVIG-QGEIAVKRLLGKSGQ--E------------------------IKELKNEASVIAQVQHKNL  166 (432)
Q Consensus       114 ~~~ig~G~~g~Vy~~~~~-~~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~h~ni  166 (432)
                      ...||+|++|.||+|.+. +..||+|++......  .                        ......|++.+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            467999999999999986 448999998543211  0                        1123459999999987776


Q ss_pred             eeeEeEEEeCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEeccCCCCCEEEcC
Q 014024          167 VKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYL-HQYSRVRIIHRDLKASNILLDK  245 (432)
Q Consensus       167 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~L-H~~~~~~ivH~Dlkp~NIll~~  245 (432)
                      .....+..  ...++||||++++++.....   ....++......++.|++.+|.++ |+.+   |+||||||+||+++ 
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-  152 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-  152 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence            43332222  23389999999987765432   224588999999999999999999 6888   99999999999998 


Q ss_pred             CCCEEEeeccccee
Q 014024          246 DMNSKISDFGMARI  259 (432)
Q Consensus       246 ~~~~kl~Dfg~a~~  259 (432)
                      ++.++|+|||++..
T Consensus       153 ~~~v~LiDFG~a~~  166 (190)
T cd05147         153 DGKLYIIDVSQSVE  166 (190)
T ss_pred             CCcEEEEEcccccc
Confidence            47899999999975

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.86  E-value=8.1e-21  Score=166.43  Aligned_cols=187  Identities=19%  Similarity=0.141  Sum_probs=138.6

Q ss_pred             cCceeccCCcEEEEEEEECCceEEEEEEcCCChH----hHHHHHHHHHHHHhcC-CCceeeeEeEEEeCCeeEEEEecCC
Q 014024          113 AANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQ----EIKELKNEASVIAQVQ-HKNLVKLLGCCIEKDERLLIYEYMP  187 (432)
Q Consensus       113 ~~~~ig~G~~g~Vy~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~  187 (432)
                      ....|++|+||+||.+...+.+++.+.+......    ....+.+|+++|++++ |+++++++++    +..+++|||+.
T Consensus         6 ~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~   81 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA   81 (218)
T ss_pred             cceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence            4678999999999988887778887777544331    2235789999999995 4789998886    34699999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccC-CCCCEEEcCCCCEEEeecccceeccCCCCc
Q 014024          188 NKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDL-KASNILLDKDMNSKISDFGMARIVFGGNDE  266 (432)
Q Consensus       188 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  266 (432)
                      |.+|.+.+.    .      ....++.|++.+|.++|+.|   |+|||| ||+|||++.++.++|+|||++.........
T Consensus        82 G~~L~~~~~----~------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~  148 (218)
T PRK12274         82 GAAMYQRPP----R------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW  148 (218)
T ss_pred             CccHHhhhh----h------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence            999865431    1      11357789999999999999   999999 799999999999999999999864221110


Q ss_pred             ------ccc-ccccccccccCCccChhhhccC-CCC-chhhhHHHHHHHHHHHhCCCCC
Q 014024          267 ------DEL-QGNTSRISGTYGYMSPEYALEG-IFS-IKSDVFSFGVLLLEIVSGKKNT  316 (432)
Q Consensus       267 ------~~~-~~~~~~~~gt~~y~aPE~~~~~-~~t-~~~DvwSlG~il~elltg~~p~  316 (432)
                            .+. .-.......++.|++|+...-- ..+ ...+.++-|+-+|.++|++.+.
T Consensus       149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~  207 (218)
T PRK12274        149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH  207 (218)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence                  000 0001123367888888865432 333 5678899999999999998863

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.85  E-value=5.1e-21  Score=176.33  Aligned_cols=232  Identities=20%  Similarity=0.258  Sum_probs=146.1

Q ss_pred             CCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCC---hHhHHHHHHHHHHHHhcCC----------CceeeeEeEE-
Q 014024          110 NFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS---GQEIKELKNEASVIAQVQH----------KNLVKLLGCC-  173 (432)
Q Consensus       110 ~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h----------~niv~~~~~~-  173 (432)
                      ++...+.||.|+++.||.+.+.+  .++++|.+....   ....+++.+|.-....+.+          -.++--++.. 
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            44557889999999999999977  489999884332   2345666666544444322          1222222221 


Q ss_pred             --------EeCC--------eeEEEEecCCCCChhhhhcC---C-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 014024          174 --------IEKD--------ERLLIYEYMPNKSLDCFLFD---P-TKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH  233 (432)
Q Consensus       174 --------~~~~--------~~~lv~e~~~~gsL~~~l~~---~-~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH  233 (432)
                              ....        +.+++|+-+ .++|.+++..   . ..+..+....+..+..|+++.+++||+.|   ++|
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH  168 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH  168 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence                    1111        236678877 5677776531   1 11223445566677799999999999999   999


Q ss_pred             ccCCCCCEEEcCCCCEEEeecccceeccCCCCccccccccccccccCCccChhhhccC--------CCCchhhhHHHHHH
Q 014024          234 RDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEG--------IFSIKSDVFSFGVL  305 (432)
Q Consensus       234 ~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~t~~~DvwSlG~i  305 (432)
                      +||+|+|++++.+|.++|+||+.....  +       ........+..|.+||.....        .+|.+.|.|+||++
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~--g-------~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~  239 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRA--G-------TRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGIT  239 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEET--T-------EEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHH
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeec--C-------ceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHH
Confidence            999999999999999999999887653  0       011113445779999977542        47899999999999


Q ss_pred             HHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCC
Q 014024          306 LLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDR  374 (432)
Q Consensus       306 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~R  374 (432)
                      +|.|.||..||+..........                   .-..|. +.++.+..|+..+|+.||++|
T Consensus       240 ly~lWC~~lPf~~~~~~~~~~~-------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  240 LYSLWCGRLPFGLSSPEADPEW-------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHHHHSS-STCCCGGGSTSGG-------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HHHHHHccCCCCCCCccccccc-------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            9999999999875433111100                   112334 677888999999999999988

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.85  E-value=2.8e-20  Score=164.81  Aligned_cols=139  Identities=19%  Similarity=0.185  Sum_probs=108.5

Q ss_pred             cCceeccCCcEEEEEEEEC-CceEEEEEEcCCChH--------------------------hHHHHHHHHHHHHhcCCCc
Q 014024          113 AANKLGEGGFGTVYKGVIG-QGEIAVKRLLGKSGQ--------------------------EIKELKNEASVIAQVQHKN  165 (432)
Q Consensus       113 ~~~~ig~G~~g~Vy~~~~~-~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~h~n  165 (432)
                      +...||+|++|.||+|.+. +..||+|++......                          ....+..|.+.+.++.|++
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           1 INGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CCceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            3578999999999999986 459999998654210                          0123467899999999988


Q ss_pred             eeeeEeEEEeCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCCCCCEEEc
Q 014024          166 LVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ-YSRVRIIHRDLKASNILLD  244 (432)
Q Consensus       166 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dlkp~NIll~  244 (432)
                      +.....+...  ..++||||++++++.....   ....++......++.|++.++.++|+ .|   |+||||||+||+++
T Consensus        81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~  152 (190)
T cd05145          81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH  152 (190)
T ss_pred             CCCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE
Confidence            7544443332  2489999999886543321   22347888899999999999999999 88   99999999999998


Q ss_pred             CCCCEEEeecccceec
Q 014024          245 KDMNSKISDFGMARIV  260 (432)
Q Consensus       245 ~~~~~kl~Dfg~a~~~  260 (432)
                       ++.++|+|||++...
T Consensus       153 -~~~~~liDFG~a~~~  167 (190)
T cd05145         153 -DGKPYIIDVSQAVEL  167 (190)
T ss_pred             -CCCEEEEEcccceec
Confidence             889999999999864

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.84  E-value=5.5e-21  Score=186.93  Aligned_cols=218  Identities=24%  Similarity=0.355  Sum_probs=161.8

Q ss_pred             HHhcCCCceeeeEeEEEeCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCC
Q 014024          158 IAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLK  237 (432)
Q Consensus       158 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlk  237 (432)
                      |+.+.|.|+.+++|.+.++...+.|.+||..|+|.|.+....  -.+++.....+..+++.||+|||...  -..|+.++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~--~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED--IKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc--cCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence            456899999999999999999999999999999999997633  33899999999999999999999875  13999999


Q ss_pred             CCCEEEcCCCCEEEeecccceeccCCCCccccccccccccccCCccChhhhccC-------CCCchhhhHHHHHHHHHHH
Q 014024          238 ASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEG-------IFSIKSDVFSFGVLLLEIV  310 (432)
Q Consensus       238 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~t~~~DvwSlG~il~ell  310 (432)
                      +.|+++|..+.+||+|||+.........    ........-..-|.|||.+...       ..+.+.|+||||++++|++
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~~~~~----~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~  152 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLEETAE----PEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEIL  152 (484)
T ss_pred             cccceeeeeEEEEechhhhccccccccc----ccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHH
Confidence            9999999999999999999887522100    1111122234569999988753       2577899999999999999


Q ss_pred             hCCCCCCCcccccc--chhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014024          311 SGKKNTGFYRTKSL--NLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEA  388 (432)
Q Consensus       311 tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~  388 (432)
                      +.+.||+.......  .....+..     .....+.+.+...  .+....+..++.+||..+|++||++++|-..++...
T Consensus       153 ~r~~~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~  225 (484)
T KOG1023|consen  153 FRSGPFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN  225 (484)
T ss_pred             hccCccccccccCChHHHHHHHHh-----cCCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence            99999875333111  11111111     0111111111100  133447889999999999999999999999988766


Q ss_pred             cC
Q 014024          389 SS  390 (432)
Q Consensus       389 ~~  390 (432)
                      ..
T Consensus       226 ~~  227 (484)
T KOG1023|consen  226 KG  227 (484)
T ss_pred             cc
Confidence            53

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.83  E-value=5.9e-21  Score=186.86  Aligned_cols=229  Identities=26%  Similarity=0.289  Sum_probs=177.7

Q ss_pred             eeccCCcEEEEEEEE-----CCceEEEEEEcCCChH--hHHHHHHHHHHHHhcC-CCceeeeEeEEEeCCeeEEEEecCC
Q 014024          116 KLGEGGFGTVYKGVI-----GQGEIAVKRLLGKSGQ--EIKELKNEASVIAQVQ-HKNLVKLLGCCIEKDERLLIYEYMP  187 (432)
Q Consensus       116 ~ig~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~  187 (432)
                      ++|.|.||.|++..-     .+.-+++|........  .......|..++..++ ||.++++...+..+...+++.+|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            378999999997542     3335666665433211  1114556788888887 9999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCcc
Q 014024          188 NKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDED  267 (432)
Q Consensus       188 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  267 (432)
                      +|.|...+   .....++......+...++-+++.+|+.+   ++|||+|++||+++.+|++++.|||+++.....    
T Consensus        81 gg~lft~l---~~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~----  150 (612)
T KOG0603|consen   81 GGDLFTRL---SKEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE----  150 (612)
T ss_pred             cchhhhcc---ccCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhh----
Confidence            99998877   34445777788888889999999999999   999999999999999999999999999875221    


Q ss_pred             ccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhhh
Q 014024          268 ELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVL  347 (432)
Q Consensus       268 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  347 (432)
                            ...+||..|||||++.  ....++|.||||++++||+||..||..                      +....++
T Consensus       151 ------~~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----------------------~~~~~Il  200 (612)
T KOG0603|consen  151 ------KIACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----------------------DTMKRIL  200 (612)
T ss_pred             ------hhcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----------------------HHHHHHh
Confidence                  1228999999999988  667899999999999999999999752                      1111222


Q ss_pred             --hhcccHHHHHHHHHHHHHhhccCCCCCCCH--HHHHHHh
Q 014024          348 --EEASFNESLSRYVHIALLCVQERAEDRPTM--SDVVSML  384 (432)
Q Consensus       348 --~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~--~evl~~L  384 (432)
                        ....+.+......+++..++..+|.+|.-.  ..+.+..
T Consensus       201 ~~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik  241 (612)
T KOG0603|consen  201 KAELEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIK  241 (612)
T ss_pred             hhccCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHh
Confidence              123455666777889999999999999866  3444433

>PRK10345 hypothetical protein; Provisional

Probab=99.82  E-value=1.4e-19  Score=161.47  Aligned_cols=135  Identities=19%  Similarity=0.243  Sum_probs=105.1

Q ss_pred             cCceeccCCcEEEEEEEECCceEEEEEEcCCChHhHHHHHHHHHHHHhc-----CCCceeeeEeEEEeCC---eeE-EEE
Q 014024          113 AANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQV-----QHKNLVKLLGCCIEKD---ERL-LIY  183 (432)
Q Consensus       113 ~~~~ig~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~---~~~-lv~  183 (432)
                      -.+.||+|+||.||. .-.....++|+.........+.+.+|+.+++.+     +||||+++++++.++.   ..+ +|+
T Consensus         6 ~~~~LG~G~~~~Vy~-hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~   84 (210)
T PRK10345          6 EQSPLGTGRHRKCYA-HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA   84 (210)
T ss_pred             CcceecCCCceEEEE-CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence            357899999999996 222234578988665444567799999999999     5799999999998874   333 789


Q ss_pred             ec--CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeEeccCCCCCEEEcC----CCCEEEeeccc
Q 014024          184 EY--MPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL-LYLHQYSRVRIIHRDLKASNILLDK----DMNSKISDFGM  256 (432)
Q Consensus       184 e~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l-~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~Dfg~  256 (432)
                      ||  +.+++|.+++.+.    .+++.  ..++.|++.++ +|||+++   |+||||||+|||++.    ++.++|+||+.
T Consensus        85 e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~G  155 (210)
T PRK10345         85 DFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNIG  155 (210)
T ss_pred             cCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence            99  5589999999432    25555  35677888777 9999999   999999999999974    34799999544


Q ss_pred             c
Q 014024          257 A  257 (432)
Q Consensus       257 a  257 (432)
                      +
T Consensus       156 ~  156 (210)
T PRK10345        156 E  156 (210)
T ss_pred             C
Confidence            4

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.82  E-value=7.9e-20  Score=190.71  Aligned_cols=199  Identities=19%  Similarity=0.226  Sum_probs=157.5

Q ss_pred             HhhhhCCCCcCceeccCCcEEEEEEEECCc-eEEEEEEcCCChHhHHHHHHHHHHHHhcC---CCceeeeEeEEEeCCee
Q 014024          104 VSSATGNFSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKSGQEIKELKNEASVIAQVQ---HKNLVKLLGCCIEKDER  179 (432)
Q Consensus       104 ~~~~~~~y~~~~~ig~G~~g~Vy~~~~~~~-~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~  179 (432)
                      .......|.|.+.||+|+||+||+|...++ .+|+|.-.......   |.--.+++.+|+   -+.|.++..++.-.+..
T Consensus       693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S  769 (974)
T KOG1166|consen  693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNAS  769 (974)
T ss_pred             eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence            334567899999999999999999997666 78999876654432   111123334444   23455666666667778


Q ss_pred             EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEc-------CCCCEEEe
Q 014024          180 LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLD-------KDMNSKIS  252 (432)
Q Consensus       180 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~-------~~~~~kl~  252 (432)
                      ++|+||.+.|+|.+++.   ..+.++|..++.+..|++..++.||..+   ||||||||+|.||.       ++..++|+
T Consensus       770 ~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lI  843 (974)
T KOG1166|consen  770 VLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLI  843 (974)
T ss_pred             eeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEE
Confidence            99999999999999995   5566999999999999999999999999   99999999999994       33458999


Q ss_pred             ecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCC
Q 014024          253 DFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKN  315 (432)
Q Consensus       253 Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p  315 (432)
                      |||.+..+..-.+.    ......++|-.+-.+|...++.++...|.|.|+.+++.|+.|+..
T Consensus       844 DfG~siDm~lfp~~----~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  844 DFGRSIDMKLFPDG----TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             ecccceeeeEcCCC----cEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            99999765322211    234556788999999999999999999999999999999999864

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.79  E-value=1.4e-18  Score=156.62  Aligned_cols=134  Identities=18%  Similarity=0.291  Sum_probs=113.8

Q ss_pred             ceeccCCcEEEEEEEECCceEEEEEEcCCCh--------HhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecC
Q 014024          115 NKLGEGGFGTVYKGVIGQGEIAVKRLLGKSG--------QEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYM  186 (432)
Q Consensus       115 ~~ig~G~~g~Vy~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  186 (432)
                      +.||+|++|.||+|...+..+++|+......        .....+.+|++++..++|+++.....++.+.+..+++|||+
T Consensus         2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   81 (211)
T PRK14879          2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI   81 (211)
T ss_pred             cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence            5799999999999999888999998754321        12245778999999999999887777777778889999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeeccccee
Q 014024          187 PNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARI  259 (432)
Q Consensus       187 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  259 (432)
                      +|++|.+++...      .+ .+..++.+++.+|.++|+.+   ++|+|++|.||+++ ++.++|+|||.+..
T Consensus        82 ~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         82 EGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             CCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            999999988421      12 77889999999999999999   99999999999999 78999999999864

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.78  E-value=7.8e-20  Score=175.78  Aligned_cols=180  Identities=23%  Similarity=0.329  Sum_probs=131.2

Q ss_pred             eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccc
Q 014024          178 ERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMA  257 (432)
Q Consensus       178 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  257 (432)
                      ..|+.|++|...+|.+|+.........++.....++.|++.|+.|   ++   .+|+|+||.||+...+..+||+|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence            568999999999999999765555668889999999999999999   66   999999999999999999999999998


Q ss_pred             eeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhC-CCCCCCccccccchhhhhHHhhhc
Q 014024          258 RIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG-KKNTGFYRTKSLNLIGYAWDLWIS  336 (432)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~  336 (432)
                      ................+...||..||+||.+.+..|+.++||||||++|+|++.- ..++..                 .
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er-----------------~  466 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER-----------------I  466 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH-----------------H
Confidence            7653332111122344567899999999999999999999999999999999972 111100                 0


Q ss_pred             cchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 014024          337 NKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVV  381 (432)
Q Consensus       337 ~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl  381 (432)
                      ....++-+..+.+....+. ..=..++.+++...|.+||++.++.
T Consensus       467 ~t~~d~r~g~ip~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~~~  510 (516)
T KOG1033|consen  467 ATLTDIRDGIIPPEFLQDY-PEEYTLLQQLLSPSPEERPSAIEVA  510 (516)
T ss_pred             HhhhhhhcCCCChHHhhcC-cHHHHHHHHhcCCCcccCchHHHHh
Confidence            0011111111110111111 1224688999999999999555443

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.78  E-value=1.4e-18  Score=160.98  Aligned_cols=200  Identities=22%  Similarity=0.266  Sum_probs=141.0

Q ss_pred             CCCceeeeEeEEEe---------------------------CCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHH
Q 014024          162 QHKNLVKLLGCCIE---------------------------KDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIK  214 (432)
Q Consensus       162 ~h~niv~~~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~  214 (432)
                      +|||||++.++|.+                           +...|+||.-++. +|.+++..    ...+.....-++.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~----~~~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT----RHRSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc----CCCchHHHHHHHH
Confidence            59999999987743                           3456899988854 78888843    2366777788999


Q ss_pred             HHHHHHHHHHhcCCCCeEeccCCCCCEEE--cCCC--CEEEeecccceeccCCCC--ccccccccccccccCCccChhhh
Q 014024          215 GVAQGLLYLHQYSRVRIIHRDLKASNILL--DKDM--NSKISDFGMARIVFGGND--EDELQGNTSRISGTYGYMSPEYA  288 (432)
Q Consensus       215 qi~~~l~~LH~~~~~~ivH~Dlkp~NIll--~~~~--~~kl~Dfg~a~~~~~~~~--~~~~~~~~~~~~gt~~y~aPE~~  288 (432)
                      |+++|+.|||.+|   +.|||+|++|||+  |+++  .+.++|||.+.-.  .+.  .-......-..-|...-||||+.
T Consensus       349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd--~~hGlqlpy~S~~Vd~GGNa~lmAPEi~  423 (598)
T KOG4158|consen  349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLAD--DNHGLQLPYESDEVDLGGNAKLMAPEIA  423 (598)
T ss_pred             HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeec--cccccccccccccccCCCcceecchhhh
Confidence            9999999999999   9999999999998  4443  4789999987532  111  11112223345577889999988


Q ss_pred             ccCC------CCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHH
Q 014024          289 LEGI------FSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHI  362 (432)
Q Consensus       289 ~~~~------~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l  362 (432)
                      ....      --.++|.|+.|.+.||+++...||-.-...-.+...|              .+.-....+..++..+.++
T Consensus       424 ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Y--------------qe~qLPalp~~vpp~~rql  489 (598)
T KOG4158|consen  424 TAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTY--------------QESQLPALPSRVPPVARQL  489 (598)
T ss_pred             hcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhh--------------hhhhCCCCcccCChHHHHH
Confidence            7532      1258999999999999999999974211111111111              1111223345566788999


Q ss_pred             HHHhhccCCCCCCCHHHHHHHhc
Q 014024          363 ALLCVQERAEDRPTMSDVVSMLT  385 (432)
Q Consensus       363 ~~~cl~~dp~~RPt~~evl~~L~  385 (432)
                      +...|+.||.+|++..-..+.|+
T Consensus       490 V~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  490 VFDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             HHHHhcCCccccCCccHHHhHHH
Confidence            99999999999999876666554

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.78  E-value=2.1e-18  Score=154.11  Aligned_cols=130  Identities=21%  Similarity=0.343  Sum_probs=107.3

Q ss_pred             eeccCCcEEEEEEEECCceEEEEEEcCCCh--------HhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecCC
Q 014024          116 KLGEGGFGTVYKGVIGQGEIAVKRLLGKSG--------QEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMP  187 (432)
Q Consensus       116 ~ig~G~~g~Vy~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  187 (432)
                      .||+|++|.||+|...+..+++|.......        .....+.+|++++..++|+++.....++...+..+++|||++
T Consensus         1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~   80 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE   80 (199)
T ss_pred             CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence            489999999999998888999998754321        123567789999999998876655555566677799999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeeccccee
Q 014024          188 NKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARI  259 (432)
Q Consensus       188 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  259 (432)
                      |++|.+++...   . .      .++.+++.+|.+||+.+   ++|+|++|.||+++ ++.++++|||++..
T Consensus        81 g~~l~~~~~~~---~-~------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        81 GKPLKDVIEEG---N-D------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CccHHHHHhhc---H-H------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            99999887321   1 1      78999999999999999   99999999999999 88999999999875

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>smart00090 RIO RIO-like kinase

Probab=99.77  E-value=4e-18  Score=155.76  Aligned_cols=146  Identities=16%  Similarity=0.139  Sum_probs=111.2

Q ss_pred             HhhhhCCCCcCceeccCCcEEEEEEE-E--CCceEEEEEEcCCChH------------------------hHHHHHHHHH
Q 014024          104 VSSATGNFSAANKLGEGGFGTVYKGV-I--GQGEIAVKRLLGKSGQ------------------------EIKELKNEAS  156 (432)
Q Consensus       104 ~~~~~~~y~~~~~ig~G~~g~Vy~~~-~--~~~~vavK~~~~~~~~------------------------~~~~~~~E~~  156 (432)
                      +.....-|.+.+.||+|++|.||+|. +  .+..||+|.+......                        ....+..|+.
T Consensus        23 ~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~  102 (237)
T smart00090       23 LLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFR  102 (237)
T ss_pred             HHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHH
Confidence            33444468899999999999999998 3  3458999988643210                        1123578999


Q ss_pred             HHHhcCCC--ceeeeEeEEEeCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 014024          157 VIAQVQHK--NLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHR  234 (432)
Q Consensus       157 ~l~~l~h~--niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~  234 (432)
                      .+.++.+.  .+.+++++    ...++||||+++++|.....   ....+.......++.|++.++++||+.+  .++||
T Consensus       103 ~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~  173 (237)
T smart00090      103 NLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHG  173 (237)
T ss_pred             HHHHHHhcCCCCCeeeEe----cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeC
Confidence            99999753  23444433    23589999999988876542   2233566677899999999999999986  49999


Q ss_pred             cCCCCCEEEcCCCCEEEeeccccee
Q 014024          235 DLKASNILLDKDMNSKISDFGMARI  259 (432)
Q Consensus       235 Dlkp~NIll~~~~~~kl~Dfg~a~~  259 (432)
                      ||||+||+++ ++.++|+|||.+..
T Consensus       174 Dikp~NIli~-~~~i~LiDFg~a~~  197 (237)
T smart00090      174 DLSEYNILVH-DGKVVIIDVSQSVE  197 (237)
T ss_pred             CCChhhEEEE-CCCEEEEEChhhhc
Confidence            9999999999 88999999999875

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.77  E-value=3.1e-18  Score=175.48  Aligned_cols=139  Identities=19%  Similarity=0.331  Sum_probs=115.9

Q ss_pred             hhhCCCCcCceeccCCcEEEEEEEECCceEEEEEEcCCC--------hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC
Q 014024          106 SATGNFSAANKLGEGGFGTVYKGVIGQGEIAVKRLLGKS--------GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKD  177 (432)
Q Consensus       106 ~~~~~y~~~~~ig~G~~g~Vy~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  177 (432)
                      .....|...+.||+|+||.||+|.+.+..+++|+.....        ....+.+.+|+++++.++|++++....++.+..
T Consensus       330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~  409 (535)
T PRK09605        330 EVKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE  409 (535)
T ss_pred             ccccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence            344556778999999999999999877766666542221        112356889999999999999988888877777


Q ss_pred             eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccc
Q 014024          178 ERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMA  257 (432)
Q Consensus       178 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  257 (432)
                      ..++||||+++++|.+++.           ....++.|++++|.+||+.+   ++||||||+||++ +++.++|+|||++
T Consensus       410 ~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla  474 (535)
T PRK09605        410 EKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLG  474 (535)
T ss_pred             CCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccc
Confidence            8899999999999998873           34678999999999999998   9999999999999 6789999999999


Q ss_pred             ee
Q 014024          258 RI  259 (432)
Q Consensus       258 ~~  259 (432)
                      +.
T Consensus       475 ~~  476 (535)
T PRK09605        475 KY  476 (535)
T ss_pred             cc
Confidence            75

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.74  E-value=3.8e-17  Score=145.88  Aligned_cols=142  Identities=18%  Similarity=0.167  Sum_probs=109.2

Q ss_pred             hHhhhhCCCCcCceeccCCcEEEEEEEEC-CceEEEEEEcCCCh----------------------HhHHHHHHHHHHHH
Q 014024          103 SVSSATGNFSAANKLGEGGFGTVYKGVIG-QGEIAVKRLLGKSG----------------------QEIKELKNEASVIA  159 (432)
Q Consensus       103 ~~~~~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~  159 (432)
                      ++......|.+.+.||+|+||.||++... +..+++|++.....                      ........|..++.
T Consensus         9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   88 (198)
T cd05144           9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK   88 (198)
T ss_pred             HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence            34444445888999999999999999885 44899998654321                      01123567888999


Q ss_pred             hcCCCc--eeeeEeEEEeCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCC
Q 014024          160 QVQHKN--LVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLK  237 (432)
Q Consensus       160 ~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlk  237 (432)
                      .+.|++  +...++    ....++||||+++++|......         .....++.+++.++.++|+.+   ++||||+
T Consensus        89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~  152 (198)
T cd05144          89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGDLS  152 (198)
T ss_pred             HHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCCCC
Confidence            887774  444443    2345899999999998765420         234578899999999999998   9999999


Q ss_pred             CCCEEEcCCCCEEEeecccceec
Q 014024          238 ASNILLDKDMNSKISDFGMARIV  260 (432)
Q Consensus       238 p~NIll~~~~~~kl~Dfg~a~~~  260 (432)
                      |+||++++++.++|+|||++...
T Consensus       153 p~Nill~~~~~~~liDfg~~~~~  175 (198)
T cd05144         153 EFNILVDDDEKIYIIDWPQMVST  175 (198)
T ss_pred             cccEEEcCCCcEEEEECCccccC
Confidence            99999999999999999999654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.72  E-value=5.7e-18  Score=173.98  Aligned_cols=215  Identities=20%  Similarity=0.266  Sum_probs=140.2

Q ss_pred             hhhCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEE
Q 014024          106 SATGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       106 ~~~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  183 (432)
                      ....+|+.+++|..|+||-||..++...  .+|+|+ .++.--    +.+   ++....+|.+|                
T Consensus        80 p~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~li----lRn---ilt~a~npfvv----------------  135 (1205)
T KOG0606|consen   80 PSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNLI----LRN---ILTFAGNPFVV----------------  135 (1205)
T ss_pred             CCccccceeEeeccCCCCceeeeeccccccchhhcc-cccchh----hhc---cccccCCccee----------------
Confidence            4467899999999999999999988744  677743 221110    111   22223333333                


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCC
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGG  263 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  263 (432)
                           |+-...+..   -++++.        +++.+++|||+.+   |+|||+||+|.+|+.-|++|++|||+++.-...
T Consensus       136 -----gDc~tllk~---~g~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms  196 (1205)
T KOG0606|consen  136 -----GDCATLLKN---IGPLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS  196 (1205)
T ss_pred             -----chhhhhccc---CCCCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence                 333333322   122332        2278899999999   999999999999999999999999998763111


Q ss_pred             C---------CccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhh
Q 014024          264 N---------DEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLW  334 (432)
Q Consensus       264 ~---------~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  334 (432)
                      .         ..+.........+||+.|+|||++....|...+|+|++|+|+||.+-|+.||.....++. +...+    
T Consensus       197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel-fg~vi----  271 (1205)
T KOG0606|consen  197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL-FGQVI----  271 (1205)
T ss_pred             ccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH-Hhhhh----
Confidence            0         001112223456899999999999999999999999999999999999999853322110 00000    


Q ss_pred             hccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCC
Q 014024          335 ISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPT  376 (432)
Q Consensus       335 ~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt  376 (432)
                           .+.+.   -.+.....+.+..+++.+.|+.+|..|--
T Consensus       272 -----sd~i~---wpE~dea~p~Ea~dli~~LL~qnp~~Rlg  305 (1205)
T KOG0606|consen  272 -----SDDIE---WPEEDEALPPEAQDLIEQLLRQNPLCRLG  305 (1205)
T ss_pred             -----hhhcc---ccccCcCCCHHHHHHHHHHHHhChHhhcc
Confidence                 00000   01112234466778888888888888853

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.72  E-value=6.1e-17  Score=137.24  Aligned_cols=135  Identities=21%  Similarity=0.217  Sum_probs=115.0

Q ss_pred             cCceeccCCcEEEEEEEECCceEEEEEEcCCChHhHHHHHHHHHHHHhcCC--CceeeeEeEEEeCCeeEEEEecCCCCC
Q 014024          113 AANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQH--KNLVKLLGCCIEKDERLLIYEYMPNKS  190 (432)
Q Consensus       113 ~~~~ig~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~gs  190 (432)
                      +.+.||.|.++.||++...+..+++|.......  ...+.+|+..++.++|  .++++++.+....+..+++|||++++.
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~   79 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET   79 (155)
T ss_pred             cceecccccccceEEEEecCCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence            457899999999999999888899998855443  4678899999999976  589999988888788999999999887


Q ss_pred             hhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeeccccee
Q 014024          191 LDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARI  259 (432)
Q Consensus       191 L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  259 (432)
                      +..+          +......++.+++.+++++|.....+++|+|++|+||++++.+.+++.|||.+..
T Consensus        80 ~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          80 LDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             cccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            6543          4566678899999999999986444599999999999999989999999999864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.68  E-value=6.2e-16  Score=141.61  Aligned_cols=135  Identities=21%  Similarity=0.254  Sum_probs=105.9

Q ss_pred             Cceec-cCCcEEEEEEEECCceEEEEEEcCCC-------------hHhHHHHHHHHHHHHhcCCCce--eeeEeEEEeCC
Q 014024          114 ANKLG-EGGFGTVYKGVIGQGEIAVKRLLGKS-------------GQEIKELKNEASVIAQVQHKNL--VKLLGCCIEKD  177 (432)
Q Consensus       114 ~~~ig-~G~~g~Vy~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~~~  177 (432)
                      ...|| .||.|+||.....+..+++|.+....             ......+.+|++++.+++|+++  ++.+++.....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             CceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            35687 89999999999988899999874321             1233567889999999998774  66777654332


Q ss_pred             e----eEEEEecCCC-CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEe
Q 014024          178 E----RLLIYEYMPN-KSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKIS  252 (432)
Q Consensus       178 ~----~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  252 (432)
                      .    .++|||++++ .+|.+++..    ..++..    .+.+++.++.+||+.|   |+|+||||.|||++.++.++|+
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI  184 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI  184 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence            2    2599999997 688888743    235543    3578999999999999   9999999999999999999999


Q ss_pred             eccccee
Q 014024          253 DFGMARI  259 (432)
Q Consensus       253 Dfg~a~~  259 (432)
                      |||.+..
T Consensus       185 Dfg~~~~  191 (239)
T PRK01723        185 DFDRGEL  191 (239)
T ss_pred             ECCCccc
Confidence            9999875

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.65  E-value=7.5e-16  Score=136.12  Aligned_cols=135  Identities=19%  Similarity=0.251  Sum_probs=96.4

Q ss_pred             CceeccCCcEEEEEEEEC-CceEEEEEEcCCChH--hHHH----------------------HHHHHHHHHhcCCCc--e
Q 014024          114 ANKLGEGGFGTVYKGVIG-QGEIAVKRLLGKSGQ--EIKE----------------------LKNEASVIAQVQHKN--L  166 (432)
Q Consensus       114 ~~~ig~G~~g~Vy~~~~~-~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~h~n--i  166 (432)
                      .+.||+|+||.||+|.+. +..||+|++......  ....                      ...|.+.+.++.+.+  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            578999999999999987 458999987543211  1111                      135666666665432  4


Q ss_pred             eeeEeEEEeCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCCCCCEEEcC
Q 014024          167 VKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ-YSRVRIIHRDLKASNILLDK  245 (432)
Q Consensus       167 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dlkp~NIll~~  245 (432)
                      .+.+++    ...++||||++++.+.........   .. .....++.+++.++.++|+ .+   ++|+||||+||+++ 
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence            444443    245899999999654322111000   11 5677899999999999999 87   99999999999999 


Q ss_pred             CCCEEEeecccceec
Q 014024          246 DMNSKISDFGMARIV  260 (432)
Q Consensus       246 ~~~~kl~Dfg~a~~~  260 (432)
                      ++.++++|||.+...
T Consensus       150 ~~~~~liDfg~a~~~  164 (187)
T cd05119         150 DGKVYIIDVPQAVEI  164 (187)
T ss_pred             CCcEEEEECcccccc
Confidence            899999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.63  E-value=2e-17  Score=169.30  Aligned_cols=258  Identities=20%  Similarity=0.269  Sum_probs=189.9

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECCc---eEEEEEEcCCC--hHhHHHHHHHHHHHHhcC-CCceeeeEeEEEeCCeeEE
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQG---EIAVKRLLGKS--GQEIKELKNEASVIAQVQ-HKNLVKLLGCCIEKDERLL  181 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~~---~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~l  181 (432)
                      ...|.+.+.||+|.|+.|-.......   .+++|.+....  .........|..+-..+. |.|++++++...+.+..++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            45677788899999999988776433   45666553332  333445556788888887 9999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeEeccCCCCCEEEcCCC-CEEEeeccccee
Q 014024          182 IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLH-QYSRVRIIHRDLKASNILLDKDM-NSKISDFGMARI  259 (432)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH-~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~  259 (432)
                      +++|..++++.+.+.... ....+....-.++.|+..++.|+| ..+   +.|+||||+|.+++.++ ..+++|||+|..
T Consensus        99 ~~~~s~g~~~f~~i~~~~-~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~  174 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPD-STGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATA  174 (601)
T ss_pred             ccCcccccccccccccCC-ccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcc
Confidence            999999999988883211 112566667789999999999999 887   99999999999999999 999999999987


Q ss_pred             ccCCCCccccccccccccc-cCCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhcc
Q 014024          260 VFGGNDEDELQGNTSRISG-TYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISN  337 (432)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~g-t~~y~aPE~~~~~-~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  337 (432)
                      +..-++.   .......+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+............|.....   
T Consensus       175 ~~~~~g~---~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~---  248 (601)
T KOG0590|consen  175 YRNKNGA---ERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKG---  248 (601)
T ss_pred             ccccCCc---ceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeeccccc---
Confidence            6431111   223344567 9999999998874 4578899999999999999999998776654433332221110   


Q ss_pred             chhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          338 KIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       338 ~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                              ...............++...++..+|..|.+.+++-..
T Consensus       249 --------~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d  286 (601)
T KOG0590|consen  249 --------RFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD  286 (601)
T ss_pred             --------ccccCccccCChhhhhcccccccCCchhcccccccccc
Confidence                    00011111223345567778888999999999887653

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.48  E-value=3.4e-14  Score=129.27  Aligned_cols=207  Identities=23%  Similarity=0.268  Sum_probs=138.4

Q ss_pred             HHHhcCCCceeeeEeEEEeCC-----eeEEEEecCCCCChhhhhcCCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 014024          157 VIAQVQHKNLVKLLGCCIEKD-----ERLLIYEYMPNKSLDCFLFDPTK-REILDWRTRVQIIKGVAQGLLYLHQYSRVR  230 (432)
Q Consensus       157 ~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~  230 (432)
                      -|-++-|.|+|+++.|+.+.+     ...++.||+..|++..+|++... +..+....-.+|+-||+.||.|||+.. ++
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-Pp  198 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-PP  198 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-Cc
Confidence            445567999999999986554     35788999999999999976433 334777777899999999999999975 67


Q ss_pred             eEeccCCCCCEEEcCCCCEEEeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHH
Q 014024          231 IIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIV  310 (432)
Q Consensus       231 ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ell  310 (432)
                      |+|+++.-+.|++..+|-+|++----......  -............+.++|.+||.-..-..+.++|||+||+..++|.
T Consensus       199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s--~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPS--VNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             cccCCcchhheeecCCceEEecccCccccchh--hhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence            99999999999999999888743211110000  0000111122334678999999877777888999999999999998


Q ss_pred             hCCCCCCCccccccchhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          311 SGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       311 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                      -|..-.......      +.......+.+..+-+. +           =+.++..|++..|..||+|++++.|.
T Consensus       277 ilEiq~tnseS~------~~~ee~ia~~i~~len~-l-----------qr~~i~kcl~~eP~~rp~ar~llfHp  332 (458)
T KOG1266|consen  277 ILEIQSTNSESK------VEVEENIANVIIGLENG-L-----------QRGSITKCLEGEPNGRPDARLLLFHP  332 (458)
T ss_pred             HheeccCCCcce------eehhhhhhhheeeccCc-c-----------ccCcCcccccCCCCCCcchhhhhcCc
Confidence            876431111100      00000000111000001 0           12456789999999999999988654

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.47  E-value=4.5e-13  Score=133.22  Aligned_cols=139  Identities=23%  Similarity=0.262  Sum_probs=97.5

Q ss_pred             CceeccCCcEEEEEEEECCc-eEEEEEEcCCChHhHH----------------------------------------HHH
Q 014024          114 ANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKSGQEIK----------------------------------------ELK  152 (432)
Q Consensus       114 ~~~ig~G~~g~Vy~~~~~~~-~vavK~~~~~~~~~~~----------------------------------------~~~  152 (432)
                      .+.||.|++|.||+|+..++ .||||+..........                                        .+.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            36799999999999998654 8999998654321110                                        144


Q ss_pred             HHHHHHHhcC----CCceeeeEeEE-EeCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHH-HHHHHHhc
Q 014024          153 NEASVIAQVQ----HKNLVKLLGCC-IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQ-GLLYLHQY  226 (432)
Q Consensus       153 ~E~~~l~~l~----h~niv~~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~-~l~~LH~~  226 (432)
                      +|++.+.+++    |.+-+.+-.++ ......++||||++|++|.++...... + .   ....++.+++. .+..+|..
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~-~---~~~~ia~~~~~~~l~ql~~~  276 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-G-L---DRKALAENLARSFLNQVLRD  276 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-C-C---CHHHHHHHHHHHHHHHHHhC
Confidence            4666666552    33323333333 223457999999999999887632111 1 2   23456666666 47889998


Q ss_pred             CCCCeEeccCCCCCEEEcCCCCEEEeecccceec
Q 014024          227 SRVRIIHRDLKASNILLDKDMNSKISDFGMARIV  260 (432)
Q Consensus       227 ~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  260 (432)
                      |   ++|+|++|.||++++++.++++|||++..+
T Consensus       277 g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l  307 (437)
T TIGR01982       277 G---FFHADLHPGNIFVLKDGKIIALDFGIVGRL  307 (437)
T ss_pred             C---ceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence            8   999999999999999999999999999875

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.45  E-value=4.2e-13  Score=116.45  Aligned_cols=131  Identities=21%  Similarity=0.177  Sum_probs=98.2

Q ss_pred             CceeccCCcEEEEEEEECCceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCcee-eeEeEEEeCCeeEEEEecCCCCChh
Q 014024          114 ANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLV-KLLGCCIEKDERLLIYEYMPNKSLD  192 (432)
Q Consensus       114 ~~~ig~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~gsL~  192 (432)
                      .+.|+.|.++.||++...++.+++|....... ....+..|+.+++.+.+.+++ +++.+.  ....++||||+++.++.
T Consensus         3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~   79 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL   79 (170)
T ss_pred             eeecCCcccCceEEEEECCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence            46789999999999998888999998754432 223467899999998765544 444433  33458999999998875


Q ss_pred             hhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEeccCCCCCEEEcCCCCEEEeeccccee
Q 014024          193 CFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYS--RVRIIHRDLKASNILLDKDMNSKISDFGMARI  259 (432)
Q Consensus       193 ~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  259 (432)
                      +.-        .   ....++.+++++|+.||+.+  ...++|+|++|.||+++ ++.++++|||.+..
T Consensus        80 ~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          80 TED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             ccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            430        1   11245678999999999987  22359999999999999 67899999998864

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.43  E-value=1e-13  Score=136.30  Aligned_cols=251  Identities=22%  Similarity=0.257  Sum_probs=175.7

Q ss_pred             CCCCcCceecc--CCcEEEEEEEEC--C--ceEEEEEEcCCC--hHhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCee
Q 014024          109 GNFSAANKLGE--GGFGTVYKGVIG--Q--GEIAVKRLLGKS--GQEIKELKNEASVIAQV-QHKNLVKLLGCCIEKDER  179 (432)
Q Consensus       109 ~~y~~~~~ig~--G~~g~Vy~~~~~--~--~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  179 (432)
                      ..+.+.+.+|.  |.+|.+|.+...  .  ..+|+|+-....  ......=.+|+.....+ .|+|.++.+..+...+..
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence            45667788999  999999998862  2  267888743222  12222334566666666 489999999999999999


Q ss_pred             EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCeEeccCCCCCEEEcCC-CCEEEeec
Q 014024          180 LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQ----GLLYLHQYSRVRIIHRDLKASNILLDKD-MNSKISDF  254 (432)
Q Consensus       180 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~----~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Df  254 (432)
                      ++-+|++. .+|..+....  ...++....+....+..+    |+..+|+.+   ++|-|+||.||+..++ ...+++||
T Consensus       194 fiqtE~~~-~sl~~~~~~~--~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df  267 (524)
T KOG0601|consen  194 FIQTELCG-ESLQSYCHTP--CNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF  267 (524)
T ss_pred             eeeecccc-chhHHhhhcc--cccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence            99999995 6777766443  233777788888888888    999999998   9999999999999999 88999999


Q ss_pred             ccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhh
Q 014024          255 GMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLW  334 (432)
Q Consensus       255 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  334 (432)
                      |+...+..++-... ........|...|++||.. .+-++.++|+|++|.+..+..+|.......-.          ..|
T Consensus       268 ~~v~~i~~~~~~~~-~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~----------~~W  335 (524)
T KOG0601|consen  268 GLVSKISDGNFSSV-FKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKN----------SSW  335 (524)
T ss_pred             ceeEEccCCccccc-eeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCC----------CCc
Confidence            99988644332211 1122334677889999955 57788999999999999999998776432100          001


Q ss_pred             hccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014024          335 ISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVS  382 (432)
Q Consensus       335 ~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~  382 (432)
                      ...+-.. +...    +...-..++...+..+++.+|..|++.+.+..
T Consensus       336 ~~~r~~~-ip~e----~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  336 SQLRQGY-IPLE----FCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             ccccccc-Cchh----hhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            1011000 1111    11112234455888999999999999887765

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.36  E-value=1.6e-11  Score=107.76  Aligned_cols=135  Identities=16%  Similarity=0.136  Sum_probs=97.6

Q ss_pred             CceeccCCcEEEEEEEECC--------ceEEEEEEcCCC----------------------hHhHHHHH----HHHHHHH
Q 014024          114 ANKLGEGGFGTVYKGVIGQ--------GEIAVKRLLGKS----------------------GQEIKELK----NEASVIA  159 (432)
Q Consensus       114 ~~~ig~G~~g~Vy~~~~~~--------~~vavK~~~~~~----------------------~~~~~~~~----~E~~~l~  159 (432)
                      ...||.|-.+.||.|...+        ..+|+|+..-..                      ......+.    +|++.|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3569999999999998653        489999763110                      01122333    7999999


Q ss_pred             hcCC--CceeeeEeEEEeCCeeEEEEecCCCCChhh-hhcCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEecc
Q 014024          160 QVQH--KNLVKLLGCCIEKDERLLIYEYMPNKSLDC-FLFDPTKREILDWRTRVQIIKGVAQGLLYL-HQYSRVRIIHRD  235 (432)
Q Consensus       160 ~l~h--~niv~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~qi~~~l~~L-H~~~~~~ivH~D  235 (432)
                      ++..  -++.+.+++    ...++||||+.++.+.. .+.    ...++......+..+++.+|..| |..+   ++|||
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk----d~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGD  150 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK----DAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHAD  150 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh----ccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence            9853  456666654    45689999997754421 221    12245556677889999999998 7888   99999


Q ss_pred             CCCCCEEEcCCCCEEEeecccceec
Q 014024          236 LKASNILLDKDMNSKISDFGMARIV  260 (432)
Q Consensus       236 lkp~NIll~~~~~~kl~Dfg~a~~~  260 (432)
                      |++.||+++ ++.+.|+|||.+...
T Consensus       151 Ls~~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         151 LSEYNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             CCHHHEEEE-CCcEEEEECCCceeC
Confidence            999999997 468999999998753

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.35  E-value=1.3e-11  Score=104.78  Aligned_cols=131  Identities=22%  Similarity=0.318  Sum_probs=104.0

Q ss_pred             ceeccCCcEEEEEEEECCceEEEEEEcCCC--------hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecC
Q 014024          115 NKLGEGGFGTVYKGVIGQGEIAVKRLLGKS--------GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYM  186 (432)
Q Consensus       115 ~~ig~G~~g~Vy~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  186 (432)
                      ..+++|+-+.+|.+.+.+.++++|.-.++.        .-....-.+|++++.+++--.|.--+-+..+.+...|+|||+
T Consensus         2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I   81 (204)
T COG3642           2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI   81 (204)
T ss_pred             chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence            458899999999998877778888665442        112334667999999987656555555667778889999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeeccccee
Q 014024          187 PNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARI  259 (432)
Q Consensus       187 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  259 (432)
                      +|..|.+.+...          ...++..+-.-+.-||..|   |+|+||.++||++.+.. +.++|||++..
T Consensus        82 ~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          82 EGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             CChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence            999999988433          2457778888889999999   99999999999997765 99999999975

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.33  E-value=4.5e-11  Score=119.03  Aligned_cols=163  Identities=16%  Similarity=0.228  Sum_probs=121.8

Q ss_pred             ceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHH
Q 014024          133 GEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQI  212 (432)
Q Consensus       133 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i  212 (432)
                      .++.|...........+...+-++.|+.++||||+++++.++..+..|+|+|-+.-  |..++.+      +........
T Consensus        38 ~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P--l~~~lk~------l~~~~v~~G  109 (690)
T KOG1243|consen   38 GPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP--LETVLKE------LGKEEVCLG  109 (690)
T ss_pred             CceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc--HHHHHHH------hHHHHHHHH
Confidence            36777666555555556678889999999999999999999999999999998743  3444422      335566778


Q ss_pred             HHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCccccccccccccccCCccChhhhccCC
Q 014024          213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGI  292 (432)
Q Consensus       213 ~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  292 (432)
                      +.||+.||.|||+.+  .++|++|.-+.|+|+..|..||++|.++....+.+.      ......--..|..|+.+....
T Consensus       110 l~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~------~~~~~~~~~s~~~P~~~~~s~  181 (690)
T KOG1243|consen  110 LFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA------PAKSLYLIESFDDPEEIDPSE  181 (690)
T ss_pred             HHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc------ccccchhhhcccChhhcCccc
Confidence            899999999998655  499999999999999999999999998865321111      111112223466777554333


Q ss_pred             CCchhhhHHHHHHHHHHHhCC
Q 014024          293 FSIKSDVFSFGVLLLEIVSGK  313 (432)
Q Consensus       293 ~t~~~DvwSlG~il~elltg~  313 (432)
                        -..|.|.|||+++|++.|.
T Consensus       182 --~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  182 --WSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             --cchhhhhHHHHHHHHhCcc
Confidence              3579999999999999993

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.32  E-value=3.1e-11  Score=102.04  Aligned_cols=143  Identities=22%  Similarity=0.308  Sum_probs=109.9

Q ss_pred             cCceeccCCcEEEEEEEECCceEEEEEEcCCC--------hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEe
Q 014024          113 AANKLGEGGFGTVYKGVIGQGEIAVKRLLGKS--------GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYE  184 (432)
Q Consensus       113 ~~~~ig~G~~g~Vy~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  184 (432)
                      ....|-+|+.+.|+++.+.+....||....+.        .-......+|++.|.+++--.|.--.-++.+...-.|+||
T Consensus        11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME   90 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME   90 (229)
T ss_pred             cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence            46789999999999999999988888654332        1234557889999999876555555556667777789999


Q ss_pred             cCCC-CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCC---EEEeeccccee
Q 014024          185 YMPN-KSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN---SKISDFGMARI  259 (432)
Q Consensus       185 ~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Dfg~a~~  259 (432)
                      |+++ .++.++++...... ........++..+-+.+.-||.++   |+||||..+||++.+++.   +.++|||++..
T Consensus        91 ~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   91 FIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             eccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence            9977 57888886544333 223333678889999999999999   999999999999965543   58999999965

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.28  E-value=6e-12  Score=126.77  Aligned_cols=141  Identities=18%  Similarity=0.199  Sum_probs=91.5

Q ss_pred             CCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCChH----------------------------------hHHH--
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSGQ----------------------------------EIKE--  150 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~~----------------------------------~~~~--  150 (432)
                      ..|+. +.||+|++|.||+|+..+  ..||||+..+....                                  ..+.  
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            45676 789999999999999865  48999999654211                                  1112  


Q ss_pred             ----HHHHHHHHHhcC----CCceeeeEeEEEe-CCeeEEEEecCCCCChhhhhc--CCC-CCCCCCHHHHHHHHHHHHH
Q 014024          151 ----LKNEASVIAQVQ----HKNLVKLLGCCIE-KDERLLIYEYMPNKSLDCFLF--DPT-KREILDWRTRVQIIKGVAQ  218 (432)
Q Consensus       151 ----~~~E~~~l~~l~----h~niv~~~~~~~~-~~~~~lv~e~~~~gsL~~~l~--~~~-~~~~l~~~~~~~i~~qi~~  218 (432)
                          +.+|+..+.+++    +.+.+.+-.++.+ ....++||||++|+.+.++-.  ..+ ....+.......++.    
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~----  274 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFT----  274 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHH----
Confidence                233444444442    3333444344432 345689999999999977421  111 011122222333333    


Q ss_pred             HHHHHHhcCCCCeEeccCCCCCEEEcCCC----CEEEeecccceec
Q 014024          219 GLLYLHQYSRVRIIHRDLKASNILLDKDM----NSKISDFGMARIV  260 (432)
Q Consensus       219 ~l~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Dfg~a~~~  260 (432)
                         .+...|   ++|+|++|.||+++.++    .+++.|||+...+
T Consensus       275 ---Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l  314 (537)
T PRK04750        275 ---QVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL  314 (537)
T ss_pred             ---HHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence               344567   99999999999999888    9999999999875

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.22  E-value=1.5e-10  Score=104.93  Aligned_cols=141  Identities=18%  Similarity=0.277  Sum_probs=109.5

Q ss_pred             ceeccCCcEEEEEEEECC-ceEEEEEEcCCCh-HhHHHHHHHHHHHHhcCCC--ceeeeEeEEEeCC---eeEEEEecCC
Q 014024          115 NKLGEGGFGTVYKGVIGQ-GEIAVKRLLGKSG-QEIKELKNEASVIAQVQHK--NLVKLLGCCIEKD---ERLLIYEYMP  187 (432)
Q Consensus       115 ~~ig~G~~g~Vy~~~~~~-~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~--niv~~~~~~~~~~---~~~lv~e~~~  187 (432)
                      +.|+.|..+.+|++...+ ..+++|....... .....+..|+++++.+++.  ++.+++.+..+..   ..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            568999999999999877 5899998654322 1345788999999999763  4566777766542   5689999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 014024          188 NKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYS----------------------------------------  227 (432)
Q Consensus       188 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~----------------------------------------  227 (432)
                      |.++.+.+..    ..++......++.+++++|..||+..                                        
T Consensus        84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            9988776521    34777888888999999999998531                                        


Q ss_pred             -------------CCCeEeccCCCCCEEEcC--CCCEEEeeccccee
Q 014024          228 -------------RVRIIHRDLKASNILLDK--DMNSKISDFGMARI  259 (432)
Q Consensus       228 -------------~~~ivH~Dlkp~NIll~~--~~~~kl~Dfg~a~~  259 (432)
                                   ...++|+|+.|.||++++  ++.+.|+||+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                         245899999999999998  56689999998864

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.17  E-value=1.3e-11  Score=121.62  Aligned_cols=246  Identities=17%  Similarity=0.178  Sum_probs=171.7

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEEC---CceEEEEEEcCCChHhHHHH--HHHHHHHHhc-CCCceeeeEeEEEeCCeeE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIG---QGEIAVKRLLGKSGQEIKEL--KNEASVIAQV-QHKNLVKLLGCCIEKDERL  180 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~---~~~vavK~~~~~~~~~~~~~--~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  180 (432)
                      -+.+|..+..||.|.|+.|+....+   +..+++|...........++  ..|+.+...+ .|.++++.+..+...++.|
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~  342 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY  342 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence            4578889999999999999987643   34788888765543322222  3455555555 5888999888888888888


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCC-CCEEEeeccccee
Q 014024          181 LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKD-MNSKISDFGMARI  259 (432)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~  259 (432)
                      +=-|||+++++....   .....+++...+++..|++.++.++|+..   ++|+|++|+||++..+ +.-+++|||....
T Consensus       343 ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~  416 (524)
T KOG0601|consen  343 IPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTR  416 (524)
T ss_pred             CchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccc
Confidence            889999999987665   22334778888999999999999999988   9999999999999876 7789999998864


Q ss_pred             ccCCCCccccccccccccccCCcc--ChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhcc
Q 014024          260 VFGGNDEDELQGNTSRISGTYGYM--SPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISN  337 (432)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  337 (432)
                      +         ........+.-++.  +|+......+..+.|++|||.-+.+.++|..-..-.                 .
T Consensus       417 ~---------~~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~-----------------~  470 (524)
T KOG0601|consen  417 L---------AFSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG-----------------V  470 (524)
T ss_pred             c---------ceecccccccccccccchhhccccccccccccccccccccccccCcccCccc-----------------c
Confidence            2         11111122233344  555555677889999999999999999987531100                 0


Q ss_pred             chhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014024          338 KIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN  386 (432)
Q Consensus       338 ~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~  386 (432)
                      ....+... .....+... ..+..+...+...++..||.+.++..+.+-
T Consensus       471 ~~~~i~~~-~~p~~~~~~-~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~  517 (524)
T KOG0601|consen  471 QSLTIRSG-DTPNLPGLK-LQLQVLLKVMINPDRKRRPSAVELSLHSEF  517 (524)
T ss_pred             cceeeecc-cccCCCchH-HhhhhhhhhhcCCccccchhhhhhcccchh
Confidence            01111111 001111111 556667778888999999999888765543

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.15  E-value=1.6e-09  Score=102.51  Aligned_cols=266  Identities=13%  Similarity=0.080  Sum_probs=162.0

Q ss_pred             cCceeccCCcEEEEEEEECCceEEEEEEcCCChHhHHHHHHHHHHHHhc-CCCceeeeEeE----E--EeC-CeeEEEEe
Q 014024          113 AANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQV-QHKNLVKLLGC----C--IEK-DERLLIYE  184 (432)
Q Consensus       113 ~~~~ig~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~----~--~~~-~~~~lv~e  184 (432)
                      ..+.||+|+.+.+|-.-.-.+. +.|+..........+...   .|... .||-+-.-+.+    .  -+. ...-+.|+
T Consensus        15 ~gr~LgqGgea~ly~l~e~~d~-VAKIYh~Pppa~~aqk~a---~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP   90 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEVRDQ-VAKIYHAPPPAAQAQKVA---ELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP   90 (637)
T ss_pred             CCccccCCccceeeecchhhch-hheeecCCCchHHHHHHH---HhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence            4577999999999954332223 346665544433333222   22222 34432221111    1  111 22456777


Q ss_pred             cCCCCCh-hhhhcCC---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceec
Q 014024          185 YMPNKSL-DCFLFDP---TKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIV  260 (432)
Q Consensus       185 ~~~~gsL-~~~l~~~---~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  260 (432)
                      .+.+.-- ..++...   ..-...+|+..++.+..++.+.+.||..|   .+-||+.++|+|+.+++.+.|.|-+.-...
T Consensus        91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi~  167 (637)
T COG4248          91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQIN  167 (637)
T ss_pred             cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceeec
Confidence            7766432 2222211   12234789999999999999999999999   999999999999999999999996554432


Q ss_pred             cCCCCccccccccccccccCCccChhhhc-----cCCCCchhhhHHHHHHHHHHHhC-CCCCCCcccc--ccchhhhhHH
Q 014024          261 FGGNDEDELQGNTSRISGTYGYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSG-KKNTGFYRTK--SLNLIGYAWD  332 (432)
Q Consensus       261 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~~DvwSlG~il~elltg-~~p~~~~~~~--~~~~~~~~~~  332 (432)
                             .........+|...|.+||...     +..-+...|.|.||+++++++.| ++||......  ..+..+....
T Consensus       168 -------~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia  240 (637)
T COG4248         168 -------ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIA  240 (637)
T ss_pred             -------cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhh
Confidence                   1122344567899999999765     34567889999999999999886 8998543221  1111110000


Q ss_pred             hh---hccchhhhhhhhhhhcccHHHHHHHHHHHHHhhcc--CCCCCCCHHHHHHHhcccccCCC
Q 014024          333 LW---ISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQE--RAEDRPTMSDVVSMLTNEASSLL  392 (432)
Q Consensus       333 ~~---~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~--dp~~RPt~~evl~~L~~~~~~~~  392 (432)
                      ..   ...+...-..+--........+.++..+..+|+..  ++.-|||++-++..|..+..++.
T Consensus       241 ~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~  305 (637)
T COG4248         241 HGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLK  305 (637)
T ss_pred             cceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhh
Confidence            00   00000000011111122334567788899999875  46789999999998887766553

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.13  E-value=2.5e-09  Score=103.67  Aligned_cols=168  Identities=21%  Similarity=0.307  Sum_probs=124.4

Q ss_pred             cEEEEEEEEC--CceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEe----CCeeEEEEecCCC-CChhhh
Q 014024          122 FGTVYKGVIG--QGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIE----KDERLLIYEYMPN-KSLDCF  194 (432)
Q Consensus       122 ~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~-gsL~~~  194 (432)
                      -.+.|++...  +..+++|++.............-++..+++.|.|+|++.+++..    +...++||+|+++ ++|.++
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            4677888753  34788888854433333333445778899999999999998863    3467899999986 467665


Q ss_pred             hcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccC
Q 014024          195 LFDPT------------KREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFG  262 (432)
Q Consensus       195 l~~~~------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  262 (432)
                      -+...            .+...++...|.++.|+..||.++|+.|   +..+-|.|.+|+++++.+++|+..|....+..
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            54321            2234678899999999999999999999   99999999999999999999999888776421


Q ss_pred             CCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCC
Q 014024          263 GNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKN  315 (432)
Q Consensus       263 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p  315 (432)
                      ..                  .+|  +.   --.+-|.=.||.+++.|.||...
T Consensus       446 d~------------------~~~--le---~~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  446 DP------------------TEP--LE---SQQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CC------------------Ccc--hh---HHhhhhHHHHHHHHHHHhhcccc
Confidence            10                  001  11   12357888999999999999764

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.10  E-value=2.4e-09  Score=99.23  Aligned_cols=141  Identities=20%  Similarity=0.139  Sum_probs=102.4

Q ss_pred             ceeccCCcEEEEEEEECCceEEEEEEcCCChH-hHH----------HHHHHHHHHHhcCCCc--eeeeEeEEEe-----C
Q 014024          115 NKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQ-EIK----------ELKNEASVIAQVQHKN--LVKLLGCCIE-----K  176 (432)
Q Consensus       115 ~~ig~G~~g~Vy~~~~~~~~vavK~~~~~~~~-~~~----------~~~~E~~~l~~l~h~n--iv~~~~~~~~-----~  176 (432)
                      +.+-......|.+...++..+.+|........ ..+          .+.+|.+.+.++...+  .+..+++...     .
T Consensus        28 e~v~~~~~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~  107 (268)
T PRK15123         28 EVFRELEGRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT  107 (268)
T ss_pred             cEEecCCCceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence            44554455557788888889999987544321 111          3678999888885333  3344555543     2


Q ss_pred             CeeEEEEecCCCC-ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcC-------CCC
Q 014024          177 DERLLIYEYMPNK-SLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDK-------DMN  248 (432)
Q Consensus       177 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-------~~~  248 (432)
                      ...++|+|++++. +|.+++.... ....+......++.+++..+.-||..|   |+|+|++++|||++.       ++.
T Consensus       108 ~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~  183 (268)
T PRK15123        108 RTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLK  183 (268)
T ss_pred             ceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCce
Confidence            3468999999886 8888874322 233566777889999999999999999   999999999999975       467


Q ss_pred             EEEeeccccee
Q 014024          249 SKISDFGMARI  259 (432)
Q Consensus       249 ~kl~Dfg~a~~  259 (432)
                      +.++||+.+..
T Consensus       184 ~~LIDl~r~~~  194 (268)
T PRK15123        184 LSVIDLHRAQI  194 (268)
T ss_pred             EEEEECCcccc
Confidence            99999998854

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.06  E-value=2.8e-11  Score=125.50  Aligned_cols=249  Identities=18%  Similarity=0.198  Sum_probs=165.5

Q ss_pred             hhhCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEc---CCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeE
Q 014024          106 SATGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLL---GKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERL  180 (432)
Q Consensus       106 ~~~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~---~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  180 (432)
                      ...+.+.+.+-+.+|.++.++.+.-...  ..+.|...   .-.....+....+-.++-..++|-++...--+.-....+
T Consensus       801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~  880 (1205)
T KOG0606|consen  801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP  880 (1205)
T ss_pred             CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence            4567788888999999999998764322  12222211   111111222223333333334566665554455567789


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceec
Q 014024          181 LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIV  260 (432)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  260 (432)
                      ++++|..+++|...++...   ..+..-.......+.+++++||...   +.|+|++|.|++...+++.+++|||.....
T Consensus       881 L~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v  954 (1205)
T KOG0606|consen  881 LVGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV  954 (1205)
T ss_pred             hhhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence            9999999999998886543   3555555666777889999999987   899999999999999999999999844332


Q ss_pred             cCC--------C-------------Ccccc----ccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCC
Q 014024          261 FGG--------N-------------DEDEL----QGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKN  315 (432)
Q Consensus       261 ~~~--------~-------------~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p  315 (432)
                      ..-        .             .....    ........+|+.|.+||...+......+|.|+.|++++|.++|..|
T Consensus       955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen  955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred             ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence            100        0             00000    1223456789999999999999999999999999999999999999


Q ss_pred             CCCccccccchhhhhHHhhhccchhhhhhhhhhhc-----ccHHHHHHHHHHHHHhhccCCCCCCCHH
Q 014024          316 TGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEA-----SFNESLSRYVHIALLCVQERAEDRPTMS  378 (432)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~-----~~~~~~~~l~~l~~~cl~~dp~~RPt~~  378 (432)
                      |.....+                  +.++..+...     .+........+++...+..+|.+|-.+.
T Consensus      1035 ~na~tpq------------------~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1035 FNAETPQ------------------QIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCcchh------------------hhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            8543321                  1111111111     1223344566777888888999998776

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.96  E-value=6.9e-09  Score=90.80  Aligned_cols=123  Identities=24%  Similarity=0.277  Sum_probs=79.5

Q ss_pred             EEEEEEECCc-eEEEEEEcCCC--------------------------hHhHHHHHHHHHHHHhcCCC--ceeeeEeEEE
Q 014024          124 TVYKGVIGQG-EIAVKRLLGKS--------------------------GQEIKELKNEASVIAQVQHK--NLVKLLGCCI  174 (432)
Q Consensus       124 ~Vy~~~~~~~-~vavK~~~~~~--------------------------~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~  174 (432)
                      .||.|...++ .+|+|......                          ........+|.+.|.++...  ++.+.+++- 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            4899998655 89999774221                          01233467899999999765  456666442 


Q ss_pred             eCCeeEEEEecCC--CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCCeEeccCCCCCEEEcCCCCEEE
Q 014024          175 EKDERLLIYEYMP--NKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLY-LHQYSRVRIIHRDLKASNILLDKDMNSKI  251 (432)
Q Consensus       175 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~-LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  251 (432)
                         ..++||||++  |..+..+... .    ++......++.+++..+.. +|..|   ++||||++.||+++++ .+.+
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~-~----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i  147 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDV-D----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI  147 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHC-G----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred             ---CCEEEEEecCCCccchhhHHhc-c----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence               3479999998  5555443311 1    1133445677788775555 57888   9999999999999888 9999


Q ss_pred             eeccccee
Q 014024          252 SDFGMARI  259 (432)
Q Consensus       252 ~Dfg~a~~  259 (432)
                      +|||.+..
T Consensus       148 IDf~qav~  155 (188)
T PF01163_consen  148 IDFGQAVD  155 (188)
T ss_dssp             --GTTEEE
T ss_pred             EecCccee
Confidence            99999875

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.89  E-value=1.5e-08  Score=91.40  Aligned_cols=145  Identities=19%  Similarity=0.201  Sum_probs=101.0

Q ss_pred             chhhHhhhhCCCCcCceeccCCcEEEEEEEECCc-eEEEEEEcCCC----------------------hHhHHHHHHHHH
Q 014024          100 SFSSVSSATGNFSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKS----------------------GQEIKELKNEAS  156 (432)
Q Consensus       100 ~~~~~~~~~~~y~~~~~ig~G~~g~Vy~~~~~~~-~vavK~~~~~~----------------------~~~~~~~~~E~~  156 (432)
                      .+..+.....=+.++..||.|--+.||.|.+..+ ++++|.-....                      .......++|.+
T Consensus        82 AL~~l~~r~~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~  161 (304)
T COG0478          82 ALHALVKRGIVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFE  161 (304)
T ss_pred             HHHHHHHcChHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHH
Confidence            3333333333456778999999999999999754 89998442111                      112334678999


Q ss_pred             HHHhcCCC--ceeeeEeEEEeCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 014024          157 VIAQVQHK--NLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHR  234 (432)
Q Consensus       157 ~l~~l~h~--niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~  234 (432)
                      +|.++...  .+.+.+++    +...+|||+++|-.|...-        ++....-.++..|++-+.-+-..|   ++|+
T Consensus       162 ~L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHG  226 (304)
T COG0478         162 ALQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHG  226 (304)
T ss_pred             HHHHhhhcCCCCCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---cccc
Confidence            99998754  56665554    4558999999986664332        123333445566666666555777   9999


Q ss_pred             cCCCCCEEEcCCCCEEEeeccccee
Q 014024          235 DLKASNILLDKDMNSKISDFGMARI  259 (432)
Q Consensus       235 Dlkp~NIll~~~~~~kl~Dfg~a~~  259 (432)
                      |+++-||+++++|.+.++||-.+..
T Consensus       227 DlSefNIlV~~dg~~~vIDwPQ~v~  251 (304)
T COG0478         227 DLSEFNILVTEDGDIVVIDWPQAVP  251 (304)
T ss_pred             CCchheEEEecCCCEEEEeCccccc
Confidence            9999999999999999999976643

>PRK09902 hypothetical protein; Provisional

Probab=98.81  E-value=1.2e-07  Score=83.51  Aligned_cols=138  Identities=17%  Similarity=0.127  Sum_probs=103.1

Q ss_pred             eccCCcEEEEEEEECCceEEEEEEcCCC------hHhHHHHHHHHHHHHhcCCC--ceeeeEeEEE-e--C--CeeEEEE
Q 014024          117 LGEGGFGTVYKGVIGQGEIAVKRLLGKS------GQEIKELKNEASVIAQVQHK--NLVKLLGCCI-E--K--DERLLIY  183 (432)
Q Consensus       117 ig~G~~g~Vy~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~-~--~--~~~~lv~  183 (432)
                      -|+||-+-|+.-..++..+.+|+-...-      ......|.+|...+.++...  .+.+.. ++. .  +  -..+||+
T Consensus        26 ~~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         26 YRRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT  104 (216)
T ss_pred             cCCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence            4668888899988877788898764221      22456799999999998532  244444 332 1  1  1357999


Q ss_pred             ecCCC-CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCC--EEEeeccccee
Q 014024          184 EYMPN-KSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN--SKISDFGMARI  259 (432)
Q Consensus       184 e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~  259 (432)
                      |-+++ -+|.+++.+... ...+......++.+++.++.-||+.|   +.|+|+.+.||+++.++.  ++++||.-++.
T Consensus       105 e~L~g~~~L~~~l~~~~~-~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        105 EDMAGFISIADWYAQHAV-SPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EeCCCCccHHHHHhcCCc-CCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            97754 588888754322 23677778899999999999999999   999999999999986677  99999987764

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.80  E-value=1.4e-09  Score=109.02  Aligned_cols=157  Identities=22%  Similarity=0.304  Sum_probs=105.6

Q ss_pred             HHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCC---ccccccccccccccCCccChhhhcc
Q 014024          214 KGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGND---EDELQGNTSRISGTYGYMSPEYALE  290 (432)
Q Consensus       214 ~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~~~~~~gt~~y~aPE~~~~  290 (432)
                      .+++.|+.|+|..-  ++||++|.|++|.++.++..||+.|+++....++.+   ............-...|.|||++..
T Consensus       106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            34559999999754  699999999999999999999999998865433211   0111111222344678999999999


Q ss_pred             CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccC
Q 014024          291 GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQER  370 (432)
Q Consensus       291 ~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~d  370 (432)
                      ...+.++|+||+|+++|.+..|..+.-.....   ...+.        .....+..-...+....+.++.+=+..++..+
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~---~~~~~--------~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~  252 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGG---LLSYS--------FSRNLLNAGAFGYSNNLPSELRESLKKLLNGD  252 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCC---cchhh--------hhhcccccccccccccCcHHHHHHHHHHhcCC
Confidence            88899999999999999999665553111100   00000        00011111112223456678888888999999


Q ss_pred             CCCCCCHHHHHHH
Q 014024          371 AEDRPTMSDVVSM  383 (432)
Q Consensus       371 p~~RPt~~evl~~  383 (432)
                      +..||++.++...
T Consensus       253 ~~~rp~~~~l~~~  265 (700)
T KOG2137|consen  253 SAVRPTLDLLLSI  265 (700)
T ss_pred             cccCcchhhhhcc
Confidence            9999988877653

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.78  E-value=5.3e-08  Score=87.24  Aligned_cols=105  Identities=25%  Similarity=0.301  Sum_probs=82.4

Q ss_pred             HHHHHHHHHHHhcCC--CceeeeEeEEEeCC----eeEEEEecCCCC-ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHH
Q 014024          149 KELKNEASVIAQVQH--KNLVKLLGCCIEKD----ERLLIYEYMPNK-SLDCFLFDPTKREILDWRTRVQIIKGVAQGLL  221 (432)
Q Consensus       149 ~~~~~E~~~l~~l~h--~niv~~~~~~~~~~----~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~  221 (432)
                      ....+|.+.+..+..  -...+.+++.....    ..++|+|++++. +|.+++.....   .+......++.+++..++
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLIA  132 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHHH
Confidence            456778888887753  33455666655432    348999999885 79888854222   566677889999999999


Q ss_pred             HHHhcCCCCeEeccCCCCCEEEcCCC---CEEEeeccccee
Q 014024          222 YLHQYSRVRIIHRDLKASNILLDKDM---NSKISDFGMARI  259 (432)
Q Consensus       222 ~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~Dfg~a~~  259 (432)
                      -||..|   |+|+|+++.|||++.++   .+.++||+-++.
T Consensus       133 ~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  133 KLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            999999   99999999999999887   899999998875

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.64  E-value=6.1e-07  Score=79.50  Aligned_cols=137  Identities=13%  Similarity=0.132  Sum_probs=95.5

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECCceEEEEEEcCCChHhHHH---------HHHHHHHHHhcCC---CceeeeEeEEE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKE---------LKNEASVIAQVQH---KNLVKLLGCCI  174 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~h---~niv~~~~~~~  174 (432)
                      ..++|.+.+++-......|.+-..+++.+++|.......-..+.         ..+++..+..++.   .....++.+..
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e  108 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE  108 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence            46789999999999999999999999999999876554322222         2233444444432   23333333332


Q ss_pred             e-----CCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCE
Q 014024          175 E-----KDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNS  249 (432)
Q Consensus       175 ~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  249 (432)
                      .     ....+++|||++|..|.+...       ++.    .++..+.+++..||+.|   +.|+|..|.|+++++++ +
T Consensus       109 kk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~-i  173 (229)
T PF06176_consen  109 KKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG-I  173 (229)
T ss_pred             eeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-E
Confidence            2     234568999999988766531       222    25566778899999999   99999999999998655 9


Q ss_pred             EEeecccce
Q 014024          250 KISDFGMAR  258 (432)
Q Consensus       250 kl~Dfg~a~  258 (432)
                      ++.||+..+
T Consensus       174 ~iID~~~k~  182 (229)
T PF06176_consen  174 RIIDTQGKR  182 (229)
T ss_pred             EEEECcccc
Confidence            999997664

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.63  E-value=6.9e-07  Score=81.12  Aligned_cols=132  Identities=20%  Similarity=0.180  Sum_probs=85.5

Q ss_pred             ceeccCCcEEEEEEEECCceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCc--eeeeEeEEEeCCeeEEEEecCCCCC-h
Q 014024          115 NKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKN--LVKLLGCCIEKDERLLIYEYMPNKS-L  191 (432)
Q Consensus       115 ~~ig~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~gs-L  191 (432)
                      ..||+|..+.||+.  .++.+++|......  ......+|.++++.+..-+  +.+.+++....+...+|||+++|.+ +
T Consensus         7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~   82 (226)
T TIGR02172         7 TQTGEGGNGESYTH--KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF   82 (226)
T ss_pred             eeecCCCCcceeEe--cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence            56899999999984  24467778775433  2345688999999986443  4667778777777889999999963 2


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------c-CCCCe
Q 014024          192 DCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ---------------------------------------Y-SRVRI  231 (432)
Q Consensus       192 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---------------------------------------~-~~~~i  231 (432)
                      ...+.       .+......++.++++.+.-||+                                       . ....+
T Consensus        83 ~~~~~-------~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~  155 (226)
T TIGR02172        83 SRIIS-------DNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTC  155 (226)
T ss_pred             hhhhc-------CCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCce
Confidence            21110       0011111112222222222221                                       1 12357


Q ss_pred             EeccCCCCCEEEcCCCCEEEeecccce
Q 014024          232 IHRDLKASNILLDKDMNSKISDFGMAR  258 (432)
Q Consensus       232 vH~Dlkp~NIll~~~~~~kl~Dfg~a~  258 (432)
                      +|+|+.|.||++++++ +.++||+.+.
T Consensus       156 ~HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       156 LHGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             EecCCCCCcEEEcCCC-cEEEechhcC
Confidence            9999999999999888 9999998875

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.51  E-value=1.8e-06  Score=78.62  Aligned_cols=144  Identities=24%  Similarity=0.253  Sum_probs=86.2

Q ss_pred             CceeccCCcEEEEEEEECCceEEEEEEcCCChHhHHHHHHHHHHHHhcCCC--ceeeeEeEEEe---CCeeEEEEecCCC
Q 014024          114 ANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHK--NLVKLLGCCIE---KDERLLIYEYMPN  188 (432)
Q Consensus       114 ~~~ig~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~~---~~~~~lv~e~~~~  188 (432)
                      ++.++.|..+.||+....++.+++|.....  .....+.+|..+++.+...  .+.+++.....   ....+++|+++++
T Consensus         2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g   79 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG   79 (239)
T ss_dssp             EEEEEESSSSEEEEEEETTSEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred             CccCCCCCeeeEEEEEECCcEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence            367899999999999998889999987554  4556788899999888533  35566664432   3346899999999


Q ss_pred             CChhh----------------hh---cCC-CCCCCCCHHH---------HHHH------------HHHHHH-HHHHHHh-
Q 014024          189 KSLDC----------------FL---FDP-TKREILDWRT---------RVQI------------IKGVAQ-GLLYLHQ-  225 (432)
Q Consensus       189 gsL~~----------------~l---~~~-~~~~~l~~~~---------~~~i------------~~qi~~-~l~~LH~-  225 (432)
                      ..+..                .+   +.. .....+....         ....            ...+.+ .+..+++ 
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (239)
T PF01636_consen   80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL  159 (239)
T ss_dssp             EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence            88877                11   011 0001111100         0000            011222 2333332 


Q ss_pred             ---cCCCCeEeccCCCCCEEEc-CCCCEEEeeccccee
Q 014024          226 ---YSRVRIIHRDLKASNILLD-KDMNSKISDFGMARI  259 (432)
Q Consensus       226 ---~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~  259 (432)
                         .....++|+|+.|.||+++ +++.+.|.||+.+..
T Consensus       160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             hccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence               1334599999999999999 666678999988764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.42  E-value=3.7e-06  Score=77.41  Aligned_cols=139  Identities=17%  Similarity=0.153  Sum_probs=84.7

Q ss_pred             eccCCc-EEEEEEEECCceEEEEEEcCCChHhHHHHHHHHHHHHhcC-CCceeeeEeEEEeCCeeEEEEecCCCCChhhh
Q 014024          117 LGEGGF-GTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQ-HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCF  194 (432)
Q Consensus       117 ig~G~~-g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~  194 (432)
                      |..|.. ..||+....+..+++|......   ...+.+|+++++.+. +--+.+++++....+..++|||+++|.++...
T Consensus         6 ~~~g~~~~~v~~~~~~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~   82 (244)
T cd05150           6 VTEGQSGATVYRLDGKNPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL   82 (244)
T ss_pred             cCCCCCcCeEEEEcCCCCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence            444555 7889987766678888775443   345678999988884 34456677777766678999999999887643


Q ss_pred             h-------------------cCCCC-CCCCCHH--HHHHHHH--------------------HHHHHHHHHHh----cCC
Q 014024          195 L-------------------FDPTK-REILDWR--TRVQIIK--------------------GVAQGLLYLHQ----YSR  228 (432)
Q Consensus       195 l-------------------~~~~~-~~~l~~~--~~~~i~~--------------------qi~~~l~~LH~----~~~  228 (432)
                      .                   +.... ..++...  .......                    .+...+..|-.    ...
T Consensus        83 ~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  162 (244)
T cd05150          83 WEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEED  162 (244)
T ss_pred             hcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCc
Confidence            2                   11000 0011100  0000000                    01111122211    112


Q ss_pred             CCeEeccCCCCCEEEcCCCCEEEeecccce
Q 014024          229 VRIIHRDLKASNILLDKDMNSKISDFGMAR  258 (432)
Q Consensus       229 ~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  258 (432)
                      +.++|+|+.|.||++++++...|+||+.+.
T Consensus       163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             eEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            459999999999999998778899998875

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.35  E-value=8e-06  Score=73.27  Aligned_cols=148  Identities=17%  Similarity=0.181  Sum_probs=95.5

Q ss_pred             hhhHhhhhCCCCcCc---eeccCCcEEEEEEEECC-ceEEEEEEcCCChHh------------------------HHHHH
Q 014024          101 FSSVSSATGNFSAAN---KLGEGGFGTVYKGVIGQ-GEIAVKRLLGKSGQE------------------------IKELK  152 (432)
Q Consensus       101 ~~~~~~~~~~y~~~~---~ig~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~------------------------~~~~~  152 (432)
                      .+.+....++..+..   .|..|-.+.||+|...+ ..+|+|++.......                        ..-..
T Consensus        37 ~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~  116 (268)
T COG1718          37 LETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWAR  116 (268)
T ss_pred             HHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHH
Confidence            334444444544444   46678888999999764 489999885332110                        11134


Q ss_pred             HHHHHHHhcC--CCceeeeEeEEEeCCeeEEEEecCCCCC-hhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCC
Q 014024          153 NEASVIAQVQ--HKNLVKLLGCCIEKDERLLIYEYMPNKS-LDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ-YSR  228 (432)
Q Consensus       153 ~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~gs-L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~  228 (432)
                      +|...|+++.  +-.+.+-+++.    .-.|||||+.... -.-.|    ..-.+...+...+..++++.+.-|-. .+ 
T Consensus       117 kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~l~~~a~-  187 (268)
T COG1718         117 KEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRRLYKEAG-  187 (268)
T ss_pred             HHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHHHHHhcC-
Confidence            5777777774  23344444443    3379999996541 11112    11123333566778888888888777 56 


Q ss_pred             CCeEeccCCCCCEEEcCCCCEEEeecccceec
Q 014024          229 VRIIHRDLKASNILLDKDMNSKISDFGMARIV  260 (432)
Q Consensus       229 ~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  260 (432)
                        +||+||+.-|||+. ++.+.++|+|.|...
T Consensus       188 --LVHgDLSEyNiL~~-~~~p~iID~~QaV~~  216 (268)
T COG1718         188 --LVHGDLSEYNILVH-DGEPYIIDVSQAVTI  216 (268)
T ss_pred             --cccccchhhheEEE-CCeEEEEECcccccc
Confidence              99999999999999 889999999988653

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.29  E-value=4.5e-06  Score=73.37  Aligned_cols=105  Identities=21%  Similarity=0.209  Sum_probs=83.1

Q ss_pred             HHHHHHHHhcCC-CceeeeEeEEEeCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 014024          152 KNEASVIAQVQH-KNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVR  230 (432)
Q Consensus       152 ~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~  230 (432)
                      .+|.-+++.+++ +++.+++|.|-+    +++.||...+++...-.....-...+|..+.+|+.++++.+.+|++.....
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            457888888876 699999999933    779999987765421100011123789999999999999999999866666


Q ss_pred             eEeccCCCCCEEEcCCCCEEEeecccceec
Q 014024          231 IIHRDLKASNILLDKDMNSKISDFGMARIV  260 (432)
Q Consensus       231 ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  260 (432)
                      +.-.|++|+|+-+++++++|+.|.+.....
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            999999999999999999999999877653

Proteins in this uncharacterised family are described as transmembrane proteins.

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.28  E-value=5.7e-06  Score=70.22  Aligned_cols=129  Identities=22%  Similarity=0.281  Sum_probs=91.7

Q ss_pred             CcCceeccCCcEEEEEEEECCceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceee-eEeEEEeCCeeEEEEecCCCCC
Q 014024          112 SAANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVK-LLGCCIEKDERLLIYEYMPNKS  190 (432)
Q Consensus       112 ~~~~~ig~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-~~~~~~~~~~~~lv~e~~~~gs  190 (432)
                      +..+.|++|.+|.||+|.+.+..+|+|+-...+  ....+..|+++|..+.-.++.+ ++.|-.+    ++.|||+.|-.
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~~   98 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWRGGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGRP   98 (201)
T ss_pred             hhhhhhhcccccEEEEeeccCceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCcc
Confidence            345789999999999999999999999876554  3567899999999998766655 3433222    35599999988


Q ss_pred             hhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCC-CCCEEEcCCCCEEEeeccccee
Q 014024          191 LDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLK-ASNILLDKDMNSKISDFGMARI  259 (432)
Q Consensus       191 L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlk-p~NIll~~~~~~kl~Dfg~a~~  259 (432)
                      |.++-..      .+...    ...+++.---|...|   |-|+.|. |...++..++.+.|+||..|..
T Consensus        99 L~~~~~~------~~rk~----l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          99 LGKLEIG------GDRKH----LLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hhhhhhc------ccHHH----HHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            8766421      12222    333444444455566   9999997 5555555555999999999874

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.27  E-value=6.3e-06  Score=83.01  Aligned_cols=138  Identities=18%  Similarity=0.227  Sum_probs=89.9

Q ss_pred             ceeccCCcEEEEEEEECC-ceEEEEEEcCCChHh------------------------------H----HH------HHH
Q 014024          115 NKLGEGGFGTVYKGVIGQ-GEIAVKRLLGKSGQE------------------------------I----KE------LKN  153 (432)
Q Consensus       115 ~~ig~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~------------------------------~----~~------~~~  153 (432)
                      +-|+.++-|.||+|+..+ ..||||+..+.-...                              .    +.      +.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            679999999999999985 599999886542110                              1    11      334


Q ss_pred             HHHHHHhcC----CCceeeeEeEE-EeCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHH-HHHHHhcC
Q 014024          154 EASVIAQVQ----HKNLVKLLGCC-IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQG-LLYLHQYS  227 (432)
Q Consensus       154 E~~~l~~l~----h~niv~~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~-l~~LH~~~  227 (432)
                      |+..+.+++    +..-+++=.++ .-.....++|||++|-.+.+...-..  ..++..   .++..++++ +..+=..|
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k---~ia~~~~~~f~~q~~~dg  285 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRK---ELAELLVRAFLRQLLRDG  285 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHH---HHHHHHHHHHHHHHHhcC
Confidence            555555552    22222222333 23456789999999999888752222  114432   233333332 33333356


Q ss_pred             CCCeEeccCCCCCEEEcCCCCEEEeecccceec
Q 014024          228 RVRIIHRDLKASNILLDKDMNSKISDFGMARIV  260 (432)
Q Consensus       228 ~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  260 (432)
                         +.|.|..|.||+++.+|.+.+.|||+...+
T Consensus       286 ---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l  315 (517)
T COG0661         286 ---FFHADPHPGNILVRSDGRIVLLDFGIVGRL  315 (517)
T ss_pred             ---ccccCCCccceEEecCCcEEEEcCcceecC
Confidence               999999999999999999999999998765

>PRK10593 hypothetical protein; Provisional

Probab=98.22  E-value=2.4e-05  Score=74.17  Aligned_cols=76  Identities=12%  Similarity=0.109  Sum_probs=58.0

Q ss_pred             CceeccCCcEEEEEEEECCceEEEEEEcCCChHhHHHHHHHHHHHHhcCC---CceeeeEeEEEeC---CeeEEEEecCC
Q 014024          114 ANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQH---KNLVKLLGCCIEK---DERLLIYEYMP  187 (432)
Q Consensus       114 ~~~ig~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~~~~~~~~~---~~~~lv~e~~~  187 (432)
                      .+.||.|..+.||.....++.+.+|.....  .....+..|++.|+.+..   -.+.++++++...   +..++|||+++
T Consensus        19 ~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~   96 (297)
T PRK10593         19 VECISEQPYAALWALYDSQGNPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLR   96 (297)
T ss_pred             eeecCCccceeEEEEEcCCCCEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccC
Confidence            567999999999999877777777775331  123578899999998853   3678888887543   56899999999


Q ss_pred             CCCh
Q 014024          188 NKSL  191 (432)
Q Consensus       188 ~gsL  191 (432)
                      ++++
T Consensus        97 G~~~  100 (297)
T PRK10593         97 GVSV  100 (297)
T ss_pred             CEec
Confidence            8765

>PLN02876 acyl-CoA dehydrogenase

Probab=98.19  E-value=2.6e-05  Score=84.30  Aligned_cols=78  Identities=15%  Similarity=0.324  Sum_probs=56.6

Q ss_pred             CceeccCCcEEEEEEEECC----ceEEEEEEcCCC-hHhHHHHHHHHHHHHhcC-CCce--eeeEeEEEeC---CeeEEE
Q 014024          114 ANKLGEGGFGTVYKGVIGQ----GEIAVKRLLGKS-GQEIKELKNEASVIAQVQ-HKNL--VKLLGCCIEK---DERLLI  182 (432)
Q Consensus       114 ~~~ig~G~~g~Vy~~~~~~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~ni--v~~~~~~~~~---~~~~lv  182 (432)
                      .+.++.|.+..+|+....+    ..+++|+..... ......+.+|+++|+.+. |.++  .+++.+|.+.   +..|+|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            5778999999999987655    256777654322 122356889999999995 6654  7788887664   457899


Q ss_pred             EecCCCCCh
Q 014024          183 YEYMPNKSL  191 (432)
Q Consensus       183 ~e~~~~gsL  191 (432)
                      |||++|..+
T Consensus       123 ME~v~G~~~  131 (822)
T PLN02876        123 MEYLEGRIF  131 (822)
T ss_pred             EEecCCccc
Confidence            999998654

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.19  E-value=2.3e-07  Score=92.50  Aligned_cols=187  Identities=17%  Similarity=0.092  Sum_probs=133.2

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECCce-EEEEEEcCCChHhHHHHHHHHHHHHhcCCCc-eeeeEeEEEeCCeeEEEEec
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQGE-IAVKRLLGKSGQEIKELKNEASVIAQVQHKN-LVKLLGCCIEKDERLLIYEY  185 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~~~-vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~  185 (432)
                      +.-+...+-.++|+++++++.+....+ ...+.+...     ....-++++|.+++||| .++.++-+..++...+.+++
T Consensus       241 ~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i  315 (829)
T KOG0576|consen  241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRI  315 (829)
T ss_pred             ccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhh
Confidence            334455566899999999998876553 223333221     34456889999999999 77777777777888999999


Q ss_pred             CCCC-ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCC
Q 014024          186 MPNK-SLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGN  264 (432)
Q Consensus       186 ~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  264 (432)
                      +.++ +-..-..  .....+...+...++..-+++++++|+..   =+|+|    ||+..+ +..+..||+....+... 
T Consensus       316 ~s~~rs~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~-  384 (829)
T KOG0576|consen  316 CSTGRSSALEMT--VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRT-  384 (829)
T ss_pred             hcCCccccccCC--hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCcc-
Confidence            9887 2211110  11112444445566677788999999874   48888    777654 67899999988765221 


Q ss_pred             CccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCC
Q 014024          265 DEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNT  316 (432)
Q Consensus       265 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~  316 (432)
                            .......+++.++|||+...+.+..+.|+|++|+--.+|--|-+|-
T Consensus       385 ------~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  385 ------MKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             ------cccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence                  1345678999999999999999999999999999877777777664

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.16  E-value=3.9e-05  Score=67.32  Aligned_cols=126  Identities=24%  Similarity=0.342  Sum_probs=92.6

Q ss_pred             hCCCCcCceeccCCc-EEEEEEEECCceEEEEEEcC---CC-----------h-------HhHHHHHHHHHHHHhcC---
Q 014024          108 TGNFSAANKLGEGGF-GTVYKGVIGQGEIAVKRLLG---KS-----------G-------QEIKELKNEASVIAQVQ---  162 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~-g~Vy~~~~~~~~vavK~~~~---~~-----------~-------~~~~~~~~E~~~l~~l~---  162 (432)
                      +.+++.++.||.|.- |.||++...+..+|+|.+..   ..           .       ...+-|..|.+...+++   
T Consensus        36 ~~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   36 GDDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CCcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            378999999999999 99999999999999999321   00           0       22345788999888885   


Q ss_pred             CCce--eeeEeEEEeC------------------CeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 014024          163 HKNL--VKLLGCCIEK------------------DERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLY  222 (432)
Q Consensus       163 h~ni--v~~~~~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~  222 (432)
                      +.++  |+++||..-.                  ..+.||.||++...            .+...    -+.++.+-+..
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~~----~~~~~~~dl~~  179 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQIR----DIPQMLRDLKI  179 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccchh----HHHHHHHHHHH
Confidence            4456  9999987322                  12357778775543            12222    34566777888


Q ss_pred             HHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccc
Q 014024          223 LHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMA  257 (432)
Q Consensus       223 LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  257 (432)
                      +|..|   |+-+|+++.|..     .-||+|||.+
T Consensus       180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence            99999   999999999988     4589999864

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.12  E-value=2.8e-05  Score=71.13  Aligned_cols=73  Identities=10%  Similarity=0.187  Sum_probs=45.7

Q ss_pred             ceeccCCcE-EEEEEEECCceEEEEEEcCCChHhHHHHHHHHHHHHhcCCC---ceeeeEeEEEeC---CeeEEEEecCC
Q 014024          115 NKLGEGGFG-TVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHK---NLVKLLGCCIEK---DERLLIYEYMP  187 (432)
Q Consensus       115 ~~ig~G~~g-~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~~~---~~~~lv~e~~~  187 (432)
                      +.|+.||.. .||+.   +..+++|.....  .....+..|.++++.+...   .+.++++.....   ...+++|++++
T Consensus         3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~   77 (235)
T cd05155           3 EPVDSGGTDNATFRL---GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE   77 (235)
T ss_pred             eeccCCCcccceEEc---CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence            457777776 48875   235667764432  2345788999999888532   244444443322   23478999999


Q ss_pred             CCChh
Q 014024          188 NKSLD  192 (432)
Q Consensus       188 ~gsL~  192 (432)
                      |.++.
T Consensus        78 G~~l~   82 (235)
T cd05155          78 GETAT   82 (235)
T ss_pred             CCCCC
Confidence            97774

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.09  E-value=3.9e-05  Score=81.84  Aligned_cols=202  Identities=21%  Similarity=0.217  Sum_probs=138.6

Q ss_pred             HhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeE----EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHH
Q 014024          146 QEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERL----LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLL  221 (432)
Q Consensus       146 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~----lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~  221 (432)
                      ........|...+..+.|+|++.++.|-.+....-    +..|++...++...++.   -...+....+.+..++..|++
T Consensus       224 ~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~---v~~i~~~~~r~~~~~~~~GL~  300 (1351)
T KOG1035|consen  224 KEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS---VGSIPLETLRILHQKLLEGLA  300 (1351)
T ss_pred             HHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh---ccccCHHHHHHHHHHHhhhHH
Confidence            34455667888888999999999999986654332    34578888888877743   334788888999999999999


Q ss_pred             HHHhcCCCCeEeccCCCC---CEEEcCCCCEEEe--ecccceeccCCCCccccccccccccccCCccChhhhccCCCCc-
Q 014024          222 YLHQYSRVRIIHRDLKAS---NILLDKDMNSKIS--DFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSI-  295 (432)
Q Consensus       222 ~LH~~~~~~ivH~Dlkp~---NIll~~~~~~kl~--Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~-  295 (432)
                      |+|+..   ..|.-+..+   +--.+..+....+  ||+....+....       .......+..+.+||......+.. 
T Consensus       301 ~~h~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~-------~~~~~~~~~~~~~~e~~~~~~~~~~  370 (1351)
T KOG1035|consen  301 YLHSLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNE-------KSFSDLLAEIRNADEDLKENTAKKS  370 (1351)
T ss_pred             HHHHhc---cceeEEecccccccccCccceeecchhhhcccccCCCcc-------cchhhcCccccccccccccccchhh
Confidence            999986   666555555   5555666777776  888877642211       112223345678888777665544 


Q ss_pred             -hhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCC
Q 014024          296 -KSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDR  374 (432)
Q Consensus       296 -~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~R  374 (432)
                       ..|+|++|..+..+..|..+-.....                     +...+...    ....+......|+..++++|
T Consensus       371 r~~dL~~lgll~~~~~~~~~i~~~~~~---------------------~~~~l~~~----~~~~~~d~~~~~~~~~~~~R  425 (1351)
T KOG1035|consen  371 RLTDLWCLGLLLLQLSQGEDISEKSAV---------------------PVSLLDVL----STSELLDALPKCLDEDSEER  425 (1351)
T ss_pred             hhhHHHHHHHHHhhhhhcCcccccccc---------------------hhhhhccc----cchhhhhhhhhhcchhhhhc
Confidence             47999999999999998765321111                     11111111    11145667788999999999


Q ss_pred             CCHHHHHHHhc
Q 014024          375 PTMSDVVSMLT  385 (432)
Q Consensus       375 Pt~~evl~~L~  385 (432)
                      +++.+++.+.-
T Consensus       426 l~~~~ll~~~f  436 (1351)
T KOG1035|consen  426 LSALELLTHPF  436 (1351)
T ss_pred             cchhhhhhchh
Confidence            99999998653

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.08  E-value=4.7e-05  Score=67.30  Aligned_cols=128  Identities=17%  Similarity=0.225  Sum_probs=88.5

Q ss_pred             CceeccCCcEEEEEEEECCceEEEEEEcCCC----------------hHhHHHHHHHHHHHHhcC------CCceeeeEe
Q 014024          114 ANKLGEGGFGTVYKGVIGQGEIAVKRLLGKS----------------GQEIKELKNEASVIAQVQ------HKNLVKLLG  171 (432)
Q Consensus       114 ~~~ig~G~~g~Vy~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h~niv~~~~  171 (432)
                      ...||+|+.-.||.--. +...+||+.....                .....+..+|+....++.      +.+|.+++|
T Consensus         6 ~~~i~~G~~R~cy~HP~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G   84 (199)
T PF10707_consen    6 SDLIAQGGERDCYQHPD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG   84 (199)
T ss_pred             CcccccCCCceEEECCC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence            46799999999995322 2357788775544                223456667777666665      788999999


Q ss_pred             EEEeCCeeEEEEecCCC------CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcC
Q 014024          172 CCIEKDERLLIYEYMPN------KSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDK  245 (432)
Q Consensus       172 ~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~  245 (432)
                      +.+++...-+|+|.+.+      -+|.+++.+    +.++. ...+.+.   +-..||-+.+   |+.+|++|.||++..
T Consensus        85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~----~~~~~-~~~~~L~---~f~~~l~~~~---Iv~~dl~~~NIv~~~  153 (199)
T PF10707_consen   85 FVETNLGLGLVVELIRDADGNISPTLEDYLKE----GGLTE-ELRQALD---EFKRYLLDHH---IVIRDLNPHNIVVQR  153 (199)
T ss_pred             EEecCCceEEEEEEEECCCCCcCccHHHHHHc----CCccH-HHHHHHH---HHHHHHHHcC---CeecCCCcccEEEEe
Confidence            99999988999987643      346777732    23555 3334444   3355666777   999999999999954


Q ss_pred             CC----CEEEee
Q 014024          246 DM----NSKISD  253 (432)
Q Consensus       246 ~~----~~kl~D  253 (432)
                      +.    .+.|+|
T Consensus       154 ~~~~~~~lvlID  165 (199)
T PF10707_consen  154 RDSGEFRLVLID  165 (199)
T ss_pred             cCCCceEEEEEe
Confidence            32    466777

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>TIGR02721 ycfN_thiK thiamine kinase

Probab=98.04  E-value=3.6e-05  Score=71.40  Aligned_cols=138  Identities=12%  Similarity=0.063  Sum_probs=78.3

Q ss_pred             eccCCcEEEEEEEECCceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCce-eeeEeEEEeCCeeEEEEecCCCCChhhh-
Q 014024          117 LGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNL-VKLLGCCIEKDERLLIYEYMPNKSLDCF-  194 (432)
Q Consensus       117 ig~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~gsL~~~-  194 (432)
                      +..|-...+|+....+..+++|..........-...+|.++++.+...++ .+++....    -++||||++|..+... 
T Consensus         4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~~   79 (256)
T TIGR02721         4 LSGGLTNRSWRIEHPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLDQ   79 (256)
T ss_pred             CCCcCcCCeEEEEeCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccccc
Confidence            45677788998887666888886543322211235778899998864433 33343321    3689999998776421 


Q ss_pred             ----------------hcCCCC-CCCCCHHHH-HHHHHHH---------HHHHHHHHhc-----CCCCeEeccCCCCCEE
Q 014024          195 ----------------LFDPTK-REILDWRTR-VQIIKGV---------AQGLLYLHQY-----SRVRIIHRDLKASNIL  242 (432)
Q Consensus       195 ----------------l~~~~~-~~~l~~~~~-~~i~~qi---------~~~l~~LH~~-----~~~~ivH~Dlkp~NIl  242 (432)
                                      ++.... ..+++.... ..+..++         ...+..+-..     ....++|+|+.|.||+
T Consensus        80 ~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Nil  159 (256)
T TIGR02721        80 FVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNLV  159 (256)
T ss_pred             ccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcEE
Confidence                            111110 111222111 1111111         1112222111     1234899999999999


Q ss_pred             EcCCCCEEEeeccccee
Q 014024          243 LDKDMNSKISDFGMARI  259 (432)
Q Consensus       243 l~~~~~~kl~Dfg~a~~  259 (432)
                      +++++ +.++||+.+..
T Consensus       160 ~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       160 VTPQG-LKLIDWEYASD  175 (256)
T ss_pred             EeCCC-CEEEeccccCc
Confidence            99877 78999988864

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.94  E-value=5.8e-05  Score=71.62  Aligned_cols=143  Identities=17%  Similarity=0.159  Sum_probs=86.6

Q ss_pred             CceeccCCcEEEEEEEECCceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCc--eeeeEeE------EEeCCeeEEEEec
Q 014024          114 ANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKN--LVKLLGC------CIEKDERLLIYEY  185 (432)
Q Consensus       114 ~~~ig~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~------~~~~~~~~lv~e~  185 (432)
                      .+.|..|....+|+....++.+++|+....   ..+.+..|++++..+.+.+  +.+++..      ....+..+++++|
T Consensus        19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~   95 (296)
T cd05153          19 FEGISAGIENTNYFVTTDSGRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEF   95 (296)
T ss_pred             eecccCccccceEEEEeCCCcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEe
Confidence            456777877899998877778899887542   2345677888888885332  4444331      1234456899999


Q ss_pred             CCCCChhh----hh----------cCC----CC----CCCCCHHHHH----------HHHHHHHHHHHHHHhc----CCC
Q 014024          186 MPNKSLDC----FL----------FDP----TK----REILDWRTRV----------QIIKGVAQGLLYLHQY----SRV  229 (432)
Q Consensus       186 ~~~gsL~~----~l----------~~~----~~----~~~l~~~~~~----------~i~~qi~~~l~~LH~~----~~~  229 (432)
                      ++|..+..    ..          +..    ..    .....|....          .....+..++.++...    -..
T Consensus        96 i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~  175 (296)
T cd05153          96 LAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR  175 (296)
T ss_pred             CCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence            99877532    00          100    00    0111221110          0111223344454431    123


Q ss_pred             CeEeccCCCCCEEEcCCCCEEEeeccccee
Q 014024          230 RIIHRDLKASNILLDKDMNSKISDFGMARI  259 (432)
Q Consensus       230 ~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  259 (432)
                      .++|+|+.|.||++++++...|.||+.+..
T Consensus       176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         176 GVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             cCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            499999999999999987778999988753

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK05231 homoserine kinase; Provisional

Probab=97.92  E-value=0.0003  Score=67.49  Aligned_cols=143  Identities=18%  Similarity=0.196  Sum_probs=78.5

Q ss_pred             CceeccCCcEEEEEEEECCceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCc--eeeeEe------EEEeCCeeEEEEec
Q 014024          114 ANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKN--LVKLLG------CCIEKDERLLIYEY  185 (432)
Q Consensus       114 ~~~ig~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~------~~~~~~~~~lv~e~  185 (432)
                      .+.|+.|....+|+....++.+++|++....   .+.+..|+.++..+...+  +.+.+.      +....+..++++||
T Consensus        27 ~~~l~~G~~n~~y~v~t~~g~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~  103 (319)
T PRK05231         27 LKGIAEGIENSNFFLTTTQGEYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF  103 (319)
T ss_pred             cchhccccccceEEEEeCCCcEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence            3456677778899988877789999875222   233445566666653211  333332      12234567899999


Q ss_pred             CCCCChhh-----------hh---cCCCC--------CCCCCH-HHHHH------------HHHH-HHHHHHHHHhc---
Q 014024          186 MPNKSLDC-----------FL---FDPTK--------REILDW-RTRVQ------------IIKG-VAQGLLYLHQY---  226 (432)
Q Consensus       186 ~~~gsL~~-----------~l---~~~~~--------~~~l~~-~~~~~------------i~~q-i~~~l~~LH~~---  226 (432)
                      ++|..+..           .+   +....        ...+.| .....            .+.+ +...+..+...   
T Consensus       104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  183 (319)
T PRK05231        104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP  183 (319)
T ss_pred             cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence            99875421           11   11000        000111 11111            1111 11122233211   


Q ss_pred             -CCCCeEeccCCCCCEEEcCCCCEEEeeccccee
Q 014024          227 -SRVRIIHRDLKASNILLDKDMNSKISDFGMARI  259 (432)
Q Consensus       227 -~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  259 (432)
                       -+.+++|+|+.|.||+++++...-+.||+.+..
T Consensus       184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             cCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence             123599999999999998766568999998854

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.86  E-value=0.00011  Score=73.88  Aligned_cols=139  Identities=15%  Similarity=0.178  Sum_probs=86.0

Q ss_pred             ceeccCCcEEEEEEEECCc-eEEEEEEcCCChH-------------------------------hHHH------HHHHHH
Q 014024          115 NKLGEGGFGTVYKGVIGQG-EIAVKRLLGKSGQ-------------------------------EIKE------LKNEAS  156 (432)
Q Consensus       115 ~~ig~G~~g~Vy~~~~~~~-~vavK~~~~~~~~-------------------------------~~~~------~~~E~~  156 (432)
                      +.||.-+.|.||+|+..++ .||||+-.+.-..                               -.+.      |.+|++
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            6799999999999999777 7999987544211                               1111      333444


Q ss_pred             HHHhc----CCCc---eeeeEeEEE-eCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 014024          157 VIAQV----QHKN---LVKLLGCCI-EKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSR  228 (432)
Q Consensus       157 ~l~~l----~h~n---iv~~~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~  228 (432)
                      ...++    .|-+   =|.+=.++. -.....|+|||++|..+.|.-.-  .+..++...+..-+.+...  ..|=..| 
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i--~~~gi~~~~i~~~l~~~~~--~qIf~~G-  321 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI--DKRGISPHDILNKLVEAYL--EQIFKTG-  321 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH--HHcCCCHHHHHHHHHHHHH--HHHHhcC-
Confidence            43333    3434   111222222 23467899999999888766421  1122555544333333221  2222345 


Q ss_pred             CCeEeccCCCCCEEEcC----CCCEEEeecccceec
Q 014024          229 VRIIHRDLKASNILLDK----DMNSKISDFGMARIV  260 (432)
Q Consensus       229 ~~ivH~Dlkp~NIll~~----~~~~kl~Dfg~a~~~  260 (432)
                        ++|+|=.|.||+++.    ++.+.+.|||+...+
T Consensus       322 --ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i  355 (538)
T KOG1235|consen  322 --FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI  355 (538)
T ss_pred             --CccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence              999999999999984    678999999998764

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.85  E-value=0.00026  Score=69.30  Aligned_cols=75  Identities=17%  Similarity=0.284  Sum_probs=53.4

Q ss_pred             CceeccCCcEEEEEEEECCc--eEEEEEEcCC------C-hHhHHHHHHHHHHHHhcC---CCceeeeEeEEEeCCeeEE
Q 014024          114 ANKLGEGGFGTVYKGVIGQG--EIAVKRLLGK------S-GQEIKELKNEASVIAQVQ---HKNLVKLLGCCIEKDERLL  181 (432)
Q Consensus       114 ~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~------~-~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~l  181 (432)
                      .+.||.|.+..||+..+.++  .++||.-...      . ....+....|.+.|+.+.   -.++.+++.+  +.+..++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            36799999999999998775  7999975321      1 123456777888888763   2356666666  4456789


Q ss_pred             EEecCCCCC
Q 014024          182 IYEYMPNKS  190 (432)
Q Consensus       182 v~e~~~~gs  190 (432)
                      ||||+++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999998743

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.82  E-value=0.00023  Score=65.05  Aligned_cols=140  Identities=21%  Similarity=0.261  Sum_probs=80.1

Q ss_pred             ceeccCCcEEEEEEEEC---CceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCce-eeeEeEEEeCCeeEEEEecCCCCC
Q 014024          115 NKLGEGGFGTVYKGVIG---QGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNL-VKLLGCCIEKDERLLIYEYMPNKS  190 (432)
Q Consensus       115 ~~ig~G~~g~Vy~~~~~---~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~gs  190 (432)
                      +.|..|-...+|+....   +..+++|....... ......+|+.+++.+...++ .++++.+.    ..++|||++|.+
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~   78 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT   78 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence            56777888899998876   35788886643322 22234578889988854333 34444332    247999999977


Q ss_pred             hhhh-------h----------cCCCCC--------CCCC-HHHHHHHHH----------------------HHHHHHHH
Q 014024          191 LDCF-------L----------FDPTKR--------EILD-WRTRVQIIK----------------------GVAQGLLY  222 (432)
Q Consensus       191 L~~~-------l----------~~~~~~--------~~l~-~~~~~~i~~----------------------qi~~~l~~  222 (432)
                      +...       +          +.....        .... +.....+..                      .+...+..
T Consensus        79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  158 (235)
T cd05157          79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW  158 (235)
T ss_pred             CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence            6321       0          111110        0111 112111111                      11111112


Q ss_pred             H----Hhc-CCCCeEeccCCCCCEEEcC-CCCEEEeeccccee
Q 014024          223 L----HQY-SRVRIIHRDLKASNILLDK-DMNSKISDFGMARI  259 (432)
Q Consensus       223 L----H~~-~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~~  259 (432)
                      |    ... ....++|+|+.+.|||+++ ++.+.++||..+..
T Consensus       159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~  201 (235)
T cd05157         159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY  201 (235)
T ss_pred             HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence            1    111 2345999999999999998 57899999988753

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.80  E-value=0.00032  Score=66.99  Aligned_cols=144  Identities=17%  Similarity=0.185  Sum_probs=83.5

Q ss_pred             CceeccCCcEEEEEEEECCceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCc--eeeeEeE------EEeCCeeEEEEec
Q 014024          114 ANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKN--LVKLLGC------CIEKDERLLIYEY  185 (432)
Q Consensus       114 ~~~ig~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~------~~~~~~~~lv~e~  185 (432)
                      .+.++.|....+|+....++.+++|+......  .+.+..|.+++..+...+  +.+++..      ....+..++++||
T Consensus        27 i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~  104 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVGRYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEF  104 (307)
T ss_pred             ccccCCccccceEEEEeCCCcEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEe
Confidence            45677777789999887777888887644321  234556777777774322  3343331      1223556899999


Q ss_pred             CCCCChhhh--------------hcCCCC----C--C---CCCHHHHH------------HHHHHHHHHHHHHHh----c
Q 014024          186 MPNKSLDCF--------------LFDPTK----R--E---ILDWRTRV------------QIIKGVAQGLLYLHQ----Y  226 (432)
Q Consensus       186 ~~~gsL~~~--------------l~~~~~----~--~---~l~~~~~~------------~i~~qi~~~l~~LH~----~  226 (432)
                      ++|..+...              ++....    .  .   .-.|....            .....+.+.++++..    .
T Consensus       105 i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~  184 (307)
T TIGR00938       105 LQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRD  184 (307)
T ss_pred             CCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhc
Confidence            988654210              011000    0  0   01111110            001123334555543    1


Q ss_pred             CCCCeEeccCCCCCEEEcCCCCEEEeeccccee
Q 014024          227 SRVRIIHRDLKASNILLDKDMNSKISDFGMARI  259 (432)
Q Consensus       227 ~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  259 (432)
                      .+..++|+|+.+.||++++++...|.||+.+..
T Consensus       185 ~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       185 LPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             CCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence            234599999999999999888778999998753

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.60  E-value=0.00087  Score=63.43  Aligned_cols=139  Identities=18%  Similarity=0.239  Sum_probs=89.6

Q ss_pred             CcCceeccCCcEEEEEEEECCceEEEEEEc--CCChHhHHHHHHHHHHHHhcCC--CceeeeEeEEEeCC--eeEEEEec
Q 014024          112 SAANKLGEGGFGTVYKGVIGQGEIAVKRLL--GKSGQEIKELKNEASVIAQVQH--KNLVKLLGCCIEKD--ERLLIYEY  185 (432)
Q Consensus       112 ~~~~~ig~G~~g~Vy~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~--~~~lv~e~  185 (432)
                      .+.+.+..|..-.+|.....+.++++. ..  ...........+|..+++.+.-  --+...+++|.++.  ..+.||+|
T Consensus        28 ~~v~~~~~G~sn~t~~~~~~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~  106 (321)
T COG3173          28 LIVEEISGGWSNDTFRLGDTGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEW  106 (321)
T ss_pred             ceeeeccCCcccceEEEecCCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEE
Confidence            344555445555566666666677777 32  1223344556778888887743  33455677777766  67999999


Q ss_pred             CCCCChhhhhcCCCCCCCCCHHHHHHHH-HHHHHHHHHHHhcC-------------------------------------
Q 014024          186 MPNKSLDCFLFDPTKREILDWRTRVQII-KGVAQGLLYLHQYS-------------------------------------  227 (432)
Q Consensus       186 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~-~qi~~~l~~LH~~~-------------------------------------  227 (432)
                      ++|..+.+.+..    ....    .+++ ..++..|+.||+-.                                     
T Consensus       107 veGe~~~~~~~~----~~~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p  178 (321)
T COG3173         107 VEGEVVWSALPP----ESLG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIP  178 (321)
T ss_pred             ecceeccCcCCc----ccch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCc
Confidence            998644333311    1011    1222 35666666666432                                     


Q ss_pred             ------------------CCCeEeccCCCCCEEEcCCCCEEEeeccccee
Q 014024          228 ------------------RVRIIHRDLKASNILLDKDMNSKISDFGMARI  259 (432)
Q Consensus       228 ------------------~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  259 (432)
                                        .+.++|||+.+.|+++++++-+-+.||+++..
T Consensus       179 ~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         179 LADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             hHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence                              25799999999999999988899999999975

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.53  E-value=0.00071  Score=64.36  Aligned_cols=140  Identities=24%  Similarity=0.292  Sum_probs=81.5

Q ss_pred             ceeccCCcEEEEEEEECC--------ceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCcee-eeEeEEEeCCeeEEEEec
Q 014024          115 NKLGEGGFGTVYKGVIGQ--------GEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLV-KLLGCCIEKDERLLIYEY  185 (432)
Q Consensus       115 ~~ig~G~~g~Vy~~~~~~--------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~  185 (432)
                      +.+..|-...+|+....+        ..+++|...... .......+|.+++..+...++. ++++++..    .+|+||
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~   78 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF   78 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence            445566667888887654        478888864433 2334567888888888543333 44555432    358999


Q ss_pred             CCCCChhhhh-----------------cCCCCCC------CCC--HHHHHH--------------------------HHH
Q 014024          186 MPNKSLDCFL-----------------FDPTKRE------ILD--WRTRVQ--------------------------IIK  214 (432)
Q Consensus       186 ~~~gsL~~~l-----------------~~~~~~~------~l~--~~~~~~--------------------------i~~  214 (432)
                      ++|..+....                 +......      ..+  +.....                          +..
T Consensus        79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (302)
T cd05156          79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE  158 (302)
T ss_pred             eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence            9987764311                 1111110      111  111111                          111


Q ss_pred             HHHHHHHHHHh------cCCCCeEeccCCCCCEEEcCC----CCEEEeeccccee
Q 014024          215 GVAQGLLYLHQ------YSRVRIIHRDLKASNILLDKD----MNSKISDFGMARI  259 (432)
Q Consensus       215 qi~~~l~~LH~------~~~~~ivH~Dlkp~NIll~~~----~~~kl~Dfg~a~~  259 (432)
                      .+...+..|-.      .....++|+|+.|.||+++++    +.+.++||+.+..
T Consensus       159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence            22222334432      134469999999999999985    8899999988853

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.47  E-value=2e-05  Score=85.86  Aligned_cols=161  Identities=14%  Similarity=0.043  Sum_probs=114.2

Q ss_pred             HHHHHHHHHHHhcCCCceeeeEeEEEe--CCeeEEEEecCCCCChhhhhcCCCCCC-CCCHHHHHHHHHHH-HHHHHHHH
Q 014024          149 KELKNEASVIAQVQHKNLVKLLGCCIE--KDERLLIYEYMPNKSLDCFLFDPTKRE-ILDWRTRVQIIKGV-AQGLLYLH  224 (432)
Q Consensus       149 ~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~-~l~~~~~~~i~~qi-~~~l~~LH  224 (432)
                      +....|.+-++...|+++.....-...  ....+.+++|+.+|.+.+.+-....+. .++..- ....+++ ..+..-+|
T Consensus      1274 emll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~-v~~~~kvsvl~~~~~l 1352 (2724)
T KOG1826|consen 1274 EMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSP-VHLRHKVSVLNRNVIL 1352 (2724)
T ss_pred             HhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhch-HHHHHHHHHhccchhh
Confidence            334445555666789888776665533  345688999999999999886544432 233322 2233333 55555555


Q ss_pred             hcC--CCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHH
Q 014024          225 QYS--RVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSF  302 (432)
Q Consensus       225 ~~~--~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSl  302 (432)
                      +..  ....+|+++|+.|.++..+..+|++++|+.+....      .........+++-|++|++...-.++.++|+|..
T Consensus      1353 s~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp------~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~ 1426 (2724)
T KOG1826|consen 1353 SLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP------VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRR 1426 (2724)
T ss_pred             hcccCCccchhhhhhhhccceecCCcccccccccccccCc------hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHH
Confidence            433  23478999999999999999999999999984211      1223344567788999999888889999999999


Q ss_pred             HHHHHHHHhCCCCC
Q 014024          303 GVLLLEIVSGKKNT  316 (432)
Q Consensus       303 G~il~elltg~~p~  316 (432)
                      |+-+|+..-|..++
T Consensus      1427 s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1427 SLSLYLRSDGNAYF 1440 (2724)
T ss_pred             HHHHHHHhcccHHH
Confidence            99999999888775

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.40  E-value=0.0013  Score=61.79  Aligned_cols=74  Identities=15%  Similarity=0.186  Sum_probs=49.6

Q ss_pred             cCceeccCCcEEEEEEEECCceEEEEEEcCCChHhHHHHHHHHHHHHhcC---CCceeeeEeEEEeCCeeEEEEecCCCC
Q 014024          113 AANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQ---HKNLVKLLGCCIEKDERLLIYEYMPNK  189 (432)
Q Consensus       113 ~~~~ig~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~g  189 (432)
                      -.+.++-|....+|+....++.+.+|.-.   ......|..|++-|+.+.   --.+.+.+++....+..++++||++.+
T Consensus        21 ~~~~v~GG~i~~a~~~~~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~   97 (288)
T PF03881_consen   21 SIEPVSGGDINEAYRLDTDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG   97 (288)
T ss_dssp             EEEEE--SSSSEEEEEETTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred             eeEecCCCChhheEEEECCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence            34678889999999988777799999876   233456888888888884   345778888888777789999999877

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.20  E-value=0.0053  Score=60.13  Aligned_cols=73  Identities=16%  Similarity=0.208  Sum_probs=51.5

Q ss_pred             CceeccCCcEEEEEEEECCceEEEEEEcCCC----h---HhHHHHHHHHHHHHhcC---CCceeeeEeEEEeCCeeEEEE
Q 014024          114 ANKLGEGGFGTVYKGVIGQGEIAVKRLLGKS----G---QEIKELKNEASVIAQVQ---HKNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       114 ~~~ig~G~~g~Vy~~~~~~~~vavK~~~~~~----~---~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~  183 (432)
                      .+.||-|....||+..+.++.++||.-....    .   .....-..|++.|+.+.   ..++.+++.++.  +..+++|
T Consensus        37 ~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlvM  114 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIGM  114 (418)
T ss_pred             EEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEEE
Confidence            5778999999999988877789999764211    1   12334445677777664   246778888876  4467889


Q ss_pred             ecCCC
Q 014024          184 EYMPN  188 (432)
Q Consensus       184 e~~~~  188 (432)
                      ||+++
T Consensus       115 E~L~~  119 (418)
T PLN02756        115 RYLEP  119 (418)
T ss_pred             eecCC
Confidence            99977

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=97.19  E-value=0.0075  Score=57.60  Aligned_cols=31  Identities=23%  Similarity=0.356  Sum_probs=28.0

Q ss_pred             CCeEeccCCCCCEEEcCCCCEEEeeccccee
Q 014024          229 VRIIHRDLKASNILLDKDMNSKISDFGMARI  259 (432)
Q Consensus       229 ~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  259 (432)
                      ..++|+|+.++|+++++++.+.++||..+..
T Consensus       196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       196 TVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            3599999999999999999999999988864

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.15  E-value=0.0072  Score=56.62  Aligned_cols=31  Identities=29%  Similarity=0.602  Sum_probs=25.8

Q ss_pred             CCeEeccCCCCCEEEcCCCC-EEEeeccccee
Q 014024          229 VRIIHRDLKASNILLDKDMN-SKISDFGMARI  259 (432)
Q Consensus       229 ~~ivH~Dlkp~NIll~~~~~-~kl~Dfg~a~~  259 (432)
                      ..++|+|++|.||++++++. .-|.||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            34899999999999997555 46999998864

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02236 choline kinase

Probab=97.13  E-value=0.004  Score=60.36  Aligned_cols=140  Identities=16%  Similarity=0.192  Sum_probs=79.3

Q ss_pred             ceeccCCcEEEEEEEECC------ceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCcee-eeEeEEEeCCeeEEEEecCC
Q 014024          115 NKLGEGGFGTVYKGVIGQ------GEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLV-KLLGCCIEKDERLLIYEYMP  187 (432)
Q Consensus       115 ~~ig~G~~g~Vy~~~~~~------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~  187 (432)
                      +.+-.|-.-.+|+....+      ..+++|..........+ ..+|..+++.+...++. ++++.+..+    .|+||++
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~  116 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH  116 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence            345457777888876422      36778876544333222 36788999888654443 455555332    5799998


Q ss_pred             CCChhhh-----------------hcCCC--C-CCCCCHHHHHHHHHHH-----------------HHHHHHHH----h-
Q 014024          188 NKSLDCF-----------------LFDPT--K-REILDWRTRVQIIKGV-----------------AQGLLYLH----Q-  225 (432)
Q Consensus       188 ~gsL~~~-----------------l~~~~--~-~~~l~~~~~~~i~~qi-----------------~~~l~~LH----~-  225 (432)
                      +.++...                 ++...  . .....+.....+..++                 ...+..|.    . 
T Consensus       117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~  196 (344)
T PLN02236        117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD  196 (344)
T ss_pred             CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence            7776421                 11111  0 1111122222332211                 11122222    1 


Q ss_pred             cCCCCeEeccCCCCCEEEcC-CCCEEEeeccccee
Q 014024          226 YSRVRIIHRDLKASNILLDK-DMNSKISDFGMARI  259 (432)
Q Consensus       226 ~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~~  259 (432)
                      .....++|+|+++.||++++ ++.+.++||..+..
T Consensus       197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            12335999999999999986 47899999988864

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.01  E-value=0.00095  Score=62.37  Aligned_cols=140  Identities=16%  Similarity=0.173  Sum_probs=92.9

Q ss_pred             hHhhhhCCCCcCceeccCCcEEEEEEEECCc-eEEEEEEcCCC-----------------hH-----hHHHHHHHHHHHH
Q 014024          103 SVSSATGNFSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKS-----------------GQ-----EIKELKNEASVIA  159 (432)
Q Consensus       103 ~~~~~~~~y~~~~~ig~G~~g~Vy~~~~~~~-~vavK~~~~~~-----------------~~-----~~~~~~~E~~~l~  159 (432)
                      .+..-..-+..++.||-|.-+.+|.+-+..+ +.++|.-....                 ..     ..-...+|...|+
T Consensus        86 tL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmk  165 (465)
T KOG2268|consen   86 TLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMK  165 (465)
T ss_pred             HHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHH
Confidence            3333344567889999999999999998754 66766321110                 00     1112456888888


Q ss_pred             hcCC-C-ceeeeEeEEEeCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCC
Q 014024          160 QVQH-K-NLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLK  237 (432)
Q Consensus       160 ~l~h-~-niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlk  237 (432)
                      .+.. . -+.+.+++    +..++|||++.+-.|...-      ...+..+   +...+..-+--|-.+|   +||||..
T Consensus       166 aL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~------~v~d~~~---ly~~lm~~Iv~la~~G---lIHgDFN  229 (465)
T KOG2268|consen  166 ALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVR------HVEDPPT---LYDDLMGLIVRLANHG---LIHGDFN  229 (465)
T ss_pred             HHHHcCCCCCCcccc----cceeeHHHhhcccceeeee------ecCChHH---HHHHHHHHHHHHHHcC---ceecccc
Confidence            8743 2 23444443    3558999999988876442      1123333   3444445566677788   9999999


Q ss_pred             CCCEEEcCCCCEEEeecccce
Q 014024          238 ASNILLDKDMNSKISDFGMAR  258 (432)
Q Consensus       238 p~NIll~~~~~~kl~Dfg~a~  258 (432)
                      -=||++++++.++++||--..
T Consensus       230 EFNimv~dd~~i~vIDFPQmv  250 (465)
T KOG2268|consen  230 EFNIMVKDDDKIVVIDFPQMV  250 (465)
T ss_pred             hheeEEecCCCEEEeechHhh
Confidence            999999999999999996543

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.91  E-value=0.012  Score=56.06  Aligned_cols=140  Identities=16%  Similarity=0.192  Sum_probs=93.8

Q ss_pred             CcCceeccCCcEEEEEEEECCc-eEEEEEEcCC-------------------------ChHhH-HHHHHHHHHHHhcCCC
Q 014024          112 SAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGK-------------------------SGQEI-KELKNEASVIAQVQHK  164 (432)
Q Consensus       112 ~~~~~ig~G~~g~Vy~~~~~~~-~vavK~~~~~-------------------------~~~~~-~~~~~E~~~l~~l~h~  164 (432)
                      .+...|..|--+.||.+...++ .+|||++.-.                         ..... --...|++-|.+++..
T Consensus       147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            4456788899999999987666 7899976311                         01111 1245788999998765


Q ss_pred             ceeeeEeEEEeCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEc
Q 014024          165 NLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLD  244 (432)
Q Consensus       165 niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~  244 (432)
                      .|.----+..  ...+|||+|+....   |.......-.++...+..+-.|++.-+.-|.+.+  .+||.||+--|+|+-
T Consensus       227 GIP~PePIlL--k~hVLVM~FlGrdg---w~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh  299 (520)
T KOG2270|consen  227 GIPCPEPILL--KNHVLVMEFLGRDG---WAAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH  299 (520)
T ss_pred             CCCCCCceee--ecceEeeeeccCCC---CcCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE
Confidence            5322111111  23479999996432   2222233445777777777788888888887766  599999999999984


Q ss_pred             CCCCEEEeeccccee
Q 014024          245 KDMNSKISDFGMARI  259 (432)
Q Consensus       245 ~~~~~kl~Dfg~a~~  259 (432)
                       +|.+.++|-+-+.-
T Consensus       300 -dG~lyiIDVSQSVE  313 (520)
T KOG2270|consen  300 -DGKLYIIDVSQSVE  313 (520)
T ss_pred             -CCEEEEEEcccccc
Confidence             56899999876643

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.81  E-value=0.018  Score=54.84  Aligned_cols=64  Identities=16%  Similarity=0.213  Sum_probs=40.0

Q ss_pred             EEEEEEECCceEEEEEEcCCChHhHHHHHHHHHHHHhcCCC--ceeeeEeE------EEeCCeeEEEEecCCCCCh
Q 014024          124 TVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHK--NLVKLLGC------CIEKDERLLIYEYMPNKSL  191 (432)
Q Consensus       124 ~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~------~~~~~~~~lv~e~~~~gsL  191 (432)
                      .||+....++.+++|+....    ...+..|+..+..+...  .+++++..      ...++..++++||++|..+
T Consensus        11 ~v~~v~t~~g~~~LK~~~~~----~~~~~~~~~~~~~L~~~g~~vp~~i~t~~g~~~~~~~~~~~~l~~~i~G~~~   82 (313)
T TIGR02906        11 NVYKVETDSGNKCLKKINYP----PERLLFILGAQEHLRKNGFNIPKILKTKDGELYVKYNGDLYVLTEWIEGREC   82 (313)
T ss_pred             cEEEEEeCCCCeEEEEcCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEehhccCcCC
Confidence            48998877778999987432    12345566666666432  23333321      2235567899999998665

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=96.77  E-value=0.025  Score=50.54  Aligned_cols=75  Identities=19%  Similarity=0.333  Sum_probs=56.7

Q ss_pred             ceeccCCcEEEEEEEECCceEEEEEEcCCChHhHHHHHHHHHHHHhcC---CCceeeeEeEEEeCCeeEEEEecCCCCCh
Q 014024          115 NKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQ---HKNLVKLLGCCIEKDERLLIYEYMPNKSL  191 (432)
Q Consensus       115 ~~ig~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~gsL  191 (432)
                      +.+.-|.--..|...+...++.+|.-   .......|..|+.-|..+.   --.+.+++.+-.+..+.|+|+||++.+.+
T Consensus        22 ~~v~gG~inea~~v~dg~~~~FvK~n---~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~   98 (286)
T COG3001          22 EEVSGGDINEAWRLRDGTDPFFVKCN---QREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPL   98 (286)
T ss_pred             cccCCccccceeEeecCCcceEEEec---chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCC
Confidence            44555666677877777778999864   3345567888887777774   35678888888889999999999998777


Q ss_pred             h
Q 014024          192 D  192 (432)
Q Consensus       192 ~  192 (432)
                      +
T Consensus        99 d   99 (286)
T COG3001          99 D   99 (286)
T ss_pred             C
Confidence            5

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.66  E-value=0.012  Score=56.66  Aligned_cols=140  Identities=16%  Similarity=0.245  Sum_probs=77.6

Q ss_pred             ceeccCCcEEEEEEEECCc-----eEEEEEEcCCChHhHHHHHHHHHHHHhcCCCcee-eeEeEEEeCCeeEEEEecCCC
Q 014024          115 NKLGEGGFGTVYKGVIGQG-----EIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLV-KLLGCCIEKDERLLIYEYMPN  188 (432)
Q Consensus       115 ~~ig~G~~g~Vy~~~~~~~-----~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~  188 (432)
                      +.|..|=...+|+....+.     .+++|........ .-.-.+|..+++.+...++. ++++++. .+   +|.+|+++
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g   94 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA   94 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence            3444466677887765432     6777776544332 22346788898888655543 4555552 22   58999987


Q ss_pred             CChhhh-------h----------cCCC---CCCCCCHHHHHHHHHHH----------------------HHHHHHHHh-
Q 014024          189 KSLDCF-------L----------FDPT---KREILDWRTRVQIIKGV----------------------AQGLLYLHQ-  225 (432)
Q Consensus       189 gsL~~~-------l----------~~~~---~~~~l~~~~~~~i~~qi----------------------~~~l~~LH~-  225 (432)
                      ..+..-       +          +...   ...+-.+.....+..++                      .+-+..+.. 
T Consensus        95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~  174 (330)
T PLN02421         95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI  174 (330)
T ss_pred             CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence            765321       1          1111   01111223222222221                      111222211 


Q ss_pred             ----cCCCCeEeccCCCCCEEEcC-CCCEEEeeccccee
Q 014024          226 ----YSRVRIIHRDLKASNILLDK-DMNSKISDFGMARI  259 (432)
Q Consensus       226 ----~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~~  259 (432)
                          ..+..++|+|+.+.||++++ ++.++++||..|..
T Consensus       175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence                11234899999999999975 57899999998854

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.54  E-value=0.0042  Score=55.70  Aligned_cols=30  Identities=40%  Similarity=0.568  Sum_probs=21.8

Q ss_pred             CeEeccCCCCCEEE-cCCCCEEEeeccccee
Q 014024          230 RIIHRDLKASNILL-DKDMNSKISDFGMARI  259 (432)
Q Consensus       230 ~ivH~Dlkp~NIll-~~~~~~kl~Dfg~a~~  259 (432)
                      .++|+|+.|.||++ +.++.++++||..+..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            49999999999999 8899999999998865

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.45  E-value=0.02  Score=50.88  Aligned_cols=152  Identities=18%  Similarity=0.131  Sum_probs=90.1

Q ss_pred             CcEEEEEEEECCceEEEEEEcCCChH-hHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecCCCCChhhhhcCCC
Q 014024          121 GFGTVYKGVIGQGEIAVKRLLGKSGQ-EIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPT  199 (432)
Q Consensus       121 ~~g~Vy~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~  199 (432)
                      +-++.-.+...-++..+|++..-.-. ...-+.++.+++++++  .|+++..-  +.-..-++.|+|-.-..        
T Consensus        74 gNsTl~~~kt~iG~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i--------  141 (308)
T PF07387_consen   74 GNSTLLIGKTKIGPLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI--------  141 (308)
T ss_pred             CceEEEEeccccchhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc--------
Confidence            33444444444456667776433222 3345678888888875  36666522  33345688898843211        


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCcccccccccccccc
Q 014024          200 KREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGT  279 (432)
Q Consensus       200 ~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt  279 (432)
                          ..   .-.|..+ +.+|.-.|+.+ ...+|||-.|+||+-|..|.+||.|-+.-..                  .+
T Consensus       142 ----~~---~N~i~ag-i~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~------------------~~  194 (308)
T PF07387_consen  142 ----NF---SNFITAG-IKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE------------------NQ  194 (308)
T ss_pred             ----ch---hHHHHHh-HHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhhhh------------------he
Confidence                11   1112222 36678888543 3599999999999999999999999764321                  01


Q ss_pred             CCccChhhhccCCCCchhhhHHHHHHHHHHHhCCC
Q 014024          280 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK  314 (432)
Q Consensus       280 ~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~  314 (432)
                      ..|.-   ......|.++.+-+|=.-++++....+
T Consensus       195 V~~vN---~~Y~~lT~~aE~~~fv~s~l~~v~~~~  226 (308)
T PF07387_consen  195 VNMVN---IEYESLTQEAEVKVFVKSCLKLVEKQR  226 (308)
T ss_pred             eeEEe---eeccccChHHHHHHHHHHHHHHHHHHh
Confidence            11222   112446777888788777777776543

The function of this family is unknown.

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.40  E-value=0.033  Score=53.70  Aligned_cols=72  Identities=15%  Similarity=0.285  Sum_probs=46.6

Q ss_pred             eeccCCcEEEEEEEECCc--eEEEEEEcCC------C-hHhHHHHHHHHHHHHhcC--CCc-eeeeEeEEEeCCeeEEEE
Q 014024          116 KLGEGGFGTVYKGVIGQG--EIAVKRLLGK------S-GQEIKELKNEASVIAQVQ--HKN-LVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       116 ~ig~G~~g~Vy~~~~~~~--~vavK~~~~~------~-~~~~~~~~~E~~~l~~l~--h~n-iv~~~~~~~~~~~~~lv~  183 (432)
                      .||-|....||++.+.++  .++||.-...      + .-..++..-|.+.|+...  .|. +.+++.  .+++...+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence            479999999999998753  7899865311      1 223445556778887663  343 334433  3445667899


Q ss_pred             ecCCCC
Q 014024          184 EYMPNK  189 (432)
Q Consensus       184 e~~~~g  189 (432)
                      |+++..
T Consensus        80 EdL~~~   85 (370)
T TIGR01767        80 EDLSHH   85 (370)
T ss_pred             hhCccc
Confidence            998653

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.36  E-value=0.048  Score=52.26  Aligned_cols=141  Identities=21%  Similarity=0.245  Sum_probs=82.8

Q ss_pred             eeccCCcEEEEEEEECCceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCc------eeeeEeEE----EeCCeeEEEEec
Q 014024          116 KLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKN------LVKLLGCC----IEKDERLLIYEY  185 (432)
Q Consensus       116 ~ig~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~~----~~~~~~~lv~e~  185 (432)
                      .|.+ .-..+|+....++.+++|.....  ....++..|...|..+.-.+      +...-|-.    ..+...+-+++|
T Consensus        33 ~l~s-~eN~~f~~~~~~g~~iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~  109 (331)
T COG2334          33 GLNS-EENSNFRVQTEDGRYILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY  109 (331)
T ss_pred             cccc-ccCceEEEEecCCCeEEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence            3444 55679999988888888887665  34456677788887773211      22222211    112366789999


Q ss_pred             CCCCChhh-hh------------------cCC-----CCCCCCCHHH-------------HHHHHHHHHHHHHHHHhc--
Q 014024          186 MPNKSLDC-FL------------------FDP-----TKREILDWRT-------------RVQIIKGVAQGLLYLHQY--  226 (432)
Q Consensus       186 ~~~gsL~~-~l------------------~~~-----~~~~~l~~~~-------------~~~i~~qi~~~l~~LH~~--  226 (432)
                      ++|..+.. .-                  .+.     .......|..             ......++...+..+.+.  
T Consensus       110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~  189 (331)
T COG2334         110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP  189 (331)
T ss_pred             cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence            99988773 11                  000     0011123320             001223334444444432  


Q ss_pred             --CCC-C--eEeccCCCCCEEEcCCCC-EEEeeccccee
Q 014024          227 --SRV-R--IIHRDLKASNILLDKDMN-SKISDFGMARI  259 (432)
Q Consensus       227 --~~~-~--ivH~Dlkp~NIll~~~~~-~kl~Dfg~a~~  259 (432)
                        -.. +  +||+|+.|.||+++++.. ..+.||+.+..
T Consensus       190 ~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~  228 (331)
T COG2334         190 AHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY  228 (331)
T ss_pred             hhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence              112 2  899999999999999885 89999998853

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.29  E-value=0.011  Score=57.52  Aligned_cols=73  Identities=12%  Similarity=0.174  Sum_probs=48.8

Q ss_pred             CceeccCCcEEEEEEEEC--CceEEEEEEcCC-----C-hHhHHHHHHHHHHHHhcC--CCc-eeeeEeEEEeCCeeEEE
Q 014024          114 ANKLGEGGFGTVYKGVIG--QGEIAVKRLLGK-----S-GQEIKELKNEASVIAQVQ--HKN-LVKLLGCCIEKDERLLI  182 (432)
Q Consensus       114 ~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~-----~-~~~~~~~~~E~~~l~~l~--h~n-iv~~~~~~~~~~~~~lv  182 (432)
                      .+.||-|.-..||++.+.  ++.++||.-...     + .-..++..-|.+.|+...  .|. +.+++.+  +++...+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            567899999999999975  457999865321     1 223456667788888763  354 4444433  44566789


Q ss_pred             EecCCC
Q 014024          183 YEYMPN  188 (432)
Q Consensus       183 ~e~~~~  188 (432)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            999865

>PTZ00384 choline kinase; Provisional

Probab=95.76  E-value=0.077  Score=52.10  Aligned_cols=74  Identities=14%  Similarity=0.284  Sum_probs=44.7

Q ss_pred             CceeccCCcEEEEEEEECCc---e-----EEEEEEcCCChHhHHHHHHHHHHHHhcCCCceee-eEeEEEeCCeeEEEEe
Q 014024          114 ANKLGEGGFGTVYKGVIGQG---E-----IAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVK-LLGCCIEKDERLLIYE  184 (432)
Q Consensus       114 ~~~ig~G~~g~Vy~~~~~~~---~-----vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-~~~~~~~~~~~~lv~e  184 (432)
                      .+.|..|-...+|++...+.   .     |.++.. .......-.-.+|.++++.+...++.+ +++.+..    .+++|
T Consensus        55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~-g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~e  129 (383)
T PTZ00384         55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKS-STYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQE  129 (383)
T ss_pred             EEEeCCcccceEEEEEecCCCCCccccceEEEEec-cCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEE
Confidence            34565688888999875432   2     333332 222222223467899999997655444 5555532    58999


Q ss_pred             cCCCCChh
Q 014024          185 YMPNKSLD  192 (432)
Q Consensus       185 ~~~~gsL~  192 (432)
                      |++|.+|.
T Consensus       130 fIeGr~l~  137 (383)
T PTZ00384        130 WVEGNTMG  137 (383)
T ss_pred             EeccccCC
Confidence            99998764

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.71  E-value=0.074  Score=50.88  Aligned_cols=73  Identities=19%  Similarity=0.196  Sum_probs=55.5

Q ss_pred             CeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeeccc
Q 014024          177 DERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGM  256 (432)
Q Consensus       177 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  256 (432)
                      ...|++|++. |+++.-       .....+.+...++.+-+..++-+...-  +.-|||+.-.|||++ +|++.|+||-+
T Consensus       299 ~y~yl~~kdh-gt~is~-------ik~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfkl  367 (488)
T COG5072         299 LYLYLHFKDH-GTPISI-------IKADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKL  367 (488)
T ss_pred             eEEEEEEecC-Cceeee-------eecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeee
Confidence            3456777765 444421       122567888888888887777777654  588999999999999 99999999999


Q ss_pred             ceec
Q 014024          257 ARIV  260 (432)
Q Consensus       257 a~~~  260 (432)
                      ++.-
T Consensus       368 sRl~  371 (488)
T COG5072         368 SRLS  371 (488)
T ss_pred             eecc
Confidence            9853

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.61  E-value=0.4  Score=46.11  Aligned_cols=71  Identities=13%  Similarity=0.087  Sum_probs=42.0

Q ss_pred             CCcEEEEEEEECCc-eEEEEEEcCCChHhHHHHHHHHHHHHhcCCCc--eeeeE---e--EEEeCCeeEEEEecCCCCCh
Q 014024          120 GGFGTVYKGVIGQG-EIAVKRLLGKSGQEIKELKNEASVIAQVQHKN--LVKLL---G--CCIEKDERLLIYEYMPNKSL  191 (432)
Q Consensus       120 G~~g~Vy~~~~~~~-~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~---~--~~~~~~~~~lv~e~~~~gsL  191 (432)
                      +....||+....++ .+++|..... .....++..|.+.+..+....  ++...   |  ....++..+.++++++|...
T Consensus        36 s~eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~  114 (325)
T PRK11768         36 SYENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP  114 (325)
T ss_pred             cccceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence            44567898887655 6777776432 223456677888877763211  22211   1  12234567889999987653

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=95.34  E-value=0.083  Score=52.73  Aligned_cols=69  Identities=17%  Similarity=0.221  Sum_probs=44.1

Q ss_pred             EEEEEECCceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeC-CeeEEEEecCCCCChhhhhc
Q 014024          125 VYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEK-DERLLIYEYMPNKSLDCFLF  196 (432)
Q Consensus       125 Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~~gsL~~~l~  196 (432)
                      ++.|....+.|+..-+...  ....++.-...+++.++|+|+..++.+-... ....+|+|++ +.+|.+.+.
T Consensus         5 ~~~a~~~~~~~c~nglplt--~~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~   74 (725)
T KOG1093|consen    5 TFFAQEKPGDVCSNGLPLT--PNSIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILK   74 (725)
T ss_pred             EEehhcCCCccccCCCcCC--CcHHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHH
Confidence            4555554444543222111  1223455567889999999999998886543 3467889999 668888874

>PF11883 DUF3403: Domain of unknown function (DUF3403); InterPro: IPR021820 This functionally uncharacterised domain of around 50 amino acids is found in the C terminus of eukaryotic S-locus receptor kinase proteins

Probab=94.92  E-value=0.036  Score=36.48  Aligned_cols=44  Identities=41%  Similarity=0.668  Sum_probs=32.7

Q ss_pred             cCCCCCCCCccccccCCcCCCCccccC-CCcccccceeeecccCC
Q 014024          389 SSLLPPKQPAFCNLRNMESSTSTTEKS-WADCSINEVTVSILDAR  432 (432)
Q Consensus       389 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  432 (432)
                      ..++.|++|+|...+......+++... -..++.|.+|.+.+++|
T Consensus         4 ~~LP~PKqPgF~~~r~~~e~~sSss~~~~~~~SvNevTiT~l~~R   48 (48)
T PF11883_consen    4 ATLPQPKQPGFFTGRSPSETDSSSSKQRDESCSVNEVTITMLEAR   48 (48)
T ss_pred             ccCCCCCCCCEEeEcCCCCcCCCcccccCCCCCeeeEEEEeEecC
Confidence            457889999999888654444333222 35789999999999998

; GO: 0004674 protein serine/threonine kinase activity

>PTZ00296 choline kinase; Provisional

Probab=94.44  E-value=0.32  Score=48.72  Aligned_cols=73  Identities=12%  Similarity=0.109  Sum_probs=44.0

Q ss_pred             CceeccCCcEEEEEEEEC----------CceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCcee-eeEeEEEeCCeeEEE
Q 014024          114 ANKLGEGGFGTVYKGVIG----------QGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLV-KLLGCCIEKDERLLI  182 (432)
Q Consensus       114 ~~~ig~G~~g~Vy~~~~~----------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~lv  182 (432)
                      .+.|..|-.-.+|+....          +..|++++.-....... .-..|..+++.+...++- ++++.+.    -..|
T Consensus       110 i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~----gg~I  184 (442)
T PTZ00296        110 VNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELY-NPISEFEVYKTMSKYRIAPQLLNTFS----GGRI  184 (442)
T ss_pred             EEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcccee-CHHHHHHHHHHHHHCCCCCceEEEeC----CCEE
Confidence            455666777778887654          23577776644333322 346688888888654444 3455442    2457


Q ss_pred             EecCCCCCh
Q 014024          183 YEYMPNKSL  191 (432)
Q Consensus       183 ~e~~~~gsL  191 (432)
                      .||++|.+|
T Consensus       185 ~efi~g~~l  193 (442)
T PTZ00296        185 EEWLYGDPL  193 (442)
T ss_pred             EEeeCCccC
Confidence            999988754

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	432
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-49
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-48
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-44
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		4e-44
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		5e-44
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		3e-42
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		4e-39
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		3e-38
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		6e-25
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-24
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-23
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-23
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-23
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-23
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-23
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-23
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-23
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-23
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-23
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-23
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-23
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		3e-23
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-23
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		3e-23
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		3e-23
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		4e-23
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		4e-23
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		4e-23
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-23
2pl0_A	289	Lck Bound To Imatinib Length = 289		4e-23
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		4e-23
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		4e-23
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		5e-23
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		5e-23
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		5e-23
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		7e-23
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		8e-23
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		8e-23
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		8e-23
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		8e-23
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		9e-23
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-22
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-22
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-22
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-22
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-22
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-22
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-22
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-22
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-22
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-22
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-22
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-22
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-22
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-22
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-22
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-22
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-22
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-22
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-22
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		3e-22
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-22
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		4e-22
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-22
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		4e-22
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		5e-22
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		5e-22
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		5e-22
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-22
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		6e-22
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		7e-22
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-22
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-21
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-21
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-21
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-21
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-21
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-21
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-21
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-21
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-21
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-21
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-21
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-21
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-21
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-21
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-21
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		4e-21
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		5e-21
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		5e-21
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		6e-21
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		6e-21
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-21
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		6e-21
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		7e-21
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		7e-21
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		7e-21
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		8e-21
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		8e-21
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		8e-21
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		9e-21
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		9e-21
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		9e-21
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-20
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-20
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-20
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-20
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-20
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-20
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-20
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-20
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-20
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-20
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-20
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-20
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-20
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-20
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-20
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-20
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		3e-20
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		4e-20
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		4e-20
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-20
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		5e-20
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		6e-20
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-20
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		6e-20
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		7e-20
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		7e-20
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		8e-20
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		8e-20
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		9e-20
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		9e-20
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-19
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-19
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-19
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-19
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-19
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-19
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-19
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-19
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-19
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-19
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-19
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-19
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-19
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-19
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-19
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		3e-19
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		3e-19
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-19
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		3e-19
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		3e-19
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-19
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		3e-19
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		3e-19
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-19
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		3e-19
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-19
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		3e-19
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		3e-19
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		3e-19
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-19
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-19
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-19
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		3e-19
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-19
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-19
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-19
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-19
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-19
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		3e-19
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		3e-19
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		3e-19
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		3e-19
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-19
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-19
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		4e-19
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		4e-19
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		4e-19
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		4e-19
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		4e-19
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		4e-19
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		4e-19
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		5e-19
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		5e-19
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		5e-19
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		5e-19
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		5e-19
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		7e-19
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		7e-19
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		7e-19
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		8e-19
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		8e-19
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		8e-19
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		8e-19
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		8e-19
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		8e-19
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		9e-19
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		9e-19
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		9e-19
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		9e-19
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		9e-19
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		9e-19
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		9e-19
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-18
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-18
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-18
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-18
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-18
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-18
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-18
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-18
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-18
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-18
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-18
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-18
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-18
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-18
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-18
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		3e-18
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-18
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		3e-18
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		4e-18
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		4e-18
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		4e-18
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		5e-18
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		5e-18
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		5e-18
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		6e-18
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		6e-18
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		6e-18
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		6e-18
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		7e-18
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		7e-18
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		8e-18
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-17
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-17
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		1e-17
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-17
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-17
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-17
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-17
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-17
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		3e-17
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-17
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		4e-17
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		4e-17
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		6e-17
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		6e-17
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		6e-17
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		6e-17
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		8e-17
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		8e-17
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		8e-17
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		9e-17
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-16
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-16
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-16
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-16
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-16
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-16
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-16
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-16
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-16
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		3e-16
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-16
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-16
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		4e-16
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		4e-16
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		4e-16
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		4e-16
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		4e-16
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		4e-16
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-16
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		4e-16
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		4e-16
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-16
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		4e-16
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		4e-16
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		4e-16
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		4e-16
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-16
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		5e-16
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		5e-16
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-16
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		5e-16
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		5e-16
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		5e-16
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-16
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-16
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		6e-16
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		6e-16
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		6e-16
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		6e-16
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		6e-16
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		6e-16
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-16
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		7e-16
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-16
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		7e-16
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		7e-16
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-16
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		8e-16
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		8e-16
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		8e-16
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		8e-16
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		8e-16
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		9e-16
1fvr_A	327	Tie2 Kinase Domain Length = 327		9e-16
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-15
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-15
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-15
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-15
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-15
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-15
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-15
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-15
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-15
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-15
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-15
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-15
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-15
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-15
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-15
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-15
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-15
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-15
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-15
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-15
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-15
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-15
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-15
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-15
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-15
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-15
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-15
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-15
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-15
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-15
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-15
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-15
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-15
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-15
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-15
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-15
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-15
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-15
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		3e-15
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-15
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		3e-15
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		3e-15
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		3e-15
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-15
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-15
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		3e-15
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		4e-15
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		4e-15
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		4e-15
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		4e-15
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		4e-15
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		4e-15
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		4e-15
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		5e-15
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-15
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		6e-15
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-15
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-15
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		8e-15
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		8e-15
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		8e-15
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-15
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		9e-15
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		9e-15
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-14
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-14
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-14
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-14
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-14
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-14
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-14
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-14
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-14
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-14
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-14
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		3e-14
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-14
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		3e-14
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-14
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-14
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-14
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		3e-14
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		4e-14
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		4e-14
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		4e-14
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		4e-14
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		4e-14
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		4e-14
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		4e-14
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		4e-14
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		4e-14
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		4e-14
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		4e-14
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		4e-14
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		4e-14
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		4e-14
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-14
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		5e-14
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		5e-14
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		5e-14
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		5e-14
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		5e-14
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		6e-14
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		6e-14
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		7e-14
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		7e-14
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		7e-14
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		7e-14
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		8e-14
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		8e-14
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		8e-14
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		8e-14
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		9e-14
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-13
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-13
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-13
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-13
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-13
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-13
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-13
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-13
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-13
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-13
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-13
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-13
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-13
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-13
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-13
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		3e-13
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-13
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		3e-13
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		4e-13
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		4e-13
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		4e-13
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		4e-13
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		4e-13
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		4e-13
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		4e-13
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		4e-13
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		4e-13
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		4e-13
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		5e-13
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-13
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-13
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		5e-13
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		5e-13
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		5e-13
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		5e-13
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		5e-13
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		5e-13
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		5e-13
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		5e-13
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		6e-13
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		6e-13
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		6e-13
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		6e-13
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		7e-13
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		7e-13
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		8e-13
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		8e-13
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		8e-13
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		8e-13
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		8e-13
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		8e-13
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		8e-13
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-13
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		9e-13
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		9e-13
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-12
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-12
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-12
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-12
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-12
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-12
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-12
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-12
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-12
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-12
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-12
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-12
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-12
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-12
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-12
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-12
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-12
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-12
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-12
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-12
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-12
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-12
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-12
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-12
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-12
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-12
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-12
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-12
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		3e-12
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-12
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-12
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-12
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		3e-12
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-12
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		3e-12
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-12
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		3e-12
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-12
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-12
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		3e-12
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-12
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-12
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		3e-12
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-12
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-12
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-12
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		4e-12
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-12
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-12
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		4e-12
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		4e-12
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-12
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-12
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		4e-12
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		4e-12
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-12
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-12
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		5e-12
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		5e-12
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		5e-12
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		5e-12
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		5e-12
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		5e-12
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		6e-12
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		6e-12
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		6e-12
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		6e-12
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-12
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		6e-12
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		6e-12
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		6e-12
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		7e-12
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		7e-12
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		7e-12
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		7e-12
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		8e-12
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		8e-12
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		8e-12
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-12
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		8e-12
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		9e-12
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		9e-12
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-11
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-11
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-11
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-11
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-11
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-11
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-11
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-11
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-11
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-11
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-11
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-11
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-11
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-11
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-11
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-11
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-11
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-11
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-11
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-11
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-11
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-11
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-11
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-11
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-11
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-11
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-11
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-11
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-11
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-11
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-11
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-11
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-11
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-11
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		3e-11
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-11
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-11
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		4e-11
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		4e-11
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		4e-11
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-11
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		5e-11
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		5e-11
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		5e-11
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		5e-11
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		5e-11
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		6e-11
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		7e-11
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		7e-11
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		7e-11
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		7e-11
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		7e-11
3soa_A	444	Full-Length Human Camkii Length = 444		8e-11
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		8e-11
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		8e-11
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		9e-11
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		9e-11
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-10
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-10
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-10
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-10
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-10
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-10
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-10
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-10
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-10
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-10
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-10
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-10
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-10
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-10
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-10
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-10
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-10
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-10
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-10
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-10
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-10
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-10
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-10
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-10
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		3e-10
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-10
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		4e-10
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		4e-10
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		4e-10
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		4e-10
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		5e-10
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-10
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		5e-10
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		6e-10
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		6e-10
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		6e-10
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		6e-10
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		6e-10
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		7e-10
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		7e-10
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		7e-10
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		8e-10
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-10
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		9e-10
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		9e-10
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		9e-10
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		9e-10
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-09
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-09
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-09
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-09
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-09
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-09
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-09
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-09
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-09
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-09
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-09
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-09
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-09
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-09
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-09
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-09
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-09
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-09
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-09
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-09
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-09
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-09
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-09
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-09
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-09
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-09
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-09
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-09
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-09
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-09
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-09
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-09
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-09
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-09
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-09
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-09
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-09
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-09
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-09
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-09
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-09
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-09
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-09
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-09
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-09
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-09
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-09
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-09
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-09
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-09
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-09
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-09
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-09
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-09
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-09
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-09
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-09
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-09
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-09
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-09
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-09
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-09
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-09
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-09
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-09
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-09
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-09
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-09
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-09
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-09
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-09
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-09
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-09
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-09
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-09
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-09
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-09
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-09
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-09
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-09
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-09
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-09
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-09
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-09
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-09
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-09
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-09
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-09
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		3e-09
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		3e-09
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-09
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-09
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-09
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		3e-09
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		3e-09
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-09
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-09
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		3e-09
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-09
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		4e-09
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		4e-09
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-09
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-09
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		4e-09
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		4e-09
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		4e-09
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		4e-09
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		5e-09
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		5e-09
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		5e-09
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		5e-09
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		5e-09
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		5e-09
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		5e-09
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		5e-09
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		5e-09
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		5e-09
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-09
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		5e-09
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		6e-09
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		6e-09
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-09
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		6e-09
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		6e-09
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		6e-09
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		6e-09
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		6e-09
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		6e-09
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		6e-09
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		6e-09
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		6e-09
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		6e-09
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		7e-09
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		7e-09
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		7e-09
4ae9_A	343	Structure And Function Of The Human Sperm-specific		7e-09
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		7e-09
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		7e-09
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		7e-09
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		8e-09
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		8e-09
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		9e-09
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		9e-09
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-08
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-08
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-08
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-08
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-08
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		1e-08
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-08
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-08
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-08
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-08
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-08
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-08
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-08
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-08
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-08
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-08
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-08
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-08
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-08
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-08
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-08
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-08
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-08
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-08
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-08
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-08
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-08
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-08
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-08
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-08
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		3e-08
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		4e-08
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		4e-08
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		4e-08
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-08
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		4e-08
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		5e-08
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		5e-08
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		5e-08
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		6e-08
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		6e-08
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		6e-08
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		6e-08
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		7e-08
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		7e-08
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		7e-08
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		7e-08
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		7e-08
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		7e-08
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		7e-08
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		8e-08
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		8e-08
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		8e-08
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		8e-08
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		8e-08
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		8e-08
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		8e-08
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		8e-08
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		8e-08
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		8e-08
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		8e-08
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		8e-08
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		9e-08
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		9e-08
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		9e-08
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		9e-08
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		9e-08
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		9e-08
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		1e-07
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-07
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-07
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-07
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-07
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-07
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-07
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-07
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-07
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-07
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-07
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-07
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-07
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		1e-07
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-07
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-07
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-07
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-07
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-07
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-07
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-07
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-07
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-07
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-07
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-07
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-07
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		3e-07
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		3e-07
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		3e-07
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		3e-07
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-07
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		3e-07
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		4e-07
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		4e-07
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		4e-07
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		4e-07
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		4e-07
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		4e-07
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		4e-07
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		4e-07
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		4e-07
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		4e-07
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		4e-07
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		5e-07
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		5e-07
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		5e-07
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		5e-07
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		6e-07
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		6e-07
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		6e-07
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		6e-07
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		6e-07
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		6e-07
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		7e-07
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		9e-07
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		9e-07
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		9e-07
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		9e-07
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		9e-07
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-06
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-06
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		1e-06
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-06
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-06
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-06
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		1e-06
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		2e-06
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-06
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-06
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-06
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-06
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-06
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		2e-06
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-06
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		2e-06
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-06
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		3e-06
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		3e-06
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-06
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		3e-06
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		3e-06
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		3e-06
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		3e-06
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-06
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		3e-06
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		3e-06
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		3e-06
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		3e-06
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		3e-06
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		4e-06
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		4e-06
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-06
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-06
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		4e-06
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		4e-06
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		4e-06
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		4e-06
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		4e-06
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		4e-06
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		4e-06
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		4e-06
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		4e-06
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		5e-06
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		5e-06
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		5e-06
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		5e-06
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		5e-06
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		6e-06
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		6e-06
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		7e-06
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		8e-06
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		9e-06
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		2e-05
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		2e-05
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-05
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-05
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		3e-05
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		3e-05
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-05
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		3e-05
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-05
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		6e-05
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		1e-04
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		1e-04
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  194 bits (492), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 114/306 (37%), Positives = 175/306 (57%), Gaps = 13/306 (4%)
Query: 90  EKEVDQFPLFSFSSVSSATGNFSAANKLGEGGFGTVYKGVIGQGE-IAVKRLLGK--SGQ 146
           E  + Q   FS   +  A+ NFS  N LG GGFG VYKG +  G  +AVKRL  +   G 
Sbjct: 19  EVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGG 78
Query: 147 EIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSL-DCFLFDPTKREILD 205
           E+ + + E  +I+   H+NL++L G C+   ERLL+Y YM N S+  C    P  +  LD
Sbjct: 79  EL-QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLD 137
Query: 206 WRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGND 265
           W  R +I  G A+GL YLH +   +IIHRD+KA+NILLD++  + + DFG+A+++    D
Sbjct: 138 WPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM----D 193
Query: 266 EDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKS-- 323
             +     + + GT G+++PEY   G  S K+DVF +GV+LLE+++G++     R  +  
Sbjct: 194 YKDXHVXXA-VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD 252
Query: 324 -LNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVS 382
            + L+ +   L    K+  L+D  L+    +E + + + +ALLC Q    +RP MS+VV 
Sbjct: 253 DVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVR 312
Query: 383 MLTNEA 388
           ML  + 
Sbjct: 313 MLEGDG 318

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  190 bits (483), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 112/306 (36%), Positives = 173/306 (56%), Gaps = 13/306 (4%)
Query: 90  EKEVDQFPLFSFSSVSSATGNFSAANKLGEGGFGTVYKGVIGQGE-IAVKRLLGK--SGQ 146
           E  + Q   FS   +  A+ NF   N LG GGFG VYKG +  G  +AVKRL  +   G 
Sbjct: 11  EVHLGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGG 70
Query: 147 EIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSL-DCFLFDPTKREILD 205
           E+ + + E  +I+   H+NL++L G C+   ERLL+Y YM N S+  C    P  +  LD
Sbjct: 71  EL-QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLD 129
Query: 206 WRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGND 265
           W  R +I  G A+GL YLH +   +IIHRD+KA+NILLD++  + + DFG+A+++    D
Sbjct: 130 WPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM----D 185
Query: 266 EDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKS-- 323
             +     + + G  G+++PEY   G  S K+DVF +GV+LLE+++G++     R  +  
Sbjct: 186 YKDXHVXXA-VRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD 244
Query: 324 -LNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVS 382
            + L+ +   L    K+  L+D  L+    +E + + + +ALLC Q    +RP MS+VV 
Sbjct: 245 DVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVR 304
Query: 383 MLTNEA 388
           ML  + 
Sbjct: 305 MLEGDG 310

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  177 bits (448), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 116/310 (37%), Positives = 163/310 (52%), Gaps = 27/310 (8%)
Query: 95  QFPLFSFSSVSSATGNFS------AANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEI 148
           +F  FSF  + + T NF         NK+GEGGFG VYKG +    +AVK+L        
Sbjct: 11  RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITT 70
Query: 149 KELKN----EASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKS----LDCFLFDPTK 200
           +ELK     E  V+A+ QH+NLV+LLG   + D+  L+Y YMPN S    L C    P  
Sbjct: 71  EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP- 129
Query: 201 REILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIV 260
              L W  R +I +G A G+ +LH+      IHRD+K++NILLD+   +KISDFG+AR  
Sbjct: 130 ---LSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLAR-- 181
Query: 261 FGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYR 320
              +++       SRI GT  YM+PE AL G  + KSD++SFGV+LLEI++G      +R
Sbjct: 182 --ASEKFAQTVMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR 238
Query: 321 TKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDV 380
              L L            I D ID  + +A  + S+     +A  C+ E+   RP +  V
Sbjct: 239 EPQLLLDIKEEIEDEEKTIEDYIDKKMNDAD-STSVEAMYSVASQCLHEKKNKRPDIKKV 297
Query: 381 VSMLTNEASS 390
             +L    +S
Sbjct: 298 QQLLQEMTAS 307

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  175 bits (443), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 115/310 (37%), Positives = 162/310 (52%), Gaps = 27/310 (8%)
Query: 95  QFPLFSFSSVSSATGNFS------AANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEI 148
           +F  FSF  + + T NF         NK+GEGGFG VYKG +    +AVK+L        
Sbjct: 11  RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITT 70
Query: 149 KELKN----EASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKS----LDCFLFDPTK 200
           +ELK     E  V+A+ QH+NLV+LLG   + D+  L+Y YMPN S    L C    P  
Sbjct: 71  EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP- 129
Query: 201 REILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIV 260
              L W  R +I +G A G+ +LH+      IHRD+K++NILLD+   +KISDFG+AR  
Sbjct: 130 ---LSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLAR-- 181
Query: 261 FGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYR 320
              +++        RI GT  YM+PE AL G  + KSD++SFGV+LLEI++G      +R
Sbjct: 182 --ASEKFAQTVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR 238
Query: 321 TKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDV 380
              L L            I D ID  + +A  + S+     +A  C+ E+   RP +  V
Sbjct: 239 EPQLLLDIKEEIEDEEKTIEDYIDKKMNDAD-STSVEAMYSVASQCLHEKKNKRPDIKKV 297
Query: 381 VSMLTNEASS 390
             +L    +S
Sbjct: 298 QQLLQEMTAS 307

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  175 bits (443), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 115/310 (37%), Positives = 162/310 (52%), Gaps = 27/310 (8%)
Query: 95  QFPLFSFSSVSSATGNFS------AANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEI 148
           +F  FSF  + + T NF         NK+GEGGFG VYKG +    +AVK+L        
Sbjct: 5   RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITT 64
Query: 149 KELKN----EASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKS----LDCFLFDPTK 200
           +ELK     E  V+A+ QH+NLV+LLG   + D+  L+Y YMPN S    L C    P  
Sbjct: 65  EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP- 123
Query: 201 REILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIV 260
              L W  R +I +G A G+ +LH+      IHRD+K++NILLD+   +KISDFG+AR  
Sbjct: 124 ---LSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLAR-- 175
Query: 261 FGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYR 320
              +++        RI GT  YM+PE AL G  + KSD++SFGV+LLEI++G      +R
Sbjct: 176 --ASEKFAQXVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR 232
Query: 321 TKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDV 380
              L L            I D ID  + +A  + S+     +A  C+ E+   RP +  V
Sbjct: 233 EPQLLLDIKEEIEDEEKTIEDYIDKKMNDAD-STSVEAMYSVASQCLHEKKNKRPDIKKV 291
Query: 381 VSMLTNEASS 390
             +L    +S
Sbjct: 292 QQLLQEMTAS 301

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  169 bits (428), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 114/310 (36%), Positives = 158/310 (50%), Gaps = 27/310 (8%)
Query: 95  QFPLFSFSSVSSATGNFS------AANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEI 148
           +F  FSF  + + T NF         NK GEGGFG VYKG +    +AVK+L        
Sbjct: 2   RFHSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITT 61
Query: 149 KELKN----EASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSL----DCFLFDPTK 200
           +ELK     E  V A+ QH+NLV+LLG   + D+  L+Y Y PN SL     C    P  
Sbjct: 62  EELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPP- 120
Query: 201 REILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIV 260
              L W  R +I +G A G+ +LH+      IHRD+K++NILLD+   +KISDFG+AR  
Sbjct: 121 ---LSWHXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLAR-- 172
Query: 261 FGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYR 320
              +++       SRI GT  Y +PE AL G  + KSD++SFGV+LLEI++G      +R
Sbjct: 173 --ASEKFAQXVXXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR 229
Query: 321 TKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDV 380
              L L            I D ID    +A  + S+     +A  C+ E+   RP +  V
Sbjct: 230 EPQLLLDIKEEIEDEEKTIEDYIDKKXNDAD-STSVEAXYSVASQCLHEKKNKRPDIKKV 288
Query: 381 VSMLTNEASS 390
             +L    +S
Sbjct: 289 QQLLQEXTAS 298

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  159 bits (401), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 103/283 (36%), Positives = 165/283 (58%), Gaps = 14/283 (4%)
Query: 104 VSSATGNFSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKSGQEIKELKNEASVIAQVQ 162
           +  AT NF     +G G FG VYKGV+  G ++A+KR   +S Q I+E + E   ++  +
Sbjct: 34  LEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCR 93
Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFD---PTKREILDWRTRVQIIKGVAQG 219
           H +LV L+G C E++E +LIY+YM N +L   L+    PT    + W  R++I  G A+G
Sbjct: 94  HPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMS--MSWEQRLEICIGAARG 151
Query: 220 LLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGT 279
           L YLH  +   IIHRD+K+ NILLD++   KI+DFG+++    G + D+       + GT
Sbjct: 152 LHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISK---KGTELDQTHLXXV-VKGT 204
Query: 280 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSL-NLIGYAWDLWISNK 338
            GY+ PEY ++G  + KSDV+SFGV+L E++  +        + + NL  +A +   + +
Sbjct: 205 LGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264
Query: 339 IIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVV 381
           +  ++D  L +    ESL ++   A+ C+   +EDRP+M DV+
Sbjct: 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  156 bits (394), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 105/286 (36%), Positives = 165/286 (57%), Gaps = 20/286 (6%)
Query: 104 VSSATGNFSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKSGQEIKELKNEASVIAQVQ 162
           +  AT NF     +G G FG VYKGV+  G ++A+KR   +S Q I+E + E   ++  +
Sbjct: 34  LEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCR 93
Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFD---PTKREILDWRTRVQIIKGVAQG 219
           H +LV L+G C E++E +LIY+YM N +L   L+    PT    + W  R++I  G A+G
Sbjct: 94  HPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMS--MSWEQRLEICIGAARG 151
Query: 220 LLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR---I 276
           L YLH  +   IIHRD+K+ NILLD++   KI+DFG+++         EL G T     +
Sbjct: 152 LHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISK------KGTEL-GQTHLXXVV 201
Query: 277 SGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSL-NLIGYAWDLWI 335
            GT GY+ PEY ++G  + KSDV+SFGV+L E++  +        + + NL  +A +   
Sbjct: 202 KGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN 261
Query: 336 SNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVV 381
           + ++  ++D  L +    ESL ++   A+ C+   +EDRP+M DV+
Sbjct: 262 NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  112 bits (279), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 112/204 (54%), Gaps = 9/204 (4%)
Query: 116 KLGEGGFGTVYKGVIGQGEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCC 173
           K+G G FGTV++      ++AVK L+ +    + + E   E +++ +++H N+V  +G  
Sbjct: 44  KIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
            +     ++ EY+   SL   L     RE LD R R+ +   VA+G+ YLH  +   I+H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVH 162
Query: 234 RDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIF 293
           RDLK+ N+L+DK    K+ DFG++R+      +      +   +GT  +M+PE   +   
Sbjct: 163 RDLKSPNLLVDKKYTVKVCDFGLSRL------KASXFLXSKXAAGTPEWMAPEVLRDEPS 216
Query: 294 SIKSDVFSFGVLLLEIVSGKKNTG 317
           + KSDV+SFGV+L E+ + ++  G
Sbjct: 217 NEKSDVYSFGVILWELATLQQPWG 240

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 113/204 (55%), Gaps = 9/204 (4%)
Query: 116 KLGEGGFGTVYKGVIGQGEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCC 173
           K+G G FGTV++      ++AVK L+ +    + + E   E +++ +++H N+V  +G  
Sbjct: 44  KIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
            +     ++ EY+   SL   L     RE LD R R+ +   VA+G+ YLH  +   I+H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVH 162
Query: 234 RDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIF 293
           R+LK+ N+L+DK    K+ DFG++R+      +     ++   +GT  +M+PE   +   
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRL------KASTFLSSKSAAGTPEWMAPEVLRDEPS 216
Query: 294 SIKSDVFSFGVLLLEIVSGKKNTG 317
           + KSDV+SFGV+L E+ + ++  G
Sbjct: 217 NEKSDVYSFGVILWELATLQQPWG 240

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 84/285 (29%), Positives = 141/285 (49%), Gaps = 28/285 (9%)
Query: 116 KLGEGGFGTVYKGVI-GQGEIAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNLVKLLGCC 173
           KLG+G FG V+ G   G   +A+K L  K G    E    EA V+ +++H+ LV+L    
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV- 247
Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
           + ++   ++ EYM   SL  FL   T +  L     V +   +A G+ Y+    R+  +H
Sbjct: 248 VSEEPIYIVTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVH 303
Query: 234 RDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIF 293
           RDL+A+NIL+ +++  K++DFG+AR++   N+    QG    I  T    +PE AL G F
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWT----APEAALYGRF 358
Query: 294 SIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFN 353
           +IKSDV+SFG+LL E+ +  +                +   ++ +++D ++         
Sbjct: 359 TIKSDVWSFGILLTELTTKGR--------------VPYPGMVNREVLDQVERGYRMPCPP 404
Query: 354 ESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQPA 398
           E       +   C ++  E+RPT   + + L +  +S  P  QP 
Sbjct: 405 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQXQPG 449

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 84/285 (29%), Positives = 141/285 (49%), Gaps = 28/285 (9%)
Query: 116 KLGEGGFGTVYKGVI-GQGEIAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNLVKLLGCC 173
           KLG+G FG V+ G   G   +A+K L  K G    E    EA V+ +++H+ LV+L    
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV- 247
Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
           + ++   ++ EYM   SL  FL   T +  L     V +   +A G+ Y+    R+  +H
Sbjct: 248 VSEEPIYIVTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVH 303
Query: 234 RDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIF 293
           RDL+A+NIL+ +++  K++DFG+AR++   N+    QG    I  T    +PE AL G F
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWT----APEAALYGRF 358
Query: 294 SIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFN 353
           +IKSDV+SFG+LL E+ +  +                +   ++ +++D ++         
Sbjct: 359 TIKSDVWSFGILLTELTTKGR--------------VPYPGMVNREVLDQVERGYRMPCPP 404
Query: 354 ESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQPA 398
           E       +   C ++  E+RPT   + + L +  +S  P  QP 
Sbjct: 405 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 449

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 84/285 (29%), Positives = 141/285 (49%), Gaps = 28/285 (9%)
Query: 116 KLGEGGFGTVYKGVI-GQGEIAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNLVKLLGCC 173
           KLG+G FG V+ G   G   +A+K L  K G    E    EA V+ +++H+ LV+L    
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV- 247
Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
           + ++   ++ EYM   SL  FL   T +  L     V +   +A G+ Y+    R+  +H
Sbjct: 248 VSEEPIYIVGEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVH 303
Query: 234 RDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIF 293
           RDL+A+NIL+ +++  K++DFG+AR++   N+    QG    I  T    +PE AL G F
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWT----APEAALYGRF 358
Query: 294 SIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFN 353
           +IKSDV+SFG+LL E+ +  +                +   ++ +++D ++         
Sbjct: 359 TIKSDVWSFGILLTELTTKGR--------------VPYPGMVNREVLDQVERGYRMPCPP 404
Query: 354 ESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQPA 398
           E       +   C ++  E+RPT   + + L +  +S  P  QP 
Sbjct: 405 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQXQPG 449

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 85/277 (30%), Positives = 139/277 (50%), Gaps = 36/277 (12%)
Query: 116 KLGEGGFGTVYKGVI-GQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCI 174
           +LG G FG V+ G   G  ++AVK L  +          EA+++ Q+QH+ LV+L    +
Sbjct: 26  RLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLY-AVV 83
Query: 175 EKDERLLIYEYMPNKSLDCFLFDP-----TKREILDWRTRVQIIKGVAQGLLYLHQYSRV 229
            ++   +I EYM N SL  FL  P     T  ++LD      +   +A+G+ ++ + +  
Sbjct: 84  TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD------MAAQIAEGMAFIEERN-- 135
Query: 230 RIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL 289
             IHRDL+A+NIL+   ++ KI+DFG+AR++   N+    +G    I  T    +PE   
Sbjct: 136 -YIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWT----APEAIN 189
Query: 290 EGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEE 349
            G F+IKSDV+SFG+LL EIV+  +         +   G       + ++I  ++     
Sbjct: 190 YGTFTIKSDVWSFGILLTEIVTHGR---------IPYPGMT-----NPEVIQNLERGYRM 235
Query: 350 ASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN 386
              +        +  LC +ER EDRPT   + S+L +
Sbjct: 236 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 272

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 85/277 (30%), Positives = 139/277 (50%), Gaps = 36/277 (12%)
Query: 116 KLGEGGFGTVYKGVI-GQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCI 174
           +LG G FG V+ G   G  ++AVK L  +          EA+++ Q+QH+ LV+L    +
Sbjct: 29  RLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLY-AVV 86
Query: 175 EKDERLLIYEYMPNKSLDCFLFDP-----TKREILDWRTRVQIIKGVAQGLLYLHQYSRV 229
            ++   +I EYM N SL  FL  P     T  ++LD      +   +A+G+ ++ + +  
Sbjct: 87  TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD------MAAQIAEGMAFIEERN-- 138
Query: 230 RIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL 289
             IHRDL+A+NIL+   ++ KI+DFG+AR++   N+    +G    I  T    +PE   
Sbjct: 139 -YIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWT----APEAIN 192
Query: 290 EGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEE 349
            G F+IKSDV+SFG+LL EIV+  +         +   G       + ++I  ++     
Sbjct: 193 YGTFTIKSDVWSFGILLTEIVTHGR---------IPYPGMT-----NPEVIQNLERGYRM 238
Query: 350 ASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN 386
              +        +  LC +ER EDRPT   + S+L +
Sbjct: 239 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 275

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 85/277 (30%), Positives = 139/277 (50%), Gaps = 36/277 (12%)
Query: 116 KLGEGGFGTVYKGVI-GQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCI 174
           +LG G FG V+ G   G  ++AVK L  +          EA+++ Q+QH+ LV+L    +
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLY-AVV 77
Query: 175 EKDERLLIYEYMPNKSLDCFLFDP-----TKREILDWRTRVQIIKGVAQGLLYLHQYSRV 229
            ++   +I EYM N SL  FL  P     T  ++LD      +   +A+G+ ++ + +  
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD------MAAQIAEGMAFIEERN-- 129
Query: 230 RIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL 289
             IHRDL+A+NIL+   ++ KI+DFG+AR++   N+    +G    I  T    +PE   
Sbjct: 130 -YIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWT----APEAIN 183
Query: 290 EGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEE 349
            G F+IKSDV+SFG+LL EIV+  +         +   G       + ++I  ++     
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGR---------IPYPGMT-----NPEVIQNLERGYRM 229
Query: 350 ASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN 386
              +        +  LC +ER EDRPT   + S+L +
Sbjct: 230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 141/285 (49%), Gaps = 28/285 (9%)
Query: 116 KLGEGGFGTVYKGVI-GQGEIAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNLVKLLGCC 173
           KLG+G FG V+ G   G   +A+K L  K G    E    EA V+ +++H+ LV+L    
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKLVQLY-AV 330
Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
           + ++   ++ EYM   SL  FL   T +  L     V +   +A G+ Y+    R+  +H
Sbjct: 331 VSEEPIYIVTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVH 386
Query: 234 RDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIF 293
           RDL+A+NIL+ +++  K++DFG+AR++   N+    QG    I     + +PE AL G F
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIK----WTAPEAALYGRF 441
Query: 294 SIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFN 353
           +IKSDV+SFG+LL E+ +  +                +   ++ +++D ++         
Sbjct: 442 TIKSDVWSFGILLTELTTKGR--------------VPYPGMVNREVLDQVERGYRMPCPP 487
Query: 354 ESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQPA 398
           E       +   C ++  E+RPT   + + L +  +S  P  QP 
Sbjct: 488 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQXQPG 532

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 85/277 (30%), Positives = 139/277 (50%), Gaps = 36/277 (12%)
Query: 116 KLGEGGFGTVYKGVI-GQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCI 174
           +LG G FG V+ G   G  ++AVK L  +          EA+++ Q+QH+ LV+L    +
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLY-AVV 77
Query: 175 EKDERLLIYEYMPNKSLDCFLFDP-----TKREILDWRTRVQIIKGVAQGLLYLHQYSRV 229
            ++   +I EYM N SL  FL  P     T  ++LD      +   +A+G+ ++ + +  
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD------MAAQIAEGMAFIEERN-- 129
Query: 230 RIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL 289
             IHRDL+A+NIL+   ++ KI+DFG+AR++   N+    +G    I  T    +PE   
Sbjct: 130 -YIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWT----APEAIN 183
Query: 290 EGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEE 349
            G F+IKSDV+SFG+LL EIV+  +         +   G       + ++I  ++     
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGR---------IPYPGMT-----NPEVIQNLERGYRM 229
Query: 350 ASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN 386
              +        +  LC +ER EDRPT   + S+L +
Sbjct: 230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 85/277 (30%), Positives = 139/277 (50%), Gaps = 36/277 (12%)
Query: 116 KLGEGGFGTVYKGVI-GQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCI 174
           +LG G FG V+ G   G  ++AVK L  +          EA+++ Q+QH+ LV+L    +
Sbjct: 21  RLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLY-AVV 78
Query: 175 EKDERLLIYEYMPNKSLDCFLFDP-----TKREILDWRTRVQIIKGVAQGLLYLHQYSRV 229
            ++   +I EYM N SL  FL  P     T  ++LD      +   +A+G+ ++ + +  
Sbjct: 79  TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD------MAAQIAEGMAFIEERN-- 130
Query: 230 RIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL 289
             IHRDL+A+NIL+   ++ KI+DFG+AR++   N+    +G    I  T    +PE   
Sbjct: 131 -YIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWT----APEAIN 184
Query: 290 EGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEE 349
            G F+IKSDV+SFG+LL EIV+  +         +   G       + ++I  ++     
Sbjct: 185 YGTFTIKSDVWSFGILLTEIVTHGR---------IPYPGMT-----NPEVIQNLERGYRM 230
Query: 350 ASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN 386
              +        +  LC +ER EDRPT   + S+L +
Sbjct: 231 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 267

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 85/277 (30%), Positives = 139/277 (50%), Gaps = 36/277 (12%)
Query: 116 KLGEGGFGTVYKGVI-GQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCI 174
           +LG G FG V+ G   G  ++AVK L  +          EA+++ Q+QH+ LV+L    +
Sbjct: 22  RLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLY-AVV 79
Query: 175 EKDERLLIYEYMPNKSLDCFLFDP-----TKREILDWRTRVQIIKGVAQGLLYLHQYSRV 229
            ++   +I EYM N SL  FL  P     T  ++LD      +   +A+G+ ++ + +  
Sbjct: 80  TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD------MAAQIAEGMAFIEERN-- 131
Query: 230 RIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL 289
             IHRDL+A+NIL+   ++ KI+DFG+AR++   N+    +G    I  T    +PE   
Sbjct: 132 -YIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWT----APEAIN 185
Query: 290 EGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEE 349
            G F+IKSDV+SFG+LL EIV+  +         +   G       + ++I  ++     
Sbjct: 186 YGTFTIKSDVWSFGILLTEIVTHGR---------IPYPGMT-----NPEVIQNLERGYRM 231
Query: 350 ASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN 386
              +        +  LC +ER EDRPT   + S+L +
Sbjct: 232 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 268

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 85/277 (30%), Positives = 139/277 (50%), Gaps = 36/277 (12%)
Query: 116 KLGEGGFGTVYKGVI-GQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCI 174
           +LG G FG V+ G   G  ++AVK L  +          EA+++ Q+QH+ LV+L    +
Sbjct: 28  RLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLY-AVV 85
Query: 175 EKDERLLIYEYMPNKSLDCFLFDP-----TKREILDWRTRVQIIKGVAQGLLYLHQYSRV 229
            ++   +I EYM N SL  FL  P     T  ++LD      +   +A+G+ ++ + +  
Sbjct: 86  TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD------MAAQIAEGMAFIEERN-- 137
Query: 230 RIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL 289
             IHRDL+A+NIL+   ++ KI+DFG+AR++   N+    +G    I  T    +PE   
Sbjct: 138 -YIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWT----APEAIN 191
Query: 290 EGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEE 349
            G F+IKSDV+SFG+LL EIV+  +         +   G       + ++I  ++     
Sbjct: 192 YGTFTIKSDVWSFGILLTEIVTHGR---------IPYPGMT-----NPEVIQNLERGYRM 237
Query: 350 ASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN 386
              +        +  LC +ER EDRPT   + S+L +
Sbjct: 238 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 274

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 84/285 (29%), Positives = 141/285 (49%), Gaps = 28/285 (9%)
Query: 116 KLGEGGFGTVYKGVI-GQGEIAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNLVKLLGCC 173
           KLG+G FG V+ G   G   +A+K L  K G    E    EA V+ +++H+ LV+L    
Sbjct: 15  KLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV- 71
Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
           + ++   ++ EYM   SL  FL   T +  L     V +   +A G+ Y+    R+  +H
Sbjct: 72  VSEEPIXIVTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVH 127
Query: 234 RDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIF 293
           RDL+A+NIL+ +++  K++DFG+AR++   N+    QG    I  T    +PE AL G F
Sbjct: 128 RDLRAANILVGENLVCKVADFGLARLI-EDNEXTARQGAKFPIKWT----APEAALYGRF 182
Query: 294 SIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFN 353
           +IKSDV+SFG+LL E+ +  +                +   ++ +++D ++         
Sbjct: 183 TIKSDVWSFGILLTELTTKGR--------------VPYPGMVNREVLDQVERGYRMPCPP 228
Query: 354 ESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQPA 398
           E       +   C ++  E+RPT   + + L +  +S  P  QP 
Sbjct: 229 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 273

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 85/277 (30%), Positives = 139/277 (50%), Gaps = 36/277 (12%)
Query: 116 KLGEGGFGTVYKGVI-GQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCI 174
           +LG G FG V+ G   G  ++AVK L  +          EA+++ Q+QH+ LV+L    +
Sbjct: 26  RLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLY-AVV 83
Query: 175 EKDERLLIYEYMPNKSLDCFLFDP-----TKREILDWRTRVQIIKGVAQGLLYLHQYSRV 229
            ++   +I EYM N SL  FL  P     T  ++LD      +   +A+G+ ++ + +  
Sbjct: 84  TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD------MAAQIAEGMAFIEERN-- 135
Query: 230 RIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL 289
             IHRDL+A+NIL+   ++ KI+DFG+AR++   N+    +G    I  T    +PE   
Sbjct: 136 -YIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWT----APEAIN 189
Query: 290 EGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEE 349
            G F+IKSDV+SFG+LL EIV+  +         +   G       + ++I  ++     
Sbjct: 190 YGTFTIKSDVWSFGILLTEIVTHGR---------IPYPGMT-----NPEVIQNLERGYRM 235
Query: 350 ASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN 386
              +        +  LC +ER EDRPT   + S+L +
Sbjct: 236 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 272

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 85/277 (30%), Positives = 139/277 (50%), Gaps = 36/277 (12%)
Query: 116 KLGEGGFGTVYKGVI-GQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCI 174
           +LG G FG V+ G   G  ++AVK L  +          EA+++ Q+QH+ LV+L    +
Sbjct: 25  RLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLY-AVV 82
Query: 175 EKDERLLIYEYMPNKSLDCFLFDP-----TKREILDWRTRVQIIKGVAQGLLYLHQYSRV 229
            ++   +I EYM N SL  FL  P     T  ++LD      +   +A+G+ ++ + +  
Sbjct: 83  TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD------MAAQIAEGMAFIEERN-- 134
Query: 230 RIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL 289
             IHRDL+A+NIL+   ++ KI+DFG+AR++   N+    +G    I  T    +PE   
Sbjct: 135 -YIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWT----APEAIN 188
Query: 290 EGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEE 349
            G F+IKSDV+SFG+LL EIV+  +         +   G       + ++I  ++     
Sbjct: 189 YGTFTIKSDVWSFGILLTEIVTHGR---------IPYPGMT-----NPEVIQNLERGYRM 234
Query: 350 ASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN 386
              +        +  LC +ER EDRPT   + S+L +
Sbjct: 235 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 271

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 85/277 (30%), Positives = 139/277 (50%), Gaps = 36/277 (12%)
Query: 116 KLGEGGFGTVYKGVI-GQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCI 174
           +LG G FG V+ G   G  ++AVK L  +          EA+++ Q+QH+ LV+L    +
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLY-AVV 77
Query: 175 EKDERLLIYEYMPNKSLDCFLFDP-----TKREILDWRTRVQIIKGVAQGLLYLHQYSRV 229
            ++   +I EYM N SL  FL  P     T  ++LD      +   +A+G+ ++ + +  
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD------MAAQIAEGMAFIEERN-- 129
Query: 230 RIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL 289
             IHRDL+A+NIL+   ++ KI+DFG+AR++   N+    +G    I  T    +PE   
Sbjct: 130 -YIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWT----APEAIN 183
Query: 290 EGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEE 349
            G F+IKSDV+SFG+LL EIV+  +         +   G       + ++I  ++     
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGR---------IPYPGMT-----NPEVIQNLERGYRM 229
Query: 350 ASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN 386
              +        +  LC +ER EDRPT   + S+L +
Sbjct: 230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 71/213 (33%), Positives = 121/213 (56%), Gaps = 22/213 (10%)
Query: 109 GNFSAANKLGEGGFGTVYKGVIGQGEIAVKRL--LGKSGQEIKELKNEASVIAQVQHKNL 166
           G  +   ++G G FGTVYKG    G++AVK L     + Q+++  KNE  V+ + +H N+
Sbjct: 10  GQITVGQRIGSGSFGTVYKGK-WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 68
Query: 167 VKLLGCCIEKDERLLIYEYMPNKSLDCFL-FDPTKREILDWRTRVQIIKGVAQGLLYLHQ 225
           +  +G    K +  ++ ++    SL   L    TK E++     + I +  AQG+ YLH 
Sbjct: 69  LLFMGYST-KPQLAIVTQWCEGSSLYHHLHIIETKFEMIK---LIDIARQTAQGMDYLHA 124
Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIV--FGGNDEDELQGNTSRISGTYGYM 283
            S   IIHRDLK++NI L +D+  KI DFG+A +   + G+ + E      ++SG+  +M
Sbjct: 125 KS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE------QLSGSILWM 175
Query: 284 SPEYAL---EGIFSIKSDVFSFGVLLLEIVSGK 313
           +PE      +  +S +SDV++FG++L E+++G+
Sbjct: 176 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 208

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 71/213 (33%), Positives = 121/213 (56%), Gaps = 22/213 (10%)
Query: 109 GNFSAANKLGEGGFGTVYKGVIGQGEIAVKRL--LGKSGQEIKELKNEASVIAQVQHKNL 166
           G  +   ++G G FGTVYKG    G++AVK L     + Q+++  KNE  V+ + +H N+
Sbjct: 13  GQITVGQRIGSGSFGTVYKGK-WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 71
Query: 167 VKLLGCCIEKDERLLIYEYMPNKSLDCFL-FDPTKREILDWRTRVQIIKGVAQGLLYLHQ 225
           +  +G    K +  ++ ++    SL   L    TK E++     + I +  AQG+ YLH 
Sbjct: 72  LLFMGYST-KPQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHA 127
Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIV--FGGNDEDELQGNTSRISGTYGYM 283
            S   IIHRDLK++NI L +D+  KI DFG+A +   + G+ + E      ++SG+  +M
Sbjct: 128 KS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE------QLSGSILWM 178
Query: 284 SPEYAL---EGIFSIKSDVFSFGVLLLEIVSGK 313
           +PE      +  +S +SDV++FG++L E+++G+
Sbjct: 179 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 84/285 (29%), Positives = 141/285 (49%), Gaps = 28/285 (9%)
Query: 116 KLGEGGFGTVYKGVI-GQGEIAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNLVKLLGCC 173
           KLG+G FG V+ G   G   +A+K L  K G    E    EA V+ +++H+ LV+L    
Sbjct: 18  KLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV- 74
Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
           + ++   ++ EYM   SL  FL   T +  L     V +   +A G+ Y+    R+  +H
Sbjct: 75  VSEEPIYIVTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVH 130
Query: 234 RDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIF 293
           RDL+A+NIL+ +++  K++DFG+AR++   N+    QG    I  T    +PE AL G F
Sbjct: 131 RDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWT----APEAALYGRF 185
Query: 294 SIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFN 353
           +IKSDV+SFG+LL E+ +  +                +   ++ +++D ++         
Sbjct: 186 TIKSDVWSFGILLTELTTKGR--------------VPYPGMVNREVLDQVERGYRMPCPP 231
Query: 354 ESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQPA 398
           E       +   C ++  E+RPT   + + L +  +S  P  QP 
Sbjct: 232 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 276

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 71/213 (33%), Positives = 121/213 (56%), Gaps = 22/213 (10%)
Query: 109 GNFSAANKLGEGGFGTVYKGVIGQGEIAVKRL--LGKSGQEIKELKNEASVIAQVQHKNL 166
           G  +   ++G G FGTVYKG    G++AVK L     + Q+++  KNE  V+ + +H N+
Sbjct: 8   GQITVGQRIGSGSFGTVYKGK-WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 66
Query: 167 VKLLGCCIEKDERLLIYEYMPNKSLDCFL-FDPTKREILDWRTRVQIIKGVAQGLLYLHQ 225
           +  +G    K +  ++ ++    SL   L    TK E++     + I +  AQG+ YLH 
Sbjct: 67  LLFMGYST-KPQLAIVTQWCEGSSLYHHLHIIETKFEMIK---LIDIARQTAQGMDYLHA 122
Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIV--FGGNDEDELQGNTSRISGTYGYM 283
            S   IIHRDLK++NI L +D+  KI DFG+A +   + G+ + E      ++SG+  +M
Sbjct: 123 KS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE------QLSGSILWM 173
Query: 284 SPEYAL---EGIFSIKSDVFSFGVLLLEIVSGK 313
           +PE      +  +S +SDV++FG++L E+++G+
Sbjct: 174 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 85/277 (30%), Positives = 139/277 (50%), Gaps = 36/277 (12%)
Query: 116 KLGEGGFGTVYKGVI-GQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCI 174
           +LG G FG V+ G   G  ++AVK L  +          EA+++ Q+QH+ LV+L    +
Sbjct: 30  RLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLY-AVV 87
Query: 175 EKDERLLIYEYMPNKSLDCFLFDP-----TKREILDWRTRVQIIKGVAQGLLYLHQYSRV 229
            ++   +I EYM N SL  FL  P     T  ++LD      +   +A+G+ ++ + +  
Sbjct: 88  TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD------MAAQIAEGMAFIEERN-- 139
Query: 230 RIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL 289
             IHRDL+A+NIL+   ++ KI+DFG+AR++   N+    +G    I  T    +PE   
Sbjct: 140 -YIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWT----APEAIN 193
Query: 290 EGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEE 349
            G F+IKSDV+SFG+LL EIV+  +         +   G       + ++I  ++     
Sbjct: 194 YGTFTIKSDVWSFGILLTEIVTHGR---------IPYPGMT-----NPEVIQNLERGYRM 239
Query: 350 ASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN 386
              +        +  LC +ER EDRPT   + S+L +
Sbjct: 240 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 276

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 78/275 (28%), Positives = 139/275 (50%), Gaps = 29/275 (10%)
Query: 117 LGEGGFGTVYKGVI----GQGEIAVKRLLGKSGQEIKE---LKNEASVIAQVQHKNLVKL 169
           +G G FG VYKG++    G+ E+ V     K+G   K+      EA ++ Q  H N+++L
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 170 LGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRV 229
            G   +    ++I EYM N +LD FL +  K         V +++G+A G+ YL   + +
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYL---ANM 166
Query: 230 RIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL 289
             +HRDL A NIL++ ++  K+SDFG++R++    D+ E    TS       + +PE   
Sbjct: 167 NYVHRDLAARNILVNSNLVCKVSDFGLSRVL---EDDPEATYTTSGGKIPIRWTAPEAIS 223
Query: 290 EGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEE 349
              F+  SDV+SFG+++ E+++       Y  +        W+L  +++++  I+     
Sbjct: 224 YRKFTSASDVWSFGIVMWEVMT-------YGERPY------WEL-SNHEVMKAINDGFRL 269
Query: 350 ASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML 384
            +  +  S    + + C Q+    RP  +D+VS+L
Sbjct: 270 PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 304

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 71/213 (33%), Positives = 121/213 (56%), Gaps = 22/213 (10%)
Query: 109 GNFSAANKLGEGGFGTVYKGVIGQGEIAVKRL--LGKSGQEIKELKNEASVIAQVQHKNL 166
           G  +   ++G G FGTVYKG    G++AVK L     + Q+++  KNE  V+ + +H N+
Sbjct: 13  GQITVGQRIGSGSFGTVYKGK-WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 71
Query: 167 VKLLGCCIEKDERLLIYEYMPNKSLDCFL-FDPTKREILDWRTRVQIIKGVAQGLLYLHQ 225
           +  +G    K +  ++ ++    SL   L    TK E++     + I +  AQG+ YLH 
Sbjct: 72  LLFMGYST-KPQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHA 127
Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIV--FGGNDEDELQGNTSRISGTYGYM 283
            S   IIHRDLK++NI L +D+  KI DFG+A +   + G+ + E      ++SG+  +M
Sbjct: 128 KS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE------QLSGSILWM 178
Query: 284 SPEYAL---EGIFSIKSDVFSFGVLLLEIVSGK 313
           +PE      +  +S +SDV++FG++L E+++G+
Sbjct: 179 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 71/213 (33%), Positives = 121/213 (56%), Gaps = 22/213 (10%)
Query: 109 GNFSAANKLGEGGFGTVYKGVIGQGEIAVKRL--LGKSGQEIKELKNEASVIAQVQHKNL 166
           G  +   ++G G FGTVYKG    G++AVK L     + Q+++  KNE  V+ + +H N+
Sbjct: 35  GQITVGQRIGSGSFGTVYKGKW-HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 93
Query: 167 VKLLGCCIEKDERLLIYEYMPNKSLDCFL-FDPTKREILDWRTRVQIIKGVAQGLLYLHQ 225
           +  +G    K +  ++ ++    SL   L    TK E++     + I +  AQG+ YLH 
Sbjct: 94  LLFMGYST-KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKL---IDIARQTAQGMDYLHA 149
Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIV--FGGNDEDELQGNTSRISGTYGYM 283
            S   IIHRDLK++NI L +D+  KI DFG+A +   + G+ + E      ++SG+  +M
Sbjct: 150 KS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE------QLSGSILWM 200
Query: 284 SPEYAL---EGIFSIKSDVFSFGVLLLEIVSGK 313
           +PE      +  +S +SDV++FG++L E+++G+
Sbjct: 201 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 233

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 71/213 (33%), Positives = 121/213 (56%), Gaps = 22/213 (10%)
Query: 109 GNFSAANKLGEGGFGTVYKGVIGQGEIAVKRL--LGKSGQEIKELKNEASVIAQVQHKNL 166
           G  +   ++G G FGTVYKG    G++AVK L     + Q+++  KNE  V+ + +H N+
Sbjct: 36  GQITVGQRIGSGSFGTVYKGKW-HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 94
Query: 167 VKLLGCCIEKDERLLIYEYMPNKSLDCFL-FDPTKREILDWRTRVQIIKGVAQGLLYLHQ 225
           +  +G    K +  ++ ++    SL   L    TK E++     + I +  AQG+ YLH 
Sbjct: 95  LLFMGYST-KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKL---IDIARQTAQGMDYLHA 150
Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIV--FGGNDEDELQGNTSRISGTYGYM 283
            S   IIHRDLK++NI L +D+  KI DFG+A +   + G+ + E      ++SG+  +M
Sbjct: 151 KS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE------QLSGSILWM 201
Query: 284 SPEYAL---EGIFSIKSDVFSFGVLLLEIVSGK 313
           +PE      +  +S +SDV++FG++L E+++G+
Sbjct: 202 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 86/277 (31%), Positives = 139/277 (50%), Gaps = 36/277 (12%)
Query: 116 KLGEGGFGTVYKGVI-GQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCI 174
           +LG G FG V+ G   G  ++AVK L  +          EA+++ Q+QH+ LV+L    +
Sbjct: 15  RLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLY-AVV 72
Query: 175 EKDERLLIYEYMPNKSLDCFLFDP-----TKREILDWRTRVQIIKGVAQGLLYLHQYSRV 229
            ++   +I EYM N SL  FL  P     T  ++LD      +   +A+G+ ++ + +  
Sbjct: 73  TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD------MAAQIAEGMAFIEERN-- 124
Query: 230 RIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL 289
             IHRDL+A+NIL+   ++ KI+DFG+AR++   N+    +G    I  T    +PE   
Sbjct: 125 -YIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWT----APEAIN 178
Query: 290 EGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEE 349
            G F+IKSDV+SFG+LL EIV+  +            I Y      + ++I  ++     
Sbjct: 179 YGTFTIKSDVWSFGILLTEIVTHGR------------IPYPG--MTNPEVIQNLERGYRM 224
Query: 350 ASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN 386
              +        +  LC +ER EDRPT   + S+L +
Sbjct: 225 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 261

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 71/213 (33%), Positives = 121/213 (56%), Gaps = 22/213 (10%)
Query: 109 GNFSAANKLGEGGFGTVYKGVIGQGEIAVKRL--LGKSGQEIKELKNEASVIAQVQHKNL 166
           G  +   ++G G FGTVYKG    G++AVK L     + Q+++  KNE  V+ + +H N+
Sbjct: 8   GQITVGQRIGSGSFGTVYKGK-WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 66
Query: 167 VKLLGCCIEKDERLLIYEYMPNKSLDCFL-FDPTKREILDWRTRVQIIKGVAQGLLYLHQ 225
           +  +G    K +  ++ ++    SL   L    TK E++     + I +  AQG+ YLH 
Sbjct: 67  LLFMGYST-KPQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHA 122
Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMA--RIVFGGNDEDELQGNTSRISGTYGYM 283
            S   IIHRDLK++NI L +D+  KI DFG+A  +  + G+ + E      ++SG+  +M
Sbjct: 123 KS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFE------QLSGSILWM 173
Query: 284 SPEYAL---EGIFSIKSDVFSFGVLLLEIVSGK 313
           +PE      +  +S +SDV++FG++L E+++G+
Sbjct: 174 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 84/285 (29%), Positives = 141/285 (49%), Gaps = 28/285 (9%)
Query: 116 KLGEGGFGTVYKGVI-GQGEIAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNLVKLLGCC 173
           KLG+G FG V+ G   G   +A+K L  K G    E    EA V+ +++H+ LV+L    
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV- 78
Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
           + ++   ++ EYM   SL  FL   T +  L     V +   +A G+ Y+    R+  +H
Sbjct: 79  VSEEPIYIVTEYMNKGSLLDFLKGETGK-YLRLPQLVDMSAQIASGMAYVE---RMNYVH 134
Query: 234 RDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIF 293
           RDL+A+NIL+ +++  K++DFG+AR++   N+    QG    I  T    +PE AL G F
Sbjct: 135 RDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWT----APEAALYGRF 189
Query: 294 SIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFN 353
           +IKSDV+SFG+LL E+ +  +                +   ++ +++D ++         
Sbjct: 190 TIKSDVWSFGILLTELTTKGR--------------VPYPGMVNREVLDQVERGYRMPCPP 235
Query: 354 ESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQPA 398
           E       +   C ++  E+RPT   + + L +  +S  P  QP 
Sbjct: 236 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 280

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 71/213 (33%), Positives = 121/213 (56%), Gaps = 22/213 (10%)
Query: 109 GNFSAANKLGEGGFGTVYKGVIGQGEIAVKRL--LGKSGQEIKELKNEASVIAQVQHKNL 166
           G  +   ++G G FGTVYKG    G++AVK L     + Q+++  KNE  V+ + +H N+
Sbjct: 28  GQITVGQRIGSGSFGTVYKGK-WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 86
Query: 167 VKLLGCCIEKDERLLIYEYMPNKSLDCFL-FDPTKREILDWRTRVQIIKGVAQGLLYLHQ 225
           +  +G    K +  ++ ++    SL   L    TK E++     + I +  AQG+ YLH 
Sbjct: 87  LLFMGYST-KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKL---IDIARQTAQGMDYLHA 142
Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMA--RIVFGGNDEDELQGNTSRISGTYGYM 283
            S   IIHRDLK++NI L +D+  KI DFG+A  +  + G+ + E      ++SG+  +M
Sbjct: 143 KS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFE------QLSGSILWM 193
Query: 284 SPEYAL---EGIFSIKSDVFSFGVLLLEIVSGK 313
           +PE      +  +S +SDV++FG++L E+++G+
Sbjct: 194 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 226

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 71/213 (33%), Positives = 121/213 (56%), Gaps = 22/213 (10%)
Query: 109 GNFSAANKLGEGGFGTVYKGVIGQGEIAVKRL--LGKSGQEIKELKNEASVIAQVQHKNL 166
           G  +   ++G G FGTVYKG    G++AVK L     + Q+++  KNE  V+ + +H N+
Sbjct: 36  GQITVGQRIGSGSFGTVYKGKW-HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 94
Query: 167 VKLLGCCIEKDERLLIYEYMPNKSLDCFL-FDPTKREILDWRTRVQIIKGVAQGLLYLHQ 225
           +  +G    K +  ++ ++    SL   L    TK E++     + I +  AQG+ YLH 
Sbjct: 95  LLFMGYST-KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKL---IDIARQTAQGMDYLHA 150
Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMA--RIVFGGNDEDELQGNTSRISGTYGYM 283
            S   IIHRDLK++NI L +D+  KI DFG+A  +  + G+ + E      ++SG+  +M
Sbjct: 151 KS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFE------QLSGSILWM 201
Query: 284 SPEYAL---EGIFSIKSDVFSFGVLLLEIVSGK 313
           +PE      +  +S +SDV++FG++L E+++G+
Sbjct: 202 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 84/285 (29%), Positives = 141/285 (49%), Gaps = 28/285 (9%)
Query: 116 KLGEGGFGTVYKGVI-GQGEIAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNLVKLLGCC 173
           KLG+G FG V+ G   G   +A+K L  K G    E    EA V+ +++H+ LV+L    
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV- 78
Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
           + ++   ++ EYM   SL  FL   T +  L     V +   +A G+ Y+    R+  +H
Sbjct: 79  VSEEPIYIVTEYMNKGSLLDFLKGETGK-YLRLPQLVDMSAQIASGMAYVE---RMNYVH 134
Query: 234 RDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIF 293
           RDL+A+NIL+ +++  K++DFG+AR++   N+    QG    I  T    +PE AL G F
Sbjct: 135 RDLRAANILVGENLVCKVADFGLARLI-EDNEWTARQGAKFPIKWT----APEAALYGRF 189
Query: 294 SIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFN 353
           +IKSDV+SFG+LL E+ +  +                +   ++ +++D ++         
Sbjct: 190 TIKSDVWSFGILLTELTTKGR--------------VPYPGMVNREVLDQVERGYRMPCPP 235
Query: 354 ESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQPA 398
           E       +   C ++  E+RPT   + + L +  +S  P  QP 
Sbjct: 236 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 280

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  104 bits (260), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 73/210 (34%), Positives = 112/210 (53%), Gaps = 26/210 (12%)
Query: 117 LGEGGFGTVYKGVIGQGEIAVKRLLGKS----GQEIKELKNEASVIAQVQHKNLVKLLGC 172
           +G GGFG VY+      E+AVK           Q I+ ++ EA + A ++H N++ L G 
Sbjct: 15  IGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGV 74
Query: 173 CIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRII 232
           C+++    L+ E+     L+  L    KR   D    V     +A+G+ YLH  + V II
Sbjct: 75  CLKEPNLCLVMEFARGGPLNRVL--SGKRIPPD--ILVNWAVQIARGMNYLHDEAIVPII 130
Query: 233 HRDLKASNILL-----DKDMNSKI---SDFGMARIVFGGNDEDELQGNTS-RISGTYGYM 283
           HRDLK+SNIL+     + D+++KI   +DFG+AR         E    T    +G Y +M
Sbjct: 131 HRDLKSSNILILQKVENGDLSNKILKITDFGLAR---------EWHRTTKMSAAGAYAWM 181
Query: 284 SPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           +PE     +FS  SDV+S+GVLL E+++G+
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTGE 211

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 85/288 (29%), Positives = 143/288 (49%), Gaps = 34/288 (11%)
Query: 116 KLGEGGFGTVYKGVI-GQGEIAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNLVKLLGCC 173
           KLG+G FG V+ G   G   +A+K L  K G    E    EA V+ +++H+ LV+L    
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKIRHEKLVQLYAV- 81
Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQ---GLLYLHQYSRVR 230
           + ++   ++ EYM   SL  FL    K E+  +    Q++   AQ   G+ Y+    R+ 
Sbjct: 82  VSEEPIYIVTEYMSKGSLLDFL----KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMN 134
Query: 231 IIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE 290
            +HRDL+A+NIL+ +++  K++DFG+AR++   N+    QG    I  T    +PE AL 
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWT----APEAALY 189
Query: 291 GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEA 350
           G F+IKSDV+SFG+LL E+ +  +                +   ++ +++D ++      
Sbjct: 190 GRFTIKSDVWSFGILLTELTTKGR--------------VPYPGMVNREVLDQVERGYRMP 235
Query: 351 SFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQPA 398
              E       +   C ++  E+RPT   + + L +  +S  P  QP 
Sbjct: 236 CPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQYQPG 283

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 87/288 (30%), Positives = 143/288 (49%), Gaps = 34/288 (11%)
Query: 116 KLGEGGFGTVYKGVI-GQGEIAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNLVKLLGCC 173
           KLG+G FG V+ G   G   +A+K L  K G    E    EA V+ +++H+ LV+L    
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQ---GLLYLHQYSRVR 230
            E+   ++I EYM   SL  FL    K E+  +    Q++   AQ   G+ Y+    R+ 
Sbjct: 83  SEEPIYIVI-EYMSKGSLLDFL----KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMN 134
Query: 231 IIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE 290
            +HRDL+A+NIL+ +++  K++DFG+AR++   N+    QG    I  T    +PE AL 
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLARLI-EDNEXTARQGAKFPIKWT----APEAALY 189
Query: 291 GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEA 350
           G F+IKSDV+SFG+LL E+ +  +                +   ++ +++D ++      
Sbjct: 190 GRFTIKSDVWSFGILLTELTTKGR--------------VPYPGMVNREVLDQVERGYRMP 235
Query: 351 SFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQPA 398
              E       +   C ++  E+RPT   + + L +  +S  P  QP 
Sbjct: 236 CPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQYQPG 283

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 87/288 (30%), Positives = 143/288 (49%), Gaps = 34/288 (11%)
Query: 116 KLGEGGFGTVYKGVI-GQGEIAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNLVKLLGCC 173
           KLG+G FG V+ G   G   +A+K L  K G    E    EA V+ +++H+ LV+L    
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQ---GLLYLHQYSRVR 230
            E+   ++I EYM   SL  FL    K E+  +    Q++   AQ   G+ Y+    R+ 
Sbjct: 83  SEEPIYIVI-EYMSKGSLLDFL----KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMN 134
Query: 231 IIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE 290
            +HRDL+A+NIL+ +++  K++DFG+AR++   N+    QG    I  T    +PE AL 
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWT----APEAALY 189
Query: 291 GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEA 350
           G F+IKSDV+SFG+LL E+ +  +                +   ++ +++D ++      
Sbjct: 190 GRFTIKSDVWSFGILLTELTTKGR--------------VPYPGMVNREVLDQVERGYRMP 235
Query: 351 SFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQPA 398
              E       +   C ++  E+RPT   + + L +  +S  P  QP 
Sbjct: 236 CPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQYQPG 283

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 85/288 (29%), Positives = 143/288 (49%), Gaps = 34/288 (11%)
Query: 116 KLGEGGFGTVYKGVI-GQGEIAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNLVKLLGCC 173
           KLG+G FG V+ G   G   +A+K L  K G    E    EA V+ +++H+ LV+L    
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV- 81
Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQ---GLLYLHQYSRVR 230
           + ++   ++ EYM   SL  FL    K E+  +    Q++   AQ   G+ Y+    R+ 
Sbjct: 82  VSEEPIYIVTEYMSKGSLLDFL----KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMN 134
Query: 231 IIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE 290
            +HRDL+A+NIL+ +++  K++DFG+AR++   N+    QG    I  T    +PE AL 
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWT----APEAALY 189
Query: 291 GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEA 350
           G F+IKSDV+SFG+LL E+ +  +                +   ++ +++D ++      
Sbjct: 190 GRFTIKSDVWSFGILLTELTTKGR--------------VPYPGMVNREVLDQVERGYRMP 235
Query: 351 SFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQPA 398
              E       +   C ++  E+RPT   + + L +  +S  P  QP 
Sbjct: 236 CPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQYQPG 283

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 85/288 (29%), Positives = 143/288 (49%), Gaps = 34/288 (11%)
Query: 116 KLGEGGFGTVYKGVI-GQGEIAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNLVKLLGCC 173
           KLG+G FG V+ G   G   +A+K L  K G    E    EA V+ +++H+ LV+L    
Sbjct: 14  KLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV- 70
Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQ---GLLYLHQYSRVR 230
           + ++   ++ EYM   SL  FL    K E+  +    Q++   AQ   G+ Y+    R+ 
Sbjct: 71  VSEEPIYIVTEYMSKGSLLDFL----KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMN 123
Query: 231 IIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE 290
            +HRDL+A+NIL+ +++  K++DFG+AR++   N+    QG    I  T    +PE AL 
Sbjct: 124 YVHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWT----APEAALY 178
Query: 291 GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEA 350
           G F+IKSDV+SFG+LL E+ +  +                +   ++ +++D ++      
Sbjct: 179 GRFTIKSDVWSFGILLTELTTKGR--------------VPYPGMVNREVLDQVERGYRMP 224
Query: 351 SFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQPA 398
              E       +   C ++  E+RPT   + + L +  +S  P  QP 
Sbjct: 225 CPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQYQPG 272

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 85/288 (29%), Positives = 143/288 (49%), Gaps = 34/288 (11%)
Query: 116 KLGEGGFGTVYKGVI-GQGEIAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNLVKLLGCC 173
           KLG+G FG V+ G   G   +A+K L  K G    E    EA V+ +++H+ LV+L    
Sbjct: 16  KLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV- 72
Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQ---GLLYLHQYSRVR 230
           + ++   ++ EYM   SL  FL    K E+  +    Q++   AQ   G+ Y+    R+ 
Sbjct: 73  VSEEPIYIVTEYMSKGSLLDFL----KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMN 125
Query: 231 IIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE 290
            +HRDL+A+NIL+ +++  K++DFG+AR++   N+    QG    I  T    +PE AL 
Sbjct: 126 YVHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWT----APEAALY 180
Query: 291 GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEA 350
           G F+IKSDV+SFG+LL E+ +  +                +   ++ +++D ++      
Sbjct: 181 GRFTIKSDVWSFGILLTELTTKGR--------------VPYPGMVNREVLDQVERGYRMP 226
Query: 351 SFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQPA 398
              E       +   C ++  E+RPT   + + L +  +S  P  QP 
Sbjct: 227 CPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQYQPG 274

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 92/319 (28%), Positives = 144/319 (45%), Gaps = 54/319 (16%)
Query: 93  VDQFPLFSFSSVSSATGNFSAANKLGEGGFGTV-------YKGVIGQGEIAVKRLL-GKS 144
           VD F +           N      LGEG FG V        KG  G   +AVK L    S
Sbjct: 7   VDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS 66
Query: 145 GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTK---- 200
             E+++L +E +V+ QV H +++KL G C +    LLI EY    SL  FL +  K    
Sbjct: 67  PSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPG 126
Query: 201 ---------REILDWRTRVQIIKG--------VAQGLLYLHQYSRVRIIHRDLKASNILL 243
                       LD      +  G        ++QG+ YL   + ++++HRDL A NIL+
Sbjct: 127 YLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILV 183
Query: 244 DKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFG 303
            +    KISDFG++R V+   ++  ++ +  RI     +M+ E   + I++ +SDV+SFG
Sbjct: 184 AEGRKMKISDFGLSRDVY--EEDSXVKRSQGRIP--VKWMAIESLFDHIYTTQSDVWSFG 239
Query: 304 VLLLEIVS--GKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVH 361
           VLL EIV+  G    G    +  NL+        +   ++  D+  EE            
Sbjct: 240 VLLWEIVTLGGNPYPGIPPERLFNLLK-------TGHRMERPDNCSEEM---------YR 283
Query: 362 IALLCVQERAEDRPTMSDV 380
           + L C ++  + RP  +D+
Sbjct: 284 LMLQCWKQEPDKRPVFADI 302

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 139/279 (49%), Gaps = 26/279 (9%)
Query: 115 NKLGEGGFGTVYKGV-IGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCC 173
            ++G G FG V+ G  + + ++A+K +   +  E ++   EA V+ ++ H  LV+L G C
Sbjct: 13  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
           +E+    L++E+M +  L  +L   T+R +    T + +   V +G+ YL + S   +IH
Sbjct: 72  LEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAS---VIH 126
Query: 234 RDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIF 293
           RDL A N L+ ++   K+SDFGM R V      D+   +++       + SPE      +
Sbjct: 127 RDLAARNCLVGENQVIKVSDFGMTRFVL-----DDQYTSSTGTKFPVKWASPEVFSFSRY 181
Query: 294 SIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFN 353
           S KSDV+SFGVL+ E+ S  K    Y  +S            ++++++ I +        
Sbjct: 182 SSKSDVWSFGVLMWEVFSEGKIP--YENRS------------NSEVVEDISTGFRLYKPR 227
Query: 354 ESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLL 392
            + +    I   C +ER EDRP  S ++  L   A+S L
Sbjct: 228 LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAAIAASGL 266

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 85/277 (30%), Positives = 139/277 (50%), Gaps = 36/277 (12%)
Query: 116 KLGEGGFGTVYKGVI-GQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCI 174
           +LG G FG V+ G   G  ++AVK L  +          EA+++ Q+QH+ LV+L    +
Sbjct: 16  RLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLY-AVV 73
Query: 175 EKDERLLIYEYMPNKSLDCFLFDP-----TKREILDWRTRVQIIKGVAQGLLYLHQYSRV 229
            ++   +I EYM N SL  FL  P     T  ++LD      +   +A+G+ ++ + +  
Sbjct: 74  TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD------MAAQIAEGMAFIEERN-- 125
Query: 230 RIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL 289
             IHR+L+A+NIL+   ++ KI+DFG+AR++   N+    +G    I  T    +PE   
Sbjct: 126 -YIHRNLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWT----APEAIN 179
Query: 290 EGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEE 349
            G F+IKSDV+SFG+LL EIV+  +            I Y      + ++I  ++     
Sbjct: 180 YGTFTIKSDVWSFGILLTEIVTHGR------------IPYPG--MTNPEVIQNLERGYRM 225
Query: 350 ASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN 386
              +        +  LC +ER EDRPT   + S+L +
Sbjct: 226 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 262

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 142/288 (49%), Gaps = 34/288 (11%)
Query: 116 KLGEGGFGTVYKGVI-GQGEIAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNLVKLLGCC 173
           KLG+G FG V+ G   G   +A+K L  K G    E    EA V+ +++H+ LV+L    
Sbjct: 192 KLGQGCFGEVWMGTWNGTTRVAIKTL--KPGNMSPEAFLQEAQVMKKLRHEKLVQLYAV- 248
Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQ---GLLYLHQYSRVR 230
           + ++   ++ EYM   SL  FL    K E+  +    Q++   AQ   G+ Y+    R+ 
Sbjct: 249 VSEEPIYIVTEYMSKGSLLDFL----KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMN 301
Query: 231 IIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE 290
            +HRDL+A+NIL+ +++  K++DFG+ R++   N+    QG    I  T    +PE AL 
Sbjct: 302 YVHRDLRAANILVGENLVCKVADFGLGRLI-EDNEYTARQGAKFPIKWT----APEAALY 356
Query: 291 GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEA 350
           G F+IKSDV+SFG+LL E+ +  +                +   ++ +++D ++      
Sbjct: 357 GRFTIKSDVWSFGILLTELTTKGR--------------VPYPGMVNREVLDQVERGYRMP 402
Query: 351 SFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQPA 398
              E       +   C ++  E+RPT   + + L +  +S  P  QP 
Sbjct: 403 CPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQXQPG 450

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 120/213 (56%), Gaps = 22/213 (10%)
Query: 109 GNFSAANKLGEGGFGTVYKGVIGQGEIAVKRL--LGKSGQEIKELKNEASVIAQVQHKNL 166
           G  +   ++G G FGTVYKG    G++AVK L     + Q+++  KNE  V+ + +H N+
Sbjct: 8   GQITVGQRIGSGSFGTVYKGK-WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 66
Query: 167 VKLLGCCIEKDERLLIYEYMPNKSLDCFL-FDPTKREILDWRTRVQIIKGVAQGLLYLHQ 225
           +  +G      +  ++ ++    SL   L    TK E++     + I +  AQG+ YLH 
Sbjct: 67  LLFMGYSTAP-QLAIVTQWCEGSSLYHHLHIIETKFEMIK---LIDIARQTAQGMDYLHA 122
Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIV--FGGNDEDELQGNTSRISGTYGYM 283
            S   IIHRDLK++NI L +D+  KI DFG+A +   + G+ + E      ++SG+  +M
Sbjct: 123 KS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE------QLSGSILWM 173
Query: 284 SPEYAL---EGIFSIKSDVFSFGVLLLEIVSGK 313
           +PE      +  +S +SDV++FG++L E+++G+
Sbjct: 174 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 93/319 (29%), Positives = 143/319 (44%), Gaps = 54/319 (16%)
Query: 93  VDQFPLFSFSSVSSATGNFSAANKLGEGGFGTV-------YKGVIGQGEIAVKRLL-GKS 144
           VD F +           N      LGEG FG V        KG  G   +AVK L    S
Sbjct: 7   VDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS 66
Query: 145 GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTK---- 200
             E+++L +E +V+ QV H +++KL G C +    LLI EY    SL  FL +  K    
Sbjct: 67  PSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPG 126
Query: 201 ---------REILDWRTRVQIIKG--------VAQGLLYLHQYSRVRIIHRDLKASNILL 243
                       LD      +  G        ++QG+ YL + S   ++HRDL A NIL+
Sbjct: 127 YLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMS---LVHRDLAARNILV 183
Query: 244 DKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFG 303
            +    KISDFG++R V+   ++  ++ +  RI     +M+ E   + I++ +SDV+SFG
Sbjct: 184 AEGRKMKISDFGLSRDVY--EEDSXVKRSQGRIP--VKWMAIESLFDHIYTTQSDVWSFG 239
Query: 304 VLLLEIVS--GKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVH 361
           VLL EIV+  G    G    +  NL+        +   ++  D+  EE            
Sbjct: 240 VLLWEIVTLGGNPYPGIPPERLFNLLK-------TGHRMERPDNCSEEM---------YR 283
Query: 362 IALLCVQERAEDRPTMSDV 380
           + L C ++  + RP  +D+
Sbjct: 284 LMLQCWKQEPDKRPVFADI 302

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 85/288 (29%), Positives = 143/288 (49%), Gaps = 34/288 (11%)
Query: 116 KLGEGGFGTVYKGVI-GQGEIAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNLVKLLGCC 173
           KLG+G FG V+ G   G   +A+K L  K G    E    EA V+ +++H+ LV+L    
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV- 81
Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQ---GLLYLHQYSRVR 230
           + ++   ++ EYM   SL  FL    K E+  +    Q++   AQ   G+ Y+    R+ 
Sbjct: 82  VSEEPIYIVCEYMSKGSLLDFL----KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMN 134
Query: 231 IIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE 290
            +HRDL+A+NIL+ +++  K++DFG+AR++   N+    QG    I  T    +PE AL 
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWT----APEAALY 189
Query: 291 GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEA 350
           G F+IKSDV+SFG+LL E+ +  +                +   ++ +++D ++      
Sbjct: 190 GRFTIKSDVWSFGILLTELTTKGR--------------VPYPGMVNREVLDQVERGYRMP 235
Query: 351 SFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQPA 398
              E       +   C ++  E+RPT   + + L +  +S  P  QP 
Sbjct: 236 CPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQYQPG 283

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 92/319 (28%), Positives = 144/319 (45%), Gaps = 54/319 (16%)
Query: 93  VDQFPLFSFSSVSSATGNFSAANKLGEGGFGTV-------YKGVIGQGEIAVKRLL-GKS 144
           VD F +           N      LGEG FG V        KG  G   +AVK L    S
Sbjct: 7   VDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS 66
Query: 145 GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTK---- 200
             E+++L +E +V+ QV H +++KL G C +    LLI EY    SL  FL +  K    
Sbjct: 67  PSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPG 126
Query: 201 ---------REILDWRTRVQIIKG--------VAQGLLYLHQYSRVRIIHRDLKASNILL 243
                       LD      +  G        ++QG+ YL   + ++++HRDL A NIL+
Sbjct: 127 YLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILV 183
Query: 244 DKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFG 303
            +    KISDFG++R V+   ++  ++ +  RI     +M+ E   + I++ +SDV+SFG
Sbjct: 184 AEGRKMKISDFGLSRDVY--EEDSYVKRSQGRIP--VKWMAIESLFDHIYTTQSDVWSFG 239
Query: 304 VLLLEIVS--GKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVH 361
           VLL EIV+  G    G    +  NL+        +   ++  D+  EE            
Sbjct: 240 VLLWEIVTLGGNPYPGIPPERLFNLLK-------TGHRMERPDNCSEEM---------YR 283
Query: 362 IALLCVQERAEDRPTMSDV 380
           + L C ++  + RP  +D+
Sbjct: 284 LMLQCWKQEPDKRPVFADI 302

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 85/277 (30%), Positives = 138/277 (49%), Gaps = 34/277 (12%)
Query: 117 LGEGGFGTVYKG---VIGQGEI--AVKRL-LGKSGQEIKELKNEASVIAQVQHKNLVKLL 170
           +G G FG V  G   V G+ EI  A+K L  G + ++ ++  +EAS++ Q  H N++ L 
Sbjct: 37  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 96
Query: 171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVR 230
           G   +    ++I EYM N SLD FL     R  +     V +++G+  G+ YL   S V 
Sbjct: 97  GVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV--IQLVGMLRGIGSGMKYLSDMSAV- 153
Query: 231 IIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE 290
             HRDL A NIL++ ++  K+SDFGM+R++    D+ E    T        + +PE    
Sbjct: 154 --HRDLAARNILVNSNLVCKVSDFGMSRVL---EDDPEAAYTTRGGKIPIRWTAPEAIAY 208
Query: 291 GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEA 350
             F+  SDV+S+G+++ E++S       Y  +        WD+  SN+  D+I ++ E  
Sbjct: 209 RKFTSASDVWSYGIVMWEVMS-------YGERPY------WDM--SNQ--DVIKAIEEGY 251
Query: 351 SFNESLSRYV---HIALLCVQERAEDRPTMSDVVSML 384
                +   +    + L C Q+   DRP    +V+ML
Sbjct: 252 RLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNML 288

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 85/277 (30%), Positives = 138/277 (49%), Gaps = 34/277 (12%)
Query: 117 LGEGGFGTVYKG---VIGQGEI--AVKRL-LGKSGQEIKELKNEASVIAQVQHKNLVKLL 170
           +G G FG V  G   V G+ EI  A+K L  G + ++ ++  +EAS++ Q  H N++ L 
Sbjct: 16  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 75
Query: 171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVR 230
           G   +    ++I EYM N SLD FL     R  +     V +++G+  G+ YL   S V 
Sbjct: 76  GVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV--IQLVGMLRGIGSGMKYLSDMSYV- 132
Query: 231 IIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE 290
             HRDL A NIL++ ++  K+SDFGM+R++    D+ E    T        + +PE    
Sbjct: 133 --HRDLAARNILVNSNLVCKVSDFGMSRVL---EDDPEAAYTTRGGKIPIRWTAPEAIAY 187
Query: 291 GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEA 350
             F+  SDV+S+G+++ E++S       Y  +        WD+  SN+  D+I ++ E  
Sbjct: 188 RKFTSASDVWSYGIVMWEVMS-------YGERPY------WDM--SNQ--DVIKAIEEGY 230
Query: 351 SFNESLSRYV---HIALLCVQERAEDRPTMSDVVSML 384
                +   +    + L C Q+   DRP    +V+ML
Sbjct: 231 RLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNML 267

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 119/213 (55%), Gaps = 22/213 (10%)
Query: 109 GNFSAANKLGEGGFGTVYKGVIGQGEIAVKRL--LGKSGQEIKELKNEASVIAQVQHKNL 166
           G  +   ++G G FGTVYKG    G++AVK L     + Q+++  KNE  V+ + +H N+
Sbjct: 12  GQITVGQRIGSGSFGTVYKGKW-HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 70
Query: 167 VKLLGCCIEKDERLLIYEYMPNKSLDCFLF-DPTKREILDWRTRVQIIKGVAQGLLYLHQ 225
           +  +G    K +  ++ ++    SL   L    TK E+   +  + I +  A+G+ YLH 
Sbjct: 71  LLFMGYST-KPQLAIVTQWCEGSSLYHHLHASETKFEM---KKLIDIARQTARGMDYLHA 126
Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIV--FGGNDEDELQGNTSRISGTYGYM 283
            S   IIHRDLK++NI L +D   KI DFG+A +   + G+ + E      ++SG+  +M
Sbjct: 127 KS---IIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFE------QLSGSILWM 177
Query: 284 SPEYAL---EGIFSIKSDVFSFGVLLLEIVSGK 313
           +PE         +S +SDV++FG++L E+++G+
Sbjct: 178 APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 210

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 85/277 (30%), Positives = 138/277 (49%), Gaps = 34/277 (12%)
Query: 117 LGEGGFGTVYKG---VIGQGEI--AVKRL-LGKSGQEIKELKNEASVIAQVQHKNLVKLL 170
           +G G FG V  G   V G+ EI  A+K L  G + ++ ++  +EAS++ Q  H N++ L 
Sbjct: 22  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 81
Query: 171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVR 230
           G   +    ++I EYM N SLD FL     R  +     V +++G+  G+ YL   S V 
Sbjct: 82  GVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVI--QLVGMLRGIGSGMKYLSDMSYV- 138
Query: 231 IIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE 290
             HRDL A NIL++ ++  K+SDFGM+R++    D+ E    T        + +PE    
Sbjct: 139 --HRDLAARNILVNSNLVCKVSDFGMSRVL---EDDPEAAYTTRGGKIPIRWTAPEAIAY 193
Query: 291 GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEA 350
             F+  SDV+S+G+++ E++S       Y  +        WD+  SN+  D+I ++ E  
Sbjct: 194 RKFTSASDVWSYGIVMWEVMS-------YGERPY------WDM--SNQ--DVIKAIEEGY 236
Query: 351 SFNESLSRYV---HIALLCVQERAEDRPTMSDVVSML 384
                +   +    + L C Q+   DRP    +V+ML
Sbjct: 237 RLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNML 273

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 67/203 (33%), Positives = 109/203 (53%), Gaps = 10/203 (4%)
Query: 110 NFSAANKLGEGGFGTVYKGVIGQGEIAVK-RLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
           + +  +KLG G +G VY GV  +  + V  + L +   E++E   EA+V+ +++H NLV+
Sbjct: 33  DITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 92
Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSR 228
           LLG C  +    ++ EYMP  +L  +L +  + E+    T V ++    Q    +    +
Sbjct: 93  LLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEV----TAVVLLYMATQISSAMEYLEK 148
Query: 229 VRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYA 288
              IHRDL A N L+ ++   K++DFG++R++  G+      G    I  T    +PE  
Sbjct: 149 KNFIHRDLAARNCLVGENHVVKVADFGLSRLM-TGDTYTAHAGAKFPIKWT----APESL 203
Query: 289 LEGIFSIKSDVFSFGVLLLEIVS 311
               FSIKSDV++FGVLL EI +
Sbjct: 204 AYNTFSIKSDVWAFGVLLWEIAT 226

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 86/285 (30%), Positives = 140/285 (49%), Gaps = 28/285 (9%)
Query: 116 KLGEGGFGTVYKGVI-GQGEIAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNLVKLLGCC 173
           +LG G FG V+ G   G  ++A+K L  K G    E    EA ++ +++H  LV+L    
Sbjct: 16  RLGNGQFGEVWMGTWNGNTKVAIKTL--KPGTMSPESFLEEAQIMKKLKHDKLVQLY-AV 72
Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
           + ++   ++ EYM   SL  FL D   R  L     V +   VA G+ Y+    R+  IH
Sbjct: 73  VSEEPIYIVTEYMNKGSLLDFLKDGEGR-ALKLPNLVDMAAQVAAGMAYIE---RMNYIH 128
Query: 234 RDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIF 293
           RDL+++NIL+   +  KI+DFG+AR++   N+    QG    I  T    +PE AL G F
Sbjct: 129 RDLRSANILVGNGLICKIADFGLARLI-EDNEXTARQGAKFPIKWT----APEAALYGRF 183
Query: 294 SIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFN 353
           +IKSDV+SFG+LL E+V+     G      +N          + ++++ ++         
Sbjct: 184 TIKSDVWSFGILLTELVT----KGRVPYPGMN----------NREVLEQVERGYRMPCPQ 229
Query: 354 ESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQPA 398
           +       + + C ++  E+RPT   + S L +  ++  P  QP 
Sbjct: 230 DCPISLHELMIHCWKKDPEERPTFEYLQSFLEDYFTATEPQYQPG 274

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 85/288 (29%), Positives = 142/288 (49%), Gaps = 34/288 (11%)
Query: 116 KLGEGGFGTVYKGVI-GQGEIAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNLVKLLGCC 173
           KLG+G FG V+ G   G   +A+K L  K G    E    EA V+ +++H+ LV+L    
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV- 81
Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQ---GLLYLHQYSRVR 230
           + ++   ++ EYM   SL  FL    K E+  +    Q++   AQ   G+ Y+    R+ 
Sbjct: 82  VSEEPIYIVTEYMSKGSLLDFL----KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMN 134
Query: 231 IIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE 290
            +HRDL A+NIL+ +++  K++DFG+AR++   N+    QG    I  T    +PE AL 
Sbjct: 135 YVHRDLAAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWT----APEAALY 189
Query: 291 GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEA 350
           G F+IKSDV+SFG+LL E+ +  +                +   ++ +++D ++      
Sbjct: 190 GRFTIKSDVWSFGILLTELTTKGR--------------VPYPGMVNREVLDQVERGYRMP 235
Query: 351 SFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQPA 398
              E       +   C ++  E+RPT   + + L +  +S  P  QP 
Sbjct: 236 CPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQYQPG 283

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 85/288 (29%), Positives = 143/288 (49%), Gaps = 34/288 (11%)
Query: 116 KLGEGGFGTVYKGVI-GQGEIAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNLVKLLGCC 173
           KLG+G FG V+ G   G   +A+K L  K G    E    EA V+ +++H+ LV+L    
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV- 81
Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQ---GLLYLHQYSRVR 230
           + ++   ++ EYM   S  C L D  K E+  +    Q++   AQ   G+ Y+    R+ 
Sbjct: 82  VSEEPIYIVMEYM---SKGCLL-DFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMN 134
Query: 231 IIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE 290
            +HRDL+A+NIL+ +++  K++DFG+AR++   N+    QG    I  T    +PE AL 
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWT----APEAALY 189
Query: 291 GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEA 350
           G F+IKSDV+SFG+LL E+ +  +                +   ++ +++D ++      
Sbjct: 190 GRFTIKSDVWSFGILLTELTTKGR--------------VPYPGMVNREVLDQVERGYRMP 235
Query: 351 SFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQPA 398
              E       +   C ++  E+RPT   + + L +  +S  P  QP 
Sbjct: 236 CPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQYQPG 283

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 82/285 (28%), Positives = 141/285 (49%), Gaps = 36/285 (12%)
Query: 110 NFSAANKLGEGGFGTVYKGVIG-----QGEIAVKRL-LGKSGQEIKELKNEASVIAQVQH 163
           N S    +G G FG V  G +      +  +A+K L +G + ++ ++   EAS++ Q  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 164 KNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQII---KGVAQGL 220
            N+++L G   +    +++ EYM N SLD FL     R+     T +Q++   +G+A G+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-----RKHDAQFTVIQLVGMLRGIASGM 160
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY 280
            YL   S +  +HRDL A NIL++ ++  K+SDFG+AR++    D+ E    T       
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVL---EDDPEAAYTTRGGKIPI 214
Query: 281 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNK-I 339
            + SPE      F+  SDV+S+G++L E++S       Y  +        W++  SN+ +
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS-------YGERPY------WEM--SNQDV 259
Query: 340 IDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML 384
           I  +D         +  +    + L C Q+   +RP    +VS+L
Sbjct: 260 IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 85/288 (29%), Positives = 143/288 (49%), Gaps = 34/288 (11%)
Query: 116 KLGEGGFGTVYKGVI-GQGEIAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNLVKLLGCC 173
           KLG+G FG V+ G   G   +A+K L  K G    E    EA V+ +++H+ LV+L    
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV- 81
Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQ---GLLYLHQYSRVR 230
           + ++   ++ EYM   S  C L D  K E+  +    Q++   AQ   G+ Y+    R+ 
Sbjct: 82  VSEEPIYIVTEYM---SKGCLL-DFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMN 134
Query: 231 IIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE 290
            +HRDL+A+NIL+ +++  K++DFG+AR++   N+    QG    I  T    +PE AL 
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWT----APEAALY 189
Query: 291 GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEA 350
           G F+IKSDV+SFG+LL E+ +  +                +   ++ +++D ++      
Sbjct: 190 GRFTIKSDVWSFGILLTELTTKGR--------------VPYPGMVNREVLDQVERGYRMP 235
Query: 351 SFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQPA 398
              E       +   C ++  E+RPT   + + L +  +S  P  QP 
Sbjct: 236 CPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQYQPG 283

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 80/279 (28%), Positives = 137/279 (49%), Gaps = 26/279 (9%)
Query: 115 NKLGEGGFGTVYKGV-IGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCC 173
            ++G G FG V+ G  + + ++A+K +   +  E ++   EA V+ ++ H  LV+L G C
Sbjct: 11  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
           +E+    L++E+M +  L  +L   T+R +    T + +   V +G+ YL +     +IH
Sbjct: 70  LEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 124
Query: 234 RDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIF 293
           RDL A N L+ ++   K+SDFGM R V      D+   +++       + SPE      +
Sbjct: 125 RDLAARNCLVGENQVIKVSDFGMTRFVL-----DDQYTSSTGTKFPVKWASPEVFSFSRY 179
Query: 294 SIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFN 353
           S KSDV+SFGVL+ E+ S  K    Y  +S            ++++++ I +        
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIP--YENRS------------NSEVVEDISTGFRLYKPR 225
Query: 354 ESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLL 392
            + +    I   C +ER EDRP  S ++  L   A S L
Sbjct: 226 LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESGL 264

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 80/279 (28%), Positives = 137/279 (49%), Gaps = 26/279 (9%)
Query: 115 NKLGEGGFGTVYKGV-IGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCC 173
            ++G G FG V+ G  + + ++A+K +   +  E ++   EA V+ ++ H  LV+L G C
Sbjct: 13  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
           +E+    L++E+M +  L  +L   T+R +    T + +   V +G+ YL +     +IH
Sbjct: 72  LEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 126
Query: 234 RDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIF 293
           RDL A N L+ ++   K+SDFGM R V      D+   +++       + SPE      +
Sbjct: 127 RDLAARNCLVGENQVIKVSDFGMTRFVL-----DDQYTSSTGTKFPVKWASPEVFSFSRY 181
Query: 294 SIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFN 353
           S KSDV+SFGVL+ E+ S  K    Y  +S            ++++++ I +        
Sbjct: 182 SSKSDVWSFGVLMWEVFSEGKIP--YENRS------------NSEVVEDISTGFRLYKPR 227
Query: 354 ESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLL 392
            + +    I   C +ER EDRP  S ++  L   A S L
Sbjct: 228 LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESGL 266

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 80/279 (28%), Positives = 137/279 (49%), Gaps = 26/279 (9%)
Query: 115 NKLGEGGFGTVYKGV-IGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCC 173
            ++G G FG V+ G  + + ++A+K +   +  E ++   EA V+ ++ H  LV+L G C
Sbjct: 16  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVC 74
Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
           +E+    L++E+M +  L  +L   T+R +    T + +   V +G+ YL +     +IH
Sbjct: 75  LEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 129
Query: 234 RDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIF 293
           RDL A N L+ ++   K+SDFGM R V      D+   +++       + SPE      +
Sbjct: 130 RDLAARNCLVGENQVIKVSDFGMTRFVL-----DDQYTSSTGTKFPVKWASPEVFSFSRY 184
Query: 294 SIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFN 353
           S KSDV+SFGVL+ E+ S  K    Y  +S            ++++++ I +        
Sbjct: 185 SSKSDVWSFGVLMWEVFSEGKIP--YENRS------------NSEVVEDISTGFRLYKPR 230
Query: 354 ESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLL 392
            + +    I   C +ER EDRP  S ++  L   A S L
Sbjct: 231 LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESGL 269

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 119/213 (55%), Gaps = 22/213 (10%)
Query: 109 GNFSAANKLGEGGFGTVYKGVIGQGEIAVKRL--LGKSGQEIKELKNEASVIAQVQHKNL 166
           G  +   ++G G FGTVYKG    G++AVK L     + Q+++  KNE  V+ + +H N+
Sbjct: 24  GQITVGQRIGSGSFGTVYKGKW-HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 82
Query: 167 VKLLGCCIEKDERLLIYEYMPNKSLDCFLF-DPTKREILDWRTRVQIIKGVAQGLLYLHQ 225
           +  +G    K +  ++ ++    SL   L    TK E+   +  + I +  A+G+ YLH 
Sbjct: 83  LLFMGYST-KPQLAIVTQWCEGSSLYHHLHASETKFEM---KKLIDIARQTARGMDYLHA 138
Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMA--RIVFGGNDEDELQGNTSRISGTYGYM 283
            S   IIHRDLK++NI L +D   KI DFG+A  +  + G+ + E      ++SG+  +M
Sbjct: 139 KS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFE------QLSGSILWM 189
Query: 284 SPEYAL---EGIFSIKSDVFSFGVLLLEIVSGK 313
           +PE         +S +SDV++FG++L E+++G+
Sbjct: 190 APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 136/279 (48%), Gaps = 26/279 (9%)
Query: 115 NKLGEGGFGTVYKGV-IGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCC 173
            ++G G FG V+ G  + + ++A+K +   S  E  +   EA V+ ++ H  LV+L G C
Sbjct: 33  QEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSE-DDFIEEAEVMMKLSHPKLVQLYGVC 91
Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
           +E+    L++E+M +  L  +L   T+R +    T + +   V +G+ YL +     +IH
Sbjct: 92  LEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 146
Query: 234 RDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIF 293
           RDL A N L+ ++   K+SDFGM R V      D+   +++       + SPE      +
Sbjct: 147 RDLAARNCLVGENQVIKVSDFGMTRFVL-----DDQYTSSTGTKFPVKWASPEVFSFSRY 201
Query: 294 SIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFN 353
           S KSDV+SFGVL+ E+ S  K    Y  +S            ++++++ I +        
Sbjct: 202 SSKSDVWSFGVLMWEVFSEGKIP--YENRS------------NSEVVEDISTGFRLYKPR 247
Query: 354 ESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLL 392
            + +    I   C +ER EDRP  S ++  L   A S L
Sbjct: 248 LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESGL 286

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 83/279 (29%), Positives = 138/279 (49%), Gaps = 40/279 (14%)
Query: 116 KLGEGGFGTVYKGVI-GQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCI 174
           +LG G  G V+ G   G  ++AVK L  +          EA+++ Q+QH+ LV+L    +
Sbjct: 20  RLGAGQAGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLY-AVV 77
Query: 175 EKDERLLIYEYMPNKSLDCFLFDP-----TKREILDWRTRVQIIKGVAQGLLYLHQYSRV 229
            ++   +I EYM N SL  FL  P     T  ++LD      +   +A+G+ ++ + +  
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD------MAAQIAEGMAFIEERN-- 129
Query: 230 RIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYG--YMSPEY 287
             IHRDL+A+NIL+   ++ KI+DFG+AR++       E    T+R    +   + +PE 
Sbjct: 130 -YIHRDLRAANILVSDTLSCKIADFGLARLI-------EDAEXTAREGAKFPIKWTAPEA 181
Query: 288 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVL 347
              G F+IKSDV+SFG+LL EIV+  +         +   G       + ++I  ++   
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGR---------IPYPGMT-----NPEVIQNLERGY 227
Query: 348 EEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN 386
                +        +  LC +ER EDRPT   + S+L +
Sbjct: 228 RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score =  101 bits (252), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 141/285 (49%), Gaps = 36/285 (12%)
Query: 110 NFSAANKLGEGGFGTVYKGVIG-----QGEIAVKRL-LGKSGQEIKELKNEASVIAQVQH 163
           N S    +G G FG V  G +      +  +A+K L +G + ++ ++   EAS++ Q  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 164 KNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQII---KGVAQGL 220
            N+++L G   +    +++ EYM N SLD FL     R+     T +Q++   +G+A G+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-----RKHDAQFTVIQLVGMLRGIASGM 160
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY 280
            YL   S +  +HRDL A NIL++ ++  K+SDFG++R++    D+ E    T       
Sbjct: 161 KYL---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVL---EDDPEAAYTTRGGKIPI 214
Query: 281 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNK-I 339
            + SPE      F+  SDV+S+G++L E++S       Y  +        W++  SN+ +
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS-------YGERPY------WEM--SNQDV 259
Query: 340 IDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML 384
           I  +D         +  +    + L C Q+   +RP    +VS+L
Sbjct: 260 IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 126/272 (46%), Gaps = 23/272 (8%)
Query: 115 NKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCI 174
            +LG G FG V+ G          + L      ++    EA+++  +QH  LV+L     
Sbjct: 19  KRLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 78
Query: 175 EKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHR 234
            ++   +I EYM   SL  FL      ++L  +  +     +A+G+ Y+    R   IHR
Sbjct: 79  REEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKL-IDFSAQIAEGMAYIE---RKNYIHR 134
Query: 235 DLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFS 294
           DL+A+N+L+ + +  KI+DFG+AR++   N+    +G    I  T    +PE    G F+
Sbjct: 135 DLRAANVLVSESLMCKIADFGLARVI-EDNEYTAREGAKFPIKWT----APEAINFGCFT 189
Query: 295 IKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNE 354
           IKSDV+SFG+LL EIV+  K     RT +               ++  +           
Sbjct: 190 IKSDVWSFGILLYEIVTYGKIPYPGRTNA--------------DVMTALSQGYRMPRVEN 235
Query: 355 SLSRYVHIALLCVQERAEDRPTMSDVVSMLTN 386
                  I  +C +E+AE+RPT   + S+L +
Sbjct: 236 CPDELYDIMKMCWKEKAEERPTFDYLQSVLDD 267

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 141/285 (49%), Gaps = 36/285 (12%)
Query: 110 NFSAANKLGEGGFGTVYKGVIG-----QGEIAVKRL-LGKSGQEIKELKNEASVIAQVQH 163
           N S    +G G FG V  G +      +  +A+K L +G + ++ ++   EAS++ Q  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 164 KNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQII---KGVAQGL 220
            N+++L G   +    +++ EYM N SLD FL     R+     T +Q++   +G+A G+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-----RKHDAQFTVIQLVGMLRGIASGM 160
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY 280
            YL   S +  +HRDL A NIL++ ++  K+SDFG++R++    D+ E    T       
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVL---EDDPEAAYTTRGGKIPI 214
Query: 281 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNK-I 339
            + SPE      F+  SDV+S+G++L E++S       Y  +        W++  SN+ +
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS-------YGERPY------WEM--SNQDV 259
Query: 340 IDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML 384
           I  +D         +  +    + L C Q+   +RP    +VS+L
Sbjct: 260 IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 84/277 (30%), Positives = 136/277 (49%), Gaps = 19/277 (6%)
Query: 117 LGEGGFGTV----YKGV-IGQGE-IAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNLVKL 169
           LGEG FG V    Y     G GE +AVK L    G + +   K E  ++  + H++++K 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 170 LGCCIEKDER--LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYS 227
            GCC ++ E+   L+ EY+P  SL  +L     R  +     +   + + +G+ YLH   
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLHS-- 135
Query: 228 RVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEY 287
               IHR+L A N+LLD D   KI DFG+A+ V  G++   ++ +    S  + Y +PE 
Sbjct: 136 -QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD--SPVFWY-APEC 191
Query: 288 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVL 347
             E  F   SDV+SFGV L E+++   ++    TK L LIG A       ++ +L++   
Sbjct: 192 LKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGE 251
Query: 348 EEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML 384
                ++      H+   C +  A  RPT  +++ +L
Sbjct: 252 RLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPIL 288

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 141/285 (49%), Gaps = 36/285 (12%)
Query: 110 NFSAANKLGEGGFGTVYKGVIG-----QGEIAVKRL-LGKSGQEIKELKNEASVIAQVQH 163
           N S    +G G FG V  G +      +  +A+K L +G + ++ ++   EAS++ Q  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 164 KNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQII---KGVAQGL 220
            N+++L G   +    +++ EYM N SLD FL     R+     T +Q++   +G+A G+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-----RKHDAQFTVIQLVGMLRGIASGM 160
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY 280
            YL   S +  +HRDL A NIL++ ++  K+SDFG++R++    D+ E    T       
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVL---EDDPEAAYTTRGGKIPI 214
Query: 281 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNK-I 339
            + SPE      F+  SDV+S+G++L E++S       Y  +        W++  SN+ +
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS-------YGERPY------WEM--SNQDV 259
Query: 340 IDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML 384
           I  +D         +  +    + L C Q+   +RP    +VS+L
Sbjct: 260 IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 141/285 (49%), Gaps = 36/285 (12%)
Query: 110 NFSAANKLGEGGFGTVYKGVIG-----QGEIAVKRL-LGKSGQEIKELKNEASVIAQVQH 163
           N S    +G G FG V  G +      +  +A+K L +G + ++ ++   EAS++ Q  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 164 KNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQII---KGVAQGL 220
            N+++L G   +    +++ EYM N SLD FL     R+     T +Q++   +G+A G+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-----RKHDAQFTVIQLVGMLRGIASGM 160
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY 280
            YL   S +  +HRDL A NIL++ ++  K+SDFG++R++    D+ E    T       
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVL---EDDPEAAYTTRGGKIPI 214
Query: 281 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNK-I 339
            + SPE      F+  SDV+S+G++L E++S       Y  +        W++  SN+ +
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS-------YGERPY------WEM--SNQDV 259
Query: 340 IDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML 384
           I  +D         +  +    + L C Q+   +RP    +VS+L
Sbjct: 260 IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 141/285 (49%), Gaps = 36/285 (12%)
Query: 110 NFSAANKLGEGGFGTVYKGVIG-----QGEIAVKRL-LGKSGQEIKELKNEASVIAQVQH 163
           N S    +G G FG V  G +      +  +A+K L +G + ++ ++   EAS++ Q  H
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 164 KNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQII---KGVAQGL 220
            N+++L G   +    +++ EYM N SLD FL     R+     T +Q++   +G+A G+
Sbjct: 77  PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-----RKHDAQFTVIQLVGMLRGIASGM 131
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY 280
            YL   S +  +HRDL A NIL++ ++  K+SDFG++R++    D+ E    T       
Sbjct: 132 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVL---EDDPEAAYTTRGGKIPI 185
Query: 281 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNK-I 339
            + SPE      F+  SDV+S+G++L E++S       Y  +        W++  SN+ +
Sbjct: 186 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS-------YGERPY------WEM--SNQDV 230
Query: 340 IDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML 384
           I  +D         +  +    + L C Q+   +RP    +VS+L
Sbjct: 231 IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 275

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 84/277 (30%), Positives = 136/277 (49%), Gaps = 19/277 (6%)
Query: 117 LGEGGFGTV----YKGV-IGQGE-IAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNLVKL 169
           LGEG FG V    Y     G GE +AVK L    G + +   K E  ++  + H++++K 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 170 LGCCIEKDER--LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYS 227
            GCC ++ E+   L+ EY+P  SL  +L     R  +     +   + + +G+ YLH   
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLHA-- 135
Query: 228 RVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEY 287
               IHR+L A N+LLD D   KI DFG+A+ V  G++   ++ +    S  + Y +PE 
Sbjct: 136 -QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD--SPVFWY-APEC 191
Query: 288 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVL 347
             E  F   SDV+SFGV L E+++   ++    TK L LIG A       ++ +L++   
Sbjct: 192 LKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGE 251
Query: 348 EEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML 384
                ++      H+   C +  A  RPT  +++ +L
Sbjct: 252 RLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPIL 288

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 141/285 (49%), Gaps = 36/285 (12%)
Query: 110 NFSAANKLGEGGFGTVYKGVIG-----QGEIAVKRL-LGKSGQEIKELKNEASVIAQVQH 163
           N S    +G G FG V  G +      +  +A+K L +G + ++ ++   EAS++ Q  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 164 KNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQII---KGVAQGL 220
            N+++L G   +    +++ EYM N SLD FL     R+     T +Q++   +G+A G+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-----RKHDAQFTVIQLVGMLRGIASGM 160
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY 280
            YL   S +  +HRDL A NIL++ ++  K+SDFG++R++    D+ E    T       
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVL---EDDPEAAYTTRGGKIPI 214
Query: 281 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNK-I 339
            + SPE      F+  SDV+S+G++L E++S       Y  +        W++  SN+ +
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS-------YGERPY------WEM--SNQDV 259
Query: 340 IDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML 384
           I  +D         +  +    + L C Q+   +RP    +VS+L
Sbjct: 260 IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 141/285 (49%), Gaps = 36/285 (12%)
Query: 110 NFSAANKLGEGGFGTVYKGVIG-----QGEIAVKRL-LGKSGQEIKELKNEASVIAQVQH 163
           N S    +G G FG V  G +      +  +A+K L +G + ++ ++   EAS++ Q  H
Sbjct: 34  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 93
Query: 164 KNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQII---KGVAQGL 220
            N+++L G   +    +++ EYM N SLD FL     R+     T +Q++   +G+A G+
Sbjct: 94  PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-----RKHDAQFTVIQLVGMLRGIASGM 148
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY 280
            YL   S +  +HRDL A NIL++ ++  K+SDFG++R++    D+ E    T       
Sbjct: 149 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVL---EDDPEAAYTTRGGKIPI 202
Query: 281 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNK-I 339
            + SPE      F+  SDV+S+G++L E++S       Y  +        W++  SN+ +
Sbjct: 203 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS-------YGERPY------WEM--SNQDV 247
Query: 340 IDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML 384
           I  +D         +  +    + L C Q+   +RP    +VS+L
Sbjct: 248 IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 292

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 141/285 (49%), Gaps = 36/285 (12%)
Query: 110 NFSAANKLGEGGFGTVYKGVIG-----QGEIAVKRL-LGKSGQEIKELKNEASVIAQVQH 163
           N S    +G G FG V  G +      +  +A+K L +G + ++ ++   EAS++ Q  H
Sbjct: 44  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 103
Query: 164 KNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQII---KGVAQGL 220
            N+++L G   +    +++ EYM N SLD FL     R+     T +Q++   +G+A G+
Sbjct: 104 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-----RKHDAQFTVIQLVGMLRGIASGM 158
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY 280
            YL   S +  +HRDL A NIL++ ++  K+SDFG++R++    D+ E    T       
Sbjct: 159 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVL---EDDPEAAYTTRGGKIPI 212
Query: 281 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNK-I 339
            + SPE      F+  SDV+S+G++L E++S       Y  +        W++  SN+ +
Sbjct: 213 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS-------YGERPY------WEM--SNQDV 257
Query: 340 IDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML 384
           I  +D         +  +    + L C Q+   +RP    +VS+L
Sbjct: 258 IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 302

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 140/285 (49%), Gaps = 36/285 (12%)
Query: 110 NFSAANKLGEGGFGTVYKGVIG-----QGEIAVKRL-LGKSGQEIKELKNEASVIAQVQH 163
           N S    +G G FG V  G +      +  +A+K L +G + ++ ++   EAS++ Q  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 164 KNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQII---KGVAQGL 220
            N+++L G   +    +++ EYM N SLD FL     R+     T +Q++   +G+A G+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-----RKHDAQFTVIQLVGMLRGIASGM 160
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY 280
            YL   S +  +HRDL A NIL++ ++  K+SDFG+ R++    D+ E    T       
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVL---EDDPEAAYTTRGGKIPI 214
Query: 281 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNK-I 339
            + SPE      F+  SDV+S+G++L E++S       Y  +        W++  SN+ +
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS-------YGERPY------WEM--SNQDV 259
Query: 340 IDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML 384
           I  +D         +  +    + L C Q+   +RP    +VS+L
Sbjct: 260 IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 80/279 (28%), Positives = 136/279 (48%), Gaps = 26/279 (9%)
Query: 115 NKLGEGGFGTVYKGV-IGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCC 173
            ++G G FG V+ G  + + ++A+K +   +  E ++   EA V+ ++ H  LV+L G C
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
           +E+    L+ E+M +  L  +L   T+R +    T + +   V +G+ YL +     +IH
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 127
Query: 234 RDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIF 293
           RDL A N L+ ++   K+SDFGM R V      D+   +++       + SPE      +
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFVL-----DDQYTSSTGTKFPVKWASPEVFSFSRY 182
Query: 294 SIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFN 353
           S KSDV+SFGVL+ E+ S  K    Y  +S            ++++++ I +        
Sbjct: 183 SSKSDVWSFGVLMWEVFSEGKIP--YENRS------------NSEVVEDISTGFRLYKPR 228
Query: 354 ESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLL 392
            + +    I   C +ER EDRP  S ++  L   A S L
Sbjct: 229 LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESGL 267

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 118/213 (55%), Gaps = 22/213 (10%)
Query: 109 GNFSAANKLGEGGFGTVYKGVIGQGEIAVKRL--LGKSGQEIKELKNEASVIAQVQHKNL 166
           G  +   ++G G FGTVYKG    G++AVK L     + Q+++  KNE  V+ + +H N+
Sbjct: 24  GQITVGQRIGSGSFGTVYKGKW-HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 82
Query: 167 VKLLGCCIEKDERLLIYEYMPNKSLDCFLF-DPTKREILDWRTRVQIIKGVAQGLLYLHQ 225
           +  +G      +  ++ ++    SL   L    TK E+   +  + I +  A+G+ YLH 
Sbjct: 83  LLFMGYSTAP-QLAIVTQWCEGSSLYHHLHASETKFEM---KKLIDIARQTARGMDYLHA 138
Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMA--RIVFGGNDEDELQGNTSRISGTYGYM 283
            S   IIHRDLK++NI L +D   KI DFG+A  +  + G+ + E      ++SG+  +M
Sbjct: 139 KS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFE------QLSGSILWM 189
Query: 284 SPEYAL---EGIFSIKSDVFSFGVLLLEIVSGK 313
           +PE         +S +SDV++FG++L E+++G+
Sbjct: 190 APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 84/277 (30%), Positives = 135/277 (48%), Gaps = 19/277 (6%)
Query: 117 LGEGGFGTV----YKGV-IGQGE-IAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNLVKL 169
           LGEG FG V    Y     G GE +AVK L   +G + +   K E  ++  + H++++K 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 170 LGCCIEKDER--LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYS 227
            GCC +       L+ EY+P  SL  +L     R  +     +   + + +G+ YLH   
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLHA-- 152
Query: 228 RVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEY 287
               IHRDL A N+LLD D   KI DFG+A+ V  G++   ++ +    S  + Y +PE 
Sbjct: 153 -QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGD--SPVFWY-APEC 208
Query: 288 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVL 347
             E  F   SDV+SFGV L E+++   ++    TK L LIG A       ++ +L++   
Sbjct: 209 LKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGE 268
Query: 348 EEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML 384
                ++  +   H+   C +  A  RPT  +++ +L
Sbjct: 269 RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPIL 305

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 110/205 (53%), Gaps = 14/205 (6%)
Query: 110 NFSAANKLGEGGFGTVYKGVIGQGEIAVK-RLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
           + +  +KLG G FG VY+GV  +  + V  + L +   E++E   EA+V+ +++H NLV+
Sbjct: 12  DITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 71
Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSR 228
           LLG C  +    +I E+M   +L  +L +  ++E+    + V ++    Q    +    +
Sbjct: 72  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV----SAVVLLYMATQISSAMEYLEK 127
Query: 229 VRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYG--YMSPE 286
              IHRDL A N L+ ++   K++DFG++R++ G          T+     +   + +PE
Sbjct: 128 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-------XTAHAGAKFPIKWTAPE 180
Query: 287 YALEGIFSIKSDVFSFGVLLLEIVS 311
                 FSIKSDV++FGVLL EI +
Sbjct: 181 SLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 76/271 (28%), Positives = 127/271 (46%), Gaps = 23/271 (8%)
Query: 116 KLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIE 175
           KLG G FG V+ G          + L      ++    EA+++  +QH  LV+L     +
Sbjct: 19  KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 78
Query: 176 KDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRD 235
           ++   +I E+M   SL  FL      ++L  +  +     +A+G+ Y+    R   IHRD
Sbjct: 79  EEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKL-IDFSAQIAEGMAYIE---RKNYIHRD 134
Query: 236 LKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSI 295
           L+A+N+L+ + +  KI+DFG+AR++   N+    +G    I  T    +PE    G F+I
Sbjct: 135 LRAANVLVSESLMCKIADFGLARVI-EDNEYTAREGAKFPIKWT----APEAINFGCFTI 189
Query: 296 KSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNES 355
           KS+V+SFG+LL EIV+  K     RT +               ++  +            
Sbjct: 190 KSNVWSFGILLYEIVTYGKIPYPGRTNA--------------DVMSALSQGYRMPRMENC 235
Query: 356 LSRYVHIALLCVQERAEDRPTMSDVVSMLTN 386
                 I  +C +E+AE+RPT   + S+L +
Sbjct: 236 PDELYDIMKMCWKEKAEERPTFDYLQSVLDD 266

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 76/218 (34%), Positives = 117/218 (53%), Gaps = 30/218 (13%)
Query: 116 KLGEGGFGTVYKGVI---GQGE----IAVKRLLGKS-GQEIKELKNEASVIAQVQHKNLV 167
           +LGE  FG VYKG +     GE    +A+K L  K+ G   +E ++EA + A++QH N+V
Sbjct: 33  ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 92
Query: 168 KLLGCCIEKDERL-LIYEYMPNKSLDCFLF-------------DPTKREILDWRTRVQII 213
            LLG  + KD+ L +I+ Y  +  L  FL              D T +  L+    V ++
Sbjct: 93  CLLGV-VTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 151
Query: 214 KGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNT 273
             +A G+ YL   S   ++H+DL   N+L+   +N KISD G+ R V+   D  +L GN+
Sbjct: 152 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAA-DYYKLLGNS 207
Query: 274 SRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
                   +M+PE  + G FSI SD++S+GV+L E+ S
Sbjct: 208 LL---PIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 112/203 (55%), Gaps = 10/203 (4%)
Query: 110 NFSAANKLGEGGFGTVYKGVIGQGEIAVK-RLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
           + +  +KLG G +G VY+GV  +  + V  + L +   E++E   EA+V+ +++H NLV+
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 78
Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSR 228
           LLG C  +    +I E+M   +L  +L +  ++E+ +    + +   ++  + YL    +
Sbjct: 79  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYL---EK 134
Query: 229 VRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYA 288
              IHRDL A N L+ ++   K++DFG++R++  G+      G    I  T    +PE  
Sbjct: 135 KNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWT----APESL 189
Query: 289 LEGIFSIKSDVFSFGVLLLEIVS 311
               FSIKSDV++FGVLL EI +
Sbjct: 190 AYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 112/203 (55%), Gaps = 10/203 (4%)
Query: 110 NFSAANKLGEGGFGTVYKGVIGQGEIAVK-RLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
           + +  +KLG G +G VY+GV  +  + V  + L +   E++E   EA+V+ +++H NLV+
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 78
Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSR 228
           LLG C  +    +I E+M   +L  +L +  ++E+ +    + +   ++  + YL    +
Sbjct: 79  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYL---EK 134
Query: 229 VRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYA 288
              IHRDL A N L+ ++   K++DFG++R++  G+      G    I  T    +PE  
Sbjct: 135 KNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWT----APESL 189
Query: 289 LEGIFSIKSDVFSFGVLLLEIVS 311
               FSIKSDV++FGVLL EI +
Sbjct: 190 AYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 112/203 (55%), Gaps = 10/203 (4%)
Query: 110 NFSAANKLGEGGFGTVYKGVIGQGEIAVK-RLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
           + +  +KLG G +G VY+GV  +  + V  + L +   E++E   EA+V+ +++H NLV+
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 78
Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSR 228
           LLG C  +    +I E+M   +L  +L +  ++E+ +    + +   ++  + YL    +
Sbjct: 79  LLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYL---EK 134
Query: 229 VRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYA 288
              IHRDL A N L+ ++   K++DFG++R++  G+      G    I  T    +PE  
Sbjct: 135 KNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWT----APESL 189
Query: 289 LEGIFSIKSDVFSFGVLLLEIVS 311
               FSIKSDV++FGVLL EI +
Sbjct: 190 AYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 110/203 (54%), Gaps = 10/203 (4%)
Query: 110 NFSAANKLGEGGFGTVYKGVIGQGEIAVK-RLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
           + +  +KLG G +G VY+GV  +  + V  + L +   E++E   EA+V+ +++H NLV+
Sbjct: 12  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 71
Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSR 228
           LLG C  +    +I E+M   +L  +L +  ++E+    + V ++    Q    +    +
Sbjct: 72  LLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEV----SAVVLLYMATQISSAMEYLEK 127
Query: 229 VRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYA 288
              IHRDL A N L+ ++   K++DFG++R++  G+      G    I  T    +PE  
Sbjct: 128 KNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWT----APESL 182
Query: 289 LEGIFSIKSDVFSFGVLLLEIVS 311
               FSIKSDV++FGVLL EI +
Sbjct: 183 AYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 112/203 (55%), Gaps = 10/203 (4%)
Query: 110 NFSAANKLGEGGFGTVYKGVIGQGEIAVK-RLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
           + +  +KLG G +G VY+GV  +  + V  + L +   E++E   EA+V+ +++H NLV+
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 73
Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSR 228
           LLG C  +    +I E+M   +L  +L +  ++E+ +    + +   ++  + YL    +
Sbjct: 74  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYL---EK 129
Query: 229 VRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYA 288
              IHRDL A N L+ ++   K++DFG++R++  G+      G    I  T    +PE  
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWT----APESL 184
Query: 289 LEGIFSIKSDVFSFGVLLLEIVS 311
               FSIKSDV++FGVLL EI +
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 112/203 (55%), Gaps = 10/203 (4%)
Query: 110 NFSAANKLGEGGFGTVYKGVIGQGEIAVK-RLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
           + +  +KLG G +G VY+GV  +  + V  + L +   E++E   EA+V+ +++H NLV+
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 73
Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSR 228
           LLG C  +    +I E+M   +L  +L +  ++E+ +    + +   ++  + YL    +
Sbjct: 74  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYL---EK 129
Query: 229 VRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYA 288
              IHRDL A N L+ ++   K++DFG++R++  G+      G    I  T    +PE  
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWT----APESL 184
Query: 289 LEGIFSIKSDVFSFGVLLLEIVS 311
               FSIKSDV++FGVLL EI +
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 112/203 (55%), Gaps = 10/203 (4%)
Query: 110 NFSAANKLGEGGFGTVYKGVIGQGEIAVK-RLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
           + +  +KLG G +G VY+GV  +  + V  + L +   E++E   EA+V+ +++H NLV+
Sbjct: 18  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 77
Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSR 228
           LLG C  +    +I E+M   +L  +L +  ++E+ +    + +   ++  + YL    +
Sbjct: 78  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYL---EK 133
Query: 229 VRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYA 288
              IHRDL A N L+ ++   K++DFG++R++  G+      G    I  T    +PE  
Sbjct: 134 KNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWT----APESL 188
Query: 289 LEGIFSIKSDVFSFGVLLLEIVS 311
               FSIKSDV++FGVLL EI +
Sbjct: 189 AYNKFSIKSDVWAFGVLLWEIAT 211

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 110/205 (53%), Gaps = 14/205 (6%)
Query: 110 NFSAANKLGEGGFGTVYKGVIGQGEIAVK-RLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
           + +  +KLG G +G VY+GV  +  + V  + L +   E++E   EA+V+ +++H NLV+
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 78
Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSR 228
           LLG C  +    +I E+M   +L  +L +  ++E+    + V ++    Q    +    +
Sbjct: 79  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV----SAVVLLYMATQISSAMEYLEK 134
Query: 229 VRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYG--YMSPE 286
              IHRDL A N L+ ++   K++DFG++R++ G          T+     +   + +PE
Sbjct: 135 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-------YTAHAGAKFPIKWTAPE 187
Query: 287 YALEGIFSIKSDVFSFGVLLLEIVS 311
                 FSIKSDV++FGVLL EI +
Sbjct: 188 SLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 110/205 (53%), Gaps = 14/205 (6%)
Query: 110 NFSAANKLGEGGFGTVYKGVIGQGEIAVK-RLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
           + +  +KLG G +G VY+GV  +  + V  + L +   E++E   EA+V+ +++H NLV+
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 73
Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSR 228
           LLG C  +    +I E+M   +L  +L +  ++E+    + V ++    Q    +    +
Sbjct: 74  LLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEV----SAVVLLYMATQISSAMEYLEK 129
Query: 229 VRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYG--YMSPE 286
              IHRDL A N L+ ++   K++DFG++R++ G          T+     +   + +PE
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-------YTAHAGAKFPIKWTAPE 182
Query: 287 YALEGIFSIKSDVFSFGVLLLEIVS 311
                 FSIKSDV++FGVLL EI +
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 76/218 (34%), Positives = 117/218 (53%), Gaps = 30/218 (13%)
Query: 116 KLGEGGFGTVYKGVI---GQGE----IAVKRLLGKS-GQEIKELKNEASVIAQVQHKNLV 167
           +LGE  FG VYKG +     GE    +A+K L  K+ G   +E ++EA + A++QH N+V
Sbjct: 16  ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 75
Query: 168 KLLGCCIEKDERL-LIYEYMPNKSLDCFLF-------------DPTKREILDWRTRVQII 213
            LLG  + KD+ L +I+ Y  +  L  FL              D T +  L+    V ++
Sbjct: 76  CLLGV-VTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 214 KGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNT 273
             +A G+ YL   S   ++H+DL   N+L+   +N KISD G+ R V+   D  +L GN+
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAA-DYYKLLGNS 190
Query: 274 SRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
                   +M+PE  + G FSI SD++S+GV+L E+ S
Sbjct: 191 LL---PIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 112/205 (54%), Gaps = 14/205 (6%)
Query: 110 NFSAANKLGEGGFGTVYKGVIGQGEIAVK-RLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
           + +  +KLG G +G VY+GV  +  + V  + L +   E++E   EA+V+ +++H NLV+
Sbjct: 15  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 74
Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSR 228
           LLG C  +    +I E+M   +L  +L +  ++E+ +    + +   ++  + YL    +
Sbjct: 75  LLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYL---EK 130
Query: 229 VRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYG--YMSPE 286
              IHRDL A N L+ ++   K++DFG++R++ G          T+     +   + +PE
Sbjct: 131 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-------XTAHAGAKFPIKWTAPE 183
Query: 287 YALEGIFSIKSDVFSFGVLLLEIVS 311
                 FSIKSDV++FGVLL EI +
Sbjct: 184 SLAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 98.2 bits (243), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 110/205 (53%), Gaps = 14/205 (6%)
Query: 110 NFSAANKLGEGGFGTVYKGVIGQGEIAVK-RLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
           + +  +KLG G +G VY+GV  +  + V  + L +   E++E   EA+V+ +++H NLV+
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 73
Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSR 228
           LLG C  +    +I E+M   +L  +L +  ++E+    + V ++    Q    +    +
Sbjct: 74  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV----SAVVLLYMATQISSAMEYLEK 129
Query: 229 VRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYG--YMSPE 286
              IHRDL A N L+ ++   K++DFG++R++ G          T+     +   + +PE
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-------YTAHAGAKFPIKWTAPE 182
Query: 287 YALEGIFSIKSDVFSFGVLLLEIVS 311
                 FSIKSDV++FGVLL EI +
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 98.2 bits (243), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 112/205 (54%), Gaps = 14/205 (6%)
Query: 110 NFSAANKLGEGGFGTVYKGVIGQGEIAVK-RLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
           + +  +KLG G +G VY+GV  +  + V  + L +   E++E   EA+V+ +++H NLV+
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 75
Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSR 228
           LLG C  +    +I E+M   +L  +L +  ++E+ +    + +   ++  + YL    +
Sbjct: 76  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYL---EK 131
Query: 229 VRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYG--YMSPE 286
              IHRDL A N L+ ++   K++DFG++R++ G          T+     +   + +PE
Sbjct: 132 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-------YTAHAGAKFPIKWTAPE 184
Query: 287 YALEGIFSIKSDVFSFGVLLLEIVS 311
                 FSIKSDV++FGVLL EI +
Sbjct: 185 SLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 110/205 (53%), Gaps = 14/205 (6%)
Query: 110 NFSAANKLGEGGFGTVYKGVIGQGEIAVK-RLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
           + +  +KLG G +G VY+GV  +  + V  + L +   E++E   EA+V+ +++H NLV+
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 73
Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSR 228
           LLG C  +    +I E+M   +L  +L +  ++E+    + V ++    Q    +    +
Sbjct: 74  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV----SAVVLLYMATQISSAMEYLEK 129
Query: 229 VRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYG--YMSPE 286
              IHRDL A N L+ ++   K++DFG++R++ G          T+     +   + +PE
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-------YTAHAGAKFPIKWTAPE 182
Query: 287 YALEGIFSIKSDVFSFGVLLLEIVS 311
                 FSIKSDV++FGVLL EI +
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 112/203 (55%), Gaps = 10/203 (4%)
Query: 110 NFSAANKLGEGGFGTVYKGVIGQGEIAVK-RLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
           + +  +KLG G +G VY+GV  +  + V  + L +   E++E   EA+V+ +++H NLV+
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 75
Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSR 228
           LLG C  +    +I E+M   +L  +L +  ++E+ +    + +   ++  + YL    +
Sbjct: 76  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYL---EK 131
Query: 229 VRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYA 288
              IHRDL A N L+ ++   K++DFG++R++  G+      G    I  T    +PE  
Sbjct: 132 KNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAPAGAKFPIKWT----APESL 186
Query: 289 LEGIFSIKSDVFSFGVLLLEIVS 311
               FSIKSDV++FGVLL EI +
Sbjct: 187 AYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 110/205 (53%), Gaps = 14/205 (6%)
Query: 110 NFSAANKLGEGGFGTVYKGVIGQGEIAVK-RLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
           + +  +KLG G +G VY+GV  +  + V  + L +   E++E   EA+V+ +++H NLV+
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 73
Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSR 228
           LLG C  +    +I E+M   +L  +L +  ++E+    + V ++    Q    +    +
Sbjct: 74  LLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEV----SAVVLLYMATQISSAMEYLEK 129
Query: 229 VRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYG--YMSPE 286
              IHRDL A N L+ ++   K++DFG++R++ G          T+     +   + +PE
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-------YTAHAGAKFPIKWTAPE 182
Query: 287 YALEGIFSIKSDVFSFGVLLLEIVS 311
                 FSIKSDV++FGVLL EI +
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 112/205 (54%), Gaps = 14/205 (6%)
Query: 110 NFSAANKLGEGGFGTVYKGVIGQGEIAVK-RLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
           + +  +KLG G +G VY+GV  +  + V  + L +   E++E   EA+V+ +++H NLV+
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 75
Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSR 228
           LLG C  +    +I E+M   +L  +L +  ++E+ +    + +   ++  + YL    +
Sbjct: 76  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYL---EK 131
Query: 229 VRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYG--YMSPE 286
              IHRDL A N L+ ++   K++DFG++R++ G          T+     +   + +PE
Sbjct: 132 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-------YTAHAGAKFPIKWTAPE 184
Query: 287 YALEGIFSIKSDVFSFGVLLLEIVS 311
                 FSIKSDV++FGVLL EI +
Sbjct: 185 SLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 82/277 (29%), Positives = 132/277 (47%), Gaps = 19/277 (6%)
Query: 117 LGEGGFGTVYKGVI-----GQGE-IAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNLVKL 169
           LGEG FG V          G GE +AVK L    G +++   + E  ++  + H+++VK 
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 170 LGCCIEKDER--LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYS 227
            GCC ++ E+   L+ EY+P  SL  +L     R  +     +   + + +G+ YLH   
Sbjct: 77  KGCCEDQGEKSVQLVMEYVPLGSLRDYL----PRHCVGLAQLLLFAQQICEGMAYLHA-- 130
Query: 228 RVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEY 287
               IHR L A N+LLD D   KI DFG+A+ V  G++   ++ +    S  + Y +PE 
Sbjct: 131 -QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD--SPVFWY-APEC 186
Query: 288 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVL 347
             E  F   SDV+SFGV L E+++   +     TK   LIG+        ++ +L++   
Sbjct: 187 LKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERGE 246
Query: 348 EEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML 384
                +       H+   C +  A  RPT  ++V +L
Sbjct: 247 RLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLVPIL 283

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 112/203 (55%), Gaps = 10/203 (4%)
Query: 110 NFSAANKLGEGGFGTVYKGVIGQGEIAVK-RLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
           + +  +KLG G +G VY+GV  +  + V  + L +   E++E   EA+V+ +++H NLV+
Sbjct: 27  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 86
Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSR 228
           LLG C  +    +I E+M   +L  +L +  ++E+ +    + +   ++  + YL    +
Sbjct: 87  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYL---EK 142
Query: 229 VRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYA 288
              IHRDL A N L+ ++   K++DFG++R++  G+      G    I  T    +PE  
Sbjct: 143 KNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWT----APESL 197
Query: 289 LEGIFSIKSDVFSFGVLLLEIVS 311
               FSIKSDV++FGVLL EI +
Sbjct: 198 AYNKFSIKSDVWAFGVLLWEIAT 220

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 140/285 (49%), Gaps = 36/285 (12%)
Query: 110 NFSAANKLGEGGFGTVYKGVIG-----QGEIAVKRL-LGKSGQEIKELKNEASVIAQVQH 163
           N S    +G G FG V  G +      +  +A+K L +G + ++ ++   EAS++ Q  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 164 KNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQII---KGVAQGL 220
            N+++L G   +    +++ E M N SLD FL     R+     T +Q++   +G+A G+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL-----RKHDAQFTVIQLVGMLRGIASGM 160
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY 280
            YL   S +  +HRDL A NIL++ ++  K+SDFG++R++    D+ E    T       
Sbjct: 161 KYL---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVL---EDDPEAAYTTRGGKIPI 214
Query: 281 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNK-I 339
            + SPE      F+  SDV+S+G++L E++S       Y  +        W++  SN+ +
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS-------YGERPY------WEM--SNQDV 259
Query: 340 IDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML 384
           I  +D         +  +    + L C Q+   +RP    +VS+L
Sbjct: 260 IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 112/203 (55%), Gaps = 10/203 (4%)
Query: 110 NFSAANKLGEGGFGTVYKGVIGQGEIAVK-RLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
           + +  +KLG G +G VY+GV  +  + V  + L +   E++E   EA+V+ +++H NLV+
Sbjct: 15  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 74
Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSR 228
           LLG C  +    +I E+M   +L  +L +  ++E+ +    + +   ++  + YL    +
Sbjct: 75  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYL---EK 130
Query: 229 VRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYA 288
              IHRDL A N L+ ++   K++DFG++R++  G+      G    I  T    +PE  
Sbjct: 131 KNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAPAGAKFPIKWT----APESL 185
Query: 289 LEGIFSIKSDVFSFGVLLLEIVS 311
               FSIKSDV++FGVLL EI +
Sbjct: 186 AYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 112/205 (54%), Gaps = 14/205 (6%)
Query: 110 NFSAANKLGEGGFGTVYKGVIGQGEIAVK-RLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
           + +  +KLG G +G VY+GV  +  + V  + L +   E++E   EA+V+ +++H NLV+
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 78
Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSR 228
           LLG C  +    +I E+M   +L  +L +  ++E+ +    + +   ++  + YL    +
Sbjct: 79  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYL---EK 134
Query: 229 VRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYG--YMSPE 286
              IHRDL A N L+ ++   K++DFG++R++ G          T+     +   + +PE
Sbjct: 135 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-------YTAHAGAKFPIKWTAPE 187
Query: 287 YALEGIFSIKSDVFSFGVLLLEIVS 311
                 FSIKSDV++FGVLL EI +
Sbjct: 188 SLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 82/277 (29%), Positives = 132/277 (47%), Gaps = 19/277 (6%)
Query: 117 LGEGGFGTVYKGVI-----GQGE-IAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNLVKL 169
           LGEG FG V          G GE +AVK L    G +++   + E  ++  + H+++VK 
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 170 LGCCIEKDER--LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYS 227
            GCC ++ E+   L+ EY+P  SL  +L     R  +     +   + + +G+ YLH   
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGSLRDYL----PRHCVGLAQLLLFAQQICEGMAYLHA-- 129
Query: 228 RVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEY 287
               IHR L A N+LLD D   KI DFG+A+ V  G++   ++ +    S  + Y +PE 
Sbjct: 130 -QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD--SPVFWY-APEC 185
Query: 288 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVL 347
             E  F   SDV+SFGV L E+++   +     TK   LIG+        ++ +L++   
Sbjct: 186 LKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERGE 245
Query: 348 EEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML 384
                +       H+   C +  A  RPT  ++V +L
Sbjct: 246 RLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLVPIL 282

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 140/285 (49%), Gaps = 36/285 (12%)
Query: 110 NFSAANKLGEGGFGTVYKGVIG-----QGEIAVKRL-LGKSGQEIKELKNEASVIAQVQH 163
           N S    +G G FG V  G +      +  +A+K L +G + ++ ++   EAS++ Q  H
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 164 KNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQII---KGVAQGL 220
            N+++L G   +    +++ E M N SLD FL     R+     T +Q++   +G+A G+
Sbjct: 77  PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL-----RKHDAQFTVIQLVGMLRGIASGM 131
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY 280
            YL   S +  +HRDL A NIL++ ++  K+SDFG++R++    D+ E    T       
Sbjct: 132 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVL---EDDPEAAYTTRGGKIPI 185
Query: 281 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNK-I 339
            + SPE      F+  SDV+S+G++L E++S       Y  +        W++  SN+ +
Sbjct: 186 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS-------YGERPY------WEM--SNQDV 230
Query: 340 IDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML 384
           I  +D         +  +    + L C Q+   +RP    +VS+L
Sbjct: 231 IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 275

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 110/205 (53%), Gaps = 14/205 (6%)
Query: 110 NFSAANKLGEGGFGTVYKGVIGQGEIAVK-RLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
           + +  +KLG G +G VY+GV  +  + V  + L +   E++E   EA+V+ +++H NLV+
Sbjct: 12  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 71
Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSR 228
           LLG C  +    +I E+M   +L  +L +  ++E+    + V ++    Q    +    +
Sbjct: 72  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV----SAVVLLYMATQISSAMEYLEK 127
Query: 229 VRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYG--YMSPE 286
              IHRDL A N L+ ++   K++DFG++R++ G          T+     +   + +PE
Sbjct: 128 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-------FTAHAGAKFPIKWTAPE 180
Query: 287 YALEGIFSIKSDVFSFGVLLLEIVS 311
                 FSIKSDV++FGVLL EI +
Sbjct: 181 SLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 140/285 (49%), Gaps = 36/285 (12%)
Query: 110 NFSAANKLGEGGFGTVYKGVIG-----QGEIAVKRL-LGKSGQEIKELKNEASVIAQVQH 163
           N S    +G G FG V  G +      +  +A+K L +G + ++ ++   EAS++ Q  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 164 KNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQII---KGVAQGL 220
            N+++L G   +    +++ E M N SLD FL     R+     T +Q++   +G+A G+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL-----RKHDAQFTVIQLVGMLRGIASGM 160
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY 280
            YL   S +  +HRDL A NIL++ ++  K+SDFG++R++    D+ E    T       
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVL---EDDPEAAYTTRGGKIPI 214
Query: 281 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNK-I 339
            + SPE      F+  SDV+S+G++L E++S       Y  +        W++  SN+ +
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS-------YGERPY------WEM--SNQDV 259
Query: 340 IDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML 384
           I  +D         +  +    + L C Q+   +RP    +VS+L
Sbjct: 260 IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/274 (27%), Positives = 137/274 (50%), Gaps = 28/274 (10%)
Query: 117 LGEGGFGTVYKGVI---GQGE--IAVKRL-LGKSGQEIKELKNEASVIAQVQHKNLVKLL 170
           +G G FG V  G +   G+ E  +A+K L +G + ++ ++   EAS++ Q  H N++ L 
Sbjct: 30  IGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLE 89
Query: 171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVR 230
           G   +    +++ EYM N SLD FL     +  +     V +++G++ G+ YL   S + 
Sbjct: 90  GVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTV--IQLVGMLRGISAGMKYL---SDMG 144
Query: 231 IIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE 290
            +HRDL A NIL++ ++  K+SDFG++R++    D+ E    T        + +PE    
Sbjct: 145 YVHRDLAARNILINSNLVCKVSDFGLSRVL---EDDPEAAYTTRGGKIPIRWTAPEAIAF 201
Query: 291 GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEA 350
             F+  SDV+S+G+++ E+VS       Y  +        W++  +  +I  ++      
Sbjct: 202 RKFTSASDVWSYGIVMWEVVS-------YGERPY------WEM-TNQDVIKAVEEGYRLP 247
Query: 351 SFNESLSRYVHIALLCVQERAEDRPTMSDVVSML 384
           S  +  +    + L C Q+    RP   ++V+ML
Sbjct: 248 SPMDCPAALYQLMLDCWQKERNSRPKFDEIVNML 281

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 72/229 (31%), Positives = 112/229 (48%), Gaps = 30/229 (13%)
Query: 110 NFSAANKLGEGGFGTV-----YKGVIGQGEI--AVKRLLGKSGQEIKELKNEASVIAQVQ 162
           N     +LGEG FG V     Y     Q +I  AVK L   S    K+   EA ++  +Q
Sbjct: 14  NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 73
Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLF-------------DPTKREILDWRTR 209
           H+++VK  G C+E D  ++++EYM +  L+ FL               PT+   L     
Sbjct: 74  HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTE---LTQSQM 130
Query: 210 VQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDEL 269
           + I + +A G++YL   +    +HRDL   N L+ +++  KI DFGM+R V+   D   +
Sbjct: 131 LHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVY-STDYYRV 186
Query: 270 QGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGF 318
            G+T        +M PE  +   F+ +SDV+S GV+L EI +  K   +
Sbjct: 187 GGHTML---PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWY 232

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/277 (29%), Positives = 137/277 (49%), Gaps = 34/277 (12%)
Query: 117 LGEGGFGTVYKG---VIGQGEI--AVKRL-LGKSGQEIKELKNEASVIAQVQHKNLVKLL 170
           +G G  G V  G   V GQ ++  A+K L  G + ++ ++  +EAS++ Q  H N+++L 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVR 230
           G        +++ EYM N SLD FL   T          V +++GV  G+ YL   S + 
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLR--THDGQFTIMQLVGMLRGVGAGMRYL---SDLG 171
Query: 231 IIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE 290
            +HRDL A N+L+D ++  K+SDFG++R++    D+ +    T+       + +PE    
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRVL---EDDPDAAXTTTGGKIPIRWTAPEAIAF 228
Query: 291 GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEA 350
             FS  SDV+SFGV++ E+++  +                W++  +N+  D+I SV E  
Sbjct: 229 RTFSSASDVWSFGVVMWEVLAYGERP-------------YWNM--TNR--DVISSVEEGY 271
Query: 351 SFNESL--SRYVHIALL-CVQERAEDRPTMSDVVSML 384
                +     +H  +L C  +    RP  S +VS+L
Sbjct: 272 RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVL 308

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 85/296 (28%), Positives = 132/296 (44%), Gaps = 36/296 (12%)
Query: 110 NFSAANKLGEGGFGTVYKG-VIGQGE------IAVKRLLGKSGQEIKE-LKNEASVIAQV 161
           N      LG G FG V +    G G+      +AVK L   +  + KE L +E  +++ +
Sbjct: 39  NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHL 98
Query: 162 -QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFL-------FDPTKREILDWRTRVQII 213
            QH+N+V LLG C      L+I EY     L  FL        D      L+ R  +   
Sbjct: 99  GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFS 158
Query: 214 KGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNT 273
             VAQG+ +L   +    IHRD+ A N+LL     +KI DFG+AR +   ND + +    
Sbjct: 159 SQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIM--NDSNYIVKGN 213
Query: 274 SRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDL 333
           +R+     +M+PE   + +++++SDV+S+G+LL EI             SL L  Y   +
Sbjct: 214 ARLP--VKWMAPESIFDCVYTVQSDVWSYGILLWEIF------------SLGLNPYP-GI 258
Query: 334 WISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS 389
            +++K   L+    + A    +      I   C       RPT   + S L  +A 
Sbjct: 259 LVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 314

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/219 (32%), Positives = 122/219 (55%), Gaps = 35/219 (15%)
Query: 117 LGEGGFGTVYKGV-IGQGE-----IAVKRLLGKSGQEIK-ELKNEASVIAQVQHKNLVKL 169
           LG G FGTVYKG+ + +GE     +A+K L   +G +   E  +EA ++A + H +LV+L
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 105
Query: 170 LGCCIEKDERLLIYEYMPNKSLDCFLFDPT----KREILDWRTRVQIIKGVAQGLLYLHQ 225
           LG C+    +L + + MP+  L  ++ +       + +L+W  ++      A+G++YL +
Sbjct: 106 LGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQI------AKGMMYLEE 158
Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
               R++HRDL A N+L+    + KI+DFG+AR++ G  DE E   +  ++   +     
Sbjct: 159 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEG--DEKEYNADGGKMPIKW----- 208
Query: 286 EYALEGI----FSIKSDVFSFGVLLLEIVS--GKKNTGF 318
             ALE I    F+ +SDV+S+GV + E+++  GK   G 
Sbjct: 209 -MALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI 246

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 71/219 (32%), Positives = 122/219 (55%), Gaps = 35/219 (15%)
Query: 117 LGEGGFGTVYKGV-IGQGE-----IAVKRLLGKSGQEIK-ELKNEASVIAQVQHKNLVKL 169
           LG G FGTVYKG+ + +GE     +A+K L   +G +   E  +EA ++A + H +LV+L
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 82
Query: 170 LGCCIEKDERLLIYEYMPNKSLDCFLFDPT----KREILDWRTRVQIIKGVAQGLLYLHQ 225
           LG C+    +L + + MP+  L  ++ +       + +L+W  ++      A+G++YL +
Sbjct: 83  LGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQI------AKGMMYLEE 135
Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
               R++HRDL A N+L+    + KI+DFG+AR++ G  DE E   +  ++   +     
Sbjct: 136 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEG--DEKEYNADGGKMPIKW----- 185
Query: 286 EYALEGI----FSIKSDVFSFGVLLLEIVS--GKKNTGF 318
             ALE I    F+ +SDV+S+GV + E+++  GK   G 
Sbjct: 186 -MALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI 223

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 117/206 (56%), Gaps = 18/206 (8%)
Query: 114 ANKLGEGGFGTVYKGVIGQGEIAVK--RLLGKSGQEIKELKNEASVIAQVQHKNLVKLLG 171
           + ++G G FGTVYKG    G++AVK  +++  + ++ +  +NE +V+ + +H N++  +G
Sbjct: 41  STRIGSGSFGTVYKGK-WHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMG 99
Query: 172 CCIEKDERLLIYEYMPNKSLDCFLF-DPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVR 230
             + KD   ++ ++    SL   L    TK ++      + I +  AQG+ YLH  +   
Sbjct: 100 Y-MTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQL---IDIARQTAQGMDYLHAKN--- 152
Query: 231 IIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL- 289
           IIHRD+K++NI L + +  KI DFG+A +    +   +++  T    G+  +M+PE    
Sbjct: 153 IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPT----GSVLWMAPEVIRM 208
Query: 290 --EGIFSIKSDVFSFGVLLLEIVSGK 313
                FS +SDV+S+G++L E+++G+
Sbjct: 209 QDNNPFSFQSDVYSYGIVLYELMTGE 234

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 81/277 (29%), Positives = 137/277 (49%), Gaps = 34/277 (12%)
Query: 117 LGEGGFGTVYKG---VIGQGEI--AVKRL-LGKSGQEIKELKNEASVIAQVQHKNLVKLL 170
           +G G  G V  G   V GQ ++  A+K L  G + ++ ++  +EAS++ Q  H N+++L 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVR 230
           G        +++ EYM N SLD FL   T          V +++GV  G+ YL   S + 
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLR--THDGQFTIMQLVGMLRGVGAGMRYL---SDLG 171
Query: 231 IIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE 290
            +HRDL A N+L+D ++  K+SDFG++R++    D+ +    T+       + +PE    
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRVL---EDDPDAAYTTTGGKIPIRWTAPEAIAF 228
Query: 291 GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEA 350
             FS  SDV+SFGV++ E+++  +                W++  +N+  D+I SV E  
Sbjct: 229 RTFSSASDVWSFGVVMWEVLAYGERP-------------YWNM--TNR--DVISSVEEGY 271
Query: 351 SFNESL--SRYVHIALL-CVQERAEDRPTMSDVVSML 384
                +     +H  +L C  +    RP  S +VS+L
Sbjct: 272 RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVL 308

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 85/296 (28%), Positives = 132/296 (44%), Gaps = 36/296 (12%)
Query: 110 NFSAANKLGEGGFGTVYKG-VIGQGE------IAVKRLLGKSGQEIKE-LKNEASVIAQV 161
           N      LG G FG V +    G G+      +AVK L   +  + KE L +E  +++ +
Sbjct: 47  NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHL 106
Query: 162 -QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFL-------FDPTKREILDWRTRVQII 213
            QH+N+V LLG C      L+I EY     L  FL        D      L+ R  +   
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFS 166
Query: 214 KGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNT 273
             VAQG+ +L   +    IHRD+ A N+LL     +KI DFG+AR +   ND + +    
Sbjct: 167 SQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIM--NDSNYIVKGN 221
Query: 274 SRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDL 333
           +R+     +M+PE   + +++++SDV+S+G+LL EI             SL L  Y   +
Sbjct: 222 ARLP--VKWMAPESIFDCVYTVQSDVWSYGILLWEIF------------SLGLNPYP-GI 266
Query: 334 WISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS 389
            +++K   L+    + A    +      I   C       RPT   + S L  +A 
Sbjct: 267 LVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 322

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 147/288 (51%), Gaps = 40/288 (13%)
Query: 117 LGEGGFGTVYKGVI---GQGE--IAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLL 170
           +G G FG V +G +   G+ E  +A+K L G  + ++ +E  +EAS++ Q +H N+++L 
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 83
Query: 171 GCCIEKDERLLIYEYMPNKSLDCFL-FDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRV 229
           G        +++ E+M N +LD FL  +  +  ++     V +++G+A G+ YL + S V
Sbjct: 84  GVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQL---VGMLRGIASGMRYLAEMSYV 140
Query: 230 RIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYG--YMSPEY 287
              HRDL A NIL++ ++  K+SDFG++R +   N  D  +  TS + G     + +PE 
Sbjct: 141 ---HRDLAARNILVNSNLVCKVSDFGLSRFL-EENSSDPTE--TSSLGGKIPIRWTAPEA 194
Query: 288 ALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNK-IIDLIDS 345
                F+  SD +S+G+++ E++S G++                WD+  SN+ +I+ I+ 
Sbjct: 195 IAFRKFTSASDAWSYGIVMWEVMSFGERPY--------------WDM--SNQDVINAIEQ 238
Query: 346 VLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVS----MLTNEAS 389
                   +  +    + L C Q+    RP    VVS    M+ N AS
Sbjct: 239 DYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKMIRNPAS 286

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 108/200 (54%), Gaps = 14/200 (7%)
Query: 115 NKLGEGGFGTVYKGVIGQGEIAVK-RLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCC 173
           +KLG G +G VY+GV  +  + V  + L +   E++E   EA+V+ +++H NLV+LLG C
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 285
Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
             +    +I E+M   +L  +L +  ++E+    + V ++    Q    +    +   IH
Sbjct: 286 TREPPFYIITEFMTYGNLLDYLRECNRQEV----SAVVLLYMATQISSAMEYLEKKNFIH 341
Query: 234 RDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYG--YMSPEYALEG 291
           R+L A N L+ ++   K++DFG++R++ G          T+     +   + +PE     
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMTGDT-------YTAHAGAKFPIKWTAPESLAYN 394
Query: 292 IFSIKSDVFSFGVLLLEIVS 311
            FSIKSDV++FGVLL EI +
Sbjct: 395 KFSIKSDVWAFGVLLWEIAT 414

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 80/274 (29%), Positives = 131/274 (47%), Gaps = 28/274 (10%)
Query: 115 NKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCI 174
            KLG G FG V+     +      + +      ++    EA+V+  +QH  LVKL    +
Sbjct: 21  KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKL-HAVV 79
Query: 175 EKDERLLIYEYMPNKSLDCFL-FDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
            K+   +I E+M   SL  FL  D   ++ L     +     +A+G+ ++ Q +    IH
Sbjct: 80  TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQRN---YIH 134
Query: 234 RDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIF 293
           RDL+A+NIL+   +  KI+DFG+AR++   N+    +G    I  T    +PE    G F
Sbjct: 135 RDLRAANILVSASLVCKIADFGLARVI-EDNEYTAREGAKFPIKWT----APEAINFGSF 189
Query: 294 SIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISN-KIIDLIDSVLEEASF 352
           +IKSDV+SFG+LL+EIV+  +            I Y     +SN ++I  ++        
Sbjct: 190 TIKSDVWSFGILLMEIVTYGR------------IPYP---GMSNPEVIRALERGYRMPRP 234
Query: 353 NESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN 386
                   +I + C + R E+RPT   + S+L +
Sbjct: 235 ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 268

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 87/318 (27%), Positives = 141/318 (44%), Gaps = 56/318 (17%)
Query: 93  VDQFPLFSFSSVSSATG--------NFSAANKLGEGGFGTVYKGVIG-------QGEIAV 137
            D  P +SF+  +S+          N +    LG G FG VY+G +          ++AV
Sbjct: 7   TDYNPNYSFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAV 66
Query: 138 KRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLF 196
           K L    S Q+  +   EA +I+++ H+N+V+ +G  ++   R ++ E M    L  FL 
Sbjct: 67  KTLPEVCSEQDELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLR 126
Query: 197 D----PTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLD---KDMNS 249
           +    P++   L     + + + +A G  YL +      IHRD+ A N LL        +
Sbjct: 127 ETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVA 183
Query: 250 KISDFGMARIVFGGNDEDELQGNTSRISG----TYGYMSPEYALEGIFSIKSDVFSFGVL 305
           KI DFGMAR ++        + +  R  G       +M PE  +EGIF+ K+D +SFGVL
Sbjct: 184 KIGDFGMARDIY--------RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVL 235
Query: 306 LLEIVSGKKNTGF--YRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIA 363
           L EI S     G+  Y +KS            + ++++ + S                I 
Sbjct: 236 LWEIFS----LGYMPYPSKS------------NQEVLEFVTSGGRMDPPKNCPGPVYRIM 279
Query: 364 LLCVQERAEDRPTMSDVV 381
             C Q + EDRP  + ++
Sbjct: 280 TQCWQHQPEDRPNFAIIL 297

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 86/302 (28%), Positives = 135/302 (44%), Gaps = 42/302 (13%)
Query: 110 NFSAANKLGEGGFGTVYKG-VIGQGE------IAVKRLLGKSGQEIKE-LKNEASVIAQV 161
           N      LG G FG V +    G G+      +AVK L   +  + KE L +E  +++ +
Sbjct: 47  NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHL 106
Query: 162 -QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFL-----------FDPTK--REILDWR 207
            QH+N+V LLG C      L+I EY     L  FL           ++P+    E L  R
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSR 166
Query: 208 TRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDED 267
             +     VAQG+ +L   +    IHRD+ A N+LL     +KI DFG+AR +   ND +
Sbjct: 167 DLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIM--NDSN 221
Query: 268 ELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLI 327
            +    +R+     +M+PE   + +++++SDV+S+G+LL EI             SL L 
Sbjct: 222 YIVKGNARLP--VKWMAPESIFDCVYTVQSDVWSYGILLWEIF------------SLGLN 267
Query: 328 GYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNE 387
            Y   + +++K   L+    + A    +      I   C       RPT   + S L  +
Sbjct: 268 PYP-GILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 326
Query: 388 AS 389
           A 
Sbjct: 327 AQ 328

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 80/279 (28%), Positives = 135/279 (48%), Gaps = 36/279 (12%)
Query: 117 LGEGGFGTVYKGVI---GQGEIAVKRLLGKSGQEIKELKN---EASVIAQVQHKNLVKLL 170
           +G G FG V  G +   G+ EI V     KSG   K+ ++   EAS++ Q  H N++ L 
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 100
Query: 171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQII---KGVAQGLLYLHQYS 227
           G   +    ++I E+M N SLD FL     R+     T +Q++   +G+A G+ YL   +
Sbjct: 101 GVVTKSTPVMIITEFMENGSLDSFL-----RQNDGQFTVIQLVGMLRGIAAGMKYL---A 152
Query: 228 RVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYG--YMSP 285
            +  +HRDL A NIL++ ++  K+SDFG++R +    D+      TS + G     + +P
Sbjct: 153 DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL---EDDTSDPTYTSALGGKIPIRWTAP 209
Query: 286 EYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDS 345
           E      F+  SDV+S+G+++ E++S       Y  +        WD+  +  +I+ I+ 
Sbjct: 210 EAIQYRKFTSASDVWSYGIVMWEVMS-------YGERPY------WDM-TNQDVINAIEQ 255
Query: 346 VLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML 384
                   +  S    + L C Q+    RP    +V+ L
Sbjct: 256 DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 294

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 111/224 (49%), Gaps = 27/224 (12%)
Query: 115 NKLGEGGFGTVY-------KGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLV 167
            +LGEG FG V+            +  +AVK L   +    K+ + EA ++  +QH+++V
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 168 KLLGCCIEKDERLLIYEYMPNKSLDCFL--FDPTKREILDWRTR-----------VQIIK 214
           K  G C + D  ++++EYM +  L+ FL    P    ++D + R           + I  
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 215 GVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTS 274
            +A G++YL   +    +HRDL   N L+  ++  KI DFGM+R V+   D   + G+T 
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVY-STDYYRVGGHTM 196
Query: 275 RISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGF 318
                  +M PE  +   F+ +SDV+SFGV+L EI +  K   F
Sbjct: 197 L---PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWF 237

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 110/200 (55%), Gaps = 14/200 (7%)
Query: 115 NKLGEGGFGTVYKGVIGQGEIAVK-RLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCC 173
           +KLG G +G VY+GV  +  + V  + L +   E++E   EA+V+ +++H NLV+LLG C
Sbjct: 265 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 324
Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
             +    +I E+M   +L  +L +  ++E+ +    + +   ++  + YL    +   IH
Sbjct: 325 TREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYL---EKKNFIH 380
Query: 234 RDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYG--YMSPEYALEG 291
           R+L A N L+ ++   K++DFG++R++ G          T+     +   + +PE     
Sbjct: 381 RNLAARNCLVGENHLVKVADFGLSRLMTGDT-------YTAHAGAKFPIKWTAPESLAYN 433
Query: 292 IFSIKSDVFSFGVLLLEIVS 311
            FSIKSDV++FGVLL EI +
Sbjct: 434 KFSIKSDVWAFGVLLWEIAT 453

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 146/288 (50%), Gaps = 40/288 (13%)
Query: 117 LGEGGFGTVYKGVI---GQGE--IAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLL 170
           +G G FG V +G +   G+ E  +A+K L G  + ++ +E  +EAS++ Q +H N+++L 
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 81
Query: 171 GCCIEKDERLLIYEYMPNKSLDCFL-FDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRV 229
           G        +++ E+M N +LD FL  +  +  ++     V +++G+A G+ YL + S V
Sbjct: 82  GVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQ---LVGMLRGIASGMRYLAEMSYV 138
Query: 230 RIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYG--YMSPEY 287
              HRDL A NIL++ ++  K+SDFG++R +   + +      TS + G     + +PE 
Sbjct: 139 ---HRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTY---TSSLGGKIPIRWTAPEA 192
Query: 288 ALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNK-IIDLIDS 345
                F+  SD +S+G+++ E++S G++                WD+  SN+ +I+ I+ 
Sbjct: 193 IAFRKFTSASDAWSYGIVMWEVMSFGERPY--------------WDM--SNQDVINAIEQ 236
Query: 346 VLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVS----MLTNEAS 389
                   +  +    + L C Q+    RP    VVS    M+ N AS
Sbjct: 237 DYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKMIRNPAS 284

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 86/307 (28%), Positives = 141/307 (45%), Gaps = 38/307 (12%)
Query: 82  NNKCKKGCEKEVDQFPLFSFSSVSSATGNFSAANKLGEGGFGTVYKGVIGQGEIAVKRLL 141
           ++K +K  EK+  + P  S               KLG G FG V+     +      + +
Sbjct: 171 SSKPQKPWEKDAWEIPRESLK----------LEKKLGAGQFGEVWMATYNKHTKVAVKTM 220
Query: 142 GKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFL-FDPTK 200
                 ++    EA+V+  +QH  LVKL    + K+   +I E+M   SL  FL  D   
Sbjct: 221 KPGSMSVEAFLAEANVMKTLQHDKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGS 279
Query: 201 REILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIV 260
           ++ L     +     +A+G+ ++ Q +    IHRDL+A+NIL+   +  KI+DFG+AR++
Sbjct: 280 KQPLP--KLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVI 334
Query: 261 FGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYR 320
              N+    +G    I  T    +PE    G F+IKSDV+SFG+LL+EIV          
Sbjct: 335 -EDNEYTAREGAKFPIKWT----APEAINFGSFTIKSDVWSFGILLMEIV---------- 379
Query: 321 TKSLNLIGYAWDLWISN-KIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSD 379
             +   I Y     +SN ++I  ++                +I + C + R E+RPT   
Sbjct: 380 --TYGRIPYP---GMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEY 434
Query: 380 VVSMLTN 386
           + S+L +
Sbjct: 435 IQSVLDD 441

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 86/314 (27%), Positives = 141/314 (44%), Gaps = 48/314 (15%)
Query: 93  VDQFPLFSFSSVSSATG--------NFSAANKLGEGGFGTVYKGVIG-------QGEIAV 137
            D  P +SF+  +S+          N +    LG G FG VY+G +          ++AV
Sbjct: 13  TDYNPNYSFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAV 72
Query: 138 KRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLF 196
           K L    S Q+  +   EA +I++  H+N+V+ +G  ++   R ++ E M    L  FL 
Sbjct: 73  KTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLR 132
Query: 197 D----PTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLD---KDMNS 249
           +    P++   L     + + + +A G  YL +      IHRD+ A N LL        +
Sbjct: 133 ETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVA 189
Query: 250 KISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEI 309
           KI DFGMAR ++  +     +G  + +     +M PE  +EGIF+ K+D +SFGVLL EI
Sbjct: 190 KIGDFGMARDIYRASYYR--KGGCAMLP--VKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 245
Query: 310 VSGKKNTGF--YRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCV 367
            S     G+  Y +KS            + ++++ + S                I   C 
Sbjct: 246 FS----LGYMPYPSKS------------NQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCW 289
Query: 368 QERAEDRPTMSDVV 381
           Q + EDRP  + ++
Sbjct: 290 QHQPEDRPNFAIIL 303

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 87/318 (27%), Positives = 140/318 (44%), Gaps = 56/318 (17%)
Query: 93  VDQFPLFSFSSVSSATG--------NFSAANKLGEGGFGTVYKGVIG-------QGEIAV 137
            D  P +SF+  +S+          N +    LG G FG VY+G +          ++AV
Sbjct: 7   TDYNPNYSFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAV 66
Query: 138 KRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLF 196
           K L    S Q+  +   EA +I++  H+N+V+ +G  ++   R ++ E M    L  FL 
Sbjct: 67  KTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLR 126
Query: 197 D----PTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLD---KDMNS 249
           +    P++   L     + + + +A G  YL +      IHRD+ A N LL        +
Sbjct: 127 ETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVA 183
Query: 250 KISDFGMARIVFGGNDEDELQGNTSRISG----TYGYMSPEYALEGIFSIKSDVFSFGVL 305
           KI DFGMAR ++        + +  R  G       +M PE  +EGIF+ K+D +SFGVL
Sbjct: 184 KIGDFGMARDIY--------RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVL 235
Query: 306 LLEIVSGKKNTGF--YRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIA 363
           L EI S     G+  Y +KS            + ++++ + S                I 
Sbjct: 236 LWEIFS----LGYMPYPSKS------------NQEVLEFVTSGGRMDPPKNCPGPVYRIM 279
Query: 364 LLCVQERAEDRPTMSDVV 381
             C Q + EDRP  + ++
Sbjct: 280 TQCWQHQPEDRPNFAIIL 297

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 87/318 (27%), Positives = 140/318 (44%), Gaps = 56/318 (17%)
Query: 93  VDQFPLFSFSSVSSATG--------NFSAANKLGEGGFGTVYKGVIG-------QGEIAV 137
            D  P +SF+  +S+          N +    LG G FG VY+G +          ++AV
Sbjct: 33  TDYNPNYSFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAV 92
Query: 138 KRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLF 196
           K L    S Q+  +   EA +I++  H+N+V+ +G  ++   R ++ E M    L  FL 
Sbjct: 93  KTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLR 152
Query: 197 D----PTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLD---KDMNS 249
           +    P++   L     + + + +A G  YL +      IHRD+ A N LL        +
Sbjct: 153 ETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVA 209
Query: 250 KISDFGMARIVFGGNDEDELQGNTSRISG----TYGYMSPEYALEGIFSIKSDVFSFGVL 305
           KI DFGMAR ++        + +  R  G       +M PE  +EGIF+ K+D +SFGVL
Sbjct: 210 KIGDFGMARDIY--------RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVL 261
Query: 306 LLEIVSGKKNTGF--YRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIA 363
           L EI S     G+  Y +KS            + ++++ + S                I 
Sbjct: 262 LWEIFS----LGYMPYPSKS------------NQEVLEFVTSGGRMDPPKNCPGPVYRIM 305
Query: 364 LLCVQERAEDRPTMSDVV 381
             C Q + EDRP  + ++
Sbjct: 306 TQCWQHQPEDRPNFAIIL 323

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 137/301 (45%), Gaps = 52/301 (17%)
Query: 116 KLGEGGFGTVYKG-----VIGQGE--IAVKRL-LGKSGQEIKELKNEASVIAQVQHKNLV 167
           +LG+G FG VY+G     + G+ E  +AVK +    S +E  E  NEASV+      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 168 KLLGCCIEKDERLLIYEYMPNKSLDCFL-------------FDPTKREILDWRTRVQIIK 214
           +LLG   +    L++ E M +  L  +L               PT +E+      +Q+  
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM------IQMAA 137
Query: 215 GVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTS 274
            +A G+ YL+     + +HRDL A N ++  D   KI DFGM R ++    E +      
Sbjct: 138 EIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIY----ETDYYRKGG 190
Query: 275 RISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS--GKKNTGFYRTKSLNLIGYAWD 332
           +      +M+PE   +G+F+  SD++SFGV+L EI S   +   G    + L  +     
Sbjct: 191 KGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV----- 245
Query: 333 LWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLL 392
             +    +D  D+  E         R   +  +C Q   + RPT  ++V++L ++     
Sbjct: 246 --MDGGYLDQPDNCPE---------RVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSF 294
Query: 393 P 393
           P
Sbjct: 295 P 295

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 137/305 (44%), Gaps = 60/305 (19%)
Query: 116 KLGEGGFGTVYKG-----VIGQGE--IAVKRL-LGKSGQEIKELKNEASVIAQVQHKNLV 167
           +LG+G FG VY+G     + G+ E  +AVK +    S +E  E  NEASV+      ++V
Sbjct: 21  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 80
Query: 168 KLLGCCIEKDERLLIYEYMPNKSLDCFLFD-------------PTKREILDWRTRVQIIK 214
           +LLG   +    L++ E M +  L  +L               PT +E+      +Q+  
Sbjct: 81  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM------IQMAA 134
Query: 215 GVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTS 274
            +A G+ YL+     + +HRDL A N ++  D   KI DFGM R        D  + +  
Sbjct: 135 EIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR--------DIXETDXX 183
Query: 275 RISG----TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS--GKKNTGFYRTKSLNLIG 328
           R  G       +M+PE   +G+F+  SD++SFGV+L EI S   +   G    + L  + 
Sbjct: 184 RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV- 242
Query: 329 YAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEA 388
                 +    +D  D+  E         R   +  +C Q   + RPT  ++V++L ++ 
Sbjct: 243 ------MDGGYLDQPDNCPE---------RVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 287
Query: 389 SSLLP 393
               P
Sbjct: 288 HPSFP 292

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/293 (27%), Positives = 132/293 (45%), Gaps = 48/293 (16%)
Query: 110 NFSAANKLGEGGFGTVYKGVIG-------QGEIAVKRLLGK-SGQEIKELKNEASVIAQV 161
           N +    LG G FG VY+G +          ++AVK L    S Q+  +   EA +I+++
Sbjct: 46  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKL 105
Query: 162 QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFD----PTKREILDWRTRVQIIKGVA 217
            H+N+V+ +G  ++   R ++ E M    L  FL +    P++   L     + + + +A
Sbjct: 106 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 165
Query: 218 QGLLYLHQYSRVRIIHRDLKASNILL---DKDMNSKISDFGMARIVFGGNDEDELQGNTS 274
            G  YL +      IHRD+ A N LL        +KI DFGMAR ++        + +  
Sbjct: 166 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--------RASYY 214
Query: 275 RISG----TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGF--YRTKSLNLIG 328
           R  G       +M PE  +EGIF+ K+D +SFGVLL EI S     G+  Y +KS     
Sbjct: 215 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS----LGYMPYPSKS----- 265
Query: 329 YAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVV 381
                  + ++++ + S                I   C Q + EDRP  + ++
Sbjct: 266 -------NQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 311

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 86/299 (28%), Positives = 132/299 (44%), Gaps = 40/299 (13%)
Query: 110 NFSAANKLGEGGFGTVYKG-VIGQGE------IAVKRLLGKSGQEIKE-LKNEASVIAQV 161
           N      LG G FG V +    G G+      +AVK L   +  + KE L +E  +++ +
Sbjct: 47  NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHL 106
Query: 162 -QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFL--------FDPT---KREILDWRTR 209
            QH+N+V LLG C      L+I EY     L  FL         DP        L  R  
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDL 166
Query: 210 VQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDEL 269
           +     VAQG+ +L   +    IHRD+ A N+LL     +KI DFG+AR +   ND + +
Sbjct: 167 LHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIM--NDSNYI 221
Query: 270 QGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGY 329
               +R+     +M+PE   + +++++SDV+S+G+LL EI             SL L  Y
Sbjct: 222 VKGNARLP--VKWMAPESIFDCVYTVQSDVWSYGILLWEIF------------SLGLNPY 267
Query: 330 AWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEA 388
              + +++K   L+    + A    +      I   C       RPT   + S L  +A
Sbjct: 268 P-GILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 137/305 (44%), Gaps = 60/305 (19%)
Query: 116 KLGEGGFGTVYKG-----VIGQGE--IAVKRL-LGKSGQEIKELKNEASVIAQVQHKNLV 167
           +LG+G FG VY+G     + G+ E  +AVK +    S +E  E  NEASV+      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 168 KLLGCCIEKDERLLIYEYMPNKSLDCFL-------------FDPTKREILDWRTRVQIIK 214
           +LLG   +    L++ E M +  L  +L               PT +E+      +Q+  
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM------IQMAA 137
Query: 215 GVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTS 274
            +A G+ YL+     + +HRDL A N ++  D   KI DFGM R        D  + +  
Sbjct: 138 EIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR--------DIXETDXX 186
Query: 275 RISG----TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS--GKKNTGFYRTKSLNLIG 328
           R  G       +M+PE   +G+F+  SD++SFGV+L EI S   +   G    + L  + 
Sbjct: 187 RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV- 245
Query: 329 YAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEA 388
                 +    +D  D+  E         R   +  +C Q   + RPT  ++V++L ++ 
Sbjct: 246 ------MDGGYLDQPDNCPE---------RVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 290
Query: 389 SSLLP 393
               P
Sbjct: 291 HPSFP 295

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 132/289 (45%), Gaps = 40/289 (13%)
Query: 110 NFSAANKLGEGGFGTVYKGVIG-------QGEIAVKRLLGK-SGQEIKELKNEASVIAQV 161
           N +    LG G FG VY+G +          ++AVK L    S Q+  +   EA +I++ 
Sbjct: 31  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 90
Query: 162 QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFD----PTKREILDWRTRVQIIKGVA 217
            H+N+V+ +G  ++   R ++ E M    L  FL +    P++   L     + + + +A
Sbjct: 91  NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 150
Query: 218 QGLLYLHQYSRVRIIHRDLKASNILL---DKDMNSKISDFGMARIVFGGNDEDELQGNTS 274
            G  YL +      IHRD+ A N LL        +KI DFGMAR ++  +     +G  +
Sbjct: 151 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR--KGGCA 205
Query: 275 RISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGF--YRTKSLNLIGYAWD 332
            +     +M PE  +EGIF+ K+D +SFGVLL EI S     G+  Y +KS         
Sbjct: 206 MLP--VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS----LGYMPYPSKS--------- 250
Query: 333 LWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVV 381
              + ++++ + S                I   C Q + EDRP  + ++
Sbjct: 251 ---NQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 296

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 132/289 (45%), Gaps = 40/289 (13%)
Query: 110 NFSAANKLGEGGFGTVYKGVIG-------QGEIAVKRLLGK-SGQEIKELKNEASVIAQV 161
           N +    LG G FG VY+G +          ++AVK L    S Q+  +   EA +I++ 
Sbjct: 31  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 90
Query: 162 QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFD----PTKREILDWRTRVQIIKGVA 217
            H+N+V+ +G  ++   R ++ E M    L  FL +    P++   L     + + + +A
Sbjct: 91  NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 150
Query: 218 QGLLYLHQYSRVRIIHRDLKASNILLD---KDMNSKISDFGMARIVFGGNDEDELQGNTS 274
            G  YL +      IHRD+ A N LL        +KI DFGMAR ++  +     +G  +
Sbjct: 151 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR--KGGCA 205
Query: 275 RISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGF--YRTKSLNLIGYAWD 332
            +     +M PE  +EGIF+ K+D +SFGVLL EI S     G+  Y +KS         
Sbjct: 206 MLP--VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS----LGYMPYPSKS--------- 250
Query: 333 LWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVV 381
              + ++++ + S                I   C Q + EDRP  + ++
Sbjct: 251 ---NQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 296

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 132/289 (45%), Gaps = 40/289 (13%)
Query: 110 NFSAANKLGEGGFGTVYKGVIG-------QGEIAVKRLLGK-SGQEIKELKNEASVIAQV 161
           N +    LG G FG VY+G +          ++AVK L    S Q+  +   EA +I++ 
Sbjct: 23  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 82
Query: 162 QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFD----PTKREILDWRTRVQIIKGVA 217
            H+N+V+ +G  ++   R ++ E M    L  FL +    P++   L     + + + +A
Sbjct: 83  NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 142
Query: 218 QGLLYLHQYSRVRIIHRDLKASNILL---DKDMNSKISDFGMARIVFGGNDEDELQGNTS 274
            G  YL +      IHRD+ A N LL        +KI DFGMAR ++  +     +G  +
Sbjct: 143 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR--KGGCA 197
Query: 275 RISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGF--YRTKSLNLIGYAWD 332
            +     +M PE  +EGIF+ K+D +SFGVLL EI S     G+  Y +KS         
Sbjct: 198 MLP--VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS----LGYMPYPSKS--------- 242
Query: 333 LWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVV 381
              + ++++ + S                I   C Q + EDRP  + ++
Sbjct: 243 ---NQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 288

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/293 (27%), Positives = 131/293 (44%), Gaps = 48/293 (16%)
Query: 110 NFSAANKLGEGGFGTVYKGVIG-------QGEIAVKRLLG-KSGQEIKELKNEASVIAQV 161
           N +    LG G FG VY+G +          ++AVK L    S Q+  +   EA +I++ 
Sbjct: 46  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKF 105
Query: 162 QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFD----PTKREILDWRTRVQIIKGVA 217
            H+N+V+ +G  ++   R ++ E M    L  FL +    P++   L     + + + +A
Sbjct: 106 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 165
Query: 218 QGLLYLHQYSRVRIIHRDLKASNILL---DKDMNSKISDFGMARIVFGGNDEDELQGNTS 274
            G  YL +      IHRD+ A N LL        +KI DFGMAR ++        + +  
Sbjct: 166 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--------RASYY 214
Query: 275 RISG----TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGF--YRTKSLNLIG 328
           R  G       +M PE  +EGIF+ K+D +SFGVLL EI S     G+  Y +KS     
Sbjct: 215 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS----LGYMPYPSKS----- 265
Query: 329 YAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVV 381
                  + ++++ + S                I   C Q + EDRP  + ++
Sbjct: 266 -------NQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 311

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 117/213 (54%), Gaps = 25/213 (11%)
Query: 110 NFSAANKLGEGGFGTVYKGV-IGQGE-----IAVKRLL-GKSGQEIKELKNEASVIAQVQ 162
            F     LG G FGTVYKG+ I +GE     +A+K L    S +  KE+ +EA V+A V 
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPT----KREILDWRTRVQIIKGVAQ 218
           + ++ +LLG C+    +L I + MP   L  ++ +       + +L+W  ++      A+
Sbjct: 77  NPHVCRLLGICLTSTVQL-IMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQI------AK 129
Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
           G+ YL      R++HRDL A N+L+    + KI+DFG+A+++  G +E E      ++  
Sbjct: 130 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVP- 183
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
              +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 184 -IKWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 117/213 (54%), Gaps = 25/213 (11%)
Query: 110 NFSAANKLGEGGFGTVYKGV-IGQGE-----IAVKRLL-GKSGQEIKELKNEASVIAQVQ 162
            F     LG G FGTVYKG+ I +GE     +A+K L    S +  KE+ +EA V+A V 
Sbjct: 13  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 72
Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPT----KREILDWRTRVQIIKGVAQ 218
           + ++ +LLG C+    +L I + MP   L  ++ +       + +L+W  ++      A+
Sbjct: 73  NPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AE 125
Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
           G+ YL      R++HRDL A N+L+    + KI+DFG+A+++  G +E E      ++  
Sbjct: 126 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVP- 179
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
              +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 180 -IKWMALESILHRIYTHQSDVWSYGVTVWELMT 211

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 137/301 (45%), Gaps = 52/301 (17%)
Query: 116 KLGEGGFGTVYKG-----VIGQGE--IAVKRL-LGKSGQEIKELKNEASVIAQVQHKNLV 167
           +LG+G FG VY+G     + G+ E  +AVK +    S +E  E  NEASV+      ++V
Sbjct: 23  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 82
Query: 168 KLLGCCIEKDERLLIYEYMPNKSLDCFL-------------FDPTKREILDWRTRVQIIK 214
           +LLG   +    L++ E M +  L  +L               PT +E+      +Q+  
Sbjct: 83  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM------IQMAA 136
Query: 215 GVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTS 274
            +A G+ YL+     + +HRDL A N ++  D   KI DFGM R ++    E +      
Sbjct: 137 EIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIY----ETDYYRKGG 189
Query: 275 RISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS--GKKNTGFYRTKSLNLIGYAWD 332
           +      +M+PE   +G+F+  SD++SFGV+L EI S   +   G    + L  +     
Sbjct: 190 KGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV----- 244
Query: 333 LWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLL 392
             +    +D  D+  E         R   +  +C Q   + RPT  ++V++L ++     
Sbjct: 245 --MDGGYLDQPDNCPE---------RVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSF 293
Query: 393 P 393
           P
Sbjct: 294 P 294

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 117/213 (54%), Gaps = 25/213 (11%)
Query: 110 NFSAANKLGEGGFGTVYKGV-IGQGE-----IAVKRLL-GKSGQEIKELKNEASVIAQVQ 162
            F     LG G FGTVYKG+ I +GE     +A+K L    S +  KE+ +EA V+A V 
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPT----KREILDWRTRVQIIKGVAQ 218
           + ++ +LLG C+    +L I + MP   L  ++ +       + +L+W  ++      A+
Sbjct: 77  NPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 129
Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
           G+ YL      R++HRDL A N+L+    + KI+DFG+A+++  G +E E      ++  
Sbjct: 130 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVP- 183
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
              +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 184 -IKWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 136/305 (44%), Gaps = 60/305 (19%)
Query: 116 KLGEGGFGTVYKG-----VIGQGE--IAVKRL-LGKSGQEIKELKNEASVIAQVQHKNLV 167
           +LG+G FG VY+G     + G+ E  +AVK +    S +E  E  NEASV+      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 168 KLLGCCIEKDERLLIYEYMPNKSLDCFL-------------FDPTKREILDWRTRVQIIK 214
           +LLG   +    L++ E M +  L  +L               PT +E+      +Q+  
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM------IQMAA 137
Query: 215 GVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTS 274
            +A G+ YL+     + +HRDL A N ++  D   KI DFGM R        D  + +  
Sbjct: 138 EIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR--------DIXETDXX 186
Query: 275 RISG----TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS--GKKNTGFYRTKSLNLIG 328
           R  G       +M+PE   +G+F+  SD++SFGV+L EI S   +   G    + L  + 
Sbjct: 187 RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV- 245
Query: 329 YAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEA 388
                 +    +D  D+  E         R   +  +C Q     RPT  ++V++L ++ 
Sbjct: 246 ------MDGGYLDQPDNCPE---------RVTDLMRMCWQFNPNMRPTFLEIVNLLKDDL 290
Query: 389 SSLLP 393
               P
Sbjct: 291 HPSFP 295

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 117/213 (54%), Gaps = 25/213 (11%)
Query: 110 NFSAANKLGEGGFGTVYKGV-IGQGE-----IAVKRLL-GKSGQEIKELKNEASVIAQVQ 162
            F     LG G FGTVYKG+ I +GE     +A+K L    S +  KE+ +EA V+A V 
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPT----KREILDWRTRVQIIKGVAQ 218
           + ++ +LLG C+    +L I + MP   L  ++ +       + +L+W  ++      A+
Sbjct: 70  NPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 122
Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
           G+ YL      R++HRDL A N+L+    + KI+DFG+A+++  G +E E      ++  
Sbjct: 123 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVP- 176
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
              +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 177 -IKWMALESILHRIYTHQSDVWSYGVTVWELMT 208

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 108/205 (52%), Gaps = 16/205 (7%)
Query: 115 NKLGEGGFGTV----YKGVIGQ-GEI-AVKRLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
            +LG+G FG+V    Y  +    GE+ AVK+L   + + +++ + E  ++  +QH N+VK
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 169 LLGCCIEKDER--LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQY 226
             G C     R   LI EY+P  SL  +L     +E +D    +Q    + +G+ YL   
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 161
Query: 227 SRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPE 286
              R IHRDL   NIL++ +   KI DFG+ +++    D++  +      S  + Y +PE
Sbjct: 162 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVL--PQDKEXXKVKEPGESPIFWY-APE 218
Query: 287 YALEGIFSIKSDVFSFGVLLLEIVS 311
              E  FS+ SDV+SFGV+L E+ +
Sbjct: 219 SLTESKFSVASDVWSFGVVLYELFT 243

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 117/213 (54%), Gaps = 25/213 (11%)
Query: 110 NFSAANKLGEGGFGTVYKGV-IGQGE-----IAVKRLL-GKSGQEIKELKNEASVIAQVQ 162
            F     LG G FGTVYKG+ I +GE     +A+K L    S +  KE+ +EA V+A V 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPT----KREILDWRTRVQIIKGVAQ 218
           + ++ +LLG C+    +L I + MP   L  ++ +       + +L+W  ++      A+
Sbjct: 79  NPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 131
Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
           G+ YL      R++HRDL A N+L+    + KI+DFG+A+++  G +E E      ++  
Sbjct: 132 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVP- 185
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
              +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 186 -IKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 132/289 (45%), Gaps = 40/289 (13%)
Query: 110 NFSAANKLGEGGFGTVYKGVIG-------QGEIAVKRLLGK-SGQEIKELKNEASVIAQV 161
           N +    LG G FG VY+G +          ++AVK L    S Q+  +   EA +I++ 
Sbjct: 48  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 107
Query: 162 QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFD----PTKREILDWRTRVQIIKGVA 217
            H+N+V+ +G  ++   R ++ E M    L  FL +    P++   L     + + + +A
Sbjct: 108 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 167
Query: 218 QGLLYLHQYSRVRIIHRDLKASNILLD---KDMNSKISDFGMARIVFGGNDEDELQGNTS 274
            G  YL +      IHRD+ A N LL        +KI DFGMAR ++  +     +G  +
Sbjct: 168 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR--KGGCA 222
Query: 275 RISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGF--YRTKSLNLIGYAWD 332
            +     +M PE  +EGIF+ K+D +SFGVLL EI S     G+  Y +KS         
Sbjct: 223 MLP--VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS----LGYMPYPSKS--------- 267
Query: 333 LWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVV 381
              + ++++ + S                I   C Q + EDRP  + ++
Sbjct: 268 ---NQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 313

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 82/293 (27%), Positives = 131/293 (44%), Gaps = 48/293 (16%)
Query: 110 NFSAANKLGEGGFGTVYKGVIG-------QGEIAVKRLLGK-SGQEIKELKNEASVIAQV 161
           N +    LG G FG VY+G +          ++AVK L    S Q+  +   EA +I++ 
Sbjct: 46  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 105
Query: 162 QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFD----PTKREILDWRTRVQIIKGVA 217
            H+N+V+ +G  ++   R ++ E M    L  FL +    P++   L     + + + +A
Sbjct: 106 NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 165
Query: 218 QGLLYLHQYSRVRIIHRDLKASNILL---DKDMNSKISDFGMARIVFGGNDEDELQGNTS 274
            G  YL +      IHRD+ A N LL        +KI DFGMAR ++        + +  
Sbjct: 166 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--------RASYY 214
Query: 275 RISG----TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGF--YRTKSLNLIG 328
           R  G       +M PE  +EGIF+ K+D +SFGVLL EI S     G+  Y +KS     
Sbjct: 215 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS----LGYMPYPSKS----- 265
Query: 329 YAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVV 381
                  + ++++ + S                I   C Q + EDRP  + ++
Sbjct: 266 -------NQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 311

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 117/213 (54%), Gaps = 25/213 (11%)
Query: 110 NFSAANKLGEGGFGTVYKGV-IGQGE-----IAVKRLL-GKSGQEIKELKNEASVIAQVQ 162
            F     LG G FGTVYKG+ I +GE     +A+K L    S +  KE+ +EA V+A V 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPT----KREILDWRTRVQIIKGVAQ 218
           + ++ +LLG C+    +L I + MP   L  ++ +       + +L+W  ++      A+
Sbjct: 78  NPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 130
Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
           G+ YL      R++HRDL A N+L+    + KI+DFG+A+++  G +E E      ++  
Sbjct: 131 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVP- 184
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
              +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 185 -IKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 117/213 (54%), Gaps = 25/213 (11%)
Query: 110 NFSAANKLGEGGFGTVYKGV-IGQGE-----IAVKRLL-GKSGQEIKELKNEASVIAQVQ 162
            F     LG G FGTVYKG+ I +GE     +A+K L    S +  KE+ +EA V+A V 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPT----KREILDWRTRVQIIKGVAQ 218
           + ++ +LLG C+    +L I + MP   L  ++ +       + +L+W  ++      A+
Sbjct: 76  NPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 128
Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
           G+ YL      R++HRDL A N+L+    + KI+DFG+A+++  G +E E      ++  
Sbjct: 129 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVP- 182
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
              +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 183 -IKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 117/213 (54%), Gaps = 25/213 (11%)
Query: 110 NFSAANKLGEGGFGTVYKGV-IGQGE-----IAVKRLL-GKSGQEIKELKNEASVIAQVQ 162
            F     LG G FGTVYKG+ I +GE     +A+K L    S +  KE+ +EA V+A V 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPT----KREILDWRTRVQIIKGVAQ 218
           + ++ +LLG C+    +L I + MP   L  ++ +       + +L+W  ++      A+
Sbjct: 76  NPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 128
Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
           G+ YL      R++HRDL A N+L+    + KI+DFG+A+++  G +E E      ++  
Sbjct: 129 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVP- 182
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
              +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 183 -IKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 117/213 (54%), Gaps = 25/213 (11%)
Query: 110 NFSAANKLGEGGFGTVYKGV-IGQGE-----IAVKRLL-GKSGQEIKELKNEASVIAQVQ 162
            F     LG G FGTVYKG+ I +GE     +A+K L    S +  KE+ +EA V+A V 
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPT----KREILDWRTRVQIIKGVAQ 218
           + ++ +LLG C+    +L I + MP   L  ++ +       + +L+W  ++      A+
Sbjct: 80  NPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 132
Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
           G+ YL      R++HRDL A N+L+    + KI+DFG+A+++  G +E E      ++  
Sbjct: 133 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVP- 186
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
              +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 187 -IKWMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 136/301 (45%), Gaps = 52/301 (17%)
Query: 116 KLGEGGFGTVYKG-----VIGQGE--IAVKRL-LGKSGQEIKELKNEASVIAQVQHKNLV 167
           +LG+G FG VY+G     + G+ E  +AVK +    S +E  E  NEASV+      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 168 KLLGCCIEKDERLLIYEYMPNKSLDCFL-------------FDPTKREILDWRTRVQIIK 214
           +LLG   +    L++ E M +  L  +L               PT +E+      +Q+  
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM------IQMAA 137
Query: 215 GVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTS 274
            +A G+ YL+     + +HRDL A N ++  D   KI DFGM R ++    E        
Sbjct: 138 EIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIY----ETAYYRKGG 190
Query: 275 RISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS--GKKNTGFYRTKSLNLIGYAWD 332
           +      +M+PE   +G+F+  SD++SFGV+L EI S   +   G    + L  +     
Sbjct: 191 KGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV----- 245
Query: 333 LWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLL 392
             +    +D  D+  E         R   +  +C Q   + RPT  ++V++L ++     
Sbjct: 246 --MDGGYLDQPDNCPE---------RVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSF 294
Query: 393 P 393
           P
Sbjct: 295 P 295

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 108/205 (52%), Gaps = 16/205 (7%)
Query: 115 NKLGEGGFGTV----YKGVIGQ-GEI-AVKRLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
            +LG+G FG+V    Y  +    GE+ AVK+L   + + +++ + E  ++  +QH N+VK
Sbjct: 20  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 79
Query: 169 LLGCCIEKDER--LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQY 226
             G C     R   LI EY+P  SL  +L     +E +D    +Q    + +G+ YL   
Sbjct: 80  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 134
Query: 227 SRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPE 286
              R IHRDL   NIL++ +   KI DFG+ +++    D++  +      S  + Y +PE
Sbjct: 135 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVL--PQDKEXXKVKEPGESPIFWY-APE 191
Query: 287 YALEGIFSIKSDVFSFGVLLLEIVS 311
              E  FS+ SDV+SFGV+L E+ +
Sbjct: 192 SLTESKFSVASDVWSFGVVLYELFT 216

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 131/289 (45%), Gaps = 40/289 (13%)
Query: 110 NFSAANKLGEGGFGTVYKGVIG-------QGEIAVKRLLGK-SGQEIKELKNEASVIAQV 161
           N +    LG G FG VY+G +          ++AVK L    S Q+  +   EA +I++ 
Sbjct: 72  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 131
Query: 162 QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFD----PTKREILDWRTRVQIIKGVA 217
            H+N+V+ +G  ++   R ++ E M    L  FL +    P++   L     + + + +A
Sbjct: 132 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 191
Query: 218 QGLLYLHQYSRVRIIHRDLKASNILLD---KDMNSKISDFGMARIVFGGNDEDELQGNTS 274
            G  YL +      IHRD+ A N LL        +KI DFGMAR ++        +G  +
Sbjct: 192 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR--KGGCA 246
Query: 275 RISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGF--YRTKSLNLIGYAWD 332
            +     +M PE  +EGIF+ K+D +SFGVLL EI S     G+  Y +KS         
Sbjct: 247 MLP--VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS----LGYMPYPSKS--------- 291
Query: 333 LWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVV 381
              + ++++ + S                I   C Q + EDRP  + ++
Sbjct: 292 ---NQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 337

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 117/213 (54%), Gaps = 25/213 (11%)
Query: 110 NFSAANKLGEGGFGTVYKGV-IGQGE-----IAVKRLL-GKSGQEIKELKNEASVIAQVQ 162
            F     LG G FGTVYKG+ I +GE     +A+K L    S +  KE+ +EA V+A V 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPT----KREILDWRTRVQIIKGVAQ 218
           + ++ +LLG C+    +L I + MP   L  ++ +       + +L+W  ++      A+
Sbjct: 76  NPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 128
Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
           G+ YL      R++HRDL A N+L+    + KI+DFG+A+++  G +E E      ++  
Sbjct: 129 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVP- 182
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
              +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 183 -IKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 117/213 (54%), Gaps = 25/213 (11%)
Query: 110 NFSAANKLGEGGFGTVYKGV-IGQGE-----IAVKRLL-GKSGQEIKELKNEASVIAQVQ 162
            F     LG G FGTVYKG+ I +GE     +A+K L    S +  KE+ +EA V+A V 
Sbjct: 26  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 85
Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPT----KREILDWRTRVQIIKGVAQ 218
           + ++ +LLG C+    +L I + MP   L  ++ +       + +L+W  ++      A+
Sbjct: 86  NPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 138
Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
           G+ YL      R++HRDL A N+L+    + KI+DFG+A+++  G +E E      ++  
Sbjct: 139 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVP- 192
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
              +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 193 -IKWMALESILHRIYTHQSDVWSYGVTVWELMT 224

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 108/205 (52%), Gaps = 16/205 (7%)
Query: 115 NKLGEGGFGTV----YKGVIGQ-GEI-AVKRLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
            +LG+G FG+V    Y  +    GE+ AVK+L   + + +++ + E  ++  +QH N+VK
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 169 LLGCCIEKDER--LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQY 226
             G C     R   LI EY+P  SL  +L     +E +D    +Q    + +G+ YL   
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 130
Query: 227 SRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPE 286
              R IHRDL   NIL++ +   KI DFG+ +++    D++  +      S  + Y +PE
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVL--PQDKEXXKVKEPGESPIFWY-APE 187
Query: 287 YALEGIFSIKSDVFSFGVLLLEIVS 311
              E  FS+ SDV+SFGV+L E+ +
Sbjct: 188 SLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 108/205 (52%), Gaps = 16/205 (7%)
Query: 115 NKLGEGGFGTV----YKGVIGQ-GEI-AVKRLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
            +LG+G FG+V    Y  +    GE+ AVK+L   + + +++ + E  ++  +QH N+VK
Sbjct: 15  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 74
Query: 169 LLGCCIEKDER--LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQY 226
             G C     R   LI EY+P  SL  +L     +E +D    +Q    + +G+ YL   
Sbjct: 75  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 129
Query: 227 SRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPE 286
              R IHRDL   NIL++ +   KI DFG+ +++    D++  +      S  + Y +PE
Sbjct: 130 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVL--PQDKEXXKVKEPGESPIFWY-APE 186
Query: 287 YALEGIFSIKSDVFSFGVLLLEIVS 311
              E  FS+ SDV+SFGV+L E+ +
Sbjct: 187 SLTESKFSVASDVWSFGVVLYELFT 211

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 117/213 (54%), Gaps = 25/213 (11%)
Query: 110 NFSAANKLGEGGFGTVYKGV-IGQGE-----IAVKRLL-GKSGQEIKELKNEASVIAQVQ 162
            F     LG G FGTVYKG+ I +GE     +A+K L    S +  KE+ +EA V+A V 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPT----KREILDWRTRVQIIKGVAQ 218
           + ++ +LLG C+    +L I + MP   L  ++ +       + +L+W  ++      A+
Sbjct: 76  NPHVCRLLGICLTSTVQL-ITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQI------AK 128
Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
           G+ YL      R++HRDL A N+L+    + KI+DFG+A+++  G +E E      ++  
Sbjct: 129 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVP- 182
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
              +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 183 -IKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 108/205 (52%), Gaps = 16/205 (7%)
Query: 115 NKLGEGGFGTV----YKGVIGQ-GEI-AVKRLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
            +LG+G FG+V    Y  +    GE+ AVK+L   + + +++ + E  ++  +QH N+VK
Sbjct: 14  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 73
Query: 169 LLGCCIEKDER--LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQY 226
             G C     R   LI EY+P  SL  +L     +E +D    +Q    + +G+ YL   
Sbjct: 74  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 128
Query: 227 SRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPE 286
              R IHRDL   NIL++ +   KI DFG+ +++    D++  +      S  + Y +PE
Sbjct: 129 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVL--PQDKEXXKVKEPGESPIFWY-APE 185
Query: 287 YALEGIFSIKSDVFSFGVLLLEIVS 311
              E  FS+ SDV+SFGV+L E+ +
Sbjct: 186 SLTESKFSVASDVWSFGVVLYELFT 210

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 108/205 (52%), Gaps = 16/205 (7%)
Query: 115 NKLGEGGFGTV----YKGVIGQ-GEI-AVKRLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
            +LG+G FG+V    Y  +    GE+ AVK+L   + + +++ + E  ++  +QH N+VK
Sbjct: 22  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 81
Query: 169 LLGCCIEKDER--LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQY 226
             G C     R   LI EY+P  SL  +L     +E +D    +Q    + +G+ YL   
Sbjct: 82  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 136
Query: 227 SRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPE 286
              R IHRDL   NIL++ +   KI DFG+ +++    D++  +      S  + Y +PE
Sbjct: 137 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVL--PQDKEXXKVKEPGESPIFWY-APE 193
Query: 287 YALEGIFSIKSDVFSFGVLLLEIVS 311
              E  FS+ SDV+SFGV+L E+ +
Sbjct: 194 SLTESKFSVASDVWSFGVVLYELFT 218

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 117/213 (54%), Gaps = 25/213 (11%)
Query: 110 NFSAANKLGEGGFGTVYKGV-IGQGE-----IAVKRLL-GKSGQEIKELKNEASVIAQVQ 162
            F     LG G FGTVYKG+ I +GE     +A+K L    S +  KE+ +EA V+A V 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPT----KREILDWRTRVQIIKGVAQ 218
           + ++ +LLG C+    +L I + MP   L  ++ +       + +L+W  ++      A+
Sbjct: 79  NPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 131
Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
           G+ YL      R++HRDL A N+L+    + KI+DFG+A+++  G +E E      ++  
Sbjct: 132 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVP- 185
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
              +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 186 -IKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 117/213 (54%), Gaps = 25/213 (11%)
Query: 110 NFSAANKLGEGGFGTVYKGV-IGQGE-----IAVKRLL-GKSGQEIKELKNEASVIAQVQ 162
            F     LG G FGTVYKG+ I +GE     +A+K L    S +  KE+ +EA V+A V 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPT----KREILDWRTRVQIIKGVAQ 218
           + ++ +LLG C+    +L I + MP   L  ++ +       + +L+W  ++      A+
Sbjct: 78  NPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 130
Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
           G+ YL      R++HRDL A N+L+    + KI+DFG+A+++  G +E E      ++  
Sbjct: 131 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVP- 184
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
              +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 185 -IKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 117/213 (54%), Gaps = 25/213 (11%)
Query: 110 NFSAANKLGEGGFGTVYKGV-IGQGE-----IAVKRLL-GKSGQEIKELKNEASVIAQVQ 162
            F     LG G FGTVYKG+ I +GE     +A+K L    S +  KE+ +EA V+A V 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPT----KREILDWRTRVQIIKGVAQ 218
           + ++ +LLG C+    +L I + MP   L  ++ +       + +L+W  ++      A+
Sbjct: 79  NPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 131
Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
           G+ YL      R++HRDL A N+L+    + KI+DFG+A+++  G +E E      ++  
Sbjct: 132 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVP- 185
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
              +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 186 -IKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 117/213 (54%), Gaps = 25/213 (11%)
Query: 110 NFSAANKLGEGGFGTVYKGV-IGQGE-----IAVKRLL-GKSGQEIKELKNEASVIAQVQ 162
            F     LG G FGTVYKG+ I +GE     +A+K L    S +  KE+ +EA V+A V 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPT----KREILDWRTRVQIIKGVAQ 218
           + ++ +LLG C+    +L I + MP   L  ++ +       + +L+W  ++      A+
Sbjct: 79  NPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 131
Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
           G+ YL      R++HRDL A N+L+    + KI+DFG+A+++  G +E E      ++  
Sbjct: 132 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVP- 185
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
              +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 186 -IKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 82/293 (27%), Positives = 130/293 (44%), Gaps = 48/293 (16%)
Query: 110 NFSAANKLGEGGFGTVYKGVIG-------QGEIAVKRLLGK-SGQEIKELKNEASVIAQV 161
           N +    LG G FG VY+G +          ++AVK L    S Q+  +   EA +I++ 
Sbjct: 49  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 108
Query: 162 QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFD----PTKREILDWRTRVQIIKGVA 217
            H+N+V+ +G  ++   R ++ E M    L  FL +    P++   L     + + + +A
Sbjct: 109 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 168
Query: 218 QGLLYLHQYSRVRIIHRDLKASNILL---DKDMNSKISDFGMARIVFGGNDEDELQGNTS 274
            G  YL +      IHRD+ A N LL        +KI DFGMAR ++        +    
Sbjct: 169 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--------RAGYY 217
Query: 275 RISG----TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGF--YRTKSLNLIG 328
           R  G       +M PE  +EGIF+ K+D +SFGVLL EI S     G+  Y +KS     
Sbjct: 218 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS----LGYMPYPSKS----- 268
Query: 329 YAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVV 381
                  + ++++ + S                I   C Q + EDRP  + ++
Sbjct: 269 -------NQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 314

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 108/205 (52%), Gaps = 16/205 (7%)
Query: 115 NKLGEGGFGTV----YKGVIGQ-GEI-AVKRLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
            +LG+G FG+V    Y  +    GE+ AVK+L   + + +++ + E  ++  +QH N+VK
Sbjct: 21  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 80
Query: 169 LLGCCIEKDER--LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQY 226
             G C     R   LI EY+P  SL  +L     +E +D    +Q    + +G+ YL   
Sbjct: 81  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 135
Query: 227 SRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPE 286
              R IHRDL   NIL++ +   KI DFG+ +++    D++  +      S  + Y +PE
Sbjct: 136 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVL--PQDKEXXKVKEPGESPIFWY-APE 192
Query: 287 YALEGIFSIKSDVFSFGVLLLEIVS 311
              E  FS+ SDV+SFGV+L E+ +
Sbjct: 193 SLTESKFSVASDVWSFGVVLYELFT 217

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 108/205 (52%), Gaps = 16/205 (7%)
Query: 115 NKLGEGGFGTV----YKGVIGQ-GEI-AVKRLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
            +LG+G FG+V    Y  +    GE+ AVK+L   + + +++ + E  ++  +QH N+VK
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 169 LLGCCIEKDER--LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQY 226
             G C     R   LI EY+P  SL  +L     +E +D    +Q    + +G+ YL   
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 130
Query: 227 SRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPE 286
              R IHRDL   NIL++ +   KI DFG+ +++    D++  +      S  + Y +PE
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVL--PQDKEXXKVKEPGESPIFWY-APE 187
Query: 287 YALEGIFSIKSDVFSFGVLLLEIVS 311
              E  FS+ SDV+SFGV+L E+ +
Sbjct: 188 SLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 117/213 (54%), Gaps = 25/213 (11%)
Query: 110 NFSAANKLGEGGFGTVYKGV-IGQGE-----IAVKRLL-GKSGQEIKELKNEASVIAQVQ 162
            F     LG G FGTVYKG+ I +GE     +A+K L    S +  KE+ +EA V+A V 
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPT----KREILDWRTRVQIIKGVAQ 218
           + ++ +LLG C+    +L I + MP   L  ++ +       + +L+W  ++      A+
Sbjct: 83  NPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 135
Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
           G+ YL      R++HRDL A N+L+    + KI+DFG+A+++  G +E E      ++  
Sbjct: 136 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVP- 189
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
              +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 190 -IKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 108/205 (52%), Gaps = 16/205 (7%)
Query: 115 NKLGEGGFGTV----YKGVIGQ-GEI-AVKRLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
            +LG+G FG+V    Y  +    GE+ AVK+L   + + +++ + E  ++  +QH N+VK
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 169 LLGCCIEKDER--LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQY 226
             G C     R   LI EY+P  SL  +L     +E +D    +Q    + +G+ YL   
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 133
Query: 227 SRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPE 286
              R IHRDL   NIL++ +   KI DFG+ +++    D++  +      S  + Y +PE
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVL--PQDKEXXKVKEPGESPIFWY-APE 190
Query: 287 YALEGIFSIKSDVFSFGVLLLEIVS 311
              E  FS+ SDV+SFGV+L E+ +
Sbjct: 191 SLTESKFSVASDVWSFGVVLYELFT 215

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 117/213 (54%), Gaps = 25/213 (11%)
Query: 110 NFSAANKLGEGGFGTVYKGV-IGQGE-----IAVKRLL-GKSGQEIKELKNEASVIAQVQ 162
            F     LG G FGTVYKG+ I +GE     +A+K L    S +  KE+ +EA V+A V 
Sbjct: 22  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 81
Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPT----KREILDWRTRVQIIKGVAQ 218
           + ++ +LLG C+    +L I + MP   L  ++ +       + +L+W  ++      A+
Sbjct: 82  NPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 134
Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
           G+ YL      R++HRDL A N+L+    + KI+DFG+A+++  G +E E      ++  
Sbjct: 135 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVP- 188
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
              +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 189 -IKWMALESILHRIYTHQSDVWSYGVTVWELMT 220

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 108/205 (52%), Gaps = 16/205 (7%)
Query: 115 NKLGEGGFGTV----YKGVIGQ-GEI-AVKRLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
            +LG+G FG+V    Y  +    GE+ AVK+L   + + +++ + E  ++  +QH N+VK
Sbjct: 23  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 82
Query: 169 LLGCCIEKDER--LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQY 226
             G C     R   LI EY+P  SL  +L     +E +D    +Q    + +G+ YL   
Sbjct: 83  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 137
Query: 227 SRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPE 286
              R IHRDL   NIL++ +   KI DFG+ +++    D++  +      S  + Y +PE
Sbjct: 138 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVL--PQDKEXXKVKEPGESPIFWY-APE 194
Query: 287 YALEGIFSIKSDVFSFGVLLLEIVS 311
              E  FS+ SDV+SFGV+L E+ +
Sbjct: 195 SLTESKFSVASDVWSFGVVLYELFT 219

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 117/212 (55%), Gaps = 25/212 (11%)
Query: 111 FSAANKLGEGGFGTVYKGV-IGQGE-----IAVKRLL-GKSGQEIKELKNEASVIAQVQH 163
           F     LG G FGTVYKG+ I +GE     +A+K L    S +  KE+ +EA V+A V +
Sbjct: 42  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 101
Query: 164 KNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPT----KREILDWRTRVQIIKGVAQG 219
            ++ +LLG C+    +L I + MP   L  ++ +       + +L+W  ++      A+G
Sbjct: 102 PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 154
Query: 220 LLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGT 279
           + YL      R++HRDL A N+L+    + KI+DFG+A+++  G +E E      ++   
Sbjct: 155 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVP-- 207
Query: 280 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
             +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 208 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 239

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 108/204 (52%), Gaps = 16/204 (7%)
Query: 116 KLGEGGFGTV----YKGVIGQ-GEI-AVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKL 169
           +LG+G FG+V    Y  +    GE+ AVK+L   + + +++ + E  ++  +QH N+VK 
Sbjct: 35  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 170 LGCCIEKDER--LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYS 227
            G C     R   LI EY+P  SL  +L     +E +D    +Q    + +G+ YL    
Sbjct: 95  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 149
Query: 228 RVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEY 287
             R IHRDL   NIL++ +   KI DFG+ +++    D++  +      S  + Y +PE 
Sbjct: 150 TKRYIHRDLATRNILVENENRVKIGDFGLTKVL--PQDKEXXKVKEPGESPIFWY-APES 206
Query: 288 ALEGIFSIKSDVFSFGVLLLEIVS 311
             E  FS+ SDV+SFGV+L E+ +
Sbjct: 207 LTESKFSVASDVWSFGVVLYELFT 230

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 86/318 (27%), Positives = 140/318 (44%), Gaps = 56/318 (17%)
Query: 93  VDQFPLFSFSSVSSATG--------NFSAANKLGEGGFGTVYKGVIG-------QGEIAV 137
            D  P +SF+  +S+          N +    LG G FG VY+G +          ++AV
Sbjct: 7   TDYNPNYSFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAV 66
Query: 138 KRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLF 196
           K L    S Q+  +   EA +I++  H+N+V+ +G  ++   R ++ E M    L  FL 
Sbjct: 67  KTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLR 126
Query: 197 D----PTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLD---KDMNS 249
           +    P++   L     + + + +A G  YL +      IHRD+ A N LL        +
Sbjct: 127 ETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVA 183
Query: 250 KISDFGMARIVFGGNDEDELQGNTSRISG----TYGYMSPEYALEGIFSIKSDVFSFGVL 305
           KI DFGMA+ ++        + +  R  G       +M PE  +EGIF+ K+D +SFGVL
Sbjct: 184 KIGDFGMAQDIY--------RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVL 235
Query: 306 LLEIVSGKKNTGF--YRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIA 363
           L EI S     G+  Y +KS            + ++++ + S                I 
Sbjct: 236 LWEIFS----LGYMPYPSKS------------NQEVLEFVTSGGRMDPPKNCPGPVYRIM 279
Query: 364 LLCVQERAEDRPTMSDVV 381
             C Q + EDRP  + ++
Sbjct: 280 TQCWQHQPEDRPNFAIIL 297

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 108/204 (52%), Gaps = 16/204 (7%)
Query: 116 KLGEGGFGTV----YKGVIGQ-GEI-AVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKL 169
           +LG+G FG+V    Y  +    GE+ AVK+L   + + +++ + E  ++  +QH N+VK 
Sbjct: 35  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 170 LGCCIEKDER--LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYS 227
            G C     R   LI EY+P  SL  +L     +E +D    +Q    + +G+ YL    
Sbjct: 95  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 149
Query: 228 RVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEY 287
             R IHRDL   NIL++ +   KI DFG+ +++    D++  +      S  + Y +PE 
Sbjct: 150 TKRYIHRDLATRNILVENENRVKIGDFGLTKVL--PQDKEXXKVKEPGESPIFWY-APES 206
Query: 288 ALEGIFSIKSDVFSFGVLLLEIVS 311
             E  FS+ SDV+SFGV+L E+ +
Sbjct: 207 LTESKFSVASDVWSFGVVLYELFT 230

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 108/205 (52%), Gaps = 16/205 (7%)
Query: 115 NKLGEGGFGTV----YKGVIGQ-GEI-AVKRLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
            +LG+G FG+V    Y  +    GE+ AVK+L   + + +++ + E  ++  +QH N+VK
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 169 LLGCCIEKDER--LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQY 226
             G C     R   LI EY+P  SL  +L     +E +D    +Q    + +G+ YL   
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 130
Query: 227 SRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPE 286
              R IHRDL   NIL++ +   KI DFG+ +++    D++  +      S  + Y +PE
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVL--PQDKEFFKVKEPGESPIFWY-APE 187
Query: 287 YALEGIFSIKSDVFSFGVLLLEIVS 311
              E  FS+ SDV+SFGV+L E+ +
Sbjct: 188 SLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 77/278 (27%), Positives = 137/278 (49%), Gaps = 36/278 (12%)
Query: 117 LGEGGFGTVYKGVI---GQGEIAVKRLLGKSGQEIKELKN---EASVIAQVQHKNLVKLL 170
           +G G FG V  G +   G+ ++AV     K G   K+ ++   EAS++ Q  H N+V L 
Sbjct: 51  IGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLE 110
Query: 171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQII---KGVAQGLLYLHQYS 227
           G        +++ E+M N +LD FL     R+     T +Q++   +G+A G+ YL   +
Sbjct: 111 GVVTRGKPVMIVIEFMENGALDAFL-----RKHDGQFTVIQLVGMLRGIAAGMRYL---A 162
Query: 228 RVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEY 287
            +  +HRDL A NIL++ ++  K+SDFG++R++    D+ E    T+       + +PE 
Sbjct: 163 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVI---EDDPEAVYTTTGGKIPVRWTAPEA 219
Query: 288 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNK-IIDLIDSV 346
                F+  SDV+S+G+++ E++S       Y  +        WD+  SN+ +I  I+  
Sbjct: 220 IQYRKFTSASDVWSYGIVMWEVMS-------YGERPY------WDM--SNQDVIKAIEEG 264
Query: 347 LEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML 384
               +  +  +    + L C Q+   +RP    +V +L
Sbjct: 265 YRLPAPMDCPAGLHQLMLDCWQKERAERPKFEQIVGIL 302

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 108/205 (52%), Gaps = 16/205 (7%)
Query: 115 NKLGEGGFGTV----YKGVIGQ-GEI-AVKRLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
            +LG+G FG+V    Y  +    GE+ AVK+L   + + +++ + E  ++  +QH N+VK
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 169 LLGCCIEKDER--LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQY 226
             G C     R   LI EY+P  SL  +L    +R  +D    +Q    + +G+ YL   
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAER--IDHIKLLQYTSQICKGMEYL--- 133
Query: 227 SRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPE 286
              R IHRDL   NIL++ +   KI DFG+ +++    D++  +      S  + Y +PE
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVL--PQDKEXXKVKEPGESPIFWY-APE 190
Query: 287 YALEGIFSIKSDVFSFGVLLLEIVS 311
              E  FS+ SDV+SFGV+L E+ +
Sbjct: 191 SLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 116/213 (54%), Gaps = 25/213 (11%)
Query: 110 NFSAANKLGEGGFGTVYKGV-IGQGE-----IAVKRLL-GKSGQEIKELKNEASVIAQVQ 162
            F     LG G FGTVYKG+ I +GE     +A+K L    S +  KE+ +EA V+A V 
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPT----KREILDWRTRVQIIKGVAQ 218
           + ++ +LLG C+    +L I + MP   L  ++ +       + +L+W  ++      A+
Sbjct: 80  NPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 132
Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
           G+ YL      R++HRDL A N+L+    + KI+DFG A+++  G +E E      ++  
Sbjct: 133 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLL--GAEEKEYHAEGGKVP- 186
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
              +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 187 -IKWMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 131/299 (43%), Gaps = 40/299 (13%)
Query: 110 NFSAANKLGEGGFGTVYKG-VIGQGE------IAVKRLLGKSGQEIKE-LKNEASVIAQV 161
           N      LG G FG V +    G G+      +AVK L   +  + KE L +E  +++ +
Sbjct: 47  NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHL 106
Query: 162 -QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFL--------FDPT---KREILDWRTR 209
            QH+N+V LLG C      L+I EY     L  FL         DP           R  
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDL 166
Query: 210 VQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDEL 269
           +     VAQG+ +L   +    IHRD+ A N+LL     +KI DFG+AR +   ND + +
Sbjct: 167 LHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIM--NDSNYI 221
Query: 270 QGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGY 329
               +R+     +M+PE   + +++++SDV+S+G+LL EI             SL L  Y
Sbjct: 222 VKGNARLP--VKWMAPESIFDCVYTVQSDVWSYGILLWEIF------------SLGLNPY 267
Query: 330 AWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEA 388
              + +++K   L+    + A    +      I   C       RPT   + S L  +A
Sbjct: 268 P-GILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 134/279 (48%), Gaps = 30/279 (10%)
Query: 115 NKLGEGGFGTV-YKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCC 173
            +LG G FG V Y    GQ ++A+K +   S  E  E   EA V+  + H+ LV+L G C
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
            ++    +I EYM N  L  +L +   R     +  +++ K V + + YL      + +H
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLES---KQFLH 143
Query: 234 RDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIF 293
           RDL A N L++     K+SDFG++R V    D++E     S+    +    PE  +   F
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVL---DDEETSSVGSKFPVRWS--PPEVLMYSKF 198
Query: 294 SIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFN 353
           S KSD+++FGVL+ EI S  K                ++ + +++  + I   L     +
Sbjct: 199 SSKSDIWAFGVLMWEIYSLGK--------------MPYERFTNSETAEHIAQGLRLYRPH 244
Query: 354 ESLSRYVHIALLCVQERAEDRPT----MSDVVSMLTNEA 388
            +  +   I   C  E+A++RPT    +S+++ ++  E+
Sbjct: 245 LASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEES 283

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 81/301 (26%), Positives = 136/301 (45%), Gaps = 52/301 (17%)
Query: 116 KLGEGGFGTVYKG-----VIGQGE--IAVKRL-LGKSGQEIKELKNEASVIAQVQHKNLV 167
           +LG+G FG VY+G     + G+ E  +AVK +    S +E  E  NEASV+      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 168 KLLGCCIEKDERLLIYEYMPNKSLDCFL-------------FDPTKREILDWRTRVQIIK 214
           +LLG   +    L++ E M +  L  +L               PT +E+      +Q+  
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM------IQMAA 137
Query: 215 GVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTS 274
            +A G+ YL+     + +HR+L A N ++  D   KI DFGM R ++    E +      
Sbjct: 138 EIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIY----ETDYYRKGG 190
Query: 275 RISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS--GKKNTGFYRTKSLNLIGYAWD 332
           +      +M+PE   +G+F+  SD++SFGV+L EI S   +   G    + L  +     
Sbjct: 191 KGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV----- 245
Query: 333 LWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLL 392
             +    +D  D+  E         R   +  +C Q     RPT  ++V++L ++     
Sbjct: 246 --MDGGYLDQPDNCPE---------RVTDLMRMCWQFNPNMRPTFLEIVNLLKDDLHPSF 294
Query: 393 P 393
           P
Sbjct: 295 P 295

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 81/301 (26%), Positives = 136/301 (45%), Gaps = 52/301 (17%)
Query: 116 KLGEGGFGTVYKG-----VIGQGE--IAVKRL-LGKSGQEIKELKNEASVIAQVQHKNLV 167
           +LG+G FG VY+G     + G+ E  +AVK +    S +E  E  NEASV+      ++V
Sbjct: 25  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 84
Query: 168 KLLGCCIEKDERLLIYEYMPNKSLDCFL-------------FDPTKREILDWRTRVQIIK 214
           +LLG   +    L++ E M +  L  +L               PT +E+      +Q+  
Sbjct: 85  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM------IQMAA 138
Query: 215 GVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTS 274
            +A G+ YL+     + +HR+L A N ++  D   KI DFGM R ++    E +      
Sbjct: 139 EIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIY----ETDYYRKGG 191
Query: 275 RISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS--GKKNTGFYRTKSLNLIGYAWD 332
           +      +M+PE   +G+F+  SD++SFGV+L EI S   +   G    + L  +     
Sbjct: 192 KGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV----- 246
Query: 333 LWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLL 392
             +    +D  D+  E         R   +  +C Q     RPT  ++V++L ++     
Sbjct: 247 --MDGGYLDQPDNCPE---------RVTDLMRMCWQFNPNMRPTFLEIVNLLKDDLHPSF 295
Query: 393 P 393
           P
Sbjct: 296 P 296

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 116/213 (54%), Gaps = 25/213 (11%)
Query: 110 NFSAANKLGEGGFGTVYKGV-IGQGE-----IAVKRLL-GKSGQEIKELKNEASVIAQVQ 162
            F     LG G FGTVYKG+ I +GE     +A+K L    S +  KE+ +EA V+A V 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPT----KREILDWRTRVQIIKGVAQ 218
           + ++ +LLG C+    +L I + MP   L  ++ +       + +L+W  ++      A+
Sbjct: 78  NPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 130
Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
           G+ YL      R++HRDL A N+L+    + KI+DFG A+++  G +E E      ++  
Sbjct: 131 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLL--GAEEKEYHAEGGKVP- 184
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
              +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 185 -IKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 116/213 (54%), Gaps = 25/213 (11%)
Query: 110 NFSAANKLGEGGFGTVYKGV-IGQGE-----IAVKRLL-GKSGQEIKELKNEASVIAQVQ 162
            F     LG G FGTVYKG+ I +GE     +A+K L    S +  KE+ +EA V+A V 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPT----KREILDWRTRVQIIKGVAQ 218
           + ++ +LLG C+    +L I + MP   L  ++ +       + +L+W  ++      A+
Sbjct: 76  NPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 128
Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
           G+ YL      R++HRDL A N+L+    + KI+DFG A+++  G +E E      ++  
Sbjct: 129 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLL--GAEEKEYHAEGGKVP- 182
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
              +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 183 -IKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 116/213 (54%), Gaps = 25/213 (11%)
Query: 110 NFSAANKLGEGGFGTVYKGV-IGQGE-----IAVKRLL-GKSGQEIKELKNEASVIAQVQ 162
            F     LG G FGTVYKG+ I +GE     +A+K L    S +  KE+ +EA V+A V 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPT----KREILDWRTRVQIIKGVAQ 218
           + ++ +LLG C+    +L I + MP   L  ++ +       + +L+W  ++      A+
Sbjct: 78  NPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 130
Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
           G+ YL      R++HRDL A N+L+    + KI+DFG A+++  G +E E      ++  
Sbjct: 131 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLL--GAEEKEYHAEGGKVP- 184
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
              +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 185 -IKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 116/213 (54%), Gaps = 25/213 (11%)
Query: 110 NFSAANKLGEGGFGTVYKGV-IGQGE-----IAVKRLL-GKSGQEIKELKNEASVIAQVQ 162
            F     LG G FGTVYKG+ I +GE     +A+K L    S +  KE+ +EA V+A V 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPT----KREILDWRTRVQIIKGVAQ 218
           + ++ +LLG C+    +L I + MP   L  ++ +       + +L+W  ++      A+
Sbjct: 78  NPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 130
Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
           G+ YL      R++HRDL A N+L+    + KI+DFG A+++  G +E E      ++  
Sbjct: 131 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLL--GAEEKEYHAEGGKVP- 184
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
              +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 185 -IKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 81/298 (27%), Positives = 132/298 (44%), Gaps = 42/298 (14%)
Query: 116 KLGEGGFGTVY----KGVIGQGE---IAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
           +LGEG FG V+      ++ + +   +AVK L   S    ++ + EA ++  +QH+++V+
Sbjct: 25  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 84
Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFL--FDPTKREI----------LDWRTRVQIIKGV 216
             G C E    L+++EYM +  L+ FL    P  + +          L     + +   V
Sbjct: 85  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 144
Query: 217 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRI 276
           A G++YL   + +  +HRDL   N L+ + +  KI DFGM+R ++   D   + G T   
Sbjct: 145 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIY-STDYYRVGGRTML- 199
Query: 277 SGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWIS 336
                +M PE  L   F+ +SDV+SFGV+L EI +  K                W    +
Sbjct: 200 --PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP--------------WYQLSN 243
Query: 337 NKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPP 394
            + ID I    E             I   C Q   + R ++ DV + L   A +  PP
Sbjct: 244 TEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA--PP 299

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 74/258 (28%), Positives = 132/258 (51%), Gaps = 23/258 (8%)
Query: 134 EIAVKRL-LGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKS-L 191
           ++A+KR+ L K    + EL  E   ++Q  H N+V      + KDE  L+ + +   S L
Sbjct: 42  KVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVL 101
Query: 192 DCFLFDPTKRE----ILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDM 247
           D       K E    +LD  T   I++ V +GL YLH+  +   IHRD+KA NILL +D 
Sbjct: 102 DIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDG 158
Query: 248 NSKISDFGMARIVFGGNDEDELQGNTSRIS--GTYGYMSPEYALEGI--FSIKSDVFSFG 303
           + +I+DFG++  +  G D   +  N  R +  GT  +M+PE  +E +  +  K+D++SFG
Sbjct: 159 SVQIADFGVSAFLATGGD---ITRNKVRKTFVGTPCWMAPE-VMEQVRGYDFKADIWSFG 214
Query: 304 VLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIA 363
           +  +E+ +G     +++   + ++     L + N    L   V ++    +    +  + 
Sbjct: 215 ITAIELATGA--APYHKYPPMKVLM----LTLQNDPPSLETGVQDKEMLKKYGKSFRKMI 268
Query: 364 LLCVQERAEDRPTMSDVV 381
            LC+Q+  E RPT ++++
Sbjct: 269 SLCLQKDPEKRPTAAELL 286

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 81/298 (27%), Positives = 132/298 (44%), Gaps = 42/298 (14%)
Query: 116 KLGEGGFGTVY----KGVIGQGE---IAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
           +LGEG FG V+      ++ + +   +AVK L   S    ++ + EA ++  +QH+++V+
Sbjct: 19  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 78
Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFL--FDPTKREI----------LDWRTRVQIIKGV 216
             G C E    L+++EYM +  L+ FL    P  + +          L     + +   V
Sbjct: 79  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 217 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRI 276
           A G++YL   + +  +HRDL   N L+ + +  KI DFGM+R ++   D   + G T   
Sbjct: 139 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIY-STDYYRVGGRTML- 193
Query: 277 SGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWIS 336
                +M PE  L   F+ +SDV+SFGV+L EI +  K                W    +
Sbjct: 194 --PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP--------------WYQLSN 237
Query: 337 NKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPP 394
            + ID I    E             I   C Q   + R ++ DV + L   A +  PP
Sbjct: 238 TEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA--PP 293

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 116/213 (54%), Gaps = 25/213 (11%)
Query: 110 NFSAANKLGEGGFGTVYKGV-IGQGE-----IAVKRLL-GKSGQEIKELKNEASVIAQVQ 162
            F     LG G FGTVYKG+ I +GE     +A+K L    S +  KE+ +EA V+A V 
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPT----KREILDWRTRVQIIKGVAQ 218
           + ++ +LLG C+    +L I + MP   L  ++ +       + +L+W  ++      A+
Sbjct: 83  NPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 135
Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
           G+ YL      R++HRDL A N+L+    + KI+DFG A+++  G +E E      ++  
Sbjct: 136 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLL--GAEEKEYHAEGGKVP- 189
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
              +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 190 -IKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 81/298 (27%), Positives = 133/298 (44%), Gaps = 42/298 (14%)
Query: 116 KLGEGGFGTVY----KGVIGQGE---IAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
           +LGEG FG V+      ++ + +   +AVK L   S    ++ + EA ++  +QH+++V+
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFL--FDPTKREI----------LDWRTRVQIIKGV 216
             G C E    L+++EYM +  L+ FL    P  + +          L     + +   V
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 217 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRI 276
           A G++YL   + +  +HRDL   N L+ + +  KI DFGM+R ++   D   + G T   
Sbjct: 168 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIY-STDYYRVGGRTML- 222
Query: 277 SGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWIS 336
                +M PE  L   F+ +SDV+SFGV+L EI +  K                W    +
Sbjct: 223 --PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP--------------WYQLSN 266
Query: 337 NKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPP 394
            + ID I    E             I   C Q   + R ++ DV + L  +A +  PP
Sbjct: 267 TEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARL--QALAQAPP 322

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 108/204 (52%), Gaps = 16/204 (7%)
Query: 116 KLGEGGFGTV----YKGVIGQ-GEI-AVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKL 169
           +LG+G FG+V    Y  +    GE+ AVK+L   + + +++ + E  ++  +QH N+VK 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 170 LGCCIEKDER--LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYS 227
            G C     R   LI E++P  SL  +L     +E +D    +Q    + +G+ YL    
Sbjct: 80  KGVCYSAGRRNLKLIMEFLPYGSLREYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 134
Query: 228 RVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEY 287
             R IHRDL   NIL++ +   KI DFG+ +++    D++  +      S  + Y +PE 
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVL--PQDKEXXKVKEPGESPIFWY-APES 191
Query: 288 ALEGIFSIKSDVFSFGVLLLEIVS 311
             E  FS+ SDV+SFGV+L E+ +
Sbjct: 192 LTESKFSVASDVWSFGVVLYELFT 215

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 74/258 (28%), Positives = 132/258 (51%), Gaps = 23/258 (8%)
Query: 134 EIAVKRL-LGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKS-L 191
           ++A+KR+ L K    + EL  E   ++Q  H N+V      + KDE  L+ + +   S L
Sbjct: 37  KVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVL 96
Query: 192 DCFLFDPTKRE----ILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDM 247
           D       K E    +LD  T   I++ V +GL YLH+  +   IHRD+KA NILL +D 
Sbjct: 97  DIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDG 153
Query: 248 NSKISDFGMARIVFGGNDEDELQGNTSRIS--GTYGYMSPEYALEGI--FSIKSDVFSFG 303
           + +I+DFG++  +  G D   +  N  R +  GT  +M+PE  +E +  +  K+D++SFG
Sbjct: 154 SVQIADFGVSAFLATGGD---ITRNKVRKTFVGTPCWMAPE-VMEQVRGYDFKADIWSFG 209
Query: 304 VLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIA 363
           +  +E+ +G     +++   + ++     L + N    L   V ++    +    +  + 
Sbjct: 210 ITAIELATGA--APYHKYPPMKVLM----LTLQNDPPSLETGVQDKEMLKKYGKSFRKMI 263
Query: 364 LLCVQERAEDRPTMSDVV 381
            LC+Q+  E RPT ++++
Sbjct: 264 SLCLQKDPEKRPTAAELL 281

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 134/279 (48%), Gaps = 36/279 (12%)
Query: 117 LGEGGFGTVYKGVI---GQGEIAVKRLLGKSGQEIKELKN---EASVIAQVQHKNLVKLL 170
           +G G FG V  G +   G+ EI V     KSG   K+ ++   EAS++ Q  H N++ L 
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 74
Query: 171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQII---KGVAQGLLYLHQYS 227
           G   +    ++I E+M N SLD FL     R+     T +Q++   +G+A G+ YL   +
Sbjct: 75  GVVTKSTPVMIITEFMENGSLDSFL-----RQNDGQFTVIQLVGMLRGIAAGMKYL---A 126
Query: 228 RVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYG--YMSP 285
            +  +HR L A NIL++ ++  K+SDFG++R +    D+      TS + G     + +P
Sbjct: 127 DMNYVHRALAARNILVNSNLVCKVSDFGLSRFL---EDDTSDPTYTSALGGKIPIRWTAP 183
Query: 286 EYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDS 345
           E      F+  SDV+S+G+++ E++S       Y  +        WD+  +  +I+ I+ 
Sbjct: 184 EAIQYRKFTSASDVWSYGIVMWEVMS-------YGERPY------WDM-TNQDVINAIEQ 229
Query: 346 VLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML 384
                   +  S    + L C Q+    RP    +V+ L
Sbjct: 230 DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 268

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 85/309 (27%), Positives = 132/309 (42%), Gaps = 49/309 (15%)
Query: 110 NFSAANKLGEGGFGTVYKG-VIGQGE------IAVKRLLGKSGQEIKE-LKNEASVIAQV 161
           N      LG G FG V +    G G+      +AVK L   +  + KE L +E  +++ +
Sbjct: 32  NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHL 91
Query: 162 -QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFL--------------------FDPTK 200
            QH+N+V LLG C      L+I EY     L  FL                     D   
Sbjct: 92  GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKED 151
Query: 201 REILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIV 260
              L+ R  +     VAQG+ +L   +    IHRD+ A N+LL     +KI DFG+AR +
Sbjct: 152 GRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI 208
Query: 261 FGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYR 320
              ND + +    +R+     +M+PE   + +++++SDV+S+G+LL EI           
Sbjct: 209 M--NDSNYIVKGNARLP--VKWMAPESIFDCVYTVQSDVWSYGILLWEIF---------- 254
Query: 321 TKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDV 380
             SL L  Y   + +++K   L+    + A    +      I   C       RPT   +
Sbjct: 255 --SLGLNPYP-GILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQI 311
Query: 381 VSMLTNEAS 389
            S L  +A 
Sbjct: 312 CSFLQEQAQ 320

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 108/204 (52%), Gaps = 16/204 (7%)
Query: 116 KLGEGGFGTV----YKGVIGQ-GEI-AVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKL 169
           +LG+G FG+V    Y  +    GE+ AVK+L   + + +++ + E  ++  +QH N+VK 
Sbjct: 18  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 77
Query: 170 LGCCIEKDER--LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYS 227
            G C     R   LI EY+P  SL  +L     +E +D    +Q    + +G+ YL    
Sbjct: 78  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 132
Query: 228 RVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEY 287
             R IHR+L   NIL++ +   KI DFG+ +++    D++  +      S  + Y +PE 
Sbjct: 133 TKRYIHRNLATRNILVENENRVKIGDFGLTKVL--PQDKEYYKVKEPGESPIFWY-APES 189
Query: 288 ALEGIFSIKSDVFSFGVLLLEIVS 311
             E  FS+ SDV+SFGV+L E+ +
Sbjct: 190 LTESKFSVASDVWSFGVVLYELFT 213

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 116/213 (54%), Gaps = 25/213 (11%)
Query: 110 NFSAANKLGEGGFGTVYKGV-IGQGE-----IAVKRLL-GKSGQEIKELKNEASVIAQVQ 162
            F     LG G FGTVYKG+ I +GE     +A+  L    S +  KE+ +EA V+A V 
Sbjct: 50  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVD 109
Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPT----KREILDWRTRVQIIKGVAQ 218
           + ++ +LLG C+    +L I + MP   L  ++ +       + +L+W  ++      A+
Sbjct: 110 NPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 162
Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
           G+ YL      R++HRDL A N+L+    + KI+DFG+A+++  G +E E      ++  
Sbjct: 163 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVP- 216
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
              +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 217 -IKWMALESILHRIYTHQSDVWSYGVTVWELMT 248

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 116/213 (54%), Gaps = 25/213 (11%)
Query: 110 NFSAANKLGEGGFGTVYKGV-IGQGE-----IAVKRLL-GKSGQEIKELKNEASVIAQVQ 162
            F     L  G FGTVYKG+ I +GE     +A+K L    S +  KE+ +EA V+A V 
Sbjct: 16  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPT----KREILDWRTRVQIIKGVAQ 218
           + ++ +LLG C+    +L I + MP   L  ++ +       + +L+W  ++      A+
Sbjct: 76  NPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 128
Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
           G+ YL      R++HRDL A N+L+    + KI+DFG+A+++  G +E E      ++  
Sbjct: 129 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVP- 182
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
              +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 183 -IKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 116/213 (54%), Gaps = 25/213 (11%)
Query: 110 NFSAANKLGEGGFGTVYKGV-IGQGE-----IAVKRLL-GKSGQEIKELKNEASVIAQVQ 162
            F     L  G FGTVYKG+ I +GE     +A+K L    S +  KE+ +EA V+A V 
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPT----KREILDWRTRVQIIKGVAQ 218
           + ++ +LLG C+    +L I + MP   L  ++ +       + +L+W  ++      A+
Sbjct: 83  NPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 135
Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
           G+ YL      R++HRDL A N+L+    + KI+DFG+A+++  G +E E      ++  
Sbjct: 136 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVP- 189
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
              +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 190 -IKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 135/281 (48%), Gaps = 34/281 (12%)
Query: 115 NKLGEGGFGTV-YKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCC 173
            +LG G FG V Y    GQ ++A+K +   S  E  E   EA V+  + H+ LV+L G C
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
            ++    +I EYM N  L  +L +   R     +  +++ K V + + YL      + +H
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLES---KQFLH 143
Query: 234 RDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYG--YMSPEYALEG 291
           RDL A N L++     K+SDFG++R V     +DE    TS +   +   +  PE  +  
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVL----DDEY---TSSVGSKFPVRWSPPEVLMYS 196
Query: 292 IFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEAS 351
            FS KSD+++FGVL+ EI S  K                ++ + +++  + I   L    
Sbjct: 197 KFSSKSDIWAFGVLMWEIYSLGK--------------MPYERFTNSETAEHIAQGLRLYR 242
Query: 352 FNESLSRYVHIALLCVQERAEDRPT----MSDVVSMLTNEA 388
            + +  +   I   C  E+A++RPT    +S+++ ++  E+
Sbjct: 243 PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEES 283

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 116/213 (54%), Gaps = 25/213 (11%)
Query: 110 NFSAANKLGEGGFGTVYKGV-IGQGE-----IAVKRLL-GKSGQEIKELKNEASVIAQVQ 162
            F     L  G FGTVYKG+ I +GE     +A+K L    S +  KE+ +EA V+A V 
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPT----KREILDWRTRVQIIKGVAQ 218
           + ++ +LLG C+    +L I + MP   L  ++ +       + +L+W  ++      A+
Sbjct: 83  NPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 135
Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
           G+ YL      R++HRDL A N+L+    + KI+DFG+A+++  G +E E      ++  
Sbjct: 136 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVP- 189
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
              +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 190 -IKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 135/281 (48%), Gaps = 34/281 (12%)
Query: 115 NKLGEGGFGTV-YKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCC 173
            +LG G FG V Y    GQ ++A+K +   S  E  E   EA V+  + H+ LV+L G C
Sbjct: 14  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVC 72
Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
            ++    +I EYM N  L  +L +   R     +  +++ K V + + YL      + +H
Sbjct: 73  TKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLES---KQFLH 127
Query: 234 RDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYG--YMSPEYALEG 291
           RDL A N L++     K+SDFG++R V     +DE    TS +   +   +  PE  +  
Sbjct: 128 RDLAARNCLVNDQGVVKVSDFGLSRYVL----DDEY---TSSVGSKFPVRWSPPEVLMYS 180
Query: 292 IFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEAS 351
            FS KSD+++FGVL+ EI S  K                ++ + +++  + I   L    
Sbjct: 181 KFSSKSDIWAFGVLMWEIYSLGK--------------MPYERFTNSETAEHIAQGLRLYR 226
Query: 352 FNESLSRYVHIALLCVQERAEDRPT----MSDVVSMLTNEA 388
            + +  +   I   C  E+A++RPT    +S+++ ++  E+
Sbjct: 227 PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEES 267

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 135/281 (48%), Gaps = 34/281 (12%)
Query: 115 NKLGEGGFGTV-YKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCC 173
            +LG G FG V Y    GQ ++A+K +   S  E  E   EA V+  + H+ LV+L G C
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
            ++    +I EYM N  L  +L +   R     +  +++ K V + + YL      + +H
Sbjct: 69  TKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLES---KQFLH 123
Query: 234 RDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYG--YMSPEYALEG 291
           RDL A N L++     K+SDFG++R V     +DE    TS +   +   +  PE  +  
Sbjct: 124 RDLAARNCLVNDQGVVKVSDFGLSRYVL----DDEY---TSSVGSKFPVRWSPPEVLMYS 176
Query: 292 IFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEAS 351
            FS KSD+++FGVL+ EI S  K                ++ + +++  + I   L    
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGK--------------MPYERFTNSETAEHIAQGLRLYR 222
Query: 352 FNESLSRYVHIALLCVQERAEDRPT----MSDVVSMLTNEA 388
            + +  +   I   C  E+A++RPT    +S+++ ++  E+
Sbjct: 223 PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEES 263

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 135/281 (48%), Gaps = 34/281 (12%)
Query: 115 NKLGEGGFGTV-YKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCC 173
            +LG G FG V Y    GQ ++A+K +   S  E  E   EA V+  + H+ LV+L G C
Sbjct: 21  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVC 79
Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
            ++    +I EYM N  L  +L +   R     +  +++ K V + + YL      + +H
Sbjct: 80  TKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLES---KQFLH 134
Query: 234 RDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYG--YMSPEYALEG 291
           RDL A N L++     K+SDFG++R V     +DE    TS +   +   +  PE  +  
Sbjct: 135 RDLAARNCLVNDQGVVKVSDFGLSRYVL----DDEY---TSSVGSKFPVRWSPPEVLMYS 187
Query: 292 IFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEAS 351
            FS KSD+++FGVL+ EI S  K                ++ + +++  + I   L    
Sbjct: 188 KFSSKSDIWAFGVLMWEIYSLGK--------------MPYERFTNSETAEHIAQGLRLYR 233
Query: 352 FNESLSRYVHIALLCVQERAEDRPT----MSDVVSMLTNEA 388
            + +  +   I   C  E+A++RPT    +S+++ ++  E+
Sbjct: 234 PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEES 274

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 85/307 (27%), Positives = 137/307 (44%), Gaps = 48/307 (15%)
Query: 82  NNKCKKGCEKEVDQFPLFSFSSVSSATGNFSAANKLGEGGFGTVYKGVIGQGEIAVKRLL 141
           ++K +K  EK+  + P  S               KLG G FG V+     +      + +
Sbjct: 165 SSKPQKPWEKDAWEIPRESLK----------LEKKLGAGQFGEVWMATYNKHTKVAVKTM 214
Query: 142 GKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFL-FDPTK 200
                 ++    EA+V+  +QH  LVKL    + K+   +I E+M   SL  FL  D   
Sbjct: 215 KPGSMSVEAFLAEANVMKTLQHDKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGS 273
Query: 201 REILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIV 260
           ++ L     +     +A+G+ ++ Q +    IHRDL+A+NIL+   +  KI+DFG+AR+ 
Sbjct: 274 KQPLP--KLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARV- 327
Query: 261 FGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYR 320
                     G    I  T    +PE    G F+IKSDV+SFG+LL+EIV          
Sbjct: 328 ----------GAKFPIKWT----APEAINFGSFTIKSDVWSFGILLMEIV---------- 363
Query: 321 TKSLNLIGYAWDLWISN-KIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSD 379
             +   I Y     +SN ++I  ++                +I + C + R E+RPT   
Sbjct: 364 --TYGRIPYP---GMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEY 418
Query: 380 VVSMLTN 386
           + S+L +
Sbjct: 419 IQSVLDD 425

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 109/206 (52%), Gaps = 21/206 (10%)
Query: 117 LGEGGFGTVY------KGVIGQGEIAVKRLLGKSG-QEIKELKNEASVIAQVQHKNLVKL 169
           LGEG FG V       +G     ++AVK L  +SG   I +LK E  ++  + H+N+VK 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 170 LGCCIEKDER--LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYL--HQ 225
            G C E       LI E++P+ SL  +L  P  +  ++ + +++    + +G+ YL   Q
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLGSRQ 146
Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
           Y     +HRDL A N+L++ +   KI DFG+ + +    D++       R S  + Y +P
Sbjct: 147 Y-----VHRDLAARNVLVESEHQVKIGDFGLTKAI--ETDKEXXTVKDDRDSPVFWY-AP 198
Query: 286 EYALEGIFSIKSDVFSFGVLLLEIVS 311
           E  ++  F I SDV+SFGV L E+++
Sbjct: 199 ECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/271 (28%), Positives = 129/271 (47%), Gaps = 30/271 (11%)
Query: 115 NKLGEGGFGTV-YKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCC 173
            +LG G FG V Y    GQ ++A+K +   S  E  E   EA V+  + H+ LV+L G C
Sbjct: 15  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
            ++    +I EYM N  L  +L +   R     +  +++ K V + + YL      + +H
Sbjct: 74  TKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLES---KQFLH 128
Query: 234 RDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYG--YMSPEYALEG 291
           RDL A N L++     K+SDFG++R V     +DE    TS +   +   +  PE  +  
Sbjct: 129 RDLAARNCLVNDQGVVKVSDFGLSRYVL----DDEY---TSSVGSKFPVRWSPPEVLMYS 181
Query: 292 IFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEAS 351
            FS KSD+++FGVL+ EI S  K                ++ + +++  + I   L    
Sbjct: 182 KFSSKSDIWAFGVLMWEIYSLGK--------------MPYERFTNSETAEHIAQGLRLYR 227
Query: 352 FNESLSRYVHIALLCVQERAEDRPTMSDVVS 382
            + +  +   I   C  E+A++RPT   ++S
Sbjct: 228 PHLASEKVYTIMYSCWHEKADERPTFKILLS 258

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 109/206 (52%), Gaps = 21/206 (10%)
Query: 117 LGEGGFGTVY------KGVIGQGEIAVKRLLGKSG-QEIKELKNEASVIAQVQHKNLVKL 169
           LGEG FG V       +G     ++AVK L  +SG   I +LK E  ++  + H+N+VK 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 170 LGCCIEKDER--LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYL--HQ 225
            G C E       LI E++P+ SL  +L  P  +  ++ + +++    + +G+ YL   Q
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLGSRQ 134
Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
           Y     +HRDL A N+L++ +   KI DFG+ + +    D++       R S  + Y +P
Sbjct: 135 Y-----VHRDLAARNVLVESEHQVKIGDFGLTKAI--ETDKEXXTVKDDRDSPVFWY-AP 186
Query: 286 EYALEGIFSIKSDVFSFGVLLLEIVS 311
           E  ++  F I SDV+SFGV L E+++
Sbjct: 187 ECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/269 (28%), Positives = 127/269 (47%), Gaps = 26/269 (9%)
Query: 115 NKLGEGGFGTV-YKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCC 173
            +LG G FG V Y    GQ ++A+K +   S  E  E   EA V+  + H+ LV+L G C
Sbjct: 15  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
            ++    +I EYM N  L  +L +   R     +  +++ K V + + YL      + +H
Sbjct: 74  TKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLES---KQFLH 128
Query: 234 RDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIF 293
           RDL A N L++     K+SDFG++R V    D++      S+    +    PE  +   F
Sbjct: 129 RDLAARNCLVNDQGVVKVSDFGLSRYVL---DDEYTSSRGSKFPVRWS--PPEVLMYSKF 183
Query: 294 SIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFN 353
           S KSD+++FGVL+ EI S  K                ++ + +++  + I   L     +
Sbjct: 184 SSKSDIWAFGVLMWEIYSLGK--------------MPYERFTNSETAEHIAQGLRLYRPH 229
Query: 354 ESLSRYVHIALLCVQERAEDRPTMSDVVS 382
            +  +   I   C  E+A++RPT   ++S
Sbjct: 230 LASEKVYTIMYSCWHEKADERPTFKILLS 258

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/196 (34%), Positives = 102/196 (52%), Gaps = 16/196 (8%)
Query: 117 LGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEK 176
           +G+G FG V  G     ++AVK +  K+    +    EASV+ Q++H NLV+LLG  +E+
Sbjct: 20  IGKGEFGDVMLGDYRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 77
Query: 177 DERL-LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRD 235
              L ++ EYM   SL  +L     R +L     ++    V + + YL   +    +HRD
Sbjct: 78  KGGLYIVTEYMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRD 133
Query: 236 LKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSI 295
           L A N+L+ +D  +K+SDFG+ +      D  +L            + +PE   E  FS 
Sbjct: 134 LAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL---------PVKWTAPEALREAAFST 184
Query: 296 KSDVFSFGVLLLEIVS 311
           KSDV+SFG+LL EI S
Sbjct: 185 KSDVWSFGILLWEIYS 200

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 108/220 (49%), Gaps = 22/220 (10%)
Query: 107 ATGNFSAANKLGEGGFGTVYKGVI-------GQGEIAVKRL-LGKSGQEIKELKNEASVI 158
           A    + + +LG+G FG VY+GV         +  +A+K +    S +E  E  NEASV+
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 82
Query: 159 AQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFL--FDPT--KREIL---DWRTRVQ 211
            +    ++V+LLG   +    L+I E M    L  +L    P      +L        +Q
Sbjct: 83  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 142
Query: 212 IIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQG 271
           +   +A G+ YL+     + +HRDL A N ++ +D   KI DFGM R ++    E +   
Sbjct: 143 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY----ETDYYR 195
Query: 272 NTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
              +      +MSPE   +G+F+  SDV+SFGV+L EI +
Sbjct: 196 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 108/220 (49%), Gaps = 22/220 (10%)
Query: 107 ATGNFSAANKLGEGGFGTVYKGVI-------GQGEIAVKRL-LGKSGQEIKELKNEASVI 158
           A    + + +LG+G FG VY+GV         +  +A+K +    S +E  E  NEASV+
Sbjct: 13  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 72
Query: 159 AQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFL--FDPT--KREIL---DWRTRVQ 211
            +    ++V+LLG   +    L+I E M    L  +L    P      +L        +Q
Sbjct: 73  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 132
Query: 212 IIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQG 271
           +   +A G+ YL+     + +HRDL A N ++ +D   KI DFGM R ++    E +   
Sbjct: 133 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY----ETDYYR 185
Query: 272 NTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
              +      +MSPE   +G+F+  SDV+SFGV+L EI +
Sbjct: 186 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 108/220 (49%), Gaps = 22/220 (10%)
Query: 107 ATGNFSAANKLGEGGFGTVYKGVI-------GQGEIAVKRL-LGKSGQEIKELKNEASVI 158
           A    + + +LG+G FG VY+GV         +  +A+K +    S +E  E  NEASV+
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 75
Query: 159 AQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFL--FDPT--KREIL---DWRTRVQ 211
            +    ++V+LLG   +    L+I E M    L  +L    P      +L        +Q
Sbjct: 76  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 135
Query: 212 IIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQG 271
           +   +A G+ YL+     + +HRDL A N ++ +D   KI DFGM R ++    E +   
Sbjct: 136 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY----ETDYYR 188
Query: 272 NTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
              +      +MSPE   +G+F+  SDV+SFGV+L EI +
Sbjct: 189 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 114/231 (49%), Gaps = 36/231 (15%)
Query: 110 NFSAANKLGEGGFGTVYK----GVIGQGE---IAVKRLLGKSGQEIK-ELKNEASVIAQV 161
           N      +GEG FG V++    G++       +AVK L  ++  +++ + + EA+++A+ 
Sbjct: 48  NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 107
Query: 162 QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREI-------LDWRTRVQ--- 211
            + N+VKLLG C       L++EYM    L+ FL   +   +       L  R RV    
Sbjct: 108 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 167
Query: 212 -----------IIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIV 260
                      I + VA G+ YL   S  + +HRDL   N L+ ++M  KI+DFG++R +
Sbjct: 168 PPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 224
Query: 261 FGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
           +   D  +  GN +       +M PE      ++ +SDV+++GV+L EI S
Sbjct: 225 YSA-DYYKADGNDAI---PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 108/220 (49%), Gaps = 22/220 (10%)
Query: 107 ATGNFSAANKLGEGGFGTVYKGVI-------GQGEIAVKRL-LGKSGQEIKELKNEASVI 158
           A    + + +LG+G FG VY+GV         +  +A+K +    S +E  E  NEASV+
Sbjct: 14  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 73
Query: 159 AQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFL--FDPT--KREIL---DWRTRVQ 211
            +    ++V+LLG   +    L+I E M    L  +L    P      +L        +Q
Sbjct: 74  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 133
Query: 212 IIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQG 271
           +   +A G+ YL+     + +HRDL A N ++ +D   KI DFGM R ++    E +   
Sbjct: 134 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY----ETDYYR 186
Query: 272 NTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
              +      +MSPE   +G+F+  SDV+SFGV+L EI +
Sbjct: 187 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 108/220 (49%), Gaps = 22/220 (10%)
Query: 107 ATGNFSAANKLGEGGFGTVYKGVI-------GQGEIAVKRL-LGKSGQEIKELKNEASVI 158
           A    + + +LG+G FG VY+GV         +  +A+K +    S +E  E  NEASV+
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 75
Query: 159 AQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFL--FDPT--KREIL---DWRTRVQ 211
            +    ++V+LLG   +    L+I E M    L  +L    P      +L        +Q
Sbjct: 76  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 135
Query: 212 IIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQG 271
           +   +A G+ YL+     + +HRDL A N ++ +D   KI DFGM R ++    E +   
Sbjct: 136 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY----ETDYYR 188
Query: 272 NTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
              +      +MSPE   +G+F+  SDV+SFGV+L EI +
Sbjct: 189 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 108/220 (49%), Gaps = 22/220 (10%)
Query: 107 ATGNFSAANKLGEGGFGTVYKGVI-------GQGEIAVKRL-LGKSGQEIKELKNEASVI 158
           A    + + +LG+G FG VY+GV         +  +A+K +    S +E  E  NEASV+
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 82
Query: 159 AQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFL--FDPT--KREIL---DWRTRVQ 211
            +    ++V+LLG   +    L+I E M    L  +L    P      +L        +Q
Sbjct: 83  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 142
Query: 212 IIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQG 271
           +   +A G+ YL+     + +HRDL A N ++ +D   KI DFGM R ++    E +   
Sbjct: 143 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY----ETDYYR 195
Query: 272 NTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
              +      +MSPE   +G+F+  SDV+SFGV+L EI +
Sbjct: 196 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 70/224 (31%), Positives = 108/224 (48%), Gaps = 30/224 (13%)
Query: 107 ATGNFSAANKLGEGGFGTVYKGVI-------GQGEIAVKRL-LGKSGQEIKELKNEASVI 158
           A    + + +LG+G FG VY+GV         +  +A+K +    S +E  E  NEASV+
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 76
Query: 159 AQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFL--FDPT--KREIL---DWRTRVQ 211
            +    ++V+LLG   +    L+I E M    L  +L    P      +L        +Q
Sbjct: 77  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 136
Query: 212 IIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQG 271
           +   +A G+ YL+     + +HRDL A N ++ +D   KI DFGM R        D  + 
Sbjct: 137 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--------DIXET 185
Query: 272 NTSRISG----TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
           +  R  G       +MSPE   +G+F+  SDV+SFGV+L EI +
Sbjct: 186 DXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 70/224 (31%), Positives = 108/224 (48%), Gaps = 30/224 (13%)
Query: 107 ATGNFSAANKLGEGGFGTVYKGVI-------GQGEIAVKRL-LGKSGQEIKELKNEASVI 158
           A    + + +LG+G FG VY+GV         +  +A+K +    S +E  E  NEASV+
Sbjct: 8   AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 67
Query: 159 AQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFL--FDPT--KREIL---DWRTRVQ 211
            +    ++V+LLG   +    L+I E M    L  +L    P      +L        +Q
Sbjct: 68  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 127
Query: 212 IIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQG 271
           +   +A G+ YL+     + +HRDL A N ++ +D   KI DFGM R        D  + 
Sbjct: 128 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--------DIXET 176
Query: 272 NTSRISG----TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
           +  R  G       +MSPE   +G+F+  SDV+SFGV+L EI +
Sbjct: 177 DXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 108/220 (49%), Gaps = 22/220 (10%)
Query: 107 ATGNFSAANKLGEGGFGTVYKGVI-------GQGEIAVKRL-LGKSGQEIKELKNEASVI 158
           A    + + +LG+G FG VY+GV         +  +A+K +    S +E  E  NEASV+
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 69
Query: 159 AQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFL--FDPT--KREIL---DWRTRVQ 211
            +    ++V+LLG   +    L+I E M    L  +L    P      +L        +Q
Sbjct: 70  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 129
Query: 212 IIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQG 271
           +   +A G+ YL+     + +HRDL A N ++ +D   KI DFGM R ++    E +   
Sbjct: 130 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY----ETDYYR 182
Query: 272 NTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
              +      +MSPE   +G+F+  SDV+SFGV+L EI +
Sbjct: 183 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 108/220 (49%), Gaps = 22/220 (10%)
Query: 107 ATGNFSAANKLGEGGFGTVYKGVI-------GQGEIAVKRL-LGKSGQEIKELKNEASVI 158
           A    + + +LG+G FG VY+GV         +  +A+K +    S +E  E  NEASV+
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 76
Query: 159 AQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFL--FDPT--KREIL---DWRTRVQ 211
            +    ++V+LLG   +    L+I E M    L  +L    P      +L        +Q
Sbjct: 77  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 136
Query: 212 IIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQG 271
           +   +A G+ YL+     + +HRDL A N ++ +D   KI DFGM R ++    E +   
Sbjct: 137 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY----ETDYYR 189
Query: 272 NTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
              +      +MSPE   +G+F+  SDV+SFGV+L EI +
Sbjct: 190 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 108/220 (49%), Gaps = 22/220 (10%)
Query: 107 ATGNFSAANKLGEGGFGTVYKGVI-------GQGEIAVKRL-LGKSGQEIKELKNEASVI 158
           A    + + +LG+G FG VY+GV         +  +A+K +    S +E  E  NEASV+
Sbjct: 45  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 104
Query: 159 AQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFL--FDPT--KREIL---DWRTRVQ 211
            +    ++V+LLG   +    L+I E M    L  +L    P      +L        +Q
Sbjct: 105 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 164
Query: 212 IIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQG 271
           +   +A G+ YL+     + +HRDL A N ++ +D   KI DFGM R ++    E +   
Sbjct: 165 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY----ETDYYR 217
Query: 272 NTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
              +      +MSPE   +G+F+  SDV+SFGV+L EI +
Sbjct: 218 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 99/316 (31%), Positives = 151/316 (47%), Gaps = 62/316 (19%)
Query: 117 LGEGGFGTVYK--GVIGQGEIAVKRLLGKSGQEIKE---LKNEASVIAQVQHKNLVKLLG 171
           LG+G FG V K    I Q E AVK ++ K+  + K+   +  E  ++ ++ H N++KL  
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVK-VINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 172 CCIEKDERLLIYEYMPNKSLDCFLFDPT-KREILDWRTRVQIIKGVAQGLLYLHQYSRVR 230
              +     ++ E      L    FD   KR+        +IIK V  G+ Y+H+++   
Sbjct: 89  ILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--- 141
Query: 231 IIHRDLKASNILL---DKDMNSKISDFGMARIVFGGNDEDELQGNT---SRISGTYGYMS 284
           I+HRDLK  NILL   +KD + KI DFG++            Q NT    RI GT  Y++
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTC---------FQQNTKMKDRI-GTAYYIA 191
Query: 285 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLI------GYAWDL--W-- 334
           PE  L G +  K DV+S GV+L  ++SG     FY     +++       YA+DL  W  
Sbjct: 192 PE-VLRGTYDEKCDVWSAGVILYILLSG--TPPFYGKNEYDILKRVETGKYAFDLPQWRT 248
Query: 335 ISNKIIDLIDSVLEEASFNESLSRYVHIALL---CVQERAEDRPTMSDVVSMLTNEASSL 391
           IS+   DLI  +L   +F+ SL R      L    +Q+ + + PT+SD            
Sbjct: 249 ISDDAKDLIRKML---TFHPSL-RITATQCLEHPWIQKYSSETPTISD------------ 292
Query: 392 LPPKQPAFCNLRNMES 407
           LP  + A  N+R  ++
Sbjct: 293 LPSLESAMTNIRQFQA 308

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 67/196 (34%), Positives = 102/196 (52%), Gaps = 16/196 (8%)
Query: 117 LGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEK 176
           +G+G FG V  G     ++AVK +  K+    +    EASV+ Q++H NLV+LLG  +E+
Sbjct: 201 IGKGEFGDVMLGDYRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 258
Query: 177 DERL-LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRD 235
              L ++ EYM   SL  +L     R +L     ++    V + + YL   +    +HRD
Sbjct: 259 KGGLYIVTEYMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRD 314
Query: 236 LKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSI 295
           L A N+L+ +D  +K+SDFG+ +      D  +L            + +PE   E  FS 
Sbjct: 315 LAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL---------PVKWTAPEALREKKFST 365
Query: 296 KSDVFSFGVLLLEIVS 311
           KSDV+SFG+LL EI S
Sbjct: 366 KSDVWSFGILLWEIYS 381

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/196 (34%), Positives = 102/196 (52%), Gaps = 16/196 (8%)
Query: 117 LGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEK 176
           +G+G FG V  G     ++AVK +  K+    +    EASV+ Q++H NLV+LLG  +E+
Sbjct: 29  IGKGEFGDVMLGDYRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 86
Query: 177 DERL-LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRD 235
              L ++ EYM   SL  +L     R +L     ++    V + + YL   +    +HRD
Sbjct: 87  KGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRD 142
Query: 236 LKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSI 295
           L A N+L+ +D  +K+SDFG+ +      D  +L            + +PE   E  FS 
Sbjct: 143 LAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL---------PVKWTAPEALREKKFST 193
Query: 296 KSDVFSFGVLLLEIVS 311
           KSDV+SFG+LL EI S
Sbjct: 194 KSDVWSFGILLWEIYS 209

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/196 (34%), Positives = 102/196 (52%), Gaps = 16/196 (8%)
Query: 117 LGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEK 176
           +G+G FG V  G     ++AVK +  K+    +    EASV+ Q++H NLV+LLG  +E+
Sbjct: 14  IGKGEFGDVMLGDYRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 71
Query: 177 DERL-LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRD 235
              L ++ EYM   SL  +L     R +L     ++    V + + YL   +    +HRD
Sbjct: 72  KGGLYIVTEYMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRD 127
Query: 236 LKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSI 295
           L A N+L+ +D  +K+SDFG+ +      D  +L            + +PE   E  FS 
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL---------PVKWTAPEALREKKFST 178
Query: 296 KSDVFSFGVLLLEIVS 311
           KSDV+SFG+LL EI S
Sbjct: 179 KSDVWSFGILLWEIYS 194

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 113/206 (54%), Gaps = 25/206 (12%)
Query: 117 LGEGGFGTVYKGV-IGQGE-----IAVKRLL-GKSGQEIKELKNEASVIAQVQHKNLVKL 169
           LG G FGTVYKG+ I  GE     +A+K L    S +  KE+ +EA V+A V    + +L
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRL 84
Query: 170 LGCCIEKDERLLIYEYMPNKSLDCFLFDPTKR----EILDWRTRVQIIKGVAQGLLYLHQ 225
           LG C+    +L + + MP   L   + +   R    ++L+W  ++      A+G+ YL  
Sbjct: 85  LGICLTSTVQL-VTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQI------AKGMSYLED 137
Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
              VR++HRDL A N+L+    + KI+DFG+AR++    DE E   +  ++     +M+ 
Sbjct: 138 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLL--DIDETEYHADGGKVP--IKWMAL 190
Query: 286 EYALEGIFSIKSDVFSFGVLLLEIVS 311
           E  L   F+ +SDV+S+GV + E+++
Sbjct: 191 ESILRRRFTHQSDVWSYGVTVWELMT 216

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 125/269 (46%), Gaps = 26/269 (9%)
Query: 115 NKLGEGGFGTVYKGVI-GQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCC 173
            +LG G FG V  G   GQ ++AVK +   S  E  E   EA  + ++ H  LVK  G C
Sbjct: 14  KELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE-DEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
            ++    ++ EY+ N  L  +L    K   L+    +++   V +G+ +L  +   + IH
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYLRSHGKG--LEPSQLLEMCYDVCEGMAFLESH---QFIH 127
Query: 234 RDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIF 293
           RDL A N L+D+D+  K+SDFGM R V    D+  +    ++    +   +PE      +
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVL---DDQYVSSVGTKFPVKWS--APEVFHYFKY 182
Query: 294 SIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFN 353
           S KSDV++FG+L+ E+ S  K                +DL+ +++++  +         +
Sbjct: 183 SSKSDVWAFGILMWEVFSLGKM--------------PYDLYTNSEVVLKVSQGHRLYRPH 228
Query: 354 ESLSRYVHIALLCVQERAEDRPTMSDVVS 382
            +      I   C  E  E RPT   ++S
Sbjct: 229 LASDTIYQIMYSCWHELPEKRPTFQQLLS 257

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 109/217 (50%), Gaps = 26/217 (11%)
Query: 114 ANKLGEGGFGTVYKG-VIGQGEIAVKRLL-------GKSGQEIKELKNEASVIAQV-QHK 164
              LG G FG V +    G  + A  R +       G +  E + L +E  ++  +  H 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 165 NLVKLLGCCIEKDERLL-IYEYMPNKSLDCFL------FDPTKREILDWRTRVQIIK--- 214
           N+V LLG C +    L+ I E+    +L  +L      F P K    D+ T   +I    
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSF 151
Query: 215 GVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTS 274
            VA+G+ +L   +  + IHRDL A NILL +    KI DFG+AR ++   D D ++   +
Sbjct: 152 QVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIY--KDPDYVRKGDA 206
Query: 275 RISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
           R+     +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 207 RLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 114/210 (54%), Gaps = 22/210 (10%)
Query: 117 LGEGGFGTVYKGVIGQGE-----IAVK--RLLGKSGQEIKELKNEASVIAQVQHKNLVKL 169
           LGEG FG+V +G + Q +     +AVK  +L   S +EI+E  +EA+ +    H N+++L
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 170 LGCCIEKDER-----LLIYEYMPNKSLDCFLFDP---TKREILDWRTRVQIIKGVAQGLL 221
           LG CIE   +     ++I  +M    L  +L      T  + +  +T ++ +  +A G+ 
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 222 YLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYG 281
           YL   S    +HRDL A N +L  DM   ++DFG+++ ++ G+     QG  +++     
Sbjct: 162 YL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR--QGRIAKMP--VK 214
Query: 282 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
           +++ E   + +++ KSDV++FGV + EI +
Sbjct: 215 WIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 107/220 (48%), Gaps = 22/220 (10%)
Query: 107 ATGNFSAANKLGEGGFGTVYKGVI-------GQGEIAVKRL-LGKSGQEIKELKNEASVI 158
           A    + + +LG+G FG VY+GV         +  +A+K +    S +E  E  NEASV+
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 69
Query: 159 AQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFL--FDPT--KREIL---DWRTRVQ 211
            +    ++V+LLG   +    L+I E M    L  +L    P      +L        +Q
Sbjct: 70  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 129
Query: 212 IIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQG 271
           +   +A G+ YL+     + +HRDL A N  + +D   KI DFGM R ++    E +   
Sbjct: 130 MAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIY----ETDYYR 182
Query: 272 NTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
              +      +MSPE   +G+F+  SDV+SFGV+L EI +
Sbjct: 183 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 109/217 (50%), Gaps = 26/217 (11%)
Query: 114 ANKLGEGGFGTVYKG-VIGQGEIAVKRLL-------GKSGQEIKELKNEASVIAQV-QHK 164
              LG G FG V +    G  + A  R +       G +  E + L +E  ++  +  H 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 165 NLVKLLGCCIEKDERLL-IYEYMPNKSLDCFL------FDPTKREILDWRTRVQIIK--- 214
           N+V LLG C +    L+ I E+    +L  +L      F P K    D+ T   +I    
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSF 151
Query: 215 GVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTS 274
            VA+G+ +L   +  + IHRDL A NILL +    KI DFG+AR ++   D D ++   +
Sbjct: 152 QVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIY--KDPDYVRKGDA 206
Query: 275 RISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
           R+     +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 207 RLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 109/210 (51%), Gaps = 18/210 (8%)
Query: 110 NFSAANKLGEGGFGTVYKG-VIGQG-EIAVK----RLLGKSGQEIKELKNEASVIAQVQH 163
           +F   N LG+G F  VY+   I  G E+A+K    + + K+G  ++ ++NE  +  Q++H
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGM-VQRVQNEVKIHCQLKH 70
Query: 164 KNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYL 223
            ++++L     + +   L+ E   N  ++ +L +  K            +  +  G+LYL
Sbjct: 71  PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKP--FSENEARHFMHQIITGMLYL 128
Query: 224 HQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYM 283
           H +    I+HRDL  SN+LL ++MN KI+DFG+A  +   +++         + GT  Y+
Sbjct: 129 HSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH------YTLCGTPNYI 179
Query: 284 SPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           SPE A      ++SDV+S G +   ++ G+
Sbjct: 180 SPEIATRSAHGLESDVWSLGCMFYTLLIGR 209

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 129/274 (47%), Gaps = 38/274 (13%)
Query: 111 FSAANKLGEGGFGTVY--KGVIGQGEIAVKRLL--GK-SGQEIKELKNEASVIAQVQHKN 165
           FS   ++G G FG VY  + V     +A+K++   GK S ++ +++  E   + +++H N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ 225
            ++  GC + +    L+ EY    + D  L +  K+ + +      +  G  QGL YLH 
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEI-AAVTHGALQGLAYLHS 172
Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
           ++   +IHRD+KA NILL +    K+ DFG A I+   N             GT  +M+P
Sbjct: 173 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN----------XFVGTPYWMAP 219
Query: 286 EYAL---EGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDL 342
           E  L   EG +  K DV+S G+  +E+   ++    +   +++ + +         I   
Sbjct: 220 EVILAMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYH---------IAQN 268
Query: 343 IDSVLEEASFNESLSRYVHIALLCVQERAEDRPT 376
               L+   ++E    +V     C+Q+  +DRPT
Sbjct: 269 ESPALQSGHWSEYFRNFVDS---CLQKIPQDRPT 299

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 71/274 (25%), Positives = 128/274 (46%), Gaps = 38/274 (13%)
Query: 111 FSAANKLGEGGFGTVY--KGVIGQGEIAVKRLL---GKSGQEIKELKNEASVIAQVQHKN 165
           FS   ++G G FG VY  + V     +A+K++     +S ++ +++  E   + +++H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ 225
            ++  GC + +    L+ EY    + D  L +  K+ + +      +  G  QGL YLH 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEI-AAVTHGALQGLAYLHS 133
Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
           ++   +IHRD+KA NILL +    K+ DFG A I+   N             GT  +M+P
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN----------XFVGTPYWMAP 180
Query: 286 EYAL---EGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDL 342
           E  L   EG +  K DV+S G+  +E+   ++    +   +++ + +         I   
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYH---------IAQN 229
Query: 343 IDSVLEEASFNESLSRYVHIALLCVQERAEDRPT 376
               L+   ++E    +V     C+Q+  +DRPT
Sbjct: 230 ESPALQSGHWSEYFRNFVDS---CLQKIPQDRPT 260

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 73/219 (33%), Positives = 110/219 (50%), Gaps = 28/219 (12%)
Query: 114 ANKLGEGGFGTVYKG-VIGQGEIAVKRLL-------GKSGQEIKELKNEASVIAQV-QHK 164
              LG G FG V +    G  + A  R +       G +  E + L +E  ++  +  H 
Sbjct: 34  GKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 93
Query: 165 NLVKLLGCCIEKDERLL-IYEYMPNKSLDCFL------FDPTKREIL--DWRTRVQIIK- 214
           N+V LLG C +    L+ I E+    +L  +L      F P K E L  D+ T   +I  
Sbjct: 94  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXY 153
Query: 215 --GVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
              VA+G+ +L   +  + IHRDL A NILL +    KI DFG+AR +    D D ++  
Sbjct: 154 SFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIX--KDPDXVRKG 208
Query: 273 TSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
            +R+     +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 209 DARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 122/274 (44%), Gaps = 33/274 (12%)
Query: 117 LGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEK 176
           +G G FG V K      ++A+K++  +S  E K    E   +++V H N+VKL G C+  
Sbjct: 17  VGRGAFGVVCKAKWRAKDVAIKQI--ESESERKAFIVELRQLSRVNHPNIVKLYGACL-- 72
Query: 177 DERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGV---AQGLLYLHQYSRVRIIH 233
           +   L+ EY    SL   L      E L + T    +      +QG+ YLH      +IH
Sbjct: 73  NPVCLVMEYAEGGSLYNVLHG---AEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 129
Query: 234 RDLKASNILLDKDMNS-KISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGI 292
           RDLK  N+LL       KI DFG A          ++Q + +   G+  +M+PE      
Sbjct: 130 RDLKPPNLLLVAGGTVLKICDFGTA---------CDIQTHMTNNKGSAAWMAPEVFEGSN 180
Query: 293 FSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASF 352
           +S K DVFS+G++L E+++        R K  + IG       + +I+  + +       
Sbjct: 181 YSEKCDVFSWGIILWEVIT--------RRKPFDEIGGP-----AFRIMWAVHNGTRPPLI 227
Query: 353 NESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN 386
                    +   C  +    RP+M ++V ++T+
Sbjct: 228 KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTH 261

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 112/205 (54%), Gaps = 15/205 (7%)
Query: 111 FSAANKLGEGGFGTVYKGVIGQ-GEI-AVKRLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
           F    KLGEG +G+VYK +  + G+I A+K++  +S  +++E+  E S++ Q    ++VK
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVK 88
Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSR 228
             G   +  +  ++ EY    S+   +    + + L       I++   +GL YLH    
Sbjct: 89  YYGSYFKNTDLWIVMEYCGAGSVSDIIR--LRNKTLTEDEIATILQSTLKGLEYLH---F 143
Query: 229 VRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYA 288
           +R IHRD+KA NILL+ + ++K++DFG+A     G   D +    + + GT  +M+PE  
Sbjct: 144 MRKIHRDIKAGNILLNTEGHAKLADFGVA-----GQLTDXM-AKRNXVIGTPFWMAPEVI 197
Query: 289 LEGIFSIKSDVFSFGVLLLEIVSGK 313
            E  ++  +D++S G+  +E+  GK
Sbjct: 198 QEIGYNCVADIWSLGITAIEMAEGK 222

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 111/225 (49%), Gaps = 23/225 (10%)
Query: 101 FSSVSSATGNFSAANKLGEGGFGTVYKGV-IGQGEIAVKRLLGKSGQEIKELKNEASVIA 159
            S++    G F     +G G +G VYKG  +  G++A  +++  +G E +E+K E +++ 
Sbjct: 16  LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLK 75
Query: 160 QV-QHKNLVKLLGCCIEK------DERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQI 212
           +   H+N+    G  I+K      D+  L+ E+    S+   L   TK   L       I
Sbjct: 76  KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSV-TDLIKNTKGNTLKEEWIAYI 134
Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
            + + +GL +LHQ+   ++IHRD+K  N+LL ++   K+ DFG++  +      D   G 
Sbjct: 135 CREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL------DRTVGR 185
Query: 273 TSRISGTYGYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSG 312
            +   GT  +M+PE        +  +  KSD++S G+  +E+  G
Sbjct: 186 RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 122/274 (44%), Gaps = 33/274 (12%)
Query: 117 LGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEK 176
           +G G FG V K      ++A+K++  +S  E K    E   +++V H N+VKL G C+  
Sbjct: 16  VGRGAFGVVCKAKWRAKDVAIKQI--ESESERKAFIVELRQLSRVNHPNIVKLYGACL-- 71
Query: 177 DERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGV---AQGLLYLHQYSRVRIIH 233
           +   L+ EY    SL   L      E L + T    +      +QG+ YLH      +IH
Sbjct: 72  NPVCLVMEYAEGGSLYNVLHG---AEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128
Query: 234 RDLKASNILLDKDMNS-KISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGI 292
           RDLK  N+LL       KI DFG A          ++Q + +   G+  +M+PE      
Sbjct: 129 RDLKPPNLLLVAGGTVLKICDFGTA---------CDIQTHMTNNKGSAAWMAPEVFEGSN 179
Query: 293 FSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASF 352
           +S K DVFS+G++L E+++        R K  + IG       + +I+  + +       
Sbjct: 180 YSEKCDVFSWGIILWEVIT--------RRKPFDEIGGP-----AFRIMWAVHNGTRPPLI 226
Query: 353 NESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN 386
                    +   C  +    RP+M ++V ++T+
Sbjct: 227 KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTH 260

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 107/208 (51%), Gaps = 22/208 (10%)
Query: 106 SATGNFSAANKLGEGGFGTV---YKGVIGQG---EIAVKRLLGKSGQEIKELKNEASVIA 159
           +  GN+     LGEG FG V   Y    GQ    +I  K++L KS  +   ++ E S + 
Sbjct: 1   AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQ-GRIEREISYLR 59
Query: 160 QVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQG 219
            ++H +++KL      KDE +++ EY  N+  D  +    +R+ +  +   +  + +   
Sbjct: 60  LLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV----QRDKMSEQEARRFFQQIISA 115
Query: 220 LLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGT 279
           + Y H++   +I+HRDLK  N+LLD+ +N KI+DFG++ I+  GN             G+
Sbjct: 116 VEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-------FLKTSCGS 165
Query: 280 YGYMSPEYALEGIFS-IKSDVFSFGVLL 306
             Y +PE     +++  + DV+S GV+L
Sbjct: 166 PNYAAPEVISGKLYAGPEVDVWSCGVIL 193

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 104/218 (47%), Gaps = 15/218 (6%)
Query: 98  LFSFSSVSSATGNFSAANKLGEGGFGTVYKGV-IGQGEIAVKRLLGKSGQEIKELK-NEA 155
           L S  SV      ++   K+G+G  GTVY  + +  G+    R +    Q  KEL  NE 
Sbjct: 9   LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 156 SVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKG 215
            V+ + ++ N+V  L   +  DE  ++ EY+   SL     D      +D      + + 
Sbjct: 69  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 124
Query: 216 VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR 275
             Q L +LH     ++IHRD+K+ NILL  D + K++DFG     F      E Q   S 
Sbjct: 125 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG-----FCAQITPE-QSKRSE 175
Query: 276 ISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           + GT  +M+PE      +  K D++S G++ +E++ G+
Sbjct: 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 104/208 (50%), Gaps = 22/208 (10%)
Query: 106 SATGNFSAANKLGEGGFGTV---YKGVIGQG---EIAVKRLLGKSGQEIKELKNEASVIA 159
           +  GN+     LGEG FG V   Y    GQ    +I  K++L KS  +   ++ E S + 
Sbjct: 11  AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQ-GRIEREISYLR 69
Query: 160 QVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQG 219
            ++H +++KL      KDE +++ EY  N+  D  +      E    R   QII  V   
Sbjct: 70  LLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVE-- 127
Query: 220 LLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGT 279
             Y H++   +I+HRDLK  N+LLD+ +N KI+DFG++ I+  GN             G+
Sbjct: 128 --YCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-------FLKTSCGS 175
Query: 280 YGYMSPEYALEGIFS-IKSDVFSFGVLL 306
             Y +PE     +++  + DV+S GV+L
Sbjct: 176 PNYAAPEVISGKLYAGPEVDVWSCGVIL 203

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 104/218 (47%), Gaps = 15/218 (6%)
Query: 98  LFSFSSVSSATGNFSAANKLGEGGFGTVYKGV-IGQGEIAVKRLLGKSGQEIKELK-NEA 155
           L S  SV      ++   K+G+G  GTVY  + +  G+    R +    Q  KEL  NE 
Sbjct: 10  LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 69
Query: 156 SVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKG 215
            V+ + ++ N+V  L   +  DE  ++ EY+   SL     D      +D      + + 
Sbjct: 70  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 125
Query: 216 VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR 275
             Q L +LH     ++IHRD+K+ NILL  D + K++DFG     F      E Q   S 
Sbjct: 126 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG-----FCAQITPE-QSKRSX 176
Query: 276 ISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           + GT  +M+PE      +  K D++S G++ +E++ G+
Sbjct: 177 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 104/208 (50%), Gaps = 22/208 (10%)
Query: 106 SATGNFSAANKLGEGGFGTV---YKGVIGQG---EIAVKRLLGKSGQEIKELKNEASVIA 159
           +  GN+     LGEG FG V   Y    GQ    +I  K++L KS  +   ++ E S + 
Sbjct: 10  AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQ-GRIEREISYLR 68
Query: 160 QVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQG 219
            ++H +++KL      KDE +++ EY  N+  D  +      E    R   QII  V   
Sbjct: 69  LLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVE-- 126
Query: 220 LLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGT 279
             Y H++   +I+HRDLK  N+LLD+ +N KI+DFG++ I+  GN             G+
Sbjct: 127 --YCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-------FLKTSCGS 174
Query: 280 YGYMSPEYALEGIFS-IKSDVFSFGVLL 306
             Y +PE     +++  + DV+S GV+L
Sbjct: 175 PNYAAPEVISGKLYAGPEVDVWSCGVIL 202

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 107/208 (51%), Gaps = 22/208 (10%)
Query: 106 SATGNFSAANKLGEGGFGTV---YKGVIGQG---EIAVKRLLGKSGQEIKELKNEASVIA 159
           +  GN+     LGEG FG V   Y    GQ    +I  K++L KS  +   ++ E S + 
Sbjct: 5   AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQ-GRIEREISYLR 63
Query: 160 QVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQG 219
            ++H +++KL      KDE +++ EY  N+  D  +    +R+ +  +   +  + +   
Sbjct: 64  LLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV----QRDKMSEQEARRFFQQIISA 119
Query: 220 LLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGT 279
           + Y H++   +I+HRDLK  N+LLD+ +N KI+DFG++ I+  GN             G+
Sbjct: 120 VEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-------FLKTSCGS 169
Query: 280 YGYMSPEYALEGIFS-IKSDVFSFGVLL 306
             Y +PE     +++  + DV+S GV+L
Sbjct: 170 PNYAAPEVISGKLYAGPEVDVWSCGVIL 197

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 104/218 (47%), Gaps = 15/218 (6%)
Query: 98  LFSFSSVSSATGNFSAANKLGEGGFGTVYKGV-IGQGEIAVKRLLGKSGQEIKELK-NEA 155
           L S  SV      ++   K+G+G  GTVY  + +  G+    R +    Q  KEL  NE 
Sbjct: 9   LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 156 SVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKG 215
            V+ + ++ N+V  L   +  DE  ++ EY+   SL     D      +D      + + 
Sbjct: 69  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 124
Query: 216 VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR 275
             Q L +LH     ++IHRD+K+ NILL  D + K++DFG     F      E Q   S 
Sbjct: 125 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG-----FCAQITPE-QSKRSX 175
Query: 276 ISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           + GT  +M+PE      +  K D++S G++ +E++ G+
Sbjct: 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 104/218 (47%), Gaps = 15/218 (6%)
Query: 98  LFSFSSVSSATGNFSAANKLGEGGFGTVYKGV-IGQGEIAVKRLLGKSGQEIKELK-NEA 155
           L S  SV      ++   K+G+G  GTVY  + +  G+    R +    Q  KEL  NE 
Sbjct: 9   LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 156 SVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKG 215
            V+ + ++ N+V  L   +  DE  ++ EY+   SL     D      +D      + + 
Sbjct: 69  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 124
Query: 216 VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR 275
             Q L +LH     ++IHRD+K+ NILL  D + K++DFG     F      E Q   S 
Sbjct: 125 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG-----FCAQITPE-QSKRST 175
Query: 276 ISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           + GT  +M+PE      +  K D++S G++ +E++ G+
Sbjct: 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 138/288 (47%), Gaps = 38/288 (13%)
Query: 117 LGEGGFGTVYKGVIGQGE-----IAVKRL--LGKSGQEIKELKNEASVIAQVQHKNLVKL 169
           +G G FG VY G +   +      AVK L  +   G E+ +   E  ++    H N++ L
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGIIMKDFSHPNVLSL 95
Query: 170 LGCCIEKD-ERLLIYEYMPNKSLDCFL----FDPTKREILDWRTRVQIIKGVAQGLLYLH 224
           LG C+  +   L++  YM +  L  F+     +PT ++++ +  +V      A+G+ YL 
Sbjct: 96  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL- 148
Query: 225 QYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMS 284
             +  + +HRDL A N +LD+    K++DFG+AR ++  + E     N +       +M+
Sbjct: 149 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY--DKEXXSVHNKTGAKLPVKWMA 204
Query: 285 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLID 344
            E      F+ KSDV+SFGVLL E+++ +    +    + ++  Y   L    ++     
Sbjct: 205 LESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVY---LLQGRRL----- 255
Query: 345 SVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLL 392
             L+     + L     + L C   +AE RP+ S++VS ++   S+ +
Sbjct: 256 --LQPEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRISAIFSTFI 298

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 108/203 (53%), Gaps = 20/203 (9%)
Query: 116 KLGEGGFGTVYKGVIGQGEI--AVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCC 173
           +LG+G FG VYK    +  +  A K +  KS +E+++   E  ++A   H N+VKLL   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQII-KGVAQGLLYLHQYSRVRII 232
             ++   ++ E+    ++D  + +  +R + +  +++Q++ K     L YLH     +II
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLE-LERPLTE--SQIQVVCKQTLDALNYLHDN---KII 157
Query: 233 HRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL--- 289
           HRDLKA NIL   D + K++DFG++       +   +Q   S I GT  +M+PE  +   
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVS-----AKNTRXIQRRDSFI-GTPYWMAPEVVMCET 211
Query: 290 --EGIFSIKSDVFSFGVLLLEIV 310
             +  +  K+DV+S G+ L+E+ 
Sbjct: 212 SKDRPYDYKADVWSLGITLIEMA 234

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 108/203 (53%), Gaps = 20/203 (9%)
Query: 116 KLGEGGFGTVYKGVIGQGEI--AVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCC 173
           +LG+G FG VYK    +  +  A K +  KS +E+++   E  ++A   H N+VKLL   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQII-KGVAQGLLYLHQYSRVRII 232
             ++   ++ E+    ++D  + +  +R + +  +++Q++ K     L YLH     +II
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLE-LERPLTE--SQIQVVCKQTLDALNYLHDN---KII 157
Query: 233 HRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL--- 289
           HRDLKA NIL   D + K++DFG++       +   +Q   S I GT  +M+PE  +   
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVS-----AKNTRTIQRRDSFI-GTPYWMAPEVVMCET 211
Query: 290 --EGIFSIKSDVFSFGVLLLEIV 310
             +  +  K+DV+S G+ L+E+ 
Sbjct: 212 SKDRPYDYKADVWSLGITLIEMA 234

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 110/219 (50%), Gaps = 31/219 (14%)
Query: 117 LGEGGFG-TVYKGVIGQGE--------IAVKRLLGKSGQ-EIKELKNEASVIAQV-QHKN 165
           LGEG FG  V    IG  +        +AVK L   + + ++ +L +E  ++  + +HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSLDCFL-----------FDPT--KREILDWRTRVQI 212
           ++ LLG C +     +I EY    +L  +L           F+P+    E L  +  V  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
              VA+G+ YL   +  + IHRDL A N+L+ +D   KI+DFG+AR +       +    
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH----HIDXXKK 208
Query: 273 TSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
           T+       +M+PE   + I++ +SDV+SFGVLL EI +
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 121/222 (54%), Gaps = 19/222 (8%)
Query: 111 FSAANKLGEGGFGTVYKGVIGQGE--IAVKRL-LGKSGQEIKELKNEASVIAQVQHKNLV 167
           F+  +++G+G FG VYKG+    +  +A+K + L ++  EI++++ E +V++Q     + 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 168 KLLGCCIEKDERLLIYEYMPNKS-LDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQY 226
           +  G  ++  +  +I EY+   S LD     P +   +       I++ + +GL YLH  
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYI-----ATILREILKGLDYLHS- 134
Query: 227 SRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPE 286
              R IHRD+KA+N+LL +  + K++DFG+A    G   + +++ N     GT  +M+PE
Sbjct: 135 --ERKIHRDIKAANVLLSEQGDVKLADFGVA----GQLTDTQIKRNX--FVGTPFWMAPE 186
Query: 287 YALEGIFSIKSDVFSFGVLLLEIVSGK-KNTGFYRTKSLNLI 327
              +  +  K+D++S G+  +E+  G+  N+  +  + L LI
Sbjct: 187 VIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI 228

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 123/231 (53%), Gaps = 33/231 (14%)
Query: 116 KLGEGGFGTVYKG--VIGQGEIAVKRL-LGKSGQE------IKELKNEASVIAQVQHKNL 166
           ++G+GGFG V+KG  V  +  +A+K L LG S  E       +E + E  +++ + H N+
Sbjct: 26  QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 167 VKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQY 226
           VKL G  +  +   ++ E++P   L   L D  K   + W  +++++  +A G+ Y+ Q 
Sbjct: 86  VKLYG--LMHNPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYM-QN 140
Query: 227 SRVRIIHRDLKASNILLDK-DMN----SKISDFGMARIVFGGNDEDELQGNTSRISGTYG 281
               I+HRDL++ NI L   D N    +K++DFG+++         +   + S + G + 
Sbjct: 141 QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ---------QSVHSVSGLLGNFQ 191
Query: 282 YMSPEY--ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFY---RTKSLNLI 327
           +M+PE   A E  ++ K+D +SF ++L  I++G+     Y   + K +N+I
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI 242

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 138/288 (47%), Gaps = 38/288 (13%)
Query: 117 LGEGGFGTVYKGVIGQGE-----IAVKRL--LGKSGQEIKELKNEASVIAQVQHKNLVKL 169
           +G G FG VY G +   +      AVK L  +   G E+ +   E  ++    H N++ L
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGIIMKDFSHPNVLSL 115
Query: 170 LGCCIEKD-ERLLIYEYMPNKSLDCFL----FDPTKREILDWRTRVQIIKGVAQGLLYLH 224
           LG C+  +   L++  YM +  L  F+     +PT ++++ +  +V      A+G+ YL 
Sbjct: 116 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL- 168
Query: 225 QYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMS 284
             +  + +HRDL A N +LD+    K++DFG+AR ++  + E     N +       +M+
Sbjct: 169 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY--DKEYYSVHNKTGAKLPVKWMA 224
Query: 285 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLID 344
            E      F+ KSDV+SFGVLL E+++ +    +    + ++  Y     +  +      
Sbjct: 225 LESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYL----LQGR------ 273
Query: 345 SVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLL 392
            +L+     + L     + L C   +AE RP+ S++VS ++   S+ +
Sbjct: 274 RLLQPEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRISAIFSTFI 318

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 118/248 (47%), Gaps = 36/248 (14%)
Query: 88  GCEKEVDQFPLFSFSSVSSATGNFSAANKLGEGGFG-TVYKGVIGQGE--------IAVK 138
           G E E+ + P +         G       LGEG FG  V    IG  +        +AVK
Sbjct: 1   GSEYELPEDPRWELPRDRLVLGK-----PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVK 55
Query: 139 RLLGKSGQ-EIKELKNEASVIAQV-QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFL- 195
            L   + + ++ +L +E  ++  + +HKN++ LLG C +     +I EY    +L  +L 
Sbjct: 56  MLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQ 115
Query: 196 ----------FDPTK--REILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILL 243
                     ++P+    E L  +  V     VA+G+ YL   +  + IHRDL A N+L+
Sbjct: 116 ARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLV 172
Query: 244 DKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFG 303
            +D   KI+DFG+AR +       +    T+       +M+PE   + I++ +SDV+SFG
Sbjct: 173 TEDNVMKIADFGLARDIH----HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 228
Query: 304 VLLLEIVS 311
           VLL EI +
Sbjct: 229 VLLWEIFT 236

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 138/288 (47%), Gaps = 38/288 (13%)
Query: 117 LGEGGFGTVYKGVIGQGE-----IAVKRL--LGKSGQEIKELKNEASVIAQVQHKNLVKL 169
           +G G FG VY G +   +      AVK L  +   G E+ +   E  ++    H N++ L
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGIIMKDFSHPNVLSL 91
Query: 170 LGCCIEKD-ERLLIYEYMPNKSLDCFL----FDPTKREILDWRTRVQIIKGVAQGLLYLH 224
           LG C+  +   L++  YM +  L  F+     +PT ++++ +  +V      A+G+ YL 
Sbjct: 92  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL- 144
Query: 225 QYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMS 284
             +  + +HRDL A N +LD+    K++DFG+AR ++  + E     N +       +M+
Sbjct: 145 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY--DKEYYSVHNKTGAKLPVKWMA 200
Query: 285 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLID 344
            E      F+ KSDV+SFGVLL E+++ +    +    + ++  Y     +  +      
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYL----LQGR------ 249
Query: 345 SVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLL 392
            +L+     + L     + L C   +AE RP+ S++VS ++   S+ +
Sbjct: 250 RLLQPEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 138/288 (47%), Gaps = 38/288 (13%)
Query: 117 LGEGGFGTVYKGVIGQGE-----IAVKRL--LGKSGQEIKELKNEASVIAQVQHKNLVKL 169
           +G G FG VY G +   +      AVK L  +   G E+ +   E  ++    H N++ L
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGIIMKDFSHPNVLSL 94
Query: 170 LGCCIEKD-ERLLIYEYMPNKSLDCFL----FDPTKREILDWRTRVQIIKGVAQGLLYLH 224
           LG C+  +   L++  YM +  L  F+     +PT ++++ +  +V      A+G+ YL 
Sbjct: 95  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL- 147
Query: 225 QYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMS 284
             +  + +HRDL A N +LD+    K++DFG+AR ++  + E     N +       +M+
Sbjct: 148 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY--DKEYYSVHNKTGAKLPVKWMA 203
Query: 285 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLID 344
            E      F+ KSDV+SFGVLL E+++ +    +    + ++  Y   L    ++     
Sbjct: 204 LESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVY---LLQGRRL----- 254
Query: 345 SVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLL 392
             L+     + L     + L C   +AE RP+ S++VS ++   S+ +
Sbjct: 255 --LQPEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRISAIFSTFI 297

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 138/288 (47%), Gaps = 38/288 (13%)
Query: 117 LGEGGFGTVYKGVIGQGE-----IAVKRL--LGKSGQEIKELKNEASVIAQVQHKNLVKL 169
           +G G FG VY G +   +      AVK L  +   G E+ +   E  ++    H N++ L
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGIIMKDFSHPNVLSL 88
Query: 170 LGCCIEKD-ERLLIYEYMPNKSLDCFL----FDPTKREILDWRTRVQIIKGVAQGLLYLH 224
           LG C+  +   L++  YM +  L  F+     +PT ++++ +  +V      A+G+ YL 
Sbjct: 89  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL- 141
Query: 225 QYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMS 284
             +  + +HRDL A N +LD+    K++DFG+AR ++  + E     N +       +M+
Sbjct: 142 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY--DKEYYSVHNKTGAKLPVKWMA 197
Query: 285 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLID 344
            E      F+ KSDV+SFGVLL E+++ +    +    + ++  Y     +  +      
Sbjct: 198 LESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYL----LQGR------ 246
Query: 345 SVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLL 392
            +L+     + L     + L C   +AE RP+ S++VS ++   S+ +
Sbjct: 247 RLLQPEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRISAIFSTFI 291

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 138/288 (47%), Gaps = 38/288 (13%)
Query: 117 LGEGGFGTVYKGVIGQGE-----IAVKRL--LGKSGQEIKELKNEASVIAQVQHKNLVKL 169
           +G G FG VY G +   +      AVK L  +   G E+ +   E  ++    H N++ L
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGIIMKDFSHPNVLSL 93
Query: 170 LGCCIEKD-ERLLIYEYMPNKSLDCFL----FDPTKREILDWRTRVQIIKGVAQGLLYLH 224
           LG C+  +   L++  YM +  L  F+     +PT ++++ +  +V      A+G+ YL 
Sbjct: 94  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL- 146
Query: 225 QYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMS 284
             +  + +HRDL A N +LD+    K++DFG+AR ++  + E     N +       +M+
Sbjct: 147 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY--DKEYYSVHNKTGAKLPVKWMA 202
Query: 285 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLID 344
            E      F+ KSDV+SFGVLL E+++ +    +    + ++  Y     +  +      
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYL----LQGR------ 251
Query: 345 SVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLL 392
            +L+     + L     + L C   +AE RP+ S++VS ++   S+ +
Sbjct: 252 RLLQPEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRISAIFSTFI 296

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 138/288 (47%), Gaps = 38/288 (13%)
Query: 117 LGEGGFGTVYKGVIGQGE-----IAVKRL--LGKSGQEIKELKNEASVIAQVQHKNLVKL 169
           +G G FG VY G +   +      AVK L  +   G E+ +   E  ++    H N++ L
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGIIMKDFSHPNVLSL 96
Query: 170 LGCCIEKD-ERLLIYEYMPNKSLDCFL----FDPTKREILDWRTRVQIIKGVAQGLLYLH 224
           LG C+  +   L++  YM +  L  F+     +PT ++++ +  +V      A+G+ YL 
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL- 149
Query: 225 QYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMS 284
             +  + +HRDL A N +LD+    K++DFG+AR ++  + E     N +       +M+
Sbjct: 150 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY--DKEYYSVHNKTGAKLPVKWMA 205
Query: 285 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLID 344
            E      F+ KSDV+SFGVLL E+++ +    +    + ++  Y   L    ++     
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVY---LLQGRRL----- 256
Query: 345 SVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLL 392
             L+     + L     + L C   +AE RP+ S++VS ++   S+ +
Sbjct: 257 --LQPEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRISAIFSTFI 299

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 138/288 (47%), Gaps = 38/288 (13%)
Query: 117 LGEGGFGTVYKGVIGQGE-----IAVKRL--LGKSGQEIKELKNEASVIAQVQHKNLVKL 169
           +G G FG VY G +   +      AVK L  +   G E+ +   E  ++    H N++ L
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGIIMKDFSHPNVLSL 96
Query: 170 LGCCIEKD-ERLLIYEYMPNKSLDCFL----FDPTKREILDWRTRVQIIKGVAQGLLYLH 224
           LG C+  +   L++  YM +  L  F+     +PT ++++ +  +V      A+G+ YL 
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL- 149
Query: 225 QYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMS 284
             +  + +HRDL A N +LD+    K++DFG+AR ++  + E     N +       +M+
Sbjct: 150 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY--DKEYYSVHNKTGAKLPVKWMA 205
Query: 285 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLID 344
            E      F+ KSDV+SFGVLL E+++ +    +    + ++  Y   L    ++     
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVY---LLQGRRL----- 256
Query: 345 SVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLL 392
             L+     + L     + L C   +AE RP+ S++VS ++   S+ +
Sbjct: 257 --LQPEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRISAIFSTFI 299

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 139/276 (50%), Gaps = 35/276 (12%)
Query: 111 FSAANKLGEGGFGTVYKGVIG--QGEIAVKRL-LGKSGQEIKELKNEASVIAQVQHKNLV 167
           F+   K+G+G FG V+KG+    Q  +A+K + L ++  EI++++ E +V++Q     + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 168 KLLGCCIEKDERLLIYEYMPNKS-LDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQY 226
           K  G  ++  +  +I EY+   S LD     P     LD      I++ + +GL YLH  
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-----LDETQIATILREILKGLDYLHSE 123
Query: 227 SRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPE 286
            +   IHRD+KA+N+LL +    K++DFG+A    G   + +++ NT    GT  +M+PE
Sbjct: 124 KK---IHRDIKAANVLLSEHGEVKLADFGVA----GQLTDTQIKRNT--FVGTPFWMAPE 174
Query: 287 YALEGIFSIKSDVFSFGVLLLEIVSGK-KNTGFYRTKSLNLIGYAWDLWISNKIIDLIDS 345
              +  +  K+D++S G+  +E+  G+  ++  +  K L LI         N    L   
Sbjct: 175 VIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIP-------KNNPPTL--- 224
Query: 346 VLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVV 381
              E ++++ L  +V     C+ +    RPT  +++
Sbjct: 225 ---EGNYSKPLKEFVEA---CLNKEPSFRPTAKELL 254

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 138/288 (47%), Gaps = 38/288 (13%)
Query: 117 LGEGGFGTVYKGVIGQGE-----IAVKRL--LGKSGQEIKELKNEASVIAQVQHKNLVKL 169
           +G G FG VY G +   +      AVK L  +   G E+ +   E  ++    H N++ L
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGIIMKDFSHPNVLSL 114
Query: 170 LGCCIEKD-ERLLIYEYMPNKSLDCFL----FDPTKREILDWRTRVQIIKGVAQGLLYLH 224
           LG C+  +   L++  YM +  L  F+     +PT ++++ +  +V      A+G+ YL 
Sbjct: 115 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL- 167
Query: 225 QYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMS 284
             +  + +HRDL A N +LD+    K++DFG+AR ++  + E     N +       +M+
Sbjct: 168 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY--DKEYYSVHNKTGAKLPVKWMA 223
Query: 285 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLID 344
            E      F+ KSDV+SFGVLL E+++ +    +    + ++  Y   L    ++     
Sbjct: 224 LESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVY---LLQGRRL----- 274
Query: 345 SVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLL 392
             L+     + L     + L C   +AE RP+ S++VS ++   S+ +
Sbjct: 275 --LQPEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRISAIFSTFI 317

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 138/288 (47%), Gaps = 38/288 (13%)
Query: 117 LGEGGFGTVYKGVIGQGE-----IAVKRL--LGKSGQEIKELKNEASVIAQVQHKNLVKL 169
           +G G FG VY G +   +      AVK L  +   G E+ +   E  ++    H N++ L
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGIIMKDFSHPNVLSL 95
Query: 170 LGCCIEKD-ERLLIYEYMPNKSLDCFL----FDPTKREILDWRTRVQIIKGVAQGLLYLH 224
           LG C+  +   L++  YM +  L  F+     +PT ++++ +  +V      A+G+ YL 
Sbjct: 96  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL- 148
Query: 225 QYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMS 284
             +  + +HRDL A N +LD+    K++DFG+AR ++  + E     N +       +M+
Sbjct: 149 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY--DKEYYSVHNKTGAKLPVKWMA 204
Query: 285 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLID 344
            E      F+ KSDV+SFGVLL E+++ +    +    + ++  Y     +  +      
Sbjct: 205 LESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYL----LQGR------ 253
Query: 345 SVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLL 392
            +L+     + L     + L C   +AE RP+ S++VS ++   S+ +
Sbjct: 254 RLLQPEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRISAIFSTFI 298

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 139/288 (48%), Gaps = 38/288 (13%)
Query: 117 LGEGGFGTVYKGVIGQGE-----IAVKRL--LGKSGQEIKELKNEASVIAQVQHKNLVKL 169
           +G G FG VY G +   +      AVK L  +   G E+ +   E  ++    H N++ L
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGIIMKDFSHPNVLSL 94
Query: 170 LGCCIEKD-ERLLIYEYMPNKSLDCFL----FDPTKREILDWRTRVQIIKGVAQGLLYLH 224
           LG C+  +   L++  YM +  L  F+     +PT ++++ +  +V      A+G+ +L 
Sbjct: 95  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKFL- 147
Query: 225 QYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMS 284
             +  + +HRDL A N +LD+    K++DFG+AR ++  + E +   N +       +M+
Sbjct: 148 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY--DKEFDSVHNKTGAKLPVKWMA 203
Query: 285 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLID 344
            E      F+ KSDV+SFGVLL E+++ +    +    + ++  Y   L    ++     
Sbjct: 204 LESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVY---LLQGRRL----- 254
Query: 345 SVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLL 392
             L+     + L     + L C   +AE RP+ S++VS ++   S+ +
Sbjct: 255 --LQPEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRISAIFSTFI 297

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 139/276 (50%), Gaps = 35/276 (12%)
Query: 111 FSAANKLGEGGFGTVYKGVIG--QGEIAVKRL-LGKSGQEIKELKNEASVIAQVQHKNLV 167
           F+   K+G+G FG V+KG+    Q  +A+K + L ++  EI++++ E +V++Q     + 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 168 KLLGCCIEKDERLLIYEYMPNKS-LDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQY 226
           K  G  ++  +  +I EY+   S LD     P     LD      I++ + +GL YLH  
Sbjct: 89  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-----LDETQIATILREILKGLDYLHSE 143
Query: 227 SRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPE 286
            +   IHRD+KA+N+LL +    K++DFG+A    G   + +++ NT    GT  +M+PE
Sbjct: 144 KK---IHRDIKAANVLLSEHGEVKLADFGVA----GQLTDTQIKRNT--FVGTPFWMAPE 194
Query: 287 YALEGIFSIKSDVFSFGVLLLEIVSGK-KNTGFYRTKSLNLIGYAWDLWISNKIIDLIDS 345
              +  +  K+D++S G+  +E+  G+  ++  +  K L LI         N    L   
Sbjct: 195 VIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIP-------KNNPPTL--- 244
Query: 346 VLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVV 381
              E ++++ L  +V     C+ +    RPT  +++
Sbjct: 245 ---EGNYSKPLKEFVEA---CLNKEPSFRPTAKELL 274

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 104/205 (50%), Gaps = 17/205 (8%)
Query: 117 LGEGGFGTVYKGVIGQ-GEIAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNLVKLLGCCI 174
           LG+G FG   K    + GE+ V + L +  +E +     E  V+  ++H N++K +G  +
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV-L 76
Query: 175 EKDERL-LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
            KD+RL  I EY+   +L   +   +      W  RV   K +A G+ YLH    + IIH
Sbjct: 77  YKDKRLNFITEYIKGGTLRGII--KSMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIH 131
Query: 234 RDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR--------ISGTYGYMSP 285
           RDL + N L+ ++ N  ++DFG+AR++     + E   +  +        + G   +M+P
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 286 EYALEGIFSIKSDVFSFGVLLLEIV 310
           E      +  K DVFSFG++L EI+
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEII 216

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 108/221 (48%), Gaps = 31/221 (14%)
Query: 114 ANKLGEGGFGTVYKG-VIGQGEIAVKRLL-------GKSGQEIKELKNEASVIAQV-QHK 164
              LG G FG V +    G  + A  R +       G +  E + L +E  ++  +  H 
Sbjct: 33  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 92
Query: 165 NLVKLLGCCIEKDERLL-IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKG-------- 215
           N+V LLG C +    L+ I E+    +L  +L    + E + ++T   + K         
Sbjct: 93  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS-KRNEFVPYKTPEDLYKDFLTLEHLI 151
Query: 216 -----VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQ 270
                VA+G+ +L   +  + IHRDL A NILL +    KI DFG+AR +    D D ++
Sbjct: 152 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIX--KDPDXVR 206
Query: 271 GNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
              +R+     +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 207 KGDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 139/288 (48%), Gaps = 38/288 (13%)
Query: 117 LGEGGFGTVYKGVIGQGE-----IAVKRL--LGKSGQEIKELKNEASVIAQVQHKNLVKL 169
           +G G FG VY G +   +      AVK L  +   G E+ +   E  ++    H N++ L
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGIIMKDFSHPNVLSL 96
Query: 170 LGCCIEKD-ERLLIYEYMPNKSLDCFL----FDPTKREILDWRTRVQIIKGVAQGLLYLH 224
           LG C+  +   L++  YM +  L  F+     +PT ++++ +  +V      A+G+ +L 
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKFL- 149
Query: 225 QYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMS 284
             +  + +HRDL A N +LD+    K++DFG+AR ++  + E +   N +       +M+
Sbjct: 150 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY--DKEFDSVHNKTGAKLPVKWMA 205
Query: 285 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLID 344
            E      F+ KSDV+SFGVLL E+++ +    +    + ++  Y   L    ++     
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVY---LLQGRRL----- 256
Query: 345 SVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLL 392
             L+     + L     + L C   +AE RP+ S++VS ++   S+ +
Sbjct: 257 --LQPEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRISAIFSTFI 299

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 139/288 (48%), Gaps = 38/288 (13%)
Query: 117 LGEGGFGTVYKGVIGQGE-----IAVKRL--LGKSGQEIKELKNEASVIAQVQHKNLVKL 169
           +G G FG VY G +   +      AVK L  +   G E+ +   E  ++    H N++ L
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGIIMKDFSHPNVLSL 96
Query: 170 LGCCIEKD-ERLLIYEYMPNKSLDCFL----FDPTKREILDWRTRVQIIKGVAQGLLYLH 224
           LG C+  +   L++  YM +  L  F+     +PT ++++ +  +V      A+G+ +L 
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKFL- 149
Query: 225 QYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMS 284
             +  + +HRDL A N +LD+    K++DFG+AR ++  + E +   N +       +M+
Sbjct: 150 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY--DKEFDSVHNKTGAKLPVKWMA 205
Query: 285 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLID 344
            E      F+ KSDV+SFGVLL E+++ +    +    + ++  Y   L    ++     
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVY---LLQGRRL----- 256
Query: 345 SVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLL 392
             L+     + L     + L C   +AE RP+ S++VS ++   S+ +
Sbjct: 257 --LQPEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRISAIFSTFI 299

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 139/288 (48%), Gaps = 38/288 (13%)
Query: 117 LGEGGFGTVYKGVIGQGE-----IAVKRL--LGKSGQEIKELKNEASVIAQVQHKNLVKL 169
           +G G FG VY G +   +      AVK L  +   G E+ +   E  ++    H N++ L
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGIIMKDFSHPNVLSL 101
Query: 170 LGCCIEKD-ERLLIYEYMPNKSLDCFL----FDPTKREILDWRTRVQIIKGVAQGLLYLH 224
           LG C+  +   L++  YM +  L  F+     +PT ++++ +  +V      A+G+ +L 
Sbjct: 102 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKFL- 154
Query: 225 QYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMS 284
             +  + +HRDL A N +LD+    K++DFG+AR ++  + E +   N +       +M+
Sbjct: 155 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY--DKEFDSVHNKTGAKLPVKWMA 210
Query: 285 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLID 344
            E      F+ KSDV+SFGVLL E+++ +    +    + ++  Y   L    ++     
Sbjct: 211 LESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVY---LLQGRRL----- 261
Query: 345 SVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLL 392
             L+     + L     + L C   +AE RP+ S++VS ++   S+ +
Sbjct: 262 --LQPEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRISAIFSTFI 304

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 110/219 (50%), Gaps = 31/219 (14%)
Query: 117 LGEGGFG-TVYKGVIGQGE--------IAVKRLLGKSGQ-EIKELKNEASVIAQV-QHKN 165
           LGEG FG  V    IG  +        +AVK L   + + ++ +L +E  ++  + +HKN
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSLDCFL-----------FDPTK--REILDWRTRVQI 212
           ++ LLG C +     +I EY    +L  +L           ++P+    E L  +  V  
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
              VA+G+ YL   +  + IHRDL A N+L+ +D   KI+DFG+AR +       +    
Sbjct: 141 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH----HIDYYKK 193
Query: 273 TSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
           T+       +M+PE   + I++ +SDV+SFGVLL EI +
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 110/219 (50%), Gaps = 31/219 (14%)
Query: 117 LGEGGFG-TVYKGVIGQGE--------IAVKRLLGKSGQ-EIKELKNEASVIAQV-QHKN 165
           LGEG FG  V    IG  +        +AVK L   + + ++ +L +E  ++  + +HKN
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSLDCFL-----------FDPTK--REILDWRTRVQI 212
           ++ LLG C +     +I EY    +L  +L           ++P+    E L  +  V  
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
              VA+G+ YL   +  + IHRDL A N+L+ +D   KI+DFG+AR +       +    
Sbjct: 149 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH----HIDYYKK 201
Query: 273 TSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
           T+       +M+PE   + I++ +SDV+SFGVLL EI +
Sbjct: 202 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 108/221 (48%), Gaps = 30/221 (13%)
Query: 114 ANKLGEGGFGTVYKG-VIGQGEIAVKRLL-------GKSGQEIKELKNEASVIAQV-QHK 164
              LG G FG V +    G  + A  R +       G +  E + L +E  ++  +  H 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 165 NLVKLLGCCIEKDERLL-IYEYMPNKSLDCFL------FDPTK-------REILDWRTRV 210
           N+V LLG C +    L+ I E+    +L  +L      F P K       ++ L     +
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 211 QIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQ 270
                VA+G+ +L   +  + IHRDL A NILL +    KI DFG+AR ++   D D ++
Sbjct: 152 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY--KDPDXVR 206
Query: 271 GNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
              +R+     +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 207 KGDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 111/222 (50%), Gaps = 37/222 (16%)
Query: 117 LGEGGFGTVYKGVIGQG------------EIAVKRLLGKSGQ-EIKELKNEASVIAQV-Q 162
           LGEG FG V   V+ +             ++AVK L   + + ++ +L +E  ++  + +
Sbjct: 77  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFL-----------FDPT--KREILDWRTR 209
           HKN++ LLG C +     +I EY    +L  +L           ++P+    E L  +  
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 210 VQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDEL 269
           V     VA+G+ YL   +  + IHRDL A N+L+ +D   KI+DFG+AR +       + 
Sbjct: 194 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH----HIDY 246
Query: 270 QGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
              T+       +M+PE   + I++ +SDV+SFGVLL EI +
Sbjct: 247 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 139/288 (48%), Gaps = 38/288 (13%)
Query: 117 LGEGGFGTVYKGVIGQGE-----IAVKRL--LGKSGQEIKELKNEASVIAQVQHKNLVKL 169
           +G G FG VY G +   +      AVK L  +   G E+ +   E  ++    H N++ L
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGIIMKDFSHPNVLSL 97
Query: 170 LGCCIEKD-ERLLIYEYMPNKSLDCFL----FDPTKREILDWRTRVQIIKGVAQGLLYLH 224
           LG C+  +   L++  YM +  L  F+     +PT ++++ +  +V      A+G+ +L 
Sbjct: 98  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKFL- 150
Query: 225 QYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMS 284
             +  + +HRDL A N +LD+    K++DFG+AR ++  + E +   N +       +M+
Sbjct: 151 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY--DKEFDSVHNKTGAKLPVKWMA 206
Query: 285 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLID 344
            E      F+ KSDV+SFGVLL E+++ +    +    + ++  Y   L    ++     
Sbjct: 207 LESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVY---LLQGRRL----- 257
Query: 345 SVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLL 392
             L+     + L     + L C   +AE RP+ S++VS ++   S+ +
Sbjct: 258 --LQPEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRISAIFSTFI 300

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 139/288 (48%), Gaps = 38/288 (13%)
Query: 117 LGEGGFGTVYKGVIGQGE-----IAVKRL--LGKSGQEIKELKNEASVIAQVQHKNLVKL 169
           +G G FG VY G +   +      AVK L  +   G E+ +   E  ++    H N++ L
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGIIMKDFSHPNVLSL 155
Query: 170 LGCCIEKD-ERLLIYEYMPNKSLDCFL----FDPTKREILDWRTRVQIIKGVAQGLLYLH 224
           LG C+  +   L++  YM +  L  F+     +PT ++++ +  +V      A+G+ +L 
Sbjct: 156 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKFL- 208
Query: 225 QYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMS 284
             +  + +HRDL A N +LD+    K++DFG+AR ++  + E +   N +       +M+
Sbjct: 209 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY--DKEFDSVHNKTGAKLPVKWMA 264
Query: 285 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLID 344
            E      F+ KSDV+SFGVLL E+++ +    +    + ++  Y   L    ++     
Sbjct: 265 LESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVY---LLQGRRL----- 315
Query: 345 SVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLL 392
             L+     + L     + L C   +AE RP+ S++VS ++   S+ +
Sbjct: 316 --LQPEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 110/219 (50%), Gaps = 31/219 (14%)
Query: 117 LGEGGFG-TVYKGVIGQGE--------IAVKRLLGKSGQ-EIKELKNEASVIAQV-QHKN 165
           LGEG FG  V    IG  +        +AVK L   + + ++ +L +E  ++  + +HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSLDCFL-----------FDPTK--REILDWRTRVQI 212
           ++ LLG C +     +I EY    +L  +L           ++P+    E L  +  V  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
              VA+G+ YL   +  + IHRDL A N+L+ +D   KI+DFG+AR +       +    
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH----HIDYYKK 208
Query: 273 TSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
           T+       +M+PE   + I++ +SDV+SFGVLL EI +
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 110/219 (50%), Gaps = 31/219 (14%)
Query: 117 LGEGGFG-TVYKGVIGQGE--------IAVKRLLGKSGQ-EIKELKNEASVIAQV-QHKN 165
           LGEG FG  V    IG  +        +AVK L   + + ++ +L +E  ++  + +HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSLDCFL-----------FDPTK--REILDWRTRVQI 212
           ++ LLG C +     +I EY    +L  +L           ++P+    E L  +  V  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
              VA+G+ YL   +  + IHRDL A N+L+ +D   KI+DFG+AR +       +    
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH----HIDYYKK 208
Query: 273 TSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
           T+       +M+PE   + I++ +SDV+SFGVLL EI +
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 112/218 (51%), Gaps = 23/218 (10%)
Query: 110 NFSAANKLGEGGFGTVYKGVIGQGE-----IAVKRLLGK--SGQEIKELKNEASVIAQVQ 162
            F+    LG+G FG+V +  + Q +     +AVK L     +  +I+E   EA+ + +  
Sbjct: 24  QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFD 83
Query: 163 HKNLVKLLGCCIEKDER------LLIYEYMPNKSLDCFLFDPTKREI---LDWRTRVQII 213
           H ++ KL+G  +    +      ++I  +M +  L  FL      E    L  +T V+ +
Sbjct: 84  HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFM 143
Query: 214 KGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNT 273
             +A G+ YL   S    IHRDL A N +L +DM   ++DFG++R ++ G+     QG  
Sbjct: 144 VDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR--QGCA 198
Query: 274 SRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
           S++     +++ E   + ++++ SDV++FGV + EI++
Sbjct: 199 SKLP--VKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 122/231 (52%), Gaps = 33/231 (14%)
Query: 116 KLGEGGFGTVYKG--VIGQGEIAVKRL-LGKSGQE------IKELKNEASVIAQVQHKNL 166
           ++G+GGFG V+KG  V  +  +A+K L LG S  E       +E + E  +++ + H N+
Sbjct: 26  QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 167 VKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQY 226
           VKL G  +  +   ++ E++P   L   L D  K   + W  +++++  +A G+ Y+ Q 
Sbjct: 86  VKLYG--LMHNPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYM-QN 140
Query: 227 SRVRIIHRDLKASNILLDK-DMN----SKISDFGMARIVFGGNDEDELQGNTSRISGTYG 281
               I+HRDL++ NI L   D N    +K++DFG ++         +   + S + G + 
Sbjct: 141 QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ---------QSVHSVSGLLGNFQ 191
Query: 282 YMSPEY--ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFY---RTKSLNLI 327
           +M+PE   A E  ++ K+D +SF ++L  I++G+     Y   + K +N+I
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI 242

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 107/203 (52%), Gaps = 20/203 (9%)
Query: 116 KLGEGGFGTVYKGVIGQGEI--AVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCC 173
           +LG+G FG VYK    +  +  A K +  KS +E+++   E  ++A   H N+VKLL   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQII-KGVAQGLLYLHQYSRVRII 232
             ++   ++ E+    ++D  + +  +R + +  +++Q++ K     L YLH     +II
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLE-LERPLTE--SQIQVVCKQTLDALNYLHDN---KII 157
Query: 233 HRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL--- 289
           HRDLKA NIL   D + K++DFG++       +   +Q     I GT  +M+PE  +   
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVS-----AKNTRXIQRRDXFI-GTPYWMAPEVVMCET 211
Query: 290 --EGIFSIKSDVFSFGVLLLEIV 310
             +  +  K+DV+S G+ L+E+ 
Sbjct: 212 SKDRPYDYKADVWSLGITLIEMA 234

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 110/219 (50%), Gaps = 31/219 (14%)
Query: 117 LGEGGFG-TVYKGVIGQGE--------IAVKRLLGKSGQ-EIKELKNEASVIAQV-QHKN 165
           LGEG FG  V    IG  +        +AVK L   + + ++ +L +E  ++  + +HKN
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSLDCFL-----------FDPTK--REILDWRTRVQI 212
           ++ LLG C +     +I EY    +L  +L           ++P+    E L  +  V  
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
              VA+G+ YL   +  + IHRDL A N+L+ +D   KI+DFG+AR +       +    
Sbjct: 148 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH----HIDYYKK 200
Query: 273 TSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
           T+       +M+PE   + I++ +SDV+SFGVLL EI +
Sbjct: 201 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 110/219 (50%), Gaps = 31/219 (14%)
Query: 117 LGEGGFG-TVYKGVIGQGE--------IAVKRLLGKSGQ-EIKELKNEASVIAQV-QHKN 165
           LGEG FG  V    IG  +        +AVK L   + + ++ +L +E  ++  + +HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSLDCFL-----------FDPTK--REILDWRTRVQI 212
           ++ LLG C +     +I EY    +L  +L           ++P+    E L  +  V  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
              VA+G+ YL   +  + IHRDL A N+L+ +D   KI+DFG+AR +       +    
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH----HIDYYKK 208
Query: 273 TSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
           T+       +M+PE   + I++ +SDV+SFGVLL EI +
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 108/221 (48%), Gaps = 30/221 (13%)
Query: 114 ANKLGEGGFGTVYKG-VIGQGEIAVKRLL-------GKSGQEIKELKNEASVIAQV-QHK 164
              LG G FG V +    G  + A  R +       G +  E + L +E  ++  +  H 
Sbjct: 23  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 82
Query: 165 NLVKLLGCCIEKDERLL-IYEYMPNKSLDCFL------FDPTK-------REILDWRTRV 210
           N+V LLG C +    L+ I E+    +L  +L      F P K       ++ L     +
Sbjct: 83  NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 142
Query: 211 QIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQ 270
                VA+G+ +L   +  + IHRDL A NILL +    KI DFG+AR ++   D D ++
Sbjct: 143 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY--KDPDYVR 197
Query: 271 GNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
              +R+     +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 198 KGDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 110/203 (54%), Gaps = 18/203 (8%)
Query: 116 KLGEGGFGTVYKGVIGQ-GEIAVKRLL-GKSGQEIKELKNEASVIAQVQHKNLVKLLGCC 173
           +LG+G FG VYK    + G +A  +++  KS +E+++   E  ++A   H  +VKLLG  
Sbjct: 18  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 77
Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
               +  ++ E+ P  ++D  + +   R + + + +V + + + + L +LH     RIIH
Sbjct: 78  YHDGKLWIMIEFCPGGAVDAIMLE-LDRGLTEPQIQV-VCRQMLEALNFLHSK---RIIH 132
Query: 234 RDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL---- 289
           RDLKA N+L+  + + +++DFG++       +   LQ   S I GT  +M+PE  +    
Sbjct: 133 RDLKAGNVLMTLEGDIRLADFGVS-----AKNLKTLQKRDSFI-GTPYWMAPEVVMCETM 186
Query: 290 -EGIFSIKSDVFSFGVLLLEIVS 311
            +  +  K+D++S G+ L+E+  
Sbjct: 187 KDTPYDYKADIWSLGITLIEMAQ 209

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 108/221 (48%), Gaps = 30/221 (13%)
Query: 114 ANKLGEGGFGTVYKG-VIGQGEIAVKRLL-------GKSGQEIKELKNEASVIAQV-QHK 164
              LG G FG V +    G  + A  R +       G +  E + L +E  ++  +  H 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 165 NLVKLLGCCIEKDERLL-IYEYMPNKSLDCFL------FDPTK-------REILDWRTRV 210
           N+V LLG C +    L+ I E+    +L  +L      F P K       ++ L     +
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 211 QIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQ 270
                VA+G+ +L   +  + IHRDL A NILL +    KI DFG+AR ++   D D ++
Sbjct: 152 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY--KDPDYVR 206
Query: 271 GNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
              +R+     +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 207 KGDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 110/203 (54%), Gaps = 18/203 (8%)
Query: 116 KLGEGGFGTVYKGVIGQ-GEIAVKRLL-GKSGQEIKELKNEASVIAQVQHKNLVKLLGCC 173
           +LG+G FG VYK    + G +A  +++  KS +E+++   E  ++A   H  +VKLLG  
Sbjct: 26  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
               +  ++ E+ P  ++D  + +   R + + + +V + + + + L +LH     RIIH
Sbjct: 86  YHDGKLWIMIEFCPGGAVDAIMLE-LDRGLTEPQIQV-VCRQMLEALNFLHSK---RIIH 140
Query: 234 RDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL---- 289
           RDLKA N+L+  + + +++DFG++       +   LQ   S I GT  +M+PE  +    
Sbjct: 141 RDLKAGNVLMTLEGDIRLADFGVS-----AKNLKTLQKRDSFI-GTPYWMAPEVVMCETM 194
Query: 290 -EGIFSIKSDVFSFGVLLLEIVS 311
            +  +  K+D++S G+ L+E+  
Sbjct: 195 KDTPYDYKADIWSLGITLIEMAQ 217

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 73/231 (31%), Positives = 111/231 (48%), Gaps = 36/231 (15%)
Query: 110 NFSAANKLGEGGFGTVYK----GVIGQG---EIAVKRLLGKSGQEIKE-LKNEASVIAQV 161
           N      LG G FG V      G+   G   ++AVK L  K+    +E L +E  ++ Q+
Sbjct: 46  NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 105
Query: 162 -QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFL-------------FDPTKR------ 201
             H+N+V LLG C       LI+EY     L  +L             ++  KR      
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165
Query: 202 -EILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIV 260
             +L +   +     VA+G+ +L   S    +HRDL A N+L+      KI DFG+AR +
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDI 222
Query: 261 FGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
              +D + +    +R+   +  M+PE   EGI++IKSDV+S+G+LL EI S
Sbjct: 223 M--SDSNYVVRGNARLPVKW--MAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 108/221 (48%), Gaps = 30/221 (13%)
Query: 114 ANKLGEGGFGTVYKG-VIGQGEIAVKRLL-------GKSGQEIKELKNEASVIAQV-QHK 164
              LG G FG V +    G  + A  R +       G +  E + L +E  ++  +  H 
Sbjct: 23  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 82
Query: 165 NLVKLLGCCIEKDERLL-IYEYMPNKSLDCFL------FDPTK-------REILDWRTRV 210
           N+V LLG C +    L+ I E+    +L  +L      F P K       ++ L     +
Sbjct: 83  NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 142
Query: 211 QIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQ 270
                VA+G+ +L   +  + IHRDL A NILL +    KI DFG+AR ++   D D ++
Sbjct: 143 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY--KDPDYVR 197
Query: 271 GNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
              +R+     +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 198 KGDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 121/222 (54%), Gaps = 19/222 (8%)
Query: 111 FSAANKLGEGGFGTVYKGVIGQGE--IAVKRL-LGKSGQEIKELKNEASVIAQVQHKNLV 167
           F+   ++G+G FG V+KG+  + +  +A+K + L ++  EI++++ E +V++Q     + 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 168 KLLGCCIEKDERLLIYEYMPNKS-LDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQY 226
           K  G  ++  +  +I EY+   S LD     P      D      ++K + +GL YLH  
Sbjct: 85  KYYGSYLKGSKLWIIMEYLGGGSALDLLRAGP-----FDEFQIATMLKEILKGLDYLHSE 139
Query: 227 SRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPE 286
            +   IHRD+KA+N+LL +  + K++DFG+A    G   + +++ NT    GT  +M+PE
Sbjct: 140 KK---IHRDIKAANVLLSEQGDVKLADFGVA----GQLTDTQIKRNT--FVGTPFWMAPE 190
Query: 287 YALEGIFSIKSDVFSFGVLLLEIVSGK-KNTGFYRTKSLNLI 327
              +  +  K+D++S G+  +E+  G+  N+  +  + L LI
Sbjct: 191 VIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI 232

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 108/221 (48%), Gaps = 30/221 (13%)
Query: 114 ANKLGEGGFGTVYKG-VIGQGEIAVKRLL-------GKSGQEIKELKNEASVIAQV-QHK 164
              LG G FG V +    G  + A  R +       G +  E + L +E  ++  +  H 
Sbjct: 34  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 93
Query: 165 NLVKLLGCCIEKDERLL-IYEYMPNKSLDCFL------FDPTK-------REILDWRTRV 210
           N+V LLG C +    L+ I E+    +L  +L      F P K       ++ L     +
Sbjct: 94  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLI 153
Query: 211 QIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQ 270
                VA+G+ +L   +  + IHRDL A NILL +    KI DFG+AR ++   D D ++
Sbjct: 154 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY--KDPDYVR 208
Query: 271 GNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
              +R+     +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 209 KGDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 247

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 106/219 (48%), Gaps = 39/219 (17%)
Query: 117 LGEGGFGTVYKGVIGQG----EIAVKRLLG-KSGQEIKELKNEASVIAQV-QHKNLVKLL 170
           +GEG FG V K  I +     + A+KR+    S  + ++   E  V+ ++  H N++ LL
Sbjct: 23  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 82
Query: 171 GCCIEKDERLLIYEYMPNKSLDCFL-------FDP------TKREILDWRTRVQIIKGVA 217
           G C  +    L  EY P+ +L  FL        DP      +    L  +  +     VA
Sbjct: 83  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 142
Query: 218 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRIS 277
           +G+ YL   S+ + IHRDL A NIL+ ++  +KI+DFG++R            G    + 
Sbjct: 143 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR------------GQEVYVK 187
Query: 278 GTYG-----YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
            T G     +M+ E     +++  SDV+S+GVLL EIVS
Sbjct: 188 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 108/221 (48%), Gaps = 30/221 (13%)
Query: 114 ANKLGEGGFGTVYKG-VIGQGEIAVKRLL-------GKSGQEIKELKNEASVIAQV-QHK 164
              LG G FG V +    G  + A  R +       G +  E + L +E  ++  +  H 
Sbjct: 69  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 128
Query: 165 NLVKLLGCCIEKDERLL-IYEYMPNKSLDCFL------FDPTK-------REILDWRTRV 210
           N+V LLG C +    L+ I E+    +L  +L      F P K       ++ L     +
Sbjct: 129 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 188
Query: 211 QIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQ 270
                VA+G+ +L   +  + IHRDL A NILL +    KI DFG+AR ++   D D ++
Sbjct: 189 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY--KDPDYVR 243
Query: 271 GNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
              +R+     +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 244 KGDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 109/203 (53%), Gaps = 18/203 (8%)
Query: 116 KLGEGGFGTVYKGVI----GQGEIAVKRL-LGKSGQEIKELKNEASVIAQVQHKNLVKLL 170
           +LG G FG+V +GV      Q ++A+K L  G    + +E+  EA ++ Q+ +  +V+L+
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVR 230
           G C + +  +L+ E      L  FL    KRE +      +++  V+ G+ YL + +   
Sbjct: 77  GVC-QAEALMLVMEMAGGGPLHKFLV--GKREEIPVSNVAELLHQVSMGMKYLEEKN--- 130
Query: 231 IIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYG--YMSPEYA 288
            +HRDL A N+LL     +KISDFG+++   G +D       T+R +G +   + +PE  
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSK-ALGADD----SYYTARSAGKWPLKWYAPECI 185
Query: 289 LEGIFSIKSDVFSFGVLLLEIVS 311
               FS +SDV+S+GV + E +S
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEALS 208

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 106/219 (48%), Gaps = 39/219 (17%)
Query: 117 LGEGGFGTVYKGVIGQG----EIAVKRLLG-KSGQEIKELKNEASVIAQV-QHKNLVKLL 170
           +GEG FG V K  I +     + A+KR+    S  + ++   E  V+ ++  H N++ LL
Sbjct: 33  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 92
Query: 171 GCCIEKDERLLIYEYMPNKSLDCFL-------FDP------TKREILDWRTRVQIIKGVA 217
           G C  +    L  EY P+ +L  FL        DP      +    L  +  +     VA
Sbjct: 93  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 152
Query: 218 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRIS 277
           +G+ YL   S+ + IHRDL A NIL+ ++  +KI+DFG++R            G    + 
Sbjct: 153 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR------------GQEVYVK 197
Query: 278 GTYG-----YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
            T G     +M+ E     +++  SDV+S+GVLL EIVS
Sbjct: 198 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 86/261 (32%), Positives = 127/261 (48%), Gaps = 44/261 (16%)
Query: 117 LGEGGFGTVYK--GVIGQGEIAVKRLLGKSGQ--EIKELKNEASVIAQVQHKNLVKLLGC 172
           LG+G FG V K    I Q E AVK +   S +  +   +  E  ++ ++ H N++KL   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 173 CIEKDERLLIYEYMPNKSLDCFLFDPT-KREILDWRTRVQIIKGVAQGLLYLHQYSRVRI 231
             +     ++ E      L    FD   KR+        +IIK V  G+ Y+H+++   I
Sbjct: 90  LEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---I 142
Query: 232 IHRDLKASNILL---DKDMNSKISDFGMARIVFGGNDEDELQGNTS---RISGTYGYMSP 285
           +HRDLK  NILL   +KD + KI DFG++            Q NT    RI GT  Y++P
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTC---------FQQNTKMKDRI-GTAYYIAP 192
Query: 286 EYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLI------GYAWDL--W--I 335
           E  L G +  K DV+S GV+L  ++SG     FY     +++       YA+DL  W  I
Sbjct: 193 E-VLRGTYDEKCDVWSAGVILYILLSG--TPPFYGKNEYDILKRVETGKYAFDLPQWRTI 249
Query: 336 SNKIIDLIDSVLEEASFNESL 356
           S+   DLI  +L   +F+ SL
Sbjct: 250 SDDAKDLIRKML---TFHPSL 267

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 86/261 (32%), Positives = 127/261 (48%), Gaps = 44/261 (16%)
Query: 117 LGEGGFGTVYK--GVIGQGEIAVKRLLGKSGQ--EIKELKNEASVIAQVQHKNLVKLLGC 172
           LG+G FG V K    I Q E AVK +   S +  +   +  E  ++ ++ H N++KL   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 173 CIEKDERLLIYEYMPNKSLDCFLFDPT-KREILDWRTRVQIIKGVAQGLLYLHQYSRVRI 231
             +     ++ E      L    FD   KR+        +IIK V  G+ Y+H+++   I
Sbjct: 90  LEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---I 142
Query: 232 IHRDLKASNILL---DKDMNSKISDFGMARIVFGGNDEDELQGNTS---RISGTYGYMSP 285
           +HRDLK  NILL   +KD + KI DFG++            Q NT    RI GT  Y++P
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTC---------FQQNTKMKDRI-GTAYYIAP 192
Query: 286 EYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLI------GYAWDL--W--I 335
           E  L G +  K DV+S GV+L  ++SG     FY     +++       YA+DL  W  I
Sbjct: 193 E-VLRGTYDEKCDVWSAGVILYILLSG--TPPFYGKNEYDILKRVETGKYAFDLPQWRTI 249
Query: 336 SNKIIDLIDSVLEEASFNESL 356
           S+   DLI  +L   +F+ SL
Sbjct: 250 SDDAKDLIRKML---TFHPSL 267

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 116/264 (43%), Gaps = 25/264 (9%)
Query: 107 ATGNFSAANKLGEGGFGTVYKGVIGQGE--IAVKRL----LGKSGQEIKELKNEASVIAQ 160
           A  +F     LG+G FG VY     Q +  +A+K L    L K+G E  +L+ E  + + 
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 90
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           ++H N+++L G   +     LI EY P   L     +  K    D +     I  +A  L
Sbjct: 91  LRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANAL 147
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY 280
            Y H     R+IHRD+K  N+LL      KI+DFG +        +D        + GT 
Sbjct: 148 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDD--------LCGTL 196
Query: 281 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK----NTGFYRTKSLNLIGYAWDLWIS 336
            Y+ PE     +   K D++S GVL  E + GK     NT     K ++ + + +  +++
Sbjct: 197 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT 256
Query: 337 NKIIDLIDSVLEEASFNESLSRYV 360
               DLI  +L+       + R V
Sbjct: 257 EGARDLISRLLKHNPSQRPMLREV 280

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 138/288 (47%), Gaps = 38/288 (13%)
Query: 117 LGEGGFGTVYKGVIGQGE-----IAVKRL--LGKSGQEIKELKNEASVIAQVQHKNLVKL 169
           +G G FG VY G +   +      AVK L  +   G E+ +   E  ++    H N++ L
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGIIMKDFSHPNVLSL 97
Query: 170 LGCCIEKD-ERLLIYEYMPNKSLDCFL----FDPTKREILDWRTRVQIIKGVAQGLLYLH 224
           LG C+  +   L++  YM +  L  F+     +PT ++++ +  +V      A+G+ +L 
Sbjct: 98  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKFL- 150
Query: 225 QYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMS 284
             +  + +HRDL A N +LD+    K++DFG+AR +   + E +   N +       +M+
Sbjct: 151 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDML--DKEFDSVHNKTGAKLPVKWMA 206
Query: 285 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLID 344
            E      F+ KSDV+SFGVLL E+++ +    +    + ++  Y   L    ++     
Sbjct: 207 LESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVY---LLQGRRL----- 257
Query: 345 SVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLL 392
             L+     + L     + L C   +AE RP+ S++VS ++   S+ +
Sbjct: 258 --LQPEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRISAIFSTFI 300

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 15/213 (7%)
Query: 103 SVSSATGNFSAANKLGEGGFGTVYKGV-IGQGEIAVKRLLGKSGQEIKELK-NEASVIAQ 160
           SV      ++   K+G+G  GTVY  + +  G+    R +    Q  KEL  NE  V+ +
Sbjct: 15  SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 74
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
            ++ N+V  L   +  DE  ++ EY+   SL     D      +D      + +   Q L
Sbjct: 75  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQAL 130
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY 280
            +LH     ++IHR++K+ NILL  D + K++DFG     F      E Q   S + GT 
Sbjct: 131 EFLHSN---QVIHRNIKSDNILLGMDGSVKLTDFG-----FCAQITPE-QSKRSTMVGTP 181
Query: 281 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
            +M+PE      +  K D++S G++ +E++ G+
Sbjct: 182 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 101/215 (46%), Gaps = 30/215 (13%)
Query: 109 GNFSAANKLGEGGFGTV--YKGVIGQGEIAVKRLLGKS---GQEIKELKNEASVIAQVQH 163
           GN+     +G+G F  V   + ++   E+AV R++ K+      +++L  E  ++  + H
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKEVAV-RIIDKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 164 KNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYL 223
            N+VKL      +    L+ EY     +  +L    + +  + R + + I    Q   Y 
Sbjct: 73  PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ---YC 129
Query: 224 HQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYM 283
           HQ     I+HRDLKA N+LLD DMN KI+DFG +     GN  DE  G            
Sbjct: 130 HQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCG------------ 174
Query: 284 SPEYALEGIFSIKS------DVFSFGVLLLEIVSG 312
           SP YA   +F  K       DV+S GV+L  +VSG
Sbjct: 175 SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 16/208 (7%)
Query: 111 FSAANKLGEGGFGTVY--KGVIGQGEIAVKRLL---GKSGQEIKELKNEASVIAQVQHKN 165
           +   +KLG GG  TVY  +  I   ++A+K +     +  + +K  + E    +Q+ H+N
Sbjct: 13  YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ 225
           +V ++    E D   L+ EY+   +L  ++        L   T +     +  G+ + H 
Sbjct: 73  IVSMIDVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAHD 129
Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
              +RI+HRD+K  NIL+D +   KI DFG+A+ +     E  L   T+ + GT  Y SP
Sbjct: 130 ---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL----SETSLT-QTNHVLGTVQYFSP 181
Query: 286 EYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           E A        +D++S G++L E++ G+
Sbjct: 182 EQAKGEATDECTDIYSIGIVLYEMLVGE 209

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 118/267 (44%), Gaps = 31/267 (11%)
Query: 107 ATGNFSAANKLGEGGFGTVYKGVIGQGE--IAVKRL----LGKSGQEIKELKNEASVIAQ 160
           A  +F     LG+G FG VY     Q +  +A+K L    L K+G E  +L+ E  + + 
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 65
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           ++H N+++L G   +     LI EY P   L     +  K    D +     I  +A  L
Sbjct: 66  LRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANAL 122
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR---IS 277
            Y H     R+IHRD+K  N+LL      KI+DFG +               +SR   +S
Sbjct: 123 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-----------CHAPSSRRTTLS 168
Query: 278 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK----NTGFYRTKSLNLIGYAWDL 333
           GT  Y+ PE     +   K D++S GVL  E + GK     NT     K ++ + + +  
Sbjct: 169 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD 228
Query: 334 WISNKIIDLIDSVLEEASFNESLSRYV 360
           +++    DLI  +L+       + R V
Sbjct: 229 FVTEGARDLISRLLKHNPSQRPMLREV 255

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 123/240 (51%), Gaps = 33/240 (13%)
Query: 107 ATGNFSAANKLGEGGFGTVYKG--VIGQGEIAVKRL-LGKSGQE------IKELKNEASV 157
           A        ++G+GGFG V+KG  V  +  +A+K L LG S  E       +E + E  +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 158 IAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVA 217
           ++ + H N+VKL G  +  +   ++ E++P   L   L D  K   + W  +++++  +A
Sbjct: 77  MSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIA 132
Query: 218 QGLLYLHQYSRVRIIHRDLKASNILLDK-DMN----SKISDFGMARIVFGGNDEDELQGN 272
            G+ Y+ Q     I+HRDL++ NI L   D N    +K++DF +++         +   +
Sbjct: 133 LGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ---------QSVHS 182
Query: 273 TSRISGTYGYMSPEY--ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFY---RTKSLNLI 327
            S + G + +M+PE   A E  ++ K+D +SF ++L  I++G+     Y   + K +N+I
Sbjct: 183 VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI 242

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 120/246 (48%), Gaps = 36/246 (14%)
Query: 90  EKEVDQFPLFSFSSVSSATGNFSAANKLGEGGFGTVYKG-VIGQGE--------IAVKRL 140
           E E+ + P + F          +    LGEG FG V     +G  +        +AVK L
Sbjct: 21  EYELPEDPKWEFPR-----DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML 75
Query: 141 LGKSGQ-EIKELKNEASVIAQV-QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFL--- 195
              + + ++ +L +E  ++  + +HKN++ LLG C +     +I EY    +L  +L   
Sbjct: 76  KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRAR 135
Query: 196 ----------FDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDK 245
                      +    E + ++  V     +A+G+ YL   +  + IHRDL A N+L+ +
Sbjct: 136 RPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTE 192
Query: 246 DMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVL 305
           +   KI+DFG+AR +   N+ D  + NT+       +M+PE   + +++ +SDV+SFGVL
Sbjct: 193 NNVMKIADFGLARDI---NNIDYYK-NTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVL 248
Query: 306 LLEIVS 311
           + EI +
Sbjct: 249 MWEIFT 254

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 103/218 (47%), Gaps = 35/218 (16%)
Query: 117 LGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEK 176
           +G G +G VYKG + +  +AVK     + Q     KN   V   ++H N+ +     I  
Sbjct: 21  IGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRV-PLMEHDNIARF----IVG 75
Query: 177 DER---------LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLH--- 224
           DER         LL+ EY PN SL  +L   T     DW +  ++   V +GL YLH   
Sbjct: 76  DERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS----DWVSSCRLAHSVTRGLAYLHTEL 131
Query: 225 ---QYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRIS--GT 279
               + +  I HRDL + N+L+  D    ISDFG++  + G       + + + IS  GT
Sbjct: 132 PRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGT 191
Query: 280 YGYMSPEYALEGIFSIKS--------DVFSFGVLLLEI 309
             YM+PE  LEG  +++         D+++ G++  EI
Sbjct: 192 IRYMAPE-VLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 138/276 (50%), Gaps = 35/276 (12%)
Query: 111 FSAANKLGEGGFGTVYKGVIG--QGEIAVKRL-LGKSGQEIKELKNEASVIAQVQHKNLV 167
           F+   K+G+G FG V+KG+    Q  +A+K + L ++  EI++++ E +V++Q     + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 168 KLLGCCIEKDERLLIYEYMPNKS-LDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQY 226
           K  G  ++  +  +I EY+   S LD     P     LD      I++ + +GL YLH  
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-----LDETQIATILREILKGLDYLHSE 123
Query: 227 SRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPE 286
            +   IHRD+KA+N+LL +    K++DFG+A    G   + +++ N     GT  +M+PE
Sbjct: 124 KK---IHRDIKAANVLLSEHGEVKLADFGVA----GQLTDTQIKRNX--FVGTPFWMAPE 174
Query: 287 YALEGIFSIKSDVFSFGVLLLEIVSGK-KNTGFYRTKSLNLIGYAWDLWISNKIIDLIDS 345
              +  +  K+D++S G+  +E+  G+  ++  +  K L LI         N    L   
Sbjct: 175 VIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIP-------KNNPPTL--- 224
Query: 346 VLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVV 381
              E ++++ L  +V     C+ +    RPT  +++
Sbjct: 225 ---EGNYSKPLKEFVEA---CLNKEPSFRPTAKELL 254

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 107/221 (48%), Gaps = 30/221 (13%)
Query: 114 ANKLGEGGFGTVYKG-VIGQGEIAVKRLL-------GKSGQEIKELKNEASVIAQV-QHK 164
              LG G FG V +    G  + A  R +       G +  E + L +E  ++  +  H 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 165 NLVKLLGCCIEKDERLL-IYEYMPNKSLDCFL------FDPTK-------REILDWRTRV 210
           N+V LLG C +    L+ I E+    +L  +L      F P K       ++ L     +
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 211 QIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQ 270
                VA+G+ +L   +  + IHRDL A NILL +    KI DFG+AR +    D D ++
Sbjct: 152 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIX--KDPDXVR 206
Query: 271 GNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
              +R+     +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 207 KGDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 118/267 (44%), Gaps = 31/267 (11%)
Query: 107 ATGNFSAANKLGEGGFGTVYKGVIGQGE--IAVKRL----LGKSGQEIKELKNEASVIAQ 160
           A  +F     LG+G FG VY     Q +  +A+K L    L K+G E  +L+ E  + + 
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 90
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           ++H N+++L G   +     LI EY P   L     +  K    D +     I  +A  L
Sbjct: 91  LRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANAL 147
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR---IS 277
            Y H     R+IHRD+K  N+LL      KI+DFG +           +   +SR   + 
Sbjct: 148 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-----------VHAPSSRRTTLC 193
Query: 278 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK----NTGFYRTKSLNLIGYAWDL 333
           GT  Y+ PE     +   K D++S GVL  E + GK     NT     K ++ + + +  
Sbjct: 194 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD 253
Query: 334 WISNKIIDLIDSVLEEASFNESLSRYV 360
           +++    DLI  +L+       + R V
Sbjct: 254 FVTEGARDLISRLLKHNPSQRPMLREV 280

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 97/205 (47%), Gaps = 20/205 (9%)
Query: 114 ANKLGEGGFGTVYKGVIGQGE--IAVKRLLGKSGQEIK-ELKNEASVIAQVQHKNLVKLL 170
             ++G G FG V+ G +      +AVK        ++K +   EA ++ Q  H N+V+L+
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVR 230
           G C +K    ++ E +       FL     R  L  +T +Q++   A G+ YL       
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGAR--LRVKTLLQMVGDAAAGMEYLESKC--- 233
Query: 231 IIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG----TYGYMSPE 286
            IHRDL A N L+ +    KISDFGM+R        +E  G  +   G       + +PE
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSR--------EEADGVXAASGGLRQVPVKWTAPE 285
Query: 287 YALEGIFSIKSDVFSFGVLLLEIVS 311
               G +S +SDV+SFG+LL E  S
Sbjct: 286 ALNYGRYSSESDVWSFGILLWETFS 310

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 118/267 (44%), Gaps = 31/267 (11%)
Query: 107 ATGNFSAANKLGEGGFGTVYKGVIGQGE--IAVKRL----LGKSGQEIKELKNEASVIAQ 160
           A  +F     LG+G FG VY     Q +  +A+K L    L K+G E  +L+ E  + + 
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 81
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           ++H N+++L G   +     LI EY P   L     +  K    D +     I  +A  L
Sbjct: 82  LRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANAL 138
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR---IS 277
            Y H     R+IHRD+K  N+LL      KI+DFG +           +   +SR   + 
Sbjct: 139 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-----------VHAPSSRRTTLC 184
Query: 278 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK----NTGFYRTKSLNLIGYAWDL 333
           GT  Y+ PE     +   K D++S GVL  E + GK     NT     K ++ + + +  
Sbjct: 185 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD 244
Query: 334 WISNKIIDLIDSVLEEASFNESLSRYV 360
           +++    DLI  +L+       + R V
Sbjct: 245 FVTEGARDLISRLLKHNPSQRPMLREV 271

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/228 (31%), Positives = 107/228 (46%), Gaps = 36/228 (15%)
Query: 102 SSVSSAT------GNFSAANKLGEGGFGTV--YKGVIGQGEIAVKRLLGKS---GQEIKE 150
           +S++SAT      GN+     +G+G F  V   + V+   E+AVK ++ K+      +++
Sbjct: 2   NSITSATDEQPHIGNYRLQKTIGKGNFAKVKLARHVLTGREVAVK-IIDKTQLNPTSLQK 60
Query: 151 LKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRV 210
           L  E  ++  + H N+VKL      +    L+ EY     +  +L    + +  + R + 
Sbjct: 61  LFREVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF 120
Query: 211 QIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQ 270
           + I    Q   Y HQ     I+HRDLKA N+LLD DMN KI+DFG +     GN  D   
Sbjct: 121 RQIVSAVQ---YCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFC 174
Query: 271 GNTSRISGTYGYMSPEYALEGIFSIKS------DVFSFGVLLLEIVSG 312
           G            SP YA   +F  K       DV+S GV+L  +VSG
Sbjct: 175 G------------SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 107/221 (48%), Gaps = 30/221 (13%)
Query: 114 ANKLGEGGFGTVYKG-VIGQGEIAVKRLL-------GKSGQEIKELKNEASVIAQV-QHK 164
              LG G FG V +    G  + A  R +       G +  E + L +E  ++  +  H 
Sbjct: 23  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 82
Query: 165 NLVKLLGCCIEKDERLL-IYEYMPNKSLDCFL------FDPTK-------REILDWRTRV 210
           N+V LLG C +    L+ I E+    +L  +L      F P K       ++ L     +
Sbjct: 83  NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 142
Query: 211 QIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQ 270
                VA+G+ +L   +  + IHRDL A NILL +    KI DFG+AR +    D D ++
Sbjct: 143 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIX--KDPDXVR 197
Query: 271 GNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
              +R+     +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 198 KGDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 109/203 (53%), Gaps = 18/203 (8%)
Query: 116 KLGEGGFGTVYKGVI----GQGEIAVKRL-LGKSGQEIKELKNEASVIAQVQHKNLVKLL 170
           +LG G FG+V +GV      Q ++A+K L  G    + +E+  EA ++ Q+ +  +V+L+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVR 230
           G C + +  +L+ E      L  FL    KRE +      +++  V+ G+ YL + +   
Sbjct: 403 GVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN--- 456
Query: 231 IIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYG--YMSPEYA 288
            +HR+L A N+LL     +KISDFG+++   G +D       T+R +G +   + +PE  
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSK-ALGADD----SYYTARSAGKWPLKWYAPECI 511
Query: 289 LEGIFSIKSDVFSFGVLLLEIVS 311
               FS +SDV+S+GV + E +S
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEALS 534

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/247 (27%), Positives = 121/247 (48%), Gaps = 38/247 (15%)
Query: 90  EKEVDQFPLFSFSSVSSATGNFSAANKLGEGGFGTVYKG-VIGQGE--------IAVKRL 140
           E E+ + P + F          +    LGEG FG V     +G  +        +AVK L
Sbjct: 21  EYELPEDPKWEFPR-----DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML 75
Query: 141 LGKSGQE-IKELKNEASVIAQV-QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFL--- 195
              + +E + +L +E  ++  + +HKN++ LLG C +     +I EY    +L  +L   
Sbjct: 76  KDDATEEDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRAR 135
Query: 196 ----------FDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDK 245
                      +    E + ++  V     +A+G+ YL   +  + IHRDL A N+L+ +
Sbjct: 136 RPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTE 192
Query: 246 DMNSKISDFGMARIVFGGNDEDELQGNTS-RISGTYGYMSPEYALEGIFSIKSDVFSFGV 304
           +   KI+DFG+AR +   N+ D  +  T+ R+     +M+PE   + +++ +SDV+SFGV
Sbjct: 193 NNVMKIADFGLARDI---NNIDYYKKTTNGRLP--VKWMAPEALFDRVYTHQSDVWSFGV 247
Query: 305 LLLEIVS 311
           L+ EI +
Sbjct: 248 LMWEIFT 254

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 107/221 (48%), Gaps = 30/221 (13%)
Query: 114 ANKLGEGGFGTVYKG-VIGQGEIAVKRLL-------GKSGQEIKELKNEASVIAQV-QHK 164
              LG G FG V +    G  + A  R +       G +  E + L +E  ++  +  H 
Sbjct: 23  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 82
Query: 165 NLVKLLGCCIEKDERLL-IYEYMPNKSLDCFL------FDPTK-------REILDWRTRV 210
           N+V LLG C +    L+ I E+    +L  +L      F P K       ++ L     +
Sbjct: 83  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 142
Query: 211 QIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQ 270
                VA+G+ +L   +  + IHRDL A NILL +    KI DFG+AR +    D D ++
Sbjct: 143 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIX--KDPDXVR 197
Query: 271 GNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
              +R+     +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 198 KGDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 138/276 (50%), Gaps = 35/276 (12%)
Query: 111 FSAANKLGEGGFGTVYKGVIG--QGEIAVKRL-LGKSGQEIKELKNEASVIAQVQHKNLV 167
           F+   K+G+G FG V+KG+    Q  +A+K + L ++  EI++++ E +V++Q     + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 168 KLLGCCIEKDERLLIYEYMPNKS-LDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQY 226
           K  G  ++  +  +I EY+   S LD     P     LD      I++ + +GL YLH  
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-----LDETQIATILREILKGLDYLHSE 138
Query: 227 SRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPE 286
            +   IHRD+KA+N+LL +    K++DFG+A    G   + +++ N     GT  +M+PE
Sbjct: 139 KK---IHRDIKAANVLLSEHGEVKLADFGVA----GQLTDTQIKRNX--FVGTPFWMAPE 189
Query: 287 YALEGIFSIKSDVFSFGVLLLEIVSGK-KNTGFYRTKSLNLIGYAWDLWISNKIIDLIDS 345
              +  +  K+D++S G+  +E+  G+  ++  +  K L LI         N    L   
Sbjct: 190 VIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIP-------KNNPPTL--- 239
Query: 346 VLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVV 381
              E ++++ L  +V     C+ +    RPT  +++
Sbjct: 240 ---EGNYSKPLKEFVEA---CLNKEPSFRPTAKELL 269

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 118/267 (44%), Gaps = 31/267 (11%)
Query: 107 ATGNFSAANKLGEGGFGTVYKGVIGQGE--IAVKRL----LGKSGQEIKELKNEASVIAQ 160
           A  +F     LG+G FG VY     Q +  +A+K L    L K+G E  +L+ E  + + 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 64
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           ++H N+++L G   +     LI EY P   L     +  K    D +     I  +A  L
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR---IS 277
            Y H     R+IHRD+K  N+LL      KI+DFG +           +   +SR   + 
Sbjct: 122 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-----------VHAPSSRRTTLC 167
Query: 278 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK----NTGFYRTKSLNLIGYAWDL 333
           GT  Y+ PE     +   K D++S GVL  E + GK     NT     K ++ + + +  
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD 227
Query: 334 WISNKIIDLIDSVLEEASFNESLSRYV 360
           +++    DLI  +L+       + R V
Sbjct: 228 FVTEGARDLISRLLKHNPSQRPMLREV 254

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 118/267 (44%), Gaps = 31/267 (11%)
Query: 107 ATGNFSAANKLGEGGFGTVYKGVIGQGE--IAVKRL----LGKSGQEIKELKNEASVIAQ 160
           A  +F     LG+G FG VY     Q +  +A+K L    L K+G E  +L+ E  + + 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 64
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           ++H N+++L G   +     LI EY P   L     +  K    D +     I  +A  L
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR---IS 277
            Y H     R+IHRD+K  N+LL      KI+DFG +           +   +SR   + 
Sbjct: 122 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-----------VHAPSSRRTELC 167
Query: 278 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK----NTGFYRTKSLNLIGYAWDL 333
           GT  Y+ PE     +   K D++S GVL  E + GK     NT     K ++ + + +  
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD 227
Query: 334 WISNKIIDLIDSVLEEASFNESLSRYV 360
           +++    DLI  +L+       + R V
Sbjct: 228 FVTEGARDLISRLLKHNPSQRPMLREV 254

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 118/267 (44%), Gaps = 31/267 (11%)
Query: 107 ATGNFSAANKLGEGGFGTVYKGVIGQGE--IAVKRL----LGKSGQEIKELKNEASVIAQ 160
           A  +F     LG+G FG VY     Q +  +A+K L    L K+G E  +L+ E  + + 
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 65
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           ++H N+++L G   +     LI EY P   L     +  K    D +     I  +A  L
Sbjct: 66  LRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANAL 122
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR---IS 277
            Y H     R+IHRD+K  N+LL      KI+DFG +           +   +SR   + 
Sbjct: 123 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-----------VHAPSSRRDTLC 168
Query: 278 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK----NTGFYRTKSLNLIGYAWDL 333
           GT  Y+ PE     +   K D++S GVL  E + GK     NT     K ++ + + +  
Sbjct: 169 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD 228
Query: 334 WISNKIIDLIDSVLEEASFNESLSRYV 360
           +++    DLI  +L+       + R V
Sbjct: 229 FVTEGARDLISRLLKHNPSQRPMLREV 255

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 118/267 (44%), Gaps = 31/267 (11%)
Query: 107 ATGNFSAANKLGEGGFGTVYKGVIGQGE--IAVKRL----LGKSGQEIKELKNEASVIAQ 160
           A  +F     LG+G FG VY     Q +  +A+K L    L K+G E  +L+ E  + + 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 64
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           ++H N+++L G   +     LI EY P   L     +  K    D +     I  +A  L
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR---IS 277
            Y H     R+IHRD+K  N+LL      KI+DFG +           +   +SR   + 
Sbjct: 122 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-----------VHAPSSRRTDLC 167
Query: 278 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK----NTGFYRTKSLNLIGYAWDL 333
           GT  Y+ PE     +   K D++S GVL  E + GK     NT     K ++ + + +  
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD 227
Query: 334 WISNKIIDLIDSVLEEASFNESLSRYV 360
           +++    DLI  +L+       + R V
Sbjct: 228 FVTEGARDLISRLLKHNPSQRPMLREV 254

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 118/267 (44%), Gaps = 31/267 (11%)
Query: 107 ATGNFSAANKLGEGGFGTVYKGVIGQGE--IAVKRL----LGKSGQEIKELKNEASVIAQ 160
           A  +F     LG+G FG VY     Q +  +A+K L    L K+G E  +L+ E  + + 
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 65
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           ++H N+++L G   +     LI EY P   L     +  K    D +     I  +A  L
Sbjct: 66  LRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANAL 122
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR---IS 277
            Y H     R+IHRD+K  N+LL      KI+DFG +           +   +SR   + 
Sbjct: 123 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-----------VHAPSSRRTDLC 168
Query: 278 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK----NTGFYRTKSLNLIGYAWDL 333
           GT  Y+ PE     +   K D++S GVL  E + GK     NT     K ++ + + +  
Sbjct: 169 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD 228
Query: 334 WISNKIIDLIDSVLEEASFNESLSRYV 360
           +++    DLI  +L+       + R V
Sbjct: 229 FVTEGARDLISRLLKHNPSQRPMLREV 255

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 118/267 (44%), Gaps = 31/267 (11%)
Query: 107 ATGNFSAANKLGEGGFGTVYKGVIGQGE--IAVKRL----LGKSGQEIKELKNEASVIAQ 160
           A  +F     LG+G FG VY     Q +  +A+K L    L K+G E  +L+ E  + + 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 64
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           ++H N+++L G   +     LI EY P   L     +  K    D +     I  +A  L
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR---IS 277
            Y H     R+IHRD+K  N+LL      KI+DFG +           +   +SR   + 
Sbjct: 122 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-----------VHAPSSRRTDLC 167
Query: 278 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK----NTGFYRTKSLNLIGYAWDL 333
           GT  Y+ PE     +   K D++S GVL  E + GK     NT     K ++ + + +  
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD 227
Query: 334 WISNKIIDLIDSVLEEASFNESLSRYV 360
           +++    DLI  +L+       + R V
Sbjct: 228 FVTEGARDLISRLLKHNPSQRPMLREV 254

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 118/267 (44%), Gaps = 31/267 (11%)
Query: 107 ATGNFSAANKLGEGGFGTVYKGVIGQGE--IAVKRL----LGKSGQEIKELKNEASVIAQ 160
           A  +F     LG+G FG VY     Q +  +A+K L    L K+G E  +L+ E  + + 
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 69
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           ++H N+++L G   +     LI EY P   L     +  K    D +     I  +A  L
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANAL 126
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR---IS 277
            Y H     R+IHRD+K  N+LL      KI+DFG +           +   +SR   + 
Sbjct: 127 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-----------VHAPSSRRTTLC 172
Query: 278 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK----NTGFYRTKSLNLIGYAWDL 333
           GT  Y+ PE     +   K D++S GVL  E + GK     NT     K ++ + + +  
Sbjct: 173 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD 232
Query: 334 WISNKIIDLIDSVLEEASFNESLSRYV 360
           +++    DLI  +L+       + R V
Sbjct: 233 FVTEGARDLISRLLKHNPSQRPMLREV 259

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 118/267 (44%), Gaps = 31/267 (11%)
Query: 107 ATGNFSAANKLGEGGFGTVYKGVIGQGE--IAVKRL----LGKSGQEIKELKNEASVIAQ 160
           A  +F     LG+G FG VY     Q +  +A+K L    L K+G E  +L+ E  + + 
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 67
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           ++H N+++L G   +     LI EY P   L     +  K    D +     I  +A  L
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANAL 124
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR---IS 277
            Y H     R+IHRD+K  N+LL      KI+DFG +           +   +SR   + 
Sbjct: 125 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-----------VHAPSSRRTTLC 170
Query: 278 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK----NTGFYRTKSLNLIGYAWDL 333
           GT  Y+ PE     +   K D++S GVL  E + GK     NT     K ++ + + +  
Sbjct: 171 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD 230
Query: 334 WISNKIIDLIDSVLEEASFNESLSRYV 360
           +++    DLI  +L+       + R V
Sbjct: 231 FVTEGARDLISRLLKHNPSQRPMLREV 257

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 118/267 (44%), Gaps = 31/267 (11%)
Query: 107 ATGNFSAANKLGEGGFGTVYKGVIGQGE--IAVKRL----LGKSGQEIKELKNEASVIAQ 160
           A  +F     LG+G FG VY     Q +  +A+K L    L K+G E  +L+ E  + + 
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 69
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           ++H N+++L G   +     LI EY P   L     +  K    D +     I  +A  L
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANAL 126
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR---IS 277
            Y H     R+IHRD+K  N+LL      KI+DFG +           +   +SR   + 
Sbjct: 127 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-----------VHAPSSRRTDLC 172
Query: 278 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK----NTGFYRTKSLNLIGYAWDL 333
           GT  Y+ PE     +   K D++S GVL  E + GK     NT     K ++ + + +  
Sbjct: 173 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD 232
Query: 334 WISNKIIDLIDSVLEEASFNESLSRYV 360
           +++    DLI  +L+       + R V
Sbjct: 233 FVTEGARDLISRLLKHNPSQRPMLREV 259

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 116/264 (43%), Gaps = 25/264 (9%)
Query: 107 ATGNFSAANKLGEGGFGTVYKGVIGQGE--IAVKRL----LGKSGQEIKELKNEASVIAQ 160
           A  +F     LG+G FG VY     Q +  +A+K L    L K+G E  +L+ E  + + 
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 67
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           ++H N+++L G   +     LI EY P   L     +  K    D +     I  +A  L
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANAL 124
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY 280
            Y H     R+IHRD+K  N+LL      KI+DFG +        +D        + GT 
Sbjct: 125 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDD--------LCGTL 173
Query: 281 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK----NTGFYRTKSLNLIGYAWDLWIS 336
            Y+ PE     +   K D++S GVL  E + GK     NT     K ++ + + +  +++
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT 233
Query: 337 NKIIDLIDSVLEEASFNESLSRYV 360
               DLI  +L+       + R V
Sbjct: 234 EGARDLISRLLKHNPSQRPMLREV 257

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 83/280 (29%), Positives = 128/280 (45%), Gaps = 39/280 (13%)
Query: 117 LGEGGFGTVYKGVI--GQGE---IAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNLVKLL 170
           LGEG FG VY+GV    +GE   +AVK        + KE   +EA ++  + H ++VKL+
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 75
Query: 171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVR 230
           G  IE++   +I E  P   L  +L     +  L   T V     + + + YL     + 
Sbjct: 76  GI-IEEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAYLES---IN 129
Query: 231 IIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE 290
            +HRD+   NIL+      K+ DFG++R +    DED  + + +R+     +MSPE    
Sbjct: 130 CVHRDIAVRNILVASPECVKLGDFGLSRYI---EDEDYYKASVTRLP--IKWMSPESINF 184
Query: 291 GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEA 350
             F+  SDV+ F V + EI+S  K   F               W+ NK  D+I  VLE+ 
Sbjct: 185 RRFTTASDVWMFAVCMWEILSFGKQPFF---------------WLENK--DVI-GVLEKG 226
Query: 351 S--FNESLSRYVHIALL--CVQERAEDRPTMSDVVSMLTN 386
                  L   V   L+  C      DRP  +++V  L++
Sbjct: 227 DRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSD 266

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 118/267 (44%), Gaps = 31/267 (11%)
Query: 107 ATGNFSAANKLGEGGFGTVYKGVIGQGE--IAVKRL----LGKSGQEIKELKNEASVIAQ 160
           A  +F     LG+G FG VY     Q +  +A+K L    L K+G E  +L+ E  + + 
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 66
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           ++H N+++L G   +     LI EY P   L     +  K    D +     I  +A  L
Sbjct: 67  LRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANAL 123
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR---IS 277
            Y H     R+IHRD+K  N+LL      KI+DFG +           +   +SR   + 
Sbjct: 124 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-----------VHAPSSRRXXLC 169
Query: 278 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK----NTGFYRTKSLNLIGYAWDL 333
           GT  Y+ PE     +   K D++S GVL  E + GK     NT     K ++ + + +  
Sbjct: 170 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD 229
Query: 334 WISNKIIDLIDSVLEEASFNESLSRYV 360
           +++    DLI  +L+       + R V
Sbjct: 230 FVTEGARDLISRLLKHNPSQRPMLREV 256

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 118/267 (44%), Gaps = 31/267 (11%)
Query: 107 ATGNFSAANKLGEGGFGTVYKGVIGQGE--IAVKRL----LGKSGQEIKELKNEASVIAQ 160
           A  +F     LG+G FG VY     Q +  +A+K L    L K+G E  +L+ E  + + 
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 67
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           ++H N+++L G   +     LI EY P   L     +  K    D +     I  +A  L
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANAL 124
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR---IS 277
            Y H     R+IHRD+K  N+LL      KI+DFG +           +   +SR   + 
Sbjct: 125 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-----------VHAPSSRRTTLC 170
Query: 278 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK----NTGFYRTKSLNLIGYAWDL 333
           GT  Y+ PE     +   K D++S GVL  E + GK     NT     K ++ + + +  
Sbjct: 171 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD 230
Query: 334 WISNKIIDLIDSVLEEASFNESLSRYV 360
           +++    DLI  +L+       + R V
Sbjct: 231 FVTEGARDLISRLLKHNPSQRPMLREV 257

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 97/205 (47%), Gaps = 20/205 (9%)
Query: 114 ANKLGEGGFGTVYKGVIGQGE--IAVKRLLGKSGQEIK-ELKNEASVIAQVQHKNLVKLL 170
             ++G G FG V+ G +      +AVK        ++K +   EA ++ Q  H N+V+L+
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVR 230
           G C +K    ++ E +       FL     R  L  +T +Q++   A G+ YL       
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGAR--LRVKTLLQMVGDAAAGMEYLESKC--- 233
Query: 231 IIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG----TYGYMSPE 286
            IHRDL A N L+ +    KISDFGM+R        +E  G  +   G       + +PE
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSR--------EEADGVYAASGGLRQVPVKWTAPE 285
Query: 287 YALEGIFSIKSDVFSFGVLLLEIVS 311
               G +S +SDV+SFG+LL E  S
Sbjct: 286 ALNYGRYSSESDVWSFGILLWETFS 310

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 120/274 (43%), Gaps = 31/274 (11%)
Query: 100 SFSSVSSATGNFSAANKLGEGGFGTVYKGVIGQGE--IAVKRL----LGKSGQEIKELKN 153
           +  S   A  +F     LG+G FG VY     Q +  +A+K L    L K+G E  +L+ 
Sbjct: 2   AMGSRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRR 60
Query: 154 EASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQII 213
           E  + + ++H N+++L G   +     LI EY P   L     +  K    D +     I
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYI 117
Query: 214 KGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNT 273
             +A  L Y H     R+IHRD+K  N+LL      KI+DFG +           +   +
Sbjct: 118 TELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-----------VHAPS 163
Query: 274 SR---ISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK----NTGFYRTKSLNL 326
           SR   + GT  Y+ PE     +   K D++S GVL  E + GK     NT     K ++ 
Sbjct: 164 SRRAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR 223
Query: 327 IGYAWDLWISNKIIDLIDSVLEEASFNESLSRYV 360
           + + +  +++    DLI  +L+       + R V
Sbjct: 224 VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREV 257

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 118/267 (44%), Gaps = 31/267 (11%)
Query: 107 ATGNFSAANKLGEGGFGTVYKGVIGQGE--IAVKRL----LGKSGQEIKELKNEASVIAQ 160
           A  +F     LG+G FG VY     Q +  +A+K L    L K+G E  +L+ E  + + 
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 63
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           ++H N+++L G   +     LI EY P   L     +  K    D +     I  +A  L
Sbjct: 64  LRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANAL 120
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR---IS 277
            Y H     R+IHRD+K  N+LL      KI+DFG +           +   +SR   + 
Sbjct: 121 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-----------VHAPSSRRTTLC 166
Query: 278 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK----NTGFYRTKSLNLIGYAWDL 333
           GT  Y+ PE     +   K D++S GVL  E + GK     NT     K ++ + + +  
Sbjct: 167 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD 226
Query: 334 WISNKIIDLIDSVLEEASFNESLSRYV 360
           +++    DLI  +L+       + R V
Sbjct: 227 FVTEGARDLISRLLKHNPSQRPMLREV 253

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 106/219 (48%), Gaps = 39/219 (17%)
Query: 117 LGEGGFGTVYKGVIGQG----EIAVKRLLG-KSGQEIKELKNEASVIAQV-QHKNLVKLL 170
           +GEG FG V K  I +     + A+KR+    S  + ++   E  V+ ++  H N++ LL
Sbjct: 30  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 89
Query: 171 GCCIEKDERLLIYEYMPNKSLDCFL-------FDP------TKREILDWRTRVQIIKGVA 217
           G C  +    L  EY P+ +L  FL        DP      +    L  +  +     VA
Sbjct: 90  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 149
Query: 218 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRIS 277
           +G+ YL   S+ + IHR+L A NIL+ ++  +KI+DFG++R            G    + 
Sbjct: 150 RGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSR------------GQEVYVK 194
Query: 278 GTYG-----YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
            T G     +M+ E     +++  SDV+S+GVLL EIVS
Sbjct: 195 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 111/211 (52%), Gaps = 22/211 (10%)
Query: 110 NFSAANKLGEGGFGTVYKGVIGQGEI-AVKRL-LGKSGQEIKELK-NEASVIAQVQHKNL 166
            +    K+GEG +G VYK    QG I A+KR+ L    + I      E S++ ++ H N+
Sbjct: 22  KYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNI 81
Query: 167 VKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRV---QIIKGVAQGLLYL 223
           V L+     +    L++E+M  K L   L D  K  + D + ++   Q+++GVA    + 
Sbjct: 82  VSLIDVIHSERCLTLVFEFM-EKDLKKVL-DENKTGLQDSQIKIYLYQLLRGVA----HC 135
Query: 224 HQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYM 283
           HQ+   RI+HRDLK  N+L++ D   K++DFG+AR  FG      ++  T  +  T  Y 
Sbjct: 136 HQH---RILHRDLKPQNLLINSDGALKLADFGLAR-AFG----IPVRSYTHEVV-TLWYR 186
Query: 284 SPEYAL-EGIFSIKSDVFSFGVLLLEIVSGK 313
           +P+  +    +S   D++S G +  E+++GK
Sbjct: 187 APDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 83/280 (29%), Positives = 128/280 (45%), Gaps = 39/280 (13%)
Query: 117 LGEGGFGTVYKGVI--GQGE---IAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNLVKLL 170
           LGEG FG VY+GV    +GE   +AVK        + KE   +EA ++  + H ++VKL+
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 91
Query: 171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVR 230
           G  IE++   +I E  P   L  +L     +  L   T V     + + + YL     + 
Sbjct: 92  GI-IEEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAYLES---IN 145
Query: 231 IIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE 290
            +HRD+   NIL+      K+ DFG++R +    DED  + + +R+     +MSPE    
Sbjct: 146 CVHRDIAVRNILVASPECVKLGDFGLSRYI---EDEDYYKASVTRLP--IKWMSPESINF 200
Query: 291 GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEA 350
             F+  SDV+ F V + EI+S  K   F               W+ NK  D+I  VLE+ 
Sbjct: 201 RRFTTASDVWMFAVCMWEILSFGKQPFF---------------WLENK--DVI-GVLEKG 242
Query: 351 S--FNESLSRYVHIALL--CVQERAEDRPTMSDVVSMLTN 386
                  L   V   L+  C      DRP  +++V  L++
Sbjct: 243 DRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSD 282

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 118/267 (44%), Gaps = 31/267 (11%)
Query: 107 ATGNFSAANKLGEGGFGTVYKGVIGQGE--IAVKRL----LGKSGQEIKELKNEASVIAQ 160
           A  +F     LG+G FG VY     Q +  +A+K L    L K+G E  +L+ E  + + 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 64
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           ++H N+++L G   +     LI EY P   L     +  K    D +     I  +A  L
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR---IS 277
            Y H     R+IHRD+K  N+LL      KI+DFG +           +   +SR   + 
Sbjct: 122 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-----------VHAPSSRRAALC 167
Query: 278 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK----NTGFYRTKSLNLIGYAWDL 333
           GT  Y+ PE     +   K D++S GVL  E + GK     NT     K ++ + + +  
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD 227
Query: 334 WISNKIIDLIDSVLEEASFNESLSRYV 360
           +++    DLI  +L+       + R V
Sbjct: 228 FVTEGARDLISRLLKHNPSQRPMLREV 254

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 83/280 (29%), Positives = 128/280 (45%), Gaps = 39/280 (13%)
Query: 117 LGEGGFGTVYKGVI--GQGE---IAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNLVKLL 170
           LGEG FG VY+GV    +GE   +AVK        + KE   +EA ++  + H ++VKL+
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVR 230
           G  IE++   +I E  P   L  +L     +  L   T V     + + + YL     + 
Sbjct: 80  GI-IEEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAYLES---IN 133
Query: 231 IIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE 290
            +HRD+   NIL+      K+ DFG++R +    DED  + + +R+     +MSPE    
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFGLSRYI---EDEDYYKASVTRLP--IKWMSPESINF 188
Query: 291 GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEA 350
             F+  SDV+ F V + EI+S  K   F               W+ NK  D+I  VLE+ 
Sbjct: 189 RRFTTASDVWMFAVCMWEILSFGKQPFF---------------WLENK--DVI-GVLEKG 230
Query: 351 S--FNESLSRYVHIALL--CVQERAEDRPTMSDVVSMLTN 386
                  L   V   L+  C      DRP  +++V  L++
Sbjct: 231 DRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSD 270

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 118/267 (44%), Gaps = 31/267 (11%)
Query: 107 ATGNFSAANKLGEGGFGTVYKGVIGQGE--IAVKRL----LGKSGQEIKELKNEASVIAQ 160
           A  +F     LG+G FG VY     Q +  +A+K L    L K+G E  +L+ E  + + 
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 67
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           ++H N+++L G   +     LI EY P   L     +  K    D +     I  +A  L
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANAL 124
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR---IS 277
            Y H     R+IHRD+K  N+LL      KI+DFG +           +   +SR   + 
Sbjct: 125 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-----------VHAPSSRRXXLC 170
Query: 278 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK----NTGFYRTKSLNLIGYAWDL 333
           GT  Y+ PE     +   K D++S GVL  E + GK     NT     K ++ + + +  
Sbjct: 171 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD 230
Query: 334 WISNKIIDLIDSVLEEASFNESLSRYV 360
           +++    DLI  +L+       + R V
Sbjct: 231 FVTEGARDLISRLLKHNPSQRPMLREV 257

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 111/211 (52%), Gaps = 22/211 (10%)
Query: 110 NFSAANKLGEGGFGTVYKGVIGQGEI-AVKRL-LGKSGQEIKELK-NEASVIAQVQHKNL 166
            +    K+GEG +G VYK    QG I A+KR+ L    + I      E S++ ++ H N+
Sbjct: 22  KYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNI 81
Query: 167 VKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRV---QIIKGVAQGLLYL 223
           V L+     +    L++E+M  K L   L D  K  + D + ++   Q+++GVA    + 
Sbjct: 82  VSLIDVIHSERCLTLVFEFM-EKDLKKVL-DENKTGLQDSQIKIYLYQLLRGVA----HC 135
Query: 224 HQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYM 283
           HQ+   RI+HRDLK  N+L++ D   K++DFG+AR  FG      ++  T  +  T  Y 
Sbjct: 136 HQH---RILHRDLKPQNLLINSDGALKLADFGLAR-AFG----IPVRSYTHEVV-TLWYR 186
Query: 284 SPEYAL-EGIFSIKSDVFSFGVLLLEIVSGK 313
           +P+  +    +S   D++S G +  E+++GK
Sbjct: 187 APDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 118/267 (44%), Gaps = 31/267 (11%)
Query: 107 ATGNFSAANKLGEGGFGTVYKGVIGQGE--IAVKRL----LGKSGQEIKELKNEASVIAQ 160
           A  +F     LG+G FG VY     Q +  +A+K L    L K+G E  +L+ E  + + 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 64
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           ++H N+++L G   +     LI EY P   L     +  K    D +     I  +A  L
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR---IS 277
            Y H     R+IHRD+K  N+LL      KI+DFG +           +   +SR   + 
Sbjct: 122 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-----------VHAPSSRRTXLC 167
Query: 278 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK----NTGFYRTKSLNLIGYAWDL 333
           GT  Y+ PE     +   K D++S GVL  E + GK     NT     K ++ + + +  
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD 227
Query: 334 WISNKIIDLIDSVLEEASFNESLSRYV 360
           +++    DLI  +L+       + R V
Sbjct: 228 FVTEGARDLISRLLKHNPSQRPMLREV 254

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 118/267 (44%), Gaps = 31/267 (11%)
Query: 107 ATGNFSAANKLGEGGFGTVYKGVIGQGE--IAVKRL----LGKSGQEIKELKNEASVIAQ 160
           A  +F     LG+G FG VY     Q +  +A+K L    L K+G E  +L+ E  + + 
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 68
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           ++H N+++L G   +     LI EY P   L     +  K    D +     I  +A  L
Sbjct: 69  LRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANAL 125
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR---IS 277
            Y H     R+IHRD+K  N+LL      KI+DFG +           +   +SR   + 
Sbjct: 126 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-----------VHAPSSRRTTLC 171
Query: 278 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK----NTGFYRTKSLNLIGYAWDL 333
           GT  Y+ PE     +   K D++S GVL  E + GK     NT     K ++ + + +  
Sbjct: 172 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD 231
Query: 334 WISNKIIDLIDSVLEEASFNESLSRYV 360
           +++    DLI  +L+       + R V
Sbjct: 232 FVTEGARDLISRLLKHNPSQRPMLREV 258

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 104/205 (50%), Gaps = 20/205 (9%)
Query: 117 LGEGGFGTVYKG--VIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCI 174
           LG+G +G VY G  +  Q  IA+K +  +  +  + L  E ++   ++HKN+V+ LG   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 175 EKDERLLIYEYMPNKSLDCFL---FDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRI 231
           E     +  E +P  SL   L   + P K    + +T     K + +GL YLH     +I
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKWGPLKD---NEQTIGFYTKQILEGLKYLHDN---QI 143
Query: 232 IHRDLKASNILLDKDMNS-KISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE 290
           +HRD+K  N+L++      KISDFG ++ + G N        T   +GT  YM+PE   +
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP------CTETFTGTLQYMAPEIIDK 197
Query: 291 GI--FSIKSDVFSFGVLLLEIVSGK 313
           G   +   +D++S G  ++E+ +GK
Sbjct: 198 GPRGYGKAADIWSLGCTIIEMATGK 222

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 116/267 (43%), Gaps = 31/267 (11%)
Query: 107 ATGNFSAANKLGEGGFGTVY------KGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQ 160
           A  +F     LG+G FG VY      +  I   ++  K  L K+G E  +L+ E  + + 
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 61
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           ++H N+++L G   +     LI EY P   L     +  K    D +     I  +A  L
Sbjct: 62  LRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANAL 118
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR---IS 277
            Y H     R+IHRD+K  N+LL      KI+DFG +           +   +SR   + 
Sbjct: 119 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-----------VHAPSSRRTTLC 164
Query: 278 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK----NTGFYRTKSLNLIGYAWDL 333
           GT  Y+ PE     +   K D++S GVL  E + GK     NT     K ++ + + +  
Sbjct: 165 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD 224
Query: 334 WISNKIIDLIDSVLEEASFNESLSRYV 360
           +++    DLI  +L+       + R V
Sbjct: 225 FVTEGARDLISRLLKHNPSQRPMLREV 251

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 119/267 (44%), Gaps = 31/267 (11%)
Query: 107 ATGNFSAANKLGEGGFGTVYKGVIGQGE--IAVKRL----LGKSGQEIKELKNEASVIAQ 160
           A  +F     LG+G FG VY     Q +  +A+K L    L K+G E  +L+ E  + + 
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 69
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           ++H N+++L G   +     LI EY P   +   L   +K    D +     I  +A  L
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK---FDEQRTATYITELANAL 126
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR---IS 277
            Y H     R+IHRD+K  N+LL      KI+DFG +           +   +SR   + 
Sbjct: 127 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-----------VHAPSSRRXXLX 172
Query: 278 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK----NTGFYRTKSLNLIGYAWDL 333
           GT  Y+ PE     +   K D++S GVL  E + GK     NT     K ++ + + +  
Sbjct: 173 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD 232
Query: 334 WISNKIIDLIDSVLEEASFNESLSRYV 360
           +++    DLI  +L+       + R V
Sbjct: 233 FVTEGARDLISRLLKHNPSQRPMLREV 259

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 119/267 (44%), Gaps = 31/267 (11%)
Query: 107 ATGNFSAANKLGEGGFGTVYKGVIGQGE--IAVKRL----LGKSGQEIKELKNEASVIAQ 160
           A  +F     LG+G FG VY     Q +  +A+K L    L K+G E  +L+ E  + + 
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 69
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           ++H N+++L G   +     LI EY P   +   L   +K    D +     I  +A  L
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK---FDEQRTATYITELANAL 126
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR---IS 277
            Y H     R+IHRD+K  N+LL      KI+DFG +           +   +SR   + 
Sbjct: 127 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-----------VHAPSSRRTTLC 172
Query: 278 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK----NTGFYRTKSLNLIGYAWDL 333
           GT  Y+ PE     +   K D++S GVL  E + GK     NT     K ++ + + +  
Sbjct: 173 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD 232
Query: 334 WISNKIIDLIDSVLEEASFNESLSRYV 360
           +++    DLI  +L+       + R V
Sbjct: 233 FVTEGARDLISRLLKHNPSQRPMLREV 259

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 118/267 (44%), Gaps = 31/267 (11%)
Query: 107 ATGNFSAANKLGEGGFGTVYKGVIGQGE--IAVKRL----LGKSGQEIKELKNEASVIAQ 160
           A  +F     LG+G FG VY     Q +  +A+K L    L K+G E  +L+ E  + + 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 64
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           ++H N+++L G   +     LI EY P   L     +  K    D +     I  +A  L
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR---IS 277
            Y H     R+IHRD+K  N+LL      KI+DFG +           +   +SR   + 
Sbjct: 122 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-----------VHAPSSRRXXLC 167
Query: 278 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK----NTGFYRTKSLNLIGYAWDL 333
           GT  Y+ PE     +   K D++S GVL  E + GK     NT     K ++ + + +  
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD 227
Query: 334 WISNKIIDLIDSVLEEASFNESLSRYV 360
           +++    DLI  +L+       + R V
Sbjct: 228 FVTEGARDLISRLLKHNPSQRPMLREV 254

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/247 (27%), Positives = 121/247 (48%), Gaps = 38/247 (15%)
Query: 90  EKEVDQFPLFSFSSVSSATGNFSAANKLGEGGFGTVYKG-VIGQGE--------IAVKRL 140
           E E+ + P + F          +    LGEG FG V     +G  +        +AVK L
Sbjct: 21  EYELPEDPKWEFPR-----DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML 75
Query: 141 LGKSGQ-EIKELKNEASVIAQV-QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFL--- 195
              + + ++ +L +E  ++  + +HKN++ LLG C +     +I EY    +L  +L   
Sbjct: 76  KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRAR 135
Query: 196 ----------FDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDK 245
                      +    E + ++  V     +A+G+ YL   +  + IHRDL A N+L+ +
Sbjct: 136 RPPGMEXSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTE 192
Query: 246 DMNSKISDFGMARIVFGGNDEDELQGNTS-RISGTYGYMSPEYALEGIFSIKSDVFSFGV 304
           +   KI+DFG+AR +   N+ D  +  T+ R+     +M+PE   + +++ +SDV+SFGV
Sbjct: 193 NNVMKIADFGLARDI---NNIDXXKKTTNGRLP--VKWMAPEALFDRVYTHQSDVWSFGV 247
Query: 305 LLLEIVS 311
           L+ EI +
Sbjct: 248 LMWEIFT 254

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 68/247 (27%), Positives = 121/247 (48%), Gaps = 38/247 (15%)
Query: 90  EKEVDQFPLFSFSSVSSATGNFSAANKLGEGGFGTVYKG-VIGQGE--------IAVKRL 140
           E E+ + P + F          +    LGEG FG V     +G  +        +AVK L
Sbjct: 21  EYELPEDPKWEFPR-----DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML 75
Query: 141 LGKSGQ-EIKELKNEASVIAQV-QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFL--- 195
              + + ++ +L +E  ++  + +HKN++ LLG C +     +I EY    +L  +L   
Sbjct: 76  KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRAR 135
Query: 196 ----------FDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDK 245
                      +    E + ++  V     +A+G+ YL   +  + IHRDL A N+L+ +
Sbjct: 136 RPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTE 192
Query: 246 DMNSKISDFGMARIVFGGNDEDELQGNTS-RISGTYGYMSPEYALEGIFSIKSDVFSFGV 304
           +   KI+DFG+AR +   N+ D  +  T+ R+     +M+PE   + +++ +SDV+SFGV
Sbjct: 193 NNVMKIADFGLARDI---NNIDXXKKTTNGRLP--VKWMAPEALFDRVYTHQSDVWSFGV 247
Query: 305 LLLEIVS 311
           L+ EI +
Sbjct: 248 LMWEIFT 254

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 100/215 (46%), Gaps = 30/215 (13%)
Query: 109 GNFSAANKLGEGGFGTV--YKGVIGQGEIAVKRLLGKS---GQEIKELKNEASVIAQVQH 163
           GN+     +G+G F  V   + ++   E+AV R++ K+      +++L  E  ++  + H
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKEVAV-RIIDKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 164 KNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYL 223
            N+VKL      +    L+ EY     +  +L    + +  + R + + I    Q   Y 
Sbjct: 73  PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ---YC 129
Query: 224 HQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYM 283
           HQ     I+HRDLKA N+LLD DMN KI+DFG +     GN  D   G            
Sbjct: 130 HQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCG------------ 174
Query: 284 SPEYALEGIFSIKS------DVFSFGVLLLEIVSG 312
           SP YA   +F  K       DV+S GV+L  +VSG
Sbjct: 175 SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 104/205 (50%), Gaps = 20/205 (9%)
Query: 117 LGEGGFGTVYKG--VIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCI 174
           LG+G +G VY G  +  Q  IA+K +  +  +  + L  E ++   ++HKN+V+ LG   
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 75
Query: 175 EKDERLLIYEYMPNKSLDCFL---FDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRI 231
           E     +  E +P  SL   L   + P K    + +T     K + +GL YLH     +I
Sbjct: 76  ENGFIKIFMEQVPGGSLSALLRSKWGPLKD---NEQTIGFYTKQILEGLKYLHDN---QI 129
Query: 232 IHRDLKASNILLDKDMNS-KISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE 290
           +HRD+K  N+L++      KISDFG ++ + G N        T   +GT  YM+PE   +
Sbjct: 130 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP------CTETFTGTLQYMAPEIIDK 183
Query: 291 GI--FSIKSDVFSFGVLLLEIVSGK 313
           G   +   +D++S G  ++E+ +GK
Sbjct: 184 GPRGYGKAADIWSLGCTIIEMATGK 208

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 68/247 (27%), Positives = 121/247 (48%), Gaps = 38/247 (15%)
Query: 90  EKEVDQFPLFSFSSVSSATGNFSAANKLGEGGFGTVYKG-VIGQGE--------IAVKRL 140
           E E+ + P + F          +    LGEG FG V     +G  +        +AVK L
Sbjct: 21  EYELPEDPKWEFPR-----DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML 75
Query: 141 LGKSGQ-EIKELKNEASVIAQV-QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFL--- 195
              + + ++ +L +E  ++  + +HKN++ LLG C +     +I EY    +L  +L   
Sbjct: 76  KDDATEKDLSDLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRAR 135
Query: 196 ----------FDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDK 245
                      +    E + ++  V     +A+G+ YL   +  + IHRDL A N+L+ +
Sbjct: 136 RPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTE 192
Query: 246 DMNSKISDFGMARIVFGGNDEDELQGNTS-RISGTYGYMSPEYALEGIFSIKSDVFSFGV 304
           +   KI+DFG+AR +   N+ D  +  T+ R+     +M+PE   + +++ +SDV+SFGV
Sbjct: 193 NNVMKIADFGLARDI---NNIDYYKKTTNGRLP--VKWMAPEALFDRVYTHQSDVWSFGV 247
Query: 305 LLLEIVS 311
           L+ EI +
Sbjct: 248 LMWEIFT 254

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 68/247 (27%), Positives = 121/247 (48%), Gaps = 38/247 (15%)
Query: 90  EKEVDQFPLFSFSSVSSATGNFSAANKLGEGGFGTVYKG-VIGQGE--------IAVKRL 140
           E E+ + P + F          +    LGEG FG V     +G  +        +AVK L
Sbjct: 21  EYELPEDPKWEFPR-----DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML 75
Query: 141 LGKSGQ-EIKELKNEASVIAQV-QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFL--- 195
              + + ++ +L +E  ++  + +HKN++ LLG C +     +I EY    +L  +L   
Sbjct: 76  KDDATEKDLSDLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRAR 135
Query: 196 ----------FDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDK 245
                      +    E + ++  V     +A+G+ YL   +  + IHRDL A N+L+ +
Sbjct: 136 RPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTE 192
Query: 246 DMNSKISDFGMARIVFGGNDEDELQGNTS-RISGTYGYMSPEYALEGIFSIKSDVFSFGV 304
           +   KI+DFG+AR +   N+ D  +  T+ R+     +M+PE   + +++ +SDV+SFGV
Sbjct: 193 NNVMKIADFGLARDI---NNIDYYKKTTNGRLP--VKWMAPEALFDRVYTHQSDVWSFGV 247
Query: 305 LLLEIVS 311
           L+ EI +
Sbjct: 248 LMWEIFT 254

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 74/267 (27%), Positives = 118/267 (44%), Gaps = 31/267 (11%)
Query: 107 ATGNFSAANKLGEGGFGTVYKGVIGQGE--IAVKRL----LGKSGQEIKELKNEASVIAQ 160
           A  +F     LG+G FG VY     Q +  +A+K L    L K+G E  +L+ E  + + 
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 66
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           ++H N+++L G   +     LI EY P   L     +  K    D +     I  +A  L
Sbjct: 67  LRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANAL 123
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR---IS 277
            Y H     R+IHRD+K  N+LL      KI++FG +           +   +SR   + 
Sbjct: 124 SYCHS---KRVIHRDIKPENLLLGSAGELKIANFGWS-----------VHAPSSRRTTLC 169
Query: 278 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK----NTGFYRTKSLNLIGYAWDL 333
           GT  Y+ PE     +   K D++S GVL  E + GK     NT     K ++ + + +  
Sbjct: 170 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD 229
Query: 334 WISNKIIDLIDSVLEEASFNESLSRYV 360
           +++    DLI  +L+       + R V
Sbjct: 230 FVTEGARDLISRLLKHNPSQRPMLREV 256

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 100/215 (46%), Gaps = 30/215 (13%)
Query: 109 GNFSAANKLGEGGFGTV--YKGVIGQGEIAVKRLLGKS---GQEIKELKNEASVIAQVQH 163
           GN+     +G+G F  V   + ++   E+AVK ++ K+      +++L  E  ++  + H
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKEVAVK-IIDKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 164 KNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYL 223
            N+VKL      +    L+ EY     +  +L    + +  + R + + I    Q   Y 
Sbjct: 73  PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ---YC 129
Query: 224 HQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYM 283
           HQ     I+HRDLKA N+LLD DMN KI+DFG +     GN  D   G            
Sbjct: 130 HQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCG------------ 174
Query: 284 SPEYALEGIFSIKS------DVFSFGVLLLEIVSG 312
           SP YA   +F  K       DV+S GV+L  +VSG
Sbjct: 175 SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 114/256 (44%), Gaps = 31/256 (12%)
Query: 107 ATGNFSAANKLGEGGFGTVYKGVIGQGE--IAVKRL----LGKSGQEIKELKNEASVIAQ 160
           A  +F     LG+G FG VY     Q +  +A+K L    L K+G E  +L+ E  + + 
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 69
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           ++H N+++L G   +     LI EY P   L     +  K    D +     I  +A  L
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANAL 126
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR---IS 277
            Y H     R+IHRD+K  N+LL      KI+DFG +           +   +SR   + 
Sbjct: 127 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-----------VHAPSSRRTTLC 172
Query: 278 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK----NTGFYRTKSLNLIGYAWDL 333
           GT  Y+ PE         K D++S GVL  E + GK     NT     K ++ + + +  
Sbjct: 173 GTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD 232
Query: 334 WISNKIIDLIDSVLEE 349
           +++    DLI  +L+ 
Sbjct: 233 FVTEGARDLISRLLKH 248

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 100/215 (46%), Gaps = 30/215 (13%)
Query: 109 GNFSAANKLGEGGFGTV--YKGVIGQGEIAVKRLLGKS---GQEIKELKNEASVIAQVQH 163
           GN+     +G+G F  V   + ++   E+AVK ++ K+      +++L  E  ++  + H
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKEVAVK-IIDKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 164 KNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYL 223
            N+VKL      +    L+ EY     +  +L    + +  + R + + I    Q   Y 
Sbjct: 73  PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ---YC 129
Query: 224 HQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYM 283
           HQ     I+HRDLKA N+LLD DMN KI+DFG +     GN  D   G            
Sbjct: 130 HQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCG------------ 174
Query: 284 SPEYALEGIFSIKS------DVFSFGVLLLEIVSG 312
           SP YA   +F  K       DV+S GV+L  +VSG
Sbjct: 175 SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 106/209 (50%), Gaps = 16/209 (7%)
Query: 110 NFSAANKLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNL 166
           ++     LGEG +G V   V  + +  +AVK +  K   +  E +K E  + A + H+N+
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENV 67
Query: 167 VKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQ-IIKGVAQGLLYLHQ 225
           VK  G   E + + L  EY     L    FD  + +I       Q     +  G++YLH 
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
              + I HRD+K  N+LLD+  N KISDFG+A  VF  N+ + L    +++ GT  Y++P
Sbjct: 124 ---IGITHRDIKPENLLLDERDNLKISDFGLA-TVFRYNNRERL---LNKMCGTLPYVAP 176
Query: 286 EYALEGIFSIKS-DVFSFGVLLLEIVSGK 313
           E      F  +  DV+S G++L  +++G+
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 68/247 (27%), Positives = 121/247 (48%), Gaps = 38/247 (15%)
Query: 90  EKEVDQFPLFSFSSVSSATGNFSAANKLGEGGFGTVYKG-VIGQGE--------IAVKRL 140
           E E+ + P + F          +    LGEG FG V     +G  +        +AVK L
Sbjct: 67  EYELPEDPKWEFPR-----DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML 121
Query: 141 LGKSGQ-EIKELKNEASVIAQV-QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFL--- 195
              + + ++ +L +E  ++  + +HKN++ LLG C +     +I EY    +L  +L   
Sbjct: 122 KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRAR 181
Query: 196 ----------FDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDK 245
                      +    E + ++  V     +A+G+ YL   +  + IHRDL A N+L+ +
Sbjct: 182 RPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTE 238
Query: 246 DMNSKISDFGMARIVFGGNDEDELQGNTS-RISGTYGYMSPEYALEGIFSIKSDVFSFGV 304
           +   KI+DFG+AR +   N+ D  +  T+ R+     +M+PE   + +++ +SDV+SFGV
Sbjct: 239 NNVMKIADFGLARDI---NNIDYYKKTTNGRLP--VKWMAPEALFDRVYTHQSDVWSFGV 293
Query: 305 LLLEIVS 311
           L+ EI +
Sbjct: 294 LMWEIFT 300

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/267 (27%), Positives = 118/267 (44%), Gaps = 31/267 (11%)
Query: 107 ATGNFSAANKLGEGGFGTVYKGVIGQGE--IAVKRL----LGKSGQEIKELKNEASVIAQ 160
           A  +F     LG+G FG VY     Q +  +A+K L    L K+G E  +L+ E  + + 
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 67
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           ++H N+++L G   +     LI EY P   L     +  K    D +     I  +A  L
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANAL 124
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR---IS 277
            Y H     R+IHRD+K  N+LL      KI++FG +           +   +SR   + 
Sbjct: 125 SYCHS---KRVIHRDIKPENLLLGSAGELKIANFGWS-----------VHAPSSRRTTLC 170
Query: 278 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK----NTGFYRTKSLNLIGYAWDL 333
           GT  Y+ PE     +   K D++S GVL  E + GK     NT     K ++ + + +  
Sbjct: 171 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD 230
Query: 334 WISNKIIDLIDSVLEEASFNESLSRYV 360
           +++    DLI  +L+       + R V
Sbjct: 231 FVTEGARDLISRLLKHNPSQRPMLREV 257

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/247 (27%), Positives = 121/247 (48%), Gaps = 38/247 (15%)
Query: 90  EKEVDQFPLFSFSSVSSATGNFSAANKLGEGGFGTVYKG-VIGQGE--------IAVKRL 140
           E E+ + P + F          +    LGEG FG V     +G  +        +AVK L
Sbjct: 13  EYELPEDPKWEFPR-----DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML 67
Query: 141 LGKSGQ-EIKELKNEASVIAQV-QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFL--- 195
              + + ++ +L +E  ++  + +HKN++ LLG C +     +I EY    +L  +L   
Sbjct: 68  KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRAR 127
Query: 196 ----------FDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDK 245
                      +    E + ++  V     +A+G+ YL   +  + IHRDL A N+L+ +
Sbjct: 128 RPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTE 184
Query: 246 DMNSKISDFGMARIVFGGNDEDELQGNTS-RISGTYGYMSPEYALEGIFSIKSDVFSFGV 304
           +   KI+DFG+AR +   N+ D  +  T+ R+     +M+PE   + +++ +SDV+SFGV
Sbjct: 185 NNVMKIADFGLARDI---NNIDYYKKTTNGRLP--VKWMAPEALFDRVYTHQSDVWSFGV 239
Query: 305 LLLEIVS 311
           L+ EI +
Sbjct: 240 LMWEIFT 246

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/247 (27%), Positives = 121/247 (48%), Gaps = 38/247 (15%)
Query: 90  EKEVDQFPLFSFSSVSSATGNFSAANKLGEGGFGTVYKG-VIGQGE--------IAVKRL 140
           E E+ + P + F          +    LGEG FG V     +G  +        +AVK L
Sbjct: 8   EYELPEDPKWEFPR-----DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML 62
Query: 141 LGKSGQ-EIKELKNEASVIAQV-QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFL--- 195
              + + ++ +L +E  ++  + +HKN++ LLG C +     +I EY    +L  +L   
Sbjct: 63  KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRAR 122
Query: 196 ----------FDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDK 245
                      +    E + ++  V     +A+G+ YL   +  + IHRDL A N+L+ +
Sbjct: 123 RPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLTARNVLVTE 179
Query: 246 DMNSKISDFGMARIVFGGNDEDELQGNTS-RISGTYGYMSPEYALEGIFSIKSDVFSFGV 304
           +   KI+DFG+AR +   N+ D  +  T+ R+     +M+PE   + +++ +SDV+SFGV
Sbjct: 180 NNVMKIADFGLARDI---NNIDYYKKTTNGRLP--VKWMAPEALFDRVYTHQSDVWSFGV 234
Query: 305 LLLEIVS 311
           L+ EI +
Sbjct: 235 LMWEIFT 241

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/247 (27%), Positives = 121/247 (48%), Gaps = 38/247 (15%)
Query: 90  EKEVDQFPLFSFSSVSSATGNFSAANKLGEGGFGTVYKG-VIGQGE--------IAVKRL 140
           E E+ + P + F          +    LGEG FG V     +G  +        +AVK L
Sbjct: 21  EYELPEDPKWEFPR-----DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML 75
Query: 141 LGKSGQ-EIKELKNEASVIAQV-QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFL--- 195
              + + ++ +L +E  ++  + +HKN++ LLG C +     +I EY    +L  +L   
Sbjct: 76  KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRAR 135
Query: 196 ----------FDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDK 245
                      +    E + ++  V     +A+G+ YL   +  + IHRDL A N+L+ +
Sbjct: 136 RPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTE 192
Query: 246 DMNSKISDFGMARIVFGGNDEDELQGNTS-RISGTYGYMSPEYALEGIFSIKSDVFSFGV 304
           +   +I+DFG+AR +   N+ D  +  T+ R+     +M+PE   + +++ +SDV+SFGV
Sbjct: 193 NNVMRIADFGLARDI---NNIDYYKKTTNGRLP--VKWMAPEALFDRVYTHQSDVWSFGV 247
Query: 305 LLLEIVS 311
           L+ EI +
Sbjct: 248 LMWEIFT 254

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 102/222 (45%), Gaps = 30/222 (13%)
Query: 102 SSVSSATGNFSAANKLGEGGFGTV--YKGVIGQGEIAVKRLLGKS---GQEIKELKNEAS 156
           S      GN+     +G+G F  V   + ++   E+A+K ++ K+      +++L  E  
Sbjct: 5   SDEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIK-IIDKTQLNPTSLQKLFREVR 63
Query: 157 VIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGV 216
           ++  + H N+VKL      +    LI EY     +  +L    + +  + R++ + I   
Sbjct: 64  IMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSA 123
Query: 217 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRI 276
            Q   Y HQ    RI+HRDLKA N+LLD DMN KI+DFG +     G   D   G     
Sbjct: 124 VQ---YCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCG----- 172
Query: 277 SGTYGYMSPEYALEGIFSIKS------DVFSFGVLLLEIVSG 312
                  SP YA   +F  K       DV+S GV+L  +VSG
Sbjct: 173 -------SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 207

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/247 (27%), Positives = 121/247 (48%), Gaps = 38/247 (15%)
Query: 90  EKEVDQFPLFSFSSVSSATGNFSAANKLGEGGFGTVYKG-VIGQGE--------IAVKRL 140
           E E+ + P + F          +    LGEG FG V     +G  +        +AVK L
Sbjct: 10  EYELPEDPKWEFPR-----DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML 64
Query: 141 LGKSGQ-EIKELKNEASVIAQV-QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFL--- 195
              + + ++ +L +E  ++  + +HKN++ LLG C +     +I EY    +L  +L   
Sbjct: 65  KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRAR 124
Query: 196 ----------FDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDK 245
                      +    E + ++  V     +A+G+ YL   +  + IHRDL A N+L+ +
Sbjct: 125 RPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTE 181
Query: 246 DMNSKISDFGMARIVFGGNDEDELQGNTS-RISGTYGYMSPEYALEGIFSIKSDVFSFGV 304
           +   KI+DFG+AR +   N+ D  +  T+ R+     +M+PE   + +++ +SDV+SFGV
Sbjct: 182 NNVMKIADFGLARDI---NNIDYYKKTTNGRLP--VKWMAPEALFDRVYTHQSDVWSFGV 236
Query: 305 LLLEIVS 311
           L+ EI +
Sbjct: 237 LMWEIFT 243

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 109/210 (51%), Gaps = 33/210 (15%)
Query: 117 LGEGGFGTVYKGV-IGQGE-----IAVKRLLGKSG-QEIKELKNEASVIAQVQHKNLVKL 169
           LG G FGTV+KGV I +GE     + +K +  KSG Q  + + +    I  + H ++V+L
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 170 LGCCIEKDERLLIYEYMPNKSLDCFLFDPTKRE--------ILDWRTRVQIIKGVAQGLL 221
           LG C     +L + +Y+P  SL     D  ++         +L+W  ++      A+G+ 
Sbjct: 81  LGLCPGSSLQL-VTQYLPLGSL----LDHVRQHRGALGPQLLLNWGVQI------AKGMY 129
Query: 222 YLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYG 281
           YL ++    ++HR+L A N+LL      +++DFG+A ++      D+ Q   S       
Sbjct: 130 YLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL----PPDDKQLLYSEAKTPIK 182
Query: 282 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
           +M+ E    G ++ +SDV+S+GV + E+++
Sbjct: 183 WMALESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 109/210 (51%), Gaps = 33/210 (15%)
Query: 117 LGEGGFGTVYKGV-IGQGE-----IAVKRLLGKSG-QEIKELKNEASVIAQVQHKNLVKL 169
           LG G FGTV+KGV I +GE     + +K +  KSG Q  + + +    I  + H ++V+L
Sbjct: 39  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 98
Query: 170 LGCCIEKDERLLIYEYMPNKSLDCFLFDPTKRE--------ILDWRTRVQIIKGVAQGLL 221
           LG C     +L + +Y+P  SL     D  ++         +L+W  ++      A+G+ 
Sbjct: 99  LGLCPGSSLQL-VTQYLPLGSL----LDHVRQHRGALGPQLLLNWGVQI------AKGMY 147
Query: 222 YLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYG 281
           YL ++    ++HR+L A N+LL      +++DFG+A ++      D+ Q   S       
Sbjct: 148 YLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL----PPDDKQLLYSEAKTPIK 200
Query: 282 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
           +M+ E    G ++ +SDV+S+GV + E+++
Sbjct: 201 WMALESIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 100/215 (46%), Gaps = 30/215 (13%)
Query: 109 GNFSAANKLGEGGFGTV--YKGVIGQGEIAVKRLLGKS---GQEIKELKNEASVIAQVQH 163
           GN+     +G+G F  V   + ++   E+AVK ++ K+      +++L  E  ++  + H
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKEVAVK-IIDKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 164 KNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYL 223
            N+VKL      +    L+ EY     +  +L    + +  + R + + I    Q   Y 
Sbjct: 73  PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ---YC 129
Query: 224 HQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYM 283
           HQ     I+HRDLKA N+LLD DMN KI+DFG +     GN  D   G            
Sbjct: 130 HQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCG------------ 174
Query: 284 SPEYALEGIFSIKS------DVFSFGVLLLEIVSG 312
           +P YA   +F  K       DV+S GV+L  +VSG
Sbjct: 175 APPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 113/224 (50%), Gaps = 35/224 (15%)
Query: 106 SATGNFSAANKLGEGGFGTVYKGV-------IGQGEIAVKRLLGKSGQEIKELKNEASVI 158
           S++  F    KLG G + TVYKG+       +   E+ +    G     I+E+    S++
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREI----SLM 57
Query: 159 AQVQHKNLVKLLGCCIEKDERLLIYEYMPN---KSLDCFLFDPTKREILDWRTRVQIIK- 214
            +++H+N+V+L      +++  L++E+M N   K +D      T R +      + ++K 
Sbjct: 58  KELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGL-----ELNLVKY 112
Query: 215 ---GVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQG 271
               + QGL + H+    +I+HRDLK  N+L++K    K+ DFG+AR  FG      +  
Sbjct: 113 FQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLAR-AFG------IPV 162
Query: 272 NT-SRISGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGK 313
           NT S    T  Y +P+  +    +S   D++S G +L E+++GK
Sbjct: 163 NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 103/210 (49%), Gaps = 20/210 (9%)
Query: 109 GNFSAANKLGEGGFGTV--YKGVIGQGEIAVKRLLGKS---GQEIKELKNEASVIAQVQH 163
           GN+     +G+G F  V   + ++   E+A+K ++ K+      +++L  E  ++  + H
Sbjct: 15  GNYRLLKTIGKGNFAKVKLARHILTGREVAIK-IIDKTQLNPTSLQKLFREVRIMKILNH 73
Query: 164 KNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYL 223
            N+VKL      +    LI EY     +  +L    + +  + R++ + I    Q   Y 
Sbjct: 74  PNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ---YC 130
Query: 224 HQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYM 283
           HQ    RI+HRDLKA N+LLD DMN KI+DFG +       +E  + G      G   Y 
Sbjct: 131 HQK---RIVHRDLKAENLLLDADMNIKIADFGFS-------NEFTVGGKLDAFCGAPPYA 180
Query: 284 SPE-YALEGIFSIKSDVFSFGVLLLEIVSG 312
           +PE +  +     + DV+S GV+L  +VSG
Sbjct: 181 APELFQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 134/278 (48%), Gaps = 16/278 (5%)
Query: 115 NKLGEGGFGTV---YKGVIGQGE---IAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
           ++LG+G FG+V       +G      +AVK+L      + ++ + E  ++  +    +VK
Sbjct: 13  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 72
Query: 169 LLGCCIE--KDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQY 226
             G      + E  L+ EY+P+  L  FL     R  LD    +     + +G+ YL   
Sbjct: 73  YRGVSYGPGRPELRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLG-- 128
Query: 227 SRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPE 286
           SR R +HRDL A NIL++ + + KI+DFG+A+++    D+D         S  + Y +PE
Sbjct: 129 SR-RCVHRDLAARNILVESEAHVKIADFGLAKLL--PLDKDXXVVREPGQSPIFWY-APE 184
Query: 287 YALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSV 346
              + IFS +SDV+SFGV+L E+ +    +     + L ++G   D+    ++++L++  
Sbjct: 185 SLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALCRLLELLEEG 244
Query: 347 LEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML 384
               +     +    +  LC     +DRP+ S +   L
Sbjct: 245 QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQL 282

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/247 (27%), Positives = 120/247 (48%), Gaps = 38/247 (15%)
Query: 90  EKEVDQFPLFSFSSVSSATGNFSAANKLGEGGFGTVYKG-VIGQGE--------IAVKRL 140
           E E+ + P + F          +    LGEG FG V     +G  +        +AVK L
Sbjct: 21  EYELPEDPKWEFPR-----DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML 75
Query: 141 LGKSGQ-EIKELKNEASVIAQV-QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFL--- 195
              + + ++ +L +E  ++  + +HKN++ LLG C +     +I  Y    +L  +L   
Sbjct: 76  KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRAR 135
Query: 196 ----------FDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDK 245
                      +    E + ++  V     +A+G+ YL   +  + IHRDL A N+L+ +
Sbjct: 136 RPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTE 192
Query: 246 DMNSKISDFGMARIVFGGNDEDELQGNTS-RISGTYGYMSPEYALEGIFSIKSDVFSFGV 304
           +   KI+DFG+AR +   N+ D  +  T+ R+     +M+PE   + +++ +SDV+SFGV
Sbjct: 193 NNVMKIADFGLARDI---NNIDYYKKTTNGRLP--VKWMAPEALFDRVYTHQSDVWSFGV 247
Query: 305 LLLEIVS 311
           L+ EI +
Sbjct: 248 LMWEIFT 254

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 72/267 (26%), Positives = 115/267 (43%), Gaps = 31/267 (11%)
Query: 107 ATGNFSAANKLGEGGFGTVY------KGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQ 160
           A  +F     LG+G FG VY         I   ++  K  L K+G E  +L+ E  + + 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 64
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           ++H N+++L G   +     LI EY P   L     +  K    D +     I  +A  L
Sbjct: 65  LRHPNILRLYGYFHDSTRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR---IS 277
            Y H     ++IHRD+K  N+LL      KI+DFG +           +   +SR   + 
Sbjct: 122 SYCHS---KKVIHRDIKPENLLLGSAGELKIADFGWS-----------VHAPSSRRAALC 167
Query: 278 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK----NTGFYRTKSLNLIGYAWDL 333
           GT  Y+ PE     +   K D++S GVL  E + GK     NT     K ++ + + +  
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTFPD 227
Query: 334 WISNKIIDLIDSVLEEASFNESLSRYV 360
           +++    DLI  +L+       + R V
Sbjct: 228 FVTEGARDLISRLLKHNPSQRPMLREV 254

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 99/215 (46%), Gaps = 30/215 (13%)
Query: 109 GNFSAANKLGEGGFGTV--YKGVIGQGEIAVKRLLGKS---GQEIKELKNEASVIAQVQH 163
           GN+     +G+G F  V   + ++   E+AVK ++ K+      +++L  E  ++  + H
Sbjct: 7   GNYRLLKTIGKGNFAKVKLARHILTGKEVAVK-IIDKTQLNSSSLQKLFREVRIMKVLNH 65
Query: 164 KNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYL 223
            N+VKL      +    L+ EY     +  +L      +  + R + + I    Q   Y 
Sbjct: 66  PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQ---YC 122
Query: 224 HQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYM 283
           HQ     I+HRDLKA N+LLD DMN KI+DFG +     GN  D   G            
Sbjct: 123 HQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCG------------ 167
Query: 284 SPEYALEGIFSIKS------DVFSFGVLLLEIVSG 312
           SP YA   +F  K       DV+S GV+L  +VSG
Sbjct: 168 SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 202

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 106/209 (50%), Gaps = 16/209 (7%)
Query: 110 NFSAANKLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNL 166
           ++     LGEG +G V   V  + +  +AVK +  K   +  E +K E  +   + H+N+
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 167 VKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREI-LDWRTRVQIIKGVAQGLLYLHQ 225
           VK  G   E + + L  EY     L    FD  + +I +      +    +  G++YLH 
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
              + I HRD+K  N+LLD+  N KISDFG+A  VF  N+ + L    +++ GT  Y++P
Sbjct: 124 ---IGITHRDIKPENLLLDERDNLKISDFGLA-TVFRYNNRERL---LNKMCGTLPYVAP 176
Query: 286 EYALEGIFSIKS-DVFSFGVLLLEIVSGK 313
           E      F  +  DV+S G++L  +++G+
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 106/209 (50%), Gaps = 16/209 (7%)
Query: 110 NFSAANKLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNL 166
           ++     LGEG +G V   V  + +  +AVK +  K   +  E +K E  +   + H+N+
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 167 VKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREI-LDWRTRVQIIKGVAQGLLYLHQ 225
           VK  G   E + + L  EY     L    FD  + +I +      +    +  G++YLH 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
              + I HRD+K  N+LLD+  N KISDFG+A  VF  N+ + L    +++ GT  Y++P
Sbjct: 123 ---IGITHRDIKPENLLLDERDNLKISDFGLA-TVFRYNNRERL---LNKMCGTLPYVAP 175
Query: 286 EYALEGIFSIKS-DVFSFGVLLLEIVSGK 313
           E      F  +  DV+S G++L  +++G+
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 106/209 (50%), Gaps = 16/209 (7%)
Query: 110 NFSAANKLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNL 166
           ++     LGEG +G V   V  + +  +AVK +  K   +  E +K E  +   + H+N+
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 167 VKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREI-LDWRTRVQIIKGVAQGLLYLHQ 225
           VK  G   E + + L  EY     L    FD  + +I +      +    +  G++YLH 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
              + I HRD+K  N+LLD+  N KISDFG+A  VF  N+ + L    +++ GT  Y++P
Sbjct: 123 ---IGITHRDIKPENLLLDERDNLKISDFGLA-TVFRYNNRERL---LNKMCGTLPYVAP 175
Query: 286 EYALEGIFSIKS-DVFSFGVLLLEIVSGK 313
           E      F  +  DV+S G++L  +++G+
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 106/209 (50%), Gaps = 16/209 (7%)
Query: 110 NFSAANKLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNL 166
           ++     LGEG +G V   V  + +  +AVK +  K   +  E +K E  +   + H+N+
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 167 VKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREI-LDWRTRVQIIKGVAQGLLYLHQ 225
           VK  G   E + + L  EY     L    FD  + +I +      +    +  G++YLH 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
              + I HRD+K  N+LLD+  N KISDFG+A  VF  N+ + L    +++ GT  Y++P
Sbjct: 123 ---IGITHRDIKPENLLLDERDNLKISDFGLA-TVFRYNNRERL---LNKMCGTLPYVAP 175
Query: 286 EYALEGIFSIKS-DVFSFGVLLLEIVSGK 313
           E      F  +  DV+S G++L  +++G+
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 106/209 (50%), Gaps = 16/209 (7%)
Query: 110 NFSAANKLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNL 166
           ++     LGEG +G V   V  + +  +AVK +  K   +  E +K E  +   + H+N+
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENV 66
Query: 167 VKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREI-LDWRTRVQIIKGVAQGLLYLHQ 225
           VK  G   E + + L  EY     L    FD  + +I +      +    +  G++YLH 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
              + I HRD+K  N+LLD+  N KISDFG+A  VF  N+ + L    +++ GT  Y++P
Sbjct: 123 ---IGITHRDIKPENLLLDERDNLKISDFGLA-TVFRYNNRERL---LNKMCGTLPYVAP 175
Query: 286 EYALEGIFSIKS-DVFSFGVLLLEIVSGK 313
           E      F  +  DV+S G++L  +++G+
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 106/209 (50%), Gaps = 16/209 (7%)
Query: 110 NFSAANKLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNL 166
           ++     LGEG +G V   V  + +  +AVK +  K   +  E +K E  +   + H+N+
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 167 VKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREI-LDWRTRVQIIKGVAQGLLYLHQ 225
           VK  G   E + + L  EY     L    FD  + +I +      +    +  G++YLH 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
              + I HRD+K  N+LLD+  N KISDFG+A  VF  N+ + L    +++ GT  Y++P
Sbjct: 123 ---IGITHRDIKPENLLLDERDNLKISDFGLA-TVFRYNNRERL---LNKMXGTLPYVAP 175
Query: 286 EYALEGIFSIKS-DVFSFGVLLLEIVSGK 313
           E      F  +  DV+S G++L  +++G+
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 106/209 (50%), Gaps = 16/209 (7%)
Query: 110 NFSAANKLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNL 166
           ++     LGEG +G V   V  + +  +AVK +  K   +  E +K E  +   + H+N+
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 167 VKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREI-LDWRTRVQIIKGVAQGLLYLHQ 225
           VK  G   E + + L  EY     L    FD  + +I +      +    +  G++YLH 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
              + I HRD+K  N+LLD+  N KISDFG+A  VF  N+ + L    +++ GT  Y++P
Sbjct: 123 ---IGITHRDIKPENLLLDERDNLKISDFGLA-TVFRYNNRERL---LNKMXGTLPYVAP 175
Query: 286 EYALEGIFSIKS-DVFSFGVLLLEIVSGK 313
           E      F  +  DV+S G++L  +++G+
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 106/209 (50%), Gaps = 16/209 (7%)
Query: 110 NFSAANKLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNL 166
           ++     LGEG +G V   V  + +  +AVK +  K   +  E +K E  +   + H+N+
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 167 VKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREI-LDWRTRVQIIKGVAQGLLYLHQ 225
           VK  G   E + + L  EY     L    FD  + +I +      +    +  G++YLH 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
              + I HRD+K  N+LLD+  N KISDFG+A  VF  N+ + L    +++ GT  Y++P
Sbjct: 123 ---IGITHRDIKPENLLLDERDNLKISDFGLA-TVFRYNNRERL---LNKMCGTLPYVAP 175
Query: 286 EYALEGIFSIKS-DVFSFGVLLLEIVSGK 313
           E      F  +  DV+S G++L  +++G+
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 106/209 (50%), Gaps = 16/209 (7%)
Query: 110 NFSAANKLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNL 166
           ++     LGEG +G V   V  + +  +AVK +  K   +  E +K E  +   + H+N+
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 167 VKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREI-LDWRTRVQIIKGVAQGLLYLHQ 225
           VK  G   E + + L  EY     L    FD  + +I +      +    +  G++YLH 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
              + I HRD+K  N+LLD+  N KISDFG+A  VF  N+ + L    +++ GT  Y++P
Sbjct: 123 ---IGITHRDIKPENLLLDERDNLKISDFGLA-TVFRYNNRERL---LNKMCGTLPYVAP 175
Query: 286 EYALEGIFSIKS-DVFSFGVLLLEIVSGK 313
           E      F  +  DV+S G++L  +++G+
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 106/209 (50%), Gaps = 16/209 (7%)
Query: 110 NFSAANKLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNL 166
           ++     LGEG +G V   V  + +  +AVK +  K   +  E +K E  +   + H+N+
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENV 66
Query: 167 VKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREI-LDWRTRVQIIKGVAQGLLYLHQ 225
           VK  G   E + + L  EY     L    FD  + +I +      +    +  G++YLH 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
              + I HRD+K  N+LLD+  N KISDFG+A  VF  N+ + L    +++ GT  Y++P
Sbjct: 123 ---IGITHRDIKPENLLLDERDNLKISDFGLA-TVFRYNNRERL---LNKMXGTLPYVAP 175
Query: 286 EYALEGIFSIKS-DVFSFGVLLLEIVSGK 313
           E      F  +  DV+S G++L  +++G+
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 78/297 (26%), Positives = 129/297 (43%), Gaps = 39/297 (13%)
Query: 109 GNFSAANKLGEGGFGTVYKG--VIGQGEIAVKRLLGKSGQEIKELKN---EASVIAQVQH 163
            NF    K+G G F  VY+   ++    +A+K++      + K   +   E  ++ Q+ H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 164 KNLVKLLGCCIEKDERLLIYEYMPNKSLDCFL--FDPTKREILD---WRTRVQIIKGVAQ 218
            N++K     IE +E  ++ E      L   +  F   KR I +   W+  VQ+   +  
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE- 150
Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
                H +SR R++HRD+K +N+ +      K+ D G+ R                 + G
Sbjct: 151 -----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA------AHSLVG 198
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNK 338
           T  YMSPE   E  ++ KSD++S G LL E+ + +  + FY  K +NL        +  K
Sbjct: 199 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ--SPFYGDK-MNLYS------LCKK 249
Query: 339 IIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVS----MLTNEASSL 391
           I       L    ++E L + V+   +C+    E RP ++ V      M    ASSL
Sbjct: 250 IEQCDYPPLPSDHYSEELRQLVN---MCINPDPEKRPDVTYVYDVAKRMHACTASSL 303

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 106/209 (50%), Gaps = 16/209 (7%)
Query: 110 NFSAANKLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNL 166
           ++     LGEG +G V   V  + +  +AVK +  K   +  E +K E  +   + H+N+
Sbjct: 6   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65
Query: 167 VKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREI-LDWRTRVQIIKGVAQGLLYLHQ 225
           VK  G   E + + L  EY     L    FD  + +I +      +    +  G++YLH 
Sbjct: 66  VKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
              + I HRD+K  N+LLD+  N KISDFG+A  VF  N+ + L    +++ GT  Y++P
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLA-TVFRYNNRERL---LNKMCGTLPYVAP 174
Query: 286 EYALEGIFSIKS-DVFSFGVLLLEIVSGK 313
           E      F  +  DV+S G++L  +++G+
Sbjct: 175 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 203

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 105/209 (50%), Gaps = 16/209 (7%)
Query: 110 NFSAANKLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNL 166
           ++     LGEG +G V   V  + +  +AVK +  K   +  E +K E  +   + H+N+
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 167 VKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQ-IIKGVAQGLLYLHQ 225
           VK  G   E + + L  EY     L    FD  + +I       Q     +  G++YLH 
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
              + I HRD+K  N+LLD+  N KISDFG+A  VF  N+ + L    +++ GT  Y++P
Sbjct: 124 ---IGITHRDIKPENLLLDERDNLKISDFGLA-TVFRYNNRERL---LNKMCGTLPYVAP 176
Query: 286 EYALEGIFSIKS-DVFSFGVLLLEIVSGK 313
           E      F  +  DV+S G++L  +++G+
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 105/209 (50%), Gaps = 16/209 (7%)
Query: 110 NFSAANKLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNL 166
           ++     LGEG +G V   V  + +  +AVK +  K   +  E +K E  +   + H+N+
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 167 VKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQ-IIKGVAQGLLYLHQ 225
           VK  G   E + + L  EY     L    FD  + +I       Q     +  G++YLH 
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
              + I HRD+K  N+LLD+  N KISDFG+A  VF  N+ + L    +++ GT  Y++P
Sbjct: 124 ---IGITHRDIKPENLLLDERDNLKISDFGLA-TVFRYNNRERL---LNKMCGTLPYVAP 176
Query: 286 EYALEGIFSIKS-DVFSFGVLLLEIVSGK 313
           E      F  +  DV+S G++L  +++G+
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 105/209 (50%), Gaps = 16/209 (7%)
Query: 110 NFSAANKLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNL 166
           ++     LGEG +G V   V  + +  +AVK +  K   +  E +K E  +   + H+N+
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 167 VKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQ-IIKGVAQGLLYLHQ 225
           VK  G   E + + L  EY     L    FD  + +I       Q     +  G++YLH 
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
              + I HRD+K  N+LLD+  N KISDFG+A  VF  N+ + L    +++ GT  Y++P
Sbjct: 124 ---IGITHRDIKPENLLLDERDNLKISDFGLA-TVFRYNNRERL---LNKMCGTLPYVAP 176
Query: 286 EYALEGIFSIKS-DVFSFGVLLLEIVSGK 313
           E      F  +  DV+S G++L  +++G+
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 105/209 (50%), Gaps = 16/209 (7%)
Query: 110 NFSAANKLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNL 166
           ++     LGEG +G V   V  + +  +AVK +  K   +  E +K E  +   + H+N+
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 167 VKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQ-IIKGVAQGLLYLHQ 225
           VK  G   E + + L  EY     L    FD  + +I       Q     +  G++YLH 
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
              + I HRD+K  N+LLD+  N KISDFG+A  VF  N+ + L    +++ GT  Y++P
Sbjct: 124 ---IGITHRDIKPENLLLDERDNLKISDFGLA-TVFRYNNRERL---LNKMCGTLPYVAP 176
Query: 286 EYALEGIFSIKS-DVFSFGVLLLEIVSGK 313
           E      F  +  DV+S G++L  +++G+
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 110/220 (50%), Gaps = 25/220 (11%)
Query: 107 ATGNFSAANKLGEGGFGTVYKGVI---GQGEIAVKRLLGKSGQEIKELKN--EASVIAQV 161
           A   +    ++GEG +G V+K      G   +A+KR+  ++G+E   L    E +V+  +
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 162 Q---HKNLVKLLGCCI----EKDERL-LIYEYMPNKSLDCFLFDPTKREILDWRTRVQII 213
           +   H N+V+L   C     +++ +L L++E++ ++ L  +L D      +   T   ++
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMM 126
Query: 214 KGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNT 273
             + +GL +LH +   R++HRDLK  NIL+      K++DFG+ARI          Q   
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY-------SFQMAL 176
Query: 274 SRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           + +  T  Y +PE  L+  ++   D++S G +  E+   K
Sbjct: 177 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 67/247 (27%), Positives = 120/247 (48%), Gaps = 38/247 (15%)
Query: 90  EKEVDQFPLFSFSSVSSATGNFSAANKLGEGGFGTVYKG-VIGQGE--------IAVKRL 140
           E E+ + P + F          +    LGEG FG V     +G  +        +AVK L
Sbjct: 21  EYELPEDPKWEFPR-----DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML 75
Query: 141 LGKSGQ-EIKELKNEASVIAQV-QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFL--- 195
              + + ++ +L +E  ++  + +HKN++ LLG C +     +I  Y    +L  +L   
Sbjct: 76  KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRAR 135
Query: 196 ----------FDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDK 245
                      +    E + ++  V     +A+G+ YL   +  + IHRDL A N+L+ +
Sbjct: 136 RPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTE 192
Query: 246 DMNSKISDFGMARIVFGGNDEDELQGNTS-RISGTYGYMSPEYALEGIFSIKSDVFSFGV 304
           +   KI+DFG+AR +   N+ D  +  T+ R+     +M+PE   + +++ +SDV+SFGV
Sbjct: 193 NNVMKIADFGLARDI---NNIDYYKKTTNGRLP--VKWMAPEALFDRVYTHQSDVWSFGV 247
Query: 305 LLLEIVS 311
           L+ EI +
Sbjct: 248 LMWEIFT 254

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 105/209 (50%), Gaps = 16/209 (7%)
Query: 110 NFSAANKLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNL 166
           ++     LGEG +G V   V  + +  +AVK +  K   +  E +K E  +   + H+N+
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 167 VKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQ-IIKGVAQGLLYLHQ 225
           VK  G   E + + L  EY     L    FD  + +I       Q     +  G++YLH 
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
              + I HRD+K  N+LLD+  N KISDFG+A  VF  N+ + L    +++ GT  Y++P
Sbjct: 124 ---IGITHRDIKPENLLLDERDNLKISDFGLA-TVFRYNNRERL---LNKMCGTLPYVAP 176
Query: 286 EYALEGIFSIKS-DVFSFGVLLLEIVSGK 313
           E      F  +  DV+S G++L  +++G+
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 106/209 (50%), Gaps = 16/209 (7%)
Query: 110 NFSAANKLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNL 166
           ++     LGEG +G V   V  + +  +AVK +  K   +  E +K E  +   + H+N+
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 167 VKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREI-LDWRTRVQIIKGVAQGLLYLHQ 225
           VK  G   E + + L  EY     L    FD  + +I +      +    +  G++YLH 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
              + I HRD+K  N+LLD+  N KISDFG+A  VF  N+ + L    +++ GT  Y++P
Sbjct: 123 ---IGITHRDIKPENLLLDERDNLKISDFGLA-TVFRYNNRERL---LNKMXGTLPYVAP 175
Query: 286 EYALEGIFSIKS-DVFSFGVLLLEIVSGK 313
           E      F  +  DV+S G++L  +++G+
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 105/209 (50%), Gaps = 16/209 (7%)
Query: 110 NFSAANKLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNL 166
           ++     LGEG +G V   V  + +  +AVK +  K   +  E +K E  +   + H+N+
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 167 VKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQ-IIKGVAQGLLYLHQ 225
           VK  G   E + + L  EY     L    FD  + +I       Q     +  G++YLH 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
              + I HRD+K  N+LLD+  N KISDFG+A  VF  N+ + L    +++ GT  Y++P
Sbjct: 123 ---IGITHRDIKPENLLLDERDNLKISDFGLA-TVFRYNNRERL---LNKMCGTLPYVAP 175
Query: 286 EYALEGIFSIKS-DVFSFGVLLLEIVSGK 313
           E      F  +  DV+S G++L  +++G+
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 132/278 (47%), Gaps = 16/278 (5%)
Query: 115 NKLGEGGFGTV---YKGVIGQGE---IAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
           ++LG+G FG+V       +G      +AVK+L      + ++ + E  ++  +    +VK
Sbjct: 16  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 75
Query: 169 LLGCCIEKDER--LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQY 226
             G       +   L+ EY+P+  L  FL     R  LD    +     + +G+ YL   
Sbjct: 76  YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL--- 130
Query: 227 SRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPE 286
              R +HRDL A NIL++ + + KI+DFG+A+++    D+D         S  + Y +PE
Sbjct: 131 GSRRCVHRDLAARNILVESEAHVKIADFGLAKLL--PLDKDYYVVREPGQSPIFWY-APE 187
Query: 287 YALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSV 346
              + IFS +SDV+SFGV+L E+ +    +     + L ++G   D+   +++++L++  
Sbjct: 188 SLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGSERDVPALSRLLELLEEG 247
Query: 347 LEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML 384
               +     +    +  LC     +DRP+ S +   L
Sbjct: 248 QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQL 285

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 106/209 (50%), Gaps = 16/209 (7%)
Query: 110 NFSAANKLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNL 166
           ++     LGEG +G V   V  + +  +AVK +  K   +  E +K E  +   + H+N+
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENV 67
Query: 167 VKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREI-LDWRTRVQIIKGVAQGLLYLHQ 225
           VK  G   E + + L  EY     L    FD  + +I +      +    +  G++YLH 
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
              + I HRD+K  N+LLD+  N KISDFG+A  VF  N+ + L    +++ GT  Y++P
Sbjct: 124 ---IGITHRDIKPENLLLDERDNLKISDFGLA-TVFRYNNRERL---LNKMXGTLPYVAP 176
Query: 286 EYALEGIFSIKS-DVFSFGVLLLEIVSGK 313
           E      F  +  DV+S G++L  +++G+
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 110/220 (50%), Gaps = 25/220 (11%)
Query: 107 ATGNFSAANKLGEGGFGTVYKGVI---GQGEIAVKRLLGKSGQEIKELKN--EASVIAQV 161
           A   +    ++GEG +G V+K      G   +A+KR+  ++G+E   L    E +V+  +
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 162 Q---HKNLVKLLGCCI----EKDERL-LIYEYMPNKSLDCFLFDPTKREILDWRTRVQII 213
           +   H N+V+L   C     +++ +L L++E++ ++ L  +L D      +   T   ++
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMM 126
Query: 214 KGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNT 273
             + +GL +LH +   R++HRDLK  NIL+      K++DFG+ARI          Q   
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY-------SFQMAL 176
Query: 274 SRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           + +  T  Y +PE  L+  ++   D++S G +  E+   K
Sbjct: 177 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 110/220 (50%), Gaps = 25/220 (11%)
Query: 107 ATGNFSAANKLGEGGFGTVYKGVI---GQGEIAVKRLLGKSGQEIKELKN--EASVIAQV 161
           A   +    ++GEG +G V+K      G   +A+KR+  ++G+E   L    E +V+  +
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 162 Q---HKNLVKLLGCCI----EKDERL-LIYEYMPNKSLDCFLFDPTKREILDWRTRVQII 213
           +   H N+V+L   C     +++ +L L++E++ ++ L  +L D      +   T   ++
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMM 126
Query: 214 KGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNT 273
             + +GL +LH +   R++HRDLK  NIL+      K++DFG+ARI          Q   
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY-------SFQMAL 176
Query: 274 SRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           + +  T  Y +PE  L+  ++   D++S G +  E+   K
Sbjct: 177 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 132/278 (47%), Gaps = 16/278 (5%)
Query: 115 NKLGEGGFGTV---YKGVIGQGE---IAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
           ++LG+G FG+V       +G      +AVK+L      + ++ + E  ++  +    +VK
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 169 LLGCCIEKDER--LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQY 226
             G       +   L+ EY+P+  L  FL     R  LD    +     + +G+ YL   
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL--- 143
Query: 227 SRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPE 286
              R +HRDL A NIL++ + + KI+DFG+A+++    D+D         S  + Y +PE
Sbjct: 144 GSRRCVHRDLAARNILVESEAHVKIADFGLAKLL--PLDKDYYVVREPGQSPIFWY-APE 200
Query: 287 YALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSV 346
              + IFS +SDV+SFGV+L E+ +    +     + L ++G   D+   +++++L++  
Sbjct: 201 SLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEG 260
Query: 347 LEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML 384
               +     +    +  LC     +DRP+ S +   L
Sbjct: 261 QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQL 298

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 97/212 (45%), Gaps = 27/212 (12%)
Query: 110 NFSAANKLGEGGFGTVYKGVIGQGE--IAVKRL----LGKSGQEIKELKNEASVIAQVQH 163
           +F     LG+G FG VY     Q +  +A+K L    L K+G E  +L+ E  + + ++H
Sbjct: 13  DFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVE-HQLRREVEIQSHLRH 71
Query: 164 KNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYL 223
            N+++L G   +     LI EY P   L     +  K    D +     I  +A  L Y 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSRFDEQRTATYITELANALSYC 128
Query: 224 HQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR---ISGTY 280
           H     R+IHRD+K  N+LL  +   KI+DFG +           +   +SR   + GT 
Sbjct: 129 HS---KRVIHRDIKPENLLLGSNGELKIADFGWS-----------VHAPSSRRTTLCGTL 174
Query: 281 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
            Y+ PE     +   K D++S GVL  E + G
Sbjct: 175 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 97/212 (45%), Gaps = 27/212 (12%)
Query: 110 NFSAANKLGEGGFGTVYKGVIGQGE--IAVKRL----LGKSGQEIKELKNEASVIAQVQH 163
           +F     LG+G FG VY     Q +  +A+K L    L K+G E  +L+ E  + + ++H
Sbjct: 13  DFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVE-HQLRREVEIQSHLRH 71
Query: 164 KNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYL 223
            N+++L G   +     LI EY P   L     +  K    D +     I  +A  L Y 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSRFDEQRTATYITELANALSYC 128
Query: 224 HQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR---ISGTY 280
           H     R+IHRD+K  N+LL  +   KI+DFG +           +   +SR   + GT 
Sbjct: 129 HS---KRVIHRDIKPENLLLGSNGELKIADFGWS-----------VHAPSSRRDTLCGTL 174
Query: 281 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
            Y+ PE     +   K D++S GVL  E + G
Sbjct: 175 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 104/202 (51%), Gaps = 16/202 (7%)
Query: 116 KLGEGGFGTVYKG---VIGQGEIAVKRLLGKSGQEIK---ELKNEASVIAQVQHKNLVKL 169
           +LG G FGTV KG   +    +    ++L     +     EL  EA+V+ Q+ +  +V++
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 77
Query: 170 LGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRV 229
           +G C E +  +L+ E      L+ +L     R + D +  ++++  V+ G+ YL + +  
Sbjct: 78  IGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEESN-- 131
Query: 230 RIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL 289
             +HRDL A N+LL     +KISDFG+++ +    DE+  +  T        Y +PE   
Sbjct: 132 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRA--DENXYKAQTHGKWPVKWY-APECIN 187
Query: 290 EGIFSIKSDVFSFGVLLLEIVS 311
              FS KSDV+SFGVL+ E  S
Sbjct: 188 YYKFSSKSDVWSFGVLMWEAFS 209

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 106/206 (51%), Gaps = 17/206 (8%)
Query: 116 KLGEGGFGTVYKG---VIGQGEIAVKRLLGKSGQEIK---ELKNEASVIAQVQHKNLVKL 169
           +LG G FGTV KG   +    +    ++L     +     EL  EA+V+ Q+ +  +V++
Sbjct: 34  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 93
Query: 170 LGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRV 229
           +G C E +  +L+ E      L+ +L     R + D +  ++++  V+ G+ YL +    
Sbjct: 94  IGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEE---S 146
Query: 230 RIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL 289
             +HRDL A N+LL     +KISDFG+++ +    DE+  +  T        Y +PE   
Sbjct: 147 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRA--DENYYKAQTHGKWPVKWY-APECIN 203
Query: 290 EGIFSIKSDVFSFGVLLLEIVS-GKK 314
              FS KSDV+SFGVL+ E  S G+K
Sbjct: 204 YYKFSSKSDVWSFGVLMWEAFSYGQK 229

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 106/206 (51%), Gaps = 17/206 (8%)
Query: 116 KLGEGGFGTVYKG---VIGQGEIAVKRLLGKSGQEIK---ELKNEASVIAQVQHKNLVKL 169
           +LG G FGTV KG   +    +    ++L     +     EL  EA+V+ Q+ +  +V++
Sbjct: 34  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 93
Query: 170 LGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRV 229
           +G C E +  +L+ E      L+ +L     R + D +  ++++  V+ G+ YL +    
Sbjct: 94  IGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEE---S 146
Query: 230 RIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL 289
             +HRDL A N+LL     +KISDFG+++ +    DE+  +  T        Y +PE   
Sbjct: 147 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRA--DENYYKAQTHGKWPVKWY-APECIN 203
Query: 290 EGIFSIKSDVFSFGVLLLEIVS-GKK 314
              FS KSDV+SFGVL+ E  S G+K
Sbjct: 204 YYKFSSKSDVWSFGVLMWEAFSYGQK 229

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 106/206 (51%), Gaps = 17/206 (8%)
Query: 116 KLGEGGFGTVYKG---VIGQGEIAVKRLLGKSGQEIK---ELKNEASVIAQVQHKNLVKL 169
           +LG G FGTV KG   +    +    ++L     +     EL  EA+V+ Q+ +  +V++
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 170 LGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRV 229
           +G C E +  +L+ E      L+ +L     R + D +  ++++  V+ G+ YL +    
Sbjct: 74  IGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEE---S 126
Query: 230 RIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL 289
             +HRDL A N+LL     +KISDFG+++ +    DE+  +  T        Y +PE   
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRA--DENYYKAQTHGKWPVKWY-APECIN 183
Query: 290 EGIFSIKSDVFSFGVLLLEIVS-GKK 314
              FS KSDV+SFGVL+ E  S G+K
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQK 209

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 104/202 (51%), Gaps = 16/202 (7%)
Query: 116 KLGEGGFGTVYKG---VIGQGEIAVKRLLGKSGQEIK---ELKNEASVIAQVQHKNLVKL 169
           +LG G FGTV KG   +    +    ++L     +     EL  EA+V+ Q+ +  +V++
Sbjct: 12  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 71
Query: 170 LGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRV 229
           +G C E +  +L+ E      L+ +L     R + D +  ++++  V+ G+ YL + +  
Sbjct: 72  IGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEESN-- 125
Query: 230 RIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL 289
             +HRDL A N+LL     +KISDFG+++ +    DE+  +  T        Y +PE   
Sbjct: 126 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRA--DENYYKAQTHGKWPVKWY-APECIN 181
Query: 290 EGIFSIKSDVFSFGVLLLEIVS 311
              FS KSDV+SFGVL+ E  S
Sbjct: 182 YYKFSSKSDVWSFGVLMWEAFS 203

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 106/206 (51%), Gaps = 17/206 (8%)
Query: 116 KLGEGGFGTVYKG---VIGQGEIAVKRLLGKSGQEIK---ELKNEASVIAQVQHKNLVKL 169
           +LG G FGTV KG   +    +    ++L     +     EL  EA+V+ Q+ +  +V++
Sbjct: 32  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 91
Query: 170 LGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRV 229
           +G C E +  +L+ E      L+ +L     R + D +  ++++  V+ G+ YL +    
Sbjct: 92  IGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEE---S 144
Query: 230 RIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL 289
             +HRDL A N+LL     +KISDFG+++ +    DE+  +  T        Y +PE   
Sbjct: 145 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRA--DENYYKAQTHGKWPVKWY-APECIN 201
Query: 290 EGIFSIKSDVFSFGVLLLEIVS-GKK 314
              FS KSDV+SFGVL+ E  S G+K
Sbjct: 202 YYKFSSKSDVWSFGVLMWEAFSYGQK 227

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 104/202 (51%), Gaps = 16/202 (7%)
Query: 116 KLGEGGFGTVYKG---VIGQGEIAVKRLLGKSGQEIK---ELKNEASVIAQVQHKNLVKL 169
           +LG G FGTV KG   +    +    ++L     +     EL  EA+V+ Q+ +  +V++
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 77
Query: 170 LGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRV 229
           +G C E +  +L+ E      L+ +L     R + D +  ++++  V+ G+ YL + +  
Sbjct: 78  IGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEESN-- 131
Query: 230 RIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL 289
             +HRDL A N+LL     +KISDFG+++ +    DE+  +  T        Y +PE   
Sbjct: 132 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRA--DENYYKAQTHGKWPVKWY-APECIN 187
Query: 290 EGIFSIKSDVFSFGVLLLEIVS 311
              FS KSDV+SFGVL+ E  S
Sbjct: 188 YYKFSSKSDVWSFGVLMWEAFS 209

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 107/206 (51%), Gaps = 17/206 (8%)
Query: 116 KLGEGGFGTVYKG---VIGQGEIAVKRLLGKSGQEIK---ELKNEASVIAQVQHKNLVKL 169
           +LG G FGTV KG   +    +    ++L     +     EL  EA+V+ Q+ +  +V++
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 170 LGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRV 229
           +G C E +  +L+ E      L+ +L     R + D +  ++++  V+ G+ YL + +  
Sbjct: 84  IGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEESN-- 137
Query: 230 RIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL 289
             +HRDL A N+LL     +KISDFG+++ +    DE+  +  T        Y +PE   
Sbjct: 138 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRA--DENYYKAQTHGKWPVKWY-APECIN 193
Query: 290 EGIFSIKSDVFSFGVLLLEIVS-GKK 314
              FS KSDV+SFGVL+ E  S G+K
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFSYGQK 219

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 131/278 (47%), Gaps = 16/278 (5%)
Query: 115 NKLGEGGFGTV---YKGVIGQGE---IAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
           ++LG+G FG+V       +G      +AVK+L      + ++ + E  ++  +    +VK
Sbjct: 17  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 76
Query: 169 LLGCCIEKDER--LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQY 226
             G       +   L+ EY+P+  L  FL     R  LD    +     + +G+ YL   
Sbjct: 77  YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL--- 131
Query: 227 SRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPE 286
              R +HRDL A NIL++ + + KI+DFG+A+++    D+D         S  + Y +PE
Sbjct: 132 GSRRCVHRDLAARNILVESEAHVKIADFGLAKLL--PLDKDYYVVREPGQSPIFWY-APE 188
Query: 287 YALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSV 346
              + IFS +SDV+SFGV+L E+ +    +     + L ++G   D+    ++++L++  
Sbjct: 189 SLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALCRLLELLEEG 248
Query: 347 LEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML 384
               +     +    +  LC     +DRP+ S +   L
Sbjct: 249 QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQL 286

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 106/221 (47%), Gaps = 20/221 (9%)
Query: 99  FSFSSVSSATGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGK--SGQEIKELKNE 154
           F  ++ +  + N+    +LG+G F  V + V      E A K +  K  S ++ ++L+ E
Sbjct: 19  FMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLERE 78
Query: 155 ASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIK 214
           A +  ++QH N+V+L     E+    L+++ +    L     D   RE          I+
Sbjct: 79  ARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQ 135
Query: 215 GVAQGLLYLHQYSRVRIIHRDLKASNILLD---KDMNSKISDFGMARIVFGGNDEDELQG 271
            + + + Y H      I+HR+LK  N+LL    K    K++DFG+A  V   ND +   G
Sbjct: 136 QILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV---NDSEAWHG 189
Query: 272 NTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
                +GT GY+SPE   +  +S   D+++ GV+L  ++ G
Sbjct: 190 ----FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 105/209 (50%), Gaps = 16/209 (7%)
Query: 110 NFSAANKLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNL 166
           ++     LGEG  G V   V  + +  +AVK +  K   +  E +K E  +   + H+N+
Sbjct: 7   DWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 167 VKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREI-LDWRTRVQIIKGVAQGLLYLHQ 225
           VK  G   E + + L  EY     L    FD  + +I +      +    +  G++YLH 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
              + I HRD+K  N+LLD+  N KISDFG+A  VF  N+ + L    +++ GT  Y++P
Sbjct: 123 ---IGITHRDIKPENLLLDERDNLKISDFGLA-TVFRYNNRERL---LNKMCGTLPYVAP 175
Query: 286 EYALEGIFSIKS-DVFSFGVLLLEIVSGK 313
           E      F  +  DV+S G++L  +++G+
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 20/212 (9%)
Query: 108 TGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGK--SGQEIKELKNEASVIAQVQH 163
           + N+    +LG+G F  V + V      E A K +  K  S ++ ++L+ EA +  ++QH
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 164 KNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYL 223
            N+V+L     E+    L+++ +    L     D   RE          I+ + + + Y 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQILESIAYC 121
Query: 224 HQYSRVRIIHRDLKASNILLD---KDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY 280
           H      I+HR+LK  N+LL    K    K++DFG+A  V   ND +   G     +GT 
Sbjct: 122 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV---NDSEAWHG----FAGTP 171
Query: 281 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           GY+SPE   +  +S   D+++ GV+L  ++ G
Sbjct: 172 GYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 100/204 (49%), Gaps = 21/204 (10%)
Query: 117 LGEGGFGTVYKGV------IGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLL 170
           LG+GGF   Y+        +  G++  K +L K  Q+ K +  E ++   + + ++V   
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEK-MSTEIAIHKSLDNPHVVGFH 108
Query: 171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVR 230
           G   + D   ++ E    +SL        ++ + +   R   ++   QG+ YLH     R
Sbjct: 109 GFFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARY-FMRQTIQGVQYLHNN---R 162
Query: 231 IIHRDLKASNILLDKDMNSKISDFGMA-RIVFGGNDEDELQGNTSRISGTYGYMSPEYAL 289
           +IHRDLK  N+ L+ DM+ KI DFG+A +I F G  + +L        GT  Y++PE   
Sbjct: 163 VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDL-------CGTPNYIAPEVLC 215
Query: 290 EGIFSIKSDVFSFGVLLLEIVSGK 313
           +   S + D++S G +L  ++ GK
Sbjct: 216 KKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 104/202 (51%), Gaps = 16/202 (7%)
Query: 116 KLGEGGFGTVYKG---VIGQGEIAVKRLLGKSGQEIK---ELKNEASVIAQVQHKNLVKL 169
           +LG G FGTV KG   +    +    ++L     +     EL  EA+V+ Q+ +  +V++
Sbjct: 376 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 435
Query: 170 LGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRV 229
           +G C E +  +L+ E      L+ +L     R + D +  ++++  V+ G+ YL + +  
Sbjct: 436 IGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEESN-- 489
Query: 230 RIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL 289
             +HRDL A N+LL     +KISDFG+++ +    DE+  +  T        Y +PE   
Sbjct: 490 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRA--DENYYKAQTHGKWPVKWY-APECIN 545
Query: 290 EGIFSIKSDVFSFGVLLLEIVS 311
              FS KSDV+SFGVL+ E  S
Sbjct: 546 YYKFSSKSDVWSFGVLMWEAFS 567

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 102/214 (47%), Gaps = 27/214 (12%)
Query: 110 NFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKS---GQEIKELKNEASVIAQVQHK 164
           +F     LGEG F TV   + +    E A+K L  +      ++  +  E  V++++ H 
Sbjct: 38  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 97
Query: 165 NLVKLLGCCIEKDERLLI-YEYMPNKSLDCFL-----FDPTKREILDWRTRVQIIKGVAQ 218
             VKL   C + DE+L     Y  N  L  ++     FD T        TR    + +  
Sbjct: 98  FFVKLY-FCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-------TRFYTAE-IVS 148
Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
            L YLH      IIHRDLK  NILL++DM+ +I+DFG A+++      +  Q   +   G
Sbjct: 149 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL----SPESKQARANXFVG 201
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           T  Y+SPE   E      SD+++ G ++ ++V+G
Sbjct: 202 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 20/212 (9%)
Query: 108 TGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGK--SGQEIKELKNEASVIAQVQH 163
           + N+    +LG+G F  V + V      E A K +  K  S ++ ++L+ EA +  ++QH
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 164 KNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYL 223
            N+V+L     E+    L+++ +    L     D   RE          I+ + + + Y 
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQILESIAYC 120
Query: 224 HQYSRVRIIHRDLKASNILLD---KDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY 280
           H      I+HR+LK  N+LL    K    K++DFG+A  V   ND +   G     +GT 
Sbjct: 121 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV---NDSEAWHG----FAGTP 170
Query: 281 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           GY+SPE   +  +S   D+++ GV+L  ++ G
Sbjct: 171 GYLSPEVLKKDPYSKPVDIWACGVILYILLVG 202

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 20/212 (9%)
Query: 108 TGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGK--SGQEIKELKNEASVIAQVQH 163
           + N+    +LG+G F  V + V      E A K +  K  S ++ ++L+ EA +  ++QH
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 164 KNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYL 223
            N+V+L     E+    L+++ +    L     D   RE          I+ + + + Y 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQILESIAYC 121
Query: 224 HQYSRVRIIHRDLKASNILLD---KDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY 280
           H      I+HR+LK  N+LL    K    K++DFG+A  V   ND +   G     +GT 
Sbjct: 122 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV---NDSEAWHG----FAGTP 171
Query: 281 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           GY+SPE   +  +S   D+++ GV+L  ++ G
Sbjct: 172 GYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 100/204 (49%), Gaps = 21/204 (10%)
Query: 117 LGEGGFGTVYKGV------IGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLL 170
           LG+GGF   Y+        +  G++  K +L K  Q+ K +  E ++   + + ++V   
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEK-MSTEIAIHKSLDNPHVVGFH 92
Query: 171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVR 230
           G   + D   ++ E    +SL        ++ + +   R   ++   QG+ YLH     R
Sbjct: 93  GFFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARY-FMRQTIQGVQYLHNN---R 146
Query: 231 IIHRDLKASNILLDKDMNSKISDFGMA-RIVFGGNDEDELQGNTSRISGTYGYMSPEYAL 289
           +IHRDLK  N+ L+ DM+ KI DFG+A +I F G  + +L        GT  Y++PE   
Sbjct: 147 VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDL-------CGTPNYIAPEVLC 199
Query: 290 EGIFSIKSDVFSFGVLLLEIVSGK 313
           +   S + D++S G +L  ++ GK
Sbjct: 200 KKGHSFEVDIWSLGCILYTLLVGK 223

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 98/215 (45%), Gaps = 30/215 (13%)
Query: 109 GNFSAANKLGEGGFGTV--YKGVIGQGEIAVKRLLGKS---GQEIKELKNEASVIAQVQH 163
           GN+     +G+G F  V   + ++   E+AVK ++ K+      +++L  E  +   + H
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKEVAVK-IIDKTQLNSSSLQKLFREVRIXKVLNH 72
Query: 164 KNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYL 223
            N+VKL      +    L+ EY     +  +L    + +  + R + + I    Q   Y 
Sbjct: 73  PNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQ---YC 129
Query: 224 HQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYM 283
           HQ     I+HRDLKA N+LLD D N KI+DFG +     GN  D   G            
Sbjct: 130 HQKF---IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFCG------------ 174
Query: 284 SPEYALEGIFSIKS------DVFSFGVLLLEIVSG 312
           +P YA   +F  K       DV+S GV+L  +VSG
Sbjct: 175 APPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 104/202 (51%), Gaps = 16/202 (7%)
Query: 116 KLGEGGFGTVYKG---VIGQGEIAVKRLLGKSGQEIK---ELKNEASVIAQVQHKNLVKL 169
           +LG G FGTV KG   +    +    ++L     +     EL  EA+V+ Q+ +  +V++
Sbjct: 377 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 436
Query: 170 LGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRV 229
           +G C E +  +L+ E      L+ +L     R + D +  ++++  V+ G+ YL + +  
Sbjct: 437 IGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEESN-- 490
Query: 230 RIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL 289
             +HRDL A N+LL     +KISDFG+++ +    DE+  +  T        Y +PE   
Sbjct: 491 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRA--DENYYKAQTHGKWPVKWY-APECIN 546
Query: 290 EGIFSIKSDVFSFGVLLLEIVS 311
              FS KSDV+SFGVL+ E  S
Sbjct: 547 YYKFSSKSDVWSFGVLMWEAFS 568

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 102/226 (45%), Gaps = 32/226 (14%)
Query: 110 NFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNL 166
           +F     LG GGFG V+  K  +     A+KR+   + +  +E +  E   +A+++H  +
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 167 VKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDW---------RTR---VQIIK 214
           V+     +EK+    +    P   L   +    K  + DW         R R   + I  
Sbjct: 66  VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFL 125
Query: 215 GVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNT- 273
            +A+ + +LH      ++HRDLK SNI    D   K+ DFG+   +    D+DE +    
Sbjct: 126 QIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAM----DQDEEEQTVL 178
Query: 274 ------SRISGTYG---YMSPEYALEGIFSIKSDVFSFGVLLLEIV 310
                 +R +G  G   YMSPE      +S K D+FS G++L E++
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 21/204 (10%)
Query: 117 LGEGGFGTVYK------GVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLL 170
           LG+GGF   ++        +  G+I  K LL K  Q  K +  E S+   + H+++V   
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFH 105
Query: 171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVR 230
           G   + D   ++ E    +SL   L    +R+ L        ++ +  G  YLH   R R
Sbjct: 106 GFFEDNDFVFVVLELCRRRSL---LELHKRRKALTEPEARYYLRQIVLGCQYLH---RNR 159
Query: 231 IIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRI-SGTYGYMSPEYAL 289
           +IHRDLK  N+ L++D+  KI DFG+A  V       E  G   ++  GT  Y++PE   
Sbjct: 160 VIHRDLKLGNLFLNEDLEVKIGDFGLATKV-------EYDGERKKVLCGTPNYIAPEVLS 212
Query: 290 EGIFSIKSDVFSFGVLLLEIVSGK 313
           +   S + DV+S G ++  ++ GK
Sbjct: 213 KKGHSFEVDVWSIGCIMYTLLVGK 236

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 111/214 (51%), Gaps = 26/214 (12%)
Query: 110 NFSAANKLGEGGFGTVYKG---VIGQGEIAVKRLL------GKSGQEIKELKNEASVIAQ 160
           NF    K+GEG +G VYK    + G+  +A+K++       G     I+E+    S++ +
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGE-VVALKKIRLDTETEGVPSTAIREI----SLLKE 58
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           + H N+VKLL     +++  L++E++ ++ L  F+ D +    +        +  + QGL
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGL 116
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY 280
            + H +   R++HRDLK  N+L++ +   K++DFG+AR  FG      ++  T  +  T 
Sbjct: 117 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGV----PVRTYTHEVV-TL 167
Query: 281 GYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGK 313
            Y +PE  L    +S   D++S G +  E+V+ +
Sbjct: 168 WYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 21/204 (10%)
Query: 117 LGEGGFGTVYK------GVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLL 170
           LG+GGF   ++        +  G+I  K LL K  Q  K +  E S+   + H+++V   
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFH 81
Query: 171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVR 230
           G   + D   ++ E    +SL   L    +R+ L        ++ +  G  YLH   R R
Sbjct: 82  GFFEDNDFVFVVLELCRRRSL---LELHKRRKALTEPEARYYLRQIVLGCQYLH---RNR 135
Query: 231 IIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRI-SGTYGYMSPEYAL 289
           +IHRDLK  N+ L++D+  KI DFG+A  V       E  G   ++  GT  Y++PE   
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKV-------EYDGERKKVLCGTPNYIAPEVLS 188
Query: 290 EGIFSIKSDVFSFGVLLLEIVSGK 313
           +   S + DV+S G ++  ++ GK
Sbjct: 189 KKGHSFEVDVWSIGCIMYTLLVGK 212

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 127/303 (41%), Gaps = 44/303 (14%)
Query: 111 FSAANKLGEGGFGTVYK----GVI---GQGEIAVKRLLGKSG-QEIKELKNEASVIAQV- 161
            S    LG G FG V +    G+I       +AVK L   +   E + L +E  V++ + 
Sbjct: 48  LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG 107
Query: 162 QHKNLVKLLGCCIEKDERLLIYEY--------MPNKSLDCFLFDPTKREILDWRTRVQII 213
            H N+V LLG C      L+I EY           +  D F+   T   I++       +
Sbjct: 108 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 167
Query: 214 KG-------VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDE 266
           +        VA+G+ +L   +    IHRDL A NILL     +KI DFG+AR +   ND 
Sbjct: 168 EDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARHI--KNDS 222
Query: 267 DELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNL 326
           + +    +R+     +M+PE     +++ +SDV+S+G+ L E+             SL  
Sbjct: 223 NYVVKGNARLP--VKWMAPESIFNCVYTFESDVWSYGIFLWELF------------SLGS 268
Query: 327 IGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN 386
             Y   + + +K   +I       S   + +    I   C       RPT   +V ++  
Sbjct: 269 SPYP-GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 327
Query: 387 EAS 389
           + S
Sbjct: 328 QIS 330

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 129/284 (45%), Gaps = 43/284 (15%)
Query: 117 LGEGGFGTVYKGVIGQGEIAVKRLLGKSGQE--IKELKNEASVIAQVQHKNLVKLLGCCI 174
           +G+G FG VY G    GE+A++ +  +   E  +K  K E     Q +H+N+V  +G C+
Sbjct: 41  IGKGRFGQVYHGRW-HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACM 99
Query: 175 EKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHR 234
                 +I      ++L   + D   + +LD     QI + + +G+ YLH      I+H+
Sbjct: 100 SPPHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHK 154
Query: 235 DLKASNILLDKDMNSK--ISDFGM---ARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL 289
           DLK+ N+  D   N K  I+DFG+   + ++  G  ED+L+      +G   +++PE   
Sbjct: 155 DLKSKNVFYD---NGKVVITDFGLFSISGVLQAGRREDKLRIQ----NGWLCHLAPEIIR 207
Query: 290 E---------GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKII 340
           +           FS  SDVF+ G +  E+ + +     ++T+    I   W +    K  
Sbjct: 208 QLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP---FKTQPAEAI--IWQMGTGMK-- 260
Query: 341 DLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML 384
                 L +    + +S    I L C     E+RPT + ++ ML
Sbjct: 261 ----PNLSQIGMGKEIS---DILLFCWAFEQEERPTFTKLMDML 297

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 21/204 (10%)
Query: 117 LGEGGFGTVYK------GVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLL 170
           LG+GGF   ++        +  G+I  K LL K  Q  K +  E S+   + H+++V   
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFH 107
Query: 171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVR 230
           G   + D   ++ E    +SL   L    +R+ L        ++ +  G  YLH   R R
Sbjct: 108 GFFEDNDFVFVVLELCRRRSL---LELHKRRKALTEPEARYYLRQIVLGCQYLH---RNR 161
Query: 231 IIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRI-SGTYGYMSPEYAL 289
           +IHRDLK  N+ L++D+  KI DFG+A  V       E  G   ++  GT  Y++PE   
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKV-------EYDGERKKVLCGTPNYIAPEVLS 214
Query: 290 EGIFSIKSDVFSFGVLLLEIVSGK 313
           +   S + DV+S G ++  ++ GK
Sbjct: 215 KKGHSFEVDVWSIGCIMYTLLVGK 238

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 99/204 (48%), Gaps = 21/204 (10%)
Query: 117 LGEGGFGTVYKGV------IGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLL 170
           LG+GGF   Y+        +  G++  K +L K  Q+ K +  E ++   + + ++V   
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEK-MSTEIAIHKSLDNPHVVGFH 108
Query: 171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVR 230
           G   + D   ++ E    +SL        ++ + +   R   ++   QG+ YLH     R
Sbjct: 109 GFFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARY-FMRQTIQGVQYLHNN---R 162
Query: 231 IIHRDLKASNILLDKDMNSKISDFGMA-RIVFGGNDEDELQGNTSRISGTYGYMSPEYAL 289
           +IHRDLK  N+ L+ DM+ KI DFG+A +I F G  +  L        GT  Y++PE   
Sbjct: 163 VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTL-------CGTPNYIAPEVLC 215
Query: 290 EGIFSIKSDVFSFGVLLLEIVSGK 313
           +   S + D++S G +L  ++ GK
Sbjct: 216 KKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 99/204 (48%), Gaps = 21/204 (10%)
Query: 117 LGEGGFGTVYKGV------IGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLL 170
           LG+GGF   Y+        +  G++  K +L K  Q+ K +  E ++   + + ++V   
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEK-MSTEIAIHKSLDNPHVVGFH 108
Query: 171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVR 230
           G   + D   ++ E    +SL        ++ + +   R   ++   QG+ YLH     R
Sbjct: 109 GFFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARY-FMRQTIQGVQYLHNN---R 162
Query: 231 IIHRDLKASNILLDKDMNSKISDFGMA-RIVFGGNDEDELQGNTSRISGTYGYMSPEYAL 289
           +IHRDLK  N+ L+ DM+ KI DFG+A +I F G  +  L        GT  Y++PE   
Sbjct: 163 VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXL-------CGTPNYIAPEVLC 215
Query: 290 EGIFSIKSDVFSFGVLLLEIVSGK 313
           +   S + D++S G +L  ++ GK
Sbjct: 216 KKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 103/206 (50%), Gaps = 22/206 (10%)
Query: 117 LGEGGFGTVYKG-VIGQGE----IAVKRLLGKSG-QEIKELKNEASVIAQVQHKNLVKLL 170
           +G+G FG VY G  I Q +     A+K L   +  Q+++    E  ++  + H N++ L+
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 171 GCCIEKDE-RLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRV 229
           G  +  +    ++  YM +  L  F+  P +   +  +  +     VA+G+ YL   +  
Sbjct: 89  GIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV--KDLISFGLQVARGMEYL---AEQ 143
Query: 230 RIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL 289
           + +HRDL A N +LD+    K++DFG+AR +         Q   +R+   +       AL
Sbjct: 144 KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT------AL 197
Query: 290 EGI----FSIKSDVFSFGVLLLEIVS 311
           E +    F+ KSDV+SFGVLL E+++
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLT 223

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 21/204 (10%)
Query: 117 LGEGGFGTVYK------GVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLL 170
           LG+GGF   ++        +  G+I  K LL K  Q  K +  E S+   + H+++V   
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFH 87
Query: 171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVR 230
           G   + D   ++ E    +SL   L    +R+ L        ++ +  G  YLH   R R
Sbjct: 88  GFFEDNDFVFVVLELCRRRSL---LELHKRRKALTEPEARYYLRQIVLGCQYLH---RNR 141
Query: 231 IIHRDLKASNILLDKDMNSKISDFGMA-RIVFGGNDEDELQGNTSRISGTYGYMSPEYAL 289
           +IHRDLK  N+ L++D+  KI DFG+A ++ + G  +  L        GT  Y++PE   
Sbjct: 142 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTL-------CGTPNYIAPEVLS 194
Query: 290 EGIFSIKSDVFSFGVLLLEIVSGK 313
           +   S + DV+S G ++  ++ GK
Sbjct: 195 KKGHSFEVDVWSIGCIMYTLLVGK 218

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 111/214 (51%), Gaps = 26/214 (12%)
Query: 110 NFSAANKLGEGGFGTVYKG---VIGQGEIAVKRLL------GKSGQEIKELKNEASVIAQ 160
           NF    K+GEG +G VYK    + G+  +A+K++       G     I+E+    S++ +
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGE-VVALKKIRLDTETEGVPSTAIREI----SLLKE 57
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           + H N+VKLL     +++  L++E++ ++ L  F+ D +    +        +  + QGL
Sbjct: 58  LNHPNIVKLLDVIHTENKLYLVFEHV-HQDLKTFM-DASALTGIPLPLIKSYLFQLLQGL 115
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY 280
            + H +   R++HRDLK  N+L++ +   K++DFG+AR  FG      ++  T  +  T 
Sbjct: 116 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGV----PVRTYTHEVV-TL 166
Query: 281 GYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGK 313
            Y +PE  L    +S   D++S G +  E+V+ +
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 111/214 (51%), Gaps = 26/214 (12%)
Query: 110 NFSAANKLGEGGFGTVYKG---VIGQGEIAVKRLL------GKSGQEIKELKNEASVIAQ 160
           NF    K+GEG +G VYK    + G+  +A+K++       G     I+E+    S++ +
Sbjct: 11  NFQKVEKIGEGTYGVVYKARNKLTGE-VVALKKIRLDTETEGVPSTAIREI----SLLKE 65
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           + H N+VKLL     +++  L++E++ ++ L  F+ D +    +        +  + QGL
Sbjct: 66  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGL 123
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY 280
            + H +   R++HRDLK  N+L++ +   K++DFG+AR  FG      ++  T  +  T 
Sbjct: 124 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGV----PVRTYTHEVV-TL 174
Query: 281 GYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGK 313
            Y +PE  L    +S   D++S G +  E+V+ +
Sbjct: 175 WYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 116/223 (52%), Gaps = 18/223 (8%)
Query: 117 LGEGGFGTVYK-GVIGQG-EIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCI 174
           LG G FG V+K      G ++A K +  +  ++ +E+KNE SV+ Q+ H NL++L     
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE 156
Query: 175 EKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHR 234
            K++ +L+ EY+    L   + D +    L     +  +K + +G+ ++HQ   + I+H 
Sbjct: 157 SKNDIVLVMEYVDGGELFDRIIDESYN--LTELDTILFMKQICEGIRHMHQ---MYILHL 211
Query: 235 DLKASNIL-LDKDMNS-KISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGI 292
           DLK  NIL +++D    KI DFG+AR        ++L+ N     GT  +++PE      
Sbjct: 212 DLKPENILCVNRDAKQIKIIDFGLARRY---KPREKLKVNF----GTPEFLAPEVVNYDF 264
Query: 293 FSIKSDVFSFGVLLLEIVSG-KKNTGFYRTKSL-NLIGYAWDL 333
            S  +D++S GV+   ++SG     G    ++L N++   WDL
Sbjct: 265 VSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDL 307

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 117/273 (42%), Gaps = 38/273 (13%)
Query: 116 KLGEGGFGTVYKGVIGQGE-----IAVKRL---LGKSGQEIKELKNEASVIAQVQHKNLV 167
           KLG+G FG V +G           +AVK L   +    + + +   E + +  + H+NL+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 168 KLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYS 227
           +L G  +    ++ + E  P  SL   L       +L   +R  +   VA+G+ YL    
Sbjct: 75  RLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK- 130
Query: 228 RVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEY 287
             R IHRDL A N+LL      KI DFG+ R +   +D   +Q +       + + +PE 
Sbjct: 131 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV---PFAWCAPES 185
Query: 288 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWI---SNKIIDLID 344
                FS  SD + FGV L E+ +                 Y  + WI    ++I+  ID
Sbjct: 186 LKTRTFSHASDTWMFGVTLWEMFT-----------------YGQEPWIGLNGSQILHKID 228
Query: 345 SVLEEASFNESLSRYVH-IALLCVQERAEDRPT 376
              E     E   + ++ + + C   + EDRPT
Sbjct: 229 KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPT 261

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 21/204 (10%)
Query: 117 LGEGGFGTVYK------GVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLL 170
           LG+GGF   ++        +  G+I  K LL K  Q  K +  E S+   + H+++V   
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFH 83
Query: 171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVR 230
           G   + D   ++ E    +SL   L    +R+ L        ++ +  G  YLH   R R
Sbjct: 84  GFFEDNDFVFVVLELCRRRSL---LELHKRRKALTEPEARYYLRQIVLGCQYLH---RNR 137
Query: 231 IIHRDLKASNILLDKDMNSKISDFGMA-RIVFGGNDEDELQGNTSRISGTYGYMSPEYAL 289
           +IHRDLK  N+ L++D+  KI DFG+A ++ + G  +  L        GT  Y++PE   
Sbjct: 138 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTL-------CGTPNYIAPEVLS 190
Query: 290 EGIFSIKSDVFSFGVLLLEIVSGK 313
           +   S + DV+S G ++  ++ GK
Sbjct: 191 KKGHSFEVDVWSIGCIMYTLLVGK 214

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 21/204 (10%)
Query: 117 LGEGGFGTVYK------GVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLL 170
           LG+GGF   ++        +  G+I  K LL K  Q  K +  E S+   + H+++V   
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFH 83
Query: 171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVR 230
           G   + D   ++ E    +SL   L    +R+ L        ++ +  G  YLH   R R
Sbjct: 84  GFFEDNDFVFVVLELCRRRSL---LELHKRRKALTEPEARYYLRQIVLGCQYLH---RNR 137
Query: 231 IIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR-ISGTYGYMSPEYAL 289
           +IHRDLK  N+ L++D+  KI DFG+A  V       E  G   + + GT  Y++PE   
Sbjct: 138 VIHRDLKLGNLFLNEDLEVKIGDFGLATKV-------EYDGERKKTLCGTPNYIAPEVLS 190
Query: 290 EGIFSIKSDVFSFGVLLLEIVSGK 313
           +   S + DV+S G ++  ++ GK
Sbjct: 191 KKGHSFEVDVWSIGCIMYTLLVGK 214

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 105/225 (46%), Gaps = 31/225 (13%)
Query: 111 FSAANKLGEGGFGTVYK----GVI---GQGEIAVKRLLGKSG-QEIKELKNEASVIAQV- 161
            S    LG G FG V +    G+I       +AVK L   +   E + L +E  V++ + 
Sbjct: 25  LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG 84
Query: 162 QHKNLVKLLGCCIEKDERLLIYEYMPNKSL--------DCFLFDPTKREILDWRTRVQII 213
            H N+V LLG C      L+I EY     L        D F+   T   I++       +
Sbjct: 85  NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 214 KG-------VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDE 266
           +        VA+G+ +L   +    IHRDL A NILL     +KI DFG+AR +   ND 
Sbjct: 145 EDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDI--KNDS 199
Query: 267 DELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
           + +    +R+     +M+PE     +++ +SDV+S+G+ L E+ S
Sbjct: 200 NYVVKGNARLP--VKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 127/303 (41%), Gaps = 44/303 (14%)
Query: 111 FSAANKLGEGGFGTVYK----GVI---GQGEIAVKRLLGKSG-QEIKELKNEASVIAQV- 161
            S    LG G FG V +    G+I       +AVK L   +   E + L +E  V++ + 
Sbjct: 48  LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG 107
Query: 162 QHKNLVKLLGCCIEKDERLLIYEY--------MPNKSLDCFLFDPTKREILDWRTRVQII 213
            H N+V LLG C      L+I EY           +  D F+   T   I++       +
Sbjct: 108 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 167
Query: 214 KG-------VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDE 266
           +        VA+G+ +L   +    IHRDL A NILL     +KI DFG+AR +   ND 
Sbjct: 168 EDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDI--KNDS 222
Query: 267 DELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNL 326
           + +    +R+     +M+PE     +++ +SDV+S+G+ L E+             SL  
Sbjct: 223 NYVVKGNARLP--VKWMAPESIFNCVYTFESDVWSYGIFLWELF------------SLGS 268
Query: 327 IGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN 386
             Y   + + +K   +I       S   + +    I   C       RPT   +V ++  
Sbjct: 269 SPYP-GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 327
Query: 387 EAS 389
           + S
Sbjct: 328 QIS 330

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 111/214 (51%), Gaps = 26/214 (12%)
Query: 110 NFSAANKLGEGGFGTVYKG---VIGQGEIAVKRLL------GKSGQEIKELKNEASVIAQ 160
           NF    K+GEG +G VYK    + G+  +A+K++       G     I+E+    S++ +
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGE-VVALKKIRLDTETEGVPSTAIREI----SLLKE 58
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           + H N+VKLL     +++  L++E++ ++ L  F+ D +    +        +  + QGL
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGL 116
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY 280
            + H +   R++HRDLK  N+L++ +   K++DFG+AR  FG      ++  T  +  T 
Sbjct: 117 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGV----PVRTYTHEVV-TL 167
Query: 281 GYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGK 313
            Y +PE  L    +S   D++S G +  E+V+ +
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 117/274 (42%), Gaps = 38/274 (13%)
Query: 115 NKLGEGGFGTVYKGVIGQGE-----IAVKRL---LGKSGQEIKELKNEASVIAQVQHKNL 166
            KLG+G FG V +G           +AVK L   +    + + +   E + +  + H+NL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 167 VKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQY 226
           ++L G  +    ++ + E  P  SL   L       +L   +R  +   VA+G+ YL   
Sbjct: 84  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 140
Query: 227 SRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPE 286
              R IHRDL A N+LL      KI DFG+ R +   +D   +Q +       + + +PE
Sbjct: 141 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV---PFAWCAPE 194
Query: 287 YALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWI---SNKIIDLI 343
                 FS  SD + FGV L E+ +                 Y  + WI    ++I+  I
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFT-----------------YGQEPWIGLNGSQILHKI 237
Query: 344 DSVLEEASFNESLSRYVH-IALLCVQERAEDRPT 376
           D   E     E   + ++ + + C   + EDRPT
Sbjct: 238 DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPT 271

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 111/214 (51%), Gaps = 26/214 (12%)
Query: 110 NFSAANKLGEGGFGTVYKG---VIGQGEIAVKRLL------GKSGQEIKELKNEASVIAQ 160
           NF    K+GEG +G VYK    + G+  +A+K++       G     I+E+    S++ +
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGE-VVALKKIRLDTETEGVPSTAIREI----SLLKE 57
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           + H N+VKLL     +++  L++E++ ++ L  F+ D +    +        +  + QGL
Sbjct: 58  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGL 115
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY 280
            + H +   R++HRDLK  N+L++ +   K++DFG+AR  FG      ++  T  +  T 
Sbjct: 116 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGV----PVRTYTHEVV-TL 166
Query: 281 GYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGK 313
            Y +PE  L    +S   D++S G +  E+V+ +
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 111/214 (51%), Gaps = 26/214 (12%)
Query: 110 NFSAANKLGEGGFGTVYKG---VIGQGEIAVKRLL------GKSGQEIKELKNEASVIAQ 160
           NF    K+GEG +G VYK    + G+  +A+K++       G     I+E+    S++ +
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGE-VVALKKIRLDTETEGVPSTAIREI----SLLKE 57
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           + H N+VKLL     +++  L++E++ ++ L  F+ D +    +        +  + QGL
Sbjct: 58  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGL 115
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY 280
            + H +   R++HRDLK  N+L++ +   K++DFG+AR  FG      ++  T  +  T 
Sbjct: 116 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGV----PVRTYTHEVV-TL 166
Query: 281 GYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGK 313
            Y +PE  L    +S   D++S G +  E+V+ +
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 127/303 (41%), Gaps = 44/303 (14%)
Query: 111 FSAANKLGEGGFGTVYK----GVI---GQGEIAVKRLLGKSG-QEIKELKNEASVIAQV- 161
            S    LG G FG V +    G+I       +AVK L   +   E + L +E  V++ + 
Sbjct: 41  LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG 100
Query: 162 QHKNLVKLLGCCIEKDERLLIYEY--------MPNKSLDCFLFDPTKREILDWRTRVQII 213
            H N+V LLG C      L+I EY           +  D F+   T   I++       +
Sbjct: 101 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 160
Query: 214 KG-------VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDE 266
           +        VA+G+ +L   +    IHRDL A NILL     +KI DFG+AR +   ND 
Sbjct: 161 EDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDI--KNDS 215
Query: 267 DELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNL 326
           + +    +R+     +M+PE     +++ +SDV+S+G+ L E+             SL  
Sbjct: 216 NYVVKGNARLP--VKWMAPESIFNCVYTFESDVWSYGIFLWELF------------SLGS 261
Query: 327 IGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN 386
             Y   + + +K   +I       S   + +    I   C       RPT   +V ++  
Sbjct: 262 SPYP-GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 320
Query: 387 EAS 389
           + S
Sbjct: 321 QIS 323

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 105/225 (46%), Gaps = 31/225 (13%)
Query: 111 FSAANKLGEGGFGTVYK----GVI---GQGEIAVKRLLGKSG-QEIKELKNEASVIAQV- 161
            S    LG G FG V +    G+I       +AVK L   +   E + L +E  V++ + 
Sbjct: 43  LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG 102
Query: 162 QHKNLVKLLGCCIEKDERLLIYEY--------MPNKSLDCFLFDPTKREILDWRTRVQII 213
            H N+V LLG C      L+I EY           +  D F+   T   I++       +
Sbjct: 103 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 162
Query: 214 KG-------VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDE 266
           +        VA+G+ +L   +    IHRDL A NILL     +KI DFG+AR +   ND 
Sbjct: 163 EDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDI--KNDS 217
Query: 267 DELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
           + +    +R+     +M+PE     +++ +SDV+S+G+ L E+ S
Sbjct: 218 NYVVKGNARLP--VKWMAPESIFNCVYTFESDVWSYGIFLWELFS 260

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 111/214 (51%), Gaps = 26/214 (12%)
Query: 110 NFSAANKLGEGGFGTVYKG---VIGQGEIAVKRLL------GKSGQEIKELKNEASVIAQ 160
           NF    K+GEG +G VYK    + G+  +A+K++       G     I+E+    S++ +
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGE-VVALKKIRLDTETEGVPSTAIREI----SLLKE 58
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           + H N+VKLL     +++  L++E++ ++ L  F+ D +    +        +  + QGL
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGL 116
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY 280
            + H +   R++HRDLK  N+L++ +   K++DFG+AR  FG      ++  T  +  T 
Sbjct: 117 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGV----PVRTYTHEVV-TL 167
Query: 281 GYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGK 313
            Y +PE  L    +S   D++S G +  E+V+ +
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 111/214 (51%), Gaps = 26/214 (12%)
Query: 110 NFSAANKLGEGGFGTVYKG---VIGQGEIAVKRLL------GKSGQEIKELKNEASVIAQ 160
           NF    K+GEG +G VYK    + G+  +A+K++       G     I+E+    S++ +
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGE-VVALKKIRLDTETEGVPSTAIREI----SLLKE 59
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           + H N+VKLL     +++  L++E++ ++ L  F+ D +    +        +  + QGL
Sbjct: 60  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGL 117
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY 280
            + H +   R++HRDLK  N+L++ +   K++DFG+AR  FG      ++  T  +  T 
Sbjct: 118 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGV----PVRTYTHEVV-TL 168
Query: 281 GYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGK 313
            Y +PE  L    +S   D++S G +  E+V+ +
Sbjct: 169 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 111/214 (51%), Gaps = 26/214 (12%)
Query: 110 NFSAANKLGEGGFGTVYKG---VIGQGEIAVKRLL------GKSGQEIKELKNEASVIAQ 160
           NF    K+GEG +G VYK    + G+  +A+K++       G     I+E+    S++ +
Sbjct: 8   NFQKVEKIGEGTYGVVYKARNKLTGE-VVALKKIRLDTETEGVPSTAIREI----SLLKE 62
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           + H N+VKLL     +++  L++E++ ++ L  F+ D +    +        +  + QGL
Sbjct: 63  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGL 120
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY 280
            + H +   R++HRDLK  N+L++ +   K++DFG+AR  FG      ++  T  +  T 
Sbjct: 121 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGV----PVRTYTHEVV-TL 171
Query: 281 GYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGK 313
            Y +PE  L    +S   D++S G +  E+V+ +
Sbjct: 172 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 111/214 (51%), Gaps = 26/214 (12%)
Query: 110 NFSAANKLGEGGFGTVYKG---VIGQGEIAVKRLL------GKSGQEIKELKNEASVIAQ 160
           NF    K+GEG +G VYK    + G+  +A+K++       G     I+E+    S++ +
Sbjct: 11  NFQKVEKIGEGTYGVVYKARNKLTGE-VVALKKIRLDTETEGVPSTAIREI----SLLKE 65
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           + H N+VKLL     +++  L++E++ ++ L  F+ D +    +        +  + QGL
Sbjct: 66  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGL 123
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY 280
            + H +   R++HRDLK  N+L++ +   K++DFG+AR  FG      ++  T  +  T 
Sbjct: 124 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGV----PVRTYTHEVV-TL 174
Query: 281 GYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGK 313
            Y +PE  L    +S   D++S G +  E+V+ +
Sbjct: 175 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 117/273 (42%), Gaps = 38/273 (13%)
Query: 116 KLGEGGFGTVYKGVIGQGE-----IAVKRL---LGKSGQEIKELKNEASVIAQVQHKNLV 167
           KLG+G FG V +G           +AVK L   +    + + +   E + +  + H+NL+
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 168 KLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYS 227
           +L G  +    ++ + E  P  SL   L       +L   +R  +   VA+G+ YL    
Sbjct: 79  RLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK- 134
Query: 228 RVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEY 287
             R IHRDL A N+LL      KI DFG+ R +   +D   +Q +       + + +PE 
Sbjct: 135 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV---PFAWCAPES 189
Query: 288 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWI---SNKIIDLID 344
                FS  SD + FGV L E+ +                 Y  + WI    ++I+  ID
Sbjct: 190 LKTRTFSHASDTWMFGVTLWEMFT-----------------YGQEPWIGLNGSQILHKID 232
Query: 345 SVLEEASFNESLSRYVH-IALLCVQERAEDRPT 376
              E     E   + ++ + + C   + EDRPT
Sbjct: 233 KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPT 265

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 105/217 (48%), Gaps = 15/217 (6%)
Query: 104 VSSATGNFSAANKLGEGGFGTVYK-GVIGQGEIAVKRLL---GKSGQEIKELKNEASVIA 159
           + S   ++     +G G +G   K      G+I V + L     +  E + L +E +++ 
Sbjct: 1   MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLR 60
Query: 160 QVQHKNLVKLLGCCIEKDERLL--IYEYMPNKSLDCFLFDPTK-REILDWRTRVQIIKGV 216
           +++H N+V+     I++    L  + EY     L   +   TK R+ LD    ++++  +
Sbjct: 61  ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 120
Query: 217 AQGLLYLHQYSR--VRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTS 274
              L   H+ S     ++HRDLK +N+ LD   N K+ DFG+ARI+   +DED       
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDED----FAK 174
Query: 275 RISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
              GT  YMSPE      ++ KSD++S G LL E+ +
Sbjct: 175 EFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA 211

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 105/209 (50%), Gaps = 16/209 (7%)
Query: 110 NFSAANKLGEGGFGTVYKG---VIGQGEIAVKRLLGKSGQEIKELK-NEASVIAQVQHKN 165
           NF    K+GEG +G VYK    + G+     K  L    + +      E S++ ++ H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ 225
           +VKLL     +++  L++E++ ++ L  F+ D +    +        +  + QGL + H 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
           +   R++HRDLK  N+L++ +   K++DFG+AR  FG      ++  T  +  T  Y +P
Sbjct: 122 H---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGV----PVRTYTHEVV-TLWYRAP 172
Query: 286 EYALE-GIFSIKSDVFSFGVLLLEIVSGK 313
           E  L    +S   D++S G +  E+V+ +
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 105/209 (50%), Gaps = 16/209 (7%)
Query: 110 NFSAANKLGEGGFGTVYKG---VIGQGEIAVKRLLGKSGQEIKELK-NEASVIAQVQHKN 165
           NF    K+GEG +G VYK    + G+     K  L    + +      E S++ ++ H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ 225
           +VKLL     +++  L++E++ ++ L  F+ D +    +        +  + QGL + H 
Sbjct: 63  IVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
           +   R++HRDLK  N+L++ +   K++DFG+AR  FG      ++  T  +  T  Y +P
Sbjct: 121 H---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGV----PVRTYTHEVV-TLWYRAP 171
Query: 286 EYALE-GIFSIKSDVFSFGVLLLEIVSGK 313
           E  L    +S   D++S G +  E+V+ +
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 108/212 (50%), Gaps = 28/212 (13%)
Query: 111 FSAANKLGEGGFGTVYKGVIGQGE-IAVKRL-LGKSGQEIKELK-NEASVIAQVQHKNLV 167
           +    K+GEG +G VYK     GE  A+K++ L K  + I      E S++ +++H N+V
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 168 KLLGCCIEKDERLLIYEYMPN---KSLDCF---LFDPTKREILDWRTRVQIIKGVAQGLL 221
           KL      K   +L++E++     K LD     L   T +  L     +Q++ G+A    
Sbjct: 64  KLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFL-----LQLLNGIA---- 114
Query: 222 YLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYG 281
           Y H     R++HRDLK  N+L++++   KI+DFG+AR  FG      ++  T  I  T  
Sbjct: 115 YCHDR---RVLHRDLKPQNLLINREGELKIADFGLAR-AFG----IPVRKYTHEIV-TLW 165
Query: 282 YMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSG 312
           Y +P+  +    +S   D++S G +  E+V+G
Sbjct: 166 YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 102/213 (47%), Gaps = 35/213 (16%)
Query: 120 GGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASV--IAQVQHKNLVKLLGCCIEKD 177
           G FG V+K  +    +AVK       Q+ +  +NE  V  +  ++H+N+++ +G   EK 
Sbjct: 35  GRFGCVWKAQLLNEYVAVKIF---PIQDKQSWQNEYEVYSLPGMKHENILQFIGA--EKR 89
Query: 178 ------ERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ------ 225
                 +  LI  +    SL  FL    K  ++ W     I + +A+GL YLH+      
Sbjct: 90  GTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIAETMARGLAYLHEDIPGLK 145
Query: 226 -YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMS 284
              +  I HRD+K+ N+LL  ++ + I+DFG+A     G       G+T    GT  YM+
Sbjct: 146 DGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS----AGDTHGQVGTRRYMA 201
Query: 285 PEYALEGIFSIKSDVF------SFGVLLLEIVS 311
           PE  LEG  + + D F      + G++L E+ S
Sbjct: 202 PE-VLEGAINFQRDAFLRIDMYAMGLVLWELAS 233

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 111/214 (51%), Gaps = 26/214 (12%)
Query: 110 NFSAANKLGEGGFGTVYKG---VIGQGEIAVKRLL------GKSGQEIKELKNEASVIAQ 160
           NF    K+GEG +G VYK    + G+  +A+K++       G     I+E+    S++ +
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGE-VVALKKIRLDTETEGVPSTAIREI----SLLKE 58
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           + H N+VKLL     +++  L++E++ ++ L  F+ D +    +        +  + QGL
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGL 116
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY 280
            + H +   R++HRDLK  N+L++ +   K++DFG+AR  FG      ++  T  +  T 
Sbjct: 117 SFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGV----PVRTYTHEVV-TL 167
Query: 281 GYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGK 313
            Y +PE  L    +S   D++S G +  E+V+ +
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 117/273 (42%), Gaps = 38/273 (13%)
Query: 116 KLGEGGFGTVYKGVIGQGE-----IAVKRL---LGKSGQEIKELKNEASVIAQVQHKNLV 167
           KLG+G FG V +G           +AVK L   +    + + +   E + +  + H+NL+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 168 KLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYS 227
           +L G  +    ++ + E  P  SL   L       +L   +R  +   VA+G+ YL    
Sbjct: 75  RLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK- 130
Query: 228 RVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEY 287
             R IHRDL A N+LL      KI DFG+ R +   +D   +Q +       + + +PE 
Sbjct: 131 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV---PFAWCAPES 185
Query: 288 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWI---SNKIIDLID 344
                FS  SD + FGV L E+ +                 Y  + WI    ++I+  ID
Sbjct: 186 LKTRTFSHASDTWMFGVTLWEMFT-----------------YGQEPWIGLNGSQILHKID 228
Query: 345 SVLEEASFNESLSRYVH-IALLCVQERAEDRPT 376
              E     E   + ++ + + C   + EDRPT
Sbjct: 229 KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPT 261

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 117/274 (42%), Gaps = 38/274 (13%)
Query: 115 NKLGEGGFGTVYKGVIGQGE-----IAVKRL---LGKSGQEIKELKNEASVIAQVQHKNL 166
            KLG+G FG V +G           +AVK L   +    + + +   E + +  + H+NL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 167 VKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQY 226
           ++L G  +    ++ + E  P  SL   L       +L   +R  +   VA+G+ YL   
Sbjct: 84  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 140
Query: 227 SRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPE 286
              R IHRDL A N+LL      KI DFG+ R +   +D   +Q +       + + +PE
Sbjct: 141 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV---PFAWCAPE 194
Query: 287 YALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWI---SNKIIDLI 343
                 FS  SD + FGV L E+ +                 Y  + WI    ++I+  I
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFT-----------------YGQEPWIGLNGSQILHKI 237
Query: 344 DSVLEEASFNESLSRYVH-IALLCVQERAEDRPT 376
           D   E     E   + ++ + + C   + EDRPT
Sbjct: 238 DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPT 271

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 104/220 (47%), Gaps = 24/220 (10%)
Query: 107 ATGNFSAANKLGEGGFGTVYKGVIGQGE--IAVKRLL---GKSGQEIKELKNEASV--IA 159
           AT  +    ++G G +GTVYK         +A+K +    G+ G  I  ++  A +  + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 160 QVQHKNLVKLLG-CCIEKDER----LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIK 214
             +H N+V+L+  C   + +R     L++E++ ++ L  +L D      L   T   +++
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 215 GVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTS 274
              +GL +LH      I+HRDLK  NIL+      K++DFG+ARI          Q   +
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY-------SYQMALA 169
Query: 275 RISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK 314
            +  T  Y +PE  L+  ++   D++S G +  E+   K 
Sbjct: 170 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKP 209

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 117/273 (42%), Gaps = 38/273 (13%)
Query: 116 KLGEGGFGTVYKGVIGQGE-----IAVKRL---LGKSGQEIKELKNEASVIAQVQHKNLV 167
           KLG+G FG V +G           +AVK L   +    + + +   E + +  + H+NL+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 168 KLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYS 227
           +L G  +    ++ + E  P  SL   L       +L   +R  +   VA+G+ YL    
Sbjct: 75  RLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK- 130
Query: 228 RVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEY 287
             R IHRDL A N+LL      KI DFG+ R +   +D   +Q +       + + +PE 
Sbjct: 131 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV---PFAWCAPES 185
Query: 288 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWI---SNKIIDLID 344
                FS  SD + FGV L E+ +                 Y  + WI    ++I+  ID
Sbjct: 186 LKTRTFSHASDTWMFGVTLWEMFT-----------------YGQEPWIGLNGSQILHKID 228
Query: 345 SVLEEASFNESLSRYVH-IALLCVQERAEDRPT 376
              E     E   + ++ + + C   + EDRPT
Sbjct: 229 KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPT 261

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 97/209 (46%), Gaps = 17/209 (8%)
Query: 110 NFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKS---GQEIKELKNEASVIAQVQHK 164
           +F     LGEG F TV   + +    E A+K L  +      ++  +  E  V++++ H 
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 165 NLVKLLGCCIEKDERLLI-YEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYL 223
             VKL     + DE+L     Y  N    C L    K    D          +   L YL
Sbjct: 93  FFVKLY-FTFQDDEKLYFGLSYAKN---GCLLKYIRKIGSFDETCTRFYTAEIVSALEYL 148
Query: 224 HQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYM 283
           H      IIHRDLK  NILL++DM+ +I+DFG A+++      +  Q   +   GT  Y+
Sbjct: 149 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL----SPESKQARANSFVGTAQYV 201
Query: 284 SPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           SPE   E   S  SD+++ G ++ ++V+G
Sbjct: 202 SPELLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 108/212 (50%), Gaps = 28/212 (13%)
Query: 111 FSAANKLGEGGFGTVYKGVIGQGE-IAVKRL-LGKSGQEIKELK-NEASVIAQVQHKNLV 167
           +    K+GEG +G VYK     GE  A+K++ L K  + I      E S++ +++H N+V
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 168 KLLGCCIEKDERLLIYEYMPN---KSLDCF---LFDPTKREILDWRTRVQIIKGVAQGLL 221
           KL      K   +L++E++     K LD     L   T +  L     +Q++ G+A    
Sbjct: 64  KLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFL-----LQLLNGIA---- 114
Query: 222 YLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYG 281
           Y H     R++HRDLK  N+L++++   KI+DFG+AR  FG      ++  T  +  T  
Sbjct: 115 YCHDR---RVLHRDLKPQNLLINREGELKIADFGLAR-AFG----IPVRKYTHEVV-TLW 165
Query: 282 YMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSG 312
           Y +P+  +    +S   D++S G +  E+V+G
Sbjct: 166 YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 108/212 (50%), Gaps = 28/212 (13%)
Query: 111 FSAANKLGEGGFGTVYKGVIGQGE-IAVKRL-LGKSGQEIKELK-NEASVIAQVQHKNLV 167
           +    K+GEG +G VYK     GE  A+K++ L K  + I      E S++ +++H N+V
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 168 KLLGCCIEKDERLLIYEYMPN---KSLDCF---LFDPTKREILDWRTRVQIIKGVAQGLL 221
           KL      K   +L++E++     K LD     L   T +  L     +Q++ G+A    
Sbjct: 64  KLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFL-----LQLLNGIA---- 114
Query: 222 YLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYG 281
           Y H     R++HRDLK  N+L++++   KI+DFG+AR  FG      ++  T  +  T  
Sbjct: 115 YCHDR---RVLHRDLKPQNLLINREGELKIADFGLAR-AFG----IPVRKYTHEVV-TLW 165
Query: 282 YMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSG 312
           Y +P+  +    +S   D++S G +  E+V+G
Sbjct: 166 YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 117/273 (42%), Gaps = 38/273 (13%)
Query: 116 KLGEGGFGTVYKGVIGQGE-----IAVKRL---LGKSGQEIKELKNEASVIAQVQHKNLV 167
           KLG+G FG V +G           +AVK L   +    + + +   E + +  + H+NL+
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 168 KLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYS 227
           +L G  +    ++ + E  P  SL   L       +L   +R  +   VA+G+ YL    
Sbjct: 79  RLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK- 134
Query: 228 RVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEY 287
             R IHRDL A N+LL      KI DFG+ R +   +D   +Q +       + + +PE 
Sbjct: 135 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV---PFAWCAPES 189
Query: 288 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWI---SNKIIDLID 344
                FS  SD + FGV L E+ +                 Y  + WI    ++I+  ID
Sbjct: 190 LKTRTFSHASDTWMFGVTLWEMFT-----------------YGQEPWIGLNGSQILHKID 232
Query: 345 SVLEEASFNESLSRYVH-IALLCVQERAEDRPT 376
              E     E   + ++ + + C   + EDRPT
Sbjct: 233 KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPT 265

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 107/214 (50%), Gaps = 26/214 (12%)
Query: 110 NFSAANKLGEGGFGTVYKG---VIGQGEIAVKRLL------GKSGQEIKELKNEASVIAQ 160
           NF    K+GEG +G VYK    + G+  +A+K++       G     I+E+    S++ +
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGE-VVALKKIRLDTETEGVPSTAIREI----SLLKE 61
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           + H N+VKLL     +++  L++E++ ++ L  F+ D +    +        +  + QGL
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKTFM-DASALTGIPLPLIKSYLFQLLQGL 119
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY 280
            + H +   R++HRDLK  N+L++ +   K++DFG+AR  FG                T 
Sbjct: 120 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-----TL 170
Query: 281 GYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGK 313
            Y +PE  L    +S   D++S G +  E+V+ +
Sbjct: 171 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 104/220 (47%), Gaps = 24/220 (10%)
Query: 107 ATGNFSAANKLGEGGFGTVYKGVIGQGE--IAVKRLLGKSGQE---IKELKNEASV--IA 159
           AT  +    ++G G +GTVYK         +A+K +   +G+E   I  ++  A +  + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 160 QVQHKNLVKLLG-CCIEKDER----LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIK 214
             +H N+V+L+  C   + +R     L++E++ ++ L  +L D      L   T   +++
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 215 GVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTS 274
              +GL +LH      I+HRDLK  NIL+      K++DFG+ARI          Q    
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY-------SYQMALD 169
Query: 275 RISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK 314
            +  T  Y +PE  L+  ++   D++S G +  E+   K 
Sbjct: 170 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKP 209

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 107/214 (50%), Gaps = 26/214 (12%)
Query: 110 NFSAANKLGEGGFGTVYKG---VIGQGEIAVKRLL------GKSGQEIKELKNEASVIAQ 160
           NF    K+GEG +G VYK    + G+  +A+K++       G     I+E+    S++ +
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGE-VVALKKIRLDTETEGVPSTAIREI----SLLKE 58
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           + H N+VKLL     +++  L++E++ ++ L  F+ D +    +        +  + QGL
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGL 116
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY 280
            + H +   R++HRDLK  N+L++ +   K++DFG+AR  FG                T 
Sbjct: 117 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-----TL 167
Query: 281 GYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGK 313
            Y +PE  L    +S   D++S G +  E+V+ +
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 101/214 (47%), Gaps = 27/214 (12%)
Query: 110 NFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKS---GQEIKELKNEASVIAQVQHK 164
           +F     LGEG F TV   + +    E A+K L  +      ++  +  E  V++++ H 
Sbjct: 8   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 67
Query: 165 NLVKLLGCCIEKDERLLI-YEYMPNKSLDCFL-----FDPTKREILDWRTRVQIIKGVAQ 218
             VKL     + DE+L     Y  N  L  ++     FD T        TR    + +  
Sbjct: 68  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-------TRFYTAE-IVS 118
Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
            L YLH      IIHRDLK  NILL++DM+ +I+DFG A+++      +  Q   +   G
Sbjct: 119 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL----SPESKQARANXFVG 171
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           T  Y+SPE   E      SD+++ G ++ ++V+G
Sbjct: 172 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 107/214 (50%), Gaps = 26/214 (12%)
Query: 110 NFSAANKLGEGGFGTVYKG---VIGQGEIAVKRLL------GKSGQEIKELKNEASVIAQ 160
           NF    K+GEG +G VYK    + G+  +A+K++       G     I+E+    S++ +
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGE-VVALKKIRLDTETEGVPSTAIREI----SLLKE 58
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           + H N+VKLL     +++  L++E++ ++ L  F+ D +    +        +  + QGL
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGL 116
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY 280
            + H +   R++HRDLK  N+L++ +   K++DFG+AR  FG                T 
Sbjct: 117 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-----TL 167
Query: 281 GYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGK 313
            Y +PE  L    +S   D++S G +  E+V+ +
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 107/214 (50%), Gaps = 26/214 (12%)
Query: 110 NFSAANKLGEGGFGTVYKG---VIGQGEIAVKRLL------GKSGQEIKELKNEASVIAQ 160
           NF    K+GEG +G VYK    + G+  +A+K++       G     I+E+    S++ +
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGE-VVALKKIRLDTETEGVPSTAIREI----SLLKE 57
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           + H N+VKLL     +++  L++E++ ++ L  F+ D +    +        +  + QGL
Sbjct: 58  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGL 115
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY 280
            + H +   R++HRDLK  N+L++ +   K++DFG+AR  FG                T 
Sbjct: 116 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-----TL 166
Query: 281 GYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGK 313
            Y +PE  L    +S   D++S G +  E+V+ +
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 107/214 (50%), Gaps = 26/214 (12%)
Query: 110 NFSAANKLGEGGFGTVYKG---VIGQGEIAVKRLL------GKSGQEIKELKNEASVIAQ 160
           NF    K+GEG +G VYK    + G+  +A+K++       G     I+E+    S++ +
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGE-VVALKKIRLDTETEGVPSTAIREI----SLLKE 58
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           + H N+VKLL     +++  L++E++ ++ L  F+ D +    +        +  + QGL
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGL 116
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY 280
            + H +   R++HRDLK  N+L++ +   K++DFG+AR  FG                T 
Sbjct: 117 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-----TL 167
Query: 281 GYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGK 313
            Y +PE  L    +S   D++S G +  E+V+ +
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 101/214 (47%), Gaps = 27/214 (12%)
Query: 110 NFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKS---GQEIKELKNEASVIAQVQHK 164
           +F     LGEG F TV   + +    E A+K L  +      ++  +  E  V++++ H 
Sbjct: 11  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 70
Query: 165 NLVKLLGCCIEKDERLLI-YEYMPNKSLDCFL-----FDPTKREILDWRTRVQIIKGVAQ 218
             VKL     + DE+L     Y  N  L  ++     FD T        TR    + +  
Sbjct: 71  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-------TRFYTAE-IVS 121
Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
            L YLH      IIHRDLK  NILL++DM+ +I+DFG A+++      +  Q   +   G
Sbjct: 122 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL----SPESKQARANXFVG 174
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           T  Y+SPE   E      SD+++ G ++ ++V+G
Sbjct: 175 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 101/214 (47%), Gaps = 27/214 (12%)
Query: 110 NFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKS---GQEIKELKNEASVIAQVQHK 164
           +F     LGEG F TV   + +    E A+K L  +      ++  +  E  V++++ H 
Sbjct: 10  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 69
Query: 165 NLVKLLGCCIEKDERLLI-YEYMPNKSLDCFL-----FDPTKREILDWRTRVQIIKGVAQ 218
             VKL     + DE+L     Y  N  L  ++     FD T        TR    + +  
Sbjct: 70  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-------TRFYTAE-IVS 120
Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
            L YLH      IIHRDLK  NILL++DM+ +I+DFG A+++      +  Q   +   G
Sbjct: 121 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL----SPESKQARANXFVG 173
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           T  Y+SPE   E      SD+++ G ++ ++V+G
Sbjct: 174 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 101/214 (47%), Gaps = 27/214 (12%)
Query: 110 NFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKS---GQEIKELKNEASVIAQVQHK 164
           +F     LGEG F TV   + +    E A+K L  +      ++  +  E  V++++ H 
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 165 NLVKLLGCCIEKDERLLI-YEYMPNKSLDCFL-----FDPTKREILDWRTRVQIIKGVAQ 218
             VKL     + DE+L     Y  N  L  ++     FD T        TR    + +  
Sbjct: 69  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-------TRFYTAE-IVS 119
Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
            L YLH      IIHRDLK  NILL++DM+ +I+DFG A+++      +  Q   +   G
Sbjct: 120 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL----SPESKQARANXFVG 172
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           T  Y+SPE   E      SD+++ G ++ ++V+G
Sbjct: 173 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 106/215 (49%), Gaps = 28/215 (13%)
Query: 109 GNFSAANKLGEGGFGTV-----YKGVIGQGEIAVK----RLLGKSGQEIKELKNEASVIA 159
           G +     LGEG FG V     YK    Q ++A+K    +LL KS   ++ ++ E S + 
Sbjct: 9   GPYIIRETLGEGSFGKVKLATHYKT---QQKVALKFISRQLLKKSDMHMR-VEREISYLK 64
Query: 160 QVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQG 219
            ++H +++KL        + +++ EY   +  D  +      E    R   QII  +   
Sbjct: 65  LLRHPHIIKLYDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIE-- 122
Query: 220 LLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGT 279
             Y H++   +I+HRDLK  N+LLD ++N KI+DFG++ I+  GN             G+
Sbjct: 123 --YCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-------FLKTSCGS 170
Query: 280 YGYMSPEYALEGIFS-IKSDVFSFGVLLLEIVSGK 313
             Y +PE     +++  + DV+S G++L  ++ G+
Sbjct: 171 PNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGR 205

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 107/214 (50%), Gaps = 26/214 (12%)
Query: 110 NFSAANKLGEGGFGTVYKG---VIGQGEIAVKRLL------GKSGQEIKELKNEASVIAQ 160
           NF    K+GEG +G VYK    + G+  +A+K++       G     I+E+    S++ +
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGE-VVALKKIRLDTETEGVPSTAIREI----SLLKE 58
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           + H N+VKLL     +++  L++E++ ++ L  F+ D +    +        +  + QGL
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGL 116
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY 280
            + H +   R++HRDLK  N+L++ +   K++DFG+AR  FG                T 
Sbjct: 117 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-----TL 167
Query: 281 GYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGK 313
            Y +PE  L    +S   D++S G +  E+V+ +
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 101/214 (47%), Gaps = 27/214 (12%)
Query: 110 NFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKS---GQEIKELKNEASVIAQVQHK 164
           +F     LGEG F TV   + +    E A+K L  +      ++  +  E  V++++ H 
Sbjct: 15  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 74
Query: 165 NLVKLLGCCIEKDERLLI-YEYMPNKSLDCFL-----FDPTKREILDWRTRVQIIKGVAQ 218
             VKL     + DE+L     Y  N  L  ++     FD T        TR    + +  
Sbjct: 75  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-------TRFYTAE-IVS 125
Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
            L YLH      IIHRDLK  NILL++DM+ +I+DFG A+++      +  Q   +   G
Sbjct: 126 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL----SPESKQARANXFVG 178
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           T  Y+SPE   E      SD+++ G ++ ++V+G
Sbjct: 179 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 107/214 (50%), Gaps = 26/214 (12%)
Query: 110 NFSAANKLGEGGFGTVYKG---VIGQGEIAVKRLL------GKSGQEIKELKNEASVIAQ 160
           NF    K+GEG +G VYK    + G+  +A+K++       G     I+E+    S++ +
Sbjct: 6   NFQKVEKIGEGTYGVVYKARNKLTGE-VVALKKIRLDTETEGVPSTAIREI----SLLKE 60
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           + H N+VKLL     +++  L++E++ ++ L  F+ D +    +        +  + QGL
Sbjct: 61  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGL 118
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY 280
            + H +   R++HRDLK  N+L++ +   K++DFG+AR  FG                T 
Sbjct: 119 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-----TL 169
Query: 281 GYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGK 313
            Y +PE  L    +S   D++S G +  E+V+ +
Sbjct: 170 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 107/214 (50%), Gaps = 26/214 (12%)
Query: 110 NFSAANKLGEGGFGTVYKG---VIGQGEIAVKRLL------GKSGQEIKELKNEASVIAQ 160
           NF    K+GEG +G VYK    + G+  +A+K++       G     I+E+    S++ +
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGE-VVALKKIRLDTETEGVPSTAIREI----SLLKE 57
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           + H N+VKLL     +++  L++E++ ++ L  F+ D +    +        +  + QGL
Sbjct: 58  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGL 115
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY 280
            + H +   R++HRDLK  N+L++ +   K++DFG+AR  FG                T 
Sbjct: 116 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-----TL 166
Query: 281 GYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGK 313
            Y +PE  L    +S   D++S G +  E+V+ +
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 103/220 (46%), Gaps = 24/220 (10%)
Query: 107 ATGNFSAANKLGEGGFGTVYKGVIGQGE--IAVKRLL---GKSGQEIKELKNEASV--IA 159
           AT  +    ++G G +GTVYK         +A+K +    G+ G  I  ++  A +  + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 160 QVQHKNLVKLLG-CCIEKDER----LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIK 214
             +H N+V+L+  C   + +R     L++E++ ++ L  +L D      L   T   +++
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 215 GVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTS 274
              +GL +LH      I+HRDLK  NIL+      K++DFG+ARI          Q    
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY-------SYQMALF 169
Query: 275 RISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK 314
            +  T  Y +PE  L+  ++   D++S G +  E+   K 
Sbjct: 170 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKP 209

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 107/214 (50%), Gaps = 26/214 (12%)
Query: 110 NFSAANKLGEGGFGTVYKG---VIGQGEIAVKRLL------GKSGQEIKELKNEASVIAQ 160
           NF    K+GEG +G VYK    + G+  +A+K++       G     I+E+    S++ +
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGE-VVALKKIRLDTETEGVPSTAIREI----SLLKE 59
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           + H N+VKLL     +++  L++E++ ++ L  F+ D +    +        +  + QGL
Sbjct: 60  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGL 117
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY 280
            + H +   R++HRDLK  N+L++ +   K++DFG+AR  FG                T 
Sbjct: 118 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-----TL 168
Query: 281 GYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGK 313
            Y +PE  L    +S   D++S G +  E+V+ +
Sbjct: 169 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 107/214 (50%), Gaps = 26/214 (12%)
Query: 110 NFSAANKLGEGGFGTVYKG---VIGQGEIAVKRLL------GKSGQEIKELKNEASVIAQ 160
           NF    K+GEG +G VYK    + G+  +A+K++       G     I+E+    S++ +
Sbjct: 8   NFQKVEKIGEGTYGVVYKARNKLTGE-VVALKKIRLDTETEGVPSTAIREI----SLLKE 62
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           + H N+VKLL     +++  L++E++ ++ L  F+ D +    +        +  + QGL
Sbjct: 63  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGL 120
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY 280
            + H +   R++HRDLK  N+L++ +   K++DFG+AR  FG                T 
Sbjct: 121 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-----TL 171
Query: 281 GYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGK 313
            Y +PE  L    +S   D++S G +  E+V+ +
Sbjct: 172 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 107/214 (50%), Gaps = 26/214 (12%)
Query: 110 NFSAANKLGEGGFGTVYKG---VIGQGEIAVKRLL------GKSGQEIKELKNEASVIAQ 160
           NF    K+GEG +G VYK    + G+  +A+K++       G     I+E+    S++ +
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGE-VVALKKIRLDTETEGVPSTAIREI----SLLKE 59
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           + H N+VKLL     +++  L++E++ ++ L  F+ D +    +        +  + QGL
Sbjct: 60  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGL 117
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY 280
            + H +   R++HRDLK  N+L++ +   K++DFG+AR  FG                T 
Sbjct: 118 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-----TL 168
Query: 281 GYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGK 313
            Y +PE  L    +S   D++S G +  E+V+ +
Sbjct: 169 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 108/227 (47%), Gaps = 30/227 (13%)
Query: 98  LFSFSSVSSATGNFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKSGQEIKELKNEA 155
           +F   S +  +  +     LG+G FG V   K  I   E AVK +   S +++K+  ++ 
Sbjct: 15  MFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVI---SKRQVKQKTDKE 71
Query: 156 SVIAQVQ------HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPT-KREILDWRT 208
           S++ +VQ      H N++KL     +K    L+ E      L    FD    R+      
Sbjct: 72  SLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVD 127
Query: 209 RVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLD---KDMNSKISDFGMARIVFGGND 265
             +II+ V  G+ Y+H   + +I+HRDLK  N+LL+   KD N +I DFG++        
Sbjct: 128 AARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF----- 179
Query: 266 EDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
             E         GT  Y++PE  L G +  K DV+S GV+L  ++SG
Sbjct: 180 --EASKKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 107/214 (50%), Gaps = 26/214 (12%)
Query: 110 NFSAANKLGEGGFGTVYKG---VIGQGEIAVKRLL------GKSGQEIKELKNEASVIAQ 160
           NF    K+GEG +G VYK    + G+  +A+K++       G     I+E+    S++ +
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGE-VVALKKIRLDTETEGVPSTAIREI----SLLKE 61
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           + H N+VKLL     +++  L++E++ ++ L  F+ D +    +        +  + QGL
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGL 119
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY 280
            + H +   R++HRDLK  N+L++ +   K++DFG+AR  FG                T 
Sbjct: 120 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-----TL 170
Query: 281 GYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGK 313
            Y +PE  L    +S   D++S G +  E+V+ +
Sbjct: 171 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 107/214 (50%), Gaps = 26/214 (12%)
Query: 110 NFSAANKLGEGGFGTVYKG---VIGQGEIAVKRLL------GKSGQEIKELKNEASVIAQ 160
           NF    K+GEG +G VYK    + G+  +A+K++       G     I+E+    S++ +
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGE-VVALKKIRLDTETEGVPSTAIREI----SLLKE 59
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           + H N+VKLL     +++  L++E++ ++ L  F+ D +    +        +  + QGL
Sbjct: 60  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGL 117
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY 280
            + H +   R++HRDLK  N+L++ +   K++DFG+AR  FG                T 
Sbjct: 118 AFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-----TL 168
Query: 281 GYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGK 313
            Y +PE  L    +S   D++S G +  E+V+ +
Sbjct: 169 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 107/214 (50%), Gaps = 26/214 (12%)
Query: 110 NFSAANKLGEGGFGTVYKG---VIGQGEIAVKRLL------GKSGQEIKELKNEASVIAQ 160
           NF    K+GEG +G VYK    + G+  +A+K++       G     I+E+    S++ +
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGE-VVALKKIRLDTETEGVPSTAIREI----SLLKE 58
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           + H N+VKLL     +++  L++E++ ++ L  F+ D +    +        +  + QGL
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKDFM-DASALTGIPLPLIKSYLFQLLQGL 116
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY 280
            + H +   R++HRDLK  N+L++ +   K++DFG+AR  FG                T 
Sbjct: 117 AFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-----TL 167
Query: 281 GYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGK 313
            Y +PE  L    +S   D++S G +  E+V+ +
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 107/214 (50%), Gaps = 26/214 (12%)
Query: 110 NFSAANKLGEGGFGTVYKG---VIGQGEIAVKRLL------GKSGQEIKELKNEASVIAQ 160
           NF    K+GEG +G VYK    + G+  +A+K++       G     I+E+    S++ +
Sbjct: 6   NFQKVEKIGEGTYGVVYKARNKLTGE-VVALKKIRLDTETEGVPSTAIREI----SLLKE 60
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           + H N+VKLL     +++  L++E++ ++ L  F+ D +    +        +  + QGL
Sbjct: 61  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGL 118
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY 280
            + H +   R++HRDLK  N+L++ +   K++DFG+AR  FG                T 
Sbjct: 119 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-----TL 169
Query: 281 GYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGK 313
            Y +PE  L    +S   D++S G +  E+V+ +
Sbjct: 170 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 107/214 (50%), Gaps = 26/214 (12%)
Query: 110 NFSAANKLGEGGFGTVYKG---VIGQGEIAVKRLL------GKSGQEIKELKNEASVIAQ 160
           NF    K+GEG +G VYK    + G+  +A+K++       G     I+E+    S++ +
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGE-VVALKKIRLDTETEGVPSTAIREI----SLLKE 61
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           + H N+VKLL     +++  L++E++ ++ L  F+ D +    +        +  + QGL
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGL 119
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY 280
            + H +   R++HRDLK  N+L++ +   K++DFG+AR  FG                T 
Sbjct: 120 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-----TL 170
Query: 281 GYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGK 313
            Y +PE  L    +S   D++S G +  E+V+ +
Sbjct: 171 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 101/214 (47%), Gaps = 27/214 (12%)
Query: 110 NFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKS---GQEIKELKNEASVIAQVQHK 164
           +F     LGEG F TV   + +    E A+K L  +      ++  +  E  V++++ H 
Sbjct: 30  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 89
Query: 165 NLVKLLGCCIEKDERLLI-YEYMPNKSLDCFL-----FDPTKREILDWRTRVQIIKGVAQ 218
             VKL     + DE+L     Y  N  L  ++     FD T        TR    + +  
Sbjct: 90  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-------TRFYTAE-IVS 140
Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
            L YLH      IIHRDLK  NILL++DM+ +I+DFG A+++      +  Q   +   G
Sbjct: 141 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL----SPESKQARANSFVG 193
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           T  Y+SPE   E      SD+++ G ++ ++V+G
Sbjct: 194 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 107/214 (50%), Gaps = 26/214 (12%)
Query: 110 NFSAANKLGEGGFGTVYKG---VIGQGEIAVKRLL------GKSGQEIKELKNEASVIAQ 160
           NF    K+GEG +G VYK    + G+  +A+K++       G     I+E+    S++ +
Sbjct: 6   NFQKVEKIGEGTYGVVYKARNKLTGE-VVALKKIRLDTETEGVPSTAIREI----SLLKE 60
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           + H N+VKLL     +++  L++E++ ++ L  F+ D +    +        +  + QGL
Sbjct: 61  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGL 118
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY 280
            + H +   R++HRDLK  N+L++ +   K++DFG+AR  FG                T 
Sbjct: 119 AFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-----TL 169
Query: 281 GYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGK 313
            Y +PE  L    +S   D++S G +  E+V+ +
Sbjct: 170 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 101/214 (47%), Gaps = 27/214 (12%)
Query: 110 NFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKS---GQEIKELKNEASVIAQVQHK 164
           +F     LGEG F TV   + +    E A+K L  +      ++  +  E  V++++ H 
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 165 NLVKLLGCCIEKDERLLI-YEYMPNKSLDCFL-----FDPTKREILDWRTRVQIIKGVAQ 218
             VKL     + DE+L     Y  N  L  ++     FD T        TR    + +  
Sbjct: 91  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-------TRFYTAE-IVS 141
Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
            L YLH      IIHRDLK  NILL++DM+ +I+DFG A+++      +  Q   +   G
Sbjct: 142 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL----SPESKQARANXFVG 194
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           T  Y+SPE   E      SD+++ G ++ ++V+G
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 101/214 (47%), Gaps = 27/214 (12%)
Query: 110 NFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKS---GQEIKELKNEASVIAQVQHK 164
           +F     LGEG F TV   + +    E A+K L  +      ++  +  E  V++++ H 
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 165 NLVKLLGCCIEKDERLLI-YEYMPNKSLDCFL-----FDPTKREILDWRTRVQIIKGVAQ 218
             VKL     + DE+L     Y  N  L  ++     FD T        TR    + +  
Sbjct: 93  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-------TRFYTAE-IVS 143
Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
            L YLH      IIHRDLK  NILL++DM+ +I+DFG A+++      +  Q   +   G
Sbjct: 144 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL----SPESKQARANXFVG 196
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           T  Y+SPE   E      SD+++ G ++ ++V+G
Sbjct: 197 TAQYVSPELLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 101/214 (47%), Gaps = 27/214 (12%)
Query: 110 NFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKS---GQEIKELKNEASVIAQVQHK 164
           +F     LGEG F TV   + +    E A+K L  +      ++  +  E  V++++ H 
Sbjct: 30  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 89
Query: 165 NLVKLLGCCIEKDERLLI-YEYMPNKSLDCFL-----FDPTKREILDWRTRVQIIKGVAQ 218
             VKL     + DE+L     Y  N  L  ++     FD T        TR    + +  
Sbjct: 90  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-------TRFYTAE-IVS 140
Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
            L YLH      IIHRDLK  NILL++DM+ +I+DFG A+++      +  Q   +   G
Sbjct: 141 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL----SPESKQARANXFVG 193
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           T  Y+SPE   E      SD+++ G ++ ++V+G
Sbjct: 194 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 101/214 (47%), Gaps = 27/214 (12%)
Query: 110 NFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKS---GQEIKELKNEASVIAQVQHK 164
           +F     LGEG F TV   + +    E A+K L  +      ++  +  E  V++++ H 
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 165 NLVKLLGCCIEKDERLLI-YEYMPNKSLDCFL-----FDPTKREILDWRTRVQIIKGVAQ 218
             VKL     + DE+L     Y  N  L  ++     FD T        TR    + +  
Sbjct: 91  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-------TRFYTAE-IVS 141
Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
            L YLH      IIHRDLK  NILL++DM+ +I+DFG A+++      +  Q   +   G
Sbjct: 142 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL----SPESKQARANXFVG 194
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           T  Y+SPE   E      SD+++ G ++ ++V+G
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 101/214 (47%), Gaps = 27/214 (12%)
Query: 110 NFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKS---GQEIKELKNEASVIAQVQHK 164
           +F     LGEG F TV   + +    E A+K L  +      ++  +  E  V++++ H 
Sbjct: 36  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 95
Query: 165 NLVKLLGCCIEKDERLLI-YEYMPNKSLDCFL-----FDPTKREILDWRTRVQIIKGVAQ 218
             VKL     + DE+L     Y  N  L  ++     FD T        TR    + +  
Sbjct: 96  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-------TRFYTAE-IVS 146
Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
            L YLH      IIHRDLK  NILL++DM+ +I+DFG A+++      +  Q   +   G
Sbjct: 147 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL----SPESKQARANXFVG 199
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           T  Y+SPE   E      SD+++ G ++ ++V+G
Sbjct: 200 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 101/214 (47%), Gaps = 27/214 (12%)
Query: 110 NFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKS---GQEIKELKNEASVIAQVQHK 164
           +F     LGEG F TV   + +    E A+K L  +      ++  +  E  V++++ H 
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 165 NLVKLLGCCIEKDERLLI-YEYMPNKSLDCFL-----FDPTKREILDWRTRVQIIKGVAQ 218
             VKL     + DE+L     Y  N  L  ++     FD T        TR    + +  
Sbjct: 93  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-------TRFYTAE-IVS 143
Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
            L YLH      IIHRDLK  NILL++DM+ +I+DFG A+++      +  Q   +   G
Sbjct: 144 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL----SPESKQARANXFVG 196
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           T  Y+SPE   E      SD+++ G ++ ++V+G
Sbjct: 197 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 101/214 (47%), Gaps = 27/214 (12%)
Query: 110 NFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKS---GQEIKELKNEASVIAQVQHK 164
           +F     LGEG F TV   + +    E A+K L  +      ++  +  E  V++++ H 
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 165 NLVKLLGCCIEKDERLLI-YEYMPNKSLDCFL-----FDPTKREILDWRTRVQIIKGVAQ 218
             VKL     + DE+L     Y  N  L  ++     FD T        TR    + +  
Sbjct: 91  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-------TRFYTAE-IVS 141
Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
            L YLH      IIHRDLK  NILL++DM+ +I+DFG A+++      +  Q   +   G
Sbjct: 142 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL----SPESKQARANAFVG 194
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           T  Y+SPE   E      SD+++ G ++ ++V+G
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 99/200 (49%), Gaps = 15/200 (7%)
Query: 116 KLGEGGFGTV--YKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCC 173
           K+GEG  G V   +      ++AVK +  +  Q  + L NE  ++   QH N+V++    
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
           +  +E  ++ E++   +L     D   +  L+      + + V Q L YLH      +IH
Sbjct: 112 LVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHAQG---VIH 164
Query: 234 RDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIF 293
           RD+K+ +ILL  D   K+SDFG     F      ++      + GT  +M+PE     ++
Sbjct: 165 RDIKSDSILLTLDGRVKLSDFG-----FCAQISKDVPKRKXLV-GTPYWMAPEVISRSLY 218
Query: 294 SIKSDVFSFGVLLLEIVSGK 313
           + + D++S G++++E+V G+
Sbjct: 219 ATEVDIWSLGIMVIEMVDGE 238

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 101/214 (47%), Gaps = 27/214 (12%)
Query: 110 NFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKS---GQEIKELKNEASVIAQVQHK 164
           +F     LGEG F TV   + +    E A+K L  +      ++  +  E  V++++ H 
Sbjct: 34  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 93
Query: 165 NLVKLLGCCIEKDERLLI-YEYMPNKSLDCFL-----FDPTKREILDWRTRVQIIKGVAQ 218
             VKL     + DE+L     Y  N  L  ++     FD T        TR    + +  
Sbjct: 94  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-------TRFYTAE-IVS 144
Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
            L YLH      IIHRDLK  NILL++DM+ +I+DFG A+++      +  Q   +   G
Sbjct: 145 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL----SPESKQARANXFVG 197
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           T  Y+SPE   E      SD+++ G ++ ++V+G
Sbjct: 198 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 101/214 (47%), Gaps = 27/214 (12%)
Query: 110 NFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKS---GQEIKELKNEASVIAQVQHK 164
           +F     LGEG F TV   + +    E A+K L  +      ++  +  E  V++++ H 
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 165 NLVKLLGCCIEKDERLLI-YEYMPNKSLDCFL-----FDPTKREILDWRTRVQIIKGVAQ 218
             VKL     + DE+L     Y  N  L  ++     FD T        TR    + +  
Sbjct: 93  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-------TRFYTAE-IVS 143
Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
            L YLH      IIHRDLK  NILL++DM+ +I+DFG A+++      +  Q   +   G
Sbjct: 144 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL----SPESKQARANXFVG 196
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           T  Y+SPE   E      SD+++ G ++ ++V+G
Sbjct: 197 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 79/304 (25%), Positives = 135/304 (44%), Gaps = 55/304 (18%)
Query: 117 LGEGGFGTVYK------GVIGQGEIAVKRLLGKSGQEI--KELKNEASVIAQVQHKNLVK 168
           +GEG +G V K      G I    +A+K+ L     ++  K    E  ++ Q++H+NLV 
Sbjct: 33  VGEGSYGMVMKCRNKDTGRI----VAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVN 88
Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSR 228
           LL  C +K    L++E++ +  LD     P     LD++   + +  +  G+ + H ++ 
Sbjct: 89  LLEVCKKKKRWYLVFEFVDHTILDDLELFPNG---LDYQVVQKYLFQIINGIGFCHSHN- 144
Query: 229 VRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGND--EDELQGNTSRISGTYGYMSPE 286
             IIHRD+K  NIL+ +    K+ DFG AR +    +  +DE+         T  Y +PE
Sbjct: 145 --IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEV--------ATRWYRAPE 194
Query: 287 YALEGI-FSIKSDVFSFGVLLLEIVSGKK--------NTGFYRTKSL-NLIGYAWDLWIS 336
             +  + +    DV++ G L+ E+  G+         +  ++    L NLI    +L+  
Sbjct: 195 LLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK 254
Query: 337 NKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQ 396
           N +   +   L E    E L R                P +S+VV  L  +   + P K+
Sbjct: 255 NPVFAGVR--LPEIKEREPLERRY--------------PKLSEVVIDLAKKCLHIDPDKR 298
Query: 397 PAFC 400
           P FC
Sbjct: 299 P-FC 301

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 101/214 (47%), Gaps = 27/214 (12%)
Query: 110 NFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKS---GQEIKELKNEASVIAQVQHK 164
           +F     LGEG F TV   + +    E A+K L  +      ++  +  E  V++++ H 
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 165 NLVKLLGCCIEKDERLLI-YEYMPNKSLDCFL-----FDPTKREILDWRTRVQIIKGVAQ 218
             VKL     + DE+L     Y  N  L  ++     FD T        TR    + +  
Sbjct: 93  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-------TRFYTAE-IVS 143
Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
            L YLH      IIHRDLK  NILL++DM+ +I+DFG A+++      +  Q   +   G
Sbjct: 144 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL----SPESKQARANXFVG 196
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           T  Y+SPE   E      SD+++ G ++ ++V+G
Sbjct: 197 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 101/214 (47%), Gaps = 27/214 (12%)
Query: 110 NFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKS---GQEIKELKNEASVIAQVQHK 164
           +F     LGEG F TV   + +    E A+K L  +      ++  +  E  V++++ H 
Sbjct: 34  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 93
Query: 165 NLVKLLGCCIEKDERLLI-YEYMPNKSLDCFL-----FDPTKREILDWRTRVQIIKGVAQ 218
             VKL     + DE+L     Y  N  L  ++     FD T        TR    + +  
Sbjct: 94  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-------TRFYTAE-IVS 144
Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
            L YLH      IIHRDLK  NILL++DM+ +I+DFG A+++      +  Q   +   G
Sbjct: 145 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL----SPESKQARANSFVG 197
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           T  Y+SPE   E      SD+++ G ++ ++V+G
Sbjct: 198 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 101/214 (47%), Gaps = 27/214 (12%)
Query: 110 NFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKS---GQEIKELKNEASVIAQVQHK 164
           +F     LGEG F TV   + +    E A+K L  +      ++  +  E  V++++ H 
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 165 NLVKLLGCCIEKDERLLI-YEYMPNKSLDCFL-----FDPTKREILDWRTRVQIIKGVAQ 218
             VKL     + DE+L     Y  N  L  ++     FD T        TR    + +  
Sbjct: 93  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-------TRFYTAE-IVS 143
Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
            L YLH      IIHRDLK  NILL++DM+ +I+DFG A+++      +  Q   +   G
Sbjct: 144 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL----SPESKQARANXFVG 196
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           T  Y+SPE   E      SD+++ G ++ ++V+G
Sbjct: 197 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 40/96 (41%), Positives = 61/96 (63%), Gaps = 7/96 (7%)
Query: 216 VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR 275
           VA+G+ +L   +  + IHRDL A NILL +    KI DFG+AR ++   D D ++   +R
Sbjct: 200 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY--KDPDYVRKGDAR 254
Query: 276 ISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
           +     +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 255 LP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 108/227 (47%), Gaps = 30/227 (13%)
Query: 98  LFSFSSVSSATGNFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKSGQEIKELKNEA 155
           +F   S +  +  +     LG+G FG V   K  I   E AVK +   S +++K+  ++ 
Sbjct: 21  MFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVI---SKRQVKQKTDKE 77
Query: 156 SVIAQVQ------HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPT-KREILDWRT 208
           S++ +VQ      H N++KL     +K    L+ E      L    FD    R+      
Sbjct: 78  SLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVD 133
Query: 209 RVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLD---KDMNSKISDFGMARIVFGGND 265
             +II+ V  G+ Y+H   + +I+HRDLK  N+LL+   KD N +I DFG++        
Sbjct: 134 AARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF----- 185
Query: 266 EDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
             E         GT  Y++PE  L G +  K DV+S GV+L  ++SG
Sbjct: 186 --EASKKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 229

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 104/216 (48%), Gaps = 40/216 (18%)
Query: 115 NKLGEGGFGTVYKGVIGQG----------EIAVKRLLGKSGQEIKELKNEASVIAQVQHK 164
            K+GEG FG   K ++ +           EI + R+   S +E +E + E +V+A ++H 
Sbjct: 30  QKIGEGSFG---KAILVKSTEDGRQYVIKEINISRM---SSKEREESRREVAVLANMKHP 83
Query: 165 NLVKLLGCCIEKDERLLIYEYMPNKSL-------DCFLFDPTKREILDWRTRVQIIKGVA 217
           N+V+      E     ++ +Y     L          LF   + +ILDW   VQI     
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQ--EDQILDWF--VQIC---- 135
Query: 218 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRIS 277
             L   H + R +I+HRD+K+ NI L KD   ++ DFG+AR++   N   EL        
Sbjct: 136 --LALKHVHDR-KILHRDIKSQNIFLTKDGTVQLGDFGIARVL---NSTVEL---ARACI 186
Query: 278 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           GT  Y+SPE      ++ KSD+++ G +L E+ + K
Sbjct: 187 GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLK 222

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 40/96 (41%), Positives = 61/96 (63%), Gaps = 7/96 (7%)
Query: 216 VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR 275
           VA+G+ +L   +  + IHRDL A NILL +    KI DFG+AR ++   D D ++   +R
Sbjct: 209 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY--KDPDYVRKGDAR 263
Query: 276 ISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
           +     +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 264 LP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 40/96 (41%), Positives = 61/96 (63%), Gaps = 7/96 (7%)
Query: 216 VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR 275
           VA+G+ +L   +  + IHRDL A NILL +    KI DFG+AR ++   D D ++   +R
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY--KDPDYVRKGDAR 256
Query: 276 ISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
           +     +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 257 LP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 113/234 (48%), Gaps = 21/234 (8%)
Query: 87  KGCEKEVDQFPLFSFSSVSSATGNFSAANKLGEGGFGTVY--KGVI--GQGEIAVKRLLG 142
           +G  KE+         S  +   +F     LG+G FG V+  + V     G +   ++L 
Sbjct: 6   EGVLKEISITHHVKAGSEKADPSHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLK 65
Query: 143 KSGQEIKE---LKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPT 199
           K+  ++++    K E  ++A V H  +VKL      + +  LI +++    L    F   
Sbjct: 66  KATLKVRDRVRTKMERDILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDL----FTRL 121
Query: 200 KREILDWRTRVQI-IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMAR 258
            +E++     V+  +  +A GL +LH    + II+RDLK  NILLD++ + K++DFG+++
Sbjct: 122 SKEVMFTEEDVKFYLAELALGLDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK 178
Query: 259 IVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
                    + +       GT  YM+PE       S  +D +S+GVL+ E+++G
Sbjct: 179 EAI------DHEKKAYSFCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTG 226

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 40/96 (41%), Positives = 61/96 (63%), Gaps = 7/96 (7%)
Query: 216 VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR 275
           VA+G+ +L   +  + IHRDL A NILL +    KI DFG+AR ++   D D ++   +R
Sbjct: 207 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY--KDPDYVRKGDAR 261
Query: 276 ISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
           +     +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 262 LP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 106/215 (49%), Gaps = 28/215 (13%)
Query: 110 NFSAANKLGEGGFGTVYKG---VIGQGEIAVKRLL------GKSGQEIKELKNEASVIAQ 160
           NF    K+GEG +G VYK    + G+  +A+K++       G     I+E+    S++ +
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGE-VVALKKIRLDTETEGVPSTAIREI----SLLKE 59
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLF-DPTKREILDWRTRVQIIKGVAQG 219
           + H N+VKLL     +++  L++E++   S+D   F D +    +        +  + QG
Sbjct: 60  LNHPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQG 116
Query: 220 LLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGT 279
           L + H +   R++HRDLK  N+L++ +   K++DFG+AR  FG                T
Sbjct: 117 LAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-----T 167
Query: 280 YGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGK 313
             Y +PE  L    +S   D++S G +  E+V+ +
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 106/215 (49%), Gaps = 28/215 (13%)
Query: 110 NFSAANKLGEGGFGTVYKG---VIGQGEIAVKRLL------GKSGQEIKELKNEASVIAQ 160
           NF    K+GEG +G VYK    + G+  +A+K++       G     I+E+    S++ +
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGE-VVALKKIRLDTETEGVPSTAIREI----SLLKE 61
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLF-DPTKREILDWRTRVQIIKGVAQG 219
           + H N+VKLL     +++  L++E++   S+D   F D +    +        +  + QG
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQG 118
Query: 220 LLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGT 279
           L + H +   R++HRDLK  N+L++ +   K++DFG+AR  FG                T
Sbjct: 119 LAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-----T 169
Query: 280 YGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGK 313
             Y +PE  L    +S   D++S G +  E+V+ +
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 17/200 (8%)
Query: 117 LGEGGFGTVYKGVIGQGE-----IAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNLVKLL 170
           +GEG FG V++G+    E     +A+K     +   ++E    EA  + Q  H ++VKL+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVR 230
           G  I ++   +I E      L  FL    ++  LD  + +     ++  L YL      R
Sbjct: 78  GV-ITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 131
Query: 231 IIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE 290
            +HRD+ A N+L+  +   K+ DFG++R +     ED      S+      +M+PE    
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-----EDSTXXKASKGKLPIKWMAPESINF 186
Query: 291 GIFSIKSDVFSFGVLLLEIV 310
             F+  SDV+ FGV + EI+
Sbjct: 187 RRFTSASDVWMFGVCMWEIL 206

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 97/218 (44%), Gaps = 18/218 (8%)
Query: 102 SSVSSATGNFSAANKLGEGGFGTVYKGVIGQ-GEIAVKRLLGK----SGQEIKELKNEAS 156
           SS      NF     LG+G FG V    + + G++   ++L K       +++    E  
Sbjct: 16  SSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKR 75
Query: 157 VIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGV 216
           +++  ++   +  L CC +  +RL       N   D        R   + R R    + +
Sbjct: 76  ILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGG-DLMFHIQKSRRFDEARARFYAAE-I 133
Query: 217 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQG-NTSR 275
              L++LH      II+RDLK  N+LLD + + K++DFGM +       E    G  T+ 
Sbjct: 134 ISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK-------EGICNGVTTAT 183
Query: 276 ISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
             GT  Y++PE   E ++    D ++ GVLL E++ G 
Sbjct: 184 FCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 109/222 (49%), Gaps = 42/222 (18%)
Query: 110 NFSAANKLGEGGFGTVYKG---VIGQGEIAVKRLL------GKSGQEIKELKNEASVIAQ 160
           NF    K+GEG +G VYK    + G+  +A+K++       G     I+E+    S++ +
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGE-VVALKKIRLDTETEGVPSTAIREI----SLLKE 61
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRT----RVQIIKG- 215
           + H N+VKLL     +++  L++E++   S+D        ++ +D        + +IK  
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFL---SMDL-------KDFMDASALTGIPLPLIKSY 111
Query: 216 ---VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
              + QGL + H +   R++HRDLK  N+L++ +   K++DFG+AR  FG          
Sbjct: 112 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEV 167
Query: 273 TSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGK 313
                 T  Y +PE  L    +S   D++S G +  E+V+ +
Sbjct: 168 V-----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 109/222 (49%), Gaps = 42/222 (18%)
Query: 110 NFSAANKLGEGGFGTVYKG---VIGQGEIAVKRLL------GKSGQEIKELKNEASVIAQ 160
           NF    K+GEG +G VYK    + G+  +A+K++       G     I+E+    S++ +
Sbjct: 6   NFQKVEKIGEGTYGVVYKARNKLTGE-VVALKKIRLDTETEGVPSTAIREI----SLLKE 60
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRT----RVQIIKG- 215
           + H N+VKLL     +++  L++E++   S+D        ++ +D        + +IK  
Sbjct: 61  LNHPNIVKLLDVIHTENKLYLVFEFL---SMDL-------KDFMDASALTGIPLPLIKSY 110
Query: 216 ---VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
              + QGL + H +   R++HRDLK  N+L++ +   K++DFG+AR  FG          
Sbjct: 111 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEV 166
Query: 273 TSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGK 313
                 T  Y +PE  L    +S   D++S G +  E+V+ +
Sbjct: 167 V-----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 108/227 (47%), Gaps = 30/227 (13%)
Query: 98  LFSFSSVSSATGNFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKSGQEIKELKNEA 155
           +F   S +  +  +     LG+G FG V   K  I   E AVK +   S +++K+  ++ 
Sbjct: 38  MFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVI---SKRQVKQKTDKE 94
Query: 156 SVIAQVQ------HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPT-KREILDWRT 208
           S++ +VQ      H N++KL     +K    L+ E      L    FD    R+      
Sbjct: 95  SLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVD 150
Query: 209 RVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLD---KDMNSKISDFGMARIVFGGND 265
             +II+ V  G+ Y+H   + +I+HRDLK  N+LL+   KD N +I DFG++        
Sbjct: 151 AARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF----- 202
Query: 266 EDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
             E         GT  Y++PE  L G +  K DV+S GV+L  ++SG
Sbjct: 203 --EASKKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 246

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 97/200 (48%), Gaps = 15/200 (7%)
Query: 116 KLGEGGFGTV-YKGVIGQGE-IAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCC 173
           K+GEG  G V    V   G+ +AVK++  +  Q  + L NE  ++   QH+N+V++    
Sbjct: 27  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
           +  DE  ++ E++   +L     D      ++      +   V Q L  LH      +IH
Sbjct: 87  LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIH 139
Query: 234 RDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIF 293
           RD+K+ +ILL  D   K+SDFG     F      E+      + GT  +M+PE      +
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFG-----FCAQVSKEVP-RRKXLVGTPYWMAPELISRLPY 193
Query: 294 SIKSDVFSFGVLLLEIVSGK 313
             + D++S G++++E+V G+
Sbjct: 194 GPEVDIWSLGIMVIEMVDGE 213

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 97/200 (48%), Gaps = 15/200 (7%)
Query: 116 KLGEGGFGTV-YKGVIGQGE-IAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCC 173
           K+GEG  G V    V   G+ +AVK++  +  Q  + L NE  ++   QH+N+V++    
Sbjct: 31  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 90
Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
           +  DE  ++ E++   +L     D      ++      +   V Q L  LH      +IH
Sbjct: 91  LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIH 143
Query: 234 RDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIF 293
           RD+K+ +ILL  D   K+SDFG     F      E+      + GT  +M+PE      +
Sbjct: 144 RDIKSDSILLTHDGRVKLSDFG-----FCAQVSKEVP-RRKXLVGTPYWMAPELISRLPY 197
Query: 294 SIKSDVFSFGVLLLEIVSGK 313
             + D++S G++++E+V G+
Sbjct: 198 GPEVDIWSLGIMVIEMVDGE 217

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 107/214 (50%), Gaps = 26/214 (12%)
Query: 110 NFSAANKLGEGGFGTVYKG---VIGQGEIAVKRLL------GKSGQEIKELKNEASVIAQ 160
           NF    K+GEG +G VYK    + G+  +A+K++       G     I+E+    S++ +
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGE-VVALKKIRLDTETEGVPSTAIREI----SLLKE 61
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           + H N+VKLL     +++  L++E++ ++ L  F+ D +    +        +  + QGL
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEHV-DQDLKKFM-DASALTGIPLPLIKSYLFQLLQGL 119
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY 280
            + H +   R++HRDLK  N+L++ +   K++DFG+AR  FG                T 
Sbjct: 120 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-----TL 170
Query: 281 GYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGK 313
            Y +PE  L    +S   D++S G +  E+V+ +
Sbjct: 171 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 108/227 (47%), Gaps = 30/227 (13%)
Query: 98  LFSFSSVSSATGNFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKSGQEIKELKNEA 155
           +F   S +  +  +     LG+G FG V   K  I   E AVK +   S +++K+  ++ 
Sbjct: 39  MFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVI---SKRQVKQKTDKE 95
Query: 156 SVIAQVQ------HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPT-KREILDWRT 208
           S++ +VQ      H N++KL     +K    L+ E      L    FD    R+      
Sbjct: 96  SLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVD 151
Query: 209 RVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLD---KDMNSKISDFGMARIVFGGND 265
             +II+ V  G+ Y+H   + +I+HRDLK  N+LL+   KD N +I DFG++        
Sbjct: 152 AARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF----- 203
Query: 266 EDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
             E         GT  Y++PE  L G +  K DV+S GV+L  ++SG
Sbjct: 204 --EASKKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 247

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 41/96 (42%), Positives = 61/96 (63%), Gaps = 7/96 (7%)
Query: 216 VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR 275
           VA+G+ +L   S  + IHRDL A NILL ++   KI DFG+AR ++   + D ++   +R
Sbjct: 208 VARGMEFL---SSRKCIHRDLAARNILLSENNVVKICDFGLARDIY--KNPDYVRKGDTR 262
Query: 276 ISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
           +     +M+PE   + I+S KSDV+S+GVLL EI S
Sbjct: 263 L--PLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 25/214 (11%)
Query: 111 FSAANKLGEGGFGTVYK------GVIGQGEIAVKRLLGKS--GQEIKELKNEASVIAQVQ 162
           +    +LG G F  V K      G+    +   KR    S  G   ++++ E S++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLY 222
           H N++ L      K + +LI E +    L  FL    ++E L      + +K +  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 129
Query: 223 LHQYSRVRIIHRDLKASNI-LLDKDMNS---KISDFGMARIVFGGNDEDELQGNTSRISG 278
           LH    ++I H DLK  NI LLD+++     KI DFG+A  +  GN+          I G
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-------FKNIFG 179
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           T  +++PE        +++D++S GV+   ++SG
Sbjct: 180 TPAFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 97/200 (48%), Gaps = 15/200 (7%)
Query: 116 KLGEGGFGTV-YKGVIGQGE-IAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCC 173
           K+GEG  G V    V   G+ +AVK++  +  Q  + L NE  ++   QH+N+V++    
Sbjct: 36  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 95
Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
           +  DE  ++ E++   +L     D      ++      +   V Q L  LH      +IH
Sbjct: 96  LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIH 148
Query: 234 RDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIF 293
           RD+K+ +ILL  D   K+SDFG     F      E+      + GT  +M+PE      +
Sbjct: 149 RDIKSDSILLTHDGRVKLSDFG-----FCAQVSKEVP-RRKXLVGTPYWMAPELISRLPY 202
Query: 294 SIKSDVFSFGVLLLEIVSGK 313
             + D++S G++++E+V G+
Sbjct: 203 GPEVDIWSLGIMVIEMVDGE 222

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 102/211 (48%), Gaps = 22/211 (10%)
Query: 107 ATGNFSAANKLGEGGFGTVYKGVIGQGEIAVKRLLG-KSGQEIKELKNEASVIAQVQHKN 165
            +G F+   K  + G G  Y        I  +RL   + G   +E++ E +++ +++H N
Sbjct: 35  GSGQFAIVRKCRQKGTGKEYAAKF----IKKRRLXSSRRGVSREEIEREVNILREIRHPN 90
Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ 225
           ++ L      K + +LI E +    L  FL    ++E L      Q +K +  G+ YLH 
Sbjct: 91  IITLHDIFENKTDVVLILELVSGGELFDFL---AEKESLTEDEATQFLKQILDGVHYLHS 147
Query: 226 YSRVRIIHRDLKASNI-LLDKDMNS---KISDFGMARIVFGGNDEDELQGNTSRISGTYG 281
               RI H DLK  NI LLDK++ +   K+ DFG+A  +  GN+          I GT  
Sbjct: 148 K---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-------FKNIFGTPE 197
Query: 282 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           +++PE        +++D++S GV+   ++SG
Sbjct: 198 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 228

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 97/200 (48%), Gaps = 15/200 (7%)
Query: 116 KLGEGGFGTV-YKGVIGQGE-IAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCC 173
           K+GEG  G V    V   G+ +AVK++  +  Q  + L NE  ++   QH+N+V++    
Sbjct: 38  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 97
Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
           +  DE  ++ E++   +L     D      ++      +   V Q L  LH      +IH
Sbjct: 98  LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIH 150
Query: 234 RDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIF 293
           RD+K+ +ILL  D   K+SDFG     F      E+      + GT  +M+PE      +
Sbjct: 151 RDIKSDSILLTHDGRVKLSDFG-----FCAQVSKEVP-RRKXLVGTPYWMAPELISRLPY 204
Query: 294 SIKSDVFSFGVLLLEIVSGK 313
             + D++S G++++E+V G+
Sbjct: 205 GPEVDIWSLGIMVIEMVDGE 224

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 17/200 (8%)
Query: 117 LGEGGFGTVYKGVIGQGE-----IAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNLVKLL 170
           +GEG FG V++G+    E     +A+K     +   ++E    EA  + Q  H ++VKL+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVR 230
           G  I ++   +I E      L  FL    ++  LD  + +     ++  L YL      R
Sbjct: 78  GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 131
Query: 231 IIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE 290
            +HRD+ A N+L+  +   K+ DFG++R +     ED      S+      +M+PE    
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-----EDSTYYKASKGKLPIKWMAPESINF 186
Query: 291 GIFSIKSDVFSFGVLLLEIV 310
             F+  SDV+ FGV + EI+
Sbjct: 187 RRFTSASDVWMFGVCMWEIL 206

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 17/200 (8%)
Query: 117 LGEGGFGTVYKGVIGQGE-----IAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNLVKLL 170
           +GEG FG V++G+    E     +A+K     +   ++E    EA  + Q  H ++VKL+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVR 230
           G  I ++   +I E      L  FL    ++  LD  + +     ++  L YL      R
Sbjct: 78  GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 131
Query: 231 IIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE 290
            +HRD+ A N+L+  +   K+ DFG++R +     ED      S+      +M+PE    
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-----EDSTYYKASKGKLPIKWMAPESINF 186
Query: 291 GIFSIKSDVFSFGVLLLEIV 310
             F+  SDV+ FGV + EI+
Sbjct: 187 RRFTSASDVWMFGVCMWEIL 206

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 102/212 (48%), Gaps = 24/212 (11%)
Query: 107 ATGNFSAANKLGEGGFGTVYKGVIGQGEIAVKRLLGKS--GQEIKELKNEASVIAQVQHK 164
            +G F+   K  + G G  Y       +   KR L  S  G   +E++ E +++ +++H 
Sbjct: 21  GSGQFAIVRKCRQKGTGKEY-----AAKFIKKRRLSSSRRGVSREEIEREVNILREIRHP 75
Query: 165 NLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLH 224
           N++ L      K + +LI E +    L  FL    ++E L      Q +K +  G+ YLH
Sbjct: 76  NIITLHDIFENKTDVVLILELVSGGELFDFL---AEKESLTEDEATQFLKQILDGVHYLH 132
Query: 225 QYSRVRIIHRDLKASNI-LLDKDMNS---KISDFGMARIVFGGNDEDELQGNTSRISGTY 280
                RI H DLK  NI LLDK++ +   K+ DFG+A  +  GN+          I GT 
Sbjct: 133 SK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-------FKNIFGTP 182
Query: 281 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
            +++PE        +++D++S GV+   ++SG
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 17/200 (8%)
Query: 117 LGEGGFGTVYKGVIGQGE-----IAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNLVKLL 170
           +GEG FG V++G+    E     +A+K     +   ++E    EA  + Q  H ++VKL+
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVR 230
           G  I ++   +I E      L  FL    ++  LD  + +     ++  L YL      R
Sbjct: 106 GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 159
Query: 231 IIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE 290
            +HRD+ A N+L+  +   K+ DFG++R +     ED      S+      +M+PE    
Sbjct: 160 FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-----EDSTYYKASKGKLPIKWMAPESINF 214
Query: 291 GIFSIKSDVFSFGVLLLEIV 310
             F+  SDV+ FGV + EI+
Sbjct: 215 RRFTSASDVWMFGVCMWEIL 234

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 101/214 (47%), Gaps = 27/214 (12%)
Query: 110 NFSAANKLGEGGFGT--VYKGVIGQGEIAVKRLLGKS---GQEIKELKNEASVIAQVQHK 164
           +F     LGEG F T  + + +    E A+K L  +      ++  +  E  V++++ H 
Sbjct: 31  DFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 165 NLVKLLGCCIEKDERLLI-YEYMPNKSLDCFL-----FDPTKREILDWRTRVQIIKGVAQ 218
             VKL     + DE+L     Y  N  L  ++     FD T        TR    + +  
Sbjct: 91  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-------TRFYTAE-IVS 141
Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
            L YLH      IIHRDLK  NILL++DM+ +I+DFG A+++      +  Q   +   G
Sbjct: 142 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL----SPESKQARANXFVG 194
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           T  Y+SPE   E      SD+++ G ++ ++V+G
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 17/200 (8%)
Query: 117 LGEGGFGTVYKGVIGQGE-----IAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNLVKLL 170
           +GEG FG V++G+    E     +A+K     +   ++E    EA  + Q  H ++VKL+
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVR 230
           G  I ++   +I E      L  FL    ++  LD  + +     ++  L YL      R
Sbjct: 75  GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 128
Query: 231 IIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE 290
            +HRD+ A N+L+  +   K+ DFG++R +     ED      S+      +M+PE    
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-----EDSTYYKASKGKLPIKWMAPESINF 183
Query: 291 GIFSIKSDVFSFGVLLLEIV 310
             F+  SDV+ FGV + EI+
Sbjct: 184 RRFTSASDVWMFGVCMWEIL 203

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 102/212 (48%), Gaps = 24/212 (11%)
Query: 107 ATGNFSAANKLGEGGFGTVYKGVIGQGEIAVKRLLGKS--GQEIKELKNEASVIAQVQHK 164
            +G F+   K  + G G  Y       +   KR L  S  G   +E++ E +++ +++H 
Sbjct: 14  GSGQFAIVRKCRQKGTGKEY-----AAKFIKKRRLSSSRRGVSREEIEREVNILREIRHP 68
Query: 165 NLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLH 224
           N++ L      K + +LI E +    L  FL    ++E L      Q +K +  G+ YLH
Sbjct: 69  NIITLHDIFENKTDVVLILELVSGGELFDFL---AEKESLTEDEATQFLKQILDGVHYLH 125
Query: 225 QYSRVRIIHRDLKASNI-LLDKDMNS---KISDFGMARIVFGGNDEDELQGNTSRISGTY 280
                RI H DLK  NI LLDK++ +   K+ DFG+A  +  GN+          I GT 
Sbjct: 126 SK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-------FKNIFGTP 175
Query: 281 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
            +++PE        +++D++S GV+   ++SG
Sbjct: 176 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 17/200 (8%)
Query: 117 LGEGGFGTVYKGVIGQGE-----IAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNLVKLL 170
           +GEG FG V++G+    E     +A+K     +   ++E    EA  + Q  H ++VKL+
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVR 230
           G  I ++   +I E      L  FL    ++  LD  + +     ++  L YL      R
Sbjct: 83  GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 136
Query: 231 IIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE 290
            +HRD+ A N+L+  +   K+ DFG++R +     ED      S+      +M+PE    
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-----EDSTYYKASKGKLPIKWMAPESINF 191
Query: 291 GIFSIKSDVFSFGVLLLEIV 310
             F+  SDV+ FGV + EI+
Sbjct: 192 RRFTSASDVWMFGVCMWEIL 211

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 17/200 (8%)
Query: 117 LGEGGFGTVYKGVIGQGE-----IAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNLVKLL 170
           +GEG FG V++G+    E     +A+K     +   ++E    EA  + Q  H ++VKL+
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVR 230
           G  I ++   +I E      L  FL    ++  LD  + +     ++  L YL      R
Sbjct: 80  GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 133
Query: 231 IIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE 290
            +HRD+ A N+L+  +   K+ DFG++R +     ED      S+      +M+PE    
Sbjct: 134 FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-----EDSTYYKASKGKLPIKWMAPESINF 188
Query: 291 GIFSIKSDVFSFGVLLLEIV 310
             F+  SDV+ FGV + EI+
Sbjct: 189 RRFTSASDVWMFGVCMWEIL 208

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 104/217 (47%), Gaps = 15/217 (6%)
Query: 104 VSSATGNFSAANKLGEGGFGTVYK-GVIGQGEIAVKRLL---GKSGQEIKELKNEASVIA 159
           + S   ++     +G G +G   K      G+I V + L     +  E + L +E +++ 
Sbjct: 1   MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLR 60
Query: 160 QVQHKNLVKLLGCCIEKDERLL--IYEYMPNKSLDCFLFDPTK-REILDWRTRVQIIKGV 216
           +++H N+V+     I++    L  + EY     L   +   TK R+ LD    ++++  +
Sbjct: 61  ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 120
Query: 217 AQGLLYLHQYSR--VRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTS 274
              L   H+ S     ++HRDLK +N+ LD   N K+ DFG+ARI+    + D     T 
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL----NHDTSFAKT- 175
Query: 275 RISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
              GT  YMSPE      ++ KSD++S G LL E+ +
Sbjct: 176 -FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA 211

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 97/212 (45%), Gaps = 32/212 (15%)
Query: 120 GGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKD-- 177
           G FG V+K  +    +AVK    +  Q  +  + E      ++H+NL++ +    EK   
Sbjct: 26  GRFGCVWKAQLMNDFVAVKIFPLQDKQSWQS-EREIFSTPGMKHENLLQFIAA--EKRGS 82
Query: 178 ----ERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ-------- 225
               E  LI  +    SL  +L    K  I+ W     + + +++GL YLH+        
Sbjct: 83  NLEVELWLITAFHDKGSLTDYL----KGNIITWNELCHVAETMSRGLSYLHEDVPWCRGE 138
Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
             +  I HRD K+ N+LL  D+ + ++DFG+A     G    +  G      GT  YM+P
Sbjct: 139 GHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQV----GTRRYMAP 194
Query: 286 EYALEGIFSIKSDVF------SFGVLLLEIVS 311
           E  LEG  + + D F      + G++L E+VS
Sbjct: 195 E-VLEGAINFQRDAFLRIDMYAMGLVLWELVS 225

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 17/200 (8%)
Query: 117 LGEGGFGTVYKGVIGQGE-----IAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNLVKLL 170
           +GEG FG V++G+    E     +A+K     +   ++E    EA  + Q  H ++VKL+
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVR 230
           G  I ++   +I E      L  FL    ++  LD  + +     ++  L YL      R
Sbjct: 81  GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 134
Query: 231 IIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE 290
            +HRD+ A N+L+  +   K+ DFG++R +     ED      S+      +M+PE    
Sbjct: 135 FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-----EDSTYYKASKGKLPIKWMAPESINF 189
Query: 291 GIFSIKSDVFSFGVLLLEIV 310
             F+  SDV+ FGV + EI+
Sbjct: 190 RRFTSASDVWMFGVCMWEIL 209

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 23/210 (10%)
Query: 111 FSAANKLGEGGFGTVYKGV---IGQGEIAVKRLL-GKSGQEIKELK-NEASVIAQVQHKN 165
           +    K+GEG +G V+K      GQ  +A+K+ L  +    IK++   E  ++ Q++H N
Sbjct: 5   YEKIGKIGEGSYGVVFKCRNRDTGQI-VAIKKFLESEDDPVIKKIALREIRMLKQLKHPN 63
Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ 225
           LV LL     K    L++EY  +  L     D  +R + +   +  I     Q + + H+
Sbjct: 64  LVNLLEVFRRKRRLHLVFEYCDHTVL--HELDRYQRGVPEHLVK-SITWQTLQAVNFCHK 120
Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGND--EDELQGNTSRISGTYGYM 283
           ++    IHRD+K  NIL+ K    K+ DFG AR++ G +D  +DE+         T  Y 
Sbjct: 121 HN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV--------ATRWYR 169
Query: 284 SPEYAL-EGIFSIKSDVFSFGVLLLEIVSG 312
           SPE  + +  +    DV++ G +  E++SG
Sbjct: 170 SPELLVGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 25/214 (11%)
Query: 111 FSAANKLGEGGFGTVYK------GVIGQGEIAVKRLLGKS--GQEIKELKNEASVIAQVQ 162
           +    +LG G F  V K      G+    +   KR    S  G   ++++ E S++ ++Q
Sbjct: 13  YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLY 222
           H N++ L      K + +LI E +    L  FL    ++E L      + +K +  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 129
Query: 223 LHQYSRVRIIHRDLKASNI-LLDKDMNS---KISDFGMARIVFGGNDEDELQGNTSRISG 278
           LH    ++I H DLK  NI LLD+++     KI DFG+A  +  GN+          I G
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-------FKNIFG 179
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           T  +++PE        +++D++S GV+   ++SG
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 25/214 (11%)
Query: 111 FSAANKLGEGGFGTVYK------GVIGQGEIAVKRLLGKS--GQEIKELKNEASVIAQVQ 162
           +    +LG G F  V K      G+    +   KR    S  G   ++++ E S++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLY 222
           H N++ L      K + +LI E +    L  FL    ++E L      + +K +  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 129
Query: 223 LHQYSRVRIIHRDLKASNI-LLDKDMNS---KISDFGMARIVFGGNDEDELQGNTSRISG 278
           LH    ++I H DLK  NI LLD+++     KI DFG+A  +  GN+          I G
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-------FKNIFG 179
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           T  +++PE        +++D++S GV+   ++SG
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 25/214 (11%)
Query: 111 FSAANKLGEGGFGTVYK------GVIGQGEIAVKRLLGKS--GQEIKELKNEASVIAQVQ 162
           +    +LG G F  V K      G+    +   KR    S  G   ++++ E S++ ++Q
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLY 222
           H N++ L      K + +LI E +    L  FL    ++E L      + +K +  G+ Y
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 128
Query: 223 LHQYSRVRIIHRDLKASNI-LLDKDMNS---KISDFGMARIVFGGNDEDELQGNTSRISG 278
           LH    ++I H DLK  NI LLD+++     KI DFG+A  +  GN+          I G
Sbjct: 129 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-------FKNIFG 178
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           T  +++PE        +++D++S GV+   ++SG
Sbjct: 179 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 25/214 (11%)
Query: 111 FSAANKLGEGGFGTVYK------GVIGQGEIAVKRLLGKS--GQEIKELKNEASVIAQVQ 162
           +    +LG G F  V K      G+    +   KR    S  G   ++++ E S++ ++Q
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLY 222
           H N++ L      K + +LI E +    L  FL    ++E L      + +K +  G+ Y
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 128
Query: 223 LHQYSRVRIIHRDLKASNI-LLDKDMNS---KISDFGMARIVFGGNDEDELQGNTSRISG 278
           LH    ++I H DLK  NI LLD+++     KI DFG+A  +  GN+          I G
Sbjct: 129 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-------FKNIFG 178
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           T  +++PE        +++D++S GV+   ++SG
Sbjct: 179 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 75/306 (24%), Positives = 130/306 (42%), Gaps = 64/306 (20%)
Query: 110 NFSAANKLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLV 167
           +F     +G GGFG V+K    I      ++R+   + +  +E+K     +A++ H N+V
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAEREVK----ALAKLDHVNIV 68
Query: 168 KLLGCCI-------EKDERLLIYEYMPNKSLD-------CFLF--------------DPT 199
              GC           D+ L   +Y P  S +       C                 +  
Sbjct: 69  HYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 128
Query: 200 KREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARI 259
           + E LD    +++ + + +G+ Y+H     ++IHRDLK SNI L      KI DFG+   
Sbjct: 129 RGEKLDKVLALELFEQITKGVDYIHSK---KLIHRDLKPSNIFLVDTKQVKIGDFGLVTS 185
Query: 260 VFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFY 319
           +   ND     G  +R  GT  YMSPE      +  + D+++ G++L E+          
Sbjct: 186 L--KND-----GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAEL---------- 228
Query: 320 RTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSD 379
               L++   A++   S    DL D ++ +  F++     +   L    ++ EDRP  S+
Sbjct: 229 ----LHVCDTAFE--TSKFFTDLRDGIISDI-FDKKEKTLLQKLL---SKKPEDRPNTSE 278
Query: 380 VVSMLT 385
           ++  LT
Sbjct: 279 ILRTLT 284

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 25/214 (11%)
Query: 111 FSAANKLGEGGFGTVYK------GVIGQGEIAVKRLLGKS--GQEIKELKNEASVIAQVQ 162
           +    +LG G F  V K      G+    +   KR    S  G   ++++ E S++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLY 222
           H N++ L      K + +LI E +    L  FL    ++E L      + +K +  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 129
Query: 223 LHQYSRVRIIHRDLKASNI-LLDKDMNS---KISDFGMARIVFGGNDEDELQGNTSRISG 278
           LH    ++I H DLK  NI LLD+++     KI DFG+A  +  GN+          I G
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-------FKNIFG 179
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           T  +++PE        +++D++S GV+   ++SG
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 25/214 (11%)
Query: 111 FSAANKLGEGGFGTVYK------GVIGQGEIAVKRLLGKS--GQEIKELKNEASVIAQVQ 162
           +    +LG G F  V K      G+    +   KR    S  G   ++++ E S++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLY 222
           H N++ L      K + +LI E +    L  FL    ++E L      + +K +  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 129
Query: 223 LHQYSRVRIIHRDLKASNI-LLDKDMNS---KISDFGMARIVFGGNDEDELQGNTSRISG 278
           LH    ++I H DLK  NI LLD+++     KI DFG+A  +  GN+          I G
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-------FKNIFG 179
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           T  +++PE        +++D++S GV+   ++SG
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 104/220 (47%), Gaps = 21/220 (9%)
Query: 104 VSSATGNFSAANKLGEGGFGTVYK-GVIGQGEIAVKRLL---GKSGQEIKELKNEASVIA 159
           + S   ++     +G G +G   K      G+I V + L     +  E + L +E +++ 
Sbjct: 1   MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLR 60
Query: 160 QVQHKNLVKLLGCCIEKDERLL--IYEYMPNKSLDCFLFDPTK-REILDWRTRVQIIKGV 216
           +++H N+V+     I++    L  + EY     L   +   TK R+ LD    ++++  +
Sbjct: 61  ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 120
Query: 217 AQGLLYLHQYSR--VRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTS 274
              L   H+ S     ++HRDLK +N+ LD   N K+ DFG+ARI         L  +TS
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI---------LNHDTS 171
Query: 275 ---RISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
                 GT  YMSPE      ++ KSD++S G LL E+ +
Sbjct: 172 FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA 211

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 97/200 (48%), Gaps = 15/200 (7%)
Query: 116 KLGEGGFGTV-YKGVIGQGE-IAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCC 173
           K+GEG  G V    V   G+ +AVK++  +  Q  + L NE  ++   QH+N+V++    
Sbjct: 158 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 217
Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
           +  DE  ++ E++   +L     D      ++      +   V Q L  LH      +IH
Sbjct: 218 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIH 270
Query: 234 RDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIF 293
           RD+K+ +ILL  D   K+SDFG     F      E+      + GT  +M+PE      +
Sbjct: 271 RDIKSDSILLTHDGRVKLSDFG-----FCAQVSKEVP-RRKXLVGTPYWMAPELISRLPY 324
Query: 294 SIKSDVFSFGVLLLEIVSGK 313
             + D++S G++++E+V G+
Sbjct: 325 GPEVDIWSLGIMVIEMVDGE 344

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 25/214 (11%)
Query: 111 FSAANKLGEGGFGTVYK------GVIGQGEIAVKRLLGKS--GQEIKELKNEASVIAQVQ 162
           +    +LG G F  V K      G+    +   KR    S  G   ++++ E S++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLY 222
           H N++ L      K + +LI E +    L  FL    ++E L      + +K +  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 129
Query: 223 LHQYSRVRIIHRDLKASNI-LLDKDMNS---KISDFGMARIVFGGNDEDELQGNTSRISG 278
           LH    ++I H DLK  NI LLD+++     KI DFG+A  +  GN+          I G
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-------FKNIFG 179
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           T  +++PE        +++D++S GV+   ++SG
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 104/212 (49%), Gaps = 24/212 (11%)
Query: 115 NKLGEGGFGTVYKGVIGQGEIAVKRLLG-KSGQEIKELKNEASVIAQVQHKNLVKLLGCC 173
            ++G+G +G V+ G     ++AVK     +     +E +   +V+  ++H+N++  +   
Sbjct: 43  KQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVL--MRHENILGFIAAD 100
Query: 174 IEKD----ERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ---- 225
           I+      +  LI +Y  N SL    +D  K   LD ++ +++      GL +LH     
Sbjct: 101 IKGTGSWTQLYLITDYHENGSL----YDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFS 156
Query: 226 -YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMS 284
              +  I HRDLK+ NIL+ K+    I+D G+A       +E ++  NT R+ GT  YM 
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNT-RV-GTKRYMP 214
Query: 285 PEYALEGIFS------IKSDVFSFGVLLLEIV 310
           PE   E +        I +D++SFG++L E+ 
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 85/164 (51%), Gaps = 17/164 (10%)
Query: 150 ELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSL-----DCFLFDPTKREIL 204
           + KNE  +I  ++++  +   G     DE  +IYEYM N S+       F+ D      +
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 205 DWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGN 264
             +    IIK V     Y+H  +   I HRD+K SNIL+DK+   K+SDFG +  +    
Sbjct: 149 PIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV--- 203
Query: 265 DEDELQGNTSRISGTYGYMSPE-YALEGIFS-IKSDVFSFGVLL 306
            + +++G  SR  GTY +M PE ++ E  ++  K D++S G+ L
Sbjct: 204 -DKKIKG--SR--GTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 97/200 (48%), Gaps = 15/200 (7%)
Query: 116 KLGEGGFGTV-YKGVIGQGE-IAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCC 173
           K+GEG  G V    V   G+ +AVK++  +  Q  + L NE  ++   QH+N+V++    
Sbjct: 81  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 140
Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
           +  DE  ++ E++   +L     D      ++      +   V Q L  LH      +IH
Sbjct: 141 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIH 193
Query: 234 RDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIF 293
           RD+K+ +ILL  D   K+SDFG     F      E+      + GT  +M+PE      +
Sbjct: 194 RDIKSDSILLTHDGRVKLSDFG-----FCAQVSKEVP-RRKXLVGTPYWMAPELISRLPY 247
Query: 294 SIKSDVFSFGVLLLEIVSGK 313
             + D++S G++++E+V G+
Sbjct: 248 GPEVDIWSLGIMVIEMVDGE 267

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 25/214 (11%)
Query: 111 FSAANKLGEGGFGTVYK------GVIGQGEIAVKRLLGKS--GQEIKELKNEASVIAQVQ 162
           +    +LG G F  V K      G+    +   KR    S  G   ++++ E S++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLY 222
           H N++ L      K + +LI E +    L  FL    ++E L      + +K +  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 129
Query: 223 LHQYSRVRIIHRDLKASNI-LLDKDMNS---KISDFGMARIVFGGNDEDELQGNTSRISG 278
           LH    ++I H DLK  NI LLD+++     KI DFG+A  +  GN+          I G
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-------FKNIFG 179
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           T  +++PE        +++D++S GV+   ++SG
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 25/214 (11%)
Query: 111 FSAANKLGEGGFGTVYK------GVIGQGEIAVKRLLGKS--GQEIKELKNEASVIAQVQ 162
           +    +LG G F  V K      G+    +   KR    S  G   ++++ E S++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLY 222
           H N++ L      K + +LI E +    L  FL    ++E L      + +K +  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 129
Query: 223 LHQYSRVRIIHRDLKASNI-LLDKDMNS---KISDFGMARIVFGGNDEDELQGNTSRISG 278
           LH    ++I H DLK  NI LLD+++     KI DFG+A  +  GN+          I G
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-------FKNIFG 179
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           T  +++PE        +++D++S GV+   ++SG
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 25/214 (11%)
Query: 111 FSAANKLGEGGFGTVYK------GVIGQGEIAVKRLLGKS--GQEIKELKNEASVIAQVQ 162
           +    +LG G F  V K      G+    +   KR    S  G   ++++ E S++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLY 222
           H N++ L      K + +LI E +    L  FL    ++E L      + +K +  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 129
Query: 223 LHQYSRVRIIHRDLKASNI-LLDKDMNS---KISDFGMARIVFGGNDEDELQGNTSRISG 278
           LH    ++I H DLK  NI LLD+++     KI DFG+A  +  GN+          I G
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-------FKNIFG 179
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           T  +++PE        +++D++S GV+   ++SG
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 19/205 (9%)
Query: 115 NKLGEGGFGTVYK--GVIGQGEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLL 170
            +LG+G F  V +   V+   E A K +  K  S ++ ++L+ EA +   ++H N+V+L 
Sbjct: 28  EELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 87
Query: 171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVR 230
               E+    LI++ +    L     D   RE          I+ + + +L+ HQ     
Sbjct: 88  DSISEEGHHYLIFDLVTGGEL---FEDIVAREYYSEADASHCIQQILEAVLHCHQMG--- 141
Query: 231 IIHRDLKASNILLDKDMNS---KISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEY 287
           ++HRDLK  N+LL   +     K++DFG+A  V G       Q      +GT GY+SPE 
Sbjct: 142 VVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGE------QQAWFGFAGTPGYLSPEV 195
Query: 288 ALEGIFSIKSDVFSFGVLLLEIVSG 312
             +  +    D+++ GV+L  ++ G
Sbjct: 196 LRKDPYGKPVDLWACGVILYILLVG 220

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 104/225 (46%), Gaps = 35/225 (15%)
Query: 104 VSSATGNFSA----ANKLGEGGFGTVY--KGVIGQGEIAVK--RLLGKSGQEIKELKNEA 155
           ++S  G+ S       KLG G +G V   +  +   E A+K  R    S     +L  E 
Sbjct: 28  ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEV 87
Query: 156 SVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCF----LFDPT-KREILDWRTRV 210
           +V+  + H N++KL     +K    L+ E        C+    LFD    R   +     
Sbjct: 88  AVLKLLDHPNIMKLYDFFEDKRNYYLVME--------CYKGGELFDEIIHRMKFNEVDAA 139
Query: 211 QIIKGVAQGLLYLHQYSRVRIIHRDLKASNILL---DKDMNSKISDFGMARIVFGGNDED 267
            IIK V  G+ YLH+++   I+HRDLK  N+LL   +KD   KI DFG++ +        
Sbjct: 140 VIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF------- 189
Query: 268 ELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           E Q       GT  Y++PE  L   +  K DV+S GV+L  +++G
Sbjct: 190 ENQKKMKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAG 233

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 106/225 (47%), Gaps = 34/225 (15%)
Query: 104 VSSATGNFSAANK----LGEGGFGTVY--KGVIGQGEIAVKRLLGKSGQEIKELKNEASV 157
           V  +T  FS   K    LG+G FG V   K  I   E AVK +   S +++K+  ++ S+
Sbjct: 17  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVI---SKRQVKQKTDKESL 73
Query: 158 IAQVQ------HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPT-KREILDWRTRV 210
           + +VQ      H N+ KL     +K    L+ E      L    FD    R+        
Sbjct: 74  LREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAA 129
Query: 211 QIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLD---KDMNSKISDFGMARIVFGGNDED 267
           +II+ V  G+ Y H   + +I+HRDLK  N+LL+   KD N +I DFG++          
Sbjct: 130 RIIRQVLSGITYXH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF------- 179
Query: 268 ELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           E         GT  Y++PE  L G +  K DV+S GV+L  ++SG
Sbjct: 180 EASKKXKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 107/223 (47%), Gaps = 26/223 (11%)
Query: 117 LGEGGFGTVYK---------GVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLV 167
           LG+GG+G V++         G I   ++  K ++ ++ ++    K E +++ +V+H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 168 KLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKRE-ILDWRTRVQIIKGVAQGLLYLHQY 226
            L+       +  LI EY+    L    F   +RE I    T    +  ++  L +LHQ 
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGEL----FMQLEREGIFMEDTACFYLAEISMALGHLHQK 140
Query: 227 SRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN-TSRISGTYGYMSP 285
               II+RDLK  NI+L+   + K++DFG+ +       E    G  T    GT  YM+P
Sbjct: 141 G---IIYRDLKPENIMLNHQGHVKLTDFGLCK-------ESIHDGTVTHXFCGTIEYMAP 190
Query: 286 EYALEGIFSIKSDVFSFGVLLLEIVSGKKN-TGFYRTKSLNLI 327
           E  +    +   D +S G L+ ++++G    TG  R K+++ I
Sbjct: 191 EILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKI 233

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 25/214 (11%)
Query: 111 FSAANKLGEGGFGTVYK------GVIGQGEIAVKRLLGKS--GQEIKELKNEASVIAQVQ 162
           +    +LG G F  V K      G+    +   KR    S  G   ++++ E S++ ++Q
Sbjct: 13  YDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLY 222
           H N++ L      K + +LI E +    L  FL    ++E L      + +K +  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 129
Query: 223 LHQYSRVRIIHRDLKASNI-LLDKDMNS---KISDFGMARIVFGGNDEDELQGNTSRISG 278
           LH    ++I H DLK  NI LLD+++     KI DFG+A  +  GN+          I G
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-------FKNIFG 179
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           T  +++PE        +++D++S GV+   ++SG
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 94/200 (47%), Gaps = 17/200 (8%)
Query: 117 LGEGGFGTVYKGVIGQGE-----IAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNLVKLL 170
           +GEG FG V++G+    E     +A+K     +   ++E    EA  + Q  H ++VKL+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVR 230
           G  I ++   +I E      L  FL    ++  LD  + +     ++  L YL      R
Sbjct: 78  GV-ITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 131
Query: 231 IIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE 290
            +HRD+ A N+L+      K+ DFG++R +     ED      S+      +M+PE    
Sbjct: 132 FVHRDIAARNVLVSATDCVKLGDFGLSRYM-----EDSTYYKASKGKLPIKWMAPESINF 186
Query: 291 GIFSIKSDVFSFGVLLLEIV 310
             F+  SDV+ FGV + EI+
Sbjct: 187 RRFTSASDVWMFGVCMWEIL 206

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 25/214 (11%)
Query: 111 FSAANKLGEGGFGTVYK------GVIGQGEIAVKRLLGKS--GQEIKELKNEASVIAQVQ 162
           +    +LG G F  V K      G+    +   KR    S  G   ++++ E S++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLY 222
           H N++ L      K + +LI E +    L  FL    ++E L      + +K +  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 129
Query: 223 LHQYSRVRIIHRDLKASNI-LLDKDMNS---KISDFGMARIVFGGNDEDELQGNTSRISG 278
           LH    ++I H DLK  NI LLD+++     KI DFG+A  +  GN+          I G
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-------FKNIFG 179
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           T  +++PE        +++D++S GV+   ++SG
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 107/223 (47%), Gaps = 26/223 (11%)
Query: 117 LGEGGFGTVYK---------GVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLV 167
           LG+GG+G V++         G I   ++  K ++ ++ ++    K E +++ +V+H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 168 KLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKRE-ILDWRTRVQIIKGVAQGLLYLHQY 226
            L+       +  LI EY+    L    F   +RE I    T    +  ++  L +LHQ 
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGEL----FMQLEREGIFMEDTACFYLAEISMALGHLHQK 140
Query: 227 SRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN-TSRISGTYGYMSP 285
               II+RDLK  NI+L+   + K++DFG+ +       E    G  T    GT  YM+P
Sbjct: 141 G---IIYRDLKPENIMLNHQGHVKLTDFGLCK-------ESIHDGTVTHTFCGTIEYMAP 190
Query: 286 EYALEGIFSIKSDVFSFGVLLLEIVSGKKN-TGFYRTKSLNLI 327
           E  +    +   D +S G L+ ++++G    TG  R K+++ I
Sbjct: 191 EILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKI 233

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 25/214 (11%)
Query: 111 FSAANKLGEGGFGTVYK------GVIGQGEIAVKRLLGKS--GQEIKELKNEASVIAQVQ 162
           +    +LG G F  V K      G+    +   KR    S  G   ++++ E S++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLY 222
           H N++ L      K + +LI E +    L  FL    ++E L      + +K +  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILIGELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 129
Query: 223 LHQYSRVRIIHRDLKASNI-LLDKDMNS---KISDFGMARIVFGGNDEDELQGNTSRISG 278
           LH    ++I H DLK  NI LLD+++     KI DFG+A  +  GN+          I G
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-------FKNIFG 179
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           T  +++PE        +++D++S GV+   ++SG
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 34/226 (15%)
Query: 110 NFSAANKLGEGGFGTV-----------YKGVIGQGEIAVKRLLGKSGQEIKELKNEASVI 158
           +F     LG G FG V           Y   + + EI V+       ++++   +E  ++
Sbjct: 7   DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRL------KQVEHTNDERLML 60
Query: 159 AQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQ 218
           + V H  ++++ G   +  +  +I +Y+    L   L    K +             V  
Sbjct: 61  SIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL---RKSQRFPNPVAKFYAAEVCL 117
Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
            L YLH      II+RDLK  NILLDK+ + KI+DFG A+ V            T  + G
Sbjct: 118 ALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYV---------PDVTYXLCG 165
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSL 324
           T  Y++PE      ++   D +SFG+L+ E+++G   T FY + ++
Sbjct: 166 TPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY--TPFYDSNTM 209

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 40/108 (37%), Positives = 59/108 (54%), Gaps = 12/108 (11%)
Query: 216 VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR 275
           +  GL +LHQ +   II+RDLK  N+LLD D N +ISD G+A  +  G      Q  T  
Sbjct: 298 IVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAG------QTKTKG 348
Query: 276 ISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKS 323
            +GT G+M+PE  L   +    D F+ GV L E+++ +   G +R + 
Sbjct: 349 YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR---GPFRARG 393

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 105/211 (49%), Gaps = 21/211 (9%)
Query: 109 GNFSAANKLGEGGFGTVYKGV--IGQGEIAVK---RLLGKSGQEIKELKNEASVIAQVQH 163
           G++   + LG G FG V  G   +   ++AVK   R   +S   + +++ E   +   +H
Sbjct: 16  GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRH 75
Query: 164 KNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYL 223
            +++KL        +  ++ EY+    L  ++    K   LD +   ++ + +  G+ Y 
Sbjct: 76  PHIIKLYQVISTPSDIFMVMEYVSGGELFDYI---CKNGRLDEKESRRLFQQILSGVDYC 132
Query: 224 HQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRIS-GTYGY 282
           H++    ++HRDLK  N+LLD  MN+KI+DFG++ ++          G   R S G+  Y
Sbjct: 133 HRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS--------DGEFLRXSCGSPNY 181
Query: 283 MSPEYALEGIFS-IKSDVFSFGVLLLEIVSG 312
            +PE     +++  + D++S GV+L  ++ G
Sbjct: 182 AAPEVISGRLYAGPEVDIWSSGVILYALLCG 212

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 40/108 (37%), Positives = 59/108 (54%), Gaps = 12/108 (11%)
Query: 216 VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR 275
           +  GL +LHQ +   II+RDLK  N+LLD D N +ISD G+A  +  G      Q  T  
Sbjct: 298 IVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAG------QTKTKG 348
Query: 276 ISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKS 323
            +GT G+M+PE  L   +    D F+ GV L E+++ +   G +R + 
Sbjct: 349 YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR---GPFRARG 393

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 17/200 (8%)
Query: 117 LGEGGFGTVYKGVIGQGE-----IAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNLVKLL 170
           +GEG FG V++G+    E     +A+K     +   ++E    EA  + Q  H ++VKL+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVR 230
           G  I ++   +I E      L  FL    ++  LD  + +     ++  L YL      R
Sbjct: 458 GV-ITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 511
Query: 231 IIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE 290
            +HRD+ A N+L+  +   K+ DFG++R +     ED      S+      +M+PE    
Sbjct: 512 FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-----EDSTYYKASKGKLPIKWMAPESINF 566
Query: 291 GIFSIKSDVFSFGVLLLEIV 310
             F+  SDV+ FGV + EI+
Sbjct: 567 RRFTSASDVWMFGVCMWEIL 586

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 40/108 (37%), Positives = 59/108 (54%), Gaps = 12/108 (11%)
Query: 216 VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR 275
           +  GL +LHQ +   II+RDLK  N+LLD D N +ISD G+A  +  G      Q  T  
Sbjct: 298 IVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAG------QTKTKG 348
Query: 276 ISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKS 323
            +GT G+M+PE  L   +    D F+ GV L E+++ +   G +R + 
Sbjct: 349 YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR---GPFRARG 393

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 40/108 (37%), Positives = 59/108 (54%), Gaps = 12/108 (11%)
Query: 216 VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR 275
           +  GL +LHQ +   II+RDLK  N+LLD D N +ISD G+A  +  G      Q  T  
Sbjct: 298 IVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAG------QTKTKG 348
Query: 276 ISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKS 323
            +GT G+M+PE  L   +    D F+ GV L E+++ +   G +R + 
Sbjct: 349 YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR---GPFRARG 393

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 104/222 (46%), Gaps = 25/222 (11%)
Query: 101 FSSVSSATGNFSAANKLGEGGFGTVYKGV--IGQGEIAVKRLLGK--SGQEIKELKNEAS 156
            ++ +  T ++    +LG+G F  V + V      E A K +  K  S ++ ++L+ EA 
Sbjct: 23  MATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREAR 82
Query: 157 VIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGV 216
           +   ++H N+V+L     E+    L+++ +    L     D   RE          I  +
Sbjct: 83  ICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGEL---FEDIVAREYYSEADASHCIHQI 139
Query: 217 AQGLLYLHQYSRVRIIHRDLKASNILLD---KDMNSKISDFGMARIVFGGNDEDELQGNT 273
            + + ++HQ+    I+HRDLK  N+LL    K    K++DFG+A          E+QG  
Sbjct: 140 LESVNHIHQHD---IVHRDLKPENLLLASKCKGAAVKLADFGLA---------IEVQGEQ 187
Query: 274 SR---ISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
                 +GT GY+SPE   +  +    D+++ GV+L  ++ G
Sbjct: 188 QAWFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 106/210 (50%), Gaps = 24/210 (11%)
Query: 117 LGEGGFGTVYKGVIGQGEIAVKRLLGKSGQE-IKELKNEASVIAQVQHKNLVKLLGCCI- 174
           +G+G +G V++G+     +AVK    +  Q   +E +   +V+  ++H N++  +   + 
Sbjct: 16  VGKGRYGEVWRGLWHGESVAVKIFSSRDEQSWFRETEIYNTVL--LRHDNILGFIASDMT 73
Query: 175 ---EKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLH-----QY 226
                 +  LI  Y  + SL  FL    +R+ L+    +++    A GL +LH       
Sbjct: 74  SRNSSTQLWLITHYHEHGSLYDFL----QRQTLEPHLALRLAVSAACGLAHLHVEIFGTQ 129
Query: 227 SRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPE 286
            +  I HRD K+ N+L+  ++   I+D G+A +   G+D  ++ GN  R+ GT  YM+PE
Sbjct: 130 GKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDI-GNNPRV-GTKRYMAPE 187
Query: 287 YALEGIF-----SIK-SDVFSFGVLLLEIV 310
              E I      S K +D+++FG++L EI 
Sbjct: 188 VLDEQIRTDCFESYKWTDIWAFGLVLWEIA 217

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 104/210 (49%), Gaps = 19/210 (9%)
Query: 110 NFSAANKLGEGGFGTVY--KGVIGQG--EIAVKRLLGKSGQEIKE---LKNEASVIAQVQ 162
            F     LG+G FG V+  K + G    ++   ++L K+  ++++    K E  ++ +V 
Sbjct: 25  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN 84
Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLY 222
           H  +VKL      + +  LI +++    L    F    +E++     V+    +A+  L 
Sbjct: 85  HPFIVKLHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFY--LAELALA 138
Query: 223 LHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGY 282
           L     + II+RDLK  NILLD++ + K++DFG+++      +  + +       GT  Y
Sbjct: 139 LDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK------ESIDHEKKAYSFCGTVEY 192
Query: 283 MSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           M+PE       +  +D +SFGVL+ E+++G
Sbjct: 193 MAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 95/207 (45%), Gaps = 18/207 (8%)
Query: 117 LGEGGFGTVY--KGVIGQGEIAVKRL---LGKSGQEIKELKNEASVIAQVQHKNLVKLLG 171
           LG GG   V+  + +    ++AVK L   L +        + EA   A + H  +V +  
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 172 CC-IEKDERLLIY---EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYS 227
               E     L Y   EY+   +L   +   T+  +   R  +++I    Q L + HQ  
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVH--TEGPMTPKRA-IEVIADACQALNFSHQNG 136
Query: 228 RVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEY 287
              IIHRD+K +NIL+      K+ DFG+AR +    D       T+ + GT  Y+SPE 
Sbjct: 137 ---IIHRDVKPANILISATNAVKVVDFGIARAIA---DSGNSVXQTAAVIGTAQYLSPEQ 190
Query: 288 ALEGIFSIKSDVFSFGVLLLEIVSGKK 314
           A       +SDV+S G +L E+++G+ 
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLTGEP 217

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 101/214 (47%), Gaps = 19/214 (8%)
Query: 106 SATGNFSAANKLGEGGFGTVYKGV--IGQGEIAVKRLLGK--SGQEIKELKNEASVIAQV 161
           S T  +     +G+G F  V + V      E A K +  K  S ++ ++L+ EA +   +
Sbjct: 1   SMTDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLL 60
Query: 162 QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLL 221
           +H N+V+L     E+    L+++ +    L     D   RE          I+ + + +L
Sbjct: 61  KHSNIVRLHDSISEEGFHYLVFDLVTGGEL---FEDIVAREYYSEADASHCIQQILEAVL 117
Query: 222 YLHQYSRVRIIHRDLKASNILLD---KDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
           + HQ     ++HRDLK  N+LL    K    K++DFG+A  V G  D+    G     +G
Sbjct: 118 HCHQMG---VVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQG--DQQAWFG----FAG 168
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           T GY+SPE   +  +    D+++ GV+L  ++ G
Sbjct: 169 TPGYLSPEVLRKEAYGKPVDIWACGVILYILLVG 202

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 98/225 (43%), Gaps = 27/225 (12%)
Query: 105 SSATGNFSAANKLGEGGFGTVYKGVIGQ-GEIAVKRLLGKSGQEIKELKNEASVIAQV-- 161
           S AT  +    ++G G +GTVYK      G     + +              S + +V  
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64
Query: 162 -------QHKNLVKLLG-CCIEKDER----LLIYEYMPNKSLDCFLFDPTKREILDWRTR 209
                  +H N+V+L+  C   + +R     L++E++ ++ L  +L D      L   T 
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETI 122
Query: 210 VQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDEL 269
             +++   +GL +LH      I+HRDLK  NIL+      K++DFG+ARI          
Sbjct: 123 KDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY-------SY 172
Query: 270 QGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK 314
           Q   + +  T  Y +PE  L+  ++   D++S G +  E+   K 
Sbjct: 173 QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKP 217

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 106/230 (46%), Gaps = 36/230 (15%)
Query: 108 TGNFSAANKLGEGGFGTVYKG--VIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQH-- 163
             +F     LG+G FG V K    +     A+K++   + +++  + +E  ++A + H  
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQY 63
Query: 164 -----------KNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILD--WRTRV 210
                      +N VK +    +K    +  EY  N++L   +      +  D  WR   
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFR 123
Query: 211 QIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGG-----ND 265
           QI+    + L Y+H      IIHRDLK  NI +D+  N KI DFG+A+ V         D
Sbjct: 124 QIL----EALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 266 EDELQGNTSRIS---GTYGYMSPEYALEGI--FSIKSDVFSFGVLLLEIV 310
              L G++  ++   GT  Y++ E  L+G   ++ K D++S G++  E++
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 28/215 (13%)
Query: 110 NFSAANKLGEGGFGTVYKGVIGQGEI-----AVKRLLGKSGQEIKELKNEASVIAQVQHK 164
           +F     LG+G FG V+     +        A+K+ +     +++    E  V++     
Sbjct: 19  DFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 78
Query: 165 NLVKLLGCCIEKDERLL-IYEYMPNKSL-----DCFLFDPTKREILDWRTRVQIIKGVAQ 218
             +  + C  +  E L  + EY+    L      C  FD ++          +II     
Sbjct: 79  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF----YAAEII----L 130
Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
           GL +LH      I++RDLK  NILLDKD + KI+DFGM +    G+        T+   G
Sbjct: 131 GLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD------AKTNEFCG 181
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           T  Y++PE  L   ++   D +SFGVLL E++ G+
Sbjct: 182 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 216

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 104/210 (49%), Gaps = 19/210 (9%)
Query: 110 NFSAANKLGEGGFGTVY--KGVIGQG--EIAVKRLLGKSGQEIKE---LKNEASVIAQVQ 162
            F     LG+G FG V+  K + G    ++   ++L K+  ++++    K E  ++ +V 
Sbjct: 25  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN 84
Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLY 222
           H  +VKL      + +  LI +++    L    F    +E++     V+    +A+  L 
Sbjct: 85  HPFIVKLHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFY--LAELALA 138
Query: 223 LHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGY 282
           L     + II+RDLK  NILLD++ + K++DFG+++      +  + +       GT  Y
Sbjct: 139 LDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK------ESIDHEKKAYSFCGTVEY 192
Query: 283 MSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           M+PE       +  +D +SFGVL+ E+++G
Sbjct: 193 MAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 104/210 (49%), Gaps = 19/210 (9%)
Query: 110 NFSAANKLGEGGFGTVY--KGVIGQG--EIAVKRLLGKSGQEIKE---LKNEASVIAQVQ 162
            F     LG+G FG V+  K + G    ++   ++L K+  ++++    K E  ++ +V 
Sbjct: 26  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN 85
Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLY 222
           H  +VKL      + +  LI +++    L    F    +E++     V+    +A+  L 
Sbjct: 86  HPFIVKLHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFY--LAELALA 139
Query: 223 LHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGY 282
           L     + II+RDLK  NILLD++ + K++DFG+++      +  + +       GT  Y
Sbjct: 140 LDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK------ESIDHEKKAYSFCGTVEY 193
Query: 283 MSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           M+PE       +  +D +SFGVL+ E+++G
Sbjct: 194 MAPEVVNRRGHTQSADWWSFGVLMFEMLTG 223

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 94/200 (47%), Gaps = 17/200 (8%)
Query: 117 LGEGGFGTVYKGVIGQGE-----IAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNLVKLL 170
           +GEG FG V++G+    E     +A+K     +   ++E    EA  + Q  H ++VKL+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVR 230
           G  I ++   +I E      L  FL    ++  LD  + +     ++  L YL      R
Sbjct: 458 GV-ITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 511
Query: 231 IIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE 290
            +HRD+ A N+L+      K+ DFG++R +     ED      S+      +M+PE    
Sbjct: 512 FVHRDIAARNVLVSATDCVKLGDFGLSRYM-----EDSTYYKASKGKLPIKWMAPESINF 566
Query: 291 GIFSIKSDVFSFGVLLLEIV 310
             F+  SDV+ FGV + EI+
Sbjct: 567 RRFTSASDVWMFGVCMWEIL 586

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 102/215 (47%), Gaps = 20/215 (9%)
Query: 104 VSSATGNFSAANKLGEGGFGTVYKGVIGQGE--IAVKRLLGKSGQEIKELKN-----EAS 156
           V S    +   + LGEG F TVYK         +A+K++      E K+  N     E  
Sbjct: 5   VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK 64
Query: 157 VIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGV 216
           ++ ++ H N++ LL     K    L++++M    L+  + D     +L        +   
Sbjct: 65  LLQELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKD--NSLVLTPSHIKAYMLMT 121
Query: 217 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRI 276
            QGL YLHQ+    I+HRDLK +N+LLD++   K++DFG+A+  FG  +        +R 
Sbjct: 122 LQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK-SFGSPNRAYXHQVVTR- 176
Query: 277 SGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIV 310
                Y +PE      ++ +  D+++ G +L E++
Sbjct: 177 ----WYRAPELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 97/208 (46%), Gaps = 20/208 (9%)
Query: 117 LGEGGFGTVY--KGVIGQGEIAVKRL---LGKSGQEIKELKNEASVIAQVQHKNLVKLLG 171
           LG GG   V+  + +    ++AVK L   L +        + EA   A + H  +V +  
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 172 CC-IEKDERLLIY---EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYS 227
               E     L Y   EY+   +L   +   T+  +   R  +++I    Q L + HQ  
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVH--TEGPMTPKRA-IEVIADACQALNFSHQNG 136
Query: 228 RVRIIHRDLKASNILLDKDMNSKISDFGMAR-IVFGGNDEDELQGNTSRISGTYGYMSPE 286
              IIHRD+K +NI++      K+ DFG+AR I   GN   +    T+ + GT  Y+SPE
Sbjct: 137 ---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ----TAAVIGTAQYLSPE 189
Query: 287 YALEGIFSIKSDVFSFGVLLLEIVSGKK 314
            A       +SDV+S G +L E+++G+ 
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGEP 217

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 97/208 (46%), Gaps = 20/208 (9%)
Query: 117 LGEGGFGTVY--KGVIGQGEIAVKRL---LGKSGQEIKELKNEASVIAQVQHKNLVKLLG 171
           LG GG   V+  + +    ++AVK L   L +        + EA   A + H  +V +  
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 172 CC-IEKDERLLIY---EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYS 227
               E     L Y   EY+   +L   +   T+  +   R  +++I    Q L + HQ  
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVH--TEGPMTPKRA-IEVIADACQALNFSHQNG 136
Query: 228 RVRIIHRDLKASNILLDKDMNSKISDFGMAR-IVFGGNDEDELQGNTSRISGTYGYMSPE 286
              IIHRD+K +NI++      K+ DFG+AR I   GN   +    T+ + GT  Y+SPE
Sbjct: 137 ---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ----TAAVIGTAQYLSPE 189
Query: 287 YALEGIFSIKSDVFSFGVLLLEIVSGKK 314
            A       +SDV+S G +L E+++G+ 
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGEP 217

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 103/207 (49%), Gaps = 24/207 (11%)
Query: 115 NKLGEGGFGTVYKGV--IGQGEIAVK--RLLGKSGQEIKELKNEASVIAQVQHKNLVKLL 170
           +KLGEG + TVYKG   +    +A+K  RL  + G     ++ E S++  ++H N+V L 
Sbjct: 8   DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLH 66
Query: 171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVR 230
                +    L++EY+ +K L  +L D     I++       +  + +GL Y H   R +
Sbjct: 67  DIIHTEKSLTLVFEYL-DKDLKQYLDDCGN--IINMHNVKLFLFQLLRGLAYCH---RQK 120
Query: 231 IIHRDLKASNILLDKDMNSKISDFGMAR---IVFGGNDEDELQGNTSRISGTYGYMSPEY 287
           ++HRDLK  N+L+++    K++DFG+AR   I     D + +         T  Y  P+ 
Sbjct: 121 VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV---------TLWYRPPDI 171
Query: 288 ALEGI-FSIKSDVFSFGVLLLEIVSGK 313
            L    +S + D++  G +  E+ +G+
Sbjct: 172 LLGSTDYSTQIDMWGVGCIFYEMATGR 198

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 93/200 (46%), Gaps = 15/200 (7%)
Query: 116 KLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCC 173
           K+GEG  G V          ++AVK++  +  Q  + L NE  ++    H N+V +    
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSY 111
Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
           +  DE  ++ E++   +L     D      ++      +   V + L YLH      +IH
Sbjct: 112 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIH 164
Query: 234 RDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIF 293
           RD+K+ +ILL  D   K+SDFG     F      E+      + GT  +M+PE      +
Sbjct: 165 RDIKSDSILLTSDGRIKLSDFG-----FCAQVSKEVP-KRKXLVGTPYWMAPEVISRLPY 218
Query: 294 SIKSDVFSFGVLLLEIVSGK 313
             + D++S G++++E++ G+
Sbjct: 219 GTEVDIWSLGIMVIEMIDGE 238

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 94/209 (44%), Gaps = 21/209 (10%)
Query: 110 NFSAANKLGEGGFGTVY------KGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQH 163
           +F     LG+G FG VY         I   ++  K  + K G E  +L+ E  + A + H
Sbjct: 24  DFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVE-HQLRREIEIQAHLHH 82
Query: 164 KNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYL 223
            N+++L     ++    LI EY P   L   L    K    D +    I++ +A  L+Y 
Sbjct: 83  PNILRLYNYFYDRRRIYLILEYAPRGELYKEL---QKSCTFDEQRTATIMEELADALMYC 139
Query: 224 HQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYM 283
           H     ++IHRD+K  N+LL      KI+DFG +           L+  T  + GT  Y+
Sbjct: 140 HG---KKVIHRDIKPENLLLGLKGELKIADFGWS------VHAPSLRRKT--MCGTLDYL 188
Query: 284 SPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
            PE     + + K D++  GVL  E++ G
Sbjct: 189 PPEMIEGRMHNEKVDLWCIGVLCYELLVG 217

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 131/291 (45%), Gaps = 60/291 (20%)
Query: 116 KLGEGGFGTVYKGVI-GQGEI-AVKRLLGKSGQ-EIKELKNEASVIAQVQH-KNLVKLLG 171
           ++G G +G+V K V    G+I AVKR+     + E K+L  +  V+ +      +V+  G
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 172 CCIEKDERLLIYEYMPNKSLDCF-------LFDPTKREILDWRTRVQIIKGVAQGLLYLH 224
               + +  +  E M + S D F       L D    EIL      +I     + L +L 
Sbjct: 89  ALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILG-----KITLATVKALNHLK 142
Query: 225 QYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMS 284
           +   ++IIHRD+K SNILLD+  N K+ DFG++     G   D +    +R +G   YM+
Sbjct: 143 E--NLKIIHRDIKPSNILLDRSGNIKLCDFGIS-----GQLVDSIA--KTRDAGCRPYMA 193
Query: 285 PEY----ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKII 340
           PE     A    + ++SDV+S G+ L E+ +G+               + +  W  N + 
Sbjct: 194 PERIDPSASRQGYDVRSDVWSLGITLYELATGR---------------FPYPKW--NSVF 236
Query: 341 DLIDSVL----------EEASFNESLSRYVHIALLCVQERAEDRPTMSDVV 381
           D +  V+          EE  F+ S   +V+   LC+ +    RP   +++
Sbjct: 237 DQLTQVVKGDPPQLSNSEEREFSPSFINFVN---LCLTKDESKRPKYKELL 284

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 97/208 (46%), Gaps = 20/208 (9%)
Query: 117 LGEGGFGTVY--KGVIGQGEIAVKRL---LGKSGQEIKELKNEASVIAQVQHKNLVKLLG 171
           LG GG   V+  + +    ++AVK L   L +        + EA   A + H  +V +  
Sbjct: 20  LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYA 79
Query: 172 CC-IEKDERLLIY---EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYS 227
               E     L Y   EY+   +L   +   T+  +   R  +++I    Q L + HQ  
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVH--TEGPMTPKRA-IEVIADACQALNFSHQNG 136
Query: 228 RVRIIHRDLKASNILLDKDMNSKISDFGMAR-IVFGGNDEDELQGNTSRISGTYGYMSPE 286
              IIHRD+K +NI++      K+ DFG+AR I   GN   +    T+ + GT  Y+SPE
Sbjct: 137 ---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ----TAAVIGTAQYLSPE 189
Query: 287 YALEGIFSIKSDVFSFGVLLLEIVSGKK 314
            A       +SDV+S G +L E+++G+ 
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGEP 217

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 59/106 (55%), Gaps = 8/106 (7%)
Query: 210 VQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMAR-IVFGGNDEDE 268
           +++I    Q L + HQ     IIHRD+K +NI++      K+ DFG+AR I   GN   +
Sbjct: 119 IEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 175
Query: 269 LQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK 314
               T+ + GT  Y+SPE A       +SDV+S G +L E+++G+ 
Sbjct: 176 ----TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 217

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 24/208 (11%)
Query: 115 NKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSGQEI--KELKNEASVIAQVQHKNLVKLL 170
             +G G +G V   V G+   ++A+K+L      E+  K    E  ++  ++H+N++ LL
Sbjct: 31  QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 90
Query: 171 GCCIEK---DERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQ-IIKGVAQGLLYLHQY 226
                    D+    Y  MP    D  L    K E L    R+Q ++  + +GL Y+H  
Sbjct: 91  DVFTPDETLDDFTDFYLVMPFMGTD--LGKLMKHEKLG-EDRIQFLVYQMLKGLRYIHAA 147
Query: 227 SRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPE 286
               IIHRDLK  N+ +++D   KI DFG+AR       + E+ G       T  Y +PE
Sbjct: 148 G---IIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMXGXVV----TRWYRAPE 195
Query: 287 YALEGI-FSIKSDVFSFGVLLLEIVSGK 313
             L  + ++   D++S G ++ E+++GK
Sbjct: 196 VILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 76/294 (25%), Positives = 129/294 (43%), Gaps = 53/294 (18%)
Query: 110 NFSAANKLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLV 167
           +F     +G GGFG V+K    I      +KR+  K   E  E   E   +A++ H N+V
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV--KYNNEKAE--REVKALAKLDHVNIV 67
Query: 168 KLLGC---------------CIEKDERLLI-YEYMPNKSLDCFLFDPTKREILDWRTRVQ 211
              GC                  K + L I  E+    +L+ ++ +  + E LD    ++
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLALE 126
Query: 212 IIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQG 271
           + + + +G+ Y+H     ++I+RDLK SNI L      KI DFG+   +   ND     G
Sbjct: 127 LFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL--KND-----G 176
Query: 272 NTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAW 331
              R  GT  YMSPE      +  + D+++ G++L E+              L++   A+
Sbjct: 177 KRXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAEL--------------LHVCDTAF 222
Query: 332 DLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLT 385
           +   S    DL D ++ +  F++     +   L    ++ EDRP  S+++  LT
Sbjct: 223 E--TSKFFTDLRDGIISDI-FDKKEKTLLQKLL---SKKPEDRPNTSEILRTLT 270

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 101/215 (46%), Gaps = 25/215 (11%)
Query: 108 TGNFSAANKLGEGGFGTVYKGV---IGQGEIAV----KRLLGKSGQEIKELKNEASVIAQ 160
           T  +    +LG+G F  V + V    GQ   A+    K+L   S ++ ++L+ EA +   
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL---SARDHQKLEREARICRL 66
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           ++H N+V+L     E+    LI++ +    L     D   RE          I+ + + +
Sbjct: 67  LKHPNIVRLHDSISEEGHHYLIFDLVTGGEL---FEDIVAREYYSEADASHCIQQILEAV 123
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNS---KISDFGMARIVFGGNDEDELQGNTSRIS 277
           L+ HQ     ++HR+LK  N+LL   +     K++DFG+A  V G       Q      +
Sbjct: 124 LHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE------QQAWFGFA 174
Query: 278 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           GT GY+SPE   +  +    D+++ GV+L  ++ G
Sbjct: 175 GTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 111/226 (49%), Gaps = 31/226 (13%)
Query: 111 FSAANKLGEGGFGTVYKGVIGQ-GEI-AVKRLLG--KSGQEIKELKNEASVIAQVQ-HKN 165
           +    KLG+G +G V+K +  + GE+ AVK++    ++  + +    E  ++ ++  H+N
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHEN 70
Query: 166 LVKLLGCCIEKDER--LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYL 223
           +V LL      ++R   L+++YM     +  L    +  IL+   +  ++  + + + YL
Sbjct: 71  IVNLLNVLRADNDRDVYLVFDYM-----ETDLHAVIRANILEPVHKQYVVYQLIKVIKYL 125
Query: 224 HQYSRVRIIHRDLKASNILLDKDMNSKISDFGMAR-------------IVFGGNDE--DE 268
           H      ++HRD+K SNILL+ + + K++DFG++R             +    N E  D+
Sbjct: 126 HSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDD 182
Query: 269 LQGNTSRISGTYGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGK 313
            Q   +    T  Y +PE  L      K  D++S G +L EI+ GK
Sbjct: 183 DQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 102/211 (48%), Gaps = 24/211 (11%)
Query: 110 NFSAANKLGEGGFGTVYK-GVIGQGEIAVKRLLGKSGQEIK-----ELKNEASVIAQVQH 163
           +F   ++LG G  G V+K      G +  ++L+     EIK     ++  E  V+ +   
Sbjct: 10  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH---LEIKPAIRNQIIRELQVLHECNS 66
Query: 164 KNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTK-REILDWRTRVQIIKGVAQGLLY 222
             +V   G      E  +  E+M   SLD  L    +  E +  +  + +IKG    L Y
Sbjct: 67  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG----LTY 122
Query: 223 LHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGY 282
           L +  + +I+HRD+K SNIL++     K+ DFG++     G   DE+    +   GT  Y
Sbjct: 123 LRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDEM---ANEFVGTRSY 172
Query: 283 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           MSPE      +S++SD++S G+ L+E+  G+
Sbjct: 173 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 203

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 28/215 (13%)
Query: 110 NFSAANKLGEGGFGTVYKGVIGQGEI-----AVKRLLGKSGQEIKELKNEASVIAQVQHK 164
           +F     LG+G FG V+     +        A+K+ +     +++    E  V++     
Sbjct: 18  DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 77
Query: 165 NLVKLLGCCIEKDERLL-IYEYMPNKSL-----DCFLFDPTKREILDWRTRVQIIKGVAQ 218
             +  + C  +  E L  + EY+    L      C  FD ++          +II     
Sbjct: 78  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF----YAAEII----L 129
Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
           GL +LH      I++RDLK  NILLDKD + KI+DFGM +    G+        T+   G
Sbjct: 130 GLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD------AKTNXFCG 180
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           T  Y++PE  L   ++   D +SFGVLL E++ G+
Sbjct: 181 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 102/216 (47%), Gaps = 28/216 (12%)
Query: 108 TGNFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKSGQEIKE----LKNEASVIAQV 161
           +  +    KLG G +G V   K  +   E A+K ++ KS          L +E +V+ Q+
Sbjct: 20  SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIK-IIKKSSVTTTSNSGALLDEVAVLKQL 78
Query: 162 QHKNLVKLLGCCIEKDERLLIYE-YMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
            H N++KL     +K    L+ E Y   +  D  +      E+        I+K V  G 
Sbjct: 79  DHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEV----DAAVIMKQVLSGT 134
Query: 221 LYLHQYSRVRIIHRDLKASNILLD---KDMNSKISDFGM-ARIVFGGNDEDELQGNTSRI 276
            YLH+++   I+HRDLK  N+LL+   +D   KI DFG+ A    GG  ++ L       
Sbjct: 135 TYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERL------- 184
Query: 277 SGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
            GT  Y++PE  L   +  K DV+S GV+L  ++ G
Sbjct: 185 -GTAYYIAPE-VLRKKYDEKCDVWSCGVILYILLCG 218

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 59/106 (55%), Gaps = 8/106 (7%)
Query: 210 VQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMAR-IVFGGNDEDE 268
           +++I    Q L + HQ     IIHRD+K +NI++      K+ DFG+AR I   GN   +
Sbjct: 136 IEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 192
Query: 269 LQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK 314
               T+ + GT  Y+SPE A       +SDV+S G +L E+++G+ 
Sbjct: 193 ----TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 234

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 105/230 (45%), Gaps = 36/230 (15%)
Query: 108 TGNFSAANKLGEGGFGTVYKG--VIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQH-- 163
             +F     LG+G FG V K    +     A+K++   + +++  + +E  ++A + H  
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQY 63
Query: 164 -----------KNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILD--WRTRV 210
                      +N VK +    +K    +  EY  N +L   +      +  D  WR   
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 211 QIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGG-----ND 265
           QI+    + L Y+H      IIHRDLK  NI +D+  N KI DFG+A+ V         D
Sbjct: 124 QIL----EALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 266 EDELQGNTSRIS---GTYGYMSPEYALEGI--FSIKSDVFSFGVLLLEIV 310
              L G++  ++   GT  Y++ E  L+G   ++ K D++S G++  E++
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 100/210 (47%), Gaps = 24/210 (11%)
Query: 117 LGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCI-- 174
           +G+G +G V++G   QGE    ++     ++    + E      ++H+N++  +   +  
Sbjct: 45  VGKGRYGEVWRGS-WQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTS 103
Query: 175 --EKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLH-----QYS 227
                +  LI  Y    SL    +D  +   LD  + ++I+  +A GL +LH        
Sbjct: 104 RHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQG 159
Query: 228 RVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQ-GNTSRISGTYGYMSPE 286
           +  I HRDLK+ NIL+ K+    I+D G+A  V      ++L  GN  R+ GT  YM+PE
Sbjct: 160 KPAIAHRDLKSKNILVKKNGQCCIADLGLA--VMHSQSTNQLDVGNNPRV-GTKRYMAPE 216
Query: 287 YALEGI------FSIKSDVFSFGVLLLEIV 310
              E I         + D+++FG++L E+ 
Sbjct: 217 VLDETIQVDCFDSYKRVDIWAFGLVLWEVA 246

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 117 LGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCI-- 174
           +G+G +G V++G   QGE    ++     ++    + E      ++H+N++  +   +  
Sbjct: 16  VGKGRYGEVWRGS-WQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTS 74
Query: 175 --EKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLH-----QYS 227
                +  LI  Y    SL    +D  +   LD  + ++I+  +A GL +LH        
Sbjct: 75  RHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQG 130
Query: 228 RVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQ-GNTSRISGTYGYMSPE 286
           +  I HRDLK+ NIL+ K+    I+D G+A  V      ++L  GN  R+ GT  YM+PE
Sbjct: 131 KPAIAHRDLKSKNILVKKNGQCCIADLGLA--VMHSQSTNQLDVGNNPRV-GTKRYMAPE 187
Query: 287 YALEGI------FSIKSDVFSFGVLLLEI 309
              E I         + D+++FG++L E+
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 117 LGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCI-- 174
           +G+G +G V++G   QGE    ++     ++    + E      ++H+N++  +   +  
Sbjct: 16  VGKGRYGEVWRGS-WQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTS 74
Query: 175 --EKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLH-----QYS 227
                +  LI  Y    SL    +D  +   LD  + ++I+  +A GL +LH        
Sbjct: 75  RHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQG 130
Query: 228 RVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQ-GNTSRISGTYGYMSPE 286
           +  I HRDLK+ NIL+ K+    I+D G+A  V      ++L  GN  R+ GT  YM+PE
Sbjct: 131 KPAIAHRDLKSKNILVKKNGQCCIADLGLA--VMHSQSTNQLDVGNNPRV-GTKRYMAPE 187
Query: 287 YALEGI------FSIKSDVFSFGVLLLEI 309
              E I         + D+++FG++L E+
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 106/211 (50%), Gaps = 29/211 (13%)
Query: 116 KLGEGGFGTVYKG---VIGQGEIAVKRLL---GKSGQEIKELKNEASVIAQVQHKNLVKL 169
           K+G+G FG V+K      GQ ++A+K++L    K G  I  L+ E  ++  ++H+N+V L
Sbjct: 25  KIGQGTFGEVFKARHRKTGQ-KVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNL 82
Query: 170 LGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQI------IKGVAQ----G 219
           +  C     R     Y   K+    +FD  + ++    + V +      IK V Q    G
Sbjct: 83  IEIC-----RTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 137
Query: 220 LLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGT 279
           L Y+H   R +I+HRD+KA+N+L+ +D   K++DFG+AR  F      +     +R+  T
Sbjct: 138 LYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLAR-AFSLAKNSQPNRYXNRVV-T 192
Query: 280 YGYMSPEYAL-EGIFSIKSDVFSFGVLLLEI 309
             Y  PE  L E  +    D++  G ++ E+
Sbjct: 193 LWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 72/232 (31%), Positives = 109/232 (46%), Gaps = 41/232 (17%)
Query: 99  FSFSSVSSATG--NFSAANKLGEGGFGTVYKGV--IGQGEIAVKRLL------GKSGQEI 148
            S S+  SAT    +    KLGEG +G VYK +  +    +A+KR+       G  G  I
Sbjct: 22  MSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAI 81
Query: 149 KELKNEASVIAQVQHKNLVKLLGCCIEKDERL-LIYEYMPN---KSLDCFLFDPTKREIL 204
           +E+    S++ ++QH+N+++ L   I  + RL LI+EY  N   K +D       K   +
Sbjct: 82  REV----SLLKELQHRNIIE-LKSVIHHNHRLHLIFEYAENDLKKYMD-------KNPDV 129
Query: 205 DWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNS-----KISDFGMARI 259
             R     +  +  G+ + H  SR R +HRDLK  N+LL     S     KI DFG+AR 
Sbjct: 130 SMRVIKSFLYQLINGVNFCH--SR-RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR- 185
Query: 260 VFGGNDEDELQGNTSRISGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIV 310
            FG      ++  T  I  T  Y  PE  L    +S   D++S   +  E++
Sbjct: 186 AFG----IPIRQFTHEII-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 105/211 (49%), Gaps = 29/211 (13%)
Query: 116 KLGEGGFGTVYKG---VIGQGEIAVKRLL---GKSGQEIKELKNEASVIAQVQHKNLVKL 169
           K+G+G FG V+K      GQ ++A+K++L    K G  I  L+ E  ++  ++H+N+V L
Sbjct: 25  KIGQGTFGEVFKARHRKTGQ-KVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNL 82
Query: 170 LGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQI------IKGVAQ----G 219
           +  C     R     Y   K     +FD  + ++    + V +      IK V Q    G
Sbjct: 83  IEIC-----RTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 137
Query: 220 LLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGT 279
           L Y+H   R +I+HRD+KA+N+L+ +D   K++DFG+AR  F      +     +R+  T
Sbjct: 138 LYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLAR-AFSLAKNSQPNRYXNRVV-T 192
Query: 280 YGYMSPEYAL-EGIFSIKSDVFSFGVLLLEI 309
             Y  PE  L E  +    D++  G ++ E+
Sbjct: 193 LWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 102/216 (47%), Gaps = 28/216 (12%)
Query: 108 TGNFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKSGQEIKE----LKNEASVIAQV 161
           +  +    KLG G +G V   K  +   E A+K ++ KS          L +E +V+ Q+
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIK-IIKKSSVTTTSNSGALLDEVAVLKQL 61
Query: 162 QHKNLVKLLGCCIEKDERLLIYE-YMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
            H N++KL     +K    L+ E Y   +  D  +      E+        I+K V  G 
Sbjct: 62  DHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEV----DAAVIMKQVLSGT 117
Query: 221 LYLHQYSRVRIIHRDLKASNILLD---KDMNSKISDFGM-ARIVFGGNDEDELQGNTSRI 276
            YLH+++   I+HRDLK  N+LL+   +D   KI DFG+ A    GG  ++ L       
Sbjct: 118 TYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERL------- 167
Query: 277 SGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
            GT  Y++PE  L   +  K DV+S GV+L  ++ G
Sbjct: 168 -GTAYYIAPE-VLRKKYDEKCDVWSCGVILYILLCG 201

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 109/211 (51%), Gaps = 21/211 (9%)
Query: 109 GNFSAANKLGEGGFGTVYKG---VIGQGEIAVK---RLLGKSGQEIKELKNEASVIAQVQ 162
           G++   + LG G FG V  G   + G  ++AVK   R   +S   + ++K E   +   +
Sbjct: 11  GHYVLGDTLGVGTFGKVKIGEHQLTGH-KVAVKILNRQKIRSLDVVGKIKREIQNLKLFR 69
Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLY 222
           H +++KL        +  ++ EY+    L  ++    + E ++ R   ++ + +   + Y
Sbjct: 70  HPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR---RLFQQILSAVDY 126
Query: 223 LHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGY 282
            H++    ++HRDLK  N+LLD  MN+KI+DFG++ ++   +D + L+ +     G+  Y
Sbjct: 127 CHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM---SDGEFLRDSC----GSPNY 176
Query: 283 MSPEYALEGIFS-IKSDVFSFGVLLLEIVSG 312
            +PE     +++  + D++S GV+L  ++ G
Sbjct: 177 AAPEVISGRLYAGPEVDIWSCGVILYALLCG 207

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 109/211 (51%), Gaps = 21/211 (9%)
Query: 109 GNFSAANKLGEGGFGTVYKG---VIGQGEIAVK---RLLGKSGQEIKELKNEASVIAQVQ 162
           G++   + LG G FG V  G   + G  ++AVK   R   +S   + ++K E   +   +
Sbjct: 11  GHYVLGDTLGVGTFGKVKIGEHQLTGH-KVAVKILNRQKIRSLDVVGKIKREIQNLKLFR 69
Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLY 222
           H +++KL        +  ++ EY+    L  ++    + E ++ R   ++ + +   + Y
Sbjct: 70  HPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR---RLFQQILSAVDY 126
Query: 223 LHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGY 282
            H++    ++HRDLK  N+LLD  MN+KI+DFG++ ++   +D + L+ +     G+  Y
Sbjct: 127 CHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM---SDGEFLRTS----CGSPNY 176
Query: 283 MSPEYALEGIFS-IKSDVFSFGVLLLEIVSG 312
            +PE     +++  + D++S GV+L  ++ G
Sbjct: 177 AAPEVISGRLYAGPEVDIWSCGVILYALLCG 207

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 105/225 (46%), Gaps = 24/225 (10%)
Query: 110 NFSAANKLGEGGFGTVYK-GVIGQGEIAVKRLLGKSGQEIK-----ELKNEASVIAQVQH 163
           +F   ++LG G  G V+K      G +  ++L+     EIK     ++  E  V+ +   
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH---LEIKPAIRNQIIRELQVLHECNS 63
Query: 164 KNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTK-REILDWRTRVQIIKGVAQGLLY 222
             +V   G      E  +  E+M   SLD  L    +  E +  +  + +IKG    L Y
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG----LTY 119
Query: 223 LHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGY 282
           L +  + +I+HRD+K SNIL++     K+ DFG++     G   D +    +   GT  Y
Sbjct: 120 LRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSM---ANSFVGTRSY 169
Query: 283 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLI 327
           MSPE      +S++SD++S G+ L+E+  G+        K L L+
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 214

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 103/219 (47%), Gaps = 40/219 (18%)
Query: 116 KLGEGGFGTVY--KGVIGQGEIAVKRLL------GKSGQEIK-------ELKNEASVIAQ 160
           KLG G +G V   K   G  E A+K +       G+   + K       E+ NE S++  
Sbjct: 43  KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDP-TKREILDWRTRVQIIKGVAQG 219
           + H N++KL     +K    L+ E+         LF+    R   D      I+K +  G
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGE----LFEQIINRHKFDECDAANIMKQILSG 158
Query: 220 LLYLHQYSRVRIIHRDLKASNILLDKD---MNSKISDFGMARIVFGGND---EDELQGNT 273
           + YLH+++   I+HRD+K  NILL+     +N KI DFG++   F   D    D L    
Sbjct: 159 ICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSS--FFSKDYKLRDRL---- 209
Query: 274 SRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
               GT  Y++PE  L+  ++ K DV+S GV++  ++ G
Sbjct: 210 ----GTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 105/225 (46%), Gaps = 24/225 (10%)
Query: 110 NFSAANKLGEGGFGTVYK-GVIGQGEIAVKRLLGKSGQEIK-----ELKNEASVIAQVQH 163
           +F   ++LG G  G V+K      G +  ++L+     EIK     ++  E  V+ +   
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH---LEIKPAIRNQIIRELQVLHECNS 63
Query: 164 KNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTK-REILDWRTRVQIIKGVAQGLLY 222
             +V   G      E  +  E+M   SLD  L    +  E +  +  + +IKG    L Y
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG----LTY 119
Query: 223 LHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGY 282
           L +  + +I+HRD+K SNIL++     K+ DFG++     G   D +    +   GT  Y
Sbjct: 120 LRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSM---ANSFVGTRSY 169
Query: 283 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLI 327
           MSPE      +S++SD++S G+ L+E+  G+        K L L+
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 214

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 105/225 (46%), Gaps = 24/225 (10%)
Query: 110 NFSAANKLGEGGFGTVYK-GVIGQGEIAVKRLLGKSGQEIK-----ELKNEASVIAQVQH 163
           +F   ++LG G  G V+K      G +  ++L+     EIK     ++  E  V+ +   
Sbjct: 69  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH---LEIKPAIRNQIIRELQVLHECNS 125
Query: 164 KNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTK-REILDWRTRVQIIKGVAQGLLY 222
             +V   G      E  +  E+M   SLD  L    +  E +  +  + +IKG    L Y
Sbjct: 126 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG----LTY 181
Query: 223 LHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGY 282
           L +  + +I+HRD+K SNIL++     K+ DFG++     G   D +    +   GT  Y
Sbjct: 182 LRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSM---ANSFVGTRSY 231
Query: 283 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLI 327
           MSPE      +S++SD++S G+ L+E+  G+        K L L+
Sbjct: 232 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 276

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 105/225 (46%), Gaps = 24/225 (10%)
Query: 110 NFSAANKLGEGGFGTVYK-GVIGQGEIAVKRLLGKSGQEIK-----ELKNEASVIAQVQH 163
           +F   ++LG G  G V+K      G +  ++L+     EIK     ++  E  V+ +   
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH---LEIKPAIRNQIIRELQVLHECNS 63
Query: 164 KNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTK-REILDWRTRVQIIKGVAQGLLY 222
             +V   G      E  +  E+M   SLD  L    +  E +  +  + +IKG    L Y
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG----LTY 119
Query: 223 LHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGY 282
           L +  + +I+HRD+K SNIL++     K+ DFG++     G   D +    +   GT  Y
Sbjct: 120 LRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSM---ANSFVGTRSY 169
Query: 283 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLI 327
           MSPE      +S++SD++S G+ L+E+  G+        K L L+
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 214

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 105/225 (46%), Gaps = 24/225 (10%)
Query: 110 NFSAANKLGEGGFGTVYK-GVIGQGEIAVKRLLGKSGQEIK-----ELKNEASVIAQVQH 163
           +F   ++LG G  G V+K      G +  ++L+     EIK     ++  E  V+ +   
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH---LEIKPAIRNQIIRELQVLHECNS 63
Query: 164 KNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTK-REILDWRTRVQIIKGVAQGLLY 222
             +V   G      E  +  E+M   SLD  L    +  E +  +  + +IKG    L Y
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG----LTY 119
Query: 223 LHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGY 282
           L +  + +I+HRD+K SNIL++     K+ DFG++     G   D +    +   GT  Y
Sbjct: 120 LRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSM---ANSFVGTRSY 169
Query: 283 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLI 327
           MSPE      +S++SD++S G+ L+E+  G+        K L L+
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 214

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 106/216 (49%), Gaps = 29/216 (13%)
Query: 111 FSAANKLGEGGFGTVYKG---VIGQGEIAVKRLL---GKSGQEIKELKNEASVIAQVQHK 164
           +    K+G+G FG V+K      GQ ++A+K++L    K G  I  L+ E  ++  ++H+
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQ-KVALKKVLMENEKEGFPITALR-EIKILQLLKHE 77
Query: 165 NLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQI------IKGVAQ 218
           N+V L+  C     R     Y   K     +FD  + ++    + V +      IK V Q
Sbjct: 78  NVVNLIEIC-----RTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQ 132
Query: 219 ----GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTS 274
               GL Y+H   R +I+HRD+KA+N+L+ +D   K++DFG+AR  F      +     +
Sbjct: 133 MLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLAR-AFSLAKNSQPNRYXN 188
Query: 275 RISGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEI 309
           R+  T  Y  PE  L E  +    D++  G ++ E+
Sbjct: 189 RVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 105/211 (49%), Gaps = 29/211 (13%)
Query: 116 KLGEGGFGTVYKG---VIGQGEIAVKRLL---GKSGQEIKELKNEASVIAQVQHKNLVKL 169
           K+G+G FG V+K      GQ ++A+K++L    K G  I  L+ E  ++  ++H+N+V L
Sbjct: 24  KIGQGTFGEVFKARHRKTGQ-KVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNL 81
Query: 170 LGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQI------IKGVAQ----G 219
           +  C  K        Y   K     +FD  + ++    + V +      IK V Q    G
Sbjct: 82  IEICRTKAS-----PYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 136
Query: 220 LLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGT 279
           L Y+H   R +I+HRD+KA+N+L+ +D   K++DFG+AR  F      +     +R+  T
Sbjct: 137 LYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLAR-AFSLAKNSQPNRYXNRVV-T 191
Query: 280 YGYMSPEYAL-EGIFSIKSDVFSFGVLLLEI 309
             Y  PE  L E  +    D++  G ++ E+
Sbjct: 192 LWYRPPELLLGERDYGPPIDLWGAGCIMAEM 222

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 116/227 (51%), Gaps = 32/227 (14%)
Query: 111 FSAANKLGEGGFGTVYKGV-IGQG-EIAVKRLLGKSGQEI---KELKNEASVIAQVQHKN 165
           +   + +G G +G+V     +  G +IAVK+L  +  Q I   K    E  ++  ++H+N
Sbjct: 53  YQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHEN 111
Query: 166 LVKLL-----GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQ-IIKGVAQG 219
           ++ LL        +E+   + +  ++    L+  +     +++ D    VQ +I  + +G
Sbjct: 112 VIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIV---KCQKLTD--DHVQFLIYQILRG 166
Query: 220 LLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGT 279
           L Y+H      IIHRDLK SN+ +++D   KI DFG+AR     + +DE+ G  +    T
Sbjct: 167 LKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVA----T 214
Query: 280 YGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLN 325
             Y +PE  L  + +++  D++S G ++ E+++G+  T F  T  +N
Sbjct: 215 RWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR--TLFPGTDHIN 259

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 102/215 (47%), Gaps = 24/215 (11%)
Query: 110 NFSAANKLGEGGFGTVYK-GVIGQGEIAVKRLLGKSGQEIK-----ELKNEASVIAQVQH 163
           +F   ++LG G  G V+K      G +  ++L+     EIK     ++  E  V+ +   
Sbjct: 26  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH---LEIKPAIRNQIIRELQVLHECNS 82
Query: 164 KNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTK-REILDWRTRVQIIKGVAQGLLY 222
             +V   G      E  +  E+M   SLD  L    +  E +  +  + +IKG    L Y
Sbjct: 83  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG----LTY 138
Query: 223 LHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGY 282
           L +  + +I+HRD+K SNIL++     K+ DFG++     G   D +    +   GT  Y
Sbjct: 139 LRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSM---ANSFVGTRSY 188
Query: 283 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTG 317
           MSPE      +S++SD++S G+ L+E+  G+   G
Sbjct: 189 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIG 223

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 105/230 (45%), Gaps = 36/230 (15%)
Query: 108 TGNFSAANKLGEGGFGTVYKG--VIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKN 165
             +F     LG+G FG V K    +     A+K++   + +++  + +E  ++A + H+ 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVXLLASLNHQY 63
Query: 166 LVKLLGCCIE------------KDERLLI-YEYMPNKSLDCFLFDPTKREILD--WRTRV 210
           +V+     +E            K   L I  EY  N++L   +      +  D  WR   
Sbjct: 64  VVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFR 123
Query: 211 QIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGG-----ND 265
           QI+    + L Y+H      IIHR+LK  NI +D+  N KI DFG+A+ V         D
Sbjct: 124 QIL----EALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 266 EDELQGNTSRIS---GTYGYMSPEYALEGI--FSIKSDVFSFGVLLLEIV 310
              L G++  ++   GT  Y++ E  L+G   ++ K D +S G++  E +
Sbjct: 177 SQNLPGSSDNLTSAIGTAXYVATE-VLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 85/178 (47%), Gaps = 13/178 (7%)
Query: 137 VKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLL-IYEYMPNKSLDCFL 195
           VK+ L    ++I  ++ E  V  Q  +   +  L  C + + RL  + EY+     D   
Sbjct: 85  VKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYV--NGGDLMF 142
Query: 196 FDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFG 255
               +R++ +   R    + ++  L YLH+     II+RDLK  N+LLD + + K++D+G
Sbjct: 143 HMQRQRKLPEEHARFYSAE-ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYG 198
Query: 256 MARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           M +      D       TS   GT  Y++PE      +    D ++ GVL+ E+++G+
Sbjct: 199 MCKEGLRPGD------TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 105/225 (46%), Gaps = 24/225 (10%)
Query: 110 NFSAANKLGEGGFGTVYK-GVIGQGEIAVKRLLGKSGQEIK-----ELKNEASVIAQVQH 163
           +F   ++LG G  G V+K      G +  ++L+     EIK     ++  E  V+ +   
Sbjct: 34  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH---LEIKPAIRNQIIRELQVLHECNS 90
Query: 164 KNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTK-REILDWRTRVQIIKGVAQGLLY 222
             +V   G      E  +  E+M   SLD  L    +  E +  +  + +IKG    L Y
Sbjct: 91  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG----LTY 146
Query: 223 LHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGY 282
           L +  + +I+HRD+K SNIL++     K+ DFG++     G   D +    +   GT  Y
Sbjct: 147 LRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSM---ANSFVGTRSY 196
Query: 283 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLI 327
           MSPE      +S++SD++S G+ L+E+  G+        K L L+
Sbjct: 197 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 241

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 110/231 (47%), Gaps = 30/231 (12%)
Query: 116 KLGEGGFGTVYKGVIGQGE--IAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKL---- 169
            LG GG G V+  V    +  +A+K+++    Q +K    E  +I ++ H N+VK+    
Sbjct: 18  PLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEIL 77
Query: 170 ----------LGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQG 219
                     +G   E +   ++ EYM     +     P    +L+   R+ + + + +G
Sbjct: 78  GPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGP----LLEEHARLFMYQ-LLRG 132
Query: 220 LLYLHQYSRVRIIHRDLKASNILLD-KDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
           L Y+H      ++HRDLK +N+ ++ +D+  KI DFG+ARI+   +     +G+ S    
Sbjct: 133 LKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIM---DPHYSHKGHLSEGLV 186
Query: 279 TYGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGFYRTKSLNLI 327
           T  Y SP   L      K+ D+++ G +  E+++GK    G +  + + LI
Sbjct: 187 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI 237

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 85/178 (47%), Gaps = 13/178 (7%)
Query: 137 VKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLL-IYEYMPNKSLDCFL 195
           VK+ L    ++I  ++ E  V  Q  +   +  L  C + + RL  + EY+     D   
Sbjct: 53  VKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYV--NGGDLMF 110
Query: 196 FDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFG 255
               +R++ +   R    + ++  L YLH+     II+RDLK  N+LLD + + K++D+G
Sbjct: 111 HMQRQRKLPEEHARFYSAE-ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYG 166
Query: 256 MARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           M +      D       TS   GT  Y++PE      +    D ++ GVL+ E+++G+
Sbjct: 167 MCKEGLRPGD------TTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 218

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 85/179 (47%), Gaps = 13/179 (7%)
Query: 136 AVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLL-IYEYMPNKSLDCF 194
            VK+ L    ++I  ++ E  V  Q  +   +  L  C + + RL  + EY+     D  
Sbjct: 41  VVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYV--NGGDLM 98
Query: 195 LFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDF 254
                +R++ +   R    + ++  L YLH+     II+RDLK  N+LLD + + K++D+
Sbjct: 99  FHMQRQRKLPEEHARFYSAE-ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDY 154
Query: 255 GMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           GM +      D       TS   GT  Y++PE      +    D ++ GVL+ E+++G+
Sbjct: 155 GMCKEGLRPGD------TTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 85/179 (47%), Gaps = 13/179 (7%)
Query: 136 AVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLL-IYEYMPNKSLDCF 194
            VK+ L    ++I  ++ E  V  Q  +   +  L  C + + RL  + EY+     D  
Sbjct: 37  VVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYV--NGGDLM 94
Query: 195 LFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDF 254
                +R++ +   R    + ++  L YLH+     II+RDLK  N+LLD + + K++D+
Sbjct: 95  FHMQRQRKLPEEHARFYSAE-ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDY 150
Query: 255 GMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           GM +      D       TS   GT  Y++PE      +    D ++ GVL+ E+++G+
Sbjct: 151 GMCKEGLRPGD------TTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 203

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 101/211 (47%), Gaps = 24/211 (11%)
Query: 110 NFSAANKLGEGGFGTVYK-GVIGQGEIAVKRLLGKSGQEIK-----ELKNEASVIAQVQH 163
           +F   ++LG G  G V+K      G +  ++L+     EIK     ++  E  V+ +   
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH---LEIKPAIRNQIIRELQVLHECNS 63
Query: 164 KNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTK-REILDWRTRVQIIKGVAQGLLY 222
             +V   G      E  +  E+M   SLD  L    +  E +  +  + +IKG    L Y
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG----LTY 119
Query: 223 LHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGY 282
           L +  + +I+HRD+K SNIL++     K+ DFG++     G   D +    +   GT  Y
Sbjct: 120 LRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSM---ANSFVGTRSY 169
Query: 283 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           MSPE      +S++SD++S G+ L+E+  G+
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 100/225 (44%), Gaps = 48/225 (21%)
Query: 110 NFSAANKLGEGGFGT-VYKGVIGQGEIAVKRLLGK----SGQEIKELKNEASVIAQVQHK 164
           +F   + LG G  GT VY+G+    ++AVKR+L +    + +E++ L+         +H 
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESD------EHP 78
Query: 165 NLVKLLGCCIEKDERL----------LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIK 214
           N+++    C EKD +            + EY+  K       +P           + +++
Sbjct: 79  NVIRYF--CTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEP-----------ITLLQ 125
Query: 215 GVAQGLLYLHQYSRVRIIHRDLKASNILLDKD-----MNSKISDFGMARIVFGGNDEDEL 269
               GL +LH    + I+HRDLK  NIL+        + + ISDFG+ + +  G      
Sbjct: 126 QTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS--- 179
Query: 270 QGNTSRISGTYGYMSPEYALEGI---FSIKSDVFSFGVLLLEIVS 311
               S + GT G+++PE   E      +   D+FS G +   ++S
Sbjct: 180 FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 95/202 (47%), Gaps = 21/202 (10%)
Query: 117 LGEGGFGTVY--KGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCI 174
           LG G F  V+  K  +     A+K +          L+NE +V+ +++H+N+V L     
Sbjct: 17  LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE 76
Query: 175 EKDERLLIYEYMPNKSLDCFLFDPT-KREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
                 L+ + +    L    FD   +R +   +    +I+ V   + YLH+     I+H
Sbjct: 77  STTHYYLVMQLVSGGEL----FDRILERGVYTEKDASLVIQQVLSAVKYLHENG---IVH 129
Query: 234 RDLKASNIL-LDKDMNSKI--SDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE 290
           RDLK  N+L L  + NSKI  +DFG++++        E  G  S   GT GY++PE   +
Sbjct: 130 RDLKPENLLYLTPEENSKIMITDFGLSKM--------EQNGIMSTACGTPGYVAPEVLAQ 181
Query: 291 GIFSIKSDVFSFGVLLLEIVSG 312
             +S   D +S GV+   ++ G
Sbjct: 182 KPYSKAVDCWSIGVITYILLCG 203

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 76/161 (47%), Gaps = 11/161 (6%)
Query: 153 NEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQI 212
           NE  ++ +V  + +V L      KD   L+   M    L   ++   +    + R  V  
Sbjct: 233 NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARA-VFY 291
Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
              +  GL  LH   R RI++RDLK  NILLD   + +ISD G+A  V  G      Q  
Sbjct: 292 AAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG------QTI 342
Query: 273 TSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
             R+ GT GYM+PE      ++   D ++ G LL E+++G+
Sbjct: 343 KGRV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 93/187 (49%), Gaps = 21/187 (11%)
Query: 134 EIAVKRLLGKSGQEIKEL-KNEASVIAQVQ-HKNLVKLLGCCIEKDERLLIYEYMPNKSL 191
           E+  +RL  +  +E++E  + E  ++ QV  H +++ L+          L+++ M    L
Sbjct: 128 EVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL 187
Query: 192 DCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKI 251
             +L   T++  L  +    I++ + + + +LH  +   I+HRDLK  NILLD +M  ++
Sbjct: 188 FDYL---TEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRL 241
Query: 252 SDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEY------ALEGIFSIKSDVFSFGVL 305
           SDFG +  +  G    EL        GT GY++PE            +  + D+++ GV+
Sbjct: 242 SDFGFSCHLEPGEKLREL-------CGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVI 294
Query: 306 LLEIVSG 312
           L  +++G
Sbjct: 295 LFTLLAG 301

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 76/161 (47%), Gaps = 11/161 (6%)
Query: 153 NEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQI 212
           NE  ++ +V  + +V L      KD   L+   M    L   ++   +    + R  V  
Sbjct: 233 NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARA-VFY 291
Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
              +  GL  LH   R RI++RDLK  NILLD   + +ISD G+A  V  G      Q  
Sbjct: 292 AAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG------QTI 342
Query: 273 TSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
             R+ GT GYM+PE      ++   D ++ G LL E+++G+
Sbjct: 343 KGRV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 94/171 (54%), Gaps = 18/171 (10%)
Query: 148 IKELKNEASVIAQVQHKNLVKLLGCCIE--KDERLLIYEYMPNKSLDCFLFDPTKREILD 205
           I+++  E +++ ++ H N+VKL+    +  +D   +++E +    +   +  PT + + +
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV---MEVPTLKPLSE 136
Query: 206 WRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGND 265
            + R    + + +G+ YLH     +IIHRD+K SN+L+ +D + KI+DFG++    G   
Sbjct: 137 DQARF-YFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS-- 190
Query: 266 EDELQGNTSRISGTYGYMSPEYALE--GIFSIKS-DVFSFGVLLLEIVSGK 313
            D L  NT    GT  +M+PE   E   IFS K+ DV++ GV L   V G+
Sbjct: 191 -DALLSNT---VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 18/217 (8%)
Query: 102 SSVSSATGNFSAANKLGEGGFGTVYKGVIGQGEI--AVKRLLGKS---GQEIKELKNEAS 156
           S+  +   +F     +G+G FG V        E+  AVK L  K+    +E K + +E +
Sbjct: 31  SNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERN 90
Query: 157 VIAQ-VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKG 215
           V+ + V+H  LV L       D+   + +Y+    L  F     +R  L+ R R    + 
Sbjct: 91  VLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFYAAE- 147
Query: 216 VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR 275
           +A  L YLH    + I++RDLK  NILLD   +  ++DFG+ +      +  E    TS 
Sbjct: 148 IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCK------ENIEHNSTTST 198
Query: 276 ISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
             GT  Y++PE   +  +    D +  G +L E++ G
Sbjct: 199 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 235

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 91/212 (42%), Gaps = 27/212 (12%)
Query: 110 NFSAANKLGEGGFGTVYKGVIGQGE------IAVKRLLGKSGQEIKELKNEASVIAQVQH 163
           +F     LG+G FG VY     Q +      +  K  L K G E  +L+ E  + + ++H
Sbjct: 15  DFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVE-HQLRREIEIQSHLRH 73
Query: 164 KNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYL 223
            N++++     ++    L+ E+ P   L   L    K    D +     ++ +A  L Y 
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATFMEELADALHYC 130
Query: 224 HQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR---ISGTY 280
           H+    ++IHRD+K  N+L+      KI+DFG +           +   + R   + GT 
Sbjct: 131 HER---KVIHRDIKPENLLMGYKGELKIADFGWS-----------VHAPSLRRRXMCGTL 176
Query: 281 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
            Y+ PE         K D++  GVL  E + G
Sbjct: 177 DYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 208

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 91/212 (42%), Gaps = 27/212 (12%)
Query: 110 NFSAANKLGEGGFGTVYKGVIGQGE------IAVKRLLGKSGQEIKELKNEASVIAQVQH 163
           +F     LG+G FG VY     Q +      +  K  L K G E  +L+ E  + + ++H
Sbjct: 16  DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVE-HQLRREIEIQSHLRH 74
Query: 164 KNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYL 223
            N++++     ++    L+ E+ P   L   L    K    D +     ++ +A  L Y 
Sbjct: 75  PNILRMYNYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATFMEELADALHYC 131
Query: 224 HQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR---ISGTY 280
           H+    ++IHRD+K  N+L+      KI+DFG +           +   + R   + GT 
Sbjct: 132 HE---RKVIHRDIKPENLLMGYKGELKIADFGWS-----------VHAPSLRRRXMCGTL 177
Query: 281 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
            Y+ PE         K D++  GVL  E + G
Sbjct: 178 DYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 209

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 100/227 (44%), Gaps = 42/227 (18%)
Query: 117 LGEGGFGTVYKGV---IGQGEIAVK-----RLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
           +G+G F  V + +    GQ + AVK     +     G   ++LK EAS+   ++H ++V+
Sbjct: 32  IGKGAFSVVRRCINRETGQ-QFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKRE----ILDWRTRVQIIKGVAQGLLYLH 224
           LL          +++E+M    L    F+  KR     +         ++ + + L Y H
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVASHYMRQILEALRYCH 147
Query: 225 QYSRVRIIHRDLKASNILLDKDMNS---KISDFGMA------RIVFGGNDEDELQGNTSR 275
             +   IIHRD+K  N+LL    NS   K+ DFG+A       +V GG            
Sbjct: 148 DNN---IIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGR----------- 193
Query: 276 ISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTK 322
             GT  +M+PE      +    DV+  GV+L  ++SG     FY TK
Sbjct: 194 -VGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG--CLPFYGTK 237

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 104/222 (46%), Gaps = 44/222 (19%)
Query: 111 FSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEI---KELKNEASVIAQVQHKN 165
           +   + +G G +G+V      +    +AVK+L  +  Q I   K    E  ++  ++H+N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSL----DCFLFDPTKREILDWRTRVQ---------I 212
           ++ LL              + P +SL    D +L        L+   + Q         +
Sbjct: 83  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
           I  + +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR     + +DE+ G 
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 182
Query: 273 TSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
            +    T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 183 VA----TRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 104/224 (46%), Gaps = 22/224 (9%)
Query: 110 NFSAANKLGEGGFGTVYK-GVIGQGEIAVKRLLGKSGQEIK-----ELKNEASVIAQVQH 163
           +F   ++LG G  G V K      G I  ++L+     EIK     ++  E  V+ +   
Sbjct: 17  DFERISELGAGNGGVVTKVQHRPSGLIMARKLIH---LEIKPAIRNQIIRELQVLHECNS 73
Query: 164 KNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYL 223
             +V   G      E  +  E+M   SLD  L +  KR   +   +V I   V +GL YL
Sbjct: 74  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKE-AKRIPEEILGKVSI--AVLRGLAYL 130
Query: 224 HQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYM 283
            +  + +I+HRD+K SNIL++     K+ DFG++     G   D +    +   GT  YM
Sbjct: 131 RE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSM---ANSFVGTRSYM 180
Query: 284 SPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLI 327
           +PE      +S++SD++S G+ L+E+  G+        K L  I
Sbjct: 181 APERLQGTHYSVQSDIWSMGLSLVELAVGRYPIPPPDAKELEAI 224

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 104/222 (46%), Gaps = 44/222 (19%)
Query: 111 FSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEI---KELKNEASVIAQVQHKN 165
           +   + +G G +G+V      +    +AVK+L  K  Q I   K    E  ++  ++H+N
Sbjct: 36  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SKPFQSIIHAKRTYRELRLLKHMKHEN 94
Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSL----DCFLFDPTKREILDWRTRVQ---------I 212
           ++ LL              + P +SL    D +L        L+   + Q         +
Sbjct: 95  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 142
Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
           I  + +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR     + +DE+ G 
Sbjct: 143 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 194
Query: 273 TSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
            +    T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 195 VA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 102/226 (45%), Gaps = 24/226 (10%)
Query: 100 SFSSVSSATGNFSAANKLGEGGFGTVYKGV---IGQGEIAVKRLLGKSGQEIKELKN-EA 155
           S S  +   G +    +LG GGFG V + +    G+ ++A+K+   +   + +E    E 
Sbjct: 5   SPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGE-QVAIKQCRQELSPKNRERWCLEI 63
Query: 156 SVIAQVQHKNLVKL------LGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTR 209
            ++ ++ H N+V        L      D  LL  EY     L  +L        L     
Sbjct: 64  QIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPI 123
Query: 210 VQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLD---KDMNSKISDFGMARIVFGGNDE 266
             ++  ++  L YLH+    RIIHRDLK  NI+L    + +  KI D G A+ +    D+
Sbjct: 124 RTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL----DQ 176
Query: 267 DELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
            EL    +   GT  Y++PE   +  +++  D +SFG L  E ++G
Sbjct: 177 GEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITG 219

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 104/222 (46%), Gaps = 44/222 (19%)
Query: 111 FSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEI---KELKNEASVIAQVQHKN 165
           +   + +G G +G+V      +    +AVK+L  +  Q I   K    E  ++  ++H+N
Sbjct: 29  YQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHEN 87
Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSL----DCFLFDPTKREILDWRTRVQ---------I 212
           ++ LL              + P +SL    D +L        L+   + Q         +
Sbjct: 88  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 135
Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
           I  + +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR     + +DE+ G 
Sbjct: 136 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLAR-----HTDDEMTGY 187
Query: 273 TSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
            +    T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 188 VA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 102/215 (47%), Gaps = 21/215 (9%)
Query: 106 SATGNFSAANKLGEGGFGTVYKGV---IGQGEIAVKRLLGK--SGQEIKELKNEASVIAQ 160
           S T  +    +LG+G F  V + +    GQ E A K +  K  S ++ ++L+ EA +   
Sbjct: 1   SMTDEYQLFEELGKGAFSVVRRCMKIPTGQ-EYAAKIINTKKLSARDHQKLEREARICRL 59
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           ++H N+V+L     E+    L+++ +    L     D   RE          I+ + + +
Sbjct: 60  LKHPNIVRLHDSISEEGFHYLVFDLVTGGEL---FEDIVAREYYSEADASHCIQQILESV 116
Query: 221 LYLHQYSRVRIIHRDLKASNILL---DKDMNSKISDFGMARIVFGGNDEDELQGNTSRIS 277
            + H      I+HRDLK  N+LL    K    K++DFG+A  V G  D+    G     +
Sbjct: 117 NHCHLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQG--DQQAWFG----FA 167
Query: 278 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           GT GY+SPE   +  +    D+++ GV+L  ++ G
Sbjct: 168 GTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 102/226 (45%), Gaps = 24/226 (10%)
Query: 100 SFSSVSSATGNFSAANKLGEGGFGTVYKGV---IGQGEIAVKRLLGKSGQEIKELKN-EA 155
           S S  +   G +    +LG GGFG V + +    G+ ++A+K+   +   + +E    E 
Sbjct: 6   SPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGE-QVAIKQCRQELSPKNRERWCLEI 64
Query: 156 SVIAQVQHKNLVKL------LGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTR 209
            ++ ++ H N+V        L      D  LL  EY     L  +L        L     
Sbjct: 65  QIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPI 124
Query: 210 VQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLD---KDMNSKISDFGMARIVFGGNDE 266
             ++  ++  L YLH+    RIIHRDLK  NI+L    + +  KI D G A+ +    D+
Sbjct: 125 RTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL----DQ 177
Query: 267 DELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
            EL    +   GT  Y++PE   +  +++  D +SFG L  E ++G
Sbjct: 178 GEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITG 220

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 96/207 (46%), Gaps = 10/207 (4%)
Query: 111 FSAANKLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQEI-KELKNEASVIAQVQHKNLV 167
           ++    +GEG +G V      + +  +A+K++     Q   +    E  ++ + +H+N++
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVI 104
Query: 168 KLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYS 227
            +           +   Y+    ++  L+   K + L        +  + +GL Y+H   
Sbjct: 105 GIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHS-- 162
Query: 228 RVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEY 287
              ++HRDLK SN+L++   + KI DFG+ARI    + E +  G  +    T  Y +PE 
Sbjct: 163 -ANVLHRDLKPSNLLINTTCDLKICDFGLARI---ADPEHDHTGFLTEXVATRWYRAPEI 218
Query: 288 ALEGIFSIKS-DVFSFGVLLLEIVSGK 313
            L      KS D++S G +L E++S +
Sbjct: 219 MLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 104/222 (46%), Gaps = 44/222 (19%)
Query: 111 FSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEI---KELKNEASVIAQVQHKN 165
           +   + +G G +G+V      +    +AVK+L  +  Q I   K    E  ++  ++H+N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSL----DCFLFDPTKREILDWRTRVQ---------I 212
           ++ LL              + P +SL    D +L        L+   + Q         +
Sbjct: 83  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
           I  + +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR     + +DE+ G 
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGX 182
Query: 273 TSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
            +    T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 183 VA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 25/214 (11%)
Query: 111 FSAANKLGEGGFGTVYK------GVIGQGEIAVKRL--LGKSGQEIKELKNEASVIAQVQ 162
           +    +LG G F  V K      G+    +   KR     + G   +E++ E S++ QV 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLY 222
           H N++ L      + + +LI E +    L  FL    ++E L        IK +  G+ Y
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNY 130
Query: 223 LHQYSRVRIIHRDLKASNI-LLDKDM---NSKISDFGMARIVFGGNDEDELQGNTSRISG 278
           LH     +I H DLK  NI LLDK++   + K+ DFG+A  +  G +          I G
Sbjct: 131 LHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-------FKNIFG 180
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           T  +++PE        +++D++S GV+   ++SG
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 105/223 (47%), Gaps = 46/223 (20%)
Query: 111 FSAANKLGEGGFGTV---YKGVIGQGEIAVKRLLGKSGQEI---KELKNEASVIAQVQHK 164
           +   + +G G +G+V   +    G   +AVK+L  +  Q I   K    E  ++  ++H+
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGH-RVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 165 NLVKLLGCCIEKDERLLIYEYMPNKSL----DCFLFDPTKREILDWRTRVQ--------- 211
           N++ LL              + P +SL    D +L        L+   + Q         
Sbjct: 78  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 125
Query: 212 IIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQG 271
           +I  + +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR     + +DE+ G
Sbjct: 126 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 177
Query: 272 NTSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
             +    T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 178 YVA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 102/215 (47%), Gaps = 21/215 (9%)
Query: 106 SATGNFSAANKLGEGGFGTVYKGV---IGQGEIAVKRLLGK--SGQEIKELKNEASVIAQ 160
           S T  +    +LG+G F  V + +    GQ E A K +  K  S ++ ++L+ EA +   
Sbjct: 1   SMTDEYQLFEELGKGAFSVVRRCMKIPTGQ-EYAAKIINTKKLSARDHQKLEREARICRL 59
Query: 161 VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           ++H N+V+L     E+    L+++ +    L     D   RE          I+ + + +
Sbjct: 60  LKHPNIVRLHDSISEEGFHYLVFDLVTGGEL---FEDIVAREYYSEADASHCIQQILESV 116
Query: 221 LYLHQYSRVRIIHRDLKASNILL---DKDMNSKISDFGMARIVFGGNDEDELQGNTSRIS 277
            + H      I+HRDLK  N+LL    K    K++DFG+A  V G  D+    G     +
Sbjct: 117 NHCHLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQG--DQQAWFG----FA 167
Query: 278 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           GT GY+SPE   +  +    D+++ GV+L  ++ G
Sbjct: 168 GTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 136/297 (45%), Gaps = 50/297 (16%)
Query: 103 SVSSATGNFSAANKLGEGGFGTVYK-GVIGQGEI-AVKRLLGK-SGQEIKELKNEASV-I 158
           S+     +     +LG G +G V K   +  G+I AVKR+    + QE K L  +  + +
Sbjct: 1   SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM 60
Query: 159 AQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRV------QI 212
             V     V   G    + +  +  E M + SLD F      ++++D    +      +I
Sbjct: 61  RTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFY-----KQVIDKGQTIPEDILGKI 114
Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
              + + L +LH  S++ +IHRD+K SN+L++     K+ DFG++     G   D++  +
Sbjct: 115 AVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGIS-----GYLVDDVAKD 167
Query: 273 TSRISGTYGYMSPEYALEGI----FSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIG 328
               +G   YM+PE     +    +S+KSD++S G+ ++E               L ++ 
Sbjct: 168 ID--AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIE---------------LAILR 210
Query: 329 YAWDLWISNKIIDLIDSVLEEAS----FNESLSRYVHIALLCVQERAEDRPTMSDVV 381
           + +D W        +  V+EE S     ++  + +V     C+++ +++RPT  +++
Sbjct: 211 FPYDSW--GTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELM 265

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 101/211 (47%), Gaps = 18/211 (8%)
Query: 111 FSAANKLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQEI-KELKNEASVIAQVQHKNLV 167
           ++  + +GEG +G V      + +  +A+K++     Q   +    E  ++ + +H+N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 168 KL----LGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYL 223
            +        IE+ + + I + +    ++  L+   K + L        +  + +GL Y+
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDL----METDLYKLLKTQHLSNDHICYFLYQILRGLKYI 140
Query: 224 HQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYM 283
           H      ++HRDLK SN+LL+   + KI DFG+AR+    +D     G  +    T  Y 
Sbjct: 141 HS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDH---TGFLTEYVATRWYR 194
Query: 284 SPEYALEGIFSIKS-DVFSFGVLLLEIVSGK 313
           +PE  L      KS D++S G +L E++S +
Sbjct: 195 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 25/214 (11%)
Query: 111 FSAANKLGEGGFGTVYK------GVIGQGEIAVKRL--LGKSGQEIKELKNEASVIAQVQ 162
           +    +LG G F  V K      G+    +   KR     + G   +E++ E S++ QV 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLY 222
           H N++ L      + + +LI E +    L  FL    ++E L        IK +  G+ Y
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNY 130
Query: 223 LHQYSRVRIIHRDLKASNI-LLDKDM---NSKISDFGMARIVFGGNDEDELQGNTSRISG 278
           LH     +I H DLK  NI LLDK++   + K+ DFG+A  +  G +          I G
Sbjct: 131 LHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-------FKNIFG 180
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           T  +++PE        +++D++S GV+   ++SG
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 104/222 (46%), Gaps = 44/222 (19%)
Query: 111 FSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEI---KELKNEASVIAQVQHKN 165
           +   + +G G +G+V      +    +AVK+L  +  Q I   K    E  ++  ++H+N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSL----DCFLFDPTKREILDWRTRVQ---------I 212
           ++ LL              + P +SL    D +L        L+   + Q         +
Sbjct: 83  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFL 130
Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
           I  + +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR     + +DE+ G 
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLAR-----HTDDEMTGY 182
Query: 273 TSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
            +    T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 183 VA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 104/222 (46%), Gaps = 44/222 (19%)
Query: 111 FSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEI---KELKNEASVIAQVQHKN 165
           +   + +G G +G+V      +    +AVK+L  +  Q I   K    E  ++  ++H+N
Sbjct: 29  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHEN 87
Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSL----DCFLFDPTKREILDWRTRVQ---------I 212
           ++ LL              + P +SL    D +L        L+   + Q         +
Sbjct: 88  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 135
Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
           I  + +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR     + +DE+ G 
Sbjct: 136 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLAR-----HTDDEMTGY 187
Query: 273 TSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
            +    T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 188 VA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 25/214 (11%)
Query: 111 FSAANKLGEGGFGTVYK------GVIGQGEIAVKRL--LGKSGQEIKELKNEASVIAQVQ 162
           +    +LG G F  V K      G+    +   KR     + G   +E++ E S++ QV 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLY 222
           H N++ L      + + +LI E +    L  FL    ++E L        IK +  G+ Y
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNY 130
Query: 223 LHQYSRVRIIHRDLKASNI-LLDKDM---NSKISDFGMARIVFGGNDEDELQGNTSRISG 278
           LH     +I H DLK  NI LLDK++   + K+ DFG+A  +  G +          I G
Sbjct: 131 LHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-------FKNIFG 180
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           T  +++PE        +++D++S GV+   ++SG
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 104/223 (46%), Gaps = 46/223 (20%)
Query: 111 FSAANKLGEGGFGTV---YKGVIGQGEIAVKRLLGKSGQEI---KELKNEASVIAQVQHK 164
           +   + +G G +G+V   +    G   +AVK+L  +  Q I   K    E  ++  ++H+
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGH-RVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 165 NLVKLLGCCIEKDERLLIYEYMPNKSL----DCFLFDPTKREILDWRTRVQ--------- 211
           N++ LL              + P +SL    D +L        L+   + Q         
Sbjct: 78  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 125
Query: 212 IIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQG 271
           +I  + +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR     + +DE+ G
Sbjct: 126 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMAG 177
Query: 272 NTSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
                  T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 178 ----FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 131/284 (46%), Gaps = 50/284 (17%)
Query: 116 KLGEGGFGTVYK-GVIGQGEI-AVKRLLGK-SGQEIKELKNEASV-IAQVQHKNLVKLLG 171
           +LG G +G V K   +  G+I AVKR+    + QE K L  +  + +  V     V   G
Sbjct: 58  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 117
Query: 172 CCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRV------QIIKGVAQGLLYLHQ 225
               + +  +  E M + SLD F      ++++D    +      +I   + + L +LH 
Sbjct: 118 ALFREGDVWICMELM-DTSLDKFY-----KQVIDKGQTIPEDILGKIAVSIVKALEHLH- 170
Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
            S++ +IHRD+K SN+L++     K+ DFG++     G   D +       +G   YM+P
Sbjct: 171 -SKLSVIHRDVKPSNVLINALGQVKMCDFGIS-----GYLVDSVAKTID--AGCKPYMAP 222
Query: 286 EYALEGI----FSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIID 341
           E     +    +S+KSD++S G+ ++E               L ++ + +D W       
Sbjct: 223 ERINPELNQKGYSVKSDIWSLGITMIE---------------LAILRFPYDSW--GTPFQ 265
Query: 342 LIDSVLEEAS----FNESLSRYVHIALLCVQERAEDRPTMSDVV 381
            +  V+EE S     ++  + +V     C+++ +++RPT  +++
Sbjct: 266 QLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELM 309

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 110 NFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKSGQEIKELK---NEASVIAQVQHK 164
            F     +G G FG V   K +      A+K L  +   ++K+++   NE  ++  V   
Sbjct: 42  QFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 165 NLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLH 224
            LVKL     +     ++ EYMP   +   L     R I  + +        AQ +L   
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYMPGGDMFSHL-----RRIGRF-SEPHARFYAAQIVLTFE 155
Query: 225 QYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMS 284
               + +I+RDLK  N+L+D+    K++DFG A+ V         +G T  + GT  Y++
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV---------KGRTWXLCGTPEYLA 206
Query: 285 PEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 25/214 (11%)
Query: 111 FSAANKLGEGGFGTVYK------GVIGQGEIAVKRL--LGKSGQEIKELKNEASVIAQVQ 162
           +    +LG G F  V K      G+    +   KR     + G   +E++ E S++ QV 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLY 222
           H N++ L      + + +LI E +    L  FL    ++E L        IK +  G+ Y
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNY 130
Query: 223 LHQYSRVRIIHRDLKASNI-LLDKDM---NSKISDFGMARIVFGGNDEDELQGNTSRISG 278
           LH     +I H DLK  NI LLDK++   + K+ DFG+A  +  G +          I G
Sbjct: 131 LHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-------FKNIFG 180
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           T  +++PE        +++D++S GV+   ++SG
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 101/211 (47%), Gaps = 18/211 (8%)
Query: 111 FSAANKLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQEI-KELKNEASVIAQVQHKNLV 167
           ++  + +GEG +G V      + +  +A+K++     Q   +    E  ++ + +H+N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 168 KL----LGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYL 223
            +        IE+ + + I + +    ++  L+   K + L        +  + +GL Y+
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDL----METDLYKLLKTQHLSNDHICYFLYQILRGLKYI 140
Query: 224 HQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYM 283
           H      ++HRDLK SN+LL+   + KI DFG+AR+    +D     G  +    T  Y 
Sbjct: 141 HS---ANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDH---TGFLTEYVATRWYR 194
Query: 284 SPEYALEGIFSIKS-DVFSFGVLLLEIVSGK 313
           +PE  L      KS D++S G +L E++S +
Sbjct: 195 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 99/211 (46%), Gaps = 20/211 (9%)
Query: 110 NFSAANKLGEGGFGTVY-KGVIGQGEIAVKRLLGK----SGQEIKELKNEASVIAQVQHK 164
           +F+    LG+G FG V      G  E+   ++L K       +++    E  V+A +   
Sbjct: 20  DFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKP 79
Query: 165 NLVKLLGCCIEKDERL-LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYL 223
             +  L  C +  +RL  + EY+    L   ++   +         V     ++ GL +L
Sbjct: 80  PFLTQLHSCFQTVDRLYFVMEYVNGGDL---MYHIQQVGKFKEPQAVFYAAEISIGLFFL 136
Query: 224 HQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR-ISGTYGY 282
           H+     II+RDLK  N++LD + + KI+DFGM +       E  + G T+R   GT  Y
Sbjct: 137 HKRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK-------EHMMDGVTTREFCGTPDY 186
Query: 283 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           ++PE      +    D +++GVLL E+++G+
Sbjct: 187 IAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 217

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 104/222 (46%), Gaps = 44/222 (19%)
Query: 111 FSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEI---KELKNEASVIAQVQHKN 165
           +   + +G G +G+V      +    +AVK+L  +  Q I   K    E  ++  ++H+N
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHEN 78
Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSL----DCFLFDPTKREILDWRTRVQ---------I 212
           ++ LL              + P +SL    D +L        L+   + Q         +
Sbjct: 79  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 126
Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
           I  + +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR     + +DE+ G 
Sbjct: 127 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 178
Query: 273 TSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
            +    T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 179 VA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 105/223 (47%), Gaps = 46/223 (20%)
Query: 111 FSAANKLGEGGFGTV---YKGVIGQGEIAVKRLLGKSGQEI---KELKNEASVIAQVQHK 164
           +   + +G G +G+V   +    G   +AVK+L  +  Q I   K    E  ++  ++H+
Sbjct: 44  YQNLSPVGSGAYGSVCAAFDTKTGH-RVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHE 101
Query: 165 NLVKLLGCCIEKDERLLIYEYMPNKSL----DCFLFDPTKREILDWRTRVQ--------- 211
           N++ LL              + P +SL    D +L        L+   + Q         
Sbjct: 102 NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 149
Query: 212 IIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQG 271
           +I  + +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR     + +DE+ G
Sbjct: 150 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMXG 201
Query: 272 NTSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
             +    T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 202 XVA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 104/222 (46%), Gaps = 44/222 (19%)
Query: 111 FSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEI---KELKNEASVIAQVQHKN 165
           +   + +G G +G+V      +    +AVK+L  +  Q I   K    E  ++  ++H+N
Sbjct: 21  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHEN 79
Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSL----DCFLFDPTKREILDWRTRVQ---------I 212
           ++ LL              + P +SL    D +L        L+   + Q         +
Sbjct: 80  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 127
Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
           I  + +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR     + +DE+ G 
Sbjct: 128 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 179
Query: 273 TSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
            +    T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 180 VA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 105/223 (47%), Gaps = 46/223 (20%)
Query: 111 FSAANKLGEGGFGTV---YKGVIGQGEIAVKRLLGKSGQEI---KELKNEASVIAQVQHK 164
           +   + +G G +G+V   +    G   +AVK+L  +  Q I   K    E  ++  ++H+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGH-RVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 165 NLVKLLGCCIEKDERLLIYEYMPNKSL----DCFLFDPTKREILDWRTRVQ--------- 211
           N++ LL              + P +SL    D +L        L+   + Q         
Sbjct: 82  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 212 IIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQG 271
           +I  + +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR     + +DE+ G
Sbjct: 130 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 181
Query: 272 NTSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
             +    T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 182 YVA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 104/222 (46%), Gaps = 44/222 (19%)
Query: 111 FSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEI---KELKNEASVIAQVQHKN 165
           +   + +G G +G+V      +    +AVK+L  +  Q I   K    E  ++  ++H+N
Sbjct: 21  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHEN 79
Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSL----DCFLFDPTKREILDWRTRVQ---------I 212
           ++ LL              + P +SL    D +L        L+   + Q         +
Sbjct: 80  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 127
Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
           I  + +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR     + +DE+ G 
Sbjct: 128 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 179
Query: 273 TSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
            +    T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 180 VA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 110 NFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKSGQEIKELK---NEASVIAQVQHK 164
            F     +G G FG V   K +      A+K L  +   ++K+++   NE  ++  V   
Sbjct: 42  QFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 165 NLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLH 224
            LVKL     +     ++ EYMP   +   L     R I  + +        AQ +L   
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYMPGGDMFSHL-----RRIGRF-SEPHARFYAAQIVLTFE 155
Query: 225 QYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMS 284
               + +I+RDLK  N+L+D+    K++DFG A+ V         +G T  + GT  Y++
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV---------KGRTWXLCGTPEYLA 206
Query: 285 PEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 104/222 (46%), Gaps = 44/222 (19%)
Query: 111 FSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEI---KELKNEASVIAQVQHKN 165
           +   + +G G +G+V      +    +AVK+L  +  Q I   K    E  ++  ++H+N
Sbjct: 29  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHEN 87
Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSL----DCFLFDPTKREILDWRTRVQ---------I 212
           ++ LL              + P +SL    D +L        L+   + Q         +
Sbjct: 88  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 135
Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
           I  + +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR     + +DE+ G 
Sbjct: 136 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 187
Query: 273 TSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
            +    T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 188 VA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 101/211 (47%), Gaps = 18/211 (8%)
Query: 111 FSAANKLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQEI-KELKNEASVIAQVQHKNLV 167
           ++  + +GEG +G V      + +  +A+K++     Q   +    E  ++ + +H+N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 168 KL----LGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYL 223
            +        IE+ + + I + +    ++  L+   K + L        +  + +GL Y+
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDL----METDLYKLLKTQHLSNDHICYFLYQILRGLKYI 140
Query: 224 HQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYM 283
           H      ++HRDLK SN+LL+   + KI DFG+AR+    +D     G  +    T  Y 
Sbjct: 141 HS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDH---TGFLTEYVATRWYR 194
Query: 284 SPEYALEGIFSIKS-DVFSFGVLLLEIVSGK 313
           +PE  L      KS D++S G +L E++S +
Sbjct: 195 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 104/223 (46%), Gaps = 46/223 (20%)
Query: 111 FSAANKLGEGGFGTV---YKGVIGQGEIAVKRLLGKSGQEI---KELKNEASVIAQVQHK 164
           +   + +G G +G+V   +    G   +AVK+L  +  Q I   K    E  ++  ++H+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGH-RVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 165 NLVKLLGCCIEKDERLLIYEYMPNKSL----DCFLFDPTKREILDWRTRVQ--------- 211
           N++ LL              + P +SL    D +L        L+   + Q         
Sbjct: 82  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 212 IIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQG 271
           +I  + +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR     + +DE+ G
Sbjct: 130 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMAG 181
Query: 272 NTSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
                  T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 182 ----FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 104/222 (46%), Gaps = 44/222 (19%)
Query: 111 FSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEI---KELKNEASVIAQVQHKN 165
           +   + +G G +G+V      +    +AVK+L  +  Q I   K    E  ++  ++H+N
Sbjct: 22  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHEN 80
Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSL----DCFLFDPTKREILDWRTRVQ---------I 212
           ++ LL              + P +SL    D +L        L+   + Q         +
Sbjct: 81  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 128
Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
           I  + +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR     + +DE+ G 
Sbjct: 129 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 180
Query: 273 TSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
            +    T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 181 VA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 104/222 (46%), Gaps = 44/222 (19%)
Query: 111 FSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEI---KELKNEASVIAQVQHKN 165
           +   + +G G +G+V      +    +AVK+L  +  Q I   K    E  ++  ++H+N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSL----DCFLFDPTKREILDWRTRVQ---------I 212
           ++ LL              + P +SL    D +L        L+   + Q         +
Sbjct: 83  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
           I  + +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR     + +DE+ G 
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 182
Query: 273 TSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
            +    T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 183 VA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 104/222 (46%), Gaps = 44/222 (19%)
Query: 111 FSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEI---KELKNEASVIAQVQHKN 165
           +   + +G G +G+V      +    +AVK+L  +  Q I   K    E  ++  ++H+N
Sbjct: 35  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHEN 93
Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSL----DCFLFDPTKREILDWRTRVQ---------I 212
           ++ LL              + P +SL    D +L        L+   + Q         +
Sbjct: 94  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 141
Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
           I  + +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR     + +DE+ G 
Sbjct: 142 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLAR-----HTDDEMTGY 193
Query: 273 TSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
            +    T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 194 VA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 101/211 (47%), Gaps = 18/211 (8%)
Query: 111 FSAANKLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQEI-KELKNEASVIAQVQHKNLV 167
           ++  + +GEG +G V      + +  +A+K++     Q   +    E  ++ + +H+N++
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 86
Query: 168 KL----LGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYL 223
            +        IE+ + + I + +    ++  L+   K + L        +  + +GL Y+
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDL----METDLYKLLKTQHLSNDHICYFLYQILRGLKYI 142
Query: 224 HQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYM 283
           H      ++HRDLK SN+LL+   + KI DFG+AR+    +D     G  +    T  Y 
Sbjct: 143 HS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH---TGFLTEYVATRWYR 196
Query: 284 SPEYALEGIFSIKS-DVFSFGVLLLEIVSGK 313
           +PE  L      KS D++S G +L E++S +
Sbjct: 197 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 104/222 (46%), Gaps = 44/222 (19%)
Query: 111 FSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEI---KELKNEASVIAQVQHKN 165
           +   + +G G +G+V      +    +AVK+L  +  Q I   K    E  ++  ++H+N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSL----DCFLFDPTKREILDWRTRVQ---------I 212
           ++ LL              + P +SL    D +L        L+   + Q         +
Sbjct: 83  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
           I  + +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR     + +DE+ G 
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 182
Query: 273 TSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
            +    T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 183 VA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 104/223 (46%), Gaps = 46/223 (20%)
Query: 111 FSAANKLGEGGFGTV---YKGVIGQGEIAVKRLLGKSGQEI---KELKNEASVIAQVQHK 164
           +   + +G G +G+V   +    G   +AVK+L  +  Q I   K    E  ++  ++H+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGH-RVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 165 NLVKLLGCCIEKDERLLIYEYMPNKSL----DCFLFDPTKREILDWRTRVQ--------- 211
           N++ LL              + P +SL    D +L        L+   + Q         
Sbjct: 82  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 212 IIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQG 271
           +I  + +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR     + +DE+ G
Sbjct: 130 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMAG 181
Query: 272 NTSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
                  T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 182 ----FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 101/211 (47%), Gaps = 18/211 (8%)
Query: 111 FSAANKLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQEI-KELKNEASVIAQVQHKNLV 167
           ++  + +GEG +G V      + +  +A+K++     Q   +    E  ++ + +H+N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 168 KL----LGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYL 223
            +        IE+ + + I + +    ++  L+   K + L        +  + +GL Y+
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDL----METDLYKLLKTQHLSNDHICYFLYQILRGLKYI 140
Query: 224 HQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYM 283
           H      ++HRDLK SN+LL+   + KI DFG+AR+    +D     G  +    T  Y 
Sbjct: 141 HS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH---TGFLTEYVATRWYR 194
Query: 284 SPEYALEGIFSIKS-DVFSFGVLLLEIVSGK 313
           +PE  L      KS D++S G +L E++S +
Sbjct: 195 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 25/207 (12%)
Query: 117 LGEGGFGTVYKG-VIGQGEIAVKRLLGKSGQEIKELKN-EASVIAQVQHKNLVKLLGCCI 174
           +G G FG V++  ++   E+A+K++L     + K  KN E  ++  V+H N+V L     
Sbjct: 48  IGNGSFGVVFQAKLVESDEVAIKKVL-----QDKRFKNRELQIMRIVKHPNVVDLKAFFY 102
Query: 175 ----EKDERLL--IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSR 228
               +KDE  L  + EY+P             ++ +        +  + + L Y+H    
Sbjct: 103 SNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS--- 159
Query: 229 VRIIHRDLKASNILLDKDMNS-KISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEY 287
           + I HRD+K  N+LLD      K+ DFG A+I+  G      + N S I   Y Y +PE 
Sbjct: 160 IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG------EPNVSXICSRY-YRAPEL 212
Query: 288 ALEGI-FSIKSDVFSFGVLLLEIVSGK 313
                 ++   D++S G ++ E++ G+
Sbjct: 213 IFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 104/222 (46%), Gaps = 44/222 (19%)
Query: 111 FSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEI---KELKNEASVIAQVQHKN 165
           +   + +G G +G+V      +    +AVK+L  +  Q I   K    E  ++  ++H+N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSL----DCFLFDPTKREILDWRTRVQ---------I 212
           ++ LL              + P +SL    D +L        L+   + Q         +
Sbjct: 83  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
           I  + +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR     + +DE+ G 
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 182
Query: 273 TSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
            +    T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 183 VA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 104/222 (46%), Gaps = 44/222 (19%)
Query: 111 FSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEI---KELKNEASVIAQVQHKN 165
           +   + +G G +G+V      +    +AVK+L  +  Q I   K    E  ++  ++H+N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSL----DCFLFDPTKREILDWRTRVQ---------I 212
           ++ LL              + P +SL    D +L        L+   + Q         +
Sbjct: 83  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
           I  + +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR     + +DE+ G 
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 182
Query: 273 TSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
            +    T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 183 VA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 25/214 (11%)
Query: 111 FSAANKLGEGGFGTVYK------GVIGQGEIAVKRL--LGKSGQEIKELKNEASVIAQVQ 162
           +    +LG G F  V K      G+    +   KR     + G   +E++ E S++ QV 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLY 222
           H N++ L      + + +LI E +    L  FL    ++E L        IK +  G+ Y
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNY 130
Query: 223 LHQYSRVRIIHRDLKASNI-LLDKDM---NSKISDFGMARIVFGGNDEDELQGNTSRISG 278
           LH     +I H DLK  NI LLDK++   + K+ DFG+A  +  G +          I G
Sbjct: 131 LHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-------FKNIFG 180
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           T  +++PE        +++D++S GV+   ++SG
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 104/222 (46%), Gaps = 44/222 (19%)
Query: 111 FSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEI---KELKNEASVIAQVQHKN 165
           +   + +G G +G+V      +    +AVK+L  +  Q I   K    E  ++  ++H+N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSL----DCFLFDPTKREILDWRTRVQ---------I 212
           ++ LL              + P +SL    D +L        L+   + Q         +
Sbjct: 83  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
           I  + +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR     + +DE+ G 
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 182
Query: 273 TSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
            +    T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 183 VA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 104/222 (46%), Gaps = 44/222 (19%)
Query: 111 FSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEI---KELKNEASVIAQVQHKN 165
           +   + +G G +G+V      +    +AVK+L  +  Q I   K    E  ++  ++H+N
Sbjct: 26  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHEN 84
Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSL----DCFLFDPTKREILDWRTRVQ---------I 212
           ++ LL              + P +SL    D +L        L+   + Q         +
Sbjct: 85  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 132
Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
           I  + +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR     + +DE+ G 
Sbjct: 133 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 184
Query: 273 TSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
            +    T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 185 VA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 105/223 (47%), Gaps = 46/223 (20%)
Query: 111 FSAANKLGEGGFGTV---YKGVIGQGEIAVKRLLGKSGQEI---KELKNEASVIAQVQHK 164
           +   + +G G +G+V   +    G   +AVK+L  +  Q I   K    E  ++  ++H+
Sbjct: 30  YQNLSPVGSGAYGSVCAAFDTKTGH-RVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHE 87
Query: 165 NLVKLLGCCIEKDERLLIYEYMPNKSL----DCFLFDPTKREILDWRTRVQ--------- 211
           N++ LL              + P +SL    D +L        L+   + Q         
Sbjct: 88  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 135
Query: 212 IIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQG 271
           +I  + +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR     + +DE+ G
Sbjct: 136 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 187
Query: 272 NTSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
             +    T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 188 YVA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 103/217 (47%), Gaps = 46/217 (21%)
Query: 117 LGEGGFGTV---YKGVIGQGEIAVKRLLGKSGQEI---KELKNEASVIAQVQHKNLVKLL 170
           +G G +G+V   +    G   +AVK+L  +  Q I   K    E  ++  ++H+N++ LL
Sbjct: 40  VGSGAYGSVCAAFDTKTGH-RVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 97
Query: 171 GCCIEKDERLLIYEYMPNKSL----DCFLFDPTKREILDWRTRVQ---------IIKGVA 217
                         + P +SL    D +L        L+   + Q         +I  + 
Sbjct: 98  DV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 145
Query: 218 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRIS 277
           +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR     + +DE+ G  +   
Sbjct: 146 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVA--- 194
Query: 278 GTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
            T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 195 -TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 101/211 (47%), Gaps = 18/211 (8%)
Query: 111 FSAANKLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQEIKELK-NEASVIAQVQHKNLV 167
           ++  + +GEG +G V      + +  +A+K++     Q   +    E  ++ + +H+N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENII 88
Query: 168 KL----LGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYL 223
            +        IE+ + + I + +    ++  L+   K + L        +  + +GL Y+
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDL----METDLYKLLKTQHLSNDHICYFLYQILRGLKYI 144
Query: 224 HQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYM 283
           H      ++HRDLK SN+LL+   + KI DFG+AR+    +D     G  +    T  Y 
Sbjct: 145 HS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDH---TGFLTEYVATRWYR 198
Query: 284 SPEYALEGIFSIKS-DVFSFGVLLLEIVSGK 313
           +PE  L      KS D++S G +L E++S +
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 25/214 (11%)
Query: 111 FSAANKLGEGGFGTVYK------GVIGQGEIAVKRLLGKSGQEI--KELKNEASVIAQVQ 162
           +    +LG G F  V K      G+    +   KR    S + +  +E++ E S++ QV 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLY 222
           H N++ L      + + +LI E +    L  FL    ++E L        IK +  G+ Y
Sbjct: 74  HPNIITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNY 130
Query: 223 LHQYSRVRIIHRDLKASNI-LLDKDM---NSKISDFGMARIVFGGNDEDELQGNTSRISG 278
           LH     +I H DLK  NI LLDK++   + K+ DFG+A  +  G +          I G
Sbjct: 131 LHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-------FKNIFG 180
Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           T  +++PE        +++D++S GV+   ++SG
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 104/222 (46%), Gaps = 44/222 (19%)
Query: 111 FSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEI---KELKNEASVIAQVQHKN 165
           +   + +G G +G+V      +    +AVK+L  +  Q I   K    E  ++  ++H+N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSL----DCFLFDPTKREILDWRTRVQ---------I 212
           ++ LL              + P +SL    D +L        L+   + Q         +
Sbjct: 83  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
           I  + +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR     + +DE+ G 
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 182
Query: 273 TSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
            +    T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 183 VA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 104/222 (46%), Gaps = 44/222 (19%)
Query: 111 FSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEI---KELKNEASVIAQVQHKN 165
           +   + +G G +G+V      +    +AVK+L  +  Q I   K    E  ++  ++H+N
Sbjct: 29  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHEN 87
Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSL----DCFLFDPTKREILDWRTRVQ---------I 212
           ++ LL              + P +SL    D +L        L+   + Q         +
Sbjct: 88  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 135
Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
           I  + +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR     + +DE+ G 
Sbjct: 136 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 187
Query: 273 TSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
            +    T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 188 VA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 104/222 (46%), Gaps = 44/222 (19%)
Query: 111 FSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEI---KELKNEASVIAQVQHKN 165
           +   + +G G +G+V      +    +AVK+L  +  Q I   K    E  ++  ++H+N
Sbjct: 23  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHEN 81
Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSL----DCFLFDPTKREILDWRTRVQ---------I 212
           ++ LL              + P +SL    D +L        L+   + Q         +
Sbjct: 82  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 129
Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
           I  + +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR     + +DE+ G 
Sbjct: 130 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 181
Query: 273 TSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
            +    T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 182 VA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 105/223 (47%), Gaps = 46/223 (20%)
Query: 111 FSAANKLGEGGFGTV---YKGVIGQGEIAVKRLLGKSGQEI---KELKNEASVIAQVQHK 164
           +   + +G G +G+V   +    G   +AVK+L  +  Q I   K    E  ++  ++H+
Sbjct: 44  YQNLSPVGSGAYGSVCAAFDTKTGH-RVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHE 101
Query: 165 NLVKLLGCCIEKDERLLIYEYMPNKSL----DCFLFDPTKREILDWRTRVQ--------- 211
           N++ LL              + P +SL    D +L        L+   + Q         
Sbjct: 102 NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 149
Query: 212 IIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQG 271
           +I  + +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR     + +DE+ G
Sbjct: 150 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 201
Query: 272 NTSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
             +    T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 202 YVA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 104/222 (46%), Gaps = 44/222 (19%)
Query: 111 FSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEI---KELKNEASVIAQVQHKN 165
           +   + +G G +G+V      +    +AVK+L  +  Q I   K    E  ++  ++H+N
Sbjct: 36  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHEN 94
Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSL----DCFLFDPTKREILDWRTRVQ---------I 212
           ++ LL              + P +SL    D +L        L+   + Q         +
Sbjct: 95  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 142
Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
           I  + +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR     + +DE+ G 
Sbjct: 143 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 194
Query: 273 TSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
            +    T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 195 VA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 104/222 (46%), Gaps = 44/222 (19%)
Query: 111 FSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEI---KELKNEASVIAQVQHKN 165
           +   + +G G +G+V      +    +AVK+L  +  Q I   K    E  ++  ++H+N
Sbjct: 26  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHEN 84
Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSL----DCFLFDPTKREILDWRTRVQ---------I 212
           ++ LL              + P +SL    D +L        L+   + Q         +
Sbjct: 85  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 132
Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
           I  + +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR     + +DE+ G 
Sbjct: 133 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 184
Query: 273 TSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
            +    T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 185 VA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 104/222 (46%), Gaps = 44/222 (19%)
Query: 111 FSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEI---KELKNEASVIAQVQHKN 165
           +   + +G G +G+V      +    +AVK+L  +  Q I   K    E  ++  ++H+N
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHEN 89
Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSL----DCFLFDPTKREILDWRTRVQ---------I 212
           ++ LL              + P +SL    D +L        L+   + Q         +
Sbjct: 90  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 137
Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
           I  + +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR     + +DE+ G 
Sbjct: 138 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 189
Query: 273 TSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
            +    T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 190 VA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 104/222 (46%), Gaps = 44/222 (19%)
Query: 111 FSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEI---KELKNEASVIAQVQHKN 165
           +   + +G G +G+V      +    +AVK+L  +  Q I   K    E  ++  ++H+N
Sbjct: 36  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHEN 94
Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSL----DCFLFDPTKREILDWRTRVQ---------I 212
           ++ LL              + P +SL    D +L        L+   + Q         +
Sbjct: 95  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 142
Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
           I  + +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR     + +DE+ G 
Sbjct: 143 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 194
Query: 273 TSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
            +    T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 195 VA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 104/222 (46%), Gaps = 44/222 (19%)
Query: 111 FSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEI---KELKNEASVIAQVQHKN 165
           +   + +G G +G+V      +    +AVK+L  +  Q I   K    E  ++  ++H+N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSL----DCFLFDPTKREILDWRTRVQ---------I 212
           ++ LL              + P +SL    D +L        L+   + Q         +
Sbjct: 83  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFL 130
Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
           I  + +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR     + +DE+ G 
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 182
Query: 273 TSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
            +    T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 183 VA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 105/223 (47%), Gaps = 46/223 (20%)
Query: 111 FSAANKLGEGGFGTV---YKGVIGQGEIAVKRLLGKSGQEI---KELKNEASVIAQVQHK 164
           +   + +G G +G+V   +    G   +AVK+L  +  Q I   K    E  ++  ++H+
Sbjct: 43  YQNLSPVGSGAYGSVCAAFDTKTGH-RVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHE 100
Query: 165 NLVKLLGCCIEKDERLLIYEYMPNKSL----DCFLFDPTKREILDWRTRVQ--------- 211
           N++ LL              + P +SL    D +L        L+   + Q         
Sbjct: 101 NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 148
Query: 212 IIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQG 271
           +I  + +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR     + +DE+ G
Sbjct: 149 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 200
Query: 272 NTSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
             +    T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 201 YVA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 104/222 (46%), Gaps = 44/222 (19%)
Query: 111 FSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEI---KELKNEASVIAQVQHKN 165
           +   + +G G +G+V      +    +AVK+L  +  Q I   K    E  ++  ++H+N
Sbjct: 47  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHEN 105
Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSL----DCFLFDPTKREILDWRTRVQ---------I 212
           ++ LL              + P +SL    D +L        L+   + Q         +
Sbjct: 106 VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 153
Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
           I  + +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR     + +DE+ G 
Sbjct: 154 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMXGY 205
Query: 273 TSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
            +    T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 206 VA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 110 NFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKSGQEIKELK---NEASVIAQVQHK 164
            F     LG G FG V   K +      A+K L  +   ++KE++   NE  ++  V   
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFP 101
Query: 165 NLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLH 224
            LVKL     +     ++ EY P   +   L     R I  + +        AQ +L   
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL-----RRIGRF-SEPHARFYAAQIVLTFE 155
Query: 225 QYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMS 284
               + +I+RDLK  N+++D+    K++DFG+A+ V         +G T  + GT  Y++
Sbjct: 156 YLHSLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRV---------KGRTWXLCGTPEYLA 206
Query: 285 PEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 104/222 (46%), Gaps = 44/222 (19%)
Query: 111 FSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEI---KELKNEASVIAQVQHKN 165
           +   + +G G +G+V      +    +AVK+L  +  Q I   K    E  ++  ++H+N
Sbjct: 26  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHEN 84
Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSL----DCFLFDPTKREILDWRTRVQ---------I 212
           ++ LL              + P +SL    D +L        L+   + Q         +
Sbjct: 85  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 132
Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
           I  + +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR     + +DE+ G 
Sbjct: 133 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 184
Query: 273 TSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
            +    T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 185 VA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 104/222 (46%), Gaps = 44/222 (19%)
Query: 111 FSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEI---KELKNEASVIAQVQHKN 165
           +   + +G G +G+V      +    +AVK+L  +  Q I   K    E  ++  ++H+N
Sbjct: 30  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHEN 88
Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSL----DCFLFDPTKREILDWRTRVQ---------I 212
           ++ LL              + P +SL    D +L        L+   + Q         +
Sbjct: 89  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 136
Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
           I  + +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR     + +DE+ G 
Sbjct: 137 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 188
Query: 273 TSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
            +    T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 189 VA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 104/222 (46%), Gaps = 44/222 (19%)
Query: 111 FSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEI---KELKNEASVIAQVQHKN 165
           +   + +G G +G+V      +    +AVK+L  +  Q I   K    E  ++  ++H+N
Sbjct: 30  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHEN 88
Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSL----DCFLFDPTKREILDWRTRVQ---------I 212
           ++ LL              + P +SL    D +L        L+   + Q         +
Sbjct: 89  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 136
Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
           I  + +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR     + +DE+ G 
Sbjct: 137 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 188
Query: 273 TSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
            +    T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 189 VA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 101/211 (47%), Gaps = 18/211 (8%)
Query: 111 FSAANKLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQEI-KELKNEASVIAQVQHKNLV 167
           ++  + +GEG +G V      + +  +A+K++     Q   +    E  ++ + +H+N++
Sbjct: 33  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 92
Query: 168 KL----LGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYL 223
            +        IE+ + + I + +    ++  L+   K + L        +  + +GL Y+
Sbjct: 93  GINDIIRAPTIEQMKDVYIVQDL----METDLYKLLKTQHLSNDHICYFLYQILRGLKYI 148
Query: 224 HQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYM 283
           H      ++HRDLK SN+LL+   + KI DFG+AR+    +D     G  +    T  Y 
Sbjct: 149 HS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH---TGFLTEYVATRWYR 202
Query: 284 SPEYALEGIFSIKS-DVFSFGVLLLEIVSGK 313
           +PE  L      KS D++S G +L E++S +
Sbjct: 203 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 101/211 (47%), Gaps = 18/211 (8%)
Query: 111 FSAANKLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQEI-KELKNEASVIAQVQHKNLV 167
           ++  + +GEG +G V      + +  +A+K++     Q   +    E  ++ + +H+N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 168 KL----LGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYL 223
            +        IE+ + + I + +    ++  L+   K + L        +  + +GL Y+
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDL----METDLYKLLKTQHLSNDHICYFLYQILRGLKYI 140
Query: 224 HQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYM 283
           H      ++HRDLK SN+LL+   + KI DFG+AR+    +D     G  +    T  Y 
Sbjct: 141 HS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH---TGFLTEYVATRWYR 194
Query: 284 SPEYALEGIFSIKS-DVFSFGVLLLEIVSGK 313
           +PE  L      KS D++S G +L E++S +
Sbjct: 195 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 104/222 (46%), Gaps = 44/222 (19%)
Query: 111 FSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEI---KELKNEASVIAQVQHKN 165
           +   + +G G +G+V      +    +AVK+L  +  Q I   K    E  ++  ++H+N
Sbjct: 35  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHEN 93
Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSL----DCFLFDPTKREILDWRTRVQ---------I 212
           ++ LL              + P +SL    D +L        L+   + Q         +
Sbjct: 94  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 141
Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
           I  + +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR     + +DE+ G 
Sbjct: 142 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 193
Query: 273 TSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
            +    T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 194 VA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 104/222 (46%), Gaps = 44/222 (19%)
Query: 111 FSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEI---KELKNEASVIAQVQHKN 165
           +   + +G G +G+V      +    +AVK+L  +  Q I   K    E  ++  ++H+N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSL----DCFLFDPTKREILDWRTRVQ---------I 212
           ++ LL              + P +SL    D +L        L+   + Q         +
Sbjct: 83  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
           I  + +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR     + +DE+ G 
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 182
Query: 273 TSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
            +    T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 183 VA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 87/182 (47%), Gaps = 22/182 (12%)
Query: 135 IAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCF 194
           IA K L GK G     ++NE +V+ +++H N+V L           LI + +    L   
Sbjct: 51  IAKKALEGKEGS----MENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL--- 103
Query: 195 LFDP-TKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNIL---LDKDMNSK 250
            FD   ++     R   ++I  V   + YLH    + I+HRDLK  N+L   LD+D    
Sbjct: 104 -FDRIVEKGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIM 159
Query: 251 ISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIV 310
           ISDFG++++   G+         S   GT GY++PE   +  +S   D +S GV+   ++
Sbjct: 160 ISDFGLSKMEDPGS-------VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILL 212
Query: 311 SG 312
            G
Sbjct: 213 CG 214

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 104/222 (46%), Gaps = 44/222 (19%)
Query: 111 FSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEI---KELKNEASVIAQVQHKN 165
           +   + +G G +G+V      +    +AVK+L  +  Q I   K    E  ++  ++H+N
Sbjct: 26  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHEN 84
Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSL----DCFLFDPTKREILDWRTRVQ---------I 212
           ++ LL              + P +SL    D +L        L+   + Q         +
Sbjct: 85  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 132
Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
           I  + +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR     + +DE+ G 
Sbjct: 133 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLAR-----HTDDEMTGY 184
Query: 273 TSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
            +    T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 185 VA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 104/222 (46%), Gaps = 44/222 (19%)
Query: 111 FSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEI---KELKNEASVIAQVQHKN 165
           +   + +G G +G+V      +    +AVK+L  +  Q I   K    E  ++  ++H+N
Sbjct: 30  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHEN 88
Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSL----DCFLFDPTKREILDWRTRVQ---------I 212
           ++ LL              + P +SL    D +L        L+   + Q         +
Sbjct: 89  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 136
Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
           I  + +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR     + +DE+ G 
Sbjct: 137 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLAR-----HTDDEMTGY 188
Query: 273 TSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
            +    T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 189 VA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 105/219 (47%), Gaps = 46/219 (21%)
Query: 115 NKLGEGGFGTV---YKGVIGQGEIAVKRLLGKSGQEI---KELKNEASVIAQVQHKNLVK 168
           + +G G +G+V   +    G   +AVK+L  +  Q I   K    E  ++  ++H+N++ 
Sbjct: 24  SPVGSGAYGSVCAAFDTKTGH-RVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIG 81
Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCF--LFDPTKREILDWRTRVQ-----------IIKG 215
           LL              + P +SL+ F  ++  T     D    V+           +I  
Sbjct: 82  LLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQ 129
Query: 216 VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR 275
           + +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR     + +DE+ G  + 
Sbjct: 130 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVA- 180
Query: 276 ISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
              T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 181 ---TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 100/205 (48%), Gaps = 24/205 (11%)
Query: 116 KLGEGGFGTVYKGV-IGQGEIAVKRLLGKSGQEIK-ELKNEASVIAQVQHKNLVKLLGCC 173
           +LG G FG V++ V    G + V + +       K  +KNE S++ Q+ H  L+ L    
Sbjct: 58  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 117
Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTR----VQIIKGVAQGLLYLHQYSRV 229
            +K E +LI E++    L    FD    E  D++      +  ++   +GL ++H++S  
Sbjct: 118 EDKYEMVLILEFLSGGEL----FDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS-- 169
Query: 230 RIIHRDLKASNILLD--KDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEY 287
            I+H D+K  NI+ +  K  + KI DFG+A  +    + DE+   T   + T  + +PE 
Sbjct: 170 -IVHLDIKPENIMCETKKASSVKIIDFGLATKL----NPDEIVKVT---TATAEFAAPEI 221
Query: 288 ALEGIFSIKSDVFSFGVLLLEIVSG 312
                    +D+++ GVL   ++SG
Sbjct: 222 VDREPVGFYTDMWAIGVLGYVLLSG 246

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 104/222 (46%), Gaps = 44/222 (19%)
Query: 111 FSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEI---KELKNEASVIAQVQHKN 165
           +   + +G G +G+V      +    +AVK+L  +  Q I   K    E  ++  ++H+N
Sbjct: 47  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHEN 105
Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSL----DCFLFDPTKREILDWRTRVQ---------I 212
           ++ LL              + P +SL    D +L        L+   + Q         +
Sbjct: 106 VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 153
Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
           I  + +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR     + +DE+ G 
Sbjct: 154 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 205
Query: 273 TSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
            +    T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 206 VA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 101/211 (47%), Gaps = 18/211 (8%)
Query: 111 FSAANKLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQEI-KELKNEASVIAQVQHKNLV 167
           ++  + +GEG +G V      + +  +A+K++     Q   +    E  ++ + +H+N++
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 104
Query: 168 KL----LGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYL 223
            +        IE+ + + I + +    ++  L+   K + L        +  + +GL Y+
Sbjct: 105 GINDIIRAPTIEQMKDVYIVQDL----METDLYKLLKTQHLSNDHICYFLYQILRGLKYI 160
Query: 224 HQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYM 283
           H      ++HRDLK SN+LL+   + KI DFG+AR+    +D     G  +    T  Y 
Sbjct: 161 HS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH---TGFLTEYVATRWYR 214
Query: 284 SPEYALEGIFSIKS-DVFSFGVLLLEIVSGK 313
           +PE  L      KS D++S G +L E++S +
Sbjct: 215 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 95/210 (45%), Gaps = 26/210 (12%)
Query: 111 FSAANKLGEGGFGTVY----KGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNL 166
           F   ++LG G    VY    KG   Q   A+K L  K   + K ++ E  V+ ++ H N+
Sbjct: 55  FEVESELGRGATSIVYRCKQKGT--QKPYALKVL--KKTVDKKIVRTEIGVLLRLSHPNI 110
Query: 167 VKLLGCCIEKDERLLIYEYMPNKSLDCFLFDP-TKREILDWRTRVQIIKGVAQGLLYLHQ 225
           +KL        E  L+ E +    L    FD   ++     R     +K + + + YLH+
Sbjct: 111 IKLKEIFETPTEISLVLELVTGGEL----FDRIVEKGYYSERDAADAVKQILEAVAYLHE 166
Query: 226 YSRVRIIHRDLKASNILLD---KDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGY 282
                I+HRDLK  N+L      D   KI+DFG+++IV       E Q     + GT GY
Sbjct: 167 NG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV-------EHQVLMKTVCGTPGY 216
Query: 283 MSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
            +PE      +  + D++S G++   ++ G
Sbjct: 217 CAPEILRGCAYGPEVDMWSVGIITYILLCG 246

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 104/222 (46%), Gaps = 44/222 (19%)
Query: 111 FSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEI---KELKNEASVIAQVQHKN 165
           +   + +G G +G+V      +    +AVK+L  +  Q I   K    E  ++  ++H+N
Sbjct: 43  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHEN 101
Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSL----DCFLFDPTKREILDWRTRVQ---------I 212
           ++ LL              + P +SL    D +L        L+   + Q         +
Sbjct: 102 VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 149
Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
           I  + +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR     + +DE+ G 
Sbjct: 150 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 201
Query: 273 TSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
            +    T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 202 VA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 101/211 (47%), Gaps = 18/211 (8%)
Query: 111 FSAANKLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQEI-KELKNEASVIAQVQHKNLV 167
           ++  + +GEG +G V      + +  +A+K++     Q   +    E  ++ + +H+N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 168 KL----LGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYL 223
            +        IE+ + + I + +    ++  L+   K + L        +  + +GL Y+
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDL----METDLYKLLKTQHLSNDHICYFLYQILRGLKYI 144
Query: 224 HQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYM 283
           H      ++HRDLK SN+LL+   + KI DFG+AR+    +D     G  +    T  Y 
Sbjct: 145 HS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDH---TGFLTEYVATRWYR 198
Query: 284 SPEYALEGIFSIKS-DVFSFGVLLLEIVSGK 313
           +PE  L      KS D++S G +L E++S +
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 98/195 (50%), Gaps = 26/195 (13%)
Query: 144 SGQEIKELK----NEASVIAQVQ-HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDP 198
           S +E++EL+     E  ++ +V  H N+++L           L+++ M    L  +L   
Sbjct: 46  SAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--- 102
Query: 199 TKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMAR 258
           T++  L  +   +I++ + + +  LH   ++ I+HRDLK  NILLD DMN K++DFG + 
Sbjct: 103 TEKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSC 159
Query: 259 IVFGGNDEDELQGNTSRISGTYGYMSPEYALEGI------FSIKSDVFSFGVLLLEIVSG 312
            +  G    E       + GT  Y++PE     +      +  + D++S GV++  +++G
Sbjct: 160 QLDPGEKLRE-------VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 212
Query: 313 KKNTGFYRTKSLNLI 327
             +  F+  K + ++
Sbjct: 213 --SPPFWHRKQMLML 225

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 99/211 (46%), Gaps = 27/211 (12%)
Query: 111 FSAANKLGEGGFGTVYKGV-IGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKL 169
           +  A  LG G FG V++ V     +  + + +   G +   +K E S++   +H+N++ L
Sbjct: 7   YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66
Query: 170 LGCCIEKDERLLIYEYMPNKSLDCF------LFDPTKREILDWRTRVQIIKGVAQGLLYL 223
                  +E ++I+E++    LD F       F+  +REI+ +      +  V + L +L
Sbjct: 67  HESFESMEELVMIFEFISG--LDIFERINTSAFELNEREIVSY------VHQVCEALQFL 118
Query: 224 HQYSRVRIIHRDLKASNILLDKDMNS--KISDFGMARIVFGGNDEDELQGNTSRISGTYG 281
           H ++   I H D++  NI+     +S  KI +FG AR +  G+       N   +     
Sbjct: 119 HSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-------NFRLLFTAPE 168
Query: 282 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           Y +PE     + S  +D++S G L+  ++SG
Sbjct: 169 YYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 101/211 (47%), Gaps = 18/211 (8%)
Query: 111 FSAANKLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQEI-KELKNEASVIAQVQHKNLV 167
           ++  + +GEG +G V      + +  +A+K++     Q   +    E  ++ + +H+N++
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 89
Query: 168 KL----LGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYL 223
            +        IE+ + + I + +    ++  L+   K + L        +  + +GL Y+
Sbjct: 90  GINDIIRAPTIEQMKDVYIVQDL----METDLYKLLKTQHLSNDHICYFLYQILRGLKYI 145
Query: 224 HQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYM 283
           H      ++HRDLK SN+LL+   + KI DFG+AR+    +D     G  +    T  Y 
Sbjct: 146 HS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH---TGFLTEYVATRWYR 199
Query: 284 SPEYALEGIFSIKS-DVFSFGVLLLEIVSGK 313
           +PE  L      KS D++S G +L E++S +
Sbjct: 200 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 104/222 (46%), Gaps = 44/222 (19%)
Query: 111 FSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEI---KELKNEASVIAQVQHKN 165
           +   + +G G +G+V      +    +AVK+L  +  Q I   K    E  ++  ++H+N
Sbjct: 44  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHEN 102
Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSL----DCFLFDPTKREILDWRTRVQ---------I 212
           ++ LL              + P +SL    D +L        L+   + Q         +
Sbjct: 103 VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 150
Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
           I  + +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR     + +DE+ G 
Sbjct: 151 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 202
Query: 273 TSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
            +    T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 203 VA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 101/211 (47%), Gaps = 18/211 (8%)
Query: 111 FSAANKLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQEI-KELKNEASVIAQVQHKNLV 167
           ++  + +GEG +G V      + +  +A+K++     Q   +    E  ++ + +H+N++
Sbjct: 31  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 90
Query: 168 KL----LGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYL 223
            +        IE+ + + I + +    ++  L+   K + L        +  + +GL Y+
Sbjct: 91  GINDIIRAPTIEQMKDVYIVQDL----METDLYKLLKTQHLSNDHICYFLYQILRGLKYI 146
Query: 224 HQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYM 283
           H      ++HRDLK SN+LL+   + KI DFG+AR+    +D     G  +    T  Y 
Sbjct: 147 HS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH---TGFLTEYVATRWYR 200
Query: 284 SPEYALEGIFSIKS-DVFSFGVLLLEIVSGK 313
           +PE  L      KS D++S G +L E++S +
Sbjct: 201 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 101/211 (47%), Gaps = 18/211 (8%)
Query: 111 FSAANKLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQEI-KELKNEASVIAQVQHKNLV 167
           ++  + +GEG +G V      + +  +A+K++     Q   +    E  ++ + +H+N++
Sbjct: 22  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 81
Query: 168 KL----LGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYL 223
            +        IE+ + + I + +    ++  L+   K + L        +  + +GL Y+
Sbjct: 82  GINDIIRAPTIEQMKDVYIVQDL----METDLYKLLKTQHLSNDHICYFLYQILRGLKYI 137
Query: 224 HQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYM 283
           H      ++HRDLK SN+LL+   + KI DFG+AR+    +D     G  +    T  Y 
Sbjct: 138 HS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH---TGFLTEYVATRWYR 191
Query: 284 SPEYALEGIFSIKS-DVFSFGVLLLEIVSGK 313
           +PE  L      KS D++S G +L E++S +
Sbjct: 192 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 101/211 (47%), Gaps = 18/211 (8%)
Query: 111 FSAANKLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQEI-KELKNEASVIAQVQHKNLV 167
           ++  + +GEG +G V      + +  +A+K++     Q   +    E  ++ + +H+N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 168 KL----LGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYL 223
            +        IE+ + + I + +    ++  L+   K + L        +  + +GL Y+
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDL----METDLYKLLKTQHLSNDHICYFLYQILRGLKYI 144
Query: 224 HQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYM 283
           H      ++HRDLK SN+LL+   + KI DFG+AR+    +D     G  +    T  Y 
Sbjct: 145 HS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH---TGFLTEYVATRWYR 198
Query: 284 SPEYALEGIFSIKS-DVFSFGVLLLEIVSGK 313
           +PE  L      KS D++S G +L E++S +
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 95/207 (45%), Gaps = 10/207 (4%)
Query: 111 FSAANKLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQEI-KELKNEASVIAQVQHKNLV 167
           ++  + +GEG +G V      + +  +A+K++     Q   +    E  ++ + +H+N++
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 104
Query: 168 KLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYS 227
            +           +   Y+    +   L+   K + L        +  + +GL Y+H   
Sbjct: 105 GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHS-- 162
Query: 228 RVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEY 287
              ++HRDLK SN+LL+   + KI DFG+AR+    +D     G  +    T  Y +PE 
Sbjct: 163 -ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDH---TGFLTEYVATRWYRAPEI 218
Query: 288 ALEGIFSIKS-DVFSFGVLLLEIVSGK 313
            L      KS D++S G +L E++S +
Sbjct: 219 MLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 103/213 (48%), Gaps = 29/213 (13%)
Query: 111 FSAANKLGEGGFGTVYKGVIGQ----GEIAVKRLLGKSGQEIKE--LKNEASVIAQVQHK 164
           F     LG G F  V   V+ +    G++   + + K   + KE  ++NE +V+ +++H+
Sbjct: 24  FEFKETLGTGAFSEV---VLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHE 80
Query: 165 NLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDP-TKREILDWRTRVQIIKGVAQGLLYL 223
           N+V L       +   L+ + +    L    FD   ++     +    +I+ V   + YL
Sbjct: 81  NIVALEDIYESPNHLYLVMQLVSGGEL----FDRIVEKGFYTEKDASTLIRQVLDAVYYL 136
Query: 224 HQYSRVRIIHRDLKASNILL-DKDMNSKI--SDFGMARIVFGGNDEDELQGNT-SRISGT 279
           H   R+ I+HRDLK  N+L   +D  SKI  SDFG++++        E +G+  S   GT
Sbjct: 137 H---RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKM--------EGKGDVMSTACGT 185
Query: 280 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
            GY++PE   +  +S   D +S GV+   ++ G
Sbjct: 186 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 98/195 (50%), Gaps = 26/195 (13%)
Query: 144 SGQEIKELK----NEASVIAQVQ-HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDP 198
           S +E++EL+     E  ++ +V  H N+++L           L+++ M    L  +L   
Sbjct: 59  SAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--- 115
Query: 199 TKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMAR 258
           T++  L  +   +I++ + + +  LH   ++ I+HRDLK  NILLD DMN K++DFG + 
Sbjct: 116 TEKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSC 172
Query: 259 IVFGGNDEDELQGNTSRISGTYGYMSPEYALEGI------FSIKSDVFSFGVLLLEIVSG 312
            +  G    E       + GT  Y++PE     +      +  + D++S GV++  +++G
Sbjct: 173 QLDPGEKLRE-------VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
Query: 313 KKNTGFYRTKSLNLI 327
             +  F+  K + ++
Sbjct: 226 --SPPFWHRKQMLML 238

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 101/211 (47%), Gaps = 18/211 (8%)
Query: 111 FSAANKLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQEI-KELKNEASVIAQVQHKNLV 167
           ++  + +GEG +G V      + +  +A+K++     Q   +    E  ++ + +H+N++
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 82
Query: 168 KL----LGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYL 223
            +        IE+ + + I + +    ++  L+   K + L        +  + +GL Y+
Sbjct: 83  GINDIIRAPTIEQMKDVYIVQDL----METDLYKLLKTQHLSNDHICYFLYQILRGLKYI 138
Query: 224 HQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYM 283
           H      ++HRDLK SN+LL+   + KI DFG+AR+    +D     G  +    T  Y 
Sbjct: 139 HS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH---TGFLTEYVATRWYR 192
Query: 284 SPEYALEGIFSIKS-DVFSFGVLLLEIVSGK 313
           +PE  L      KS D++S G +L E++S +
Sbjct: 193 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 100/211 (47%), Gaps = 18/211 (8%)
Query: 111 FSAANKLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQEI-KELKNEASVIAQVQHKNLV 167
           ++  + +GEG +G V      + +  +A+K++     Q   +    E  ++   +H+N++
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENII 86
Query: 168 KL----LGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYL 223
            +        IE+ + + I + +    ++  L+   K + L        +  + +GL Y+
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDL----METDLYKLLKTQHLSNDHICYFLYQILRGLKYI 142
Query: 224 HQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYM 283
           H      ++HRDLK SN+LL+   + KI DFG+AR+    +D     G  +    T  Y 
Sbjct: 143 HS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH---TGFLTEYVATRWYR 196
Query: 284 SPEYALEGIFSIKS-DVFSFGVLLLEIVSGK 313
           +PE  L      KS D++S G +L E++S +
Sbjct: 197 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 101/211 (47%), Gaps = 18/211 (8%)
Query: 111 FSAANKLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQEI-KELKNEASVIAQVQHKNLV 167
           ++  + +GEG +G V      + +  +A+K++     Q   +    E  ++ + +H+N++
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 82
Query: 168 KL----LGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYL 223
            +        IE+ + + I + +    ++  L+   K + L        +  + +GL Y+
Sbjct: 83  GINDIIRAPTIEQMKDVYIVQDL----METDLYKLLKTQHLSNDHICYFLYQILRGLKYI 138
Query: 224 HQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYM 283
           H      ++HRDLK SN+LL+   + KI DFG+AR+    +D     G  +    T  Y 
Sbjct: 139 HS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH---TGFLTEYVATRWYR 192
Query: 284 SPEYALEGIFSIKS-DVFSFGVLLLEIVSGK 313
           +PE  L      KS D++S G +L E++S +
Sbjct: 193 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 30/213 (14%)
Query: 117 LGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQV--QHKNLVKLLGCCI 174
           +G+G FG V++G     E+AVK     S +E +    EA +   V  +H+N++  +    
Sbjct: 12  IGKGRFGEVWRGKWRGEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFIAA-D 67
Query: 175 EKD-----ERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ---- 225
            KD     +  L+ +Y  + SL    FD   R  +     +++    A GL +LH     
Sbjct: 68  NKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVG 123
Query: 226 -YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMS 284
              +  I HRDLK+ NIL+ K+    I+D G+A       D  ++  N  R+ GT  YM+
Sbjct: 124 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPN-HRV-GTKRYMA 181
Query: 285 PEYALEGIFSIK-------SDVFSFGVLLLEIV 310
           PE  L+   ++K       +D+++ G++  EI 
Sbjct: 182 PE-VLDDSINMKHFESFKRADIYAMGLVFWEIA 213

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 103/222 (46%), Gaps = 44/222 (19%)
Query: 111 FSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEI---KELKNEASVIAQVQHKN 165
           +   + +G G +G+V      +    +AVK+L  +  Q I   K    E  ++  ++H+N
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHEN 89
Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSL----DCFLFDPTKREILDWRTRVQ---------I 212
           ++ LL              + P +SL    D +L        L+   + Q         +
Sbjct: 90  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 137
Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
           I  + +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR     +  DE+ G 
Sbjct: 138 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTADEMTGY 189
Query: 273 TSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
            +    T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 190 VA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 30/213 (14%)
Query: 117 LGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQV--QHKNLVKLLGCCI 174
           +G+G FG V++G     E+AVK     S +E +    EA +   V  +H+N++  +    
Sbjct: 11  IGKGRFGEVWRGKWRGEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFIAA-D 66
Query: 175 EKD-----ERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ---- 225
            KD     +  L+ +Y  + SL    FD   R  +     +++    A GL +LH     
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 226 -YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMS 284
              +  I HRDLK+ NIL+ K+    I+D G+A       D  ++  N  R+ GT  YM+
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPN-HRV-GTKRYMA 180
Query: 285 PEYALEGIFSIK-------SDVFSFGVLLLEIV 310
           PE  L+   ++K       +D+++ G++  EI 
Sbjct: 181 PE-VLDDSINMKHFESFKRADIYAMGLVFWEIA 212

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 101/212 (47%), Gaps = 28/212 (13%)
Query: 117 LGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQV--QHKNLVKLLGCCI 174
           +G+G FG V++G     E+AVK     S +E +    EA +   V  +H+N++  +    
Sbjct: 50  IGKGRFGEVWRGKWRGEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFIAADN 106
Query: 175 EKD----ERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ----- 225
           + +    +  L+ +Y  + SL    FD   R  +     +++    A GL +LH      
Sbjct: 107 KDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGT 162
Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
             +  I HRDLK+ NIL+ K+    I+D G+A       D  ++  N  R+ GT  YM+P
Sbjct: 163 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPN-HRV-GTKRYMAP 220
Query: 286 EYALEGIFSIK-------SDVFSFGVLLLEIV 310
           E  L+   ++K       +D+++ G++  EI 
Sbjct: 221 E-VLDDSINMKHFESFKRADIYAMGLVFWEIA 251

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 30/213 (14%)
Query: 117 LGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQV--QHKNLVKLLGCCI 174
           +G+G FG V++G     E+AVK     S +E +    EA +   V  +H+N++  +    
Sbjct: 37  IGKGRFGEVWRGKWRGEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFIAA-D 92
Query: 175 EKD-----ERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ---- 225
            KD     +  L+ +Y  + SL    FD   R  +     +++    A GL +LH     
Sbjct: 93  NKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVG 148
Query: 226 -YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMS 284
              +  I HRDLK+ NIL+ K+    I+D G+A       D  ++  N  R+ GT  YM+
Sbjct: 149 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPN-HRV-GTKRYMA 206
Query: 285 PEYALEGIFSIK-------SDVFSFGVLLLEIV 310
           PE  L+   ++K       +D+++ G++  EI 
Sbjct: 207 PE-VLDDSINMKHFESFKRADIYAMGLVFWEIA 238

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 103/222 (46%), Gaps = 44/222 (19%)
Query: 111 FSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEI---KELKNEASVIAQVQHKN 165
           +   + +G G +G+V      +    +AVK+L  +  Q I   K    E  ++  ++H+N
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHEN 89
Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSL----DCFLFDPTKREILDWRTRVQ---------I 212
           ++ LL              + P +SL    D +L        L+   + Q         +
Sbjct: 90  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 137
Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
           I  + +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR     +  DE+ G 
Sbjct: 138 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTADEMTGY 189
Query: 273 TSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
            +    T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 190 VA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 103/222 (46%), Gaps = 44/222 (19%)
Query: 111 FSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEI---KELKNEASVIAQVQHKN 165
           +   + +G G +G+V      +    +AVK+L  +  Q I   K    E  ++  ++H+N
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHEN 89
Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSL----DCFLFDPTKREILDWRTRVQ---------I 212
           ++ LL              + P +SL    D +L        L+   + Q         +
Sbjct: 90  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 137
Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
           I  + +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR     +  DE+ G 
Sbjct: 138 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTADEMTGY 189
Query: 273 TSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
            +    T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 190 VA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/269 (23%), Positives = 103/269 (38%), Gaps = 73/269 (27%)
Query: 110 NFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNL 166
           +F     +G GGFG V+  K  +     A+KR+   + +  +E +  E   +A+++H  +
Sbjct: 7   DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 66
Query: 167 VKLLGCCIEKDERLLIYE----YMPNKSLDCFLFDPT----------------------- 199
           V+     +E        E    ++ ++S D  L  P+                       
Sbjct: 67  VRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQ 126
Query: 200 ------------------KREILDWRTR------------VQIIKGVAQGLLYLHQYSRV 229
                             K  + DW  R            + I   +A+ + +LH     
Sbjct: 127 LQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG-- 184
Query: 230 RIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRIS--------GTYG 281
            ++HRDLK SNI    D   K+ DFG+  +     DE+E    T   +        GT  
Sbjct: 185 -LMHRDLKPSNIFFTMDDVVKVGDFGL--VTAMDQDEEEQTVLTPMPAYATHXGQVGTKL 241
Query: 282 YMSPEYALEGIFSIKSDVFSFGVLLLEIV 310
           YMSPE      +S K D+FS G++L E++
Sbjct: 242 YMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 30/213 (14%)
Query: 117 LGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQV--QHKNLVKLLGCCI 174
           +G+G FG V++G     E+AVK     S +E +    EA +   V  +H+N++  +    
Sbjct: 17  IGKGRFGEVWRGKWRGEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFIAA-D 72
Query: 175 EKD-----ERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ---- 225
            KD     +  L+ +Y  + SL    FD   R  +     +++    A GL +LH     
Sbjct: 73  NKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVG 128
Query: 226 -YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMS 284
              +  I HRDLK+ NIL+ K+    I+D G+A       D  ++  N  R+ GT  YM+
Sbjct: 129 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPN-HRV-GTKRYMA 186
Query: 285 PEYALEGIFSIK-------SDVFSFGVLLLEIV 310
           PE  L+   ++K       +D+++ G++  EI 
Sbjct: 187 PE-VLDDSINMKHFESFKRADIYAMGLVFWEIA 218

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 104/222 (46%), Gaps = 44/222 (19%)
Query: 111 FSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEI---KELKNEASVIAQVQHKN 165
           +   + +G G +G+V      +    +AVK+L  +  Q I   K    E  ++  ++H+N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSL----DCFLFDPTKREILDWRTRVQ---------I 212
           ++ LL              + P +SL    D +L        L+   + Q         +
Sbjct: 83  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
           I  + +GL Y+H      IIHRDLK SN+ +++D   KI D+G+AR     + +DE+ G 
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDYGLAR-----HTDDEMTGY 182
Query: 273 TSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
            +    T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 183 VA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 97/195 (49%), Gaps = 26/195 (13%)
Query: 144 SGQEIKELK----NEASVIAQVQ-HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDP 198
           S +E++EL+     E  ++ +V  H N+++L           L+++ M    L  +L   
Sbjct: 59  SAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--- 115
Query: 199 TKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMAR 258
           T++  L  +   +I++ + + +  LH   ++ I+HRDLK  NILLD DMN K++DFG + 
Sbjct: 116 TEKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSC 172
Query: 259 IVFGGNDEDELQGNTSRISGTYGYMSPEYALEGI------FSIKSDVFSFGVLLLEIVSG 312
            +  G            + GT  Y++PE     +      +  + D++S GV++  +++G
Sbjct: 173 QLDPGE-------KLRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
Query: 313 KKNTGFYRTKSLNLI 327
             +  F+  K + ++
Sbjct: 226 --SPPFWHRKQMLML 238

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 30/213 (14%)
Query: 117 LGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQV--QHKNLVKLLGCCI 174
           +G+G FG V++G     E+AVK     S +E +    EA +   V  +H+N++  +    
Sbjct: 14  IGKGRFGEVWRGKWRGEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFIAA-D 69
Query: 175 EKD-----ERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ---- 225
            KD     +  L+ +Y  + SL    FD   R  +     +++    A GL +LH     
Sbjct: 70  NKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVG 125
Query: 226 -YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMS 284
              +  I HRDLK+ NIL+ K+    I+D G+A       D  ++  N  R+ GT  YM+
Sbjct: 126 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPN-HRV-GTKRYMA 183
Query: 285 PEYALEGIFSIK-------SDVFSFGVLLLEIV 310
           PE  L+   ++K       +D+++ G++  EI 
Sbjct: 184 PE-VLDDSINMKHFESFKRADIYAMGLVFWEIA 215

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 100/211 (47%), Gaps = 18/211 (8%)
Query: 111 FSAANKLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQEI-KELKNEASVIAQVQHKNLV 167
           ++  + +GEG +G V      + +  +A+K++     Q   +    E  ++   +H+N++
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENII 86
Query: 168 KL----LGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYL 223
            +        IE+ + + I + +    ++  L+   K + L        +  + +GL Y+
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDL----METDLYKLLKTQHLSNDHICYFLYQILRGLKYI 142
Query: 224 HQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYM 283
           H      ++HRDLK SN+LL+   + KI DFG+AR+    +D     G  +    T  Y 
Sbjct: 143 HS---ANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDH---TGFLTEYVATRWYR 196
Query: 284 SPEYALEGIFSIKS-DVFSFGVLLLEIVSGK 313
           +PE  L      KS D++S G +L E++S +
Sbjct: 197 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 94/210 (44%), Gaps = 24/210 (11%)
Query: 110 NFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKSGQEIKELK---NEASVIAQVQHK 164
            F     LG G FG V   K +      A+K L  +   ++K+++   NE  ++  V   
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 165 NLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKR--EILDWRTRVQIIKGVAQGLLY 222
            LVKL     +     ++ EY+P   +    F   +R     +   R       AQ +L 
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPHARFY----AAQIVLT 153
Query: 223 LHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGY 282
                 + +I+RDLK  N+L+D+    +++DFG A+ V         +G T  + GT  Y
Sbjct: 154 FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV---------KGRTWXLCGTPEY 204
Query: 283 MSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           ++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 101/211 (47%), Gaps = 18/211 (8%)
Query: 111 FSAANKLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQEI-KELKNEASVIAQVQHKNLV 167
           ++  + +GEG +G V      + +  +A++++     Q   +    E  ++ + +H+N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 168 KL----LGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYL 223
            +        IE+ + + I + +    ++  L+   K + L        +  + +GL Y+
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDL----METDLYKLLKTQHLSNDHICYFLYQILRGLKYI 144
Query: 224 HQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYM 283
           H      ++HRDLK SN+LL+   + KI DFG+AR+    +D     G  +    T  Y 
Sbjct: 145 HS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH---TGFLTEYVATRWYR 198
Query: 284 SPEYALEGIFSIKS-DVFSFGVLLLEIVSGK 313
           +PE  L      KS D++S G +L E++S +
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 94/210 (44%), Gaps = 24/210 (11%)
Query: 110 NFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKSGQEIKELK---NEASVIAQVQHK 164
            F     LG G FG V   K +      A+K L  +   ++K+++   NE  ++  V   
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 102
Query: 165 NLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKR--EILDWRTRVQIIKGVAQGLLY 222
            LVKL     +     ++ EY+P   +    F   +R     +   R       AQ +L 
Sbjct: 103 FLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPHARFY----AAQIVLT 154
Query: 223 LHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGY 282
                 + +I+RDLK  N+L+D+    +++DFG A+ V         +G T  + GT  Y
Sbjct: 155 FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV---------KGRTWXLCGTPEY 205
Query: 283 MSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           ++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 94/210 (44%), Gaps = 24/210 (11%)
Query: 110 NFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKSGQEIKELK---NEASVIAQVQHK 164
            F     LG G FG V   K +      A+K L  +   ++K+++   NE  ++  V   
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 165 NLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKR--EILDWRTRVQIIKGVAQGLLY 222
            LVKL     +     ++ EY+P   +    F   +R     +   R       AQ +L 
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPHARFY----AAQIVLT 153
Query: 223 LHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGY 282
                 + +I+RDLK  N+L+D+    +++DFG A+ V         +G T  + GT  Y
Sbjct: 154 FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV---------KGRTWXLCGTPEY 204
Query: 283 MSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           ++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 110 NFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKSGQEIKELK---NEASVIAQVQHK 164
            F     LG G FG V   K +      A+K L  +   ++KE++   NE  ++  V   
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFP 101
Query: 165 NLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLH 224
            LVKL     +     ++ EY P   +   L     R I  + +        AQ +L   
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL-----RRIGRF-SEPHARFYAAQIVLTFE 155
Query: 225 QYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMS 284
               + +I+RDLK  N+++D+    +++DFG+A+ V         +G T  + GT  Y++
Sbjct: 156 YLHSLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRV---------KGRTWXLCGTPEYLA 206
Query: 285 PEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 96/207 (46%), Gaps = 10/207 (4%)
Query: 111 FSAANKLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQEI-KELKNEASVIAQVQHKNLV 167
           ++  + +GEG +G V      + +  +A+K++     Q   +    E  ++ + +H+N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 168 KLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYS 227
            +           +   Y+    ++  L+   K + L        +  + +GL Y+H   
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIHS-- 146
Query: 228 RVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEY 287
              ++HRDLK SN+LL+   + KI DFG+AR+    +D     G  +    T  Y +PE 
Sbjct: 147 -ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH---TGFLTEYVATRWYRAPEI 202
Query: 288 ALEGIFSIKS-DVFSFGVLLLEIVSGK 313
            L      KS D++S G +L E++S +
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 87/182 (47%), Gaps = 22/182 (12%)
Query: 135 IAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCF 194
           IA + L GK G     ++NE +V+ +++H N+V L           LI + +    L   
Sbjct: 51  IAKEALEGKEGS----MENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL--- 103
Query: 195 LFDP-TKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNIL---LDKDMNSK 250
            FD   ++     R   ++I  V   + YLH    + I+HRDLK  N+L   LD+D    
Sbjct: 104 -FDRIVEKGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIM 159
Query: 251 ISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIV 310
           ISDFG++++   G+         S   GT GY++PE   +  +S   D +S GV+   ++
Sbjct: 160 ISDFGLSKMEDPGS-------VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILL 212
Query: 311 SG 312
            G
Sbjct: 213 CG 214

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 87/182 (47%), Gaps = 22/182 (12%)
Query: 135 IAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCF 194
           IA + L GK G     ++NE +V+ +++H N+V L           LI + +    L   
Sbjct: 51  IAKEALEGKEGS----MENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL--- 103
Query: 195 LFDP-TKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNIL---LDKDMNSK 250
            FD   ++     R   ++I  V   + YLH    + I+HRDLK  N+L   LD+D    
Sbjct: 104 -FDRIVEKGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIM 159
Query: 251 ISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIV 310
           ISDFG++++   G+         S   GT GY++PE   +  +S   D +S GV+   ++
Sbjct: 160 ISDFGLSKMEDPGS-------VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILL 212
Query: 311 SG 312
            G
Sbjct: 213 CG 214

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 24/210 (11%)
Query: 110 NFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKSGQEIKELK---NEASVIAQVQHK 164
            F     LG G FG V   K +      A+K L  +   ++K+++   NE  ++  V   
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 165 NLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKR--EILDWRTRVQIIKGVAQGLLY 222
            LVKL     +     ++ EY P   +    F   +R     +   R       AQ +L 
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFXEPHARFY----AAQIVLT 153
Query: 223 LHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGY 282
                 + +I+RDLK  N+++D+    K++DFG A+ V         +G T  + GT  Y
Sbjct: 154 FEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV---------KGRTWXLCGTPEY 204
Query: 283 MSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           ++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 111/216 (51%), Gaps = 37/216 (17%)
Query: 117 LGEGGFGTVYKGV---------IGQGEIAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNL 166
           LG+G F  ++KGV         + + E+ +K +L K+ +   E     AS+++++ HK+L
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLK-VLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 167 VKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQY 226
           V   G C+  DE +L+ E++   SLD +L     +  ++   ++++ K +A  + +L + 
Sbjct: 75  VLNYGVCVCGDENILVQEFVKFGSLDTYL--KKNKNCINILWKLEVAKQLAAAMHFLEEN 132
Query: 227 SRVRIIHRDLKASNILLDKDMNS--------KISDFGMARIVFGGNDEDELQGNTSRISG 278
           +   +IH ++ A NILL ++ +         K+SD G++  V     +D LQ    RI  
Sbjct: 133 T---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVL---PKDILQ---ERIP- 182
Query: 279 TYGYMSPEYALEGI--FSIKSDVFSFGVLLLEIVSG 312
              ++ PE  +E     ++ +D +SFG  L EI SG
Sbjct: 183 ---WVPPE-CIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 100/211 (47%), Gaps = 18/211 (8%)
Query: 111 FSAANKLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQEI-KELKNEASVIAQVQHKNLV 167
           ++  + +GEG +G V      + +  +A+K++     Q   +    E  ++ + +H+N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 168 KL----LGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYL 223
            +        IE+ + + I + +    ++  L+   K + L        +  + +GL Y+
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDL----METDLYKLLKTQHLSNDHICYFLYQILRGLKYI 144
Query: 224 HQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYM 283
           H      ++HRDLK SN+LL+   + KI DFG+AR+    +D     G       T  Y 
Sbjct: 145 HS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH---TGFLXEXVATRWYR 198
Query: 284 SPEYALEGIFSIKS-DVFSFGVLLLEIVSGK 313
           +PE  L      KS D++S G +L E++S +
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 100/211 (47%), Gaps = 18/211 (8%)
Query: 111 FSAANKLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQEI-KELKNEASVIAQVQHKNLV 167
           ++  + +GEG +G V      + +  +A+K++     Q   +    E  ++ + +H+N++
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 89
Query: 168 KL----LGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYL 223
            +        IE+ + + I + +    ++  L+   K + L        +  + +GL Y+
Sbjct: 90  GINDIIRAPTIEQMKDVYIVQDL----METDLYKLLKTQHLSNDHICYFLYQILRGLKYI 145
Query: 224 HQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYM 283
           H      ++HRDLK SN+LL+   + KI DFG+AR+    +D     G       T  Y 
Sbjct: 146 HS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH---TGFLXEXVATRWYR 199
Query: 284 SPEYALEGIFSIKS-DVFSFGVLLLEIVSGK 313
           +PE  L      KS D++S G +L E++S +
Sbjct: 200 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 29/207 (14%)
Query: 117 LGEGGFGTVY-------KGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKL 169
           LG G F  V        + ++    IA + L GK G     ++NE +V+ +++H N+V L
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGS----MENEIAVLHKIKHPNIVAL 81
Query: 170 LGCCIEKDERLLIYEYMPNKSLDCFLFDP-TKREILDWRTRVQIIKGVAQGLLYLHQYSR 228
                      LI + +    L    FD   ++     R   ++I  V   + YLH    
Sbjct: 82  DDIYESGGHLYLIMQLVSGGEL----FDRIVEKGFYTERDASRLIFQVLDAVKYLHD--- 134
Query: 229 VRIIHRDLKASNIL---LDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
           + I+HRDLK  N+L   LD+D    ISDFG++++   G+         S   GT GY++P
Sbjct: 135 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS-------VLSTACGTPGYVAP 187
Query: 286 EYALEGIFSIKSDVFSFGVLLLEIVSG 312
           E   +  +S   D +S GV+   ++ G
Sbjct: 188 EVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 110 NFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKSGQEIKELK---NEASVIAQVQHK 164
            F     LG G FG V   K +      A+K L  +   ++K+++   NE  ++  V   
Sbjct: 28  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 87
Query: 165 NLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLH 224
            LVKL     +     ++ EY+P   +   L     R I  + +        AQ +L   
Sbjct: 88  FLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-----RRIGRF-SEPHARFYAAQIVLTFE 141
Query: 225 QYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMS 284
               + +I+RDLK  N+L+D+    +++DFG A+ V         +G T  + GT  Y++
Sbjct: 142 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV---------KGRTWTLCGTPEYLA 192
Query: 285 PEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 193 PEIILSKGYNKAVDWWALGVLIYEMAAG 220

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 110 NFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKSGQEIKELK---NEASVIAQVQHK 164
            F     +G G FG V   K +      A+K L  +   ++K+++   NE  ++  V   
Sbjct: 42  QFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 165 NLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLH 224
            LVKL     +     ++ EY+P   +   L     R I  + +        AQ +L   
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-----RRIGRF-SEPHARFYAAQIVLTFE 155
Query: 225 QYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMS 284
               + +I+RDLK  N+L+D+    K++DFG A+ V         +G T  + GT  Y++
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV---------KGRTWXLCGTPEYLA 206
Query: 285 PEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 26/215 (12%)
Query: 110 NFSAANKLGEGGFGTVYKG-VIGQGE-IAVKRLLGKSGQEIKELKN-EASVIAQVQHKNL 166
           +++    +G G FG VY+  +   GE +A+K++L     + K  KN E  ++ ++ H N+
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQIMRKLDHCNI 109
Query: 167 VKL----LGCCIEKDERLL--IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           V+L         +KDE  L  + +Y+P             ++ L        +  + + L
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 169
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNS-KISDFGMARIVFGGNDEDELQGNTSRISGT 279
            Y+H +    I HRD+K  N+LLD D    K+ DFG A+ +  G      + N S I   
Sbjct: 170 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG------EPNVSXICSR 220
Query: 280 YGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
           Y Y +PE       ++   DV+S G +L E++ G+
Sbjct: 221 Y-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 26/215 (12%)
Query: 110 NFSAANKLGEGGFGTVYKG-VIGQGE-IAVKRLLGKSGQEIKELKN-EASVIAQVQHKNL 166
           +++    +G G FG VY+  +   GE +A+K++L     + K  KN E  ++ ++ H N+
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQIMRKLDHCNI 103
Query: 167 VKL----LGCCIEKDERLL--IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           V+L         +KDE  L  + +Y+P             ++ L        +  + + L
Sbjct: 104 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 163
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNS-KISDFGMARIVFGGNDEDELQGNTSRISGT 279
            Y+H +    I HRD+K  N+LLD D    K+ DFG A+ +  G      + N S I   
Sbjct: 164 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG------EPNVSYICSR 214
Query: 280 YGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
           Y Y +PE       ++   DV+S G +L E++ G+
Sbjct: 215 Y-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 110 NFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKSGQEIKELK---NEASVIAQVQHK 164
            F     LG G FG V   K +      A+K L  +   ++K+++   NE  ++  V   
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 165 NLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLH 224
            LVKL     +     ++ EY+P   +   L     R I  + +        AQ +L   
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-----RRIGRF-SEPHARFYAAQIVLTFE 155
Query: 225 QYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMS 284
               + +I+RDLK  N+L+D+    +++DFG A+ V         +G T  + GT  Y++
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV---------KGRTWXLCGTPEYLA 206
Query: 285 PEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 26/216 (12%)
Query: 110 NFSAANKLGEGGFGTVYKG-VIGQGE-IAVKRLLGKSGQEIKELKN-EASVIAQVQHKNL 166
           +++    +G G FG VY+  +   GE +A+K++L     + K  KN E  ++ ++ H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQIMRKLDHCNI 75
Query: 167 VKL----LGCCIEKDERLL--IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           V+L         +KDE  L  + +Y+P             ++ L        +  + + L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNS-KISDFGMARIVFGGNDEDELQGNTSRISGT 279
            Y+H +    I HRD+K  N+LLD D    K+ DFG A+ +  G      + N S I   
Sbjct: 136 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG------EPNVSXICSR 186
Query: 280 YGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGKK 314
           Y Y +PE       ++   DV+S G +L E++ G+ 
Sbjct: 187 Y-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 221

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 26/215 (12%)
Query: 110 NFSAANKLGEGGFGTVYKG-VIGQGE-IAVKRLLGKSGQEIKELKN-EASVIAQVQHKNL 166
           +++    +G G FG VY+  +   GE +A+K++L     + K  KN E  ++ ++ H N+
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQIMRKLDHCNI 94
Query: 167 VKL----LGCCIEKDERLL--IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           V+L         +KDE  L  + +Y+P             ++ L        +  + + L
Sbjct: 95  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 154
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNS-KISDFGMARIVFGGNDEDELQGNTSRISGT 279
            Y+H +    I HRD+K  N+LLD D    K+ DFG A+ +  G      + N S I   
Sbjct: 155 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG------EPNVSXICSR 205
Query: 280 YGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
           Y Y +PE       ++   DV+S G +L E++ G+
Sbjct: 206 Y-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 110 NFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKSGQEIKELK---NEASVIAQVQHK 164
            F     LG G FG V   K +      A+K L  +   ++K+++   NE  ++  V   
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 165 NLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLH 224
            LVKL     +     ++ EY+P   +   L     R I  + +        AQ +L   
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-----RRIGRF-SEPHARFYAAQIVLTFE 155
Query: 225 QYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMS 284
               + +I+RDLK  N+L+D+    +++DFG A+ V         +G T  + GT  Y++
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV---------KGRTWXLCGTPEYLA 206
Query: 285 PEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 110 NFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKSGQEIKELK---NEASVIAQVQHK 164
            F     LG G FG V   K +      A+K L  +   ++K+++   NE  ++  V   
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 165 NLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLH 224
            LVKL     +     ++ EY+P   +   L     R I  + +        AQ +L   
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-----RRIGRF-SEPHARFYAAQIVLTFE 155
Query: 225 QYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMS 284
               + +I+RDLK  N+L+D+    +++DFG A+ V         +G T  + GT  Y++
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV---------KGRTWXLCGTPEYLA 206
Query: 285 PEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 110 NFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKSGQEIKELK---NEASVIAQVQHK 164
            F     LG G FG V   K +      A+K L  +   ++K+++   NE  ++  V   
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 102
Query: 165 NLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLH 224
            LVKL     +     ++ EY+P   +   L     R I  + +        AQ +L   
Sbjct: 103 FLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-----RRIGRF-SEPHARFYAAQIVLTFE 156
Query: 225 QYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMS 284
               + +I+RDLK  N+L+D+    +++DFG A+ V         +G T  + GT  Y++
Sbjct: 157 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV---------KGRTWXLCGTPEYLA 207
Query: 285 PEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 26/215 (12%)
Query: 110 NFSAANKLGEGGFGTVYKG-VIGQGE-IAVKRLLGKSGQEIKELKN-EASVIAQVQHKNL 166
           +++    +G G FG VY+  +   GE +A+K++L     + K  KN E  ++ ++ H N+
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQIMRKLDHCNI 83
Query: 167 VKL----LGCCIEKDERLL--IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           V+L         +KDE  L  + +Y+P             ++ L        +  + + L
Sbjct: 84  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 143
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNS-KISDFGMARIVFGGNDEDELQGNTSRISGT 279
            Y+H +    I HRD+K  N+LLD D    K+ DFG A+ +  G      + N S I   
Sbjct: 144 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG------EPNVSXICSR 194
Query: 280 YGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
           Y Y +PE       ++   DV+S G +L E++ G+
Sbjct: 195 Y-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 26/216 (12%)
Query: 110 NFSAANKLGEGGFGTVYKG-VIGQGE-IAVKRLLGKSGQEIKELKN-EASVIAQVQHKNL 166
           +++    +G G FG VY+  +   GE +A+K++L     + K  KN E  ++ ++ H N+
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQIMRKLDHCNI 76
Query: 167 VKL----LGCCIEKDERLL--IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           V+L         +KDE  L  + +Y+P             ++ L        +  + + L
Sbjct: 77  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 136
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNS-KISDFGMARIVFGGNDEDELQGNTSRISGT 279
            Y+H +    I HRD+K  N+LLD D    K+ DFG A+ +  G      + N S I   
Sbjct: 137 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG------EPNVSXICSR 187
Query: 280 YGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGKK 314
           Y Y +PE       ++   DV+S G +L E++ G+ 
Sbjct: 188 Y-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 222

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 26/216 (12%)
Query: 110 NFSAANKLGEGGFGTVYKG-VIGQGE-IAVKRLLGKSGQEIKELKN-EASVIAQVQHKNL 166
           +++    +G G FG VY+  +   GE +A+K++L     + K  KN E  ++ ++ H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQIMRKLDHCNI 75
Query: 167 VKL----LGCCIEKDERLL--IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           V+L         +KDE  L  + +Y+P             ++ L        +  + + L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNS-KISDFGMARIVFGGNDEDELQGNTSRISGT 279
            Y+H +    I HRD+K  N+LLD D    K+ DFG A+ +  G      + N S I   
Sbjct: 136 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG------EPNVSXICSR 186
Query: 280 YGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGKK 314
           Y Y +PE       ++   DV+S G +L E++ G+ 
Sbjct: 187 Y-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 221

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 26/215 (12%)
Query: 110 NFSAANKLGEGGFGTVYKG-VIGQGE-IAVKRLLGKSGQEIKELKN-EASVIAQVQHKNL 166
           +++    +G G FG VY+  +   GE +A+K++L     + K  KN E  ++ ++ H N+
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQIMRKLDHCNI 87
Query: 167 VKL----LGCCIEKDERLL--IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           V+L         +KDE  L  + +Y+P             ++ L        +  + + L
Sbjct: 88  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 147
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNS-KISDFGMARIVFGGNDEDELQGNTSRISGT 279
            Y+H +    I HRD+K  N+LLD D    K+ DFG A+ +  G      + N S I   
Sbjct: 148 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG------EPNVSXICSR 198
Query: 280 YGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
           Y Y +PE       ++   DV+S G +L E++ G+
Sbjct: 199 Y-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 20/208 (9%)
Query: 110 NFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKSGQEIKELK---NEASVIAQVQHK 164
            F     LG G FG V   K +      A+K L  +   ++K+++   NE  ++  V   
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 165 NLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLH 224
            LVKL     +     ++ EY P   +   L     R I  + +        AQ +L   
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL-----RRIGRF-SEPHARFYAAQIVLTFE 155
Query: 225 QYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMS 284
               + +I+RDLK  N+++D+    K++DFG A+ V         +G T  + GT  Y++
Sbjct: 156 YLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV---------KGRTWXLCGTPEYLA 206
Query: 285 PEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 110 NFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKSGQEIKELK---NEASVIAQVQHK 164
            F     LG G FG V   K +      A+K L  +   ++K+++   NE  ++  V   
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 102
Query: 165 NLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLH 224
            LVKL     +     ++ EY+P   +   L     R I  + +        AQ +L   
Sbjct: 103 FLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-----RRIGRF-SEPHARFYAAQIVLTFE 156
Query: 225 QYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMS 284
               + +I+RDLK  N+L+D+    +++DFG A+ V         +G T  + GT  Y++
Sbjct: 157 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV---------KGRTWTLCGTPEYLA 207
Query: 285 PEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 26/215 (12%)
Query: 110 NFSAANKLGEGGFGTVYKG-VIGQGE-IAVKRLLGKSGQEIKELKN-EASVIAQVQHKNL 166
           +++    +G G FG VY+  +   GE +A+K++L     + K  KN E  ++ ++ H N+
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQIMRKLDHCNI 87
Query: 167 VKL----LGCCIEKDERLL--IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           V+L         +KDE  L  + +Y+P             ++ L        +  + + L
Sbjct: 88  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 147
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNS-KISDFGMARIVFGGNDEDELQGNTSRISGT 279
            Y+H +    I HRD+K  N+LLD D    K+ DFG A+ +  G      + N S I   
Sbjct: 148 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG------EPNVSXICSR 198
Query: 280 YGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
           Y Y +PE       ++   DV+S G +L E++ G+
Sbjct: 199 Y-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 26/216 (12%)
Query: 110 NFSAANKLGEGGFGTVYKG-VIGQGE-IAVKRLLGKSGQEIKELKN-EASVIAQVQHKNL 166
           +++    +G G FG VY+  +   GE +A+K++L     + K  KN E  ++ ++ H N+
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQIMRKLDHCNI 80
Query: 167 VKL----LGCCIEKDERLL--IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           V+L         +KDE  L  + +Y+P             ++ L        +  + + L
Sbjct: 81  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 140
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNS-KISDFGMARIVFGGNDEDELQGNTSRISGT 279
            Y+H +    I HRD+K  N+LLD D    K+ DFG A+ +  G      + N S I   
Sbjct: 141 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG------EPNVSYICSR 191
Query: 280 YGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGKK 314
           Y Y +PE       ++   DV+S G +L E++ G+ 
Sbjct: 192 Y-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 226

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 26/215 (12%)
Query: 110 NFSAANKLGEGGFGTVYKG-VIGQGE-IAVKRLLGKSGQEIKELKN-EASVIAQVQHKNL 166
           +++    +G G FG VY+  +   GE +A+K++L     + K  KN E  ++ ++ H N+
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQIMRKLDHCNI 88
Query: 167 VKL----LGCCIEKDERLL--IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           V+L         +KDE  L  + +Y+P             ++ L        +  + + L
Sbjct: 89  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 148
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNS-KISDFGMARIVFGGNDEDELQGNTSRISGT 279
            Y+H +    I HRD+K  N+LLD D    K+ DFG A+ +  G      + N S I   
Sbjct: 149 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG------EPNVSYICSR 199
Query: 280 YGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
           Y Y +PE       ++   DV+S G +L E++ G+
Sbjct: 200 Y-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 26/215 (12%)
Query: 110 NFSAANKLGEGGFGTVYKG-VIGQGE-IAVKRLLGKSGQEIKELKN-EASVIAQVQHKNL 166
           +++    +G G FG VY+  +   GE +A+K++L     + K  KN E  ++ ++ H N+
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQIMRKLDHCNI 109
Query: 167 VKL----LGCCIEKDERLL--IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           V+L         +KDE  L  + +Y+P             ++ L        +  + + L
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 169
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNS-KISDFGMARIVFGGNDEDELQGNTSRISGT 279
            Y+H +    I HRD+K  N+LLD D    K+ DFG A+ +  G      + N S I   
Sbjct: 170 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG------EPNVSYICSR 220
Query: 280 YGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
           Y Y +PE       ++   DV+S G +L E++ G+
Sbjct: 221 Y-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 26/216 (12%)
Query: 110 NFSAANKLGEGGFGTVYKG-VIGQGE-IAVKRLLGKSGQEIKELKN-EASVIAQVQHKNL 166
           +++    +G G FG VY+  +   GE +A+K++L     + K  KN E  ++ ++ H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQIMRKLDHCNI 75
Query: 167 VKL----LGCCIEKDERLL--IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           V+L         +KDE  L  + +Y+P             ++ L        +  + + L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNS-KISDFGMARIVFGGNDEDELQGNTSRISGT 279
            Y+H +    I HRD+K  N+LLD D    K+ DFG A+ +  G      + N S I   
Sbjct: 136 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG------EPNVSYICSR 186
Query: 280 YGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGKK 314
           Y Y +PE       ++   DV+S G +L E++ G+ 
Sbjct: 187 Y-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 221

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 105/216 (48%), Gaps = 31/216 (14%)
Query: 110 NFSAANKLGEGGFGTVYKGVIGQ-GE-IAVKRLLGKSGQEI--KELKNEASVIAQVQHKN 165
            + +   +G G +G+V   +  + GE +A+K+L      EI  K    E  ++  +QH+N
Sbjct: 25  TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHEN 84
Query: 166 LVKLLGCCIEKDERLLIYEY---MPNKSLDCFLFDPTKREILDWR---TRVQ-IIKGVAQ 218
           ++ LL            Y++   MP    D        ++I+  +    ++Q ++  + +
Sbjct: 85  VIGLLDVFTPASSLRNFYDFYLVMPFMQTDL-------QKIMGLKFSEEKIQYLVYQMLK 137
Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
           GL Y+H      ++HRDLK  N+ +++D   KI DFG+AR     + + E+ G       
Sbjct: 138 GLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVV---- 185
Query: 279 TYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
           T  Y +PE  L  + ++   D++S G ++ E+++GK
Sbjct: 186 TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 26/216 (12%)
Query: 110 NFSAANKLGEGGFGTVYKG-VIGQGE-IAVKRLLGKSGQEIKELKN-EASVIAQVQHKNL 166
           +++    +G G FG VY+  +   GE +A+K++L     + K  KN E  ++ ++ H N+
Sbjct: 57  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQIMRKLDHCNI 111
Query: 167 VKL----LGCCIEKDERLL--IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           V+L         +KDE  L  + +Y+P             ++ L        +  + + L
Sbjct: 112 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 171
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNS-KISDFGMARIVFGGNDEDELQGNTSRISGT 279
            Y+H +    I HRD+K  N+LLD D    K+ DFG A+ +  G      + N S I   
Sbjct: 172 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG------EPNVSYICSR 222
Query: 280 YGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGKK 314
           Y Y +PE       ++   DV+S G +L E++ G+ 
Sbjct: 223 Y-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 257

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 24/210 (11%)
Query: 110 NFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKSGQEIKELK---NEASVIAQVQHK 164
            F     LG G FG V   K        A+K L  +   ++K+++   NE  ++  V   
Sbjct: 35  QFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 94
Query: 165 NLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKR--EILDWRTRVQIIKGVAQGLLY 222
            LVKL     +     ++ EY+P   +    F   +R     +   R       AQ +L 
Sbjct: 95  FLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPHARFY----AAQIVLT 146
Query: 223 LHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGY 282
                 + +I+RDLK  N+L+D+    +++DFG A+ V         +G T  + GT  Y
Sbjct: 147 FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV---------KGRTWXLCGTPEY 197
Query: 283 MSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           ++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 198 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 74/286 (25%), Positives = 128/286 (44%), Gaps = 55/286 (19%)
Query: 116 KLGEGGFGTVYKGVIGQGEIAVK------RLLGKSGQEIKELKNEASVIAQVQHKNLVKL 169
           ++G G F TVYKG+  +  + V       R L KS  E +  K EA  +  +QH N+V+ 
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS--ERQRFKEEAEXLKGLQHPNIVRF 90
Query: 170 LGC---------CIEKDERLLIYEYMPNKSLDCFL--FDPTKREILDWRTRVQIIKGVAQ 218
                       CI     +L+ E   + +L  +L  F   K ++L    R QI+KG   
Sbjct: 91  YDSWESTVKGKKCI-----VLVTELXTSGTLKTYLKRFKVXKIKVLRSWCR-QILKG--- 141
Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNS-KISDFGMARIVFGGNDEDELQGNTSRIS 277
            L +LH  +   IIHRDLK  NI +     S KI D G+A +        +       + 
Sbjct: 142 -LQFLHTRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATL--------KRASFAKAVI 191
Query: 278 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISN 337
           GT  + +PE   E  +    DV++FG   LE  + +    +  ++  N          + 
Sbjct: 192 GTPEFXAPE-XYEEKYDESVDVYAFGXCXLEXATSE----YPYSECQN----------AA 236
Query: 338 KIIDLIDSVLEEASFNE-SLSRYVHIALLCVQERAEDRPTMSDVVS 382
           +I   + S ++ ASF++ ++     I   C+++  ++R ++ D+++
Sbjct: 237 QIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 26/216 (12%)
Query: 110 NFSAANKLGEGGFGTVYKG-VIGQGE-IAVKRLLGKSGQEIKELKN-EASVIAQVQHKNL 166
           +++    +G G FG VY+  +   GE +A+K++L     + K  KN E  ++ ++ H N+
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQIMRKLDHCNI 79
Query: 167 VKL----LGCCIEKDERLL--IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           V+L         +KDE  L  + +Y+P             ++ L        +  + + L
Sbjct: 80  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 139
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNS-KISDFGMARIVFGGNDEDELQGNTSRISGT 279
            Y+H +    I HRD+K  N+LLD D    K+ DFG A+ +  G      + N S I   
Sbjct: 140 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG------EPNVSXICSR 190
Query: 280 YGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGKK 314
           Y Y +PE       ++   DV+S G +L E++ G+ 
Sbjct: 191 Y-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 225

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 26/216 (12%)
Query: 110 NFSAANKLGEGGFGTVYKG-VIGQGE-IAVKRLLGKSGQEIKELKN-EASVIAQVQHKNL 166
           +++    +G G FG VY+  +   GE +A+K++L     + K  KN E  ++ ++ H N+
Sbjct: 59  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQIMRKLDHCNI 113
Query: 167 VKL----LGCCIEKDERLL--IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           V+L         +KDE  L  + +Y+P             ++ L        +  + + L
Sbjct: 114 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 173
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNS-KISDFGMARIVFGGNDEDELQGNTSRISGT 279
            Y+H +    I HRD+K  N+LLD D    K+ DFG A+ +  G      + N S I   
Sbjct: 174 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG------EPNVSYICSR 224
Query: 280 YGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGKK 314
           Y Y +PE       ++   DV+S G +L E++ G+ 
Sbjct: 225 Y-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 259

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 65/244 (26%), Positives = 108/244 (44%), Gaps = 31/244 (12%)
Query: 85  CKKGCEKE-VDQFP-------LFSFSSVSSATGN---FSAANKLGEGGFGTVY--KGVIG 131
            KKG E+E V +F        L  + S +  T +   F     LG G FG V   K    
Sbjct: 7   AKKGSEQESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKET 66
Query: 132 QGEIAVKRLLGKSGQEIKELK---NEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPN 188
               A+K L  +   ++K+++   NE  ++  V    LVKL     +     ++ EY+P 
Sbjct: 67  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPG 126
Query: 189 KSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN 248
             +   L     R I  + +        AQ +L       + +I+RDLK  N+L+D+   
Sbjct: 127 GEMFSHL-----RRIGRF-SEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY 180
Query: 249 SKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLE 308
            +++DFG A+ V         +G T  + GT  Y++PE  L   ++   D ++ GVL+ E
Sbjct: 181 IQVTDFGFAKRV---------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 231
Query: 309 IVSG 312
           + +G
Sbjct: 232 MAAG 235

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 26/216 (12%)
Query: 110 NFSAANKLGEGGFGTVYKG-VIGQGE-IAVKRLLGKSGQEIKELKN-EASVIAQVQHKNL 166
           +++    +G G FG VY+  +   GE +A+K++L     + K  KN E  ++ ++ H N+
Sbjct: 100 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQIMRKLDHCNI 154
Query: 167 VKL----LGCCIEKDERLL--IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           V+L         +KDE  L  + +Y+P             ++ L        +  + + L
Sbjct: 155 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 214
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNS-KISDFGMARIVFGGNDEDELQGNTSRISGT 279
            Y+H +    I HRD+K  N+LLD D    K+ DFG A+ +  G      + N S I   
Sbjct: 215 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG------EPNVSYICSR 265
Query: 280 YGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGKK 314
           Y Y +PE       ++   DV+S G +L E++ G+ 
Sbjct: 266 Y-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 300

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 105/223 (47%), Gaps = 46/223 (20%)
Query: 111 FSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEI---KELKNEASVIAQVQHKN 165
           +   + +G G +G+V      +    +AVK+L  +  Q I   K    E  ++  ++H+N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSLDCF-------------LFDPTKREILDWRTRVQ- 211
           ++ LL              + P +SL+ F             L +  K + L     VQ 
Sbjct: 83  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLT-DDHVQF 129
Query: 212 IIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQG 271
           +I  + +GL Y+H      IIHRDLK SN+ +++D   KI DFG+ R     + +DE+ G
Sbjct: 130 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLCR-----HTDDEMTG 181
Query: 272 NTSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
             +    T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 182 YVA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 65/244 (26%), Positives = 108/244 (44%), Gaps = 31/244 (12%)
Query: 85  CKKGCEKE-VDQFP-------LFSFSSVSSATGN---FSAANKLGEGGFGTVY--KGVIG 131
            KKG E+E V +F        L  + S +  T +   F     LG G FG V   K    
Sbjct: 7   AKKGSEQESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKET 66
Query: 132 QGEIAVKRLLGKSGQEIKELK---NEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPN 188
               A+K L  +   ++K+++   NE  ++  V    LVKL     +     ++ EY+P 
Sbjct: 67  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPG 126
Query: 189 KSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN 248
             +   L     R I  + +        AQ +L       + +I+RDLK  N+L+D+   
Sbjct: 127 GEMFSHL-----RRIGRF-SEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY 180
Query: 249 SKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLE 308
            +++DFG A+ V         +G T  + GT  Y++PE  L   ++   D ++ GVL+ E
Sbjct: 181 IQVTDFGFAKRV---------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 231
Query: 309 IVSG 312
           + +G
Sbjct: 232 MAAG 235

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 20/208 (9%)
Query: 110 NFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKSGQEIKELK---NEASVIAQVQHK 164
            F     LG G FG V   K        A+K L  +   ++K+++   NE  ++  V   
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 165 NLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLH 224
            LVKL     +     ++ EY+P   +   L     R I  + +        AQ +L   
Sbjct: 102 FLVKLEYSFKDNSNLYMVMEYVPGGEMFSHL-----RRIGRF-SEPHARFYAAQIVLTFE 155
Query: 225 QYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMS 284
               + +I+RDLK  N+L+D+    +++DFG A+ V         +G T  + GT  Y++
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV---------KGRTWXLCGTPEYLA 206
Query: 285 PEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 26/216 (12%)
Query: 110 NFSAANKLGEGGFGTVYKG-VIGQGE-IAVKRLLGKSGQEIKELKN-EASVIAQVQHKNL 166
           +++    +G G FG VY+  +   GE +A+K++L     + K  KN E  ++ ++ H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QGKAFKNRELQIMRKLDHCNI 75
Query: 167 VKL----LGCCIEKDERLL--IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           V+L         +KDE  L  + +Y+P             ++ L        +  + + L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNS-KISDFGMARIVFGGNDEDELQGNTSRISGT 279
            Y+H +    I HRD+K  N+LLD D    K+ DFG A+ +  G      + N S I   
Sbjct: 136 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG------EPNVSYICSR 186
Query: 280 YGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGKK 314
           Y Y +PE       ++   DV+S G +L E++ G+ 
Sbjct: 187 Y-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 221

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/244 (26%), Positives = 107/244 (43%), Gaps = 31/244 (12%)
Query: 85  CKKGCEKE-VDQFP-------LFSFSSVSSATGN---FSAANKLGEGGFGTVY--KGVIG 131
            KKG E+E V +F        L  + S +  T +   F     LG G FG V   K    
Sbjct: 7   AKKGSEQESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKET 66
Query: 132 QGEIAVKRLLGKSGQEIKELK---NEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPN 188
               A+K L  +   ++K+++   NE  ++  V    LVKL     +     ++ EY P 
Sbjct: 67  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPG 126
Query: 189 KSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN 248
             +   L     R I  + +        AQ +L       + +I+RDLK  N+++D+   
Sbjct: 127 GEMFSHL-----RRIGRF-SEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGY 180
Query: 249 SKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLE 308
            K++DFG A+ V         +G T  + GT  Y++PE  L   ++   D ++ GVL+ E
Sbjct: 181 IKVTDFGFAKRV---------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 231
Query: 309 IVSG 312
           + +G
Sbjct: 232 MAAG 235

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 20/208 (9%)
Query: 110 NFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKSGQEIKELK---NEASVIAQVQHK 164
            F     LG G FG V   K        A+K L  +   ++K+++   NE  ++  V   
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 165 NLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLH 224
            LVKL     +     ++ EY+P   +   L     R I  + +        AQ +L   
Sbjct: 102 FLVKLEYSFKDNSNLYMVMEYVPGGEMFSHL-----RRIGRF-SEPHARFYAAQIVLTFE 155
Query: 225 QYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMS 284
               + +I+RDLK  N+L+D+    +++DFG A+ V         +G T  + GT  Y++
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV---------KGRTWXLCGTPEYLA 206
Query: 285 PEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 20/208 (9%)
Query: 110 NFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKSGQEIKELK---NEASVIAQVQHK 164
            F     LG G FG V   K        A+K L  +   ++K+++   NE  ++  V   
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 165 NLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLH 224
            LVKL     +     ++ EY+P   +   L     R I  + +        AQ +L   
Sbjct: 102 FLVKLEYSFKDNSNLYMVMEYVPGGEMFSHL-----RRIGRF-SEPHARFYAAQIVLTFE 155
Query: 225 QYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMS 284
               + +I+RDLK  N+L+D+    +++DFG A+ V         +G T  + GT  Y++
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV---------KGRTWXLCGTPEYLA 206
Query: 285 PEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 110/216 (50%), Gaps = 37/216 (17%)
Query: 117 LGEGGFGTVYKGV---------IGQGEIAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNL 166
           LG+G F  ++KGV         + + E+ +K +L K+ +   E     AS+++++ HK+L
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLK-VLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 167 VKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQY 226
           V   G C   DE +L+ E++   SLD +L     +  ++   ++++ K +A  + +L + 
Sbjct: 75  VLNYGVCFCGDENILVQEFVKFGSLDTYL--KKNKNCINILWKLEVAKQLAWAMHFLEEN 132
Query: 227 SRVRIIHRDLKASNILLDKDMNS--------KISDFGMARIVFGGNDEDELQGNTSRISG 278
           +   +IH ++ A NILL ++ +         K+SD G++  V     +D LQ    RI  
Sbjct: 133 T---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVL---PKDILQ---ERIP- 182
Query: 279 TYGYMSPEYALEGI--FSIKSDVFSFGVLLLEIVSG 312
              ++ PE  +E     ++ +D +SFG  L EI SG
Sbjct: 183 ---WVPPE-CIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 20/208 (9%)
Query: 110 NFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKSGQEIKELK---NEASVIAQVQHK 164
            F     LG G FG V   K        A+K L  +   ++K+++   NE  ++  V   
Sbjct: 35  QFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 94
Query: 165 NLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLH 224
            LVKL     +     ++ EY+P   +   L     R I  + +        AQ +L   
Sbjct: 95  FLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-----RRIGRF-SEPHARFYAAQIVLTFE 148
Query: 225 QYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMS 284
               + +I+RDLK  N+L+D+    +++DFG A+ V         +G T  + GT  Y++
Sbjct: 149 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV---------KGRTWXLCGTPEYLA 199
Query: 285 PEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 200 PEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/244 (26%), Positives = 108/244 (44%), Gaps = 31/244 (12%)
Query: 85  CKKGCEKE-VDQFP-------LFSFSSVSSATGN---FSAANKLGEGGFGTVY--KGVIG 131
            KKG E+E V +F        L  + S +  T +   F     LG G FG V   K    
Sbjct: 7   AKKGXEQESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKET 66
Query: 132 QGEIAVKRLLGKSGQEIKELK---NEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPN 188
               A+K L  +   ++K+++   NE  ++  V    LVKL     +     ++ EY+P 
Sbjct: 67  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPG 126
Query: 189 KSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN 248
             +   L     R I  + +        AQ +L       + +I+RDLK  N+L+D+   
Sbjct: 127 GEMFSHL-----RRIGRF-SEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY 180
Query: 249 SKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLE 308
            +++DFG A+ V         +G T  + GT  Y++PE  L   ++   D ++ GVL+ E
Sbjct: 181 IQVTDFGFAKRV---------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 231
Query: 309 IVSG 312
           + +G
Sbjct: 232 MAAG 235

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 26/216 (12%)
Query: 110 NFSAANKLGEGGFGTVYKG-VIGQGE-IAVKRLLGKSGQEIKELKN-EASVIAQVQHKNL 166
           +++    +G G FG VY+  +   GE +A+K++L     + K  KN E  ++ ++ H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QGKAFKNRELQIMRKLDHCNI 75
Query: 167 VKL----LGCCIEKDERLL--IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           V+L         +KDE  L  + +Y+P             ++ L        +  + + L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNS-KISDFGMARIVFGGNDEDELQGNTSRISGT 279
            Y+H +    I HRD+K  N+LLD D    K+ DFG A+ +  G      + N S I   
Sbjct: 136 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG------EPNVSYICSR 186
Query: 280 YGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGKK 314
           Y Y +PE       ++   DV+S G +L E++ G+ 
Sbjct: 187 Y-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 221

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 26/216 (12%)
Query: 110 NFSAANKLGEGGFGTVYKG-VIGQGE-IAVKRLLGKSGQEIKELKN-EASVIAQVQHKNL 166
           +++    +G G FG VY+  +   GE +A+K++L     + K  KN E  ++ ++ H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QGKAFKNRELQIMRKLDHCNI 75
Query: 167 VKL----LGCCIEKDERLL--IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           V+L         +KDE  L  + +Y+P             ++ L        +  + + L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNS-KISDFGMARIVFGGNDEDELQGNTSRISGT 279
            Y+H +    I HRD+K  N+LLD D    K+ DFG A+ +  G      + N S I   
Sbjct: 136 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG------EPNVSXICSR 186
Query: 280 YGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGKK 314
           Y Y +PE       ++   DV+S G +L E++ G+ 
Sbjct: 187 Y-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 221

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 99/216 (45%), Gaps = 26/216 (12%)
Query: 110 NFSAANKLGEGGFGTVYKG-VIGQGE-IAVKRLLGKSGQEIKELKN-EASVIAQVQHKNL 166
           +++    +G G FG VY+  +   GE +A+K++L     + K  KN E  ++ ++ H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQIMRKLDHCNI 75
Query: 167 VKLLGCCIEKDERL------LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
           V+L        E+       L+ +Y+P             ++ L        +  + + L
Sbjct: 76  VRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNS-KISDFGMARIVFGGNDEDELQGNTSRISGT 279
            Y+H +    I HRD+K  N+LLD D    K+ DFG A+ +  G      + N S I   
Sbjct: 136 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG------EPNVSXICSR 186
Query: 280 YGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGKK 314
           Y Y +PE       ++   DV+S G +L E++ G+ 
Sbjct: 187 Y-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 221

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/244 (26%), Positives = 108/244 (44%), Gaps = 31/244 (12%)
Query: 85  CKKGCEKE-VDQFP-------LFSFSSVSSATGN---FSAANKLGEGGFGTVY--KGVIG 131
            KKG E+E V +F        L  + S +  T +   F     LG G FG V   K    
Sbjct: 27  AKKGSEQESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKET 86
Query: 132 QGEIAVKRLLGKSGQEIKELK---NEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPN 188
               A+K L  +   ++K+++   NE  ++  V    LVKL     +     ++ EY+P 
Sbjct: 87  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPG 146
Query: 189 KSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN 248
             +   L     R I  + +        AQ +L       + +I+RDLK  N+L+D+   
Sbjct: 147 GEMFSHL-----RRIGRF-SEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY 200
Query: 249 SKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLE 308
            +++DFG A+ V         +G T  + GT  Y++PE  L   ++   D ++ GVL+ E
Sbjct: 201 IQVTDFGFAKRV---------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 251
Query: 309 IVSG 312
           + +G
Sbjct: 252 MAAG 255

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 104/223 (46%), Gaps = 46/223 (20%)
Query: 111 FSAANKLGEGGFGTV---YKGVIGQGEIAVKRLLGKSGQEI---KELKNEASVIAQVQHK 164
           +   + +G G +G+V   +    G   +AVK+L  +  Q I   K    E  ++  ++H+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGH-RVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 165 NLVKLLGCCIEKDERLLIYEYMPNKSL----DCFLFDPTKREILDWRTRVQ--------- 211
           N++ LL              + P +SL    D +L        L+   + Q         
Sbjct: 82  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 212 IIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQG 271
           +I  + +GL Y+H      IIHRDLK SN+ +++D   KI DF +AR     + +DE+ G
Sbjct: 130 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFYLAR-----HTDDEMTG 181
Query: 272 NTSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
             +    T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 182 YVA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 24/210 (11%)
Query: 110 NFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKSGQEIKELK---NEASVIAQVQHK 164
            F     LG G FG V   K +      A+K L  +   ++K+++   NE  ++  V   
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 102
Query: 165 NLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKR--EILDWRTRVQIIKGVAQGLLY 222
            L KL     +     ++ EY P   +    F   +R     +   R       AQ +L 
Sbjct: 103 FLTKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFXEPHARFY----AAQIVLT 154
Query: 223 LHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGY 282
                 + +I+RDLK  N+++D+    K++DFG A+ V         +G T  + GT  Y
Sbjct: 155 FEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV---------KGRTWXLCGTPEY 205
Query: 283 MSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           ++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 104/216 (48%), Gaps = 31/216 (14%)
Query: 110 NFSAANKLGEGGFGTVYKGVIGQ-GE-IAVKRLLGKSGQEI--KELKNEASVIAQVQHKN 165
            + +   +G G +G+V   +  + GE +A+K+L      EI  K    E  ++  +QH+N
Sbjct: 43  TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHEN 102
Query: 166 LVKLLGCCIEKDERLLIYEY---MPNKSLDCFLFDPTKREILDWR---TRVQ-IIKGVAQ 218
           ++ LL            Y++   MP    D        ++I+       ++Q ++  + +
Sbjct: 103 VIGLLDVFTPASSLRNFYDFYLVMPFMQTDL-------QKIMGMEFSEEKIQYLVYQMLK 155
Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
           GL Y+H      ++HRDLK  N+ +++D   KI DFG+AR     + + E+ G       
Sbjct: 156 GLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVV---- 203
Query: 279 TYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
           T  Y +PE  L  + ++   D++S G ++ E+++GK
Sbjct: 204 TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 103/222 (46%), Gaps = 44/222 (19%)
Query: 111 FSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEI---KELKNEASVIAQVQHKN 165
           +   + +G G +G+V      +    +AVK+L  +  Q I   K    E  ++  ++H+N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSL----DCFLFDPTKREILDWRTRVQ---------I 212
           ++ LL              + P +SL    D +L        L+   + Q         +
Sbjct: 83  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
           I  + +GL Y+H      IIHRDLK SN+ +++D   KI D G+AR     + +DE+ G 
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDAGLAR-----HTDDEMTGY 182
Query: 273 TSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
            +    T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 183 VA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 103/222 (46%), Gaps = 44/222 (19%)
Query: 111 FSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEI---KELKNEASVIAQVQHKN 165
           +   + +G G +G+V      +    +AVK+L  +  Q I   K    E  ++  ++H+N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSL----DCFLFDPTKREILDWRTRVQ---------I 212
           ++ LL              + P +SL    D +L        L+   + Q         +
Sbjct: 83  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
           I  + +GL Y+H      IIHRDLK SN+ +++D   KI  FG+AR     + +DE+ G 
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILGFGLAR-----HTDDEMTGY 182
Query: 273 TSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
            +    T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 183 VA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 93/208 (44%), Gaps = 20/208 (9%)
Query: 110 NFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKSGQEIKELK---NEASVIAQVQHK 164
            F     LG G FG V   K +      A+K L  +   ++K+++   NE  ++  V   
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 165 NLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLH 224
            LVKL     +     ++ EY P   +   L     R I  + +        AQ +L   
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL-----RRIGRF-SEPHARFYAAQIVLTFE 155
Query: 225 QYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMS 284
               + +I+RDLK  N+++D+    +++DFG A+ V         +G T  + GT  Y++
Sbjct: 156 YLHSLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRV---------KGRTWXLCGTPEYLA 206
Query: 285 PEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 92/208 (44%), Gaps = 20/208 (9%)
Query: 110 NFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKSGQEIKELK---NEASVIAQVQHK 164
            F     LG G FG V   K +      A+K L  +   ++K+++   NE  ++  V   
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 102
Query: 165 NLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLH 224
            L KL     +     ++ EY P   +   L     R I  + +        AQ +L   
Sbjct: 103 FLTKLEFSFKDNSNLYMVMEYAPGGEMFSHL-----RRIGRF-SEPHARFYAAQIVLTFE 156
Query: 225 QYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMS 284
               + +I+RDLK  N+++D+    K++DFG A+ V         +G T  + GT  Y++
Sbjct: 157 YLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV---------KGRTWXLCGTPEYLA 207
Query: 285 PEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 92/208 (44%), Gaps = 20/208 (9%)
Query: 110 NFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKSGQEIKELK---NEASVIAQVQHK 164
            F     LG G FG V   K +      A+K L  +   ++K+++   NE  ++  V   
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 102
Query: 165 NLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLH 224
            L KL     +     ++ EY P   +   L     R I  + +        AQ +L   
Sbjct: 103 FLTKLEFSFKDNSNLYMVMEYAPGGEMFSHL-----RRIGRF-SEPHARFYAAQIVLTFE 156
Query: 225 QYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMS 284
               + +I+RDLK  N+++D+    K++DFG A+ V         +G T  + GT  Y++
Sbjct: 157 YLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV---------KGRTWXLCGTPEYLA 207
Query: 285 PEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 103/222 (46%), Gaps = 44/222 (19%)
Query: 111 FSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEI---KELKNEASVIAQVQHKN 165
           +   + +G G +G+V      +    +AVK+L  +  Q I   K    E  ++  ++H+N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSL----DCFLFDPTKREILDWRTRVQ---------I 212
           ++ LL              + P +SL    D +L        L+   + Q         +
Sbjct: 83  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
           I  + +GL Y+H      IIHRDLK SN+ +++D   KI D G+AR     + +DE+ G 
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDRGLAR-----HTDDEMTGY 182
Query: 273 TSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
            +    T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 183 VA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 61/105 (58%), Gaps = 10/105 (9%)
Query: 224 HQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYM 283
           H ++R  +++RDLK +NILLD+  + +ISD G+A       D  + + + S   GT+GYM
Sbjct: 307 HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLA------CDFSKKKPHAS--VGTHGYM 357
Query: 284 SPEYALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLI 327
           +PE   +G+ +   +D FS G +L +++ G      ++TK  + I
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 402

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 61/105 (58%), Gaps = 10/105 (9%)
Query: 224 HQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYM 283
           H ++R  +++RDLK +NILLD+  + +ISD G+A       D  + + + S   GT+GYM
Sbjct: 307 HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLA------CDFSKKKPHAS--VGTHGYM 357
Query: 284 SPEYALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLI 327
           +PE   +G+ +   +D FS G +L +++ G      ++TK  + I
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 402

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 61/105 (58%), Gaps = 10/105 (9%)
Query: 224 HQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYM 283
           H ++R  +++RDLK +NILLD+  + +ISD G+A       D  + + + S   GT+GYM
Sbjct: 306 HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLA------CDFSKKKPHAS--VGTHGYM 356
Query: 284 SPEYALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLI 327
           +PE   +G+ +   +D FS G +L +++ G      ++TK  + I
Sbjct: 357 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 401

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 61/105 (58%), Gaps = 10/105 (9%)
Query: 224 HQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYM 283
           H ++R  +++RDLK +NILLD+  + +ISD G+A       D  + + + S   GT+GYM
Sbjct: 307 HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLA------CDFSKKKPHAS--VGTHGYM 357
Query: 284 SPEYALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLI 327
           +PE   +G+ +   +D FS G +L +++ G      ++TK  + I
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 402

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 32/215 (14%)
Query: 117 LGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQ-HKNLVKLLGCC 173
           LGEG    V   +  I   E AVK +  + G     +  E  ++ Q Q H+N+++L+   
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
            E+D   L++E M   S+   L    KR   +      +++ VA  L +LH      I H
Sbjct: 81  EEEDRFYLVFEKMRGGSI---LSHIHKRRHFNELEASVVVQDVASALDFLHNKG---IAH 134
Query: 234 RDLKASNILLDKDMN---SKISDFGMARIVFGGNDEDELQGNTSRIS--------GTYGY 282
           RDLK  NIL +        KI DFG+   +       +L G+ S IS        G+  Y
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFGLGSGI-------KLNGDCSPISTPELLTPCGSAEY 187
Query: 283 MSPE----YALEG-IFSIKSDVFSFGVLLLEIVSG 312
           M+PE    ++ E  I+  + D++S GV+L  ++SG
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 103/222 (46%), Gaps = 44/222 (19%)
Query: 111 FSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEI---KELKNEASVIAQVQHKN 165
           +   + +G G +G+V      +    +AVK+L  +  Q I   K    E  ++  ++H+N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSL----DCFLFDPTKREILDWRTRVQ---------I 212
           ++ LL              + P +SL    D +L        L+   + Q         +
Sbjct: 83  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
           I  + +GL Y+H      IIHRDLK SN+ +++D   KI D G+AR     + +DE+ G 
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDGGLAR-----HTDDEMTGY 182
Query: 273 TSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
            +    T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 183 VA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 106/244 (43%), Gaps = 31/244 (12%)
Query: 85  CKKGCEKE-VDQFP-------LFSFSSVSSATGN---FSAANKLGEGGFGTVY--KGVIG 131
            KKG E+E V +F        L  + S +  T +   F     LG G FG V   K    
Sbjct: 7   AKKGXEQESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIRTLGTGSFGRVMLVKHKET 66
Query: 132 QGEIAVKRLLGKSGQEIKELK---NEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPN 188
               A+K L  +   ++K+++   NE  +   V    LVKL     +     ++ EY P 
Sbjct: 67  GNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPG 126
Query: 189 KSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN 248
             +   L     R I  + +        AQ +L       + +I+RDLK  N+L+D+   
Sbjct: 127 GEMFSHL-----RRIGRF-SEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY 180
Query: 249 SKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLE 308
            K++DFG A+ V         +G T  + GT  Y++PE  L   ++   D ++ GVL+ E
Sbjct: 181 IKVADFGFAKRV---------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 231
Query: 309 IVSG 312
           + +G
Sbjct: 232 MAAG 235

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 56/99 (56%), Gaps = 11/99 (11%)
Query: 216 VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR 275
           +A GL +L       II+RDLK  N++LD + + KI+DFGM +       E+   G T++
Sbjct: 451 IAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK-------ENIWDGVTTK 500
Query: 276 -ISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
              GT  Y++PE      +    D ++FGVLL E+++G+
Sbjct: 501 XFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 56/99 (56%), Gaps = 11/99 (11%)
Query: 216 VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR 275
           +A GL +L       II+RDLK  N++LD + + KI+DFGM +       E+   G T++
Sbjct: 130 IAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK-------ENIWDGVTTK 179
Query: 276 -ISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
              GT  Y++PE      +    D ++FGVLL E+++G+
Sbjct: 180 XFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 92/203 (45%), Gaps = 20/203 (9%)
Query: 116 KLGEGGFGTVYKGVIGQGEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCC 173
           KL E   G ++KG     +I VK L  +  S ++ ++   E   +    H N++ +LG C
Sbjct: 17  KLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 174 --IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRI 231
                    LI  +MP  SL   L + T   ++D    V+    +A+G+ +LH    + I
Sbjct: 77  QSPPAPHPTLITHWMPYGSLYNVLHEGTNF-VVDQSQAVKFALDMARGMAFLHTLEPL-I 134
Query: 232 IHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEY---A 288
               L + ++++D+DM ++IS   MA + F       +            +++PE     
Sbjct: 135 PRHALNSRSVMIDEDMTARIS---MADVKFSFQSPGRMYAP--------AWVAPEALQKK 183
Query: 289 LEGIFSIKSDVFSFGVLLLEIVS 311
            E      +D++SF VLL E+V+
Sbjct: 184 PEDTNRRSADMWSFAVLLWELVT 206

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 102/209 (48%), Gaps = 30/209 (14%)
Query: 117 LGEGGFGTV---YKGVIGQGEIAVKRLLGKSGQEI---KELKNEASVIAQVQHKNLVKLL 170
           +G G +G+V   Y   + Q ++AVK+L  +  Q +   +    E  ++  ++H+N++ LL
Sbjct: 36  VGSGAYGSVCSAYDARLRQ-KVAVKKL-SRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 171 -----GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ 225
                   IE    +    Y+    +   L +  K + L       ++  + +GL Y+H 
Sbjct: 94  DVFTPATSIEDFSEV----YLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHS 149
Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
                IIHRDLK SN+ +++D   +I DFG+AR       ++E+ G  +    T  Y +P
Sbjct: 150 AG---IIHRDLKPSNVAVNEDSELRILDFGLAR-----QADEEMTGYVA----TRWYRAP 197
Query: 286 EYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
           E  L  + ++   D++S G ++ E++ GK
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 98/241 (40%), Gaps = 54/241 (22%)
Query: 100 SFSSVSSATGNFSAANK------LGEGGFGTV---YKGVIGQGEIAVKRLLG--KSGQEI 148
            F SV      F+   +      +G G  G V   Y  V+ +  +A+K+L    ++    
Sbjct: 9   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN-VAIKKLSRPFQNQTHA 67
Query: 149 KELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCF--------LFDPTK 200
           K    E  ++  V HKN++ LL              + P K+L+ F        L D   
Sbjct: 68  KRAYRELVLMKXVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANL 115
Query: 201 REI----LDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGM 256
            ++    LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+
Sbjct: 116 XQVIQMELDHERMSYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGL 172
Query: 257 ARIVFGGNDEDELQGNTSRISGTY----GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           AR              TS +   Y     Y +PE  L   +    D++S G ++ E+V  
Sbjct: 173 ART-----------AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 221
Query: 313 K 313
           K
Sbjct: 222 K 222

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 63/239 (26%), Positives = 98/239 (41%), Gaps = 52/239 (21%)
Query: 100 SFSSVSSATGNFSAANK------LGEGGFGTVYKG--VIGQGEIAVKRLLG--KSGQEIK 149
           +F SV      F+   +      +G G  G V      I +  +A+K+L    ++    K
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAK 68
Query: 150 ELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCF--------LFDPTKR 201
               E  ++  V HKN++ LL              + P KSL+ F        L D    
Sbjct: 69  RAYRELVLMKVVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLS 116
Query: 202 EI----LDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMA 257
           ++    LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+A
Sbjct: 117 QVIQMELDHERMSYLLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLA 173
Query: 258 RIVFGGNDEDELQGNTSRISGTY----GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           R              TS +   Y     Y +PE  L   +    D++S GV++ E++ G
Sbjct: 174 RT-----------AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 100/240 (41%), Gaps = 54/240 (22%)
Query: 100 SFSSVSSATGNFSAANK------LGEGGFGTV---YKGVIGQGEIAVKRLLG--KSGQEI 148
           +F SV      F+   +      +G G  G V   Y  ++ +  +A+K+L    ++    
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN-VAIKKLSRPFQNQTHA 67
Query: 149 KELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCF--------LFDPTK 200
           K    E  ++  V HKN++ LL              + P KSL+ F        L D   
Sbjct: 68  KRAYRELVLMKVVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANL 115
Query: 201 REI----LDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGM 256
            ++    LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+
Sbjct: 116 SQVIQMELDHERMSYLLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGL 172
Query: 257 ARIVFGGNDEDELQGNTSRISGTY----GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           AR              TS +   Y     Y +PE  L   +    D++S GV++ E++ G
Sbjct: 173 ART-----------AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 99/236 (41%), Gaps = 46/236 (19%)
Query: 100 SFSSVSSATGNFSAANK------LGEGGFGTV---YKGVIGQGEIAVKRLLG--KSGQEI 148
            F SV  A   F+   +      +G G  G V   +  V+G   +AVK+L    ++    
Sbjct: 9   QFYSVEVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGIN-VAVKKLSRPFQNQTHA 67
Query: 149 KELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCF--------LFDPTK 200
           K    E  ++  V HKN++ LL              + P K+L+ F        L D   
Sbjct: 68  KRAYRELVLLKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANL 115
Query: 201 REI----LDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGM 256
            ++    LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+
Sbjct: 116 CQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172
Query: 257 ARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           AR              T  +   Y Y +PE  L   ++   D++S G ++ E+V G
Sbjct: 173 ARTACTNF------MMTPYVVTRY-YRAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 96/216 (44%), Gaps = 20/216 (9%)
Query: 102 SSVSSATGNFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKSGQEIKELK---NEAS 156
           S  ++    F     LG G FG V   K        A+K L  +   ++K+++   NE  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 157 VIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGV 216
           ++  V    LVKL     +     ++ EY+    +   L     R I  + +        
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-----RRIGRF-SEPHARFYA 147
Query: 217 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRI 276
           AQ +L       + +I+RDLK  N+L+D+    +++DFG A+ V         +G T  +
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV---------KGRTWXL 198
Query: 277 SGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           +GT  Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 199 AGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 32/215 (14%)
Query: 117 LGEGGFGTVYKGV-IGQG-EIAVKRLLGKSGQEIKELKNEASVIAQVQ-HKNLVKLLGCC 173
           L EGGF  VY+   +G G E A+KRLL    ++ + +  E   + ++  H N+V+     
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 174 -IEKDER-------LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ 225
            I K+E        LL+ E    + ++ FL     R  L   T ++I     + + ++H+
Sbjct: 96  SIGKEESDTGQAEFLLLTELCKGQLVE-FLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGND-----------EDELQGNTS 274
             +  IIHRDLK  N+LL      K+ DFG A  +    D           E+E+  NT+
Sbjct: 155 -QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 275 RISGTYGYMSPEYA-LEGIFSI--KSDVFSFGVLL 306
            +     Y +PE   L   F I  K D+++ G +L
Sbjct: 214 PM-----YRTPEIIDLYSNFPIGEKQDIWALGCIL 243

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 95/218 (43%), Gaps = 24/218 (11%)
Query: 102 SSVSSATGNFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKSGQEIKELK---NEAS 156
           S  ++    F     LG G FG V   K        A+K L  +   ++K+++   NE  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 157 VIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKR--EILDWRTRVQIIK 214
           ++  V    LVKL     +     ++ EY+    +    F   +R     +   R     
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFXEPHARFY--- 146
Query: 215 GVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTS 274
             AQ +L       + +I+RDLK  N+L+D+    +++DFG A+ V         +G T 
Sbjct: 147 -AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV---------KGRTW 196
Query: 275 RISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
            + GT  Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 102/209 (48%), Gaps = 30/209 (14%)
Query: 117 LGEGGFGTV---YKGVIGQGEIAVKRLLGKSGQEI---KELKNEASVIAQVQHKNLVKLL 170
           +G G +G+V   Y   + Q ++AVK+L  +  Q +   +    E  ++  ++H+N++ LL
Sbjct: 28  VGSGAYGSVCSAYDARLRQ-KVAVKKL-SRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 171 -----GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ 225
                   IE    +    Y+    +   L +  K + L       ++  + +GL Y+H 
Sbjct: 86  DVFTPATSIEDFSEV----YLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHS 141
Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
                IIHRDLK SN+ +++D   +I DFG+AR       ++E+ G  +    T  Y +P
Sbjct: 142 AG---IIHRDLKPSNVAVNEDCELRILDFGLAR-----QADEEMTGYVA----TRWYRAP 189
Query: 286 EYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
           E  L  + ++   D++S G ++ E++ GK
Sbjct: 190 EIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 95/218 (43%), Gaps = 24/218 (11%)
Query: 102 SSVSSATGNFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKSGQEIKELK---NEAS 156
           S  ++    F     LG G FG V   K        A+K L  +   ++K+++   NE  
Sbjct: 29  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 88
Query: 157 VIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKR--EILDWRTRVQIIK 214
           ++  V    LVKL     +     ++ EY+    +    F   +R     +   R     
Sbjct: 89  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFXEPHARFY--- 141
Query: 215 GVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTS 274
             AQ +L       + +I+RDLK  N+L+D+    +++DFG A+ V         +G T 
Sbjct: 142 -AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV---------KGRTW 191
Query: 275 RISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
            + GT  Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 192 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 229

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 95/218 (43%), Gaps = 24/218 (11%)
Query: 102 SSVSSATGNFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKSGQEIKELK---NEAS 156
           S  ++    F     LG G FG V   K        A+K L  +   ++K+++   NE  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 157 VIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKR--EILDWRTRVQIIK 214
           ++  V    LVKL     +     ++ EY+    +    F   +R     +   R     
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFXEPHARFY--- 146
Query: 215 GVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTS 274
             AQ +L       + +I+RDLK  N+L+D+    +++DFG A+ V         +G T 
Sbjct: 147 -AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV---------KGRTW 196
Query: 275 RISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
            + GT  Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 96/207 (46%), Gaps = 16/207 (7%)
Query: 110 NFSAANKLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLV 167
           ++    +LG G FG V++          A K ++     + + ++ E   ++ ++H  LV
Sbjct: 52  HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 111
Query: 168 KLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYS 227
            L     + +E ++IYE+M    L   + D   +   D    V+ ++ V +GL ++H+ +
Sbjct: 112 NLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSED--EAVEYMRQVCKGLCHMHENN 169
Query: 228 RVRIIHRDLKASNILLDKDMNS--KISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
               +H DLK  NI+     ++  K+ DFG+   +       + + +    +GT  + +P
Sbjct: 170 ---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL-------DPKQSVKVTTGTAEFAAP 219
Query: 286 EYALEGIFSIKSDVFSFGVLLLEIVSG 312
           E A        +D++S GVL   ++SG
Sbjct: 220 EVAEGKPVGYYTDMWSVGVLSYILLSG 246

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 95/218 (43%), Gaps = 24/218 (11%)
Query: 102 SSVSSATGNFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKSGQEIKELK---NEAS 156
           S  ++    F     LG G FG V   K        A+K L  +   ++K+++   NE  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 157 VIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKR--EILDWRTRVQIIK 214
           ++  V    LVKL     +     ++ EY+    +    F   +R     +   R     
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFXEPHARFY--- 146
Query: 215 GVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTS 274
             AQ +L       + +I+RDLK  N+L+D+    +++DFG A+ V         +G T 
Sbjct: 147 -AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV---------KGRTW 196
Query: 275 RISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
            + GT  Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 107/210 (50%), Gaps = 19/210 (9%)
Query: 111 FSAANKLGEGGFGTVYKGVIGQGE--IAVKRLLGKSGQE--IKELKNEASVIAQVQHKNL 166
           +    K+GEG +GTV+K    +    +A+KR+      E        E  ++ +++HKN+
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 167 VKLLGCCIEKDERL-LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ 225
           V+L    +  D++L L++E+  ++ L  + FD    + LD       +  + +GL + H 
Sbjct: 64  VRLHDV-LHSDKKLTLVFEFC-DQDLKKY-FDSCNGD-LDPEIVKSFLFQLLKGLGFCHS 119
Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
            +   ++HRDLK  N+L++++   K++DFG+AR  FG      ++  ++ +  T  Y  P
Sbjct: 120 RN---VLHRDLKPQNLLINRNGELKLADFGLAR-AFGI----PVRCYSAEVV-TLWYRPP 170
Query: 286 EYALEG-IFSIKSDVFSFGVLLLEIVSGKK 314
           +      ++S   D++S G +  E+ +  +
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAAR 200

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 96/207 (46%), Gaps = 16/207 (7%)
Query: 110 NFSAANKLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLV 167
           ++    +LG G FG V++          A K ++     + + ++ E   ++ ++H  LV
Sbjct: 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 217
Query: 168 KLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYS 227
            L     + +E ++IYE+M    L   + D   +   D    V+ ++ V +GL ++H+ +
Sbjct: 218 NLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSED--EAVEYMRQVCKGLCHMHENN 275
Query: 228 RVRIIHRDLKASNILLDKDMNS--KISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
               +H DLK  NI+     ++  K+ DFG+   +       + + +    +GT  + +P
Sbjct: 276 ---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL-------DPKQSVKVTTGTAEFAAP 325
Query: 286 EYALEGIFSIKSDVFSFGVLLLEIVSG 312
           E A        +D++S GVL   ++SG
Sbjct: 326 EVAEGKPVGYYTDMWSVGVLSYILLSG 352

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 21/207 (10%)
Query: 110 NFSAANKLGEGGFGTVYKGVIGQ-GEI-AVKRLLGKSGQEIKELKNEASVIAQVQHKNLV 167
           +F   ++LG G +G V+K    + G + AVKR    S    +  K+ A  +A+V     V
Sbjct: 58  SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKR----SMSPFRGPKDRARKLAEVGSHEKV 113
Query: 168 KLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILD-WRT---RVQIIKGVAQGLLYL 223
               CC+  ++    +E      L   L  P+ ++  + W       Q+   +   LL L
Sbjct: 114 GQHPCCVRLEQ---AWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLAL 170
Query: 224 HQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYM 283
                  ++H D+K +NI L      K+ DFG+  +  G     E+Q    R      YM
Sbjct: 171 AHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLL-VELGTAGAGEVQEGDPR------YM 223
Query: 284 SPEYALEGIFSIKSDVFSFGVLLLEIV 310
           +PE  L+G +   +DVFS G+ +LE+ 
Sbjct: 224 APEL-LQGSYGTAADVFSLGLTILEVA 249

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 95/218 (43%), Gaps = 24/218 (11%)
Query: 102 SSVSSATGNFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKSGQEIKELK---NEAS 156
           S  ++    F     LG G FG V   K        A+K L  +   ++K+++   NE  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 157 VIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKR--EILDWRTRVQIIK 214
           ++  V    LVKL     +     ++ EY+    +    F   +R     +   R     
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFAEPHARFY--- 146
Query: 215 GVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTS 274
             AQ +L       + +I+RDLK  N+L+D+    +++DFG A+ V         +G T 
Sbjct: 147 -AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV---------KGRTW 196
Query: 275 RISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
            + GT  Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 103/217 (47%), Gaps = 17/217 (7%)
Query: 104 VSSATGNFSAANKLGEGGFGTVYKGVIGQ-GEI-AVKRL--LGKSGQEIKELKNEASVIA 159
           V + + +F   + LGEG +G V        GEI A+K++    K    ++ L+ E  ++ 
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILK 64
Query: 160 QVQHKNLVKLLGCCIEKDERLLIYE--YMPNKSLDCFLFDPTKREILDWRTRVQIIKGVA 217
             +H+N++ +    I++ +    +   Y+  + +   L      ++L        I    
Sbjct: 65  HFKHENIITIFN--IQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTL 122
Query: 218 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIV-FGGNDEDELQGNTSRI 276
           + +  LH  +   +IHRDLK SN+L++ + + K+ DFG+ARI+     D  E  G  S +
Sbjct: 123 RAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 277 S---GTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEI 309
           +    T  Y +PE  L    +S   DV+S G +L E+
Sbjct: 180 TEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 57/103 (55%), Gaps = 14/103 (13%)
Query: 216 VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR 275
           + + L YL +  +  +IHRD+K SNILLD+    K+ DFG++  +     +D       R
Sbjct: 133 IVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKD-------R 183
Query: 276 ISGTYGYMSPEY-----ALEGIFSIKSDVFSFGVLLLEIVSGK 313
            +G   YM+PE        +  + I++DV+S G+ L+E+ +G+
Sbjct: 184 SAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 93/208 (44%), Gaps = 20/208 (9%)
Query: 110 NFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKSGQEIKELK---NEASVIAQVQHK 164
            F     LG G FG V   K +      A+K L  +   ++K+++   NE  ++  V   
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 165 NLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLH 224
            LVKL     +     ++ EY+    +   L     R I  + +        AQ +L   
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-----RRIGRF-SEPHARFYAAQIVLTFE 155
Query: 225 QYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMS 284
               + +I+RDLK  N+L+D+    +++DFG A+ V         +G T  + GT  Y++
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV---------KGRTWXLCGTPEYLA 206
Query: 285 PEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 98/227 (43%), Gaps = 42/227 (18%)
Query: 117 LGEGGFGTVYKGV---IGQGEIAVK-----RLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
           +G+G F  V + +    GQ + AVK     +     G   ++LK EAS+   ++H ++V+
Sbjct: 32  IGKGPFSVVRRCINRETGQ-QFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKRE----ILDWRTRVQIIKGVAQGLLYLH 224
           LL          +++E+M    L    F+  KR     +         ++ + + L Y H
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVASHYMRQILEALRYCH 147
Query: 225 QYSRVRIIHRDLKASNILLDKDMNS---KISDFGMA------RIVFGGNDEDELQGNTSR 275
             +   IIHRD+K   +LL    NS   K+  FG+A       +V GG            
Sbjct: 148 DNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR----------- 193
Query: 276 ISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTK 322
             GT  +M+PE      +    DV+  GV+L  ++SG     FY TK
Sbjct: 194 -VGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG--CLPFYGTK 237

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 98/241 (40%), Gaps = 54/241 (22%)
Query: 100 SFSSVSSATGNFSAANK------LGEGGFGTV---YKGVIGQGEIAVKRLLG--KSGQEI 148
            F SV      F+   +      +G G  G V   Y  V+ +  +A+K+L    ++    
Sbjct: 9   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN-VAIKKLSRPFQNQTHA 67
Query: 149 KELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCF--------LFDPTK 200
           K    E  ++  V HKN++ LL              + P K+L+ F        L D   
Sbjct: 68  KRAYRELVLMKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANL 115
Query: 201 REI----LDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGM 256
            ++    LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+
Sbjct: 116 XQVIQMELDHERMSYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGL 172
Query: 257 ARIVFGGNDEDELQGNTSRISGTY----GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           AR              TS +   Y     Y +PE  L   +    D++S G ++ E+V  
Sbjct: 173 ART-----------AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 221
Query: 313 K 313
           K
Sbjct: 222 K 222

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 98/241 (40%), Gaps = 54/241 (22%)
Query: 100 SFSSVSSATGNFSAANK------LGEGGFGTV---YKGVIGQGEIAVKRLLG--KSGQEI 148
            F SV      F+   +      +G G  G V   Y  V+ +  +A+K+L    ++    
Sbjct: 9   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN-VAIKKLSRPFQNQTHA 67
Query: 149 KELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCF--------LFDPTK 200
           K    E  ++  V HKN++ LL              + P K+L+ F        L D   
Sbjct: 68  KRAYRELVLMKXVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANL 115
Query: 201 REI----LDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGM 256
            ++    LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+
Sbjct: 116 XQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGL 172
Query: 257 ARIVFGGNDEDELQGNTSRISGTY----GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           AR              TS +   Y     Y +PE  L   +    D++S G ++ E+V  
Sbjct: 173 ART-----------AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 221
Query: 313 K 313
           K
Sbjct: 222 K 222

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 67/283 (23%), Positives = 129/283 (45%), Gaps = 50/283 (17%)
Query: 116 KLGEGGFGTVYKGV-IGQGEI-AVKRLLGK-SGQEIKELKNEASVIAQ-VQHKNLVKLLG 171
           +LG G +G V K   +  G+I AVKR+    + QE K L  +  +  + V     V   G
Sbjct: 41  ELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPFTVTFYG 100
Query: 172 CCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRV------QIIKGVAQGLLYLHQ 225
               + +  +  E + + SLD F      ++++D    +      +I   + + L +LH 
Sbjct: 101 ALFREGDVWICXE-LXDTSLDKFY-----KQVIDKGQTIPEDILGKIAVSIVKALEHLH- 153
Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
            S++ +IHRD+K SN+L++     K  DFG++     G   D++  +    +G   Y +P
Sbjct: 154 -SKLSVIHRDVKPSNVLINALGQVKXCDFGIS-----GYLVDDVAKDID--AGCKPYXAP 205
Query: 286 EYALEGI----FSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIID 341
           E     +    +S+KSD++S G+  +E               L ++ + +D W       
Sbjct: 206 ERINPELNQKGYSVKSDIWSLGITXIE---------------LAILRFPYDSW--GTPFQ 248
Query: 342 LIDSVLEEAS----FNESLSRYVHIALLCVQERAEDRPTMSDV 380
            +  V+EE S     ++  + +V     C+++ +++RPT  ++
Sbjct: 249 QLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPEL 291

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 95/216 (43%), Gaps = 20/216 (9%)
Query: 102 SSVSSATGNFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKSGQEIKELK---NEAS 156
           S  ++    F     LG G FG V   K        A+K L  +   ++K+++   NE  
Sbjct: 21  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 80
Query: 157 VIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGV 216
           ++  V    LVKL     +     ++ EY+    +   L     R I  + +        
Sbjct: 81  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-----RRIGRF-SEPHARFYA 134
Query: 217 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRI 276
           AQ +L       + +I+RDLK  N+L+D+    +++DFG A+ V         +G T  +
Sbjct: 135 AQIVLTFEYLHSLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRV---------KGRTWXL 185
Query: 277 SGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
            GT  Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 186 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 221

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 103/217 (47%), Gaps = 17/217 (7%)
Query: 104 VSSATGNFSAANKLGEGGFGTVYKGVIGQ-GEI-AVKRL--LGKSGQEIKELKNEASVIA 159
           V + + +F   + LGEG +G V        GEI A+K++    K    ++ L+ E  ++ 
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILK 64
Query: 160 QVQHKNLVKLLGCCIEKDERLLIYE--YMPNKSLDCFLFDPTKREILDWRTRVQIIKGVA 217
             +H+N++ +    I++ +    +   Y+  + +   L      ++L        I    
Sbjct: 65  HFKHENIITIFN--IQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTL 122
Query: 218 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIV-FGGNDEDELQGNTSRI 276
           + +  LH  +   +IHRDLK SN+L++ + + K+ DFG+ARI+     D  E  G  S +
Sbjct: 123 RAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 277 S---GTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEI 309
           +    T  Y +PE  L    +S   DV+S G +L E+
Sbjct: 180 TEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 73/277 (26%), Positives = 120/277 (43%), Gaps = 50/277 (18%)
Query: 81  GNNKCKKGCEKEVDQFPLFSFSSVSSATGNFSAANK-LGEGGFGTV-YKGVIGQGEIAVK 138
           G+   KKG +  +   P F       +  N   + K LG G  GTV ++G      +AVK
Sbjct: 9   GSRGGKKGRKSRIANIPNFE-----QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVK 63
Query: 139 RLL----GKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCF 194
           R+L      +  EIK L           H N+++   C    D  L I   + N +L   
Sbjct: 64  RMLIDFCDIALMEIKLLTESDD------HPNVIRYY-CSETTDRFLYIALELCNLNLQDL 116
Query: 195 LFDPTKREILDWRTRVQ-------IIKGVAQGLLYLHQYSRVRIIHRDLKASNILLD--- 244
           +     + + D   ++Q       +++ +A G+ +LH    ++IIHRDLK  NIL+    
Sbjct: 117 V---ESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSS 170
Query: 245 ----------KDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGI-- 292
                     +++   ISDFG+ + +  G  +   + N +  SGT G+ +PE   E    
Sbjct: 171 RFTADQQTGAENLRILISDFGLCKKLDSG--QXXFRXNLNNPSGTSGWRAPELLEESTKR 228
Query: 293 -FSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLI 327
             +   D+FS G +   I+S GK   G   ++  N+I
Sbjct: 229 RLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNII 265

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 95/216 (43%), Gaps = 20/216 (9%)
Query: 102 SSVSSATGNFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKSGQEIKELK---NEAS 156
           S  ++    F     LG G FG V   K        A+K L  +   ++K+++   NE  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 157 VIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGV 216
           ++  V    LVKL     +     ++ EY+    +   L     R I  + +        
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-----RRIGRF-SEPHARFYA 147
Query: 217 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRI 276
           AQ +L       + +I+RDLK  N+L+D+    +++DFG A+ V         +G T  +
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV---------KGRTWXL 198
Query: 277 SGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
            GT  Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 199 XGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 98/241 (40%), Gaps = 54/241 (22%)
Query: 100 SFSSVSSATGNFSAANK------LGEGGFGTV---YKGVIGQGEIAVKRLLG--KSGQEI 148
            F SV      F+   +      +G G  G V   Y  V+ +  +A+K+L    ++    
Sbjct: 2   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN-VAIKKLSRPFQNQTHA 60
Query: 149 KELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCF--------LFDPTK 200
           K    E  ++  V HKN++ LL              + P K+L+ F        L D   
Sbjct: 61  KRAYRELVLMKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANL 108
Query: 201 REI----LDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGM 256
            ++    LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+
Sbjct: 109 XQVIQMELDHERMSYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGL 165
Query: 257 ARIVFGGNDEDELQGNTSRISGTY----GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           AR              TS +   Y     Y +PE  L   +    D++S G ++ E+V  
Sbjct: 166 ART-----------AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 214
Query: 313 K 313
           K
Sbjct: 215 K 215

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 102/209 (48%), Gaps = 30/209 (14%)
Query: 117 LGEGGFGTV---YKGVIGQGEIAVKRLLGKSGQEI---KELKNEASVIAQVQHKNLVKLL 170
           +G G +G+V   Y   + Q ++AVK+L  +  Q +   +    E  ++  ++H+N++ LL
Sbjct: 36  VGSGAYGSVCSAYDARLRQ-KVAVKKL-SRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 171 -----GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ 225
                   IE    +    Y+    +   L +  K + L       ++  + +GL Y+H 
Sbjct: 94  DVFTPATSIEDFSEV----YLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHS 149
Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
                IIHRDLK SN+ +++D   +I DFG+AR       ++E+ G  +    T  Y +P
Sbjct: 150 AG---IIHRDLKPSNVAVNEDSELRILDFGLAR-----QADEEMTGYVA----TRWYRAP 197
Query: 286 EYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
           E  L  + ++   D++S G ++ E++ GK
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 73/277 (26%), Positives = 120/277 (43%), Gaps = 50/277 (18%)
Query: 81  GNNKCKKGCEKEVDQFPLFSFSSVSSATGNFSAANK-LGEGGFGTV-YKGVIGQGEIAVK 138
           G+   KKG +  +   P F       +  N   + K LG G  GTV ++G      +AVK
Sbjct: 9   GSRGGKKGRKSRIANIPNFE-----QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVK 63
Query: 139 RLL----GKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCF 194
           R+L      +  EIK L           H N+++   C    D  L I   + N +L   
Sbjct: 64  RMLIDFCDIALMEIKLLTESDD------HPNVIRYY-CSETTDRFLYIALELCNLNLQDL 116
Query: 195 LFDPTKREILDWRTRVQ-------IIKGVAQGLLYLHQYSRVRIIHRDLKASNILLD--- 244
           +     + + D   ++Q       +++ +A G+ +LH    ++IIHRDLK  NIL+    
Sbjct: 117 V---ESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSS 170
Query: 245 ----------KDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGI-- 292
                     +++   ISDFG+ + +  G  +   + N +  SGT G+ +PE   E    
Sbjct: 171 RFTADQQTGAENLRILISDFGLCKKLDSG--QXXFRXNLNNPSGTSGWRAPELLEESTKR 228
Query: 293 -FSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLI 327
             +   D+FS G +   I+S GK   G   ++  N+I
Sbjct: 229 RLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNII 265

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 89/210 (42%), Gaps = 19/210 (9%)
Query: 110 NFSAANKLGEGGFGTV-YKGVIGQGEIAVKRLLGK----SGQEIKELKNEASVIAQVQHK 164
           +F     LG+G FG V        G     ++L K    +  E+     E+ V+   +H 
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 165 NLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLH 224
            L  L       D    + EY     L  F     +R   + R R    + +   L YLH
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAE-IVSALEYLH 122
Query: 225 QYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR-ISGTYGYM 283
                 +++RD+K  N++LDKD + KI+DFG+ +       E    G T +   GT  Y+
Sbjct: 123 SRD---VVYRDIKLENLMLDKDGHIKITDFGLCK-------EGISDGATMKTFCGTPEYL 172
Query: 284 SPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           +PE   +  +    D +  GV++ E++ G+
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 98/227 (43%), Gaps = 42/227 (18%)
Query: 117 LGEGGFGTVYKGV---IGQGEIAVK-----RLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
           +G+G F  V + +    GQ + AVK     +     G   ++LK EAS+   ++H ++V+
Sbjct: 34  IGKGPFSVVRRCINRETGQ-QFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 92
Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKRE----ILDWRTRVQIIKGVAQGLLYLH 224
           LL          +++E+M    L    F+  KR     +         ++ + + L Y H
Sbjct: 93  LLETYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVASHYMRQILEALRYCH 149
Query: 225 QYSRVRIIHRDLKASNILLDKDMNS---KISDFGMA------RIVFGGNDEDELQGNTSR 275
             +   IIHRD+K   +LL    NS   K+  FG+A       +V GG            
Sbjct: 150 DNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR----------- 195
Query: 276 ISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTK 322
             GT  +M+PE      +    DV+  GV+L  ++SG     FY TK
Sbjct: 196 -VGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG--CLPFYGTK 239

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 101/211 (47%), Gaps = 22/211 (10%)
Query: 111 FSAANKLGEGGFGTVYKGVIGQGEIAVKRLL-----GKSGQEIKELKNEASVIAQVQHKN 165
           F    KLG G FG V+  ++ +    ++R++      +S   +++++ E  V+  + H N
Sbjct: 24  FIFKRKLGSGAFGDVH--LVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPN 81
Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKR-EILDWRTRVQIIKGVAQGLLYLH 224
           ++K+     +     ++ E      L   +     R + L      +++K +   L Y H
Sbjct: 82  IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141
Query: 225 QYSRVRIIHRDLKASNILL-DKDMNS--KISDFGMARIVFGGNDEDELQGNTSRISGTYG 281
                 ++H+DLK  NIL  D   +S  KI DFG+A +    +DE     +++  +GT  
Sbjct: 142 SQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF--KSDE-----HSTNAAGTAL 191
Query: 282 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           YM+PE     + + K D++S GV++  +++G
Sbjct: 192 YMAPEVFKRDV-TFKCDIWSAGVVMYFLLTG 221

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 89/210 (42%), Gaps = 19/210 (9%)
Query: 110 NFSAANKLGEGGFGTV-YKGVIGQGEIAVKRLLGK----SGQEIKELKNEASVIAQVQHK 164
           +F     LG+G FG V        G     ++L K    +  E+     E+ V+   +H 
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 165 NLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLH 224
            L  L       D    + EY     L  F     +R   + R R    + +   L YLH
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAE-IVSALEYLH 122
Query: 225 QYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR-ISGTYGYM 283
                 +++RD+K  N++LDKD + KI+DFG+ +       E    G T +   GT  Y+
Sbjct: 123 SRD---VVYRDIKLENLMLDKDGHIKITDFGLCK-------EGISDGATMKTFCGTPEYL 172
Query: 284 SPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           +PE   +  +    D +  GV++ E++ G+
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 95/216 (43%), Gaps = 20/216 (9%)
Query: 102 SSVSSATGNFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKSGQEIKELK---NEAS 156
           S  ++    F     LG G FG V   K        A+K L  +   ++K+++   NE  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 157 VIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGV 216
           ++  V    LVKL     +     ++ EY+    +   L     R I  + +        
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-----RRIGRF-SEPHARFYA 147
Query: 217 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRI 276
           AQ +L       + +I+RDLK  N+L+D+    +++DFG A+ V         +G T  +
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV---------KGRTWXL 198
Query: 277 SGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
            GT  Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 95/216 (43%), Gaps = 20/216 (9%)
Query: 102 SSVSSATGNFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKSGQEIKELK---NEAS 156
           S  ++    F     LG G FG V   K        A+K L  +   ++K+++   NE  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 157 VIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGV 216
           ++  V    LVKL     +     ++ EY+    +   L     R I  + +        
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-----RRIGRF-SEPHARFYA 147
Query: 217 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRI 276
           AQ +L       + +I+RDLK  N+L+D+    +++DFG A+ V         +G T  +
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV---------KGRTWXL 198
Query: 277 SGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
            GT  Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 95/218 (43%), Gaps = 24/218 (11%)
Query: 102 SSVSSATGNFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKSGQEIKELK---NEAS 156
           S  ++    F     LG G FG V   K        A+K L  +   ++K+++   NE  
Sbjct: 55  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 114
Query: 157 VIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKR--EILDWRTRVQIIK 214
           ++  V    LVKL     +     ++ EY+    +    F   +R     +   R     
Sbjct: 115 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFXEPHARFY--- 167
Query: 215 GVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTS 274
             AQ +L       + +I+RDLK  N+L+D+    +++DFG A+ V         +G T 
Sbjct: 168 -AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV---------KGRTW 217
Query: 275 RISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
            + GT  Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 218 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 95/216 (43%), Gaps = 20/216 (9%)
Query: 102 SSVSSATGNFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKSGQEIKELK---NEAS 156
           S  ++    F     LG G FG V   K        A+K L  +   ++K+++   NE  
Sbjct: 35  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 94
Query: 157 VIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGV 216
           ++  V    LVKL     +     ++ EY+    +   L     R I  + +        
Sbjct: 95  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-----RRIGRF-SEPHARFYA 148
Query: 217 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRI 276
           AQ +L       + +I+RDLK  N+L+D+    +++DFG A+ V         +G T  +
Sbjct: 149 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV---------KGRTWXL 199
Query: 277 SGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
            GT  Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 89/210 (42%), Gaps = 19/210 (9%)
Query: 110 NFSAANKLGEGGFGTV-YKGVIGQGEIAVKRLLGK----SGQEIKELKNEASVIAQVQHK 164
           +F     LG+G FG V        G     ++L K    +  E+     E+ V+   +H 
Sbjct: 9   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 68
Query: 165 NLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLH 224
            L  L       D    + EY     L  F     +R   + R R    + +   L YLH
Sbjct: 69  FLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAE-IVSALEYLH 125
Query: 225 QYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR-ISGTYGYM 283
                 +++RD+K  N++LDKD + KI+DFG+ +       E    G T +   GT  Y+
Sbjct: 126 SRD---VVYRDIKLENLMLDKDGHIKITDFGLCK-------EGISDGATMKTFCGTPEYL 175
Query: 284 SPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           +PE   +  +    D +  GV++ E++ G+
Sbjct: 176 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 205

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 95/216 (43%), Gaps = 20/216 (9%)
Query: 102 SSVSSATGNFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKSGQEIKELK---NEAS 156
           S  ++    F     LG G FG V   K        A+K L  +   ++K+++   NE  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 157 VIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGV 216
           ++  V    LVKL     +     ++ EY+    +   L     R I  + +        
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-----RRIGRF-SEPHARFYA 147
Query: 217 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRI 276
           AQ +L       + +I+RDLK  N+L+D+    +++DFG A+ V         +G T  +
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV---------KGRTWXL 198
Query: 277 SGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
            GT  Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 89/210 (42%), Gaps = 19/210 (9%)
Query: 110 NFSAANKLGEGGFGTV-YKGVIGQGEIAVKRLLGK----SGQEIKELKNEASVIAQVQHK 164
           +F     LG+G FG V        G     ++L K    +  E+     E+ V+   +H 
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 165 NLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLH 224
            L  L       D    + EY     L  F     +R   + R R    + +   L YLH
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAE-IVSALEYLH 122
Query: 225 QYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR-ISGTYGYM 283
                 +++RD+K  N++LDKD + KI+DFG+ +       E    G T +   GT  Y+
Sbjct: 123 SRD---VVYRDIKLENLMLDKDGHIKITDFGLCK-------EGISDGATMKXFCGTPEYL 172
Query: 284 SPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           +PE   +  +    D +  GV++ E++ G+
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 89/210 (42%), Gaps = 19/210 (9%)
Query: 110 NFSAANKLGEGGFGTV-YKGVIGQGEIAVKRLLGK----SGQEIKELKNEASVIAQVQHK 164
           +F     LG+G FG V        G     ++L K    +  E+     E+ V+   +H 
Sbjct: 11  DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 70
Query: 165 NLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLH 224
            L  L       D    + EY     L  F     +R   + R R    + +   L YLH
Sbjct: 71  FLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAE-IVSALEYLH 127
Query: 225 QYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR-ISGTYGYM 283
                 +++RD+K  N++LDKD + KI+DFG+ +       E    G T +   GT  Y+
Sbjct: 128 SRD---VVYRDIKLENLMLDKDGHIKITDFGLCK-------EGISDGATMKXFCGTPEYL 177
Query: 284 SPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           +PE   +  +    D +  GV++ E++ G+
Sbjct: 178 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 89/210 (42%), Gaps = 19/210 (9%)
Query: 110 NFSAANKLGEGGFGTV-YKGVIGQGEIAVKRLLGK----SGQEIKELKNEASVIAQVQHK 164
           +F     LG+G FG V        G     ++L K    +  E+     E+ V+   +H 
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 165 NLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLH 224
            L  L       D    + EY     L  F     +R   + R R    + +   L YLH
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAE-IVSALEYLH 122
Query: 225 QYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR-ISGTYGYM 283
                 +++RD+K  N++LDKD + KI+DFG+ +       E    G T +   GT  Y+
Sbjct: 123 SRD---VVYRDIKLENLMLDKDGHIKITDFGLCK-------EGISDGATMKXFCGTPEYL 172
Query: 284 SPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           +PE   +  +    D +  GV++ E++ G+
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 95/216 (43%), Gaps = 20/216 (9%)
Query: 102 SSVSSATGNFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKSGQEIKELK---NEAS 156
           S  ++    F     LG G FG V   K        A+K L  +   ++K+++   NE  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 157 VIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGV 216
           ++  V    LVKL     +     ++ EY+    +   L     R I  + +        
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-----RRIGRF-SEPHARFYA 147
Query: 217 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRI 276
           AQ +L       + +I+RDLK  N+L+D+    +++DFG A+ V         +G T  +
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV---------KGRTWXL 198
Query: 277 SGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
            GT  Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 95/216 (43%), Gaps = 20/216 (9%)
Query: 102 SSVSSATGNFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKSGQEIKELK---NEAS 156
           S  ++    F     LG G FG V   K        A+K L  +   ++K+++   NE  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 157 VIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGV 216
           ++  V    LVKL     +     ++ EY+    +   L     R I  + +        
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-----RRIGRF-SEPHARFYA 147
Query: 217 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRI 276
           AQ +L       + +I+RDLK  N+L+D+    +++DFG A+ V         +G T  +
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV---------KGRTWXL 198
Query: 277 SGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
            GT  Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 89/210 (42%), Gaps = 19/210 (9%)
Query: 110 NFSAANKLGEGGFGTV-YKGVIGQGEIAVKRLLGK----SGQEIKELKNEASVIAQVQHK 164
           +F     LG+G FG V        G     ++L K    +  E+     E+ V+   +H 
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 165 NLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLH 224
            L  L       D    + EY     L  F     +R   + R R    + +   L YLH
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAE-IVSALEYLH 122
Query: 225 QYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR-ISGTYGYM 283
                 +++RD+K  N++LDKD + KI+DFG+ +       E    G T +   GT  Y+
Sbjct: 123 SRD---VVYRDIKLENLMLDKDGHIKITDFGLCK-------EGISDGATMKXFCGTPEYL 172
Query: 284 SPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           +PE   +  +    D +  GV++ E++ G+
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 101/217 (46%), Gaps = 17/217 (7%)
Query: 104 VSSATGNFSAANKLGEGGFGTVYKGVIGQ-GEI-AVKRL--LGKSGQEIKELKNEASVIA 159
           V + + +F   + LGEG +G V        GEI A+K++    K    ++ L+ E  ++ 
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILK 64
Query: 160 QVQHKNLVKLLGCCIEKDERLLIYE--YMPNKSLDCFLFDPTKREILDWRTRVQIIKGVA 217
             +H+N++ +    I++ +    +   Y+  + +   L      ++L        I    
Sbjct: 65  HFKHENIITIFN--IQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTL 122
Query: 218 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIV-FGGNDEDELQGNTS-- 274
           + +  LH  +   +IHRDLK SN+L++ + + K+ DFG+ARI+     D  E  G  S  
Sbjct: 123 RAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 275 -RISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEI 309
                T  Y +PE  L    +S   DV+S G +L E+
Sbjct: 180 VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 66/252 (26%), Positives = 115/252 (45%), Gaps = 29/252 (11%)
Query: 113 AANKLGEGGFGTVYKGV---IGQGEIAVKRLLGKS-GQEIK-ELKNEASVIAQVQH-KNL 166
            + +LG G F  V + +    GQ E A K L  +  GQ+ + E+ +E +V+   +    +
Sbjct: 33  TSKELGRGKFAVVRQCISKSTGQ-EYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91
Query: 167 VKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQY 226
           + L        E +LI EY     +      P   E++     +++IK + +G+ YLHQ 
Sbjct: 92  INLHEVYENTSEIILILEYAAGGEIFSLCL-PELAEMVSENDVIRLIKQILEGVYYLHQN 150
Query: 227 SRVRIIHRDLKASNILLDKDM---NSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYM 283
           +   I+H DLK  NILL       + KI DFGM+R +    +  E       I GT  Y+
Sbjct: 151 N---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE-------IMGTPEYL 200
Query: 284 SPEYALEGIFSIKSDVFSFGVLLLEIVS------GKKNTGFYRTKSLNLIGYAWDLW--I 335
           +PE       +  +D+++ G++   +++      G+ N   Y   S   + Y+ + +  +
Sbjct: 201 APEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSV 260
Query: 336 SNKIIDLIDSVL 347
           S    D I S+L
Sbjct: 261 SQLATDFIQSLL 272

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 100/215 (46%), Gaps = 23/215 (10%)
Query: 110 NFSAANKLGEGGFGTVY--KGVIGQ--GEIAVKRLLGKS-----GQEIKELKNEASVIAQ 160
           NF     LG G +G V+  + + G   G++   ++L K+      +  +  + E  V+  
Sbjct: 55  NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 114
Query: 161 VQHKNLVKLLGCCIEKDERL-LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQG 219
           ++    +  L    + + +L LI +Y+    L   L   ++RE       VQI   V + 
Sbjct: 115 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL---SQRERFT-EHEVQIY--VGEI 168
Query: 220 LLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGT 279
           +L L    ++ II+RD+K  NILLD + +  ++DFG+++      DE E         GT
Sbjct: 169 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA--DETE---RAYDFCGT 223
Query: 280 YGYMSPEYALEGI--FSIKSDVFSFGVLLLEIVSG 312
             YM+P+    G        D +S GVL+ E+++G
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 99/215 (46%), Gaps = 32/215 (14%)
Query: 117 LGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQ-HKNLVKLLGCC 173
           LGEG    V   +  I   E AVK +  + G     +  E  ++ Q Q H+N+++L+   
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
            E+D   L++E M   S+   L    KR   +      +++ VA  L +LH      I H
Sbjct: 81  EEEDRFYLVFEKMRGGSI---LSHIHKRRHFNELEASVVVQDVASALDFLHNKG---IAH 134
Query: 234 RDLKASNILLDKDMN---SKISDFGMARIVFGGNDEDELQGNTSRIS--------GTYGY 282
           RDLK  NIL +        KI DF +   +       +L G+ S IS        G+  Y
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFDLGSGI-------KLNGDCSPISTPELLTPCGSAEY 187
Query: 283 MSPE----YALEG-IFSIKSDVFSFGVLLLEIVSG 312
           M+PE    ++ E  I+  + D++S GV+L  ++SG
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 98/241 (40%), Gaps = 54/241 (22%)
Query: 100 SFSSVSSATGNFSAANK------LGEGGFGTV---YKGVIGQGEIAVKRLLG--KSGQEI 148
            F SV      F+   +      +G G  G V   Y  V+ +  +A+K+L    ++    
Sbjct: 9   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN-VAIKKLSRPFQNQTHA 67
Query: 149 KELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCF--------LFDPTK 200
           K    E  ++  V HKN++ LL              + P K+L+ F        L D   
Sbjct: 68  KRAYRELVLMKXVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANL 115
Query: 201 REI----LDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGM 256
            ++    LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+
Sbjct: 116 CQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGL 172
Query: 257 ARIVFGGNDEDELQGNTSRISGTY----GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           AR              TS +   Y     Y +PE  L   +    D++S G ++ E+V  
Sbjct: 173 ART-----------AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 221
Query: 313 K 313
           K
Sbjct: 222 K 222

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 100/240 (41%), Gaps = 54/240 (22%)
Query: 100 SFSSVSSATGNFSAANK------LGEGGFGTV---YKGVIGQGEIAVKRLLG--KSGQEI 148
            F SV  A   F+   +      +G G  G V   +  V+G   +AVK+L    ++    
Sbjct: 7   QFYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGIN-VAVKKLSRPFQNQTHA 65
Query: 149 KELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCF--------LFDPTK 200
           K    E  ++  V HKN++ LL              + P K+L+ F        L D   
Sbjct: 66  KRAYRELVLLKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANL 113
Query: 201 REI----LDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGM 256
            ++    LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+
Sbjct: 114 CQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 170
Query: 257 ARIVFGGNDEDELQGNTSRISGTY----GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           AR             +T+ +   Y     Y +PE  L   +    D++S G ++ E+V G
Sbjct: 171 ART-----------ASTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 99/240 (41%), Gaps = 54/240 (22%)
Query: 100 SFSSVSSATGNFSAANK------LGEGGFGTV---YKGVIGQGEIAVKRLLG--KSGQEI 148
           +F SV      F+   +      +G G  G V   Y  ++ +  +A+K+L    ++    
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN-VAIKKLSRPFQNQTHA 67
Query: 149 KELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCF--------LFDPTK 200
           K    E  ++  V HKN++ LL              + P KSL+ F        L D   
Sbjct: 68  KRAYRELVLMKVVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANL 115
Query: 201 REI----LDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGM 256
            ++    LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+
Sbjct: 116 SQVIQMELDHERMSYLLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGL 172
Query: 257 ARIVFGGNDEDELQGNTSRISGTY----GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           AR              TS +   Y     Y +PE  L   +    D++S G ++ E++ G
Sbjct: 173 ART-----------AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 86/206 (41%), Gaps = 19/206 (9%)
Query: 109 GNFSAANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
           G F     + E   G  Y   I + E+ V +       E+     E  V+   +H  L  
Sbjct: 19  GTFGKVILVKEKATGRYYAMKILKKEVIVAK------DEVAHTLTENRVLQNSRHPFLTA 72
Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSR 228
           L       D    + EY     L  F     +R   + R R    + +   L YLH  S 
Sbjct: 73  LKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAE-IVSALDYLH--SE 127
Query: 229 VRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR-ISGTYGYMSPEY 287
             +++RDLK  N++LDKD + KI+DFG+ +       E    G T +   GT  Y++PE 
Sbjct: 128 KNVVYRDLKLENLMLDKDGHIKITDFGLCK-------EGIKDGATMKXFCGTPEYLAPEV 180
Query: 288 ALEGIFSIKSDVFSFGVLLLEIVSGK 313
             +  +    D +  GV++ E++ G+
Sbjct: 181 LEDNDYGRAVDWWGLGVVMYEMMCGR 206

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 95/216 (43%), Gaps = 20/216 (9%)
Query: 102 SSVSSATGNFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKSGQEIKELK---NEAS 156
           S  ++    F     LG G FG V   K        A+K L  +   ++K+++   NE  
Sbjct: 55  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 114
Query: 157 VIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGV 216
           ++  V    LVKL     +     ++ EY+    +   L     R I  + +        
Sbjct: 115 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-----RRIGRF-SEPHARFYA 168
Query: 217 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRI 276
           AQ +L       + +I+RDLK  N+L+D+    +++DFG A+ V         +G T  +
Sbjct: 169 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV---------KGATWTL 219
Query: 277 SGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
            GT  Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 220 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 86/206 (41%), Gaps = 19/206 (9%)
Query: 109 GNFSAANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
           G F     + E   G  Y   I + E+ V +       E+     E  V+   +H  L  
Sbjct: 20  GTFGKVILVKEKATGRYYAMKILKKEVIVAK------DEVAHTLTENRVLQNSRHPFLTA 73
Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSR 228
           L       D    + EY     L  F     +R   + R R    + +   L YLH  S 
Sbjct: 74  LKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAE-IVSALDYLH--SE 128
Query: 229 VRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR-ISGTYGYMSPEY 287
             +++RDLK  N++LDKD + KI+DFG+ +       E    G T +   GT  Y++PE 
Sbjct: 129 KNVVYRDLKLENLMLDKDGHIKITDFGLCK-------EGIKDGATMKXFCGTPEYLAPEV 181
Query: 288 ALEGIFSIKSDVFSFGVLLLEIVSGK 313
             +  +    D +  GV++ E++ G+
Sbjct: 182 LEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 101/226 (44%), Gaps = 44/226 (19%)
Query: 115 NKLGEGGFGTV--YKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGC 172
            KLGEGGF  V   +G+      A+KR+L    Q+ +E + EA +     H N+++L+  
Sbjct: 35  QKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAY 94
Query: 173 CIE----KDERLLIYEYMPNKSL----------DCFLFDPTKREILDWRTRVQIIKGVAQ 218
           C+     K E  L+  +    +L            FL   T+ +IL W     ++ G+ +
Sbjct: 95  CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFL---TEDQIL-W-----LLLGICR 145
Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFG---MARIVFGGNDEDELQGNTSR 275
           GL  +H        HRDLK +NILL  +    + D G    A I   G+ +     + + 
Sbjct: 146 GLEAIHAKGYA---HRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAA 202
Query: 276 ISGTYGYMSPEYALEGIFSIKS--------DVFSFGVLLLEIVSGK 313
              T  Y +PE     +FS++S        DV+S G +L  ++ G+
Sbjct: 203 QRCTISYRAPE-----LFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 99/240 (41%), Gaps = 54/240 (22%)
Query: 100 SFSSVSSATGNFSAANK------LGEGGFGTV---YKGVIGQGEIAVKRLLG--KSGQEI 148
           +F SV      F+   +      +G G  G V   Y  ++ +  +A+K+L    ++    
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN-VAIKKLSRPFQNQTHA 67
Query: 149 KELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCF--------LFDPTK 200
           K    E  ++  V HKN++ LL              + P KSL+ F        L D   
Sbjct: 68  KRAYRELVLMKVVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANL 115
Query: 201 REI----LDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGM 256
            ++    LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+
Sbjct: 116 SQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGL 172
Query: 257 ARIVFGGNDEDELQGNTSRISGTY----GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           AR              TS +   Y     Y +PE  L   +    D++S G ++ E++ G
Sbjct: 173 ART-----------AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 86/206 (41%), Gaps = 19/206 (9%)
Query: 109 GNFSAANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
           G F     + E   G  Y   I + E+ V +       E+     E  V+   +H  L  
Sbjct: 21  GTFGKVILVKEKATGRYYAMKILKKEVIVAK------DEVAHTLTENRVLQNSRHPFLTA 74
Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSR 228
           L       D    + EY     L  F     +R   + R R    + +   L YLH  S 
Sbjct: 75  LKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAE-IVSALDYLH--SE 129
Query: 229 VRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR-ISGTYGYMSPEY 287
             +++RDLK  N++LDKD + KI+DFG+ +       E    G T +   GT  Y++PE 
Sbjct: 130 KNVVYRDLKLENLMLDKDGHIKITDFGLCK-------EGIKDGATMKXFCGTPEYLAPEV 182
Query: 288 ALEGIFSIKSDVFSFGVLLLEIVSGK 313
             +  +    D +  GV++ E++ G+
Sbjct: 183 LEDNDYGRAVDWWGLGVVMYEMMCGR 208

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 95/216 (43%), Gaps = 20/216 (9%)
Query: 102 SSVSSATGNFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKSGQEIKELK---NEAS 156
           S  ++    F     LG G FG V   K        A+K L  +   ++K+++   NE  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 157 VIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGV 216
           ++  V    LVKL     +     ++ EY+    +   L     R I  + +        
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-----RRIGRF-SEPHARFYA 147
Query: 217 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRI 276
           AQ +L       + +I+RDLK  N+L+D+    +++DFG A+ V         +G T  +
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV---------KGRTWXL 198
Query: 277 SGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
            GT  Y++PE  L   ++   D ++ GVL+ ++ +G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 86/206 (41%), Gaps = 19/206 (9%)
Query: 109 GNFSAANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
           G F     + E   G  Y   I + E+ V +       E+     E  V+   +H  L  
Sbjct: 159 GTFGKVILVKEKATGRYYAMKILKKEVIVAK------DEVAHTLTENRVLQNSRHPFLTA 212
Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSR 228
           L       D    + EY     L  F     +R   + R R    + +   L YLH  S 
Sbjct: 213 LKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAE-IVSALDYLH--SE 267
Query: 229 VRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR-ISGTYGYMSPEY 287
             +++RDLK  N++LDKD + KI+DFG+ +       E    G T +   GT  Y++PE 
Sbjct: 268 KNVVYRDLKLENLMLDKDGHIKITDFGLCK-------EGIKDGATMKTFCGTPEYLAPEV 320
Query: 288 ALEGIFSIKSDVFSFGVLLLEIVSGK 313
             +  +    D +  GV++ E++ G+
Sbjct: 321 LEDNDYGRAVDWWGLGVVMYEMMCGR 346

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 86/206 (41%), Gaps = 19/206 (9%)
Query: 109 GNFSAANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
           G F     + E   G  Y   I + E+ V +       E+     E  V+   +H  L  
Sbjct: 162 GTFGKVILVKEKATGRYYAMKILKKEVIVAK------DEVAHTLTENRVLQNSRHPFLTA 215
Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSR 228
           L       D    + EY     L  F     +R   + R R    + +   L YLH  S 
Sbjct: 216 LKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAE-IVSALDYLH--SE 270
Query: 229 VRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR-ISGTYGYMSPEY 287
             +++RDLK  N++LDKD + KI+DFG+ +       E    G T +   GT  Y++PE 
Sbjct: 271 KNVVYRDLKLENLMLDKDGHIKITDFGLCK-------EGIKDGATMKTFCGTPEYLAPEV 323
Query: 288 ALEGIFSIKSDVFSFGVLLLEIVSGK 313
             +  +    D +  GV++ E++ G+
Sbjct: 324 LEDNDYGRAVDWWGLGVVMYEMMCGR 349

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 99/240 (41%), Gaps = 54/240 (22%)
Query: 100 SFSSVSSATGNFSAANK------LGEGGFGTV---YKGVIGQGEIAVKRLLG--KSGQEI 148
           +F SV      F+   +      +G G  G V   Y  ++ +  +A+K+L    ++    
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN-VAIKKLSRPFQNQTHA 67
Query: 149 KELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCF--------LFDPTK 200
           K    E  ++  V HKN++ LL              + P KSL+ F        L D   
Sbjct: 68  KRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANL 115
Query: 201 REI----LDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGM 256
            ++    LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+
Sbjct: 116 SQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGL 172
Query: 257 ARIVFGGNDEDELQGNTSRISGTY----GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           AR              TS +   Y     Y +PE  L   +    D++S G ++ E++ G
Sbjct: 173 ART-----------AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 103/215 (47%), Gaps = 25/215 (11%)
Query: 110 NFSAANKLGEGGFGTVYKGVIGQGEI----AVKRLLGKSGQEIKELKN---EASVIAQVQ 162
           +F     +G+G FG V   ++ + +     A+K +  +   E  E++N   E  ++  ++
Sbjct: 16  HFEILRAIGKGSFGKV--CIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE 73
Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLY 222
           H  LV L     ++++  ++ + +    L   L    ++ +      V++   + + ++ 
Sbjct: 74  HPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHL----QQNVHFKEETVKLF--ICELVMA 127
Query: 223 LHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGY 282
           L      RIIHRD+K  NILLD+  +  I+DF +A ++         +   + ++GT  Y
Sbjct: 128 LDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAML-------PRETQITTMAGTKPY 180
Query: 283 MSPEY--ALEGI-FSIKSDVFSFGVLLLEIVSGKK 314
           M+PE   + +G  +S   D +S GV   E++ G++
Sbjct: 181 MAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 66/253 (26%), Positives = 103/253 (40%), Gaps = 58/253 (22%)
Query: 88  GCEKEVDQFPLFSFSSVSSATGNFSAANK------LGEGGFGTV---YKGVIGQGEIAVK 138
           G + +VD      F SV      F+   +      +G G  G V   Y  V+ +  +A+K
Sbjct: 2   GSKSKVDN----QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN-VAIK 56
Query: 139 RLLG--KSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCF-- 194
           +L    ++    K    E  ++  V HKN++ LL              + P K+L+ F  
Sbjct: 57  KLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV------------FTPQKTLEEFQD 104
Query: 195 ------LFDPTKREI----LDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLD 244
                 L D    ++    LD      ++  +  G+ +LH      IIHRDLK SNI++ 
Sbjct: 105 VYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVK 161
Query: 245 KDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY----GYMSPEYALEGIFSIKSDVF 300
            D   KI DFG+AR              TS +   Y     Y +PE  L   +    D++
Sbjct: 162 SDCTLKILDFGLART-----------AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIW 210
Query: 301 SFGVLLLEIVSGK 313
           S G ++ E+V  K
Sbjct: 211 SVGCIMGEMVRHK 223

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 98/241 (40%), Gaps = 54/241 (22%)
Query: 100 SFSSVSSATGNFSAANK------LGEGGFGTV---YKGVIGQGEIAVKRLLG--KSGQEI 148
            F SV      F+   +      +G G  G V   Y  V+ +  +A+K+L    ++    
Sbjct: 9   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN-VAIKKLSRPFQNQTHA 67
Query: 149 KELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCF--------LFDPTK 200
           K    E  ++  V HKN++ LL              + P K+L+ F        L D   
Sbjct: 68  KRAYRELVLMKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANL 115
Query: 201 REI----LDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGM 256
            ++    LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+
Sbjct: 116 CQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172
Query: 257 ARIVFGGNDEDELQGNTSRISGTY----GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           AR              TS +   Y     Y +PE  L   +    D++S G ++ E+V  
Sbjct: 173 ART-----------AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 221
Query: 313 K 313
           K
Sbjct: 222 K 222

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 99/240 (41%), Gaps = 54/240 (22%)
Query: 100 SFSSVSSATGNFSAANK------LGEGGFGTV---YKGVIGQGEIAVKRLLG--KSGQEI 148
           +F SV      F+   +      +G G  G V   Y  ++ +  +A+K+L    ++    
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN-VAIKKLSRPFQNQTHA 67
Query: 149 KELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCF--------LFDPTK 200
           K    E  ++  V HKN++ LL              + P KSL+ F        L D   
Sbjct: 68  KRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANL 115
Query: 201 REI----LDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGM 256
            ++    LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+
Sbjct: 116 SQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172
Query: 257 ARIVFGGNDEDELQGNTSRISGTY----GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           AR              TS +   Y     Y +PE  L   +    D++S G ++ E++ G
Sbjct: 173 ART-----------AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 104/213 (48%), Gaps = 33/213 (15%)
Query: 117 LGEGGFGTVYKG--VIGQGEIAVK-----RLLGKSG-QEIKELKNEASVIAQV----QHK 164
           LG+GGFGTV+ G  +  + ++A+K     R+LG S   +      E +++ +V     H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 165 NLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRV---QIIKGVAQGLL 221
            +++LL    E  E  ++    P  + D F +   K  + +  +R    Q++  +     
Sbjct: 99  GVIRLLD-WFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQ---- 153
Query: 222 YLHQYSRVRIIHRDLKASNILLD-KDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY 280
             H +SR  ++HRD+K  NIL+D +   +K+ DFG   ++   +DE       +   GT 
Sbjct: 154 --HCHSR-GVVHRDIKDENILIDLRRGCAKLIDFGSGALL---HDE-----PYTDFDGTR 202
Query: 281 GYMSPEY-ALEGIFSIKSDVFSFGVLLLEIVSG 312
            Y  PE+ +     ++ + V+S G+LL ++V G
Sbjct: 203 VYSPPEWISRHQYHALPATVWSLGILLYDMVCG 235

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 98/241 (40%), Gaps = 54/241 (22%)
Query: 100 SFSSVSSATGNFSAANK------LGEGGFGTV---YKGVIGQGEIAVKRLLG--KSGQEI 148
            F SV      F+   +      +G G  G V   Y  V+ +  +A+K+L    ++    
Sbjct: 8   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN-VAIKKLSRPFQNQTHA 66
Query: 149 KELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCF--------LFDPTK 200
           K    E  ++  V HKN++ LL              + P K+L+ F        L D   
Sbjct: 67  KRAYRELVLMKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANL 114
Query: 201 REI----LDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGM 256
            ++    LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+
Sbjct: 115 CQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 171
Query: 257 ARIVFGGNDEDELQGNTSRISGTY----GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           AR              TS +   Y     Y +PE  L   +    D++S G ++ E+V  
Sbjct: 172 ART-----------AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 220
Query: 313 K 313
           K
Sbjct: 221 K 221

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 98/241 (40%), Gaps = 54/241 (22%)
Query: 100 SFSSVSSATGNFSAANK------LGEGGFGTV---YKGVIGQGEIAVKRLLG--KSGQEI 148
            F SV      F+   +      +G G  G V   Y  V+ +  +A+K+L    ++    
Sbjct: 2   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN-VAIKKLSRPFQNQTHA 60
Query: 149 KELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCF--------LFDPTK 200
           K    E  ++  V HKN++ LL              + P K+L+ F        L D   
Sbjct: 61  KRAYRELVLMKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANL 108
Query: 201 REI----LDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGM 256
            ++    LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+
Sbjct: 109 CQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165
Query: 257 ARIVFGGNDEDELQGNTSRISGTY----GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           AR              TS +   Y     Y +PE  L   +    D++S G ++ E+V  
Sbjct: 166 ART-----------AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 214
Query: 313 K 313
           K
Sbjct: 215 K 215

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 98/241 (40%), Gaps = 54/241 (22%)
Query: 100 SFSSVSSATGNFSAANK------LGEGGFGTV---YKGVIGQGEIAVKRLLG--KSGQEI 148
            F SV      F+   +      +G G  G V   Y  V+ +  +A+K+L    ++    
Sbjct: 10  QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN-VAIKKLSRPFQNQTHA 68
Query: 149 KELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCF--------LFDPTK 200
           K    E  ++  V HKN++ LL              + P K+L+ F        L D   
Sbjct: 69  KRAYRELVLMKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANL 116
Query: 201 REI----LDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGM 256
            ++    LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+
Sbjct: 117 CQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 173
Query: 257 ARIVFGGNDEDELQGNTSRISGTY----GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           AR              TS +   Y     Y +PE  L   +    D++S G ++ E+V  
Sbjct: 174 ART-----------AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 222
Query: 313 K 313
           K
Sbjct: 223 K 223

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 98/241 (40%), Gaps = 54/241 (22%)
Query: 100 SFSSVSSATGNFSAANK------LGEGGFGTV---YKGVIGQGEIAVKRLLG--KSGQEI 148
            F SV      F+   +      +G G  G V   Y  V+ +  +A+K+L    ++    
Sbjct: 3   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN-VAIKKLSRPFQNQTHA 61
Query: 149 KELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCF--------LFDPTK 200
           K    E  ++  V HKN++ LL              + P K+L+ F        L D   
Sbjct: 62  KRAYRELVLMKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANL 109
Query: 201 REI----LDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGM 256
            ++    LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+
Sbjct: 110 CQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 166
Query: 257 ARIVFGGNDEDELQGNTSRISGTY----GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           AR              TS +   Y     Y +PE  L   +    D++S G ++ E+V  
Sbjct: 167 ART-----------AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 215
Query: 313 K 313
           K
Sbjct: 216 K 216

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 93/221 (42%), Gaps = 23/221 (10%)
Query: 99  FSFSSVSSATGNFSAANKLGEGGFGTVYKGVIGQGEI--AVKRLLGKSGQEIKELKNEAS 156
           F  S+       ++  N +G G +G V   V     I  A K++     +++   K E  
Sbjct: 16  FQGSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIE 75
Query: 157 VIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPT-KREILDWRTRVQIIKG 215
           ++  + H N+++L     +  +  L+ E      L    F+    + +       +I+K 
Sbjct: 76  IMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGEL----FERVVHKRVFRESDAARIMKD 131
Query: 216 VAQGLLYLHQYSRVRIIHRDLKASNILL---DKDMNSKISDFGMARIVFGGNDEDELQGN 272
           V   + Y H   ++ + HRDLK  N L      D   K+ DFG+A             G 
Sbjct: 132 VLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF--------KPGK 180
Query: 273 TSRIS-GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
             R   GT  Y+SP+  LEG++  + D +S GV++  ++ G
Sbjct: 181 MMRTKVGTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCG 220

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 98/241 (40%), Gaps = 54/241 (22%)
Query: 100 SFSSVSSATGNFSAANK------LGEGGFGTV---YKGVIGQGEIAVKRLLG--KSGQEI 148
            F SV      F+   +      +G G  G V   Y  V+ +  +A+K+L    ++    
Sbjct: 9   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN-VAIKKLSRPFQNQTHA 67
Query: 149 KELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCF--------LFDPTK 200
           K    E  ++  V HKN++ LL              + P K+L+ F        L D   
Sbjct: 68  KRAYRELVLMKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANL 115
Query: 201 REI----LDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGM 256
            ++    LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+
Sbjct: 116 CQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172
Query: 257 ARIVFGGNDEDELQGNTSRISGTY----GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           AR              TS +   Y     Y +PE  L   +    D++S G ++ E+V  
Sbjct: 173 ART-----------AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 221
Query: 313 K 313
           K
Sbjct: 222 K 222

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 98/241 (40%), Gaps = 54/241 (22%)
Query: 100 SFSSVSSATGNFSAANK------LGEGGFGTV---YKGVIGQGEIAVKRLLG--KSGQEI 148
            F SV      F+   +      +G G  G V   Y  V+ +  +A+K+L    ++    
Sbjct: 3   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN-VAIKKLSRPFQNQTHA 61
Query: 149 KELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCF--------LFDPTK 200
           K    E  ++  V HKN++ LL              + P K+L+ F        L D   
Sbjct: 62  KRAYRELVLMKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANL 109
Query: 201 REI----LDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGM 256
            ++    LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+
Sbjct: 110 CQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 166
Query: 257 ARIVFGGNDEDELQGNTSRISGTY----GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           AR              TS +   Y     Y +PE  L   +    D++S G ++ E+V  
Sbjct: 167 ART-----------AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 215
Query: 313 K 313
           K
Sbjct: 216 K 216

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 107/210 (50%), Gaps = 19/210 (9%)
Query: 111 FSAANKLGEGGFGTVYKGVIGQGE--IAVKRLLGKSGQE--IKELKNEASVIAQVQHKNL 166
           +    K+GEG +GTV+K    +    +A+KR+      E        E  ++ +++HKN+
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 167 VKLLGCCIEKDERL-LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ 225
           V+L    +  D++L L++E+  ++ L  + FD    + LD       +  + +GL + H 
Sbjct: 64  VRLHDV-LHSDKKLTLVFEFC-DQDLKKY-FDSCNGD-LDPEIVKSFLFQLLKGLGFCHS 119
Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
            +   ++HRDLK  N+L++++   K+++FG+AR  FG      ++  ++ +  T  Y  P
Sbjct: 120 RN---VLHRDLKPQNLLINRNGELKLANFGLAR-AFGI----PVRCYSAEVV-TLWYRPP 170
Query: 286 EYALEG-IFSIKSDVFSFGVLLLEIVSGKK 314
           +      ++S   D++S G +  E+ +  +
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGR 200

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 93/208 (44%), Gaps = 21/208 (10%)
Query: 111 FSAANKLGEGGFGTVYKGVIGQGEI--AVKRLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
           ++  N +G G +G V   V     I  A K++     +++   K E  ++  + H N+++
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 70
Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFLFDPT-KREILDWRTRVQIIKGVAQGLLYLHQYS 227
           L     +  +  L+ E      L    F+    + +       +I+K V   + Y H   
Sbjct: 71  LYETFEDNTDIYLVMELCTGGEL----FERVVHKRVFRESDAARIMKDVLSAVAYCH--- 123
Query: 228 RVRIIHRDLKASNILL---DKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMS 284
           ++ + HRDLK  N L      D   K+ DFG+A     G      +   +++ GT  Y+S
Sbjct: 124 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG------KMMRTKV-GTPYYVS 176
Query: 285 PEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           P+  LEG++  + D +S GV++  ++ G
Sbjct: 177 PQ-VLEGLYGPECDEWSAGVMMYVLLCG 203

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 95/216 (43%), Gaps = 20/216 (9%)
Query: 102 SSVSSATGNFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKSGQEIKELK---NEAS 156
           S  ++    F     LG G FG V   K        A+K L  +   ++K+++   NE  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 157 VIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGV 216
           ++  V    LVKL     +     ++ EY+    +   L     R I  + +        
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-----RRIGRF-SEPHARFYA 147
Query: 217 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRI 276
           AQ +L       + +I+RDLK  N+++D+    +++DFG A+ V         +G T  +
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRV---------KGRTWXL 198
Query: 277 SGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
            GT  Y++PE  +   ++   D ++ GVL+ E+ +G
Sbjct: 199 CGTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 42/216 (19%)
Query: 129 VIGQGEIA-VKRLLGKSGQEIKELK-----------------NEASVIAQVQHKNLVKLL 170
           VIG+G    V+ +  K+ Q++  +K                  E  ++A      +V+L 
Sbjct: 82  VIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 141
Query: 171 GCCIEKDERL-LIYEYMPNKSLDCFL--FDPTKREILDWRTRVQIIKGVAQGLLYLHQYS 227
            C  + D+ L ++ EYMP   L   +  +D  ++    W          A+ +L L    
Sbjct: 142 -CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK----WAKFY-----TAEVVLALDAIH 191
Query: 228 RVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEY 287
            + +IHRD+K  N+LLDK  + K++DFG    +    DE  +    + + GT  Y+SPE 
Sbjct: 192 SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM----DETGMVHCDTAV-GTPDYISPEV 246
Query: 288 ----ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFY 319
                 +G +  + D +S GV L E++ G  +T FY
Sbjct: 247 LKSQGGDGYYGRECDWWSVGVFLFEMLVG--DTPFY 280

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 99/240 (41%), Gaps = 54/240 (22%)
Query: 100 SFSSVSSATGNFSAANK------LGEGGFGTV---YKGVIGQGEIAVKRLLG--KSGQEI 148
           +F SV      F+   +      +G G  G V   Y  ++ +  +A+K+L    ++    
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAIL-ERNVAIKKLSRPFQNQTHA 67
Query: 149 KELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCF--------LFDPTK 200
           K    E  ++  V HKN++ LL              + P KSL+ F        L D   
Sbjct: 68  KRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANL 115
Query: 201 REI----LDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGM 256
            ++    LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+
Sbjct: 116 CQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172
Query: 257 ARIVFGGNDEDELQGNTSRISGTY----GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           AR              TS +   Y     Y +PE  L   +    D++S G ++ E++ G
Sbjct: 173 ART-----------AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 98/241 (40%), Gaps = 54/241 (22%)
Query: 100 SFSSVSSATGNFSAANK------LGEGGFGTV---YKGVIGQGEIAVKRLLG--KSGQEI 148
            F SV      F+   +      +G G  G V   Y  V+ +  +A+K+L    ++    
Sbjct: 47  QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN-VAIKKLSRPFQNQTHA 105
Query: 149 KELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCF--------LFDPTK 200
           K    E  ++  V HKN++ LL              + P K+L+ F        L D   
Sbjct: 106 KRAYRELVLMKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANL 153
Query: 201 REI----LDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGM 256
            ++    LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+
Sbjct: 154 CQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL 210
Query: 257 ARIVFGGNDEDELQGNTSRISGTY----GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           AR              TS +   Y     Y +PE  L   +    D++S G ++ E+V  
Sbjct: 211 ART-----------AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 259
Query: 313 K 313
           K
Sbjct: 260 K 260

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 98/240 (40%), Gaps = 54/240 (22%)
Query: 101 FSSVSSATGNFSAANK------LGEGGFGTV---YKGVIGQGEIAVKRLLG--KSGQEIK 149
           F SV      F+   +      +G G  G V   Y  V+ +  +A+K+L    ++    K
Sbjct: 48  FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN-VAIKKLSRPFQNQTHAK 106
Query: 150 ELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCF--------LFDPTKR 201
               E  ++  V HKN++ LL              + P K+L+ F        L D    
Sbjct: 107 RAYRELVLMKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLC 154
Query: 202 EI----LDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMA 257
           ++    LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+A
Sbjct: 155 QVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 211
Query: 258 RIVFGGNDEDELQGNTSRISGTY----GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           R              TS +   Y     Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 212 RT-----------AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 101/228 (44%), Gaps = 25/228 (10%)
Query: 103 SVSSATGNFSAANKL-----GEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEIKELKNEA 155
           S  S  G F    KL     GEG +  V   V  Q   E AVK +  ++G     +  E 
Sbjct: 2   STDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREV 61
Query: 156 SVIAQVQ-HKNLVKLLGCCIEKDERL-LIYEYMPNKSLDCFLFDPTKREILDWRTRVQII 213
             + Q Q +KN+++L+    E D R  L++E +   S+   L    K++  + R   +++
Sbjct: 62  ETLYQCQGNKNILELIEF-FEDDTRFYLVFEKLQGGSI---LAHIQKQKHFNEREASRVV 117
Query: 214 KGVAQGLLYLHQYSRVRIIHRDLKASNILL---DKDMNSKISDFGMARIVFGGNDEDEL- 269
           + VA  L +LH      I HRDLK  NIL    +K    KI DF +   +   N    + 
Sbjct: 118 RDVAAALDFLHTKG---IAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPIT 174
Query: 270 QGNTSRISGTYGYMSPEYA-----LEGIFSIKSDVFSFGVLLLEIVSG 312
               +   G+  YM+PE           +  + D++S GV+L  ++SG
Sbjct: 175 TPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSG 222

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 41/106 (38%), Positives = 60/106 (56%), Gaps = 8/106 (7%)
Query: 218 QGLLYLHQYSRVRIIHRDLKASNILLDKD-MNSKISDFGMARIV-FGGNDEDELQGNTSR 275
           +GL YLH  SR RI+H D+KA N+LL  D  ++ + DFG A  +   G  +D L G+   
Sbjct: 177 EGLEYLH--SR-RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDY-- 231
Query: 276 ISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG-KKNTGFYR 320
           I GT  +M+PE  L      K DV+S   ++L +++G    T F+R
Sbjct: 232 IPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFR 277

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 94/216 (43%), Gaps = 20/216 (9%)
Query: 102 SSVSSATGNFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKSGQEIKELK---NEAS 156
           S  ++    F     LG G FG V   K        A+K L  +   ++K+++   NE  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 157 VIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGV 216
           ++  V    LVKL     +     ++ EY+    +   L     R I  + +        
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-----RRIGRF-SEPHARFYA 147
Query: 217 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRI 276
           AQ +L       + +I+RDLK  N+L+D+    +++DFG A+ V         +G T  +
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV---------KGRTWXL 198
Query: 277 SGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
            GT  Y++P   L   ++   D ++ GVL+ E+ +G
Sbjct: 199 CGTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/234 (24%), Positives = 112/234 (47%), Gaps = 37/234 (15%)
Query: 117 LGEGGFGTVYKGV--IGQGEIAVKRLLG--KSGQEIKELKNEASVIAQVQHKNLVKLLGC 172
           +G G +G V +    + +  +A+K++L   +   + K +  E +++ ++ H ++VK+L  
Sbjct: 61  IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDI 120
Query: 173 CIEKD----ERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSR 228
            I KD    + L +   + +         P     L  +T   ++  +  G+ Y+H    
Sbjct: 121 VIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKT---LLYNLLVGVKYVHSAG- 176
Query: 229 VRIIHRDLKASNILLDKDMNSKISDFGMARIV---FGGND-------EDELQGNT----- 273
             I+HRDLK +N L+++D + K+ DFG+AR V     GN        ED++   T     
Sbjct: 177 --ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTK 234
Query: 274 ---SRISG---TYGYMSPEYA-LEGIFSIKSDVFSFGVLLLEIVSG-KKNTGFY 319
               +++G   T  Y +PE   L+  ++   DV+S G +  E+++  K+N  ++
Sbjct: 235 NLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH 288

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 99/240 (41%), Gaps = 54/240 (22%)
Query: 100 SFSSVSSATGNFSAANK------LGEGGFGTV---YKGVIGQGEIAVKRLLG--KSGQEI 148
           +F SV      F+   +      +G G  G V   Y  ++ +  +A+K+L    ++    
Sbjct: 10  NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAIL-ERNVAIKKLSRPFQNQTHA 68
Query: 149 KELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCF--------LFDPTK 200
           K    E  ++  V HKN++ LL              + P KSL+ F        L D   
Sbjct: 69  KRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANL 116
Query: 201 REI----LDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGM 256
            ++    LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+
Sbjct: 117 CQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 173
Query: 257 ARIVFGGNDEDELQGNTSRISGTY----GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           AR              TS +   Y     Y +PE  L   +    D++S G ++ E++ G
Sbjct: 174 ART-----------AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 111/245 (45%), Gaps = 50/245 (20%)
Query: 117 LGEGGFGTV-YKGVIGQGEIAVKRLL----GKSGQEIKELKNEASVIAQVQHKNLVKLLG 171
           LG G  GTV ++G      +AVKR+L      +  EIK L           H N+++   
Sbjct: 23  LGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDD------HPNVIRYY- 75
Query: 172 CCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQ-------IIKGVAQGLLYLH 224
           C    D  L I   + N +L   +     + + D   ++Q       +++ +A G+ +LH
Sbjct: 76  CSETTDRFLYIALELCNLNLQDLV---ESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 225 QYSRVRIIHRDLKASNILLD-------------KDMNSKISDFGMARIVFGGNDEDELQG 271
               ++IIHRDLK  NIL+              +++   ISDFG+ + +  G  +   + 
Sbjct: 133 S---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG--QSSFRT 187
Query: 272 NTSRISGTYGYMSPEYALEGIFSIKS--------DVFSFGVLLLEIVS-GKKNTGFYRTK 322
           N +  SGT G+ +PE  LE   ++++        D+FS G +   I+S GK   G   ++
Sbjct: 188 NLNNPSGTSGWRAPE-LLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246
Query: 323 SLNLI 327
             N+I
Sbjct: 247 ESNII 251

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 99/240 (41%), Gaps = 54/240 (22%)
Query: 100 SFSSVSSATGNFSAANK------LGEGGFGTV---YKGVIGQGEIAVKRLLG--KSGQEI 148
           +F SV      F+   +      +G G  G V   Y  ++ +  +A+K+L    ++    
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN-VAIKKLSRPFQNQTHA 67
Query: 149 KELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCF--------LFDPTK 200
           K    E  ++  V HKN++ LL              + P KSL+ F        L D   
Sbjct: 68  KRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANL 115
Query: 201 REI----LDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGM 256
            ++    LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+
Sbjct: 116 CQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172
Query: 257 ARIVFGGNDEDELQGNTSRISGTY----GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           AR              TS +   Y     Y +PE  L   +    D++S G ++ E++ G
Sbjct: 173 ART-----------AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 100/239 (41%), Gaps = 52/239 (21%)
Query: 100 SFSSVSSATGNFSAANK------LGEGGFGTV---YKGVIGQGEIAVKRLLG--KSGQEI 148
           +F SV      F+   +      +G G  G V   Y  ++ +  +A+K+L    ++    
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN-VAIKKLSRPFQNQTHA 67
Query: 149 KELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCF--------LFDPTK 200
           K    E  ++  V HKN++ LL              + P KSL+ F        L D   
Sbjct: 68  KRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANL 115
Query: 201 REI----LDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGM 256
            ++    LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+
Sbjct: 116 CQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172
Query: 257 ARIVFGGNDEDELQGNTSRISG---TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           AR            G +  ++    T  Y +PE  L   +    D++S G ++ E++ G
Sbjct: 173 ARTA----------GTSFMMTPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 68/145 (46%), Gaps = 33/145 (22%)
Query: 222 YLHQYSRVRIIHRDLKASNILL---DKDMNSKISDFGMARIVFGGNDEDELQGNTS---R 275
           YLH+     IIHRDLK  N+LL   ++D   KI+DFG ++I+          G TS    
Sbjct: 129 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----------GETSLMRT 175
Query: 276 ISGTYGYMSPEYALE---GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTK---------- 322
           + GT  Y++PE  +      ++   D +S GV+L   +SG      +RT+          
Sbjct: 176 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 235
Query: 323 SLNLIGYAWDLWISNKIIDLIDSVL 347
             N I   W   +S K +DL+  +L
Sbjct: 236 KYNFIPEVW-AEVSEKALDLVKKLL 259

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 68/145 (46%), Gaps = 33/145 (22%)
Query: 222 YLHQYSRVRIIHRDLKASNILL---DKDMNSKISDFGMARIVFGGNDEDELQGNTS---R 275
           YLH+     IIHRDLK  N+LL   ++D   KI+DFG ++I+          G TS    
Sbjct: 129 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----------GETSLMRT 175
Query: 276 ISGTYGYMSPEYALE---GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTK---------- 322
           + GT  Y++PE  +      ++   D +S GV+L   +SG      +RT+          
Sbjct: 176 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 235
Query: 323 SLNLIGYAWDLWISNKIIDLIDSVL 347
             N I   W   +S K +DL+  +L
Sbjct: 236 KYNFIPEVW-AEVSEKALDLVKKLL 259

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 111/245 (45%), Gaps = 50/245 (20%)
Query: 117 LGEGGFGTV-YKGVIGQGEIAVKRLL----GKSGQEIKELKNEASVIAQVQHKNLVKLLG 171
           LG G  GTV ++G      +AVKR+L      +  EIK L           H N+++   
Sbjct: 23  LGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDD------HPNVIRYY- 75
Query: 172 CCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQ-------IIKGVAQGLLYLH 224
           C    D  L I   + N +L   +     + + D   ++Q       +++ +A G+ +LH
Sbjct: 76  CSETTDRFLYIALELCNLNLQDLV---ESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 225 QYSRVRIIHRDLKASNILLD-------------KDMNSKISDFGMARIVFGGNDEDELQG 271
               ++IIHRDLK  NIL+              +++   ISDFG+ + +  G  +   + 
Sbjct: 133 S---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG--QXXFRX 187
Query: 272 NTSRISGTYGYMSPEYALEGIFSIKS--------DVFSFGVLLLEIVS-GKKNTGFYRTK 322
           N +  SGT G+ +PE  LE   ++++        D+FS G +   I+S GK   G   ++
Sbjct: 188 NLNNPSGTSGWRAPE-LLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246
Query: 323 SLNLI 327
             N+I
Sbjct: 247 ESNII 251

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 68/145 (46%), Gaps = 33/145 (22%)
Query: 222 YLHQYSRVRIIHRDLKASNILL---DKDMNSKISDFGMARIVFGGNDEDELQGNTS---R 275
           YLH+     IIHRDLK  N+LL   ++D   KI+DFG ++I+          G TS    
Sbjct: 129 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----------GETSLMRT 175
Query: 276 ISGTYGYMSPEYALE---GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTK---------- 322
           + GT  Y++PE  +      ++   D +S GV+L   +SG      +RT+          
Sbjct: 176 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 235
Query: 323 SLNLIGYAWDLWISNKIIDLIDSVL 347
             N I   W   +S K +DL+  +L
Sbjct: 236 KYNFIPEVW-AEVSEKALDLVKKLL 259

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 68/145 (46%), Gaps = 33/145 (22%)
Query: 222 YLHQYSRVRIIHRDLKASNILL---DKDMNSKISDFGMARIVFGGNDEDELQGNTS---R 275
           YLH+     IIHRDLK  N+LL   ++D   KI+DFG ++I+          G TS    
Sbjct: 128 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----------GETSLMRT 174
Query: 276 ISGTYGYMSPEYALE---GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTK---------- 322
           + GT  Y++PE  +      ++   D +S GV+L   +SG      +RT+          
Sbjct: 175 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 234
Query: 323 SLNLIGYAWDLWISNKIIDLIDSVL 347
             N I   W   +S K +DL+  +L
Sbjct: 235 KYNFIPEVW-AEVSEKALDLVKKLL 258

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 68/145 (46%), Gaps = 33/145 (22%)
Query: 222 YLHQYSRVRIIHRDLKASNILL---DKDMNSKISDFGMARIVFGGNDEDELQGNTS---R 275
           YLH+     IIHRDLK  N+LL   ++D   KI+DFG ++I+          G TS    
Sbjct: 135 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----------GETSLMRT 181
Query: 276 ISGTYGYMSPEYALE---GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTK---------- 322
           + GT  Y++PE  +      ++   D +S GV+L   +SG      +RT+          
Sbjct: 182 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 241
Query: 323 SLNLIGYAWDLWISNKIIDLIDSVL 347
             N I   W   +S K +DL+  +L
Sbjct: 242 KYNFIPEVW-AEVSEKALDLVKKLL 265

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 99/241 (41%), Gaps = 54/241 (22%)
Query: 100 SFSSVSSATGNFSAANK------LGEGGFGTV---YKGVIGQGEIAVKRLLG--KSGQEI 148
           +F SV      F+   +      +G G  G V   Y  ++ +  +A+K+L    ++    
Sbjct: 3   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN-VAIKKLSRPFQNQTHA 61
Query: 149 KELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCF--------LFDPTK 200
           K    E  ++  V HKN++ LL              + P KSL+ F        L D   
Sbjct: 62  KRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANL 109
Query: 201 REI----LDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGM 256
            ++    LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+
Sbjct: 110 CQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 166
Query: 257 ARIVFGGNDEDELQGNTSRISGTY----GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           AR              TS +   Y     Y +PE  L   +    D++S G ++ E+V  
Sbjct: 167 ART-----------AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCH 215
Query: 313 K 313
           K
Sbjct: 216 K 216

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 81/175 (46%), Gaps = 28/175 (16%)
Query: 154 EASVIAQVQHKNLVKLLGCCIEKDER--LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQ 211
           E  V+ ++ HKN+VKL     E   R  +LI E+ P  SL   L +P+    L     + 
Sbjct: 57  EFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLI 116
Query: 212 IIKGVAQGLLYLHQYSRVRIIHRDLKASNIL--LDKDMNS--KISDFGMARIVFGGNDED 267
           +++ V  G+ +L +     I+HR++K  NI+  + +D  S  K++DFG AR         
Sbjct: 117 VLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR--------- 164
Query: 268 ELQGNTSRIS--GTYGYMSPEYALEGI--------FSIKSDVFSFGVLLLEIVSG 312
           EL+ +   +S  GT  Y+ P+     +        +    D++S GV      +G
Sbjct: 165 ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 94/216 (43%), Gaps = 20/216 (9%)
Query: 102 SSVSSATGNFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKSGQEIKELK---NEAS 156
           S  ++    F     LG G FG V   K        A+K L  +   ++K+++   NE  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 157 VIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGV 216
           ++  V    LVKL     +     ++ EY+    +   L     R I  + +        
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-----RRIGRF-SEPHARFYA 147
Query: 217 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRI 276
           AQ +L       + +I+RDLK  N+L+D+    +++DFG A+ V         +G T  +
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV---------KGRTWXL 198
Query: 277 SGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
            GT   ++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 199 CGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 99/240 (41%), Gaps = 52/240 (21%)
Query: 100 SFSSVSSATGNFSAANK------LGEGGFGTV---YKGVIGQGEIAVKRLLG--KSGQEI 148
           +F SV      F+   +      +G G  G V   Y  ++ +  +A+K+L    ++    
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN-VAIKKLSRPFQNQTHA 67
Query: 149 KELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCF--------LFDPTK 200
           K    E  ++  V HKN++ LL              + P KSL+ F        L D   
Sbjct: 68  KRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANL 115
Query: 201 REI----LDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGM 256
            ++    LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+
Sbjct: 116 CQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172
Query: 257 ARIVFGGNDEDELQGNTSRISG---TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           AR            G +  +     T  Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 173 ARTA----------GTSFMMEPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 99/241 (41%), Gaps = 54/241 (22%)
Query: 100 SFSSVSSATGNFSAANK------LGEGGFGTV---YKGVIGQGEIAVKRLLG--KSGQEI 148
           +F SV      F+   +      +G G  G V   Y  ++ +  +A+K+L    ++    
Sbjct: 14  NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAIL-ERNVAIKKLSRPFQNQTHA 72
Query: 149 KELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCF--------LFDPTK 200
           K    E  ++  V HKN++ LL              + P KSL+ F        L D   
Sbjct: 73  KRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANL 120
Query: 201 REI----LDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGM 256
            ++    LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+
Sbjct: 121 CQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 177
Query: 257 ARIVFGGNDEDELQGNTSRISGTY----GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           AR              TS +   Y     Y +PE  L   +    D++S G ++ E+V  
Sbjct: 178 ART-----------AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCH 226
Query: 313 K 313
           K
Sbjct: 227 K 227

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 81/173 (46%), Gaps = 24/173 (13%)
Query: 154 EASVIAQVQHKNLVKLLGCCIEKDER--LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQ 211
           E  V+ ++ HKN+VKL     E   R  +LI E+ P  SL   L +P+    L     + 
Sbjct: 57  EFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLI 116
Query: 212 IIKGVAQGLLYLHQYSRVRIIHRDLKASNIL--LDKDMNS--KISDFGMARIVFGGNDED 267
           +++ V  G+ +L +     I+HR++K  NI+  + +D  S  K++DFG AR +     ED
Sbjct: 117 VLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL-----ED 168
Query: 268 ELQGNTSRISGTYGYMSPEYALEGI--------FSIKSDVFSFGVLLLEIVSG 312
           + Q     + GT  Y+ P+     +        +    D++S GV      +G
Sbjct: 169 DEQ--FVXLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 76/318 (23%), Positives = 124/318 (38%), Gaps = 49/318 (15%)
Query: 110 NFSAANKLGEGGFGTVYKG--VIGQGEIAVKRLLGKSGQEIKELKNEASVIAQV------ 161
            +     LG GGFG+VY G  V     +A+K +      +  EL N   V  +V      
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 162 --QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQG 219
                 +++LL      D  +LI E  P    D F F  T+R  L           V + 
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEA 127
Query: 220 LLYLHQYSRVRIIHRDLKASNILLDKDMNS-KISDFGMARIVFGGNDEDELQGNTSRISG 278
           + + H      ++HRD+K  NIL+D +    K+ DFG   ++     +D +  +     G
Sbjct: 128 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALL-----KDTVYTD---FDG 176
Query: 279 TYGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISN 337
           T  Y  PE+     +  +S  V+S G+LL ++V G              I +  D  I  
Sbjct: 177 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD-------------IPFEHDEEIIR 223
Query: 338 KIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQP 397
             +     V  E           H+   C+  R  DRPT  ++ +    +   +L P++ 
Sbjct: 224 GQVFFRQRVSSECQ---------HLIRWCLALRPSDRPTFEEIQNHPWMQ--DVLLPQET 272
Query: 398 AFCNLRNMESSTSTTEKS 415
           A  +L ++    S +  S
Sbjct: 273 AEIHLHSLSPGPSKSGPS 290

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 73/318 (22%), Positives = 128/318 (40%), Gaps = 53/318 (16%)
Query: 110 NFSAANKLGEGGFGTVYKG--VIGQGEIAVKRLLGKSGQEIKELKNEASVIAQV------ 161
            +     LG GGFG+VY G  V     +A+K +      +  EL N   V  +V      
Sbjct: 9   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 68
Query: 162 --QHKNLVKLLGCCIEKDERLLIYEYM-PNKSLDCFLFDPTKREILDWRTRVQIIKGVAQ 218
                 +++LL      D  +LI E M P + L  F+   T+R  L           V +
Sbjct: 69  SSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFI---TERGALQEELARSFFWQVLE 125
Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNS-KISDFGMARIVFGGNDEDELQGNTSRIS 277
            + + H      ++HRD+K  NIL+D +    K+ DFG   ++     +D +  +     
Sbjct: 126 AVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALL-----KDTVYTD---FD 174
Query: 278 GTYGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWIS 336
           GT  Y  PE+     +  +S  V+S G+LL ++V G  +  F   + +            
Sbjct: 175 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDEEI------------ 220
Query: 337 NKIIDLIDSVLEEASFNESLSRYV-HIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPK 395
                    +  +  F + +S    H+   C+  R  DRPT  ++ +    +   +L P+
Sbjct: 221 ---------IRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ--DVLLPQ 269
Query: 396 QPAFCNLRNMESSTSTTE 413
           + A  +L ++    S  +
Sbjct: 270 ETAEIHLHSLSPGPSKVD 287

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 99/240 (41%), Gaps = 52/240 (21%)
Query: 100 SFSSVSSATGNFSAANK------LGEGGFGTV---YKGVIGQGEIAVKRLLG--KSGQEI 148
           +F SV      F+   +      +G G  G V   Y  ++ +  +A+K+L    ++    
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN-VAIKKLSRPFQNQTHA 67
Query: 149 KELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCF--------LFDPTK 200
           K    E  ++  V HKN++ LL              + P KSL+ F        L D   
Sbjct: 68  KRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANL 115
Query: 201 REI----LDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGM 256
            ++    LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+
Sbjct: 116 CQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172
Query: 257 ARIVFGGNDEDELQGNTSRISG---TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           AR            G +  +     T  Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 173 ARTA----------GTSFMMEPEVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 99/236 (41%), Gaps = 46/236 (19%)
Query: 100 SFSSVSSATGNFSAANK------LGEGGFGTV---YKGVIGQGEIAVKRLLG--KSGQEI 148
           +F SV      F+   +      +G G  G V   Y  ++ +  +A+K+L    ++    
Sbjct: 11  NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAIL-ERNVAIKKLSRPFQNQTHA 69
Query: 149 KELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCF--------LFDPTK 200
           K    E  ++  V HKN++ LL              + P KSL+ F        L D   
Sbjct: 70  KRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANL 117
Query: 201 REI----LDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGM 256
            ++    LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+
Sbjct: 118 CQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 174
Query: 257 ARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           AR    G     +    +R      Y +PE  L   +    D++S G ++ E++ G
Sbjct: 175 ART--AGTSFMMVPFVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 68/145 (46%), Gaps = 33/145 (22%)
Query: 222 YLHQYSRVRIIHRDLKASNILL---DKDMNSKISDFGMARIVFGGNDEDELQGNTS---R 275
           YLH+     IIHRDLK  N+LL   ++D   KI+DFG ++I+          G TS    
Sbjct: 254 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----------GETSLMRT 300
Query: 276 ISGTYGYMSPEYALE---GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTK---------- 322
           + GT  Y++PE  +      ++   D +S GV+L   +SG      +RT+          
Sbjct: 301 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 360
Query: 323 SLNLIGYAWDLWISNKIIDLIDSVL 347
             N I   W   +S K +DL+  +L
Sbjct: 361 KYNFIPEVW-AEVSEKALDLVKKLL 384

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 80/170 (47%), Gaps = 18/170 (10%)
Query: 154 EASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQII 213
           E  ++A      +V+L     +     ++ EYMP   L   +   +  ++ +   R    
Sbjct: 124 ERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM---SNYDVPEKWARFY-- 178
Query: 214 KGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNT 273
              A+ +L L     +  IHRD+K  N+LLDK  + K++DFG    +   N E  ++ +T
Sbjct: 179 --TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM---NKEGMVRCDT 233
Query: 274 SRISGTYGYMSPEY----ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFY 319
           +   GT  Y+SPE       +G +  + D +S GV L E++ G  +T FY
Sbjct: 234 A--VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG--DTPFY 279

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 73/317 (23%), Positives = 126/317 (39%), Gaps = 51/317 (16%)
Query: 110 NFSAANKLGEGGFGTVYKG--VIGQGEIAVKRLLGKSGQEIKELKNEASVIAQV------ 161
            +     LG GGFG+VY G  V     +A+K +      +  EL N   V  +V      
Sbjct: 9   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 68
Query: 162 --QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQG 219
                 +++LL      D  +LI E  P    D F F  T+R  L           V + 
Sbjct: 69  SSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEA 126
Query: 220 LLYLHQYSRVRIIHRDLKASNILLDKDMNS-KISDFGMARIVFGGNDEDELQGNTSRISG 278
           + + H      ++HRD+K  NIL+D +    K+ DFG   ++     +D +  +     G
Sbjct: 127 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALL-----KDTVYTD---FDG 175
Query: 279 TYGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISN 337
           T  Y  PE+     +  +S  V+S G+LL ++V G  +  F   + +             
Sbjct: 176 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDEEI------------- 220
Query: 338 KIIDLIDSVLEEASFNESLSRYV-HIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQ 396
                   +  +  F + +S    H+   C+  R  DRPT  ++ +    +   +L P++
Sbjct: 221 --------IRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ--DVLLPQE 270
Query: 397 PAFCNLRNMESSTSTTE 413
            A  +L ++    S  +
Sbjct: 271 TAEIHLHSLSPGPSKVD 287

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 80/170 (47%), Gaps = 18/170 (10%)
Query: 154 EASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQII 213
           E  ++A      +V+L     +     ++ EYMP   L   +   +  ++ +   R    
Sbjct: 124 ERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM---SNYDVPEKWARFY-- 178
Query: 214 KGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNT 273
              A+ +L L     +  IHRD+K  N+LLDK  + K++DFG    +   N E  ++ +T
Sbjct: 179 --TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM---NKEGMVRCDT 233
Query: 274 SRISGTYGYMSPE----YALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFY 319
           +   GT  Y+SPE       +G +  + D +S GV L E++ G  +T FY
Sbjct: 234 A--VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG--DTPFY 279

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 73/317 (23%), Positives = 126/317 (39%), Gaps = 51/317 (16%)
Query: 110 NFSAANKLGEGGFGTVYKG--VIGQGEIAVKRLLGKSGQEIKELKNEASVIAQV------ 161
            +     LG GGFG+VY G  V     +A+K +      +  EL N   V  +V      
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 162 --QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQG 219
                 +++LL      D  +LI E  P    D F F  T+R  L           V + 
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEA 127
Query: 220 LLYLHQYSRVRIIHRDLKASNILLDKDMNS-KISDFGMARIVFGGNDEDELQGNTSRISG 278
           + + H      ++HRD+K  NIL+D +    K+ DFG   ++     +D +  +     G
Sbjct: 128 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALL-----KDTVYTD---FDG 176
Query: 279 TYGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISN 337
           T  Y  PE+     +  +S  V+S G+LL ++V G  +  F   + +             
Sbjct: 177 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDEEI------------- 221
Query: 338 KIIDLIDSVLEEASFNESLSRYV-HIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQ 396
                   +  +  F + +S    H+   C+  R  DRPT  ++ +    +   +L P++
Sbjct: 222 --------IRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ--DVLLPQE 271
Query: 397 PAFCNLRNMESSTSTTE 413
            A  +L ++    S  +
Sbjct: 272 TAEIHLHSLSPGPSKVD 288

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 80/170 (47%), Gaps = 18/170 (10%)
Query: 154 EASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQII 213
           E  ++A      +V+L     +     ++ EYMP   L   +   +  ++ +   R    
Sbjct: 119 ERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM---SNYDVPEKWARFY-- 173
Query: 214 KGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNT 273
              A+ +L L     +  IHRD+K  N+LLDK  + K++DFG    +   N E  ++ +T
Sbjct: 174 --TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM---NKEGMVRCDT 228
Query: 274 SRISGTYGYMSPE----YALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFY 319
           +   GT  Y+SPE       +G +  + D +S GV L E++ G  +T FY
Sbjct: 229 A--VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG--DTPFY 274

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 68/145 (46%), Gaps = 33/145 (22%)
Query: 222 YLHQYSRVRIIHRDLKASNILL---DKDMNSKISDFGMARIVFGGNDEDELQGNTS---R 275
           YLH+     IIHRDLK  N+LL   ++D   KI+DFG ++I+          G TS    
Sbjct: 268 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----------GETSLMRT 314
Query: 276 ISGTYGYMSPEYALE---GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTK---------- 322
           + GT  Y++PE  +      ++   D +S GV+L   +SG      +RT+          
Sbjct: 315 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 374
Query: 323 SLNLIGYAWDLWISNKIIDLIDSVL 347
             N I   W   +S K +DL+  +L
Sbjct: 375 KYNFIPEVWAE-VSEKALDLVKKLL 398

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 73/314 (23%), Positives = 125/314 (39%), Gaps = 51/314 (16%)
Query: 110 NFSAANKLGEGGFGTVYKG--VIGQGEIAVKRLLGKSGQEIKELKNEASVIAQV------ 161
            +     LG GGFG+VY G  V     +A+K +      +  EL N   V  +V      
Sbjct: 24  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 83
Query: 162 --QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQG 219
                 +++LL      D  +LI E  P    D F F  T+R  L           V + 
Sbjct: 84  SSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEA 141
Query: 220 LLYLHQYSRVRIIHRDLKASNILLDKDMNS-KISDFGMARIVFGGNDEDELQGNTSRISG 278
           + + H      ++HRD+K  NIL+D +    K+ DFG   ++     +D +  +     G
Sbjct: 142 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALL-----KDTVYTD---FDG 190
Query: 279 TYGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISN 337
           T  Y  PE+     +  +S  V+S G+LL ++V G  +  F   + +             
Sbjct: 191 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDEEI------------- 235
Query: 338 KIIDLIDSVLEEASFNESLSRYV-HIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQ 396
                   +  +  F + +S    H+   C+  R  DRPT  ++ +    +   +L P++
Sbjct: 236 --------IRGQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQ--DVLLPQE 285
Query: 397 PAFCNLRNMESSTS 410
            A  +L ++    S
Sbjct: 286 TAEIHLHSLSPGPS 299

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 74/314 (23%), Positives = 126/314 (40%), Gaps = 51/314 (16%)
Query: 110 NFSAANKLGEGGFGTVYKG--VIGQGEIAVKRLLGKSGQEIKELKNEASVIAQV------ 161
            +     LG GGFG+VY G  V     +A+K +      +  EL N   V  +V      
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 162 --QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQG 219
                 +++LL      D  +LI E  P    D F F  T+R  L           V + 
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEA 155
Query: 220 LLYLHQYSRVRIIHRDLKASNILLDKDMNS-KISDFGMARIVFGGNDEDELQGNTSRISG 278
           + + H      ++HRD+K  NIL+D +    K+ DFG   ++     +D +  +     G
Sbjct: 156 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALL-----KDTVYTD---FDG 204
Query: 279 TYGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISN 337
           T  Y  PE+     +  +S  V+S G+LL ++V G  +  F   + +          I  
Sbjct: 205 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDEEI----------IGG 252
Query: 338 KIIDLIDSVLEEASFNESLSRYV-HIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQ 396
           ++            F + +S    H+   C+  R  DRPT  ++ +    +   +L P++
Sbjct: 253 QVF-----------FRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQ--DVLLPQE 299
Query: 397 PAFCNLRNMESSTS 410
            A  +L ++    S
Sbjct: 300 TAEIHLHSLSPGPS 313

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 74/314 (23%), Positives = 126/314 (40%), Gaps = 51/314 (16%)
Query: 110 NFSAANKLGEGGFGTVYKG--VIGQGEIAVKRLLGKSGQEIKELKNEASVIAQV------ 161
            +     LG GGFG+VY G  V     +A+K +      +  EL N   V  +V      
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 162 --QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQG 219
                 +++LL      D  +LI E  P    D F F  T+R  L           V + 
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEA 154
Query: 220 LLYLHQYSRVRIIHRDLKASNILLDKDMNS-KISDFGMARIVFGGNDEDELQGNTSRISG 278
           + + H      ++HRD+K  NIL+D +    K+ DFG   ++     +D +  +     G
Sbjct: 155 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALL-----KDTVYTD---FDG 203
Query: 279 TYGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISN 337
           T  Y  PE+     +  +S  V+S G+LL ++V G  +  F   + +          I  
Sbjct: 204 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDEEI----------IGG 251
Query: 338 KIIDLIDSVLEEASFNESLSRYV-HIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQ 396
           ++            F + +S    H+   C+  R  DRPT  ++ +    +   +L P++
Sbjct: 252 QVF-----------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ--DVLLPQE 298
Query: 397 PAFCNLRNMESSTS 410
            A  +L ++    S
Sbjct: 299 TAEIHLHSLSPGPS 312

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 73/314 (23%), Positives = 125/314 (39%), Gaps = 51/314 (16%)
Query: 110 NFSAANKLGEGGFGTVYKG--VIGQGEIAVKRLLGKSGQEIKELKNEASVIAQV------ 161
            +     LG GGFG+VY G  V     +A+K +      +  EL N   V  +V      
Sbjct: 25  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 162 --QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQG 219
                 +++LL      D  +LI E  P    D F F  T+R  L           V + 
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEA 142
Query: 220 LLYLHQYSRVRIIHRDLKASNILLDKDMNS-KISDFGMARIVFGGNDEDELQGNTSRISG 278
           + + H      ++HRD+K  NIL+D +    K+ DFG   ++     +D +  +     G
Sbjct: 143 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALL-----KDTVYTD---FDG 191
Query: 279 TYGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISN 337
           T  Y  PE+     +  +S  V+S G+LL ++V G  +  F   + +             
Sbjct: 192 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDEEI------------- 236
Query: 338 KIIDLIDSVLEEASFNESLSRYV-HIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQ 396
                   +  +  F + +S    H+   C+  R  DRPT  ++ +    +   +L P++
Sbjct: 237 --------IRGQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQ--DVLLPQE 286
Query: 397 PAFCNLRNMESSTS 410
            A  +L ++    S
Sbjct: 287 TAEIHLHSLSPGPS 300

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 73/314 (23%), Positives = 125/314 (39%), Gaps = 51/314 (16%)
Query: 110 NFSAANKLGEGGFGTVYKG--VIGQGEIAVKRLLGKSGQEIKELKNEASVIAQV------ 161
            +     LG GGFG+VY G  V     +A+K +      +  EL N   V  +V      
Sbjct: 25  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 162 --QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQG 219
                 +++LL      D  +LI E  P    D F F  T+R  L           V + 
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEA 142
Query: 220 LLYLHQYSRVRIIHRDLKASNILLDKDMNS-KISDFGMARIVFGGNDEDELQGNTSRISG 278
           + + H      ++HRD+K  NIL+D +    K+ DFG   ++     +D +  +     G
Sbjct: 143 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALL-----KDTVYTD---FDG 191
Query: 279 TYGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISN 337
           T  Y  PE+     +  +S  V+S G+LL ++V G  +  F   + +             
Sbjct: 192 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDEEI------------- 236
Query: 338 KIIDLIDSVLEEASFNESLSRYV-HIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQ 396
                   +  +  F + +S    H+   C+  R  DRPT  ++ +    +   +L P++
Sbjct: 237 --------IRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ--DVLLPQE 286
Query: 397 PAFCNLRNMESSTS 410
            A  +L ++    S
Sbjct: 287 TAEIHLHSLSPGPS 300

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 73/314 (23%), Positives = 125/314 (39%), Gaps = 51/314 (16%)
Query: 110 NFSAANKLGEGGFGTVYKG--VIGQGEIAVKRLLGKSGQEIKELKNEASVIAQV------ 161
            +     LG GGFG+VY G  V     +A+K +      +  EL N   V  +V      
Sbjct: 24  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 83
Query: 162 --QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQG 219
                 +++LL      D  +LI E  P    D F F  T+R  L           V + 
Sbjct: 84  SSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEA 141
Query: 220 LLYLHQYSRVRIIHRDLKASNILLDKDMNS-KISDFGMARIVFGGNDEDELQGNTSRISG 278
           + + H      ++HRD+K  NIL+D +    K+ DFG   ++     +D +  +     G
Sbjct: 142 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALL-----KDTVYTD---FDG 190
Query: 279 TYGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISN 337
           T  Y  PE+     +  +S  V+S G+LL ++V G  +  F   + +             
Sbjct: 191 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDEEI------------- 235
Query: 338 KIIDLIDSVLEEASFNESLSRYV-HIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQ 396
                   +  +  F + +S    H+   C+  R  DRPT  ++ +    +   +L P++
Sbjct: 236 --------IRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ--DVLLPQE 285
Query: 397 PAFCNLRNMESSTS 410
            A  +L ++    S
Sbjct: 286 TAEIHLHSLSPGPS 299

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 74/314 (23%), Positives = 126/314 (40%), Gaps = 51/314 (16%)
Query: 110 NFSAANKLGEGGFGTVYKG--VIGQGEIAVKRLLGKSGQEIKELKNEASVIAQV------ 161
            +     LG GGFG+VY G  V     +A+K +      +  EL N   V  +V      
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 162 --QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQG 219
                 +++LL      D  +LI E  P    D F F  T+R  L           V + 
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEA 155
Query: 220 LLYLHQYSRVRIIHRDLKASNILLDKDMNS-KISDFGMARIVFGGNDEDELQGNTSRISG 278
           + + H      ++HRD+K  NIL+D +    K+ DFG   ++     +D +  +     G
Sbjct: 156 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALL-----KDTVYTD---FDG 204
Query: 279 TYGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISN 337
           T  Y  PE+     +  +S  V+S G+LL ++V G  +  F   + +          I  
Sbjct: 205 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDEEI----------IGG 252
Query: 338 KIIDLIDSVLEEASFNESLSRYV-HIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQ 396
           ++            F + +S    H+   C+  R  DRPT  ++ +    +   +L P++
Sbjct: 253 QVF-----------FRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQ--DVLLPQE 299
Query: 397 PAFCNLRNMESSTS 410
            A  +L ++    S
Sbjct: 300 TAEIHLHSLSPGPS 313

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 74/314 (23%), Positives = 126/314 (40%), Gaps = 51/314 (16%)
Query: 110 NFSAANKLGEGGFGTVYKG--VIGQGEIAVKRLLGKSGQEIKELKNEASVIAQV------ 161
            +     LG GGFG+VY G  V     +A+K +      +  EL N   V  +V      
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 162 --QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQG 219
                 +++LL      D  +LI E  P    D F F  T+R  L           V + 
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEA 154
Query: 220 LLYLHQYSRVRIIHRDLKASNILLDKDMNS-KISDFGMARIVFGGNDEDELQGNTSRISG 278
           + + H      ++HRD+K  NIL+D +    K+ DFG   ++     +D +  +     G
Sbjct: 155 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALL-----KDTVYTD---FDG 203
Query: 279 TYGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISN 337
           T  Y  PE+     +  +S  V+S G+LL ++V G  +  F   + +          I  
Sbjct: 204 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDEEI----------IGG 251
Query: 338 KIIDLIDSVLEEASFNESLSRYV-HIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQ 396
           ++            F + +S    H+   C+  R  DRPT  ++ +    +   +L P++
Sbjct: 252 QVF-----------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ--DVLLPQE 298
Query: 397 PAFCNLRNMESSTS 410
            A  +L ++    S
Sbjct: 299 TAEIHLHSLSPGPS 312

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 40/106 (37%), Positives = 59/106 (55%), Gaps = 8/106 (7%)
Query: 218 QGLLYLHQYSRVRIIHRDLKASNILLDKD-MNSKISDFGMARIV-FGGNDEDELQGNTSR 275
           +GL YLH  SR RI+H D+KA N+LL  D  ++ + DFG A  +   G  +  L G+   
Sbjct: 196 EGLEYLH--SR-RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDY-- 250
Query: 276 ISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG-KKNTGFYR 320
           I GT  +M+PE  L      K DV+S   ++L +++G    T F+R
Sbjct: 251 IPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFR 296

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 74/314 (23%), Positives = 126/314 (40%), Gaps = 51/314 (16%)
Query: 110 NFSAANKLGEGGFGTVYKG--VIGQGEIAVKRLLGKSGQEIKELKNEASVIAQV------ 161
            +     LG GGFG+VY G  V     +A+K +      +  EL N   V  +V      
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 162 --QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQG 219
                 +++LL      D  +LI E  P    D F F  T+R  L           V + 
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEA 127
Query: 220 LLYLHQYSRVRIIHRDLKASNILLDKDMNS-KISDFGMARIVFGGNDEDELQGNTSRISG 278
           + + H      ++HRD+K  NIL+D +    K+ DFG   ++     +D +  +     G
Sbjct: 128 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALL-----KDTVYTD---FDG 176
Query: 279 TYGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISN 337
           T  Y  PE+     +  +S  V+S G+LL ++V G  +  F   + +          I  
Sbjct: 177 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDEEI----------IRG 224
Query: 338 KIIDLIDSVLEEASFNESLSRYV-HIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQ 396
           ++            F + +S    H+   C+  R  DRPT  ++ +    +   +L P++
Sbjct: 225 QVF-----------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ--DVLLPQE 271
Query: 397 PAFCNLRNMESSTS 410
            A  +L ++    S
Sbjct: 272 TAEIHLHSLSPGPS 285

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 64/292 (21%), Positives = 132/292 (45%), Gaps = 45/292 (15%)
Query: 116 KLGEGGFGTVYKGVIGQGE----IAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLG 171
           K+G G +G VYK     G+     A+K++ G +G  +   + E +++ +++H N++ L  
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQIEG-TGISMSACR-EIALLRELKHPNVISLQK 85
Query: 172 CCIEKDER--LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLY-----LH 224
             +   +R   L+++Y  +       F    +     +  VQ+ +G+ + LLY     +H
Sbjct: 86  VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPVQLPRGMVKSLLYQILDGIH 142
Query: 225 QYSRVRIIHRDLKASNILL----DKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY 280
                 ++HRDLK +NIL+     +    KI+D G AR+    N   +   +   +  T+
Sbjct: 143 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF---NSPLKPLADLDPVVVTF 199
Query: 281 GYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGK----------KNTGFYRTKSL----N 325
            Y +PE  L      K+ D+++ G +  E+++ +          K +  Y    L    N
Sbjct: 200 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 259
Query: 326 LIGYAWDLWISNKIIDLIDSVLEEASFNESLSR--YVHIALLCVQERAEDRP 375
           ++G+      ++K  + I  + E ++  +   R  Y + +L+   E+ + +P
Sbjct: 260 VMGFP-----ADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKP 306

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 73/314 (23%), Positives = 125/314 (39%), Gaps = 51/314 (16%)
Query: 110 NFSAANKLGEGGFGTVYKG--VIGQGEIAVKRLLGKSGQEIKELKNEASVIAQV------ 161
            +     LG GGFG+VY G  V     +A+K +      +  EL N   V  +V      
Sbjct: 25  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 162 --QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQG 219
                 +++LL      D  +LI E  P    D F F  T+R  L           V + 
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEA 142
Query: 220 LLYLHQYSRVRIIHRDLKASNILLDKDMNS-KISDFGMARIVFGGNDEDELQGNTSRISG 278
           + + H      ++HRD+K  NIL+D +    K+ DFG   ++     +D +  +     G
Sbjct: 143 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALL-----KDTVYTD---FDG 191
Query: 279 TYGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISN 337
           T  Y  PE+     +  +S  V+S G+LL ++V G  +  F   + +             
Sbjct: 192 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDEEI------------- 236
Query: 338 KIIDLIDSVLEEASFNESLSRYV-HIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQ 396
                   +  +  F + +S    H+   C+  R  DRPT  ++ +    +   +L P++
Sbjct: 237 --------IRGQVFFRQRVSXECQHLIRWCLALRPXDRPTFEEIQNHPWMQ--DVLLPQE 286
Query: 397 PAFCNLRNMESSTS 410
            A  +L ++    S
Sbjct: 287 TAEIHLHSLSPGPS 300

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 74/314 (23%), Positives = 126/314 (40%), Gaps = 51/314 (16%)
Query: 110 NFSAANKLGEGGFGTVYKG--VIGQGEIAVKRLLGKSGQEIKELKNEASVIAQV------ 161
            +     LG GGFG+VY G  V     +A+K +      +  EL N   V  +V      
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 162 --QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQG 219
                 +++LL      D  +LI E  P    D F F  T+R  L           V + 
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEA 154
Query: 220 LLYLHQYSRVRIIHRDLKASNILLDKDMNS-KISDFGMARIVFGGNDEDELQGNTSRISG 278
           + + H      ++HRD+K  NIL+D +    K+ DFG   ++     +D +  +     G
Sbjct: 155 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALL-----KDTVYTD---FDG 203
Query: 279 TYGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISN 337
           T  Y  PE+     +  +S  V+S G+LL ++V G  +  F   + +          I  
Sbjct: 204 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDEEI----------IGG 251
Query: 338 KIIDLIDSVLEEASFNESLSRYV-HIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQ 396
           ++            F + +S    H+   C+  R  DRPT  ++ +    +   +L P++
Sbjct: 252 QVF-----------FRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQ--DVLLPQE 298
Query: 397 PAFCNLRNMESSTS 410
            A  +L ++    S
Sbjct: 299 TAEIHLHSLSPGPS 312

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 91/215 (42%), Gaps = 25/215 (11%)
Query: 110 NFSAANKLGEGGFGTVYKG--VIGQGEIAVKRLLGKSGQEIKELKNEASVIAQV------ 161
            +     LG GGFG+VY G  V     +A+K +      +  EL N   V  +V      
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 162 --QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQG 219
                 +++LL      D  +LI E  P    D F F  T+R  L           V + 
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEA 122
Query: 220 LLYLHQYSRVRIIHRDLKASNILLDKDMNS-KISDFGMARIVFGGNDEDELQGNTSRISG 278
           + + H      ++HRD+K  NIL+D +    K+ DFG   ++     +D +  +     G
Sbjct: 123 VRHCHNXG---VLHRDIKDENILIDLNRGELKLIDFGSGALL-----KDTVYTD---FDG 171
Query: 279 TYGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSG 312
           T  Y  PE+     +  +S  V+S G+LL ++V G
Sbjct: 172 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 74/314 (23%), Positives = 126/314 (40%), Gaps = 51/314 (16%)
Query: 110 NFSAANKLGEGGFGTVYKG--VIGQGEIAVKRLLGKSGQEIKELKNEASVIAQV------ 161
            +     LG GGFG+VY G  V     +A+K +      +  EL N   V  +V      
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 162 --QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQG 219
                 +++LL      D  +LI E  P    D F F  T+R  L           V + 
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEA 155
Query: 220 LLYLHQYSRVRIIHRDLKASNILLDKDMNS-KISDFGMARIVFGGNDEDELQGNTSRISG 278
           + + H      ++HRD+K  NIL+D +    K+ DFG   ++     +D +  +     G
Sbjct: 156 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALL-----KDTVYTD---FDG 204
Query: 279 TYGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISN 337
           T  Y  PE+     +  +S  V+S G+LL ++V G  +  F   + +          I  
Sbjct: 205 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDEEI----------IGG 252
Query: 338 KIIDLIDSVLEEASFNESLSRYV-HIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQ 396
           ++            F + +S    H+   C+  R  DRPT  ++ +    +   +L P++
Sbjct: 253 QVF-----------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ--DVLLPQE 299
Query: 397 PAFCNLRNMESSTS 410
            A  +L ++    S
Sbjct: 300 TAEIHLHSLSPGPS 313

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 74/314 (23%), Positives = 126/314 (40%), Gaps = 51/314 (16%)
Query: 110 NFSAANKLGEGGFGTVYKG--VIGQGEIAVKRLLGKSGQEIKELKNEASVIAQV------ 161
            +     LG GGFG+VY G  V     +A+K +      +  EL N   V  +V      
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 162 --QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQG 219
                 +++LL      D  +LI E  P    D F F  T+R  L           V + 
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEA 155
Query: 220 LLYLHQYSRVRIIHRDLKASNILLDKDMNS-KISDFGMARIVFGGNDEDELQGNTSRISG 278
           + + H      ++HRD+K  NIL+D +    K+ DFG   ++     +D +  +     G
Sbjct: 156 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALL-----KDTVYTD---FDG 204
Query: 279 TYGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISN 337
           T  Y  PE+     +  +S  V+S G+LL ++V G  +  F   + +          I  
Sbjct: 205 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDEEI----------IGG 252
Query: 338 KIIDLIDSVLEEASFNESLSRYV-HIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQ 396
           ++            F + +S    H+   C+  R  DRPT  ++ +    +   +L P++
Sbjct: 253 QVF-----------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ--DVLLPQE 299
Query: 397 PAFCNLRNMESSTS 410
            A  +L ++    S
Sbjct: 300 TAEIHLHSLSPGPS 313

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 75/313 (23%), Positives = 122/313 (38%), Gaps = 49/313 (15%)
Query: 110 NFSAANKLGEGGFGTVYKG--VIGQGEIAVKRLLGKSGQEIKELKNEASVIAQV------ 161
            +     LG GGFG+VY G  V     +A+K +      +  EL N   V  +V      
Sbjct: 52  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 111
Query: 162 --QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQG 219
                 +++LL      D  +LI E  P    D F F  T+R  L           V + 
Sbjct: 112 SSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEA 169
Query: 220 LLYLHQYSRVRIIHRDLKASNILLDKDMNS-KISDFGMARIVFGGNDEDELQGNTSRISG 278
           + + H      ++HRD+K  NIL+D +    K+ DFG   ++     +D +  +     G
Sbjct: 170 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALL-----KDTVYTD---FDG 218
Query: 279 TYGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISN 337
           T  Y  PE+     +  +S  V+S G+LL ++V G              I +  D  I  
Sbjct: 219 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD-------------IPFEHDEEIIR 265
Query: 338 KIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQP 397
             +     V  E           H+   C+  R  DRPT  ++ +    +   +L P++ 
Sbjct: 266 GQVFFRQRVSSECQ---------HLIRWCLALRPSDRPTFEEIQNHPWMQ--DVLLPQET 314
Query: 398 AFCNLRNMESSTS 410
           A  +L ++    S
Sbjct: 315 AEIHLHSLSPGPS 327

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 45/227 (19%)
Query: 109 GNFSAANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEI--------KELKNEASVIAQ 160
           G +   + LGEG +G V K V+   E   +R +    ++           +K E  ++ +
Sbjct: 5   GKYLMGDLLGEGSYGKV-KEVL-DSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRR 62
Query: 161 VQHKNLVKLLGCCI--EKDERLLIYEYMPNKSLDCFLFDPTKREILD--WRTRVQIIKG- 215
           ++HKN+++L+      EK +  ++ EY       C       +E+LD     R  + +  
Sbjct: 63  LRHKNVIQLVDVLYNEEKQKMYMVMEY-------CVC---GMQEMLDSVPEKRFPVCQAH 112
Query: 216 -----VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIV--FGGNDEDE 268
                +  GL YLH      I+H+D+K  N+LL      KIS  G+A  +  F  +D   
Sbjct: 113 GYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADD--- 166
Query: 269 LQGNTSRIS-GTYGYMSPEYA--LEGIFSIKSDVFSFGVLLLEIVSG 312
               T R S G+  +  PE A  L+     K D++S GV L  I +G
Sbjct: 167 ----TCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTG 209

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 73/314 (23%), Positives = 125/314 (39%), Gaps = 51/314 (16%)
Query: 110 NFSAANKLGEGGFGTVYKG--VIGQGEIAVKRLLGKSGQEIKELKNEASVIAQV------ 161
            +     LG GGFG+VY G  V     +A+K +      +  EL N   V  +V      
Sbjct: 32  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 91
Query: 162 --QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQG 219
                 +++LL      D  +LI E  P    D F F  T+R  L           V + 
Sbjct: 92  SSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEA 149
Query: 220 LLYLHQYSRVRIIHRDLKASNILLDKDMNS-KISDFGMARIVFGGNDEDELQGNTSRISG 278
           + + H      ++HRD+K  NIL+D +    K+ DFG   ++     +D +    +   G
Sbjct: 150 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALL-----KDTV---YTDFDG 198
Query: 279 TYGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISN 337
           T  Y  PE+     +  +S  V+S G+LL ++V G  +  F   + +             
Sbjct: 199 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDEEI------------- 243
Query: 338 KIIDLIDSVLEEASFNESLSRYV-HIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQ 396
                   +  +  F + +S    H+   C+  R  DRPT  ++ +    +   +L P++
Sbjct: 244 --------IRGQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQ--DVLLPQE 293
Query: 397 PAFCNLRNMESSTS 410
            A  +L ++    S
Sbjct: 294 TAEIHLHSLSPGPS 307

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 73/314 (23%), Positives = 125/314 (39%), Gaps = 51/314 (16%)
Query: 110 NFSAANKLGEGGFGTVYKG--VIGQGEIAVKRLLGKSGQEIKELKNEASVIAQV------ 161
            +     LG GGFG+VY G  V     +A+K +      +  EL N   V  +V      
Sbjct: 52  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 111
Query: 162 --QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQG 219
                 +++LL      D  +LI E  P    D F F  T+R  L           V + 
Sbjct: 112 SSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEA 169
Query: 220 LLYLHQYSRVRIIHRDLKASNILLDKDMNS-KISDFGMARIVFGGNDEDELQGNTSRISG 278
           + + H      ++HRD+K  NIL+D +    K+ DFG   ++     +D +  +     G
Sbjct: 170 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALL-----KDTVYTD---FDG 218
Query: 279 TYGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISN 337
           T  Y  PE+     +  +S  V+S G+LL ++V G  +  F   + +             
Sbjct: 219 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDEEI------------- 263
Query: 338 KIIDLIDSVLEEASFNESLSRYV-HIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQ 396
                   +  +  F + +S    H+   C+  R  DRPT  ++ +    +   +L P++
Sbjct: 264 --------IRGQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQ--DVLLPQE 313
Query: 397 PAFCNLRNMESSTS 410
            A  +L ++    S
Sbjct: 314 TAEIHLHSLSPGPS 327

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 89/207 (42%), Gaps = 29/207 (14%)
Query: 117 LGEGGFGTVYKGVIGQG------EIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLL 170
           LGEG F    K V  +       +I  KR+   + +EI  LK          H N+VKL 
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEG------HPNIVKLH 72
Query: 171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQ-IIKGVAQGLLYLHQYSRV 229
               ++    L+ E +    L    F+  K++     T    I++ +   + ++H    V
Sbjct: 73  EVFHDQLHTFLVMELLNGGEL----FERIKKKKHFSETEASYIMRKLVSAVSHMHD---V 125
Query: 230 RIIHRDLKASNILL---DKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPE 286
            ++HRDLK  N+L    + ++  KI DFG AR+    N              T  Y +PE
Sbjct: 126 GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP------LKTPCFTLHYAAPE 179
Query: 287 YALEGIFSIKSDVFSFGVLLLEIVSGK 313
              +  +    D++S GV+L  ++SG+
Sbjct: 180 LLNQNGYDESCDLWSLGVILYTMLSGQ 206

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 73/314 (23%), Positives = 125/314 (39%), Gaps = 51/314 (16%)
Query: 110 NFSAANKLGEGGFGTVYKG--VIGQGEIAVKRLLGKSGQEIKELKNEASVIAQV------ 161
            +     LG GGFG+VY G  V     +A+K +      +  EL N   V  +V      
Sbjct: 44  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 162 --QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQG 219
                 +++LL      D  +LI E  P    D F F  T+R  L           V + 
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEA 161
Query: 220 LLYLHQYSRVRIIHRDLKASNILLDKDMNS-KISDFGMARIVFGGNDEDELQGNTSRISG 278
           + + H      ++HRD+K  NIL+D +    K+ DFG   ++     +D +  +     G
Sbjct: 162 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALL-----KDTVYTD---FDG 210
Query: 279 TYGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISN 337
           T  Y  PE+     +  +S  V+S G+LL ++V G  +  F   + +             
Sbjct: 211 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDEEI------------- 255
Query: 338 KIIDLIDSVLEEASFNESLSRYV-HIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQ 396
                   +  +  F + +S    H+   C+  R  DRPT  ++ +    +   +L P++
Sbjct: 256 --------IRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ--DVLLPQE 305
Query: 397 PAFCNLRNMESSTS 410
            A  +L ++    S
Sbjct: 306 TAEIHLHSLSPGPS 319

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 73/314 (23%), Positives = 125/314 (39%), Gaps = 51/314 (16%)
Query: 110 NFSAANKLGEGGFGTVYKG--VIGQGEIAVKRLLGKSGQEIKELKNEASVIAQV------ 161
            +     LG GGFG+VY G  V     +A+K +      +  EL N   V  +V      
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 162 --QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQG 219
                 +++LL      D  +LI E  P    D F F  T+R  L           V + 
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEA 154
Query: 220 LLYLHQYSRVRIIHRDLKASNILLDKDMNS-KISDFGMARIVFGGNDEDELQGNTSRISG 278
           + + H      ++HRD+K  NIL+D +    K+ DFG   ++     +D +  +     G
Sbjct: 155 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALL-----KDTVYTD---FDG 203
Query: 279 TYGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISN 337
           T  Y  PE+     +  +S  V+S G+LL ++V G  +  F   + +             
Sbjct: 204 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDEEI------------- 248
Query: 338 KIIDLIDSVLEEASFNESLSRYV-HIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQ 396
                   +  +  F + +S    H+   C+  R  DRPT  ++ +    +   +L P++
Sbjct: 249 --------IRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ--DVLLPQE 298
Query: 397 PAFCNLRNMESSTS 410
            A  +L ++    S
Sbjct: 299 TAEIHLHSLSPGPS 312

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 54/98 (55%), Gaps = 6/98 (6%)
Query: 218 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRIS 277
           +GL Y+H     ++IHRDLK SN+L++++   KI DFGMAR +       E Q   +   
Sbjct: 170 RGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLC--TSPAEHQYFMTEYV 224
Query: 278 GTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKK 314
            T  Y +PE  L    ++   D++S G +  E+++ ++
Sbjct: 225 ATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 91/215 (42%), Gaps = 25/215 (11%)
Query: 110 NFSAANKLGEGGFGTVYKG--VIGQGEIAVKRLLGKSGQEIKELKNEASVIAQV------ 161
            +     LG GGFG+VY G  V     +A+K +      +  EL N   V  +V      
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 162 --QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQG 219
                 +++LL      D  +LI E  P    D F F  T+R  L           V + 
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEA 122
Query: 220 LLYLHQYSRVRIIHRDLKASNILLDKDMNS-KISDFGMARIVFGGNDEDELQGNTSRISG 278
           + + H      ++HRD+K  NIL+D +    K+ DFG   ++     +D +  +     G
Sbjct: 123 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALL-----KDTVYTD---FDG 171
Query: 279 TYGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSG 312
           T  Y  PE+     +  +S  V+S G+LL ++V G
Sbjct: 172 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 91/215 (42%), Gaps = 25/215 (11%)
Query: 110 NFSAANKLGEGGFGTVYKG--VIGQGEIAVKRLLGKSGQEIKELKNEASVIAQV------ 161
            +     LG GGFG+VY G  V     +A+K +      +  EL N   V  +V      
Sbjct: 8   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 67
Query: 162 --QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQG 219
                 +++LL      D  +LI E  P    D F F  T+R  L           V + 
Sbjct: 68  SSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEA 125
Query: 220 LLYLHQYSRVRIIHRDLKASNILLDKDMNS-KISDFGMARIVFGGNDEDELQGNTSRISG 278
           + + H      ++HRD+K  NIL+D +    K+ DFG   ++     +D +  +     G
Sbjct: 126 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALL-----KDTVYTD---FDG 174
Query: 279 TYGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSG 312
           T  Y  PE+     +  +S  V+S G+LL ++V G
Sbjct: 175 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 209

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 73/314 (23%), Positives = 125/314 (39%), Gaps = 51/314 (16%)
Query: 110 NFSAANKLGEGGFGTVYKG--VIGQGEIAVKRLLGKSGQEIKELKNEASVIAQV------ 161
            +     LG GGFG+VY G  V     +A+K +      +  EL N   V  +V      
Sbjct: 57  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 116
Query: 162 --QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQG 219
                 +++LL      D  +LI E  P    D F F  T+R  L           V + 
Sbjct: 117 SSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEA 174
Query: 220 LLYLHQYSRVRIIHRDLKASNILLDKDMNS-KISDFGMARIVFGGNDEDELQGNTSRISG 278
           + + H      ++HRD+K  NIL+D +    K+ DFG   ++     +D +  +     G
Sbjct: 175 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALL-----KDTVYTD---FDG 223
Query: 279 TYGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISN 337
           T  Y  PE+     +  +S  V+S G+LL ++V G  +  F   + +             
Sbjct: 224 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDEEI------------- 268
Query: 338 KIIDLIDSVLEEASFNESLSRYV-HIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQ 396
                   +  +  F + +S    H+   C+  R  DRPT  ++ +    +   +L P++
Sbjct: 269 --------IRGQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQ--DVLLPQE 318
Query: 397 PAFCNLRNMESSTS 410
            A  +L ++    S
Sbjct: 319 TAEIHLHSLSPGPS 332

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 53/237 (22%), Positives = 98/237 (41%), Gaps = 30/237 (12%)
Query: 102 SSVSSATGNFSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLG--KSGQEI---------K 149
           + + +    ++    +  G +G V  GV  +G  +A+KR+      G+ +         K
Sbjct: 15  AELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCK 74
Query: 150 ELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTR 209
            +  E  ++    H N++ L    +  +E  +   Y+  + +   L     + I D R  
Sbjct: 75  RVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDL----AQVIHDQRIV 130
Query: 210 V---QIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDE 266
           +    I   +   LL LH      ++HRDL   NILL  + +  I DF +AR       E
Sbjct: 131 ISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR-------E 183
Query: 267 DELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGK---KNTGFY 319
           D    N +       Y +PE  ++   F+   D++S G ++ E+ + K   + + FY
Sbjct: 184 DTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY 240

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 53/237 (22%), Positives = 98/237 (41%), Gaps = 30/237 (12%)
Query: 102 SSVSSATGNFSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLG--KSGQEI---------K 149
           + + +    ++    +  G +G V  GV  +G  +A+KR+      G+ +         K
Sbjct: 15  AELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCK 74
Query: 150 ELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTR 209
            +  E  ++    H N++ L    +  +E  +   Y+  + +   L     + I D R  
Sbjct: 75  RVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDL----AQVIHDQRIV 130
Query: 210 V---QIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDE 266
           +    I   +   LL LH      ++HRDL   NILL  + +  I DF +AR       E
Sbjct: 131 ISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR-------E 183
Query: 267 DELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGK---KNTGFY 319
           D    N +       Y +PE  ++   F+   D++S G ++ E+ + K   + + FY
Sbjct: 184 DTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY 240

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 91/215 (42%), Gaps = 25/215 (11%)
Query: 110 NFSAANKLGEGGFGTVYKG--VIGQGEIAVKRLLGKSGQEIKELKNEASVIAQV------ 161
            +     LG GGFG+VY G  V     +A+K +      +  EL N   V  +V      
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 162 --QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQG 219
                 +++LL      D  +LI E  P    D F F  T+R  L           V + 
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEA 122
Query: 220 LLYLHQYSRVRIIHRDLKASNILLDKDMNS-KISDFGMARIVFGGNDEDELQGNTSRISG 278
           + + H      ++HRD+K  NIL+D +    K+ DFG   ++     +D +  +     G
Sbjct: 123 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALL-----KDTVYTD---FDG 171
Query: 279 TYGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSG 312
           T  Y  PE+     +  +S  V+S G+LL ++V G
Sbjct: 172 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 54/98 (55%), Gaps = 6/98 (6%)
Query: 218 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRIS 277
           +GL Y+H     ++IHRDLK SN+L++++   KI DFGMAR +     E   Q   +   
Sbjct: 169 RGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEH--QYFMTEYV 223
Query: 278 GTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKK 314
            T  Y +PE  L    ++   D++S G +  E+++ ++
Sbjct: 224 ATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 95/216 (43%), Gaps = 31/216 (14%)
Query: 110 NFSAANKLGEGGFGTVYKGVIGQG--EIAVK-----RLLGKSGQEIKELKN---EASVIA 159
            +S  + LG G FG V+  V  +   E+ VK     ++L     E  +L     E ++++
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 160 QVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLF---DPTKREILDWRTRVQIIKGV 216
           +V+H N++K+L     +    L+ E      LD F F    P   E L      Q++  V
Sbjct: 85  RVEHANIIKVLDIFENQGFFQLVMEKH-GSGLDLFAFIDRHPRLDEPLASYIFRQLVSAV 143
Query: 217 AQGLLYLHQYSRVR-IIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR 275
                    Y R++ IIHRD+K  NI++ +D   K+ DFG A  +  G            
Sbjct: 144 G--------YLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK-------LFYT 188
Query: 276 ISGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIV 310
             GT  Y +PE  +   +   + +++S GV L  +V
Sbjct: 189 FCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLV 224

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 60/109 (55%), Gaps = 12/109 (11%)
Query: 216 VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR 275
           + + +L +    ++  +HRD+K  N+LLD + + +++DFG        ND+  +Q + + 
Sbjct: 181 IGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSC---LKMNDDGTVQSSVA- 236
Query: 276 ISGTYGYMSPE--YALE---GIFSIKSDVFSFGVLLLEIVSGKKNTGFY 319
             GT  Y+SPE   A+E   G +  + D +S GV + E++ G+  T FY
Sbjct: 237 -VGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE--TPFY 282

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 60/109 (55%), Gaps = 12/109 (11%)
Query: 216 VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR 275
           + + +L +    ++  +HRD+K  N+LLD + + +++DFG        ND+  +Q  +S 
Sbjct: 197 IGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSC---LKMNDDGTVQ--SSV 251
Query: 276 ISGTYGYMSPE--YALE---GIFSIKSDVFSFGVLLLEIVSGKKNTGFY 319
             GT  Y+SPE   A+E   G +  + D +S GV + E++ G+  T FY
Sbjct: 252 AVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE--TPFY 298

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 58/263 (22%), Positives = 115/263 (43%), Gaps = 45/263 (17%)
Query: 88  GCEKEVDQFPLFSFSSVSSATGNFSAANKLGEGGFGTVYKGV----IGQGE-IAVKRLLG 142
           G +K++++     + +V   +  F   +K+GEG F +VY       +G  E IA+K L+ 
Sbjct: 4   GVKKDIEKL----YEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIP 59
Query: 143 KSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKRE 202
            S   I+       +       N++ +  C  + D  ++   Y+ ++S    L   + +E
Sbjct: 60  TS-HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILNSLSFQE 118
Query: 203 ILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNS-KISDFGMA---- 257
           + ++      +  + + L  +HQ+    I+HRD+K SN L ++ +    + DFG+A    
Sbjct: 119 VREY------MLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH 169
Query: 258 -------RIVFGGNDEDELQGNTSRI-----------SGTYGYMSPEYALEGIFSIKS-D 298
                  + V     ++    N   I           +GT G+ +PE   +      + D
Sbjct: 170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAID 229
Query: 299 VFSFGVLLLEIVSGKKNTGFYRT 321
           ++S GV+ L ++SG+    FY+ 
Sbjct: 230 MWSAGVIFLSLLSGR--YPFYKA 250

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 62/163 (38%), Gaps = 47/163 (28%)
Query: 109 GNFSAANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
           G +    KLG G F TV+     QG+  V   + KS Q   E   +            +K
Sbjct: 31  GRYHVIRKLGWGHFSTVWLCWDMQGKRFVAMKVVKSAQHYTETALDE-----------IK 79
Query: 169 LLGCCIEKDERLLIYEYMPNKSLD-----------------CFLFDPTKREILDW----- 206
           LL C  E D         PNK +                  C +F+     +L W     
Sbjct: 80  LLKCVRESDPS------DPNKDMVVQLIDDFKISGMNGIHVCMVFEVLGHHLLKWIIKSN 133
Query: 207 ------RTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILL 243
                 R    II+ V QGL YLH  S+ +IIH D+K  NIL+
Sbjct: 134 YQGLPVRCVKSIIRQVLQGLDYLH--SKCKIIHTDIKPENILM 174

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 81/163 (49%), Gaps = 12/163 (7%)
Query: 110 NFSAANKLGEGGFGTVYKGVIGQGE--IAVKRL--LGKSGQEIKELKNEASVIAQVQHKN 165
           N+   + +G G +G VY          +A+K++  + +   + K +  E +++ +++   
Sbjct: 29  NYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDY 88
Query: 166 LVKLLGCCIEKDERLLIYE--YMPNKSLDCFLFDPTKREILDWRTRVQ-IIKGVAQGLLY 222
           +++L    I +D  LL ++  Y+  +  D  L    K  I      V+ I+  +  G  +
Sbjct: 89  IIRLHDLIIPED--LLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVKTILYNLLLGEKF 146
Query: 223 LHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGND 265
           +H+     IIHRDLK +N LL++D + KI DFG+AR +    D
Sbjct: 147 IHESG---IIHRDLKPANCLLNQDCSVKICDFGLARTINSDKD 186

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 106/235 (45%), Gaps = 40/235 (17%)
Query: 101 FSSVSSATGNFSAANKLGEGGFGTVYKGVIGQGEI-AVK--RLLGKSGQEIKELKNEASV 157
           F S+S     +S   ++G GG   V++ +  + +I A+K   L     Q +   +NE + 
Sbjct: 20  FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 79
Query: 158 IAQVQHKN--LVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKG 215
           + ++Q  +  +++L    I       IY  M   ++D   +   K+ I  W  R    K 
Sbjct: 80  LNKLQQHSDKIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWE-RKSYWKN 135
Query: 216 VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR 275
           + + +  +HQ+    I+H DLK +N L+   M  K+ DFG+A         +++Q +T+ 
Sbjct: 136 MLEAVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIA---------NQMQPDTTS 182
Query: 276 I-----SGTYGYMSPEYALEGIFSIKS------------DVFSFGVLLLEIVSGK 313
           +      GT  YM PE A++ + S +             DV+S G +L  +  GK
Sbjct: 183 VVKDSQVGTVNYMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/230 (24%), Positives = 107/230 (46%), Gaps = 31/230 (13%)
Query: 107 ATGNFSAANKLGEGGFGTVYKGVIGQGE--IAVKRL--LGKSGQEIKELKNEASVIAQVQ 162
              N+   + +G G +G VY       E  +A+K++  + +   + K +  E +++ +++
Sbjct: 24  VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLK 83
Query: 163 HKNLVKLLGCCIEKDERLLIYE--YMPNKSLDCFLFDPTKREILDWRTRVQ-IIKGVAQG 219
              +++L    I  D  LL ++  Y+  +  D  L    K  I      ++ I+  +  G
Sbjct: 84  SDYIIRLYDLIIPDD--LLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLG 141
Query: 220 LLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGND--------EDELQG 271
             ++H+     IIHRDLK +N LL++D + K+ DFG+AR +    D        E+E  G
Sbjct: 142 ENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPG 198
Query: 272 N---------TSRISGTYGYMSPEYA-LEGIFSIKSDVFSFGVLLLEIVS 311
                     TS +  T  Y +PE   L+  ++   D++S G +  E+++
Sbjct: 199 PHNKNLKKQLTSHVV-TRWYRAPELILLQENYTKSIDIWSTGCIFAELLN 247

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 99/221 (44%), Gaps = 34/221 (15%)
Query: 111 FSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
           F      G+G FGTV  G        +A+K+++       +EL+     +A + H N+V+
Sbjct: 25  FQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQD-LAVLHHPNIVQ 83
Query: 169 L------LGCCIEKDERLL----IYEYMPNKSLDC----FLFDPTKREILDWRTRVQIIK 214
           L      LG   E+D R +    + EY+P+    C    +        IL      Q+I+
Sbjct: 84  LQSYFYTLG---ERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIR 140
Query: 215 GVAQGLLYLHQYSRVRIIHRDLKASNILLDK-DMNSKISDFGMARIVFGGNDEDELQGNT 273
            +  G L+L     V + HRD+K  N+L+++ D   K+ DFG A+ +         + N 
Sbjct: 141 SI--GCLHL---PSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPS------EPNV 189
Query: 274 SRISGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGK 313
           + I   Y Y +PE       ++   D++S G +  E++ G+
Sbjct: 190 AYICSRY-YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 53/97 (54%), Gaps = 7/97 (7%)
Query: 218 QGLLYLHQYSRVRIIHRDLKASNILLDKDMN-SKISDFGMARIV-FGGNDEDELQGNTSR 275
           +GL YLH     RI+H D+KA N+LL  D + + + DFG A  +   G  +  L G+   
Sbjct: 177 EGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY-- 231
Query: 276 ISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           I GT  +M+PE  +      K D++S   ++L +++G
Sbjct: 232 IPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 268

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 53/97 (54%), Gaps = 7/97 (7%)
Query: 218 QGLLYLHQYSRVRIIHRDLKASNILLDKDMN-SKISDFGMARIV-FGGNDEDELQGNTSR 275
           +GL YLH     RI+H D+KA N+LL  D + + + DFG A  +   G  +  L G+   
Sbjct: 161 EGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY-- 215
Query: 276 ISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           I GT  +M+PE  +      K D++S   ++L +++G
Sbjct: 216 IPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/263 (22%), Positives = 111/263 (42%), Gaps = 55/263 (20%)
Query: 99  FSFSSVSSATGNFSAANKLGEGGFGTVYKGVIGQGE-IAVKRLLGKS------GQEIKEL 151
           F   S+      +     +G+G +G V   +  Q   I   +++ K+       ++++ +
Sbjct: 16  FQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERI 75
Query: 152 KNEASVIAQVQHKNLVKLLGCCIEKDERLLIYE-----YMPNKSLDCFLFDPTK------ 200
           K E  ++ ++ H N+ +L     ++    L+ E     ++ +K L+ F+ D T       
Sbjct: 76  KTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDK-LNVFIDDSTGKCAMDV 134
Query: 201 -----------------------REILDWRTRVQIIKGVAQ----GLLYLHQYSRVRIIH 233
                                  RE LD+  R ++I  + +     L YLH      I H
Sbjct: 135 VKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICH 191
Query: 234 RDLKASNILL--DKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEY--AL 289
           RD+K  N L   +K    K+ DFG+++  +  N+  E  G T++ +GT  +++PE     
Sbjct: 192 RDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNN-GEYYGMTTK-AGTPYFVAPEVLNTT 249
Query: 290 EGIFSIKSDVFSFGVLLLEIVSG 312
              +  K D +S GVLL  ++ G
Sbjct: 250 NESYGPKCDAWSAGVLLHLLLMG 272

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 53/97 (54%), Gaps = 7/97 (7%)
Query: 218 QGLLYLHQYSRVRIIHRDLKASNILLDKDMN-SKISDFGMARIV-FGGNDEDELQGNTSR 275
           +GL YLH     RI+H D+KA N+LL  D + + + DFG A  +   G  +  L G+   
Sbjct: 175 EGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY-- 229
Query: 276 ISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           I GT  +M+PE  +      K D++S   ++L +++G
Sbjct: 230 IPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 266

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 61/110 (55%), Gaps = 14/110 (12%)
Query: 216 VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMA-RIVFGGNDEDELQGNTS 274
           +A+ ++ +    ++  +HRD+K  NIL+D + + +++DFG   +++  G  +      +S
Sbjct: 181 LAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ------SS 234
Query: 275 RISGTYGYMSPE--YALE---GIFSIKSDVFSFGVLLLEIVSGKKNTGFY 319
              GT  Y+SPE   A+E   G +  + D +S GV + E++ G+  T FY
Sbjct: 235 VAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE--TPFY 282

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 102/225 (45%), Gaps = 40/225 (17%)
Query: 111 FSAANKLGEGGFGTVYKGVIGQGEI-AVK--RLLGKSGQEIKELKNEASVIAQVQHKN-- 165
           +S   ++G GG   V++ +  + +I A+K   L     Q +   +NE + + ++Q  +  
Sbjct: 14  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 73
Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ 225
           +++L    I       IY  M   ++D   +   K+ I  W  R    K + + +  +HQ
Sbjct: 74  IIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWE-RKSYWKNMLEAVHTIHQ 129
Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRI-----SGTY 280
           +    I+H DLK +N L+   M  K+ DFG+A         +++Q +T+ +      GT 
Sbjct: 130 HG---IVHSDLKPANFLIVDGM-LKLIDFGIA---------NQMQPDTTSVVKDSQVGTV 176
Query: 281 GYMSPEYALEGIFSIKS------------DVFSFGVLLLEIVSGK 313
            YM PE A++ + S +             DV+S G +L  +  GK
Sbjct: 177 NYMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 220

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 60/257 (23%), Positives = 106/257 (41%), Gaps = 59/257 (22%)
Query: 94  DQFPLFSFSSVSSATGNFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKSGQEIKEL 151
           D+   FS+         F    K+G+G FG V   + +  +   AVK ++    +  +  
Sbjct: 20  DEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVK-VVRNIKKYTRSA 78
Query: 152 KNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTR-- 209
           K EA ++ ++Q+ ++       ++   + + Y++M      C +F+P    + +  TR  
Sbjct: 79  KIEADILKKIQNDDINNNNI--VKYHGKFMYYDHM------CLIFEPLGPSLYEIITRNN 130
Query: 210 -----VQIIK----GVAQGLLYLHQYSRVRIIHRDLKASNILLD---------------- 244
                ++ IK     + + L YL + S   + H DLK  NILLD                
Sbjct: 131 YNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTD 187
Query: 245 ---------KDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSI 295
                    K    K+ DFG A        + +  G+   I  T  Y +PE  L   + +
Sbjct: 188 GKKIQIYRTKSTGIKLIDFGCATF------KSDYHGS---IINTRQYRAPEVILNLGWDV 238
Query: 296 KSDVFSFGVLLLEIVSG 312
            SD++SFG +L E+ +G
Sbjct: 239 SSDMWSFGCVLAELYTG 255

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 102/225 (45%), Gaps = 40/225 (17%)
Query: 111 FSAANKLGEGGFGTVYKGVIGQGEI-AVK--RLLGKSGQEIKELKNEASVIAQVQHKN-- 165
           +S   ++G GG   V++ +  + +I A+K   L     Q +   +NE + + ++Q  +  
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117
Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ 225
           +++L    I       IY  M   ++D   +   K+ I  W  R    K + + +  +HQ
Sbjct: 118 IIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWE-RKSYWKNMLEAVHTIHQ 173
Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRI-----SGTY 280
           +    I+H DLK +N L+   M  K+ DFG+A         +++Q +T+ +      GT 
Sbjct: 174 HG---IVHSDLKPANFLIVDGM-LKLIDFGIA---------NQMQPDTTSVVKDSQVGTV 220
Query: 281 GYMSPEYALEGIFSIKS------------DVFSFGVLLLEIVSGK 313
            YM PE A++ + S +             DV+S G +L  +  GK
Sbjct: 221 NYMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	432
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-141
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-136
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-120
3soc_A	322	Activin receptor type-2A; structural genomics cons	4e-90
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-80
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-65
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-63
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	4e-63
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-62
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-60
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	4e-60
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-58
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	4e-58
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	4e-58
3q4u_A	301	Activin receptor type-1; structural genomics conso	6e-56
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-55
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-55
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	5e-54
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-52
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-52
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-52
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-51
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-51
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-51
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	6e-51
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-50
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-50
4aoj_A	329	High affinity nerve growth factor receptor; transf	4e-50
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	6e-50
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-49
3pls_A	298	Macrophage-stimulating protein receptor; protein k	4e-49
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	5e-49
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	8e-49
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	9e-49
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-48
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-48
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-48
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-48
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-48
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-48
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	4e-48
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	4e-48
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	6e-48
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	6e-48
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	6e-48
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	8e-48
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	9e-48
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-47
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-47
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-47
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-47
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-47
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-47
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	4e-47
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	5e-47
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	6e-47
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-46
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-46
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-46
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-46
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-46
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-46
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-45
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-45
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-45
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-45
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	4e-45
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	9e-45
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-44
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	5e-44
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-37
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-37
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-37
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	5e-36
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	8e-36
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-34
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-34
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-34
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-34
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	3e-34
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	5e-34
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	9e-34
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-33
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	4e-33
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-32
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	5e-32
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-31
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-31
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-31
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-31
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	4e-31
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	6e-31
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	8e-31
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-30
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-30
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-30
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-30
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	5e-30
2dyl_A	318	Dual specificity mitogen-activated protein kinase	7e-30
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-29
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-29
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-29
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	4e-29
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	8e-29
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-28
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-28
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-28
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-28
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-28
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	7e-28
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	8e-28
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-27
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-27
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	4e-27
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	5e-27
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	6e-27
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	8e-27
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	8e-27
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-26
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	5e-26
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-25
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-25
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-25
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-25
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	4e-25
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	5e-25
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	5e-25
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	6e-25
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-24
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-24
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-24
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-24
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-24
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	5e-24
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	5e-24
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	5e-24
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	6e-24
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-23
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-23
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-23
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-23
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-23
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-23
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-23
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-23
3o0g_A	292	Cell division protein kinase 5; kinase activator c	5e-23
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	7e-23
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	8e-23
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-22
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-22
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-22
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-22
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-22
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-22
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-22
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-22
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	5e-22
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	6e-22
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	8e-22
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	8e-22
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-21
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-21
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-21
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-21
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-21
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-21
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-21
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	7e-13
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	5e-21
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	6e-21
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	7e-21
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-20
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-20
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-20
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-20
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-20
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-20
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	5e-20
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-19
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-19
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	7e-19
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-18
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-18
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	6e-18
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-17
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-17
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	4e-17
3uqc_A	286	Probable conserved transmembrane protein; structur	5e-17
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-16
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-15
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-15
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	5e-15
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	6e-15
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	7e-15
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-14
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-14
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-14
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-14
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-14
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-14
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	7e-14
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	8e-14
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-13
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-13
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-13
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-13
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-13
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	4e-13
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	5e-13
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	7e-13
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	9e-13
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	9e-13
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-12
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-12
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-12
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-12
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-12
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-12
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	4e-12
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	6e-12
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-08
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	7e-12
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	5e-11
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	5e-11
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	5e-11
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	6e-11
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	3e-10
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	4e-10
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	5e-10
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-09
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	6e-09
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-08
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-08
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-08
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-07
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-06
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-05
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-04
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	2e-04

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  405 bits (1043), Expect = e-141
 Identities = 111/307 (36%), Positives = 163/307 (53%), Gaps = 21/307 (6%)

Query: 95  QFPLFSFSSVSSATGNFS------AANKLGEGGFGTVYKGVIGQGEIAVKRL----LGKS 144
           +F  FSF  + + T NF         NK+GEGGFG VYKG +    +AVK+L       +
Sbjct: 11  RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITT 70

Query: 145 GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREIL 204
            +  ++   E  V+A+ QH+NLV+LLG   + D+  L+Y YMPN SL   L        L
Sbjct: 71  EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPL 130

Query: 205 DWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGN 264
            W  R +I +G A G+ +LH+      IHRD+K++NILLD+   +KISDFG+AR     +
Sbjct: 131 SWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARA----S 183

Query: 265 DEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSL 324
           ++      TSRI GT  YM+PE  L G  + KSD++SFGV+LLEI++G      +R    
Sbjct: 184 EKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQ- 241

Query: 325 NLIGYAWDLWISNK-IIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM 383
            L+    ++    K I D ID  + +A     +     +A  C+ E+   RP +  V  +
Sbjct: 242 LLLDIKEEIEDEEKTIEDYIDKKMNDADSTS-VEAMYSVASQCLHEKKNKRPDIKKVQQL 300

Query: 384 LTNEASS 390
           L    +S
Sbjct: 301 LQEMTAS 307

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  393 bits (1011), Expect = e-136
 Identities = 110/297 (37%), Positives = 172/297 (57%), Gaps = 11/297 (3%)

Query: 99  FSFSSVSSATGNFSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKSGQEIK-ELKNEAS 156
           FS   +  A+ NFS  N LG GGFG VYKG +  G  +AVKRL  +  Q  + + + E  
Sbjct: 20  FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79

Query: 157 VIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTK-REILDWRTRVQIIKG 215
           +I+   H+NL++L G C+   ERLL+Y YM N S+   L +  + +  LDW  R +I  G
Sbjct: 80  MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139

Query: 216 VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR 275
            A+GL YLH +   +IIHRD+KA+NILLD++  + + DFG+A+++     + +    T+ 
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM-----DYKDTHVTTA 194

Query: 276 ISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRT---KSLNLIGYAWD 332
           + GT G+++PEY   G  S K+DVF +GV+LLE+++G++     R      + L+ +   
Sbjct: 195 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254

Query: 333 LWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS 389
           L    K+  L+D  L+    +E + + + +ALLC Q    +RP MS+VV ML  +  
Sbjct: 255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  351 bits (902), Expect = e-120
 Identities = 103/289 (35%), Positives = 166/289 (57%), Gaps = 10/289 (3%)

Query: 99  FSFSSVSSATGNFSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKSGQEIKELKNEASV 157
                +  AT NF     +G G FG VYKGV+  G ++A+KR   +S Q I+E + E   
Sbjct: 29  VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88

Query: 158 IAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTK-REILDWRTRVQIIKGV 216
           ++  +H +LV L+G C E++E +LIY+YM N +L   L+        + W  R++I  G 
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148

Query: 217 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRI 276
           A+GL YLH  +   IIHRD+K+ NILLD++   KI+DFG+++    G + D+   +T  +
Sbjct: 149 ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKK---GTELDQTHLST-VV 201

Query: 277 SGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKS-LNLIGYAWDLWI 335
            GT GY+ PEY ++G  + KSDV+SFGV+L E++  +        +  +NL  +A +   
Sbjct: 202 KGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN 261

Query: 336 SNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML 384
           + ++  ++D  L +    ESL ++   A+ C+   +EDRP+M DV+  L
Sbjct: 262 NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  275 bits (704), Expect = 4e-90
 Identities = 65/315 (20%), Positives = 127/315 (40%), Gaps = 40/315 (12%)

Query: 99  FSFSSVSSATGNFSAANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASV- 157
               ++   +           G FG V+K  +    +AVK       Q+ +  +NE  V 
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIF---PIQDKQSWQNEYEVY 70

Query: 158 -IAQVQHKNLVKLLGCCIEKD----ERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQI 212
            +  ++H+N+++ +G          +  LI  +    SL  FL    K  ++ W     I
Sbjct: 71  SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHI 126

Query: 213 IKGVAQGLLYLHQ-------YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGND 265
            + +A+GL YLH+         +  I HRD+K+ N+LL  ++ + I+DFG+A       +
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKF----E 182

Query: 266 EDELQGNTSRISGTYGYMSPEYALEGI-----FSIKSDVFSFGVLLLEIVSGKKNTGFYR 320
             +  G+T    GT  YM+PE     I       ++ D+++ G++L E+ S         
Sbjct: 183 AGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242

Query: 321 TKSLNLIGYAWDLWISNKIIDLIDSVLEEA---------SFNESLSRYVHIALLCVQERA 371
            +   ++ +  ++     + D+ + V+ +            +  ++        C    A
Sbjct: 243 DE--YMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDA 300

Query: 372 EDRPTMSDVVSMLTN 386
           E R +   V   +T 
Sbjct: 301 EARLSAGCVGERITQ 315

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  250 bits (640), Expect = 2e-80
 Identities = 73/333 (21%), Positives = 125/333 (37%), Gaps = 41/333 (12%)

Query: 99  FSFSSVSSATGNFSAANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASV- 157
            + S  S    N      +G G +G VYKG + +  +AVK     S    +   NE ++ 
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVF---SFANRQNFINEKNIY 59

Query: 158 -IAQVQHKNLVKLLGCCIE-----KDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQ 211
            +  ++H N+ + +          + E LL+ EY PN SL  +L         DW +  +
Sbjct: 60  RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVSSCR 115

Query: 212 IIKGVAQGLLYLHQ------YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGN- 264
           +   V +GL YLH       + +  I HRDL + N+L+  D    ISDFG++  + G   
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175

Query: 265 -DEDELQGNTSRISGTYGYMSPEYALEGIFSI--------KSDVFSFGVLLLEIVSGKKN 315
               E         GT  YM+PE  LEG  ++        + D+++ G++  EI     +
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEV-LEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234

Query: 316 TGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEE----------ASFNESLSRYVHIALL 365
                +     + +  ++       D+   V  E             + ++         
Sbjct: 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIED 294

Query: 366 CVQERAEDRPTMSDVVSMLTNEASSLLPPKQPA 398
           C  + AE R T       +          K  +
Sbjct: 295 CWDQDAEARLTAQXAEERMAELMMIWERNKSVS 327

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  211 bits (538), Expect = 2e-65
 Identities = 74/284 (26%), Positives = 135/284 (47%), Gaps = 23/284 (8%)

Query: 115 NKLGEGGFGTVYKGVIGQGEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGC 172
            K+G G FGTV++      ++AVK L+ +    + + E   E +++ +++H N+V  +G 
Sbjct: 43  EKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102

Query: 173 CIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRII 232
             +     ++ EY+   SL   L     RE LD R R+ +   VA+G+ YLH      I+
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIV 161

Query: 233 HRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGI 292
           HR+LK+ N+L+DK    K+ DFG++R+    +     +       GT  +M+PE   +  
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRLK--ASTFLSSKSAA----GTPEWMAPEVLRDEP 215

Query: 293 FSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASF 352
            + KSDV+SFGV+L E+ + ++    +   +LN       +    K +++  ++  +   
Sbjct: 216 SNEKSDVYSFGVILWELATLQQ---PW--GNLNPAQVVAAVGFKCKRLEIPRNLNPQ--- 267

Query: 353 NESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQ 396
                    I   C       RP+ + ++ +L     S +PP  
Sbjct: 268 ------VAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPN 305

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  206 bits (526), Expect = 1e-63
 Identities = 75/310 (24%), Positives = 127/310 (40%), Gaps = 31/310 (10%)

Query: 115 NKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCI 174
             +G G FG V K      ++A+K++  +S  E K    E   +++V H N+VKL G C+
Sbjct: 14  EVVGRGAFGVVCKAKWRAKDVAIKQI--ESESERKAFIVELRQLSRVNHPNIVKLYGACL 71

Query: 175 EKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHR 234
                 L+ EY    SL   L              +      +QG+ YLH      +IHR
Sbjct: 72  NP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHR 129

Query: 235 DLKASNILLDKDMNS-KISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIF 293
           DLK  N+LL       KI DFG A          ++Q + +   G+  +M+PE      +
Sbjct: 130 DLKPPNLLLVAGGTVLKICDFGTAC---------DIQTHMTNNKGSAAWMAPEVFEGSNY 180

Query: 294 SIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFN 353
           S K DVFS+G++L E+++ +K    +           W +  +     LI ++ +     
Sbjct: 181 SEKCDVFSWGIILWEVITRRK---PFDEIGGPAFRIMWAV-HNGTRPPLIKNLPKP---- 232

Query: 354 ESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN----EASSLLPPKQPAFCNLRNMESST 409
                   +   C  +    RP+M ++V ++T+       +  P + P   +L   E   
Sbjct: 233 -----IESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGEDGR 287

Query: 410 STTEKSWADC 419
                 +A+ 
Sbjct: 288 VEPYVDFAEF 297

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  205 bits (523), Expect = 4e-63
 Identities = 67/296 (22%), Positives = 114/296 (38%), Gaps = 32/296 (10%)

Query: 115 NKLGEGGFGTVYKGV-IGQGE-IAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGC 172
             LG+G FG   K      GE + +K L+    +  +    E  V+  ++H N++K +G 
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75

Query: 173 CIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRII 232
             +      I EY+   +L   +     +    W  RV   K +A G+ YLH  +   II
Sbjct: 76  LYKDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDIASGMAYLHSMN---II 130

Query: 233 HRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR--------ISGTYGYMS 284
           HRDL + N L+ ++ N  ++DFG+AR++     + E   +  +        + G   +M+
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190

Query: 285 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNK--IIDL 342
           PE      +  K DVFSFG++L EI+                   A   ++         
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVN---------------ADPDYLPRTMDFGLN 235

Query: 343 IDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQPA 398
           +   L+          +  I + C     E RP+   +   L      L       
Sbjct: 236 VRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLG 291

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  197 bits (502), Expect = 2e-60
 Identities = 73/284 (25%), Positives = 133/284 (46%), Gaps = 38/284 (13%)

Query: 115 NKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQE----IKELKNEASVIAQVQHKNLVKLL 170
             +G GGFG VY+      E+AVK       ++    I+ ++ EA + A ++H N++ L 
Sbjct: 13  EIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72

Query: 171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVR 230
           G C+++    L+ E+     L+  L      + +     V     +A+G+ YLH  + V 
Sbjct: 73  GVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEAIVP 128

Query: 231 IIHRDLKASNILLDKDMNS--------KISDFGMARIVFGGNDEDELQGNTSRISGTYGY 282
           IIHRDLK+SNIL+ + + +        KI+DFG+AR                   G Y +
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW----HRTTKMSAA----GAYAW 180

Query: 283 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDL 342
           M+PE     +FS  SDV+S+GVLL E+++G+     +  + ++ +  A+ + ++   + +
Sbjct: 181 MAPEVIRASMFSKGSDVWSYGVLLWELLTGEV---PF--RGIDGLAVAYGVAMNKLALPI 235

Query: 343 IDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN 386
             +  E          +  +   C       RP+ ++++  LT 
Sbjct: 236 PSTCPEP---------FAKLMEDCWNPDPHSRPSFTNILDQLTT 270

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  196 bits (501), Expect = 4e-60
 Identities = 69/282 (24%), Positives = 141/282 (50%), Gaps = 40/282 (14%)

Query: 115 NKLGEGGFGTVYKGVIGQGEIAVKRLL--GKSGQEIKELKNEASVIAQVQHKNLVKLLGC 172
            ++G G FGTVYKG    G++AVK L     + Q+++  KNE  V+ + +H N++  +G 
Sbjct: 30  QRIGSGSFGTVYKGKW-HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88

Query: 173 CIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRII 232
                +  ++ ++    SL   L     +   + +  + I +  A+G+ YLH      II
Sbjct: 89  ST-APQLAIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHA---KSII 142

Query: 233 HRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPE---YAL 289
           HRDLK++NI L +D   KI DFG+A      +   + +  +    G+  +M+PE      
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLS----GSILWMAPEVIRMQD 198

Query: 290 EGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLI------ 343
              +S +SDV++FG++L E+++G+             + Y+ ++   ++II+++      
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQ-------------LPYS-NINNRDQIIEMVGRGSLS 244

Query: 344 -DSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML 384
            D     ++  + + R   +   C++++ ++RP+   +++ +
Sbjct: 245 PDLSKVRSNCPKRMKR---LMAECLKKKRDERPSFPRILAEI 283

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  192 bits (490), Expect = 2e-58
 Identities = 64/288 (22%), Positives = 128/288 (44%), Gaps = 42/288 (14%)

Query: 115 NKLGEGGFGTVYKGV-IGQG-EIAVKRLLGKSGQE-------IKELKNEASVIAQVQHKN 165
            ++G+GGFG V+KG  +     +A+K L+    +         +E + E  +++ + H N
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84

Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ 225
           +VKL G         ++ E++P   L   L D  K   + W  +++++  +A G+ Y+  
Sbjct: 85  IVKLYGLMHNPP--RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQN 140

Query: 226 YSRVRIIHRDLKASNILLDK-----DMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY 280
                I+HRDL++ NI L        + +K++DFG+++         +   + S + G +
Sbjct: 141 -QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ---------QSVHSVSGLLGNF 190

Query: 281 GYMSPE--YALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNK 338
            +M+PE   A E  ++ K+D +SF ++L  I++G+     +   S   I +   +     
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG---PFDEYSYGKIKFINMIREEGL 247

Query: 339 IIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN 386
              + +                ++  LC     + RP  S +V  L+ 
Sbjct: 248 RPTIPEDCPPR---------LRNVIELCWSGDPKKRPHFSYIVKELSE 286

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  192 bits (489), Expect = 4e-58
 Identities = 66/294 (22%), Positives = 120/294 (40%), Gaps = 33/294 (11%)

Query: 115 NKLGEGGFGTVYKGVIGQGEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGC 172
             +G+G FG VY G    GE+A++ +  +  +  ++K  K E     Q +H+N+V  +G 
Sbjct: 39  ELIGKGRFGQVYHG-RWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97

Query: 173 CIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRII 232
           C+      +I      ++L   + D   + +LD     QI + + +G+ YLH      I+
Sbjct: 98  CMSPPHLAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHA---KGIL 152

Query: 233 HRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPE------ 286
           H+DLK+ N+  D +    I+DFG+  I               +  G   +++PE      
Sbjct: 153 HKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQN-GWLCHLAPEIIRQLS 210

Query: 287 ---YALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLI 343
                 +  FS  SDVF+ G +  E+ + +     ++T+    I +      +    +L 
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWP---FKTQPAEAIIWQMG---TGMKPNLS 264

Query: 344 DSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQP 397
              + +            I L C     E+RPT + ++ ML            P
Sbjct: 265 QIGMGKE--------ISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHP 310

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  190 bits (486), Expect = 4e-58
 Identities = 59/283 (20%), Positives = 114/283 (40%), Gaps = 46/283 (16%)

Query: 115 NKLGEGGFGTVYKGVIGQGEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGC 172
            KL E   G ++KG     +I VK L  +  S ++ ++   E   +    H N++ +LG 
Sbjct: 16  TKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75

Query: 173 CIEKDERLL--IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVR 230
           C          I  +MP  SL   L + T    +D    V+    +A+G+ +LH    + 
Sbjct: 76  CQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV-VDQSQAVKFALDMARGMAFLHTLEPL- 133

Query: 231 IIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE 290
           I    L + ++++D+DM ++IS   +               +  R+     +++PE AL+
Sbjct: 134 IPRHALNSRSVMIDEDMTARISMADVKFS----------FQSPGRM-YAPAWVAPE-ALQ 181

Query: 291 G----IFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNK-----IID 341
                     +D++SF VLL E+V+ +     +     +L      + ++ +     I  
Sbjct: 182 KKPEDTNRRSADMWSFAVLLWELVTREV---PFA----DLSNMEIGMKVALEGLRPTIPP 234

Query: 342 LIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML 384
            I   + +            +  +C+ E    RP    +V +L
Sbjct: 235 GISPHVSK------------LMKICMNEDPAKRPKFDMIVPIL 265

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  186 bits (474), Expect = 6e-56
 Identities = 65/300 (21%), Positives = 121/300 (40%), Gaps = 42/300 (14%)

Query: 115 NKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASV--IAQVQHKNLVKLLGC 172
             +G+G +G V++G      +AVK     S ++ K    E  +     ++H+N++  +  
Sbjct: 14  ECVGKGRYGEVWRGSWQGENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGFIAS 70

Query: 173 CIEKD----ERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLH---- 224
            +       +  LI  Y    SL  +L    +   LD  + ++I+  +A GL +LH    
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEIF 126

Query: 225 -QYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYM 283
               +  I HRDLK+ NIL+ K+    I+D G+A +     ++ ++ GN  R+ GT  YM
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDV-GNNPRV-GTKRYM 184

Query: 284 SPE------YALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISN 337
           +PE               + D+++FG++L E+     + G             +   + N
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP-----PFYDVVPN 239

Query: 338 K--IIDLIDSVLEE---------ASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN 386
                D+   V  +            + +L+    +   C  +    R T   +   LT 
Sbjct: 240 DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  186 bits (473), Expect = 2e-55
 Identities = 71/304 (23%), Positives = 120/304 (39%), Gaps = 40/304 (13%)

Query: 115 NKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASV--IAQVQHKNLVKLLGC 172
            ++G+G +G V+ G     ++AVK        E      E  +     ++H+N++  +  
Sbjct: 43  KQIGKGRYGEVWMGKWRGEKVAVKVF---FTTEEASWFRETEIYQTVLMRHENILGFIAA 99

Query: 173 CIEKDER----LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLH---- 224
            I+         LI +Y  N SL  +L    K   LD ++ +++      GL +LH    
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTEIF 155

Query: 225 -QYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYM 283
               +  I HRDLK+ NIL+ K+    I+D G+A       +E ++  NT    GT  YM
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV--GTKRYM 213

Query: 284 SPEYALEGI-------FSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWIS 336
            PE  L+           I +D++SFG++L E+     + G         + Y   +   
Sbjct: 214 PPE-VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ---LPYHDLVPSD 269

Query: 337 NKIIDLIDSVLEE---------ASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNE 387
               D+ + V  +          S +E L +   +   C       R T   V   L   
Sbjct: 270 PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329

Query: 388 ASSL 391
           + S 
Sbjct: 330 SESQ 333

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  182 bits (463), Expect = 5e-54
 Identities = 66/299 (22%), Positives = 118/299 (39%), Gaps = 40/299 (13%)

Query: 115 NKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASV--IAQVQHKNLVKLLGC 172
             +G+G FG V++G     E+AVK     S +E +    EA +     ++H+N++  +  
Sbjct: 48  ESIGKGRFGEVWRGKWRGEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFIAA 104

Query: 173 CIEKD----ERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ--- 225
             + +    +  L+ +Y  + SL  +L     R  +     +++    A GL +LH    
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIV 160

Query: 226 --YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYM 283
               +  I HRDLK+ NIL+ K+    I+D G+A       D  ++  N     GT  YM
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV--GTKRYM 218

Query: 284 SPEYALEGI-------FSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWIS 336
           +PE  L+            ++D+++ G++  EI       G +    L    Y   +   
Sbjct: 219 APE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP---YYDLVPSD 274

Query: 337 NKIIDLIDSVLEE---------ASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN 386
             + ++   V E+             E+L     I   C       R T   +   L+ 
Sbjct: 275 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  178 bits (453), Expect = 1e-52
 Identities = 75/292 (25%), Positives = 129/292 (44%), Gaps = 39/292 (13%)

Query: 115 NKLGEGGFGTVYKGV-IGQGE-----IAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
            +LG+G FG+V         +     +AVK+L   + + +++ + E  ++  +QH N+VK
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106

Query: 169 LLGCCIEKDER--LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQY 226
             G C     R   LI EY+P  SL  +L     +E +D    +Q    + +G+ YL   
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 161

Query: 227 SRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTS---RISGTYGYM 283
              R IHRDL   NIL++ +   KI DFG+ +++    +  +++              + 
Sbjct: 162 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIF------WY 215

Query: 284 SPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYA-WDLWISNKIIDL 342
           +PE   E  FS+ SDV+SFGV+L E+ +  + +     + + +IG       I   +I+L
Sbjct: 216 APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 275

Query: 343 IDSVLEEASFNESLSR--------YVHIALLCVQERAEDRPTMSDVVSMLTN 386
           + +       N  L R        Y  I   C       RP+  D+   +  
Sbjct: 276 LKN-------NGRLPRPDGCPDEIY-MIMTECWNNNVNQRPSFRDLALRVDQ 319

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  177 bits (452), Expect = 1e-52
 Identities = 83/292 (28%), Positives = 128/292 (43%), Gaps = 41/292 (14%)

Query: 115 NKLGEGGFGTVYKGV---IGQGE---IAVKRL-LGKSGQEIKELKNEASVIAQVQHKNLV 167
             LGEG FG V          G    +AVK L      Q     K E  ++  + H++++
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96

Query: 168 KLLGCCIEKDER--LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ 225
           K  GCC +       L+ EY+P  SL  +L     R  +     +   + + +G+ YLH 
Sbjct: 97  KYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLHA 152

Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTS---RISGTYGY 282
                 IHRDL A N+LLD D   KI DFG+A+ V  G++   ++ +            +
Sbjct: 153 ---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF------W 203

Query: 283 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDL 342
            +PE   E  F   SDV+SFGV L E+++   ++    TK L LIG A       ++ +L
Sbjct: 204 YAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL 263

Query: 343 IDSVLEEASFNESLSR--------YVHIALLCVQERAEDRPTMSDVVSMLTN 386
           ++         E L R        Y H+   C +  A  RPT  +++ +L  
Sbjct: 264 LER-------GERLPRPDKCPAEVY-HLMKNCWETEASFRPTFENLIPILKT 307

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  176 bits (449), Expect = 2e-52
 Identities = 75/292 (25%), Positives = 129/292 (44%), Gaps = 39/292 (13%)

Query: 115 NKLGEGGFGTVYKGV-IGQGE-----IAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
            +LG+G FG+V         +     +AVK+L   + + +++ + E  ++  +QH N+VK
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75

Query: 169 LLGCCIEKDER--LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQY 226
             G C     R   LI EY+P  SL  +L     +E +D    +Q    + +G+ YL   
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 130

Query: 227 SRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTS---RISGTYGYM 283
              R IHRDL   NIL++ +   KI DFG+ +++    +  +++              + 
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF------WY 184

Query: 284 SPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYA-WDLWISNKIIDL 342
           +PE   E  FS+ SDV+SFGV+L E+ +  + +     + + +IG       I   +I+L
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244

Query: 343 IDSVLEEASFNESLSR--------YVHIALLCVQERAEDRPTMSDVVSMLTN 386
           + +       N  L R        Y  I   C       RP+  D+   +  
Sbjct: 245 LKN-------NGRLPRPDGCPDEIY-MIMTECWNNNVNQRPSFRDLALRVDQ 288

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  175 bits (446), Expect = 1e-51
 Identities = 74/318 (23%), Positives = 134/318 (42%), Gaps = 40/318 (12%)

Query: 115 NKLGEGGFGTVYKGV-IGQGE-----IAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
           ++LG+G FG+V        G+     +AVK+L      + ++ + E  ++  +    +VK
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88

Query: 169 LLGCCIEKDER--LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQY 226
             G       +   L+ EY+P+  L  FL     R  LD    +     + +G+ YL   
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGS- 145

Query: 227 SRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTS---RISGTYGYM 283
              R +HRDL A NIL++ + + KI+DFG+A+++    D   ++              + 
Sbjct: 146 --RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF------WY 197

Query: 284 SPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIIDL 342
           +PE   + IFS +SDV+SFGV+L E+ +   K+     +     +        +     L
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYELFTYCDKS--CSPSAEFLRMMGCERDVPALS--RL 253

Query: 343 IDSVLEEASFNESLSR--------YVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPP 394
           ++ +LEE    + L          +  +  LC     +DRP+ S +   L    S     
Sbjct: 254 LE-LLEE---GQRLPAPPACPAEVH-ELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGC 308

Query: 395 KQPAFCNLRNMESSTSTT 412
           +  AF      +  + + 
Sbjct: 309 ETHAFTAHPEGKHHSLSF 326

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  176 bits (449), Expect = 2e-51
 Identities = 72/282 (25%), Positives = 109/282 (38%), Gaps = 42/282 (14%)

Query: 116 KLGEGGFGTVYKGV--IGQGEIAVKRL-LGKSGQEIKELKNEASVIAQVQHKNLVKLLGC 172
           ++G G FG V+ G        +AVK            +   EA ++ Q  H N+V+L+G 
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180

Query: 173 CIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRII 232
           C +K    ++ E +       FL   T+   L  +T +Q++   A G+ YL        I
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFLR--TEGARLRVKTLLQMVGDAAAGMEYLES---KCCI 235

Query: 233 HRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGI 292
           HRDL A N L+ +    KISDFGM+R            G   ++     + +PE    G 
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEAD--GVYAASGGLRQVP--VKWTAPEALNYGR 291

Query: 293 FSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEAS 351
           +S +SDV+SFG+LL E  S G                Y     +SN+         E   
Sbjct: 292 YSSESDVWSFGILLWETFSLGA-------------SPYP---NLSNQ------QTREFVE 329

Query: 352 FNESLSRYVH-------IALLCVQERAEDRPTMSDVVSMLTN 386
               L            +   C       RP+ S +   L +
Sbjct: 330 KGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQS 371

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  174 bits (442), Expect = 3e-51
 Identities = 64/291 (21%), Positives = 125/291 (42%), Gaps = 41/291 (14%)

Query: 115 NKLGEGGFGTVYKGV-IGQGE-----IAVKRL-LGKSGQEIKELKNEASVIAQVQHKNLV 167
             LGEG FG V       +G+     +AVK L     G  I +LK E  ++  + H+N+V
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86

Query: 168 KLLGCCIEKDER--LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ 225
           K  G C E       LI E++P+ SL  +L  P  +  ++ + +++    + +G+ YL  
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYL-- 142

Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTS---RISGTYGY 282
               + +HRDL A N+L++ +   KI DFG+ + +    +   ++ +            +
Sbjct: 143 -GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVF------W 195

Query: 283 MSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIID 341
            +PE  ++  F I SDV+SFGV L E+++    ++         +           ++++
Sbjct: 196 YAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQ-MTVTRLVN 254

Query: 342 LIDSVLEEASFNESLSR--------YVHIALLCVQERAEDRPTMSDVVSML 384
            +          + L          Y  +   C + +  +R +  +++   
Sbjct: 255 TLKE-------GKRLPCPPNCPDEVY-QLMRKCWEFQPSNRTSFQNLIEGF 297

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  173 bits (440), Expect = 6e-51
 Identities = 75/299 (25%), Positives = 130/299 (43%), Gaps = 55/299 (18%)

Query: 115 NKLGEGGFGTVYKGVI-----GQGEI--AVKRLLGKSGQEIKELKNEASVIAQVQHKNLV 167
            +LGEG FG V+          + ++  AVK L   +    K+ + EA ++  +QH+++V
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80

Query: 168 KLLGCCIEKDERLLIYEYMPNKSLDCFL-------------FDPTKREILDWRTRVQIIK 214
           K  G C + D  ++++EYM +  L+ FL                  +  L     + I  
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140

Query: 215 GVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTS 274
            +A G++YL   +    +HRDL   N L+  ++  KI DFGM+R V+   D   + G+T 
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVY-STDYYRVGGHTM 196

Query: 275 ---RISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAW 331
              R      +M PE  +   F+ +SDV+SFGV+L EI             +     +  
Sbjct: 197 LPIR------WMPPESIMYRKFTTESDVWSFGVILWEIF------------TYGKQPWF- 237

Query: 332 DLWISNKIIDLIDSVLE----EASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN 386
              +SN   ++I+ + +    E         Y  + L C Q   + R  + ++  +L  
Sbjct: 238 --QLSNT--EVIECITQGRVLERPRVCPKEVY-DVMLGCWQREPQQRLNIKEIYKILHA 291

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  171 bits (435), Expect = 2e-50
 Identities = 85/300 (28%), Positives = 133/300 (44%), Gaps = 56/300 (18%)

Query: 115 NKLGEGGFGTVYKGVI-----GQGEI--AVKRL-LGKSGQEIKELKNEASVIAQVQHKNL 166
            +LGE  FG VYKG +     G+     A+K L     G   +E ++EA + A++QH N+
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74

Query: 167 VKLLGCCIEKDERLLIYEYMPNKSLDCFL-------------FDPTKREILDWRTRVQII 213
           V LLG   +     +I+ Y  +  L  FL              D T +  L+    V ++
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134

Query: 214 KGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNT 273
             +A G+ YL   S   ++H+DL   N+L+   +N KISD G+ R V+   D  +L GN+
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVY-AADYYKLLGNS 190

Query: 274 S---RISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYA 330
               R      +M+PE  + G FSI SD++S+GV+L E+             S  L  Y 
Sbjct: 191 LLPIR------WMAPEAIMYGKFSIDSDIWSYGVVLWEVF------------SYGLQPY- 231

Query: 331 WDLWISNKIIDLIDSVLE----EASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN 386
                SN+  D+++ +          +     Y  + + C  E    RP   D+ S L  
Sbjct: 232 CGY--SNQ--DVVEMIRNRQVLPCPDDCPAWVY-ALMIECWNEFPSRRPRFKDIHSRLRA 286

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  172 bits (437), Expect = 3e-50
 Identities = 76/289 (26%), Positives = 133/289 (46%), Gaps = 51/289 (17%)

Query: 115 NKLGEGGFGTVYKGV----IGQGEI--AVKRL-LGKSGQEIKELKNEASVIAQVQHKNLV 167
             LG G FGTVYKG+      + +I  A+K L    S +  KE+ +EA V+A V + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 168 KLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYS 227
           +LLG C       LI + MP   L  ++ +   ++ +  +  +     +A+G+ YL    
Sbjct: 81  RLLGIC-LTSTVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL---E 134

Query: 228 RVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEY 287
             R++HRDL A N+L+    + KI+DFG+A+++  G +E E      ++     +M+ E 
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVP--IKWMALES 190

Query: 288 ALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNK-IIDLIDS 345
            L  I++ +SDV+S+GV + E+++ G K              Y     I    I  +++ 
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKP-------------YD---GIPASEISSILEK 234

Query: 346 VLEEASFNESLSR--------YVHIALLCVQERAEDRPTMSDVVSMLTN 386
                   E L +        Y  I   C    A+ RP   +++   + 
Sbjct: 235 -------GERLPQPPICTIDVY-MIMRKCWMIDADSRPKFRELIIEFSK 275

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  171 bits (436), Expect = 4e-50
 Identities = 80/298 (26%), Positives = 129/298 (43%), Gaps = 54/298 (18%)

Query: 115 NKLGEGGFGTVYKGVI-----GQGEI--AVKRLLGKSGQEIKELKNEASVIAQVQHKNLV 167
            +LGEG FG V+          Q ++  AVK L   S    ++ + EA ++  +QH+++V
Sbjct: 47  WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106

Query: 168 KLLGCCIEKDERLLIYEYMPNKSLDCFL------------FDPTKREILDWRTRVQIIKG 215
           +  G C E    L+++EYM +  L+ FL             +      L     + +   
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166

Query: 216 VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTS- 274
           VA G++YL   + +  +HRDL   N L+ + +  KI DFGM+R ++   D   + G T  
Sbjct: 167 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIY-STDYYRVGGRTML 222

Query: 275 --RISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWD 332
             R      +M PE  L   F+ +SDV+SFGV+L EI             +     + + 
Sbjct: 223 PIR------WMPPESILYRKFTTESDVWSFGVVLWEIF------------TYGKQPW-YQ 263

Query: 333 LWISNKIIDLIDSVLE----EASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN 386
           L  SN   + ID + +    E         Y  I   C Q   + R ++ DV + L  
Sbjct: 264 L--SNT--EAIDCITQGRELERPRACPPEVY-AIMRGCWQREPQQRHSIKDVHARLQA 316

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  171 bits (435), Expect = 6e-50
 Identities = 76/298 (25%), Positives = 129/298 (43%), Gaps = 61/298 (20%)

Query: 115 NKLGEGGFGTVYKGVIGQGE----IAVKRL-LGKSGQEIKELKNEASVIAQV-QHKNLVK 168
           + +GEG FG V K  I +       A+KR+    S  + ++   E  V+ ++  H N++ 
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90

Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFL-------------FDPTKREILDWRTRVQIIKG 215
           LLG C  +    L  EY P+ +L  FL                +    L  +  +     
Sbjct: 91  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150

Query: 216 VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTS- 274
           VA+G+ YL   S+ + IHRDL A NIL+ ++  +KI+DFG++R       ++     T  
Sbjct: 151 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR------GQEVYVKKTMG 201

Query: 275 ----RISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYA 330
               R      +M+ E     +++  SDV+S+GVLL EIV            SL    Y 
Sbjct: 202 RLPVR------WMAIESLNYSVYTTNSDVWSYGVLLWEIV------------SLGGTPY- 242

Query: 331 WDLWISNKIIDLIDSVLE----EASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML 384
               ++    +L + + +    E   N     Y  +   C +E+  +RP+ + ++  L
Sbjct: 243 CG--MTCA--ELYEKLPQGYRLEKPLNCDDEVY-DLMRQCWREKPYERPSFAQILVSL 295

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  167 bits (426), Expect = 3e-49
 Identities = 66/204 (32%), Positives = 98/204 (48%), Gaps = 28/204 (13%)

Query: 115 NKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCI 174
             +G+G FG V  G     ++AVK +  K+    +    EASV+ Q++H NLV+LLG  +
Sbjct: 27  QTIGKGEFGDVMLGDYRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 84

Query: 175 EKDERLLI-YEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
           E+   L I  EYM   SL  +L     R +L     ++    V + + YL        +H
Sbjct: 85  EEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVH 140

Query: 234 RDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYG------YMSPEY 287
           RDL A N+L+ +D  +K+SDFG+ +      +                      + +PE 
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTK------EASS---------TQDTGKLPVKWTAPEA 185

Query: 288 ALEGIFSIKSDVFSFGVLLLEIVS 311
             E  FS KSDV+SFG+LL EI S
Sbjct: 186 LREKKFSTKSDVWSFGILLWEIYS 209

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  168 bits (427), Expect = 4e-49
 Identities = 70/288 (24%), Positives = 117/288 (40%), Gaps = 36/288 (12%)

Query: 115 NKLGEGGFGTVYKGV---IGQGEI--AVKRL-LGKSGQEIKELKNEASVIAQVQHKNLVK 168
             +G+G FG VY G      Q  I  A+K L      Q+++    E  ++  + H N++ 
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86

Query: 169 LLGCCIEKDERLLI-YEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYS 227
           L+G  +  +    +   YM +  L  F+  P  +     +  +     VA+G+ YL   +
Sbjct: 87  LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP--QRNPTVKDLISFGLQVARGMEYL---A 141

Query: 228 RVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEY 287
             + +HRDL A N +LD+    K++DFG+AR +         Q   +R+     + + E 
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLP--VKWTALES 199

Query: 288 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVL 347
                F+ KSDV+SFGVLL E++            +     Y     I     DL   + 
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELL------------TRGAPPYR---HIDPF--DLTHFLA 242

Query: 348 E----EASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSL 391
           +            S Y  +   C +     RPT   +V  +    S+L
Sbjct: 243 QGRRLPQPEYCPDSLY-QVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  168 bits (428), Expect = 5e-49
 Identities = 83/334 (24%), Positives = 147/334 (44%), Gaps = 53/334 (15%)

Query: 115 NKLGEGGFGTVYKGV----IGQGEI--AVKRL-LGKSGQEIKELKNEASVIAQVQHKNLV 167
             LG G FGTVYKG+      + +I  A+K L    S +  KE+ +EA V+A V + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 168 KLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYS 227
           +LLG C+      LI + MP   L  ++ +   ++ +  +  +     +A+G+ YL    
Sbjct: 81  RLLGICL-TSTVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL---E 134

Query: 228 RVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEY 287
             R++HRDL A N+L+    + KI+DFG+A+++  G +E E      ++     +M+ E 
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVP--IKWMALES 190

Query: 288 ALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNK-IIDLIDS 345
            L  I++ +SDV+S+GV + E+++ G K              Y     I    I  +++ 
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKP-------------YD---GIPASEISSILEK 234

Query: 346 VLEEASFNESLSR--------YVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQP 397
                   E L +        Y  I + C    A+ RP   +++   +  A    P +  
Sbjct: 235 -------GERLPQPPICTIDVY-MIMVKCWMIDADSRPKFRELIIEFSKMARD--PQRYL 284

Query: 398 AFCNLRNMESSTSTTEKSWADCSINEVTVSILDA 431
                  M   + T    +      E    ++DA
Sbjct: 285 VIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDA 318

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  171 bits (435), Expect = 8e-49
 Identities = 66/198 (33%), Positives = 102/198 (51%), Gaps = 16/198 (8%)

Query: 115 NKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCI 174
             +G+G FG V  G     ++AVK +  K+    +    EASV+ Q++H NLV+LLG  +
Sbjct: 199 QTIGKGEFGDVMLGDYRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 256

Query: 175 EKDERL-LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
           E+   L ++ EYM   SL  +L     R +L     ++    V + + YL        +H
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVH 312

Query: 234 RDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIF 293
           RDL A N+L+ +D  +K+SDFG+ +      +    Q    ++     + +PE   E  F
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTG-KL--PVKWTAPEALREKKF 363

Query: 294 SIKSDVFSFGVLLLEIVS 311
           S KSDV+SFG+LL EI S
Sbjct: 364 STKSDVWSFGILLWEIYS 381

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  167 bits (424), Expect = 9e-49
 Identities = 64/200 (32%), Positives = 108/200 (54%), Gaps = 14/200 (7%)

Query: 115 NKLGEGGFGTVYKGVIGQGEI--AVKRLLGKSG-QEIKELKNEASVIAQVQHKNLVKLLG 171
           +KLG G +G VY+GV  +  +  AVK L  K    E++E   EA+V+ +++H NLV+LLG
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 76

Query: 172 CCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRI 231
            C  +    +I E+M   +L  +L +   R+ +     + +   ++  + YL    +   
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL---EKKNF 132

Query: 232 IHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEG 291
           IHRDL A N L+ ++   K++DFG++R++     +       ++      + +PE     
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLM---TGDTYTAHAGAKFP--IKWTAPESLAYN 187

Query: 292 IFSIKSDVFSFGVLLLEIVS 311
            FSIKSDV++FGVLL EI +
Sbjct: 188 KFSIKSDVWAFGVLLWEIAT 207

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  167 bits (426), Expect = 1e-48
 Identities = 79/288 (27%), Positives = 141/288 (48%), Gaps = 49/288 (17%)

Query: 116 KLGEGGFGTVYKGV----IGQGEI--AVKRL-LGKSGQEIKELKNEASVIAQVQHKNLVK 168
            +G G FG VYKG+     G+ E+  A+K L  G + ++  +   EA ++ Q  H N+++
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110

Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSR 228
           L G   +    ++I EYM N +LD FL +            V +++G+A G+ YL   + 
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKDGE--FSVLQLVGMLRGIAAGMKYL---AN 165

Query: 229 VRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGY--MSPE 286
           +  +HRDL A NIL++ ++  K+SDFG++R++     ED+ +   +   G       +PE
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVL-----EDDPEATYTTSGGKIPIRWTAPE 220

Query: 287 YALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDS 345
                 F+  SDV+SFG+++ E+++ G++    Y           W+L  SN        
Sbjct: 221 AISYRKFTSASDVWSFGIVMWEVMTYGERP---Y-----------WEL--SNH------E 258

Query: 346 VLEEASFNESLSR------YVH-IALLCVQERAEDRPTMSDVVSMLTN 386
           V++  +    L         ++ + + C Q+    RP  +D+VS+L  
Sbjct: 259 VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 306

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  167 bits (426), Expect = 1e-48
 Identities = 80/292 (27%), Positives = 130/292 (44%), Gaps = 50/292 (17%)

Query: 115 NKLGEGGFGTVYKGVI-----GQGEI--AVKRL-LGKSGQEIKELKNEASVIAQVQHKNL 166
            +LG+G FG VY+GV       + E   A+K +    S +E  E  NEASV+ +    ++
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90

Query: 167 VKLLGCCIEKDERLLIYEYMPNKSLDCFL-------FDPTKREILDWRTRVQIIKGVAQG 219
           V+LLG   +    L+I E M    L  +L        +            +Q+   +A G
Sbjct: 91  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150

Query: 220 LLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTS---RI 276
           + YL   +  + +HRDL A N ++ +D   KI DFGM R ++   D     G      R 
Sbjct: 151 MAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY-ETDYYRKGGKGLLPVR- 205

Query: 277 SGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWIS 336
                +MSPE   +G+F+  SDV+SFGV+L EI             +L    Y     +S
Sbjct: 206 -----WMSPESLKDGVFTTYSDVWSFGVVLWEIA------------TLAEQPYQ---GLS 245

Query: 337 NKIIDLIDSVLE----EASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML 384
           N+   ++  V+E    +   N     +  +  +C Q   + RP+  +++S +
Sbjct: 246 NE--QVLRFVMEGGLLDKPDNCPDMLF-ELMRMCWQYNPKMRPSFLEIISSI 294

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  166 bits (422), Expect = 2e-48
 Identities = 73/294 (24%), Positives = 122/294 (41%), Gaps = 48/294 (16%)

Query: 115 NKLGEGGFGTVYKGVIGQGE-----IAVKRL-LGKSGQEIKELKNEASVIAQVQHKNLVK 168
             +G G FG VY G +   +      AVK L       E+ +   E  ++    H N++ 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 169 LLGCCIEKDE-RLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYS 227
           LLG C+  +   L++  YM +  L  F+ +         +  +     VA+G+ YL   +
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKYL---A 145

Query: 228 RVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYG------ 281
             + +HRDL A N +LD+    K++DFG+AR        D        +    G      
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLAR--------DMYDKEYYSVHNKTGAKLPVK 197

Query: 282 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIID 341
           +M+ E      F+ KSDV+SFGVLL E++            +     Y     ++    D
Sbjct: 198 WMALESLQTQKFTTKSDVWSFGVLLWELM------------TRGAPPYP---DVNTF--D 240

Query: 342 LIDSVLE----EASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSL 391
           +   +L+              Y  + L C   +AE RP+ S++VS ++   S+ 
Sbjct: 241 ITVYLLQGRRLLQPEYCPDPLY-EVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  165 bits (420), Expect = 2e-48
 Identities = 65/201 (32%), Positives = 104/201 (51%), Gaps = 18/201 (8%)

Query: 115 NKLGEGGFGTVYKGVI-GQGEIAVKRLLGKSG-QEIKELKNEASVIAQVQHKNLVKLLGC 172
            ++G G FG V+ G    + ++A+K +  + G    ++   EA V+ ++ H  LV+L G 
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTI--REGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71

Query: 173 CIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRII 232
           C+E+    L+ E+M +  L  +L   T+R +    T + +   V +G+ YL       +I
Sbjct: 72  CLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYL---EEACVI 126

Query: 233 HRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGY--MSPEYALE 290
           HRDL A N L+ ++   K+SDFGM R V     +D+    TS     +     SPE    
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFV----LDDQ---YTSSTGTKFPVKWASPEVFSF 179

Query: 291 GIFSIKSDVFSFGVLLLEIVS 311
             +S KSDV+SFGVL+ E+ S
Sbjct: 180 SRYSSKSDVWSFGVLMWEVFS 200

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  167 bits (424), Expect = 2e-48
 Identities = 63/206 (30%), Positives = 106/206 (51%), Gaps = 20/206 (9%)

Query: 115 NKLGEGGFGTVYKGVI---GQGEI--AVKRL-LGKSGQEIKELKNEASVIAQVQHKNLVK 168
             +G G  G V  G +   GQ ++  A+K L  G + ++ ++  +EAS++ Q  H N+++
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114

Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSR 228
           L G        +++ EYM N SLD FL     +        V +++GV  G+ YL   S 
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ--FTIMQLVGMLRGVGAGMRYL---SD 169

Query: 229 VRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTS---RISGTYGYMSP 285
           +  +HRDL A N+L+D ++  K+SDFG++R++    D            R      + +P
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIR------WTAP 223

Query: 286 EYALEGIFSIKSDVFSFGVLLLEIVS 311
           E      FS  SDV+SFGV++ E+++
Sbjct: 224 EAIAFRTFSSASDVWSFGVVMWEVLA 249

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  166 bits (423), Expect = 3e-48
 Identities = 84/294 (28%), Positives = 126/294 (42%), Gaps = 54/294 (18%)

Query: 115 NKLGEGGFGTVYKGVI-----GQGEI--AVKRL-LGKSGQEIKELKNEASVIAQVQHKNL 166
             LG G FG VY+G +         +  AVK L    S Q+  +   EA +I++  H+N+
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95

Query: 167 VKLLGCCIEKDERLLIYEYMPNKSLDCFL----FDPTKREILDWRTRVQIIKGVAQGLLY 222
           V+ +G  ++   R ++ E M    L  FL      P++   L     + + + +A G  Y
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155

Query: 223 LHQYSRVRIIHRDLKASNILLDK---DMNSKISDFGMARIVFGGNDEDELQGNTSRISGT 279
           L        IHRD+ A N LL        +KI DFGMAR        D  + +  R  G 
Sbjct: 156 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--------DIYRASYYR-KGG 203

Query: 280 YGY-----MSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLW 334
                   M PE  +EGIF+ K+D +SFGVLL EI             SL  + Y     
Sbjct: 204 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF------------SLGYMPY-PSK- 249

Query: 335 ISNKIIDLIDSVLE----EASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML 384
            SN+  ++++ V      +   N     Y  I   C Q + EDRP  + ++  +
Sbjct: 250 -SNQ--EVLEFVTSGGRMDPPKNCPGPVY-RIMTQCWQHQPEDRPNFAIILERI 299

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  166 bits (422), Expect = 4e-48
 Identities = 71/323 (21%), Positives = 134/323 (41%), Gaps = 58/323 (17%)

Query: 115 NKLGEGGFGTVYKGVIGQGE-----IAVKRLLGKSG----QEIKELKNEASVIAQVQHKN 165
             LG+G FG+V +  + Q +     +AVK L  K+      +I+E   EA+ + +  H +
Sbjct: 29  RMLGKGEFGSVREAQLKQEDGSFVKVAVKML--KADIIASSDIEEFLREAACMKEFDHPH 86

Query: 166 LVKLLGCCIEKDER------LLIYEYMPNKSLDCFLFD---PTKREILDWRTRVQIIKGV 216
           + KL+G  +    +      ++I  +M +  L  FL           L  +T V+ +  +
Sbjct: 87  VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146

Query: 217 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTS-- 274
           A G+ YL   S    IHRDL A N +L +DM   ++DFG++R ++   D       +   
Sbjct: 147 ACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIY-SGDYYRQGCASKLP 202

Query: 275 -RISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDL 333
            +      +++ E   + ++++ SDV++FGV + EI+            +     YA   
Sbjct: 203 VK------WLALESLADNLYTVHSDVWAFGVTMWEIM------------TRGQTPYA--- 241

Query: 334 WISNKIIDLIDSVLE----EASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN--- 386
            I N   ++ + ++     +         Y  +   C     + RP+ + +   L N   
Sbjct: 242 GIENA--EIYNYLIGGNRLKQPPECMEEVY-DLMYQCWSADPKQRPSFTCLRMELENILG 298

Query: 387 EASSLLPPKQPAFCNLRNMESST 409
             S L   + P + N+       
Sbjct: 299 HLSVLSTSQDPLYINIERAHHHH 321

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  170 bits (433), Expect = 4e-48
 Identities = 74/280 (26%), Positives = 127/280 (45%), Gaps = 42/280 (15%)

Query: 115 NKLGEGGFGTVYKGVIGQGEI--AVKRLLGKSGQ-EIKELKNEASVIAQVQHKNLVKLLG 171
           +KLG G +G VY+GV  +  +  AVK L  K    E++E   EA+V+ +++H NLV+LLG
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 283

Query: 172 CCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRI 231
            C  +    +I E+M   +L  +L +   R+ +     + +   ++  + YL    +   
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL---EKKNF 339

Query: 232 IHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEG 291
           IHR+L A N L+ ++   K++DFG++R++       +     +       + +PE     
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLM-----TGDTYTAHAGAKFPIKWTAPESLAYN 394

Query: 292 IFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEAS 351
            FSIKSDV++FGVLL EI +                G +    I          V E   
Sbjct: 395 KFSIKSDVWAFGVLLWEIAT---------------YGMSPYPGIDLS------QVYELLE 433

Query: 352 FNESLSR------YVH-IALLCVQERAEDRPTMSDVVSML 384
            +  + R       V+ +   C Q    DRP+ +++    
Sbjct: 434 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 473

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  165 bits (420), Expect = 6e-48
 Identities = 73/229 (31%), Positives = 107/229 (46%), Gaps = 42/229 (18%)

Query: 115 NKLGEGGFGTVYKGVI-----GQGEI--AVKRL-LGKSGQEIKELKNEASVIAQVQHKNL 166
             LGEG FG V K          G    AVK L    S  E+++L +E +V+ QV H ++
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88

Query: 167 VKLLGCCIEKDERLLIYEYMPNKSLDCFL---------------------FDPTKREILD 205
           +KL G C +    LLI EY    SL  FL                      D      L 
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148

Query: 206 WRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGND 265
               +     ++QG+ YL   + ++++HRDL A NIL+ +    KISDFG++R V    +
Sbjct: 149 MGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDV---YE 202

Query: 266 EDELQGNTSR---ISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
           ED     +     +     +M+ E   + I++ +SDV+SFGVLL EIV+
Sbjct: 203 EDSYVKRSQGRIPVK----WMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  164 bits (418), Expect = 6e-48
 Identities = 66/202 (32%), Positives = 101/202 (50%), Gaps = 20/202 (9%)

Query: 115 NKLGEGGFGTVYKGVI-GQGEIAVKRLLGKSG-QEIKELKNEASVIAQVQHKNLVKLLGC 172
            +LG G FG V  G   GQ ++A+K +  K G     E   EA V+  + H+ LV+L G 
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMI--KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87

Query: 173 CIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRII 232
           C ++    +I EYM N  L  +L     R     +  +++ K V + + YL      + +
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFL 142

Query: 233 HRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGT---YGYMSPEYAL 289
           HRDL A N L++     K+SDFG++R V     +DE     +   G+     +  PE  +
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYV----LDDE----YTSSVGSKFPVRWSPPEVLM 194

Query: 290 EGIFSIKSDVFSFGVLLLEIVS 311
              FS KSD+++FGVL+ EI S
Sbjct: 195 YSKFSSKSDIWAFGVLMWEIYS 216

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  164 bits (417), Expect = 6e-48
 Identities = 71/201 (35%), Positives = 110/201 (54%), Gaps = 18/201 (8%)

Query: 115 NKLGEGGFGTVYKGVI-GQGEIAVKRLLGKSGQ-EIKELKNEASVIAQVQHKNLVKLLGC 172
            +LG G FG V+ G   G  ++AVK L  K G         EA+++ Q+QH+ LV+L   
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSL--KQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76

Query: 173 CIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRII 232
              ++   +I EYM N SL  FL  P     L     + +   +A+G+ ++        I
Sbjct: 77  VT-QEPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFI---EERNYI 131

Query: 233 HRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGY--MSPEYALE 290
           HRDL+A+NIL+   ++ KI+DFG+AR++    +++E    T+R    +     +PE    
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLI----EDNEY---TAREGAKFPIKWTAPEAINY 184

Query: 291 GIFSIKSDVFSFGVLLLEIVS 311
           G F+IKSDV+SFG+LL EIV+
Sbjct: 185 GTFTIKSDVWSFGILLTEIVT 205

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  166 bits (423), Expect = 8e-48
 Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 14/204 (6%)

Query: 115 NKLGEGGFGTVYKGVIGQGE-----IAVKRL-LGKSGQEIKELKNEASVIAQVQHKNLVK 168
             +G G FG VY G +   +      AVK L       E+ +   E  ++    H N++ 
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154

Query: 169 LLGCCIEKDE-RLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYS 227
           LLG C+  +   L++  YM +  L  F+ +         +  +     VA+G+ +L   +
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFL---A 209

Query: 228 RVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEY 287
             + +HRDL A N +LD+    K++DFG+AR ++    +       +++     +M+ E 
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP--VKWMALES 267

Query: 288 ALEGIFSIKSDVFSFGVLLLEIVS 311
                F+ KSDV+SFGVLL E+++
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELMT 291

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  165 bits (419), Expect = 9e-48
 Identities = 61/217 (28%), Positives = 109/217 (50%), Gaps = 32/217 (14%)

Query: 115 NKLGEGGFGTVYKGVIGQGE-----IAVKRL--LGKSGQEIKELKNEASVIAQVQHKNLV 167
             LGEG FG+V +G + Q +     +AVK +     S +EI+E  +EA+ +    H N++
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99

Query: 168 KLLGCCIEKD-----ERLLIYEYMPNKSLDCFL---FDPTKREILDWRTRVQIIKGVAQG 219
           +LLG CIE       + ++I  +M    L  +L      T  + +  +T ++ +  +A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159

Query: 220 LLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGT 279
           + YL   S    +HRDL A N +L  DM   ++DFG+++ ++     D  +       G 
Sbjct: 160 MEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIY---SGDYYR------QGR 207

Query: 280 YG-----YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
                  +++ E   + +++ KSDV++FGV + EI +
Sbjct: 208 IAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  166 bits (422), Expect = 1e-47
 Identities = 84/294 (28%), Positives = 125/294 (42%), Gaps = 54/294 (18%)

Query: 115 NKLGEGGFGTVYKGVI-----GQGEI--AVKRL-LGKSGQEIKELKNEASVIAQVQHKNL 166
             LG G FG VY+G +         +  AVK L    S Q+  +   EA +I++  H+N+
Sbjct: 77  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136

Query: 167 VKLLGCCIEKDERLLIYEYMPNKSLDCFL----FDPTKREILDWRTRVQIIKGVAQGLLY 222
           V+ +G  ++   R ++ E M    L  FL      P++   L     + + + +A G  Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196

Query: 223 LHQYSRVRIIHRDLKASNILLDK---DMNSKISDFGMARIVFGGNDEDELQGNTSRISGT 279
           L        IHRD+ A N LL        +KI DFGMAR        D  +    R  G 
Sbjct: 197 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--------DIYRAGYYR-KGG 244

Query: 280 YGY-----MSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLW 334
                   M PE  +EGIF+ K+D +SFGVLL EI             SL  + Y     
Sbjct: 245 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF------------SLGYMPY-PSK- 290

Query: 335 ISNKIIDLIDSVLE----EASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML 384
            SN+  ++++ V      +   N     Y  I   C Q + EDRP  + ++  +
Sbjct: 291 -SNQ--EVLEFVTSGGRMDPPKNCPGPVY-RIMTQCWQHQPEDRPNFAIILERI 340

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  166 bits (422), Expect = 1e-47
 Identities = 65/203 (32%), Positives = 109/203 (53%), Gaps = 14/203 (6%)

Query: 115 NKLGEGGFGTVYKGVI---GQGEI--AVKRL-LGKSGQEIKELKNEASVIAQVQHKNLVK 168
             +G G FG V  G +    + EI  A+K L +G + ++ ++   EAS++ Q  H N+++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110

Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSR 228
           L G   +    +++ EYM N SLD FL     +        V +++G+A G+ YL   S 
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ--FTVIQLVGMLRGIASGMKYL---SD 165

Query: 229 VRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYA 288
           +  +HRDL A NIL++ ++  K+SDFG+ R++    D+ E    T        + SPE  
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLGRVL---EDDPEAAYTTRGGKIPIRWTSPEAI 222

Query: 289 LEGIFSIKSDVFSFGVLLLEIVS 311
               F+  SDV+S+G++L E++S
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMS 245

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  163 bits (414), Expect = 2e-47
 Identities = 65/201 (32%), Positives = 102/201 (50%), Gaps = 20/201 (9%)

Query: 116 KLGEGGFGTVYKGVI-GQGEIAVKRLLGKSG-QEIKELKNEASVIAQVQHKNLVKLLGCC 173
           +LG G FG V  G   GQ ++AVK +  K G     E   EA  + ++ H  LVK  G C
Sbjct: 15  ELGSGQFGVVKLGKWKGQYDVAVKMI--KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72

Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
            ++    ++ EY+ N  L  +L   +  + L+    +++   V +G+ +L      + IH
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL---ESHQFIH 127

Query: 234 RDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGT---YGYMSPEYALE 290
           RDL A N L+D+D+  K+SDFGM R V     +D+         GT     + +PE    
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYV----LDDQ----YVSSVGTKFPVKWSAPEVFHY 179

Query: 291 GIFSIKSDVFSFGVLLLEIVS 311
             +S KSDV++FG+L+ E+ S
Sbjct: 180 FKYSSKSDVWAFGILMWEVFS 200

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  164 bits (418), Expect = 2e-47
 Identities = 65/229 (28%), Positives = 104/229 (45%), Gaps = 42/229 (18%)

Query: 115 NKLGEGGFGTVYKGVI-----GQGEI--AVKRL-LGKSGQEIKELKNEASVIAQVQHKNL 166
             +GEG FG V++         +     AVK L    S     + + EA+++A+  + N+
Sbjct: 53  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112

Query: 167 VKLLGCCIEKDERLLIYEYMPNKSLDCFL---------------------FDPTKREILD 205
           VKLLG C       L++EYM    L+ FL                             L 
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172

Query: 206 WRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGND 265
              ++ I + VA G+ YL   S  + +HRDL   N L+ ++M  KI+DFG++R ++   D
Sbjct: 173 CAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY-SAD 228

Query: 266 EDELQGNTS---RISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
             +  GN +   R      +M PE      ++ +SDV+++GV+L EI S
Sbjct: 229 YYKADGNDAIPIR------WMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  167 bits (425), Expect = 3e-47
 Identities = 83/280 (29%), Positives = 134/280 (47%), Gaps = 44/280 (15%)

Query: 115 NKLGEGGFGTVYKGVI-GQGEIAVKRLLGKSG-QEIKELKNEASVIAQVQHKNLVKLLGC 172
            KLG G FG V+        ++AVK +  K G   ++    EA+V+  +QH  LVKL   
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTM--KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251

Query: 173 CIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRII 232
              K+   +I E+M   SL  FL    +         +     +A+G+ ++    +   I
Sbjct: 252 VT-KEPIYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFI---EQRNYI 306

Query: 233 HRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGT---YGYMSPEYAL 289
           HRDL+A+NIL+   +  KI+DFG+AR++    +++E     +   G      + +PE   
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVI----EDNE----YTAREGAKFPIKWTAPEAIN 358

Query: 290 EGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLE 348
            G F+IKSDV+SFG+LL+EIV+ G+             I Y     +SN   ++I ++  
Sbjct: 359 FGSFTIKSDVWSFGILLMEIVTYGR-------------IPYP---GMSNP--EVIRALER 400

Query: 349 ----EASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML 384
                   N     Y +I + C + R E+RPT   + S+L
Sbjct: 401 GYRMPRPENCPEELY-NIMMRCWKNRPEERPTFEYIQSVL 439

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  165 bits (419), Expect = 3e-47
 Identities = 77/305 (25%), Positives = 132/305 (43%), Gaps = 63/305 (20%)

Query: 115 NKLGEGGFGTVYKGV---IGQGE------IAVKRLLGKSG---QEIKELKNEASVIAQV- 161
             LGEG FG V       I + +      +AVK L  K     +++ +L +E  ++  + 
Sbjct: 87  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML--KDDATEKDLSDLVSEMEMMKMIG 144

Query: 162 QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFL-------------FDPTKREILDWRT 208
           +HKN++ LLG C +     +I EY    +L  +L              +    E + ++ 
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204

Query: 209 RVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDE 268
            V     +A+G+ YL   +  + IHRDL A N+L+ ++   KI+DFG+AR +   N+ D 
Sbjct: 205 LVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDI---NNIDY 258

Query: 269 LQGNTSR---ISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLN 325
            +  T+    +     +M+PE   + +++ +SDV+SFGVL+ EI             +L 
Sbjct: 259 YKKTTNGRLPVK----WMAPEALFDRVYTHQSDVWSFGVLMWEIF------------TLG 302

Query: 326 LIGYAWDLWISNKIIDLIDSVLE----EASFNESLSRYVHIALLCVQERAEDRPTMSDVV 381
              Y     I  +  +L   + E    +   N +   Y  +   C       RPT   +V
Sbjct: 303 GSPYP---GIPVE--ELFKLLKEGHRMDKPANCTNELY-MMMRDCWHAVPSQRPTFKQLV 356

Query: 382 SMLTN 386
             L  
Sbjct: 357 EDLDR 361

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  163 bits (416), Expect = 4e-47
 Identities = 65/222 (29%), Positives = 103/222 (46%), Gaps = 37/222 (16%)

Query: 115 NKLGEGGFGTVYKGV---IGQGE----IAVKRLLGKSG---QEIKELKNEASVIAQV-QH 163
             LG G FG V +     +G+ +    +AVK L  KS     E + L +E  +++ + QH
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML--KSTAHADEKEALMSELKIMSHLGQH 109

Query: 164 KNLVKLLGCCIEKDERLLIYEYMPNKSLDCFL-----------FDPTKREILDWRTRVQI 212
           +N+V LLG C      L+I EY     L  FL                      R  +  
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169

Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
              VAQG+ +L   +    IHRD+ A N+LL     +KI DFG+AR +    ++      
Sbjct: 170 SSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI---MNDSNYIVK 223

Query: 273 TSR---ISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
            +    +     +M+PE   + +++++SDV+S+G+LL EI S
Sbjct: 224 GNARLPVK----WMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  163 bits (414), Expect = 5e-47
 Identities = 75/327 (22%), Positives = 137/327 (41%), Gaps = 53/327 (16%)

Query: 115 NKLGEGGFGTVYKGV----IGQGEI--AVKRLLGKSG-QEIKELKNEASVIAQVQHKNLV 167
             LG G FGTV+KGV        +I   +K +  KSG Q  + + +    I  + H ++V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78

Query: 168 KLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYS 227
           +LLG C       L+ +Y+P  SL   +     R  L  +  +     +A+G+ YL    
Sbjct: 79  RLLGLCPG-SSLQLVTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMYYL---E 132

Query: 228 RVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEY 287
              ++HR+L A N+LL      +++DFG+A ++    D+ +L  + ++      +M+ E 
Sbjct: 133 EHGMVHRNLAARNVLLKSPSQVQVADFGVADLL--PPDDKQLLYSEAKTP--IKWMALES 188

Query: 288 ALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNK-IIDLIDS 345
              G ++ +SDV+S+GV + E+++ G +              YA    +    + DL++ 
Sbjct: 189 IHFGKYTHQSDVWSYGVTVWELMTFGAEP-------------YA---GLRLAEVPDLLEK 232

Query: 346 VLEEASFNESLSR--------YVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQP 397
                   E L++        Y  + + C       RPT  ++ +  T  A    PP+  
Sbjct: 233 -------GERLAQPQICTIDVY-MVMVKCWMIDENIRPTFKELANEFTRMARD--PPRYL 282

Query: 398 AFCNLRNMESSTSTTEKSWADCSINEV 424
                     +         +  + EV
Sbjct: 283 VIKRESGPGIAPGPEPHGLTNKKLEEV 309

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  163 bits (415), Expect = 6e-47
 Identities = 62/224 (27%), Positives = 109/224 (48%), Gaps = 37/224 (16%)

Query: 115 NKLGEGGFGTVYKGV---IGQGE------IAVKRL-LGKSGQEIKELKNEASVIAQV-QH 163
             LGEG FG V       I + +      +AVK L    + +++ +L +E  ++  + +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100

Query: 164 KNLVKLLGCCIEKDERLLIYEYMPNKSLDCFL-------------FDPTKREILDWRTRV 210
           KN++ LLG C +     +I EY    +L  +L              +    E + ++  V
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160

Query: 211 QIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQ 270
                +A+G+ YL   +  + IHRDL A N+L+ ++   KI+DFG+AR +    D  +  
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN-NIDYYKKT 216

Query: 271 GNTS---RISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
            N     +      +M+PE   + +++ +SDV+SFGVL+ EI +
Sbjct: 217 TNGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  162 bits (412), Expect = 1e-46
 Identities = 65/227 (28%), Positives = 103/227 (45%), Gaps = 44/227 (19%)

Query: 115 NKLGEGGFGTVYKGV---IGQGE----IAVKRLLGKSG---QEIKELKNEASVIAQV-QH 163
             LG G FG V +     I +      +AVK L  K G    E + L +E  ++  +  H
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHIGHH 90

Query: 164 KNLVKLLGCCIEKDE-RLLIYEYMPNKSLDCFL-------------FDPTKREILDWRTR 209
            N+V LLG C +     ++I E+    +L  +L              +   ++ L     
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150

Query: 210 VQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDEL 269
           +     VA+G+ +L   +  + IHRDL A NILL +    KI DFG+AR +     + + 
Sbjct: 151 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI---YKDPDY 204

Query: 270 QGNTS-----RISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
                     +      +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 205 VRKGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  162 bits (412), Expect = 1e-46
 Identities = 62/224 (27%), Positives = 96/224 (42%), Gaps = 37/224 (16%)

Query: 115 NKLGEGGFGTVYKGV---IGQGE----IAVKRL-LGKSGQEIKELKNEASVIAQV-QHKN 165
             LG G FG V +     + + +    +AVK L       E + L +E  V++ +  H N
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88

Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSLDCFL---------------FDPTKREILDWRTRV 210
           +V LLG C      L+I EY     L  FL                       LD    +
Sbjct: 89  IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148

Query: 211 QIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQ 270
                VA+G+ +L   +    IHRDL A NILL     +KI DFG+AR +    ++    
Sbjct: 149 SFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDI---KNDSNYV 202

Query: 271 GNTSR---ISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
              +    +     +M+PE     +++ +SDV+S+G+ L E+ S
Sbjct: 203 VKGNARLPVK----WMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  161 bits (409), Expect = 1e-46
 Identities = 73/286 (25%), Positives = 130/286 (45%), Gaps = 48/286 (16%)

Query: 116 KLGEGGFGTVYKGV----IGQGEIAVKRL-LGKSGQEIKELKNEASVIAQVQHKNLVKLL 170
           +LG G FG+V +GV      Q ++A+K L  G    + +E+  EA ++ Q+ +  +V+L+
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76

Query: 171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVR 230
           G C + +  +L+ E      L  FL    KRE +      +++  V+ G+ YL       
Sbjct: 77  GVC-QAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---EEKN 130

Query: 231 IIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY--GYMSPEYA 288
            +HRDL A N+LL     +KISDFG+++ +  G D+      T+R +G +   + +PE  
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKAL--GADDSYY---TARSAGKWPLKWYAPECI 185

Query: 289 LEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVL 347
               FS +SDV+S+GV + E +S G+K                +      +++  I+   
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEALSYGQK---------------PYKKMKGPEVMAFIEQ-- 228

Query: 348 EEASFNESLSR------YVH-IALLCVQERAEDRPTMSDVVSMLTN 386
                 + +         ++ +   C   + EDRP    V   +  
Sbjct: 229 -----GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 269

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  160 bits (407), Expect = 2e-46
 Identities = 53/202 (26%), Positives = 93/202 (46%), Gaps = 17/202 (8%)

Query: 116 KLGEGGFGTVYKGV---IGQGEI--AVKRL-LGKSGQEIKELKNEASVIAQVQHKNLVKL 169
            +GEG FG V++G+        +  A+K      S    ++   EA  + Q  H ++VKL
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81

Query: 170 LGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRV 229
           +G    ++   +I E      L  FL    ++  LD  + +     ++  L YL      
Sbjct: 82  IGVI-TENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYL---ESK 135

Query: 230 RIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL 289
           R +HRD+ A N+L+  +   K+ DFG++R +    D    + +  ++     +M+PE   
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASKGKLP--IKWMAPESIN 190

Query: 290 EGIFSIKSDVFSFGVLLLEIVS 311
              F+  SDV+ FGV + EI+ 
Sbjct: 191 FRRFTSASDVWMFGVCMWEILM 212

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  163 bits (414), Expect = 3e-46
 Identities = 81/337 (24%), Positives = 140/337 (41%), Gaps = 63/337 (18%)

Query: 115 NKLGEGGFGTVYKGV---IGQGE------IAVKRL-LGKSGQEIKELKNEASVIAQV-QH 163
             LGEG FG V       + + +      +AVK L    + +++ +L +E  ++  + +H
Sbjct: 75  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134

Query: 164 KNLVKLLGCCIEKDERLLIYEYMPNKSLDCFL-------------FDPTKREILDWRTRV 210
           KN++ LLG C +     +I EY    +L  +L                   E L  +  V
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194

Query: 211 QIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQ 270
                VA+G+ YL   +  + IHRDL A N+L+ +D   KI+DFG+AR +   +  D  +
Sbjct: 195 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI---HHIDYYK 248

Query: 271 GNTS-----RISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLN 325
             T+     +      +M+PE   + I++ +SDV+SFGVLL EI             +L 
Sbjct: 249 KTTNGRLPVK------WMAPEALFDRIYTHQSDVWSFGVLLWEIF------------TLG 290

Query: 326 LIGYAWDLWISNKIIDLIDSVLE----EASFNESLSRYVHIALLCVQERAEDRPTMSDVV 381
              Y     +  +  +L   + E    +   N +   Y  +   C       RPT   +V
Sbjct: 291 GSPYP---GVPVE--ELFKLLKEGHRMDKPSNCTNELY-MMMRDCWHAVPSQRPTFKQLV 344

Query: 382 SMLTNEASSLLPPKQPAFCNLRNMESSTSTTEKSWAD 418
             L    +     +   + +  + +    TTE  + +
Sbjct: 345 EDLDRIVALTSNQEMGYYHHHHHHDYDIPTTENLYFN 381

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  160 bits (406), Expect = 3e-46
 Identities = 74/287 (25%), Positives = 126/287 (43%), Gaps = 51/287 (17%)

Query: 116 KLGEGGFGTVYKGV---IGQGEI--AVKRL-LGKSGQEIKELKNEASVIAQVQHKNLVKL 169
            LGEG FG VY+GV       +I  AVK      +    ++  +EA ++  + H ++VKL
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78

Query: 170 LGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRV 229
           +G   E++   +I E  P   L  +L     +  L   T V     + + + YL     +
Sbjct: 79  IGII-EEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAYL---ESI 132

Query: 230 RIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL 289
             +HRD+   NIL+      K+ DFG++R +    DED  + + +R+     +MSPE   
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYI---EDEDYYKASVTRLP--IKWMSPESIN 187

Query: 290 EGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNK-IIDLIDSVL 347
              F+  SDV+ F V + EI+S GK+              +    W+ NK +I +++   
Sbjct: 188 FRRFTTASDVWMFAVCMWEILSFGKQP-------------FF---WLENKDVIGVLEK-- 229

Query: 348 EEASFNESLSR--------YVHIALLCVQERAEDRPTMSDVVSMLTN 386
                 + L +        Y  +   C      DRP  +++V  L++
Sbjct: 230 -----GDRLPKPDLCPPVLY-TLMTRCWDYDPSDRPRFTELVCSLSD 270

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  164 bits (417), Expect = 1e-45
 Identities = 80/279 (28%), Positives = 131/279 (46%), Gaps = 42/279 (15%)

Query: 115 NKLGEGGFGTVYKGVI-GQGEIAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNLVKLLGC 172
            KLG+G FG V+ G   G   +A+K L  K G    E    EA V+ +++H+ LV+L   
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330

Query: 173 CIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRII 232
             E +   ++ EYM   SL  FL      + L     V +   +A G+ Y+    R+  +
Sbjct: 331 VSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---ERMNYV 385

Query: 233 HRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGI 292
           HRDL+A+NIL+ +++  K++DFG+AR++     ED              + +PE AL G 
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLI-----EDNEYTARQGAKFPIKWTAPEAALYGR 440

Query: 293 FSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASF 352
           F+IKSDV+SFG+LL E+             +   + Y     + N+       VL++   
Sbjct: 441 FTIKSDVWSFGILLTELT------------TKGRVPYP---GMVNR------EVLDQVER 479

Query: 353 NESLSR------YVH-IALLCVQERAEDRPTMSDVVSML 384
              +         +H +   C ++  E+RPT   + + L
Sbjct: 480 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 518

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  158 bits (403), Expect = 1e-45
 Identities = 62/204 (30%), Positives = 103/204 (50%), Gaps = 20/204 (9%)

Query: 116 KLGEGGFGTVYKGVI----GQGEIAVKRLLGKSGQEIKELKN----EASVIAQVQHKNLV 167
           +LG G FGTV KG          +AVK L  K+      LK+    EA+V+ Q+ +  +V
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKIL--KNEANDPALKDELLAEANVMQQLDNPYIV 81

Query: 168 KLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYS 227
           +++G C E +  +L+ E      L+ +L    +   +  +  ++++  V+ G+ YL    
Sbjct: 82  RMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYL---E 134

Query: 228 RVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEY 287
               +HRDL A N+LL     +KISDFG+++ +    +  + Q +  +      + +PE 
Sbjct: 135 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG-KWP--VKWYAPEC 191

Query: 288 ALEGIFSIKSDVFSFGVLLLEIVS 311
                FS KSDV+SFGVL+ E  S
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFS 215

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  165 bits (419), Expect = 2e-45
 Identities = 74/298 (24%), Positives = 132/298 (44%), Gaps = 48/298 (16%)

Query: 116 KLGEGGFGTVYKGVI----GQGEIAVKRL-LGKSGQEIKELKNEASVIAQVQHKNLVKLL 170
           +LG G FG+V +GV      Q ++A+K L  G    + +E+  EA ++ Q+ +  +V+L+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402

Query: 171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVR 230
           G C + +  +L+ E      L  FL    KRE +      +++  V+ G+ YL       
Sbjct: 403 GVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYL---EEKN 456

Query: 231 IIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGY--MSPEYA 288
            +HR+L A N+LL     +KISDFG+++ +  G D+      T+R +G +     +PE  
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKAL--GADDSYY---TARSAGKWPLKWYAPECI 511

Query: 289 LEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVL 347
               FS +SDV+S+GV + E +S G+K                +      +++  I+   
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEALSYGQK---------------PYKKMKGPEVMAFIEQ-- 554

Query: 348 EEASFNESLSR------YVH-IALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQPA 398
                 + +         ++ +   C   + EDRP    V   +     SL    +  
Sbjct: 555 -----GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGG 607

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  162 bits (411), Expect = 2e-45
 Identities = 79/279 (28%), Positives = 131/279 (46%), Gaps = 42/279 (15%)

Query: 115 NKLGEGGFGTVYKGVI-GQGEIAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNLVKLLGC 172
            KLG+G FG V+ G   G   +A+K L  K G    E    EA V+ +++H+ LV+L   
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247

Query: 173 CIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRII 232
              ++   ++ EYM   SL  FL      + L     V +   +A G+ Y+    R+  +
Sbjct: 248 VS-EEPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---ERMNYV 302

Query: 233 HRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGI 292
           HRDL+A+NIL+ +++  K++DFG+AR++     ED              + +PE AL G 
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLI-----EDNEYTARQGAKFPIKWTAPEAALYGR 357

Query: 293 FSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASF 352
           F+IKSDV+SFG+LL E+             +   + Y     + N+       VL++   
Sbjct: 358 FTIKSDVWSFGILLTELT------------TKGRVPYP---GMVNR------EVLDQVER 396

Query: 353 NESLSR------YVH-IALLCVQERAEDRPTMSDVVSML 384
              +         +H +   C ++  E+RPT   + + L
Sbjct: 397 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 435

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  159 bits (403), Expect = 4e-45
 Identities = 66/231 (28%), Positives = 99/231 (42%), Gaps = 46/231 (19%)

Query: 115 NKLGEGGFGTVYKGV---IGQGE----IAVKRLLGKSG---QEIKELKNEASVIAQV-QH 163
             LG G FG V       I +      +AVK L  K      E + L +E  ++ Q+  H
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKML--KEKADSSEREALMSELKMMTQLGSH 108

Query: 164 KNLVKLLGCCIEKDERLLIYEYMPNKSLDCFL--------------------FDPTKREI 203
           +N+V LLG C       LI+EY     L  +L                     +     +
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168

Query: 204 LDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGG 263
           L +   +     VA+G+ +L        +HRDL A N+L+      KI DFG+AR +   
Sbjct: 169 LTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDI--- 222

Query: 264 NDEDELQGNTSR---ISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
             +       +    +     +M+PE   EGI++IKSDV+S+G+LL EI S
Sbjct: 223 MSDSNYVVRGNARLPVK----WMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  156 bits (396), Expect = 9e-45
 Identities = 56/214 (26%), Positives = 102/214 (47%), Gaps = 33/214 (15%)

Query: 116 KLGEGGFGTVYKGV---------IGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNL 166
            LG+G F  ++KGV         + + E+ +K L        +     AS+++++ HK+L
Sbjct: 15  SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74

Query: 167 VKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQY 226
           V   G C+  DE +L+ E++   SLD +L     +  ++   ++++ K +A  + +L   
Sbjct: 75  VLNYGVCVCGDENILVQEFVKFGSLDTYLKK--NKNCINILWKLEVAKQLAAAMHFL--- 129

Query: 227 SRVRIIHRDLKASNILLDKDMNS--------KISDFGMARIVFGGNDEDELQGNTSRISG 278
               +IH ++ A NILL ++ +         K+SD G++  V     +D LQ    RI  
Sbjct: 130 EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVL---PKDILQ---ERIP- 182

Query: 279 TYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVS 311
              ++ PE        ++ +D +SFG  L EI S
Sbjct: 183 ---WVPPECIENPKNLNLATDKWSFGTTLWEICS 213

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  162 bits (412), Expect = 3e-44
 Identities = 53/202 (26%), Positives = 93/202 (46%), Gaps = 17/202 (8%)

Query: 116 KLGEGGFGTVYKGV---IGQGEI--AVKRL-LGKSGQEIKELKNEASVIAQVQHKNLVKL 169
            +GEG FG V++G+        +  A+K      S    ++   EA  + Q  H ++VKL
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456

Query: 170 LGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRV 229
           +G    ++   +I E      L  FL    ++  LD  + +     ++  L YL      
Sbjct: 457 IGVI-TENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYL---ESK 510

Query: 230 RIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL 289
           R +HRD+ A N+L+  +   K+ DFG++R +    D    + +  ++     +M+PE   
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASKGKLP--IKWMAPESIN 565

Query: 290 EGIFSIKSDVFSFGVLLLEIVS 311
              F+  SDV+ FGV + EI+ 
Sbjct: 566 FRRFTSASDVWMFGVCMWEILM 587

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  154 bits (392), Expect = 5e-44
 Identities = 74/290 (25%), Positives = 117/290 (40%), Gaps = 54/290 (18%)

Query: 116 KLGEGGFGTVYKGVIGQGE-----IAVKRLLGKSG-----QEIKELKNEASVIAQVQHKN 165
           KLG+G FG V +G           +AVK L  K       + + +   E + +  + H+N
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCL--KPDVLSQPEAMDDFIREVNAMHSLDHRN 82

Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ 225
           L++L G  +      ++ E  P  SL   L            T  +    VA+G+ YL  
Sbjct: 83  LIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGH--FLLGTLSRYAVQVAEGMGYL-- 137

Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
               R IHRDL A N+LL      KI DFG+ R +   +D   +Q +  ++   + + +P
Sbjct: 138 -ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR-KVP--FAWCAP 193

Query: 286 EYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNK-IIDLI 343
           E      FS  SD + FGV L E+ + G++              +     ++   I+  I
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEP-------------WI---GLNGSQILHKI 237

Query: 344 DSVLEEASFNESLSR--------YVHIALLCVQERAEDRPTMSDVVSMLT 385
           D         E L R        Y ++ + C   + EDRPT   +   L 
Sbjct: 238 DKE------GERLPRPEDCPQDIY-NVMVQCWAHKPEDRPTFVALRDFLL 280

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  137 bits (348), Expect = 2e-37
 Identities = 62/289 (21%), Positives = 117/289 (40%), Gaps = 43/289 (14%)

Query: 116 KLGEGGFGTVY--KGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCC 173
           KLGEGGF  V   +G+      A+KR+L    Q+ +E + EA +     H N+++L+  C
Sbjct: 36  KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95

Query: 174 IEKDER----LLIYEYMPNKSL-DCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSR 228
           + +        L+  +    +L +       K   L     + ++ G+ +GL  +H    
Sbjct: 96  LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA--- 152

Query: 229 VRIIHRDLKASNILLDKDMNSKISDFGMARIV---FGGNDEDELQGNTSRISGTYGYMSP 285
               HRDLK +NILL  +    + D G          G+ +     + +    T  Y +P
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212

Query: 286 E-YALEGIFSI--KSDVFSFGVLLLEIVSGKK--NTGFYRTKSLNLI---GYAWDLW--I 335
           E ++++    I  ++DV+S G +L  ++ G+   +  F +  S+ L      +       
Sbjct: 213 ELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRH 272

Query: 336 SNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML 384
           S+ +  L++S                     +      RP +  ++S L
Sbjct: 273 SSALWQLLNS--------------------MMTVDPHQRPHIPLLLSQL 301

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  136 bits (345), Expect = 3e-37
 Identities = 52/208 (25%), Positives = 100/208 (48%), Gaps = 24/208 (11%)

Query: 116 KLGEGGFGTVYKGV-IGQG-EIAVK--RLLGKSGQEIKELKNEASVIAQVQHKNLVKLLG 171
           ++G G F TVYKG+      E+A    +    +  E +  K EA ++  +QH N+V+   
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 172 CCI---EKDERLLIY-EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYS 227
                 +  + +++  E M + +L  +L    + +++  +      + + +GL +LH   
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHT-R 148

Query: 228 RVRIIHRDLKASNILLD-KDMNSKISDFGMARIVFGGNDEDELQGNTSR-ISGTYGYMSP 285
              IIHRDLK  NI +     + KI D G+A +          + + ++ + GT  +M+P
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL---------KRASFAKAVIGTPEFMAP 199

Query: 286 EYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           E   E  +    DV++FG+ +LE+ + +
Sbjct: 200 EMYEEK-YDESVDVYAFGMCMLEMATSE 226

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  136 bits (345), Expect = 3e-37
 Identities = 53/215 (24%), Positives = 95/215 (44%), Gaps = 24/215 (11%)

Query: 116 KLGEGGFGTVYKGV-IGQGEI-AVKRL-LGKSGQEIKELKNEASVIAQVQHKNLVKLLGC 172
            LG GGFG V++          A+KR+ L       +++  E   +A+++H  +V+    
Sbjct: 12  CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71

Query: 173 CIEKDE---------RLLIY---EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
            +EK+          ++ +Y   +    ++L  ++      E  +    + I   +A+ +
Sbjct: 72  WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAV 131

Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRIS--- 277
            +LH      ++HRDLK SNI    D   K+ DFG+   +    +E  +       +   
Sbjct: 132 EFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHT 188

Query: 278 ---GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEI 309
              GT  YMSPE      +S K D+FS G++L E+
Sbjct: 189 GQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL 223

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  134 bits (340), Expect = 5e-36
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 26/208 (12%)

Query: 116 KLGEGGFGTVYKGV-IGQGEI-AVK--RLLGKSGQEIKELKNEASVIAQVQHKNLVKLLG 171
           K+GEG FG          G    +K   +   S +E +E + E +V+A ++H N+V+   
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90

Query: 172 CCIEKDERLLIYEYMPNKSLDCFLFDPTKR-----EILDWRTRVQIIKGVAQGLLYLHQY 226
              E     ++ +Y     L   +           +ILDW   VQI       L ++H  
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWF--VQI----CLALKHVHDR 144

Query: 227 SRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPE 286
              +I+HRD+K+ NI L KD   ++ DFG+AR++    +            GT  Y+SPE
Sbjct: 145 ---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE------LARACIGTPYYLSPE 195

Query: 287 YALEGI-FSIKSDVFSFGVLLLEIVSGK 313
              E   ++ KSD+++ G +L E+ + K
Sbjct: 196 -ICENKPYNNKSDIWALGCVLYELCTLK 222

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  133 bits (336), Expect = 8e-36
 Identities = 67/289 (23%), Positives = 118/289 (40%), Gaps = 41/289 (14%)

Query: 105 SSATGNFSAANKLGEGGFGTVYKGV-IGQGEI-AVKRLL---GKSGQEIKELKNEASVIA 159
            +   NF    K+G G F  VY+   +  G   A+K++        +   +   E  ++ 
Sbjct: 28  YNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLK 87

Query: 160 QVQHKNLVKLLGCCIEKDERLLIY-EYMPNKSLDCFLFDPTKR-------EILDWRTRVQ 211
           Q+ H N++K     IE +E L I  E      L   +    K+        +  +   VQ
Sbjct: 88  QLNHPNVIKYYASFIEDNE-LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYF--VQ 144

Query: 212 IIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQG 271
           +       L ++H     R++HRD+K +N+ +      K+ D G+ R             
Sbjct: 145 L----CSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT----AA 193

Query: 272 NTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAW 331
           ++  + GT  YMSPE   E  ++ KSD++S G LL E+ + +     +    +NL     
Sbjct: 194 HS--LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNLYS--- 245

Query: 332 DLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDV 380
              +  KI       L    ++E L + V+   +C+    E RP ++ V
Sbjct: 246 ---LCKKIEQCDYPPLPSDHYSEELRQLVN---MCINPDPEKRPDVTYV 288

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  129 bits (326), Expect = 2e-34
 Identities = 56/229 (24%), Positives = 100/229 (43%), Gaps = 34/229 (14%)

Query: 110 NFSAANKLGEGGFGTVYKGV-IGQGEI-AVKRLLGKSGQEIKELKNEASVIAQVQHKNLV 167
           +F     LG+G FG V K          A+K++   + +++  + +E  ++A + H+ +V
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVV 65

Query: 168 KLLGCCIEKDERLLIYEYMPNKSLDCF---------LFD------PTKREILDWRTRVQI 212
           +     +E+   +     +  KS             L+D        ++    WR   QI
Sbjct: 66  RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQI 125

Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
           ++ ++    Y+H      IIHRDLK  NI +D+  N KI DFG+A+ V    D  +L   
Sbjct: 126 LEALS----YIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178

Query: 273 TSRIS--------GTYGYMSPE-YALEGIFSIKSDVFSFGVLLLEIVSG 312
               S        GT  Y++ E     G ++ K D++S G++  E++  
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  128 bits (324), Expect = 2e-34
 Identities = 67/290 (23%), Positives = 118/290 (40%), Gaps = 55/290 (18%)

Query: 110 NFSAANKLGEGGFGTVYKGV-IGQGEI-AVKRLLGKSGQEIKELKNEASVIAQVQHKNLV 167
           +F     +G GGFG V+K      G+   +KR+        ++ + E   +A++ H N+V
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV----KYNNEKAEREVKALAKLDHVNIV 67

Query: 168 KLLGCCIEKDERLLIYEYMPNKSLDCFLF---------------DPTKREILDWRTRVQI 212
              GC    D          ++S    LF               +  + E LD    +++
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL 127

Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
            + + +G+ Y+H     ++I+RDLK SNI L      KI DFG+   +       +  G 
Sbjct: 128 FEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL-------KNDGK 177

Query: 273 TSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLI--GYA 330
            +R  GT  YMSPE      +  + D+++ G++L E++     T F  +K    +  G  
Sbjct: 178 RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD-TAFETSKFFTDLRDGII 236

Query: 331 WDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDV 380
            D++   K   L+                       + ++ EDRP  S++
Sbjct: 237 SDIF-DKKEKTLLQK--------------------LLSKKPEDRPNTSEI 265

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  129 bits (326), Expect = 2e-34
 Identities = 58/231 (25%), Positives = 104/231 (45%), Gaps = 30/231 (12%)

Query: 100 SFSSVSSATGNFSAANKLGEGGFGTVYKGVIGQGEI-AVKR--LLGKSGQEIKELKNEAS 156
            F S+S     +S   ++G GG   V++ +  + +I A+K   L     Q +   +NE +
Sbjct: 19  YFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIA 78

Query: 157 VIAQVQHKNL--VKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIK 214
            + ++Q  +   ++L    I      ++ E   N  L+ +L    K++ +D   R    K
Sbjct: 79  YLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL---KKKKSIDPWERKSYWK 134

Query: 215 GVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTS 274
            + + +  +HQ+    I+H DLK +N L+      K+ DFG+A  +    D   +  ++ 
Sbjct: 135 NMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQM--QPDTTSVVKDSQ 188

Query: 275 RISGTYGYMSPEYALEGI------------FSIKSDVFSFGVLLLEIVSGK 313
              GT  YM PE A++ +             S KSDV+S G +L  +  GK
Sbjct: 189 V--GTVNYMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  128 bits (324), Expect = 3e-34
 Identities = 60/203 (29%), Positives = 103/203 (50%), Gaps = 16/203 (7%)

Query: 117 LGEGGFGTVYKGV-IGQGE-IAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCI 174
           LG+G +G VY G  +     IA+K +  +  +  + L  E ++   ++HKN+V+ LG   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF- 88

Query: 175 EKDERLLIY-EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
            ++  + I+ E +P  SL   L         + +T     K + +GL YLH     +I+H
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVH 145

Query: 234 RDLKASNILLD-KDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGI 292
           RD+K  N+L++      KISDFG ++ + G N        T   +GT  YM+PE   +G 
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINP------CTETFTGTLQYMAPEIIDKGP 199

Query: 293 --FSIKSDVFSFGVLLLEIVSGK 313
             +   +D++S G  ++E+ +GK
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGK 222

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  128 bits (323), Expect = 3e-34
 Identities = 58/224 (25%), Positives = 95/224 (42%), Gaps = 27/224 (12%)

Query: 105 SSATGNFSAANKLGEGGFGTVYKGV-IGQGEI-AVK--RLLGKSGQEIKELKNEASVIAQ 160
            S   ++     +G G +G   K      G+I   K       +  E + L +E +++ +
Sbjct: 2   PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 61

Query: 161 VQHKNLVKLLGCCIEKDERLL--IYEYMPNKSLDCFLFDPTKR-------EILDWRTRVQ 211
           ++H N+V+     I++    L  + EY     L   +   TK         +L      Q
Sbjct: 62  LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM--TQ 119

Query: 212 IIKGVAQGLLYLHQ--YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDEL 269
           +       L   H+       ++HRDLK +N+ LD   N K+ DFG+ARI+    + D  
Sbjct: 120 L----TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL----NHDTS 171

Query: 270 QGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
              T    GT  YMSPE      ++ KSD++S G LL E+ +  
Sbjct: 172 FAKT--FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM 213

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  128 bits (323), Expect = 5e-34
 Identities = 55/239 (23%), Positives = 90/239 (37%), Gaps = 30/239 (12%)

Query: 87  KGCEKEVDQFPLFSFSSVSSATG-NFSAANKLGEGGFGTVYKGV-IGQGEI-AVK--RLL 141
           +G   E  Q P +  S   S    +F   ++LG G +G V+K      G + AVK     
Sbjct: 34  RGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSP 93

Query: 142 GKSGQEIKELKNEASVIAQV-QHKNLVKLLGCCIEKDERLLIY-EYMPNKSLDCFLFDPT 199
            +  ++      E     +V QH   V+L     E+   L +  E     SL        
Sbjct: 94  FRGPKDRARKLAEVGSHEKVGQHPCCVRLEQA-WEEGGILYLQTELC-GPSLQQHCEAWG 151

Query: 200 KR----EILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFG 255
                 ++  +             L +LH      ++H D+K +NI L      K+ DFG
Sbjct: 152 ASLPEAQVWGYL--RDT----LLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFG 202

Query: 256 MARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK 314
           +   +              +  G   YM+PE  L+G +   +DVFS G+ +LE+    +
Sbjct: 203 LLVEL------GTAGAGEVQE-GDPRYMAPE-LLQGSYGTAADVFSLGLTILEVACNME 253

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  129 bits (326), Expect = 9e-34
 Identities = 54/216 (25%), Positives = 98/216 (45%), Gaps = 30/216 (13%)

Query: 115 NKLGEGGFGTVYKGVIGQGEI-AVKR--LLGKSGQEIKELKNEASVIAQVQHKNL--VKL 169
            ++G GG   V++ +  + +I A+K   L     Q +   +NE + + ++Q  +   ++L
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 170 LGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRV 229
               I      ++ E   N  L+ +L    K++ +D   R    K + + +  +HQ+   
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQH--- 174

Query: 230 RIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL 289
            I+H DLK +N L+  D   K+ DFG+A  +    D   +  ++    G   YM PE A+
Sbjct: 175 GIVHSDLKPANFLIV-DGMLKLIDFGIANQM--QPDTTSVVKDSQV--GAVNYMPPE-AI 228

Query: 290 EGI------------FSIKSDVFSFGVLLLEIVSGK 313
           + +             S KSDV+S G +L  +  GK
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  127 bits (320), Expect = 2e-33
 Identities = 54/216 (25%), Positives = 98/216 (45%), Gaps = 30/216 (13%)

Query: 115 NKLGEGGFGTVYKGVIGQGEI-AVKR--LLGKSGQEIKELKNEASVIAQVQHKNL--VKL 169
            ++G GG   V++ +  + +I A+K   L     Q +   +NE + + ++Q  +   ++L
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 170 LGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRV 229
               I      ++ E   N  L+ +L    K++ +D   R    K + + +  +HQ+   
Sbjct: 75  YDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQH--- 127

Query: 230 RIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL 289
            I+H DLK +N L+      K+ DFG+A  +    D   +  ++    GT  YM PE A+
Sbjct: 128 GIVHSDLKPANFLIVDG-MLKLIDFGIANQM--QPDTTSVVKDSQV--GTVNYMPPE-AI 181

Query: 290 EGI------------FSIKSDVFSFGVLLLEIVSGK 313
           + +             S KSDV+S G +L  +  GK
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  126 bits (319), Expect = 4e-33
 Identities = 51/205 (24%), Positives = 84/205 (40%), Gaps = 21/205 (10%)

Query: 115 NKLGEGGFGTVYKGV-IGQGE-IAVK--RLLGKSGQEIKELKNEASVIAQVQHKNLVKLL 170
            ++G G FG V++      G   AVK  RL     +E+            +    +V L 
Sbjct: 64  PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACA-------GLSSPRIVPLY 116

Query: 171 GCCIEKDERLLIY-EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRV 229
           G    +   + I+ E +   SL   +    +   L     +  +    +GL YLH     
Sbjct: 117 GAV-REGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHT---R 169

Query: 230 RIIHRDLKASNILLDKDMNS-KISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYA 288
           RI+H D+KA N+LL  D +   + DFG A  +        L      I GT  +M+PE  
Sbjct: 170 RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY-IPGTETHMAPEVV 228

Query: 289 LEGIFSIKSDVFSFGVLLLEIVSGK 313
           +      K D++S   ++L +++G 
Sbjct: 229 MGKPCDAKVDIWSSCCMMLHMLNGC 253

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  123 bits (312), Expect = 1e-32
 Identities = 57/213 (26%), Positives = 103/213 (48%), Gaps = 29/213 (13%)

Query: 115 NKLGEGGFGTVYKGV-IGQGEI-AVKRL-LGKSGQEIKELKNEASVI-AQVQHKNLVKLL 170
            +LG G +G V K   +  G+I AVKR+    + QE K L  +  +    V     V   
Sbjct: 13  MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFY 72

Query: 171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRV------QIIKGVAQGLLYLH 224
           G    + +  +  E M + SLD F      ++++D    +      +I   + + L +LH
Sbjct: 73  GALFREGDVWICMELM-DTSLDKFY-----KQVIDKGQTIPEDILGKIAVSIVKALEHLH 126

Query: 225 QYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMS 284
             S++ +IHRD+K SN+L++     K+ DFG++     G   D++  +    +G   YM+
Sbjct: 127 --SKLSVIHRDVKPSNVLINALGQVKMCDFGIS-----GYLVDDVAKDID--AGCKPYMA 177

Query: 285 PE----YALEGIFSIKSDVFSFGVLLLEIVSGK 313
           PE       +  +S+KSD++S G+ ++E+   +
Sbjct: 178 PERINPELNQKGYSVKSDIWSLGITMIELAILR 210

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  123 bits (310), Expect = 5e-32
 Identities = 74/324 (22%), Positives = 119/324 (36%), Gaps = 47/324 (14%)

Query: 116 KLGEGGFGTVY--KGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQ-HKNLVKLLGC 172
            L EGGF  VY  + V    E A+KRLL    ++ + +  E   + ++  H N+V+    
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 173 CIEKDER-------LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ 225
                E         L+   +    L  FL     R  L   T ++I     + + ++H 
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH- 153

Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRIS------GT 279
             +  IIHRDLK  N+LL      K+ DFG A  +    D        + +        T
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213

Query: 280 YGYMSPE-YALEGIFSI--KSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIG--YAW--D 332
             Y +PE   L   F I  K D+++ G +L  +   +    F     L ++   Y+    
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ--HPFEDGAKLRIVNGKYSIPPH 271

Query: 333 LWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSL- 391
                    LI ++L                    Q   E+R ++++VV  L   A++  
Sbjct: 272 DTQYTVFHSLIRAML--------------------QVNPEERLSIAEVVHQLQEIAAARN 311

Query: 392 LPPKQPAFCNLRNMESSTSTTEKS 415
           + PK P    L       S T   
Sbjct: 312 VNPKSPITELLEQNGGYGSATLSR 335

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  123 bits (309), Expect = 1e-31
 Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 20/204 (9%)

Query: 115 NKLGEGGFGTVYKGV-IGQGEI-AVKRL-LGKSGQEIKELKNEASVIAQVQHKNLVKLLG 171
           ++LG G  G V+K      G + A K + L        ++  E  V+ +     +V   G
Sbjct: 39  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 98

Query: 172 CCIEKDERLLIYEYMPNKSLDCFL--FDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRV 229
                 E  +  E+M   SLD  L        +IL      ++   V +GL YL    + 
Sbjct: 99  AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL-----GKVSIAVIKGLTYLR--EKH 151

Query: 230 RIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL 289
           +I+HRD+K SNIL++     K+ DFG++     G   D +  N+    GT  YMSPE   
Sbjct: 152 KIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMA-NS--FVGTRSYMSPERLQ 203

Query: 290 EGIFSIKSDVFSFGVLLLEIVSGK 313
              +S++SD++S G+ L+E+  G+
Sbjct: 204 GTHYSVQSDIWSMGLSLVEMAVGR 227

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  121 bits (306), Expect = 2e-31
 Identities = 70/259 (27%), Positives = 114/259 (44%), Gaps = 43/259 (16%)

Query: 109 GNFSAANKLGEGGFGTVYKGV-IGQGEI-AVK----RLLGKSGQEIKELKNEASVIAQVQ 162
             +     LG+GGF   ++       E+ A K     LL K  Q  K +  E S+   + 
Sbjct: 41  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLA 99

Query: 163 HKNLVKLLGCCIEKDERL-LIYEYMPNKSLDCFLFDPTKRE--ILDWRTR---VQIIKGV 216
           H+++V   G   E ++ + ++ E    +SL     +  KR   + +   R    QI+ G 
Sbjct: 100 HQHVVGFHGF-FEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARYYLRQIVLGC 154

Query: 217 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRI 276
                YLH+    R+IHRDLK  N+ L++D+  KI DFG+A  V    D +  +     +
Sbjct: 155 Q----YLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKK--V--L 201

Query: 277 SGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK--------KNTGFYRTKSLNLIG 328
            GT  Y++PE   +   S + DV+S G ++  ++ GK        K T + R K      
Sbjct: 202 CGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET-YLRIKKNE--- 257

Query: 329 YAWDLWISNKIIDLIDSVL 347
           Y+    I+     LI  +L
Sbjct: 258 YSIPKHINPVAASLIQKML 276

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  120 bits (304), Expect = 2e-31
 Identities = 53/205 (25%), Positives = 104/205 (50%), Gaps = 15/205 (7%)

Query: 111 FSAANKLGEGGFGTVYKGV-IGQGEI-AVKRLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
           ++   K+G+G  GTVY  + +  G+  A++++  +   + + + NE  V+ + ++ N+V 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSR 228
            L   +  DE  ++ EY+   SL     D      +D      + +   Q L +LH    
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN-- 135

Query: 229 VRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYA 288
            ++IHRD+K+ NILL  D + K++DFG           ++ + +T  + GT  +M+PE  
Sbjct: 136 -QVIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKRST--MVGTPYWMAPEVV 188

Query: 289 LEGIFSIKSDVFSFGVLLLEIVSGK 313
               +  K D++S G++ +E++ G+
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGE 213

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  120 bits (303), Expect = 4e-31
 Identities = 55/205 (26%), Positives = 99/205 (48%), Gaps = 15/205 (7%)

Query: 111 FSAANKLGEGGFGTVYKGV-IGQGEI-AVKRLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
             +  K+GEG  G V        G   AVK +  +  Q  + L NE  ++   QH N+V+
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106

Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSR 228
           +    +  +E  ++ E++   +L     D   +  L+      + + V Q L YLH    
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHA--- 159

Query: 229 VRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYA 288
             +IHRD+K+ +ILL  D   K+SDFG          +D  +  +  + GT  +M+PE  
Sbjct: 160 QGVIHRDIKSDSILLTLDGRVKLSDFG----FCAQISKDVPKRKS--LVGTPYWMAPEVI 213

Query: 289 LEGIFSIKSDVFSFGVLLLEIVSGK 313
              +++ + D++S G++++E+V G+
Sbjct: 214 SRSLYATEVDIWSLGIMVIEMVDGE 238

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  119 bits (300), Expect = 6e-31
 Identities = 70/259 (27%), Positives = 114/259 (44%), Gaps = 43/259 (16%)

Query: 109 GNFSAANKLGEGGFGTVYKGV-IGQGEI-AVK----RLLGKSGQEIKELKNEASVIAQVQ 162
             +     LG+GGF   ++       E+ A K     LL K  Q  K +  E S+   + 
Sbjct: 15  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLA 73

Query: 163 HKNLVKLLGCCIEKDERL-LIYEYMPNKSLDCFLFDPTKRE--ILDWRTR---VQIIKGV 216
           H+++V   G   E ++ + ++ E    +SL     +  KR   + +   R    QI+ G 
Sbjct: 74  HQHVVGFHGF-FEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARYYLRQIVLGC 128

Query: 217 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRI 276
                YLH+    R+IHRDLK  N+ L++D+  KI DFG+A  V    D +  +     +
Sbjct: 129 Q----YLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKK--V--L 175

Query: 277 SGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK--------KNTGFYRTKSLNLIG 328
            GT  Y++PE   +   S + DV+S G ++  ++ GK        K T + R K      
Sbjct: 176 CGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET-YLRIKKNE--- 231

Query: 329 YAWDLWISNKIIDLIDSVL 347
           Y+    I+     LI  +L
Sbjct: 232 YSIPKHINPVAASLIQKML 250

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  119 bits (300), Expect = 8e-31
 Identities = 60/206 (29%), Positives = 112/206 (54%), Gaps = 16/206 (7%)

Query: 111 FSAANKLGEGGFGTVYKGV-IGQGEI-AVKRL-LGKSGQEIKELKNEASVIAQVQHKNLV 167
           F+   K+G+G FG V+KG+     ++ A+K + L ++  EI++++ E +V++Q     + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 168 KLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYS 227
           K  G  ++  +  +I EY+   S      D  +   LD      I++ + +GL YLH   
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLDYLH--- 136

Query: 228 RVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEY 287
             + IHRD+KA+N+LL +    K++DFG+A    G   + +++ NT    GT  +M+PE 
Sbjct: 137 SEKKIHRDIKAANVLLSEHGEVKLADFGVA----GQLTDTQIKRNT--FVGTPFWMAPEV 190

Query: 288 ALEGIFSIKSDVFSFGVLLLEIVSGK 313
             +  +  K+D++S G+  +E+  G+
Sbjct: 191 IKQSAYDSKADIWSLGITAIELARGE 216

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  118 bits (298), Expect = 1e-30
 Identities = 57/203 (28%), Positives = 99/203 (48%), Gaps = 16/203 (7%)

Query: 116 KLGEGGFGTVYKGV--IGQGEIAVKRL---LGKSGQEIKELKNEASVIAQVQHKNLVKLL 170
           KLG GG  TVY     I   ++A+K +     +  + +K  + E    +Q+ H+N+V ++
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77

Query: 171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVR 230
               E D   L+ EY+   +L  ++        L   T +     +  G+ + H    +R
Sbjct: 78  DVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAH---DMR 131

Query: 231 IIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE 290
           I+HRD+K  NIL+D +   KI DFG+A+ +      +     T+ + GT  Y SPE A  
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKAL-----SETSLTQTNHVLGTVQYFSPEQAKG 186

Query: 291 GIFSIKSDVFSFGVLLLEIVSGK 313
                 +D++S G++L E++ G+
Sbjct: 187 EATDECTDIYSIGIVLYEMLVGE 209

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  118 bits (299), Expect = 2e-30
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 30/213 (14%)

Query: 116 KLGEGGFGTVYKGV-IGQGEI-AVKRL-LGKSGQEIKELKNEASVI-AQVQHKNLVKLLG 171
           ++G G +G+V K V    G+I AVKR+      +E K+L  +  V+        +V+  G
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88

Query: 172 CCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRV-------QIIKGVAQGLLYLH 224
               + +  +  E M + S D F      + +      V       +I     + L +L 
Sbjct: 89  ALFREGDCWICMELM-STSFDKFY-----KYVYSVLDDVIPEEILGKITLATVKALNHLK 142

Query: 225 QYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMS 284
               ++IIHRD+K SNILLD+  N K+ DFG++     G   D +       +G   YM+
Sbjct: 143 --ENLKIIHRDIKPSNILLDRSGNIKLCDFGIS-----GQLVDSIAKTRD--AGCRPYMA 193

Query: 285 PE----YALEGIFSIKSDVFSFGVLLLEIVSGK 313
           PE     A    + ++SDV+S G+ L E+ +G+
Sbjct: 194 PERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  117 bits (296), Expect = 3e-30
 Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 15/208 (7%)

Query: 116 KLGEGGFGTVYKGV-IGQGEI-AVKRL-LGKSGQEIKELKNEASVIAQVQHKNLVKLLGC 172
            +G G    V       + E  A+KR+ L K    + EL  E   ++Q  H N+V     
Sbjct: 22  VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81

Query: 173 CIEKDERLLIYEYMPNKSL-----DCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYS 227
            + KDE  L+ + +   S+             K  +LD  T   I++ V +GL YLH   
Sbjct: 82  FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH--- 138

Query: 228 RVRIIHRDLKASNILLDKDMNSKISDFGM-ARIVFGGNDEDELQGNTSRISGTYGYMSPE 286
           +   IHRD+KA NILL +D + +I+DFG+ A +  GG+        T    GT  +M+PE
Sbjct: 139 KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT--FVGTPCWMAPE 196

Query: 287 YALEGI-FSIKSDVFSFGVLLLEIVSGK 313
              +   +  K+D++SFG+  +E+ +G 
Sbjct: 197 VMEQVRGYDFKADIWSFGITAIELATGA 224

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  116 bits (294), Expect = 3e-30
 Identities = 62/219 (28%), Positives = 109/219 (49%), Gaps = 20/219 (9%)

Query: 102 SSVSSATGNFSAANKLGEGGFGTVYKGV-IGQGEI-AVK----RLLGKSGQEIKELKNEA 155
           + +     +F   N LG+G F  VY+   I  G   A+K    + + K+G   + ++NE 
Sbjct: 4   TCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR-VQNEV 62

Query: 156 SVIAQVQHKNLVKLLGCCIEKDERL-LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIK 214
            +  Q++H ++++L     E    + L+ E   N  ++ +L +  K    +   R   + 
Sbjct: 63  KIHCQLKHPSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKP-FSENEAR-HFMH 119

Query: 215 GVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTS 274
            +  G+LYLH +    I+HRDL  SN+LL ++MN KI+DFG+A         ++    T 
Sbjct: 120 QIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLA--TQLKMPHEKHY--T- 171

Query: 275 RISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
            + GT  Y+SPE A      ++SDV+S G +   ++ G+
Sbjct: 172 -LCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGR 209

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  117 bits (295), Expect = 5e-30
 Identities = 51/227 (22%), Positives = 94/227 (41%), Gaps = 29/227 (12%)

Query: 105 SSATGNFSAANKLGEGGFGTVYKGV--IGQGEIAVKRL-LGKSGQEIKELKNEASVIAQV 161
           S++   +  ++ LG+G    V++G         A+K        + +     E  V+ ++
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64

Query: 162 QHKNLVKLLGCCIEKDERLLIY---EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQ 218
            HKN+VKL     E+          E+ P  SL   L +P+    L     + +++ V  
Sbjct: 65  NHKNIVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123

Query: 219 GLLYLHQYSRVRIIHRDLKASNILL----DKDMNSKISDFGMARIVFGGNDEDELQGNTS 274
           G+ +L +     I+HR++K  NI+     D     K++DFG AR +    ++DE      
Sbjct: 124 GMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL----EDDEQ---FV 173

Query: 275 RISGTYGYMSPE--------YALEGIFSIKSDVFSFGVLLLEIVSGK 313
            + GT  Y+ P+           +  +    D++S GV      +G 
Sbjct: 174 SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  117 bits (294), Expect = 7e-30
 Identities = 52/207 (25%), Positives = 95/207 (45%), Gaps = 21/207 (10%)

Query: 116 KLGEGGFGTVYKGV-IGQGEI-AVKRL-LGKSGQEIKELKNEASVI-AQVQHKNLVKLLG 171
           ++G G  G V+K      G + AVK++    + +E K +  +  V+        +V+  G
Sbjct: 32  EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91

Query: 172 CCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRI 231
             I   +  +  E M     +        +  +  R   ++   + + L YL    +  +
Sbjct: 92  TFITNTDVFIAMELM-GTCAE--KLKKRMQGPIPERILGKMTVAIVKALYYLK--EKHGV 146

Query: 232 IHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPE----- 286
           IHRD+K SNILLD+    K+ DFG++     G   D+   + S  +G   YM+PE     
Sbjct: 147 IHRDVKPSNILLDERGQIKLCDFGIS-----GRLVDDKAKDRS--AGCAAYMAPERIDPP 199

Query: 287 YALEGIFSIKSDVFSFGVLLLEIVSGK 313
              +  + I++DV+S G+ L+E+ +G+
Sbjct: 200 DPTKPDYDIRADVWSLGISLVELATGQ 226

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  120 bits (303), Expect = 1e-29
 Identities = 40/207 (19%), Positives = 81/207 (39%), Gaps = 29/207 (14%)

Query: 116 KLGEGGFGTVYKG---VIGQGEIAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNLVKLL- 170
            +  GG G +Y      +    + +K L+     E +     E   +A+V H ++V++  
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146

Query: 171 -GCCIEKDERLLIY---EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQY 226
                ++    + Y   EY+  +SL            L     +  +  +   L YLH  
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEILPALSYLH-- 199

Query: 227 SRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPE 286
             + +++ DLK  NI+L ++   K+ D G    +           +   + GT G+ +PE
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI----------NSFGYLYGTPGFQAPE 247

Query: 287 YALEGIFSIKSDVFSFGVLLLEIVSGK 313
               G  ++ +D+++ G  L  +    
Sbjct: 248 IVRTGP-TVATDIYTVGRTLAALTLDL 273

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  117 bits (295), Expect = 1e-29
 Identities = 51/222 (22%), Positives = 89/222 (40%), Gaps = 15/222 (6%)

Query: 102 SSVSSATGNFSAANKLGEG--GFGTVYKGV-IGQGEI-AVKR--LLGKSGQEIKELKNEA 155
           SS     G +     +G+G     TV        GE   V+R  L   S + +  L+ E 
Sbjct: 18  SSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGEL 77

Query: 156 SVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSL-DCFLFDPTKREILDWRTRVQIIK 214
            V     H N+V      I  +E  ++  +M   S  D  L      + ++      I++
Sbjct: 78  HVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKD--LICTHFMDGMNELAIAYILQ 135

Query: 215 GVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFG-MARIVFGGNDEDELQGNT 273
           GV + L Y+H       +HR +KAS+IL+  D    +S       ++  G  +  +    
Sbjct: 136 GVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFP 192

Query: 274 SRISGTYGYMSPEYALEGI--FSIKSDVFSFGVLLLEIVSGK 313
                   ++SPE   + +  +  KSD++S G+   E+ +G 
Sbjct: 193 KYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  117 bits (294), Expect = 2e-29
 Identities = 53/228 (23%), Positives = 95/228 (41%), Gaps = 31/228 (13%)

Query: 105 SSATGNFSAANKLGEGGFGTVYKGV---IGQGEIAVKRL-LGKSGQEIKELKNEASVIAQ 160
           S++   +  ++ LG+G    V++G     G    A+K        + +     E  V+ +
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGD-LFAIKVFNNISFLRPVDVQMREFEVLKK 63

Query: 161 VQHKNLVKLLGCCIEKDERLLIY---EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVA 217
           + HKN+VKL     E+          E+ P  SL   L +P+    L     + +++ V 
Sbjct: 64  LNHKNIVKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122

Query: 218 QGLLYLHQYSRVRIIHRDLKASNILL----DKDMNSKISDFGMARIVFGGNDEDELQGNT 273
            G+ +L +     I+HR++K  NI+     D     K++DFG AR +    ++DE     
Sbjct: 123 GGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL----EDDEQF--V 173

Query: 274 SRISGTYGYMSPE--------YALEGIFSIKSDVFSFGVLLLEIVSGK 313
           S   GT  Y+ P+           +  +    D++S GV      +G 
Sbjct: 174 SLY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  117 bits (294), Expect = 4e-29
 Identities = 51/260 (19%), Positives = 99/260 (38%), Gaps = 36/260 (13%)

Query: 110 NFSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKSGQEIKELKNEASVIAQV-QHKNLV 167
           +F   + LG G  GT+    +    ++AVKR+L +          E  ++ +  +H N++
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVI 81

Query: 168 KLLGCCIEKDERLLIYEYMPNKSLDCFLFD--PTKREILDWRTRVQIIKGVAQGLLYLHQ 225
           +      ++  + +  E          L +    K         + +++    GL +LH 
Sbjct: 82  RYFCTEKDRQFQYIAIELCA-----ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS 136

Query: 226 YSRVRIIHRDLKASNILL-----DKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY 280
                I+HRDLK  NIL+        + + ISDFG+ + +  G          S + GT 
Sbjct: 137 L---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSF---SRRSGVPGTE 190

Query: 281 GYMSPEYALEGIF----SIKSDVFSFGVLLLEIVSGKK--------NTGFYRTKSLNLIG 328
           G+++PE  L        +   D+FS G +   ++S                   + +L  
Sbjct: 191 GWIAPEM-LSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDC 249

Query: 329 YAWDLWISNKIIDLIDSVLE 348
              +        +LI+ ++ 
Sbjct: 250 LHPEKHEDVIARELIEKMIA 269

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  115 bits (288), Expect = 8e-29
 Identities = 27/255 (10%), Positives = 55/255 (21%), Gaps = 52/255 (20%)

Query: 97  PLFSFSSVSSATGNFSAANKLGEGGFGTVYKGV---IGQGEIAVKRLLGK---SGQEIKE 150
                S +S           L  G    V+        + + A+K        S  E++ 
Sbjct: 50  ETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLE-DFALKVFTMGAENSRSELER 108

Query: 151 LKNEASVIAQVQHKNLVKLLGCC--------------------------IEKDERLLIYE 184
           L       A++  ++  +                                     LL+  
Sbjct: 109 LHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMP 168

Query: 185 YMP---NKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNI 241
                         F    R          +   + +    L       ++H      N+
Sbjct: 169 AASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNL 225

Query: 242 LLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEG---IFSIKSD 298
            +  D    + D      V          G     S      +P   L      F+   +
Sbjct: 226 FIMPDGRLMLGDVSALWKV----------GTRGPASSVPVTYAPREFLNASTATFTHALN 275

Query: 299 VFSFGVLLLEIVSGK 313
            +  G+ +  +    
Sbjct: 276 AWQLGLSIYRVWCLF 290

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  115 bits (289), Expect = 1e-28
 Identities = 32/243 (13%), Positives = 71/243 (29%), Gaps = 60/243 (24%)

Query: 117 LGEGGFGTVYKG---VIGQGEIAVKRLL---GKSGQEIKELKNEASVIAQ---------- 160
           LG+       +      G+    V             IK++K E   +            
Sbjct: 86  LGQEDPYAYLEATDQETGE-SFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 161 ------------VQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFD--------PTK 200
                       V+     K++   +++ +  ++  +     +   L           + 
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 201 REILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIV 260
            + L    R+Q+   V + L  LH Y    ++H  L+  +I+LD+     ++ F      
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261

Query: 261 FGGNDEDELQGNTSRISGTYGYMSPEY----------ALEGIFSIKSDVFSFGVLLLEIV 310
                     G ++      G+  PE               + +   D ++ G+ +  I 
Sbjct: 262 ----------GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311

Query: 311 SGK 313
              
Sbjct: 312 CAD 314

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  113 bits (284), Expect = 2e-28
 Identities = 53/207 (25%), Positives = 90/207 (43%), Gaps = 18/207 (8%)

Query: 116 KLGEGGFGTVYKGV--IGQGEIAVKRL---LGKSGQEIKELKNEASVIAQVQHKNLVKLL 170
            LG GG   V+         ++AVK L   L +        + EA   A + H  +V + 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78

Query: 171 GCCIEKDERLLIY----EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQY 226
                +     +     EY+   +L   +        +  +  +++I    Q L + H  
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQALNFSH-- 133

Query: 227 SRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPE 286
            +  IIHRD+K +NI++      K+ DFG+AR +    D       T+ + GT  Y+SPE
Sbjct: 134 -QNGIIHRDVKPANIMISATNAVKVMDFGIARAI---ADSGNSVTQTAAVIGTAQYLSPE 189

Query: 287 YALEGIFSIKSDVFSFGVLLLEIVSGK 313
            A       +SDV+S G +L E+++G+
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGE 216

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  112 bits (282), Expect = 2e-28
 Identities = 51/243 (20%), Positives = 89/243 (36%), Gaps = 49/243 (20%)

Query: 102 SSVSSATGNFSAANKLGEGGFGTVYKGV-IGQGEI-AVKR--LLGKSGQEIKELKNEASV 157
              S  T  F    K+G G FG+V+K V    G I A+KR         + +    E   
Sbjct: 4   GMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYA 63

Query: 158 IAQV-QHKNLVKLLGCCIEKDERLLIY-EYMPNKSLDCFLFDPTKR-----EILDWRTRV 210
            A + QH ++V+      E D+ +LI  EY    SL   + +  +      E       +
Sbjct: 64  HAVLGQHSHVVRYFSAWAE-DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLL 122

Query: 211 QIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKD-------------------MNSKI 251
           Q+     +GL Y+H    + ++H D+K SNI + +                    +  KI
Sbjct: 123 QV----GRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKI 175

Query: 252 SDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIV 310
            D G    +           +     G   +++ E   E      K+D+F+  + ++   
Sbjct: 176 GDLGHVTRI----------SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAA 225

Query: 311 SGK 313
             +
Sbjct: 226 GAE 228

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  112 bits (282), Expect = 3e-28
 Identities = 57/217 (26%), Positives = 103/217 (47%), Gaps = 32/217 (14%)

Query: 111 FSAANKLGEGGFGTVYKGV-IGQGEI-AVKRLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
           +    +LG+G FG VYK      G + A K +  KS +E+++   E  ++A   H  +VK
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRV-------QIIKGVAQGLL 221
           LLG      +  ++ E+ P  ++D          I+    R         + + + + L 
Sbjct: 81  LLGAYYHDGKLWIMIEFCPGGAVD---------AIMLELDRGLTEPQIQVVCRQMLEALN 131

Query: 222 YLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYG 281
           +LH     RIIHRDLKA N+L+  + + +++DFG    V   N +   + ++    GT  
Sbjct: 132 FLHSK---RIIHRDLKAGNVLMTLEGDIRLADFG----VSAKNLKTLQKRDS--FIGTPY 182

Query: 282 YMSPE-----YALEGIFSIKSDVFSFGVLLLEIVSGK 313
           +M+PE        +  +  K+D++S G+ L+E+   +
Sbjct: 183 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  112 bits (282), Expect = 3e-28
 Identities = 63/215 (29%), Positives = 110/215 (51%), Gaps = 29/215 (13%)

Query: 108 TGNFSAANKLGEGGFGTVYKGV-IGQGEI-AVKRLLGKSGQEIKELKNEASVIAQVQHKN 165
              F    KLGEG +G+VYK +    G+I A+K++      +++E+  E S++ Q    +
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV--PVESDLQEIIKEISIMQQCDSPH 85

Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRV-------QIIKGVAQ 218
           +VK  G   +  +  ++ EY    S+          +I+  R +         I++   +
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVS---------DIIRLRNKTLTEDEIATILQSTLK 136

Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
           GL YLH     R IHRD+KA NILL+ + ++K++DFG+A    G   +   + NT  + G
Sbjct: 137 GLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVA----GQLTDTMAKRNT--VIG 187

Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           T  +M+PE   E  ++  +D++S G+  +E+  GK
Sbjct: 188 TPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  115 bits (289), Expect = 7e-28
 Identities = 61/278 (21%), Positives = 109/278 (39%), Gaps = 33/278 (11%)

Query: 105 SSATGNFSAANKLGEGGFGTVYKGV---IGQGEIAVKRLLGKSGQEIKE-LKNEASVIAQ 160
           +   G +    +LG GGFG V + +    G+ ++A+K+   +   + +E    E  ++ +
Sbjct: 10  TQTCGPWEMKERLGTGGFGYVLRWIHQDTGE-QVAIKQCRQELSPKNRERWCLEIQIMKK 68

Query: 161 VQHKNLVKLLGCCIE-------KDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQII 213
           + H N+V       +        D  LL  EY     L  +L        L       ++
Sbjct: 69  LNHPNVVSAR-EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLL 127

Query: 214 KGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNS---KISDFGMARIVFGGNDEDELQ 270
             ++  L YLH+    RIIHRDLK  NI+L         KI D G A+ +    D+ EL 
Sbjct: 128 SDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL----DQGELC 180

Query: 271 GNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK-------KNTGFYRTKS 323
             T  + GT  Y++PE   +  +++  D +SFG L  E ++G        +   ++    
Sbjct: 181 --TEFV-GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR 237

Query: 324 LNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVH 361
                +          +     +      +  L+  + 
Sbjct: 238 EKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLE 275

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  112 bits (281), Expect = 8e-28
 Identities = 56/231 (24%), Positives = 93/231 (40%), Gaps = 38/231 (16%)

Query: 109 GNFSAANKLGEGGFGTVYKGVIGQGEIAVK-----------------RLLGKSGQEIKEL 151
            ++     L +G F  +          A+K                         +  + 
Sbjct: 31  NDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDF 90

Query: 152 KNEASVIAQVQHKNLVKLLGCCIEKDERL-LIYEYMPNKSL-----DCFLFDPTKREILD 205
           KNE  +I  ++++  +   G  I   + + +IYEYM N S+       F+ D      + 
Sbjct: 91  KNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149

Query: 206 WRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGND 265
            +    IIK V     Y+H  +   I HRD+K SNIL+DK+   K+SDFG +  +     
Sbjct: 150 IQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYM----V 203

Query: 266 EDELQGNTSRISGTYGYMSPEYALEGIFSI---KSDVFSFGVLLLEIVSGK 313
           + +++   SR  GTY +M PE       S    K D++S G+ L  +    
Sbjct: 204 DKKIK--GSR--GTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNV 249

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  109 bits (276), Expect = 1e-27
 Identities = 67/254 (26%), Positives = 107/254 (42%), Gaps = 35/254 (13%)

Query: 109 GNFSAANKLGEGGFGTVYKGV-IGQGEI-AVKRL----LGKSGQEIKELKNEASVIAQVQ 162
            +F     LG+G FG VY         I A+K L    L K+G E  +L+ E  + + ++
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLR 67

Query: 163 HKNLVKLLGCCIEKDERL-LIYEYMPNKSLDCFLFDPTKRE--ILDWRTRVQIIKGVAQG 219
           H N+++L G       R+ LI EY P  ++    +   ++     + RT    I  +A  
Sbjct: 68  HPNILRLYGY-FHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTA-TYITELANA 121

Query: 220 LLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRIS-G 278
           L Y H     R+IHRD+K  N+LL      KI+DFG +              +      G
Sbjct: 122 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV---------HAPSSRRTDLCG 169

Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK-----KNTGFYRTKSLNLIGYAWDL 333
           T  Y+ PE     +   K D++S GVL  E + GK             +   +  + +  
Sbjct: 170 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-FTFPD 228

Query: 334 WISNKIIDLIDSVL 347
           +++    DLI  +L
Sbjct: 229 FVTEGARDLISRLL 242

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  109 bits (275), Expect = 3e-27
 Identities = 50/207 (24%), Positives = 86/207 (41%), Gaps = 24/207 (11%)

Query: 116 KLGEGGFGTVYKG---VIGQGEIAVKRL---LGKSGQEIKELKNEASVIAQVQHKNLVKL 169
            +G GG G VY+    V  +  +A+K +   L         ++ EA    ++Q  ++V +
Sbjct: 41  LVGRGGMGDVYEAEDTVRER-IVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99

Query: 170 --LGCCIEKDERL-LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQY 226
              G   E D +L +    +    L   L    ++  L     V I++ +   L   H  
Sbjct: 100 HDFG---EIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDAAH-- 151

Query: 227 SRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPE 286
                 HRD+K  NIL+  D  + + DFG+A         DE         GT  YM+PE
Sbjct: 152 -AAGATHRDVKPENILVSADDFAYLVDFGIASAT-----TDEKLTQLGNTVGTLYYMAPE 205

Query: 287 YALEGIFSIKSDVFSFGVLLLEIVSGK 313
              E   + ++D+++   +L E ++G 
Sbjct: 206 RFSESHATYRADIYALTCVLYECLTGS 232

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  111 bits (279), Expect = 4e-27
 Identities = 58/275 (21%), Positives = 100/275 (36%), Gaps = 55/275 (20%)

Query: 115 NKLGEGGFGTVYKGVIGQGEI-AVKRLLGKSGQEIKELKNEASVIAQV-QHKNLVKLLGC 172
             LG G  GTV      QG   AVKR+L            E  ++ +   H N+++    
Sbjct: 21  KILGYGSSGTVVFQGSFQGRPVAVKRML-I--DFCDIALMEIKLLTESDDHPNVIRYYCS 77

Query: 173 CIEKDERLLIYEYMPNKSLDCFLFD--------PTKREILDWRTRVQIIKGVAQGLLYLH 224
                   +  E       +  L D            ++      + +++ +A G+ +LH
Sbjct: 78  ETTDRFLYIALELC-----NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132

Query: 225 QYSRVRIIHRDLKASNILLD-------------KDMNSKISDFGMARIVFGGNDEDELQG 271
               ++IIHRDLK  NIL+              +++   ISDFG+ + +   + +   + 
Sbjct: 133 S---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL--DSGQSSFRT 187

Query: 272 NTSRISGTYGYMSPEYALEGIFSI-------KSDVFSFGVLLLEIVSGKKNTGFY----- 319
           N +  SGT G+ +PE   E              D+FS G +   I+S  K   F      
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK-HPFGDKYSR 246

Query: 320 ----RTKSLNLIGYAWDLW--ISNKIIDLIDSVLE 348
                    +L          +  +  DLI  +++
Sbjct: 247 ESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMID 281

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  110 bits (276), Expect = 5e-27
 Identities = 46/332 (13%), Positives = 92/332 (27%), Gaps = 84/332 (25%)

Query: 117 LGEGGFGTVYKGV-IGQGEI-AVK---RLLGKSGQEIKELKNEAS--------------- 156
           LG+       +      GE   V             IK++K E                 
Sbjct: 81  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140

Query: 157 ----------VIAQVQHKNLVKLLGCC--IEKDERLLIYEYMPNKSLDCF--LFD-PTKR 201
                     ++   Q K ++++      +    R  +Y  M +        L    +  
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200

Query: 202 EILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVF 261
           + L    R+Q+   V + L  LH Y    ++H  L+  +I+LD+     ++ F       
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLV--- 254

Query: 262 GGNDEDELQGNTSRISGTYGYMSPEYAL-----------EGIFSIKSDVFSFGVLLLEIV 310
                    G     S + G+  PE                + +   D ++ G+++  I 
Sbjct: 255 -------RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307

Query: 311 SGKKNTGFYRTKSLNLIG--YAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQ 368
                    +  +L      +     I   +  L++  L                    +
Sbjct: 308 CAD--LPITKDAALGGSEWIFRSCKNIPQPVRALLEGFL--------------------R 345

Query: 369 ERAEDRPTMSDVVSM-LTNEASSLLPPKQPAF 399
              EDR      +      +  + L    P +
Sbjct: 346 YPKEDRLLPLQAMETPEYEQLRTELSAALPLY 377

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  110 bits (275), Expect = 6e-27
 Identities = 36/252 (14%), Positives = 74/252 (29%), Gaps = 30/252 (11%)

Query: 115 NKLGEGGFGTVYKGVIGQG-------EIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLV 167
           + LGEG F  VY+   G         +  +K     +  E          +        +
Sbjct: 71  HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFM 130

Query: 168 KLLGCCIEKDERLLIYEYMPNKSLDCFL--FDPTKREILDWRTRVQIIKGVAQGLLYLHQ 225
           K     + ++  +L+ E     +L   +  +  T  +++     +     +   +  +H 
Sbjct: 131 KFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD 190

Query: 226 YSRVRIIHRDLKASNILL-----------DKDMNSKISDFGMARIVFGGNDEDELQGNTS 274
                IIH D+K  N +L           D      + D G +  +              
Sbjct: 191 ---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKC- 246

Query: 275 RISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK---KNTGFYRTKSLNLIGYAW 331
               T G+   E      ++ + D F     +  ++ G            K   L     
Sbjct: 247 ---ETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLP 303

Query: 332 DLWISNKIIDLI 343
            L + N+   ++
Sbjct: 304 HLDMWNEFFHVM 315

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  111 bits (279), Expect = 8e-27
 Identities = 72/289 (24%), Positives = 116/289 (40%), Gaps = 41/289 (14%)

Query: 83  NKCKKGCEKEVDQFPLFSFSSVSSATGNFSAA----NKLGEGGFGTVYKGV--IGQGEIA 136
           +   +                ++S  G+ S       KLG G +G V      +   E A
Sbjct: 7   HSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERA 66

Query: 137 VKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCF 194
           +K +     S     +L  E +V+  + H N++KL     +K    L+ E          
Sbjct: 67  IKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGE---- 122

Query: 195 LFDP-TKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILL---DKDMNSK 250
           LFD    R   +      IIK V  G+ YLH+++   I+HRDLK  N+LL   +KD   K
Sbjct: 123 LFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIK 179

Query: 251 ISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIV 310
           I DFG++ +     ++ +++       GT  Y++PE  L   +  K DV+S GV+L  ++
Sbjct: 180 IVDFGLSAVF---ENQKKMKE----RLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILL 231

Query: 311 SGKKNTGFY-----------RTKSLNLIGYAWDLWISNKIIDLIDSVLE 348
           +G     F                       W   +S    DLI  +L+
Sbjct: 232 AGYP--PFGGQTDQEILRKVEKGKYTFDSPEWK-NVSEGAKDLIKQMLQ 277

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  109 bits (273), Expect = 8e-27
 Identities = 63/216 (29%), Positives = 103/216 (47%), Gaps = 34/216 (15%)

Query: 111 FSAANKLGEGGFGTVYKGV-IGQGEI-AVKRL---LGKSGQEIKELKNEASVIAQVQHKN 165
           FS   ++G G FG VY    +   E+ A+K++     +S ++ +++  E   + +++H N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQI---IKGVAQGLLY 222
            ++  GC + +    L+ EY    + D  L +  K+ +      V+I     G  QGL Y
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPL----QEVEIAAVTHGALQGLAY 169

Query: 223 LHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRIS--GTY 280
           LH +    +IHRD+KA NILL +    K+ DFG A I+                S  GT 
Sbjct: 170 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM------------APANSFVGTP 214

Query: 281 GYMSPE---YALEGIFSIKSDVFSFGVLLLEIVSGK 313
            +M+PE      EG +  K DV+S G+  +E+   K
Sbjct: 215 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 250

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  107 bits (268), Expect = 3e-26
 Identities = 60/328 (18%), Positives = 104/328 (31%), Gaps = 80/328 (24%)

Query: 116 KLGEGGFGTVYKG--VIGQGEIAVKRL-LGKSGQEIKELKNEASVIAQVQHKNLVKLLGC 172
            +G GGFG V++    +     A+KR+ L       +++  E   +A+++H  +V+    
Sbjct: 13  CMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 72

Query: 173 CIEKDERLLIYEYMPNKSLDCFLFDPTKREILDW---------------RTRVQIIKGVA 217
            +E        E       D     P                        T  Q+     
Sbjct: 73  WLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSP 132

Query: 218 QGLLY----------LHQYSRVR-----------------------------IIHRDLKA 238
           +  LY          L  +   R                             ++HRDLK 
Sbjct: 133 KVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKP 192

Query: 239 SNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRIS------GTYGYMSPEYALEGI 292
           SNI    D   K+ DFG+   +    +E  +       +      GT  YMSPE      
Sbjct: 193 SNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNN 252

Query: 293 FSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASF 352
           +S K D+FS G++L E++     T   R + +                D+ +       F
Sbjct: 253 YSHKVDIFSLGLILFELLYSFS-TQMERVRIIT---------------DVRNLKFPL-LF 295

Query: 353 NESLSRYVHIALLCVQERAEDRPTMSDV 380
            +   +   +    +     +RP  +D+
Sbjct: 296 TQKYPQEHMMVQDMLSPSPTERPEATDI 323

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  106 bits (267), Expect = 5e-26
 Identities = 64/230 (27%), Positives = 112/230 (48%), Gaps = 27/230 (11%)

Query: 99  FSFSSVSSATGNFSAANKLGEGGFGTVYKGV-IGQGEI-AVKRLLGKSGQEIKELKNEAS 156
              S++    G F     +G G +G VYKG  +  G++ A+K ++  +G E +E+K E +
Sbjct: 14  IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTGDEEEEIKQEIN 72

Query: 157 VIAQV-QHKNLVKLLGC-----CIEKDERL-LIYEYMPNKSL-DCFLFDPTKREILDWRT 208
           ++ +   H+N+    G          D++L L+ E+    S+ D  L   TK   L    
Sbjct: 73  MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD--LIKNTKGNTLKEEW 130

Query: 209 RVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDE 268
              I + + +GL +LHQ+   ++IHRD+K  N+LL ++   K+ DFG++       D   
Sbjct: 131 IAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS----AQLDRTV 183

Query: 269 LQGNTSRISGTYGYMSPE-----YALEGIFSIKSDVFSFGVLLLEIVSGK 313
            + NT    GT  +M+PE        +  +  KSD++S G+  +E+  G 
Sbjct: 184 GRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  107 bits (269), Expect = 2e-25
 Identities = 72/270 (26%), Positives = 112/270 (41%), Gaps = 37/270 (13%)

Query: 100 SFSSVSSATGNFSAA----NKLGEGGFGTVYKGV-IGQGEI-AVKRLLGK--SGQEIKEL 151
           S        G F+        LG+G FG V K       +  AVK +       ++   +
Sbjct: 9   SGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTI 68

Query: 152 KNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDP-TKREILDWRTRV 210
             E  ++ ++ H N++KL     +     ++ E          LFD   KR+        
Sbjct: 69  LREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGE----LFDEIIKRKRFSEHDAA 124

Query: 211 QIIKGVAQGLLYLHQYSRVRIIHRDLKASNILL-DKDMNS--KISDFGMARIVFGGNDED 267
           +IIK V  G+ Y+H++    I+HRDLK  NILL  K+ +   KI DFG++          
Sbjct: 125 RIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNT 178

Query: 268 ELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG------KKNTGFYR- 320
           +++       GT  Y++PE  L G +  K DV+S GV+L  ++SG      K      + 
Sbjct: 179 KMKD----RIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKR 233

Query: 321 --TKSLNLIGYAWDLWISNKIIDLIDSVLE 348
             T         W   IS+   DLI  +L 
Sbjct: 234 VETGKYAFDLPQWR-TISDDAKDLIRKMLT 262

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  104 bits (261), Expect = 2e-25
 Identities = 54/214 (25%), Positives = 92/214 (42%), Gaps = 27/214 (12%)

Query: 109 GNFSAANKLGEGGFGTVYKGV-IGQGEI-AVKRL----LGKSGQEIKELKNEASVIAQVQ 162
            +F     LG+G FG VY         I A+K L    L K G E  +L+ E  + + ++
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVE-HQLRREIEIQSHLR 72

Query: 163 HKNLVKLLGCCIEKDERL-LIYEYMPNKSLDCFLFDPTKRE--ILDWRTRVQIIKGVAQG 219
           H N++++        +R+ L+ E+ P   L    +   ++     + R+    ++ +A  
Sbjct: 73  HPNILRMYNY-FHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSA-TFMEELADA 126

Query: 220 LLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGT 279
           L Y H+    ++IHRD+K  N+L+      KI+DFG +                  + GT
Sbjct: 127 LHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS--------LRRRTMCGT 175

Query: 280 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
             Y+ PE         K D++  GVL  E + G 
Sbjct: 176 LDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  107 bits (268), Expect = 2e-25
 Identities = 73/297 (24%), Positives = 121/297 (40%), Gaps = 44/297 (14%)

Query: 115 NKLGEGGFGTVYKGV-IGQGEI-AVKRLL---GKSGQEIKELKNEASVIAQVQHKNLVKL 169
             LG+G FG V        G+  AVK +     K   + + L  E  ++ Q+ H N++KL
Sbjct: 32  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91

Query: 170 LGCCIEKDERLLIYEYMPNKSLDCFLFDP-TKREILDWRTRVQIIKGVAQGLLYLHQYSR 228
                +K    L+ E          LFD    R+        +II+ V  G+ Y+H+   
Sbjct: 92  YEFFEDKGYFYLVGEVYTGGE----LFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK- 146

Query: 229 VRIIHRDLKASNILL-DKDMNS--KISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
             I+HRDLK  N+LL  K  ++  +I DFG++          +++       GT  Y++P
Sbjct: 147 --IVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMKD----KIGTAYYIAP 197

Query: 286 EYALEGIFSIKSDVFSFGVLLLEIVSG------KKNTGFYR---TKSLNLIGYAWDLWIS 336
           E  L G +  K DV+S GV+L  ++SG             +             W   +S
Sbjct: 198 E-VLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWK-KVS 255

Query: 337 NKIIDLIDSVLEE-----ASFNESLSRYVH--IALLCVQERAEDRPTMSDVVSMLTN 386
               DLI  +L        S  ++L    H  I     ++ + D P++ + +  +  
Sbjct: 256 ESAKDLIRKMLTYVPSMRISARDALD---HEWIQTYTKEQISVDVPSLDNAILNIRQ 309

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  105 bits (263), Expect = 2e-25
 Identities = 46/206 (22%), Positives = 81/206 (39%), Gaps = 28/206 (13%)

Query: 116 KLGEGGFGTVYKGV-IGQGE------IAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
            +G+G F  V + +    G+      + V +     G   ++LK EAS+   ++H ++V+
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90

Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFLFDP-TKREILDW----RTRVQIIKGVAQGLLYL 223
           LL          +++E+M        L     KR    +          ++ + + L Y 
Sbjct: 91  LLETYSSDGMLYMVFEFMDGAD----LCFEIVKRADAGFVYSEAVASHYMRQILEALRYC 146

Query: 224 HQYSRVRIIHRDLKASNILL---DKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY 280
           H      IIHRD+K   +LL   +     K+  FG+A  +                 GT 
Sbjct: 147 HDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES------GLVAGGRVGTP 197

Query: 281 GYMSPEYALEGIFSIKSDVFSFGVLL 306
            +M+PE      +    DV+  GV+L
Sbjct: 198 HFMAPEVVKREPYGKPVDVWGCGVIL 223

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  106 bits (267), Expect = 4e-25
 Identities = 50/235 (21%), Positives = 94/235 (40%), Gaps = 24/235 (10%)

Query: 82  NNKCKKGCEKEVDQFPLFSFSSVSSATGNFSA----ANKLGEGGFGTVYKGV-IGQGEI- 135
                       D +  +    V     +         +LG G FG V++      G   
Sbjct: 126 GTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNF 185

Query: 136 AVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFL 195
           A K ++     + + ++ E   ++ ++H  LV L     + +E ++IYE+M        L
Sbjct: 186 AAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGE----L 241

Query: 196 FD--PTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILL-DKDMNS-KI 251
           F+    +   +     V+ ++ V +GL ++H+ +    +H DLK  NI+   K  N  K+
Sbjct: 242 FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKL 298

Query: 252 SDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLL 306
            DFG+   +           +    +GT  + +PE A        +D++S GVL 
Sbjct: 299 IDFGLTAHLDPKQ-------SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  103 bits (258), Expect = 5e-25
 Identities = 59/199 (29%), Positives = 93/199 (46%), Gaps = 23/199 (11%)

Query: 116 KLGEGGFGTVYKGV-IGQGEI-AVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLG 171
            LG+G FG V K       +  AVK +       ++   +  E  ++ ++ H N++KL  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88

Query: 172 CCIEKDERLLIYEYMPNKSLDCFLFDP-TKREILDWRTRVQIIKGVAQGLLYLHQYSRVR 230
              +     ++ E          LFD   KR+        +IIK V  G+ Y+H+++   
Sbjct: 89  ILEDSSSFYIVGELYTGGE----LFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--- 141

Query: 231 IIHRDLKASNILL---DKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEY 287
           I+HRDLK  NILL   +KD + KI DFG++        ++          GT  Y++PE 
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF----QQNTK---MKDRIGTAYYIAPE- 193

Query: 288 ALEGIFSIKSDVFSFGVLL 306
            L G +  K DV+S GV+L
Sbjct: 194 VLRGTYDEKCDVWSAGVIL 212

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  104 bits (262), Expect = 5e-25
 Identities = 55/244 (22%), Positives = 97/244 (39%), Gaps = 30/244 (12%)

Query: 76  VELTEGNNKCKKGCEKEVDQFPLFSFSSVSSATGNFSA----ANKLGEGGFGTVYKGV-I 130
           V       K     +   D +  +    V    G+         +LG G FG V++ V  
Sbjct: 14  VRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEK 73

Query: 131 GQGEI-AVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNK 189
             G +   K +      +   +KNE S++ Q+ H  L+ L     +K E +LI E+    
Sbjct: 74  ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF---- 129

Query: 190 SLDCF---LFD--PTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLD 244
                   LFD    +   +     +  ++   +GL ++H++    I+H D+K  NI+ +
Sbjct: 130 ---LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCE 183

Query: 245 KDMNS--KISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSF 302
               S  KI DFG+A  +    + DE        + T  + +PE          +D+++ 
Sbjct: 184 TKKASSVKIIDFGLATKL----NPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAI 236

Query: 303 GVLL 306
           GVL 
Sbjct: 237 GVLG 240

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  103 bits (258), Expect = 6e-25
 Identities = 65/252 (25%), Positives = 104/252 (41%), Gaps = 35/252 (13%)

Query: 117 LGEGGFGTVYKG--VIGQGEIAVK----RLLGKSGQEIKELKNEASVIAQVQHKNLVKLL 170
           LGEG +G V +          AVK    + L +       +K E  ++ +++HKN+++L+
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 171 GCCIEKDERLLIY---EYMPNKSLDCFLFD--PTKR--EILDWRTRVQIIKGVAQGLLYL 223
              +  +E+  +Y   EY      +  + D  P KR           Q+I G+     YL
Sbjct: 73  DV-LYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGLE----YL 125

Query: 224 HQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYM 283
           H      I+H+D+K  N+LL      KIS  G+A  +     +D  +  TS   G+  + 
Sbjct: 126 HSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCR--TS--QGSPAFQ 178

Query: 284 SPEYA--LEGIFSIKSDVFSFGVLLLEIVSGK-----KNTGFYRTKSLNLIGYAWDLWIS 336
            PE A  L+     K D++S GV L  I +G       N             YA      
Sbjct: 179 PPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS-YAIPGDCG 237

Query: 337 NKIIDLIDSVLE 348
             + DL+  +LE
Sbjct: 238 PPLSDLLKGMLE 249

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  102 bits (257), Expect = 1e-24
 Identities = 46/247 (18%), Positives = 92/247 (37%), Gaps = 55/247 (22%)

Query: 116 KLGEGGFGTVYKGV--IGQGEIAVK-----RLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
            +G+G +G V   +    +   A+K     ++   + ++++ +K E  ++ ++ H N+ +
Sbjct: 33  AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92

Query: 169 LLGCCIEKDERLLIYEYM-------------------------PNKSLDCFLFDPTKREI 203
           L     ++    L+ E                             +   C   +      
Sbjct: 93  LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152

Query: 204 LDWRTRV------------QIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNS-- 249
                R              I++ +   L YLH      I HRD+K  N L   + +   
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEI 209

Query: 250 KISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGI---FSIKSDVFSFGVLL 306
           K+ DFG+++  +  N+ +     T   +GT  +++PE  L      +  K D +S GVLL
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTT--KAGTPYFVAPE-VLNTTNESYGPKCDAWSAGVLL 266

Query: 307 LEIVSGK 313
             ++ G 
Sbjct: 267 HLLLMGA 273

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  103 bits (258), Expect = 1e-24
 Identities = 63/225 (28%), Positives = 104/225 (46%), Gaps = 32/225 (14%)

Query: 97  PLFSFSSVSSATGNFSA------ANKLGEGGFGTVYKGV-IGQGEI-AVKRLLGKSGQEI 148
             F    V++  G  ++         LG G FG V+K      G   A K +  +  ++ 
Sbjct: 71  APFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK 130

Query: 149 KELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCF---LFD--PTKREI 203
           +E+KNE SV+ Q+ H NL++L      K++ +L+ EY            LFD    +   
Sbjct: 131 EEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEY-------VDGGELFDRIIDESYN 183

Query: 204 LDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILL-DKDMNS-KISDFGMARIVF 261
           L     +  +K + +G+ ++HQ     I+H DLK  NIL  ++D    KI DFG+AR   
Sbjct: 184 LTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRY- 239

Query: 262 GGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLL 306
                ++L+ N     GT  +++PE       S  +D++S GV+ 
Sbjct: 240 --KPREKLKVNF----GTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  101 bits (254), Expect = 3e-24
 Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 27/204 (13%)

Query: 116 KLGEGGFGTVYKGV-IGQGE------IAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLV 167
           +LG G F  V K      G       I  ++      G   +E++ E S++ QV H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78

Query: 168 KLLGCCIEKDERLLIYEYMPNKSLDCFLFDP-TKREILDWRTRVQIIKGVAQGLLYLHQY 226
            L      + + +LI E +        LFD   ++E L        IK +  G+ YLH  
Sbjct: 79  TLHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSEEEATSFIKQILDGVNYLHTK 134

Query: 227 SRVRIIHRDLKASNILL-DKDMNS---KISDFGMARIVFGGNDEDELQGNTSRISGTYGY 282
               I H DLK  NI+L DK++     K+ DFG+A  +    D  E +     I GT  +
Sbjct: 135 K---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKN----IFGTPEF 184

Query: 283 MSPEYALEGIFSIKSDVFSFGVLL 306
           ++PE        +++D++S GV+ 
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVIT 208

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  100 bits (252), Expect = 3e-24
 Identities = 58/199 (29%), Positives = 98/199 (49%), Gaps = 22/199 (11%)

Query: 116 KLGEGGFGTVYKGV-IGQGEI-AVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLG 171
           +LG+G F  V + V    G   A K +  K  S ++ ++L+ EA +  ++QH N+V+L  
Sbjct: 13  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 72

Query: 172 CCIEKDERLLIYEYMPNKSLDCFLFDP-TKREILDWRTRVQIIKGVAQGLLYLHQYSRVR 230
              E+    L+++ +        LF+    RE          I+ + + + Y H      
Sbjct: 73  SIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADASHCIQQILESIAYCHSN---G 125

Query: 231 IIHRDLKASNILL-DKDMNS--KISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEY 287
           I+HR+LK  N+LL  K   +  K++DFG+A  V   ND +   G     +GT GY+SPE 
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV---NDSEAWHG----FAGTPGYLSPEV 178

Query: 288 ALEGIFSIKSDVFSFGVLL 306
             +  +S   D+++ GV+L
Sbjct: 179 LKKDPYSKPVDIWACGVIL 197

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  102 bits (255), Expect = 3e-24
 Identities = 56/204 (27%), Positives = 90/204 (44%), Gaps = 27/204 (13%)

Query: 116 KLGEGGFGTVYKGV-IGQGE------IAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNLV 167
           +LG G F  V K      G       I  ++         +E ++ E S++ QV H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78

Query: 168 KLLGCCIEKDERLLIYEYMPNKSLDCFLFDP-TKREILDWRTRVQIIKGVAQGLLYLHQY 226
            L      + + +LI E +        LFD   ++E L        IK +  G+ YLH  
Sbjct: 79  TLHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSEEEATSFIKQILDGVNYLHTK 134

Query: 227 SRVRIIHRDLKASNILL-DKDMNS---KISDFGMARIVFGGNDEDELQGNTSRISGTYGY 282
               I H DLK  NI+L DK++     K+ DFG+A  +    D  E +     I GT  +
Sbjct: 135 K---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKN----IFGTPEF 184

Query: 283 MSPEYALEGIFSIKSDVFSFGVLL 306
           ++PE        +++D++S GV+ 
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVIT 208

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  101 bits (254), Expect = 5e-24
 Identities = 55/254 (21%), Positives = 102/254 (40%), Gaps = 66/254 (25%)

Query: 95  QFPLFSFSSVSSATGNFSAANKLGEGGFGTVYKGV-IGQGEI-AVKRLL---GKSG---- 145
           Q+           +  +    K+G+G FG V+K      G+  A+K++L    K G    
Sbjct: 4   QYDSVECPFCDEVS-KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPIT 62

Query: 146 --QEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERL--------LIYEYM--------- 186
             +EIK L+        ++H+N+V L+  C  K            L++++          
Sbjct: 63  ALREIKILQ-------LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS 115

Query: 187 -PNKSLD-----CFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASN 240
                         +                ++ G+     Y+H+    +I+HRD+KA+N
Sbjct: 116 NVLVKFTLSEIKRVMQ--------------MLLNGLY----YIHRN---KILHRDMKAAN 154

Query: 241 ILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL-EGIFSIKSDV 299
           +L+ +D   K++DFG+AR  F      +    T+R+  T  Y  PE  L E  +    D+
Sbjct: 155 VLITRDGVLKLADFGLAR-AFSLAKNSQPNRYTNRVV-TLWYRPPELLLGERDYGPPIDL 212

Query: 300 FSFGVLLLEIVSGK 313
           +  G ++ E+ +  
Sbjct: 213 WGAGCIMAEMWTRS 226

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  101 bits (254), Expect = 5e-24
 Identities = 58/199 (29%), Positives = 97/199 (48%), Gaps = 22/199 (11%)

Query: 116 KLGEGGFGTVYKGV-IGQGEI-AVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLG 171
           +LG+G F  V + V    G   A K +  K  S ++ ++L+ EA +  ++QH N+V+L  
Sbjct: 36  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95

Query: 172 CCIEKDERLLIYEYMPNKSLDCFLFDP-TKREILDWRTRVQIIKGVAQGLLYLHQYSRVR 230
              E+    L+++ +        LF+    RE          I+ + + + Y H      
Sbjct: 96  SIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADASHCIQQILESIAYCHSNG--- 148

Query: 231 IIHRDLKASNILL---DKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEY 287
           I+HR+LK  N+LL    K    K++DFG+A  V   ND +   G     +GT GY+SPE 
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV---NDSEAWHG----FAGTPGYLSPEV 201

Query: 288 ALEGIFSIKSDVFSFGVLL 306
             +  +S   D+++ GV+L
Sbjct: 202 LKKDPYSKPVDIWACGVIL 220

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score =  100 bits (251), Expect = 5e-24
 Identities = 47/170 (27%), Positives = 82/170 (48%), Gaps = 36/170 (21%)

Query: 110 NFSAANKLGEGGFGTVYKGV-IGQGEI-AVKRL-LGKSGQ--------EIKELKNEASVI 158
           NF    K+GEG +G VYK      GE+ A+K++ L    +        EI  LK      
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK------ 57

Query: 159 AQVQHKNLVKLLGCCIEKDERLLIYEYMPN------KSLDCFLFDPTKREILDWRTRVQI 212
            ++ H N+VKLL     +++  L++E++         +           +   +    Q+
Sbjct: 58  -ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF----QL 112

Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFG 262
           ++G+A    + H +   R++HRDLK  N+L++ +   K++DFG+AR  FG
Sbjct: 113 LQGLA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFG 154

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  100 bits (251), Expect = 6e-24
 Identities = 54/197 (27%), Positives = 91/197 (46%), Gaps = 21/197 (10%)

Query: 116 KLGEGGFGTVYKGV-IGQGEI-AVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCC 173
            LG G F  V+       G++ A+K +          L+NE +V+ +++H+N+V L    
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75

Query: 174 IEKDERLLIYEYMPNKSLDCFLFDP-TKREILDWRTRVQIIKGVAQGLLYLHQYSRVRII 232
                  L+ + +        LFD   +R +   +    +I+ V   + YLH+     I+
Sbjct: 76  ESTTHYYLVMQLVS----GGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN---GIV 128

Query: 233 HRDLKASNILL-DKDMNS--KISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL 289
           HRDLK  N+L    + NS   I+DFG++++        E  G  S   GT GY++PE   
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSKM--------EQNGIMSTACGTPGYVAPEVLA 180

Query: 290 EGIFSIKSDVFSFGVLL 306
           +  +S   D +S GV+ 
Sbjct: 181 QKPYSKAVDCWSIGVIT 197

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  102 bits (256), Expect = 1e-23
 Identities = 64/262 (24%), Positives = 112/262 (42%), Gaps = 44/262 (16%)

Query: 115 NKLGEGGFGTVYKGV-IGQGEI-AVKRL-------------LGKSGQEIKELKNEASVIA 159
            KLG G +G V            A+K +                  +  +E+ NE S++ 
Sbjct: 42  RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101

Query: 160 QVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDP-TKREILDWRTRVQIIKGVAQ 218
            + H N++KL     +K    L+ E+     L    F+    R   D      I+K +  
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL----FEQIINRHKFDECDAANIMKQILS 157

Query: 219 GLLYLHQYSRVRIIHRDLKASNILL-DKDMNS--KISDFGMARIVFGGNDEDELQGNTSR 275
           G+ YLH+++   I+HRD+K  NILL +K+     KI DFG++      + + +L+     
Sbjct: 158 GICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFF---SKDYKLRD---- 207

Query: 276 ISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG------KKNTGFYR---TKSLNL 326
             GT  Y++PE  L+  ++ K DV+S GV++  ++ G      + +    +         
Sbjct: 208 RLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYF 266

Query: 327 IGYAWDLWISNKIIDLIDSVLE 348
               W   IS++  +LI  +L 
Sbjct: 267 DFNDWK-NISDEAKELIKLMLT 287

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 99.6 bits (249), Expect = 1e-23
 Identities = 54/166 (32%), Positives = 82/166 (49%), Gaps = 30/166 (18%)

Query: 110 NFSAANKLGEGGFGTVYKGVIGQGEI-AVKRL-LGKSGQ--------EIKELKNEASVIA 159
            +    K+GEG +G VYK    QG I A+KR+ L    +        EI  LK       
Sbjct: 22  KYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLK------- 74

Query: 160 QVQHKNLVKLLGCCIEKDERLLIYEYMPN---KSLDCFLFDPTKREILDWRTRVQIIKGV 216
           ++ H N+V L+     +    L++E+M     K LD         +I  +    Q+++GV
Sbjct: 75  ELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYL--YQLLRGV 132

Query: 217 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFG 262
           A    + HQ+   RI+HRDLK  N+L++ D   K++DFG+AR  FG
Sbjct: 133 A----HCHQH---RILHRDLKPQNLLINSDGALKLADFGLAR-AFG 170

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 99.1 bits (248), Expect = 1e-23
 Identities = 51/166 (30%), Positives = 81/166 (48%), Gaps = 30/166 (18%)

Query: 110 NFSAANKLGEGGFGTVYKGVIGQGEI-AVKRL-LGKSGQ--------EIKELKNEASVIA 159
            +    K+GEG +G VYK     GE  A+K++ L K  +        EI  LK       
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILK------- 55

Query: 160 QVQHKNLVKLLGCCIEKDERLLIYEYMPN---KSLDCFLFDPTKREILDWRTRVQIIKGV 216
           +++H N+VKL      K   +L++E++     K LD             +   +Q++ G+
Sbjct: 56  ELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFL--LQLLNGI 113

Query: 217 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFG 262
           A    Y H     R++HRDLK  N+L++++   KI+DFG+AR  FG
Sbjct: 114 A----YCHDR---RVLHRDLKPQNLLINREGELKIADFGLAR-AFG 151

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 99.6 bits (249), Expect = 1e-23
 Identities = 52/173 (30%), Positives = 88/173 (50%), Gaps = 31/173 (17%)

Query: 106 SATGNFSAANKLGEGGFGTVYKGV-IGQGEI-AVK--RLLGKSG------QEIKELKNEA 155
           S++  F    KLG G + TVYKG+    G   A+K  +L  + G      +EI  +K   
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKE-- 59

Query: 156 SVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPN---KSLDCFLFDPTKREILDWRTR--- 209
                ++H+N+V+L      +++  L++E+M N   K +D      T R +     +   
Sbjct: 60  -----LKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQ 114

Query: 210 VQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFG 262
            Q+++G+A    + H+    +I+HRDLK  N+L++K    K+ DFG+AR  FG
Sbjct: 115 WQLLQGLA----FCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLAR-AFG 159

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 98.8 bits (247), Expect = 1e-23
 Identities = 47/197 (23%), Positives = 82/197 (41%), Gaps = 21/197 (10%)

Query: 116 KLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCC 173
            +G G +G V   V    +   A K++     +++   K E  ++  + H N+++L    
Sbjct: 16  TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75

Query: 174 IEKDERLLIYEYMPNKSLDCFLFDP-TKREILDWRTRVQIIKGVAQGLLYLHQYSRVRII 232
            +  +  L+ E          LF+    + +       +I+K V   + Y H+     + 
Sbjct: 76  EDNTDIYLVMELCTGGE----LFERVVHKRVFRESDAARIMKDVLSAVAYCHKL---NVA 128

Query: 233 HRDLKASNILL---DKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL 289
           HRDLK  N L      D   K+ DFG+A     G              GT  Y+SP+  L
Sbjct: 129 HRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK-------MMRTKVGTPYYVSPQ-VL 180

Query: 290 EGIFSIKSDVFSFGVLL 306
           EG++  + D +S GV++
Sbjct: 181 EGLYGPECDEWSAGVMM 197

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 99.6 bits (249), Expect = 2e-23
 Identities = 47/200 (23%), Positives = 86/200 (43%), Gaps = 27/200 (13%)

Query: 116 KLGEGGFGTVYKGV-IGQGEI-AVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCC 173
            LG G FG V++ V     +    K +    G +   +K E S++   +H+N++ L    
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNILHLHESF 70

Query: 174 IEKDERLLIYEYMPNKSLDCF---LFD--PTKREILDWRTRVQIIKGVAQGLLYLHQYSR 228
              +E ++I+E+            +F+   T    L+ R  V  +  V + L +LH ++ 
Sbjct: 71  ESMEELVMIFEF-------ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN- 122

Query: 229 VRIIHRDLKASNILLDKDMNS--KISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPE 286
             I H D++  NI+     +S  KI +FG AR +       +       +     Y +PE
Sbjct: 123 --IGHFDIRPENIIYQTRRSSTIKIIEFGQARQL----KPGDNF---RLLFTAPEYYAPE 173

Query: 287 YALEGIFSIKSDVFSFGVLL 306
                + S  +D++S G L+
Sbjct: 174 VHQHDVVSTATDMWSLGTLV 193

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 98.4 bits (246), Expect = 2e-23
 Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 33/207 (15%)

Query: 116 KLGEGGFGTVYKGV-IGQGE------IAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLV 167
           +LG G F  V K    G G+      I  +RL     G   +E++ E +++ +++H N++
Sbjct: 12  ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71

Query: 168 KLLGCCIEKDERLLIYEYMPNKSLDCF---LFDP-TKREILDWRTRVQIIKGVAQGLLYL 223
            L      K + +LI E             LFD   ++E L      Q +K +  G+ YL
Sbjct: 72  TLHDIFENKTDVVLILEL-------VSGGELFDFLAEKESLTEDEATQFLKQILDGVHYL 124

Query: 224 HQYSRVRIIHRDLKASNILL-DKDMNS---KISDFGMARIVFGGNDEDELQGNTSRISGT 279
           H     RI H DLK  NI+L DK++ +   K+ DFG+A  +      +E +     I GT
Sbjct: 125 HS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI---EAGNEFKN----IFGT 174

Query: 280 YGYMSPEYALEGIFSIKSDVFSFGVLL 306
             +++PE        +++D++S GV+ 
Sbjct: 175 PEFVAPEIVNYEPLGLEADMWSIGVIT 201

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 98.1 bits (245), Expect = 2e-23
 Identities = 48/202 (23%), Positives = 86/202 (42%), Gaps = 26/202 (12%)

Query: 116 KLGEGGFGTVYKGV--IGQGEIAVKRLL-GKSGQEIKELKNEASVIAQVQHKNLVKLLGC 172
           KLG G FG V+         E  +K +   +S   +++++ E  V+  + H N++K+   
Sbjct: 29  KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88

Query: 173 CIEKDERLLIYEYMPNKSLDCFLFD-----PTKREILDWRTRVQIIKGVAQGLLYLHQYS 227
             +     ++ E      L     +       + + L      +++K +   L Y H   
Sbjct: 89  FEDYHNMYIVMETCEGGEL----LERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ- 143

Query: 228 RVRIIHRDLKASNILL---DKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMS 284
              ++H+DLK  NIL          KI DFG+A +       DE     +  +GT  YM+
Sbjct: 144 --HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF----KSDEHS---TNAAGTALYMA 194

Query: 285 PEYALEGIFSIKSDVFSFGVLL 306
           PE   +   + K D++S GV++
Sbjct: 195 PE-VFKRDVTFKCDIWSAGVVM 215

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 97.2 bits (243), Expect = 5e-23
 Identities = 46/167 (27%), Positives = 79/167 (47%), Gaps = 31/167 (18%)

Query: 110 NFSAANKLGEGGFGTVYKGV-IGQGEI-AVKRL-LGKSGQ--------EIKELKNEASVI 158
            +    K+GEG +GTV+K       EI A+KR+ L    +        EI  LK      
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLK------ 56

Query: 159 AQVQHKNLVKLLGCCIEKDERLLIYEYMPN---KSLDCFLFDPTKREILDWRTRVQIIKG 215
            +++HKN+V+L        +  L++E+      K  D    D     +  +    Q++KG
Sbjct: 57  -ELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFL--FQLLKG 113

Query: 216 VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFG 262
           +     + H      ++HRDLK  N+L++++   K+++FG+AR  FG
Sbjct: 114 LG----FCHSR---NVLHRDLKPQNLLINRNGELKLANFGLAR-AFG 152

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 98.0 bits (245), Expect = 7e-23
 Identities = 50/188 (26%), Positives = 82/188 (43%), Gaps = 58/188 (30%)

Query: 104 VSSATGNFSAANKLGEGGFGTVYKGV-IGQGEI-AVKRL-LGKSGQ-----------EIK 149
           V S    +   + LGEG F TVYK       +I A+K++ LG   +           EIK
Sbjct: 5   VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK 64

Query: 150 ELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYM----------PNKSLD-----CF 194
            L+       ++ H N++ LL     K    L++++M           +  L       +
Sbjct: 65  LLQ-------ELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAY 117

Query: 195 LFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDF 254
           +                 ++G+     YLHQ+    I+HRDLK +N+LLD++   K++DF
Sbjct: 118 ML--------------MTLQGLE----YLHQH---WILHRDLKPNNLLLDENGVLKLADF 156

Query: 255 GMARIVFG 262
           G+A+  FG
Sbjct: 157 GLAK-SFG 163

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 97.3 bits (243), Expect = 8e-23
 Identities = 58/222 (26%), Positives = 93/222 (41%), Gaps = 25/222 (11%)

Query: 103 SVSSATGNFSA-----ANKLGEGGFGTVYKGV-IGQGEI-AVKRLLGKSGQEIKELKNEA 155
           S  S +G F        + LGEG    V   + +   +  AVK +  + G     +  E 
Sbjct: 2   STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREV 61

Query: 156 SVIAQVQ-HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDP-TKREILDWRTRVQII 213
            ++ Q Q H+N+++L+    E+D   L++E M   S+         KR   +      ++
Sbjct: 62  EMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI----LSHIHKRRHFNELEASVVV 117

Query: 214 KGVAQGLLYLHQYSRVRIIHRDLKASNILL-DKDMNS--KISDFGMARIV-FGGNDEDEL 269
           + VA  L +LH      I HRDLK  NIL    +  S  KI DF +   +   G+     
Sbjct: 118 QDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIS 174

Query: 270 QGNTSRISGTYGYMSPE-----YALEGIFSIKSDVFSFGVLL 306
                   G+  YM+PE          I+  + D++S GV+L
Sbjct: 175 TPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 98.5 bits (246), Expect = 1e-22
 Identities = 54/199 (27%), Positives = 95/199 (47%), Gaps = 21/199 (10%)

Query: 116 KLGEGGFGTVYKGV-IGQGEI-AVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLG 171
           +LG+G F  V + V +  G+  A   +  K  S ++ ++L+ EA +   ++H N+V+L  
Sbjct: 18  ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77

Query: 172 CCIEKDERLLIYEYMPNKSLDCFLFDP-TKREILDWRTRVQIIKGVAQGLLYLHQYSRVR 230
              E+    LI++ +        LF+    RE          I+ + + +L+ HQ     
Sbjct: 78  SISEEGHHYLIFDLVTGGE----LFEDIVAREYYSEADASHCIQQILEAVLHCHQMG--- 130

Query: 231 IIHRDLKASNILL---DKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEY 287
           ++HR+LK  N+LL    K    K++DFG+A  V G              +GT GY+SPE 
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ------AWFGFAGTPGYLSPEV 184

Query: 288 ALEGIFSIKSDVFSFGVLL 306
             +  +    D+++ GV+L
Sbjct: 185 LRKDPYGKPVDLWACGVIL 203

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 96.9 bits (242), Expect = 1e-22
 Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 33/207 (15%)

Query: 116 KLGEGGFGTVYKGV-IGQGE------IAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLV 167
           +LG G F  V K      G       I  +R      G   ++++ E S++ ++QH N++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77

Query: 168 KLLGCCIEKDERLLIYEYMPNKSLDCF---LFDP-TKREILDWRTRVQIIKGVAQGLLYL 223
            L      K + +LI E             LFD   ++E L      + +K +  G+ YL
Sbjct: 78  TLHEVYENKTDVILILEL-------VAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130

Query: 224 HQYSRVRIIHRDLKASNILL-DKDMNS---KISDFGMARIVFGGNDEDELQGNTSRISGT 279
           H      I H DLK  NI+L D+++     KI DFG+A  +   +  +E +     I GT
Sbjct: 131 HSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKN----IFGT 180

Query: 280 YGYMSPEYALEGIFSIKSDVFSFGVLL 306
             +++PE        +++D++S GV+ 
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVIT 207

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 97.8 bits (244), Expect = 2e-22
 Identities = 54/252 (21%), Positives = 95/252 (37%), Gaps = 36/252 (14%)

Query: 76  VELTEGNNKCKKGCEKEVDQFPLFSFSSVSSATGNFSA----ANKLGEGGFGTVYKGV-I 130
             L   +         +V  F   +    S            +  LG G  G V      
Sbjct: 98  RPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFER 157

Query: 131 GQGEI-AVK-----RLLGKSGQEIKE---LKNEASVIAQVQHKNLVKLLGCCIEKDERLL 181
              +  A++     +    S +E      ++ E  ++ ++ H  ++K+     + ++  +
Sbjct: 158 KTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYI 216

Query: 182 IYEYMPNKSLDCFLFDP-TKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASN 240
           + E M    L    FD     + L   T       +   + YLH+     IIHRDLK  N
Sbjct: 217 VLELMEGGEL----FDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPEN 269

Query: 241 ILL---DKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPE---YALEGIFS 294
           +LL   ++D   KI+DFG ++I+     E  L      + GT  Y++PE         ++
Sbjct: 270 VLLSSQEEDCLIKITDFGHSKIL----GETSL---MRTLCGTPTYLAPEVLVSVGTAGYN 322

Query: 295 IKSDVFSFGVLL 306
              D +S GV+L
Sbjct: 323 RAVDCWSLGVIL 334

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 95.7 bits (239), Expect = 2e-22
 Identities = 45/193 (23%), Positives = 75/193 (38%), Gaps = 61/193 (31%)

Query: 105 SSATGNFSAANKLGEGGFGTVYKGV-IGQGEI-AVKRLL------GKSG------QEIKE 150
           S AT  +    ++G G +GTVYK      G   A+K +       G  G      +E+  
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64

Query: 151 LKNEASVIAQVQHKNLVKLLGCCIEKDERL-----LIYEYM-----------PNKSLD-- 192
           L+     +   +H N+V+L+  C            L++E++           P   L   
Sbjct: 65  LRR----LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAE 120

Query: 193 ---CFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNS 249
                +               Q ++G+     +LH      I+HRDLK  NIL+      
Sbjct: 121 TIKDLMR--------------QFLRGLD----FLHAN---CIVHRDLKPENILVTSGGTV 159

Query: 250 KISDFGMARIVFG 262
           K++DFG+AR ++ 
Sbjct: 160 KLADFGLAR-IYS 171

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 96.1 bits (240), Expect = 2e-22
 Identities = 46/178 (25%), Positives = 78/178 (43%), Gaps = 54/178 (30%)

Query: 110 NFSAANKLGEGGFGTVYKGVIGQ-GEI-AVK--RLLGKSG------QEIKELKNEASVIA 159
            +   +KLGEG + TVYKG       + A+K  RL  + G      +E+  LK       
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLK------- 55

Query: 160 QVQHKNLVKLLGCCIEKDERLLIYEYM----------PNKSLD-----CFLFDPTKREIL 204
            ++H N+V L      +    L++EY+              ++      FLF        
Sbjct: 56  DLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLF-------- 107

Query: 205 DWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFG 262
                 Q+++G+A    Y H+    +++HRDLK  N+L+++    K++DFG+AR    
Sbjct: 108 ------QLLRGLA----YCHRQ---KVLHRDLKPQNLLINERGELKLADFGLAR-AKS 151

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 96.1 bits (240), Expect = 2e-22
 Identities = 42/186 (22%), Positives = 83/186 (44%), Gaps = 59/186 (31%)

Query: 110 NFSAANKLGEGGFGTVYKGVIGQ--GEI-AVKRL---LGKSG------QEIKELKNEASV 157
            +    ++GEG +G V+K    +  G   A+KR+    G+ G      +E+  L++    
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH---- 67

Query: 158 IAQVQHKNLVKLL----GCCIEKDERL-LIYEYM-----------PNKSLD-----CFLF 196
           +   +H N+V+L         +++ +L L++E++           P   +        +F
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 127

Query: 197 DPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGM 256
                         Q+++G+     +LH +   R++HRDLK  NIL+      K++DFG+
Sbjct: 128 --------------QLLRGLD----FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL 166

Query: 257 ARIVFG 262
           AR ++ 
Sbjct: 167 AR-IYS 171

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 95.4 bits (238), Expect = 3e-22
 Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 33/210 (15%)

Query: 116 KLGEGGFGTVYKGV-IGQGEI-AVK-----RLLGKSGQEIKE----LKNEASVIAQV-QH 163
            LG G    V + +     +  AVK          S +E++E       E  ++ +V  H
Sbjct: 24  ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83

Query: 164 KNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDP-TKREILDWRTRVQIIKGVAQGLLY 222
            N+++L           L+++ M    L    FD  T++  L  +   +I++ + + +  
Sbjct: 84  PNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTLSEKETRKIMRALLEVICA 139

Query: 223 LHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGY 282
           LH+     I+HRDLK  NILLD DMN K++DFG +  +  G            + GT  Y
Sbjct: 140 LHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE-------KLREVCGTPSY 189

Query: 283 MSPE------YALEGIFSIKSDVFSFGVLL 306
           ++PE            +  + D++S GV++
Sbjct: 190 LAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 95.8 bits (239), Expect = 3e-22
 Identities = 50/160 (31%), Positives = 73/160 (45%), Gaps = 34/160 (21%)

Query: 115 NKLGEGGFGTVYKGV-IGQGEI-AVKRLLGKSGQ---------EIKELKNEASVIAQVQH 163
             +GEG +G V K      G I A+K+ L              EIK LK       Q++H
Sbjct: 31  GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLK-------QLRH 83

Query: 164 KNLVKLLGCCIEKDERLLIYEYMPN---KSLDCF--LFDPTKREILDWRTRVQIIKGVAQ 218
           +NLV LL  C +K    L++E++ +     L+ F    D    +   +    QII G+  
Sbjct: 84  ENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLF----QIINGIG- 138

Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMAR 258
              + H +    IIHRD+K  NIL+ +    K+ DFG AR
Sbjct: 139 ---FCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFAR 172

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 94.9 bits (237), Expect = 5e-22
 Identities = 47/158 (29%), Positives = 68/158 (43%), Gaps = 30/158 (18%)

Query: 115 NKLGEGGFGTVYKGV-IGQGEI-AVKRLLGKSGQ---------EIKELKNEASVIAQVQH 163
            K+GEG +G V+K      G+I A+K+ L              EI+ LK       Q++H
Sbjct: 9   GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLK-------QLKH 61

Query: 164 KNLVKLLGCCIEKDERLLIYEYMPN---KSLDCFLFDPTKREILDWRTRVQIIKGVAQGL 220
            NLV LL     K    L++EY  +     LD        +  +       I     Q +
Sbjct: 62  PNLVNLLEVFRRKRRLHLVFEYCDHTVLHELD------RYQRGVPEHLVKSITWQTLQAV 115

Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMAR 258
            + H++     IHRD+K  NIL+ K    K+ DFG AR
Sbjct: 116 NFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFAR 150

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 95.9 bits (239), Expect = 6e-22
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 51/226 (22%)

Query: 111 FSAANKLGEGGFGTVYKGVIGQ-GEIAVKRLLGKSGQEIKELKN-EASVIAQVQHKNLVK 168
           ++    +G G FG V++  + +  E+A+K++L    Q+ K  KN E  ++  V+H N+V 
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVL----QD-KRFKNRELQIMRIVKHPNVVD 96

Query: 169 LLGCCIEKDERL------LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGV------ 216
           L        ++       L+ EY+P +++         R    +    Q +  +      
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEYVP-ETV--------YRASRHYAKLKQTMPMLLIKLYM 147

Query: 217 ---AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNS-KISDFGMARIVFGGNDEDELQGN 272
               + L Y+H    + I HRD+K  N+LLD      K+ DFG A+I+  G        N
Sbjct: 148 YQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP------N 198

Query: 273 TSRISGTYGYMSPEYALEGIF-----SIKSDVFSFGVLLLEIVSGK 313
            S I   Y Y +PE     IF     +   D++S G ++ E++ G+
Sbjct: 199 VSYICSRY-YRAPEL----IFGATNYTTNIDIWSTGCVMAELMQGQ 239

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 94.7 bits (236), Expect = 8e-22
 Identities = 51/208 (24%), Positives = 87/208 (41%), Gaps = 32/208 (15%)

Query: 116 KLGEGGFGTVYKGV-IGQGEI-AVK-----RLLGKSGQEIKE---LKNEASVIAQVQHKN 165
            LG G  G V         +  A+K     +    S +E      ++ E  ++ ++ H  
Sbjct: 17  TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76

Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDP-TKREILDWRTRVQIIKGVAQGLLYLH 224
           ++K+     + ++  ++ E M    L    FD     + L   T       +   + YLH
Sbjct: 77  IIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQMLLAVQYLH 131

Query: 225 QYSRVRIIHRDLKASNILL---DKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYG 281
           +     IIHRDLK  N+LL   ++D   KI+DFG ++I+     E  L      + GT  
Sbjct: 132 EN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----GETSL---MRTLCGTPT 181

Query: 282 YMSPE---YALEGIFSIKSDVFSFGVLL 306
           Y++PE         ++   D +S GV+L
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLGVIL 209

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 94.7 bits (236), Expect = 8e-22
 Identities = 76/276 (27%), Positives = 116/276 (42%), Gaps = 58/276 (21%)

Query: 100 SFSSVSSATGNFSAANKLGEGGFGTVYKG--VIGQGEIAVKRLLGKS---GQEIKELKNE 154
           S +      GN+     +G+G F  V     ++   E+A+K ++ K+      +++L  E
Sbjct: 6   SCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIK-IIDKTQLNPTSLQKLFRE 64

Query: 155 ASVIAQVQHKNLVKLLGCCIEKDERL-LIYEYMPNKSLDCFLFD----------PTKREI 203
             ++  + H N+VKL    IE ++ L LI EY     +    FD             R  
Sbjct: 65  VRIMKILNHPNIVKLFEV-IETEKTLYLIMEYASGGEV----FDYLVAHGRMKEKEARSK 119

Query: 204 LDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGG 263
                  QI+  V     Y HQ    RI+HRDLKA N+LLD DMN KI+DFG +      
Sbjct: 120 F-----RQIVSAVQ----YCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEF--- 164

Query: 264 NDEDELQGNTSRISGTYGYMSPEYALEGIFS------IKSDVFSFGVLLLEIVSGK---- 313
               +L  +     G   Y +PE     +F        + DV+S GV+L  +VSG     
Sbjct: 165 TVGGKL--DAF--CGAPPYAAPE-----LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

Query: 314 -KNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLE 348
            +N    R + L    Y    ++S    +L+   L 
Sbjct: 216 GQNLKELRERVLRGK-YRIPFYMSTDCENLLKRFLV 250

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 94.2 bits (235), Expect = 1e-21
 Identities = 51/173 (29%), Positives = 72/173 (41%), Gaps = 39/173 (22%)

Query: 110 NFSAANKLGEGGFGTVYKGV-IGQGEI-AVKRL-LGKSGQ--------EIKELKNEASVI 158
            +    KLGEG +G VYK +     E  A+KR+ L    +        E+  LK      
Sbjct: 35  RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLK------ 88

Query: 159 AQVQHKNLVKLLGCCIEKDERLLIYEYMPN--KSL--DCFLFDPTKREILDWRTRVQIIK 214
            ++QH+N+++L           LI+EY  N  K              +   +    Q+I 
Sbjct: 89  -ELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLY----QLIN 143

Query: 215 GVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNS-----KISDFGMARIVFG 262
           GV     + H     R +HRDLK  N+LL     S     KI DFG+AR  FG
Sbjct: 144 GVN----FCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR-AFG 188

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 94.3 bits (235), Expect = 1e-21
 Identities = 51/196 (26%), Positives = 91/196 (46%), Gaps = 20/196 (10%)

Query: 116 KLGEGGFGTVYKGV-IGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCI 174
           +LG G    VY+    G  +    ++L K+  + K ++ E  V+ ++ H N++KL     
Sbjct: 60  ELGRGATSIVYRCKQKGTQKPYALKVLKKT-VDKKIVRTEIGVLLRLSHPNIIKLKEIFE 118

Query: 175 EKDERLLIYEYMPNKSLDCFLFDP-TKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
              E  L+ E +        LFD   ++     R     +K + + + YLH+     I+H
Sbjct: 119 TPTEISLVLELVTGGE----LFDRIVEKGYYSERDAADAVKQILEAVAYLHEN---GIVH 171

Query: 234 RDLKASNILL-DKDMNS--KISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE 290
           RDLK  N+L      ++  KI+DFG+++IV    +   L      + GT GY +PE    
Sbjct: 172 RDLKPENLLYATPAPDAPLKIADFGLSKIV----EHQVL---MKTVCGTPGYCAPEILRG 224

Query: 291 GIFSIKSDVFSFGVLL 306
             +  + D++S G++ 
Sbjct: 225 CAYGPEVDMWSVGIIT 240

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 94.8 bits (236), Expect = 1e-21
 Identities = 49/209 (23%), Positives = 90/209 (43%), Gaps = 32/209 (15%)

Query: 116 KLGEGGFGTVYKGV-IGQGE------IAVKRLLGKSGQ---EIKELKNEASVIAQV-QHK 164
            +G G    V + V    G       + V        Q     +  + E  ++ QV  H 
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160

Query: 165 NLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDP-TKREILDWRTRVQIIKGVAQGLLYL 223
           +++ L+          L+++ M    L    FD  T++  L  +    I++ + + + +L
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGEL----FDYLTEKVALSEKETRSIMRSLLEAVSFL 216

Query: 224 HQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYM 283
           H      I+HRDLK  NILLD +M  ++SDFG +  +      ++L+     + GT GY+
Sbjct: 217 HAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHL---EPGEKLRE----LCGTPGYL 266

Query: 284 SPE------YALEGIFSIKSDVFSFGVLL 306
           +PE            +  + D+++ GV+L
Sbjct: 267 APEILKCSMDETHPGYGKEVDLWACGVIL 295

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 93.4 bits (233), Expect = 1e-21
 Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 31/210 (14%)

Query: 117 LGEGGFGTVY--KGVIGQGEIAVKRLLGKSG----QEIKELKNEASVIAQVQHKNLVKLL 170
           LGEG F TV   + +    E A+K +L K       ++  +  E  V++++ H   VKL 
Sbjct: 38  LGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 96

Query: 171 GCCIEKDERLL--IYEYMPNKSLDCFLFDPTKRE--ILDWRTRV---QIIKGVAQGLLYL 223
                +D+  L     Y  N  L        ++     +  TR    +I+      L YL
Sbjct: 97  FTF--QDDEKLYFGLSYAKNGEL----LKYIRKIGSFDETCTRFYTAEIV----SALEYL 146

Query: 224 HQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYM 283
           H      IIHRDLK  NILL++DM+ +I+DFG A+++      +  Q   +   GT  Y+
Sbjct: 147 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL----SPESKQARANSFVGTAQYV 199

Query: 284 SPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           SPE   E      SD+++ G ++ ++V+G 
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGL 229

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 93.1 bits (232), Expect = 2e-21
 Identities = 62/328 (18%), Positives = 110/328 (33%), Gaps = 96/328 (29%)

Query: 109 GNFSAANKLGEGGFGTVYKG--VIGQGEIAVKRL-------------LGKSGQEIKELKN 153
             +     LG+GGFGTV+ G  +  + ++A+K +                   E+  L  
Sbjct: 31  AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLW- 89

Query: 154 EASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFD----------PTKREI 203
              V A   H  +++LL     ++  +L+ E  P  + D  LFD             R  
Sbjct: 90  --KVGAGGGHPGVIRLLDWFETQEGFMLVLER-PLPAQD--LFDYITEKGPLGEGPSRCF 144

Query: 204 LDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNS-KISDFGMARIVFG 262
                  Q++  +     + H      ++HRD+K  NIL+D      K+ DFG   ++  
Sbjct: 145 F-----GQVVAAIQ----HCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD 192

Query: 263 GNDEDELQGNTSRISGTYGYMSPEYALEGI--FSIKSDVFSFGVLLLEIVSG-------- 312
                          GT  Y  PE+ +      ++ + V+S G+LL ++V G        
Sbjct: 193 EPYT------DF--DGTRVYSPPEW-ISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ 243

Query: 313 KKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAE 372
           +         +           +S     LI   L                      +  
Sbjct: 244 EILEAELHFPA----------HVSPDCCALIRRCL--------------------APKPS 273

Query: 373 DRPTMSDVVS---MLTNEASSLLPPKQP 397
            RP++ +++    M T      L P + 
Sbjct: 274 SRPSLEEILLDPWMQTPAEDVPLNPSKG 301

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 95.6 bits (238), Expect = 2e-21
 Identities = 61/208 (29%), Positives = 97/208 (46%), Gaps = 25/208 (12%)

Query: 117 LGEGGFGTVYKG-VIGQGEI-AVKRL---LGKSGQEIKELKNEASVIAQVQHKNLVKLLG 171
           LG GGFG V+   +   G++ A K+L     K  +  +    E  ++A+V  + +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA- 251

Query: 172 CCIEKDERL-LIYEYMPNKSLDCFLFDPTKRE--ILDWRTRV---QIIKGVAQGLLYLHQ 225
              E    L L+   M    +   +++  +      + R      QI+     GL +LHQ
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIV----SGLEHLHQ 307

Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
                II+RDLK  N+LLD D N +ISD G+A  +  G  +      T   +GT G+M+P
Sbjct: 308 R---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK------TKGYAGTPGFMAP 358

Query: 286 EYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           E  L   +    D F+ GV L E+++ +
Sbjct: 359 ELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 93.5 bits (232), Expect = 3e-21
 Identities = 41/111 (36%), Positives = 65/111 (58%), Gaps = 7/111 (6%)

Query: 201 REILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIV 260
           ++ L     +     VA+G+ +L   +  + IHRDL A NILL +    KI DFG+AR +
Sbjct: 187 KDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 243

Query: 261 FGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 311
           +   D D ++   +R+     +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 244 Y--KDPDYVRKGDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 68.4 bits (167), Expect = 7e-13
 Identities = 36/154 (23%), Positives = 57/154 (37%), Gaps = 20/154 (12%)

Query: 115 NKLGEGGFGTVYKGVI-------GQGEIAVKRLL-GKSGQEIKELKNEASVIAQV-QHKN 165
             LG G FG V +              +AVK L  G +  E + L +E  ++  +  H N
Sbjct: 28  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87

Query: 166 LVKLLGCCIEKDERL-LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLH 224
           +V LLG C +    L +I E+    +L  +L             R + +    +G  +  
Sbjct: 88  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTKGARFRQ 137

Query: 225 QYSRVRIIHRDLKASNILLDKDMNSKISDFGMAR 258
               V  I  DLK     +    +S  S F   +
Sbjct: 138 GKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 92.0 bits (229), Expect = 5e-21
 Identities = 61/275 (22%), Positives = 96/275 (34%), Gaps = 73/275 (26%)

Query: 109 GNFSAANKLGEGGFGTVYKG--VIGQGEIAVKRLLGKSGQEIKELKN------EASVIAQ 160
             +     LG GGFG+VY G  V     +A+K +      +  EL N      E  ++ +
Sbjct: 43  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 102

Query: 161 VQHK--NLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFD----------PTKREILDWRT 208
           V      +++LL      D  +LI E  P    D  LFD             R       
Sbjct: 103 VSSGFSGVIRLLDWFERPDSFVLILER-PEPVQD--LFDFITERGALQEELARSFF---- 155

Query: 209 RVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKD-MNSKISDFGMARIVFGGNDED 267
             Q+++ V     + H      ++HRD+K  NIL+D +    K+ DFG   ++       
Sbjct: 156 -WQVLEAVR----HCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--- 204

Query: 268 ELQGNTSRISGTYGYMSPEYALEGIFSIK------SDVFSFGVLLLEIVSG--------K 313
                     GT  Y  PE                + V+S G+LL ++V G        +
Sbjct: 205 -YT--DF--DGTRVYSPPE-----WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 254

Query: 314 KNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLE 348
              G    +            +S++   LI   L 
Sbjct: 255 IIRGQVFFRQ----------RVSSECQHLIRWCLA 279

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 91.9 bits (229), Expect = 6e-21
 Identities = 55/204 (26%), Positives = 91/204 (44%), Gaps = 29/204 (14%)

Query: 116 KLGEGGFGTVYKGV-IGQGEI-AVK----RLLGKSGQEIKELKNEASVIAQVQH-KNLVK 168
           +LG G F  V + +    G+  A K    R  G+      E+ +E +V+   +    ++ 
Sbjct: 36  ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQD--CRAEILHEIAVLELAKSCPRVIN 93

Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFLFD---PTKREILDWRTRVQIIKGVAQGLLYLHQ 225
           L        E +LI EY     +    F    P   E++     +++IK + +G+ YLHQ
Sbjct: 94  LHEVYENTSEIILILEYAAGGEI----FSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ 149

Query: 226 YSRVRIIHRDLKASNILL---DKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGY 282
                I+H DLK  NILL       + KI DFGM+R +       EL+     I GT  Y
Sbjct: 150 N---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI---GHACELRE----IMGTPEY 199

Query: 283 MSPEYALEGIFSIKSDVFSFGVLL 306
           ++PE       +  +D+++ G++ 
Sbjct: 200 LAPEILNYDPITTATDMWNIGIIA 223

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 90.7 bits (226), Expect = 7e-21
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 34/210 (16%)

Query: 117 LGEGGFGTVYKGV-IGQGE-IAVKRL-LGKSGQEIKELKNEASVIAQVQHKNLVKLLGCC 173
           LGEG +G V   V     E +AVK + + ++    + +K E  +   + H+N+VK  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 174 IEKDERLLIYEYMPNKSLDCFLFD--PTKREILDWRTRV---QIIKGVAQGLLYLHQYSR 228
            E + + L  EY     L    FD       + +   +    Q++ GV     YLH    
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHGI-- 124

Query: 229 VRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYA 288
             I HRD+K  N+LLD+  N KISDFG+A +    N E  L  N     GT  Y++PE  
Sbjct: 125 -GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL--NKM--CGTLPYVAPE-- 177

Query: 289 LEGIFSIK------SDVFSFGVLLLEIVSG 312
              +   +       DV+S G++L  +++G
Sbjct: 178 ---LLKRREFHAEPVDVWSCGIVLTAMLAG 204

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 92.0 bits (229), Expect = 1e-20
 Identities = 51/239 (21%), Positives = 95/239 (39%), Gaps = 48/239 (20%)

Query: 100 SFSSVSSATGNFSAANKLGEGGFGTVYKGVIGQ-GE-IAVKRLLGKSG------QEIKEL 151
           +          F      G+G FGTV  G     G  +A+K+++          Q +++L
Sbjct: 14  ADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDL 73

Query: 152 KNEASVIAQVQHKNLVKLLGCCIEKDER-------LLIYEYMP---NKSLDCFLFDPTKR 201
                    + H N+V+L        ER        ++ EY+P   ++    +       
Sbjct: 74  A-------VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAP 126

Query: 202 EILDWRTRV-QIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNS-KISDFGMARI 259
             +  +  + Q+I+ +      LH  S   + HRD+K  N+L+++   + K+ DFG A+ 
Sbjct: 127 PPILIKVFLFQLIRSIG----CLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKK 181

Query: 260 VFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKS-----DVFSFGVLLLEIVSGK 313
           +           N + I   Y Y +PE     IF  +      D++S G +  E++ G+
Sbjct: 182 LSPSEP------NVAYICSRY-YRAPEL----IFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 91.7 bits (228), Expect = 1e-20
 Identities = 62/270 (22%), Positives = 102/270 (37%), Gaps = 63/270 (23%)

Query: 109 GNFSAANKLGEGGFGTVYKG--VIGQGEIAVK-----RLLGKSGQEIKELKN---EASVI 158
             +S  + LG G FG V+         E+ VK     ++L     E  +L     E +++
Sbjct: 24  QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAIL 83

Query: 159 AQVQHKNLVKLLGCCIEKDERL-LIYEYMPNKSLDCFLFD-----PTKREILDWRTRVQI 212
           ++V+H N++K+L    E      L+ E   +  LD  LF      P   E L      Q+
Sbjct: 84  SRVEHANIIKVLDI-FENQGFFQLVMEKHGS-GLD--LFAFIDRHPRLDEPLASYIFRQL 139

Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
           +  V     YL       IIHRD+K  NI++ +D   K+ DFG A  +  G         
Sbjct: 140 VSAVG----YLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFY----- 187

Query: 273 TSRISGTYGYMSPEYALEGIFSIKS------DVFSFGVLLLEIVSG--------KKNTGF 318
           T    GT  Y +PE     +           +++S GV L  +V          +     
Sbjct: 188 TF--CGTIEYCAPE-----VLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAA 240

Query: 319 YRTKSLNLIGYAWDLWISNKIIDLIDSVLE 348
                           +S +++ L+  +L+
Sbjct: 241 IHPPY----------LVSKELMSLVSGLLQ 260

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 93.7 bits (233), Expect = 1e-20
 Identities = 59/203 (29%), Positives = 92/203 (45%), Gaps = 18/203 (8%)

Query: 117 LGEGGFGTVYKG-VIGQGEI-AVKRL---LGKSGQEIKELKNEASVIAQVQHKNLVKLLG 171
           LG+GGFG V    V   G++ A K+L     K  +      NE  ++ +V  + +V L  
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-A 250

Query: 172 CCIEKDERL-LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVR 230
              E  + L L+   M    L   ++   +    + R      + +  GL  LH+    R
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLEDLHRE---R 306

Query: 231 IIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE 290
           I++RDLK  NILLD   + +ISD G+A  V  G              GT GYM+PE    
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-------TIKGRVGTVGYMAPEVVKN 359

Query: 291 GIFSIKSDVFSFGVLLLEIVSGK 313
             ++   D ++ G LL E+++G+
Sbjct: 360 ERYTFSPDWWALGCLLYEMIAGQ 382

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 92.2 bits (229), Expect = 1e-20
 Identities = 40/175 (22%), Positives = 71/175 (40%), Gaps = 47/175 (26%)

Query: 116 KLGEGGFGTVYKGV---IGQGEI-AVKR-----LLGKSGQEIKELKNEASVIAQVQHKNL 166
           K+G G +G VYK         +  A+K+     +   + +EI  L+       +++H N+
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLR-------ELKHPNV 80

Query: 167 VKLLGCCIEKDERL--LIYEYM-------------PNKSLDCFLFDPTKREILDWRTRVQ 211
           + L    +   +R   L+++Y                 +           + L +    Q
Sbjct: 81  ISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLY----Q 136

Query: 212 IIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNS----KISDFGMARIVFG 262
           I+ G+     YLH      ++HRDLK +NIL+  +       KI+D G AR+ F 
Sbjct: 137 ILDGIH----YLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARL-FN 183

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 90.5 bits (225), Expect = 2e-20
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 34/210 (16%)

Query: 117 LGEGGFGTVYKGV-IGQGE-IAVKRL-LGKSGQEIKELKNEASVIAQVQHKNLVKLLGCC 173
           LGEG +G V   V     E +AVK + + ++    + +K E  +   + H+N+VK  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 174 IEKDERLLIYEYMPNKSLDCFLFD--PTKREILDWRTRV---QIIKGVAQGLLYLHQYSR 228
            E + + L  EY     L    FD       + +   +    Q++ GV     YLH    
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHGI-- 124

Query: 229 VRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYA 288
             I HRD+K  N+LLD+  N KISDFG+A +    N E  L  N     GT  Y++PE  
Sbjct: 125 -GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL--NKM--CGTLPYVAPE-- 177

Query: 289 LEGIFSIK------SDVFSFGVLLLEIVSG 312
              +   +       DV+S G++L  +++G
Sbjct: 178 ---LLKRREFHAEPVDVWSCGIVLTAMLAG 204

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 91.3 bits (227), Expect = 3e-20
 Identities = 60/223 (26%), Positives = 102/223 (45%), Gaps = 42/223 (18%)

Query: 110 NFSAANKLGEGGFGTVYKGVIGQ-GEI-AVKRLLGKSGQEIKELKN-EASVIAQVQHKNL 166
           +++    +G G FG VY+  +   GE+ A+K++L    Q+ K  KN E  ++ ++ H N+
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QD-KRFKNRELQIMRKLDHCNI 109

Query: 167 VKLLGCCIEKDERL------LIYEYMP---NKSLDCFLFDPTKREILDWRTRV-QIIKGV 216
           V+L        E+       L+ +Y+P    +    +        ++  +  + Q+ + +
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 169

Query: 217 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNS-KISDFGMARIVFGGNDEDELQGNTSR 275
           A    Y+H      I HRD+K  N+LLD D    K+ DFG A+ +  G        N S 
Sbjct: 170 A----YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP------NVSY 216

Query: 276 ISGTYGYMSPEYALEGIFSIKS-----DVFSFGVLLLEIVSGK 313
           I   Y Y +PE     IF         DV+S G +L E++ G+
Sbjct: 217 ICSRY-YRAPEL----IFGATDYTSSIDVWSAGCVLAELLLGQ 254

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 88.9 bits (221), Expect = 5e-20
 Identities = 54/236 (22%), Positives = 96/236 (40%), Gaps = 58/236 (24%)

Query: 117 LGEGGFGTVYKG--VIGQGEIAVK-----RLLGKSGQEIKE------------------- 150
           +G+G +G V            A+K     +L+ ++G   +                    
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 151 --LKNEASVIAQVQHKNLVKLLGCCIEKDERLLIY---EYMPNKSLDCFLFDPTKREILD 205
             +  E +++ ++ H N+VKL+   ++      +Y   E +    +     +    + L 
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPV----MEVPTLKPLS 135

Query: 206 ----WRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVF 261
                     +IKG+     YLH     +IIHRD+K SN+L+ +D + KI+DFG++    
Sbjct: 136 EDQARFYFQDLIKGIE----YLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188

Query: 262 GGNDEDELQGNTSRISGTYGYMSPEYALEGIFSI----KSDVFSFGVLLLEIVSGK 313
           G +         S   GT  +M+PE +L     I      DV++ GV L   V G+
Sbjct: 189 GSD------ALLSNTVGTPAFMAPE-SLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 88.1 bits (219), Expect = 2e-19
 Identities = 51/198 (25%), Positives = 85/198 (42%), Gaps = 23/198 (11%)

Query: 116 KLGEGGFGTVYKGV-IGQGEI-AVKRLLGKSGQEIKELKNEASVIAQVQ-HKNLVKLLGC 172
            LGEG F    K V     +  AVK ++ K  +     + E + +   + H N+VKL   
Sbjct: 18  PLGEGSFSICRKCVHKKSNQAFAVK-IISKRMEA--NTQKEITALKLCEGHPNIVKLHEV 74

Query: 173 CIEKDERLLIYEYMPNKSLDCFLFDP-TKREILDWRTRVQIIKGVAQGLLYLHQYSRVRI 231
             ++    L+ E +    L    F+   K++         I++ +   + ++H    V +
Sbjct: 75  FHDQLHTFLVMELLNGGEL----FERIKKKKHFSETEASYIMRKLVSAVSHMHD---VGV 127

Query: 232 IHRDLKASNILL-DKDMNS--KISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYA 288
           +HRDLK  N+L  D++ N   KI DFG AR+    N              T  Y +PE  
Sbjct: 128 VHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN------QPLKTPCFTLHYAAPELL 181

Query: 289 LEGIFSIKSDVFSFGVLL 306
            +  +    D++S GV+L
Sbjct: 182 NQNGYDESCDLWSLGVIL 199

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 88.1 bits (219), Expect = 2e-19
 Identities = 48/200 (24%), Positives = 83/200 (41%), Gaps = 25/200 (12%)

Query: 115 NKLGEGGFGTVYKGV-IGQGEI-AVKRLLGKSGQEIKELKNEASVIAQ-VQHKNLVKLLG 171
             +G G +    + +        AVK +  KS ++  E   E  ++ +  QH N++ L  
Sbjct: 28  EDIGVGSYSVCKRCIHKATNMEFAVKIID-KSKRDPTE---EIEILLRYGQHPNIITLKD 83

Query: 172 CCIEKDERLLIYEYMPNKSLDCFLFDP-TKREILDWRTRVQIIKGVAQGLLYLHQYSRVR 230
              +     ++ E M    L     D   +++    R    ++  + + + YLH      
Sbjct: 84  VYDDGKYVYVVTELMKGGEL----LDKILRQKFFSEREASAVLFTITKTVEYLHA---QG 136

Query: 231 IIHRDLKASNILL-DKDMNS---KISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPE 286
           ++HRDLK SNIL  D+  N    +I DFG A+ +   N      G       T  +++PE
Sbjct: 137 VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN------GLLMTPCYTANFVAPE 190

Query: 287 YALEGIFSIKSDVFSFGVLL 306
                 +    D++S GVLL
Sbjct: 191 VLERQGYDAACDIWSLGVLL 210

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 85.0 bits (211), Expect = 7e-19
 Identities = 62/255 (24%), Positives = 113/255 (44%), Gaps = 49/255 (19%)

Query: 117 LGEGGFGTVYKG--VIGQGEIAVK----RLLGKSGQEIKELKNEASVIAQVQHKNLVKLL 170
           LG G FG V  G   +   ++AVK    + +       K +K E   +   +H +++KL 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGK-IKREIQNLKLFRHPHIIKLY 77

Query: 171 GCCIEKDERL-LIYEYMPNKSLDCFLFD--PTKREILDWRTRV---QIIKGVAQGLLYLH 224
              I       ++ EY+    L    FD       + +   R    QI+  V     Y H
Sbjct: 78  QV-ISTPTDFFMVMEYVSGGEL----FDYICKHGRVEEMEARRLFQQILSAVD----YCH 128

Query: 225 QYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMS 284
           ++    ++HRDLK  N+LLD  MN+KI+DFG++ ++   +D + L+  TS   G+  Y +
Sbjct: 129 RH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMM---SDGEFLR--TS--CGSPNYAA 178

Query: 285 PEYALEGIFS------IKSDVFSFGVLLLEIVSGK-----KNTGFYRTKSLNLIGYAWDL 333
           PE     + S       + D++S GV+L  ++ G      ++      K    + +    
Sbjct: 179 PE-----VISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV-FYIPE 232

Query: 334 WISNKIIDLIDSVLE 348
           +++  +  L+  +L+
Sbjct: 233 YLNRSVATLLMHMLQ 247

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 84.6 bits (210), Expect = 3e-18
 Identities = 67/254 (26%), Positives = 120/254 (47%), Gaps = 48/254 (18%)

Query: 117 LGEGGFGTVYKG--VIGQGEIAVK----RLLGKSGQEIKELKNEASVIAQVQHKNLVKLL 170
           LGEG FG V        Q ++A+K    +LL KS   ++ ++ E S +  ++H +++KL 
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMR-VEREISYLKLLRHPHIIKLY 75

Query: 171 GCCIEKDERLLIYEYMPNKSLDCFLFD--PTKREILDWRTRV---QIIKGVAQGLLYLHQ 225
                  + +++ EY   +     LFD    K+ + +   R    QII  +     Y H+
Sbjct: 76  DVITTPTDIVMVIEYAGGE-----LFDYIVEKKRMTEDEGRRFFQQIICAIE----YCHR 126

Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
           +   +I+HRDLK  N+LLD ++N KI+DFG++ I+    D + L   TS   G+  Y +P
Sbjct: 127 H---KIVHRDLKPENLLLDDNLNVKIADFGLSNIM---TDGNFL--KTS--CGSPNYAAP 176

Query: 286 EYALEGIFS------IKSDVFSFGVLLLEIVSGK-----KNTGFYRTKSLNLIGYAWDLW 334
           E     + +       + DV+S G++L  ++ G+     +       K  + + Y    +
Sbjct: 177 E-----VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCV-YVMPDF 230

Query: 335 ISNKIIDLIDSVLE 348
           +S     LI  ++ 
Sbjct: 231 LSPGAQSLIRRMIV 244

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 85.3 bits (211), Expect = 6e-18
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 31/210 (14%)

Query: 117 LGEGGFGTVYKG-VIGQGEI-AVKRL---LGKSGQEIKELKNEASVIAQVQHKN---LVK 168
           +G GGFG VY       G++ A+K L     K  Q      NE  +++ V   +   +V 
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256

Query: 169 LLGCCIEKDERL-LIYEYMPNKSLDCFLFDPTKREILDWRTRV---QIIKGVAQGLLYLH 224
           +        ++L  I + M    L   L         +   R    +II     GL ++H
Sbjct: 257 M-SYAFHTPDKLSFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEII----LGLEHMH 309

Query: 225 QYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMS 284
                 +++RDLK +NILLD+  + +ISD G+A         D  +       GT+GYM+
Sbjct: 310 NR---FVVYRDLKPANILLDEHGHVRISDLGLAC--------DFSKKKPHASVGTHGYMA 358

Query: 285 PEYALEGIFSIKS-DVFSFGVLLLEIVSGK 313
           PE   +G+    S D FS G +L +++ G 
Sbjct: 359 PEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 82.0 bits (203), Expect = 2e-17
 Identities = 46/208 (22%), Positives = 81/208 (38%), Gaps = 41/208 (19%)

Query: 116 KLGEGGFGTVYKGV-IGQGEI-AVKRLLGKSGQEIKELKNEASVIAQVQ-HKNLVKLLGC 172
            LG G  G V +      G+  A+K L      +  + + E     Q     ++V +L  
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLL-----YDSPKARQEVDHHWQASGGPHIVCILDV 90

Query: 173 CIEKDER----LLIYEYMPNKSLDCFLFDPTKREILDWRTRV-------QIIKGVAQGLL 221
                      L+I E M    L    F      I +   +        +I++ +   + 
Sbjct: 91  YENMHHGKRCLLIIMECMEGGEL----FS----RIQERGDQAFTEREAAEIMRDIGTAIQ 142

Query: 222 YLHQYSRVRIIHRDLKASNILL-DKDMNS--KISDFGMARIVFGGNDEDELQGNTSRISG 278
           +LH      I HRD+K  N+L   K+ ++  K++DFG A+       ++ LQ        
Sbjct: 143 FLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET----TQNALQT----PCY 191

Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLL 306
           T  Y++PE      +    D++S GV++
Sbjct: 192 TPYYVAPEVLGPEKYDKSCDMWSLGVIM 219

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 82.9 bits (205), Expect = 2e-17
 Identities = 63/259 (24%), Positives = 114/259 (44%), Gaps = 57/259 (22%)

Query: 117 LGEGGFGTVYKG--VIGQGEIAVK----RLLGKSGQEIKELKNEASVIAQVQHKNLVKLL 170
           LG G FG V  G   +   ++AVK    + +       K ++ E   +   +H +++KL 
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGK-IRREIQNLKLFRHPHIIKLY 82

Query: 171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRV----------QIIKGVAQGL 220
                  +  ++ EY+    L    FD      +    R+          QI+ GV    
Sbjct: 83  QVISTPSDIFMVMEYVSGGEL----FD-----YICKNGRLDEKESRRLFQQILSGVD--- 130

Query: 221 LYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY 280
            Y H++    ++HRDLK  N+LLD  MN+KI+DFG++ ++   +D + L   TS   G+ 
Sbjct: 131 -YCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMM---SDGEFL--RTS--CGSP 179

Query: 281 GYMSPEYALEGIFS------IKSDVFSFGVLLLEIVSGK-----KNTGFYRTKSLNLIGY 329
            Y +PE     + S       + D++S GV+L  ++ G       +      K  + I +
Sbjct: 180 NYAAPE-----VISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI-F 233

Query: 330 AWDLWISNKIIDLIDSVLE 348
               +++  +I L+  +L+
Sbjct: 234 YTPQYLNPSVISLLKHMLQ 252

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 81.7 bits (202), Expect = 4e-17
 Identities = 47/208 (22%), Positives = 84/208 (40%), Gaps = 40/208 (19%)

Query: 116 KLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQ-HKNLVKLLG- 171
            LG G  G V +      Q + A+K L     Q+  + + E  +  +     ++V+++  
Sbjct: 69  VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 123

Query: 172 ---CCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRV-------QIIKGVAQGLL 221
                  +   L++ E +    L    F      I D   +        +I+K + + + 
Sbjct: 124 YENLYAGRKCLLIVMECLDGGEL----FS----RIQDRGDQAFTEREASEIMKSIGEAIQ 175

Query: 222 YLHQYSRVRIIHRDLKASNILL-DKDMNS--KISDFGMARIVFGGNDEDELQGNTSRISG 278
           YLH  +   I HRD+K  N+L   K  N+  K++DFG A+     N    L         
Sbjct: 176 YLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTT----PCY 225

Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLL 306
           T  Y++PE      +    D++S GV++
Sbjct: 226 TPYYVAPEVLGPEKYDKSCDMWSLGVIM 253

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 80.2 bits (198), Expect = 5e-17
 Identities = 17/204 (8%), Positives = 57/204 (27%), Gaps = 48/204 (23%)

Query: 116 KLGEGGFGTVYKG---VIGQGEIAVKRL---LGKSGQEIKELKNEASVIAQVQHKNLVKL 169
             G       ++     + + ++A+  +          ++E  +    ++++    + ++
Sbjct: 38  FHGGVPPLQFWQALDTALDR-QVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96

Query: 170 LGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRV 229
           L     +   L++ E++   SL                  ++ ++ +A      H   R 
Sbjct: 97  LDVVHTRAGGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAMQSLAAAADAAH---RA 148

Query: 230 RIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL 289
            +       S + +  D +  ++                              M      
Sbjct: 149 GVALSIDHPSRVRVSIDGDVVLAYPA--------------------------TMPDA--- 179

Query: 290 EGIFSIKSDVFSFGVLLLEIVSGK 313
               + + D+   G  L  ++  +
Sbjct: 180 ----NPQDDIRGIGASLYALLVNR 199

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 79.4 bits (196), Expect = 3e-16
 Identities = 56/207 (27%), Positives = 89/207 (42%), Gaps = 26/207 (12%)

Query: 117 LGEGGFGTVY----KGVIGQGEI-AVKRLLGK----SGQEIKELKNEASVIAQVQHKNLV 167
           LG+G FG V     K     G   A+K +L K    +  E+     E  V+   +H  L 
Sbjct: 156 LGKGTFGKVILVKEKA---TGRYYAMK-ILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 211

Query: 168 KLLGCCIEKDERL-LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQY 226
            L     +  +RL  + EY     L  F     +R   + R R    + +   L YLH  
Sbjct: 212 ALK-YSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAE-IVSALDYLH-- 265

Query: 227 SRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPE 286
           S   +++RDLK  N++LDKD + KI+DFG+ +                   GT  Y++PE
Sbjct: 266 SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT------MKTFCGTPEYLAPE 319

Query: 287 YALEGIFSIKSDVFSFGVLLLEIVSGK 313
              +  +    D +  GV++ E++ G+
Sbjct: 320 VLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 76.4 bits (189), Expect = 1e-15
 Identities = 56/217 (25%), Positives = 95/217 (43%), Gaps = 43/217 (19%)

Query: 117 LGEGGFGTVY----KGVIGQGEI-AVKRL----LGKSGQEIKELKNEASVIAQVQHKNLV 167
           LG+GG+G V+          G+I A+K L    + ++ ++    K E +++ +V+H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84

Query: 168 KLLGCCIEKDERL-LIYEYMPNKSL-----DCFLFD-PTKR----EILDWRTRVQIIKGV 216
            L+    +   +L LI EY+    L        +F   T      EI             
Sbjct: 85  DLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEIS------------ 131

Query: 217 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRI 276
              L +LHQ     II+RDLK  NI+L+   + K++DFG+ +              T   
Sbjct: 132 -MALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV------THTF 181

Query: 277 SGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
            GT  YM+PE  +    +   D +S G L+ ++++G 
Sbjct: 182 CGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 76.1 bits (186), Expect = 2e-15
 Identities = 32/211 (15%), Positives = 61/211 (28%), Gaps = 46/211 (21%)

Query: 91  KEVDQFPLFSFSSVSSATGNFSAANKLGEGGFGTVYKGVIGQGEIAVKRLL--------G 142
            E  Q     FS     T       K+GEG FG V++ +     +A+K +         G
Sbjct: 3   GECSQKGPVPFSHCLP-TEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNG 61

Query: 143 KSGQEIKELKNEASV---------IAQVQHKNLVKLLGCCIEKDER----LLIYEYMPNK 189
              +  +E+  E  +             + +  + L      +       L  +++  + 
Sbjct: 62  SHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNST 121

Query: 190 SLDCF----------------------LFDPTKREILDWRTRVQIIKGVAQGLLYLHQYS 227
                                        +  + ++    T   I+  +   L       
Sbjct: 122 KGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA-- 179

Query: 228 RVRIIHRDLKASNILLDKDMNSKISDFGMAR 258
            +R  HRDL   N+LL K    K+      +
Sbjct: 180 SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGK 210

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 75.1 bits (185), Expect = 5e-15
 Identities = 33/106 (31%), Positives = 51/106 (48%), Gaps = 23/106 (21%)

Query: 216 VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR 275
           +   L YL      RIIHRD+K  NILLD+  +  I+DF +A ++             + 
Sbjct: 124 LVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET-------QITT 173

Query: 276 ISGTYGYMSPEYALEGIFSIKS--------DVFSFGVLLLEIVSGK 313
           ++GT  YM+PE     +FS +         D +S GV   E++ G+
Sbjct: 174 MAGTKPYMAPE-----MFSSRKGAGYSFAVDWWSLGVTAYELLRGR 214

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 74.7 bits (184), Expect = 6e-15
 Identities = 62/329 (18%), Positives = 114/329 (34%), Gaps = 73/329 (22%)

Query: 117 LGEGGFGTVYKGV-IGQGE-IAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCI 174
           +G G FG           E +AVK  + +     + ++ E      ++H N+V+     +
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVK-YIERGAAIDENVQREIINHRSLRHPNIVRFKEVIL 86

Query: 175 EKDERLLIYEYMPNKSLDCFLFD----------PTKREILDWRTRVQIIKGVAQGLLYLH 224
                 +I EY     L    ++             R         Q++ GV+    Y H
Sbjct: 87  TPTHLAIIMEYASGGEL----YERICNAGRFSEDEARFFFQ-----QLLSGVS----YCH 133

Query: 225 QYSRVRIIHRDLKASNILLDKD--MNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGY 282
               ++I HRDLK  N LLD       KI DFG ++     +     Q  ++   GT  Y
Sbjct: 134 ---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-----QPKST--VGTPAY 183

Query: 283 MSPEYALEGIFSIK------SDVFSFGVLLLEIVSGK-----KNTGFYRTKSLNLIGYA- 330
           ++PE     +   +      +DV+S GV L  ++ G              K++  I    
Sbjct: 184 IAPE-----VLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVK 238

Query: 331 ----WDLWISNKIIDL--------------IDSVLEEASFNESLSRYVHIALLCVQERAE 372
                D+ IS +   L              I  +   + F ++L   +        +  E
Sbjct: 239 YSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQE 298

Query: 373 DRPTMSDVVSMLTNEASSLLPPKQPAFCN 401
               M  + +++   + + +P  +    +
Sbjct: 299 PEQPMQSLDTIMQIISEATIPAVRNRCLD 327

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 74.2 bits (183), Expect = 7e-15
 Identities = 57/209 (27%), Positives = 89/209 (42%), Gaps = 36/209 (17%)

Query: 117 LGEGGFGTVY--KGVIGQGEIAVKRLLGKSGQEIKELK------NEASVIAQVQHKNLVK 168
           LG G FG V   K        A+K L     Q++ +LK      NE  ++  V    LVK
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKIL---DKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105

Query: 169 LLGCCIEKDERLL--IYEYMPNKSLDCFLFDPTKREILDWRTR---VQIIKGVAQGLLYL 223
           L      KD   L  + EY+    +  F          +   R    QI+        YL
Sbjct: 106 LEFSF--KDNSNLYMVMEYVAGGEM--FSHLRRIGRFSEPHARFYAAQIV----LTFEYL 157

Query: 224 HQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYM 283
           H      +I+RDLK  N+L+D+    +++DFG A+          ++G T  + GT   +
Sbjct: 158 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK---------RVKGRTWTLCGTPEAL 205

Query: 284 SPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           +PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAG 234

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 74.9 bits (184), Expect = 1e-14
 Identities = 43/199 (21%), Positives = 78/199 (39%), Gaps = 40/199 (20%)

Query: 116 KLGEGGFGTVYKGV-IGQGE-IAVKRLLGKSGQ---------EIKELKNEASVIAQVQHK 164
            +G G +G V +     +   +A+K++L              EI  L        ++ H 
Sbjct: 60  LIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILN-------RLNHD 112

Query: 165 NLVKLLGCCI----EKDERL-LIYEYMP---NKSLDC--FLFDPTKREILDWRTRVQIIK 214
           ++VK+L   I    EK + L ++ E       K      +L +   + +L       ++ 
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLL-----YNLLV 167

Query: 215 GVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTS 274
           G    + Y+H      I+HRDLK +N L+++D + K+ DFG+AR V    + +     + 
Sbjct: 168 G----VKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISP 220

Query: 275 RISGTYGYMSPEYALEGIF 293
           R         P        
Sbjct: 221 REDDMNLVTFPHTKNLKRQ 239

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 73.4 bits (181), Expect = 1e-14
 Identities = 54/214 (25%), Positives = 96/214 (44%), Gaps = 39/214 (18%)

Query: 117 LGEGGFGTVY----KGVIGQGEI-AVKRLLGKS---GQEIKELKNEASVIAQVQHKNLVK 168
           LG+G FG V+           ++ A+K +L K+    ++    K E  ++ +V H  +VK
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMK-VLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90

Query: 169 LLGCCIEKDERL-LIYEYMPNKSL-----DCFLFDPTKREILDWRTRV---QIIKGVAQG 219
           L     + + +L LI +++    L        +F            +    ++       
Sbjct: 91  LH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE-------DVKFYLAELA----LA 138

Query: 220 LLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGT 279
           L +LH      II+RDLK  NILLD++ + K++DFG+++       +           GT
Sbjct: 139 LDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK------AYSFCGT 189

Query: 280 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
             YM+PE       +  +D +SFGVL+ E+++G 
Sbjct: 190 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 73.4 bits (181), Expect = 1e-14
 Identities = 52/208 (25%), Positives = 88/208 (42%), Gaps = 29/208 (13%)

Query: 117 LGEGGFGTV----YKGVIGQGEI-AVKRLLGK----SGQEIKELKNEASVIAQVQHKNLV 167
           LG+G FG V     K     G   A+K +L K    +  E+     E+ V+   +H  L 
Sbjct: 13  LGKGTFGKVILVREKA---TGRYYAMK-ILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 68

Query: 168 KLLGCCIEKDERL-LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKG-VAQGLLYLHQ 225
            L     +  +RL  + EY     L    F  ++  +     R +     +   L YLH 
Sbjct: 69  ALK-YAFQTHDRLCFVMEYANGGEL---FFHLSRERVFT-EERARFYGAEIVSALEYLHS 123

Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
                +++RD+K  N++LDKD + KI+DFG+ +                   GT  Y++P
Sbjct: 124 RD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA------TMKTFCGTPEYLAP 174

Query: 286 EYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           E   +  +    D +  GV++ E++ G+
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 73.2 bits (180), Expect = 2e-14
 Identities = 44/249 (17%), Positives = 88/249 (35%), Gaps = 62/249 (24%)

Query: 110 NFSAANKLGEGGFGTVYKGVIGQ-GE-IAVKRLLG---KSGQEIKELKNEASVIAQVQHK 164
            +S    LG G FG V +    + G+  A+K++L       +E+  +K        + H 
Sbjct: 8   KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMK-------VLDHV 60

Query: 165 NLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRV-------------- 210
           N++KL+       +        P+        +                           
Sbjct: 61  NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120

Query: 211 -----QIIKGVAQ-------------------GLLYLHQYSRVRIIHRDLKASNILLDKD 246
                +++K   +                    + ++H    + I HRD+K  N+L++  
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSK 177

Query: 247 MNS-KISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGI-FSIKSDVFSFGV 304
            N+ K+ DFG A+ +           + + I   + Y +PE  L    ++   D++S G 
Sbjct: 178 DNTLKLCDFGSAKKLIPSEP------SVAYICSRF-YRAPELMLGATEYTPSIDLWSIGC 230

Query: 305 LLLEIVSGK 313
           +  E++ GK
Sbjct: 231 VFGELILGK 239

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 72.3 bits (178), Expect = 2e-14
 Identities = 39/166 (23%), Positives = 68/166 (40%), Gaps = 33/166 (19%)

Query: 116 KLGEGGFGTVYKGV-IGQGEI-AVKRLLGKSGQEIKELKNEASVIAQV-QHKNLVKLLGC 172
            LG G  G V +       E  A+K L     Q+  + + E  +  +  Q  ++V+++  
Sbjct: 25  VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 79

Query: 173 C----IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRV-------QIIKGVAQGLL 221
                  +   L++ E +    L    F      I D   +        +I+K + + + 
Sbjct: 80  YENLYAGRKCLLIVMECLDGGEL----FS----RIQDRGDQAFTEREASEIMKSIGEAIQ 131

Query: 222 YLHQYSRVRIIHRDLKASNILL-DKDMNS--KISDFGMARIVFGGN 264
           YLH    + I HRD+K  N+L   K  N+  K++DFG A+   G  
Sbjct: 132 YLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEK 174

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 73.5 bits (180), Expect = 3e-14
 Identities = 59/208 (28%), Positives = 93/208 (44%), Gaps = 28/208 (13%)

Query: 117 LGEGGFGTV----YKGVIGQGEI-AVKRLLGK----SGQEIKELKNEASVIAQV-QHKNL 166
           LG+G FG V     KG     E+ AVK +L K       +++    E  V+A   +   L
Sbjct: 349 LGKGSFGKVMLSERKG---TDELYAVK-ILKKDVVIQDDDVECTMVEKRVLALPGKPPFL 404

Query: 167 VKLLGCCIEKDERL-LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ 225
            +L   C +  +RL  + EY+    L   ++   +         V     +A GL +L  
Sbjct: 405 TQLH-SCFQTMDRLYFVMEYVNGGDL---MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS 460

Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
                II+RDLK  N++LD + + KI+DFGM +              T    GT  Y++P
Sbjct: 461 KG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV------TTKTFCGTPDYIAP 511

Query: 286 EYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           E      +    D ++FGVLL E+++G+
Sbjct: 512 EIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 71.6 bits (176), Expect = 7e-14
 Identities = 44/222 (19%), Positives = 79/222 (35%), Gaps = 43/222 (19%)

Query: 116 KLGEGGFGTVYKGVIGQGE-IAVKRLLGKSGQEIKELKNEASVIAQ-----------VQH 163
            +  G +G V  GV  +G  +A+KR+               S + +             H
Sbjct: 29  FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88

Query: 164 KNLVKLLGCCIEKDERL-----LIYEYMPN------KSLDCFLFDPTKREILDWRTRVQI 212
            N++ L    +  +E       L+ E M              +     +  +       I
Sbjct: 89  PNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFM-----YHI 143

Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
           + G    L  LH+     ++HRDL   NILL  + +  I DF +AR       +      
Sbjct: 144 LLG----LHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAR---EDTADANKTHY 193

Query: 273 TSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGK 313
            +       Y +PE  ++   F+   D++S G ++ E+ + K
Sbjct: 194 VT----HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 71.1 bits (175), Expect = 8e-14
 Identities = 57/223 (25%), Positives = 93/223 (41%), Gaps = 58/223 (26%)

Query: 115 NKLGEGGFGTVYKGV-IGQGE-IAVKRL----LGKSGQEIKELKNEASVIAQVQHKNLVK 168
            KLG G +  V++ + I   E + VK L      K  +EIK L+N           N++ 
Sbjct: 42  RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR------GGPNIIT 95

Query: 169 LLGCCIEKDER----LLIYEYMPN---KSLDCFLFDPTKREILDWRTRVQIIKGVAQGLL 221
           L    I KD       L++E++ N   K L   L D   R  +      +I+K     L 
Sbjct: 96  LA--DIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYM-----YEILKA----LD 144

Query: 222 YLHQYSRVRIIHRDLKASNILLDKDMNS-KISDFGMARIVFGGNDEDELQGNTSRISGTY 280
           Y H  S   I+HRD+K  N+++D +    ++ D+G+A            Q    R++  Y
Sbjct: 145 YCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY------HPGQEYNVRVASRY 195

Query: 281 GYMSPE---------YALEGIFSIKSDVFSFGVLLLEIVSGKK 314
            +  PE         Y+L        D++S G +L  ++  K+
Sbjct: 196 -FKGPELLVDYQMYDYSL--------DMWSLGCMLASMIFRKE 229

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 71.7 bits (176), Expect = 1e-13
 Identities = 48/231 (20%), Positives = 88/231 (38%), Gaps = 56/231 (24%)

Query: 117 LGEGGFGTVY----KGVIGQGEI-AVKRLLGKSG----QEIKELKNEASVIAQVQHKNLV 167
           +G G F  V     K     G++ A+K ++ K       E+   + E  V+     + + 
Sbjct: 69  IGRGAFSEVAVVKMKQ---TGQVYAMK-IMNKWDMLKRGEVSCFREERDVLVNGDRRWIT 124

Query: 168 KLLGCCIEKDERL-LIYEYMP--------NKSLDCFLFDPTK---REILDWRTRVQIIKG 215
           +L     + +  L L+ EY          +K  +    +  +    EI+           
Sbjct: 125 QLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIV----------- 172

Query: 216 VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR 275
               +  +H+      +HRD+K  NILLD+  + +++DFG          +  ++     
Sbjct: 173 --MAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCL---KLRADGTVRSLV-- 222

Query: 276 ISGTYGYMSPE-------YALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFY 319
             GT  Y+SPE           G +  + D ++ GV   E+  G+  T FY
Sbjct: 223 AVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ--TPFY 271

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 71.3 bits (175), Expect = 1e-13
 Identities = 53/230 (23%), Positives = 89/230 (38%), Gaps = 56/230 (24%)

Query: 117 LGEGGFGTVY----KGVIGQGEI-AVKRLLGKSG----QEIKELKNEASVIAQVQHKNLV 167
           +G G FG V     K      ++ A+K +L K       E    + E  V+     K + 
Sbjct: 82  IGRGAFGEVAVVKLKN---ADKVFAMK-ILNKWEMLKRAETACFREERDVLVNGDSKWIT 137

Query: 168 KLLGCCIEKDERL-LIYEYMP--------NKSLDCFLFDPTK---REILDWRTRVQIIKG 215
            L     + D  L L+ +Y          +K  D    +  +    E++           
Sbjct: 138 TLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMV----------- 185

Query: 216 VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR 275
               +  +HQ      +HRD+K  NIL+D + + +++DFG    +            +S 
Sbjct: 186 --IAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ-----SSV 235

Query: 276 ISGTYGYMSPEYALEGIFSIKS------DVFSFGVLLLEIVSGKKNTGFY 319
             GT  Y+SPE  L+ +   K       D +S GV + E++ G+  T FY
Sbjct: 236 AVGTPDYISPE-ILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE--TPFY 282

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 70.0 bits (172), Expect = 2e-13
 Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 28/208 (13%)

Query: 117 LGEGGFGTVY----KGVIGQGEI-AVKRLLGK----SGQEIKELKNEASVIAQV-QHKNL 166
           +G G +  V     K       I A+K ++ K      ++I  ++ E  V  Q   H  L
Sbjct: 17  IGRGSYAKVLLVRLKK---TDRIYAMK-VVKKELVNDDEDIDWVQTEKHVFEQASNHPFL 72

Query: 167 VKLLGCCIEKDERL-LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ 225
           V L   C + + RL  + EY+    L        +R++ +   R    + ++  L YLH+
Sbjct: 73  VGLH-SCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAE-ISLALNYLHE 128

Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
                II+RDLK  N+LLD + + K++D+GM +      D       TS   GT  Y++P
Sbjct: 129 RG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT------TSTFCGTPNYIAP 179

Query: 286 EYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           E      +    D ++ GVL+ E+++G+
Sbjct: 180 EILRGEDYGFSVDWWALGVLMFEMMAGR 207

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 70.1 bits (172), Expect = 3e-13
 Identities = 55/208 (26%), Positives = 95/208 (45%), Gaps = 28/208 (13%)

Query: 117 LGEGGFGTVY----KGVIGQGEI-AVKRLLGK----SGQEIKELKNEASVIAQV-QHKNL 166
           +G G +  V     K       I A++ ++ K      ++I  ++ E  V  Q   H  L
Sbjct: 60  IGRGSYAKVLLVRLKK---TDRIYAMR-VVKKELVNDDEDIDWVQTEKHVFEQASNHPFL 115

Query: 167 VKLLGCCIEKDERL-LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ 225
           V L   C + + RL  + EY+    L        +R++ +   R    + ++  L YLH+
Sbjct: 116 VGLH-SCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAE-ISLALNYLHE 171

Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
                II+RDLK  N+LLD + + K++D+GM +      D       TS   GT  Y++P
Sbjct: 172 RG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT------TSTFCGTPNYIAP 222

Query: 286 EYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           E      +    D ++ GVL+ E+++G+
Sbjct: 223 EILRGEDYGFSVDWWALGVLMFEMMAGR 250

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 69.6 bits (171), Expect = 3e-13
 Identities = 59/208 (28%), Positives = 93/208 (44%), Gaps = 28/208 (13%)

Query: 117 LGEGGFGTV----YKGVIGQGEI-AVKRLLGK----SGQEIKELKNEASVIAQV-QHKNL 166
           LG+G FG V     KG     E+ AVK +L K       +++    E  V+A   +   L
Sbjct: 28  LGKGSFGKVMLSERKG---TDELYAVK-ILKKDVVIQDDDVECTMVEKRVLALPGKPPFL 83

Query: 167 VKLLGCCIEKDERL-LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ 225
            +L   C +  +RL  + EY+    L   ++   +         V     +A GL +L  
Sbjct: 84  TQLH-SCFQTMDRLYFVMEYVNGGDL---MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS 139

Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
                II+RDLK  N++LD + + KI+DFGM +              T    GT  Y++P
Sbjct: 140 K---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV------TTKTFCGTPDYIAP 190

Query: 286 EYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           E      +    D ++FGVLL E+++G+
Sbjct: 191 EIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 69.3 bits (170), Expect = 4e-13
 Identities = 48/176 (27%), Positives = 73/176 (41%), Gaps = 35/176 (19%)

Query: 147 EIKELKNEASVIAQVQHKNLVKLL------GCCIEKDERLLIYEYMPNKSLDCFLFDPTK 200
           E+  +K        V HKN++ LL          E  +  ++ E M     D  L    +
Sbjct: 74  ELVLMK-------CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQ 121

Query: 201 REILDWRTRV---QIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMA 257
            E+   R      Q++ G    + +LH      IIHRDLK SNI++  D   KI DFG+A
Sbjct: 122 MELDHERMSYLLYQMLCG----IKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 174

Query: 258 RIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           R              T  +  T  Y +PE  L   +    D++S G ++ E++ G 
Sbjct: 175 RTA------GTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 68.7 bits (169), Expect = 5e-13
 Identities = 57/217 (26%), Positives = 95/217 (43%), Gaps = 52/217 (23%)

Query: 117 LGEGGFGTVY----KGVIGQGEI-AVKRLLGKSGQEIKELK------NEASVIAQVQHKN 165
           LG G FG V+    +     G   A+K L     + +  LK      +E  +++ V H  
Sbjct: 14  LGTGSFGRVHLIRSRH---NGRYYAMKVL---KKEIVVRLKQVEHTNDERLMLSIVTHPF 67

Query: 166 LVKLLGCCIEKDERLL--IYEYMPNKSLDCFL-----FDPTKREILDWRTRV---QIIKG 215
           ++++ G    +D + +  I +Y+    L   L     F            +    ++   
Sbjct: 68  IIRMWGTF--QDAQQIFMIMDYIEGGELFSLLRKSQRFPNP-------VAKFYAAEVC-- 116

Query: 216 VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR 275
               L YLH      II+RDLK  NILLDK+ + KI+DFG A+          +   T  
Sbjct: 117 --LALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAK---------YVPDVTYT 162

Query: 276 ISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 312
           + GT  Y++PE      ++   D +SFG+L+ E+++G
Sbjct: 163 LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 69.0 bits (169), Expect = 7e-13
 Identities = 60/217 (27%), Positives = 96/217 (44%), Gaps = 33/217 (15%)

Query: 117 LGEGGFGTVY----KGVIGQGEI-AVKRLLGKSG----QEIKELKNEASVIAQVQHKNLV 167
           +G G FG V     K      ++ A+K LL K       +      E  ++A      +V
Sbjct: 77  IGRGAFGEVQLVRHKS---TRKVYAMK-LLSKFEMIKRSDSAFFWEERDIMAFANSPWVV 132

Query: 168 KLLGCCIEKDERL-LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQY 226
           +L     + D  L ++ EYMP   L   +   +  ++ +   R    + V   L  +H  
Sbjct: 133 QLF-YAFQDDRYLYMVMEYMPGGDLVNLM---SNYDVPEKWARFYTAE-VVLALDAIHSM 187

Query: 227 SRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPE 286
                IHRD+K  N+LLDK  + K++DFG    +   N E  ++ +T+   GT  Y+SPE
Sbjct: 188 G---FIHRDVKPDNMLLDKSGHLKLADFGTCMKM---NKEGMVRCDTA--VGTPDYISPE 239

Query: 287 ----YALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFY 319
                  +G +  + D +S GV L E++ G   T FY
Sbjct: 240 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGD--TPFY 274

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 68.0 bits (167), Expect = 9e-13
 Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 30/209 (14%)

Query: 117 LGEGGFGTVY----KGVIGQGEI-AVKRLLGK----SGQEIKELKNEASVIAQV-QHKNL 166
           LG+G FG V     K     G++ AVK +L K       +++    E  +++    H  L
Sbjct: 31  LGKGSFGKVMLARVKE---TGDLYAVK-VLKKDVILQDDDVECTMTEKRILSLARNHPFL 86

Query: 167 VKLLGCCIEKDERL-LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKG-VAQGLLYLH 224
            +L  CC +  +RL  + E++    L        ++       R +     +   L++LH
Sbjct: 87  TQLF-CCFQTPDRLFFVMEFVNGGDL----MFHIQKSRRFDEARARFYAAEIISALMFLH 141

Query: 225 QYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMS 284
                 II+RDLK  N+LLD + + K++DFGM +              T+   GT  Y++
Sbjct: 142 DKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT------TATFCGTPDYIA 192

Query: 285 PEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           PE   E ++    D ++ GVLL E++ G 
Sbjct: 193 PEILQEMLYGPAVDWWAMGVLLYEMLCGH 221

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 68.0 bits (167), Expect = 9e-13
 Identities = 57/233 (24%), Positives = 92/233 (39%), Gaps = 65/233 (27%)

Query: 116 KLGEGGFGTVYKGV--IGQGEIAVK------------RLLGKSGQEIKELKNEASVIAQV 161
            LGEG +G V           +A+K            R L    +EIK LK         
Sbjct: 18  LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL----REIKILK-------HF 66

Query: 162 QHKNLVKLLGC----CIEKDERL-LIYEYMPNKSLDCFLFDPTKREIL-DWRTRV---QI 212
           +H+N++ +         E    + +I E M        L      ++L D   +    Q 
Sbjct: 67  KHENIITIFNIQRPDSFENFNEVYIIQELM-----QTDLHRVISTQMLSDDHIQYFIYQT 121

Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
           ++     +  LH      +IHRDLK SN+L++ + + K+ DFG+ARI+      DE   +
Sbjct: 122 LRA----VKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARII------DESAAD 168

Query: 273 TSRISGTYGYMSPEY-------ALEGIFSIKS-----DVFSFGVLLLEIVSGK 313
            S  +G    M  E+       A E + +        DV+S G +L E+   +
Sbjct: 169 NSEPTGQQSGMV-EFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 68.7 bits (168), Expect = 1e-12
 Identities = 57/219 (26%), Positives = 90/219 (41%), Gaps = 46/219 (21%)

Query: 115 NKLGEGGFGTVYKGV-IGQGE-IAVKRLLG---------KSGQEIKELKNEASVIAQVQH 163
             +G G  G V           +A+K+L           ++ +E+  +K        V H
Sbjct: 68  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMK-------CVNH 120

Query: 164 KNLVKLL-----GCCIEKDERL-LIYEYMPNKSLDCFLFDPTKREILDWRTRV---QIIK 214
           KN++ LL        +E+ + + L+ E M     D  L    + E+   R      Q++ 
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERMSYLLYQMLC 175

Query: 215 GVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTS 274
           G    + +LH      IIHRDLK SNI++  D   KI DFG+AR              T 
Sbjct: 176 G----IKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA------GTSFMMTP 222

Query: 275 RISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
            +  T  Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 223 YVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 67.6 bits (166), Expect = 1e-12
 Identities = 61/207 (29%), Positives = 93/207 (44%), Gaps = 28/207 (13%)

Query: 117 LGEGGFGTV----YKGVIGQGEI-AVKRLLGK----SGQEIKELKNEASVIAQV-QHKNL 166
           LG+G FG V    +K      +  A+K  L K       +++    E  V++   +H  L
Sbjct: 25  LGKGSFGKVFLAEFKK---TNQFFAIK-ALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 80

Query: 167 VKLLGCCIEKDERL-LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ 225
             +  C  +  E L  + EY+    L   ++        D          +  GL +LH 
Sbjct: 81  THMF-CTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATFYAAEIILGLQFLHS 136

Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
                I++RDLK  NILLDKD + KI+DFGM +    G+        T+   GT  Y++P
Sbjct: 137 KG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA------KTNTFCGTPDYIAP 187

Query: 286 EYALEGIFSIKSDVFSFGVLLLEIVSG 312
           E  L   ++   D +SFGVLL E++ G
Sbjct: 188 EILLGQKYNHSVDWWSFGVLLYEMLIG 214

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 67.9 bits (166), Expect = 2e-12
 Identities = 40/196 (20%), Positives = 75/196 (38%), Gaps = 42/196 (21%)

Query: 116 KLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQ---------EIKELKNEASVIAQVQHK 164
            +G G +G VY       +  +A+K++               EI  L        +++  
Sbjct: 33  LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILN-------RLKSD 85

Query: 165 NLVKLLGCCIEKDERL-----LIYEYMPN------KSLDCFLFDPTKREILDWRTRVQII 213
            +++L    I  D        ++ E   +      K+   FL +   + IL       ++
Sbjct: 86  YIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPI-FLTEEHIKTIL-----YNLL 139

Query: 214 KGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNT 273
            G      ++H+     IIHRDLK +N LL++D + K+ DFG+AR +    D + +    
Sbjct: 140 LG----ENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLE 192

Query: 274 SRISGTYGYMSPEYAL 289
                     + +  L
Sbjct: 193 ENEEPGPHNKNLKKQL 208

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 67.3 bits (165), Expect = 2e-12
 Identities = 59/218 (27%), Positives = 92/218 (42%), Gaps = 48/218 (22%)

Query: 117 LGEGGFGTVY----KGVIGQGEI-AVKRLLGK----SGQEIKELKNEASVIAQ-VQHKNL 166
           +G+G FG V     K    +    AVK +L K      +E K + +E +V+ + V+H  L
Sbjct: 46  IGKGSFGKVLLARHKA---EEVFYAVK-VLQKKAILKKKEEKHIMSERNVLLKNVKHPFL 101

Query: 167 VKLLGCCIEKDERL-LIYEYMPNKSL-----DCFLFD-PTKR----EILDWRTRVQIIKG 215
           V L     +  ++L  + +Y+    L         F  P  R    EI            
Sbjct: 102 VGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEI------------ 148

Query: 216 VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR 275
            A  L YLH  +   I++RDLK  NILLD   +  ++DFG+ +     N        TS 
Sbjct: 149 -ASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS------TTST 198

Query: 276 ISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
             GT  Y++PE   +  +    D +  G +L E++ G 
Sbjct: 199 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 66.6 bits (163), Expect = 3e-12
 Identities = 51/220 (23%), Positives = 96/220 (43%), Gaps = 49/220 (22%)

Query: 115 NKLGEGGFGTVYKGV--IGQGEIAVKRLLG---------KSGQEIKELKNEASVIAQVQH 163
             +G G +G+V   +      ++A+K+L           ++ +E+  LK        +QH
Sbjct: 30  THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLK-------HMQH 82

Query: 164 KNLVKLL-----GCCIEKDERL-LIYEYMPNKSLDCFLFDPTKREILDWRTRV---QIIK 214
           +N++ LL        +       L+  +M        L      +  + + +    Q++K
Sbjct: 83  ENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQKIMGLKFSEEKIQYLVYQMLK 137

Query: 215 GVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTS 274
           G    L Y+H      ++HRDLK  N+ +++D   KI DFG+AR       + E+ G   
Sbjct: 138 G----LKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHA-----DAEMTGYVV 185

Query: 275 RISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGK 313
               T  Y +PE  L    ++   D++S G ++ E+++GK
Sbjct: 186 ----TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 66.5 bits (163), Expect = 3e-12
 Identities = 54/219 (24%), Positives = 97/219 (44%), Gaps = 42/219 (19%)

Query: 115 NKLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQ--------EIKELKNEASVIAQVQHK 164
           + +GEG +G V      + +  +A+K++     Q        EIK L        + +H+
Sbjct: 33  SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILL-------RFRHE 85

Query: 165 NLVKLLGCCIEKDERL-----LIYEYMPNKSLDCFLFDPTKREIL-DWRTRV---QIIKG 215
           N++ +                ++ + M     +  L+   K + L +        QI++G
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICYFLYQILRG 140

Query: 216 VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR 275
               L Y+H      ++HRDLK SN+LL+   + KI DFG+AR+     D D     T  
Sbjct: 141 ----LKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD--PDHDHTGFLTEY 191

Query: 276 ISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGK 313
           ++ T  Y +PE  L    ++   D++S G +L E++S +
Sbjct: 192 VA-TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 66.2 bits (162), Expect = 4e-12
 Identities = 52/220 (23%), Positives = 90/220 (40%), Gaps = 45/220 (20%)

Query: 117 LGEGGFGTVY----KGVIGQGEI-AVKRL----LGKSGQEIKELKNEASVIAQVQHKN-L 166
           LG G +G V+          G++ A+K L    + +  +  +  + E  V+  ++    L
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121

Query: 167 VKLLGCCIEKDERL-LIYEYMPNKSL-----DCFLFD-PTKR----EILDWRTRVQIIKG 215
           V L     + + +L LI +Y+    L         F     +    EI+           
Sbjct: 122 VTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIV----------- 169

Query: 216 VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSR 275
               L +LH+     II+RD+K  NILLD + +  ++DFG+++       E         
Sbjct: 170 --LALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-----RAYD 219

Query: 276 ISGTYGYMSPEYALEGIFSIKSDV--FSFGVLLLEIVSGK 313
             GT  YM+P+    G       V  +S GVL+ E+++G 
Sbjct: 220 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 66.8 bits (162), Expect = 6e-12
 Identities = 46/347 (13%), Positives = 102/347 (29%), Gaps = 86/347 (24%)

Query: 112 SAANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKL-- 169
            A  +L       +  GV+G          GK+      +  +  +  +VQ K   K+  
Sbjct: 142 QALLELRPAKNVLID-GVLG---------SGKT-----WVALDVCLSYKVQCKMDFKIFW 186

Query: 170 --LGCCIEKDERL-----LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLY 222
             L  C   +  L     L+Y+  PN +         K  I   +  ++        LL 
Sbjct: 187 LNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRR-------LLK 239

Query: 223 LHQYSRVRIIHRDLKASNILLDKDMNSKI----SDFGMARIVFGGND-----EDELQGNT 273
              Y    ++  +++ +      +++ KI        +   +          +       
Sbjct: 240 SKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMT-- 297

Query: 274 SRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYA--- 330
                    ++P+     +     D      L  E+++          + L++I  +   
Sbjct: 298 ---------LTPDEVKS-LLLKYLDC-RPQDLPREVLTTN-------PRRLSIIAESIRD 339

Query: 331 ----WDLW---ISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM 383
               WD W     +K+  +I+S L      E    +  +++             + ++S+
Sbjct: 340 GLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVF-----PPSAHIPTILLSL 394

Query: 384 LTNEASSLLPPKQPAFCNLRNMESSTSTTEKSWADCSINEVTVSILD 430
           +  +                 M       + S  +    E T+SI  
Sbjct: 395 IWFDVIKSDV-----------MVVVNKLHKYSLVEKQPKESTISIPS 430

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 54.5 bits (130), Expect = 4e-08
 Identities = 49/352 (13%), Positives = 101/352 (28%), Gaps = 113/352 (32%)

Query: 108 TGNFSAANKLGEGGFGTVY--KGVIGQGEIAVKRLLGKS-GQEIKELKNEA--------S 156
           T      + L       +      +      VK LL K      ++L  E         S
Sbjct: 272 TRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLS 331

Query: 157 VIA--------------QVQHKNLVKLLGCCIEK---DERLLIYEYMPNKSLDCFLFD-- 197
           +IA               V    L  ++   +      E   +++          +F   
Sbjct: 332 IIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFD-------RLSVFPPS 384

Query: 198 ---PTKR-EILDW----RTRVQII-----------KGVAQGLLYLHQYSRVRIIHRDLKA 238
              PT    ++ W    ++ V ++           K   +  + +        I+ +LK 
Sbjct: 385 AHIPTILLSLI-WFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPS------IYLELKV 437

Query: 239 SNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPE-YALEGIFSIKS 297
             +  +  ++  I D                            Y  P+ +  + +     
Sbjct: 438 -KLENEYALHRSIVDH---------------------------YNIPKTFDSDDLIPPYL 469

Query: 298 D--VFSF-GVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNE 354
           D   +S  G  L  I   ++ T F R   L+        ++  KI     +     S   
Sbjct: 470 DQYFYSHIGHHLKNIEHPERMTLF-RMVFLDF------RFLEQKIRHDSTAWNASGSILN 522

Query: 355 SLSR---YV-HIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQPAFCNL 402
           +L +   Y  +I   C  +   +R  ++ ++  L     +L+  K   + +L
Sbjct: 523 TLQQLKFYKPYI---CDNDPKYER-LVNAILDFLPKIEENLICSK---YTDL 567

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 65.0 bits (159), Expect = 7e-12
 Identities = 55/227 (24%), Positives = 101/227 (44%), Gaps = 51/227 (22%)

Query: 116 KLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQ-------EIKELKNEASVIAQVQHKNL 166
            LG GG G V+  V       +A+K+++    Q       EIK ++       ++ H N+
Sbjct: 18  PLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIR-------RLDHDNI 70

Query: 167 VKLL--------------GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREIL-DWRTRV- 210
           VK+               G   E +   ++ EYM     +  L +  ++  L +   R+ 
Sbjct: 71  VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVLEQGPLLEEHARLF 125

Query: 211 --QIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLD-KDMNSKISDFGMARIVFGGNDED 267
             Q+++G    L Y+H      ++HRDLK +N+ ++ +D+  KI DFG+ARI+       
Sbjct: 126 MYQLLRG----LKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMD--PHYS 176

Query: 268 ELQGNTSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 313
                +  +  T  Y SP   L    ++   D+++ G +  E+++GK
Sbjct: 177 HKGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 62.8 bits (153), Expect = 5e-11
 Identities = 52/227 (22%), Positives = 95/227 (41%), Gaps = 49/227 (21%)

Query: 116 KLGEGGFGTVYKGV--IGQGEIAVK-----RLLGKSGQ-EIKELK--NEASVIAQVQ--H 163
           KLG G F TV+     +    +A+K     ++  ++ + EIK L+  N+A    +     
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85

Query: 164 KNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTR-------VQIIKGV 216
            +++KLL                PN      +F+     +L    +       +  +K +
Sbjct: 86  NHILKLLDH---------FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI 136

Query: 217 AQ----GLLYLHQYSRVRIIHRDLKASNILLDKDMNS------KISDFGMARIVFGGNDE 266
           ++    GL Y+H   R  IIH D+K  N+L++   +       KI+D G A      +  
Sbjct: 137 SKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY-DEHYT 193

Query: 267 DELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           + +Q   +R      Y SPE  L   +   +D++S   L+ E+++G 
Sbjct: 194 NSIQ---TRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 62.7 bits (153), Expect = 5e-11
 Identities = 50/178 (28%), Positives = 86/178 (48%), Gaps = 39/178 (21%)

Query: 147 EIKELKNEASVIAQVQHKNLVKLL-----GCCIEKDERL-LIYEYMPNKSLDCFLFDPTK 200
           E++ LK        ++H+N++ LL        +E+   + L+   M        L +  K
Sbjct: 78  ELRLLK-------HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVK 125

Query: 201 REIL-DWRTRV---QIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGM 256
            + L D   +    QI++G    L Y+H      IIHRDLK SN+ +++D   KI DFG+
Sbjct: 126 CQKLTDDHVQFLIYQILRG----LKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL 178

Query: 257 ARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGK 313
           AR        DE+   T  ++ T  Y +PE  L    ++   D++S G ++ E+++G+
Sbjct: 179 ARHT-----ADEM---TGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 62.7 bits (153), Expect = 5e-11
 Identities = 49/178 (27%), Positives = 83/178 (46%), Gaps = 39/178 (21%)

Query: 147 EIKELKNEASVIAQVQHKNLVKLL------GCCIEKDERLLIYEYMPNKSLDCFLFDPTK 200
           E++ LK        ++H+N++ LL          +  +  L+  +M        L    K
Sbjct: 74  ELRLLK-------HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-----GTDLGKLMK 121

Query: 201 REIL-DWRTRV---QIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGM 256
            E L + R +    Q++KG    L Y+H      IIHRDLK  N+ +++D   KI DFG+
Sbjct: 122 HEKLGEDRIQFLVYQMLKG----LRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGL 174

Query: 257 ARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGK 313
           AR       + E+   T  +  T  Y +PE  L    ++   D++S G ++ E+++GK
Sbjct: 175 ARQA-----DSEM---TGYVV-TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 62.8 bits (153), Expect = 6e-11
 Identities = 62/237 (26%), Positives = 99/237 (41%), Gaps = 61/237 (25%)

Query: 115 NKLGEGGFGTVYKGV-IGQGE-IAVK-------------RLLGKSGQEIKELKNEASVIA 159
            KLG+G +G V+K +    GE +AVK             R      +EI  L        
Sbjct: 15  KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF----REIMILT------E 64

Query: 160 QVQHKNLVKLLGCCI-EKDERL-LIYEYMPNKSLDCFLFDPTKREIL-DWRTRV---QII 213
              H+N+V LL     + D  + L+++YM     +  L    +  IL     +    Q+I
Sbjct: 65  LSGHENIVNLLNVLRADNDRDVYLVFDYM-----ETDLHAVIRANILEPVHKQYVVYQLI 119

Query: 214 KGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVF-----GGNDEDE 268
           K     + YLH      ++HRD+K SNILL+ + + K++DFG++R          N    
Sbjct: 120 KV----IKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLS 172

Query: 269 LQGNTSRISGTYGYMSPEY-------ALEGIFSIKS-----DVFSFGVLLLEIVSGK 313
           +  NT         ++ +Y       A E +          D++S G +L EI+ GK
Sbjct: 173 INENTENFDDDQPILT-DYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 60.5 bits (147), Expect = 3e-10
 Identities = 36/201 (17%), Positives = 73/201 (36%), Gaps = 31/201 (15%)

Query: 109 GNFSAANKLGEGGFGTVYKGV----------IGQGEIAVKRLLGKSGQEIKELKNEASVI 158
             +   +       G +Y+              + + ++K L  K G+   E        
Sbjct: 42  RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAA 100

Query: 159 AQVQHKNLVKLLGC---CI---------EKDERLLIYEYMPNKSLDCFLFDPTKREILDW 206
             +Q     KL       I         +   R L+   +  +SL     D + + +L  
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQS-ALDVSPKHVLSE 158

Query: 207 RTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKI--SDFGMA-RIVFGG 263
           R+ +Q+   +   L +LH+      +H ++ A NI +D +  S++  + +G A R    G
Sbjct: 159 RSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSG 215

Query: 264 NDEDELQGNTSRISGTYGYMS 284
                ++G+ S   G   ++S
Sbjct: 216 KHVAYVEGSRSPHEGDLEFIS 236

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 60.8 bits (147), Expect = 4e-10
 Identities = 51/213 (23%), Positives = 95/213 (44%), Gaps = 17/213 (7%)

Query: 109 GNFSAANKLGEGGFGTVYKGV-IGQGE-IAVKRLLGKSGQEIKELKNEASVIAQVQHKNL 166
             F    K+G G FG +Y G  I   E +A+K    K+  +  +L  E+ +   +Q    
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTG 64

Query: 167 V-KLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ 225
           +  +    +E D  +L+ + +   SL+  LF+   R+ L  +T + +   +   + ++H 
Sbjct: 65  IPNVRWFGVEGDYNVLVMDLL-GPSLED-LFNFCSRK-LSLKTVLMLADQMINRVEFVHS 121

Query: 226 YSRVRIIHRDLKASNILLDKDMNSK---ISDFGMARIVFGGNDEDELQGNTSR-ISGTYG 281
            S    +HRD+K  N L+     +    I DFG+A+     +    +    ++ ++GT  
Sbjct: 122 KS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTAR 178

Query: 282 YMSPEYALEGIF-SIKSDVFSFGVLLLEIVSGK 313
           Y S      GI  S + D+ S G +L+  + G 
Sbjct: 179 YASV-NTHLGIEQSRRDDLESLGYVLMYFLRGS 210

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 59.3 bits (144), Expect = 5e-10
 Identities = 40/156 (25%), Positives = 71/156 (45%), Gaps = 14/156 (8%)

Query: 109 GNFSAANKLGEGGFGTVYKGV-IGQGE-IAVKRLLGKSGQEIKELKNEASVIAQVQHKNL 166
             +    K+G G FG +Y G  I  GE +A+K    K+  +  +L  E+ +   +Q    
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVG 66

Query: 167 V-KLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ 225
           +  +  C  E D  +++ E +   SL+  LF+   R+    +T + +   +   + Y+H 
Sbjct: 67  IPTIRWCGAEGDYNVMVMELL-GPSLED-LFNFCSRK-FSLKTVLLLADQMISRIEYIHS 123

Query: 226 YSRVRIIHRDLKASNILLDKDMNSK---ISDFGMAR 258
            +    IHRD+K  N L+          I DFG+A+
Sbjct: 124 KN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 58.2 bits (141), Expect = 2e-09
 Identities = 37/158 (23%), Positives = 63/158 (39%), Gaps = 16/158 (10%)

Query: 109 GNFSAANKLGEGGFGTVYKGV-IGQGEI-AVKRLLGKSGQEIKELKNEASVIAQVQH-KN 165
            NF    K+G G FG +  G  +   E  A+K  L        +L  E     Q+     
Sbjct: 9   PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK--LEPMKSRAPQLHLEYRFYKQLGSGDG 66

Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ 225
           + ++           ++ E +   SL+  LFD   R     +T + I   +   + Y+H 
Sbjct: 67  IPQVYYFGPCGKYNAMVLELL-GPSLE-DLFDLCDRT-FSLKTVLMIAIQLISRMEYVHS 123

Query: 226 YSRVRIIHRDLKASNILLDKDMNSK-----ISDFGMAR 258
            +   +I+RD+K  N L+ +  N       I DF +A+
Sbjct: 124 KN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 56.5 bits (136), Expect = 6e-09
 Identities = 60/278 (21%), Positives = 99/278 (35%), Gaps = 95/278 (34%)

Query: 108 TGNFSAANKLGEGGFGTVYKGVIGQGE--IAVKRLLGKSGQEIKE-LKNEASVIAQVQ-- 162
            G +    KLG G F TV+     QG+  +A+K  + KS +   E   +E  ++  V+  
Sbjct: 36  NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK--VVKSAEHYTETALDEIRLLKSVRNS 93

Query: 163 ------HKNLVKLLGCCIEKDERLLIYEYM-PNKSLDCFLFDPTKREILDWRTR------ 209
                  + +V+LL            ++    N +  C +F+     +L W  +      
Sbjct: 94  DPNDPNREMVVQLLDD----------FKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGL 143

Query: 210 -----VQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILL--------------------- 243
                 +II+ V QGL YLH  ++ RIIH D+K  NILL                     
Sbjct: 144 PLPCVKKIIQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSG 201

Query: 244 ----------------------------DKDMNSKISDFGMARIVFGGNDEDELQGNTSR 275
                                        + +  KI+D G A  V     +      T  
Sbjct: 202 APPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWV----HKH----FTED 253

Query: 276 ISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
           I  T  Y S E  +   ++  +D++S   +  E+ +G 
Sbjct: 254 IQ-TRQYRSLEVLIGSGYNTPADIWSTACMAFELATGD 290

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 55.4 bits (134), Expect = 1e-08
 Identities = 30/158 (18%), Positives = 68/158 (43%), Gaps = 16/158 (10%)

Query: 109 GNFSAANKLGEGGFGTVYKGV-IGQGE-IAVKRLLGKSGQEIKELKNEASVIAQVQHKNL 166
            ++    ++GEG FG +++G  +   + +A+K        +  +L++E      +     
Sbjct: 10  VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF--EPRRSDAPQLRDEYRTYKLLAGCTG 67

Query: 167 V-KLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ 225
           +  +     E    +L+ + +   SL+  L D   R+    +T     K +   +  +H+
Sbjct: 68  IPNVYYFGQEGLHNVLVIDLLG-PSLE-DLLDLCGRK-FSVKTVAMAAKQMLARVQSIHE 124

Query: 226 YSRVRIIHRDLKASNILLDKDMNSK-----ISDFGMAR 258
            S   +++RD+K  N L+ +  +       + DFGM +
Sbjct: 125 KS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 55.2 bits (133), Expect = 2e-08
 Identities = 48/231 (20%), Positives = 89/231 (38%), Gaps = 33/231 (14%)

Query: 109 GNFSAANKLGEGGFGTVYKGVIGQGE-------IAVKRLLGKSGQEIKELK-----NEAS 156
             +     +G+GGFG +Y   +   E         VK     +G    ELK      +  
Sbjct: 35  AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94

Query: 157 VIAQVQHKNLVKLLG----------CCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDW 206
            I +      +K LG              K  R +I +      L   +++   +     
Sbjct: 95  QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQK-IYEANAKR-FSR 151

Query: 207 RTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKI--SDFGMA-RIVFGG 263
           +T +Q+   +   L Y+H++     +H D+KASN+LL+     ++   D+G+A R    G
Sbjct: 152 KTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEG 208

Query: 264 NDEDELQGNTSRISGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIVSGK 313
             +           GT  + S + A  G+  S + D+   G  +++ ++G 
Sbjct: 209 VHKAYAADPKRCHDGTIEFTSID-AHNGVAPSRRGDLEILGYCMIQWLTGH 258

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 40/192 (20%), Positives = 73/192 (38%), Gaps = 30/192 (15%)

Query: 116 KLGEGGFGTVYKGV-IGQGEI----AVKRLLGKSGQEIKELK-----NEASVIAQVQHKN 165
           K+G GGFG +Y      + E      VK    ++G    ELK      +   I +   + 
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 166 LVKLLG----------CCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKG 215
            +  LG              +  R ++ E +    L   +            T +Q+   
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQ-KISGQNGT--FKKSTVLQLGIR 159

Query: 216 VAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKI--SDFGMA-RIVFGGNDEDELQGN 272
           +   L Y+H+      +H D+KA+N+LL      ++  +D+G++ R    GN +   +  
Sbjct: 160 MLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENP 216

Query: 273 TSRISGTYGYMS 284
               +GT  + S
Sbjct: 217 RKGHNGTIEFTS 228

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 51.3 bits (123), Expect = 3e-07
 Identities = 32/105 (30%), Positives = 48/105 (45%), Gaps = 12/105 (11%)

Query: 211 QIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNS--KISDFGMARIVFGGNDEDE 268
           +  + +   LL+L     + IIH DLK  NILL     S  KI DFG +           
Sbjct: 161 KFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC--------QL 211

Query: 269 LQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
            Q     I   + Y SPE  L   + +  D++S G +L+E+ +G+
Sbjct: 212 GQRIYQYIQSRF-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 49.3 bits (118), Expect = 1e-06
 Identities = 34/109 (31%), Positives = 50/109 (45%), Gaps = 24/109 (22%)

Query: 212 IIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNS--KISDFGMARIVFGGNDEDE- 268
               + Q L  LH+    RIIH DLK  NILL +   S  K+ DFG +        E + 
Sbjct: 205 FAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCY------EHQR 255

Query: 269 ----LQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
               +Q   SR      Y +PE  L   + +  D++S G +L E+++G 
Sbjct: 256 VYTYIQ---SRF-----YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 26/119 (21%), Positives = 43/119 (36%), Gaps = 19/119 (15%)

Query: 211 QIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQ 270
                + + L YL    ++ + H DLK  NILLD     K                   +
Sbjct: 141 LYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTK 197

Query: 271 GNTSRI----SGTYG------------YMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
               ++      T+             Y +PE  L   + + SD++SFG +L E+ +G 
Sbjct: 198 STGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 42.7 bits (101), Expect = 2e-04
 Identities = 50/245 (20%), Positives = 84/245 (34%), Gaps = 81/245 (33%)

Query: 116 KLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKN----------EASVIAQVQHK- 164
            LGEG FG V +         +    GKS   +K ++N          E +V+ +++ K 
Sbjct: 26  NLGEGTFGKVVE--------CLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKD 77

Query: 165 -----NLVKLLGC-------CI--EKDERLL---IYEYMPNKSLDCFLFDPTKREILDWR 207
                  V +          CI  E    LL    +E++   +   +     +       
Sbjct: 78  KENKFLCVLMSDWFNFHGHMCIAFE----LLGKNTFEFLKENNFQPYPLPHVRH------ 127

Query: 208 TRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNS------------------ 249
               +   +   L +LH     ++ H DLK  NIL                         
Sbjct: 128 ----MAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTS 180

Query: 250 -KISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLE 308
            +++DFG A        + E    T+ ++  + Y  PE  LE  ++   DV+S G +L E
Sbjct: 181 IRVADFGSA------TFDHEHH--TTIVATRH-YRPPEVILELGWAQPCDVWSIGCILFE 231

Query: 309 IVSGK 313
              G 
Sbjct: 232 YYRGF 236

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 31/172 (18%), Positives = 67/172 (38%), Gaps = 30/172 (17%)

Query: 106 SATGNFSAANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKEL---------KNEAS 156
                    + +G+G    + +      ++ +K  + K     + L           EA 
Sbjct: 333 KGKKRKIPEHLIGKGAEADIKRDSYLDFDVIIKERVKKG-YRDERLDENIRKSRTAREAR 391

Query: 157 VIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGV 216
            +A V+   +       ++ D + ++  Y+  K           +++++    + I   +
Sbjct: 392 YLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLA---------KDVIE--DNLDIAYKI 440

Query: 217 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDE 268
            + +  LH   +  +IH DL  SN + DKD+   I DFG+ +I    ++ DE
Sbjct: 441 GEIVGKLH---KNDVIHNDLTTSNFIFDKDL--YIIDFGLGKI----SNLDE 483

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	432
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.91
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.81
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.68
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.47
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.24
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.22
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.14
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.82
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.63
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.57
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.56
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.55
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.47
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.19
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.17
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.03
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.93
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.91
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.87
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.58
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.45
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.36
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.32
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.3
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.2
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.17
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.09
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.09
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.67
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.75
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	94.85
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.51
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	94.14
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	91.79
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	89.46
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	87.78
2k1k_A	38	Ephrin type-A receptor 1; EPHA1, receptor tyrosine	85.7

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=5.5e-58  Score=432.68  Aligned_cols=259  Identities=29%  Similarity=0.440  Sum_probs=214.6

Q ss_pred             CCCCcCceeccCCcEEEEEEEEC-------CceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEE
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIG-------QGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLL  181 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  181 (432)
                      ++|.+.+.||+|+||+||+|++.       +..||||++........++|.+|+++|++++|||||+++++|.+++..++
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            57888999999999999999864       23799999988777788899999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEE
Q 014024          182 IYEYMPNKSLDCFLFDPT----------KREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKI  251 (432)
Q Consensus       182 v~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  251 (432)
                      |||||++|+|.++|....          ....++|.+++.|+.|++.||+|||+++   |+||||||+|||+++++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence            999999999999996432          2346999999999999999999999998   999999999999999999999


Q ss_pred             eecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhh
Q 014024          252 SDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYA  330 (432)
Q Consensus       252 ~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~  330 (432)
                      +|||+|+.....+    .........||+.|||||++.++.++.++|||||||++|||+| |+.||......        
T Consensus       170 ~DFGla~~~~~~~----~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~--------  237 (299)
T 4asz_A          170 GDFGMSRDVYSTD----YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--------  237 (299)
T ss_dssp             CCCSCHHHHTGGG----CEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--------
T ss_pred             CCcccceecCCCC----ceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--------
Confidence            9999998642211    1122334578999999999999999999999999999999999 89998532211        


Q ss_pred             HHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccc
Q 014024          331 WDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS  389 (432)
Q Consensus       331 ~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~  389 (432)
                             .+...+........+..++.++.+|+.+||+.||++|||++||++.|+++..
T Consensus       238 -------~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~  289 (299)
T 4asz_A          238 -------EVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK  289 (299)
T ss_dssp             -------HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -------HHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence                   1111122212223345567789999999999999999999999999988754

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=3.2e-57  Score=433.19  Aligned_cols=260  Identities=29%  Similarity=0.427  Sum_probs=210.6

Q ss_pred             hCCCCcCceeccCCcEEEEEEEEC-------CceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeE
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIG-------QGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERL  180 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  180 (432)
                      .++|.+.++||+|+||+||+|++.       +..||||++........+.|.+|+++|++++|||||+++++|.+.+..+
T Consensus        40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~  119 (329)
T 4aoj_A           40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL  119 (329)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            356788899999999999999864       2379999998878788889999999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCC
Q 014024          181 LIYEYMPNKSLDCFLFDPT------------KREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN  248 (432)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~  248 (432)
                      ||||||++|+|.++++...            ...+++|.+++.|+.|++.||+|||+.+   |+||||||+||||++++.
T Consensus       120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~  196 (329)
T 4aoj_A          120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLV  196 (329)
T ss_dssp             EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCc
Confidence            9999999999999996532            2246999999999999999999999998   999999999999999999


Q ss_pred             EEEeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchh
Q 014024          249 SKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLI  327 (432)
Q Consensus       249 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~  327 (432)
                      +||+|||+++.....+.    ........||+.|||||++.+..++.++|||||||++|||+| |+.||......     
T Consensus       197 ~Ki~DFGla~~~~~~~~----~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~-----  267 (329)
T 4aoj_A          197 VKIGDFGMSRDIYSTDY----YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT-----  267 (329)
T ss_dssp             EEECCCC--------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH-----
T ss_pred             EEEcccccceeccCCCc----ceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH-----
Confidence            99999999986532211    122345679999999999999999999999999999999999 89998533211     


Q ss_pred             hhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccc
Q 014024          328 GYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS  389 (432)
Q Consensus       328 ~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~  389 (432)
                                .+...+....+...+..++.++.+|+.+||+.||++|||++||+++|+.+..
T Consensus       268 ----------~~~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~  319 (329)
T 4aoj_A          268 ----------EAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ  319 (329)
T ss_dssp             ----------HHHHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ----------HHHHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence                      1111122222223445567789999999999999999999999999998764

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=5.2e-57  Score=427.80  Aligned_cols=257  Identities=29%  Similarity=0.451  Sum_probs=211.7

Q ss_pred             CCCCcCceeccCCcEEEEEEEEC-------CceEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeE
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIG-------QGEIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERL  180 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~-------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  180 (432)
                      +++++.++||+|+||+||+|.+.       +..||||++... .....+.|.+|+.++++++|||||+++|+|.+++..+
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            35667899999999999999863       237999998644 3345678999999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCC
Q 014024          181 LIYEYMPNKSLDCFLFDPT-------------KREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDM  247 (432)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~  247 (432)
                      +|||||++|+|.++|....             ....++|..++.|+.|++.||+|||+++   |+||||||+||||++++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence            9999999999999996432             1345999999999999999999999998   99999999999999999


Q ss_pred             CEEEeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccch
Q 014024          248 NSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNL  326 (432)
Q Consensus       248 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~  326 (432)
                      ++||+|||+++.....+    .........||+.|||||++.++.++.++|||||||+||||+| |..||.....     
T Consensus       183 ~~Ki~DFGlar~~~~~~----~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~-----  253 (308)
T 4gt4_A          183 NVKISDLGLFREVYAAD----YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-----  253 (308)
T ss_dssp             CEEECCSCCBCGGGGGG----CBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH-----
T ss_pred             CEEECCcccceeccCCC----ceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH-----
Confidence            99999999998653221    1223445679999999999999999999999999999999999 8999853321     


Q ss_pred             hhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014024          327 IGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNE  387 (432)
Q Consensus       327 ~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~  387 (432)
                                ..+...+......+.+..++..+.+|+.+||+.||++|||+.||+++|+..
T Consensus       254 ----------~~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          254 ----------QDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             ----------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             ----------HHHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                      111122222222334556778899999999999999999999999999864

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.4e-56  Score=423.25  Aligned_cols=264  Identities=25%  Similarity=0.416  Sum_probs=206.3

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECCceEEEEEEcC--CChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEec
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQGEIAVKRLLG--KSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEY  185 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  185 (432)
                      .+++++.++||+|+||+||+|.+.+ .||||++..  ......+.|.+|+++|++++|||||++++++.+ +..+|||||
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy  112 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW  112 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence            4678889999999999999998765 699998853  345667889999999999999999999998865 568999999


Q ss_pred             CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCC
Q 014024          186 MPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGND  265 (432)
Q Consensus       186 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  265 (432)
                      |++|+|.+++....  ..+++.++..|+.|++.||+|||+++   |+||||||+||||++++++||+|||+|+.......
T Consensus       113 ~~gGsL~~~l~~~~--~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~  187 (307)
T 3omv_A          113 CEGSSLYKHLHVQE--TKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG  187 (307)
T ss_dssp             CSSCBHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred             CCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence            99999999996533  45999999999999999999999998   99999999999999999999999999986422111


Q ss_pred             ccccccccccccccCCccChhhhcc---CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhh
Q 014024          266 EDELQGNTSRISGTYGYMSPEYALE---GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDL  342 (432)
Q Consensus       266 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                          .......+||+.|||||++.+   +.|+.++|||||||+||||+||+.||.......  .   .........    
T Consensus       188 ----~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~--~---~~~~~~~~~----  254 (307)
T 3omv_A          188 ----SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD--Q---IIFMVGRGY----  254 (307)
T ss_dssp             ----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--H---HHHHHHTTC----
T ss_pred             ----ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH--H---HHHHHhcCC----
Confidence                123345689999999999864   468999999999999999999999985332210  0   000000000    


Q ss_pred             hhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccccCCC
Q 014024          343 IDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLL  392 (432)
Q Consensus       343 i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~  392 (432)
                      ..+. ....+..++..+.+|+.+||+.||++|||+.||+++|+.+..+++
T Consensus       255 ~~p~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp  303 (307)
T 3omv_A          255 ASPD-LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP  303 (307)
T ss_dssp             CCCC-STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred             CCCC-cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence            0000 011233456788999999999999999999999999988766553

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=4e-56  Score=426.17  Aligned_cols=248  Identities=22%  Similarity=0.315  Sum_probs=201.8

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEE
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  183 (432)
                      .++|++++.||+|+||+||+|++..  ..||+|++...  .....+.+.+|+++|++++|||||++++++.+++..|+||
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm  102 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM  102 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            3789999999999999999999854  48999998544  4556778999999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCC
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGG  263 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  263 (432)
                      |||+||+|.+++... ....+++..++.|+.||+.||+|||+++   |+||||||+||||+++|.+||+|||+|+.+.. 
T Consensus       103 Ey~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~-  177 (350)
T 4b9d_A          103 DYCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS-  177 (350)
T ss_dssp             ECCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCH-
T ss_pred             eCCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecC-
Confidence            999999999999643 2345899999999999999999999999   99999999999999999999999999987511 


Q ss_pred             CCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhh
Q 014024          264 NDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLI  343 (432)
Q Consensus       264 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i  343 (432)
                           ........+||+.|||||++.+..|+.++|||||||++|||+||+.||.....                  .+++
T Consensus       178 -----~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~------------------~~~~  234 (350)
T 4b9d_A          178 -----TVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM------------------KNLV  234 (350)
T ss_dssp             -----HHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------------------HHHH
T ss_pred             -----CcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------------------HHHH
Confidence                 11123456899999999999999999999999999999999999999853221                  1111


Q ss_pred             hhhhhh---cccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          344 DSVLEE---ASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       344 ~~~l~~---~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      ...+..   ..+...+.++.+|+.+||+.||++|||++|++++
T Consensus       235 ~~i~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          235 LKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHHcCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            111111   1223345678899999999999999999999874

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.3e-55  Score=421.91  Aligned_cols=249  Identities=22%  Similarity=0.312  Sum_probs=206.0

Q ss_pred             CCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecC
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYM  186 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  186 (432)
                      +.|++.+.||+|+||+||+|.+..  ..||+|++........+.+.+|+++|++++|||||++++++.+++..|||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            569999999999999999999864  489999996554445567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCc
Q 014024          187 PNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDE  266 (432)
Q Consensus       187 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  266 (432)
                      ++|+|.+++..    ..+++..+..++.||+.||+|||+++   |+||||||+|||++.+|.+||+|||+|+.+...   
T Consensus       154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~---  223 (346)
T 4fih_A          154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE---  223 (346)
T ss_dssp             TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSS---
T ss_pred             CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCC---
Confidence            99999999853    34999999999999999999999999   999999999999999999999999999875321   


Q ss_pred             cccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhh
Q 014024          267 DELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSV  346 (432)
Q Consensus       267 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  346 (432)
                         .......+||+.|||||++.+..|+.++|||||||++|||++|+.||......  ........    .     ..+ 
T Consensus       224 ---~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--~~~~~i~~----~-----~~~-  288 (346)
T 4fih_A          224 ---VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKMIRD----N-----LPP-  288 (346)
T ss_dssp             ---SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHH----S-----SCC-
T ss_pred             ---CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HHHHHHHc----C-----CCC-
Confidence               12345578999999999999999999999999999999999999998532110  00000000    0     000 


Q ss_pred             hhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          347 LEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       347 l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                       ..........++.+|+.+||+.||++|||++|++++
T Consensus       289 -~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H  324 (346)
T 4fih_A          289 -RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  324 (346)
T ss_dssp             -CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence             001122345678899999999999999999999885

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2.3e-55  Score=419.02  Aligned_cols=257  Identities=20%  Similarity=0.177  Sum_probs=204.6

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEec
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEY  185 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  185 (432)
                      .+.|++.++||+|+||.||+|++..  ..||||++.....     ..+|+.+|++++|||||++++++.+++..||||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  131 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL  131 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            4678889999999999999999864  4899999965422     24699999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCC-CEEEeecccceeccCCC
Q 014024          186 MPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDM-NSKISDFGMARIVFGGN  264 (432)
Q Consensus       186 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~  264 (432)
                      |+||+|.+++..   .+.+++..+..++.|++.||+|||+++   |+||||||+||||+.+| .+||+|||+|+.+....
T Consensus       132 ~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~  205 (336)
T 4g3f_A          132 LEGGSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG  205 (336)
T ss_dssp             CTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred             cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence            999999999953   346999999999999999999999999   99999999999999988 69999999998753221


Q ss_pred             CccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhh
Q 014024          265 DEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLID  344 (432)
Q Consensus       265 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  344 (432)
                      .. .........+||+.|||||++.+..|+.++|||||||++|||+||+.||.......  +.....    ...      
T Consensus       206 ~~-~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~~~~i~----~~~------  272 (336)
T 4g3f_A          206 LG-KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP--LCLKIA----SEP------  272 (336)
T ss_dssp             ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC--CHHHHH----HSC------
T ss_pred             cc-cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH--HHHHHH----cCC------
Confidence            11 11112334679999999999999999999999999999999999999985432211  110000    000      


Q ss_pred             hhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccc
Q 014024          345 SVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS  389 (432)
Q Consensus       345 ~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~  389 (432)
                       ......+...+..+.+++.+||+.||++|||+.|++++|.....
T Consensus       273 -~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~  316 (336)
T 4g3f_A          273 -PPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQ  316 (336)
T ss_dssp             -CGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -CCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence             00011233456778899999999999999999999999877554

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2.5e-55  Score=413.97  Aligned_cols=247  Identities=24%  Similarity=0.309  Sum_probs=205.4

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC---ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEE
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK---SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLI  182 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  182 (432)
                      .++|++.++||+|+||+||+|++..  ..||+|++...   .....+.+.+|+++|++++|||||++++++.+++..|+|
T Consensus        31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv  110 (311)
T 4aw0_A           31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG  110 (311)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            3679999999999999999999854  38999998543   223456789999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccC
Q 014024          183 YEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFG  262 (432)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  262 (432)
                      ||||+||+|.+++..   .+.+++..+..++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+|+.+..
T Consensus       111 mEy~~gG~L~~~i~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~  184 (311)
T 4aw0_A          111 LSYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP  184 (311)
T ss_dssp             ECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence            999999999999953   445999999999999999999999999   99999999999999999999999999997632


Q ss_pred             CCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhh
Q 014024          263 GNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDL  342 (432)
Q Consensus       263 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                      ...    .......+||+.|||||++.+..|+.++||||+||++|||+||+.||.....                  .++
T Consensus       185 ~~~----~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~------------------~~~  242 (311)
T 4aw0_A          185 ESK----QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE------------------GLI  242 (311)
T ss_dssp             TTT----CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH------------------HHH
T ss_pred             CCC----cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH------------------HHH
Confidence            211    2234567899999999999999999999999999999999999999853221                  111


Q ss_pred             hhhhhhh--cccHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014024          343 IDSVLEE--ASFNESLSRYVHIALLCVQERAEDRPTMSDVVS  382 (432)
Q Consensus       343 i~~~l~~--~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~  382 (432)
                      +...+..  ..+.....++.+|+.+||+.||++|||++|++.
T Consensus       243 ~~~i~~~~~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~  284 (311)
T 4aw0_A          243 FAKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG  284 (311)
T ss_dssp             HHHHHHTCCCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred             HHHHHcCCCCCCcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence            1111111  122334567889999999999999999998753

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.1e-54  Score=405.52  Aligned_cols=249  Identities=25%  Similarity=0.401  Sum_probs=196.9

Q ss_pred             CCC-CcCceeccCCcEEEEEEEECCc--eEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEe----CCee
Q 014024          109 GNF-SAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIE----KDER  179 (432)
Q Consensus       109 ~~y-~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~  179 (432)
                      ++| ++.++||+|+||+||+|.+...  .||+|++...  .....+.+.+|+++|++++|||||+++++|.+    .+..
T Consensus        25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~  104 (290)
T 3fpq_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI  104 (290)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEE
Confidence            344 6677899999999999998654  7999998543  45566789999999999999999999999865    3457


Q ss_pred             EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcC-CCCEEEeecccce
Q 014024          180 LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDK-DMNSKISDFGMAR  258 (432)
Q Consensus       180 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~  258 (432)
                      |+|||||++|+|.+++..   .+.+++..+..++.|++.||+|||+++ ++|+||||||+|||+++ ++.+||+|||+|+
T Consensus       105 ~lvmEy~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~  180 (290)
T 3fpq_A          105 VLVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EEEEeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence            999999999999999953   456999999999999999999999975 34999999999999984 7999999999997


Q ss_pred             eccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccc
Q 014024          259 IVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNK  338 (432)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  338 (432)
                      ...        .......+||+.|||||++.+ .|+.++|||||||++|||+||+.||.......     ..........
T Consensus       181 ~~~--------~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~-----~~~~~i~~~~  246 (290)
T 3fpq_A          181 LKR--------ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-----QIYRRVTSGV  246 (290)
T ss_dssp             GCC--------TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-----HHHHHHTTTC
T ss_pred             eCC--------CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH-----HHHHHHHcCC
Confidence            531        112345689999999998864 69999999999999999999999985322110     0000000000


Q ss_pred             hhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          339 IIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       339 ~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      .        ....+...+.++.+|+.+||+.||++|||++|++++
T Consensus       247 ~--------~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H  283 (290)
T 3fpq_A          247 K--------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             C--------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             C--------CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0        001111223568899999999999999999999875

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.4e-54  Score=423.19  Aligned_cols=247  Identities=23%  Similarity=0.325  Sum_probs=206.7

Q ss_pred             CCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecC
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYM  186 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  186 (432)
                      +.|++.+.||+|+||.||+|.+..  ..||||++........+.+.+|+.+|+.++|||||+++++|.+.+..|||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            569999999999999999999864  489999997665555677899999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCc
Q 014024          187 PNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDE  266 (432)
Q Consensus       187 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  266 (432)
                      +||+|.+++..    ..+++..+..++.||+.||+|||+++   |+||||||+||||+.+|.+||+|||+|+.+...   
T Consensus       231 ~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~---  300 (423)
T 4fie_A          231 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE---  300 (423)
T ss_dssp             TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSS---
T ss_pred             CCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCC---
Confidence            99999999843    34999999999999999999999999   999999999999999999999999999875322   


Q ss_pred             cccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhh
Q 014024          267 DELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSV  346 (432)
Q Consensus       267 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  346 (432)
                         .......+||+.|||||++.+..|+.++|||||||++|||++|+.||.....  ....             ..+...
T Consensus       301 ---~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~~-------------~~i~~~  362 (423)
T 4fie_A          301 ---VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAM-------------KMIRDN  362 (423)
T ss_dssp             ---CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHH-------------HHHHHS
T ss_pred             ---CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHH-------------HHHHcC
Confidence               1234567899999999999999999999999999999999999999853211  0000             001000


Q ss_pred             h--hhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          347 L--EEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       347 l--~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      .  ..........++.+|+.+||+.||++|||+.|++++
T Consensus       363 ~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H  401 (423)
T 4fie_A          363 LPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  401 (423)
T ss_dssp             CCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            0  001112345678899999999999999999999885

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.1e-54  Score=418.89  Aligned_cols=264  Identities=28%  Similarity=0.403  Sum_probs=214.5

Q ss_pred             hhhhCCCCcCceeccCCcEEEEEEEECC-------ceEEEEEEcCC-ChHhHHHHHHHHHHHHhcCC-CceeeeEeEEEe
Q 014024          105 SSATGNFSAANKLGEGGFGTVYKGVIGQ-------GEIAVKRLLGK-SGQEIKELKNEASVIAQVQH-KNLVKLLGCCIE  175 (432)
Q Consensus       105 ~~~~~~y~~~~~ig~G~~g~Vy~~~~~~-------~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~  175 (432)
                      ....++|++.+.||+|+||+||+|.+.+       ..||||++... .....+.+.+|+++|++++| ||||+++++|.+
T Consensus        60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~  139 (353)
T 4ase_A           60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK  139 (353)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             EecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe
Confidence            3446789999999999999999998643       26899998654 34556789999999999965 899999999976


Q ss_pred             C-CeeEEEEecCCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCE
Q 014024          176 K-DERLLIYEYMPNKSLDCFLFDPT-------------KREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNI  241 (432)
Q Consensus       176 ~-~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NI  241 (432)
                      . +..++|||||++|+|.++|+...             ....+++..+..++.|+|.||+|||+++   |+||||||+||
T Consensus       140 ~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~NI  216 (353)
T 4ase_A          140 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNI  216 (353)
T ss_dssp             TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred             cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCccce
Confidence            5 56899999999999999996422             1345899999999999999999999999   99999999999


Q ss_pred             EEcCCCCEEEeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCcc
Q 014024          242 LLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYR  320 (432)
Q Consensus       242 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~  320 (432)
                      |+++++.+||+|||+|+.+.....    ........||+.|||||++.++.|+.++|||||||++|||+| |+.||....
T Consensus       217 Ll~~~~~vKi~DFGlar~~~~~~~----~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~  292 (353)
T 4ase_A          217 LLSEKNVVKICDFGLARDIYKDPD----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  292 (353)
T ss_dssp             EECGGGCEEECCCGGGSCTTTCTT----SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             eeCCCCCEEECcchhhhhcccCCC----ceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence            999999999999999986532211    123345679999999999999999999999999999999998 899985322


Q ss_pred             ccccchhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccc
Q 014024          321 TKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS  389 (432)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~  389 (432)
                      ..              ......+....+...+..++.++.+++..||+.||++|||+.||+++|+.+..
T Consensus       293 ~~--------------~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq  347 (353)
T 4ase_A          293 ID--------------EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  347 (353)
T ss_dssp             CS--------------HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HH--------------HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence            11              11112222222333445566789999999999999999999999999987653

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.1e-54  Score=412.35  Aligned_cols=274  Identities=21%  Similarity=0.261  Sum_probs=202.1

Q ss_pred             CCCCcCceeccCCcEEEEEEEECCceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC----eeEEEEe
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKD----ERLLIYE  184 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e  184 (432)
                      .+|.+.++||+|+||+||+|.+.+..||||++..... .....+.|+..+.+++|||||+++++|.+++    ..+||||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E   81 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD   81 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence            4577889999999999999999988999999865432 2223345666667889999999999998764    5799999


Q ss_pred             cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEeccCCCCCEEEcCCCCEEEeeccccee
Q 014024          185 YMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYS-----RVRIIHRDLKASNILLDKDMNSKISDFGMARI  259 (432)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-----~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  259 (432)
                      ||++|+|.+++..    ..++|..+.+++.|++.||+|||++.     .++|+||||||+||||++++++||+|||+++.
T Consensus        82 y~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~  157 (303)
T 3hmm_A           82 YHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             CCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             CCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence            9999999999953    34899999999999999999999871     23499999999999999999999999999987


Q ss_pred             ccCCCCccccccccccccccCCccChhhhccC------CCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHh
Q 014024          260 VFGGNDEDELQGNTSRISGTYGYMSPEYALEG------IFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDL  333 (432)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~  333 (432)
                      .......  ........+||+.|||||++.+.      .++.++|||||||+||||+||+.|+.................
T Consensus       158 ~~~~~~~--~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~  235 (303)
T 3hmm_A          158 HDSATDT--IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EETTTTE--ESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccCCCCc--eeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence            5332211  11223346899999999998754      478899999999999999999988754332211111000000


Q ss_pred             hhccchhh-hhhhhhhhc-----ccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccc
Q 014024          334 WISNKIID-LIDSVLEEA-----SFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS  389 (432)
Q Consensus       334 ~~~~~~~~-~i~~~l~~~-----~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~  389 (432)
                      ........ ..+..++..     ...+.+..+.+|+.+||+.||++|||+.||++.|+.+..
T Consensus       236 ~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~  297 (303)
T 3hmm_A          236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             chHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence            00000111 111111111     123566789999999999999999999999999988654

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=5.2e-54  Score=399.45  Aligned_cols=246  Identities=22%  Similarity=0.324  Sum_probs=189.1

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCC---hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEE
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS---GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLI  182 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  182 (432)
                      .++|++.+.||+|+||+||+|.+..  ..||+|++....   ....+.+.+|+++|++++|||||++++++.+.+..|+|
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            4789999999999999999999753  489999985442   33456789999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccC
Q 014024          183 YEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFG  262 (432)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  262 (432)
                      |||+ +|+|.+++..   ++.+++..+..++.|++.||+|||+++   |+||||||+|||+++++++||+|||+|+....
T Consensus        92 mEy~-~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  164 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTD  164 (275)
T ss_dssp             EECC-CEEHHHHHHH---SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred             EeCC-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence            9999 6789888853   445999999999999999999999999   99999999999999999999999999986422


Q ss_pred             CCCccccccccccccccCCccChhhhccCCC-CchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhh
Q 014024          263 GNDEDELQGNTSRISGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIID  341 (432)
Q Consensus       263 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (432)
                             .......+||+.|+|||++.+..+ +.++||||+||++|+|+||+.||.....     .... ...       
T Consensus       165 -------~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~-----~~~~-~~i-------  224 (275)
T 3hyh_A          165 -------GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI-----PVLF-KNI-------  224 (275)
T ss_dssp             -----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHH-HHH-------
T ss_pred             -------CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH-----HHHH-HHH-------
Confidence                   112345689999999999998876 5899999999999999999999853211     0000 000       


Q ss_pred             hhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          342 LIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       342 ~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                       ...  ....+...+.++.+++.+||+.||++|||++|++++
T Consensus       225 -~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  263 (275)
T 3hyh_A          225 -SNG--VYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD  263 (275)
T ss_dssp             -HHT--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred             -HcC--CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence             000  001122345678899999999999999999999985

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2e-54  Score=407.69  Aligned_cols=245  Identities=23%  Similarity=0.292  Sum_probs=195.1

Q ss_pred             CCCCcCceeccCCcEEEEEEEEC-----CceEEEEEEcCCC--hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEE
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIG-----QGEIAVKRLLGKS--GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLL  181 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~-----~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  181 (432)
                      ++|++.+.||+|+||+||+|+..     +..||+|++....  ......+.+|+++|++++|||||++++++.+++..|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            57999999999999999999862     2379999985432  1223467889999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceecc
Q 014024          182 IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVF  261 (432)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  261 (432)
                      |||||+||+|.+++..   .+.+++..+..++.|++.||+|||+++   |+||||||+|||++++|++||+|||+|+...
T Consensus       104 vmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  177 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI  177 (304)
T ss_dssp             EECCCTTCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred             EEEcCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence            9999999999999953   445999999999999999999999999   9999999999999999999999999998642


Q ss_pred             CCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhh
Q 014024          262 GGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIID  341 (432)
Q Consensus       262 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (432)
                      ..      .......+||+.|||||++.+..|+.++|||||||++|||+||+.||......                  +
T Consensus       178 ~~------~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~------------------~  233 (304)
T 3ubd_A          178 DH------EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK------------------E  233 (304)
T ss_dssp             ---------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------------------H
T ss_pred             CC------CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH------------------H
Confidence            21      12334578999999999999999999999999999999999999998532211                  1


Q ss_pred             hhhhhhh--hcccHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHHH
Q 014024          342 LIDSVLE--EASFNESLSRYVHIALLCVQERAEDRPTM-----SDVVSM  383 (432)
Q Consensus       342 ~i~~~l~--~~~~~~~~~~l~~l~~~cl~~dp~~RPt~-----~evl~~  383 (432)
                      ++.....  ...+...+.++.+|+.+||+.||++|||+     +|+++|
T Consensus       234 ~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H  282 (304)
T 3ubd_A          234 TMTMILKAKLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH  282 (304)
T ss_dssp             HHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred             HHHHHHcCCCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence            1111110  11223345678899999999999999984     677764

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=7.8e-53  Score=398.00  Aligned_cols=256  Identities=22%  Similarity=0.340  Sum_probs=190.0

Q ss_pred             hCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC-------
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKD-------  177 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-------  177 (432)
                      .++|++.+.||+|+||+||+|++.  +..||+|++... .....+.+.+|+++|++++|||||++++++.+.+       
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred             chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence            356899999999999999999985  448999998543 4455678999999999999999999999987654       


Q ss_pred             -----eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEe
Q 014024          178 -----ERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKIS  252 (432)
Q Consensus       178 -----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  252 (432)
                           ..|+|||||++|+|.+++.........++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~  160 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVG  160 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEc
Confidence                 36899999999999999976555455677888999999999999999999   9999999999999999999999


Q ss_pred             ecccceeccCCCCccc------cccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccch
Q 014024          253 DFGMARIVFGGNDEDE------LQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNL  326 (432)
Q Consensus       253 Dfg~a~~~~~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~  326 (432)
                      |||+|+.+........      ........+||+.|||||++.+..|+.++|||||||++|||++   ||....    +.
T Consensus       161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~----~~  233 (299)
T 4g31_A          161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM----ER  233 (299)
T ss_dssp             CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH----HH
T ss_pred             cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc----HH
Confidence            9999987633222111      1112344679999999999999999999999999999999996   653110    00


Q ss_pred             hhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          327 IGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       327 ~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      ....         ... .................+++.+||+.||++|||+.|++++
T Consensus       234 ~~~~---------~~~-~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  280 (299)
T 4g31_A          234 VRTL---------TDV-RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN  280 (299)
T ss_dssp             HHHH---------HHH-HTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHH---------HHH-hcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            0000         000 0000001112233456789999999999999999999884

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-49  Score=388.79  Aligned_cols=266  Identities=18%  Similarity=0.258  Sum_probs=200.3

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEe------CC
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIE------KD  177 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~  177 (432)
                      .++|++++.||+|+||+||+|.+..  ..||||++...  .....+.+.+|+++|+.++|||||++++++..      .+
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            4689999999999999999999854  48999999544  34455678899999999999999999999764      35


Q ss_pred             eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccc
Q 014024          178 ERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMA  257 (432)
Q Consensus       178 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  257 (432)
                      ..|+|||||+ |+|.+++.   .++.+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|
T Consensus       133 ~~~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla  205 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA  205 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence            7899999996 67988884   3456999999999999999999999999   999999999999999999999999999


Q ss_pred             eeccCCCCccccccccccccccCCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhh--
Q 014024          258 RIVFGGNDEDELQGNTSRISGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLW--  334 (432)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~--  334 (432)
                      +.+.....  .........+||+.|+|||++.+. .++.++||||+||++|||++|+.||.......  .........  
T Consensus       206 ~~~~~~~~--~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~--~l~~I~~~~g~  281 (398)
T 4b99_A          206 RGLCTSPA--EHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH--QLQLIMMVLGT  281 (398)
T ss_dssp             BCC---------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH--HHHHHHHHHCC
T ss_pred             eecccCcc--ccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHH--HHHHHHHhcCC
Confidence            86532211  112234567899999999998875 56999999999999999999999986432211  110000000  


Q ss_pred             ---------hccchhhhhhhhhhh------cccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          335 ---------ISNKIIDLIDSVLEE------ASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       335 ---------~~~~~~~~i~~~l~~------~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                               ........+......      ........++.+|+.+||+.||++|||+.|+++|-
T Consensus       282 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp  346 (398)
T 4b99_A          282 PSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHP  346 (398)
T ss_dssp             CCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSG
T ss_pred             CChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCH
Confidence                     000001111100000      00111235678999999999999999999999863

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2.7e-49  Score=383.63  Aligned_cols=202  Identities=24%  Similarity=0.379  Sum_probs=169.5

Q ss_pred             hhhCCCCcCceeccCCcEEEEEEEEC-----CceEEEEEEcCCChHhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCee
Q 014024          106 SATGNFSAANKLGEGGFGTVYKGVIG-----QGEIAVKRLLGKSGQEIKELKNEASVIAQV-QHKNLVKLLGCCIEKDER  179 (432)
Q Consensus       106 ~~~~~y~~~~~ig~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  179 (432)
                      ...++|++.++||+|+||+||+|++.     +..||+|++.....  ...+.+|+++|+.+ +||||+++++++.+.++.
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~   95 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV   95 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence            45678999999999999999999863     23799999865533  35678899999998 699999999999999999


Q ss_pred             EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCC-CCEEEeecccce
Q 014024          180 LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKD-MNSKISDFGMAR  258 (432)
Q Consensus       180 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~  258 (432)
                      |+||||+++|+|.+++.      .+++.++..++.|++.||+|||++|   |+||||||+|||++.+ +.+||+|||+|+
T Consensus        96 ~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~  166 (361)
T 4f9c_A           96 VIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQ  166 (361)
T ss_dssp             EEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence            99999999999999982      2899999999999999999999999   9999999999999877 799999999998


Q ss_pred             eccCCCCcc----------------------ccccccccccccCCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCC
Q 014024          259 IVFGGNDED----------------------ELQGNTSRISGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKN  315 (432)
Q Consensus       259 ~~~~~~~~~----------------------~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlG~il~elltg~~p  315 (432)
                      .........                      .........+||+.|+|||++.+. .++.++||||+||++|||+||+.|
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P  246 (361)
T 4f9c_A          167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP  246 (361)
T ss_dssp             ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred             ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence            653221110                      001122345799999999999875 589999999999999999999999


Q ss_pred             CCC
Q 014024          316 TGF  318 (432)
Q Consensus       316 ~~~  318 (432)
                      |..
T Consensus       247 f~~  249 (361)
T 4f9c_A          247 FYK  249 (361)
T ss_dssp             SSC
T ss_pred             CCC
Confidence            853

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=3.9e-48  Score=371.09  Aligned_cols=284  Identities=35%  Similarity=0.606  Sum_probs=235.7

Q ss_pred             cchhhHhhhhCCCCcCceeccCCcEEEEEEEECCc-eEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC
Q 014024           99 FSFSSVSSATGNFSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKD  177 (432)
Q Consensus        99 ~~~~~~~~~~~~y~~~~~ig~G~~g~Vy~~~~~~~-~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  177 (432)
                      +++.++...+++|++.+.||+|+||.||+|.+.++ .||+|++........+.+.+|+++++.++||||+++++++.+.+
T Consensus        29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  108 (321)
T 2qkw_B           29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN  108 (321)
T ss_dssp             -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred             ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence            44556677889999999999999999999998644 89999987776667788999999999999999999999999999


Q ss_pred             eeEEEEecCCCCChhhhhcCCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeeccc
Q 014024          178 ERLLIYEYMPNKSLDCFLFDPTK-REILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGM  256 (432)
Q Consensus       178 ~~~lv~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  256 (432)
                      ..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+
T Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~  185 (321)
T 2qkw_B          109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGI  185 (321)
T ss_dssp             CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTT
T ss_pred             eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccc
Confidence            99999999999999999965432 235999999999999999999999998   99999999999999999999999999


Q ss_pred             ceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCcccc-ccchhhhhHHhhh
Q 014024          257 ARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTK-SLNLIGYAWDLWI  335 (432)
Q Consensus       257 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~-~~~~~~~~~~~~~  335 (432)
                      +........    ........||+.|+|||++.+..++.++||||||+++|||++|+.||...... ......+......
T Consensus       186 ~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  261 (321)
T 2qkw_B          186 SKKGTELDQ----THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN  261 (321)
T ss_dssp             CEECSSSSC----CCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT
T ss_pred             ccccccccc----cccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc
Confidence            986422111    11233456899999999999999999999999999999999999998654432 2233344433344


Q ss_pred             ccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccc
Q 014024          336 SNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS  389 (432)
Q Consensus       336 ~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~  389 (432)
                      .......+++.+........+..+.+++.+||+.||++|||+.|++++|+.+..
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~  315 (321)
T 2qkw_B          262 NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR  315 (321)
T ss_dssp             TTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence            444455555555556677888999999999999999999999999999998654

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=4.2e-48  Score=396.94  Aligned_cols=252  Identities=21%  Similarity=0.303  Sum_probs=207.7

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEec
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEY  185 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  185 (432)
                      .++|++.+.||+|+||.||+|.+..  ..||+|++........+.+.+|+++|+.++|||||++++++.+.+..|+||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            4689999999999999999999854  38999999877777778899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCC--CCEEEeecccceeccCC
Q 014024          186 MPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKD--MNSKISDFGMARIVFGG  263 (432)
Q Consensus       186 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~Dfg~a~~~~~~  263 (432)
                      |+||+|.+++...  +..+++.++..++.||+.||+|||+++   |+||||||+|||++.+  +.+||+|||+++.+...
T Consensus       236 ~~gg~L~~~i~~~--~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~  310 (573)
T 3uto_A          236 MSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  310 (573)
T ss_dssp             CCCCBHHHHHTCT--TSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred             cCCCcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence            9999999998543  345999999999999999999999999   9999999999999854  89999999999875221


Q ss_pred             CCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhh
Q 014024          264 NDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLI  343 (432)
Q Consensus       264 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i  343 (432)
                             ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.......  .....    .....    
T Consensus       311 -------~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~--~~~~i----~~~~~----  373 (573)
T 3uto_A          311 -------QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE--TLRNV----KSCDW----  373 (573)
T ss_dssp             -------SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH--HHHHH----HTTCC----
T ss_pred             -------CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH--HHHHH----HhCCC----
Confidence                   12345689999999999999999999999999999999999999985332210  00000    00000    


Q ss_pred             hhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          344 DSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       344 ~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                        .+..........++.+|+..||+.||++|||+.|+++|
T Consensus       374 --~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          374 --NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             --CCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             --CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              00011112234567899999999999999999999986

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=9.6e-48  Score=368.98  Aligned_cols=290  Identities=38%  Similarity=0.652  Sum_probs=238.0

Q ss_pred             CCCCccchhhHhhhhCCCCcCceeccCCcEEEEEEEECCc-eEEEEEEcCCCh-HhHHHHHHHHHHHHhcCCCceeeeEe
Q 014024           94 DQFPLFSFSSVSSATGNFSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKSG-QEIKELKNEASVIAQVQHKNLVKLLG  171 (432)
Q Consensus        94 ~~~~~~~~~~~~~~~~~y~~~~~ig~G~~g~Vy~~~~~~~-~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~  171 (432)
                      .....+++.++....++|++.+.||+|+||.||+|.+.++ .||+|++..... .....+.+|+++++.++||||+++++
T Consensus        15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~   94 (326)
T 3uim_A           15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG   94 (326)
T ss_dssp             CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred             CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence            3456688899999999999999999999999999987544 899999865432 22336889999999999999999999


Q ss_pred             EEEeCCeeEEEEecCCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEE
Q 014024          172 CCIEKDERLLIYEYMPNKSLDCFLFDPT-KREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSK  250 (432)
Q Consensus       172 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  250 (432)
                      ++.+.+..++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+....+|+||||||+|||+++++.+|
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k  174 (326)
T 3uim_A           95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV  174 (326)
T ss_dssp             EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred             EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence            9999999999999999999999997643 334599999999999999999999999212299999999999999999999


Q ss_pred             EeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccc---cccchh
Q 014024          251 ISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRT---KSLNLI  327 (432)
Q Consensus       251 l~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~---~~~~~~  327 (432)
                      |+|||++.......     ........||+.|+|||++.+..++.++||||||+++|+|++|+.||.....   ......
T Consensus       175 l~Dfg~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  249 (326)
T 3uim_A          175 VGDFGLAKLMDYKD-----THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL  249 (326)
T ss_dssp             ECCCSSCEECCSSS-----SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHH
T ss_pred             eccCccccccCccc-----ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHH
Confidence            99999998752211     1223345689999999999999999999999999999999999999864321   223334


Q ss_pred             hhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014024          328 GYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEA  388 (432)
Q Consensus       328 ~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~  388 (432)
                      .+..............+..+...........+.+++..||+.||.+|||+.||+++|++..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  310 (326)
T 3uim_A          250 DWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG  310 (326)
T ss_dssp             HHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred             HHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence            4444444445556666666666777888999999999999999999999999999999744

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=4.7e-48  Score=395.26  Aligned_cols=248  Identities=23%  Similarity=0.247  Sum_probs=198.7

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCC------ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCee
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGK------SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDER  179 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  179 (432)
                      .++|++.++||+|+||.||+|++..+  .||+|++...      ..........++.+++.++|||||+++++|.+.+..
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            47899999999999999999998644  8999998532      112222233446667778999999999999999999


Q ss_pred             EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeeccccee
Q 014024          180 LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARI  259 (432)
Q Consensus       180 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  259 (432)
                      |+|||||+||+|.+++..   .+.+++..+..++.||+.||+|||+++   |+||||||+||||+.+|++||+|||+|+.
T Consensus       268 ylVmEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~  341 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD  341 (689)
T ss_dssp             EEEECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence            999999999999999953   455999999999999999999999999   99999999999999999999999999987


Q ss_pred             ccCCCCccccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccc
Q 014024          260 VFGGNDEDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNK  338 (432)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  338 (432)
                      +..        ......+||+.|||||++.. ..|+.++|+|||||++|||++|+.||........              
T Consensus       342 ~~~--------~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~--------------  399 (689)
T 3v5w_A          342 FSK--------KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--------------  399 (689)
T ss_dssp             CSS--------CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH--------------
T ss_pred             cCC--------CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--------------
Confidence            522        12345689999999999975 5799999999999999999999999853222110              


Q ss_pred             hhhhhhhhh--hhcccHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHHh
Q 014024          339 IIDLIDSVL--EEASFNESLSRYVHIALLCVQERAEDRPT-----MSDVVSML  384 (432)
Q Consensus       339 ~~~~i~~~l--~~~~~~~~~~~l~~l~~~cl~~dp~~RPt-----~~evl~~L  384 (432)
                       ..+....+  ....+.....++.+|+..||+.||.+|++     ++||++|-
T Consensus       400 -~~i~~~i~~~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~Hp  451 (689)
T 3v5w_A          400 -HEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESP  451 (689)
T ss_dssp             -HHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSG
T ss_pred             -HHHHHhhcCCCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCc
Confidence             11111111  11123334567889999999999999998     68888643

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.4e-47  Score=365.43  Aligned_cols=268  Identities=27%  Similarity=0.417  Sum_probs=208.5

Q ss_pred             hhhCCCCcCceeccCCcEEEEEEEECCceEEEEEEcCCC--hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEE
Q 014024          106 SATGNFSAANKLGEGGFGTVYKGVIGQGEIAVKRLLGKS--GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       106 ~~~~~y~~~~~ig~G~~g~Vy~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  183 (432)
                      ...++|++.+.||+|+||.||+|.+.+..||+|++....  ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        34 i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  113 (309)
T 3p86_A           34 IPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT  113 (309)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred             CChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence            346789999999999999999999988899999986543  455678999999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCC
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGG  263 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  263 (432)
                      ||+++|+|.+++........+++..++.++.|++.||+|||+.+ .+|+||||||+||++++++.+||+|||++......
T Consensus       114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~  192 (309)
T 3p86_A          114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST  192 (309)
T ss_dssp             ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC--------
T ss_pred             ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccccc
Confidence            99999999999976544445999999999999999999999975 24999999999999999999999999999753211


Q ss_pred             CCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhh
Q 014024          264 NDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLI  343 (432)
Q Consensus       264 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i  343 (432)
                            ........||+.|+|||++.+..++.++||||||+++|+|++|+.||.......     ....         ..
T Consensus       193 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~-----~~~~---------~~  252 (309)
T 3p86_A          193 ------FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ-----VVAA---------VG  252 (309)
T ss_dssp             ---------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH-----HHHH---------HH
T ss_pred             ------ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHH---------HH
Confidence                  112344679999999999999999999999999999999999999985432211     0000         00


Q ss_pred             hhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccccCCCCC
Q 014024          344 DSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPP  394 (432)
Q Consensus       344 ~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~~~  394 (432)
                      ........+...+..+.+++..||+.||++|||+.++++.|+.......++
T Consensus       253 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~  303 (309)
T 3p86_A          253 FKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP  303 (309)
T ss_dssp             HSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-----
T ss_pred             hcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCC
Confidence            000111223344567889999999999999999999999999987765444

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=5.6e-46  Score=353.54  Aligned_cols=285  Identities=38%  Similarity=0.585  Sum_probs=228.8

Q ss_pred             CCCccchhhHhhhhCCCCcC------ceeccCCcEEEEEEEECCceEEEEEEcCC----ChHhHHHHHHHHHHHHhcCCC
Q 014024           95 QFPLFSFSSVSSATGNFSAA------NKLGEGGFGTVYKGVIGQGEIAVKRLLGK----SGQEIKELKNEASVIAQVQHK  164 (432)
Q Consensus        95 ~~~~~~~~~~~~~~~~y~~~------~~ig~G~~g~Vy~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~  164 (432)
                      ..+.+++.++..++++|...      +.||+|+||.||+|...+..+|+|++...    .....+.+.+|+.++++++||
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   90 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE   90 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence            34668888999999988776      89999999999999998889999998543    234567899999999999999


Q ss_pred             ceeeeEeEEEeCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEc
Q 014024          165 NLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLD  244 (432)
Q Consensus       165 niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~  244 (432)
                      ||+++++++.+.+..++||||+++++|.+++........+++..++.++.|++.||.|||+.+   ++||||||+||+++
T Consensus        91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~  167 (307)
T 2nru_A           91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLD  167 (307)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEC
T ss_pred             CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEc
Confidence            999999999999999999999999999999976545566999999999999999999999999   99999999999999


Q ss_pred             CCCCEEEeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCcccccc
Q 014024          245 KDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSL  324 (432)
Q Consensus       245 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~  324 (432)
                      +++.+||+|||++........    ........||+.|+|||.+.+ .++.++||||||+++|+|++|..||........
T Consensus       168 ~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~  242 (307)
T 2nru_A          168 EAFTAKISDFGLARASEKFAQ----TVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL  242 (307)
T ss_dssp             TTCCEEECCCTTCEECCSCSS----CEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB
T ss_pred             CCCcEEEeecccccccccccc----cccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH
Confidence            999999999999986422111    112234578999999998764 589999999999999999999999865433211


Q ss_pred             chhhhhHHhh-hccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccc
Q 014024          325 NLIGYAWDLW-ISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS  389 (432)
Q Consensus       325 ~~~~~~~~~~-~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~  389 (432)
                       ......... ......+.++..+ ...+...+..+.+++..||+.||.+|||+.+++++|+++..
T Consensus       243 -~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          243 -LLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             -TTHHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             -HHHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence             111111111 1122233333322 23456677889999999999999999999999999998654

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.5e-46  Score=358.20  Aligned_cols=266  Identities=24%  Similarity=0.423  Sum_probs=216.4

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEec
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEY  185 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  185 (432)
                      .++|.+.+.||+|+||.||+|.+..  ..+|+|++........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            5689999999999999999999864  48999999877788888999999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCC
Q 014024          186 MPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGND  265 (432)
Q Consensus       186 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  265 (432)
                      +++++|.+++...  ...+++..++.++.|++.||+|||+.+   |+||||||+||++++++.+||+|||++........
T Consensus        89 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  163 (310)
T 3s95_A           89 IKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT  163 (310)
T ss_dssp             CTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred             cCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence            9999999999653  334999999999999999999999999   99999999999999999999999999987532221


Q ss_pred             ccc--------cccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhcc
Q 014024          266 EDE--------LQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISN  337 (432)
Q Consensus       266 ~~~--------~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  337 (432)
                      ...        .........||+.|+|||++.+..++.++||||||+++|+|++|..|+...........         .
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~---------~  234 (310)
T 3s95_A          164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG---------L  234 (310)
T ss_dssp             ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS---------B
T ss_pred             cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh---------h
Confidence            100        01111245799999999999999999999999999999999999998764433221111         0


Q ss_pred             chhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccccCC
Q 014024          338 KIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSL  391 (432)
Q Consensus       338 ~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~  391 (432)
                      ..    ........+..++..+.+++.+||+.||++|||+.++++.|+.+....
T Consensus       235 ~~----~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~  284 (310)
T 3s95_A          235 NV----RGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL  284 (310)
T ss_dssp             CH----HHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             hh----hccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence            11    111122223344567889999999999999999999999999876544

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2.1e-46  Score=355.25  Aligned_cols=252  Identities=23%  Similarity=0.353  Sum_probs=206.7

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEe
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYE  184 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  184 (432)
                      ..++|++.+.||+|+||.||+|.+..  ..||+|++........+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   97 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence            45789999999999999999998743  4899999865555556778999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCC
Q 014024          185 YMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGN  264 (432)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  264 (432)
                      |+++|+|.+++..    ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++...... 
T Consensus        98 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  169 (297)
T 3fxz_A           98 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-  169 (297)
T ss_dssp             CCTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCST-
T ss_pred             CCCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCc-
Confidence            9999999999853    34899999999999999999999999   999999999999999999999999999875322 


Q ss_pred             CccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhh
Q 014024          265 DEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLID  344 (432)
Q Consensus       265 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  344 (432)
                           ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.......     .........       
T Consensus       170 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~~~~~~~~~-------  232 (297)
T 3fxz_A          170 -----QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-----ALYLIATNG-------  232 (297)
T ss_dssp             -----TCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-----HHHHHHHHC-------
T ss_pred             -----ccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHhCC-------
Confidence                 122345679999999999999999999999999999999999999985332110     000000000       


Q ss_pred             hhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          345 SVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       345 ~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                       ......+...+..+.+++.+||+.||++|||+.|++++-
T Consensus       233 -~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~  271 (297)
T 3fxz_A          233 -TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQ  271 (297)
T ss_dssp             -SCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCG
T ss_pred             -CCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhCh
Confidence             000111233456788999999999999999999999854

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=2e-46  Score=359.91  Aligned_cols=261  Identities=27%  Similarity=0.426  Sum_probs=211.3

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECC-----ceEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQ-----GEIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERL  180 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  180 (432)
                      ..++|++.+.||+|+||.||+|.+..     ..||+|.+... .....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus        47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  126 (325)
T 3kul_A           47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM  126 (325)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred             ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence            35689999999999999999999842     25999999654 4556678999999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceec
Q 014024          181 LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIV  260 (432)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  260 (432)
                      +||||+++++|.+++....  ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus       127 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  201 (325)
T 3kul_A          127 IVTEYMENGSLDTFLRTHD--GQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVL  201 (325)
T ss_dssp             EEEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             EEeeCCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccc
Confidence            9999999999999996432  34999999999999999999999999   999999999999999999999999999875


Q ss_pred             cCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccch
Q 014024          261 FGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKI  339 (432)
Q Consensus       261 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  339 (432)
                      ......   ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||......               ..
T Consensus       202 ~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---------------~~  263 (325)
T 3kul_A          202 EDDPDA---AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR---------------DV  263 (325)
T ss_dssp             C----C---CEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---------------HH
T ss_pred             ccCccc---eeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH---------------HH
Confidence            322111   112233456778999999999999999999999999999999 99997532221               11


Q ss_pred             hhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccccC
Q 014024          340 IDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASS  390 (432)
Q Consensus       340 ~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~  390 (432)
                      ...+........+...+..+.+++..||+.||++|||+.+|++.|+.+...
T Consensus       264 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~  314 (325)
T 3kul_A          264 ISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS  314 (325)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             HHHHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence            111111122223344567889999999999999999999999999987654

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=8.6e-46  Score=361.77  Aligned_cols=261  Identities=26%  Similarity=0.404  Sum_probs=212.1

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECC---------ceEEEEEEcCC-ChHhHHHHHHHHHHHHhc-CCCceeeeEeEEEe
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQ---------GEIAVKRLLGK-SGQEIKELKNEASVIAQV-QHKNLVKLLGCCIE  175 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~---------~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~  175 (432)
                      ..++|++.+.||+|+||.||+|.+.+         ..||+|++... .....+.+.+|+++++++ +||||+++++++.+
T Consensus        79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  158 (370)
T 2psq_A           79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  158 (370)
T ss_dssp             CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred             cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence            45789999999999999999998631         25999998654 344567899999999999 89999999999999


Q ss_pred             CCeeEEEEecCCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEE
Q 014024          176 KDERLLIYEYMPNKSLDCFLFDPTK-------------REILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNIL  242 (432)
Q Consensus       176 ~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIl  242 (432)
                      .+..++||||+++|+|.+++.....             ...+++..++.++.|++.||+|||+.+   |+||||||+|||
T Consensus       159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIl  235 (370)
T 2psq_A          159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL  235 (370)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred             CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEE
Confidence            9999999999999999999964321             234899999999999999999999999   999999999999


Q ss_pred             EcCCCCEEEeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccc
Q 014024          243 LDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRT  321 (432)
Q Consensus       243 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~  321 (432)
                      ++.++.+||+|||++........    ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus       236 l~~~~~~kl~DFG~a~~~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~  311 (370)
T 2psq_A          236 VTENNVMKIADFGLARDINNIDY----YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV  311 (370)
T ss_dssp             ECTTCCEEECCCSSCEETTCCCT----TCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             ECCCCCEEEccccCCcccCcccc----eecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            99999999999999986532211    112334567889999999999999999999999999999999 9999754322


Q ss_pred             cccchhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccc
Q 014024          322 KSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS  389 (432)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~  389 (432)
                      .               .....+........+..++..+.+++..||+.||++|||+.|+++.|+.+..
T Consensus       312 ~---------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~  364 (370)
T 2psq_A          312 E---------------ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  364 (370)
T ss_dssp             G---------------GHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             H---------------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            1               1111111111222334456788999999999999999999999999988653

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=8.5e-46  Score=355.75  Aligned_cols=248  Identities=26%  Similarity=0.351  Sum_probs=206.0

Q ss_pred             hhhCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEE
Q 014024          106 SATGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLL  181 (432)
Q Consensus       106 ~~~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  181 (432)
                      ...++|++.+.||+|+||.||+|.+.  +..||+|++...  .....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus        12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l   91 (328)
T 3fe3_A           12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL   91 (328)
T ss_dssp             CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence            34679999999999999999999984  448999998543  45566788999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceecc
Q 014024          182 IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVF  261 (432)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  261 (432)
                      ||||+++|+|.+++..   ++.+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus        92 v~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  165 (328)
T 3fe3_A           92 IMEYASGGEVFDYLVA---HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFT  165 (328)
T ss_dssp             EECCCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred             EEECCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence            9999999999999853   345999999999999999999999999   9999999999999999999999999997642


Q ss_pred             CCCCccccccccccccccCCccChhhhccCCCC-chhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchh
Q 014024          262 GGNDEDELQGNTSRISGTYGYMSPEYALEGIFS-IKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKII  340 (432)
Q Consensus       262 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t-~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                      ..       .......||+.|+|||++.+..++ .++|||||||++|+|++|+.||......                  
T Consensus       166 ~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------------------  220 (328)
T 3fe3_A          166 VG-------GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK------------------  220 (328)
T ss_dssp             SS-------CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH------------------
T ss_pred             CC-------CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH------------------
Confidence            21       123456799999999999988764 8999999999999999999998532211                  


Q ss_pred             hhhhhhhhh--cccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          341 DLIDSVLEE--ASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       341 ~~i~~~l~~--~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                      ++.......  ..+...+..+.+++..||+.||.+|||+.|++++-
T Consensus       221 ~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~  266 (328)
T 3fe3_A          221 ELRERVLRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDR  266 (328)
T ss_dssp             HHHHHHHHCCCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCT
T ss_pred             HHHHHHHhCCCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCH
Confidence            111111111  11223456788999999999999999999999864

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.6e-46  Score=355.44  Aligned_cols=277  Identities=25%  Similarity=0.396  Sum_probs=211.4

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEE------CCceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeC--Ce
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVI------GQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEK--DE  178 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~  178 (432)
                      ..++|++.+.||+|+||.||+|..      .+..||+|++........+.+.+|++++++++||||+++++++...  ..
T Consensus         8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   87 (295)
T 3ugc_A            8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN   87 (295)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred             CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence            357899999999999999999984      2347999999887777788999999999999999999999998653  56


Q ss_pred             eEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccce
Q 014024          179 RLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMAR  258 (432)
Q Consensus       179 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  258 (432)
                      .++||||+++++|.+++....  ..+++..++.++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.
T Consensus        88 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~  162 (295)
T 3ugc_A           88 LKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK  162 (295)
T ss_dssp             CEEEEECCTTCBHHHHHHHCG--GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred             eEEEEEeCCCCCHHHHHHhcc--cccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccc
Confidence            899999999999999996432  34999999999999999999999998   9999999999999999999999999998


Q ss_pred             eccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhh-hHHhhhcc
Q 014024          259 IVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGY-AWDLWISN  337 (432)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~-~~~~~~~~  337 (432)
                      .......   .........++..|+|||.+.+..++.++||||||+++|+|+||..|+............. ........
T Consensus       163 ~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (295)
T 3ugc_A          163 VLPQDKE---FFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF  239 (295)
T ss_dssp             ----------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHH
T ss_pred             cccCCcc---eeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHH
Confidence            7522211   1122233457778999999999999999999999999999999999875432110000000 00000000


Q ss_pred             chhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccccCC
Q 014024          338 KIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSL  391 (432)
Q Consensus       338 ~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~  391 (432)
                      ...+.+........+..++..+.+++..||+.||++|||+.|+++.|+.+....
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l  293 (295)
T 3ugc_A          240 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM  293 (295)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             HHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence            111122222222334456678999999999999999999999999999876543

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=6.9e-46  Score=362.79  Aligned_cols=260  Identities=28%  Similarity=0.454  Sum_probs=200.6

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEEC-----CceEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIG-----QGEIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERL  180 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  180 (432)
                      ..++|++.+.||+|+||.||+|.+.     +..||+|.+... .....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus        43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  122 (373)
T 2qol_A           43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM  122 (373)
T ss_dssp             CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred             CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence            3468999999999999999999875     237999998654 4556678999999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceec
Q 014024          181 LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIV  260 (432)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  260 (432)
                      +||||+++|+|.+++...  ...+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus       123 lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  197 (373)
T 2qol_A          123 IVTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVL  197 (373)
T ss_dssp             EEEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             EEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence            999999999999999653  234999999999999999999999998   999999999999999999999999999875


Q ss_pred             cCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccch
Q 014024          261 FGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKI  339 (432)
Q Consensus       261 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  339 (432)
                      ......   ........+++.|+|||++.+..++.++||||||+++|||++ |+.||.....               ...
T Consensus       198 ~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~---------------~~~  259 (373)
T 2qol_A          198 EDDPEA---AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---------------QDV  259 (373)
T ss_dssp             -------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH---------------HHH
T ss_pred             ccCCcc---ceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH---------------HHH
Confidence            322111   112223345778999999999999999999999999999998 9999743221               111


Q ss_pred             hhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccc
Q 014024          340 IDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS  389 (432)
Q Consensus       340 ~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~  389 (432)
                      ...+........+..++..+.+++..||+.||++||++.+|++.|+.+..
T Consensus       260 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~  309 (373)
T 2qol_A          260 IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR  309 (373)
T ss_dssp             HHHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence            12222222222334556789999999999999999999999999987643

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.9e-45  Score=352.79  Aligned_cols=255  Identities=24%  Similarity=0.310  Sum_probs=203.1

Q ss_pred             hCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCCC-hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEe
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGKS-GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYE  184 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  184 (432)
                      .++|++.+.||+|+||.||+|.+.  +..||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            578999999999999999999986  3489999985443 2334668899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCC
Q 014024          185 YMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGN  264 (432)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  264 (432)
                      |+++++|.+++..   +..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++..+....
T Consensus        86 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  159 (323)
T 3tki_A           86 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (323)
T ss_dssp             CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             cCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence            9999999999843   345999999999999999999999999   9999999999999999999999999998652221


Q ss_pred             CccccccccccccccCCccChhhhccCCC-CchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhh
Q 014024          265 DEDELQGNTSRISGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLI  343 (432)
Q Consensus       265 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i  343 (432)
                      .    ........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||............+.             
T Consensus       160 ~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~-------------  222 (323)
T 3tki_A          160 R----ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK-------------  222 (323)
T ss_dssp             E----ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHH-------------
T ss_pred             c----ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-------------
Confidence            1    122345679999999999987775 7899999999999999999999865433221111111             


Q ss_pred             hhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014024          344 DSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLT  385 (432)
Q Consensus       344 ~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~  385 (432)
                      ...............+.+++.+||+.||++|||+.|++++-.
T Consensus       223 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~  264 (323)
T 3tki_A          223 EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRW  264 (323)
T ss_dssp             TTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred             cccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChh
Confidence            000000111233456789999999999999999999998643

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-45  Score=350.85  Aligned_cols=265  Identities=25%  Similarity=0.407  Sum_probs=207.0

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECCceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecCC
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMP  187 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  187 (432)
                      .++|++.+.||+|+||.||+|...+..||+|++...  ...+.+.+|++++++++||||+++++++.+  ..++||||++
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~   82 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE   82 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred             HhHeeeeeEeecCCCceEEEEEECCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence            467889999999999999999999889999998644  345788999999999999999999998864  4799999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCC-EEEeecccceeccCCCCc
Q 014024          188 NKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN-SKISDFGMARIVFGGNDE  266 (432)
Q Consensus       188 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~-~kl~Dfg~a~~~~~~~~~  266 (432)
                      +++|.+++........+++..++.++.|+++||+|||+.+..+|+||||||+||+++.++. +||+|||++....     
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~-----  157 (307)
T 2eva_A           83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ-----  157 (307)
T ss_dssp             TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred             CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccc-----
Confidence            9999999976554445889999999999999999999932223999999999999998887 7999999997541     


Q ss_pred             cccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhh
Q 014024          267 DELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSV  346 (432)
Q Consensus       267 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  346 (432)
                          .......||+.|+|||++.+..++.++||||||+++|+|++|+.||...........   +.          +...
T Consensus       158 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~---~~----------~~~~  220 (307)
T 2eva_A          158 ----THMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM---WA----------VHNG  220 (307)
T ss_dssp             -----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHH---HH----------HHTT
T ss_pred             ----cccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHH---HH----------HhcC
Confidence                122334689999999999999999999999999999999999999864322111100   00          0000


Q ss_pred             hhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccccCCCCCCCCc
Q 014024          347 LEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQPA  398 (432)
Q Consensus       347 l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~~~~~~~  398 (432)
                      .........+..+.+++.+||+.||++|||+.++++.|+.+....+....|.
T Consensus       221 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~  272 (307)
T 2eva_A          221 TRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPL  272 (307)
T ss_dssp             CCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSCC
T ss_pred             CCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCcc
Confidence            1111223345678899999999999999999999999999877665554443

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=5.5e-46  Score=356.41  Aligned_cols=269  Identities=23%  Similarity=0.336  Sum_probs=208.4

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECCceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC----eeEEE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKD----ERLLI  182 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv  182 (432)
                      ..++|++.++||+|+||.||+|.+.+..||+|++.... ........|+.++++++||||+++++++.+..    ..++|
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           22 QSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             TTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             chhhchhhheecccCceEEEEEEECCCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            45789999999999999999999998899999986543 33445667999999999999999999998754    36999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc----------CCCCeEeccCCCCCEEEcCCCCEEEe
Q 014024          183 YEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQY----------SRVRIIHRDLKASNILLDKDMNSKIS  252 (432)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~----------~~~~ivH~Dlkp~NIll~~~~~~kl~  252 (432)
                      |||+++|+|.+++..    ..+++..++.++.|++.||+|||+.          +   |+||||||+|||++.++.+||+
T Consensus       101 ~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~  173 (322)
T 3soc_A          101 TAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIA  173 (322)
T ss_dssp             EECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEEC
T ss_pred             EecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEc
Confidence            999999999999943    3499999999999999999999998          7   9999999999999999999999


Q ss_pred             ecccceeccCCCCccccccccccccccCCccChhhhcc-----CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchh
Q 014024          253 DFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE-----GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLI  327 (432)
Q Consensus       253 Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~  327 (432)
                      |||++........    ........||+.|+|||++.+     ..++.++|||||||++|||+||+.||.......... 
T Consensus       174 DFg~a~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~-  248 (322)
T 3soc_A          174 DFGLALKFEAGKS----AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP-  248 (322)
T ss_dssp             CCTTCEEECTTSC----CCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCT-
T ss_pred             cCCcccccccccC----ccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccc-
Confidence            9999987532211    122334578999999999986     356778999999999999999999986533221111 


Q ss_pred             hhhHHhhhccchhhhhhhhh----hhc-----ccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccc
Q 014024          328 GYAWDLWISNKIIDLIDSVL----EEA-----SFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS  389 (432)
Q Consensus       328 ~~~~~~~~~~~~~~~i~~~l----~~~-----~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~  389 (432)
                       +...........++.+...    ...     .....+..+.+++.+||+.||++|||+.||++.|+.+..
T Consensus       249 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~  318 (322)
T 3soc_A          249 -FEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR  318 (322)
T ss_dssp             -THHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -hhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence             1100000111111111100    000     122456779999999999999999999999999987653

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=9.5e-46  Score=345.37  Aligned_cols=256  Identities=29%  Similarity=0.443  Sum_probs=208.7

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECCc-eEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecC
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYM  186 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~~-~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  186 (432)
                      .++|++.+.||+|+||.||+|.+.++ .+|+|++..... ..+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   87 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence            46789999999999999999998554 899999865432 3467899999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCc
Q 014024          187 PNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDE  266 (432)
Q Consensus       187 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  266 (432)
                      ++++|.+++...  ...+++..++.++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++......   
T Consensus        88 ~~~~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~---  159 (269)
T 4hcu_A           88 EHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD---  159 (269)
T ss_dssp             TTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH---
T ss_pred             CCCcHHHHHHhc--CcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccc---
Confidence            999999999653  345999999999999999999999999   999999999999999999999999999864211   


Q ss_pred             cccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchhhhhhh
Q 014024          267 DELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDS  345 (432)
Q Consensus       267 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  345 (432)
                        .........+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||.......               ....+..
T Consensus       160 --~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~---------------~~~~~~~  222 (269)
T 4hcu_A          160 --QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------------VVEDIST  222 (269)
T ss_dssp             --HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---------------HHHHHHT
T ss_pred             --ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH---------------HHHHHhc
Confidence              1112334456778999999999999999999999999999999 899975322210               0011111


Q ss_pred             hhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccc
Q 014024          346 VLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS  389 (432)
Q Consensus       346 ~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~  389 (432)
                      ......+...+..+.+++..||+.||++|||+.+++++|+++..
T Consensus       223 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          223 GFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence            11112222345678899999999999999999999999998754

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=4.9e-46  Score=357.44  Aligned_cols=277  Identities=25%  Similarity=0.353  Sum_probs=214.4

Q ss_pred             hCCCCcCceeccCCcEEEEEEEE------CCceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEE--eCCee
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVI------GQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCI--EKDER  179 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~  179 (432)
                      .++|++.+.||+|+||.||+|..      .+..||+|++........+.+.+|++++++++|+||+++++++.  +....
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            46899999999999999999984      23379999998887777888999999999999999999999987  45668


Q ss_pred             EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeeccccee
Q 014024          180 LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARI  259 (432)
Q Consensus       180 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  259 (432)
                      ++||||+++++|.+++...  ...+++..++.++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++..
T Consensus       102 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  176 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKL  176 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred             EEEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccccee
Confidence            9999999999999999542  234999999999999999999999998   99999999999999999999999999987


Q ss_pred             ccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccch
Q 014024          260 VFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKI  339 (432)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  339 (432)
                      .......   ........||+.|+|||++.+..++.++||||||+++|+|++|+.||.......................
T Consensus       177 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  253 (327)
T 3lxl_A          177 LPLDKDY---YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL  253 (327)
T ss_dssp             CCTTCSE---EECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHH
T ss_pred             cccCCcc---ceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHH
Confidence            5322111   1223345678889999999999999999999999999999999999743221110000000000000112


Q ss_pred             hhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccccCCC
Q 014024          340 IDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLL  392 (432)
Q Consensus       340 ~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~  392 (432)
                      .+.+........+...+..+.+++..||+.||++|||+.+++++|+.+.....
T Consensus       254 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~  306 (327)
T 3lxl_A          254 LELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR  306 (327)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred             HHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence            22222222333344566789999999999999999999999999998876443

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=2e-45  Score=342.81  Aligned_cols=258  Identities=27%  Similarity=0.390  Sum_probs=209.6

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECCc-eEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEec
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEY  185 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~~-~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  185 (432)
                      ..++|++.+.||+|+||.||+|.+.++ .+|+|++..... ..+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY   84 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence            357899999999999999999998776 799999865432 346789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCC
Q 014024          186 MPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGND  265 (432)
Q Consensus       186 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  265 (432)
                      +++++|.+++...  ...+++..++.++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++....... 
T Consensus        85 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  158 (268)
T 3sxs_A           85 ISNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ-  158 (268)
T ss_dssp             CTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC-
T ss_pred             cCCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhh-
Confidence            9999999999543  234999999999999999999999999   9999999999999999999999999998652221 


Q ss_pred             ccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchhhhhh
Q 014024          266 EDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIIDLID  344 (432)
Q Consensus       266 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  344 (432)
                          ........+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||........               ...+.
T Consensus       159 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---------------~~~~~  219 (268)
T 3sxs_A          159 ----YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV---------------VLKVS  219 (268)
T ss_dssp             ----EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHH---------------HHHHH
T ss_pred             ----hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHH---------------HHHHH
Confidence                112233456778999999999899999999999999999999 9999854332110               00001


Q ss_pred             hhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccccC
Q 014024          345 SVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASS  390 (432)
Q Consensus       345 ~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~  390 (432)
                      .......+...+..+.+++..||+.||++|||+.+++++|+.+...
T Consensus       220 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          220 QGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             TTCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             cCCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence            1111111222345788999999999999999999999999987653

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.9e-45  Score=359.65  Aligned_cols=266  Identities=27%  Similarity=0.392  Sum_probs=215.6

Q ss_pred             hhhCCCCcCceeccCCcEEEEEEEECC---------ceEEEEEEcCC-ChHhHHHHHHHHHHHHhc-CCCceeeeEeEEE
Q 014024          106 SATGNFSAANKLGEGGFGTVYKGVIGQ---------GEIAVKRLLGK-SGQEIKELKNEASVIAQV-QHKNLVKLLGCCI  174 (432)
Q Consensus       106 ~~~~~y~~~~~ig~G~~g~Vy~~~~~~---------~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~  174 (432)
                      ...++|.+.+.||+|+||.||+|.+.+         ..||+|++... .....+.+.+|+++++++ +||||+++++++.
T Consensus        66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  145 (382)
T 3tt0_A           66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT  145 (382)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence            345789999999999999999998632         26999998654 445567899999999999 8999999999999


Q ss_pred             eCCeeEEEEecCCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCE
Q 014024          175 EKDERLLIYEYMPNKSLDCFLFDPTK-------------REILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNI  241 (432)
Q Consensus       175 ~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NI  241 (432)
                      +.+..++||||+++|+|.+++.....             ...+++..++.++.|++.||+|||+.+   |+||||||+||
T Consensus       146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NI  222 (382)
T 3tt0_A          146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV  222 (382)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGE
T ss_pred             cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceE
Confidence            99999999999999999999965321             235999999999999999999999998   99999999999


Q ss_pred             EEcCCCCEEEeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCcc
Q 014024          242 LLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYR  320 (432)
Q Consensus       242 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~  320 (432)
                      |+++++.+||+|||++........    ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus       223 ll~~~~~~kL~DFG~a~~~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~  298 (382)
T 3tt0_A          223 LVTEDNVMKIADFGLARDIHHIDY----YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP  298 (382)
T ss_dssp             EECTTCCEEECSCSCCCCSSCCCT----TCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             EEcCCCcEEEcccCcccccccccc----cccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            999999999999999986422111    122334567889999999999999999999999999999999 999975322


Q ss_pred             ccccchhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccccCCCC
Q 014024          321 TKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLP  393 (432)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~~  393 (432)
                      ..               ...+.+........+...+..+.+++..||+.||++|||+.||+++|+.+......
T Consensus       299 ~~---------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~  356 (382)
T 3tt0_A          299 VE---------------ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSN  356 (382)
T ss_dssp             HH---------------HHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCS
T ss_pred             HH---------------HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhc
Confidence            11               11111111112222334557789999999999999999999999999998754433

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=3.6e-45  Score=366.51  Aligned_cols=253  Identities=28%  Similarity=0.403  Sum_probs=210.1

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECCceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC-eeEEEEec
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKD-ERLLIYEY  185 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~  185 (432)
                      ..++|++.+.||+|+||.||+|.+.+..||||.+....  ..+.+.+|+++|++++||||+++++++.+.+ ..++||||
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~  268 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY  268 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence            45788999999999999999999998899999997653  4567999999999999999999999987765 78999999


Q ss_pred             CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCC
Q 014024          186 MPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGND  265 (432)
Q Consensus       186 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  265 (432)
                      +++|+|.+++.... ...+++..++.++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++....   
T Consensus       269 ~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~---  341 (450)
T 1k9a_A          269 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS---  341 (450)
T ss_dssp             CTTCBHHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             cCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccc---
Confidence            99999999996532 234799999999999999999999999   99999999999999999999999999985311   


Q ss_pred             ccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchhhhhh
Q 014024          266 EDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIIDLID  344 (432)
Q Consensus       266 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  344 (432)
                            ......++..|+|||.+.+..++.++||||||+++|||+| |+.||......               .....+.
T Consensus       342 ------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~---------------~~~~~i~  400 (450)
T 1k9a_A          342 ------TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---------------DVVPRVE  400 (450)
T ss_dssp             -----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT---------------THHHHHH
T ss_pred             ------cccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---------------HHHHHHH
Confidence                  1122356889999999999999999999999999999998 99998543221               1111122


Q ss_pred             hhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccc
Q 014024          345 SVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS  389 (432)
Q Consensus       345 ~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~  389 (432)
                      ...+...+..++..+.+++..||+.||++|||+.++++.|+.+..
T Consensus       401 ~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~  445 (450)
T 1k9a_A          401 KGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT  445 (450)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence            222223344566789999999999999999999999999988654

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.6e-44  Score=347.44  Aligned_cols=268  Identities=18%  Similarity=0.169  Sum_probs=208.7

Q ss_pred             hCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCCChHhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeeEEEEe
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGKSGQEIKELKNEASVIAQV-QHKNLVKLLGCCIEKDERLLIYE  184 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  184 (432)
                      .++|++.+.||+|+||.||+|.+.  +..||+|.+.....  .+.+.+|+++++++ +|+||+++++++.+.+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            578999999999999999999964  44899999865432  24688999999999 99999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCC-----EEEeeccccee
Q 014024          185 YMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN-----SKISDFGMARI  259 (432)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~Dfg~a~~  259 (432)
                      |+ +++|.+++...  +..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.     +||+|||++..
T Consensus        86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~  159 (330)
T 2izr_A           86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE  159 (330)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred             eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence            99 99999998643  345999999999999999999999999   999999999999999887     99999999987


Q ss_pred             ccCCCCcccc-ccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccc
Q 014024          260 VFGGNDEDEL-QGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNK  338 (432)
Q Consensus       260 ~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  338 (432)
                      +......... ........||+.|+|||++.+..++.++|||||||++|||++|+.||........  .... .......
T Consensus       160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~--~~~~-~~i~~~~  236 (330)
T 2izr_A          160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTL--KERY-QKIGDTK  236 (330)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSH--HHHH-HHHHHHH
T ss_pred             eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccH--HHHH-HHHHhhh
Confidence            5433221111 1123457899999999999999999999999999999999999999864332111  0000 0000000


Q ss_pred             hhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccccCCC
Q 014024          339 IIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLL  392 (432)
Q Consensus       339 ~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~  392 (432)
                       .......+    ....+ ++.+++..||+.||.+||++.+|.+.|+++.....
T Consensus       237 -~~~~~~~~----~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~  284 (330)
T 2izr_A          237 -RATPIEVL----CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKG  284 (330)
T ss_dssp             -HHSCHHHH----TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             -ccCCHHHH----hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcC
Confidence             00000000    01123 88999999999999999999999999987665443

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=9e-45  Score=344.03  Aligned_cols=265  Identities=23%  Similarity=0.308  Sum_probs=201.9

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECCceEEEEEEcCCChHhHHHHHHHHHHHHh--cCCCceeeeEeEEEeC----CeeE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQ--VQHKNLVKLLGCCIEK----DERL  180 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~----~~~~  180 (432)
                      ..++|++.+.||+|+||.||+|.+.+..||+|++...   ....+..|.+++..  ++||||+++++++.+.    ...+
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~   82 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW   82 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence            3578999999999999999999998889999998643   33456667777777  7999999999997553    4578


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEeccCCCCCEEEcCCCCEEEe
Q 014024          181 LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLH--------QYSRVRIIHRDLKASNILLDKDMNSKIS  252 (432)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH--------~~~~~~ivH~Dlkp~NIll~~~~~~kl~  252 (432)
                      +||||+++|+|.+++.    ...+++..++.++.|++.||+|||        +.+   |+||||||+|||++.++.+||+
T Consensus        83 lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~  155 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIA  155 (301)
T ss_dssp             EEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred             EehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEe
Confidence            9999999999999993    235999999999999999999999        777   9999999999999999999999


Q ss_pred             ecccceeccCCCCccccccccccccccCCccChhhhccC------CCCchhhhHHHHHHHHHHHhC----------CCCC
Q 014024          253 DFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEG------IFSIKSDVFSFGVLLLEIVSG----------KKNT  316 (432)
Q Consensus       253 Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~t~~~DvwSlG~il~elltg----------~~p~  316 (432)
                      |||++.........  .........||+.|+|||++.+.      .++.++|||||||++|||+||          +.||
T Consensus       156 Dfg~a~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf  233 (301)
T 3q4u_A          156 DLGLAVMHSQSTNQ--LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF  233 (301)
T ss_dssp             CCTTCEEEETTTTE--EECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             eCCCeeeccccccc--ccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence            99999875332211  11122345799999999999876      566899999999999999999          5665


Q ss_pred             CCccccccchhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014024          317 GFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNE  387 (432)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~  387 (432)
                      ..........................    .........+..+.+++..||+.||++|||+.+|++.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          234 YDVVPNDPSFEDMRKVVCVDQQRPNI----PNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             TTTSCSSCCHHHHHHHHTTSCCCCCC----CGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccCCCCcchhhhhHHHhccCCCCCC----ChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            33222111111110000000000000    01112335678899999999999999999999999999864

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.5e-45  Score=352.76  Aligned_cols=273  Identities=28%  Similarity=0.406  Sum_probs=212.6

Q ss_pred             CCC-CcCceeccCCcEEEEEEEE------CCceEEEEEEcCCC-hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeC--Ce
Q 014024          109 GNF-SAANKLGEGGFGTVYKGVI------GQGEIAVKRLLGKS-GQEIKELKNEASVIAQVQHKNLVKLLGCCIEK--DE  178 (432)
Q Consensus       109 ~~y-~~~~~ig~G~~g~Vy~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~  178 (432)
                      ++| ++.+.||+|+||.||++..      .+..||+|++.... ....+.+.+|++++++++||||+++++++.+.  ..
T Consensus        30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (318)
T 3lxp_A           30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS  109 (318)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred             HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence            445 9999999999999999864      23479999996553 45567899999999999999999999999874  67


Q ss_pred             eEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccce
Q 014024          179 RLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMAR  258 (432)
Q Consensus       179 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  258 (432)
                      .++||||+++++|.+++..    ..+++..++.++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.
T Consensus       110 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~  182 (318)
T 3lxp_A          110 LQLVMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAK  182 (318)
T ss_dssp             EEEEECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             EEEEEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccc
Confidence            8999999999999999943    23999999999999999999999999   9999999999999999999999999998


Q ss_pred             eccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccc
Q 014024          259 IVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNK  338 (432)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  338 (432)
                      ........   ........+|..|+|||++.+..++.++||||||+++|+|++|+.||............+.........
T Consensus       183 ~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  259 (318)
T 3lxp_A          183 AVPEGHEY---YRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR  259 (318)
T ss_dssp             ECCTTCSE---EEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHH
T ss_pred             cccccccc---cccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHH
Confidence            75322111   122334567888999999999999999999999999999999999975322211111111111111112


Q ss_pred             hhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccccCC
Q 014024          339 IIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSL  391 (432)
Q Consensus       339 ~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~  391 (432)
                      ..+.++.......+...+..+.+++..||+.||++|||+.|+++.|+.+....
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  312 (318)
T 3lxp_A          260 LTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY  312 (318)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence            22333333333344556678999999999999999999999999999876544

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=9.4e-46  Score=362.52  Aligned_cols=259  Identities=25%  Similarity=0.365  Sum_probs=210.8

Q ss_pred             hhhCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEE
Q 014024          106 SATGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLI  182 (432)
Q Consensus       106 ~~~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  182 (432)
                      ...++|.+.+.||+|+||.||+|.+.  +..||+|.+... .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus       111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  190 (377)
T 3cbl_A          111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV  190 (377)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence            34578999999999999999999986  448999998654 344556788999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccC
Q 014024          183 YEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFG  262 (432)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  262 (432)
                      |||+++|+|.+++...  ...+++..++.++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++....
T Consensus       191 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~  265 (377)
T 3cbl_A          191 MELVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEAD  265 (377)
T ss_dssp             EECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred             EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence            9999999999999642  234899999999999999999999999   99999999999999999999999999986321


Q ss_pred             CCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchhh
Q 014024          263 GNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIID  341 (432)
Q Consensus       263 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (432)
                      .    ..........+++.|+|||.+.++.++.++|||||||++|||+| |..||......               ...+
T Consensus       266 ~----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~---------------~~~~  326 (377)
T 3cbl_A          266 G----VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ---------------QTRE  326 (377)
T ss_dssp             S----EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH---------------HHHH
T ss_pred             C----ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---------------HHHH
Confidence            1    11111122345778999999999999999999999999999998 99997543221               1112


Q ss_pred             hhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014024          342 LIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEA  388 (432)
Q Consensus       342 ~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~  388 (432)
                      .+....+...+..++..+.+++..||+.||++|||+.++++.|+.+.
T Consensus       327 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~  373 (377)
T 3cbl_A          327 FVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR  373 (377)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence            22222222334445678899999999999999999999999998764

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2.8e-45  Score=342.30  Aligned_cols=254  Identities=29%  Similarity=0.452  Sum_probs=198.6

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECCceEEEEEEcCCCh----HhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEE
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSG----QEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  183 (432)
                      .++|++.+.||+|+||.||+|.+.+..+|+|++.....    ...+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM   85 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence            46899999999999999999999988999998854422    33567899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcC--------CCCEEEeecc
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDK--------DMNSKISDFG  255 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~--------~~~~kl~Dfg  255 (432)
                      ||+++++|.+++.    +..+++..++.++.|++.||+|||+.+..+++||||||+||+++.        ++.+||+|||
T Consensus        86 e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg  161 (271)
T 3dtc_A           86 EFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG  161 (271)
T ss_dssp             ECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred             EcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence            9999999999983    335999999999999999999999988556889999999999986        7789999999


Q ss_pred             cceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhh
Q 014024          256 MARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWI  335 (432)
Q Consensus       256 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  335 (432)
                      ++.....        .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||........     .     
T Consensus       162 ~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-----~-----  223 (271)
T 3dtc_A          162 LAREWHR--------TTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV-----A-----  223 (271)
T ss_dssp             C---------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH-----H-----
T ss_pred             ccccccc--------ccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----H-----
Confidence            9976421        112245789999999999999999999999999999999999999854322100     0     


Q ss_pred             ccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014024          336 SNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNE  387 (432)
Q Consensus       336 ~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~  387 (432)
                          ............+...+..+.+++.+||+.||++|||+.|++++|+.+
T Consensus       224 ----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          224 ----YGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             ----HHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             ----HhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence                000111111122334456789999999999999999999999999863

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-45  Score=354.14  Aligned_cols=267  Identities=27%  Similarity=0.421  Sum_probs=213.8

Q ss_pred             hHhhhhCCCCcCceeccCCcEEEEEEEECC-------ceEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEE
Q 014024          103 SVSSATGNFSAANKLGEGGFGTVYKGVIGQ-------GEIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCI  174 (432)
Q Consensus       103 ~~~~~~~~y~~~~~ig~G~~g~Vy~~~~~~-------~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  174 (432)
                      ......++|++.+.||+|+||.||+|.+.+       ..||+|.+... .....+.+.+|+.++++++||||+++++++.
T Consensus        41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  120 (343)
T 1luf_A           41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA  120 (343)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            344567899999999999999999999853       47999998654 4455678999999999999999999999999


Q ss_pred             eCCeeEEEEecCCCCChhhhhcCCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 014024          175 EKDERLLIYEYMPNKSLDCFLFDPTK---------------------REILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH  233 (432)
Q Consensus       175 ~~~~~~lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH  233 (432)
                      +.+..++||||+++|+|.+++.....                     ...+++..++.++.|++.||.|||+.+   |+|
T Consensus       121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH  197 (343)
T 1luf_A          121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH  197 (343)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence            99999999999999999999965321                     146999999999999999999999999   999


Q ss_pred             ccCCCCCEEEcCCCCEEEeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-C
Q 014024          234 RDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-G  312 (432)
Q Consensus       234 ~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g  312 (432)
                      |||||+||++++++.+||+|||++.......    .........+|+.|+|||++.+..++.++||||||+++|+|++ |
T Consensus       198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g  273 (343)
T 1luf_A          198 RDLATRNCLVGENMVVKIADFGLSRNIYSAD----YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG  273 (343)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGG----CBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred             CCCCcceEEECCCCeEEEeecCCCcccccCc----cccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcC
Confidence            9999999999999999999999997642111    1122334567889999999999999999999999999999999 9


Q ss_pred             CCCCCCccccccchhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccccCC
Q 014024          313 KKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSL  391 (432)
Q Consensus       313 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~  391 (432)
                      ..||.......               ....+........+...+..+.+++..||+.||++|||+.+++++|+++....
T Consensus       274 ~~p~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~  337 (343)
T 1luf_A          274 LQPYYGMAHEE---------------VIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA  337 (343)
T ss_dssp             CCTTTTSCHHH---------------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred             CCcCCCCChHH---------------HHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence            99975322110               00011111111223344567899999999999999999999999999977543

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.3e-45  Score=357.14  Aligned_cols=269  Identities=28%  Similarity=0.398  Sum_probs=213.4

Q ss_pred             chhhHhhhhCCCCcCceeccCCcEEEEEEEECC-------ceEEEEEEcCC-ChHhHHHHHHHHHHHHhc-CCCceeeeE
Q 014024          100 SFSSVSSATGNFSAANKLGEGGFGTVYKGVIGQ-------GEIAVKRLLGK-SGQEIKELKNEASVIAQV-QHKNLVKLL  170 (432)
Q Consensus       100 ~~~~~~~~~~~y~~~~~ig~G~~g~Vy~~~~~~-------~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~  170 (432)
                      ..+......++|++.+.||+|+||.||+|.+.+       ..||+|++... .....+.+.+|+++++++ +||||++++
T Consensus        13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~   92 (359)
T 3vhe_A           13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   92 (359)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence            344555667899999999999999999998422       37999999654 345567799999999999 789999999


Q ss_pred             eEEEeCCe-eEEEEecCCCCChhhhhcCCCC-------------------------------------------------
Q 014024          171 GCCIEKDE-RLLIYEYMPNKSLDCFLFDPTK-------------------------------------------------  200 (432)
Q Consensus       171 ~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------  200 (432)
                      +++.+.+. .++||||+++|+|.+++.....                                                 
T Consensus        93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (359)
T 3vhe_A           93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS  172 (359)
T ss_dssp             EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred             eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence            99987654 8999999999999999975432                                                 


Q ss_pred             --------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCc
Q 014024          201 --------------REILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDE  266 (432)
Q Consensus       201 --------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  266 (432)
                                    +..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++........ 
T Consensus       173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~-  248 (359)
T 3vhe_A          173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-  248 (359)
T ss_dssp             -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT-
T ss_pred             cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccccc-
Confidence                          122899999999999999999999999   99999999999999999999999999986432211 


Q ss_pred             cccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchhhhhhh
Q 014024          267 DELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDS  345 (432)
Q Consensus       267 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  345 (432)
                         ........||+.|+|||++.+..++.++||||||+++|||+| |+.||.......              .....+..
T Consensus       249 ---~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--------------~~~~~~~~  311 (359)
T 3vhe_A          249 ---YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--------------EFCRRLKE  311 (359)
T ss_dssp             ---CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--------------HHHHHHHH
T ss_pred             ---chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH--------------HHHHHHHc
Confidence               122344578899999999999999999999999999999998 999985332211              01111111


Q ss_pred             hhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccc
Q 014024          346 VLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS  389 (432)
Q Consensus       346 ~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~  389 (432)
                      ......+...+..+.+++..||+.||++|||+.|++++|+.+..
T Consensus       312 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  355 (359)
T 3vhe_A          312 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  355 (359)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence            11122233345678899999999999999999999999987653

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.5e-44  Score=346.20  Aligned_cols=263  Identities=22%  Similarity=0.291  Sum_probs=210.9

Q ss_pred             CccchhhHhhhhCC----------CCcCceeccCCcEEEEEEEEC--CceEEEEEEcCCChHhHHHHHHHHHHHHhcCCC
Q 014024           97 PLFSFSSVSSATGN----------FSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGKSGQEIKELKNEASVIAQVQHK  164 (432)
Q Consensus        97 ~~~~~~~~~~~~~~----------y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  164 (432)
                      +.++++++..+++.          |...+.||+|+||.||+|.+.  +..||+|++........+.+.+|+.+++.++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            44666666665543          677789999999999999985  448999999766666677899999999999999


Q ss_pred             ceeeeEeEEEeCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEc
Q 014024          165 NLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLD  244 (432)
Q Consensus       165 niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~  244 (432)
                      ||+++++++...+..++||||+++++|.+++..    ..+++..+..++.|++.||+|||+.+   |+||||||+||+++
T Consensus       103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~  175 (321)
T 2c30_A          103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLT  175 (321)
T ss_dssp             TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC
T ss_pred             CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEC
Confidence            999999999999999999999999999999842    34999999999999999999999998   99999999999999


Q ss_pred             CCCCEEEeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCcccccc
Q 014024          245 KDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSL  324 (432)
Q Consensus       245 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~  324 (432)
                      .++.+||+|||++......      ........||+.|+|||++.+..++.++||||||+++|+|++|+.||....... 
T Consensus       176 ~~~~~kl~Dfg~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~-  248 (321)
T 2c30_A          176 LDGRVKLSDFGFCAQISKD------VPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ-  248 (321)
T ss_dssp             TTCCEEECCCTTCEECCSS------SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-
T ss_pred             CCCcEEEeeeeeeeecccC------ccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence            9999999999999875221      112344679999999999999999999999999999999999999985322110 


Q ss_pred             chhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014024          325 NLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLT  385 (432)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~  385 (432)
                       .....         .....+.+  ......+..+.+++..||+.||++|||+.|++++..
T Consensus       249 -~~~~~---------~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~  297 (321)
T 2c30_A          249 -AMKRL---------RDSPPPKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPF  297 (321)
T ss_dssp             -HHHHH---------HHSSCCCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred             -HHHHH---------hcCCCCCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence             00000         00000000  011223456889999999999999999999998644

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=3.9e-45  Score=343.68  Aligned_cols=257  Identities=28%  Similarity=0.417  Sum_probs=207.4

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECCc-eEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEec
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEY  185 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~~-~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  185 (432)
                      ..++|++.+.||+|+||.||+|.+.++ .||+|++..... ..+.+.+|++++++++|+||+++++++.+.+..++||||
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  100 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY  100 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence            457899999999999999999998776 799999865532 246789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCC
Q 014024          186 MPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGND  265 (432)
Q Consensus       186 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  265 (432)
                      +++++|.+++...  ...+++..++.++.|++.||+|||+.+   |+||||||+||++++++.+||+|||++......  
T Consensus       101 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~--  173 (283)
T 3gen_A          101 MANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD--  173 (283)
T ss_dssp             CTTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH--
T ss_pred             cCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccc--
Confidence            9999999999653  334999999999999999999999999   999999999999999999999999999864211  


Q ss_pred             ccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchhhhhh
Q 014024          266 EDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIIDLID  344 (432)
Q Consensus       266 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  344 (432)
                         .........+|+.|+|||++.+..++.++||||||+++|+|+| |+.||.......               ....+.
T Consensus       174 ---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~---------------~~~~~~  235 (283)
T 3gen_A          174 ---EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---------------TAEHIA  235 (283)
T ss_dssp             ---HHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---------------HHHHHH
T ss_pred             ---ccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH---------------HHHHHh
Confidence               1112233456788999999999999999999999999999998 999985432210               111111


Q ss_pred             hhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccc
Q 014024          345 SVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS  389 (432)
Q Consensus       345 ~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~  389 (432)
                      .......+...+..+.+++..||+.||++|||+.+++++|+++..
T Consensus       236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~  280 (283)
T 3gen_A          236 QGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD  280 (283)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence            111122223335678899999999999999999999999987653

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=8.8e-45  Score=348.63  Aligned_cols=257  Identities=22%  Similarity=0.348  Sum_probs=200.6

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC------
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKD------  177 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------  177 (432)
                      ..++|++.+.||+|+||.||+|.+.  +..||+|++... .....+.+.+|++++++++||||+++++++.+..      
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   83 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE   83 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence            3568999999999999999999985  348999998643 3345678999999999999999999999986654      


Q ss_pred             ---------------------------------------------------eeEEEEecCCCCChhhhhcCCCCCCCCCH
Q 014024          178 ---------------------------------------------------ERLLIYEYMPNKSLDCFLFDPTKREILDW  206 (432)
Q Consensus       178 ---------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~l~~  206 (432)
                                                                         ..++||||+++++|.+++.........++
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~  163 (332)
T 3qd2_B           84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH  163 (332)
T ss_dssp             HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred             hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence                                                               27999999999999999987666666788


Q ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCcccc------ccccccccccC
Q 014024          207 RTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDEL------QGNTSRISGTY  280 (432)
Q Consensus       207 ~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~------~~~~~~~~gt~  280 (432)
                      ..++.++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++............      ........||+
T Consensus       164 ~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  240 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK  240 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence            889999999999999999999   999999999999999999999999999875332211100      12234457999


Q ss_pred             CccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHH
Q 014024          281 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYV  360 (432)
Q Consensus       281 ~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~  360 (432)
                      .|+|||++.+..++.++|||||||++|+|++|..|+...       .          .....+...............+.
T Consensus       241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-------~----------~~~~~~~~~~~~~~~~~~~~~~~  303 (332)
T 3qd2_B          241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-------V----------RIITDVRNLKFPLLFTQKYPQEH  303 (332)
T ss_dssp             GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-------H----------HHHHHHHTTCCCHHHHHHCHHHH
T ss_pred             CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-------H----------HHHHHhhccCCCcccccCChhHH
Confidence            999999999999999999999999999999987763100       0          00000000011111223446678


Q ss_pred             HHHHHhhccCCCCCCCHHHHHHH
Q 014024          361 HIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       361 ~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      +++..||+.||++|||+.|++++
T Consensus       304 ~li~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          304 MMVQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             HHHHHHHCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHccCCCCcCCCHHHHhhc
Confidence            99999999999999999999975

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.8e-44  Score=341.39  Aligned_cols=261  Identities=24%  Similarity=0.368  Sum_probs=206.4

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC---ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEE
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK---SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLI  182 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  182 (432)
                      .++|++.+.||+|+||.||+|.+..  ..+|+|.+...   .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            5789999999999999999999754  38999988432   445567899999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccC
Q 014024          183 YEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFG  262 (432)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  262 (432)
                      |||+++++|.+++..   .+.+++..++.++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.....
T Consensus        90 ~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  163 (294)
T 4eqm_A           90 MEYIEGPTLSEYIES---HGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE  163 (294)
T ss_dssp             EECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred             EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence            999999999999953   345999999999999999999999999   99999999999999999999999999976421


Q ss_pred             CCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhh
Q 014024          263 GNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDL  342 (432)
Q Consensus       263 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                      ..     ........||+.|+|||.+.+..++.++||||||+++|+|++|+.||.......     ..... ....... 
T Consensus       164 ~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~-----~~~~~-~~~~~~~-  231 (294)
T 4eqm_A          164 TS-----LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS-----IAIKH-IQDSVPN-  231 (294)
T ss_dssp             ----------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH-----HHHHH-HSSCCCC-
T ss_pred             cc-----ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHH-hhccCCC-
Confidence            11     122334579999999999999999999999999999999999999985432210     00000 0000000 


Q ss_pred             hhhhhhhcccHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHhcccccC
Q 014024          343 IDSVLEEASFNESLSRYVHIALLCVQERAEDRP-TMSDVVSMLTNEASS  390 (432)
Q Consensus       343 i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RP-t~~evl~~L~~~~~~  390 (432)
                          .........+..+.+++.+||+.||++|| +++++.+.|+.....
T Consensus       232 ----~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~  276 (294)
T 4eqm_A          232 ----VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE  276 (294)
T ss_dssp             ----HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred             ----cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence                01111223456788999999999999998 999999999887653

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=6.6e-45  Score=350.69  Aligned_cols=249  Identities=21%  Similarity=0.278  Sum_probs=203.7

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC---ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEE
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK---SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLI  182 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  182 (432)
                      .++|++.+.||+|+||.||+|....  ..||+|++...   .....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            4689999999999999999999854  48999998543   123456788999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccC
Q 014024          183 YEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFG  262 (432)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  262 (432)
                      |||+++|+|.+++..   .+.+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        84 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  157 (337)
T 1o6l_A           84 MEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             EECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence            999999999999853   345999999999999999999999999   99999999999999999999999999975321


Q ss_pred             CCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhh
Q 014024          263 GNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDL  342 (432)
Q Consensus       263 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                      .      .......+||+.|+|||++.+..++.++|+|||||++|||++|+.||.......  .    ...        +
T Consensus       158 ~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~----~~~--------i  217 (337)
T 1o6l_A          158 D------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--L----FEL--------I  217 (337)
T ss_dssp             T------TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--H----HHH--------H
T ss_pred             C------CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH--H----HHH--------H
Confidence            1      123345689999999999999999999999999999999999999985322100  0    000        0


Q ss_pred             hhhhhhhcccHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHHh
Q 014024          343 IDSVLEEASFNESLSRYVHIALLCVQERAEDRP-----TMSDVVSML  384 (432)
Q Consensus       343 i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~~L  384 (432)
                      ...  ....+...+.++.+++..||+.||++||     ++.|++++-
T Consensus       218 ~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~  262 (337)
T 1o6l_A          218 LME--EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR  262 (337)
T ss_dssp             HHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred             HcC--CCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCC
Confidence            000  0112233456788999999999999999     899998753

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=3.9e-45  Score=348.60  Aligned_cols=264  Identities=30%  Similarity=0.454  Sum_probs=213.5

Q ss_pred             HhhhhCCCCcCceeccCCcEEEEEEEEC-------CceEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEe
Q 014024          104 VSSATGNFSAANKLGEGGFGTVYKGVIG-------QGEIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIE  175 (432)
Q Consensus       104 ~~~~~~~y~~~~~ig~G~~g~Vy~~~~~-------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  175 (432)
                      .....++|.+.+.||+|+||.||+|.+.       +..||+|++... .....+.+.+|++++++++||||+++++++.+
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   97 (314)
T 2ivs_A           18 WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ   97 (314)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             cccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Confidence            3445678999999999999999999862       137999998654 45566789999999999999999999999999


Q ss_pred             CCeeEEEEecCCCCChhhhhcCCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 014024          176 KDERLLIYEYMPNKSLDCFLFDPTK---------------------REILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHR  234 (432)
Q Consensus       176 ~~~~~lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~  234 (432)
                      .+..++||||+++++|.+++.....                     ...+++..++.++.|++.||+|||+.+   |+||
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~  174 (314)
T 2ivs_A           98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHR  174 (314)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred             CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Cccc
Confidence            9999999999999999999965332                     234899999999999999999999999   9999


Q ss_pred             cCCCCCEEEcCCCCEEEeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CC
Q 014024          235 DLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GK  313 (432)
Q Consensus       235 Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~  313 (432)
                      ||||+||++++++.+||+|||++........    ........+|+.|+|||.+.+..++.++||||||+++|+|++ |+
T Consensus       175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~  250 (314)
T 2ivs_A          175 DLAARNILVAEGRKMKISDFGLSRDVYEEDS----YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG  250 (314)
T ss_dssp             CCSGGGEEEETTTEEEECCCTTCEECTTTSC----EECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSC
T ss_pred             ccchheEEEcCCCCEEEcccccccccccccc----ceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCC
Confidence            9999999999999999999999987532211    112234457788999999999999999999999999999999 99


Q ss_pred             CCCCCccccccchhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccc
Q 014024          314 KNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS  389 (432)
Q Consensus       314 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~  389 (432)
                      .||......               .....+........+...+..+.+++..||+.||++|||+.+++++|+.+..
T Consensus       251 ~p~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  311 (314)
T 2ivs_A          251 NPYPGIPPE---------------RLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV  311 (314)
T ss_dssp             CSSTTCCGG---------------GHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCCHH---------------HHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            998533221               1111111111122233455778999999999999999999999999988654

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=3.5e-45  Score=367.08  Aligned_cols=263  Identities=29%  Similarity=0.427  Sum_probs=213.4

Q ss_pred             hHhhhhCCCCcCceeccCCcEEEEEEEECCc-eEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEE
Q 014024          103 SVSSATGNFSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLL  181 (432)
Q Consensus       103 ~~~~~~~~y~~~~~ig~G~~g~Vy~~~~~~~-~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  181 (432)
                      ......++|++.+.||+|+||.||+|.+.++ .||+|++.... ...+.+.+|+++|++++||||+++++++. .+..++
T Consensus       182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~l  259 (454)
T 1qcf_A          182 AWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYI  259 (454)
T ss_dssp             CSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             ceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEE
Confidence            3344567899999999999999999998754 89999987543 34678999999999999999999999986 567899


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceecc
Q 014024          182 IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVF  261 (432)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  261 (432)
                      ||||+++|+|.+++.... ...+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus       260 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  335 (454)
T 1qcf_A          260 ITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIE  335 (454)
T ss_dssp             EECCCTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred             EEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence            999999999999996432 224889999999999999999999998   9999999999999999999999999998642


Q ss_pred             CCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchh
Q 014024          262 GGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKII  340 (432)
Q Consensus       262 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                      ..     .........++..|+|||++..+.++.++||||||+++|||+| |+.||......               ...
T Consensus       336 ~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~---------------~~~  395 (454)
T 1qcf_A          336 DN-----EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---------------EVI  395 (454)
T ss_dssp             CH-----HHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---------------HHH
T ss_pred             CC-----ceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH---------------HHH
Confidence            11     0111223446778999999999999999999999999999999 99998532211               111


Q ss_pred             hhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccccCC
Q 014024          341 DLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSL  391 (432)
Q Consensus       341 ~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~  391 (432)
                      ..+....+...+..++..+.+++..||+.||++|||+.+|++.|+++....
T Consensus       396 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~  446 (454)
T 1qcf_A          396 RALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT  446 (454)
T ss_dssp             HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred             HHHHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence            112222222334455678999999999999999999999999999987654

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=4.1e-45  Score=351.11  Aligned_cols=257  Identities=26%  Similarity=0.405  Sum_probs=203.2

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECCc------eEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeE
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQG------EIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERL  180 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~~------~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  180 (432)
                      .++|++.+.||+|+||.||+|.+...      ++++|.+... .....+.+.+|+.++++++||||+++++++.+.. .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence            46799999999999999999997432      3688877433 3345678999999999999999999999998764 78


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceec
Q 014024          181 LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIV  260 (432)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  260 (432)
                      +|+||+++|+|.+++....  ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        93 ~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  167 (327)
T 3poz_A           93 LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEEECCTTCBHHHHHHHST--TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred             EEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence            8999999999999996533  44999999999999999999999998   999999999999999999999999999875


Q ss_pred             cCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccch
Q 014024          261 FGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKI  339 (432)
Q Consensus       261 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  339 (432)
                      .....    ........+|+.|+|||++.+..++.++|||||||++|||+| |+.||......               ..
T Consensus       168 ~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---------------~~  228 (327)
T 3poz_A          168 GAEEK----EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---------------EI  228 (327)
T ss_dssp             TTTCC-----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---------------GH
T ss_pred             cCCcc----cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH---------------HH
Confidence            32211    112233456889999999999999999999999999999999 99998543221               11


Q ss_pred             hhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccc
Q 014024          340 IDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS  389 (432)
Q Consensus       340 ~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~  389 (432)
                      ...+........+..++..+.+++..||+.||++|||+.+++++|+....
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          229 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             HHHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             HHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            22222222222334456678999999999999999999999999987654

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-44  Score=344.58  Aligned_cols=252  Identities=22%  Similarity=0.305  Sum_probs=203.9

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEec
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEY  185 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  185 (432)
                      .++|++.+.||+|+||.||+|.+...  .+|+|.+.... ...+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            57899999999999999999998643  78999886543 4456789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcC--CCCEEEeecccceeccCC
Q 014024          186 MPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDK--DMNSKISDFGMARIVFGG  263 (432)
Q Consensus       186 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~Dfg~a~~~~~~  263 (432)
                      +++++|.+++...  ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.  ++.+||+|||++......
T Consensus        83 ~~g~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~  157 (321)
T 1tki_A           83 ISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence            9999999999542  235999999999999999999999999   999999999999987  789999999999875221


Q ss_pred             CCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhh
Q 014024          264 NDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLI  343 (432)
Q Consensus       264 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i  343 (432)
                             .......||+.|+|||++.+..++.++|||||||++|+|++|..||.......  .....    ..... .  
T Consensus       158 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~i----~~~~~-~--  221 (321)
T 1tki_A          158 -------DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ--IIENI----MNAEY-T--  221 (321)
T ss_dssp             -------CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHHH----HHTCC-C--
T ss_pred             -------CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH--HHHHH----HcCCC-C--
Confidence                   12334678999999999998889999999999999999999999985322110  00000    00000 0  


Q ss_pred             hhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          344 DSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       344 ~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                         .........+.++.+++..||+.||++|||+.|++++-
T Consensus       222 ---~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp  259 (321)
T 1tki_A          222 ---FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHP  259 (321)
T ss_dssp             ---CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             ---CChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence               00000112346788999999999999999999999854

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.9e-44  Score=340.03  Aligned_cols=278  Identities=16%  Similarity=0.197  Sum_probs=215.9

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCCChHhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeeEEEE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGKSGQEIKELKNEASVIAQV-QHKNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  183 (432)
                      ..++|++.+.||+|+||.||+|.+.  +..||+|++....  ..+.+.+|+++++.+ +|+|++++++++.+....++||
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~   85 (298)
T 1csn_A            8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI   85 (298)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence            3578999999999999999999963  4489999885443  234678899999999 7999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCC-----EEEeecccce
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN-----SKISDFGMAR  258 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~Dfg~a~  258 (432)
                      ||+ +++|.+++...  ...+++..++.++.|++.||+|||+.+   |+||||||+||+++.++.     +||+|||++.
T Consensus        86 e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~  159 (298)
T 1csn_A           86 DLL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  159 (298)
T ss_dssp             ECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             Eec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence            999 99999999643  234999999999999999999999998   999999999999987776     9999999998


Q ss_pred             eccCCCCccccc-cccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCcccccc-chhhhhHHhhhc
Q 014024          259 IVFGGNDEDELQ-GNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSL-NLIGYAWDLWIS  336 (432)
Q Consensus       259 ~~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~-~~~~~~~~~~~~  336 (432)
                      ............ .......||+.|+|||++.+..++.++||||||+++|+|++|+.||........ ............
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  239 (298)
T 1csn_A          160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS  239 (298)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence            764332211111 223456799999999999999999999999999999999999999865432111 000000000000


Q ss_pred             cchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccccCCCCCCCCcccc
Q 014024          337 NKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQPAFCN  401 (432)
Q Consensus       337 ~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~~~~~~~~~~  401 (432)
                      ...         .......+..+.+++..||+.||++|||+++|++.|+++...........+.|
T Consensus       240 ~~~---------~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw  295 (298)
T 1csn_A          240 TPL---------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDW  295 (298)
T ss_dssp             SCH---------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGG
T ss_pred             ccH---------HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCcccc
Confidence            000         00111335678999999999999999999999999999877665544444444

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2.4e-44  Score=349.89  Aligned_cols=253  Identities=24%  Similarity=0.310  Sum_probs=203.8

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCCh------HhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCe
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSG------QEIKELKNEASVIAQVQHKNLVKLLGCCIEKDE  178 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  178 (432)
                      ..++|++.+.||+|+||.||+|.+..  ..+|+|.+.....      ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~   89 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD   89 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence            45789999999999999999999864  4899999865432      135678999999999999999999999999999


Q ss_pred             eEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCC----CEEEeec
Q 014024          179 RLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDM----NSKISDF  254 (432)
Q Consensus       179 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Df  254 (432)
                      .++||||+++|+|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||+++++    .+||+||
T Consensus        90 ~~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DF  163 (361)
T 2yab_A           90 VVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (361)
T ss_dssp             EEEEEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence            9999999999999999943   446999999999999999999999999   99999999999998877    7999999


Q ss_pred             ccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhh
Q 014024          255 GMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLW  334 (432)
Q Consensus       255 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  334 (432)
                      |++......       .......||+.|+|||++.+..++.++|||||||++|+|++|..||.......  ..    ...
T Consensus       164 G~a~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~--~~----~~i  230 (361)
T 2yab_A          164 GLAHEIEDG-------VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--TL----ANI  230 (361)
T ss_dssp             SSCEECCTT-------CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH--HH----HHH
T ss_pred             CCceEcCCC-------CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH--HH----HHH
Confidence            999875221       12344679999999999999999999999999999999999999985322110  00    000


Q ss_pred             hccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          335 ISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       335 ~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                      .... ..     .........+..+.+++..||+.||++|||+.|++++-
T Consensus       231 ~~~~-~~-----~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp  274 (361)
T 2yab_A          231 TAVS-YD-----FDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHP  274 (361)
T ss_dssp             HTTC-CC-----CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred             HhcC-CC-----CCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence            0000 00     00001112345688999999999999999999999753

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=4.1e-45  Score=366.27  Aligned_cols=267  Identities=28%  Similarity=0.451  Sum_probs=211.4

Q ss_pred             hhhhCCCCcCceeccCCcEEEEEEEECCc-eEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEE
Q 014024          105 SSATGNFSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       105 ~~~~~~y~~~~~ig~G~~g~Vy~~~~~~~-~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  183 (432)
                      ....++|++.+.||+|+||.||+|.+.++ .||+|.+.... ...+.+.+|+++|++++||||+++++++.+ +..++||
T Consensus       180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~  257 (452)
T 1fmk_A          180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT  257 (452)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             ccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEe
Confidence            34567889999999999999999999775 79999986543 235678999999999999999999999876 6789999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCC
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGG  263 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  263 (432)
                      ||+++|+|.+++... ....+++..++.++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++.....
T Consensus       258 e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  333 (452)
T 1fmk_A          258 EYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN  333 (452)
T ss_dssp             CCCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred             hhhcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence            999999999999532 1234899999999999999999999999   999999999999999999999999999864221


Q ss_pred             CCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchhhh
Q 014024          264 NDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIIDL  342 (432)
Q Consensus       264 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                      .     ........++..|+|||.+.++.++.++||||||+++|||++ |+.||......               .....
T Consensus       334 ~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~---------------~~~~~  393 (452)
T 1fmk_A          334 E-----YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---------------EVLDQ  393 (452)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---------------HHHHH
T ss_pred             c-----eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH---------------HHHHH
Confidence            1     111233456788999999999999999999999999999999 89997532211               11111


Q ss_pred             hhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccccCCCCCCCC
Q 014024          343 IDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQP  397 (432)
Q Consensus       343 i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~~~~~~  397 (432)
                      +....+...+..++..+.+++..||+.||++|||+.++++.|+.+.....+..++
T Consensus       394 i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~~~~  448 (452)
T 1fmk_A          394 VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP  448 (452)
T ss_dssp             HHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCC
T ss_pred             HHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCccccc
Confidence            1122222334456678899999999999999999999999999988766555443

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2.7e-45  Score=345.72  Aligned_cols=255  Identities=23%  Similarity=0.387  Sum_probs=204.2

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC---------ceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCe
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ---------GEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDE  178 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~---------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  178 (432)
                      .++|++.+.||+|+||.||+|.+..         ..+|+|.+........+.+.+|++++++++||||+++++++.+.+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            4689999999999999999998754         3599999977666777889999999999999999999999999999


Q ss_pred             eEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCC--------EE
Q 014024          179 RLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN--------SK  250 (432)
Q Consensus       179 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~--------~k  250 (432)
                      .++||||+++++|.+++...  ...+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.        +|
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             CEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence            99999999999999999643  234999999999999999999999999   999999999999998887        99


Q ss_pred             EeecccceeccCCCCccccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCC-CCccccccchhh
Q 014024          251 ISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNT-GFYRTKSLNLIG  328 (432)
Q Consensus       251 l~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~-~~~~~~~~~~~~  328 (432)
                      |+|||++...          .......||+.|+|||++.+ ..++.++||||||+++|+|++|..|+ .......     
T Consensus       162 l~Dfg~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~-----  226 (289)
T 4fvq_A          162 LSDPGISITV----------LPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR-----  226 (289)
T ss_dssp             ECCCCSCTTT----------SCHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-----
T ss_pred             eccCcccccc----------cCccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH-----
Confidence            9999998653          11233568899999999987 77999999999999999999965553 2211100     


Q ss_pred             hhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccccCCCCC
Q 014024          329 YAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPP  394 (432)
Q Consensus       329 ~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~~~  394 (432)
                                .......  ....+...+..+.+++..||+.||++|||+.+++++|+.+..+...+
T Consensus       227 ----------~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~  280 (289)
T 4fvq_A          227 ----------KLQFYED--RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVP  280 (289)
T ss_dssp             ----------HHHHHHT--TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC------
T ss_pred             ----------HHHHhhc--cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCC
Confidence                      0000000  01111122456789999999999999999999999999987654443

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.9e-45  Score=353.16  Aligned_cols=257  Identities=26%  Similarity=0.363  Sum_probs=202.7

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECCc------eEEEEEEcCCC-hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeE
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQG------EIAVKRLLGKS-GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERL  180 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~~------~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  180 (432)
                      .++|++.+.||+|+||.||+|.+...      ++++|.+.... ....+.+.+|+.++++++||||+++++++. .+..+
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   90 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ   90 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence            46899999999999999999997433      37888774432 233456778999999999999999999986 45688


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceec
Q 014024          181 LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIV  260 (432)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  260 (432)
                      +||||+++|+|.+++...  +..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        91 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  165 (325)
T 3kex_A           91 LVTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL  165 (325)
T ss_dssp             EEEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred             EEEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccccc
Confidence            999999999999999653  345899999999999999999999999   999999999999999999999999999875


Q ss_pred             cCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccch
Q 014024          261 FGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKI  339 (432)
Q Consensus       261 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  339 (432)
                      .....    ........+|..|+|||++.++.++.++||||||+++|+|+| |+.||......               ..
T Consensus       166 ~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---------------~~  226 (325)
T 3kex_A          166 PPDDK----QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA---------------EV  226 (325)
T ss_dssp             CCCTT----CCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT---------------HH
T ss_pred             Ccccc----cccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH---------------HH
Confidence            32211    122344567889999999999999999999999999999999 99998543221               11


Q ss_pred             hhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccc
Q 014024          340 IDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS  389 (432)
Q Consensus       340 ~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~  389 (432)
                      .+.+........+..++..+.+++..||+.||++|||+.+++++|+....
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          227 PDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             HHHHHTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             HHHHHcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            11111111122222344567889999999999999999999999988654

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=3.7e-45  Score=350.54  Aligned_cols=265  Identities=25%  Similarity=0.425  Sum_probs=197.2

Q ss_pred             hhhhCCCCcCceeccCCcEEEEEEEECCc-----eEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC
Q 014024          105 SSATGNFSAANKLGEGGFGTVYKGVIGQG-----EIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKD  177 (432)
Q Consensus       105 ~~~~~~y~~~~~ig~G~~g~Vy~~~~~~~-----~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  177 (432)
                      ....++|++.+.||+|+||.||+|.+...     .||+|++...  .....+.+.+|++++++++||||+++++++.+..
T Consensus        19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   98 (323)
T 3qup_A           19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR   98 (323)
T ss_dssp             BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred             ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence            34567899999999999999999987543     6899988654  3455678999999999999999999999998776


Q ss_pred             ee------EEEEecCCCCChhhhhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCC
Q 014024          178 ER------LLIYEYMPNKSLDCFLFDPT---KREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN  248 (432)
Q Consensus       178 ~~------~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~  248 (432)
                      ..      ++||||+++|+|.+++....   ....+++..++.++.|++.||+|||+.+   |+||||||+||++++++.
T Consensus        99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~  175 (323)
T 3qup_A           99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMT  175 (323)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSC
T ss_pred             cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCC
Confidence            55      99999999999999985322   1225899999999999999999999999   999999999999999999


Q ss_pred             EEEeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchh
Q 014024          249 SKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLI  327 (432)
Q Consensus       249 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~  327 (432)
                      +||+|||++........    ........+++.|+|||.+.+..++.++|||||||++|+|++ |..||.......    
T Consensus       176 ~kl~Dfg~a~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~----  247 (323)
T 3qup_A          176 VCVADFGLSRKIYSGDY----YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE----  247 (323)
T ss_dssp             EEECCCCC---------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----
T ss_pred             EEEeecccccccccccc----ccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH----
Confidence            99999999986522211    112233456788999999999999999999999999999999 898875432211    


Q ss_pred             hhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccccCC
Q 014024          328 GYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSL  391 (432)
Q Consensus       328 ~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~  391 (432)
                                 ....+........+...+..+.+++..||+.||++|||+.++++.|+++....
T Consensus       248 -----------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~  300 (323)
T 3qup_A          248 -----------IYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL  300 (323)
T ss_dssp             -----------HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             -----------HHHHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence                       11111111111223344567899999999999999999999999999877543

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.7e-44  Score=355.02  Aligned_cols=274  Identities=19%  Similarity=0.259  Sum_probs=206.5

Q ss_pred             hhhCCCCcCceeccC--CcEEEEEEEECC--ceEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCee
Q 014024          106 SATGNFSAANKLGEG--GFGTVYKGVIGQ--GEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDER  179 (432)
Q Consensus       106 ~~~~~y~~~~~ig~G--~~g~Vy~~~~~~--~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  179 (432)
                      ...++|++.+.||+|  +||.||+|.+..  ..||+|++...  .....+.+.+|+.++++++||||+++++++.+.+..
T Consensus        22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  101 (389)
T 3gni_B           22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL  101 (389)
T ss_dssp             CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence            356889999999999  999999999863  48999998543  345567888999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeeccccee
Q 014024          180 LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARI  259 (432)
Q Consensus       180 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  259 (432)
                      ++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||.+..
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~  177 (389)
T 3gni_B          102 WVVTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLS  177 (389)
T ss_dssp             EEEEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             EEEEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEccccccee
Confidence            99999999999999986532 234999999999999999999999999   99999999999999999999999999876


Q ss_pred             ccCCCCccc-cccccccccccCCccChhhhcc--CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhh--HHhh
Q 014024          260 VFGGNDEDE-LQGNTSRISGTYGYMSPEYALE--GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYA--WDLW  334 (432)
Q Consensus       260 ~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~--~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~--~~~~  334 (432)
                      ......... .........||+.|+|||++.+  ..++.++|||||||++|+|++|+.||..............  ....
T Consensus       178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  257 (389)
T 3gni_B          178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL  257 (389)
T ss_dssp             CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------
T ss_pred             eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcc
Confidence            433221111 1122234578999999999987  6799999999999999999999999864332111000000  0000


Q ss_pred             -------------------hccchhhhhhh---------hhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          335 -------------------ISNKIIDLIDS---------VLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       335 -------------------~~~~~~~~i~~---------~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                                         ......+.+..         .............+.+|+.+||+.||++|||+.|++++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence                               00000000000         00001122334678899999999999999999999986

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.3e-44  Score=342.93  Aligned_cols=249  Identities=23%  Similarity=0.297  Sum_probs=194.9

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCCh--------------------------HhHHHHHHHHHHHH
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSG--------------------------QEIKELKNEASVIA  159 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~  159 (432)
                      .++|++.+.||+|+||.||+|.+..  ..||+|++.....                          ...+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            5789999999999999999999754  4799999854421                          12356889999999


Q ss_pred             hcCCCceeeeEeEEEe--CCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCC
Q 014024          160 QVQHKNLVKLLGCCIE--KDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLK  237 (432)
Q Consensus       160 ~l~h~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlk  237 (432)
                      +++||||+++++++.+  .+..++||||+++++|.+++    ....+++..++.++.|++.||+|||+.+   |+|||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk  164 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK  164 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence            9999999999999987  56789999999999998875    2345999999999999999999999999   9999999


Q ss_pred             CCCEEEcCCCCEEEeecccceeccCCCCccccccccccccccCCccChhhhccCC---CCchhhhHHHHHHHHHHHhCCC
Q 014024          238 ASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGI---FSIKSDVFSFGVLLLEIVSGKK  314 (432)
Q Consensus       238 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~t~~~DvwSlG~il~elltg~~  314 (432)
                      |+||+++.++.+||+|||++......      ........||+.|+|||++.+..   ++.++|||||||++|+|++|+.
T Consensus       165 p~Nil~~~~~~~kl~Dfg~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~  238 (298)
T 2zv2_A          165 PSNLLVGEDGHIKIADFGVSNEFKGS------DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC  238 (298)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECSSS------SCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSC
T ss_pred             HHHEEECCCCCEEEecCCCccccccc------cccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence            99999999999999999999875321      11223457999999999988655   4789999999999999999999


Q ss_pred             CCCCccccccchhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          315 NTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       315 p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      ||......     ... ..        +.............+..+.+++.+||+.||++|||+.|++++
T Consensus       239 pf~~~~~~-----~~~-~~--------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h  293 (298)
T 2zv2_A          239 PFMDERIM-----CLH-SK--------IKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH  293 (298)
T ss_dssp             SSCCSSHH-----HHH-HH--------HHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred             CCCCccHH-----HHH-HH--------HhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence            98532210     000 00        000000111112345678899999999999999999999864

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=5.1e-44  Score=342.12  Aligned_cols=272  Identities=20%  Similarity=0.240  Sum_probs=211.5

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCC-hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC--eeEE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS-GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKD--ERLL  181 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~l  181 (432)
                      ..++|++.+.||+|+||.||+|.+..  ..||+|++.... ....+.+.+|++++++++||||+++++++.+..  ..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   86 (319)
T 4euu_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL   86 (319)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred             CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence            35789999999999999999999874  489999986433 234567889999999999999999999998765  7799


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEE----cCCCCEEEeecccc
Q 014024          182 IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILL----DKDMNSKISDFGMA  257 (432)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~Dfg~a  257 (432)
                      ||||+++++|.+++........+++..++.++.|++.||+|||+.+   |+||||||+|||+    +.++.+||+|||++
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a  163 (319)
T 4euu_A           87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (319)
T ss_dssp             EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred             EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence            9999999999999976544445999999999999999999999999   9999999999999    78888999999999


Q ss_pred             eeccCCCCccccccccccccccCCccChhhhc--------cCCCCchhhhHHHHHHHHHHHhCCCCCCCcccccc--chh
Q 014024          258 RIVFGGNDEDELQGNTSRISGTYGYMSPEYAL--------EGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSL--NLI  327 (432)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~--~~~  327 (432)
                      ......       .......||+.|+|||++.        +..++.++|||||||++|||++|+.||........  ...
T Consensus       164 ~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  236 (319)
T 4euu_A          164 RELEDD-------EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM  236 (319)
T ss_dssp             EECCTT-------CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHH
T ss_pred             eecCCC-------CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHH
Confidence            875221       1223456899999999886        57789999999999999999999999854332111  111


Q ss_pred             hhhHHhhhccchh---hhh--------hhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014024          328 GYAWDLWISNKII---DLI--------DSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEA  388 (432)
Q Consensus       328 ~~~~~~~~~~~~~---~~i--------~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~  388 (432)
                      .............   ...        +-.............+.+++..||+.||++|||++|++++..+..
T Consensus       237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~  308 (319)
T 4euu_A          237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (319)
T ss_dssp             HHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred             HHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence            0000000000000   000        000011234567778899999999999999999999999998754

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.9e-45  Score=351.31  Aligned_cols=265  Identities=29%  Similarity=0.418  Sum_probs=209.5

Q ss_pred             hhhCCCCcCceeccCCcEEEEEEEEC-------CceEEEEEEcCC-ChHhHHHHHHHHHHHHhc-CCCceeeeEeEEEeC
Q 014024          106 SATGNFSAANKLGEGGFGTVYKGVIG-------QGEIAVKRLLGK-SGQEIKELKNEASVIAQV-QHKNLVKLLGCCIEK  176 (432)
Q Consensus       106 ~~~~~y~~~~~ig~G~~g~Vy~~~~~-------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  176 (432)
                      ...++|++.+.||+|+||.||+|.+.       +..||+|.+... .....+.+.+|+.+++++ +||||+++++++.+.
T Consensus        42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  121 (344)
T 1rjb_A           42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS  121 (344)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence            34678999999999999999999962       226999998654 234456789999999999 899999999999999


Q ss_pred             CeeEEEEecCCCCChhhhhcCCCCC--------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccC
Q 014024          177 DERLLIYEYMPNKSLDCFLFDPTKR--------------------EILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDL  236 (432)
Q Consensus       177 ~~~~lv~e~~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dl  236 (432)
                      +..++||||+++|+|.+++......                    ..+++..++.++.|++.||+|||+.+   |+||||
T Consensus       122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Di  198 (344)
T 1rjb_A          122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDL  198 (344)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTC
T ss_pred             CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence            9999999999999999999654321                    34899999999999999999999999   999999


Q ss_pred             CCCCEEEcCCCCEEEeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCC
Q 014024          237 KASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKN  315 (432)
Q Consensus       237 kp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p  315 (432)
                      ||+||+++.++.+||+|||++........    ........||+.|+|||.+.+..++.++||||||+++|+|+| |..|
T Consensus       199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p  274 (344)
T 1rjb_A          199 AARNVLVTHGKVVKICDFGLARDIMSDSN----YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP  274 (344)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTT----SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred             ChhhEEEcCCCcEEeCCCccCcccccCcc----ceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCC
Confidence            99999999999999999999986532211    112334567889999999999999999999999999999998 9999


Q ss_pred             CCCccccccchhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccccCC
Q 014024          316 TGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSL  391 (432)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~  391 (432)
                      |.......              .....+........+...+..+.+++..||+.||.+|||+.+++++|+.+....
T Consensus       275 ~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  336 (344)
T 1rjb_A          275 YPGIPVDA--------------NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA  336 (344)
T ss_dssp             STTCCCSH--------------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             cccCCcHH--------------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence            85432211              011111111122223344577899999999999999999999999999876543

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=4.8e-45  Score=346.17  Aligned_cols=272  Identities=24%  Similarity=0.382  Sum_probs=206.9

Q ss_pred             hCCCCcCceeccCCcEEEEEEEE------CCceEEEEEEcCCC-hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeC--Ce
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVI------GQGEIAVKRLLGKS-GQEIKELKNEASVIAQVQHKNLVKLLGCCIEK--DE  178 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~  178 (432)
                      ..+|++.+.||+|+||.||+|..      .+..||+|++.... ....+.+.+|+++++.++|+||+++++++.+.  ..
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   99 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   99 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence            45689999999999999999984      23489999986443 33457789999999999999999999999876  66


Q ss_pred             eEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccce
Q 014024          179 RLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMAR  258 (432)
Q Consensus       179 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  258 (432)
                      .++||||+++++|.+++....  ..+++..++.++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.
T Consensus       100 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~  174 (302)
T 4e5w_A          100 IKLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK  174 (302)
T ss_dssp             EEEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             EEEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence            899999999999999985432  34999999999999999999999999   9999999999999999999999999998


Q ss_pred             eccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccc
Q 014024          259 IVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNK  338 (432)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  338 (432)
                      .......   .........||..|+|||.+.+..++.++||||||+++|+|++|..|+......................
T Consensus       175 ~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  251 (302)
T 4e5w_A          175 AIETDKE---YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR  251 (302)
T ss_dssp             ECCTTCC---EEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHH
T ss_pred             cccCCCc---ceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHH
Confidence            7532211   1122334567888999999999999999999999999999999998853211100000000000000111


Q ss_pred             hhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014024          339 IIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNE  387 (432)
Q Consensus       339 ~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~  387 (432)
                      ....+........+...+..+.+++..||+.||.+|||+.++++.|+.+
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  300 (302)
T 4e5w_A          252 LVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL  300 (302)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence            1122222222223445567899999999999999999999999999865

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=5.2e-45  Score=355.89  Aligned_cols=260  Identities=29%  Similarity=0.443  Sum_probs=208.9

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC-------ceEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCee
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ-------GEIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDER  179 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~-------~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  179 (432)
                      .++|++.+.||+|+||.||+|...+       ..||+|++... .......+.+|+.++++++||||+++++++.+....
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            4789999999999999999999532       26999998544 455566789999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhhhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCC---CEEEe
Q 014024          180 LLIYEYMPNKSLDCFLFDPT----KREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDM---NSKIS  252 (432)
Q Consensus       180 ~lv~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~  252 (432)
                      ++||||+++|+|.+++....    ....+++..++.++.|++.||+|||+.+   |+||||||+|||++.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence            99999999999999996432    2245899999999999999999999999   99999999999999555   59999


Q ss_pred             ecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhH
Q 014024          253 DFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAW  331 (432)
Q Consensus       253 Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~  331 (432)
                      |||+++......    .........||+.|+|||++.+..++.++|||||||++|||++ |..||......         
T Consensus       227 DFG~a~~~~~~~----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~---------  293 (367)
T 3l9p_A          227 DFGMARDIYRAG----YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---------  293 (367)
T ss_dssp             CCHHHHHHHHHS----SCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---------
T ss_pred             CCcccccccccc----ccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---------
Confidence            999997542111    1122334567899999999999999999999999999999998 99997532211         


Q ss_pred             HhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccc
Q 014024          332 DLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS  389 (432)
Q Consensus       332 ~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~  389 (432)
                            .....+........+...+..+.+++..||+.||++|||+.+|+++|+....
T Consensus       294 ------~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~  345 (367)
T 3l9p_A          294 ------EVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  345 (367)
T ss_dssp             ------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence                  1111111111122233445678899999999999999999999999987654

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=8.9e-45  Score=341.05  Aligned_cols=256  Identities=23%  Similarity=0.316  Sum_probs=196.7

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECCc-----eEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQG-----EIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERL  180 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~~-----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  180 (432)
                      ..++|++.+.||+|+||.||+|.+...     .+|+|..... .....+.+.+|+.++++++||||+++++++. .+..+
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   91 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW   91 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence            457899999999999999999997432     5889987653 4455678999999999999999999999984 56789


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceec
Q 014024          181 LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIV  260 (432)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  260 (432)
                      +||||+++++|.+++...  ...+++..++.++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++...
T Consensus        92 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  166 (281)
T 1mp8_A           92 IIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM  166 (281)
T ss_dssp             EEEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             EEEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccccc
Confidence            999999999999999643  234899999999999999999999998   999999999999999999999999999865


Q ss_pred             cCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccch
Q 014024          261 FGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKI  339 (432)
Q Consensus       261 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  339 (432)
                      ....     ........+++.|+|||.+.+..++.++||||||+++|||++ |..||.......  .             
T Consensus       167 ~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~--~-------------  226 (281)
T 1mp8_A          167 EDST-----YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--V-------------  226 (281)
T ss_dssp             -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--H-------------
T ss_pred             Cccc-----ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH--H-------------
Confidence            2211     112233456788999999999999999999999999999997 888985432211  1             


Q ss_pred             hhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014024          340 IDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEA  388 (432)
Q Consensus       340 ~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~  388 (432)
                      ...+........+...+..+.+++..||+.||++|||+.++++.|+.+.
T Consensus       227 ~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  275 (281)
T 1mp8_A          227 IGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  275 (281)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            0111111111223345677889999999999999999999999998764

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=4.2e-44  Score=341.63  Aligned_cols=265  Identities=21%  Similarity=0.271  Sum_probs=200.4

Q ss_pred             hhhhCCCCcCceeccCCcEEEEEEEECCc-eEEEEEEcCCC--hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEE
Q 014024          105 SSATGNFSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKS--GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLL  181 (432)
Q Consensus       105 ~~~~~~y~~~~~ig~G~~g~Vy~~~~~~~-~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  181 (432)
                      +...++|++.+.||+|+||.||+|.+.++ .+|+|++....  ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus        17 q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   96 (311)
T 3niz_A           17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL   96 (311)
T ss_dssp             ECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred             cchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence            34568999999999999999999998554 89999986442  2234678899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceecc
Q 014024          182 IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVF  261 (432)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  261 (432)
                      ||||+++ +|.+++...  ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus        97 v~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  170 (311)
T 3niz_A           97 VFEFMEK-DLKKVLDEN--KTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFG  170 (311)
T ss_dssp             EEECCSE-EHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred             EEcCCCC-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecC
Confidence            9999985 777777543  234999999999999999999999999   9999999999999999999999999998752


Q ss_pred             CCCCccccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhh---cc
Q 014024          262 GGNDEDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWI---SN  337 (432)
Q Consensus       262 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~  337 (432)
                      ..      ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........  .........   ..
T Consensus       171 ~~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~i~~~~~~~~~~  242 (311)
T 3niz_A          171 IP------VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ--LPKIFSILGTPNPR  242 (311)
T ss_dssp             SC------CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH--HHHHHHHHCCCCTT
T ss_pred             CC------cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHHCCCChH
Confidence            11      122334578999999999876 5689999999999999999999999864433211  111100000   00


Q ss_pred             chhhh-------------hhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          338 KIIDL-------------IDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       338 ~~~~~-------------i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      .....             .+.............++.+++..||+.||++|||++|++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  301 (311)
T 3niz_A          243 EWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH  301 (311)
T ss_dssp             TSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            00000             00000000111233577899999999999999999999984

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=6.9e-45  Score=352.78  Aligned_cols=247  Identities=23%  Similarity=0.345  Sum_probs=198.4

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC---ChHhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeeE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK---SGQEIKELKNEASVIAQV-QHKNLVKLLGCCIEKDERL  180 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  180 (432)
                      ..++|++.+.||+|+||.||+|++..  ..||+|++...   .....+.+.+|.++++.+ +||||+++++++.+.+..|
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            45789999999999999999999864  38999998643   223456678899999998 7999999999999999999


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceec
Q 014024          181 LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIV  260 (432)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  260 (432)
                      +||||+++|+|.+++..   .+.+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus       101 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~  174 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQK---SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG  174 (353)
T ss_dssp             EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             EEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence            99999999999999853   345999999999999999999999999   999999999999999999999999999753


Q ss_pred             cCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchh
Q 014024          261 FGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKII  340 (432)
Q Consensus       261 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                      ...      .......+||+.|+|||++.+..++.++|||||||++|||++|+.||......                  
T Consensus       175 ~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------------------  230 (353)
T 3txo_A          175 ICN------GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED------------------  230 (353)
T ss_dssp             CC---------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH------------------
T ss_pred             ccC------CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH------------------
Confidence            111      22344568999999999999989999999999999999999999998532211                  


Q ss_pred             hhhhhhhhh--cccHHHHHHHHHHHHHhhccCCCCCCCH------HHHHHH
Q 014024          341 DLIDSVLEE--ASFNESLSRYVHIALLCVQERAEDRPTM------SDVVSM  383 (432)
Q Consensus       341 ~~i~~~l~~--~~~~~~~~~l~~l~~~cl~~dp~~RPt~------~evl~~  383 (432)
                      ++.......  ..+......+.+++..||+.||++||++      .|++++
T Consensus       231 ~~~~~i~~~~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h  281 (353)
T 3txo_A          231 DLFEAILNDEVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH  281 (353)
T ss_dssp             HHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred             HHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence            111111111  1222345678899999999999999998      778764

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=3e-44  Score=350.19  Aligned_cols=286  Identities=15%  Similarity=0.190  Sum_probs=212.5

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECC-------ceEEEEEEcCCChHhHH-----------HHHHHHHHHHhcCCCceee
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQ-------GEIAVKRLLGKSGQEIK-----------ELKNEASVIAQVQHKNLVK  168 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~-----------~~~~E~~~l~~l~h~niv~  168 (432)
                      ..++|++.+.||+|+||.||+|.+..       ..||+|++.........           .+..|+..++.++|+||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            45789999999999999999998754       36999998665432211           2334555667778999999


Q ss_pred             eEeEEEeC----CeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEc
Q 014024          169 LLGCCIEK----DERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLD  244 (432)
Q Consensus       169 ~~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~  244 (432)
                      +++++.+.    ...++||||+ +++|.+++...  ...+++..++.++.|++.||+|||+.+   |+||||||+|||++
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~  186 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN  186 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence            99998765    4579999999 99999999643  245999999999999999999999998   99999999999999


Q ss_pred             --CCCCEEEeecccceeccCCCCccc-cccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccc
Q 014024          245 --KDMNSKISDFGMARIVFGGNDEDE-LQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRT  321 (432)
Q Consensus       245 --~~~~~kl~Dfg~a~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~  321 (432)
                        .++.+||+|||+++.+........ .........||+.|+|||++.+..++.++|||||||++|||+||+.||.....
T Consensus       187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~  266 (364)
T 3op5_A          187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK  266 (364)
T ss_dssp             SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred             cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence              899999999999987532211111 11122345699999999999999999999999999999999999999863221


Q ss_pred             cccchhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccccCCCCCCCCcccc
Q 014024          322 KSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQPAFCN  401 (432)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~~~~~~~~~~  401 (432)
                      .. ...... .........++++..+..   ...+.++.+++..||+.||++||++.+|++.|++............+.+
T Consensus       267 ~~-~~~~~~-~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw  341 (364)
T 3op5_A          267 DP-KYVRDS-KIRYRENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDL  341 (364)
T ss_dssp             CH-HHHHHH-HHHHHHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC
T ss_pred             CH-HHHHHH-HHHhhhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccce
Confidence            11 111111 111112233333332211   2335678999999999999999999999999998877665555555555


Q ss_pred             cc
Q 014024          402 LR  403 (432)
Q Consensus       402 ~~  403 (432)
                      ..
T Consensus       342 ~~  343 (364)
T 3op5_A          342 SV  343 (364)
T ss_dssp             --
T ss_pred             Ee
Confidence            44

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=4.2e-44  Score=348.74  Aligned_cols=253  Identities=23%  Similarity=0.338  Sum_probs=203.9

Q ss_pred             hhhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEE
Q 014024          106 SATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLL  181 (432)
Q Consensus       106 ~~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  181 (432)
                      ...++|++.+.||+|+||.||+|.+..  ..+|+|++...  .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l  105 (362)
T 2bdw_A           26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL  105 (362)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            346789999999999999999999864  48999998644  34556789999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCC---CEEEeecccce
Q 014024          182 IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDM---NSKISDFGMAR  258 (432)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~Dfg~a~  258 (432)
                      ||||+++|+|.+++..   +..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++   .+||+|||++.
T Consensus       106 v~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~  179 (362)
T 2bdw_A          106 VFDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAI  179 (362)
T ss_dssp             EECCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred             EEecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence            9999999999999843   445999999999999999999999999   99999999999998654   59999999998


Q ss_pred             eccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccc
Q 014024          259 IVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNK  338 (432)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  338 (432)
                      .....       .......||+.|+|||++.+..++.++|||||||++|+|++|..||......  ...    .......
T Consensus       180 ~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~--~~~----~~i~~~~  246 (362)
T 2bdw_A          180 EVNDS-------EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--RLY----AQIKAGA  246 (362)
T ss_dssp             CCTTC-------CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHH----HHHHHTC
T ss_pred             EecCC-------cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--HHH----HHHHhCC
Confidence            64211       1223467999999999999999999999999999999999999998532211  000    0000000


Q ss_pred             hhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          339 IIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       339 ~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      . ..     ........+..+.+++..||+.||++|||+.+++++
T Consensus       247 ~-~~-----~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          247 Y-DY-----PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             C-CC-----CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             C-CC-----CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            0 00     000112334678899999999999999999999875

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.5e-44  Score=344.35  Aligned_cols=265  Identities=28%  Similarity=0.395  Sum_probs=213.3

Q ss_pred             hhhhCCCCcCceeccCCcEEEEEEEEC-------CceEEEEEEcCCC-hHhHHHHHHHHHHHHhc-CCCceeeeEeEEEe
Q 014024          105 SSATGNFSAANKLGEGGFGTVYKGVIG-------QGEIAVKRLLGKS-GQEIKELKNEASVIAQV-QHKNLVKLLGCCIE  175 (432)
Q Consensus       105 ~~~~~~y~~~~~ig~G~~g~Vy~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~  175 (432)
                      ....++|++.+.||+|+||.||+|.+.       +..||+|.+.... ....+.+.+|+.+++++ +||||+++++++.+
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   98 (313)
T 1t46_A           19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI   98 (313)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence            344578999999999999999999852       2379999986543 34567899999999999 99999999999999


Q ss_pred             CCeeEEEEecCCCCChhhhhcCCCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCC
Q 014024          176 KDERLLIYEYMPNKSLDCFLFDPTK---------------REILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASN  240 (432)
Q Consensus       176 ~~~~~lv~e~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~N  240 (432)
                      .+..++||||+++|+|.+++.....               ...+++..++.++.|++.||+|||+.+   ++||||||+|
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~N  175 (313)
T 1t46_A           99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARN  175 (313)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccce
Confidence            9999999999999999999965322               224899999999999999999999998   9999999999


Q ss_pred             EEEcCCCCEEEeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCc
Q 014024          241 ILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFY  319 (432)
Q Consensus       241 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~  319 (432)
                      |+++.++.+||+|||++........    ........+|+.|+|||.+.+..++.++||||||+++|+|+| |+.||...
T Consensus       176 il~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~  251 (313)
T 1t46_A          176 ILLTHGRITKICDFGLARDIKNDSN----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM  251 (313)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTT----SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred             EEEcCCCCEEEcccccccccccccc----ceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcc
Confidence            9999999999999999986532211    112234567889999999999999999999999999999999 99997543


Q ss_pred             cccccchhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccccC
Q 014024          320 RTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASS  390 (432)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~  390 (432)
                      ....              .....+........+...+..+.+++..||+.||.+|||+.|++++|++....
T Consensus       252 ~~~~--------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  308 (313)
T 1t46_A          252 PVDS--------------KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (313)
T ss_dssp             CSSH--------------HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cchh--------------HHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence            2211              11111111112222334456789999999999999999999999999987653

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-44  Score=347.76  Aligned_cols=259  Identities=27%  Similarity=0.469  Sum_probs=203.1

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECCc------eEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeE
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQG------EIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERL  180 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~~------~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  180 (432)
                      .++|++.+.||+|+||.||+|.+...      .||+|.+... .......+.+|++++++++||||+++++++.+.+..+
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  122 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM  122 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence            46788899999999999999987432      4999998654 3445667899999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceec
Q 014024          181 LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIV  260 (432)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  260 (432)
                      +||||+++++|.+++...  ...+++..++.++.|++.||+|||+.+   |+||||||+||++++++.+||+|||++...
T Consensus       123 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  197 (333)
T 1mqb_A          123 IITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL  197 (333)
T ss_dssp             EEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             EEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhh
Confidence            999999999999999643  235999999999999999999999999   999999999999999999999999999875


Q ss_pred             cCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccch
Q 014024          261 FGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKI  339 (432)
Q Consensus       261 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  339 (432)
                      ......   ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......               ..
T Consensus       198 ~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---------------~~  259 (333)
T 1mqb_A          198 EDDPEA---TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH---------------EV  259 (333)
T ss_dssp             ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---------------HH
T ss_pred             cccccc---ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH---------------HH
Confidence            322111   112223456788999999999999999999999999999999 99997432211               01


Q ss_pred             hhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccc
Q 014024          340 IDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS  389 (432)
Q Consensus       340 ~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~  389 (432)
                      ...+........+...+..+.+++.+||+.||++||++.++++.|+.+..
T Consensus       260 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~  309 (333)
T 1mqb_A          260 MKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  309 (333)
T ss_dssp             HHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HHHHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            11111111112233455778999999999999999999999999988654

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.3e-44  Score=337.48  Aligned_cols=255  Identities=22%  Similarity=0.313  Sum_probs=207.9

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECCceEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeC--CeeEEEE
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQGEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEK--DERLLIY  183 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~  183 (432)
                      .++|++.+.||+|+||.||+|.+.+..+|+|++...  .....+.+.+|+.++++++||||+++++++.+.  +..++||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT   88 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence            468999999999999999999999889999998654  345567899999999999999999999999887  7789999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCC
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGG  263 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  263 (432)
                      ||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ .+++||||||+||++++++.++|+|||++...   
T Consensus        89 e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~---  163 (271)
T 3kmu_A           89 HWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSF---  163 (271)
T ss_dssp             ECCTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT---
T ss_pred             cccCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeee---
Confidence            9999999999996532 235899999999999999999999875 34999999999999999999999999987542   


Q ss_pred             CCccccccccccccccCCccChhhhccCCCCc---hhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchh
Q 014024          264 NDEDELQGNTSRISGTYGYMSPEYALEGIFSI---KSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKII  340 (432)
Q Consensus       264 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~---~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                              ......||+.|+|||.+.+..++.   ++||||||+++|+|++|+.||........              ..
T Consensus       164 --------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--------------~~  221 (271)
T 3kmu_A          164 --------QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI--------------GM  221 (271)
T ss_dssp             --------SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH--------------HH
T ss_pred             --------cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH--------------HH
Confidence                    123346889999999998765544   89999999999999999999853322110              01


Q ss_pred             hhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccc
Q 014024          341 DLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS  389 (432)
Q Consensus       341 ~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~  389 (432)
                      ...........+...+..+.+++..||+.||++|||+.++++.|+.+..
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          222 KVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             HHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            1111111122233445678999999999999999999999999988653

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.2e-44  Score=366.67  Aligned_cols=259  Identities=27%  Similarity=0.433  Sum_probs=213.7

Q ss_pred             hhhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEE
Q 014024          106 SATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       106 ~~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  183 (432)
                      ...++|++.+.||+|+||.||+|.+..  ..||+|.+.... ...+.+.+|+.+|++++||||++++++|.+.+..++||
T Consensus       217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  295 (495)
T 1opk_A          217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT  295 (495)
T ss_dssp             CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence            345678899999999999999999874  489999986543 34578999999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCC
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGG  263 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  263 (432)
                      ||+++|+|.+++.... ...+++..++.++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++.....
T Consensus       296 E~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  371 (495)
T 1opk_A          296 EFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGD  371 (495)
T ss_dssp             ECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred             EccCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence            9999999999996532 344899999999999999999999999   999999999999999999999999999875221


Q ss_pred             CCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchhhh
Q 014024          264 NDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIIDL  342 (432)
Q Consensus       264 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                      .     ........++..|+|||++.++.++.++|||||||++|||+| |..||......               ...+.
T Consensus       372 ~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~---------------~~~~~  431 (495)
T 1opk_A          372 T-----YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---------------QVYEL  431 (495)
T ss_dssp             C-----EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---------------GHHHH
T ss_pred             c-----eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH---------------HHHHH
Confidence            1     112233456778999999999999999999999999999999 88887533221               11222


Q ss_pred             hhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccc
Q 014024          343 IDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS  389 (432)
Q Consensus       343 i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~  389 (432)
                      +....+...+..++..+.+++.+||+.||++|||+.+|++.|+.+..
T Consensus       432 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~  478 (495)
T 1opk_A          432 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  478 (495)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred             HHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence            22222333344566788999999999999999999999999998754

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.8e-44  Score=342.45  Aligned_cols=253  Identities=23%  Similarity=0.326  Sum_probs=203.6

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCCh------HhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCe
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSG------QEIKELKNEASVIAQVQHKNLVKLLGCCIEKDE  178 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  178 (432)
                      ..++|++.+.||+|+||.||+|.+..  ..+|+|.+.....      ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus         9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   88 (326)
T 2y0a_A            9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   88 (326)
T ss_dssp             HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            34679999999999999999999864  4899998854432      135778999999999999999999999999999


Q ss_pred             eEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCC----CEEEeec
Q 014024          179 RLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDM----NSKISDF  254 (432)
Q Consensus       179 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Df  254 (432)
                      .++||||+++++|.+++..   ...+++..++.++.|++.||.|||+.+   |+||||||+||++++++    .+||+||
T Consensus        89 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Df  162 (326)
T 2y0a_A           89 VILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF  162 (326)
T ss_dssp             EEEEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence            9999999999999999943   455999999999999999999999999   99999999999999887    7999999


Q ss_pred             ccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhh
Q 014024          255 GMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLW  334 (432)
Q Consensus       255 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  334 (432)
                      |++......       .......||+.|+|||++.+..++.++|||||||++|+|++|..||.......  ......   
T Consensus       163 g~a~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~~~---  230 (326)
T 2y0a_A          163 GLAHKIDFG-------NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--TLANVS---  230 (326)
T ss_dssp             TTCEECCTT-------SCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH--HHHHHH---
T ss_pred             CCCeECCCC-------CccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH--HHHHHH---
Confidence            999875221       12234579999999999999999999999999999999999999985322110  000000   


Q ss_pred             hccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          335 ISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       335 ~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                       ... ..     .........+..+.+++..||+.||++|||+.|++++-
T Consensus       231 -~~~-~~-----~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp  273 (326)
T 2y0a_A          231 -AVN-YE-----FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHP  273 (326)
T ss_dssp             -HTC-CC-----CCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHST
T ss_pred             -hcC-CC-----cCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCC
Confidence             000 00     00001112345688999999999999999999999864

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=9.6e-45  Score=349.14  Aligned_cols=265  Identities=29%  Similarity=0.410  Sum_probs=212.2

Q ss_pred             hHhhhhCCCCcCceeccCCcEEEEEEEECC-------ceEEEEEEcCC-ChHhHHHHHHHHHHHHhc-CCCceeeeEeEE
Q 014024          103 SVSSATGNFSAANKLGEGGFGTVYKGVIGQ-------GEIAVKRLLGK-SGQEIKELKNEASVIAQV-QHKNLVKLLGCC  173 (432)
Q Consensus       103 ~~~~~~~~y~~~~~ig~G~~g~Vy~~~~~~-------~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~  173 (432)
                      ......++|++.+.||+|+||.||+|.+..       ..+|+|.+... .....+.+.+|+.+++++ +||||+++++++
T Consensus        40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  119 (333)
T 2i1m_A           40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC  119 (333)
T ss_dssp             GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            344557899999999999999999999743       26999998655 344567799999999999 899999999999


Q ss_pred             EeCCeeEEEEecCCCCChhhhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEE
Q 014024          174 IEKDERLLIYEYMPNKSLDCFLFDPT-----------KREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNIL  242 (432)
Q Consensus       174 ~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIl  242 (432)
                      .+.+..++||||+++|+|.+++....           ....+++..++.++.|++.||+|||+.+   |+||||||+||+
T Consensus       120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl  196 (333)
T 2i1m_A          120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVL  196 (333)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCE
T ss_pred             ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEE
Confidence            99999999999999999999985421           1335899999999999999999999998   999999999999


Q ss_pred             EcCCCCEEEeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccc
Q 014024          243 LDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRT  321 (432)
Q Consensus       243 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~  321 (432)
                      +++++.+||+|||++........    ........+|+.|+|||.+.+..++.++||||||+++|+|+| |..||.....
T Consensus       197 ~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  272 (333)
T 2i1m_A          197 LTNGHVAKIGDFGLARDIMNDSN----YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV  272 (333)
T ss_dssp             EEGGGEEEBCCCGGGCCGGGCTT----SEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCS
T ss_pred             ECCCCeEEECccccccccccccc----eeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccch
Confidence            99999999999999986532211    112234567889999999999999999999999999999999 8888753321


Q ss_pred             cccchhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014024          322 KSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEA  388 (432)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~  388 (432)
                      ..              .....+........+...+..+.+++..||+.||.+|||+.+++++|+...
T Consensus       273 ~~--------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~  325 (333)
T 2i1m_A          273 NS--------------KFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA  325 (333)
T ss_dssp             SH--------------HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hH--------------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence            11              011111111112222334567889999999999999999999999998754

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=4.6e-44  Score=356.91  Aligned_cols=255  Identities=23%  Similarity=0.311  Sum_probs=202.9

Q ss_pred             hhhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCC--hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEE
Q 014024          106 SATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS--GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLL  181 (432)
Q Consensus       106 ~~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  181 (432)
                      ...++|++.+.||+|+||.||+|.+..  ..+|+|++....  ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l   87 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL   87 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence            346789999999999999999998753  489999986543  3455678999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEc---CCCCEEEeecccce
Q 014024          182 IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLD---KDMNSKISDFGMAR  258 (432)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Dfg~a~  258 (432)
                      ||||+++|+|.+++..   +..+++..+..++.|++.||.|||+.+   |+||||||+|||++   +++.+||+|||++.
T Consensus        88 v~E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~  161 (444)
T 3soa_A           88 IFDLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAI  161 (444)
T ss_dssp             EECCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred             EEEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence            9999999999998854   345999999999999999999999999   99999999999998   56789999999997


Q ss_pred             eccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccc
Q 014024          259 IVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNK  338 (432)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  338 (432)
                      .....      ........||+.|+|||++.+..++.++|||||||++|+|++|..||......  ...    .......
T Consensus       162 ~~~~~------~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~--~~~----~~i~~~~  229 (444)
T 3soa_A          162 EVEGE------QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH--RLY----QQIKAGA  229 (444)
T ss_dssp             CCCTT------CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHH----HHHHHTC
T ss_pred             EecCC------CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH--HHH----HHHHhCC
Confidence            64221      11233467999999999999999999999999999999999999998532211  000    0000000


Q ss_pred             hhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          339 IIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       339 ~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                      . +.     ........+..+.+++..||+.||++|||+.|++++-
T Consensus       230 ~-~~-----~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp  269 (444)
T 3soa_A          230 Y-DF-----PSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHP  269 (444)
T ss_dssp             C-CC-----CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSC
T ss_pred             C-CC-----CccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCc
Confidence            0 00     0001123356788999999999999999999999863

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-44  Score=338.58  Aligned_cols=262  Identities=27%  Similarity=0.401  Sum_probs=210.4

Q ss_pred             hCCCCcCc-eeccCCcEEEEEEEEC----CceEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEE
Q 014024          108 TGNFSAAN-KLGEGGFGTVYKGVIG----QGEIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLL  181 (432)
Q Consensus       108 ~~~y~~~~-~ig~G~~g~Vy~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  181 (432)
                      .++|.+.+ .||+|+||.||+|.+.    +..||+|.+... .....+.+.+|++++++++||||+++++++ +.+..++
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l   86 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML   86 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence            45677776 9999999999999863    337999999664 445677899999999999999999999999 5567899


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceecc
Q 014024          182 IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVF  261 (432)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  261 (432)
                      ||||+++++|.+++...  ...+++..++.++.|++.||.|||+.+   ++||||||+||++++++.+||+|||++....
T Consensus        87 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~  161 (287)
T 1u59_A           87 VMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG  161 (287)
T ss_dssp             EEECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             EEEeCCCCCHHHHHHhC--CccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeec
Confidence            99999999999998542  345999999999999999999999999   9999999999999999999999999998753


Q ss_pred             CCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchh
Q 014024          262 GGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKII  340 (432)
Q Consensus       262 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                      .....   ........+|+.|+|||++.+..++.++||||||+++|+|++ |+.||......               ...
T Consensus       162 ~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---------------~~~  223 (287)
T 1u59_A          162 ADDSY---YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---------------EVM  223 (287)
T ss_dssp             TCSCE---ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---------------HHH
T ss_pred             cCcce---eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH---------------HHH
Confidence            22111   122233456889999999998999999999999999999998 99998543221               011


Q ss_pred             hhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccccCCCC
Q 014024          341 DLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLP  393 (432)
Q Consensus       341 ~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~~  393 (432)
                      ..+........+...+..+.+++..||+.||++||++.+++++|+....+...
T Consensus       224 ~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~  276 (287)
T 1u59_A          224 AFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS  276 (287)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred             HHHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence            11111111223345567899999999999999999999999999987654433

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.7e-44  Score=348.77  Aligned_cols=255  Identities=21%  Similarity=0.289  Sum_probs=201.4

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCC-----hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCee
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS-----GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDER  179 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  179 (432)
                      ..++|++.+.||+|+||.||+|.+..  ..||+|++....     ....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  101 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML  101 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            35689999999999999999999854  489999884321     12356789999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCC---EEEeecc
Q 014024          180 LLIYEYMPNKSLDCFLFDPT-KREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN---SKISDFG  255 (432)
Q Consensus       180 ~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Dfg  255 (432)
                      ++||||+++++|.+++.... ....+++..+..++.|++.||+|||+++   |+||||||+|||++.++.   +||+|||
T Consensus       102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg  178 (351)
T 3c0i_A          102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFG  178 (351)
T ss_dssp             EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred             EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCc
Confidence            99999999999988775322 2334899999999999999999999999   999999999999987655   9999999


Q ss_pred             cceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhh
Q 014024          256 MARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWI  335 (432)
Q Consensus       256 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  335 (432)
                      ++......      ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.....   ..    .....
T Consensus       179 ~a~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~----~~~i~  245 (351)
T 3c0i_A          179 VAIQLGES------GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE---RL----FEGII  245 (351)
T ss_dssp             TCEECCTT------SCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH---HH----HHHHH
T ss_pred             ceeEecCC------CeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH---HH----HHHHH
Confidence            99875221      1123345799999999999999999999999999999999999999853211   00    00000


Q ss_pred             ccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          336 SNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       336 ~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      .... . ..+    ......+..+.+++.+||+.||++|||+.|++++
T Consensus       246 ~~~~-~-~~~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  287 (351)
T 3c0i_A          246 KGKY-K-MNP----RQWSHISESAKDLVRRMLMLDPAERITVYEALNH  287 (351)
T ss_dssp             HTCC-C-CCH----HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cCCC-C-CCc----cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            0000 0 000    0011234678899999999999999999999974

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.2e-44  Score=345.33  Aligned_cols=260  Identities=23%  Similarity=0.316  Sum_probs=195.5

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC---ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCe---
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK---SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDE---  178 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---  178 (432)
                      ..++|++.+.||+|+||.||+|.+..  ..||+|++...   .......+.+|++++++++||||+++++++.....   
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~   89 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   89 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence            35789999999999999999999743  48999999654   34456678999999999999999999999876543   


Q ss_pred             -eEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccc
Q 014024          179 -RLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMA  257 (432)
Q Consensus       179 -~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  257 (432)
                       .++||||+++++|.+++..   ++.+++..++.++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a  163 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA  163 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred             ccEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence             3999999999999999953   345999999999999999999999999   999999999999999999999999999


Q ss_pred             eeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhcc
Q 014024          258 RIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISN  337 (432)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  337 (432)
                      ........   .........||+.|+|||++.+..++.++||||||+++|+|++|+.||.......     .........
T Consensus       164 ~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~-----~~~~~~~~~  235 (311)
T 3ork_A          164 RAIADSGN---SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS-----VAYQHVRED  235 (311)
T ss_dssp             ---------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHHHCC
T ss_pred             cccccccc---ccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHhcCC
Confidence            86522211   1122334578999999999999999999999999999999999999985432211     000000000


Q ss_pred             chhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHH-Hhccc
Q 014024          338 KIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVS-MLTNE  387 (432)
Q Consensus       338 ~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~-~L~~~  387 (432)
                      ...    .   .......+.++.+++.+||+.||++||+..+++. .|...
T Consensus       236 ~~~----~---~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          236 PIP----P---SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             CCC----H---HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             CCC----c---ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence            000    0   0001123467889999999999999997766664 44443

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=3.1e-44  Score=352.52  Aligned_cols=256  Identities=21%  Similarity=0.306  Sum_probs=201.8

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCC---ChHhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeeE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGK---SGQEIKELKNEASVIAQV-QHKNLVKLLGCCIEKDERL  180 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  180 (432)
                      ..++|++.++||+|+||.||+|++..+  .+|+|++...   .....+.+..|..++.++ +||||+++++++.+.+..+
T Consensus        50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  129 (396)
T 4dc2_A           50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF  129 (396)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence            357899999999999999999998654  7999998643   233345678899999887 8999999999999999999


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceec
Q 014024          181 LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIV  260 (432)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  260 (432)
                      +||||+++|+|.+++..   .+.+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus       130 lV~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~  203 (396)
T 4dc2_A          130 FVIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  203 (396)
T ss_dssp             EEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEEcCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeec
Confidence            99999999999999853   345999999999999999999999999   999999999999999999999999999753


Q ss_pred             cCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchh
Q 014024          261 FGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKII  340 (432)
Q Consensus       261 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                      ...      .......+||+.|+|||++.+..++.++|||||||++|||++|+.||..........         .....
T Consensus       204 ~~~------~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~---------~~~~~  268 (396)
T 4dc2_A          204 LRP------GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD---------QNTED  268 (396)
T ss_dssp             CCT------TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC---------------CCHH
T ss_pred             ccC------CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccc---------hhhHH
Confidence            111      223455789999999999999999999999999999999999999985432211000         00000


Q ss_pred             hhhhhhh--hhcccHHHHHHHHHHHHHhhccCCCCCCCH------HHHHHH
Q 014024          341 DLIDSVL--EEASFNESLSRYVHIALLCVQERAEDRPTM------SDVVSM  383 (432)
Q Consensus       341 ~~i~~~l--~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~------~evl~~  383 (432)
                      .+....+  ....+.....++.+++..||+.||.+||++      .|++++
T Consensus       269 ~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H  319 (396)
T 4dc2_A          269 YLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  319 (396)
T ss_dssp             HHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred             HHHHHHhccccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence            0111111  111233445678899999999999999995      677664

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=8.7e-45  Score=347.71  Aligned_cols=268  Identities=26%  Similarity=0.411  Sum_probs=213.5

Q ss_pred             chhhHhhhhCCCCcCceeccCCcEEEEEEEEC-------CceEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEe
Q 014024          100 SFSSVSSATGNFSAANKLGEGGFGTVYKGVIG-------QGEIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLG  171 (432)
Q Consensus       100 ~~~~~~~~~~~y~~~~~ig~G~~g~Vy~~~~~-------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~  171 (432)
                      ..++.....++|++.+.||+|+||.||+|.+.       +..||+|.+... .......+.+|+++++.++|+||+++++
T Consensus        16 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~   95 (322)
T 1p4o_A           16 VPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG   95 (322)
T ss_dssp             CCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred             ChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence            33445566789999999999999999999865       237999998654 3445567899999999999999999999


Q ss_pred             EEEeCCeeEEEEecCCCCChhhhhcCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEc
Q 014024          172 CCIEKDERLLIYEYMPNKSLDCFLFDPT-------KREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLD  244 (432)
Q Consensus       172 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~  244 (432)
                      ++.+.+..++||||+++|+|.+++....       ....+++..++.++.|++.||.|||+.+   |+||||||+||+++
T Consensus        96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~  172 (322)
T 1p4o_A           96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVA  172 (322)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEEC
T ss_pred             EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEc
Confidence            9999999999999999999999985421       1245799999999999999999999999   99999999999999


Q ss_pred             CCCCEEEeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccc
Q 014024          245 KDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKS  323 (432)
Q Consensus       245 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~  323 (432)
                      .++.+||+|||++.......    .........+|+.|+|||++.+..++.++||||||+++|+|++ |..||.......
T Consensus       173 ~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~  248 (322)
T 1p4o_A          173 EDFTVKIGDFGMTRDIYETD----YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ  248 (322)
T ss_dssp             TTCCEEECCTTCCCGGGGGG----CEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH
T ss_pred             CCCeEEECcCcccccccccc----ccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH
Confidence            99999999999997642211    1112233467889999999999999999999999999999999 888875332110


Q ss_pred             cchhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccc
Q 014024          324 LNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS  389 (432)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~  389 (432)
                                     ....+........+...+..+.+++..||+.||++|||+.|++++|++...
T Consensus       249 ---------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          249 ---------------VLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             ---------------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             ---------------HHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence                           000010000111223445678899999999999999999999999998755

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.8e-44  Score=336.05  Aligned_cols=256  Identities=29%  Similarity=0.434  Sum_probs=208.1

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECCc-eEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecC
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYM  186 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~~-~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  186 (432)
                      .++|++.+.||+|+||.||+|.+.++ .+|+|.+..... ..+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM   85 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence            46789999999999999999998655 899999865543 3467899999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCc
Q 014024          187 PNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDE  266 (432)
Q Consensus       187 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  266 (432)
                      ++++|.+++...  ...+++..++.++.|++.||.|||+.+   ++||||||+||++++++.+||+|||++......   
T Consensus        86 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~---  157 (267)
T 3t9t_A           86 EHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD---  157 (267)
T ss_dssp             TTCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH---
T ss_pred             CCCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccc---
Confidence            999999999643  245899999999999999999999999   999999999999999999999999999764211   


Q ss_pred             cccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchhhhhhh
Q 014024          267 DELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDS  345 (432)
Q Consensus       267 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  345 (432)
                        .........+++.|+|||++.+..++.++||||||+++|+|++ |+.||.......               ....+..
T Consensus       158 --~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---------------~~~~i~~  220 (267)
T 3t9t_A          158 --QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------------VVEDIST  220 (267)
T ss_dssp             --HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---------------HHHHHHT
T ss_pred             --cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH---------------HHHHHhc
Confidence              1112233456788999999999999999999999999999999 898875322110               0000111


Q ss_pred             hhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccc
Q 014024          346 VLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS  389 (432)
Q Consensus       346 ~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~  389 (432)
                      ......+...+..+.+++.+||+.||++|||+.+++++|+++..
T Consensus       221 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          221 GFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            11111222345678899999999999999999999999988754

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.4e-44  Score=340.71  Aligned_cols=259  Identities=27%  Similarity=0.436  Sum_probs=213.4

Q ss_pred             hhhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEE
Q 014024          106 SATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       106 ~~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  183 (432)
                      ...++|++.+.||+|+||.||+|.+..  ..+|+|.+.... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   88 (288)
T 3kfa_A           10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   88 (288)
T ss_dssp             CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence            356789999999999999999999875  379999986543 34678899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCC
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGG  263 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  263 (432)
                      ||+++++|.+++.... ...+++..++.++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++......
T Consensus        89 e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  164 (288)
T 3kfa_A           89 EFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  164 (288)
T ss_dssp             ECCTTEEHHHHHHHCC-TTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred             EcCCCCcHHHHHHhcc-cCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence            9999999999996532 345999999999999999999999999   999999999999999999999999999864221


Q ss_pred             CCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchhhh
Q 014024          264 NDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIIDL  342 (432)
Q Consensus       264 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                      .     ........+|+.|+|||.+.+..++.++||||||+++|+|++ |..||......               ...+.
T Consensus       165 ~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~---------------~~~~~  224 (288)
T 3kfa_A          165 T-----YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---------------QVYEL  224 (288)
T ss_dssp             S-----SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---------------GHHHH
T ss_pred             c-----cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---------------HHHHH
Confidence            1     122334567889999999999999999999999999999999 88887543221               11122


Q ss_pred             hhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccc
Q 014024          343 IDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS  389 (432)
Q Consensus       343 i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~  389 (432)
                      +........+...+..+.+++..||+.||.+|||+.++++.|+....
T Consensus       225 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~  271 (288)
T 3kfa_A          225 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  271 (288)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence            22222222334455778999999999999999999999999987653

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=4.9e-44  Score=337.91  Aligned_cols=262  Identities=19%  Similarity=0.235  Sum_probs=198.2

Q ss_pred             CCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEe
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYE  184 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  184 (432)
                      ++|++.+.||+|+||.||+|.+..  ..||+|++...  .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            579999999999999999999854  37999998544  33345678899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCC
Q 014024          185 YMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGN  264 (432)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  264 (432)
                      |++++.+..+. .  .++.+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++...... 
T Consensus        82 ~~~~~l~~~~~-~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~-  154 (292)
T 3o0g_A           82 FCDQDLKKYFD-S--CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP-  154 (292)
T ss_dssp             CCSEEHHHHHH-H--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSC-
T ss_pred             cCCCCHHHHHH-h--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCc-
Confidence            99865444443 2  2345999999999999999999999999   999999999999999999999999999875211 


Q ss_pred             CccccccccccccccCCccChhhhccCC-CCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhc---cch-
Q 014024          265 DEDELQGNTSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWIS---NKI-  339 (432)
Q Consensus       265 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~-  339 (432)
                           ........||+.|+|||++.+.. ++.++|||||||++|+|++|..|+-....... ...........   ... 
T Consensus       155 -----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~-~~~~i~~~~~~~~~~~~~  228 (292)
T 3o0g_A          155 -----VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKRIFRLLGTPTEEQWP  228 (292)
T ss_dssp             -----CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH-HHHHHHHHHCCCCTTTCT
T ss_pred             -----cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHHhCCCChhhhh
Confidence                 12234457899999999998766 89999999999999999999888532221111 11111000000   000 


Q ss_pred             --hhhhh---------hhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          340 --IDLID---------SVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       340 --~~~i~---------~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                        ....+         ..............+.+++..||+.||++|||++|++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  283 (292)
T 3o0g_A          229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             TGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence              00000         000001112345678899999999999999999999985

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=3.8e-44  Score=342.77  Aligned_cols=245  Identities=24%  Similarity=0.289  Sum_probs=202.4

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCC---hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEE
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS---GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLI  182 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  182 (432)
                      .++|++.+.||+|+||.||++....  ..+|+|++....   ....+.+.+|..+++.++||||+++++++.+.+..++|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            4679999999999999999999853  489999985432   12356678899999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccC
Q 014024          183 YEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFG  262 (432)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  262 (432)
                      |||+++|+|.+++..   ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++.... 
T Consensus        85 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~-  157 (318)
T 1fot_A           85 MDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVP-  157 (318)
T ss_dssp             ECCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECS-
T ss_pred             EeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecC-
Confidence            999999999999953   345999999999999999999999998   9999999999999999999999999998641 


Q ss_pred             CCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhh
Q 014024          263 GNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDL  342 (432)
Q Consensus       263 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                              .......||+.|+|||++.+..++.++|+|||||++|||++|+.||.......     ..         ..+
T Consensus       158 --------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~~---------~~i  215 (318)
T 1fot_A          158 --------DVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK-----TY---------EKI  215 (318)
T ss_dssp             --------SCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-----HH---------HHH
T ss_pred             --------CccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-----HH---------HHH
Confidence                    12345679999999999999999999999999999999999999985322100     00         011


Q ss_pred             hhhhhhhcccHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 014024          343 IDSVLEEASFNESLSRYVHIALLCVQERAEDRP-----TMSDVVSM  383 (432)
Q Consensus       343 i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~~  383 (432)
                      +...  ...+.....++.+++.+||+.||++||     ++.+++++
T Consensus       216 ~~~~--~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          216 LNAE--LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             HHCC--CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             HhCC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence            1110  012223456788999999999999999     89999875

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.2e-44  Score=342.89  Aligned_cols=272  Identities=24%  Similarity=0.329  Sum_probs=202.6

Q ss_pred             HhhhhCCCCcCceeccCCcEEEEEEEECCceEEEEEEcCCChHhHHHHHHHHHHHHhc--CCCceeeeEeEEEeC----C
Q 014024          104 VSSATGNFSAANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQV--QHKNLVKLLGCCIEK----D  177 (432)
Q Consensus       104 ~~~~~~~y~~~~~ig~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~~~~----~  177 (432)
                      .....++|++.+.||+|+||.||+|.+.+..||+|++....   ...+..|.+++...  +|+||+++++++.+.    .
T Consensus        32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~  108 (337)
T 3mdy_A           32 QRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT  108 (337)
T ss_dssp             HTTHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred             ccccccceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence            34456799999999999999999999998899999985432   23445555565554  899999999999887    6


Q ss_pred             eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc--------CCCCeEeccCCCCCEEEcCCCCE
Q 014024          178 ERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQY--------SRVRIIHRDLKASNILLDKDMNS  249 (432)
Q Consensus       178 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~--------~~~~ivH~Dlkp~NIll~~~~~~  249 (432)
                      ..++||||+++|+|.+++..    ..+++..++.++.|++.||+|||+.        +   |+||||||+|||++.++.+
T Consensus       109 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~  181 (337)
T 3mdy_A          109 QLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNGTC  181 (337)
T ss_dssp             EEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTSCE
T ss_pred             ceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCCCE
Confidence            88999999999999999943    3499999999999999999999998        7   9999999999999999999


Q ss_pred             EEeecccceeccCCCCccccccccccccccCCccChhhhccCCCCch------hhhHHHHHHHHHHHhCCCCCC------
Q 014024          250 KISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIK------SDVFSFGVLLLEIVSGKKNTG------  317 (432)
Q Consensus       250 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~------~DvwSlG~il~elltg~~p~~------  317 (432)
                      ||+|||++.........  .........||+.|+|||++.+...+..      +|||||||++|||+||..|+.      
T Consensus       182 kl~Dfg~a~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~  259 (337)
T 3mdy_A          182 CIADLGLAVKFISDTNE--VDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ  259 (337)
T ss_dssp             EECCCTTCEECC-----------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred             EEEeCCCceeecccccc--ccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccc
Confidence            99999999865322111  1112234579999999999987766554      999999999999999955443      


Q ss_pred             ----CccccccchhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccccCC
Q 014024          318 ----FYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSL  391 (432)
Q Consensus       318 ----~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~  391 (432)
                          ........... ..............   ........++..+.+++.+||+.||++|||+.+++++|+.+..+.
T Consensus       260 ~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  333 (337)
T 3mdy_A          260 LPYHDLVPSDPSYED-MREIVCIKKLRPSF---PNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ  333 (337)
T ss_dssp             CTTTTTSCSSCCHHH-HHHHHTTSCCCCCC---CGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             ccHhhhcCCCCchhh-hHHHHhhhccCccc---cccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence                21111111000 00000000000000   001112367788999999999999999999999999999876543

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.6e-44  Score=337.28  Aligned_cols=262  Identities=30%  Similarity=0.459  Sum_probs=208.6

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECCc-eEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEec
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEY  185 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~~-~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  185 (432)
                      ..++|++.+.||+|+||.||+|.+.++ .+|+|.+.... ...+.+.+|++++++++||||+++++++.+ +..++||||
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~   88 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY   88 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEec
Confidence            346899999999999999999998766 89999986543 235678999999999999999999999864 568999999


Q ss_pred             CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCC
Q 014024          186 MPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGND  265 (432)
Q Consensus       186 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  265 (432)
                      +++++|.+++.... ...+++..++.++.|++.||+|||+.+   ++||||||+||++++++.+||+|||++....... 
T Consensus        89 ~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  163 (279)
T 1qpc_A           89 MENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-  163 (279)
T ss_dssp             CTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-
T ss_pred             CCCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcc-
Confidence            99999999985321 125999999999999999999999999   9999999999999999999999999998753211 


Q ss_pred             ccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchhhhhh
Q 014024          266 EDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIIDLID  344 (432)
Q Consensus       266 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  344 (432)
                          ........++..|+|||.+.++.++.++||||||+++|+|++ |+.||.......               ....+.
T Consensus       164 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---------------~~~~~~  224 (279)
T 1qpc_A          164 ----YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---------------VIQNLE  224 (279)
T ss_dssp             ----EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---------------HHHHHH
T ss_pred             ----cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH---------------HHHHHh
Confidence                112233456788999999998999999999999999999999 888875322110               001111


Q ss_pred             hhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccccCCCCC
Q 014024          345 SVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPP  394 (432)
Q Consensus       345 ~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~~~  394 (432)
                      .......+...+..+.+++..||+.||++|||+.++++.|++........
T Consensus       225 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~  274 (279)
T 1qpc_A          225 RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQ  274 (279)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC---
T ss_pred             cccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccCC
Confidence            11111222344567899999999999999999999999999877654433

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1e-43  Score=348.56  Aligned_cols=254  Identities=21%  Similarity=0.254  Sum_probs=206.2

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEe
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYE  184 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  184 (432)
                      ..++|++.+.||+|+||.||+|.+..  ..+|+|.+..........+.+|+++++.++||||+++++++.+.+..++|||
T Consensus        49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E  128 (387)
T 1kob_A           49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE  128 (387)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred             cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence            35789999999999999999999864  3789999877766667789999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcC--CCCEEEeecccceeccC
Q 014024          185 YMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDK--DMNSKISDFGMARIVFG  262 (432)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~Dfg~a~~~~~  262 (432)
                      |+++|+|.+++...  ...+++..++.++.|++.||+|||+.+   |+||||||+|||++.  ++.+||+|||++.....
T Consensus       129 ~~~gg~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~  203 (387)
T 1kob_A          129 FLSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  203 (387)
T ss_dssp             CCCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             cCCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCC
Confidence            99999999998543  234899999999999999999999999   999999999999974  57799999999987522


Q ss_pred             CCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhh
Q 014024          263 GNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDL  342 (432)
Q Consensus       263 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                      .       .......||+.|+|||++.+..++.++|||||||++|+|++|..||......  .......    ....   
T Consensus       204 ~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--~~~~~i~----~~~~---  267 (387)
T 1kob_A          204 D-------EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL--ETLQNVK----RCDW---  267 (387)
T ss_dssp             T-------SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHHH----HCCC---
T ss_pred             C-------cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH--HHHHHHH----hCCC---
Confidence            1       1223457899999999999999999999999999999999999998532210  0000000    0000   


Q ss_pred             hhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          343 IDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       343 i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                         ..........+.++.+++..||+.||++|||+.|++++-
T Consensus       268 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp  306 (387)
T 1kob_A          268 ---EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHP  306 (387)
T ss_dssp             ---CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTST
T ss_pred             ---CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCc
Confidence               000111123456788999999999999999999999863

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=8.7e-44  Score=344.16  Aligned_cols=254  Identities=21%  Similarity=0.333  Sum_probs=203.5

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC---ChHhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeeEE
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK---SGQEIKELKNEASVIAQV-QHKNLVKLLGCCIEKDERLL  181 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l  181 (432)
                      .++|++.+.||+|+||.||+|++..  ..+|+|++...   .....+.+.+|..+++++ +||||+++++++.+.+..++
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            4679999999999999999999864  37999998643   345567788999999988 89999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceecc
Q 014024          182 IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVF  261 (432)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  261 (432)
                      ||||+++|+|.+++..   ...+++..++.++.|++.||+|||+.+   |+||||||+|||++.++++||+|||+++...
T Consensus        88 v~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~  161 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  161 (345)
T ss_dssp             EECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred             EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccccc
Confidence            9999999999999853   345999999999999999999999999   9999999999999999999999999997532


Q ss_pred             CCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCcccccc---chhhhhHHhhhccc
Q 014024          262 GGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSL---NLIGYAWDLWISNK  338 (432)
Q Consensus       262 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~---~~~~~~~~~~~~~~  338 (432)
                      ..      .......+||+.|+|||++.+..++.++|+|||||++|||++|+.||........   .........     
T Consensus       162 ~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-----  230 (345)
T 3a8x_A          162 RP------GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV-----  230 (345)
T ss_dssp             CT------TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHH-----
T ss_pred             CC------CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHH-----
Confidence            11      1233456899999999999999999999999999999999999999864322110   000001000     


Q ss_pred             hhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCH------HHHHHH
Q 014024          339 IIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTM------SDVVSM  383 (432)
Q Consensus       339 ~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~------~evl~~  383 (432)
                         +...  ....+......+.+++.+||+.||.+||++      .|++++
T Consensus       231 ---i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h  276 (345)
T 3a8x_A          231 ---ILEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  276 (345)
T ss_dssp             ---HHHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred             ---HHcC--CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence               0000  011223345678899999999999999995      677764

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=8.8e-44  Score=346.20  Aligned_cols=209  Identities=28%  Similarity=0.331  Sum_probs=180.6

Q ss_pred             CCccchhhHhhhhCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCCChHhHHHHHHHHHHHHhcC-----CCceee
Q 014024           96 FPLFSFSSVSSATGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGKSGQEIKELKNEASVIAQVQ-----HKNLVK  168 (432)
Q Consensus        96 ~~~~~~~~~~~~~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~  168 (432)
                      ...+++.+.....++|++.++||+|+||.||+|.+.  +..||+|++.. .....+.+..|+.+++.++     |+||++
T Consensus        22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~  100 (360)
T 3llt_A           22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIVK  100 (360)
T ss_dssp             GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred             ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence            344555666667899999999999999999999984  34799999864 3445567788999999997     999999


Q ss_pred             eEeEEEeCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcC---
Q 014024          169 LLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDK---  245 (432)
Q Consensus       169 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---  245 (432)
                      +++++...+..++||||+ +++|.+++..... ..+++..+..++.|++.||+|||+.+   |+||||||+|||+++   
T Consensus       101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~  175 (360)
T 3llt_A          101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNY-NGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYF  175 (360)
T ss_dssp             EEEEEEETTEEEEEECCC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTC
T ss_pred             ccceeeECCeeEEEEcCC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccc
Confidence            999999999999999999 9999999865332 34999999999999999999999999   999999999999975   


Q ss_pred             ----------------------CCCEEEeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHH
Q 014024          246 ----------------------DMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFG  303 (432)
Q Consensus       246 ----------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG  303 (432)
                                            ++.+||+|||++....         .......||+.|+|||++.+..++.++||||||
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG  246 (360)
T 3llt_A          176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKS---------DYHGSIINTRQYRAPEVILNLGWDVSSDMWSFG  246 (360)
T ss_dssp             CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETT---------SCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHH
T ss_pred             cccccchhcccccccccccccCCCCEEEEeccCceecC---------CCCcCccCcccccCcHHHcCCCCCCccchHHHH
Confidence                                  7899999999998641         122345789999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCc
Q 014024          304 VLLLEIVSGKKNTGFY  319 (432)
Q Consensus       304 ~il~elltg~~p~~~~  319 (432)
                      |++|+|++|+.||...
T Consensus       247 ~il~ell~g~~pf~~~  262 (360)
T 3llt_A          247 CVLAELYTGSLLFRTH  262 (360)
T ss_dssp             HHHHHHHHSSCSCCCS
T ss_pred             HHHHHHHHCCCCCCCC
Confidence            9999999999998643

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=3.7e-44  Score=342.02  Aligned_cols=246  Identities=22%  Similarity=0.253  Sum_probs=192.4

Q ss_pred             hCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCC--ChHhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeeEEE
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGK--SGQEIKELKNEASVIAQV-QHKNLVKLLGCCIEKDERLLI  182 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv  182 (432)
                      .++|++.++||+|+||+||+|.+.  +..||+|++...  ..........|+..+..+ +|+||+++++++.+.+..++|
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv  135 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ  135 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence            468999999999999999999986  448999988543  233444555666666555 899999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccC
Q 014024          183 YEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFG  262 (432)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  262 (432)
                      |||+ +++|.+++...  ...+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus       136 ~e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~  209 (311)
T 3p1a_A          136 TELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT  209 (311)
T ss_dssp             EECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred             Eecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence            9999 67888887543  235999999999999999999999998   99999999999999999999999999986421


Q ss_pred             CCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhh
Q 014024          263 GNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDL  342 (432)
Q Consensus       263 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                             ........||+.|+|||++.+ .++.++|||||||++|||++|..|+.....         +..        +
T Consensus       210 -------~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---------~~~--------~  264 (311)
T 3p1a_A          210 -------AGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---------WQQ--------L  264 (311)
T ss_dssp             ------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---------HHH--------H
T ss_pred             -------CCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---------HHH--------H
Confidence                   112334568999999998875 799999999999999999999776432110         000        1


Q ss_pred             hhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          343 IDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       343 i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                      .............+..+.+++..||+.||++|||+.|++++-
T Consensus       265 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp  306 (311)
T 3p1a_A          265 RQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALP  306 (311)
T ss_dssp             TTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred             hccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCc
Confidence            111111111223356789999999999999999999999753

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=5.7e-44  Score=338.28  Aligned_cols=264  Identities=26%  Similarity=0.372  Sum_probs=204.7

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECCc-----eEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEE-eCCee
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQG-----EIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCI-EKDER  179 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~~-----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~  179 (432)
                      ...+|++.+.||+|+||.||+|.+.+.     .+++|.+... .....+.+.+|+.++++++||||+++++++. ..+..
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  102 (298)
T 3f66_A           23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP  102 (298)
T ss_dssp             GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred             cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence            456789999999999999999986432     4788888654 4455678999999999999999999999865 45678


Q ss_pred             EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeeccccee
Q 014024          180 LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARI  259 (432)
Q Consensus       180 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  259 (432)
                      ++||||+++|+|.+++...  ...+++..++.++.|++.||+|||+.+   ++||||||+||++++++.+||+|||++..
T Consensus       103 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~  177 (298)
T 3f66_A          103 LVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARD  177 (298)
T ss_dssp             EEEEECCTTCBHHHHHHCT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred             EEEEeCCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccc
Confidence            9999999999999999653  334899999999999999999999999   99999999999999999999999999986


Q ss_pred             ccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCC-CCCCccccccchhhhhHHhhhccc
Q 014024          260 VFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK-NTGFYRTKSLNLIGYAWDLWISNK  338 (432)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~  338 (432)
                      .....  ...........+|+.|+|||.+.+..++.++||||||+++|+|++|.. |+.......  .            
T Consensus       178 ~~~~~--~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~--~------------  241 (298)
T 3f66_A          178 MYDKE--YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--I------------  241 (298)
T ss_dssp             CSCGG--GCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT--H------------
T ss_pred             ccccc--hhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH--H------------
Confidence            42211  111222344567889999999999999999999999999999999554 443221111  0            


Q ss_pred             hhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccccCCC
Q 014024          339 IIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLL  392 (432)
Q Consensus       339 ~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~  392 (432)
                       ...+........+...+..+.+++..||+.||++|||+.|+++.|+.+.....
T Consensus       242 -~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~  294 (298)
T 3f66_A          242 -TVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  294 (298)
T ss_dssp             -HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred             -HHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence             00111111111122345678899999999999999999999999998776543

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=7e-44  Score=343.45  Aligned_cols=262  Identities=26%  Similarity=0.402  Sum_probs=211.3

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEEC---------CceEEEEEEcCC-ChHhHHHHHHHHHHHHhc-CCCceeeeEeEEEe
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIG---------QGEIAVKRLLGK-SGQEIKELKNEASVIAQV-QHKNLVKLLGCCIE  175 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~---------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~  175 (432)
                      ..++|++.+.||+|+||.||+|.+.         +..||+|++... .....+.+.+|+++++++ +||||+++++++.+
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  112 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  112 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence            4578999999999999999999874         236999998654 345567899999999999 89999999999999


Q ss_pred             CCeeEEEEecCCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEE
Q 014024          176 KDERLLIYEYMPNKSLDCFLFDPTK-------------REILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNIL  242 (432)
Q Consensus       176 ~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIl  242 (432)
                      .+..++||||+++|+|.+++.....             ...+++..++.++.|++.||+|||+.+   |+||||||+||+
T Consensus       113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl  189 (334)
T 2pvf_A          113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL  189 (334)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred             CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence            9999999999999999999965432             234899999999999999999999999   999999999999


Q ss_pred             EcCCCCEEEeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccc
Q 014024          243 LDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRT  321 (432)
Q Consensus       243 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~  321 (432)
                      ++.++.+||+|||++........    ........+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.....
T Consensus       190 l~~~~~~kL~Dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~  265 (334)
T 2pvf_A          190 VTENNVMKIADFGLARDINNIDY----YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV  265 (334)
T ss_dssp             ECTTCCEEECCCTTCEECTTTSS----EECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             EcCCCCEEEcccccccccccccc----ccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH
Confidence            99999999999999987532111    112233456788999999999999999999999999999999 9999753221


Q ss_pred             cccchhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccccC
Q 014024          322 KSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASS  390 (432)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~  390 (432)
                      ..               ....+........+...+..+.+++..||+.||.+|||+.++++.|+.+...
T Consensus       266 ~~---------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~  319 (334)
T 2pvf_A          266 EE---------------LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL  319 (334)
T ss_dssp             HH---------------HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HH---------------HHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            10               1111111111222334456789999999999999999999999999987643

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=4.3e-44  Score=346.86  Aligned_cols=246  Identities=22%  Similarity=0.266  Sum_probs=203.4

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCC---hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEE
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS---GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLI  182 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  182 (432)
                      .++|++.+.||+|+||.||++.+..  ..||+|++....   ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            4789999999999999999999853  489999985432   12356788999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccC
Q 014024          183 YEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFG  262 (432)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  262 (432)
                      |||+++|+|.+++..   .+.+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++.... 
T Consensus       120 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~-  192 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-  192 (350)
T ss_dssp             EECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECS-
T ss_pred             EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceecc-
Confidence            999999999999953   345999999999999999999999999   9999999999999999999999999998752 


Q ss_pred             CCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhh
Q 014024          263 GNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDL  342 (432)
Q Consensus       263 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                              .......||+.|+|||++.+..++.++|||||||++|||++|+.||......  .    ...        .+
T Consensus       193 --------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~----~~~--------~i  250 (350)
T 1rdq_E          193 --------GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI--Q----IYE--------KI  250 (350)
T ss_dssp             --------SCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--H----HHH--------HH
T ss_pred             --------CCcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH--H----HHH--------HH
Confidence                    1234567999999999999999999999999999999999999998532210  0    000        00


Q ss_pred             hhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHHh
Q 014024          343 IDSVLEEASFNESLSRYVHIALLCVQERAEDRPT-----MSDVVSML  384 (432)
Q Consensus       343 i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt-----~~evl~~L  384 (432)
                      ...  ....+...+..+.+++..||+.||.+||+     ++|++++-
T Consensus       251 ~~~--~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~  295 (350)
T 1rdq_E          251 VSG--KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK  295 (350)
T ss_dssp             HHC--CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSG
T ss_pred             HcC--CCCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCc
Confidence            000  01122334567889999999999999998     89998754

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1e-43  Score=335.32  Aligned_cols=262  Identities=27%  Similarity=0.476  Sum_probs=197.6

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECCceEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEe
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQGEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYE  184 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  184 (432)
                      ..++|++.+.||+|+||.||+|.+.+ .+|+|++...  .....+.+.+|++++++++|+||+++++++ ..+..++|||
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e   99 (289)
T 3og7_A           22 PDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ   99 (289)
T ss_dssp             CTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred             CccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence            46789999999999999999998765 5999988543  455667899999999999999999999965 5567899999


Q ss_pred             cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCC
Q 014024          185 YMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGN  264 (432)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  264 (432)
                      |+++++|.+++...  ...+++..++.++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.......
T Consensus       100 ~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  174 (289)
T 3og7_A          100 WCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS  174 (289)
T ss_dssp             CCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred             ecCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccccc
Confidence            99999999998543  345999999999999999999999999   9999999999999999999999999997642211


Q ss_pred             CccccccccccccccCCccChhhhc---cCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhh
Q 014024          265 DEDELQGNTSRISGTYGYMSPEYAL---EGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIID  341 (432)
Q Consensus       265 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (432)
                      .    ........||+.|+|||.+.   +..++.++||||||+++|+|++|+.||....... ...............  
T Consensus       175 ~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~--  247 (289)
T 3og7_A          175 G----SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-QIIEMVGRGSLSPDL--  247 (289)
T ss_dssp             -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH-HHHHHHHHTSCCCCT--
T ss_pred             c----cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH-HHHHHhcccccCcch--
Confidence            1    12233457899999999986   5678999999999999999999999985432211 000000000000000  


Q ss_pred             hhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccc
Q 014024          342 LIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS  389 (432)
Q Consensus       342 ~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~  389 (432)
                             ......++..+.+++..||+.||++|||+.++++.|+++..
T Consensus       248 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          248 -------SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             -------TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             -------hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence                   01122345778999999999999999999999999998753

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=4e-44  Score=336.49  Aligned_cols=256  Identities=26%  Similarity=0.373  Sum_probs=204.1

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECCc-----eEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQG-----EIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERL  180 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~~-----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  180 (432)
                      ..++|.+.+.||+|+||.||+|.+.+.     .||+|.+... .....+.+.+|+.+++.++||||+++++++.+ +..+
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~   88 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW   88 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence            457899999999999999999986432     4899988654 44566789999999999999999999999865 4568


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceec
Q 014024          181 LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIV  260 (432)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  260 (432)
                      +||||+++++|.+++...  ...+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++...
T Consensus        89 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  163 (281)
T 3cc6_A           89 IIMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI  163 (281)
T ss_dssp             EEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred             EEEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence            999999999999999542  234899999999999999999999999   999999999999999999999999999864


Q ss_pred             cCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccch
Q 014024          261 FGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKI  339 (432)
Q Consensus       261 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  339 (432)
                      ....     ........+++.|+|||++.+..++.++||||||+++|+|++ |+.||.......               .
T Consensus       164 ~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~---------------~  223 (281)
T 3cc6_A          164 EDED-----YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---------------V  223 (281)
T ss_dssp             --------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---------------H
T ss_pred             cccc-----ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH---------------H
Confidence            2211     112233456788999999999999999999999999999998 999985332211               1


Q ss_pred             hhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014024          340 IDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEA  388 (432)
Q Consensus       340 ~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~  388 (432)
                      ...+........+...+..+.+++..||+.||++|||+.|++++|+.+.
T Consensus       224 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~  272 (281)
T 3cc6_A          224 IGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY  272 (281)
T ss_dssp             HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHhcCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence            1111111111122334567889999999999999999999999998754

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-43  Score=335.78  Aligned_cols=262  Identities=23%  Similarity=0.320  Sum_probs=206.9

Q ss_pred             CCCcCceeccCCcEEEEEEEECCc-----eEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCee-EEE
Q 014024          110 NFSAANKLGEGGFGTVYKGVIGQG-----EIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDER-LLI  182 (432)
Q Consensus       110 ~y~~~~~ig~G~~g~Vy~~~~~~~-----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~lv  182 (432)
                      .|.+.++||+|+||.||+|.+.+.     .+|+|.+... .....+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            456679999999999999986322     5899988654 345567899999999999999999999999876655 999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccC
Q 014024          183 YEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFG  262 (432)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  262 (432)
                      |||+.+++|.+++...  ...+++..++.++.|++.||+|||+.+   ++||||||+||++++++.+||+|||++.....
T Consensus       102 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  176 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSP--QRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD  176 (298)
T ss_dssp             ECCCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred             EecccCCCHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence            9999999999999653  345899999999999999999999999   99999999999999999999999999976422


Q ss_pred             CCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhh
Q 014024          263 GNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDL  342 (432)
Q Consensus       263 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                      ..  ...........+++.|+|||.+.+..++.++||||||+++|+|++|..|+..... .             ......
T Consensus       177 ~~--~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~-~-------------~~~~~~  240 (298)
T 3pls_A          177 RE--YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID-P-------------FDLTHF  240 (298)
T ss_dssp             GG--GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-G-------------GGHHHH
T ss_pred             Cc--ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC-H-------------HHHHHH
Confidence            11  1112233445678899999999999999999999999999999996666421111 0             111111


Q ss_pred             hhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccccCCC
Q 014024          343 IDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLL  392 (432)
Q Consensus       343 i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~  392 (432)
                      +........+...+..+.+++..||+.||.+|||+.++++.|+.+...+.
T Consensus       241 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~  290 (298)
T 3pls_A          241 LAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL  290 (298)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred             hhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence            11111122233345678899999999999999999999999998876554

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=6.5e-44  Score=336.00  Aligned_cols=255  Identities=26%  Similarity=0.490  Sum_probs=202.8

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCCChH---h----HHHHHHHHHHHHhcCCCceeeeEeEEEeCC
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGKSGQ---E----IKELKNEASVIAQVQHKNLVKLLGCCIEKD  177 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~~~---~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  177 (432)
                      ..++|++.+.||+|+||.||+|.+.  +..||+|++......   .    .+.+.+|++++++++||||+++++++.+..
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   96 (287)
T 4f0f_A           17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP   96 (287)
T ss_dssp             CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred             hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence            3578999999999999999999985  348999998543221   1    167899999999999999999999986655


Q ss_pred             eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCC-----EEEe
Q 014024          178 ERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN-----SKIS  252 (432)
Q Consensus       178 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~  252 (432)
                        ++||||+++++|.+++...  ...+++..++.++.|++.||+|||+.+ .+|+||||||+||+++.++.     +||+
T Consensus        97 --~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~  171 (287)
T 4f0f_A           97 --RMVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVA  171 (287)
T ss_dssp             --EEEEECCTTCBHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred             --eEEEEecCCCCHHHHHhcc--cCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeC
Confidence              6999999999999888653  335999999999999999999999975 24999999999999988876     9999


Q ss_pred             ecccceeccCCCCccccccccccccccCCccChhhhc--cCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhh
Q 014024          253 DFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL--EGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYA  330 (432)
Q Consensus       253 Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~  330 (432)
                      |||++...         ........||+.|+|||++.  ...++.++||||||+++|+|++|+.||............. 
T Consensus       172 Dfg~~~~~---------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~-  241 (287)
T 4f0f_A          172 DFGLSQQS---------VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINM-  241 (287)
T ss_dssp             CCTTCBCC---------SSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHH-
T ss_pred             CCCccccc---------cccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHH-
Confidence            99999753         11234467899999999984  4568899999999999999999999986443322111111 


Q ss_pred             HHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014024          331 WDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNE  387 (432)
Q Consensus       331 ~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~  387 (432)
                                 ..........+...+..+.+++..||+.||++|||+.++++.|+++
T Consensus       242 -----------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          242 -----------IREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             -----------HHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             -----------HhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence                       1111111222334557789999999999999999999999999863

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.4e-44  Score=343.88  Aligned_cols=257  Identities=26%  Similarity=0.400  Sum_probs=201.5

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECCc------eEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeE
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQG------EIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERL  180 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~~------~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  180 (432)
                      .++|++.+.||+|+||.||+|.+...      ++++|.+... .....+.+.+|+.++++++||||+++++++.+.. .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            57899999999999999999997432      3577777433 3345678899999999999999999999998765 78


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceec
Q 014024          181 LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIV  260 (432)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  260 (432)
                      +|+||+.+|+|.+++....  ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus        93 ~v~~~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~  167 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEECCCSSCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred             EEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence            8999999999999996533  34999999999999999999999999   999999999999999999999999999875


Q ss_pred             cCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccch
Q 014024          261 FGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKI  339 (432)
Q Consensus       261 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  339 (432)
                      .....    ........+|+.|+|||.+.+..++.++|||||||++|+|++ |+.||......               ..
T Consensus       168 ~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---------------~~  228 (327)
T 3lzb_A          168 GAEEK----EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---------------EI  228 (327)
T ss_dssp             ----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---------------GH
T ss_pred             cCccc----cccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH---------------HH
Confidence            22211    112233456788999999999999999999999999999999 99998543221               11


Q ss_pred             hhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccc
Q 014024          340 IDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS  389 (432)
Q Consensus       340 ~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~  389 (432)
                      ...+........+...+..+.+++..||+.||.+|||+.|+++.|+.+..
T Consensus       229 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  278 (327)
T 3lzb_A          229 SSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             HHHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred             HHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            12222222222333455678999999999999999999999999988764

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.4e-44  Score=347.75  Aligned_cols=250  Identities=25%  Similarity=0.336  Sum_probs=201.8

Q ss_pred             hhhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCC---hHhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCee
Q 014024          106 SATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS---GQEIKELKNEASVIAQV-QHKNLVKLLGCCIEKDER  179 (432)
Q Consensus       106 ~~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  179 (432)
                      ...++|++.+.||+|+||.||+|.+..  ..||+|++....   ....+.+..|..++..+ +||||+++++++.+.+..
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~   93 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL   93 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence            456899999999999999999999864  379999985432   22345678899999887 899999999999999999


Q ss_pred             EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeeccccee
Q 014024          180 LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARI  259 (432)
Q Consensus       180 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  259 (432)
                      ++||||+++|+|.+++..   ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        94 ~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~  167 (345)
T 1xjd_A           94 FFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE  167 (345)
T ss_dssp             EEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence            999999999999999953   345999999999999999999999999   99999999999999999999999999975


Q ss_pred             ccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccch
Q 014024          260 VFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKI  339 (432)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  339 (432)
                      ....      .......+||+.|+|||++.+..++.++|+|||||++|||++|+.||.......  .    .......  
T Consensus       168 ~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~----~~~i~~~--  233 (345)
T 1xjd_A          168 NMLG------DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE--L----FHSIRMD--  233 (345)
T ss_dssp             CCCT------TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--H----HHHHHHC--
T ss_pred             cccC------CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH--H----HHHHHhC--
Confidence            3211      123445689999999999999999999999999999999999999985322110  0    0000000  


Q ss_pred             hhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHH-HHHHH
Q 014024          340 IDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMS-DVVSM  383 (432)
Q Consensus       340 ~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~-evl~~  383 (432)
                              ....+......+.+++..||+.||++||++. +++++
T Consensus       234 --------~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h  270 (345)
T 1xjd_A          234 --------NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH  270 (345)
T ss_dssp             --------CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred             --------CCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence                    0111223456788999999999999999998 77653

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.7e-44  Score=338.55  Aligned_cols=253  Identities=28%  Similarity=0.398  Sum_probs=201.1

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECCceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeC-CeeEEEEec
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEK-DERLLIYEY  185 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~  185 (432)
                      ..++|++.+.||+|+||.||+|.+.+..+|+|.+....  ..+.+.+|++++++++||||+++++++.+. +..++||||
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           19 NMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             ChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            35789999999999999999999988899999986543  456789999999999999999999997654 478999999


Q ss_pred             CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCC
Q 014024          186 MPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGND  265 (432)
Q Consensus       186 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  265 (432)
                      +++++|.+++.... ...+++..++.++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++.....   
T Consensus        97 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~---  169 (278)
T 1byg_A           97 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS---  169 (278)
T ss_dssp             CTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             CCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccc---
Confidence            99999999985421 223889999999999999999999999   99999999999999999999999999875411   


Q ss_pred             ccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchhhhhh
Q 014024          266 EDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIIDLID  344 (432)
Q Consensus       266 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  344 (432)
                            ......+++.|+|||.+.+..++.++||||||+++|+|+| |+.||.......               ....+.
T Consensus       170 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---------------~~~~~~  228 (278)
T 1byg_A          170 ------TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---------------VVPRVE  228 (278)
T ss_dssp             ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---------------HHHHHT
T ss_pred             ------cccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---------------HHHHHh
Confidence                  1223457889999999999999999999999999999998 999985432211               111111


Q ss_pred             hhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccc
Q 014024          345 SVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS  389 (432)
Q Consensus       345 ~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~  389 (432)
                      .......+...+..+.+++..||+.||++|||+.++++.|+.+..
T Consensus       229 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~  273 (278)
T 1byg_A          229 KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  273 (278)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence            111122233456778999999999999999999999999988654

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=7.3e-44  Score=336.08  Aligned_cols=261  Identities=22%  Similarity=0.291  Sum_probs=196.9

Q ss_pred             CCCCcCceeccCCcEEEEEEEECCc-eEEEEEEcCCCh--HhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEec
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKSG--QEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEY  185 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~~-~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  185 (432)
                      ++|++.+.||+|+||.||+|.+..+ .+|+|++.....  ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            5799999999999999999998644 899999865432  2346788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCC
Q 014024          186 MPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGND  265 (432)
Q Consensus       186 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  265 (432)
                      +++ +|.+++...  ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++......  
T Consensus        82 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  153 (288)
T 1ob3_A           82 LDQ-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP--  153 (288)
T ss_dssp             CSE-EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             cCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcc--
Confidence            975 888888543  244899999999999999999999998   999999999999999999999999999764211  


Q ss_pred             ccccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhh---ccchhh
Q 014024          266 EDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWI---SNKIID  341 (432)
Q Consensus       266 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~  341 (432)
                          ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......  ..........   ......
T Consensus       154 ----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~  227 (288)
T 1ob3_A          154 ----VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD--QLMRIFRILGTPNSKNWPN  227 (288)
T ss_dssp             ------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCTTTSTT
T ss_pred             ----ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHHCCCChhhchh
Confidence                112234578999999999876 458999999999999999999999986433211  0000000000   000000


Q ss_pred             -----hhhhhh-------hhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          342 -----LIDSVL-------EEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       342 -----~i~~~l-------~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                           ..++..       ........+..+.+++.+||+.||++|||++|++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  281 (288)
T 1ob3_A          228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (288)
T ss_dssp             GGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence                 000000       001112235678899999999999999999999875

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1e-43  Score=341.31  Aligned_cols=249  Identities=23%  Similarity=0.282  Sum_probs=193.9

Q ss_pred             hCCCCcCceeccCCcEEEEEEEEC-----CceEEEEEEcCCC----hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCe
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIG-----QGEIAVKRLLGKS----GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDE  178 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~-----~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  178 (432)
                      .++|++.+.||+|+||.||++...     +..+|+|++....    ......+.+|+.+++.++||||+++++++.+.+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            468999999999999999999973     3489999986542    2344567889999999999999999999999999


Q ss_pred             eEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccce
Q 014024          179 RLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMAR  258 (432)
Q Consensus       179 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  258 (432)
                      .++||||+++++|.+++..   .+.+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.
T Consensus        96 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  169 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK  169 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred             EEEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence            9999999999999999853   345899999999999999999999999   9999999999999999999999999997


Q ss_pred             eccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccc
Q 014024          259 IVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNK  338 (432)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  338 (432)
                      .....      ........||+.|+|||++.+..++.++||||||+++|+|++|+.||.......  .            
T Consensus       170 ~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~------------  229 (327)
T 3a62_A          170 ESIHD------GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK--T------------  229 (327)
T ss_dssp             ---------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--H------------
T ss_pred             ccccC------CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH--H------------
Confidence            53211      112334679999999999999999999999999999999999999985322110  0            


Q ss_pred             hhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHHh
Q 014024          339 IIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRP-----TMSDVVSML  384 (432)
Q Consensus       339 ~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~~L  384 (432)
                      ...+...  ....+......+.+++.+||+.||++||     ++.|++++-
T Consensus       230 ~~~i~~~--~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp  278 (327)
T 3a62_A          230 IDKILKC--KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHP  278 (327)
T ss_dssp             HHHHHHT--CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSG
T ss_pred             HHHHHhC--CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCC
Confidence            0001110  0112233456788999999999999999     788888753

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=9.4e-44  Score=333.17  Aligned_cols=252  Identities=19%  Similarity=0.281  Sum_probs=203.2

Q ss_pred             hhhCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEE
Q 014024          106 SATGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       106 ~~~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  183 (432)
                      ...++|++.+.||+|+||.||+|.+.+.  .+|+|++........+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (277)
T 3f3z_A            6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM   85 (277)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence            3467899999999999999999998665  78999987655556678999999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEE---cCCCCEEEeecccceec
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILL---DKDMNSKISDFGMARIV  260 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~  260 (432)
                      ||+++++|.+++..   +..+++..++.++.|++.||+|||+.+   ++||||||+||++   +.++.+||+|||++...
T Consensus        86 e~~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~  159 (277)
T 3f3z_A           86 ELCTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF  159 (277)
T ss_dssp             ECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             eccCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence            99999999998853   345999999999999999999999999   9999999999999   88899999999999875


Q ss_pred             cCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchh
Q 014024          261 FGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKII  340 (432)
Q Consensus       261 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                      ...       .......||+.|+|||.+.+ .++.++||||||+++|+|++|+.||.......  ..    ........ 
T Consensus       160 ~~~-------~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~----~~~~~~~~-  224 (277)
T 3f3z_A          160 KPG-------KMMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSE--VM----LKIREGTF-  224 (277)
T ss_dssp             CTT-------SCBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HH----HHHHHCCC-
T ss_pred             cCc-------cchhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHH--HH----HHHHhCCC-
Confidence            221       12334578999999998865 49999999999999999999999985432110  00    00000000 


Q ss_pred             hhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          341 DLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       341 ~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      ....     ......+..+.+++..||+.||++|||+.+++++
T Consensus       225 ~~~~-----~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  262 (277)
T 3f3z_A          225 TFPE-----KDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH  262 (277)
T ss_dssp             CCCH-----HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             CCCc-----hhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0000     0001234678899999999999999999999874

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.2e-43  Score=343.99  Aligned_cols=253  Identities=22%  Similarity=0.300  Sum_probs=189.8

Q ss_pred             hhhhCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEE
Q 014024          105 SSATGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLI  182 (432)
Q Consensus       105 ~~~~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  182 (432)
                      ....++|++.+.||+|+||.||+|.+.+.  .||+|++....  ..+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  126 (349)
T 2w4o_A           49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV  126 (349)
T ss_dssp             SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence            34567899999999999999999998653  79999986543  345688999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcC---CCCEEEeeccccee
Q 014024          183 YEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDK---DMNSKISDFGMARI  259 (432)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg~a~~  259 (432)
                      |||+++++|.+++..   ++.+++..++.++.|++.||.|||+.+   |+||||||+|||++.   ++.+||+|||++..
T Consensus       127 ~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~  200 (349)
T 2w4o_A          127 LELVTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKI  200 (349)
T ss_dssp             ECCCCSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred             EEeCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence            999999999999953   345999999999999999999999998   999999999999975   88999999999986


Q ss_pred             ccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccch
Q 014024          260 VFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKI  339 (432)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  339 (432)
                      ...       ........||+.|+|||++.+..++.++|||||||++|||++|+.||........     ..........
T Consensus       201 ~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-----~~~~i~~~~~  268 (349)
T 2w4o_A          201 VEH-------QVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF-----MFRRILNCEY  268 (349)
T ss_dssp             -------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH-----HHHHHHTTCC
T ss_pred             cCc-------ccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH-----HHHHHHhCCC
Confidence            421       1122346789999999999999999999999999999999999999853322110     0000000000


Q ss_pred             hhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          340 IDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       340 ~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                       ..     ........+..+.+++.+||+.||++|||+.|++++
T Consensus       269 -~~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  306 (349)
T 2w4o_A          269 -YF-----ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH  306 (349)
T ss_dssp             -CC-----CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -cc-----CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             00     001112345678899999999999999999999985

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.5e-44  Score=356.63  Aligned_cols=260  Identities=18%  Similarity=0.216  Sum_probs=205.9

Q ss_pred             hhhHhhhhCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCCCh---HhHHHHHHHHHHHHhcCCCceeeeEeEEEe
Q 014024          101 FSSVSSATGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSG---QEIKELKNEASVIAQVQHKNLVKLLGCCIE  175 (432)
Q Consensus       101 ~~~~~~~~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  175 (432)
                      +.+.....++|++.++||+|+||.||+|.+..+  .+|+|++.....   ...+.+.+|..++..++||||++++++|.+
T Consensus        66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  145 (437)
T 4aw2_A           66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD  145 (437)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            445556678999999999999999999998653  799999854211   122347889999999999999999999999


Q ss_pred             CCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecc
Q 014024          176 KDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFG  255 (432)
Q Consensus       176 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  255 (432)
                      .+..++||||+++|+|.+++...  ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus       146 ~~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFG  220 (437)
T 4aw2_A          146 DNNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFG  220 (437)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CCEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchh
Confidence            99999999999999999999653  344999999999999999999999999   9999999999999999999999999


Q ss_pred             cceeccCCCCccccccccccccccCCccChhhhc-----cCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhh
Q 014024          256 MARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYA  330 (432)
Q Consensus       256 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~  330 (432)
                      +++......     .......+||+.|+|||++.     .+.++.++|||||||++|||++|+.||.......       
T Consensus       221 la~~~~~~~-----~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~-------  288 (437)
T 4aw2_A          221 SCLKLMEDG-----TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE-------  288 (437)
T ss_dssp             TCEECCTTS-----CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------
T ss_pred             hhhhcccCC-----CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH-------
Confidence            998652211     11233468999999999987     5678999999999999999999999985322110       


Q ss_pred             HHhhhccchhhhhhhhhhhccc---HHHHHHHHHHHHHhhccCCCC--CCCHHHHHHHh
Q 014024          331 WDLWISNKIIDLIDSVLEEASF---NESLSRYVHIALLCVQERAED--RPTMSDVVSML  384 (432)
Q Consensus       331 ~~~~~~~~~~~~i~~~l~~~~~---~~~~~~l~~l~~~cl~~dp~~--RPt~~evl~~L  384 (432)
                             ....++........+   ......+.+|+.+||..+|++  ||+++|++++-
T Consensus       289 -------~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hp  340 (437)
T 4aw2_A          289 -------TYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHP  340 (437)
T ss_dssp             -------HHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSG
T ss_pred             -------HHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCC
Confidence                   001111111001111   124567889999999888888  99999999853

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2.9e-44  Score=367.20  Aligned_cols=265  Identities=28%  Similarity=0.437  Sum_probs=213.8

Q ss_pred             hhhhCCCCcCceeccCCcEEEEEEEECCc-eEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEE
Q 014024          105 SSATGNFSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       105 ~~~~~~y~~~~~ig~G~~g~Vy~~~~~~~-~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  183 (432)
                      ....++|++.+.||+|+||.||+|.+.++ .||||++.... ...+.+.+|+++|++++|+||+++++++.+ +..++||
T Consensus       263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~  340 (535)
T 2h8h_A          263 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT  340 (535)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             ecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEee
Confidence            34467889999999999999999999775 79999986543 235679999999999999999999999876 6789999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCC
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGG  263 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  263 (432)
                      ||+++|+|.+++... ....+++..++.++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++.....
T Consensus       341 e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  416 (535)
T 2h8h_A          341 EYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN  416 (535)
T ss_dssp             CCCTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred             ehhcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence            999999999999532 1234899999999999999999999999   999999999999999999999999999764210


Q ss_pred             CCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchhhh
Q 014024          264 NDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIIDL  342 (432)
Q Consensus       264 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                           .........++..|+|||++.++.++.++|||||||++|||++ |+.||......               ...+.
T Consensus       417 -----~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~---------------~~~~~  476 (535)
T 2h8h_A          417 -----EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---------------EVLDQ  476 (535)
T ss_dssp             -----HHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH---------------HHHHH
T ss_pred             -----ceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---------------HHHHH
Confidence                 0111223456778999999999999999999999999999999 89897532211               11111


Q ss_pred             hhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccccCCCCCC
Q 014024          343 IDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPK  395 (432)
Q Consensus       343 i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~~~~  395 (432)
                      +....+...+..++..+.+++..||+.||++|||+.+|++.|+.+.....+..
T Consensus       477 i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~  529 (535)
T 2h8h_A          477 VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY  529 (535)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSCSS
T ss_pred             HHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCccc
Confidence            11222222344556788999999999999999999999999999877655544

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=9.8e-44  Score=347.81  Aligned_cols=247  Identities=22%  Similarity=0.330  Sum_probs=202.1

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCCC---hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEE
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKS---GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLI  182 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  182 (432)
                      .++|++.+.||+|+||.||++.+...  .+|+|.+....   ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            47899999999999999999998654  79999885432   22356788999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccC
Q 014024          183 YEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFG  262 (432)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  262 (432)
                      |||+.+|+|.+++..   +..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus        94 ~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  167 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR  167 (384)
T ss_dssp             ECCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence            999999999999954   345999999999999999999999999   99999999999999999999999999987522


Q ss_pred             CCCccccccccccccccCCccChhhhcc---CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccch
Q 014024          263 GNDEDELQGNTSRISGTYGYMSPEYALE---GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKI  339 (432)
Q Consensus       263 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  339 (432)
                             ........||+.|+|||++.+   ..++.++|||||||++|+|++|+.||........               
T Consensus       168 -------~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~---------------  225 (384)
T 4fr4_A          168 -------ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS---------------  225 (384)
T ss_dssp             -------TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCH---------------
T ss_pred             -------CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccH---------------
Confidence                   123345679999999999874   4589999999999999999999999854322111               


Q ss_pred             hhhhhhh--hhhcccHHHHHHHHHHHHHhhccCCCCCCC-HHHHHH
Q 014024          340 IDLIDSV--LEEASFNESLSRYVHIALLCVQERAEDRPT-MSDVVS  382 (432)
Q Consensus       340 ~~~i~~~--l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt-~~evl~  382 (432)
                      ..+....  .....+......+.+++..||+.||.+||+ ++++++
T Consensus       226 ~~~~~~~~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          226 KEIVHTFETTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             HHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             HHHHHHHhhcccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence            0111100  011123344567899999999999999998 777775

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.2e-43  Score=340.76  Aligned_cols=259  Identities=27%  Similarity=0.396  Sum_probs=205.0

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECCc----eEEEEEEcCC-ChHhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeeEE
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQG----EIAVKRLLGK-SGQEIKELKNEASVIAQV-QHKNLVKLLGCCIEKDERLL  181 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l  181 (432)
                      .++|++.+.||+|+||.||+|.+...    .+++|.+... .....+.+.+|+++++++ +||||+++++++.+.+..++
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l  103 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL  103 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence            36899999999999999999987433    3588888643 334556789999999999 89999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCC
Q 014024          182 IYEYMPNKSLDCFLFDPT-------------KREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN  248 (432)
Q Consensus       182 v~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~  248 (432)
                      ||||+++++|.+++....             ....+++..++.++.|++.||+|||+.+   |+||||||+||+++.++.
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~  180 (327)
T 1fvr_A          104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV  180 (327)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred             EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCe
Confidence            999999999999996542             2346999999999999999999999999   999999999999999999


Q ss_pred             EEEeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchh
Q 014024          249 SKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLI  327 (432)
Q Consensus       249 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~  327 (432)
                      +||+|||++....       .........+++.|+|||++.+..++.++||||||+++|+|++ |+.||.......    
T Consensus       181 ~kL~Dfg~~~~~~-------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~----  249 (327)
T 1fvr_A          181 AKIADFGLSRGQE-------VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE----  249 (327)
T ss_dssp             EEECCTTCEESSC-------EECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH----
T ss_pred             EEEcccCcCcccc-------ccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH----
Confidence            9999999987421       1112233456889999999998899999999999999999998 999985332110    


Q ss_pred             hhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccccCC
Q 014024          328 GYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSL  391 (432)
Q Consensus       328 ~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~  391 (432)
                                 ....+........+...+..+.+++.+||+.||++|||+.+++++|+.+....
T Consensus       250 -----------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  302 (327)
T 1fvr_A          250 -----------LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  302 (327)
T ss_dssp             -----------HHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             -----------HHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence                       00111111111222344567899999999999999999999999999876543

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=6.3e-44  Score=347.44  Aligned_cols=254  Identities=19%  Similarity=0.221  Sum_probs=193.3

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEe
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYE  184 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  184 (432)
                      ..++|++.+.||+|+||.||++.+..  ..||+|++..... ..+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e   96 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME   96 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence            46789999999999999999999863  4899999865432 23568899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCC--EEEeecccceeccC
Q 014024          185 YMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN--SKISDFGMARIVFG  262 (432)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~~  262 (432)
                      |+++|+|.+++..   .+.+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.  +||+|||+++....
T Consensus        97 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~  170 (361)
T 3uc3_A           97 YASGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  170 (361)
T ss_dssp             CCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred             eCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence            9999999999853   345999999999999999999999999   999999999999987766  99999999974311


Q ss_pred             CCCccccccccccccccCCccChhhhccCCCCch-hhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhh
Q 014024          263 GNDEDELQGNTSRISGTYGYMSPEYALEGIFSIK-SDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIID  341 (432)
Q Consensus       263 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~-~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (432)
                             ........||+.|+|||++.+..++.+ +|||||||++|+|++|+.||........ .....         ..
T Consensus       171 -------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-~~~~~---------~~  233 (361)
T 3uc3_A          171 -------HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD-YRKTI---------QR  233 (361)
T ss_dssp             -----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC-HHHHH---------HH
T ss_pred             -------cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH-HHHHH---------HH
Confidence                   122344579999999999988887655 9999999999999999999864322110 00000         00


Q ss_pred             hhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          342 LIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       342 ~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                      +................+.+++.+||+.||++|||+.|++++-
T Consensus       234 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp  276 (361)
T 3uc3_A          234 ILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHS  276 (361)
T ss_dssp             HHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSH
T ss_pred             HhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCc
Confidence            1110000011112346788999999999999999999999863

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=6.4e-44  Score=340.92  Aligned_cols=269  Identities=22%  Similarity=0.265  Sum_probs=207.8

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEe----CCeeE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIE----KDERL  180 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~  180 (432)
                      ..++|++.+.||+|+||.||++.+.  +..||+|++........+.+.+|+++++.++||||+++++++..    ....+
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  106 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW  106 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence            4578999999999999999999974  34899999877777778889999999999999999999999873    34678


Q ss_pred             EEEecCCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeeccccee
Q 014024          181 LIYEYMPNKSLDCFLFDP-TKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARI  259 (432)
Q Consensus       181 lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  259 (432)
                      +||||+++++|.+++... .....+++..++.++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++..
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~  183 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQ  183 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence            999999999999988542 12355999999999999999999999998   99999999999999999999999999876


Q ss_pred             ccCCCCccc---cccccccccccCCccChhhhccCC---CCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHh
Q 014024          260 VFGGNDEDE---LQGNTSRISGTYGYMSPEYALEGI---FSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDL  333 (432)
Q Consensus       260 ~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~---~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~  333 (432)
                      .........   .........||+.|+|||++.+..   ++.++||||||+++|+|++|+.||.......          
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----------  253 (317)
T 2buj_A          184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG----------  253 (317)
T ss_dssp             SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT----------
T ss_pred             cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc----------
Confidence            421100000   001112345799999999987554   7899999999999999999999974221111          


Q ss_pred             hhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccccCC
Q 014024          334 WISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSL  391 (432)
Q Consensus       334 ~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~  391 (432)
                         ......+............+..+.+++..||+.||.+|||+.+++++|+.+....
T Consensus       254 ---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~  308 (317)
T 2buj_A          254 ---DSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPA  308 (317)
T ss_dssp             ---SCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCC
T ss_pred             ---chhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCC
Confidence               1111111111111222334567899999999999999999999999999876543

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=5.1e-44  Score=344.39  Aligned_cols=275  Identities=23%  Similarity=0.326  Sum_probs=199.3

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECCceEEEEEEcCCChHhHHHHHHHHHH--HHhcCCCceeeeEeEEEe-----CCee
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASV--IAQVQHKNLVKLLGCCIE-----KDER  179 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~~~~~~~~-----~~~~  179 (432)
                      ..++|++.+.||+|+||.||+|...+..||+|++....   .+.+..|.++  +..++|+||+++++.+..     ....
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           11 DLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             ChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            45789999999999999999999988899999986443   2334444444  445899999999986543     2356


Q ss_pred             EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc---------CCCCeEeccCCCCCEEEcCCCCEE
Q 014024          180 LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQY---------SRVRIIHRDLKASNILLDKDMNSK  250 (432)
Q Consensus       180 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---------~~~~ivH~Dlkp~NIll~~~~~~k  250 (432)
                      ++||||+++|+|.+++..    ...++..++.++.|++.||+|||+.         +   |+||||||+|||++.++.+|
T Consensus        88 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~k  160 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCV  160 (336)
T ss_dssp             EEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEE
T ss_pred             EEEEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEE
Confidence            899999999999999943    2358999999999999999999998         7   99999999999999999999


Q ss_pred             EeecccceeccCCCCcc--ccccccccccccCCccChhhhcc-------CCCCchhhhHHHHHHHHHHHhCCCCCCCccc
Q 014024          251 ISDFGMARIVFGGNDED--ELQGNTSRISGTYGYMSPEYALE-------GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRT  321 (432)
Q Consensus       251 l~Dfg~a~~~~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~-------~~~t~~~DvwSlG~il~elltg~~p~~~~~~  321 (432)
                      |+|||++..+.......  ..........||+.|+|||++.+       ..++.++|||||||++|||++|..|+.....
T Consensus       161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~  240 (336)
T 3g2f_A          161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES  240 (336)
T ss_dssp             ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred             EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence            99999998753221110  11122334579999999999986       4567899999999999999999877633222


Q ss_pred             cccchhhhhHHhhhccc---hhhhhh-hhhhhc------ccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccccCC
Q 014024          322 KSLNLIGYAWDLWISNK---IIDLID-SVLEEA------SFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSL  391 (432)
Q Consensus       322 ~~~~~~~~~~~~~~~~~---~~~~i~-~~l~~~------~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~  391 (432)
                      .......+.........   ....+. ...+..      .....+..+.+++.+||+.||++|||++|+++.|+.+....
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~  320 (336)
T 3g2f_A          241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIW  320 (336)
T ss_dssp             CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCC
T ss_pred             hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHH
Confidence            11100000000000000   000000 000111      12235678999999999999999999999999999977654

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=7.3e-44  Score=340.13  Aligned_cols=268  Identities=28%  Similarity=0.398  Sum_probs=212.2

Q ss_pred             hhhHhhhhCCCCcCceeccCCcEEEEEEEEC-------CceEEEEEEcCC-ChHhHHHHHHHHHHHHhc-CCCceeeeEe
Q 014024          101 FSSVSSATGNFSAANKLGEGGFGTVYKGVIG-------QGEIAVKRLLGK-SGQEIKELKNEASVIAQV-QHKNLVKLLG  171 (432)
Q Consensus       101 ~~~~~~~~~~y~~~~~ig~G~~g~Vy~~~~~-------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~  171 (432)
                      ..+.....++|++.+.||+|+||.||+|.+.       +..||+|.+... .....+.+.+|+.+++++ +||||+++++
T Consensus        19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~   98 (316)
T 2xir_A           19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG   98 (316)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence            3444556789999999999999999999852       237999998654 344566789999999999 7899999999


Q ss_pred             EEEeCC-eeEEEEecCCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCC
Q 014024          172 CCIEKD-ERLLIYEYMPNKSLDCFLFDPTK-------------REILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLK  237 (432)
Q Consensus       172 ~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlk  237 (432)
                      ++.+.+ ..++||||+++++|.+++.....             +..+++..++.++.|++.||.|||+.+   |+|||||
T Consensus        99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dik  175 (316)
T 2xir_A           99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLA  175 (316)
T ss_dssp             EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred             EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCc
Confidence            987765 48999999999999999965432             223889999999999999999999998   9999999


Q ss_pred             CCCEEEcCCCCEEEeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCC
Q 014024          238 ASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNT  316 (432)
Q Consensus       238 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~  316 (432)
                      |+||+++.++.+||+|||++........    ........||+.|+|||++.+..++.++||||||+++|+|+| |..||
T Consensus       176 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~  251 (316)
T 2xir_A          176 ARNILLSEKNVVKICDFGLARDIYKDPD----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY  251 (316)
T ss_dssp             GGGEEECGGGCEEECCCGGGSCTTTCTT----SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             cceEEECCCCCEEECCCccccccccCcc----ceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCC
Confidence            9999999999999999999986532211    112334567889999999999999999999999999999998 99998


Q ss_pred             CCccccccchhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccc
Q 014024          317 GFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS  389 (432)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~  389 (432)
                      .......              .....+........+...+..+.+++..||+.||.+|||+.+++++|+.+..
T Consensus       252 ~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  310 (316)
T 2xir_A          252 PGVKIDE--------------EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  310 (316)
T ss_dssp             TTCCCSH--------------HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cccchhH--------------HHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            5432211              0011111111111223345678899999999999999999999999988653

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=9e-44  Score=344.81  Aligned_cols=249  Identities=24%  Similarity=0.295  Sum_probs=202.0

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCCC---hHhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeeE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKS---GQEIKELKNEASVIAQV-QHKNLVKLLGCCIEKDERL  180 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  180 (432)
                      ..++|++.+.||+|+||.||+|.+...  .||+|++....   ....+.+..|.+++..+ +||||+++++++.+.+..|
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            457899999999999999999998754  79999985431   23346678899999988 7999999999999999999


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceec
Q 014024          181 LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIV  260 (432)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  260 (432)
                      +||||+++|+|.+++..   .+.+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus        98 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  171 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN  171 (353)
T ss_dssp             EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence            99999999999999953   345999999999999999999999999   999999999999999999999999999753


Q ss_pred             cCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchh
Q 014024          261 FGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKII  340 (432)
Q Consensus       261 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                      ...      .......+||+.|+|||++.+..++.++|+|||||++|||++|+.||......  ..    .        .
T Consensus       172 ~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--~~----~--------~  231 (353)
T 2i0e_A          172 IWD------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--EL----F--------Q  231 (353)
T ss_dssp             CCT------TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HH----H--------H
T ss_pred             ccC------CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH--HH----H--------H
Confidence            211      12344568999999999999999999999999999999999999998532210  00    0        0


Q ss_pred             hhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 014024          341 DLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPT-----MSDVVSM  383 (432)
Q Consensus       341 ~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt-----~~evl~~  383 (432)
                      .+....  ...+...+.++.+++..||+.||++||+     +.+++++
T Consensus       232 ~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h  277 (353)
T 2i0e_A          232 SIMEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  277 (353)
T ss_dssp             HHHHCC--CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred             HHHhCC--CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            011110  1122334567889999999999999995     5788765

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.7e-43  Score=335.67  Aligned_cols=264  Identities=24%  Similarity=0.294  Sum_probs=197.7

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCC--hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEE
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS--GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  183 (432)
                      .++|++.+.||+|+||.||+|.+..  ..+|+|++....  ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF   81 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence            3689999999999999999999864  489999885443  344567889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCC
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGG  263 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  263 (432)
                      ||+++++|.+++..   ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++......
T Consensus        82 e~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  155 (311)
T 4agu_A           82 EYCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGP  155 (311)
T ss_dssp             ECCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EeCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence            99999999998843   344999999999999999999999999   999999999999999999999999999875221


Q ss_pred             CCccccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccc-hhhhh--------HHh
Q 014024          264 NDEDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLN-LIGYA--------WDL  333 (432)
Q Consensus       264 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~-~~~~~--------~~~  333 (432)
                            ........||+.|+|||++.+ ..++.++||||||+++|+|++|+.||......... .....        ...
T Consensus       156 ------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (311)
T 4agu_A          156 ------SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQV  229 (311)
T ss_dssp             ----------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred             ------ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccc
Confidence                  112334578999999999876 66899999999999999999999998654321110 00000        000


Q ss_pred             hhccchhh---hhhhh---hhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          334 WISNKIID---LIDSV---LEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       334 ~~~~~~~~---~i~~~---l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      ........   ..++.   .........+..+.+++..||+.||++|||++|++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          230 FSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             HHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             cccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            00000000   00000   0000011234568899999999999999999999985

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=8.5e-44  Score=336.07  Aligned_cols=259  Identities=27%  Similarity=0.387  Sum_probs=205.1

Q ss_pred             hhCCCCcCc-eeccCCcEEEEEEEEC----CceEEEEEEcCCC--hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCee
Q 014024          107 ATGNFSAAN-KLGEGGFGTVYKGVIG----QGEIAVKRLLGKS--GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDER  179 (432)
Q Consensus       107 ~~~~y~~~~-~ig~G~~g~Vy~~~~~----~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  179 (432)
                      ..++|.+.+ .||+|+||.||+|.+.    +..+|+|++....  ....+.+.+|+++++.++||||+++++++ +.+..
T Consensus        14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~   92 (291)
T 1xbb_A           14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW   92 (291)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred             cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence            456788888 9999999999999652    2379999986542  33467899999999999999999999999 66778


Q ss_pred             EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeeccccee
Q 014024          180 LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARI  259 (432)
Q Consensus       180 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  259 (432)
                      ++||||+++++|.+++..   +..+++..++.++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++..
T Consensus        93 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  166 (291)
T 1xbb_A           93 MLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKA  166 (291)
T ss_dssp             EEEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCccee
Confidence            999999999999999954   344999999999999999999999999   99999999999999999999999999987


Q ss_pred             ccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccc
Q 014024          260 VFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNK  338 (432)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  338 (432)
                      .......   ........+++.|+|||.+.+..++.++||||||+++|+|++ |+.||.......               
T Consensus       167 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---------------  228 (291)
T 1xbb_A          167 LRADENY---YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---------------  228 (291)
T ss_dssp             CCTTCSE---EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---------------
T ss_pred             eccCCCc---ccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---------------
Confidence            5322111   112223456788999999999899999999999999999999 999985432210               


Q ss_pred             hhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccccC
Q 014024          339 IIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASS  390 (432)
Q Consensus       339 ~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~  390 (432)
                      ....+........+...+..+.+++..||+.||++||++.++++.|++....
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  280 (291)
T 1xbb_A          229 VTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  280 (291)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            1111111111222344567889999999999999999999999999886543

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=3e-44  Score=345.86  Aligned_cols=249  Identities=22%  Similarity=0.327  Sum_probs=200.4

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCCC---hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGKS---GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLL  181 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  181 (432)
                      ..++|.+.+.||+|+||.||+|.+.  +..||+|++....   ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus         7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l   86 (336)
T 3h4j_B            7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM   86 (336)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            3578999999999999999999984  3489999985431   1223568899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceecc
Q 014024          182 IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVF  261 (432)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  261 (432)
                      ||||+ +|+|.+++..   ++.+++..++.++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||++....
T Consensus        87 v~E~~-~g~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~  159 (336)
T 3h4j_B           87 VIEYA-GGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMT  159 (336)
T ss_dssp             EECCC-CEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred             EEECC-CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence            99999 7888888843   345999999999999999999999999   9999999999999999999999999997642


Q ss_pred             CCCCccccccccccccccCCccChhhhccCCC-CchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchh
Q 014024          262 GGNDEDELQGNTSRISGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKII  340 (432)
Q Consensus       262 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                      .+       .......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||........  .         ..  
T Consensus       160 ~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~--~---------~~--  219 (336)
T 3h4j_B          160 DG-------NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL--F---------KK--  219 (336)
T ss_dssp             TS-------BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC--B---------CC--
T ss_pred             CC-------cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH--H---------HH--
Confidence            21       12344579999999999988776 7899999999999999999999854322110  0         00  


Q ss_pred             hhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014024          341 DLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLT  385 (432)
Q Consensus       341 ~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~  385 (432)
                        +... ....+...+..+.+++.+||+.||.+|||++|++++-.
T Consensus       220 --i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~  261 (336)
T 3h4j_B          220 --VNSC-VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPW  261 (336)
T ss_dssp             --CCSS-CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHH
T ss_pred             --HHcC-CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChh
Confidence              0000 00112223456789999999999999999999998543

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.2e-44  Score=345.17  Aligned_cols=254  Identities=22%  Similarity=0.311  Sum_probs=198.3

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECCc-eEEEEEEcCC--ChHhHHHHHHHHHHHHhcCC--CceeeeEeEEEeCCeeEE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGK--SGQEIKELKNEASVIAQVQH--KNLVKLLGCCIEKDERLL  181 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~~-~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~l  181 (432)
                      ..++|++.+.||+|+||.||++.+.++ .||+|++...  .....+.+.+|+.++++++|  +||+++++++.+.+..++
T Consensus         7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l   86 (343)
T 3dbq_A            7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM   86 (343)
T ss_dssp             SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence            457799999999999999999998655 7999988543  45556789999999999986  999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceecc
Q 014024          182 IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVF  261 (432)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  261 (432)
                      ||| +.+++|.+++..   +..+++..+..++.|++.||+|||+.+   |+||||||+|||++ ++.+||+|||++....
T Consensus        87 v~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~  158 (343)
T 3dbq_A           87 VME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ  158 (343)
T ss_dssp             EEC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred             EEe-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccC
Confidence            999 568899999954   345999999999999999999999999   99999999999997 6789999999998652


Q ss_pred             CCCCccccccccccccccCCccChhhhcc-----------CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhh
Q 014024          262 GGNDEDELQGNTSRISGTYGYMSPEYALE-----------GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYA  330 (432)
Q Consensus       262 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~  330 (432)
                      ...    .........||+.|+|||++.+           ..++.++|||||||++|+|++|+.||.......       
T Consensus       159 ~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-------  227 (343)
T 3dbq_A          159 PDT----TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-------  227 (343)
T ss_dssp             ---------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-------
T ss_pred             ccc----ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH-------
Confidence            211    1112334679999999999865           678999999999999999999999985322110       


Q ss_pred             HHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014024          331 WDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLT  385 (432)
Q Consensus       331 ~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~  385 (432)
                            ......++.......+......+.+++..||+.||.+|||+.|++++..
T Consensus       228 ------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~  276 (343)
T 3dbq_A          228 ------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY  276 (343)
T ss_dssp             ------HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred             ------HHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcc
Confidence                  0111122222222222333457889999999999999999999998643

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.1e-43  Score=333.66  Aligned_cols=250  Identities=24%  Similarity=0.376  Sum_probs=203.1

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEe---------
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIE---------  175 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---------  175 (432)
                      ..++|++.+.||+|+||.||+|.+.  +..+|+|.+....    +.+.+|++++++++||||+++++++..         
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            4568999999999999999999986  4489999986554    346789999999999999999999864         


Q ss_pred             -------CCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCC
Q 014024          176 -------KDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN  248 (432)
Q Consensus       176 -------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~  248 (432)
                             ....++||||+++++|.+++.... ...+++..++.++.|++.||.|||+.+   |+||||||+||++++++.
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~  160 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ  160 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence                   345799999999999999996432 245999999999999999999999998   999999999999999999


Q ss_pred             EEEeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhh
Q 014024          249 SKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIG  328 (432)
Q Consensus       249 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~  328 (432)
                      +||+|||++......       .......||+.|+|||.+.+..++.++||||||+++|+|++|..|+...         
T Consensus       161 ~kl~Dfg~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---------  224 (284)
T 2a19_B          161 VKIGDFGLVTSLKND-------GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET---------  224 (284)
T ss_dssp             EEECCCTTCEESSCC-------SCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH---------
T ss_pred             EEECcchhheecccc-------ccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH---------
Confidence            999999999875221       1223456899999999999999999999999999999999999884210         


Q ss_pred             hhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccccCC
Q 014024          329 YAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSL  391 (432)
Q Consensus       329 ~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~  391 (432)
                                 ............+...+..+.+++..||+.||++|||+.|++++|+......
T Consensus       225 -----------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~  276 (284)
T 2a19_B          225 -----------SKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP  276 (284)
T ss_dssp             -----------HHHHHHHHTTCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred             -----------HHHHHHhhcccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence                       0001111111112233456789999999999999999999999999876543

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=3.5e-43  Score=340.19  Aligned_cols=269  Identities=17%  Similarity=0.221  Sum_probs=199.7

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC-----ceEEEEEEcCCChHh-----------HHHHHHHHHHHHhcCCCceeeeEe
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ-----GEIAVKRLLGKSGQE-----------IKELKNEASVIAQVQHKNLVKLLG  171 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~-----~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~~~~  171 (432)
                      .++|++.+.||+|+||.||+|.+..     ..+|+|+........           ...+.+|+..++.++|+||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            4789999999999999999999854     379999886553221           123567888999999999999999


Q ss_pred             EEEe----CCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCC
Q 014024          172 CCIE----KDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDM  247 (432)
Q Consensus       172 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~  247 (432)
                      ++.+    ....++||||+ +++|.+++..   .+.+++..++.++.|++.||+|||+.+   |+||||||+|||++.++
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~  188 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQ---NGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN  188 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBG---GGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence            9988    67889999999 9999999853   336999999999999999999999998   99999999999998887


Q ss_pred             --CEEEeecccceeccCCCCcc-ccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCcccccc
Q 014024          248 --NSKISDFGMARIVFGGNDED-ELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSL  324 (432)
Q Consensus       248 --~~kl~Dfg~a~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~  324 (432)
                        .+||+|||+++.+....... ..........||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus       189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~  268 (345)
T 2v62_A          189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV  268 (345)
T ss_dssp             TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred             CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence              99999999998753221111 111222456799999999999999999999999999999999999999853211110


Q ss_pred             chhhhhHHhhhccchhhhhhhhhhh-cccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccc
Q 014024          325 NLIGYAWDLWISNKIIDLIDSVLEE-ASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS  389 (432)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~i~~~l~~-~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~  389 (432)
                      ... ...     ......+...+.. ......+..+.+++..||+.||++|||+.+|++.|+....
T Consensus       269 ~~~-~~~-----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          269 AVQ-TAK-----TNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             HHH-HHH-----HHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             HHH-HHH-----HhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence            000 000     0000111111100 0011345678999999999999999999999999998654

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.1e-43  Score=338.78  Aligned_cols=267  Identities=27%  Similarity=0.430  Sum_probs=202.1

Q ss_pred             hHhhhhCCCCcCceeccCCcEEEEEEEECC-----ceEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEe
Q 014024          103 SVSSATGNFSAANKLGEGGFGTVYKGVIGQ-----GEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIE  175 (432)
Q Consensus       103 ~~~~~~~~y~~~~~ig~G~~g~Vy~~~~~~-----~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  175 (432)
                      +.....++|.+.+.||+|+||.||+|.+..     ..||+|.+...  .....+.+.+|+.++++++||||+++++++.+
T Consensus        28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  107 (313)
T 3brb_A           28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE  107 (313)
T ss_dssp             TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred             hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence            344456889999999999999999998643     16999988543  44556789999999999999999999999987


Q ss_pred             CCe-----eEEEEecCCCCChhhhhcCC---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCC
Q 014024          176 KDE-----RLLIYEYMPNKSLDCFLFDP---TKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDM  247 (432)
Q Consensus       176 ~~~-----~~lv~e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~  247 (432)
                      .+.     .++||||+++++|.+++...   .....+++..++.++.|++.||.|||+.+   |+||||||+||++++++
T Consensus       108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~  184 (313)
T 3brb_A          108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDM  184 (313)
T ss_dssp             -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTS
T ss_pred             ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCC
Confidence            653     49999999999999998432   23355999999999999999999999998   99999999999999999


Q ss_pred             CEEEeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccch
Q 014024          248 NSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNL  326 (432)
Q Consensus       248 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~  326 (432)
                      .+||+|||++........    ........+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......   
T Consensus       185 ~~kl~Dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---  257 (313)
T 3brb_A          185 TVCVADFGLSKKIYSGDY----YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE---  257 (313)
T ss_dssp             CEEECSCSCC--------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---
T ss_pred             cEEEeecCcceecccccc----cCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH---
Confidence            999999999986522211    112233457788999999999999999999999999999999 888875332211   


Q ss_pred             hhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccccCC
Q 014024          327 IGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSL  391 (432)
Q Consensus       327 ~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~  391 (432)
                                  ....+........+...+..+.+++..||+.||++|||+.+++++|+.+...+
T Consensus       258 ------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l  310 (313)
T 3brb_A          258 ------------MYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL  310 (313)
T ss_dssp             ------------HHHHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             ------------HHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence                        01111111111223344567899999999999999999999999999876544

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=5.9e-43  Score=330.56  Aligned_cols=274  Identities=20%  Similarity=0.252  Sum_probs=206.4

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEE-EeCCeeEEEE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCC-IEKDERLLIY  183 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~lv~  183 (432)
                      ..++|++.+.||+|+||.||+|.+.  +..||+|+......  .+.+.+|+++++.++|++++..+..+ .+.+..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            4578999999999999999999974  34899998654322  24578899999999988766666555 6777889999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEE---cCCCCEEEeecccceec
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILL---DKDMNSKISDFGMARIV  260 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~  260 (432)
                      ||+ +++|.+++...  ...+++..++.++.|++.||+|||+.+   |+||||||+|||+   ++++.+||+|||++...
T Consensus        85 e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~  158 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             ECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             Ecc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence            999 99999998632  234999999999999999999999999   9999999999999   78999999999999875


Q ss_pred             cCCCCcccc-ccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCcccccc-chhhhhHHhhhccc
Q 014024          261 FGGNDEDEL-QGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSL-NLIGYAWDLWISNK  338 (432)
Q Consensus       261 ~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~  338 (432)
                      ......... ........||+.|+|||.+.+..++.++|||||||++|+|++|+.||........ ....          
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~----------  228 (296)
T 4hgt_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE----------  228 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHH----------
T ss_pred             cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhh----------
Confidence            433221111 1223456799999999999999999999999999999999999999865433211 1110          


Q ss_pred             hhhhhhhhhhhc---ccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccccCCCCCCCCccc
Q 014024          339 IIDLIDSVLEEA---SFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQPAFC  400 (432)
Q Consensus       339 ~~~~i~~~l~~~---~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~~~~~~~~~  400 (432)
                        ..........   .....+..+.+++..||+.||++|||+.++++.|+++...........++
T Consensus       229 --~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~d  291 (296)
T 4hgt_A          229 --RISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFD  291 (296)
T ss_dssp             --HHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCG
T ss_pred             --hhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccc
Confidence              1111111000   01123467899999999999999999999999999877655444333333

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=9.1e-44  Score=340.21  Aligned_cols=265  Identities=23%  Similarity=0.311  Sum_probs=188.3

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCC-hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS-GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  183 (432)
                      ..++|++.+.||+|+||.||+|.+..  ..||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   82 (317)
T 2pmi_A            3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF   82 (317)
T ss_dssp             ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred             cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence            35789999999999999999999754  489999986443 233467889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCC---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceec
Q 014024          184 EYMPNKSLDCFLFDP---TKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIV  260 (432)
Q Consensus       184 e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  260 (432)
                      ||++ ++|.+++...   .....+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus        83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~  158 (317)
T 2pmi_A           83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAF  158 (317)
T ss_dssp             ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred             EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceec
Confidence            9998 5888887532   12234899999999999999999999998   999999999999999999999999999875


Q ss_pred             cCCCCccccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhc--c
Q 014024          261 FGGNDEDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWIS--N  337 (432)
Q Consensus       261 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~  337 (432)
                      ...      ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......  ...........  .
T Consensus       159 ~~~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i~~~~~~~~~  230 (317)
T 2pmi_A          159 GIP------VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE--QLKLIFDIMGTPNE  230 (317)
T ss_dssp             TSC------CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCSCCT
T ss_pred             CCC------cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCCh
Confidence            211      112334578999999999876 468999999999999999999999986433211  00000000000  0


Q ss_pred             ------------------chhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          338 ------------------KIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       338 ------------------~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                                        .....+...+...........+.+++..||+.||++|||+.|++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  294 (317)
T 2pmi_A          231 SLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH  294 (317)
T ss_dssp             TTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence                              0000001111111112234678999999999999999999999975

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2.8e-43  Score=335.54  Aligned_cols=267  Identities=21%  Similarity=0.307  Sum_probs=201.1

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCC---ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGK---SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLL  181 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  181 (432)
                      ..++|++.+.||+|+||.||+|.+.  +..+|+|++...   .....+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l  109 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI  109 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence            4568999999999999999999974  448999998642   45566788999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceec
Q 014024          182 IYEYMPNKSLDCFLFDP-TKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIV  260 (432)
Q Consensus       182 v~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  260 (432)
                      ||||+++++|.+++... .....+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++...
T Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~  186 (310)
T 2wqm_A          110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF  186 (310)
T ss_dssp             EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC------
T ss_pred             EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence            99999999999998532 12345899999999999999999999999   999999999999999999999999999764


Q ss_pred             cCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchh
Q 014024          261 FGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKII  340 (432)
Q Consensus       261 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                      ...      ........|++.|+|||++.+..++.++||||||+++|+|++|+.||..............    ..    
T Consensus       187 ~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----~~----  252 (310)
T 2wqm_A          187 SSK------TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI----EQ----  252 (310)
T ss_dssp             ------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHH----HT----
T ss_pred             cCC------CccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHh----hc----
Confidence            221      1122345789999999999999999999999999999999999999753221110100000    00    


Q ss_pred             hhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccccCCCCC
Q 014024          341 DLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPP  394 (432)
Q Consensus       341 ~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~~~  394 (432)
                          ...........+..+.+++..||+.||++|||+.++++.|+.+......+
T Consensus       253 ----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~  302 (310)
T 2wqm_A          253 ----CDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS  302 (310)
T ss_dssp             ----TCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred             ----ccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhh
Confidence                00000011234567889999999999999999999999999987655444

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.9e-44  Score=342.82  Aligned_cols=275  Identities=25%  Similarity=0.390  Sum_probs=211.0

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEE------CCceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC--e
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVI------GQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKD--E  178 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~  178 (432)
                      ..++|++.+.||+|+||.||+|..      .+..||+|++........+.+.+|++++++++|+||+++++++...+  .
T Consensus        39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  118 (326)
T 2w1i_A           39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN  118 (326)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred             CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence            356799999999999999999984      23479999998777777788999999999999999999999986654  7


Q ss_pred             eEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccce
Q 014024          179 RLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMAR  258 (432)
Q Consensus       179 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  258 (432)
                      .++||||+++++|.+++....  ..+++..++.++.|++.||+|||+.+   |+||||||+||++++++.+||+|||++.
T Consensus       119 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~  193 (326)
T 2w1i_A          119 LKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK  193 (326)
T ss_dssp             CEEEECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             eEEEEECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchh
Confidence            899999999999999996532  34899999999999999999999998   9999999999999999999999999998


Q ss_pred             eccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhh-HHhhhcc
Q 014024          259 IVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYA-WDLWISN  337 (432)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~-~~~~~~~  337 (432)
                      ........   ........++..|+|||.+.+..++.++||||||+++|+|+||..|+......-....... .......
T Consensus       194 ~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (326)
T 2w1i_A          194 VLPQDKEY---YKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF  270 (326)
T ss_dssp             ECCSSCSE---EECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHH
T ss_pred             hccccccc---cccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHH
Confidence            75322111   1112334567789999999999999999999999999999999988642211000000000 0000000


Q ss_pred             chhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccc
Q 014024          338 KIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS  389 (432)
Q Consensus       338 ~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~  389 (432)
                      .+.+.+........+...+..+.+++..||+.||++|||+.|+++.|+.+..
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~  322 (326)
T 2w1i_A          271 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  322 (326)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            1111222211222334556789999999999999999999999999987654

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.5e-43  Score=338.21  Aligned_cols=269  Identities=22%  Similarity=0.243  Sum_probs=199.2

Q ss_pred             hhCCCCcC-ceeccCCcEEEEEEEEC--CceEEEEEEcCCChHhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeeEEE
Q 014024          107 ATGNFSAA-NKLGEGGFGTVYKGVIG--QGEIAVKRLLGKSGQEIKELKNEASVIAQV-QHKNLVKLLGCCIEKDERLLI  182 (432)
Q Consensus       107 ~~~~y~~~-~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv  182 (432)
                      ..+.|++. +.||+|+||.||+|.+.  +..||+|++........+.+.+|++++.++ +||||+++++++.+.+..++|
T Consensus        10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv   89 (316)
T 2ac3_A           10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV   89 (316)
T ss_dssp             TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence            35678884 78999999999999974  348999999766555667899999999995 799999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCC---EEEeeccccee
Q 014024          183 YEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN---SKISDFGMARI  259 (432)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Dfg~a~~  259 (432)
                      |||+++++|.+++..   +..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.   +||+|||++..
T Consensus        90 ~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~  163 (316)
T 2ac3_A           90 FEKMRGGSILSHIHK---RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSG  163 (316)
T ss_dssp             EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred             EEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence            999999999999954   345999999999999999999999998   999999999999998776   99999999976


Q ss_pred             ccCCCCccc-cccccccccccCCccChhhhcc-----CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHh
Q 014024          260 VFGGNDEDE-LQGNTSRISGTYGYMSPEYALE-----GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDL  333 (432)
Q Consensus       260 ~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-----~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~  333 (432)
                      ......... .........||+.|+|||++.+     ..++.++|||||||++|+|++|+.||............   ..
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~---~~  240 (316)
T 2ac3_A          164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDR---GE  240 (316)
T ss_dssp             ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC-------
T ss_pred             cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccc---cc
Confidence            432111110 1112234569999999999875     55889999999999999999999998654332211000   00


Q ss_pred             hhccchhhhhhhhhhh--ccc----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          334 WISNKIIDLIDSVLEE--ASF----NESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       334 ~~~~~~~~~i~~~l~~--~~~----~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                      ........+.......  ..+    ...+..+.+++.+||+.||++|||+.|++++-
T Consensus       241 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp  297 (316)
T 2ac3_A          241 ACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHP  297 (316)
T ss_dssp             CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHST
T ss_pred             cchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcCh
Confidence            0000000011111100  011    12346788999999999999999999999853

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.7e-42  Score=327.62  Aligned_cols=275  Identities=20%  Similarity=0.245  Sum_probs=211.2

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEE-EeCCeeEEEE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCC-IEKDERLLIY  183 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~lv~  183 (432)
                      ..++|++.+.||+|+||.||+|.+.  +..||+|++.....  .+.+.+|+.+++.++|++++..+..+ .+.+..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence            3578999999999999999999974  44899998865432  24688999999999988766655555 6677889999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEE---cCCCCEEEeecccceec
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILL---DKDMNSKISDFGMARIV  260 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~  260 (432)
                      ||+ +++|.+++...  +..+++..++.++.|++.||+|||+.+   |+||||||+||++   ++++.+||+|||++...
T Consensus        85 e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~  158 (296)
T 3uzp_A           85 ELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             ECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             Eec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence            999 99999998532  234999999999999999999999999   9999999999999   58899999999999875


Q ss_pred             cCCCCcccc-ccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCcccccc-chhhhhHHhhhccc
Q 014024          261 FGGNDEDEL-QGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSL-NLIGYAWDLWISNK  338 (432)
Q Consensus       261 ~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~  338 (432)
                      ......... ........||+.|+|||.+.+..++.++||||||+++|+|++|+.||........ .....         
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~---------  229 (296)
T 3uzp_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER---------  229 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHH---------
T ss_pred             cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhh---------
Confidence            433221111 1123456799999999999999999999999999999999999999865432111 11111         


Q ss_pred             hhhhhhhhhhhc---ccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccccCCCCCCCCcccc
Q 014024          339 IIDLIDSVLEEA---SFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQPAFCN  401 (432)
Q Consensus       339 ~~~~i~~~l~~~---~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~~~~~~~~~~  401 (432)
                         +........   .....+..+.+++..||+.||++|||+.++++.|+.+......+....++|
T Consensus       230 ---~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw  292 (296)
T 3uzp_A          230 ---ISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDW  292 (296)
T ss_dssp             ---HHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGG
T ss_pred             ---hcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCcccccccc
Confidence               111111000   112234678999999999999999999999999999876655544444444

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=3.1e-44  Score=345.54  Aligned_cols=268  Identities=23%  Similarity=0.273  Sum_probs=193.3

Q ss_pred             hhhhCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCCChHhHHHHHHHHHHHHhcC-CCceeeeEeEEE-------
Q 014024          105 SSATGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGKSGQEIKELKNEASVIAQVQ-HKNLVKLLGCCI-------  174 (432)
Q Consensus       105 ~~~~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~-------  174 (432)
                      .....+|++.++||+|+||.||+|.+.  +..||+|++........+.+.+|+.+++++. ||||+++++++.       
T Consensus        24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~  103 (337)
T 3ll6_A           24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD  103 (337)
T ss_dssp             EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred             eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence            344568999999999999999999984  4489999997777777788999999999996 999999999994       


Q ss_pred             -eCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEee
Q 014024          175 -EKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISD  253 (432)
Q Consensus       175 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  253 (432)
                       .....++||||+. |+|.+++........+++..++.++.|++.||+|||+.+ .+|+||||||+|||++.++.+||+|
T Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~D  181 (337)
T 3ll6_A          104 TGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCD  181 (337)
T ss_dssp             TSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred             cCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEec
Confidence             3345789999995 788888865334456999999999999999999999875 2499999999999999999999999


Q ss_pred             cccceeccCCCCccc------cccccccccccCCccChhhh---ccCCCCchhhhHHHHHHHHHHHhCCCCCCCcccccc
Q 014024          254 FGMARIVFGGNDEDE------LQGNTSRISGTYGYMSPEYA---LEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSL  324 (432)
Q Consensus       254 fg~a~~~~~~~~~~~------~~~~~~~~~gt~~y~aPE~~---~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~  324 (432)
                      ||++...........      .........||+.|+|||++   .+..++.++||||||+++|+|++|+.||......  
T Consensus       182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--  259 (337)
T 3ll6_A          182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL--  259 (337)
T ss_dssp             CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred             CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH--
Confidence            999987532211100      00112245689999999998   5677899999999999999999999998532211  


Q ss_pred             chhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccccCCC
Q 014024          325 NLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLL  392 (432)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~  392 (432)
                                      ..................+.+++..||+.||++|||+.|++++|+.+.....
T Consensus       260 ----------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~  311 (337)
T 3ll6_A          260 ----------------RIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN  311 (337)
T ss_dssp             ----------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred             ----------------HhhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence                            0111111111111223447789999999999999999999999998775443

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=3.4e-43  Score=343.64  Aligned_cols=244  Identities=25%  Similarity=0.315  Sum_probs=195.1

Q ss_pred             CceeccCCcEEEEEEEECC--ceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecCCCCCh
Q 014024          114 ANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSL  191 (432)
Q Consensus       114 ~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  191 (432)
                      .+.||+|+||.||+|.+..  ..||+|++........+.+.+|++++++++||||+++++++.+.+..++||||+++++|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            5689999999999999753  48999999877767778899999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEE--cCCCCEEEeecccceeccCCCCcccc
Q 014024          192 DCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILL--DKDMNSKISDFGMARIVFGGNDEDEL  269 (432)
Q Consensus       192 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll--~~~~~~kl~Dfg~a~~~~~~~~~~~~  269 (432)
                      .+++...  ...+++..++.++.|++.||+|||+.+   |+||||||+|||+  ++++.+||+|||++......      
T Consensus       174 ~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~------  242 (373)
T 2x4f_A          174 FDRIIDE--SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR------  242 (373)
T ss_dssp             HHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT------
T ss_pred             HHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCc------
Confidence            9988542  234999999999999999999999999   9999999999999  67789999999999875221      


Q ss_pred             ccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhh--h
Q 014024          270 QGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSV--L  347 (432)
Q Consensus       270 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~--l  347 (432)
                       .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......  ..            ..+....  .
T Consensus       243 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--~~------------~~i~~~~~~~  307 (373)
T 2x4f_A          243 -EKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE--TL------------NNILACRWDL  307 (373)
T ss_dssp             -CBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HH------------HHHHHTCCCS
T ss_pred             -cccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH--HH------------HHHHhccCCC
Confidence             12234569999999999999999999999999999999999999985332110  00            0000000  0


Q ss_pred             hhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          348 EEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       348 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      ........+..+.+++..||+.||.+|||+.|++++
T Consensus       308 ~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h  343 (373)
T 2x4f_A          308 EDEEFQDISEEAKEFISKLLIKEKSWRISASEALKH  343 (373)
T ss_dssp             CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            001112335678899999999999999999999984

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.4e-44  Score=347.79  Aligned_cols=262  Identities=27%  Similarity=0.395  Sum_probs=196.9

Q ss_pred             CCCCcCceeccCCcEEEEEEEEC--Cc---eEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEe-CCeeEE
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIG--QG---EIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIE-KDERLL  181 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~--~~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~l  181 (432)
                      ..|++.+.||+|+||.||+|.+.  ++   .+|+|.+... .....+.+.+|+.++++++||||+++++++.+ .+..++
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l  168 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  168 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence            35777899999999999999863  22   5788887543 34566789999999999999999999998754 457899


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceecc
Q 014024          182 IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVF  261 (432)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  261 (432)
                      ||||+++|+|.+++....  ..+++..++.++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++...
T Consensus       169 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~  243 (373)
T 3c1x_A          169 VLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY  243 (373)
T ss_dssp             EEECCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEECCCCCCHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence            999999999999996533  34889999999999999999999999   9999999999999999999999999998652


Q ss_pred             CCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchh
Q 014024          262 GGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKII  340 (432)
Q Consensus       262 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                      .....  .........+|+.|+|||.+.+..++.++||||||+++|||+| |..||.......  ..             
T Consensus       244 ~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~--~~-------------  306 (373)
T 3c1x_A          244 DKEFD--SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--IT-------------  306 (373)
T ss_dssp             ----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC--HH-------------
T ss_pred             ccccc--cccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH--HH-------------
Confidence            22111  1112234567788999999999999999999999999999999 566664322211  11             


Q ss_pred             hhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccccCCC
Q 014024          341 DLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLL  392 (432)
Q Consensus       341 ~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~  392 (432)
                      ..+........+..++..+.+++..||+.||++|||+.|+++.|+.+...+.
T Consensus       307 ~~~~~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~  358 (373)
T 3c1x_A          307 VYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  358 (373)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             HHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence            1111111111223345678999999999999999999999999998876554

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=7.9e-43  Score=350.35  Aligned_cols=247  Identities=23%  Similarity=0.388  Sum_probs=202.7

Q ss_pred             hCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCCCh---HhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEE
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGKSG---QEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLI  182 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  182 (432)
                      .++|.+.+.||+|+||.||+|.+.  +..||+|++.....   ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            578999999999999999999986  44899999854321   2346788999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccC
Q 014024          183 YEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFG  262 (432)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  262 (432)
                      |||+++|+|.+++..   ++.+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus        95 ~E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~  168 (476)
T 2y94_A           95 MEYVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  168 (476)
T ss_dssp             EECCSSEEHHHHTTS---SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred             EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence            999999999999943   455999999999999999999999999   99999999999999999999999999987522


Q ss_pred             CCCccccccccccccccCCccChhhhccCCC-CchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhh
Q 014024          263 GNDEDELQGNTSRISGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIID  341 (432)
Q Consensus       263 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (432)
                      +       ......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.......  ..    .        .
T Consensus       169 ~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~--~~----~--------~  227 (476)
T 2y94_A          169 G-------EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT--LF----K--------K  227 (476)
T ss_dssp             T-------CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH--HH----H--------H
T ss_pred             c-------ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH--HH----H--------H
Confidence            1       12334579999999999988765 789999999999999999999985322110  00    0        0


Q ss_pred             hhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          342 LIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       342 ~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      +.+...  ..+......+.+++..||+.||++|||+.|++++
T Consensus       228 i~~~~~--~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h  267 (476)
T 2y94_A          228 ICDGIF--YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH  267 (476)
T ss_dssp             HHTTCC--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             HhcCCc--CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence            001000  1122234578899999999999999999999984

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=3.5e-44  Score=353.98  Aligned_cols=257  Identities=20%  Similarity=0.218  Sum_probs=204.6

Q ss_pred             hhHhhhhCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCCCh---HhHHHHHHHHHHHHhcCCCceeeeEeEEEeC
Q 014024          102 SSVSSATGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSG---QEIKELKNEASVIAQVQHKNLVKLLGCCIEK  176 (432)
Q Consensus       102 ~~~~~~~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  176 (432)
                      .++....++|++.++||+|+||.||+|.+..+  .+|+|++.....   ...+.+.+|+.+++.++||||+++++++.+.
T Consensus        62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~  141 (410)
T 3v8s_A           62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  141 (410)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            34555678999999999999999999998653  799999854211   1223477899999999999999999999999


Q ss_pred             CeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeeccc
Q 014024          177 DERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGM  256 (432)
Q Consensus       177 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  256 (432)
                      +..|+||||+++|+|.+++..    ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       142 ~~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~  214 (410)
T 3v8s_A          142 RYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT  214 (410)
T ss_dssp             SEEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccce
Confidence            999999999999999999853    34899999999999999999999999   99999999999999999999999999


Q ss_pred             ceeccCCCCccccccccccccccCCccChhhhccCC----CCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHH
Q 014024          257 ARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGI----FSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWD  332 (432)
Q Consensus       257 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~  332 (432)
                      +.......     .......+||+.|+|||++.+..    ++.++|||||||++|||++|+.||.......         
T Consensus       215 a~~~~~~~-----~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---------  280 (410)
T 3v8s_A          215 CMKMNKEG-----MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG---------  280 (410)
T ss_dssp             CEECCTTS-----EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH---------
T ss_pred             eEeeccCC-----cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh---------
Confidence            98752211     11234568999999999998655    8899999999999999999999985322100         


Q ss_pred             hhhccchhhhhhhhhhhcc--cHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHHh
Q 014024          333 LWISNKIIDLIDSVLEEAS--FNESLSRYVHIALLCVQERAED--RPTMSDVVSML  384 (432)
Q Consensus       333 ~~~~~~~~~~i~~~l~~~~--~~~~~~~l~~l~~~cl~~dp~~--RPt~~evl~~L  384 (432)
                           ....+.........  .......+.+|+..||+.+|.+  ||++.||++|-
T Consensus       281 -----~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp  331 (410)
T 3v8s_A          281 -----TYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  331 (410)
T ss_dssp             -----HHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSG
T ss_pred             -----HHHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCc
Confidence                 00111111100111  1134567889999999999988  99999999864

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.3e-43  Score=348.77  Aligned_cols=252  Identities=22%  Similarity=0.314  Sum_probs=197.5

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECCc-eEEEEEEcCC--ChHhHHHHHHHHHHHHhcC--CCceeeeEeEEEeCCeeEEE
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGK--SGQEIKELKNEASVIAQVQ--HKNLVKLLGCCIEKDERLLI  182 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~~-~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv  182 (432)
                      ..+|++.+.||+|+||.||++.+..+ .||+|++...  .....+.+.+|+.+|++++  |+||+++++++...+..++|
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  134 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  134 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence            45699999999999999999998655 7999988543  4556778999999999996  59999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccC
Q 014024          183 YEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFG  262 (432)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  262 (432)
                      || +.+++|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++ ++.+||+|||++..+..
T Consensus       135 ~E-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~  206 (390)
T 2zmd_A          135 ME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  206 (390)
T ss_dssp             EE-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred             Ee-cCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence            99 678899999854   335899999999999999999999998   99999999999995 58999999999986522


Q ss_pred             CCCccccccccccccccCCccChhhhcc-----------CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhH
Q 014024          263 GNDEDELQGNTSRISGTYGYMSPEYALE-----------GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAW  331 (432)
Q Consensus       263 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~  331 (432)
                      ...    ........||+.|+|||++.+           ..++.++|||||||++|||++|+.||.......        
T Consensus       207 ~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~--------  274 (390)
T 2zmd_A          207 DTT----SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI--------  274 (390)
T ss_dssp             -----------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--------
T ss_pred             CCc----cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH--------
Confidence            111    112334579999999999865           468999999999999999999999985322110        


Q ss_pred             HhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          332 DLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       332 ~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                           .....+++.......+......+.+++..||+.||++|||+.|++++.
T Consensus       275 -----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp  322 (390)
T 2zmd_A          275 -----SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  322 (390)
T ss_dssp             -----HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             -----HHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence                 011112222111122222345788999999999999999999999754

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.4e-43  Score=342.60  Aligned_cols=261  Identities=19%  Similarity=0.260  Sum_probs=200.6

Q ss_pred             HhhhhCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCC-----ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeC
Q 014024          104 VSSATGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGK-----SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEK  176 (432)
Q Consensus       104 ~~~~~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  176 (432)
                      +....++|++.+.||+|+||.||+|.+...  .+|+|++...     .....+.+.+|++++++++||||+++++++.+.
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  100 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE  100 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence            445678899999999999999999998554  7899988533     234567899999999999999999999999999


Q ss_pred             CeeEEEEecCCCCChhhhhcCCC-------------------------------------CCCCCCHHHHHHHHHHHHHH
Q 014024          177 DERLLIYEYMPNKSLDCFLFDPT-------------------------------------KREILDWRTRVQIIKGVAQG  219 (432)
Q Consensus       177 ~~~~lv~e~~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~qi~~~  219 (432)
                      +..++||||+++|+|.+++....                                     ....+++..++.++.|++.|
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  180 (345)
T 3hko_A          101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA  180 (345)
T ss_dssp             SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            99999999999999999884210                                     01224677888999999999


Q ss_pred             HHHHHhcCCCCeEeccCCCCCEEEcCCC--CEEEeecccceeccCCCCccccccccccccccCCccChhhhcc--CCCCc
Q 014024          220 LLYLHQYSRVRIIHRDLKASNILLDKDM--NSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE--GIFSI  295 (432)
Q Consensus       220 l~~LH~~~~~~ivH~Dlkp~NIll~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~  295 (432)
                      |+|||+.+   |+||||||+||+++.++  .+||+|||++..+.......  ........||+.|+|||++.+  ..++.
T Consensus       181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~  255 (345)
T 3hko_A          181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGE--YYGMTTKAGTPYFVAPEVLNTTNESYGP  255 (345)
T ss_dssp             HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC----------CCCGGGCCHHHHTCSSSCCCT
T ss_pred             HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccc--cccccccCCCccccCchhhccCCCCCCc
Confidence            99999999   99999999999998776  89999999998753322111  112345679999999999875  67899


Q ss_pred             hhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhhh--hhcccHHHHHHHHHHHHHhhccCCCC
Q 014024          296 KSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVL--EEASFNESLSRYVHIALLCVQERAED  373 (432)
Q Consensus       296 ~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l--~~~~~~~~~~~l~~l~~~cl~~dp~~  373 (432)
                      ++||||||+++|+|++|+.||.......     ..         ..+.....  ........+..+.+++..||+.||.+
T Consensus       256 ~~DiwslG~il~el~~g~~pf~~~~~~~-----~~---------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  321 (345)
T 3hko_A          256 KCDAWSAGVLLHLLLMGAVPFPGVNDAD-----TI---------SQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDE  321 (345)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HH---------HHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTT
T ss_pred             HHHHHHHHHHHHHHHHCCCCCCCCChHH-----HH---------HHHHhcccccCCcccccCCHHHHHHHHHHcCCChhH
Confidence            9999999999999999999985432211     00         01111000  00111123567889999999999999


Q ss_pred             CCCHHHHHHH
Q 014024          374 RPTMSDVVSM  383 (432)
Q Consensus       374 RPt~~evl~~  383 (432)
                      |||+.+++++
T Consensus       322 Rps~~~~l~h  331 (345)
T 3hko_A          322 RFDAMRALQH  331 (345)
T ss_dssp             SCCHHHHHHS
T ss_pred             CCCHHHHhcC
Confidence            9999999984

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=5.9e-43  Score=327.36  Aligned_cols=254  Identities=25%  Similarity=0.322  Sum_probs=204.2

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  183 (432)
                      ..++|++.+.||+|+||.||+|.+.  +..+|+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence            3568999999999999999999986  348999998543 3345578899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCC
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGG  263 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  263 (432)
                      ||+++++|.+++..   +..+++..++.++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++......
T Consensus        85 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  158 (276)
T 2yex_A           85 EYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (276)
T ss_dssp             ECCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             EecCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence            99999999999843   345999999999999999999999999   999999999999999999999999999865221


Q ss_pred             CCccccccccccccccCCccChhhhccCCC-CchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhh
Q 014024          264 NDEDELQGNTSRISGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDL  342 (432)
Q Consensus       264 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                      ..    ........||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||............+.     ...    
T Consensus       159 ~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-----~~~----  225 (276)
T 2yex_A          159 NR----ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK-----EKK----  225 (276)
T ss_dssp             TE----ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHH-----TTC----
T ss_pred             cc----hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhh-----hcc----
Confidence            11    112344678999999999987765 7899999999999999999999864432211111110     000    


Q ss_pred             hhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          343 IDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       343 i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                          .........+..+.+++..||+.||++|||+.|++++
T Consensus       226 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (276)
T 2yex_A          226 ----TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (276)
T ss_dssp             ----TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ----cccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence                0001112334577899999999999999999999875

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=5.9e-43  Score=337.20  Aligned_cols=249  Identities=22%  Similarity=0.305  Sum_probs=204.8

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCC---ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGK---SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLL  181 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  181 (432)
                      ..++|.+.+.||+|+||.||++.+.+.  .+|+|.+...   .....+.+.+|+.+++.++|+||+++++++.+.+..++
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  118 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV  118 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence            457899999999999999999998654  7899988543   34566788999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceecc
Q 014024          182 IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVF  261 (432)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  261 (432)
                      ||||+++++|.+++..   +..+++..++.++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++....
T Consensus       119 v~e~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  192 (335)
T 2owb_A          119 VLELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  192 (335)
T ss_dssp             EECCCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEecCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence            9999999999998843   345999999999999999999999999   9999999999999999999999999998752


Q ss_pred             CCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhh
Q 014024          262 GGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIID  341 (432)
Q Consensus       262 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (432)
                      ..      ........||+.|+|||++.+..++.++||||||+++|+|++|+.||.......     . ....       
T Consensus       193 ~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~-~~~~-------  253 (335)
T 2owb_A          193 YD------GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-----T-YLRI-------  253 (335)
T ss_dssp             ST------TCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-----H-HHHH-------
T ss_pred             cC------cccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH-----H-HHHH-------
Confidence            21      112334578999999999999999999999999999999999999985432110     0 0000       


Q ss_pred             hhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          342 LIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       342 ~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                       ...  ....+......+.+++.+||+.||++|||+.|++++
T Consensus       254 -~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          254 -KKN--EYSIPKHINPVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             -HHT--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             -hcC--CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             000  001122334567899999999999999999999985

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.1e-42  Score=326.98  Aligned_cols=252  Identities=23%  Similarity=0.342  Sum_probs=202.9

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLI  182 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  182 (432)
                      ..++|++.+.||+|+||.||+|.+..  ..+|+|++...  .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   83 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   83 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence            36889999999999999999999864  38999998543  445567889999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCC---EEEeeccccee
Q 014024          183 YEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN---SKISDFGMARI  259 (432)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Dfg~a~~  259 (432)
                      |||+++++|.+++..   +..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.   +||+|||++..
T Consensus        84 ~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~  157 (284)
T 3kk8_A           84 FDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE  157 (284)
T ss_dssp             ECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence            999999999888843   345999999999999999999999999   999999999999986665   99999999976


Q ss_pred             ccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccch
Q 014024          260 VFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKI  339 (432)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  339 (432)
                      ....       .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.......  .....    .....
T Consensus       158 ~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~----~~~~~  224 (284)
T 3kk8_A          158 VNDS-------EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR--LYAQI----KAGAY  224 (284)
T ss_dssp             CCSS-------CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHH----HHTCC
T ss_pred             cccC-------ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH--HHHHH----Hhccc
Confidence            4221       12234578999999999999999999999999999999999999985322110  00000    00000


Q ss_pred             hhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          340 IDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       340 ~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                       ..     ........+..+.+++..||+.||++|||+.|++++
T Consensus       225 -~~-----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          225 -DY-----PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             -CC-----CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             -cC-----CchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence             00     000112334678899999999999999999999984

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.2e-43  Score=331.14  Aligned_cols=249  Identities=25%  Similarity=0.351  Sum_probs=201.3

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCCC---hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKS---GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLL  181 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  181 (432)
                      +.++|++.+.||+|+||.||+|.+...  .+|+|++....   ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            467899999999999999999998655  79999885432   1224568899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceecc
Q 014024          182 IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVF  261 (432)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  261 (432)
                      ||||+++++|.+++..   ...+++..++.++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++....
T Consensus        87 v~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~  160 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP  160 (279)
T ss_dssp             EECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred             EEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence            9999999999999853   344999999999999999999999998   9999999999999999999999999986531


Q ss_pred             CCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhh
Q 014024          262 GGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIID  341 (432)
Q Consensus       262 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (432)
                              ........||+.|+|||.+.+..++.++||||||+++|+|++|+.||.......     ..          .
T Consensus       161 --------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~----------~  217 (279)
T 3fdn_A          161 --------SSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-----TY----------K  217 (279)
T ss_dssp             ---------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-----HH----------H
T ss_pred             --------cccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH-----HH----------H
Confidence                    112234578999999999999999999999999999999999999985322110     00          0


Q ss_pred             hhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014024          342 LIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLT  385 (432)
Q Consensus       342 ~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~  385 (432)
                      .+.. .....+...+..+.+++..||+.||++|||+.|++++-.
T Consensus       218 ~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~  260 (279)
T 3fdn_A          218 RISR-VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW  260 (279)
T ss_dssp             HHHH-TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHH
T ss_pred             HHHh-CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCcc
Confidence            0000 011122334567889999999999999999999998654

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=6e-43  Score=330.48  Aligned_cols=254  Identities=25%  Similarity=0.344  Sum_probs=200.6

Q ss_pred             CCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecC
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYM  186 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  186 (432)
                      ++|.....||+|+||.||+|.+..+  .||+|.+........+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  101 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV  101 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence            4455567999999999999998543  79999997766666788999999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcC-CCCEEEeecccceeccCCCC
Q 014024          187 PNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDK-DMNSKISDFGMARIVFGGND  265 (432)
Q Consensus       187 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~~~  265 (432)
                      ++++|.+++........+++..+..++.|++.||.|||+.+   ++||||||+||+++. ++.+||+|||++......  
T Consensus       102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~--  176 (295)
T 2clq_A          102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI--  176 (295)
T ss_dssp             SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred             CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCC--
Confidence            99999999976544445789999999999999999999998   999999999999987 899999999999875221  


Q ss_pred             ccccccccccccccCCccChhhhccCC--CCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhh
Q 014024          266 EDELQGNTSRISGTYGYMSPEYALEGI--FSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLI  343 (432)
Q Consensus       266 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i  343 (432)
                          ........||+.|+|||++.+..  ++.++||||||+++|+|++|+.||...........             ...
T Consensus       177 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-------------~~~  239 (295)
T 2clq_A          177 ----NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF-------------KVG  239 (295)
T ss_dssp             --------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHH-------------HHH
T ss_pred             ----CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHH-------------hhc
Confidence                11223457899999999987654  89999999999999999999999843221110000             000


Q ss_pred             hhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          344 DSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       344 ~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                      ........+...+..+.+++..||+.||++|||+.+++++-
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~  280 (295)
T 2clq_A          240 MFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDE  280 (295)
T ss_dssp             HHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSG
T ss_pred             cccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence            00011122334456788999999999999999999998753

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=2.2e-43  Score=338.70  Aligned_cols=246  Identities=20%  Similarity=0.266  Sum_probs=178.7

Q ss_pred             CceeccCCcEEEEEEEECC--ceEEEEEEcCCChHhHHHHHHHHHHHHhcC-CCceeeeEeEEEeCCeeEEEEecCCCCC
Q 014024          114 ANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSGQEIKELKNEASVIAQVQ-HKNLVKLLGCCIEKDERLLIYEYMPNKS  190 (432)
Q Consensus       114 ~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gs  190 (432)
                      .+.||+|+||.||+|.+..  ..||+|++...   ....+.+|+.+++.++ ||||+++++++.+....++||||+++|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            3789999999999999864  48999998643   3456788999999997 9999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCC---CEEEeecccceeccCCCCcc
Q 014024          191 LDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDM---NSKISDFGMARIVFGGNDED  267 (432)
Q Consensus       191 L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~Dfg~a~~~~~~~~~~  267 (432)
                      |.+++..   +..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++   .+||+|||++......    
T Consensus        93 L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~----  162 (325)
T 3kn6_A           93 LFERIKK---KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD----  162 (325)
T ss_dssp             HHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred             HHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCC----
Confidence            9999954   345999999999999999999999999   99999999999997765   7999999999864221    


Q ss_pred             ccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhhh
Q 014024          268 ELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVL  347 (432)
Q Consensus       268 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  347 (432)
                        ........||+.|+|||++.+..++.++|||||||++|+|++|+.||........           .....+.+....
T Consensus       163 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-----------~~~~~~~~~~i~  229 (325)
T 3kn6_A          163 --NQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT-----------CTSAVEIMKKIK  229 (325)
T ss_dssp             -----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC------------------CCCHHHHHHHHT
T ss_pred             --CCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccc-----------cccHHHHHHHHH
Confidence              1123345789999999999999999999999999999999999999864332110           001111111111


Q ss_pred             hhc------ccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014024          348 EEA------SFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLT  385 (432)
Q Consensus       348 ~~~------~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~  385 (432)
                      ...      .....+.++.+++..||+.||++|||++|++++-.
T Consensus       230 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w  273 (325)
T 3kn6_A          230 KGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEW  273 (325)
T ss_dssp             TTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGG
T ss_pred             cCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChh
Confidence            111      01223567889999999999999999999987543

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2.1e-43  Score=341.01  Aligned_cols=253  Identities=20%  Similarity=0.258  Sum_probs=198.4

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCChHhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeeEEEE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSGQEIKELKNEASVIAQV-QHKNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  183 (432)
                      ..++|++.+.||+|+||.||+|.+..  ..+|+|++.....    ...+|++++.++ +||||+++++++.+.+..++||
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            45789999999999999999999864  3899999865432    235688888888 7999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCC----CCEEEeeccccee
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKD----MNSKISDFGMARI  259 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~Dfg~a~~  259 (432)
                      ||+++|+|.+++..   ++.+++..+..++.|++.||+|||+.+   |+||||||+|||+.++    +.+||+|||++..
T Consensus        96 E~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~  169 (342)
T 2qr7_A           96 ELMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ  169 (342)
T ss_dssp             CCCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred             eCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence            99999999999854   345999999999999999999999999   9999999999998543    3499999999987


Q ss_pred             ccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccch
Q 014024          260 VFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKI  339 (432)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  339 (432)
                      ....      ........||+.|+|||++.+..++.++|||||||++|+|++|..||........  .. ..........
T Consensus       170 ~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~-~~~~i~~~~~  240 (342)
T 2qr7_A          170 LRAE------NGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTP--EE-ILARIGSGKF  240 (342)
T ss_dssp             CBCT------TCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCH--HH-HHHHHHHCCC
T ss_pred             CcCC------CCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCH--HH-HHHHHccCCc
Confidence            5322      1223456789999999999888899999999999999999999999864221110  00 0000000000


Q ss_pred             hhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          340 IDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       340 ~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                            .+........+..+.+++..||+.||++|||+.+++++-
T Consensus       241 ------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp  279 (342)
T 2qr7_A          241 ------SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHP  279 (342)
T ss_dssp             ------CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSH
T ss_pred             ------ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCC
Confidence                  000011123456788999999999999999999999854

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=9.8e-43  Score=336.16  Aligned_cols=271  Identities=22%  Similarity=0.285  Sum_probs=207.6

Q ss_pred             HhhhhCCCCcCceeccCCcEEEEEEEECCceEEEEEEcCCChHhHHHHHHHHHHHHh--cCCCceeeeEeEEEeCC----
Q 014024          104 VSSATGNFSAANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQ--VQHKNLVKLLGCCIEKD----  177 (432)
Q Consensus       104 ~~~~~~~y~~~~~ig~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~----  177 (432)
                      .....++|++.+.||+|+||.||+|.+.+..||+|.+...   ....+.+|.+++..  ++||||+++++++.+..    
T Consensus        37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~  113 (342)
T 1b6c_B           37 QRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT  113 (342)
T ss_dssp             HHHHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred             cccccccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence            3455689999999999999999999998889999998543   34567889999988  78999999999998876    


Q ss_pred             eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEeccCCCCCEEEcCCCCE
Q 014024          178 ERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLH--------QYSRVRIIHRDLKASNILLDKDMNS  249 (432)
Q Consensus       178 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH--------~~~~~~ivH~Dlkp~NIll~~~~~~  249 (432)
                      ..++||||+++|+|.+++..    ..+++..++.++.|++.||+|||        +.+   |+||||||+||+++.++.+
T Consensus       114 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~  186 (342)
T 1b6c_B          114 QLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTC  186 (342)
T ss_dssp             CEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCE
T ss_pred             eeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCE
Confidence            78999999999999999953    34899999999999999999999        777   9999999999999999999


Q ss_pred             EEeecccceeccCCCCccccccccccccccCCccChhhhccC------CCCchhhhHHHHHHHHHHHhC----------C
Q 014024          250 KISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEG------IFSIKSDVFSFGVLLLEIVSG----------K  313 (432)
Q Consensus       250 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~t~~~DvwSlG~il~elltg----------~  313 (432)
                      ||+|||++.........  .........||+.|+|||++.+.      .++.++||||||+++|||+||          .
T Consensus       187 kL~Dfg~~~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~  264 (342)
T 1b6c_B          187 CIADLGLAVRHDSATDT--IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ  264 (342)
T ss_dssp             EECCCTTCEEEETTTTE--EEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred             EEEECCCceeccccccc--cccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccc
Confidence            99999999875332211  11123445789999999999865      344789999999999999999          5


Q ss_pred             CCCCCccccccchhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccccC
Q 014024          314 KNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASS  390 (432)
Q Consensus       314 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~  390 (432)
                      .||.............. ...........+..   ..........+.+++.+||+.||++|||+.+|+++|+.+...
T Consensus       265 ~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~  337 (342)
T 1b6c_B          265 LPYYDLVPSDPSVEEMR-KVVCEQKLRPNIPN---RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  337 (342)
T ss_dssp             CTTTTTSCSSCCHHHHH-HHHTTSCCCCCCCG---GGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             cCccccCcCcccHHHHH-HHHHHHHhCCCCcc---cccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence            55533222111111110 00000000000000   001235677899999999999999999999999999987643

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=6.5e-43  Score=331.88  Aligned_cols=251  Identities=25%  Similarity=0.387  Sum_probs=205.5

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCC-hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS-GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  183 (432)
                      ..+.|++.+.||+|+||.||+|.+..  ..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   99 (303)
T 3a7i_A           20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM   99 (303)
T ss_dssp             GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence            34679999999999999999999753  489999985442 345678999999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCC
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGG  263 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  263 (432)
                      ||+++++|.+++.    ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++......
T Consensus       100 e~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  172 (303)
T 3a7i_A          100 EYLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT  172 (303)
T ss_dssp             ECCTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred             EeCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcc
Confidence            9999999999984    245999999999999999999999999   999999999999999999999999999875221


Q ss_pred             CCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhh
Q 014024          264 NDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLI  343 (432)
Q Consensus       264 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i  343 (432)
                            ........||+.|+|||++.+..++.++||||||+++|+|++|+.||.......  ..             ..+
T Consensus       173 ------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~-------------~~~  231 (303)
T 3a7i_A          173 ------QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK--VL-------------FLI  231 (303)
T ss_dssp             ------BCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HH-------------HHH
T ss_pred             ------ccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH--HH-------------HHh
Confidence                  112344578999999999999999999999999999999999999985332110  00             000


Q ss_pred             hhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014024          344 DSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLT  385 (432)
Q Consensus       344 ~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~  385 (432)
                      ............+..+.+++..||+.||++|||+.+++++..
T Consensus       232 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~  273 (303)
T 3a7i_A          232 PKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKF  273 (303)
T ss_dssp             HHSCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred             hcCCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence            010111112233467889999999999999999999998643

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=7.6e-43  Score=334.34  Aligned_cols=253  Identities=25%  Similarity=0.311  Sum_probs=203.5

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCCh------HhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCe
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSG------QEIKELKNEASVIAQVQHKNLVKLLGCCIEKDE  178 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  178 (432)
                      ..++|++.+.||+|+||.||+|.+..  ..+|+|.+.....      ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   89 (321)
T 2a2a_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD   89 (321)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence            45679999999999999999999864  4899998854422      135779999999999999999999999999999


Q ss_pred             eEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCC----CEEEeec
Q 014024          179 RLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDM----NSKISDF  254 (432)
Q Consensus       179 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Df  254 (432)
                      .++||||+++++|.+++..   ...+++..++.++.|++.||+|||+.+   |+||||||+||++++++    .+||+||
T Consensus        90 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Df  163 (321)
T 2a2a_A           90 VVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (321)
T ss_dssp             EEEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccC
Confidence            9999999999999999954   345899999999999999999999999   99999999999999888    7999999


Q ss_pred             ccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhh
Q 014024          255 GMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLW  334 (432)
Q Consensus       255 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  334 (432)
                      |++......       .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.......  ..    ...
T Consensus       164 g~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~----~~i  230 (321)
T 2a2a_A          164 GLAHEIEDG-------VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--TL----ANI  230 (321)
T ss_dssp             TTCEECCTT-------CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH--HH----HHH
T ss_pred             ccceecCcc-------ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH--HH----HHH
Confidence            999875321       12234568999999999999999999999999999999999999985322110  00    000


Q ss_pred             hccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          335 ISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       335 ~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                      .... .. ...    ......+..+.+++..||+.||++|||+.|++++-
T Consensus       231 ~~~~-~~-~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp  274 (321)
T 2a2a_A          231 TSVS-YD-FDE----EFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHP  274 (321)
T ss_dssp             HTTC-CC-CCH----HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHST
T ss_pred             Hhcc-cc-cCh----hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence            0000 00 000    00112345688999999999999999999999853

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.4e-43  Score=365.64  Aligned_cols=258  Identities=27%  Similarity=0.399  Sum_probs=203.2

Q ss_pred             CCCCcCc-eeccCCcEEEEEEEEC---C-ceEEEEEEcCCC-hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEE
Q 014024          109 GNFSAAN-KLGEGGFGTVYKGVIG---Q-GEIAVKRLLGKS-GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLI  182 (432)
Q Consensus       109 ~~y~~~~-~ig~G~~g~Vy~~~~~---~-~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  182 (432)
                      +++.+.+ .||+|+||.||+|.+.   + ..||||++.... ....+.+.+|+++|++++||||+++++++.+ +..++|
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv  413 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV  413 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence            3444444 7999999999999874   2 269999986543 3456789999999999999999999999976 568999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccC
Q 014024          183 YEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFG  262 (432)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  262 (432)
                      |||+++|+|.+++...  ...+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++....
T Consensus       414 ~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~  488 (613)
T 2ozo_A          414 MEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGA  488 (613)
T ss_dssp             EECCTTCBHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred             EEeCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence            9999999999999643  345999999999999999999999999   99999999999999999999999999986422


Q ss_pred             CCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchhh
Q 014024          263 GNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIID  341 (432)
Q Consensus       263 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (432)
                      ...   .........+++.|+|||++.++.++.++|||||||++|||++ |+.||......               ....
T Consensus       489 ~~~---~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---------------~~~~  550 (613)
T 2ozo_A          489 DDS---YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---------------EVMA  550 (613)
T ss_dssp             ----------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH---------------HHHH
T ss_pred             CCc---eeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH---------------HHHH
Confidence            111   1111223345689999999999999999999999999999998 99998543221               1112


Q ss_pred             hhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccccC
Q 014024          342 LIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASS  390 (432)
Q Consensus       342 ~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~  390 (432)
                      .+....+...+..++..+.+++..||+.||++||++.+|++.|+....+
T Consensus       551 ~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~  599 (613)
T 2ozo_A          551 FIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  599 (613)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             HHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence            2222222334445678899999999999999999999999999886543

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2.3e-43  Score=341.63  Aligned_cols=249  Identities=27%  Similarity=0.387  Sum_probs=199.0

Q ss_pred             hCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCC---ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEE
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGK---SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLI  182 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  182 (432)
                      .+.|++.+.||+|+||.||+|.+.  +..||+|++...   .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  132 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV  132 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence            456899999999999999999974  348999998643   234456789999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccC
Q 014024          183 YEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFG  262 (432)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  262 (432)
                      |||+. |+|.+++...  +..+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++.... 
T Consensus       133 ~e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~-  205 (348)
T 1u5q_A          133 MEYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA-  205 (348)
T ss_dssp             EECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSS-
T ss_pred             EecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecC-
Confidence            99997 5777776432  345999999999999999999999999   9999999999999999999999999997641 


Q ss_pred             CCCccccccccccccccCCccChhhhc---cCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccch
Q 014024          263 GNDEDELQGNTSRISGTYGYMSPEYAL---EGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKI  339 (432)
Q Consensus       263 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  339 (432)
                               ......||+.|+|||++.   .+.++.++|||||||++|||++|+.||.......     ....       
T Consensus       206 ---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-----~~~~-------  264 (348)
T 1u5q_A          206 ---------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-----ALYH-------  264 (348)
T ss_dssp             ---------SBCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-----HHHH-------
T ss_pred             ---------CCCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-----HHHH-------
Confidence                     123457899999999984   5678999999999999999999999975322110     0000       


Q ss_pred             hhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014024          340 IDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN  386 (432)
Q Consensus       340 ~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~  386 (432)
                        +.............+..+.+++..||+.||++|||+.+++++..-
T Consensus       265 --~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~  309 (348)
T 1u5q_A          265 --IAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV  309 (348)
T ss_dssp             --HHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHH
T ss_pred             --HHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhh
Confidence              000000001112334668899999999999999999999986543

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=3.7e-43  Score=337.44  Aligned_cols=264  Identities=22%  Similarity=0.285  Sum_probs=205.7

Q ss_pred             cchhhHhhhhCCCCcC-ceeccCCcEEEEEEEECC--ceEEEEEEcCCC--hHhHHHHHHHHHHHHhcC-CCceeeeEeE
Q 014024           99 FSFSSVSSATGNFSAA-NKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS--GQEIKELKNEASVIAQVQ-HKNLVKLLGC  172 (432)
Q Consensus        99 ~~~~~~~~~~~~y~~~-~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~  172 (432)
                      ..+.......++|.+. +.||+|+||.||+|.+..  ..||+|++....  ......+.+|+.+++.++ ||||++++++
T Consensus        18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~   97 (327)
T 3lm5_A           18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV   97 (327)
T ss_dssp             CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred             hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence            3444556667788887 899999999999999863  489999886432  334577899999999995 6999999999


Q ss_pred             EEeCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcC---CCCE
Q 014024          173 CIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDK---DMNS  249 (432)
Q Consensus       173 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~  249 (432)
                      +.+.+..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+   |+||||||+||+++.   ++.+
T Consensus        98 ~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~  173 (327)
T 3lm5_A           98 YENTSEIILILEYAAGGEIFSLCLPEL-AEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDI  173 (327)
T ss_dssp             EECSSEEEEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCE
T ss_pred             EEeCCeEEEEEEecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcE
Confidence            999999999999999999999985432 345999999999999999999999999   999999999999988   7899


Q ss_pred             EEeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhh
Q 014024          250 KISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGY  329 (432)
Q Consensus       250 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~  329 (432)
                      ||+|||++......       .......||+.|+|||++.+..++.++||||||+++|+|++|+.||........  ...
T Consensus       174 kL~Dfg~a~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~  244 (327)
T 3lm5_A          174 KIVDFGMSRKIGHA-------CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET--YLN  244 (327)
T ss_dssp             EECCGGGCEEC----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHH
T ss_pred             EEeeCccccccCCc-------cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH--HHH
Confidence            99999999875211       122345789999999999999999999999999999999999999854322110  000


Q ss_pred             hHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014024          330 AWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLT  385 (432)
Q Consensus       330 ~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~  385 (432)
                      ...    .      ............+..+.+++..||+.||++|||+.+++++-.
T Consensus       245 i~~----~------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~  290 (327)
T 3lm5_A          245 ISQ----V------NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSW  290 (327)
T ss_dssp             HHH----T------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGG
T ss_pred             HHh----c------ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHh
Confidence            000    0      000001111234567889999999999999999999998643

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=9.7e-44  Score=355.90  Aligned_cols=250  Identities=21%  Similarity=0.262  Sum_probs=194.0

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC---ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK---SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLL  181 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  181 (432)
                      ..++|++.+.||+|+||.||+|.+..  ..||+|++...   .......+.+|+++++.++||||+++++++.+.+..++
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l  225 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF  225 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence            34789999999999999999999854  38999998543   23345667889999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCCCCCEEEcCCCCEEEeecccceec
Q 014024          182 IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ-YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIV  260 (432)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  260 (432)
                      ||||+++|+|.+++..   ...+++..+..++.|++.||+|||+ .+   |+||||||+|||++.++.+||+|||++...
T Consensus       226 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~  299 (446)
T 4ejn_A          226 VMEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEG  299 (446)
T ss_dssp             EECCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred             EEeeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceec
Confidence            9999999999999843   3459999999999999999999998 88   999999999999999999999999999753


Q ss_pred             cCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchh
Q 014024          261 FGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKII  340 (432)
Q Consensus       261 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                      ...      ........||+.|+|||++.+..++.++|||||||++|||++|+.||.......  ..    ..       
T Consensus       300 ~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~----~~-------  360 (446)
T 4ejn_A          300 IKD------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LF----EL-------  360 (446)
T ss_dssp             CC-----------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HH----HH-------
T ss_pred             cCC------CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH--HH----HH-------
Confidence            111      122345689999999999999999999999999999999999999985322110  00    00       


Q ss_pred             hhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHHh
Q 014024          341 DLIDSVLEEASFNESLSRYVHIALLCVQERAEDRP-----TMSDVVSML  384 (432)
Q Consensus       341 ~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~~L  384 (432)
                       +...  ....+...+..+.+++..||+.||.+||     ++.|++++-
T Consensus       361 -i~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp  406 (446)
T 4ejn_A          361 -ILME--EIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHR  406 (446)
T ss_dssp             -HHHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred             -HHhC--CCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCc
Confidence             0000  0112223456788999999999999999     999999753

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=5e-43  Score=345.38  Aligned_cols=273  Identities=20%  Similarity=0.233  Sum_probs=210.1

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCC-hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC--eeEE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS-GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKD--ERLL  181 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~l  181 (432)
                      ..++|++.+.||+|+||.||+|.+..  ..||+|++.... ....+.+.+|++++++++||||+++++++.+.+  ..++
T Consensus         7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l   86 (396)
T 4eut_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL   86 (396)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred             CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence            35689999999999999999999864  489999986432 234567789999999999999999999998765  6799


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEE----cCCCCEEEeecccc
Q 014024          182 IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILL----DKDMNSKISDFGMA  257 (432)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~Dfg~a  257 (432)
                      ||||+++|+|.+++........+++..++.++.|++.||+|||+.+   |+||||||+|||+    +.++.+||+|||++
T Consensus        87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a  163 (396)
T 4eut_A           87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (396)
T ss_dssp             EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred             EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence            9999999999999966444445999999999999999999999999   9999999999999    78888999999999


Q ss_pred             eeccCCCCccccccccccccccCCccChhhhcc--------CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccch--h
Q 014024          258 RIVFGGNDEDELQGNTSRISGTYGYMSPEYALE--------GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNL--I  327 (432)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~--~  327 (432)
                      .....       ........||+.|+|||++.+        ..++.++|||||||++|||++|+.||..........  .
T Consensus       164 ~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~  236 (396)
T 4eut_A          164 RELED-------DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM  236 (396)
T ss_dssp             EECCC-------GGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHH
T ss_pred             eEccC-------CCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHH
Confidence            87522       112234579999999999875        567889999999999999999999986433211110  0


Q ss_pred             hhhHHhhhccchh---hhh------hhh--hhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccc
Q 014024          328 GYAWDLWISNKII---DLI------DSV--LEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS  389 (432)
Q Consensus       328 ~~~~~~~~~~~~~---~~i------~~~--l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~  389 (432)
                      .............   ...      ...  ............+.+++..||+.||++||++.++++.++++..
T Consensus       237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~  309 (396)
T 4eut_A          237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (396)
T ss_dssp             HHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred             HHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence            0000000000000   000      000  0112235677888999999999999999999999998877543

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.8e-43  Score=345.13  Aligned_cols=243  Identities=25%  Similarity=0.307  Sum_probs=190.5

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCCC---hHhHHHHHHHHHH-HHhcCCCceeeeEeEEEeCCeeE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKS---GQEIKELKNEASV-IAQVQHKNLVKLLGCCIEKDERL  180 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~  180 (432)
                      ..++|++.+.||+|+||.||+|++...  .+|+|++....   ......+..|..+ ++.++||||+++++++.+.+..|
T Consensus        36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~  115 (373)
T 2r5t_A           36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY  115 (373)
T ss_dssp             CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence            457899999999999999999998654  78999985432   2334456667666 56789999999999999999999


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceec
Q 014024          181 LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIV  260 (432)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  260 (432)
                      +||||+++|+|.+++..   ...+++..++.++.|++.||+|||+++   |+||||||+|||++.++++||+|||+++..
T Consensus       116 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~  189 (373)
T 2r5t_A          116 FVLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKEN  189 (373)
T ss_dssp             EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred             EEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence            99999999999999853   345899999999999999999999999   999999999999999999999999999753


Q ss_pred             cCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchh
Q 014024          261 FGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKII  340 (432)
Q Consensus       261 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                      ...      .......+||+.|+|||++.+..++.++|+|||||++|||++|..||......                  
T Consensus       190 ~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------------------  245 (373)
T 2r5t_A          190 IEH------NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA------------------  245 (373)
T ss_dssp             BCC------CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH------------------
T ss_pred             ccC------CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------------------
Confidence            211      22345568999999999999999999999999999999999999998532210                  


Q ss_pred             hhhhhhhhh--cccHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 014024          341 DLIDSVLEE--ASFNESLSRYVHIALLCVQERAEDRPTMSD  379 (432)
Q Consensus       341 ~~i~~~l~~--~~~~~~~~~l~~l~~~cl~~dp~~RPt~~e  379 (432)
                      +..+..+..  ..+......+.+++..||+.||.+||++.+
T Consensus       246 ~~~~~i~~~~~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~  286 (373)
T 2r5t_A          246 EMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKD  286 (373)
T ss_dssp             HHHHHHHHSCCCCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred             HHHHHHHhcccCCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence            111111110  112234567889999999999999999853

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=3.3e-43  Score=342.26  Aligned_cols=263  Identities=24%  Similarity=0.343  Sum_probs=205.9

Q ss_pred             hCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEe
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYE  184 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  184 (432)
                      .++|++.+.||+|+||.||+|.+.  +..+|+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            468999999999999999999986  348999998654 45556789999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCC
Q 014024          185 YMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQY-SRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGG  263 (432)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  263 (432)
                      |+++++|.+++..   ...+++..+..++.|++.||+|||+. +   |+||||||+||+++.++.+||+|||++....  
T Consensus       112 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~--  183 (360)
T 3eqc_A          112 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--  183 (360)
T ss_dssp             CCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHH--
T ss_pred             CCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccc--
Confidence            9999999999953   34599999999999999999999996 7   9999999999999999999999999987542  


Q ss_pred             CCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchh----------------
Q 014024          264 NDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLI----------------  327 (432)
Q Consensus       264 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~----------------  327 (432)
                            ........||+.|+|||++.+..++.++|||||||++|+|++|+.||...........                
T Consensus       184 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (360)
T 3eqc_A          184 ------DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP  257 (360)
T ss_dssp             ------HHC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------
T ss_pred             ------cccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCc
Confidence                  1123345789999999999999999999999999999999999999865432111000                


Q ss_pred             --------hhhHHhhhccchhhhhhhhhhhcc----cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          328 --------GYAWDLWISNKIIDLIDSVLEEAS----FNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       328 --------~~~~~~~~~~~~~~~i~~~l~~~~----~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                              .+...........+.++.......    ....+..+.+++..||+.||++|||++|++++-
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  326 (360)
T 3eqc_A          258 RTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA  326 (360)
T ss_dssp             ----------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred             ccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence                    000000011111222222221111    112356789999999999999999999999854

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=9.2e-43  Score=349.90  Aligned_cols=260  Identities=22%  Similarity=0.235  Sum_probs=195.1

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeC------
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEK------  176 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------  176 (432)
                      ..++|++.+.||+|+||.||+|.+..  ..||+|++...  .....+.+.+|+.+++.++||||+++++++...      
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  139 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF  139 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence            46899999999999999999999854  48999998654  455667889999999999999999999999654      


Q ss_pred             CeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeeccc
Q 014024          177 DERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGM  256 (432)
Q Consensus       177 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  256 (432)
                      ...|+||||++++ |.+.+.     ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       140 ~~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~  210 (464)
T 3ttj_A          140 QDVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  210 (464)
T ss_dssp             CEEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred             CeEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEe
Confidence            3569999999765 555552     12899999999999999999999999   99999999999999999999999999


Q ss_pred             ceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhh--
Q 014024          257 ARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLW--  334 (432)
Q Consensus       257 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~--  334 (432)
                      ++....       ........||+.|+|||++.+..++.++|||||||++|||++|+.||.......  .........  
T Consensus       211 a~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~--~~~~i~~~lg~  281 (464)
T 3ttj_A          211 ARTAGT-------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID--QWNKVIEQLGT  281 (464)
T ss_dssp             C------------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCS
T ss_pred             eeecCC-------CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCC
Confidence            986421       122345689999999999999999999999999999999999999986433211  000000000  


Q ss_pred             --------hccchhhhhh---------------hhhhh---cccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          335 --------ISNKIIDLID---------------SVLEE---ASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       335 --------~~~~~~~~i~---------------~~l~~---~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                              ........+.               ..+..   ........++.+|+.+||+.||++|||++|++++-
T Consensus       282 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp  357 (464)
T 3ttj_A          282 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP  357 (464)
T ss_dssp             CCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred             CCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcCh
Confidence                    0000000000               00000   00112256789999999999999999999999864

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.8e-42  Score=327.44  Aligned_cols=250  Identities=22%  Similarity=0.291  Sum_probs=204.8

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCC---ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGK---SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLL  181 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  181 (432)
                      ..++|.+.+.||+|+||.||++.+...  .+|+|.+...   .....+.+.+|+.+++.++|+||+++++++.+.+..++
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   92 (294)
T 2rku_A           13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV   92 (294)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence            357899999999999999999998643  7899988543   34566788999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceecc
Q 014024          182 IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVF  261 (432)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  261 (432)
                      ||||+++++|.+++..   +..+++..++.++.|++.||+|||+.+   ++||||||+||++++++.+||+|||++....
T Consensus        93 v~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  166 (294)
T 2rku_A           93 VLELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  166 (294)
T ss_dssp             EEECCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence            9999999999998843   345999999999999999999999999   9999999999999999999999999998752


Q ss_pred             CCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhh
Q 014024          262 GGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIID  341 (432)
Q Consensus       262 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (432)
                      ..      ........||+.|+|||.+.+..++.++||||||+++|+|++|+.||.......     .. ...       
T Consensus       167 ~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~~-~~~-------  227 (294)
T 2rku_A          167 YD------GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-----TY-LRI-------  227 (294)
T ss_dssp             ST------TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-----HH-HHH-------
T ss_pred             cC------ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HH-HHH-------
Confidence            21      112334578999999999999899999999999999999999999985432211     00 000       


Q ss_pred             hhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          342 LIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       342 ~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                       ...  ....+......+.+++.+||+.||++|||+.|++++-
T Consensus       228 -~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~  267 (294)
T 2rku_A          228 -KKN--EYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDE  267 (294)
T ss_dssp             -HTT--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred             -hhc--cCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence             000  0011223345788999999999999999999999854

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.6e-43  Score=341.10  Aligned_cols=244  Identities=23%  Similarity=0.321  Sum_probs=201.1

Q ss_pred             hhhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCCh--------HhHHHHHHHHHHHHhcCCCceeeeEeEEEe
Q 014024          106 SATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSG--------QEIKELKNEASVIAQVQHKNLVKLLGCCIE  175 (432)
Q Consensus       106 ~~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  175 (432)
                      ...++|++.+.||+|+||.||+|.+..  ..||+|.+.....        ...+.+.+|+.++++++||||+++++++.+
T Consensus        21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~  100 (335)
T 3dls_A           21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN  100 (335)
T ss_dssp             HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence            346789999999999999999998754  3899999865421        133457789999999999999999999999


Q ss_pred             CCeeEEEEecCCCC-ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeec
Q 014024          176 KDERLLIYEYMPNK-SLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDF  254 (432)
Q Consensus       176 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  254 (432)
                      .+..++||||+.+| +|.+++..   ...+++..++.++.|++.||+|||+.+   |+||||||+|||+++++.+||+||
T Consensus       101 ~~~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Df  174 (335)
T 3dls_A          101 QGFFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDF  174 (335)
T ss_dssp             SSEEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCC
T ss_pred             CCEEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeec
Confidence            99999999999777 99999853   345999999999999999999999999   999999999999999999999999


Q ss_pred             ccceeccCCCCccccccccccccccCCccChhhhccCCC-CchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHh
Q 014024          255 GMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDL  333 (432)
Q Consensus       255 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~  333 (432)
                      |++......       .......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......           
T Consensus       175 g~a~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----------  236 (335)
T 3dls_A          175 GSAAYLERG-------KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-----------  236 (335)
T ss_dssp             TTCEECCTT-------CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-----------
T ss_pred             ccceECCCC-------CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-----------
Confidence            999875221       12334678999999999988776 88999999999999999999998532110           


Q ss_pred             hhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          334 WISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       334 ~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                               .....  ..+...+..+.+++..||+.||++|||+.+++++-
T Consensus       237 ---------~~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp  276 (335)
T 3dls_A          237 ---------VEAAI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDP  276 (335)
T ss_dssp             ---------TTTCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCT
T ss_pred             ---------Hhhcc--CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence                     00000  01112345688999999999999999999999974

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-43  Score=350.44  Aligned_cols=260  Identities=18%  Similarity=0.203  Sum_probs=204.5

Q ss_pred             chhhHhhhhCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCCC---hHhHHHHHHHHHHHHhcCCCceeeeEeEEE
Q 014024          100 SFSSVSSATGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGKS---GQEIKELKNEASVIAQVQHKNLVKLLGCCI  174 (432)
Q Consensus       100 ~~~~~~~~~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  174 (432)
                      .+.+.....++|++.+.||+|+||.||++...  +..||+|++....   ....+.+.+|..++..++|+||+++++++.
T Consensus        52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  131 (412)
T 2vd5_A           52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ  131 (412)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence            34455566789999999999999999999985  3489999985432   122345788999999999999999999999


Q ss_pred             eCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeec
Q 014024          175 EKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDF  254 (432)
Q Consensus       175 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  254 (432)
                      +.+..|+||||+++|+|.+++....  ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++++||+||
T Consensus       132 ~~~~~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DF  206 (412)
T 2vd5_A          132 DENYLYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADF  206 (412)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred             eCCEEEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeec
Confidence            9999999999999999999995422  35999999999999999999999999   999999999999999999999999


Q ss_pred             ccceeccCCCCccccccccccccccCCccChhhhc-------cCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchh
Q 014024          255 GMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL-------EGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLI  327 (432)
Q Consensus       255 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~  327 (432)
                      |++.......     .......+||+.|+|||++.       ...++.++|||||||++|||++|+.||.......  . 
T Consensus       207 Gla~~~~~~~-----~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--~-  278 (412)
T 2vd5_A          207 GSCLKLRADG-----TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE--T-  278 (412)
T ss_dssp             TTCEECCTTS-----CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--H-
T ss_pred             hhheeccCCC-----ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH--H-
Confidence            9998752211     11223468999999999987       3568999999999999999999999985322110  0 


Q ss_pred             hhhHHhhhccchhhhhhhh--hh-hcccHHHHHHHHHHHHHhhccCCCCC---CCHHHHHHHh
Q 014024          328 GYAWDLWISNKIIDLIDSV--LE-EASFNESLSRYVHIALLCVQERAEDR---PTMSDVVSML  384 (432)
Q Consensus       328 ~~~~~~~~~~~~~~~i~~~--l~-~~~~~~~~~~l~~l~~~cl~~dp~~R---Pt~~evl~~L  384 (432)
                                 ...++...  +. .......+.++.+++.+||. +|.+|   |+++|++++-
T Consensus       279 -----------~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hp  329 (412)
T 2vd5_A          279 -----------YGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHP  329 (412)
T ss_dssp             -----------HHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSG
T ss_pred             -----------HHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCC
Confidence                       00111100  00 00112345678899999999 99998   6999998753

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=8.7e-43  Score=331.86  Aligned_cols=264  Identities=23%  Similarity=0.323  Sum_probs=195.5

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCCC-----hHhHHHHHHHHHHHHhc---CCCceeeeEeEEEeC
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGKS-----GQEIKELKNEASVIAQV---QHKNLVKLLGCCIEK  176 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~  176 (432)
                      ..++|++.+.||+|+||.||+|.+.  +..||+|++....     ......+.+|+.+++++   +||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            4689999999999999999999974  3489999885322     11223556677777666   499999999999876


Q ss_pred             C-----eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEE
Q 014024          177 D-----ERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKI  251 (432)
Q Consensus       177 ~-----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  251 (432)
                      .     ..++||||+. ++|.+++..... ..+++..++.++.|++.||+|||+.+   |+||||||+||+++.++.+||
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl  161 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP-PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL  161 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence            5     4789999997 599999865432 33999999999999999999999999   999999999999999999999


Q ss_pred             eecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhH
Q 014024          252 SDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAW  331 (432)
Q Consensus       252 ~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~  331 (432)
                      +|||++.....       ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.......  ......
T Consensus       162 ~Dfg~a~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~i~  232 (308)
T 3g33_A          162 ADFGLARIYSY-------QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD--QLGKIF  232 (308)
T ss_dssp             CSCSCTTTSTT-------CCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH--HHHHHH
T ss_pred             eeCccccccCC-------CcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHH
Confidence            99999976421       122345678999999999999999999999999999999999999985433211  000000


Q ss_pred             Hhhh---ccchh---hhhhhhh-------hhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          332 DLWI---SNKII---DLIDSVL-------EEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       332 ~~~~---~~~~~---~~i~~~l-------~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                      ....   .....   .......       ...........+.+++.+||+.||++|||+.|++++-
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~  298 (308)
T 3g33_A          233 DLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHS  298 (308)
T ss_dssp             HHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTST
T ss_pred             HHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCc
Confidence            0000   00000   0000000       0001112346788999999999999999999999753

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.1e-42  Score=342.15  Aligned_cols=267  Identities=23%  Similarity=0.348  Sum_probs=192.5

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC--ChHhHHHHHHHHHHHHhcC-CCceeeeEeEEEeCC--ee
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK--SGQEIKELKNEASVIAQVQ-HKNLVKLLGCCIEKD--ER  179 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~--~~  179 (432)
                      ..++|++.+.||+|+||.||+|.+..  ..||+|++...  .....+.+.+|+.+++.+. |+||+++++++...+  ..
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~   86 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV   86 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence            46799999999999999999999854  48999998543  4556677889999999997 999999999997654  68


Q ss_pred             EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeeccccee
Q 014024          180 LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARI  259 (432)
Q Consensus       180 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  259 (432)
                      |+||||++ ++|.+++..    ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        87 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~  158 (388)
T 3oz6_A           87 YLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRS  158 (388)
T ss_dssp             EEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence            99999997 588888843    35899999999999999999999999   99999999999999999999999999987


Q ss_pred             ccCCCCc---------------cccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCccccc
Q 014024          260 VFGGNDE---------------DELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKS  323 (432)
Q Consensus       260 ~~~~~~~---------------~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~  323 (432)
                      +......               ...........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~  238 (388)
T 3oz6_A          159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN  238 (388)
T ss_dssp             SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            5321110               001122344689999999999986 679999999999999999999999986433211


Q ss_pred             cchhhhhHHhh-----------hccchhhhhhhhh----------------------hhcccHHHHHHHHHHHHHhhccC
Q 014024          324 LNLIGYAWDLW-----------ISNKIIDLIDSVL----------------------EEASFNESLSRYVHIALLCVQER  370 (432)
Q Consensus       324 ~~~~~~~~~~~-----------~~~~~~~~i~~~l----------------------~~~~~~~~~~~l~~l~~~cl~~d  370 (432)
                        .........           ........++...                      ...........+.+|+.+||+.|
T Consensus       239 --~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~d  316 (388)
T 3oz6_A          239 --QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFN  316 (388)
T ss_dssp             --HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSS
T ss_pred             --HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccC
Confidence              000000000           0000111111000                      00001123457889999999999


Q ss_pred             CCCCCCHHHHHHH
Q 014024          371 AEDRPTMSDVVSM  383 (432)
Q Consensus       371 p~~RPt~~evl~~  383 (432)
                      |++|||+.|++++
T Consensus       317 P~~R~t~~e~l~H  329 (388)
T 3oz6_A          317 PNKRISANDALKH  329 (388)
T ss_dssp             GGGSCCHHHHTTS
T ss_pred             cccCCCHHHHhCC
Confidence            9999999999987

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2.7e-43  Score=330.25  Aligned_cols=261  Identities=23%  Similarity=0.300  Sum_probs=205.0

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEe--CCeeE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIE--KDERL  180 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~  180 (432)
                      ..++|++.+.||+|+||.||++.+..  ..+++|.+...  .....+.+.+|++++++++||||+++++++.+  ....+
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   83 (279)
T 2w5a_A            4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY   83 (279)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred             chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence            35789999999999999999999853  47999998643  34566789999999999999999999998854  56789


Q ss_pred             EEEecCCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCC--CCeEeccCCCCCEEEcCCCCEEEeecccc
Q 014024          181 LIYEYMPNKSLDCFLFDPT-KREILDWRTRVQIIKGVAQGLLYLHQYSR--VRIIHRDLKASNILLDKDMNSKISDFGMA  257 (432)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~--~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  257 (432)
                      +||||+++++|.+++.... .+..+++..++.++.|++.||+|||+.+.  .+++||||||+||++++++.+||+|||++
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~  163 (279)
T 2w5a_A           84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA  163 (279)
T ss_dssp             EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred             EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence            9999999999999986422 23349999999999999999999999762  34999999999999999999999999999


Q ss_pred             eeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhcc
Q 014024          258 RIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISN  337 (432)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  337 (432)
                      ......      ........||+.|+|||.+.+..++.++||||||+++|+|++|+.||.......              
T Consensus       164 ~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------------  223 (279)
T 2w5a_A          164 RILNHD------TSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE--------------  223 (279)
T ss_dssp             HHC---------CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------------
T ss_pred             eeeccc------cccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH--------------
Confidence            764211      111234578999999999999999999999999999999999999985432110              


Q ss_pred             chhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014024          338 KIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEA  388 (432)
Q Consensus       338 ~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~  388 (432)
                       ....+........+...+..+.+++.+||+.||++|||+.|+++++....
T Consensus       224 -~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~  273 (279)
T 2w5a_A          224 -LAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE  273 (279)
T ss_dssp             -HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred             -HHHHHhhcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence             00111111111122334567899999999999999999999999876644

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=4.3e-43  Score=336.90  Aligned_cols=261  Identities=29%  Similarity=0.441  Sum_probs=205.1

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEEC-------CceEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCe
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIG-------QGEIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDE  178 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~-------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  178 (432)
                      ..++|++.+.||+|+||.||+|.+.       +..||+|.+... .......+.+|+.++++++||||+++++++.+.+.
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP  107 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence            3578999999999999999999843       237999998644 45556778999999999999999999999999999


Q ss_pred             eEEEEecCCCCChhhhhcCCCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcC---CCCEEE
Q 014024          179 RLLIYEYMPNKSLDCFLFDPTK----REILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDK---DMNSKI  251 (432)
Q Consensus       179 ~~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl  251 (432)
                      .++||||+++++|.+++.....    ...+++..++.++.|++.||.|||+.+   |+||||||+||+++.   +..+||
T Consensus       108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEE
Confidence            9999999999999999965321    244899999999999999999999999   999999999999984   456999


Q ss_pred             eecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhh
Q 014024          252 SDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYA  330 (432)
Q Consensus       252 ~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~  330 (432)
                      +|||++........    ........+|+.|+|||++.+..++.++||||||+++|+|+| |..||......        
T Consensus       185 ~Dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--------  252 (327)
T 2yfx_A          185 GDFGMARDIYRASY----YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--------  252 (327)
T ss_dssp             CCCHHHHHHHC----------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--------
T ss_pred             Cccccccccccccc----cccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH--------
Confidence            99999976422111    112234567889999999999999999999999999999998 88887532211        


Q ss_pred             HHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccc
Q 014024          331 WDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS  389 (432)
Q Consensus       331 ~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~  389 (432)
                             ...+.+........+...+..+.+++..||+.||.+|||+.+++++|+....
T Consensus       253 -------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  304 (327)
T 2yfx_A          253 -------EVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  304 (327)
T ss_dssp             -------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence                   0111111111112223445678899999999999999999999999987653

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=4.9e-43  Score=337.10  Aligned_cols=263  Identities=23%  Similarity=0.356  Sum_probs=199.2

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEE
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  183 (432)
                      .++|++.+.||+|+||.||+|.+..  ..||+|++...  .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            4689999999999999999999864  48999988544  3444567889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCC
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGG  263 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  263 (432)
                      ||+++++|.+++..   ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++......
T Consensus       104 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  177 (331)
T 4aaa_A          104 EFVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  177 (331)
T ss_dssp             ECCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             ecCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence            99999999988743   334999999999999999999999999   999999999999999999999999999764221


Q ss_pred             CCccccccccccccccCCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhh----------HH
Q 014024          264 NDEDELQGNTSRISGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYA----------WD  332 (432)
Q Consensus       264 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~----------~~  332 (432)
                            ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||........ .....          ..
T Consensus       178 ------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~  250 (331)
T 4aaa_A          178 ------GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ-LYHIMMCLGNLIPRHQE  250 (331)
T ss_dssp             ------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCSCCHHHHH
T ss_pred             ------ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCChhhhh
Confidence                  1123345789999999999875 789999999999999999999999865432110 00000          00


Q ss_pred             hhhcc------chhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          333 LWISN------KIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       333 ~~~~~------~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      .+...      ..................+..+.+++..||+.||++|||+.|++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          251 LFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             HHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             HhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            00000      0000000000001112345678999999999999999999999974

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=4.9e-43  Score=329.46  Aligned_cols=247  Identities=21%  Similarity=0.286  Sum_probs=198.3

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCC--ChHhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeeEE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGK--SGQEIKELKNEASVIAQV-QHKNLVKLLGCCIEKDERLL  181 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l  181 (432)
                      ..++|++.+.||+|+||.||+|.+.  +..||+|.+...  .......+.+|+..+..+ +||||+++++++.+.+..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            4578999999999999999999985  448999998653  334556788999999999 99999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCC--------------
Q 014024          182 IYEYMPNKSLDCFLFDPTK-REILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKD--------------  246 (432)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~--------------  246 (432)
                      ||||+++++|.+++..... ...+++..++.++.|++.||+|||+.+   |+||||||+||+++.+              
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence            9999999999999954211 245899999999999999999999999   9999999999999844              


Q ss_pred             -----CCEEEeecccceeccCCCCccccccccccccccCCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCCcc
Q 014024          247 -----MNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGFYR  320 (432)
Q Consensus       247 -----~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlG~il~elltg~~p~~~~~  320 (432)
                           ..+||+|||++.....          .....||+.|+|||++.+. .++.++||||||+++|+|++|..++....
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~  235 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISS----------PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD  235 (289)
T ss_dssp             ----CCCEEECCCTTCEETTC----------SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH
T ss_pred             ccCCceEEEEcccccccccCC----------ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh
Confidence                 4799999999987421          1223589999999999865 67789999999999999999987653211


Q ss_pred             ccccchhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          321 TKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                      .         ....         ........+...+..+.+++..||+.||++|||+.|++++-
T Consensus       236 ~---------~~~~---------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~  281 (289)
T 1x8b_A          236 Q---------WHEI---------RQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHS  281 (289)
T ss_dssp             H---------HHHH---------HTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCT
T ss_pred             H---------HHHH---------HcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhCh
Confidence            0         0000         00011112223456788999999999999999999998753

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2e-42  Score=347.60  Aligned_cols=201  Identities=25%  Similarity=0.400  Sum_probs=156.7

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeC-----C
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEK-----D  177 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~  177 (432)
                      ..++|++.+.||+|+||.||+|.+..  ..||+|++...  .....+.+.+|+++|+.++|+||+++++++...     .
T Consensus        51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  130 (458)
T 3rp9_A           51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD  130 (458)
T ss_dssp             SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence            35789999999999999999998754  48999998543  445567889999999999999999999999543     5


Q ss_pred             eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccc
Q 014024          178 ERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMA  257 (432)
Q Consensus       178 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  257 (432)
                      ..|+||||+ +++|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       131 ~~~lv~e~~-~~~L~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla  203 (458)
T 3rp9_A          131 ELYVVLEIA-DSDFKKLFRT---PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLA  203 (458)
T ss_dssp             CEEEEECCC-SEEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecc-ccchhhhccc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccc
Confidence            689999998 5788888853   345999999999999999999999999   999999999999999999999999999


Q ss_pred             eeccCCCCccc---------------------cccccccccccCCccChhhh-ccCCCCchhhhHHHHHHHHHHHhCCC
Q 014024          258 RIVFGGNDEDE---------------------LQGNTSRISGTYGYMSPEYA-LEGIFSIKSDVFSFGVLLLEIVSGKK  314 (432)
Q Consensus       258 ~~~~~~~~~~~---------------------~~~~~~~~~gt~~y~aPE~~-~~~~~t~~~DvwSlG~il~elltg~~  314 (432)
                      +..........                     ........+||+.|+|||++ .+..++.++|||||||++|||++|..
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~  282 (458)
T 3rp9_A          204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIK  282 (458)
T ss_dssp             BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTST
T ss_pred             hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcc
Confidence            87532211100                     01123456789999999986 45679999999999999999999543

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.8e-43  Score=340.81  Aligned_cols=272  Identities=15%  Similarity=0.179  Sum_probs=207.6

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC----------ceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceee---------
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ----------GEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVK---------  168 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------  168 (432)
                      .++|++.+.||+|+||.||+|.+..          ..+|+|.+...     +.+.+|++++++++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            4789999999999999999999853          48999998654     35788999999999999987         


Q ss_pred             ------eEeEEEe-CCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCE
Q 014024          169 ------LLGCCIE-KDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNI  241 (432)
Q Consensus       169 ------~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NI  241 (432)
                            +++++.. .+..++||||+ +++|.+++.... ...+++..++.++.|++.||+|||+.+   |+||||||+||
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI  190 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI  190 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence                  6777776 67889999999 999999996431 345999999999999999999999998   99999999999


Q ss_pred             EEcCCC--CEEEeecccceeccCCCCcc-ccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 014024          242 LLDKDM--NSKISDFGMARIVFGGNDED-ELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGF  318 (432)
Q Consensus       242 ll~~~~--~~kl~Dfg~a~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~  318 (432)
                      |++.++  .+||+|||++..+....... ..........||+.|+|||++.+..++.++||||||+++|+|++|+.||..
T Consensus       191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  270 (352)
T 2jii_A          191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN  270 (352)
T ss_dssp             EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            999998  89999999998753221111 111223445899999999999999999999999999999999999999854


Q ss_pred             ccccccchhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccccCCCCC
Q 014024          319 YRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPP  394 (432)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~~~  394 (432)
                      ...............  ......+.+...   .....+..+.+++..||+.||++|||+.++++.|+.+.......
T Consensus       271 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~  341 (352)
T 2jii_A          271 CLPNTEDIMKQKQKF--VDKPGPFVGPCG---HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVS  341 (352)
T ss_dssp             GTTCHHHHHHHHHHH--HHSCCCEECTTS---CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             CCcCHHHHHHHHHhc--cCChhhhhhhcc---ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCC
Confidence            321111111000000  000000000000   00123467899999999999999999999999999877654433

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=5e-43  Score=336.12  Aligned_cols=262  Identities=21%  Similarity=0.309  Sum_probs=192.9

Q ss_pred             CCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCChHh-HHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEec
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSGQE-IKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEY  185 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  185 (432)
                      ++|++.+.||+|+||.||+|.+..  ..||+|++....... ...+.+|++++++++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            579999999999999999999863  479999986443221 12455799999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCC
Q 014024          186 MPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGND  265 (432)
Q Consensus       186 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  265 (432)
                      ++ |+|.+++...  ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++......  
T Consensus        82 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~--  153 (324)
T 3mtl_A           82 LD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP--  153 (324)
T ss_dssp             CS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred             cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCC--
Confidence            97 5888887543  234999999999999999999999999   999999999999999999999999999764211  


Q ss_pred             ccccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhh---hccchhh
Q 014024          266 EDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLW---ISNKIID  341 (432)
Q Consensus       266 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~  341 (432)
                          ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......  .........   .......
T Consensus       154 ----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~i~~~~~~~~~~~~~~  227 (324)
T 3mtl_A          154 ----TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE--QLHFIFRILGTPTEETWPG  227 (324)
T ss_dssp             -------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCTTTSTT
T ss_pred             ----ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChHhchh
Confidence                122334578999999999876 568999999999999999999999986543211  111110000   0000000


Q ss_pred             hhhhh-h------------hhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          342 LIDSV-L------------EEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       342 ~i~~~-l------------~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                      ..... .            ...........+.+++..||+.||++|||+.|++++-
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp  283 (324)
T 3mtl_A          228 ILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHP  283 (324)
T ss_dssp             GGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSG
T ss_pred             hhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcCh
Confidence            00000 0            0001112345778999999999999999999999853

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.3e-43  Score=328.86  Aligned_cols=251  Identities=24%  Similarity=0.374  Sum_probs=183.0

Q ss_pred             hhhCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCCCh---HhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeE
Q 014024          106 SATGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGKSG---QEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERL  180 (432)
Q Consensus       106 ~~~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  180 (432)
                      ...++|++.+.||+|+||.||+|.+.  +..||+|.+.....   ...+.+.+|+.++++++||||+++++++.+.+..+
T Consensus         8 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   87 (278)
T 3cok_A            8 EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVY   87 (278)
T ss_dssp             SSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEE
T ss_pred             cccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEE
Confidence            34578999999999999999999974  44899999854321   22467889999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceec
Q 014024          181 LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIV  260 (432)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  260 (432)
                      +||||+++++|.+++...  ...+++..++.++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++...
T Consensus        88 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~  162 (278)
T 3cok_A           88 LVLEMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQL  162 (278)
T ss_dssp             EEEECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeec
Confidence            999999999999999643  245999999999999999999999998   999999999999999999999999999874


Q ss_pred             cCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchh
Q 014024          261 FGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKII  340 (432)
Q Consensus       261 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                      ...      ........||+.|+|||.+.+..++.++||||||+++|+|++|+.||........  .    .......  
T Consensus       163 ~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~----~~~~~~~--  228 (278)
T 3cok_A          163 KMP------HEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT--L----NKVVLAD--  228 (278)
T ss_dssp             C----------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------CCSSC--
T ss_pred             cCC------CCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH--H----HHHhhcc--
Confidence            211      1122345789999999999988999999999999999999999999864332110  0    0000000  


Q ss_pred             hhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          341 DLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       341 ~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                              ...+...+..+.+++.+||+.||++|||+.+++++
T Consensus       229 --------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  263 (278)
T 3cok_A          229 --------YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH  263 (278)
T ss_dssp             --------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             --------cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence                    01112234578899999999999999999999874

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.1e-42  Score=331.59  Aligned_cols=263  Identities=19%  Similarity=0.217  Sum_probs=199.2

Q ss_pred             hhhCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCC---ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeE
Q 014024          106 SATGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGK---SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERL  180 (432)
Q Consensus       106 ~~~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  180 (432)
                      ...++|++.+.||+|+||.||+|.+.  +..||+|++...   .....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus        31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~  110 (309)
T 2h34_A           31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY  110 (309)
T ss_dssp             ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred             cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence            44689999999999999999999975  347999998544   3344578899999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceec
Q 014024          181 LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIV  260 (432)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  260 (432)
                      +||||+++++|.+++..   ...+++..++.++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++...
T Consensus       111 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~  184 (309)
T 2h34_A          111 VDMRLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASAT  184 (309)
T ss_dssp             EEEECCCCEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred             EEEEecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence            99999999999999953   345999999999999999999999999   999999999999999999999999999764


Q ss_pred             cCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchh
Q 014024          261 FGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKII  340 (432)
Q Consensus       261 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                      ....     ........|++.|+|||.+.+..++.++||||||+++|+|++|+.||......      ..... ......
T Consensus       185 ~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~-~~~~~~  252 (309)
T 2h34_A          185 TDEK-----LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS------VMGAH-INQAIP  252 (309)
T ss_dssp             -----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH------HHHHH-HHSCCC
T ss_pred             cccc-----cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH------HHHHH-hccCCC
Confidence            2211     11223456899999999999999999999999999999999999998533211      00000 000000


Q ss_pred             hhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHhcccccCCC
Q 014024          341 DLIDSVLEEASFNESLSRYVHIALLCVQERAEDRP-TMSDVVSMLTNEASSLL  392 (432)
Q Consensus       341 ~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RP-t~~evl~~L~~~~~~~~  392 (432)
                      .      ........+..+.+++..||+.||++|| +++++++.|+.......
T Consensus       253 ~------~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~  299 (309)
T 2h34_A          253 R------PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD  299 (309)
T ss_dssp             C------GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred             C------ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence            0      0111223456788999999999999999 99999999998765443

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=3.3e-42  Score=339.77  Aligned_cols=253  Identities=18%  Similarity=0.255  Sum_probs=191.0

Q ss_pred             hhCCCCcC-ceeccCCcEEEEEEEECC--ceEEEEEEcCCChHhHHHHHHHHHHHHh-cCCCceeeeEeEEEe----CCe
Q 014024          107 ATGNFSAA-NKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSGQEIKELKNEASVIAQ-VQHKNLVKLLGCCIE----KDE  178 (432)
Q Consensus       107 ~~~~y~~~-~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~----~~~  178 (432)
                      ..++|.+. +.||+|+||+||+|.+..  ..||+|++...     ..+.+|+.++.+ .+|+||+++++++..    ...
T Consensus        59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~  133 (400)
T 1nxk_A           59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC  133 (400)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence            34667766 789999999999999864  37999998532     346778888744 589999999999876    567


Q ss_pred             eEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcC---CCCEEEeecc
Q 014024          179 RLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDK---DMNSKISDFG  255 (432)
Q Consensus       179 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg  255 (432)
                      .++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.   ++.+||+|||
T Consensus       134 ~~lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG  209 (400)
T 1nxk_A          134 LLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG  209 (400)
T ss_dssp             EEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             EEEEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecc
Confidence            899999999999999996532 235999999999999999999999998   999999999999997   7899999999


Q ss_pred             cceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccc--hhhhhHHh
Q 014024          256 MARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLN--LIGYAWDL  333 (432)
Q Consensus       256 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~--~~~~~~~~  333 (432)
                      ++.....       ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.........  ......  
T Consensus       210 ~a~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~--  280 (400)
T 1nxk_A          210 FAKETTS-------HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR--  280 (400)
T ss_dssp             TCEECC------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH--
T ss_pred             cccccCC-------CCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH--
Confidence            9986421       11234567899999999999999999999999999999999999998643321110  000000  


Q ss_pred             hhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014024          334 WISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLT  385 (432)
Q Consensus       334 ~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~  385 (432)
                        .... .     ...........++.+|+..||+.||++|||+.|++++-.
T Consensus       281 --~~~~-~-----~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~  324 (400)
T 1nxk_A          281 --MGQY-E-----FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW  324 (400)
T ss_dssp             --HTCC-C-----CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred             --cCcc-c-----CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence              0000 0     000001234567889999999999999999999998654

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2.7e-42  Score=343.92  Aligned_cols=204  Identities=24%  Similarity=0.387  Sum_probs=167.9

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeC-----C
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEK-----D  177 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~  177 (432)
                      ..++|++.+.||+|+||.||+|.+...  .||+|++...  .....+.+.+|+++|++++|+||+++++++...     +
T Consensus        24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  103 (432)
T 3n9x_A           24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD  103 (432)
T ss_dssp             CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence            357999999999999999999998654  7999999653  445567889999999999999999999999776     5


Q ss_pred             eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccc
Q 014024          178 ERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMA  257 (432)
Q Consensus       178 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  257 (432)
                      ..|+||||++ ++|.+++..   +..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla  176 (432)
T 3n9x_A          104 ELYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLA  176 (432)
T ss_dssp             CEEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCc
Confidence            6899999986 599999853   345999999999999999999999999   999999999999999999999999999


Q ss_pred             eeccCCCCcc----------------ccccccccccccCCccChhhh-ccCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 014024          258 RIVFGGNDED----------------ELQGNTSRISGTYGYMSPEYA-LEGIFSIKSDVFSFGVLLLEIVSGKKNTG  317 (432)
Q Consensus       258 ~~~~~~~~~~----------------~~~~~~~~~~gt~~y~aPE~~-~~~~~t~~~DvwSlG~il~elltg~~p~~  317 (432)
                      +.........                ..........||+.|+|||++ ....++.++|||||||++|||++|..|+.
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            8753221110                001123567899999999986 45679999999999999999999766654

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2.1e-42  Score=325.26  Aligned_cols=246  Identities=21%  Similarity=0.309  Sum_probs=201.9

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCCC---hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEE
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKS---GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLI  182 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  182 (432)
                      .++|++.+.||+|+||.||+|.+...  .+|+|.+....   ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            46899999999999999999998643  79999885432   12346788999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccC
Q 014024          183 YEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFG  262 (432)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  262 (432)
                      |||+++++|.+++..   .+.+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.....
T Consensus        93 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  166 (284)
T 2vgo_A           93 LEFAPRGELYKELQK---HGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS  166 (284)
T ss_dssp             ECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred             EEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence            999999999999853   345999999999999999999999998   99999999999999999999999999976421


Q ss_pred             CCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhh
Q 014024          263 GNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDL  342 (432)
Q Consensus       263 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                              .......|++.|+|||++.+..++.++||||||+++|+|++|+.||.......      ...        .+
T Consensus       167 --------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~--------~~  224 (284)
T 2vgo_A          167 --------LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE------THR--------RI  224 (284)
T ss_dssp             --------SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHH--------HH
T ss_pred             --------cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH------HHH--------HH
Confidence                    12234578999999999999999999999999999999999999985432110      000        00


Q ss_pred             hhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          343 IDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       343 i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      ...  ....+...+..+.+++..||+.||.+|||+.+++++
T Consensus       225 ~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  263 (284)
T 2vgo_A          225 VNV--DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH  263 (284)
T ss_dssp             HTT--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred             hcc--ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence            000  011122344678899999999999999999999974

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=2.9e-42  Score=342.26  Aligned_cols=254  Identities=21%  Similarity=0.300  Sum_probs=191.2

Q ss_pred             hhhCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCCC--------hHhHHHHHHHHHHHHhcCCCceeeeEeEEEe
Q 014024          106 SATGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKS--------GQEIKELKNEASVIAQVQHKNLVKLLGCCIE  175 (432)
Q Consensus       106 ~~~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  175 (432)
                      ...++|.+.+.||+|+||.||+|.+...  .||+|++....        ......+.+|+++|++++||||+++++++. 
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-  210 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-  210 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence            4568999999999999999999998654  89999985431        122235789999999999999999999975 


Q ss_pred             CCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCC---CEEEe
Q 014024          176 KDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDM---NSKIS  252 (432)
Q Consensus       176 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~  252 (432)
                      .+..++||||+++|+|.+++..   +..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++   .+||+
T Consensus       211 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~  284 (419)
T 3i6u_A          211 AEDYYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT  284 (419)
T ss_dssp             SSEEEEEEECCTTCBGGGGTSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred             cCceEEEEEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence            4567999999999999998843   445999999999999999999999998   99999999999997544   59999


Q ss_pred             ecccceeccCCCCccccccccccccccCCccChhhhcc---CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhh
Q 014024          253 DFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE---GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGY  329 (432)
Q Consensus       253 Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~  329 (432)
                      |||++.....       ........||+.|+|||++.+   ..++.++|||||||++|+|++|+.||........ ....
T Consensus       285 DFG~a~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-~~~~  356 (419)
T 3i6u_A          285 DFGHSKILGE-------TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-LKDQ  356 (419)
T ss_dssp             CSSTTTSCC------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC-HHHH
T ss_pred             ecccceecCC-------CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH-HHHH
Confidence            9999986421       112345679999999999863   6788999999999999999999999864322111 1000


Q ss_pred             hHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          330 AWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       330 ~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                      .    .... .....     ......+..+.+++.+||+.||++|||+.|++++-
T Consensus       357 i----~~~~-~~~~~-----~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp  401 (419)
T 3i6u_A          357 I----TSGK-YNFIP-----EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHP  401 (419)
T ss_dssp             H----HTTC-CCCCH-----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred             H----hcCC-CCCCc-----hhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCc
Confidence            0    0000 00000     00112346788999999999999999999999863

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=7.9e-43  Score=328.55  Aligned_cols=254  Identities=21%  Similarity=0.293  Sum_probs=196.9

Q ss_pred             hhhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEE
Q 014024          106 SATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLI  182 (432)
Q Consensus       106 ~~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  182 (432)
                      ...++|.+.+.||+|+||.||++.+..  ..+|+|++... .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   98 (285)
T 3is5_A           19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV   98 (285)
T ss_dssp             CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence            345789999999999999999999854  38999988544 233467889999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEE---cCCCCEEEeecccce
Q 014024          183 YEYMPNKSLDCFLFDPT-KREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILL---DKDMNSKISDFGMAR  258 (432)
Q Consensus       183 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~  258 (432)
                      |||+++++|.+++.... ....+++..++.++.|++.||+|||+.+   |+||||||+||++   +.++.+||+|||++.
T Consensus        99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~  175 (285)
T 3is5_A           99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAE  175 (285)
T ss_dssp             ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred             EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence            99999999999885421 2345999999999999999999999999   9999999999999   456889999999997


Q ss_pred             eccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccc
Q 014024          259 IVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNK  338 (432)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  338 (432)
                      .....       .......||+.|+|||.+. +.++.++||||||+++|+|++|+.||........     ........ 
T Consensus       176 ~~~~~-------~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~-----~~~~~~~~-  241 (285)
T 3is5_A          176 LFKSD-------EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV-----QQKATYKE-  241 (285)
T ss_dssp             C-----------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----HHHHHHCC-
T ss_pred             ecCCc-------ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHH-----HhhhccCC-
Confidence            64221       1233457899999999875 5789999999999999999999999854322110     00000000 


Q ss_pred             hhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          339 IIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       339 ~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                            .... ......+..+.+++..||+.||++|||+.|++++
T Consensus       242 ------~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  279 (285)
T 3is5_A          242 ------PNYA-VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH  279 (285)
T ss_dssp             ------CCCC-C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             ------cccc-cccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                  0000 0001124567899999999999999999999874

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=8.7e-43  Score=355.20  Aligned_cols=254  Identities=24%  Similarity=0.311  Sum_probs=205.2

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCCC---hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGKS---GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLL  181 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  181 (432)
                      ..++|++.++||+|+||.||+|.+.  +..||+|++....   ......+.+|+++|+.++||||+++++++.+.+..++
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l  261 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL  261 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence            4577999999999999999999985  3489999985431   1234567899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceecc
Q 014024          182 IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVF  261 (432)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  261 (432)
                      ||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus       262 VmEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~  337 (576)
T 2acx_A          262 VLTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP  337 (576)
T ss_dssp             EECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecc
Confidence            999999999999996543 334999999999999999999999999   9999999999999999999999999998752


Q ss_pred             CCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhh
Q 014024          262 GGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIID  341 (432)
Q Consensus       262 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (432)
                      ..       .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..          .+..
T Consensus       338 ~~-------~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~-~~----------~i~~  399 (576)
T 2acx_A          338 EG-------QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-RE----------EVER  399 (576)
T ss_dssp             TT-------CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC-HH----------HHHH
T ss_pred             cC-------ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh-HH----------HHHH
Confidence            21       122345899999999999999999999999999999999999999864322110 00          0001


Q ss_pred             hhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 014024          342 LIDSVLEEASFNESLSRYVHIALLCVQERAEDRP-----TMSDVVSM  383 (432)
Q Consensus       342 ~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~~  383 (432)
                      .+.. .....+......+.+++..||+.||.+||     +++|++++
T Consensus       400 ~i~~-~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          400 LVKE-VPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             HHHH-CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             Hhhc-ccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence            1110 01112233456788999999999999999     78999875

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=5.7e-43  Score=363.79  Aligned_cols=249  Identities=28%  Similarity=0.404  Sum_probs=198.5

Q ss_pred             ceeccCCcEEEEEEEEC--C--ceEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecCCC
Q 014024          115 NKLGEGGFGTVYKGVIG--Q--GEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPN  188 (432)
Q Consensus       115 ~~ig~G~~g~Vy~~~~~--~--~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  188 (432)
                      +.||+|+||.||+|.+.  .  ..||||++...  .....+.+.+|+++|++++||||+++++++.+ +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            47999999999999653  2  37999998653  33446789999999999999999999999964 568899999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCccc
Q 014024          189 KSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDE  268 (432)
Q Consensus       189 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  268 (432)
                      |+|.+++..   +..+++..++.++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++.+......  
T Consensus       454 g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~--  525 (635)
T 4fl3_A          454 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY--  525 (635)
T ss_dssp             EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred             CCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc--
Confidence            999999953   345999999999999999999999999   999999999999999999999999999875322111  


Q ss_pred             cccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchhhhhhhhh
Q 014024          269 LQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVL  347 (432)
Q Consensus       269 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  347 (432)
                       ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....               ......+....
T Consensus       526 -~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~---------------~~~~~~i~~~~  589 (635)
T 4fl3_A          526 -YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---------------SEVTAMLEKGE  589 (635)
T ss_dssp             ----------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH---------------HHHHHHHHTTC
T ss_pred             -cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH---------------HHHHHHHHcCC
Confidence             112233456788999999999999999999999999999998 9999853322               11122222222


Q ss_pred             hhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014024          348 EEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEA  388 (432)
Q Consensus       348 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~  388 (432)
                      ....+..++.++.+++..||+.||++||++.+|++.|++..
T Consensus       590 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~  630 (635)
T 4fl3_A          590 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  630 (635)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            33344456678999999999999999999999999998754

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.6e-42  Score=329.47  Aligned_cols=252  Identities=22%  Similarity=0.318  Sum_probs=201.1

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEe
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYE  184 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  184 (432)
                      ..++|.+.+.||+|+||.||++.+.  +..+|+|.+........+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ   86 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence            3568999999999999999999985  44899999976655556678999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEE---cCCCCEEEeecccceecc
Q 014024          185 YMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILL---DKDMNSKISDFGMARIVF  261 (432)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~  261 (432)
                      |+++++|.+++..   ++.+++..+..++.|++.||.|||+.+   ++||||||+||++   ++++.+||+|||++....
T Consensus        87 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~  160 (304)
T 2jam_A           87 LVSGGELFDRILE---RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ  160 (304)
T ss_dssp             CCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred             cCCCccHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence            9999999998853   345899999999999999999999998   9999999999999   788999999999987531


Q ss_pred             CCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhh
Q 014024          262 GGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIID  341 (432)
Q Consensus       262 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (432)
                              ........||+.|+|||++.+..++.++||||||+++|+|++|+.||......  ...    ........ .
T Consensus       161 --------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~----~~i~~~~~-~  225 (304)
T 2jam_A          161 --------NGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES--KLF----EKIKEGYY-E  225 (304)
T ss_dssp             --------CBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHH----HHHHHCCC-C
T ss_pred             --------CCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--HHH----HHHHcCCC-C
Confidence                    11223456899999999999999999999999999999999999998532211  000    00000000 0


Q ss_pred             hhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          342 LIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       342 ~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                           .........+..+.+++..||+.||++|||+.|++++-
T Consensus       226 -----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~  263 (304)
T 2jam_A          226 -----FESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHP  263 (304)
T ss_dssp             -----CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred             -----CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCc
Confidence                 00111123456788999999999999999999999853

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=9.5e-43  Score=327.27  Aligned_cols=251  Identities=24%  Similarity=0.327  Sum_probs=199.3

Q ss_pred             hCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCCCh------HhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCee
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGKSG------QEIKELKNEASVIAQVQHKNLVKLLGCCIEKDER  179 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  179 (432)
                      .++|++.+.||+|+||.||+|.+.  +..+|+|.+.....      ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            357899999999999999999986  34899998854321      2367899999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCC----CEEEeecc
Q 014024          180 LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDM----NSKISDFG  255 (432)
Q Consensus       180 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Dfg  255 (432)
                      ++||||+++++|.+++..   +..+++..++.++.|++.||.|||+.+   ++||||||+||++++++    .+||+|||
T Consensus        84 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg  157 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFG  157 (283)
T ss_dssp             EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecc
Confidence            999999999999999953   345999999999999999999999998   99999999999998877    89999999


Q ss_pred             cceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhh
Q 014024          256 MARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWI  335 (432)
Q Consensus       256 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  335 (432)
                      ++......       .......|++.|+|||++.+..++.++||||||+++|+|++|+.||.......  ..    ....
T Consensus       158 ~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~----~~~~  224 (283)
T 3bhy_A          158 IAHKIEAG-------NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE--TL----TNIS  224 (283)
T ss_dssp             TCEECC---------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HH----HHHH
T ss_pred             cceeccCC-------CcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH--HH----HHhH
Confidence            99875221       12234568999999999999999999999999999999999999985432110  00    0000


Q ss_pred             ccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          336 SNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       336 ~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      ... ..     .........+..+.+++.+||+.||++|||+.+++++
T Consensus       225 ~~~-~~-----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  266 (283)
T 3bhy_A          225 AVN-YD-----FDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH  266 (283)
T ss_dssp             TTC-CC-----CCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred             hcc-cC-----CcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence            000 00     0000111234568899999999999999999999984

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.2e-42  Score=351.26  Aligned_cols=254  Identities=26%  Similarity=0.336  Sum_probs=204.8

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCC---hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS---GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLL  181 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  181 (432)
                      ..++|++.++||+|+||.||+|.+..  ..||+|++....   ....+.+.+|++++++++||||+++++++.+.+..|+
T Consensus       183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l  262 (543)
T 3c4z_A          183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCL  262 (543)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEE
Confidence            34789999999999999999999853  489999985432   1234678899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceec
Q 014024          182 IYEYMPNKSLDCFLFDPTK-REILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIV  260 (432)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  260 (432)
                      ||||+++|+|.+++..... +..+++..++.++.|++.||.|||+.+   |+||||||+|||++.+|.+||+|||++...
T Consensus       263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~  339 (543)
T 3c4z_A          263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVEL  339 (543)
T ss_dssp             EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeec
Confidence            9999999999999865432 346999999999999999999999999   999999999999999999999999999875


Q ss_pred             cCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchh
Q 014024          261 FGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKII  340 (432)
Q Consensus       261 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                      ...      .......+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..             .
T Consensus       340 ~~~------~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~-~~-------------~  399 (543)
T 3c4z_A          340 KAG------QTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-EN-------------K  399 (543)
T ss_dssp             CTT------CCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC-CH-------------H
T ss_pred             cCC------CcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch-hH-------------H
Confidence            221      112334589999999999999999999999999999999999999986432110 00             0


Q ss_pred             hhhhhhhh--hcccHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHHH
Q 014024          341 DLIDSVLE--EASFNESLSRYVHIALLCVQERAEDRPTM-----SDVVSM  383 (432)
Q Consensus       341 ~~i~~~l~--~~~~~~~~~~l~~l~~~cl~~dp~~RPt~-----~evl~~  383 (432)
                      ++....+.  ...+...+..+.+++..||+.||++||++     .+++++
T Consensus       400 ~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H  449 (543)
T 3c4z_A          400 ELKQRVLEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH  449 (543)
T ss_dssp             HHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred             HHHHHHhhcccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence            11111110  11233445678899999999999999975     677653

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=3.9e-43  Score=337.55  Aligned_cols=266  Identities=21%  Similarity=0.236  Sum_probs=191.4

Q ss_pred             hhhhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCCh--HhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeE
Q 014024          105 SSATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSG--QEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERL  180 (432)
Q Consensus       105 ~~~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  180 (432)
                      ....++|++.+.||+|+||.||+|.+..  ..||+|++.....  ...+.+.+|++++++++||||+++++++.+.+..+
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (329)
T 3gbz_A           30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH  109 (329)
T ss_dssp             --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred             ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence            3456789999999999999999998754  3899999864432  23456789999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEE-----cCCCCEEEeecc
Q 014024          181 LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILL-----DKDMNSKISDFG  255 (432)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll-----~~~~~~kl~Dfg  255 (432)
                      +||||+++ +|.+++..   ...+++..++.++.|++.||+|||+.+   |+||||||+|||+     ++++.+||+|||
T Consensus       110 lv~e~~~~-~L~~~~~~---~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg  182 (329)
T 3gbz_A          110 LIFEYAEN-DLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFG  182 (329)
T ss_dssp             EEEECCSE-EHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred             EEEecCCC-CHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCC
Confidence            99999974 89888853   334999999999999999999999999   9999999999999     455569999999


Q ss_pred             cceeccCCCCccccccccccccccCCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhh
Q 014024          256 MARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLW  334 (432)
Q Consensus       256 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  334 (432)
                      ++......      ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||........ .........
T Consensus       183 ~a~~~~~~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~  255 (329)
T 3gbz_A          183 LARAFGIP------IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ-LFKIFEVLG  255 (329)
T ss_dssp             HHHHHC-----------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHC
T ss_pred             CccccCCc------ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHH-HHHHHHHhC
Confidence            99865211      1223345689999999999874 489999999999999999999999864332110 000000000


Q ss_pred             --hcc-------------chhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          335 --ISN-------------KIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       335 --~~~-------------~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                        ...             ...+.....+..........++.+++..||+.||++|||+.|++++-
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp  320 (329)
T 3gbz_A          256 LPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHP  320 (329)
T ss_dssp             CCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred             CCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCc
Confidence              000             00000000000001111346778999999999999999999999853

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2.8e-43  Score=332.12  Aligned_cols=259  Identities=25%  Similarity=0.340  Sum_probs=197.1

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC---c--eEEEEEEcCC---ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCee
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ---G--EIAVKRLLGK---SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDER  179 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~---~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  179 (432)
                      .++|++.+.||+|+||.||+|.+..   .  .||+|++...   .....+.+.+|++++++++||||+++++++.+.. .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            5689999999999999999998532   2  5899987543   3345678999999999999999999999998765 8


Q ss_pred             EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeeccccee
Q 014024          180 LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARI  259 (432)
Q Consensus       180 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  259 (432)
                      ++||||+++++|.+++...  ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++..
T Consensus        96 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~  170 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA  170 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             eeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence            8999999999999998643  245999999999999999999999998   99999999999999999999999999987


Q ss_pred             ccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccc
Q 014024          260 VFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNK  338 (432)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  338 (432)
                      .......   ........+|..|+|||++.+..++.++||||||+++|+|++ |+.||.......  .   .        
T Consensus       171 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~---~--------  234 (291)
T 1u46_A          171 LPQNDDH---YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ--I---L--------  234 (291)
T ss_dssp             CCC-CCE---EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--H---H--------
T ss_pred             ccccccc---hhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH--H---H--------
Confidence            5322111   112234567788999999999899999999999999999999 999985332110  0   0        


Q ss_pred             hhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccc
Q 014024          339 IIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS  389 (432)
Q Consensus       339 ~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~  389 (432)
                       ..+.........+...+..+.+++..||+.||++|||+.++++.|++...
T Consensus       235 -~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          235 -HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             -HHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             -HHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence             00000001111223445778999999999999999999999999998654

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=3.2e-42  Score=325.02  Aligned_cols=250  Identities=24%  Similarity=0.372  Sum_probs=197.3

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEe----CCee
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIE----KDER  179 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~  179 (432)
                      ...|.+.+.||+|+||.||+|.+...  .|++|.+...  .....+.+.+|+.++++++||||+++++++..    ....
T Consensus        25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  104 (290)
T 1t4h_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI  104 (290)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred             ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence            45578889999999999999998654  7888988543  45567789999999999999999999999875    3567


Q ss_pred             EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEc-CCCCEEEeecccce
Q 014024          180 LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLD-KDMNSKISDFGMAR  258 (432)
Q Consensus       180 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~  258 (432)
                      ++||||+++++|.+++..   ...+++..++.++.|++.||.|||+.+ .+++||||||+||+++ +++.+||+|||++.
T Consensus       105 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~  180 (290)
T 1t4h_A          105 VLVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EEEEEecCCCCHHHHHHH---ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence            999999999999999953   345899999999999999999999975 2499999999999997 78999999999997


Q ss_pred             eccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccc
Q 014024          259 IVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNK  338 (432)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  338 (432)
                      ...        ........||+.|+|||++. +.++.++||||||+++|+|++|+.||........     .........
T Consensus       181 ~~~--------~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-----~~~~~~~~~  246 (290)
T 1t4h_A          181 LKR--------ASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-----IYRRVTSGV  246 (290)
T ss_dssp             GCC--------TTSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-----HHHHHTTTC
T ss_pred             ccc--------ccccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH-----HHHHHhccC
Confidence            531        11223456899999999876 5699999999999999999999999854322110     000000000


Q ss_pred             hhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          339 IIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       339 ~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                              .....+...+..+.+++..||+.||.+|||+.|++++
T Consensus       247 --------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  283 (290)
T 1t4h_A          247 --------KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             --------CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             --------CccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence                    0001111223568899999999999999999999975

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-42  Score=337.82  Aligned_cols=258  Identities=22%  Similarity=0.327  Sum_probs=195.0

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC-----
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKD-----  177 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----  177 (432)
                      ..++|++.+.||+|+||.||+|.+..  ..||+|++...  .....+.+.+|+++++.++||||+++++++....     
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  102 (367)
T 1cm8_A           23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF  102 (367)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence            35789999999999999999999853  48999998543  3445677899999999999999999999997653     


Q ss_pred             -eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeeccc
Q 014024          178 -ERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGM  256 (432)
Q Consensus       178 -~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  256 (432)
                       ..|+||||+ +++|.+++..    ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus       103 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~  174 (367)
T 1cm8_A          103 TDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL  174 (367)
T ss_dssp             CCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             ceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeec
Confidence             459999999 8899999853    34899999999999999999999999   99999999999999999999999999


Q ss_pred             ceeccCCCCccccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHH---
Q 014024          257 ARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWD---  332 (432)
Q Consensus       257 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~---  332 (432)
                      ++...         .......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.......  .......   
T Consensus       175 a~~~~---------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~l~~i~~~~g  243 (367)
T 1cm8_A          175 ARQAD---------SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD--QLKEIMKVTG  243 (367)
T ss_dssp             CEECC---------SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHC
T ss_pred             ccccc---------cccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcC
Confidence            98641         12334578999999999887 679999999999999999999999986433211  0000000   


Q ss_pred             --------hhhccchhhhhhhhh------hhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          333 --------LWISNKIIDLIDSVL------EEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       333 --------~~~~~~~~~~i~~~l------~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                              .........++....      ...........+.+|+.+||+.||++|||+.|++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          244 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             CCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence                    000000111111000      001112335678899999999999999999999985

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.1e-42  Score=329.84  Aligned_cols=253  Identities=22%  Similarity=0.363  Sum_probs=197.9

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEe
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYE  184 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  184 (432)
                      ..++|++.+.||+|+||.||+|.+..  ..+++|.+........+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   96 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE   96 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence            45789999999999999999999864  4799999876666667889999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCC
Q 014024          185 YMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGN  264 (432)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  264 (432)
                      |+++++|.+++...  ...+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.....  
T Consensus        97 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--  169 (302)
T 2j7t_A           97 FCPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK--  169 (302)
T ss_dssp             CCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHH--
T ss_pred             eCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccc--
Confidence            99999999988542  234999999999999999999999998   99999999999999999999999998754210  


Q ss_pred             CccccccccccccccCCccChhhhc-----cCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccch
Q 014024          265 DEDELQGNTSRISGTYGYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKI  339 (432)
Q Consensus       265 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  339 (432)
                          .........||+.|+|||++.     +..++.++||||||+++|+|++|+.||.......     ....... ...
T Consensus       170 ----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~-~~~  239 (302)
T 2j7t_A          170 ----TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-----VLLKIAK-SDP  239 (302)
T ss_dssp             ----HHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-----HHHHHHH-SCC
T ss_pred             ----cccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH-----HHHHHhc-cCC
Confidence                011223457899999999883     6778999999999999999999999985432210     0000000 000


Q ss_pred             hhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          340 IDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       340 ~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      .       ....+...+..+.+++..||+.||++|||+.+++++
T Consensus       240 ~-------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  276 (302)
T 2j7t_A          240 P-------TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH  276 (302)
T ss_dssp             C-------CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred             c-------ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            0       001122335678899999999999999999999874

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=2.8e-43  Score=333.95  Aligned_cols=268  Identities=26%  Similarity=0.402  Sum_probs=187.0

Q ss_pred             hhhCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCCC-hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEE
Q 014024          106 SATGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGKS-GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLI  182 (432)
Q Consensus       106 ~~~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  182 (432)
                      ...++|++.+.||+|+||.||+|.+.  +..||+|.+.... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   91 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV   91 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence            34679999999999999999999874  4589999875432 34456788999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcC-----CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccc
Q 014024          183 YEYMPNKSLDCFLFD-----PTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMA  257 (432)
Q Consensus       183 ~e~~~~gsL~~~l~~-----~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  257 (432)
                      |||+++++|.+++..     ......+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++
T Consensus        92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~  168 (303)
T 2vwi_A           92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVS  168 (303)
T ss_dssp             EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred             ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccch
Confidence            999999999999853     112345999999999999999999999998   999999999999999999999999999


Q ss_pred             eeccCCCCccccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhc
Q 014024          258 RIVFGGNDEDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWIS  336 (432)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  336 (432)
                      ......... ..........||+.|+|||++.+ ..++.++||||||+++|+|++|+.||........  ..   ... .
T Consensus       169 ~~~~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~---~~~-~  241 (303)
T 2vwi_A          169 AFLATGGDI-TRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV--LM---LTL-Q  241 (303)
T ss_dssp             HHCC----------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH--HH---HHH-T
T ss_pred             heeccCCCc-cchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH--HH---HHh-c
Confidence            764322111 11112334578999999999876 5689999999999999999999999865432111  00   000 0


Q ss_pred             cchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          337 NKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       337 ~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      ...................+..+.+++..||+.||.+|||+.+++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  288 (303)
T 2vwi_A          242 NDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH  288 (303)
T ss_dssp             SSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             cCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            00000000000111112234578899999999999999999999974

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.1e-41  Score=332.25  Aligned_cols=255  Identities=22%  Similarity=0.350  Sum_probs=202.4

Q ss_pred             HhhhhCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCCC--------hHhHHHHHHHHHHHHhc-CCCceeeeEeE
Q 014024          104 VSSATGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGKS--------GQEIKELKNEASVIAQV-QHKNLVKLLGC  172 (432)
Q Consensus       104 ~~~~~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~h~niv~~~~~  172 (432)
                      .....++|++.+.||+|+||.||+|.+.  +..||||++....        ....+.+.+|+.+++++ +||||++++++
T Consensus        89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  168 (365)
T 2y7j_A           89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS  168 (365)
T ss_dssp             HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence            3445678999999999999999999985  4489999986543        12345688999999999 79999999999


Q ss_pred             EEeCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEe
Q 014024          173 CIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKIS  252 (432)
Q Consensus       173 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  252 (432)
                      +......++||||+++++|.+++..   +..+++..+..++.|++.||.|||+.|   ++|+||||+||++++++.+||+
T Consensus       169 ~~~~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~  242 (365)
T 2y7j_A          169 YESSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLS  242 (365)
T ss_dssp             EEBSSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred             EeeCCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEE
Confidence            9999999999999999999999853   345999999999999999999999998   9999999999999999999999


Q ss_pred             ecccceeccCCCCccccccccccccccCCccChhhhcc------CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccch
Q 014024          253 DFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE------GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNL  326 (432)
Q Consensus       253 Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~  326 (432)
                      |||++..+...       .......||+.|+|||++.+      ..++.++|||||||++|+|++|+.||......  ..
T Consensus       243 DfG~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~--~~  313 (365)
T 2y7j_A          243 DFGFSCHLEPG-------EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI--LM  313 (365)
T ss_dssp             CCTTCEECCTT-------CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HH
T ss_pred             ecCcccccCCC-------cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH--HH
Confidence            99999875321       12334678999999999863      35889999999999999999999998532210  00


Q ss_pred             hhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          327 IGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       327 ~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      ......    ... ....+     .....+..+.+++..||+.||++|||+.+++++
T Consensus       314 ~~~i~~----~~~-~~~~~-----~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  360 (365)
T 2y7j_A          314 LRMIME----GQY-QFSSP-----EWDDRSSTVKDLISRLLQVDPEARLTAEQALQH  360 (365)
T ss_dssp             HHHHHH----TCC-CCCHH-----HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHHh----CCC-CCCCc-----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            000000    000 00000     001224568899999999999999999999985

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=6.3e-42  Score=337.04  Aligned_cols=259  Identities=22%  Similarity=0.272  Sum_probs=199.5

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCChHhHHHHHHHHHHHHhcC--------CCceeeeEeEEE---
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSGQEIKELKNEASVIAQVQ--------HKNLVKLLGCCI---  174 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~~~~~~~---  174 (432)
                      .++|++.+.||+|+||.||+|.+..  ..||+|++... ....+.+.+|+++++.++        |+||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            5889999999999999999998754  37999998643 455677899999999985        788999999987   


Q ss_pred             -eCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEeccCCCCCEEEcCCC-----
Q 014024          175 -EKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQY-SRVRIIHRDLKASNILLDKDM-----  247 (432)
Q Consensus       175 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~ivH~Dlkp~NIll~~~~-----  247 (432)
                       +....++||||+ +++|.+++.... ...+++..++.++.|++.||+|||++ +   |+||||||+|||++.++     
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~  189 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIKSN-YQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR  189 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred             CCCceEEEEEecc-CccHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence             456789999999 555555554322 24499999999999999999999998 8   99999999999999775     


Q ss_pred             --------------------------------------------CEEEeecccceeccCCCCccccccccccccccCCcc
Q 014024          248 --------------------------------------------NSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYM  283 (432)
Q Consensus       248 --------------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~  283 (432)
                                                                  .+||+|||++....         .......||+.|+
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~---------~~~~~~~gt~~y~  260 (397)
T 1wak_A          190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH---------KHFTEDIQTRQYR  260 (397)
T ss_dssp             HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETT---------BCSCSCCSCGGGC
T ss_pred             hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccc---------ccCccCCCCCccc
Confidence                                                        79999999998752         1233457899999


Q ss_pred             ChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccc----hhhhhHHhhhc--------c--------------
Q 014024          284 SPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLN----LIGYAWDLWIS--------N--------------  337 (432)
Q Consensus       284 aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~----~~~~~~~~~~~--------~--------------  337 (432)
                      |||++.+..++.++|||||||++|||++|+.||.........    ...........        .              
T Consensus       261 aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~  340 (397)
T 1wak_A          261 SLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLK  340 (397)
T ss_dssp             CHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBS
T ss_pred             CChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccc
Confidence            999999999999999999999999999999999654332111    00000000000        0              


Q ss_pred             --------chhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          338 --------KIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       338 --------~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                              ...+.+..  ....+......+.+|+.+||+.||++|||++|++++
T Consensus       341 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  392 (397)
T 1wak_A          341 HITKLKPWGLFEVLVE--KYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH  392 (397)
T ss_dssp             SCCCCCCCCHHHHHHH--TSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred             cccccCCcchhHhhhh--hcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence                    00000000  112345667889999999999999999999999975

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.4e-42  Score=332.56  Aligned_cols=267  Identities=22%  Similarity=0.270  Sum_probs=195.2

Q ss_pred             hhhhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCChH-----hHHHHHHHHHHHHhcCCCceeeeEeEEEeCC
Q 014024          105 SSATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSGQ-----EIKELKNEASVIAQVQHKNLVKLLGCCIEKD  177 (432)
Q Consensus       105 ~~~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  177 (432)
                      ....++|++.+.||+|+||.||+|.+..  ..||+|++......     ..+.+.+|++++++++||||+++++++.+.+
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (346)
T 1ua2_A            6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS   85 (346)
T ss_dssp             -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence            3456889999999999999999999864  48999988543221     1246789999999999999999999999999


Q ss_pred             eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccc
Q 014024          178 ERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMA  257 (432)
Q Consensus       178 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  257 (432)
                      ..++||||+++ +|.+++...  ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++
T Consensus        86 ~~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  159 (346)
T 1ua2_A           86 NISLVFDFMET-DLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLA  159 (346)
T ss_dssp             CCEEEEECCSE-EHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred             ceEEEEEcCCC-CHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccc
Confidence            99999999986 788887543  235889999999999999999999999   999999999999999999999999999


Q ss_pred             eeccCCCCccccccccccccccCCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhc
Q 014024          258 RIVFGGNDEDELQGNTSRISGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWIS  336 (432)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  336 (432)
                      ......      ........||+.|+|||++.+. .++.++|||||||++|+|++|..||.......  ...........
T Consensus       160 ~~~~~~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~--~~~~i~~~~~~  231 (346)
T 1ua2_A          160 KSFGSP------NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD--QLTRIFETLGT  231 (346)
T ss_dssp             STTTSC------CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCC
T ss_pred             eeccCC------cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHcCC
Confidence            864221      1223445789999999998764 58999999999999999999999875432211  11111110000


Q ss_pred             ---cchh------hhhhhhh-----hhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014024          337 ---NKII------DLIDSVL-----EEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLT  385 (432)
Q Consensus       337 ---~~~~------~~i~~~l-----~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~  385 (432)
                         ....      +.+....     ...........+.+++..||+.||++|||+.|++++-.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~  294 (346)
T 1ua2_A          232 PTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY  294 (346)
T ss_dssp             CCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred             CChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChh
Confidence               0000      0000000     00001223467899999999999999999999998754

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.4e-41  Score=338.41  Aligned_cols=198  Identities=21%  Similarity=0.288  Sum_probs=171.3

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCChHhHHHHHHHHHHHHhc------CCCceeeeEeEEEeCCe
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSGQEIKELKNEASVIAQV------QHKNLVKLLGCCIEKDE  178 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~~~~~~~~~~~  178 (432)
                      ...+|++.+.||+|+||.||+|.+..  ..||+|++... ....+.+.+|+++++.+      +|+||+++++++...+.
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  173 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH  173 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence            45789999999999999999999865  38999998653 34456778899998887      56799999999999999


Q ss_pred             eEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCC--EEEeeccc
Q 014024          179 RLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN--SKISDFGM  256 (432)
Q Consensus       179 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~  256 (432)
                      .++||||+. ++|.+++..... ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.  +||+|||+
T Consensus       174 ~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~  248 (429)
T 3kvw_A          174 ICMTFELLS-MNLYELIKKNKF-QGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGS  248 (429)
T ss_dssp             EEEEECCCC-CBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             EEEEEeccC-CCHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeeccc
Confidence            999999996 688888865332 34999999999999999999999999   999999999999999987  99999999


Q ss_pred             ceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCc
Q 014024          257 ARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFY  319 (432)
Q Consensus       257 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~  319 (432)
                      +...         ........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       249 a~~~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~  302 (429)
T 3kvw_A          249 SCYE---------HQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE  302 (429)
T ss_dssp             CEET---------TCCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ceec---------CCcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence            9763         11233457899999999999999999999999999999999999998644

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.2e-43  Score=347.71  Aligned_cols=243  Identities=15%  Similarity=0.157  Sum_probs=188.7

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcC---CChHhHHHHHHHH---HHHHhcCCCceeeeE-------e
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLG---KSGQEIKELKNEA---SVIAQVQHKNLVKLL-------G  171 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~---~~~~~~~~~~~E~---~~l~~l~h~niv~~~-------~  171 (432)
                      ..++|++.+.||+|+||.||+|.+.  +..||+|++..   ......+.+.+|+   +.+++++||||++++       +
T Consensus        71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~  150 (377)
T 3byv_A           71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  150 (377)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred             CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence            4578999999999999999999964  45899999863   3444567899999   555556899999998       6


Q ss_pred             EEEeCC-----------------eeEEEEecCCCCChhhhhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 014024          172 CCIEKD-----------------ERLLIYEYMPNKSLDCFLFDPT----KREILDWRTRVQIIKGVAQGLLYLHQYSRVR  230 (432)
Q Consensus       172 ~~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~  230 (432)
                      ++.+.+                 ..++||||+ +|+|.+++....    ....+++..++.++.|++.||+|||+.+   
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---  226 (377)
T 3byv_A          151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---  226 (377)
T ss_dssp             EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence            666553                 278999999 689999985321    1123446888899999999999999999   


Q ss_pred             eEeccCCCCCEEEcCCCCEEEeecccceeccCCCCccccccccccccccCCccChhhhccC-----------CCCchhhh
Q 014024          231 IIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEG-----------IFSIKSDV  299 (432)
Q Consensus       231 ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~t~~~Dv  299 (432)
                      |+||||||+|||++.++.+||+|||++...         ........| +.|+|||++.+.           .++.++||
T Consensus       227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~---------~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dv  296 (377)
T 3byv_A          227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD---------GARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDA  296 (377)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEET---------TCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHH
T ss_pred             eecCCCCHHHEEEcCCCCEEEEechhheec---------CCcccCCCC-cCccChhhhcccccccccccccccCChhhhH
Confidence            999999999999999999999999999853         112334567 999999999887           89999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 014024          300 FSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSD  379 (432)
Q Consensus       300 wSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~e  379 (432)
                      |||||++|||++|+.||........              ...+..      .....+..+.+++..||+.||++|||+.|
T Consensus       297 wSlG~il~elltg~~Pf~~~~~~~~--------------~~~~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e  356 (377)
T 3byv_A          297 WALGLVIYWIWCADLPITKDAALGG--------------SEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQ  356 (377)
T ss_dssp             HHHHHHHHHHHHSSCCC------CC--------------SGGGGS------SCCCCCHHHHHHHHHHTCSSGGGCCCHHH
T ss_pred             HHHHHHHHHHHHCCCCCcccccccc--------------hhhhhh------hccCCCHHHHHHHHHHcCCCchhCCCHHH
Confidence            9999999999999999853222110              000000      01123467889999999999999999999


Q ss_pred             HHHH
Q 014024          380 VVSM  383 (432)
Q Consensus       380 vl~~  383 (432)
                      ++++
T Consensus       357 ~l~h  360 (377)
T 3byv_A          357 AMET  360 (377)
T ss_dssp             HHTS
T ss_pred             HhhC
Confidence            9973

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-42  Score=338.24  Aligned_cols=253  Identities=23%  Similarity=0.284  Sum_probs=201.0

Q ss_pred             hCCCCcCceeccCCcEEEEEEEE-----CCceEEEEEEcCCC----hHhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCC
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVI-----GQGEIAVKRLLGKS----GQEIKELKNEASVIAQV-QHKNLVKLLGCCIEKD  177 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~-----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  177 (432)
                      .++|++.+.||+|+||.||++..     .+..||+|++....    ....+.+.+|+++++++ +|+||+++++++.+.+
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            47899999999999999999998     34489999885431    12334567899999999 6999999999999999


Q ss_pred             eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccc
Q 014024          178 ERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMA  257 (432)
Q Consensus       178 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  257 (432)
                      ..++||||+++++|.+++..   +..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a  206 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS  206 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             eEEEEeecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence            99999999999999999953   345999999999999999999999998   999999999999999999999999999


Q ss_pred             eeccCCCCccccccccccccccCCccChhhhcc--CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhh
Q 014024          258 RIVFGGNDEDELQGNTSRISGTYGYMSPEYALE--GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWI  335 (432)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  335 (432)
                      ......     .........||+.|+|||++.+  ..++.++|||||||++|||++|+.||........ .         
T Consensus       207 ~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~---------  271 (355)
T 1vzo_A          207 KEFVAD-----ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-Q---------  271 (355)
T ss_dssp             EECCGG-----GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-H---------
T ss_pred             eecccC-----CCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch-H---------
Confidence            864211     1122334679999999999985  3478999999999999999999999864322110 0         


Q ss_pred             ccchhhhhhhhh--hhcccHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHHhc
Q 014024          336 SNKIIDLIDSVL--EEASFNESLSRYVHIALLCVQERAEDRP-----TMSDVVSMLT  385 (432)
Q Consensus       336 ~~~~~~~i~~~l--~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~~L~  385 (432)
                          ..+.....  ....+......+.+++.+||+.||++||     ++.|++++..
T Consensus       272 ----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~  324 (355)
T 1vzo_A          272 ----AEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF  324 (355)
T ss_dssp             ----HHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred             ----HHHHHHHhccCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence                01111111  1122334456788999999999999999     9999998764

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=2.1e-43  Score=337.50  Aligned_cols=270  Identities=23%  Similarity=0.346  Sum_probs=201.1

Q ss_pred             HhhhhCCCCcCceeccCCcEEEEEEEECCceEEEEEEcCCC--hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEE
Q 014024          104 VSSATGNFSAANKLGEGGFGTVYKGVIGQGEIAVKRLLGKS--GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLL  181 (432)
Q Consensus       104 ~~~~~~~y~~~~~ig~G~~g~Vy~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  181 (432)
                      .....++|++.+.||+|+||.||+|.+.+ .+++|.+....  ....+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus        28 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i  106 (319)
T 2y4i_B           28 WDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAI  106 (319)
T ss_dssp             SSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEE
T ss_pred             ccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEE
Confidence            33456889999999999999999999865 58999885432  2334567789999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceecc
Q 014024          182 IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVF  261 (432)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  261 (432)
                      ||||+++++|.+++...  ...+++..++.++.|++.||+|||+.+   ++||||||+||+++ ++.+||+|||++....
T Consensus       107 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~  180 (319)
T 2y4i_B          107 ITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISG  180 (319)
T ss_dssp             ECBCCCSEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred             EeecccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence            99999999999999543  235899999999999999999999999   99999999999998 6799999999987642


Q ss_pred             CCCCccccccccccccccCCccChhhhcc---------CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHH
Q 014024          262 GGNDEDELQGNTSRISGTYGYMSPEYALE---------GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWD  332 (432)
Q Consensus       262 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---------~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~  332 (432)
                      ... ............||+.|+|||.+.+         ..++.++||||||+++|+|++|+.||.......     ....
T Consensus       181 ~~~-~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~~~~  254 (319)
T 2y4i_B          181 VLQ-AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA-----IIWQ  254 (319)
T ss_dssp             --------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH-----HHHH
T ss_pred             ccc-ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHH
Confidence            111 1111222334568999999999874         457999999999999999999999985432211     0000


Q ss_pred             hhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccccCCCCCC
Q 014024          333 LWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPK  395 (432)
Q Consensus       333 ~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~~~~  395 (432)
                       .....     .+   .......+..+.+++..||+.||++|||+.++++.|+.+........
T Consensus       255 -~~~~~-----~~---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~  308 (319)
T 2y4i_B          255 -MGTGM-----KP---NLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLS  308 (319)
T ss_dssp             -HHTTC-----CC---CCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--------
T ss_pred             -hccCC-----CC---CCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCC
Confidence             00000     00   00011234568899999999999999999999999999876554433

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=8.2e-42  Score=347.11  Aligned_cols=247  Identities=26%  Similarity=0.364  Sum_probs=199.4

Q ss_pred             hhhCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCCCh-------------HhHHHHHHHHHHHHhcCCCceeeeE
Q 014024          106 SATGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSG-------------QEIKELKNEASVIAQVQHKNLVKLL  170 (432)
Q Consensus       106 ~~~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~~~  170 (432)
                      ...++|.+.+.||+|+||.||+|.+..+  .+|+|++.....             ...+.+.+|+.++++++||||++++
T Consensus        33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  112 (504)
T 3q5i_A           33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF  112 (504)
T ss_dssp             CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            4568899999999999999999998653  799999864321             2356789999999999999999999


Q ss_pred             eEEEeCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCC---
Q 014024          171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDM---  247 (432)
Q Consensus       171 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~---  247 (432)
                      +++.+.+..++||||+++|+|.+++..   +..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++   
T Consensus       113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~  186 (504)
T 3q5i_A          113 DVFEDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLL  186 (504)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCS
T ss_pred             EEEEcCCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCc
Confidence            999999999999999999999998853   345999999999999999999999999   99999999999998776   


Q ss_pred             CEEEeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchh
Q 014024          248 NSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLI  327 (432)
Q Consensus       248 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~  327 (432)
                      .+||+|||++......       .......||+.|+|||++. +.++.++|||||||++|+|++|..||......     
T Consensus       187 ~~kl~Dfg~a~~~~~~-------~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----  253 (504)
T 3q5i_A          187 NIKIVDFGLSSFFSKD-------YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ-----  253 (504)
T ss_dssp             SEEECCCTTCEECCTT-------SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----
T ss_pred             cEEEEECCCCEEcCCC-------CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH-----
Confidence            6999999999875221       1234457999999999887 56999999999999999999999998532211     


Q ss_pred             hhhHHhhhccchhhhhhhhhhhc------ccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          328 GYAWDLWISNKIIDLIDSVLEEA------SFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       328 ~~~~~~~~~~~~~~~i~~~l~~~------~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                                   +++.......      .....+..+.+++..||+.||.+|||+.|++++-
T Consensus       254 -------------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~  303 (504)
T 3q5i_A          254 -------------DIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSR  303 (504)
T ss_dssp             -------------HHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             -------------HHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCH
Confidence                         1111111100      0112346788999999999999999999999754

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.4e-41  Score=341.92  Aligned_cols=264  Identities=20%  Similarity=0.273  Sum_probs=204.9

Q ss_pred             hCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCCChHhHHHHHHHHHHHHhcCC-CceeeeEeEEEeCCeeEEEEe
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGKSGQEIKELKNEASVIAQVQH-KNLVKLLGCCIEKDERLLIYE  184 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e  184 (432)
                      .++|++.++||+|+||.||+|.+.  +..||||++.....  ...+..|+++++.++| +++..+..++.+.+..++|||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            578999999999999999999975  44899998754432  2357889999999987 566667777788889999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEE---cCCCCEEEeecccceecc
Q 014024          185 YMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILL---DKDMNSKISDFGMARIVF  261 (432)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~  261 (432)
                      |+ +++|.+++...  ...+++..++.|+.||+.||+|||+.+   |+||||||+|||+   +.++.+||+|||+++.+.
T Consensus        84 ~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~  157 (483)
T 3sv0_A           84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR  157 (483)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             CC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence            99 99999998643  234999999999999999999999999   9999999999999   688999999999998764


Q ss_pred             CCCCcccc-ccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCcccccc-chhhhhHHhhhccch
Q 014024          262 GGNDEDEL-QGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSL-NLIGYAWDLWISNKI  339 (432)
Q Consensus       262 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~  339 (432)
                      ........ ........||+.|+|||++.+..++.++|||||||++|||++|+.||........ ......    .....
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i----~~~~~  233 (483)
T 3sv0_A          158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI----SEKKV  233 (483)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHH----HHHHH
T ss_pred             CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHH----hhccc
Confidence            33221111 1123356899999999999999999999999999999999999999865433111 000000    00011


Q ss_pred             hhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014024          340 IDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEA  388 (432)
Q Consensus       340 ~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~  388 (432)
                      ...+..     .....+.++.+++..||+.||++||++.+|++.|+++.
T Consensus       234 ~~~~~~-----l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~  277 (483)
T 3sv0_A          234 ATSIEA-----LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLF  277 (483)
T ss_dssp             HSCHHH-----HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred             cccHHH-----HhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence            111111     11123467899999999999999999999999988764

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-42  Score=333.64  Aligned_cols=262  Identities=23%  Similarity=0.368  Sum_probs=198.7

Q ss_pred             CccchhhHhhhhCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCCChHhHHHHHHHHHHHHhc-CCCceeeeEeEE
Q 014024           97 PLFSFSSVSSATGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGKSGQEIKELKNEASVIAQV-QHKNLVKLLGCC  173 (432)
Q Consensus        97 ~~~~~~~~~~~~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~  173 (432)
                      +.+.+.++....++|++.+.||+|+||.||+|.+.  +..||+|++.... ...+.+.+|+.+++++ +||||+++++++
T Consensus        12 ~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   90 (326)
T 2x7f_A           12 DEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAF   90 (326)
T ss_dssp             ----CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred             hhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence            33455566677899999999999999999999984  4489999986443 2346788999999999 799999999999


Q ss_pred             Ee------CCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCC
Q 014024          174 IE------KDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDM  247 (432)
Q Consensus       174 ~~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~  247 (432)
                      ..      .+..++||||+++++|.+++.... ...+++..++.++.|++.||.|||+.+   ++||||||+||+++.++
T Consensus        91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~  166 (326)
T 2x7f_A           91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENA  166 (326)
T ss_dssp             EECC--CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTC
T ss_pred             eeccCccccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCC
Confidence            87      467899999999999999996532 345999999999999999999999999   99999999999999999


Q ss_pred             CEEEeecccceeccCCCCccccccccccccccCCccChhhhc-----cCCCCchhhhHHHHHHHHHHHhCCCCCCCcccc
Q 014024          248 NSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTK  322 (432)
Q Consensus       248 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~  322 (432)
                      .+||+|||++......      ........||+.|+|||++.     +..++.++|||||||++|+|++|+.||......
T Consensus       167 ~~kl~Dfg~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~  240 (326)
T 2x7f_A          167 EVKLVDFGVSAQLDRT------VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM  240 (326)
T ss_dssp             CEEECCCTTTC-------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred             CEEEeeCcCceecCcC------ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH
Confidence            9999999999764211      11233457899999999987     567899999999999999999999998532211


Q ss_pred             ccchhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          323 SLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      .     ....         +.............+..+.+++..||+.||.+|||+.+++++
T Consensus       241 ~-----~~~~---------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  287 (326)
T 2x7f_A          241 R-----ALFL---------IPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH  287 (326)
T ss_dssp             H-----HHHH---------HHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             H-----HHHH---------hhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            0     0000         000000000112234678899999999999999999999984

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.2e-41  Score=331.89  Aligned_cols=266  Identities=20%  Similarity=0.279  Sum_probs=201.0

Q ss_pred             hhhCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeC-----C
Q 014024          106 SATGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEK-----D  177 (432)
Q Consensus       106 ~~~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~  177 (432)
                      ...++|++.+.||+|+||.||+|.+...  .||+|++... .....+.+.+|++++++++||||+++++++...     .
T Consensus        24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  103 (364)
T 3qyz_A           24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK  103 (364)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred             cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence            3457899999999999999999998543  7999998643 344557889999999999999999999999765     3


Q ss_pred             eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccc
Q 014024          178 ERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMA  257 (432)
Q Consensus       178 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  257 (432)
                      ..++||||++ ++|.+++..    ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a  175 (364)
T 3qyz_A          104 DVYIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLA  175 (364)
T ss_dssp             CEEEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcce
Confidence            6799999997 588888843    34999999999999999999999999   999999999999999999999999999


Q ss_pred             eeccCCCCccccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhc
Q 014024          258 RIVFGGNDEDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWIS  336 (432)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  336 (432)
                      .......   ..........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......  ...........
T Consensus       176 ~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~i~~~~~~  250 (364)
T 3qyz_A          176 RVADPDH---DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD--QLNHILGILGS  250 (364)
T ss_dssp             EECCGGG---CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG--HHHHHHHHHCS
T ss_pred             EecCCCC---CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH--HHHHHHHHhCC
Confidence            8752211   11112344689999999998654 558999999999999999999999986433211  11100000000


Q ss_pred             c-----------chhhhhhhhhh------hcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          337 N-----------KIIDLIDSVLE------EASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       337 ~-----------~~~~~i~~~l~------~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                      .           ...........      ..........+.+++.+||+.||++|||+.|++++-
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp  315 (364)
T 3qyz_A          251 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP  315 (364)
T ss_dssp             CCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred             CCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence            0           00000000000      000112346788999999999999999999999854

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=8.6e-43  Score=328.61  Aligned_cols=253  Identities=23%  Similarity=0.335  Sum_probs=186.1

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCCC-h-HhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGKS-G-QEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLI  182 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~-~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  182 (432)
                      ..++|++.+.||+|+||.||+|.+.  +..||+|++.... . ...+.+.++...++.++||||+++++++.+.+..++|
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv   84 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC   84 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence            3578999999999999999999984  4489999986542 2 2233445555567888999999999999999999999


Q ss_pred             EecCCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEeccCCCCCEEEcCCCCEEEeecccceec
Q 014024          183 YEYMPNKSLDCFLFDP-TKREILDWRTRVQIIKGVAQGLLYLHQY-SRVRIIHRDLKASNILLDKDMNSKISDFGMARIV  260 (432)
Q Consensus       183 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  260 (432)
                      |||+++ +|.+++... .....+++..++.++.|++.||+|||+. +   ++||||||+||+++.++.+||+|||++...
T Consensus        85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            999974 777766431 2234599999999999999999999998 8   999999999999999999999999999764


Q ss_pred             cCCCCccccccccccccccCCccChhhh----ccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhc
Q 014024          261 FGGNDEDELQGNTSRISGTYGYMSPEYA----LEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWIS  336 (432)
Q Consensus       261 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  336 (432)
                      ...       .......||+.|+|||++    .+..++.++||||||+++|+|++|+.||..........          
T Consensus       161 ~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----------  223 (290)
T 3fme_A          161 VDD-------VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQL----------  223 (290)
T ss_dssp             ----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHH----------
T ss_pred             ccc-------ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHH----------
Confidence            221       122334689999999996    45678999999999999999999999986432211111          


Q ss_pred             cchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          337 NKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       337 ~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                         ...+............+..+.+++..||+.||++|||+.|++++
T Consensus       224 ---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h  267 (290)
T 3fme_A          224 ---KQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH  267 (290)
T ss_dssp             ---HHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             ---HHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence               01111111111112345678899999999999999999999884

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.1e-41  Score=327.36  Aligned_cols=257  Identities=18%  Similarity=0.288  Sum_probs=199.5

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCChHhHHHHHHHHHHHHhcC-CCceeeeEeEEEe--CCeeEE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSGQEIKELKNEASVIAQVQ-HKNLVKLLGCCIE--KDERLL  181 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~--~~~~~l  181 (432)
                      ..++|++.+.||+|+||.||+|.+..  ..||+|++....   .+.+.+|+.++++++ |+||+++++++.+  ....++
T Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l  110 (330)
T 3nsz_A           34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL  110 (330)
T ss_dssp             EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred             CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence            35789999999999999999998743  489999986543   357889999999997 9999999999988  567899


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCC-CEEEeecccceec
Q 014024          182 IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDM-NSKISDFGMARIV  260 (432)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~  260 (432)
                      ||||+++++|.+++.      .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++ .+||+|||++...
T Consensus       111 v~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~  181 (330)
T 3nsz_A          111 VFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY  181 (330)
T ss_dssp             EEECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EEeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence            999999999999873      2889999999999999999999999   99999999999999777 8999999999875


Q ss_pred             cCCCCccccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccch
Q 014024          261 FGGNDEDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKI  339 (432)
Q Consensus       261 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  339 (432)
                      ...       .......||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.........+.... ........
T Consensus       182 ~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~-~~~~~~~~  253 (330)
T 3nsz_A          182 HPG-------QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA-KVLGTEDL  253 (330)
T ss_dssp             CTT-------CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHH-HHHCHHHH
T ss_pred             CCC-------CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHH-HhcCCchh
Confidence            322       12234578899999999887 6789999999999999999999999854332111111100 00000000


Q ss_pred             hhhhh-----------------------hhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          340 IDLID-----------------------SVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       340 ~~~i~-----------------------~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      .+.++                       ..............+.+++..||+.||++|||++|++++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h  320 (330)
T 3nsz_A          254 YDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  320 (330)
T ss_dssp             HHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             hhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            01100                       011111112245678999999999999999999999985

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.5e-41  Score=326.96  Aligned_cols=260  Identities=19%  Similarity=0.238  Sum_probs=202.0

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEEC---CceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCc------eeeeEeEEEeCC
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIG---QGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKN------LVKLLGCCIEKD  177 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~---~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~~~~~~  177 (432)
                      ..++|++.+.||+|+||.||+|.+.   +..||+|++... ....+.+.+|+++++.++|++      ++++++++.+.+
T Consensus        12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~   90 (339)
T 1z57_A           12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG   90 (339)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred             ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence            3578999999999999999999872   347999998643 445677889999999987654      999999999999


Q ss_pred             eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcC------------
Q 014024          178 ERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDK------------  245 (432)
Q Consensus       178 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~------------  245 (432)
                      ..++||||+ +++|.+++.... ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.            
T Consensus        91 ~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~  165 (339)
T 1z57_A           91 HICIVFELL-GLSTYDFIKENG-FLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIK  165 (339)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----
T ss_pred             cEEEEEcCC-CCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccc
Confidence            999999999 889999886532 235899999999999999999999999   999999999999987            


Q ss_pred             -------CCCEEEeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 014024          246 -------DMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGF  318 (432)
Q Consensus       246 -------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~  318 (432)
                             ++.+||+|||++....         .......||+.|+|||++.+..++.++|||||||++|||++|..||..
T Consensus       166 ~~~~~~~~~~~kl~Dfg~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  236 (339)
T 1z57_A          166 RDERTLINPDIKVVDFGSATYDD---------EHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPT  236 (339)
T ss_dssp             CEEEEESCCCEEECCCSSCEETT---------SCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccccccCCCceEeeCcccccCc---------cccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence                   6789999999998631         122345789999999999999999999999999999999999999865


Q ss_pred             ccccccchhhhhHHhhh--cc-----------------------chhhhhhhh----h-hhcccHHHHHHHHHHHHHhhc
Q 014024          319 YRTKSLNLIGYAWDLWI--SN-----------------------KIIDLIDSV----L-EEASFNESLSRYVHIALLCVQ  368 (432)
Q Consensus       319 ~~~~~~~~~~~~~~~~~--~~-----------------------~~~~~i~~~----l-~~~~~~~~~~~l~~l~~~cl~  368 (432)
                      ......  .........  ..                       .....+...    . ........+..+.+++..||+
T Consensus       237 ~~~~~~--~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~  314 (339)
T 1z57_A          237 HDSKEH--LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLE  314 (339)
T ss_dssp             SCHHHH--HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred             CChHHH--HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhC
Confidence            433110  000000000  00                       000000000    0 001133556789999999999


Q ss_pred             cCCCCCCCHHHHHHH
Q 014024          369 ERAEDRPTMSDVVSM  383 (432)
Q Consensus       369 ~dp~~RPt~~evl~~  383 (432)
                      .||++|||+.|++++
T Consensus       315 ~dP~~Rpt~~ell~h  329 (339)
T 1z57_A          315 YDPAKRITLREALKH  329 (339)
T ss_dssp             SSTTTSCCHHHHTTS
T ss_pred             cCcccccCHHHHhcC
Confidence            999999999999875

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2.6e-42  Score=336.60  Aligned_cols=257  Identities=13%  Similarity=0.126  Sum_probs=204.3

Q ss_pred             hHhhhhCCCCcCceeccCCcEEEEEEEE-------CCceEEEEEEcCCChHhHHHHHHHHHHHHhcC---CCceeeeEeE
Q 014024          103 SVSSATGNFSAANKLGEGGFGTVYKGVI-------GQGEIAVKRLLGKSGQEIKELKNEASVIAQVQ---HKNLVKLLGC  172 (432)
Q Consensus       103 ~~~~~~~~y~~~~~ig~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~  172 (432)
                      +.....++|.+.+.||+|+||.||+|.+       .+..||+|++.....   ..+..|+++++.++   |+|+++++++
T Consensus        59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~l~~~~~~~iv~~~~~  135 (365)
T 3e7e_A           59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKFYSA  135 (365)
T ss_dssp             EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH---HHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred             eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh---hHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence            3445678899999999999999999942       334899999976543   46777888888887   8999999999


Q ss_pred             EEeCCeeEEEEecCCCCChhhhhcCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcC-----
Q 014024          173 CIEKDERLLIYEYMPNKSLDCFLFDP--TKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDK-----  245 (432)
Q Consensus       173 ~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-----  245 (432)
                      +...+..++||||+++|+|.+++...  .....+++..++.++.|++.||+|||+.+   |+||||||+|||++.     
T Consensus       136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~  212 (365)
T 3e7e_A          136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQ  212 (365)
T ss_dssp             EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC
T ss_pred             eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCc
Confidence            99999999999999999999999532  12345999999999999999999999998   999999999999998     


Q ss_pred             ------CCCEEEeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCc
Q 014024          246 ------DMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFY  319 (432)
Q Consensus       246 ------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~  319 (432)
                            ++.+||+|||+++.+.....    ........||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus       213 ~~~~~~~~~~kl~DFG~a~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~  288 (365)
T 3e7e_A          213 DDEDDLSAGLALIDLGQSIDMKLFPK----GTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKN  288 (365)
T ss_dssp             ------CTTEEECCCTTCEEGGGSCT----TEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEE
T ss_pred             cccccccCCEEEeeCchhhhhhccCC----CceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccC
Confidence                  89999999999976422111    12234567999999999999999999999999999999999999997432


Q ss_pred             cccccchhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCC-CCHHHHHHHhccccc
Q 014024          320 RTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDR-PTMSDVVSMLTNEAS  389 (432)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~R-Pt~~evl~~L~~~~~  389 (432)
                      ......                 +...+...   .....+.+++..|++.+|.+| |+++++.+.|++...
T Consensus       289 ~~~~~~-----------------~~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~  339 (365)
T 3e7e_A          289 EGGECK-----------------PEGLFRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ  339 (365)
T ss_dssp             ETTEEE-----------------ECSCCTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred             CCCcee-----------------echhcccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence            211100                 00001010   113456788999999999998 678888888877654

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=5e-42  Score=347.87  Aligned_cols=252  Identities=24%  Similarity=0.324  Sum_probs=196.3

Q ss_pred             hhhCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCCC--hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEE
Q 014024          106 SATGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKS--GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLL  181 (432)
Q Consensus       106 ~~~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  181 (432)
                      ...++|++.+.||+|+||.||+|.+...  .+|+|++....  ......+.+|+.+++.++||||+++++++.+....++
T Consensus        34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  113 (494)
T 3lij_A           34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYL  113 (494)
T ss_dssp             CHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             chhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            3456799999999999999999998643  79999986542  2335678899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCC---CCEEEeecccce
Q 014024          182 IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKD---MNSKISDFGMAR  258 (432)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Dfg~a~  258 (432)
                      ||||+++|+|.+++..   +..+++..+..++.|++.||+|||+.+   |+||||||+|||++.+   +.+||+|||++.
T Consensus       114 v~e~~~~g~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~  187 (494)
T 3lij_A          114 VMECYKGGELFDEIIH---RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSA  187 (494)
T ss_dssp             EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence            9999999999988843   345999999999999999999999999   9999999999999764   459999999998


Q ss_pred             eccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccc
Q 014024          259 IVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNK  338 (432)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  338 (432)
                      .....       .......||+.|+|||++. +.++.++|||||||++|+|++|..||.......  ......    ...
T Consensus       188 ~~~~~-------~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~i~----~~~  253 (494)
T 3lij_A          188 VFENQ-------KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE--ILRKVE----KGK  253 (494)
T ss_dssp             ECBTT-------BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHH----HTC
T ss_pred             ECCCC-------ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHH----hCC
Confidence            75221       1234457999999999886 569999999999999999999999985432210  000000    000


Q ss_pred             hhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          339 IIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       339 ~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      . .     .........+..+.+++..||+.||.+|||+.|++++
T Consensus       254 ~-~-----~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          254 Y-T-----FDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             C-C-----CCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             C-C-----CCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence            0 0     0000112234678899999999999999999999975

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.4e-41  Score=332.10  Aligned_cols=260  Identities=22%  Similarity=0.236  Sum_probs=192.5

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC-----
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKD-----  177 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----  177 (432)
                      ..++|++.+.||+|+||.||+|.+..  ..||+|++...  .....+.+.+|+.+++.++||||+++++++...+     
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  102 (371)
T 2xrw_A           23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  102 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred             hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence            35789999999999999999999753  48999998643  3455677889999999999999999999997665     


Q ss_pred             -eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeeccc
Q 014024          178 -ERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGM  256 (432)
Q Consensus       178 -~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  256 (432)
                       ..++||||+++ +|.+++.     ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       103 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~  173 (371)
T 2xrw_A          103 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  173 (371)
T ss_dssp             CEEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred             cceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeec
Confidence             67999999975 6777773     23899999999999999999999999   99999999999999999999999999


Q ss_pred             ceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHh---
Q 014024          257 ARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDL---  333 (432)
Q Consensus       257 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~---  333 (432)
                      +.....       ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.......  ........   
T Consensus       174 a~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i~~~~~~  244 (371)
T 2xrw_A          174 ARTAGT-------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID--QWNKVIEQLGT  244 (371)
T ss_dssp             -----------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHC-CCC
T ss_pred             cccccc-------ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCC
Confidence            986421       112334678999999999999999999999999999999999999986433211  00000000   


Q ss_pred             -----h--hcc---------------chhhhhhhhhhh---cccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          334 -----W--ISN---------------KIIDLIDSVLEE---ASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       334 -----~--~~~---------------~~~~~i~~~l~~---~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                           .  ...               ............   .........+.+|+.+||+.||++|||++|++++-
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp  320 (371)
T 2xrw_A          245 PCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP  320 (371)
T ss_dssp             CCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred             CCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence                 0  000               000000000000   00123356789999999999999999999999854

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.7e-41  Score=321.08  Aligned_cols=253  Identities=21%  Similarity=0.331  Sum_probs=201.9

Q ss_pred             hhhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCC---------hHhHHHHHHHHHHHHhcC-CCceeeeEeEE
Q 014024          106 SATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS---------GQEIKELKNEASVIAQVQ-HKNLVKLLGCC  173 (432)
Q Consensus       106 ~~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~~~~~~  173 (432)
                      ...++|++.+.||+|+||.||+|.+..  ..||+|.+....         ....+.+.+|++++++++ ||||+++++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   93 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            446899999999999999999999854  489999986443         233567889999999996 99999999999


Q ss_pred             EeCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEee
Q 014024          174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISD  253 (432)
Q Consensus       174 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  253 (432)
                      .+.+..++||||+++++|.+++..   +..+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~d  167 (298)
T 1phk_A           94 ETNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTD  167 (298)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred             ccCCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEec
Confidence            999999999999999999999953   345999999999999999999999999   99999999999999999999999


Q ss_pred             cccceeccCCCCccccccccccccccCCccChhhhc------cCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchh
Q 014024          254 FGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL------EGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLI  327 (432)
Q Consensus       254 fg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~  327 (432)
                      ||++......       .......|++.|+|||++.      ...++.++||||||+++|+|++|+.||.......  ..
T Consensus       168 fg~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~  238 (298)
T 1phk_A          168 FGFSCQLDPG-------EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML--ML  238 (298)
T ss_dssp             CTTCEECCTT-------CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HH
T ss_pred             ccchhhcCCC-------cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH--HH
Confidence            9999875221       1223456899999999885      4568999999999999999999999985322110  00


Q ss_pred             hhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          328 GYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       328 ~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      ..    ...... .     .........+..+.+++..||+.||++|||+.|++++
T Consensus       239 ~~----~~~~~~-~-----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (298)
T 1phk_A          239 RM----IMSGNY-Q-----FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  284 (298)
T ss_dssp             HH----HHHTCC-C-----CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HH----HhcCCc-c-----cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence            00    000000 0     0001112345678899999999999999999999874

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=4.2e-42  Score=321.64  Aligned_cols=248  Identities=22%  Similarity=0.335  Sum_probs=194.1

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCCC---hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGKS---GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLL  181 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  181 (432)
                      ..++|.+.+.||+|+||.||+|.+.  +..+|+|.+....   ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   88 (276)
T 2h6d_A            9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM   88 (276)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence            3578999999999999999999986  4489999985432   1234578899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceecc
Q 014024          182 IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVF  261 (432)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  261 (432)
                      ||||+++++|.+++..   ...+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++....
T Consensus        89 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~  162 (276)
T 2h6d_A           89 VMEYVSGGELFDYICK---HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS  162 (276)
T ss_dssp             EEECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred             EEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccC
Confidence            9999999999999853   345899999999999999999999999   9999999999999999999999999997642


Q ss_pred             CCCCccccccccccccccCCccChhhhccCCC-CchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchh
Q 014024          262 GGNDEDELQGNTSRISGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKII  340 (432)
Q Consensus       262 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                      ..       .......|++.|+|||.+.+..+ +.++||||||+++|+|++|+.||.......      ..         
T Consensus       163 ~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~---------  220 (276)
T 2h6d_A          163 DG-------EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT------LF---------  220 (276)
T ss_dssp             C--------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HH---------
T ss_pred             CC-------cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH------HH---------
Confidence            11       12234568999999999987765 689999999999999999999985322110      00         


Q ss_pred             hhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          341 DLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       341 ~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      +.+... ....+......+.+++..||+.||++|||+.+++++
T Consensus       221 ~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          221 KKIRGG-VFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             HHHHHC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             HHhhcC-cccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            000000 001122334678899999999999999999999985

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.2e-41  Score=331.31  Aligned_cols=270  Identities=19%  Similarity=0.270  Sum_probs=198.0

Q ss_pred             chhhHhhhhCCCCcCceeccCCcEEEEEEEECCc-eEEEEEEcCC-----------ChHhHHHHHHHHHHHHhcCCCcee
Q 014024          100 SFSSVSSATGNFSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGK-----------SGQEIKELKNEASVIAQVQHKNLV  167 (432)
Q Consensus       100 ~~~~~~~~~~~y~~~~~ig~G~~g~Vy~~~~~~~-~vavK~~~~~-----------~~~~~~~~~~E~~~l~~l~h~niv  167 (432)
                      ...++....++|++.+.||+|+||.||+|.+..+ .||+|++...           .....+.+.+|++++++++||||+
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   92 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL   92 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence            3456778889999999999999999999988655 8999988432           223347899999999999999999


Q ss_pred             eeEeEEEeC-----CeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEE
Q 014024          168 KLLGCCIEK-----DERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNIL  242 (432)
Q Consensus       168 ~~~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIl  242 (432)
                      ++++++...     ...++||||++ |+|.+++...  +..+++..+..++.|++.||.|||+.+   |+||||||+||+
T Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl  166 (362)
T 3pg1_A           93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ--RIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNIL  166 (362)
T ss_dssp             CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred             ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEE
Confidence            999998543     35799999997 5777777543  345999999999999999999999999   999999999999


Q ss_pred             EcCCCCEEEeecccceeccCCCCccccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCccc
Q 014024          243 LDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRT  321 (432)
Q Consensus       243 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~  321 (432)
                      ++.++.+||+|||++.....       ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.....
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~-------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~  239 (362)
T 3pg1_A          167 LADNNDITICDFNLAREDTA-------DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF  239 (362)
T ss_dssp             ECTTCCEEECCTTC----------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             EcCCCCEEEEecCccccccc-------ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH
Confidence            99999999999999975321       122334578999999999887 6799999999999999999999999864332


Q ss_pred             cccchhhhhHHhhh-----------ccchhhhhhhhhh-------hcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          322 KSLNLIGYAWDLWI-----------SNKIIDLIDSVLE-------EASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       322 ~~~~~~~~~~~~~~-----------~~~~~~~i~~~l~-------~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      ..  ..........           .....+.+.....       ..........+.+++..||+.||++|||+.|++++
T Consensus       240 ~~--~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  317 (362)
T 3pg1_A          240 YN--QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH  317 (362)
T ss_dssp             HH--HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HH--HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence            11  0000000000           0000111110000       00112234568899999999999999999999985


Q ss_pred             h
Q 014024          384 L  384 (432)
Q Consensus       384 L  384 (432)
                      -
T Consensus       318 p  318 (362)
T 3pg1_A          318 P  318 (362)
T ss_dssp             G
T ss_pred             c
Confidence            3

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.7e-42  Score=336.54  Aligned_cols=259  Identities=23%  Similarity=0.307  Sum_probs=184.4

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeC------
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEK------  176 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------  176 (432)
                      ..++|++.+.||+|+||.||+|.+..  ..||+|++...  .....+.+.+|+++++.++||||+++++++...      
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  106 (367)
T 2fst_X           27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF  106 (367)
T ss_dssp             EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence            35899999999999999999998754  48999998543  345567788999999999999999999998654      


Q ss_pred             CeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeeccc
Q 014024          177 DERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGM  256 (432)
Q Consensus       177 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  256 (432)
                      ...++|+|++ +++|.+++..    ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       107 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~  178 (367)
T 2fst_X          107 NDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL  178 (367)
T ss_dssp             CCCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC---
T ss_pred             CeEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccc
Confidence            5679999999 7899888843    45999999999999999999999999   99999999999999999999999999


Q ss_pred             ceeccCCCCccccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHh--
Q 014024          257 ARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDL--  333 (432)
Q Consensus       257 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~--  333 (432)
                      ++...         .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......  ........  
T Consensus       179 a~~~~---------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~l~~i~~~~g  247 (367)
T 2fst_X          179 ARHTA---------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID--QLKLILRLVG  247 (367)
T ss_dssp             ---------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHC
T ss_pred             ccccc---------ccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhC
Confidence            97641         12334678999999999887 679999999999999999999999986433211  11000000  


Q ss_pred             ---------hhccchhhhhhhhhhh------cccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          334 ---------WISNKIIDLIDSVLEE------ASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       334 ---------~~~~~~~~~i~~~l~~------~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                               ........++......      .........+.+|+.+||+.||++|||+.|++++-
T Consensus       248 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp  313 (367)
T 2fst_X          248 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA  313 (367)
T ss_dssp             SCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             CCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcCh
Confidence                     0000111111110000      00112245688999999999999999999999864

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=6.8e-42  Score=326.76  Aligned_cols=265  Identities=24%  Similarity=0.308  Sum_probs=196.0

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEE----------
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCI----------  174 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~----------  174 (432)
                      ..++|++.+.||+|+||.||+|.+..  ..||+|++........+.+.+|++++++++||||+++++++.          
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   88 (320)
T 2i6l_A            9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV   88 (320)
T ss_dssp             ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred             cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence            35789999999999999999999864  489999998777777888999999999999999999999873          


Q ss_pred             ----eCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEc-CCCCE
Q 014024          175 ----EKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLD-KDMNS  249 (432)
Q Consensus       175 ----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~  249 (432)
                          +....++||||++ |+|.+++.    +..+++..++.++.|++.||+|||+.+   |+||||||+||+++ +++.+
T Consensus        89 ~~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~  160 (320)
T 2i6l_A           89 GSLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVL  160 (320)
T ss_dssp             --CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEE
T ss_pred             ccccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeE
Confidence                3467899999997 69999884    345899999999999999999999999   99999999999997 56799


Q ss_pred             EEeecccceeccCCCCccccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhh
Q 014024          250 KISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIG  328 (432)
Q Consensus       250 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~  328 (432)
                      ||+|||++........   .........+|..|+|||.+.+ ..++.++||||||+++|+|++|+.||.......  ...
T Consensus       161 kl~Dfg~~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--~~~  235 (320)
T 2i6l_A          161 KIGDFGLARIMDPHYS---HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE--QMQ  235 (320)
T ss_dssp             EECCCTTCBCC-----------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH
T ss_pred             EEccCccccccCCCcc---cccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH--HHH
Confidence            9999999986422111   1122344567999999998875 679999999999999999999999986433211  000


Q ss_pred             hhHHhhh---ccc-------hhhhhhhhhhh------cccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          329 YAWDLWI---SNK-------IIDLIDSVLEE------ASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       329 ~~~~~~~---~~~-------~~~~i~~~l~~------~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                      .......   ...       ....+......      ......+..+.+++.+||+.||++|||+.|++++-
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  307 (320)
T 2i6l_A          236 LILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHP  307 (320)
T ss_dssp             HHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSH
T ss_pred             HHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCc
Confidence            0000000   000       00000000000      00112356789999999999999999999999853

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=3.3e-42  Score=348.40  Aligned_cols=252  Identities=25%  Similarity=0.309  Sum_probs=202.5

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCC---hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS---GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLL  181 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  181 (432)
                      ..++|++.+.||+|+||.||+|.+..  ..||+|++....   ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  103 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL  103 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            45789999999999999999999853  489999985432   3456789999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEE---cCCCCEEEeecccce
Q 014024          182 IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILL---DKDMNSKISDFGMAR  258 (432)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~  258 (432)
                      ||||+.+|+|.+++..   +..+++..+..++.|++.||.|||+.+   |+||||||+|||+   +.++.+||+|||++.
T Consensus       104 v~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  177 (484)
T 3nyv_A          104 VGEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST  177 (484)
T ss_dssp             EECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred             EEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence            9999999999998854   345999999999999999999999999   9999999999999   567899999999998


Q ss_pred             eccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccc
Q 014024          259 IVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNK  338 (432)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  338 (432)
                      .....       .......||+.|+|||++.+ .++.++|||||||++|+|++|..||......  .......    ...
T Consensus       178 ~~~~~-------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~----~~~  243 (484)
T 3nyv_A          178 HFEAS-------KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY--DILKKVE----KGK  243 (484)
T ss_dssp             HBCCC-------CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHH----HCC
T ss_pred             Ecccc-------cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHH----cCC
Confidence            65221       12334579999999998865 6999999999999999999999998543211  0000000    000


Q ss_pred             hhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          339 IIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       339 ~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                      ..      .........+..+.+++..||+.||.+|||+.|++++-
T Consensus       244 ~~------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~  283 (484)
T 3nyv_A          244 YT------FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHE  283 (484)
T ss_dssp             CC------CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSH
T ss_pred             CC------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhCh
Confidence            00      00011123456788999999999999999999999854

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.3e-41  Score=325.79  Aligned_cols=252  Identities=22%  Similarity=0.309  Sum_probs=194.5

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCC--------hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeC
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS--------GQEIKELKNEASVIAQVQHKNLVKLLGCCIEK  176 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  176 (432)
                      ..++|++.+.||+|+||.||+|.+..  ..||+|.+....        ......+.+|++++++++||||+++++++...
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            45689999999999999999999854  389999985432        12234588999999999999999999998765


Q ss_pred             CeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCC---EEEee
Q 014024          177 DERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN---SKISD  253 (432)
Q Consensus       177 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~D  253 (432)
                      + .++||||+++++|.+++..   +..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.   +||+|
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D  160 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD  160 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHST---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred             c-eEEEEecCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence            5 8999999999999998843   445999999999999999999999999   999999999999987665   99999


Q ss_pred             cccceeccCCCCccccccccccccccCCccChhhhc---cCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhh
Q 014024          254 FGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL---EGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYA  330 (432)
Q Consensus       254 fg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~  330 (432)
                      ||++.....       ........||+.|+|||++.   ...++.++|||||||++|+|++|..||....... ......
T Consensus       161 fg~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~  232 (322)
T 2ycf_A          161 FGHSKILGE-------TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV-SLKDQI  232 (322)
T ss_dssp             CTTCEECCC-------CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS-CHHHHH
T ss_pred             Cccceeccc-------ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH-HHHHHH
Confidence            999987421       11123457899999999874   5678999999999999999999999986433211 111000


Q ss_pred             HHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          331 WDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       331 ~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      ..    ... ...     .......+..+.+++.+||+.||++|||+.+++++
T Consensus       233 ~~----~~~-~~~-----~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h  275 (322)
T 2ycf_A          233 TS----GKY-NFI-----PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  275 (322)
T ss_dssp             HH----TCC-CCC-----HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             Hh----Ccc-ccC-----chhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence            00    000 000     00011234678899999999999999999999864

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=4.4e-42  Score=359.46  Aligned_cols=247  Identities=26%  Similarity=0.305  Sum_probs=202.7

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCC---ChHhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeeE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGK---SGQEIKELKNEASVIAQV-QHKNLVKLLGCCIEKDERL  180 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  180 (432)
                      ..++|++.++||+|+||.||+|.+...  .||+|++...   .....+.+..|..++..+ +|+||+++++++.+.+..|
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            357899999999999999999998654  6999998643   122345678899999987 7999999999999999999


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceec
Q 014024          181 LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIV  260 (432)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  260 (432)
                      +||||+++|+|.+++..   .+.+++..++.++.||+.||+|||+.+   |+||||||+|||++.++++||+|||+++..
T Consensus       419 lV~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~  492 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN  492 (674)
T ss_dssp             EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred             EEEeCcCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence            99999999999999954   345999999999999999999999999   999999999999999999999999999863


Q ss_pred             cCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchh
Q 014024          261 FGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKII  340 (432)
Q Consensus       261 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                      ...      ........||+.|+|||++.+..++.++|||||||++|||++|+.||.....                  .
T Consensus       493 ~~~------~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~------------------~  548 (674)
T 3pfq_A          493 IWD------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------------------D  548 (674)
T ss_dssp             CCT------TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------------------H
T ss_pred             ccC------CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH------------------H
Confidence            211      1234457899999999999999999999999999999999999999853221                  1


Q ss_pred             hhhhhhhh--hcccHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHHH
Q 014024          341 DLIDSVLE--EASFNESLSRYVHIALLCVQERAEDRPTM-----SDVVSM  383 (432)
Q Consensus       341 ~~i~~~l~--~~~~~~~~~~l~~l~~~cl~~dp~~RPt~-----~evl~~  383 (432)
                      ++....+.  ...+.....++.+|+..||+.||++||++     +||+++
T Consensus       549 ~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h  598 (674)
T 3pfq_A          549 ELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  598 (674)
T ss_dssp             HHHHHHHSSCCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred             HHHHHHHhCCCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence            11111111  11233445678999999999999999998     777764

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.7e-41  Score=323.64  Aligned_cols=251  Identities=25%  Similarity=0.382  Sum_probs=197.9

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEe
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYE  184 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  184 (432)
                      ..++|++.+.||+|+||.||+|.+..  ..||+|.+....  ..+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  104 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME  104 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence            46789999999999999999999864  489999986543  34678899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCC
Q 014024          185 YMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGN  264 (432)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  264 (432)
                      |+++++|.+++...  ...+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++...... 
T Consensus       105 ~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~-  178 (314)
T 3com_A          105 YCGAGSVSDIIRLR--NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT-  178 (314)
T ss_dssp             CCTTEEHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT-
T ss_pred             cCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh-
Confidence            99999999998532  345999999999999999999999999   999999999999999999999999999875221 


Q ss_pred             CccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhh
Q 014024          265 DEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLID  344 (432)
Q Consensus       265 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  344 (432)
                           ........||+.|+|||.+.+..++.++||||||+++|+|++|+.||.......     ....... ...     
T Consensus       179 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~-~~~-----  242 (314)
T 3com_A          179 -----MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR-----AIFMIPT-NPP-----  242 (314)
T ss_dssp             -----BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH-----HHHHHHH-SCC-----
T ss_pred             -----ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHhc-CCC-----
Confidence                 112334578999999999999999999999999999999999999985432210     0000000 000     


Q ss_pred             hhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          345 SVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       345 ~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      .  ....+...+..+.+++..||+.||.+|||+.+++++
T Consensus       243 ~--~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~  279 (314)
T 3com_A          243 P--TFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH  279 (314)
T ss_dssp             C--CCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             c--ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            0  000122234678899999999999999999999874

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=7e-42  Score=331.68  Aligned_cols=270  Identities=20%  Similarity=0.298  Sum_probs=198.4

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCC--hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeC-------
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS--GQEIKELKNEASVIAQVQHKNLVKLLGCCIEK-------  176 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-------  176 (432)
                      .++|++.+.||+|+||.||+|.+..  ..||+|++....  ......+.+|+++++.++||||+++++++.+.       
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            4789999999999999999999853  489999885442  22345678899999999999999999999873       


Q ss_pred             -CeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecc
Q 014024          177 -DERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFG  255 (432)
Q Consensus       177 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  255 (432)
                       +..++||||+++ +|.+.+....  ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg  169 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG  169 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CceEEEEEeccCC-CHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence             468999999975 6666664432  34999999999999999999999999   9999999999999999999999999


Q ss_pred             cceeccCCCCccccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCcccccc-chhhhh---
Q 014024          256 MARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSL-NLIGYA---  330 (432)
Q Consensus       256 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~-~~~~~~---  330 (432)
                      ++..+......  .........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ ......   
T Consensus       170 ~a~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  247 (351)
T 3mi9_A          170 LARAFSLAKNS--QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS  247 (351)
T ss_dssp             TCEECCCCSSS--SCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             hcccccccccc--cccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence            99875322111  1223345678999999998876 5689999999999999999999999864332110 000000   


Q ss_pred             -----HHhhhccchhhhhhhhhhhc-cc------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014024          331 -----WDLWISNKIIDLIDSVLEEA-SF------NESLSRYVHIALLCVQERAEDRPTMSDVVSMLT  385 (432)
Q Consensus       331 -----~~~~~~~~~~~~i~~~l~~~-~~------~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~  385 (432)
                           +.........+.+....... ..      ......+.+|+.+||+.||++|||++|++++-.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~  314 (351)
T 3mi9_A          248 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF  314 (351)
T ss_dssp             CCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             CChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCC
Confidence                 00000000000000000000 00      011345789999999999999999999998644

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=5.6e-42  Score=346.83  Aligned_cols=253  Identities=24%  Similarity=0.318  Sum_probs=199.8

Q ss_pred             hhhCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEE
Q 014024          106 SATGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLL  181 (432)
Q Consensus       106 ~~~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  181 (432)
                      ...++|++.+.||+|+||.||+|.+.  +..||+|++...  .......+.+|++++++++||||+++++++.+.+..++
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   98 (486)
T 3mwu_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (486)
T ss_dssp             HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence            45678999999999999999999986  348999998432  12245678999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEc---CCCCEEEeecccce
Q 014024          182 IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLD---KDMNSKISDFGMAR  258 (432)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Dfg~a~  258 (432)
                      ||||+++|+|.+++..   +..+++..+..++.|++.||.|||+.+   |+||||||+|||++   .++.+||+|||++.
T Consensus        99 v~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  172 (486)
T 3mwu_A           99 VGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (486)
T ss_dssp             EECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred             EEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence            9999999999988853   345999999999999999999999999   99999999999995   55679999999997


Q ss_pred             eccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccc
Q 014024          259 IVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNK  338 (432)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  338 (432)
                      .....       .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||......  .......    ...
T Consensus       173 ~~~~~-------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~----~~~  238 (486)
T 3mwu_A          173 CFQQN-------TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY--DILKRVE----TGK  238 (486)
T ss_dssp             TBCCC-----------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHH----HTC
T ss_pred             ECCCC-------CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHH----hCC
Confidence            64221       12334579999999998875 5999999999999999999999998532211  0000000    000


Q ss_pred             hhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          339 IIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       339 ~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                      .      ..........+..+.+++..||+.||.+|||+.+++++-
T Consensus       239 ~------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp  278 (486)
T 3mwu_A          239 Y------AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHP  278 (486)
T ss_dssp             C------CSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCH
T ss_pred             C------CCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCH
Confidence            0      000011123346788999999999999999999999864

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.2e-42  Score=339.85  Aligned_cols=254  Identities=11%  Similarity=0.043  Sum_probs=180.6

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCC---hHhHHHHHHHHHHHHhc--CCCceeeeE-------eEE
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS---GQEIKELKNEASVIAQV--QHKNLVKLL-------GCC  173 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~---~~~~~~~~~E~~~l~~l--~h~niv~~~-------~~~  173 (432)
                      ..+|.+.+.||+|+||.||+|.+..  ..||+|++....   ....+.+.+|+.+++.+  +|||+++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            4568999999999999999999753  489999997653   24456678885555554  699988755       444


Q ss_pred             EeC-----------------CeeEEEEecCCCCChhhhhcCCCCCCCCCHHHH------HHHHHHHHHHHHHHHhcCCCC
Q 014024          174 IEK-----------------DERLLIYEYMPNKSLDCFLFDPTKREILDWRTR------VQIIKGVAQGLLYLHQYSRVR  230 (432)
Q Consensus       174 ~~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~qi~~~l~~LH~~~~~~  230 (432)
                      ...                 ...++||||++ |+|.+++...  +..+.+..+      ..++.|++.||+|||+++   
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---  214 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--DFVYVFRGDEGILALHILTAQLIRLAANLQSKG---  214 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence            433                 23799999998 8999999643  223455555      778899999999999999   


Q ss_pred             eEeccCCCCCEEEcCCCCEEEeecccceeccCCCCccccccccccccccCCccChhhhcc--CCCCchhhhHHHHHHHHH
Q 014024          231 IIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE--GIFSIKSDVFSFGVLLLE  308 (432)
Q Consensus       231 ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~~~DvwSlG~il~e  308 (432)
                      |+||||||+|||++.++.+||+|||++....         .......+|+.|+|||++.+  ..++.++|||||||++||
T Consensus       215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~---------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~e  285 (371)
T 3q60_A          215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVG---------TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYR  285 (371)
T ss_dssp             EEETTCSGGGEEECTTSCEEECCGGGEEETT---------CEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHH
T ss_pred             CccCcCCHHHEEECCCCCEEEEecceeeecC---------CCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHH
Confidence            9999999999999999999999999998641         11224567799999999987  679999999999999999


Q ss_pred             HHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          309 IVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       309 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      |++|+.||............       ....................+..+.+++.+||+.||++|||+.+++++
T Consensus       286 lltg~~Pf~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  353 (371)
T 3q60_A          286 VWCLFLPFGLVTPGIKGSWK-------RPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET  353 (371)
T ss_dssp             HHHSSCSTTBCCTTCTTCCC-------BCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred             HHhCCCCCCCcCcccccchh-------hhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            99999998654321110000       000000000000011112345678899999999999999999999863

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=5.2e-42  Score=331.99  Aligned_cols=264  Identities=23%  Similarity=0.303  Sum_probs=203.0

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECCceEEEEEEcCCChH-----------------hHHHHHHHHHHHHhcCCCceeee
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQ-----------------EIKELKNEASVIAQVQHKNLVKL  169 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~E~~~l~~l~h~niv~~  169 (432)
                      ..++|++.+.||+|+||.||+|.+.+..||+|.+......                 ..+.+.+|+.++++++||||+++
T Consensus        29 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           29 YINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             EETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             ccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            3579999999999999999999996679999998533211                 12788999999999999999999


Q ss_pred             EeEEEeCCeeEEEEecCCCCChhhh------hcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCCCCCEE
Q 014024          170 LGCCIEKDERLLIYEYMPNKSLDCF------LFDPTKREILDWRTRVQIIKGVAQGLLYLHQ-YSRVRIIHRDLKASNIL  242 (432)
Q Consensus       170 ~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dlkp~NIl  242 (432)
                      ++++.+.+..++||||+++++|.++      +.. .....+++..++.++.|++.||.|||+ .+   ++||||||+||+
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil  184 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL  184 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence            9999999999999999999999998      532 124569999999999999999999999 88   999999999999


Q ss_pred             EcCCCCEEEeecccceeccCCCCccccccccccccccCCccChhhhccC-CCCc-hhhhHHHHHHHHHHHhCCCCCCCcc
Q 014024          243 LDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEG-IFSI-KSDVFSFGVLLLEIVSGKKNTGFYR  320 (432)
Q Consensus       243 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~-~~DvwSlG~il~elltg~~p~~~~~  320 (432)
                      ++.++.+||+|||++......        ......||+.|+|||.+.+. .++. ++||||||+++|+|++|+.||....
T Consensus       185 ~~~~~~~kl~dfg~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  256 (348)
T 2pml_X          185 MDKNGRVKLSDFGESEYMVDK--------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI  256 (348)
T ss_dssp             ECTTSCEEECCCTTCEECBTT--------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             EcCCCcEEEeccccccccccc--------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999874221        23445789999999999877 6766 9999999999999999999986433


Q ss_pred             ccccchhhhhHHhh--hccchhhhhhh---hhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          321 TKSLNLIGYAWDLW--ISNKIIDLIDS---VLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       321 ~~~~~~~~~~~~~~--~~~~~~~~i~~---~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      ... ..........  ...........   ..........+..+.+++..||+.||++|||+.|++++
T Consensus       257 ~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h  323 (348)
T 2pml_X          257 SLV-ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH  323 (348)
T ss_dssp             CSH-HHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             cHH-HHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            210 0100000000  00000000000   00000112345678899999999999999999999984

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=3e-41  Score=320.50  Aligned_cols=252  Identities=22%  Similarity=0.255  Sum_probs=195.8

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCCC----hHhHHHHHHHHHHHHhcCCCceeeeEeEEE--eCCee
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKS----GQEIKELKNEASVIAQVQHKNLVKLLGCCI--EKDER  179 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~  179 (432)
                      .++|++.+.||+|+||.||++.+...  .+|+|.+....    ....+.+.+|++++++++|+||+++++++.  +....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            57899999999999999999998543  89999985432    234567899999999999999999999984  45678


Q ss_pred             EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeeccccee
Q 014024          180 LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARI  259 (432)
Q Consensus       180 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  259 (432)
                      ++||||++++ |.+++.... ...+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++..
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence            9999999887 666664432 345999999999999999999999999   99999999999999999999999999987


Q ss_pred             ccCCCCccccccccccccccCCccChhhhccCC--CCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhcc
Q 014024          260 VFGGNDEDELQGNTSRISGTYGYMSPEYALEGI--FSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISN  337 (432)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  337 (432)
                      ......    ........||+.|+|||++.+..  ++.++||||||+++|+|++|+.||......     ... .     
T Consensus       159 ~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~-~-----  223 (305)
T 2wtk_C          159 LHPFAA----DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY-----KLF-E-----  223 (305)
T ss_dssp             CCTTCS----SCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHH-H-----
T ss_pred             cCcccc----ccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH-----HHH-H-----
Confidence            532111    11223456899999999988644  478999999999999999999998532210     000 0     


Q ss_pred             chhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          338 KIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       338 ~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                          .+... ....+...+..+.+++.+||+.||++|||+.|++++-
T Consensus       224 ----~i~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~  265 (305)
T 2wtk_C          224 ----NIGKG-SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHS  265 (305)
T ss_dssp             ----HHHHC-CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSH
T ss_pred             ----HHhcC-CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence                00000 0011223456788999999999999999999999853

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=3e-42  Score=339.48  Aligned_cols=260  Identities=19%  Similarity=0.281  Sum_probs=193.4

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECCc-eEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCe------eE
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDE------RL  180 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~~-~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------~~  180 (432)
                      ..+|++.+.||+|+||.||+|.+..+ .+|+|++......    ..+|+++++.++||||+++++++.....      .+
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            45799999999999999999998554 7999988654322    2469999999999999999999965433      78


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEc-CCCCEEEeeccccee
Q 014024          181 LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLD-KDMNSKISDFGMARI  259 (432)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~  259 (432)
                      +||||++++.+............+++..+..++.|++.||+|||+.+   |+||||||+|||++ .++.+||+|||+++.
T Consensus       115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~  191 (394)
T 4e7w_A          115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI  191 (394)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence            99999987655443322223455999999999999999999999999   99999999999999 799999999999987


Q ss_pred             ccCCCCccccccccccccccCCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccc
Q 014024          260 VFGGNDEDELQGNTSRISGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNK  338 (432)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  338 (432)
                      .....       ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.......  .............
T Consensus       192 ~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~l~~i~~~~g~p~  262 (394)
T 4e7w_A          192 LIAGE-------PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID--QLVEIIKVLGTPS  262 (394)
T ss_dssp             CCTTC-------CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCC
T ss_pred             ccCCC-------CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCC
Confidence            53221       22345789999999998764 58999999999999999999999986433211  0000000000000


Q ss_pred             ---hhhh------------hhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          339 ---IIDL------------IDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       339 ---~~~~------------i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                         +...            .............+.++.+|+.+||+.||.+|||+.|++++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          263 REQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             HHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence               0000            00000001112244678999999999999999999999986

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=4.8e-42  Score=327.45  Aligned_cols=262  Identities=23%  Similarity=0.308  Sum_probs=201.2

Q ss_pred             cchhhHhhhhCCCCcCceeccCCcEEEEEEEECCc-eEEEEEEcCC--ChHhHHHHHHHHHHHHhcC--CCceeeeEeEE
Q 014024           99 FSFSSVSSATGNFSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGK--SGQEIKELKNEASVIAQVQ--HKNLVKLLGCC  173 (432)
Q Consensus        99 ~~~~~~~~~~~~y~~~~~ig~G~~g~Vy~~~~~~~-~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~  173 (432)
                      +.+..+....++|++.+.||+|+||.||++.+.++ .+|+|.+...  .....+.+.+|++++++++  |+||+++++++
T Consensus        18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~   97 (313)
T 3cek_A           18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE   97 (313)
T ss_dssp             --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred             CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence            44555666778899999999999999999998655 7999998543  4556778999999999997  59999999999


Q ss_pred             EeCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEee
Q 014024          174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISD  253 (432)
Q Consensus       174 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  253 (432)
                      .+.+..++||| +.+++|.+++..   +..+++..++.++.|++.||.|||+.+   |+||||||+||++++ +.+||+|
T Consensus        98 ~~~~~~~lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~D  169 (313)
T 3cek_A           98 ITDQYIYMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLID  169 (313)
T ss_dssp             ECSSEEEEEEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECC
T ss_pred             ecCCEEEEEEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEee
Confidence            99999999999 668899999854   345899999999999999999999998   999999999999964 8999999


Q ss_pred             cccceeccCCCCccccccccccccccCCccChhhhcc-----------CCCCchhhhHHHHHHHHHHHhCCCCCCCcccc
Q 014024          254 FGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE-----------GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTK  322 (432)
Q Consensus       254 fg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~t~~~DvwSlG~il~elltg~~p~~~~~~~  322 (432)
                      ||++........    ........||+.|+|||.+.+           ..++.++||||||+++|+|++|+.||......
T Consensus       170 fg~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  245 (313)
T 3cek_A          170 FGIANQMQPDTT----SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ  245 (313)
T ss_dssp             CSSSCC------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH
T ss_pred             ccccccccCccc----cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH
Confidence            999986522111    112234578999999999875           46889999999999999999999998533211


Q ss_pred             ccchhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014024          323 SLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLT  385 (432)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~  385 (432)
                      ..             .....++.......+...+..+.+++..||+.||++|||+.|++++-.
T Consensus       246 ~~-------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~  295 (313)
T 3cek_A          246 IS-------------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY  295 (313)
T ss_dssp             HH-------------HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred             HH-------------HHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCcc
Confidence            00             011111211111222233467889999999999999999999998543

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=9.3e-42  Score=355.96  Aligned_cols=259  Identities=23%  Similarity=0.306  Sum_probs=204.8

Q ss_pred             HhhhhCCCCcCceeccCCcEEEEEEEECC-----ceEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC
Q 014024          104 VSSATGNFSAANKLGEGGFGTVYKGVIGQ-----GEIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKD  177 (432)
Q Consensus       104 ~~~~~~~y~~~~~ig~G~~g~Vy~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  177 (432)
                      .....++|++.+.||+|+||.||+|.+..     ..+|+|..... .....+.+.+|+.++++++||||+++++++. .+
T Consensus       385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~  463 (656)
T 2j0j_A          385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN  463 (656)
T ss_dssp             TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred             cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cC
Confidence            33456789999999999999999998743     25889987643 4455678999999999999999999999985 45


Q ss_pred             eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccc
Q 014024          178 ERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMA  257 (432)
Q Consensus       178 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  257 (432)
                      ..++||||+++|+|.+++...  ...+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       464 ~~~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a  538 (656)
T 2j0j_A          464 PVWIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLS  538 (656)
T ss_dssp             SCEEEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred             ceEEEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCC
Confidence            689999999999999999643  234899999999999999999999998   999999999999999999999999999


Q ss_pred             eeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhc
Q 014024          258 RIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWIS  336 (432)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  336 (432)
                      .......     ........+|+.|+|||++.+..++.++||||||+++|||++ |..||.......             
T Consensus       539 ~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-------------  600 (656)
T 2j0j_A          539 RYMEDST-----YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-------------  600 (656)
T ss_dssp             CSCCC---------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------------
T ss_pred             eecCCCc-----ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH-------------
Confidence            8652211     112233456789999999999999999999999999999997 888875322110             


Q ss_pred             cchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014024          337 NKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEA  388 (432)
Q Consensus       337 ~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~  388 (432)
                        ....+........+...+..+.+++..||+.||++|||+.++++.|+.+.
T Consensus       601 --~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il  650 (656)
T 2j0j_A          601 --VIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  650 (656)
T ss_dssp             --HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --HHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence              01111111112233445678899999999999999999999999998764

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=2.2e-41  Score=330.84  Aligned_cols=258  Identities=20%  Similarity=0.297  Sum_probs=196.7

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCee---
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDER---  179 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~---  179 (432)
                      ..++|.+.+.||+|+||.||+|.+..  ..||+|++...  .....+.+.+|+.+++.++||||+++++++...+..   
T Consensus        40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  119 (371)
T 4exu_A           40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  119 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred             ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence            45799999999999999999999854  48999998654  344567889999999999999999999999877654   


Q ss_pred             ---EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeeccc
Q 014024          180 ---LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGM  256 (432)
Q Consensus       180 ---~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  256 (432)
                         ++||||+. ++|.+++.     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus       120 ~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~  190 (371)
T 4exu_A          120 YDFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL  190 (371)
T ss_dssp             CCCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred             eeEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCc
Confidence               99999997 57877762     23999999999999999999999999   99999999999999999999999999


Q ss_pred             ceeccCCCCccccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHh--
Q 014024          257 ARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDL--  333 (432)
Q Consensus       257 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~--  333 (432)
                      +....         .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......  ........  
T Consensus       191 a~~~~---------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i~~~~~  259 (371)
T 4exu_A          191 ARHAD---------AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD--QLTQILKVTG  259 (371)
T ss_dssp             C-----------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHC
T ss_pred             ccccc---------cCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhC
Confidence            97641         12334578999999999987 779999999999999999999999986433211  00000000  


Q ss_pred             ---------hhccchhhhhhhhhhh------cccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          334 ---------WISNKIIDLIDSVLEE------ASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       334 ---------~~~~~~~~~i~~~l~~------~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                               .........+......      .........+.+++..||+.||++|||+.|++++-
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  325 (371)
T 4exu_A          260 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP  325 (371)
T ss_dssp             CCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred             CCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCc
Confidence                     0000000011000000      00112356789999999999999999999999864

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.3e-40  Score=325.23  Aligned_cols=260  Identities=21%  Similarity=0.266  Sum_probs=199.1

Q ss_pred             hCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCCChHhHHHHHHHHHHHHhcC-----------CCceeeeEeEEE
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGKSGQEIKELKNEASVIAQVQ-----------HKNLVKLLGCCI  174 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~~  174 (432)
                      .++|++.+.||+|+||.||+|.+.  +..||+|++.. .....+.+.+|+.++++++           |+||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            578999999999999999999974  34899999864 3445577889999999886           789999999997


Q ss_pred             eCC----eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEeccCCCCCEEEc-----
Q 014024          175 EKD----ERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQY-SRVRIIHRDLKASNILLD-----  244 (432)
Q Consensus       175 ~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~ivH~Dlkp~NIll~-----  244 (432)
                      ..+    ..++||||+ +++|.+++.... ...+++..+..++.|++.||+|||++ +   |+||||||+|||++     
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence            654    789999999 899999986533 23499999999999999999999998 8   99999999999994     


Q ss_pred             -CCCCEEEeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccc
Q 014024          245 -KDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKS  323 (432)
Q Consensus       245 -~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~  323 (432)
                       ..+.+||+|||++....         .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus       172 ~~~~~~kl~Dfg~a~~~~---------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  242 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYD---------EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHS  242 (373)
T ss_dssp             TTEEEEEECCCTTCEETT---------BCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred             cCcceEEEcccccccccC---------CCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccc
Confidence             44579999999998752         12334578999999999999999999999999999999999999986443211


Q ss_pred             c----chhhhhHHhhh--------cc-c---------------------hhhhhhhhhhhcccHHHHHHHHHHHHHhhcc
Q 014024          324 L----NLIGYAWDLWI--------SN-K---------------------IIDLIDSVLEEASFNESLSRYVHIALLCVQE  369 (432)
Q Consensus       324 ~----~~~~~~~~~~~--------~~-~---------------------~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~  369 (432)
                      .    ...........        .. .                     ..+....  ....+......+.+|+..||+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~  320 (373)
T 1q8y_A          243 YTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTE--KYKFSKDEAKEISDFLSPMLQL  320 (373)
T ss_dssp             --CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHH--TTCCCHHHHHHHHHHHGGGGCS
T ss_pred             cCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhh--cccCCcchHHHHHHHHHHHhcc
Confidence            0    00000000000        00 0                     0000010  1123456778899999999999


Q ss_pred             CCCCCCCHHHHHHHh
Q 014024          370 RAEDRPTMSDVVSML  384 (432)
Q Consensus       370 dp~~RPt~~evl~~L  384 (432)
                      ||++|||++|++++-
T Consensus       321 dP~~Rpt~~ell~hp  335 (373)
T 1q8y_A          321 DPRKRADAGGLVNHP  335 (373)
T ss_dssp             STTTCBCHHHHHTCG
T ss_pred             CccccCCHHHHhhCh
Confidence            999999999999854

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2e-41  Score=320.80  Aligned_cols=258  Identities=22%  Similarity=0.340  Sum_probs=191.7

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEe---------
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIE---------  175 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---------  175 (432)
                      ..++|++.+.||+|+||.||+|.+.  +..||+|.+.. .....+.+.+|+.++++++||||+++++++.+         
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            3568999999999999999999975  34899998854 34556788999999999999999999999865         


Q ss_pred             ----CCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEE
Q 014024          176 ----KDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKI  251 (432)
Q Consensus       176 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  251 (432)
                          .+..++||||+++++|.+++...  ...+++..++.++.|++.||+|||+.+   ++||||||+||+++.++.+||
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl  157 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKI  157 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEE
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEE
Confidence                34679999999999999999643  234888999999999999999999999   999999999999999999999


Q ss_pred             eecccceeccCCCCcc--------ccccccccccccCCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCCcccc
Q 014024          252 SDFGMARIVFGGNDED--------ELQGNTSRISGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGFYRTK  322 (432)
Q Consensus       252 ~Dfg~a~~~~~~~~~~--------~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlG~il~elltg~~p~~~~~~~  322 (432)
                      +|||++..........        ..........||+.|+|||++.+. .++.++|||||||++|+|++   |+..... 
T Consensus       158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~-  233 (303)
T 1zy4_A          158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME-  233 (303)
T ss_dssp             CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH-
T ss_pred             eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh-
Confidence            9999998643211000        001223445789999999999864 78999999999999999998   4321110 


Q ss_pred             ccchhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          323 SLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                      .....    .....      .............+..+.+++..||+.||.+|||+.+++++-
T Consensus       234 ~~~~~----~~~~~------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~  285 (303)
T 1zy4_A          234 RVNIL----KKLRS------VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSG  285 (303)
T ss_dssp             HHHHH----HHHHS------TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSS
T ss_pred             HHHHH----Hhccc------cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCC
Confidence            00000    00000      000011122334456788999999999999999999999853

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=6.9e-41  Score=328.58  Aligned_cols=201  Identities=24%  Similarity=0.300  Sum_probs=170.5

Q ss_pred             HhhhhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCChHhHHHHHHHHHHHHhcC-CC-----ceeeeEeEEEe
Q 014024          104 VSSATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSGQEIKELKNEASVIAQVQ-HK-----NLVKLLGCCIE  175 (432)
Q Consensus       104 ~~~~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~~~~~~~~  175 (432)
                      .....++|++.+.||+|+||.||+|.+..  ..||+|++... ....+.+..|+++++.++ |+     +++++++++..
T Consensus        49 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~  127 (382)
T 2vx3_A           49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF  127 (382)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred             CCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence            34457899999999999999999999864  37999998643 344567888999998885 44     49999999999


Q ss_pred             CCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh--cCCCCeEeccCCCCCEEEc--CCCCEEE
Q 014024          176 KDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ--YSRVRIIHRDLKASNILLD--KDMNSKI  251 (432)
Q Consensus       176 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~--~~~~~ivH~Dlkp~NIll~--~~~~~kl  251 (432)
                      .+..++||||++ ++|.+++..... ..+++..+..++.|++.||.|||+  .+   |+||||||+|||++  .++.+||
T Consensus       128 ~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL  202 (382)
T 2vx3_A          128 RNHLCLVFEMLS-YNLYDLLRNTNF-RGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKI  202 (382)
T ss_dssp             TTEEEEEEECCC-CBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEE
T ss_pred             CCceEEEEecCC-CCHHHHHhhcCc-CCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEE
Confidence            999999999996 599998865432 349999999999999999999995  55   99999999999994  5788999


Q ss_pred             eecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCc
Q 014024          252 SDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFY  319 (432)
Q Consensus       252 ~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~  319 (432)
                      +|||++....         .......||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus       203 ~DFG~a~~~~---------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~  261 (382)
T 2vx3_A          203 VDFGSSCQLG---------QRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA  261 (382)
T ss_dssp             CCCTTCEETT---------CCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             EeccCceecc---------cccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            9999998751         1233467899999999999999999999999999999999999998643

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.5e-41  Score=333.46  Aligned_cols=262  Identities=19%  Similarity=0.239  Sum_probs=192.9

Q ss_pred             hhhhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeC------
Q 014024          105 SSATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEK------  176 (432)
Q Consensus       105 ~~~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------  176 (432)
                      ....++|++.+.||+|+||.||+|.+..  ..||+|++.....    ...+|+++++.++|+||+++++++...      
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            3456799999999999999999999843  4899999865432    234799999999999999999998443      


Q ss_pred             --------------------------------CeeEEEEecCCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHH
Q 014024          177 --------------------------------DERLLIYEYMPNKSLDCFLFDP-TKREILDWRTRVQIIKGVAQGLLYL  223 (432)
Q Consensus       177 --------------------------------~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~l~~L  223 (432)
                                                      ...++||||++ ++|.+.+... .....+++..+..++.|++.||+||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                            34789999998 4776666421 2234599999999999999999999


Q ss_pred             HhcCCCCeEeccCCCCCEEEc-CCCCEEEeecccceeccCCCCccccccccccccccCCccChhhhccC-CCCchhhhHH
Q 014024          224 HQYSRVRIIHRDLKASNILLD-KDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEG-IFSIKSDVFS  301 (432)
Q Consensus       224 H~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwS  301 (432)
                      |+.+   |+||||||+|||++ .++.+||+|||++......       .......||+.|+|||.+.+. .++.++||||
T Consensus       158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws  227 (383)
T 3eb0_A          158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS-------EPSVAYICSRFYRAPELMLGATEYTPSIDLWS  227 (383)
T ss_dssp             HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTT-------SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHH
T ss_pred             HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCC-------CCCcCcccCCCccCHHHhcCCCCCCcchhhhh
Confidence            9998   99999999999998 6889999999999875222       122345789999999998765 4899999999


Q ss_pred             HHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhh---------------hhhhhhhcccHHHHHHHHHHHHHh
Q 014024          302 FGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDL---------------IDSVLEEASFNESLSRYVHIALLC  366 (432)
Q Consensus       302 lG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------i~~~l~~~~~~~~~~~l~~l~~~c  366 (432)
                      +||++|||++|+.||......+  ................+               .........+...+..+.+++..|
T Consensus       228 lG~il~ell~g~~pf~~~~~~~--~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  305 (383)
T 3eb0_A          228 IGCVFGELILGKPLFSGETSID--QLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQI  305 (383)
T ss_dssp             HHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHH
Confidence            9999999999999986433211  00000000000000000               000011111223456789999999


Q ss_pred             hccCCCCCCCHHHHHHH
Q 014024          367 VQERAEDRPTMSDVVSM  383 (432)
Q Consensus       367 l~~dp~~RPt~~evl~~  383 (432)
                      |+.||++|||+.|++++
T Consensus       306 L~~dP~~R~t~~e~l~h  322 (383)
T 3eb0_A          306 LRYEPDLRINPYEAMAH  322 (383)
T ss_dssp             CCSSGGGSCCHHHHHTS
T ss_pred             ccCChhhCCCHHHHhcC
Confidence            99999999999999974

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.4e-41  Score=330.57  Aligned_cols=268  Identities=17%  Similarity=0.194  Sum_probs=187.6

Q ss_pred             hHhhhhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCe--
Q 014024          103 SVSSATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDE--  178 (432)
Q Consensus       103 ~~~~~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--  178 (432)
                      ......++|++.+.||+|+||.||+|.+..  ..||+|++.... .......++++.++.++||||+++++++...+.  
T Consensus        17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~   95 (360)
T 3e3p_A           17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD   95 (360)
T ss_dssp             HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred             hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence            455677899999999999999999999863  489999885543 223456678888999999999999999976443  


Q ss_pred             -----eEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCCeEeccCCCCCEEEcC-CCCEE
Q 014024          179 -----RLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLH--QYSRVRIIHRDLKASNILLDK-DMNSK  250 (432)
Q Consensus       179 -----~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH--~~~~~~ivH~Dlkp~NIll~~-~~~~k  250 (432)
                           .++||||++++.+..+.........+++..+..++.|++.||.|||  +.+   |+||||||+|||++. ++.+|
T Consensus        96 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~k  172 (360)
T 3e3p_A           96 RRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLK  172 (360)
T ss_dssp             TTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEE
T ss_pred             ccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEE
Confidence                 7899999987543322221234455899999999999999999999  888   999999999999997 89999


Q ss_pred             EeecccceeccCCCCccccccccccccccCCccChhhhccCC-CCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhh
Q 014024          251 ISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGY  329 (432)
Q Consensus       251 l~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~  329 (432)
                      |+|||++......       .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.......  ....
T Consensus       173 l~Dfg~a~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~--~~~~  243 (360)
T 3e3p_A          173 LCDFGSAKKLSPS-------EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG--QLHE  243 (360)
T ss_dssp             ECCCTTCBCCCTT-------SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHH
T ss_pred             EeeCCCceecCCC-------CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH--HHHH
Confidence            9999999865221       1223456899999999987654 8999999999999999999999986433211  0000


Q ss_pred             hHHhhhccchhhhhh-------------------hhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          330 AWDLWISNKIIDLID-------------------SVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       330 ~~~~~~~~~~~~~i~-------------------~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                      ...... ....+.+.                   ..............+.+++..||+.||.+|||+.|++++-
T Consensus       244 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp  316 (360)
T 3e3p_A          244 IVRVLG-CPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHP  316 (360)
T ss_dssp             HHHHHC-CCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSG
T ss_pred             HHHHcC-CCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCc
Confidence            000000 00000000                   0000111122457889999999999999999999999863

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.3e-40  Score=322.66  Aligned_cols=260  Identities=19%  Similarity=0.228  Sum_probs=198.8

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECC---ceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCc------eeeeEeEEEeCC
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQ---GEIAVKRLLGKSGQEIKELKNEASVIAQVQHKN------LVKLLGCCIEKD  177 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~---~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~~~~~~  177 (432)
                      ..++|++.+.||+|+||.||+|.+..   ..||+|++... ....+.+.+|++++++++|++      ++.+++++...+
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~   95 (355)
T 2eu9_A           17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG   95 (355)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred             ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence            35799999999999999999999743   37999988643 455677889999999997765      999999999999


Q ss_pred             eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEE--------------
Q 014024          178 ERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILL--------------  243 (432)
Q Consensus       178 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll--------------  243 (432)
                      ..++||||+ ++++.+++.... ...+++..++.++.|++.||+|||+.+   |+||||||+|||+              
T Consensus        96 ~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~  170 (355)
T 2eu9_A           96 HMCIAFELL-GKNTFEFLKENN-FQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKS  170 (355)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred             eEEEEEecc-CCChHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccc
Confidence            999999999 556666664422 235999999999999999999999998   9999999999999              


Q ss_pred             -----cCCCCEEEeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 014024          244 -----DKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGF  318 (432)
Q Consensus       244 -----~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~  318 (432)
                           +.++.+||+|||++....         .......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       171 ~~~~~~~~~~~kl~Dfg~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  241 (355)
T 2eu9_A          171 CEEKSVKNTSIRVADFGSATFDH---------EHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQT  241 (355)
T ss_dssp             CCEEEESCCCEEECCCTTCEETT---------SCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ccccccCCCcEEEeecCcccccc---------ccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence                 668899999999998631         122345789999999999999999999999999999999999999865


Q ss_pred             ccccccchhhhhHHhh-----------hcc--------------chhhhhhhhh-----hhcccHHHHHHHHHHHHHhhc
Q 014024          319 YRTKSLNLIGYAWDLW-----------ISN--------------KIIDLIDSVL-----EEASFNESLSRYVHIALLCVQ  368 (432)
Q Consensus       319 ~~~~~~~~~~~~~~~~-----------~~~--------------~~~~~i~~~l-----~~~~~~~~~~~l~~l~~~cl~  368 (432)
                      ......  ........           ...              ..........     ...........+.+++..||+
T Consensus       242 ~~~~~~--~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~  319 (355)
T 2eu9_A          242 HENREH--LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLE  319 (355)
T ss_dssp             SSHHHH--HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred             CCHHHH--HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhc
Confidence            332110  00000000           000              0000000000     001123445688999999999


Q ss_pred             cCCCCCCCHHHHHHH
Q 014024          369 ERAEDRPTMSDVVSM  383 (432)
Q Consensus       369 ~dp~~RPt~~evl~~  383 (432)
                      .||++|||+.|++++
T Consensus       320 ~dP~~Rpt~~e~l~h  334 (355)
T 2eu9_A          320 FDPAQRITLAEALLH  334 (355)
T ss_dssp             SSTTTSCCHHHHTTS
T ss_pred             CChhhCcCHHHHhcC
Confidence            999999999999864

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=3.7e-41  Score=326.60  Aligned_cols=268  Identities=21%  Similarity=0.281  Sum_probs=199.7

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeC-----Ce
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEK-----DE  178 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~  178 (432)
                      ..++|++.+.||+|+||.||+|.+.  +..||+|++... .......+.+|++++++++||||+++++++...     ..
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   88 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE   88 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence            4578999999999999999999986  448999998643 344566788999999999999999999998764     67


Q ss_pred             eEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccce
Q 014024          179 RLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMAR  258 (432)
Q Consensus       179 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  258 (432)
                      .++||||+. ++|.+++..    ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.
T Consensus        89 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (353)
T 2b9h_A           89 VYIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR  160 (353)
T ss_dssp             EEEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccc
Confidence            899999997 589888843    35999999999999999999999999   9999999999999999999999999998


Q ss_pred             eccCCCCccc----cccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHh
Q 014024          259 IVFGGNDEDE----LQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDL  333 (432)
Q Consensus       259 ~~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~  333 (432)
                      ..........    .........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........  .......
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~  238 (353)
T 2b9h_A          161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ--LLLIFGI  238 (353)
T ss_dssp             ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHH
T ss_pred             ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHHHH
Confidence            7532211100    0111234578999999998764 7799999999999999999999999864432110  0000000


Q ss_pred             hh------------ccchhhhhhhhhh------hcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          334 WI------------SNKIIDLIDSVLE------EASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       334 ~~------------~~~~~~~i~~~l~------~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                      ..            .....+.+.....      .......+..+.+++.+||+.||++|||+.|++++-
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  307 (353)
T 2b9h_A          239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHP  307 (353)
T ss_dssp             HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             hCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence            00            0000111110000      001123456788999999999999999999999853

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=8.6e-41  Score=320.37  Aligned_cols=264  Identities=22%  Similarity=0.299  Sum_probs=197.2

Q ss_pred             hhhCCCCcCceeccCCcEEEEEEEEC---CceEEEEEEcCCC--hHhHHHHHHHHHHHHhc---CCCceeeeEeEEE---
Q 014024          106 SATGNFSAANKLGEGGFGTVYKGVIG---QGEIAVKRLLGKS--GQEIKELKNEASVIAQV---QHKNLVKLLGCCI---  174 (432)
Q Consensus       106 ~~~~~y~~~~~ig~G~~g~Vy~~~~~---~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~---  174 (432)
                      ...++|++.+.||+|+||.||+|.+.   +..||+|++....  ......+.+|+.+++.+   +||||+++++++.   
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            45689999999999999999999983   3378999885322  11223456677777666   8999999999987   


Q ss_pred             --eCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEe
Q 014024          175 --EKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKIS  252 (432)
Q Consensus       175 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  252 (432)
                        .....++||||++ |+|.+++.... ...+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~  162 (326)
T 1blx_A           88 TDRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA  162 (326)
T ss_dssp             CSSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred             cCCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEe
Confidence              4567899999997 69999886533 234899999999999999999999999   9999999999999999999999


Q ss_pred             ecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHH
Q 014024          253 DFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWD  332 (432)
Q Consensus       253 Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~  332 (432)
                      |||++.....       ........||+.|+|||++.+..++.++||||||+++|+|++|+.||.......  .......
T Consensus       163 Dfg~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~i~~  233 (326)
T 1blx_A          163 DFGLARIYSF-------QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD--QLGKILD  233 (326)
T ss_dssp             SCCSCCCCCG-------GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHH
T ss_pred             cCcccccccC-------CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHH
Confidence            9999976421       112344678999999999999999999999999999999999999986433211  0000000


Q ss_pred             hhhc---cchh-------hhhh---hhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          333 LWIS---NKII-------DLID---SVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       333 ~~~~---~~~~-------~~i~---~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      ....   ....       ....   ...........+..+.+++.+||+.||++|||+.|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  297 (326)
T 1blx_A          234 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  297 (326)
T ss_dssp             HHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            0000   0000       0000   000001112345678899999999999999999999974

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.6e-40  Score=322.43  Aligned_cols=257  Identities=20%  Similarity=0.295  Sum_probs=195.6

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCe-----
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDE-----  178 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-----  178 (432)
                      .++|.+.+.||+|+||.||+|.+..  ..||+|++...  .....+.+.+|+.+++.++||||+++++++...+.     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            4789999999999999999999853  48999998553  34456778999999999999999999999987654     


Q ss_pred             -eEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccc
Q 014024          179 -RLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMA  257 (432)
Q Consensus       179 -~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  257 (432)
                       .++||||+. ++|.+++.     ..+++..+..++.|++.||+|||+.+   |+||||||+||++++++.+||+|||++
T Consensus       103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~  173 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA  173 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred             eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence             499999997 58887762     23999999999999999999999999   999999999999999999999999999


Q ss_pred             eeccCCCCccccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhh--
Q 014024          258 RIVFGGNDEDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLW--  334 (432)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~--  334 (432)
                      ....         .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......  .........  
T Consensus       174 ~~~~---------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--~~~~i~~~~~~  242 (353)
T 3coi_A          174 RHAD---------AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD--QLTQILKVTGV  242 (353)
T ss_dssp             TC-----------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH--HHHHHHHHHCB
T ss_pred             cCCC---------CCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCC
Confidence            7631         12234578999999999887 678999999999999999999999986433211  000000000  


Q ss_pred             ---------hccchhhhhhhhhh------hcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          335 ---------ISNKIIDLIDSVLE------EASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       335 ---------~~~~~~~~i~~~l~------~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                               ........+.....      ..........+.+++.+||+.||++|||+.+++++-
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp  307 (353)
T 3coi_A          243 PGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP  307 (353)
T ss_dssp             CCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred             CCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence                     00000000000000      001123456789999999999999999999999753

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=7.2e-41  Score=330.96  Aligned_cols=270  Identities=19%  Similarity=0.277  Sum_probs=182.3

Q ss_pred             hCCCCc-CceeccCCcEEEEEEEEC----CceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEe--CCeeE
Q 014024          108 TGNFSA-ANKLGEGGFGTVYKGVIG----QGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIE--KDERL  180 (432)
Q Consensus       108 ~~~y~~-~~~ig~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~  180 (432)
                      .+.|++ .++||+|+||.||+|.+.    +..||+|++.....  ...+.+|+.+|++++||||+++++++..  ....+
T Consensus        19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   96 (405)
T 3rgf_A           19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVW   96 (405)
T ss_dssp             HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred             hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence            445665 568999999999999965    23799999865432  2467889999999999999999999965  66889


Q ss_pred             EEEecCCCCChhhhhcCC------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEE----cCCCCEE
Q 014024          181 LIYEYMPNKSLDCFLFDP------TKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILL----DKDMNSK  250 (432)
Q Consensus       181 lv~e~~~~gsL~~~l~~~------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~k  250 (432)
                      +||||+++ +|.+++...      .....+++..++.++.|++.||+|||+.+   |+||||||+|||+    +.++.+|
T Consensus        97 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~k  172 (405)
T 3rgf_A           97 LLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVK  172 (405)
T ss_dssp             EEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEE
T ss_pred             EEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEE
Confidence            99999965 776666321      12234999999999999999999999999   9999999999999    7789999


Q ss_pred             EeecccceeccCCCCccccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCccccc------
Q 014024          251 ISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKS------  323 (432)
Q Consensus       251 l~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~------  323 (432)
                      |+|||++........   .........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......      
T Consensus       173 l~Dfg~a~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~  249 (405)
T 3rgf_A          173 IADMGFARLFNSPLK---PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY  249 (405)
T ss_dssp             ECCTTCCC-------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCC
T ss_pred             EEECCCceecCCCCc---ccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccc
Confidence            999999987522111   1122345678999999999987 459999999999999999999999985432210      


Q ss_pred             -cchhhhhHHhh---hcc---------chhhhhhhhhhhc---c---------cHHHHHHHHHHHHHhhccCCCCCCCHH
Q 014024          324 -LNLIGYAWDLW---ISN---------KIIDLIDSVLEEA---S---------FNESLSRYVHIALLCVQERAEDRPTMS  378 (432)
Q Consensus       324 -~~~~~~~~~~~---~~~---------~~~~~i~~~l~~~---~---------~~~~~~~l~~l~~~cl~~dp~~RPt~~  378 (432)
                       ...........   ...         .............   .         .......+.+|+..||+.||.+|||++
T Consensus       250 ~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~  329 (405)
T 3rgf_A          250 HHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSE  329 (405)
T ss_dssp             CHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHH
T ss_pred             hHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHH
Confidence             00000000000   000         0000000000000   0         001135678999999999999999999


Q ss_pred             HHHHHhcc
Q 014024          379 DVVSMLTN  386 (432)
Q Consensus       379 evl~~L~~  386 (432)
                      |++++-.=
T Consensus       330 e~L~hp~f  337 (405)
T 3rgf_A          330 QAMQDPYF  337 (405)
T ss_dssp             HHHTSGGG
T ss_pred             HHhcChhh
Confidence            99986543

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2e-41  Score=336.39  Aligned_cols=260  Identities=20%  Similarity=0.277  Sum_probs=190.2

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeC------Cee
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEK------DER  179 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~  179 (432)
                      ..+|++.+.||+|+||.||+|.+..  ..||+|++.....    ...+|+++|+.++|+||+++++++...      ...
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~  128 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL  128 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence            3479999999999999999999853  4899999865432    234699999999999999999998542      236


Q ss_pred             EEEEecCCCCChhhhhcC-CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCC-CCEEEeecccc
Q 014024          180 LLIYEYMPNKSLDCFLFD-PTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKD-MNSKISDFGMA  257 (432)
Q Consensus       180 ~lv~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a  257 (432)
                      ++||||+++ ++.+.+.. ......+++..+..++.|++.||+|||+.+   |+||||||+|||++.+ +.+||+|||++
T Consensus       129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a  204 (420)
T 1j1b_A          129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSA  204 (420)
T ss_dssp             EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhh
Confidence            789999986 55544432 122345999999999999999999999998   9999999999999965 56899999999


Q ss_pred             eeccCCCCccccccccccccccCCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhc
Q 014024          258 RIVFGGNDEDELQGNTSRISGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWIS  336 (432)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  336 (432)
                      +.+....       ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+ .+.... .....
T Consensus       205 ~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~-~l~~i~-~~lg~  275 (420)
T 1j1b_A          205 KQLVRGE-------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEII-KVLGT  275 (420)
T ss_dssp             EECCTTC-------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHH-HHHCS
T ss_pred             hhcccCC-------CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHH-HHhCC
Confidence            8753221       22345789999999998764 79999999999999999999999986432211 011100 00000


Q ss_pred             c---chhhh-------hhhh-----hhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          337 N---KIIDL-------IDSV-----LEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       337 ~---~~~~~-------i~~~-----l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                      .   .+...       .-+.     .........+.++.+|+.+||+.||++|||+.|++++-
T Consensus       276 p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp  338 (420)
T 1j1b_A          276 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS  338 (420)
T ss_dssp             CCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             CCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCH
Confidence            0   00000       0000     00001122346788999999999999999999999753

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=8.6e-41  Score=314.84  Aligned_cols=253  Identities=23%  Similarity=0.309  Sum_probs=200.0

Q ss_pred             hhhhCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeE
Q 014024          105 SSATGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERL  180 (432)
Q Consensus       105 ~~~~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  180 (432)
                      ....++|++.+.||+|+||.||+|.+.  +..||+|++...  .....+.+.+|++++++++||||+++++++.+.+..+
T Consensus        18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   97 (287)
T 2wei_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY   97 (287)
T ss_dssp             HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence            455689999999999999999999985  448999998543  2334677899999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCC---CCEEEeecccc
Q 014024          181 LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKD---MNSKISDFGMA  257 (432)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Dfg~a  257 (432)
                      +||||+++++|.+++..   ...+++..++.++.|++.||.|||+.+   ++||||||+||+++.+   +.+||+|||++
T Consensus        98 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~  171 (287)
T 2wei_A           98 IVGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS  171 (287)
T ss_dssp             EEECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred             EEEEccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcc
Confidence            99999999999988853   335999999999999999999999998   9999999999999764   46999999999


Q ss_pred             eeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhcc
Q 014024          258 RIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISN  337 (432)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  337 (432)
                      ......       .......||+.|+|||.+.+ .++.++||||||+++|+|++|+.||......  ....    .....
T Consensus       172 ~~~~~~-------~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~----~~~~~  237 (287)
T 2wei_A          172 TCFQQN-------TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY--DILK----RVETG  237 (287)
T ss_dssp             GTBCCC-------SSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHH----HHHHC
T ss_pred             eeecCC-------CccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH--HHHH----HHHcC
Confidence            764211       12233468899999998875 5899999999999999999999998532211  0000    00000


Q ss_pred             chhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          338 KIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       338 ~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      ...      .........+..+.+++..||+.||++|||+.|++++
T Consensus       238 ~~~------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  277 (287)
T 2wei_A          238 KYA------FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (287)
T ss_dssp             CCC------CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             CCC------CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence            000      0000112234678899999999999999999999984

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=5e-41  Score=320.19  Aligned_cols=246  Identities=20%  Similarity=0.347  Sum_probs=190.5

Q ss_pred             HhhhhCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCCCh------HhHHHHHHHHHHHHhc----CCCceeeeEe
Q 014024          104 VSSATGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGKSG------QEIKELKNEASVIAQV----QHKNLVKLLG  171 (432)
Q Consensus       104 ~~~~~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~h~niv~~~~  171 (432)
                      .....++|++.+.||+|+||.||+|.+.  +..||+|++.....      .....+.+|+.++.++    +|+||+++++
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~  105 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD  105 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence            3455789999999999999999999874  34899999865432      1233466799999999    8999999999


Q ss_pred             EEEeCCeeEEEEec-CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEc-CCCCE
Q 014024          172 CCIEKDERLLIYEY-MPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLD-KDMNS  249 (432)
Q Consensus       172 ~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~  249 (432)
                      ++.+.+..++|||+ +.+++|.+++..   +..+++..++.++.|++.||+|||+.+   |+||||||+||+++ +++.+
T Consensus       106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~  179 (312)
T 2iwi_A          106 WFETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCA  179 (312)
T ss_dssp             EC-----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEE
T ss_pred             EEecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeE
Confidence            99999999999999 789999999954   345999999999999999999999999   99999999999999 88999


Q ss_pred             EEeecccceeccCCCCccccccccccccccCCccChhhhccCCC-CchhhhHHHHHHHHHHHhCCCCCCCccccccchhh
Q 014024          250 KISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIG  328 (432)
Q Consensus       250 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~  328 (432)
                      ||+|||++.....        .......||..|+|||++.+..+ +.++||||||+++|+|++|+.||.....       
T Consensus       180 kl~dfg~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------  244 (312)
T 2iwi_A          180 KLIDFGSGALLHD--------EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE-------  244 (312)
T ss_dssp             EECCCSSCEECCS--------SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------
T ss_pred             EEEEcchhhhccc--------CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-------
Confidence            9999999987522        12234568999999999987766 4599999999999999999999852210       


Q ss_pred             hhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014024          329 YAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLT  385 (432)
Q Consensus       329 ~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~  385 (432)
                                   .....  ...+......+.+++.+||+.||++|||+.|++++-.
T Consensus       245 -------------~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~  286 (312)
T 2iwi_A          245 -------------ILEAE--LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPW  286 (312)
T ss_dssp             -------------HHHTC--CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTT
T ss_pred             -------------Hhhhc--cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence                         00000  0112233467889999999999999999999998543

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=6.7e-41  Score=321.54  Aligned_cols=256  Identities=24%  Similarity=0.380  Sum_probs=178.0

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCC-ChHhHHHHHHHHH-HHHhcCCCceeeeEeEEEeCCeeEEE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGK-SGQEIKELKNEAS-VIAQVQHKNLVKLLGCCIEKDERLLI  182 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~-~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv  182 (432)
                      ..++|++.+.||+|+||.||+|.+.  +..||+|++... .......+..|+. +++.++||||+++++++.+.+..++|
T Consensus        20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv   99 (327)
T 3aln_A           20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC   99 (327)
T ss_dssp             CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence            3578999999999999999999986  448999998654 3344455666666 67778999999999999999999999


Q ss_pred             EecCCCCChhhhhcC--CCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEeccCCCCCEEEcCCCCEEEeeccccee
Q 014024          183 YEYMPNKSLDCFLFD--PTKREILDWRTRVQIIKGVAQGLLYLHQY-SRVRIIHRDLKASNILLDKDMNSKISDFGMARI  259 (432)
Q Consensus       183 ~e~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  259 (432)
                      |||+++ +|.+++..  ......+++..+..++.|++.||.|||+. +   ++||||||+||+++.++.+||+|||++..
T Consensus       100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~  175 (327)
T 3aln_A          100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQ  175 (327)
T ss_dssp             ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred             EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence            999985 77766642  11234599999999999999999999998 8   99999999999999999999999999976


Q ss_pred             ccCCCCccccccccccccccCCccChhhh----ccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhh
Q 014024          260 VFGGNDEDELQGNTSRISGTYGYMSPEYA----LEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWI  335 (432)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  335 (432)
                      ....       .......||+.|+|||++    .+..++.++||||||+++|+|++|+.||............     ..
T Consensus       176 ~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-----~~  243 (327)
T 3aln_A          176 LVDS-------IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQ-----VV  243 (327)
T ss_dssp             -------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CC-----CC
T ss_pred             cccc-------cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHH-----Hh
Confidence            4221       112234689999999998    4567899999999999999999999998643221000000     00


Q ss_pred             ccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          336 SNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       336 ~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      ....     +.+........+..+.+++..||+.||++|||+.+++++
T Consensus       244 ~~~~-----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  286 (327)
T 3aln_A          244 KGDP-----PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH  286 (327)
T ss_dssp             CSCC-----CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             cCCC-----CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence            0000     000111112234678899999999999999999999873

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.3e-40  Score=320.83  Aligned_cols=253  Identities=19%  Similarity=0.229  Sum_probs=174.1

Q ss_pred             hhCCCCcCc-eeccCCcEEEEEEEEC--CceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEe----CCee
Q 014024          107 ATGNFSAAN-KLGEGGFGTVYKGVIG--QGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIE----KDER  179 (432)
Q Consensus       107 ~~~~y~~~~-~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~  179 (432)
                      ..++|.+.+ +||+|+||.||+|.+.  +..||+|++.... ..   .......++.++|+||+++++++..    ....
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~---~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-KA---RQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-HH---HHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-HH---HHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            467899855 6999999999999986  4489999986532 21   2223334667799999999999976    4457


Q ss_pred             EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcC---CCCEEEeeccc
Q 014024          180 LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDK---DMNSKISDFGM  256 (432)
Q Consensus       180 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg~  256 (432)
                      ++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+.+   |+||||||+||+++.   ++.+||+|||+
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~  177 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF  177 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence            99999999999999997543 245999999999999999999999999   999999999999976   45599999999


Q ss_pred             ceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhc
Q 014024          257 ARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWIS  336 (432)
Q Consensus       257 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  336 (432)
                      +.....        .......||+.|+|||++.+..++.++||||||+++|+|++|+.||..........          
T Consensus       178 ~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~----------  239 (336)
T 3fhr_A          178 AKETTQ--------NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP----------  239 (336)
T ss_dssp             CEEC------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------
T ss_pred             ceeccc--------cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh----------
Confidence            986421        12234578999999999988899999999999999999999999985432211000          


Q ss_pred             cchhhhhhh--hhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014024          337 NKIIDLIDS--VLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLT  385 (432)
Q Consensus       337 ~~~~~~i~~--~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~  385 (432)
                      .....+...  ..........+..+.+++..||+.||++|||+.|++++-.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  290 (336)
T 3fhr_A          240 GMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPW  290 (336)
T ss_dssp             -----------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred             hHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence            000000000  0000111234567889999999999999999999998543

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=3.2e-41  Score=323.02  Aligned_cols=246  Identities=24%  Similarity=0.349  Sum_probs=197.8

Q ss_pred             hHhhhhCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCCCh------HhHHHHHHHHHHHHhcC--CCceeeeEeE
Q 014024          103 SVSSATGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGKSG------QEIKELKNEASVIAQVQ--HKNLVKLLGC  172 (432)
Q Consensus       103 ~~~~~~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~~~~~  172 (432)
                      +.....++|++.+.||+|+||.||+|.+.  +..||+|++.....      ...+.+.+|+.++++++  |+||++++++
T Consensus        37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~  116 (320)
T 3a99_A           37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW  116 (320)
T ss_dssp             ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred             ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence            34455788999999999999999999874  34899999854321      12245678999999996  5999999999


Q ss_pred             EEeCCeeEEEEecCCC-CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEc-CCCCEE
Q 014024          173 CIEKDERLLIYEYMPN-KSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLD-KDMNSK  250 (432)
Q Consensus       173 ~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~k  250 (432)
                      +.+.+..++|||++.+ ++|.+++..   +..+++..++.++.|++.||+|||+.+   |+||||||+|||++ +++.+|
T Consensus       117 ~~~~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~k  190 (320)
T 3a99_A          117 FERPDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELK  190 (320)
T ss_dssp             EECSSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEE
T ss_pred             EecCCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEE
Confidence            9999999999999976 899999853   345999999999999999999999999   99999999999999 789999


Q ss_pred             EeecccceeccCCCCccccccccccccccCCccChhhhccCCC-CchhhhHHHHHHHHHHHhCCCCCCCccccccchhhh
Q 014024          251 ISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGY  329 (432)
Q Consensus       251 l~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~  329 (432)
                      |+|||++.....        .......||+.|+|||++.+..+ +.++||||||+++|||++|+.||.....        
T Consensus       191 L~Dfg~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--------  254 (320)
T 3a99_A          191 LIDFGSGALLKD--------TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--------  254 (320)
T ss_dssp             ECCCTTCEECCS--------SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------
T ss_pred             EeeCcccccccc--------ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh--------
Confidence            999999987521        12234568999999999987665 7889999999999999999999853211        


Q ss_pred             hHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          330 AWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       330 ~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                                  .....  .......+..+.+++.+||+.||++|||+.|++++-
T Consensus       255 ------------~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp  295 (320)
T 3a99_A          255 ------------IIRGQ--VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHP  295 (320)
T ss_dssp             ------------HHHCC--CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred             ------------hhccc--ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence                        00000  001122345788999999999999999999999853

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=3.5e-40  Score=328.79  Aligned_cols=255  Identities=23%  Similarity=0.312  Sum_probs=183.6

Q ss_pred             CCCCcCceeccCCcEEEEEEE-ECCceEEEEEEcCCChHhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeeEEEEecC
Q 014024          109 GNFSAANKLGEGGFGTVYKGV-IGQGEIAVKRLLGKSGQEIKELKNEASVIAQV-QHKNLVKLLGCCIEKDERLLIYEYM  186 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~  186 (432)
                      +.|.+.+.||+|+||+||.+. ..+..||||++...   ..+.+.+|+.+++++ +||||+++++++.+.+..++||||+
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~   91 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC   91 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence            445567889999999997654 45559999998643   235678899999986 8999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCC----CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCC-------------CCE
Q 014024          187 PNKSLDCFLFDPTKRE----ILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKD-------------MNS  249 (432)
Q Consensus       187 ~~gsL~~~l~~~~~~~----~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-------------~~~  249 (432)
                      + |+|.+++.......    ..++..++.++.|++.||+|||+.+   |+||||||+|||++.+             +.+
T Consensus        92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence            5 69999996533211    1133345789999999999999998   9999999999999754             489


Q ss_pred             EEeecccceeccCCCCccccccccccccccCCccChhhhcc-------CCCCchhhhHHHHHHHHHHHh-CCCCCCCccc
Q 014024          250 KISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE-------GIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRT  321 (432)
Q Consensus       250 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~  321 (432)
                      ||+|||++........  ..........||+.|+|||++.+       ..++.++|||||||++|||+| |+.||.....
T Consensus       168 kL~DFG~a~~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~  245 (434)
T 2rio_A          168 LISDFGLCKKLDSGQS--SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS  245 (434)
T ss_dssp             EECCCTTCEECCC----------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred             EEcccccceecCCCCc--cceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence            9999999987532211  11112334679999999999975       668999999999999999999 8999853221


Q ss_pred             cccchhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          322 KSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      .....   .........        .........+.++.+++.+||+.||.+|||+.+++++
T Consensus       246 ~~~~i---~~~~~~~~~--------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  296 (434)
T 2rio_A          246 RESNI---IRGIFSLDE--------MKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH  296 (434)
T ss_dssp             HHHHH---HHTCCCCCC--------CTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             hHHHH---hcCCCCccc--------ccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence            11000   000000000        0111233556788999999999999999999999974

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=5.6e-40  Score=313.48  Aligned_cols=252  Identities=21%  Similarity=0.336  Sum_probs=178.6

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCCC-hH-hHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGKS-GQ-EIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLI  182 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  182 (432)
                      ..++|++.+.||+|+||.||+|.+.  +..||+|++.... .. ..+.+.++..+++.++||||+++++++.+.+..++|
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv  102 (318)
T 2dyl_A           23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA  102 (318)
T ss_dssp             CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence            4578999999999999999999985  4489999986543 22 233445555678888999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEeccCCCCCEEEcCCCCEEEeecccceecc
Q 014024          183 YEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQY-SRVRIIHRDLKASNILLDKDMNSKISDFGMARIVF  261 (432)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  261 (432)
                      |||+ ++++..+....  ...+++..++.++.|++.||.|||+. +   ++||||||+||+++.++.+||+|||++....
T Consensus       103 ~e~~-~~~~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  176 (318)
T 2dyl_A          103 MELM-GTCAEKLKKRM--QGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLV  176 (318)
T ss_dssp             ECCC-SEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred             Eecc-CCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence            9999 55555544321  34599999999999999999999995 8   9999999999999999999999999997642


Q ss_pred             CCCCccccccccccccccCCccChhhhc-----cCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhc
Q 014024          262 GGNDEDELQGNTSRISGTYGYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWIS  336 (432)
Q Consensus       262 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  336 (432)
                      ..       .......||+.|+|||++.     ...++.++||||||+++|+|++|+.||........ .   ... ...
T Consensus       177 ~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~---~~~-~~~  244 (318)
T 2dyl_A          177 DD-------KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE-V---LTK-VLQ  244 (318)
T ss_dssp             -----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-H---HHH-HHH
T ss_pred             CC-------ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH-H---HHH-Hhc
Confidence            21       1223456899999999984     46689999999999999999999999854221100 0   000 000


Q ss_pred             cchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          337 NKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       337 ~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      ...     ..+  ......+..+.+++.+||+.||.+|||+.+++++
T Consensus       245 ~~~-----~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          245 EEP-----PLL--PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             SCC-----CCC--CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             cCC-----CCC--CccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            000     000  0011234678899999999999999999999974

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.7e-40  Score=327.26  Aligned_cols=252  Identities=22%  Similarity=0.355  Sum_probs=185.3

Q ss_pred             hhCCCCcCceeccCCcEE-EEEEEECCceEEEEEEcCCChHhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeeEEEEe
Q 014024          107 ATGNFSAANKLGEGGFGT-VYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQV-QHKNLVKLLGCCIEKDERLLIYE  184 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~-Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  184 (432)
                      ...+|.+.++||+|+||+ +|.+...+..||||++.....   ..+.+|+++|+++ +||||+++++++.+.+..++|||
T Consensus        22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E   98 (432)
T 3p23_A           22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE   98 (432)
T ss_dssp             TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence            345789999999999998 455556667999999865432   2356799999999 79999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcC-----CCCEEEeeccccee
Q 014024          185 YMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDK-----DMNSKISDFGMARI  259 (432)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~Dfg~a~~  259 (432)
                      |++ |+|.+++.....  .+.+..++.++.|++.||+|||+.+   |+||||||+|||++.     ...+||+|||++..
T Consensus        99 ~~~-g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~  172 (432)
T 3p23_A           99 LCA-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK  172 (432)
T ss_dssp             CCS-EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred             CCC-CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence            996 599999865432  2455566789999999999999999   999999999999943     33588999999987


Q ss_pred             ccCCCCccccccccccccccCCccChhhhc---cCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhh
Q 014024          260 VFGGNDEDELQGNTSRISGTYGYMSPEYAL---EGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWI  335 (432)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  335 (432)
                      ......   .........||+.|+|||++.   ...++.++|||||||++|||++ |..||+........       ...
T Consensus       173 ~~~~~~---~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~-------~~~  242 (432)
T 3p23_A          173 LAVGRH---SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN-------ILL  242 (432)
T ss_dssp             C---------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH-------HHT
T ss_pred             ccCCCc---ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH-------HHh
Confidence            532211   112234467999999999997   4567889999999999999999 88887432211000       000


Q ss_pred             ccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          336 SNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       336 ~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      ........      .........+.+++.+||+.||++|||+.+++++
T Consensus       243 ~~~~~~~~------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h  284 (432)
T 3p23_A          243 GACSLDCL------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH  284 (432)
T ss_dssp             TCCCCTTS------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ccCCcccc------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence            00000000      0112334567899999999999999999999964

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2.4e-40  Score=340.68  Aligned_cols=260  Identities=23%  Similarity=0.305  Sum_probs=196.6

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEe------CC
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIE------KD  177 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~  177 (432)
                      ..++|++.+.||+|+||.||+|.+..  ..||+|++... .....+.+.+|++++++++||||+++++++..      .+
T Consensus        12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~   91 (676)
T 3qa8_A           12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND   91 (676)
T ss_dssp             -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred             CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence            34789999999999999999999743  48999988654 45566789999999999999999999999765      66


Q ss_pred             eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCC---EEEeec
Q 014024          178 ERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN---SKISDF  254 (432)
Q Consensus       178 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Df  254 (432)
                      ..++||||+++|+|.+++........+++..++.++.|++.||+|||+.+   |+||||||+||+++.++.   +||+||
T Consensus        92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DF  168 (676)
T 3qa8_A           92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDL  168 (676)
T ss_dssp             SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred             eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccc
Confidence            78999999999999999976555456999999999999999999999998   999999999999997765   999999


Q ss_pred             ccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHh-
Q 014024          255 GMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDL-  333 (432)
Q Consensus       255 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~-  333 (432)
                      |++......       .......||+.|+|||.+.+..++.++||||||+++|+|++|..||......    ..|.... 
T Consensus       169 G~a~~~~~~-------~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~----~~~~~~i~  237 (676)
T 3qa8_A          169 GYAKELDQG-------ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP----VQWHGKVR  237 (676)
T ss_dssp             CCCCBTTSC-------CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH----HHSSTTCC
T ss_pred             ccccccccc-------cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch----hhhhhhhh
Confidence            999865221       1223467899999999999999999999999999999999999998542110    0000000 


Q ss_pred             -------hhccchhhh--hhhhh--hhcccHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 014024          334 -------WISNKIIDL--IDSVL--EEASFNESLSRYVHIALLCVQERAEDRPTMSDV  380 (432)
Q Consensus       334 -------~~~~~~~~~--i~~~l--~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev  380 (432)
                             .........  ....+  ........+..+.+++..||+.||++|||+.++
T Consensus       238 ~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el  295 (676)
T 3qa8_A          238 EKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN  295 (676)
T ss_dssp             ------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred             cccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence                   000000000  00000  011233456789999999999999999999773

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2.7e-38  Score=297.74  Aligned_cols=233  Identities=11%  Similarity=0.062  Sum_probs=183.7

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCC---hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS---GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLL  181 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  181 (432)
                      ..++|++.+.||+|+||.||+|.+..  ..||+|++....   ....+.+.+|+..+++++|+||+++++++.+.+..|+
T Consensus        29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  108 (286)
T 3uqc_A           29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV  108 (286)
T ss_dssp             TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence            34789999999999999999999864  489999986542   4456789999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceecc
Q 014024          182 IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVF  261 (432)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  261 (432)
                      ||||+++++|.+++..    + ....++..++.|++.||+|||+.+   |+||||||+|||+++++.+||++++      
T Consensus       109 v~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------  174 (286)
T 3uqc_A          109 VAEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------  174 (286)
T ss_dssp             EEECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred             EEEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc------
Confidence            9999999999999832    2 456678899999999999999999   9999999999999999999997443      


Q ss_pred             CCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhh
Q 014024          262 GGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIID  341 (432)
Q Consensus       262 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (432)
                                          |++|       ++.++|||||||++|||+||+.||........-..  ... ....... 
T Consensus       175 --------------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~--~~~-~~~~~~~-  223 (286)
T 3uqc_A          175 --------------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP--AER-DTAGQPI-  223 (286)
T ss_dssp             --------------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE--CCB-CTTSCBC-
T ss_pred             --------------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH--HHH-HhccCCC-
Confidence                                3332       68899999999999999999999865432110000  000 0000000 


Q ss_pred             hhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccccC
Q 014024          342 LIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASS  390 (432)
Q Consensus       342 ~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~  390 (432)
                        .   ........+..+.+++.+||+.||++| |+.|+++.|+.....
T Consensus       224 --~---~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~  266 (286)
T 3uqc_A          224 --E---PADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV  266 (286)
T ss_dssp             --C---HHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred             --C---hhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence              0   000112234668899999999999999 999999999986653

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=6.3e-39  Score=337.15  Aligned_cols=238  Identities=19%  Similarity=0.325  Sum_probs=190.6

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEEC---CceEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCe----
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIG---QGEIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDE----  178 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----  178 (432)
                      ..++|++.+.||+|+||.||+|.+.   +..||+|++... .....+.+.+|++++++++||||+++++++.+.+.    
T Consensus        78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~  157 (681)
T 2pzi_A           78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP  157 (681)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred             eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence            3589999999999999999999985   348999988544 44556778999999999999999999999987665    


Q ss_pred             -eEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccc
Q 014024          179 -RLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMA  257 (432)
Q Consensus       179 -~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  257 (432)
                       .|+||||+++++|.+++..     .+++..++.++.|++.||.|||+.+   |+||||||+|||++++ .+||+|||++
T Consensus       158 ~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a  228 (681)
T 2pzi_A          158 VGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAV  228 (681)
T ss_dssp             EEEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred             eeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccc
Confidence             6999999999999987732     4999999999999999999999999   9999999999999885 8999999999


Q ss_pred             eeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhcc
Q 014024          258 RIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISN  337 (432)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  337 (432)
                      .....          .....||+.|+|||++.++. +.++|||||||++|+|++|..|+.......              
T Consensus       229 ~~~~~----------~~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~--------------  283 (681)
T 2pzi_A          229 SRINS----------FGYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG--------------  283 (681)
T ss_dssp             EETTC----------CSCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS--------------
T ss_pred             hhccc----------CCccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc--------------
Confidence            87421          13457999999999987654 899999999999999999988764211100              


Q ss_pred             chhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCC-HHHHHHHhcc
Q 014024          338 KIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPT-MSDVVSMLTN  386 (432)
Q Consensus       338 ~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt-~~evl~~L~~  386 (432)
                       ...       ..........+.+++.+||+.||++||+ ++++.+.|..
T Consensus       284 -~~~-------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          284 -LPE-------DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             -CCT-------TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             -ccc-------cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence             000       0001123356889999999999999995 5555555554

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=3.4e-38  Score=298.95  Aligned_cols=233  Identities=18%  Similarity=0.246  Sum_probs=178.0

Q ss_pred             hhCCCCcC-ceeccCCcEEEEEEEECC--ceEEEEEEcCCChHhHHHHHHHHHHH-HhcCCCceeeeEeEEEe----CCe
Q 014024          107 ATGNFSAA-NKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSGQEIKELKNEASVI-AQVQHKNLVKLLGCCIE----KDE  178 (432)
Q Consensus       107 ~~~~y~~~-~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~----~~~  178 (432)
                      ..++|.+. +.||+|+||.||+|.+..  ..||+|++...     ..+.+|+.++ +..+||||+++++++.+    ...
T Consensus        15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~   89 (299)
T 3m2w_A           15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC   89 (299)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence            35677777 789999999999999853  48999998542     3567788888 55699999999999987    667


Q ss_pred             eEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcC---CCCEEEeecc
Q 014024          179 RLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDK---DMNSKISDFG  255 (432)
Q Consensus       179 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg  255 (432)
                      .++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+   |+||||||+||+++.   ++.+||+|||
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg  165 (299)
T 3m2w_A           90 LLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG  165 (299)
T ss_dssp             EEEEECCCCSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred             EEEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccc
Confidence            899999999999999996532 235999999999999999999999999   999999999999998   7889999999


Q ss_pred             cceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhh
Q 014024          256 MARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWI  335 (432)
Q Consensus       256 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  335 (432)
                      ++....                            +..++.++|||||||++|+|++|+.||...........  ......
T Consensus       166 ~a~~~~----------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~--~~~~~~  215 (299)
T 3m2w_A          166 FAKETT----------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG--MKTRIR  215 (299)
T ss_dssp             TCEECT----------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC--SCCSSC
T ss_pred             cccccc----------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH--HHHHHh
Confidence            997531                            24467899999999999999999999854322110000  000000


Q ss_pred             ccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          336 SNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       336 ~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                       .........     .....+..+.+++..||+.||++|||+.|++++-
T Consensus       216 -~~~~~~~~~-----~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp  258 (299)
T 3m2w_A          216 -MGQYEFPNP-----EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP  258 (299)
T ss_dssp             -TTCCSSCHH-----HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             -hccccCCch-----hcccCCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence             000000000     0012346788999999999999999999999854

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.2e-38  Score=315.77  Aligned_cols=243  Identities=16%  Similarity=0.173  Sum_probs=179.0

Q ss_pred             hhhCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCCC---hHhHHHHHHHHHHHHhcCC-Cce-------------
Q 014024          106 SATGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGKS---GQEIKELKNEASVIAQVQH-KNL-------------  166 (432)
Q Consensus       106 ~~~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-~ni-------------  166 (432)
                      ....+|...+.||+|+||.||+|.+.  +..||||++....   ....+.+.+|+.+++.++| +|.             
T Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~  154 (413)
T 3dzo_A           75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF  154 (413)
T ss_dssp             SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred             CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence            34456888899999999999999986  4589999986332   2335778999999999977 221             


Q ss_pred             --ee------eEeEEEe-----CCeeEEEEecCCCCChhhhhcC----CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 014024          167 --VK------LLGCCIE-----KDERLLIYEYMPNKSLDCFLFD----PTKREILDWRTRVQIIKGVAQGLLYLHQYSRV  229 (432)
Q Consensus       167 --v~------~~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~  229 (432)
                        +.      +..++..     ....+++|+++ +++|.+++..    ...+..+++..++.++.|++.||+|||+.+  
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--  231 (413)
T 3dzo_A          155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--  231 (413)
T ss_dssp             EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence              11      1111111     12346677765 6899888831    123445889999999999999999999999  


Q ss_pred             CeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCccccccccccccccCCccChhhh----------ccCCCCchhhh
Q 014024          230 RIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYA----------LEGIFSIKSDV  299 (432)
Q Consensus       230 ~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~t~~~Dv  299 (432)
                       |+||||||+|||++.++.+||+|||+++...         .......| +.|+|||++          .+..++.++||
T Consensus       232 -iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~---------~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~Dv  300 (413)
T 3dzo_A          232 -LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG---------ASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDT  300 (413)
T ss_dssp             -EECSCCCGGGEEECTTCCEEECCGGGCEETT---------EEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHH
T ss_pred             -cccCCcccceEEEecCCeEEEEeccceeecC---------CccccCCC-CceeCchhhhccccccccccCcCCCchhhH
Confidence             9999999999999999999999999998641         11344567 999999999          55568899999


Q ss_pred             HHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 014024          300 FSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSD  379 (432)
Q Consensus       300 wSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~e  379 (432)
                      |||||++|||+||+.||........                  .+..+..  ....+..+.+++..||+.||++|||+.+
T Consensus       301 wSlGvil~elltg~~Pf~~~~~~~~------------------~~~~~~~--~~~~~~~~~~li~~~l~~dP~~Rpt~~~  360 (413)
T 3dzo_A          301 WTLGLAIYWIWCADLPNTDDAALGG------------------SEWIFRS--CKNIPQPVRALLEGFLRYPKEDRLLPLQ  360 (413)
T ss_dssp             HHHHHHHHHHHHSSCCCCTTGGGSC------------------SGGGGSS--CCCCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHHHHHHHHHHCCCCCCCcchhhh------------------HHHHHhh--cccCCHHHHHHHHHHccCChhhCcCHHH
Confidence            9999999999999999854322110                  0011110  0122367889999999999999999877


Q ss_pred             HHH
Q 014024          380 VVS  382 (432)
Q Consensus       380 vl~  382 (432)
                      +++
T Consensus       361 ~l~  363 (413)
T 3dzo_A          361 AME  363 (413)
T ss_dssp             HTT
T ss_pred             HHh
Confidence            754

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=9.8e-39  Score=307.72  Aligned_cols=245  Identities=14%  Similarity=0.158  Sum_probs=184.5

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECCceEEEEEEcCCC--------hHhHHHHHHHHHHHHhcC---------CCceeee
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQGEIAVKRLLGKS--------GQEIKELKNEASVIAQVQ---------HKNLVKL  169 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv~~  169 (432)
                      ..++|++.+.||+|+||.||+|.+.+..||+|++....        ....+.+.+|+.+++.++         |+||+++
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           18 PTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             CHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             ccccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            35789999999999999999999988899999986442        233477889999999886         6777766


Q ss_pred             EeEE-----------------Ee-------------CCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHH
Q 014024          170 LGCC-----------------IE-------------KDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQG  219 (432)
Q Consensus       170 ~~~~-----------------~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~  219 (432)
                      .+.+                 .+             .+..++||||+++|++.+.+..    ..+++..++.++.|++.|
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence            6654                 22             6789999999999977666632    448999999999999999


Q ss_pred             HHHHH-hcCCCCeEeccCCCCCEEEcCCC--------------------CEEEeecccceeccCCCCccccccccccccc
Q 014024          220 LLYLH-QYSRVRIIHRDLKASNILLDKDM--------------------NSKISDFGMARIVFGGNDEDELQGNTSRISG  278 (432)
Q Consensus       220 l~~LH-~~~~~~ivH~Dlkp~NIll~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~g  278 (432)
                      |+||| +.+   |+||||||+|||++.++                    .+||+|||+++...           .....|
T Consensus       174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~-----------~~~~~g  239 (336)
T 2vuw_A          174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLER-----------DGIVVF  239 (336)
T ss_dssp             HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEE-----------TTEEEC
T ss_pred             HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecC-----------CCcEEE
Confidence            99999 898   99999999999999887                    89999999998752           123479


Q ss_pred             cCCccChhhhccCCCCchhhhHHHHHH-HHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhhhhhcccHHHHH
Q 014024          279 TYGYMSPEYALEGIFSIKSDVFSFGVL-LLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLS  357 (432)
Q Consensus       279 t~~y~aPE~~~~~~~t~~~DvwSlG~i-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~  357 (432)
                      |+.|+|||++.+.. +.++||||+|++ .+++++|..||....     .............   ..............+.
T Consensus       240 t~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~-----~~~~~~~~~~~~~---~~~~~~~~~~~~~~s~  310 (336)
T 2vuw_A          240 CDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL-----WLHYLTDKMLKQM---TFKTKCNTPAMKQIKR  310 (336)
T ss_dssp             CCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH-----HHHHHHHHHHHTC---CCSSCCCSHHHHHHHH
T ss_pred             eecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh-----hhhHHHHhhhhhh---ccCcccchhhhhhcCH
Confidence            99999999998766 899999998777 777888988862100     0000000000000   0000001112335677


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHH-HH
Q 014024          358 RYVHIALLCVQERAEDRPTMSDVV-SM  383 (432)
Q Consensus       358 ~l~~l~~~cl~~dp~~RPt~~evl-~~  383 (432)
                      ++.+|+.+||+.|     |++|++ ++
T Consensus       311 ~~~dli~~~L~~d-----sa~e~l~~H  332 (336)
T 2vuw_A          311 KIQEFHRTMLNFS-----SATDLLCQH  332 (336)
T ss_dssp             HHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred             HHHHHHHHHhccC-----CHHHHHhcC
Confidence            8999999999976     999998 64

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=2e-31  Score=273.24  Aligned_cols=183  Identities=17%  Similarity=0.121  Sum_probs=127.7

Q ss_pred             eccCCcEEEEEEEE--CCceEEEEEEcCC----------ChHhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeeEEEE
Q 014024          117 LGEGGFGTVYKGVI--GQGEIAVKRLLGK----------SGQEIKELKNEASVIAQV-QHKNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       117 ig~G~~g~Vy~~~~--~~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  183 (432)
                      .+.|+.|.+..++.  -+..+++|.+...          .....++|.+|+++|+++ .|+||+++++++++++..||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            34455554444332  3446899988543          123456799999999999 6999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCC
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGG  263 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  263 (432)
                      ||++|++|.++|..   +++++..   +|+.||+.||+|+|++|   |+||||||+|||++++|.+||+|||+|+.....
T Consensus       322 Eyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~  392 (569)
T 4azs_A          322 EKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD  392 (569)
T ss_dssp             ECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred             ecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence            99999999999954   3447654   58899999999999999   999999999999999999999999999864221


Q ss_pred             CCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCC
Q 014024          264 NDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKN  315 (432)
Q Consensus       264 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p  315 (432)
                            .......+||+.|+|||++.+ .+..++|+||+|++++++.++..+
T Consensus       393 ------~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          393 ------CSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             -------CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             ------CccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence                  223445789999999998875 567789999999999888766543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=5.9e-28  Score=246.13  Aligned_cols=189  Identities=19%  Similarity=0.191  Sum_probs=146.8

Q ss_pred             CcCceeccCCcEEEEEEEECCceEEEEEEcCCCh--------HhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEE
Q 014024          112 SAANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSG--------QEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       112 ~~~~~ig~G~~g~Vy~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  183 (432)
                      ...++||+|+||.||+|...+..+++|+......        ...+.+.+|++++++++||||+++..++...+..++||
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm  418 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM  418 (540)
T ss_dssp             ---------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred             CCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence            3467899999999999988888999998754321        12455899999999999999997777777788889999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCC
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGG  263 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  263 (432)
                      ||+++++|.+++..           +..++.|++.||+|||+++   |+||||||+|||+++  .+||+|||+++.....
T Consensus       419 E~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~  482 (540)
T 3en9_A          419 SYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD  482 (540)
T ss_dssp             ECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred             ECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence            99999999999843           4589999999999999999   999999999999998  9999999999875211


Q ss_pred             CCcc-ccccccccccccCCccChhhhcc--CCCCchhhhHHHHHHHHHHHhCCCCC
Q 014024          264 NDED-ELQGNTSRISGTYGYMSPEYALE--GIFSIKSDVFSFGVLLLEIVSGKKNT  316 (432)
Q Consensus       264 ~~~~-~~~~~~~~~~gt~~y~aPE~~~~--~~~t~~~DvwSlG~il~elltg~~p~  316 (432)
                      .... ..........||+.|+|||++..  ..|+..+|+||..+-.++-+.++.++
T Consensus       483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            1000 00001235689999999999987  66888999999999999888877654

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.91  E-value=2.5e-24  Score=201.57  Aligned_cols=151  Identities=17%  Similarity=0.137  Sum_probs=120.6

Q ss_pred             hhHhhhhCCCCcCceeccCCcEEEEEEEECC-ceEEEEEEcCCCh------------------HhHHHHHHHHHHHHhcC
Q 014024          102 SSVSSATGNFSAANKLGEGGFGTVYKGVIGQ-GEIAVKRLLGKSG------------------QEIKELKNEASVIAQVQ  162 (432)
Q Consensus       102 ~~~~~~~~~y~~~~~ig~G~~g~Vy~~~~~~-~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~  162 (432)
                      ..+......|.+.+.||+|+||.||+|.+.+ ..+|+|.+.....                  .....+.+|+.++++++
T Consensus        83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~  162 (282)
T 1zar_A           83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ  162 (282)
T ss_dssp             HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence            3444556677788999999999999999943 4899999854321                  23567899999999999


Q ss_pred             CCceeeeEeEEEeCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEE
Q 014024          163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNIL  242 (432)
Q Consensus       163 h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIl  242 (432)
                        | +++.+++.. +..++||||+++++|.+ +..         .....++.|++.||.|||+.+   |+||||||+|||
T Consensus       163 --~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NIL  225 (282)
T 1zar_A          163 --G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVL  225 (282)
T ss_dssp             --T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEE
T ss_pred             --C-CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEE
Confidence              5 667766544 55699999999999988 411         123469999999999999999   999999999999


Q ss_pred             EcCCCCEEEeecccceeccCCCCccccccccccccccCCccChhhhc
Q 014024          243 LDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL  289 (432)
Q Consensus       243 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  289 (432)
                      ++ ++.+||+|||++..                   +..+.|||++.
T Consensus       226 l~-~~~vkl~DFG~a~~-------------------~~~~~a~e~l~  252 (282)
T 1zar_A          226 VS-EEGIWIIDFPQSVE-------------------VGEEGWREILE  252 (282)
T ss_dssp             EE-TTEEEECCCTTCEE-------------------TTSTTHHHHHH
T ss_pred             EE-CCcEEEEECCCCeE-------------------CCCCCHHHHHH
Confidence            99 99999999999964                   23478999874

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.81  E-value=3.5e-20  Score=171.22  Aligned_cols=137  Identities=15%  Similarity=0.128  Sum_probs=105.2

Q ss_pred             CCCCcCceeccCCcEEEEEEEE--CCce--EEEEEEcCCCh------------------------HhHHHHHHHHHHHHh
Q 014024          109 GNFSAANKLGEGGFGTVYKGVI--GQGE--IAVKRLLGKSG------------------------QEIKELKNEASVIAQ  160 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~--~~~~--vavK~~~~~~~------------------------~~~~~~~~E~~~l~~  160 (432)
                      .-|++.+.||+|+||.||+|.+  .+..  ||+|++.....                        .....+.+|+.+|++
T Consensus        47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~  126 (258)
T 1zth_A           47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER  126 (258)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred             CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence            3467889999999999999998  5557  99998743311                        112367889999999


Q ss_pred             cCCCce--eeeEeEEEeCCeeEEEEecCCC-C----ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeE
Q 014024          161 VQHKNL--VKLLGCCIEKDERLLIYEYMPN-K----SLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLH-QYSRVRII  232 (432)
Q Consensus       161 l~h~ni--v~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH-~~~~~~iv  232 (432)
                      ++|+++  ..++++    +..++||||+.+ |    +|.++...      .++..+..++.|++.||.||| +.+   |+
T Consensus       127 l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---iv  193 (258)
T 1zth_A          127 AKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LV  193 (258)
T ss_dssp             HHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EE
T ss_pred             HHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EE
Confidence            988754  334432    356899999942 4    56655421      224456789999999999999 888   99


Q ss_pred             eccCCCCCEEEcCCCCEEEeecccceec
Q 014024          233 HRDLKASNILLDKDMNSKISDFGMARIV  260 (432)
Q Consensus       233 H~Dlkp~NIll~~~~~~kl~Dfg~a~~~  260 (432)
                      ||||||+|||+++  .++|+|||++...
T Consensus       194 HrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          194 HADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             CSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             eCCCCHHHEEEcC--cEEEEECcccccC
Confidence            9999999999998  9999999999753

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.68  E-value=2.2e-17  Score=159.03  Aligned_cols=144  Identities=11%  Similarity=0.105  Sum_probs=101.8

Q ss_pred             hhHhhhhCCCCcCceeccCCcEEEEEEEECCc-eEEEEEEcCCC-----------------hHh-----HHHHHHHHHHH
Q 014024          102 SSVSSATGNFSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKS-----------------GQE-----IKELKNEASVI  158 (432)
Q Consensus       102 ~~~~~~~~~y~~~~~ig~G~~g~Vy~~~~~~~-~vavK~~~~~~-----------------~~~-----~~~~~~E~~~l  158 (432)
                      ..+.....=|++.+.||+|++|.||+|.+.++ .||||++....                 ...     .-....|...|
T Consensus        88 ~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL  167 (397)
T 4gyi_A           88 HTHAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFM  167 (397)
T ss_dssp             HHHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHH
Confidence            34444445599999999999999999998655 89999874220                 000     01124577777


Q ss_pred             HhcCCCceeeeEeEEEeCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCC
Q 014024          159 AQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKA  238 (432)
Q Consensus       159 ~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp  238 (432)
                      .++.+.++.-.. .+.. ...+|||||++|++|..+..       .  .....++.|++.+|.+||+.|   ||||||||
T Consensus       168 ~rL~~~gv~vp~-p~~~-~~~~LVME~i~G~~L~~l~~-------~--~~~~~l~~qll~~l~~lH~~g---IVHrDLKp  233 (397)
T 4gyi_A          168 KALYEEGFPVPE-PIAQ-SRHTIVMSLVDALPMRQVSS-------V--PDPASLYADLIALILRLAKHG---LIHGDFNE  233 (397)
T ss_dssp             HHHHHTTCSCCC-EEEE-ETTEEEEECCSCEEGGGCCC-------C--SCHHHHHHHHHHHHHHHHHTT---EECSCCST
T ss_pred             HHHHhcCCCCCe-eeec-cCceEEEEecCCccHhhhcc-------c--HHHHHHHHHHHHHHHHHHHCC---CcCCCCCH
Confidence            777544432111 1111 12379999999988876541       1  123568899999999999998   99999999


Q ss_pred             CCEEEcCCCC----------EEEeeccccee
Q 014024          239 SNILLDKDMN----------SKISDFGMARI  259 (432)
Q Consensus       239 ~NIll~~~~~----------~kl~Dfg~a~~  259 (432)
                      .|||+++++.          +.|+||+-+..
T Consensus       234 ~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          234 FNILIREEKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             TSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred             HHEEEeCCCCcccccccccceEEEEeCCccc
Confidence            9999988773          89999998764

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.47  E-value=1.5e-13  Score=126.79  Aligned_cols=147  Identities=16%  Similarity=0.098  Sum_probs=115.7

Q ss_pred             hhhhCCCCcCceeccCCcEEEEEEEECCceEEEEEEcCCChHhHHHHHHHHHHHHhcC-CCceeeeEeEEEeCCeeEEEE
Q 014024          105 SSATGNFSAANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQ-HKNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       105 ~~~~~~y~~~~~ig~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~  183 (432)
                      ....+.|++...++.|+.+.||+....++.+++|............+.+|+++++.+. +..+.++++++.+.+..++||
T Consensus        10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~   89 (263)
T 3tm0_A           10 KKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM   89 (263)
T ss_dssp             HHHHTTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred             HHHhccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence            4455678888889999999999998877899999986421122245888999999985 677888999999988999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYS------------------------------------  227 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~------------------------------------  227 (432)
                      ||++|.+|.+.+..        ......++.++++++..||+..                                    
T Consensus        90 e~i~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (263)
T 3tm0_A           90 SEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED  161 (263)
T ss_dssp             ECCSSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred             EecCCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence            99999999876411        1123468889999999999811                                    


Q ss_pred             --------------------CCCeEeccCCCCCEEEcCCCCEEEeeccccee
Q 014024          228 --------------------RVRIIHRDLKASNILLDKDMNSKISDFGMARI  259 (432)
Q Consensus       228 --------------------~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  259 (432)
                                          ...++|+|++|.||+++++..+.|+||+.+..
T Consensus       162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                                13499999999999998766667999998754

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.24  E-value=2.4e-11  Score=111.39  Aligned_cols=139  Identities=18%  Similarity=0.190  Sum_probs=101.5

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECCc-eEEEEEEcCCChHhHHHHHHHHHHHHhcCCCc--eeeeEeEEEeCCeeEEEE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKSGQEIKELKNEASVIAQVQHKN--LVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~~-~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~  183 (432)
                      ...+|.+..+.+.|..+.||+....++ .+++|.....   ....+..|+.+++.+.+.+  +.+++++..+.+..++||
T Consensus        18 ~~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~   94 (264)
T 1nd4_A           18 RLFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL   94 (264)
T ss_dssp             TTTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred             hcCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence            344555443334566699999976544 6999987543   2245788999999986544  556888888878889999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYS------------------------------------  227 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~------------------------------------  227 (432)
                      ||++|.++.  ..   .   .+   ...++.++++.|..||+..                                    
T Consensus        95 e~i~G~~l~--~~---~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (264)
T 1nd4_A           95 GEVPGQDLL--SS---H---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ  163 (264)
T ss_dssp             ECCSSEETT--TS---C---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred             EecCCcccC--cC---c---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence            999998884  21   1   11   1357788888888888753                                    


Q ss_pred             -------------------CCCeEeccCCCCCEEEcCCCCEEEeeccccee
Q 014024          228 -------------------RVRIIHRDLKASNILLDKDMNSKISDFGMARI  259 (432)
Q Consensus       228 -------------------~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  259 (432)
                                         ...++|+|++|.||++++++.+.|+||+.+..
T Consensus       164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                               12399999999999998776677999999864

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.22  E-value=5.9e-11  Score=114.55  Aligned_cols=142  Identities=13%  Similarity=0.196  Sum_probs=108.7

Q ss_pred             cCceeccCCcEEEEEEEECCceEEEEEEc--CCC-hHhHHHHHHHHHHHHhcCC--CceeeeEeEEEeC---CeeEEEEe
Q 014024          113 AANKLGEGGFGTVYKGVIGQGEIAVKRLL--GKS-GQEIKELKNEASVIAQVQH--KNLVKLLGCCIEK---DERLLIYE  184 (432)
Q Consensus       113 ~~~~ig~G~~g~Vy~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~---~~~~lv~e  184 (432)
                      ..+.|+.|.++.||+....++.+++|+..  ... ......+.+|..+++.+..  ..+.+++.++.+.   +..++|||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme  121 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME  121 (359)
T ss_dssp             EEEECCC-CCSCEEEEECSSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred             eEEEcCCcccceEEEEEECCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence            46789999999999999888888888765  322 1223568889999999974  5578888888776   44799999


Q ss_pred             cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------
Q 014024          185 YMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYS-------------------------------------  227 (432)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-------------------------------------  227 (432)
                      |++|..+.+..     -..++...+..++.+++..|+.||+..                                     
T Consensus       122 ~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (359)
T 3dxp_A          122 FVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA  196 (359)
T ss_dssp             CCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred             ecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence            99998875422     122778888999999999999999731                                     


Q ss_pred             ------------------CCCeEeccCCCCCEEEcCCCC--EEEeeccccee
Q 014024          228 ------------------RVRIIHRDLKASNILLDKDMN--SKISDFGMARI  259 (432)
Q Consensus       228 ------------------~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~  259 (432)
                                        ...++|||++|.||++++++.  +.|.||+.+..
T Consensus       197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                              245999999999999997754  68999999875

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.14  E-value=1.4e-10  Score=109.23  Aligned_cols=183  Identities=19%  Similarity=0.211  Sum_probs=123.2

Q ss_pred             CceeccCCcEEEEEEEECCceEEEEEEcCCChHhHHHHHHHHHHHHhcC-CCc--eeeeEeEEEeCC---eeEEEEecCC
Q 014024          114 ANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQ-HKN--LVKLLGCCIEKD---ERLLIYEYMP  187 (432)
Q Consensus       114 ~~~ig~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~~~~~~~~~~---~~~lv~e~~~  187 (432)
                      .+.++.|....||+..   ..+++|....  ......+.+|.++|+.+. +..  +.+++......+   ..|+|||+++
T Consensus        25 i~~~~~G~~n~v~~v~---~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~   99 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN---RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK   99 (304)
T ss_dssp             CCEEEECSSEEEEEST---TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred             eEecCCCCcceEEEEC---CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence            4568999999999863   5688887643  244567899999999884 332  344544433333   3488999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 014024          188 NKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYS----------------------------------------  227 (432)
Q Consensus       188 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~----------------------------------------  227 (432)
                      |.++.+...     ..++..++..++.+++..++.||+..                                        
T Consensus       100 G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  174 (304)
T 3sg8_A          100 GVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD  174 (304)
T ss_dssp             CEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred             CeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence            998875432     22778888889999999999999621                                        


Q ss_pred             ---------------CCCeEeccCCCCCEEEcC--CCCEEEeecccceeccCCCCccccccccccccccCCc---cChhh
Q 014024          228 ---------------RVRIIHRDLKASNILLDK--DMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGY---MSPEY  287 (432)
Q Consensus       228 ---------------~~~ivH~Dlkp~NIll~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y---~aPE~  287 (432)
                                     ...++|+|++|.||++++  ...+.|+||+.+..-....          .......+   ..|+.
T Consensus       175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~----------Dl~~~~~~~~~~~~~~  244 (304)
T 3sg8_A          175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN----------DFISLMEDDEEYGMEF  244 (304)
T ss_dssp             HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH----------HHHTTCCTTTSCCHHH
T ss_pred             HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH----------HHHHHHhhccccCHHH
Confidence                           135899999999999998  4567899999987521100          00000111   22332


Q ss_pred             hcc-----CC---------CCchhhhHHHHHHHHHHHhCCCCC
Q 014024          288 ALE-----GI---------FSIKSDVFSFGVLLLEIVSGKKNT  316 (432)
Q Consensus       288 ~~~-----~~---------~t~~~DvwSlG~il~elltg~~p~  316 (432)
                      ...     +.         .....+.|++|.+++.+.+|+.++
T Consensus       245 ~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          245 VSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            110     11         122368999999999999998763

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.63  E-value=4.2e-07  Score=85.37  Aligned_cols=136  Identities=21%  Similarity=0.214  Sum_probs=98.6

Q ss_pred             CceeccCCcEEEEEEEECCceEEEEEEcCCChHhHHHHHHHHHHHHhcCCC---ceeeeEeEEE-eCCeeEEEEecCCCC
Q 014024          114 ANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHK---NLVKLLGCCI-EKDERLLIYEYMPNK  189 (432)
Q Consensus       114 ~~~ig~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~-~~~~~~lv~e~~~~g  189 (432)
                      .+.++.|....||+.   ++.+++|.-  ........+..|.++|+.+.+.   .+.+.+.+.. ..+..++||||++|.
T Consensus        24 v~~l~~G~~n~v~~v---g~~~VlR~~--~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~   98 (306)
T 3tdw_A           24 VESLGEGFRNYAILV---NGDWVFRFP--KSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ   98 (306)
T ss_dssp             EEEEEECSSEEEEEE---TTTEEEEEE--SSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred             eeecCCCcceeEEEE---CCEEEEEec--CCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence            456888988999987   567888874  2334557889999999999752   3556666664 345678999999998


Q ss_pred             ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------------
Q 014024          190 SLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYS------------------------------------------  227 (432)
Q Consensus       190 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~------------------------------------------  227 (432)
                      ++.+....     .++......++.++++.|+.||+..                                          
T Consensus        99 ~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~  173 (306)
T 3tdw_A           99 ILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT  173 (306)
T ss_dssp             ECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred             ECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence            88763311     1455666667777777777777532                                          


Q ss_pred             ---------------CCCeEeccCCCCCEEEcC---CCCE-EEeeccccee
Q 014024          228 ---------------RVRIIHRDLKASNILLDK---DMNS-KISDFGMARI  259 (432)
Q Consensus       228 ---------------~~~ivH~Dlkp~NIll~~---~~~~-kl~Dfg~a~~  259 (432)
                                     ...++|+|++|.||++++   ++.+ .|+||+.+..
T Consensus       174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                           224799999999999987   4554 8999998865

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.56  E-value=6e-07  Score=82.53  Aligned_cols=134  Identities=19%  Similarity=0.191  Sum_probs=97.5

Q ss_pred             eeccCCcE-EEEEEEECC--ceEEEEEEcCCChHhHHHHHHHHHHHHhcC-CCceeeeEeEEEeCCeeEEEEecCCCCCh
Q 014024          116 KLGEGGFG-TVYKGVIGQ--GEIAVKRLLGKSGQEIKELKNEASVIAQVQ-HKNLVKLLGCCIEKDERLLIYEYMPNKSL  191 (432)
Q Consensus       116 ~ig~G~~g-~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL  191 (432)
                      .+..|..+ .||+.....  ..+++|+-..   .....+..|...|+.+. +--+.+++.++.+.+..++|||+++|.++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            34445544 689877643  3688887643   23456888999999885 33477788999999999999999999888


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------------
Q 014024          192 DCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYS--------------------------------------------  227 (432)
Q Consensus       192 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--------------------------------------------  227 (432)
                      .+....       .......++.+++..|..||+..                                            
T Consensus       108 ~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (272)
T 4gkh_A          108 FQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW  180 (272)
T ss_dssp             HHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred             cccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence            765421       11223456777888888888532                                            


Q ss_pred             -----------CCCeEeccCCCCCEEEcCCCCEEEeeccccee
Q 014024          228 -----------RVRIIHRDLKASNILLDKDMNSKISDFGMARI  259 (432)
Q Consensus       228 -----------~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  259 (432)
                                 ...++|+|+.+.||++++++.+-|+||+.+..
T Consensus       181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                       12489999999999999877778999998864

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.47  E-value=3.6e-07  Score=87.73  Aligned_cols=80  Identities=9%  Similarity=0.003  Sum_probs=54.9

Q ss_pred             Ccee-ccCCcEEEEEEEEC--------CceEEEEEEcCCC---hHhHHHHHHHHHHHHhcCC---CceeeeEeEEEeC--
Q 014024          114 ANKL-GEGGFGTVYKGVIG--------QGEIAVKRLLGKS---GQEIKELKNEASVIAQVQH---KNLVKLLGCCIEK--  176 (432)
Q Consensus       114 ~~~i-g~G~~g~Vy~~~~~--------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h---~niv~~~~~~~~~--  176 (432)
                      .+.| +.|....+|+....        +..+++|......   ......+..|+.+++.+..   -.+.+++.++.+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            3567 88888999988765        4578888654321   0012457788888888843   3467788777655  


Q ss_pred             -CeeEEEEecCCCCChhh
Q 014024          177 -DERLLIYEYMPNKSLDC  193 (432)
Q Consensus       177 -~~~~lv~e~~~~gsL~~  193 (432)
                       +..++||||++|..+.+
T Consensus       105 ~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             TSSCEEEEECCCCBCCCB
T ss_pred             cCCceEEEEecCCCChhh
Confidence             35689999999877654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.19  E-value=1e-05  Score=76.76  Aligned_cols=141  Identities=13%  Similarity=0.175  Sum_probs=81.4

Q ss_pred             ceeccCCcEEEEEEEECCceEEEEEEcCCChHhHHHHHHHHHHHHhcCC--CceeeeEe------EEEeCCeeEEEEecC
Q 014024          115 NKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQH--KNLVKLLG------CCIEKDERLLIYEYM  186 (432)
Q Consensus       115 ~~ig~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~------~~~~~~~~~lv~e~~  186 (432)
                      +.|+.|..+.||+....++.+++|+.... .   ..+..|..+++.+..  -.+.+++.      +....+..+++|||+
T Consensus        38 ~~l~gG~~n~~~~v~~~~~~~vlk~~~~~-~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i  113 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSGAVCLKRIHRP-E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI  113 (346)
T ss_dssp             EECC----CEEEEEEETTEEEEEEEECSC-H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred             eeccccccCcEEEEEeCCCCEEEEecCCC-H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence            44666778899999888778999988652 2   233445555555531  12333332      123466789999999


Q ss_pred             CCCChhh--------------hhcC----C--CC-----CCCCCHHHH-------------------------------H
Q 014024          187 PNKSLDC--------------FLFD----P--TK-----REILDWRTR-------------------------------V  210 (432)
Q Consensus       187 ~~gsL~~--------------~l~~----~--~~-----~~~l~~~~~-------------------------------~  210 (432)
                      +|..+..              .++.    .  ..     ...-.|...                               .
T Consensus       114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  193 (346)
T 2q83_A          114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID  193 (346)
T ss_dssp             CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred             cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence            9865420              0110    0  00     001123211                               0


Q ss_pred             HHHHHHHHHHHHHHh----------cCCCCeEeccCCCCCEEEcCCCCEEEeeccccee
Q 014024          211 QIIKGVAQGLLYLHQ----------YSRVRIIHRDLKASNILLDKDMNSKISDFGMARI  259 (432)
Q Consensus       211 ~i~~qi~~~l~~LH~----------~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  259 (432)
                      .+..++..++.+|+.          .....++|+|+++.||+++.++.+.|+||+.+..
T Consensus       194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            111223445666663          1234599999999999998888999999998754

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.17  E-value=6.3e-06  Score=80.23  Aligned_cols=74  Identities=11%  Similarity=0.226  Sum_probs=49.4

Q ss_pred             CceeccCCcEEEEEEEE--CCceEEEEEEcCCCh-------HhHHHHHHHHHHHHhcCC--Cc-eeeeEeEEEeCCeeEE
Q 014024          114 ANKLGEGGFGTVYKGVI--GQGEIAVKRLLGKSG-------QEIKELKNEASVIAQVQH--KN-LVKLLGCCIEKDERLL  181 (432)
Q Consensus       114 ~~~ig~G~~g~Vy~~~~--~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~n-iv~~~~~~~~~~~~~l  181 (432)
                      .+.||.|..+.||++..  .+..+++|.......       ...+.+..|.++++.+..  +. +.+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            56799999999999965  345899997643221       123456778899888742  33 4455543  4556789


Q ss_pred             EEecCCCC
Q 014024          182 IYEYMPNK  189 (432)
Q Consensus       182 v~e~~~~g  189 (432)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999774

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.03  E-value=6.7e-05  Score=70.32  Aligned_cols=138  Identities=16%  Similarity=0.085  Sum_probs=92.6

Q ss_pred             CceeccCCcEEEEEEEECCceEEEEEEcCCChHhHHHHHHHHHHHHhcC---CCceeeeEeEEEeCCeeEEEEecCCCCC
Q 014024          114 ANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQ---HKNLVKLLGCCIEKDERLLIYEYMPNKS  190 (432)
Q Consensus       114 ~~~ig~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~gs  190 (432)
                      .+.|+.|....+|+....++.+++|.....   ....+..|+..|+.+.   ...+.+++.+....+..++||||+++..
T Consensus        41 ~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~  117 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLINDEVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK  117 (312)
T ss_dssp             EEEECCSSSSEEEEEESSSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred             eEEeCCccceeeeEEEECCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence            467899999999999887778999987542   3567888999998884   3568888888888888999999999986


Q ss_pred             hhh-----------hhcCCCC-C----------C--------CCCHHHHH---HHHH----------------HHHHH-H
Q 014024          191 LDC-----------FLFDPTK-R----------E--------ILDWRTRV---QIIK----------------GVAQG-L  220 (432)
Q Consensus       191 L~~-----------~l~~~~~-~----------~--------~l~~~~~~---~i~~----------------qi~~~-l  220 (432)
                      +..           .++.... .          +        .-+|....   ++..                .++.. .
T Consensus       118 ~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~  197 (312)
T 3jr1_A          118 NKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVA  197 (312)
T ss_dssp             CCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHH
T ss_pred             CCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHH
Confidence            521           1111111 0          0        12354322   1111                11111 1


Q ss_pred             HHHHh-cCCCCeEeccCCCCCEEEcCCCCEEEeecc
Q 014024          221 LYLHQ-YSRVRIIHRDLKASNILLDKDMNSKISDFG  255 (432)
Q Consensus       221 ~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  255 (432)
                      ..|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus       198 ~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          198 DTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            23321 2246799999999999999887 8899973

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.93  E-value=3.8e-05  Score=75.33  Aligned_cols=78  Identities=10%  Similarity=0.081  Sum_probs=48.2

Q ss_pred             CCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCccccccccccccc--cCCccChhhhccC---CCCchhhhHHH
Q 014024          228 RVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG--TYGYMSPEYALEG---IFSIKSDVFSF  302 (432)
Q Consensus       228 ~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~t~~~DvwSl  302 (432)
                      ...++|||++|.||++++++ ++++||+.+..-..       .........  ...|++|+.....   .-....++.+.
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p-------~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPM-------GFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRT  302 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECH-------HHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCch-------HHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHH
Confidence            34599999999999998876 99999999875200       000001111  1235666544311   11234566688


Q ss_pred             HHHHHHHHhCC
Q 014024          303 GVLLLEIVSGK  313 (432)
Q Consensus       303 G~il~elltg~  313 (432)
                      ...+|+.+++.
T Consensus       303 ~~~~~~~y~~~  313 (420)
T 2pyw_A          303 IEQTWNLFNKR  313 (420)
T ss_dssp             HHHHHHHHHHH
T ss_pred             HHHHHHHHHHH
Confidence            88888887764

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.91  E-value=4.6e-05  Score=70.57  Aligned_cols=78  Identities=17%  Similarity=0.199  Sum_probs=55.3

Q ss_pred             CCCcCceeccCCcEEEEEEEECCc-eEEEEEEcCCChHhHHHHHHHHHHHHhcCCC---ceeeeEeEEEeCCeeEEEEec
Q 014024          110 NFSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKSGQEIKELKNEASVIAQVQHK---NLVKLLGCCIEKDERLLIYEY  185 (432)
Q Consensus       110 ~y~~~~~ig~G~~g~Vy~~~~~~~-~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~~~~~~~lv~e~  185 (432)
                      ...-.+.+|.|..+.||+....++ .+++|+...........+..|+..|+.+...   -+.+++++.    ..++||||
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~   91 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW   91 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence            344467899999999999998765 7899976554433345688899999988532   244455432    34789999


Q ss_pred             CCCCCh
Q 014024          186 MPNKSL  191 (432)
Q Consensus       186 ~~~gsL  191 (432)
                      ++++..
T Consensus        92 l~~~~~   97 (288)
T 3f7w_A           92 VDERPP   97 (288)
T ss_dssp             CCCCCC
T ss_pred             ecccCC
Confidence            987654

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.87  E-value=7.1e-05  Score=70.38  Aligned_cols=158  Identities=13%  Similarity=0.101  Sum_probs=87.8

Q ss_pred             chhhHhhhhCCCCc-----CceeccCCcEEEEEEEECCceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCc--eeeeEeE
Q 014024          100 SFSSVSSATGNFSA-----ANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKN--LVKLLGC  172 (432)
Q Consensus       100 ~~~~~~~~~~~y~~-----~~~ig~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~  172 (432)
                      +.+++......|.+     .+.|+.|....+|+....++.+++|.....  ...+.+..|..+++.+...+  +.+++..
T Consensus         8 ~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~   85 (322)
T 2ppq_A            8 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPR   85 (322)
T ss_dssp             CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCB
T ss_pred             CHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCccEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCC
Confidence            34444444445544     345667888999999887778999988652  11234566777777764222  2333321


Q ss_pred             ------EEeCCeeEEEEecCCCCChhhh--------------hcC----CCCC--CCC---CHHHHHH------------
Q 014024          173 ------CIEKDERLLIYEYMPNKSLDCF--------------LFD----PTKR--EIL---DWRTRVQ------------  211 (432)
Q Consensus       173 ------~~~~~~~~lv~e~~~~gsL~~~--------------l~~----~~~~--~~l---~~~~~~~------------  211 (432)
                            ....+..+++++|++|..+...              ++.    ....  ...   .|.....            
T Consensus        86 ~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~  165 (322)
T 2ppq_A           86 KDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKG  165 (322)
T ss_dssp             TTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTT
T ss_pred             CCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhh
Confidence                  1234567899999998654210              110    0000  001   1222110            


Q ss_pred             HHHHHHHHHHHHHhc----CCCCeEeccCCCCCEEEcCCCCEEEeeccccee
Q 014024          212 IIKGVAQGLLYLHQY----SRVRIIHRDLKASNILLDKDMNSKISDFGMARI  259 (432)
Q Consensus       212 i~~qi~~~l~~LH~~----~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  259 (432)
                      +...+...++.++..    ....++|+|+.+.||++++++.+.++||+.+..
T Consensus       166 l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          166 LREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             HHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            001234455566532    123599999999999998876668999988764

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.58  E-value=0.00034  Score=65.11  Aligned_cols=128  Identities=16%  Similarity=0.176  Sum_probs=76.2

Q ss_pred             CceeccCCcEEEEEEEECCceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCce-eeeEeEEEeCCeeEEEEecC-CCCCh
Q 014024          114 ANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNL-VKLLGCCIEKDERLLIYEYM-PNKSL  191 (432)
Q Consensus       114 ~~~ig~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~-~~gsL  191 (432)
                      .+.|+.|....+|+.    +.+++|+....... .....+|+.+++.+...++ .++++.  +.+.-++++||+ ++.++
T Consensus        23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~l   95 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQTM   95 (301)
T ss_dssp             CEEEESCSSEEEEEE----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEEC
T ss_pred             eeEcCCcccccccee----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCccC
Confidence            678999999999998    66888877543221 1123568888877743233 345543  344457899999 66554


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------------
Q 014024          192 DCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ----------------------------------------------  225 (432)
Q Consensus       192 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~----------------------------------------------  225 (432)
                      ......          ....++.++++.|+-||+                                              
T Consensus        96 ~~~~~~----------~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~  165 (301)
T 3dxq_A           96 SPEKFK----------TRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSA  165 (301)
T ss_dssp             CHHHHH----------HSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHH
T ss_pred             CHhhHh----------hhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHH
Confidence            310000          000112222222222222                                              


Q ss_pred             ----cCCCCeEeccCCCCCEEEcCCCCEEEeeccccee
Q 014024          226 ----YSRVRIIHRDLKASNILLDKDMNSKISDFGMARI  259 (432)
Q Consensus       226 ----~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  259 (432)
                          .....++|+|+.|.||+ .+++.+.++||..+..
T Consensus       166 l~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          166 LAAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             HHSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHhcCCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence                12234899999999999 5667789999998865

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.45  E-value=0.00021  Score=70.11  Aligned_cols=72  Identities=15%  Similarity=0.288  Sum_probs=48.2

Q ss_pred             CceeccCCcEEEEEEEEC---------CceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCce-eeeEeEEEeCCeeEEEE
Q 014024          114 ANKLGEGGFGTVYKGVIG---------QGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNL-VKLLGCCIEKDERLLIY  183 (432)
Q Consensus       114 ~~~ig~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~  183 (432)
                      .+.|+.|....+|+....         +..+++|+......  .+.+..|..+++.+...++ .++++.+.+    .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            456888888999999865         24788888744211  1345578888888853333 556665532    3899


Q ss_pred             ecCCCCCh
Q 014024          184 EYMPNKSL  191 (432)
Q Consensus       184 e~~~~gsL  191 (432)
                      ||++|.++
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99987554

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.36  E-value=0.0006  Score=65.59  Aligned_cols=141  Identities=19%  Similarity=0.239  Sum_probs=81.5

Q ss_pred             CceeccCCcEEEEEEEECC---------ceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCc-eeeeEeEEEeCCeeEEEE
Q 014024          114 ANKLGEGGFGTVYKGVIGQ---------GEIAVKRLLGKSGQEIKELKNEASVIAQVQHKN-LVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       114 ~~~ig~G~~g~Vy~~~~~~---------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~  183 (432)
                      .+.|..|-...+|+....+         ..+++|+. ...........+|.++++.+...+ ..++++.+.+    .+||
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~-g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~  129 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLY-GAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE  129 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEEC-C---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEEC-CCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence            3567667788889887642         46777775 222223456678999998885322 3456665543    2899


Q ss_pred             ecCCCCChhhh-h----------------cCC--CCCCCCC--HHHHHHHHHHHHH-------------------HHHHH
Q 014024          184 EYMPNKSLDCF-L----------------FDP--TKREILD--WRTRVQIIKGVAQ-------------------GLLYL  223 (432)
Q Consensus       184 e~~~~gsL~~~-l----------------~~~--~~~~~l~--~~~~~~i~~qi~~-------------------~l~~L  223 (432)
                      ||++|.+|..- +                +..  ...+...  +.++.++..++..                   .+..|
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            99998665321 0                111  0111122  4455555544322                   23333


Q ss_pred             H----hc-CCCCeEeccCCCCCEEEcCC----CCEEEeeccccee
Q 014024          224 H----QY-SRVRIIHRDLKASNILLDKD----MNSKISDFGMARI  259 (432)
Q Consensus       224 H----~~-~~~~ivH~Dlkp~NIll~~~----~~~kl~Dfg~a~~  259 (432)
                      .    .. ....++|+|+.+.||+++++    +.+.++||..+..
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            2    21 23459999999999999876    7899999998864

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.32  E-value=0.0012  Score=65.18  Aligned_cols=73  Identities=16%  Similarity=0.101  Sum_probs=47.8

Q ss_pred             CceeccCCcEEEEEEEECC--ceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCce-eeeEeEEEeCCeeEEEEecCCCCC
Q 014024          114 ANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNL-VKLLGCCIEKDERLLIYEYMPNKS  190 (432)
Q Consensus       114 ~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~gs  190 (432)
                      .+.|+.|-...+|+....+  ..+++|+......... ....|..+++.+...++ .++++.+.  +  .+||||++|.+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence            4568888889999999876  6788887643221111 12578999999875554 45666652  2  35999998865


Q ss_pred             h
Q 014024          191 L  191 (432)
Q Consensus       191 L  191 (432)
                      |
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            5

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.30  E-value=0.0011  Score=62.55  Aligned_cols=32  Identities=28%  Similarity=0.484  Sum_probs=27.6

Q ss_pred             CCCeEeccCCCCCEEEcCC----CCEEEeeccccee
Q 014024          228 RVRIIHRDLKASNILLDKD----MNSKISDFGMARI  259 (432)
Q Consensus       228 ~~~ivH~Dlkp~NIll~~~----~~~kl~Dfg~a~~  259 (432)
                      ...++|||+.+.||+++++    +.+.|+||+.+..
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            3459999999999999875    6789999998875

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.20  E-value=0.0025  Score=60.29  Aligned_cols=31  Identities=23%  Similarity=0.395  Sum_probs=27.8

Q ss_pred             CCeEeccCCCCCEEEcCCCCEEEeeccccee
Q 014024          229 VRIIHRDLKASNILLDKDMNSKISDFGMARI  259 (432)
Q Consensus       229 ~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  259 (432)
                      ..++|+|+.+.||++++++.+.++||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            4599999999999999888899999988765

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.17  E-value=0.0022  Score=55.92  Aligned_cols=103  Identities=12%  Similarity=0.038  Sum_probs=65.9

Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCccc
Q 014024          189 KSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDE  268 (432)
Q Consensus       189 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  268 (432)
                      -+|.+.|..  .+.++++.++|.++.|.+.+|.-+-....  -..+=+.|..|++..+|.+.+.+ +.+.          
T Consensus        33 vSL~eIL~~--~~~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------   97 (229)
T 2yle_A           33 LSLEEILRL--YNQPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD----------   97 (229)
T ss_dssp             EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred             ccHHHHHHH--cCCCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc----------
Confidence            367888753  34569999999999999999877622110  11223457999999999888764 1110          


Q ss_pred             cccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCC
Q 014024          269 LQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKN  315 (432)
Q Consensus       269 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p  315 (432)
                              .....+.|||... ...+.+.-|||||+++|.-+--..|
T Consensus        98 --------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 --------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             -----------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             --------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence                    1122366888653 4557899999999999999875444

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.09  E-value=0.0064  Score=56.90  Aligned_cols=141  Identities=14%  Similarity=0.137  Sum_probs=80.3

Q ss_pred             ceeccCCcEEEEEEEECCc-eEEEEEEcCCChHhHHHHHHHHHHHHhcCCCc--eeeeEeE-----EEeCCeeEEEEecC
Q 014024          115 NKLGEGGFGTVYKGVIGQG-EIAVKRLLGKSGQEIKELKNEASVIAQVQHKN--LVKLLGC-----CIEKDERLLIYEYM  186 (432)
Q Consensus       115 ~~ig~G~~g~Vy~~~~~~~-~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~-----~~~~~~~~lv~e~~  186 (432)
                      ..++ |....||+....++ .+++|...... ...+.+..|..+++.+....  +.+++..     ....+..+++|||+
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence            4566 88889998877555 79999886332 12345667888888774222  3444432     22345668899999


Q ss_pred             CCCChhh----h----------hc----CC--CCCCCCCHHHH----HHH---------------HHHHHHHHHHHHhc-
Q 014024          187 PNKSLDC----F----------LF----DP--TKREILDWRTR----VQI---------------IKGVAQGLLYLHQY-  226 (432)
Q Consensus       187 ~~gsL~~----~----------l~----~~--~~~~~l~~~~~----~~i---------------~~qi~~~l~~LH~~-  226 (432)
                      +|..+..    .          ++    ..  ......++...    ..+               ...+...++.+... 
T Consensus       110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  189 (328)
T 1zyl_A          110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW  189 (328)
T ss_dssp             CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence            8865421    0          01    00  01111222211    001               11111223333321 


Q ss_pred             ---CCCCeEeccCCCCCEEEcCCCCEEEeeccccee
Q 014024          227 ---SRVRIIHRDLKASNILLDKDMNSKISDFGMARI  259 (432)
Q Consensus       227 ---~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  259 (432)
                         ....++|||+++.||+++ + .+.++||+.+..
T Consensus       190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence               234589999999999999 4 899999988764

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.09  E-value=0.0014  Score=62.74  Aligned_cols=73  Identities=12%  Similarity=0.109  Sum_probs=43.1

Q ss_pred             CceeccCCcEEEEEEEECC----------ceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCc-eeeeEeEEEeCCeeEEE
Q 014024          114 ANKLGEGGFGTVYKGVIGQ----------GEIAVKRLLGKSGQEIKELKNEASVIAQVQHKN-LVKLLGCCIEKDERLLI  182 (432)
Q Consensus       114 ~~~ig~G~~g~Vy~~~~~~----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv  182 (432)
                      .+.|+.|....+|+....+          ..+++|+..... ........|..+++.+...+ ..++++..  .  -++|
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v  112 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI  112 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence            3567778888999988764          467777654322 22122467888888875333 34555443  2  3689


Q ss_pred             EecCCCCCh
Q 014024          183 YEYMPNKSL  191 (432)
Q Consensus       183 ~e~~~~gsL  191 (432)
                      |||++|..+
T Consensus       113 ~e~i~G~~l  121 (369)
T 3c5i_A          113 EEWLYGDPL  121 (369)
T ss_dssp             EECCCSEEC
T ss_pred             EEEecCCcC
Confidence            999988654

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.75  E-value=0.04  Score=53.59  Aligned_cols=140  Identities=16%  Similarity=0.189  Sum_probs=83.0

Q ss_pred             CceeccCCcEEEEEEEEC---------CceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCc-eeeeEeEEEeCCeeEEEE
Q 014024          114 ANKLGEGGFGTVYKGVIG---------QGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKN-LVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       114 ~~~ig~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~  183 (432)
                      .+.+..|-...+|+....         +..+++++...... ..-...+|..+++.+...+ ..++++.+  .  -++||
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~  149 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIE  149 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEE
Confidence            456777888899998876         45788887543322 1122357888888875323 34455433  2  27899


Q ss_pred             ecCCCCChhhh-h----------------cC--------CC--CCCCCCHHHHHHHHHHH-------------------H
Q 014024          184 EYMPNKSLDCF-L----------------FD--------PT--KREILDWRTRVQIIKGV-------------------A  217 (432)
Q Consensus       184 e~~~~gsL~~~-l----------------~~--------~~--~~~~l~~~~~~~i~~qi-------------------~  217 (432)
                      ||++|..|..- +                +.        ..  .+.+.-+.++.++..++                   .
T Consensus       150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~  229 (424)
T 3mes_A          150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL  229 (424)
T ss_dssp             ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred             EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence            99998764210 0                00        00  11222244444443322                   1


Q ss_pred             HHHHHHHh---------------------cCCCCeEeccCCCCCEEEcCCCCEEEeeccccee
Q 014024          218 QGLLYLHQ---------------------YSRVRIIHRDLKASNILLDKDMNSKISDFGMARI  259 (432)
Q Consensus       218 ~~l~~LH~---------------------~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  259 (432)
                      ..+..|.+                     .....++|+|+.+.||+ ++++.+.++||..+..
T Consensus       230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            22333321                     11245999999999999 8888999999998865

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=94.85  E-value=0.0096  Score=37.32  Aligned_cols=28  Identities=18%  Similarity=0.094  Sum_probs=14.4

Q ss_pred             EehhhHHHHHHHHHHHHhhheeeccccc
Q 014024           32 FLALSATLAGMAALGLTIFCFRRNTTNK   59 (432)
Q Consensus        32 ~~~~~~~v~~~~~~~~~~~~~~r~~~~~   59 (432)
                      ..++++++++++++++++++++|+++.+
T Consensus        14 A~gVVgGv~~~~ii~~~~~~~~RRr~~~   41 (44)
T 2ks1_B           14 ATGMVGALLLLLVVALGIGLFMRRRHIV   41 (44)
T ss_dssp             THHHHHHHHHHHHHHHHHHHHHHTTTCC
T ss_pred             EeehhHHHHHHHHHHHHHHHHhhhhHhh
Confidence            3444445555555566655555544443

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=94.51  E-value=0.11  Score=50.13  Aligned_cols=30  Identities=27%  Similarity=0.396  Sum_probs=25.6

Q ss_pred             CeEeccCCCCCEEE------cCCCCEEEeeccccee
Q 014024          230 RIIHRDLKASNILL------DKDMNSKISDFGMARI  259 (432)
Q Consensus       230 ~ivH~Dlkp~NIll------~~~~~~kl~Dfg~a~~  259 (432)
                      .++|+|+.+.||++      +++..+.++||..|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            36899999999999      4567799999998865

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=94.14  E-value=0.03  Score=34.98  Aligned_cols=26  Identities=23%  Similarity=0.295  Sum_probs=12.6

Q ss_pred             hhhHHHHHHHHHHHHhhheeeccccc
Q 014024           34 ALSATLAGMAALGLTIFCFRRNTTNK   59 (432)
Q Consensus        34 ~~~~~v~~~~~~~~~~~~~~r~~~~~   59 (432)
                      ++++++++++++++++++++|+++.+
T Consensus        15 gVVgGv~~v~ii~~~~~~~~RRRr~~   40 (44)
T 2l2t_A           15 GVIGGLFILVIVGLTFAVYVRRKSIK   40 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHTTCSS
T ss_pred             eehHHHHHHHHHHHHHHHHhhhhhhh
Confidence            33344455555555555554444433

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=91.79  E-value=0.71  Score=39.99  Aligned_cols=116  Identities=9%  Similarity=0.057  Sum_probs=80.0

Q ss_pred             CCCceeeeEeEEEeCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCE
Q 014024          162 QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNI  241 (432)
Q Consensus       162 ~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NI  241 (432)
                      .||+++.. .+-.+.+...+.++.-+.+.=...+      ..++...+++++.+++....+++.     =+|--|.|+||
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i------k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL  110 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI------KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDEL  110 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG------GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHHH------HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceE
Confidence            67888876 4656666666666654432222222      237889999999999988755554     46889999999


Q ss_pred             EEcCCCCEEEeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 014024          242 LLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTG  317 (432)
Q Consensus       242 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~  317 (432)
                      +++.++.+++.-.|+...+                       +|.     .++...=.-.+=|++..+++++..|+
T Consensus       111 ~f~~~~~p~i~~RGik~~l-----------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          111 FFTRDGLPIAKTRGLQNVV-----------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             EECTTSCEEESCCEETTTB-----------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             EEcCCCCEEEEEccCccCC-----------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            9999999999887765332                       221     12333334478889999999998864

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=89.46  E-value=0.077  Score=33.07  Aligned_cols=15  Identities=13%  Similarity=0.160  Sum_probs=5.9

Q ss_pred             HHHHHHHHhhheeec
Q 014024           41 GMAALGLTIFCFRRN   55 (432)
Q Consensus        41 ~~~~~~~~~~~~~r~   55 (432)
                      +++++++++++|.||
T Consensus        23 l~vi~~l~~~~~~RR   37 (44)
T 2jwa_A           23 LVVVLGVVFGILIKR   37 (44)
T ss_dssp             HHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhheeh
Confidence            333444444443333

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=87.78  E-value=1.2  Score=38.74  Aligned_cols=115  Identities=7%  Similarity=0.066  Sum_probs=77.9

Q ss_pred             CCCceeeeEeEEEeCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHH-HHHhcCCCCeEeccCCCCC
Q 014024          162 QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLL-YLHQYSRVRIIHRDLKASN  240 (432)
Q Consensus       162 ~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~-~LH~~~~~~ivH~Dlkp~N  240 (432)
                      .||++  -..+-.+++...+.++.-+++.=...+      ..++...+++++.+++.... +++.     -+|--|.|+|
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~N  114 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPEN  114 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCce
Confidence            57887  334446667777777765444333333      22788899999998887666 4443     5788999999


Q ss_pred             EEEcCCCCEEEeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 014024          241 ILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTG  317 (432)
Q Consensus       241 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~  317 (432)
                      |+++.++.+++.-.|+-..                       ++|.-     .+...=+-++=|++..++.++..|+
T Consensus       115 L~f~~~~~p~i~hRGi~~~-----------------------lpP~e-----~~ee~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          115 LMFNRALEPFFLHVGVKES-----------------------LPPDE-----WDDERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             EEECTTCCEEESCCEETTT-----------------------BSSCS-----CCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred             EEEeCCCcEEEEEcCCccc-----------------------CCCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            9999999999987776532                       23321     2222233478888899999887764

>2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A

Probab=85.70  E-value=0.49  Score=28.55  Aligned_cols=18  Identities=28%  Similarity=0.133  Sum_probs=7.6

Q ss_pred             HHHHHHHHHHHHhhheee
Q 014024           37 ATLAGMAALGLTIFCFRR   54 (432)
Q Consensus        37 ~~v~~~~~~~~~~~~~~r   54 (432)
                      +.++++++++.+.++++|
T Consensus        19 G~v~gv~li~~l~~~~~r   36 (38)
T 2k1k_A           19 GLLLGAALLLGILVFRSR   36 (38)
T ss_dssp             HHHHHHHHHHHHHHHHHC
T ss_pred             HHHHHHHHHHHHHHHHee
Confidence            344444444444444333

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	432
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-71
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-66
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	4e-66
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-65
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	4e-64
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-63
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-63
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-63
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	4e-62
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-61
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	4e-61
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-60
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	4e-60
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-59
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-59
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	4e-59
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	9e-58
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-57
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-57
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-57
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	4e-57
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-56
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-56
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-56
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-55
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-53
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-53
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	5e-53
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-52
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	4e-52
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	4e-51
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	4e-49
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-48
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-46
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-44
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	5e-44
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	8e-44
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	8e-43
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-42
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-42
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-42
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	7e-42
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	5e-41
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	5e-41
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-40
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	4e-40
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	7e-40
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-39
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-38
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-38
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-37
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	7e-37
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	8e-37
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	4e-36
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	8e-35
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	9e-34
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-33
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-31
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-29
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	6e-29
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-28
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	9e-26
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	4e-22

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  224 bits (573), Expect = 2e-71
 Identities = 75/292 (25%), Positives = 138/292 (47%), Gaps = 28/292 (9%)

Query: 109 GNFSAANKLGEGGFGTVYKGVIGQGEIAVKRL--LGKSGQEIKELKNEASVIAQVQHKNL 166
           G  +   ++G G FGTVYKG    G++AVK L     + Q+++  KNE  V+ + +H N+
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKW-HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 66

Query: 167 VKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQY 226
           +  +G      +  ++ ++    SL   L         +    + I +  AQG+ YLH  
Sbjct: 67  LLFMGYS-TAPQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAK 123

Query: 227 SRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPE 286
           S   IIHRDLK++NI L +D+  KI DFG+A +               ++SG+  +M+PE
Sbjct: 124 S---IIHRDLKSNNIFLHEDLTVKIGDFGLATVK----SRWSGSHQFEQLSGSILWMAPE 176

Query: 287 YAL---EGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLI 343
                 +  +S +SDV++FG++L E+++G+    +    + + I     +     +   +
Sbjct: 177 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP--YSNINNRDQI---IFMVGRGYLSPDL 231

Query: 344 DSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPK 395
             V               +   C++++ ++RP    +++ +   A SL  PK
Sbjct: 232 SKVRSNCP-----KAMKRLMAECLKKKRDERPLFPQILASIELLARSL--PK 276

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (540), Expect = 1e-66
 Identities = 76/290 (26%), Positives = 135/290 (46%), Gaps = 26/290 (8%)

Query: 110 NFSAANKLGEGGFGTVYKGVI-GQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
           +     KLG+G FG V+ G   G   +A+K L        +    EA V+ +++H+ LV+
Sbjct: 18  SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 76

Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSR 228
           L      ++   ++ EYM   SL  FL   T + +      V +   +A G+ Y+ +   
Sbjct: 77  LYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVERM-- 132

Query: 229 VRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYA 288
              +HRDL+A+NIL+ +++  K++DFG+AR++     ED              + +PE A
Sbjct: 133 -NYVHRDLRAANILVGENLVCKVADFGLARLI-----EDNEYTARQGAKFPIKWTAPEAA 186

Query: 289 LEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLE 348
           L G F+IKSDV+SFG+LL E+ +  +                +   ++ +++D ++    
Sbjct: 187 LYGRFTIKSDVWSFGILLTELTTKGRVP--------------YPGMVNREVLDQVERGYR 232

Query: 349 EASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQPA 398
                E       +   C ++  E+RPT   + + L +  +S  P  QP 
Sbjct: 233 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 282

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (536), Expect = 4e-66
 Identities = 80/276 (28%), Positives = 132/276 (47%), Gaps = 26/276 (9%)

Query: 110 NFSAANKLGEGGFGTVYKGVI-GQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
                 +LG G FG V+ G   G  ++AVK L  +          EA+++ Q+QH+ LV+
Sbjct: 14  TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVR 72

Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSR 228
           L     + +   +I EYM N SL  FL  P+  + L     + +   +A+G+ ++ + + 
Sbjct: 73  LYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN- 129

Query: 229 VRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYA 288
              IHRDL+A+NIL+   ++ KI+DFG+AR++     ED              + +PE  
Sbjct: 130 --YIHRDLRAANILVSDTLSCKIADFGLARLI-----EDNEYTAREGAKFPIKWTAPEAI 182

Query: 289 LEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLE 348
             G F+IKSDV+SFG+LL EIV+  +                +    + ++I  ++    
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRI--------------PYPGMTNPEVIQNLERGYR 228

Query: 349 EASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML 384
               +        +  LC +ER EDRPT   + S+L
Sbjct: 229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  210 bits (535), Expect = 1e-65
 Identities = 74/301 (24%), Positives = 132/301 (43%), Gaps = 35/301 (11%)

Query: 99  FSFSSVSSATGNFSAA---------NKLGEGGFGTVYKGVI---GQGEI--AVKRL-LGK 143
           F+F   + A   F+             +G G FG V  G +   G+ EI  A+K L  G 
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 144 SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREI 203
           + ++ ++  +EAS++ Q  H N++ L G   +    ++I E+M N SLD FL     +  
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125

Query: 204 LDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGG 263
                 V +++G+A G+ YL        +HRDL A NIL++ ++  K+SDFG++R +   
Sbjct: 126 -TVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181

Query: 264 NDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKS 323
             +               + +PE      F+  SDV+S+G+++ E++S  +         
Sbjct: 182 TSDPTYTSALGGK-IPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE--------- 231

Query: 324 LNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM 383
                  +    +  +I+ I+         +  S    + L C Q+    RP    +V+ 
Sbjct: 232 -----RPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286

Query: 384 L 384
           L
Sbjct: 287 L 287

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (521), Expect = 4e-64
 Identities = 75/271 (27%), Positives = 114/271 (42%), Gaps = 30/271 (11%)

Query: 115 NKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCI 174
             +G+G FG V  G     ++AVK +  K+    +    EASV+ Q++H NLV+LLG  +
Sbjct: 13  QTIGKGEFGDVMLGDYRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 70

Query: 175 EKDERL-LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
           E+   L ++ EYM   SL  +L     R +L     ++    V + + YL        +H
Sbjct: 71  EEKGGLYIVTEYMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVH 126

Query: 234 RDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIF 293
           RDL A N+L+ +D  +K+SDFG+ +         E             + +PE   E  F
Sbjct: 127 RDLAARNVLVSEDNVAKVSDFGLTK---------EASSTQDTGKLPVKWTAPEALREKKF 177

Query: 294 SIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFN 353
           S KSDV+SFG+LL EI S  +    Y    L  +            +D  D         
Sbjct: 178 STKSDVWSFGILLWEIYSFGRV--PYPRIPLKDV---VPRVEKGYKMDAPDGCPPAV--- 229

Query: 354 ESLSRYVHIALLCVQERAEDRPTMSDVVSML 384
                   +   C    A  RP+   +   L
Sbjct: 230 ------YEVMKNCWHLDAAMRPSFLQLREQL 254

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (516), Expect = 2e-63
 Identities = 72/278 (25%), Positives = 127/278 (45%), Gaps = 26/278 (9%)

Query: 110 NFSAANKLGEGGFGTVYKGVI-GQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
           + +   +LG G FG V  G   GQ ++A+K +  +      E   EA V+  + H+ LV+
Sbjct: 5   DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQ 63

Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSR 228
           L G C ++    +I EYM N  L  +L +   R     +  +++ K V + + YL     
Sbjct: 64  LYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESK-- 119

Query: 229 VRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYA 288
            + +HRDL A N L++     K+SDFG++R V           ++        +  PE  
Sbjct: 120 -QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-----SSVGSKFPVRWSPPEVL 173

Query: 289 LEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLE 348
           +   FS KSD+++FGVL+ EI S  K                ++ + +++  + I   L 
Sbjct: 174 MYSKFSSKSDIWAFGVLMWEIYSLGK--------------MPYERFTNSETAEHIAQGLR 219

Query: 349 EASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN 386
               + +  +   I   C  E+A++RPT   ++S + +
Sbjct: 220 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (516), Expect = 2e-63
 Identities = 72/276 (26%), Positives = 130/276 (47%), Gaps = 26/276 (9%)

Query: 110 NFSAANKLGEGGFGTVYKGV-IGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVK 168
             +   ++G G FG V+ G  + + ++A+K +  +     ++   EA V+ ++ H  LV+
Sbjct: 6   ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQ 64

Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSR 228
           L G C+E+    L++E+M +  L  +L    +R +    T + +   V +G+ YL +   
Sbjct: 65  LYGVCLEQAPICLVFEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEA-- 120

Query: 229 VRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYA 288
             +IHRDL A N L+ ++   K+SDFGM R V           +++       + SPE  
Sbjct: 121 -CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-----SSTGTKFPVKWASPEVF 174

Query: 289 LEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLE 348
               +S KSDV+SFGVL+ E+ S  K                ++   ++++++ I +   
Sbjct: 175 SFSRYSSKSDVWSFGVLMWEVFSEGK--------------IPYENRSNSEVVEDISTGFR 220

Query: 349 EASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML 384
                 + +    I   C +ER EDRP  S ++  L
Sbjct: 221 LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQL 256

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (517), Expect = 3e-63
 Identities = 72/291 (24%), Positives = 127/291 (43%), Gaps = 28/291 (9%)

Query: 116 KLGEGGFGTVYKGVI----GQGEIAVKRL-LGKSGQEIKELKNEASVIAQVQHKNLVKLL 170
           +LG G FG+V +GV      Q ++A+K L  G    + +E+  EA ++ Q+ +  +V+L+
Sbjct: 16  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 75

Query: 171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVR 230
           G C + +  +L+ E      L  FL    KRE +      +++  V+ G+ YL + +   
Sbjct: 76  GVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN--- 129

Query: 231 IIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE 290
            +HRDL A N+LL     +KISDFG+++ +     +D      S       + +PE    
Sbjct: 130 FVHRDLAARNVLLVNRHYAKISDFGLSKAL---GADDSYYTARSAGKWPLKWYAPECINF 186

Query: 291 GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEA 350
             FS +SDV+S+GV + E +S  +   + + K   ++          K ++       E 
Sbjct: 187 RKFSSRSDVWSYGVTMWEALSYGQ-KPYKKMKGPEVM----AFIEQGKRMECPPECPPEL 241

Query: 351 SFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQPAFCN 401
                      +   C   + EDRP    V   +     SL    +    +
Sbjct: 242 ---------YALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHHHH 283

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (511), Expect = 4e-62
 Identities = 59/292 (20%), Positives = 113/292 (38%), Gaps = 28/292 (9%)

Query: 116 KLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIE 175
            +G+G FG V++G     E+AVK    +  +     + E      ++H+N++  +    +
Sbjct: 10  SIGKGRFGEVWRGKWRGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADNK 68

Query: 176 KD----ERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ-----Y 226
            +    +  L+ +Y  + SL  +L     R  +     +++    A GL +LH       
Sbjct: 69  DNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124

Query: 227 SRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPE 286
            +  I HRDLK+ NIL+ K+    I+D G+A      +  D +    +   GT  YM+PE
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH--DSATDTIDIAPNHRVGTKRYMAPE 182

Query: 287 YALEGI------FSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKII 340
              + I         ++D+++ G++  EI       G +    L             ++ 
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242

Query: 341 DLI------DSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN 386
            ++       ++       E+L     I   C       R T   +   L+ 
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (503), Expect = 3e-61
 Identities = 70/278 (25%), Positives = 120/278 (43%), Gaps = 30/278 (10%)

Query: 115 NKLGEGGFGTVYKGVIGQG----EIAVKRLLGKSGQE--IKELKNEASVIAQVQHKNLVK 168
            +LG G FGTV KG          +AVK L  ++       EL  EA+V+ Q+ +  +V+
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 169 LLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSR 228
           ++G C E +  +L+ E      L+ +L    +   +  +  ++++  V+ G+ YL +   
Sbjct: 73  MIGIC-EAESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEES-- 126

Query: 229 VRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYA 288
              +HRDL A N+LL     +KISDFG+++ +    +  +     +       + +PE  
Sbjct: 127 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK---AQTHGKWPVKWYAPECI 182

Query: 289 LEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLE 348
               FS KSDV+SFGVL+ E  S  +   +   K   +      +    + +        
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQ-KPYRGMKGSEVT----AMLEKGERMGCPAGCPR 237

Query: 349 EASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN 386
           E            +  LC     E+RP  + V   L N
Sbjct: 238 EM---------YDLMNLCWTYDVENRPGFAAVELRLRN 266

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  198 bits (503), Expect = 4e-61
 Identities = 73/277 (26%), Positives = 134/277 (48%), Gaps = 26/277 (9%)

Query: 110 NFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLV 167
           + +  +KLG G +G VY+GV  +    +AVK L  +   E++E   EA+V+ +++H NLV
Sbjct: 18  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLV 76

Query: 168 KLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYS 227
           +LLG C  +    +I E+M   +L  +L +  ++E +     + +   ++  + YL +  
Sbjct: 77  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLEKK- 134

Query: 228 RVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEY 287
               IHRDL A N L+ ++   K++DFG++R++ G           +       + +PE 
Sbjct: 135 --NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-----AHAGAKFPIKWTAPES 187

Query: 288 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVL 347
                FSIKSDV++FGVLL EI +   +   Y    L+ +   ++L   +  ++  +   
Sbjct: 188 LAYNKFSIKSDVWAFGVLLWEIATYGMS--PYPGIDLSQV---YELLEKDYRMERPEGCP 242

Query: 348 EEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML 384
           E+            +   C Q    DRP+ +++    
Sbjct: 243 EKV---------YELMRACWQWNPSDRPSFAEIHQAF 270

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 1e-60
 Identities = 73/283 (25%), Positives = 131/283 (46%), Gaps = 31/283 (10%)

Query: 110 NFSAANKLGEGGFGTVYKGVIGQG------EIAVKRL-LGKSGQEIKELKNEASVIAQVQ 162
             +    +G G FG VYKG++          +A+K L  G + ++  +   EA ++ Q  
Sbjct: 8   CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67

Query: 163 HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLY 222
           H N+++L G   +    ++I EYM N +     F   K         V +++G+A G+ Y
Sbjct: 68  HHNIIRLEGVISKYKPMMIITEYMENGA--LDKFLREKDGEFSVLQLVGMLRGIAAGMKY 125

Query: 223 LHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGY 282
           L     +  +HRDL A NIL++ ++  K+SDFG++R++    D+ E    TS       +
Sbjct: 126 LA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL---EDDPEATYTTSGGKIPIRW 179

Query: 283 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNK-IID 341
            +PE      F+  SDV+SFG+++ E+++                G      +SN  ++ 
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTY---------------GERPYWELSNHEVMK 224

Query: 342 LIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML 384
            I+      +  +  S    + + C Q+    RP  +D+VS+L
Sbjct: 225 AINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 267

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  195 bits (497), Expect = 4e-60
 Identities = 70/304 (23%), Positives = 122/304 (40%), Gaps = 50/304 (16%)

Query: 110 NFSAANKLGEGGFGTVYKGVIGQG-------EIAVKRL-LGKSGQEIKELKNEASVIAQV 161
           N      +GEG FG V++              +AVK L    S     + + EA+++A+ 
Sbjct: 14  NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 73

Query: 162 QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREI------------------ 203
            + N+VKLLG C       L++EYM    L+ FL   +   +                  
Sbjct: 74  DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 133

Query: 204 ---LDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIV 260
              L    ++ I + VA G+ YL +    + +HRDL   N L+ ++M  KI+DFG++R +
Sbjct: 134 PPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNI 190

Query: 261 FGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYR 320
                  +        +    +M PE      ++ +SDV+++GV+L EI S       Y 
Sbjct: 191 ----YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ--PYY 244

Query: 321 TKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDV 380
             +   +           I+   ++   E           ++  LC  +   DRP+   +
Sbjct: 245 GMAHEEV---IYYVRDGNILACPENCPLEL---------YNLMRLCWSKLPADRPSFCSI 292

Query: 381 VSML 384
             +L
Sbjct: 293 HRIL 296

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 3e-59
 Identities = 66/302 (21%), Positives = 115/302 (38%), Gaps = 44/302 (14%)

Query: 110 NFSAANKLGEGGFGTVYKGV--IGQGEIAVKRL-LGKSGQEIKELKNEASVIAQVQHKNL 166
           +F   ++LG G  G V+K         +A K + L        ++  E  V+ +     +
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66

Query: 167 VKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQY 226
           V   G      E  +  E+M   SLD  L    K   +  +   ++   V +GL YL   
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLR-- 121

Query: 227 SRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPE 286
            + +I+HRD+K SNIL++     K+ DFG++  +             +   GT  YMSPE
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--------DSMANSFVGTRSYMSPE 173

Query: 287 YALEGIFSIKSDVFSFGVLLLEIVSGK------------------------KNTGFYRTK 322
                 +S++SD++S G+ L+E+  G+                        +     RT 
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233

Query: 323 SLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIAL----LCVQERAEDRPTMS 378
              L  Y  D      I +L+D ++ E         +          C+ +   +R  + 
Sbjct: 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 293

Query: 379 DV 380
            +
Sbjct: 294 QL 295

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (493), Expect = 3e-59
 Identities = 68/290 (23%), Positives = 124/290 (42%), Gaps = 30/290 (10%)

Query: 110 NFSAANKLGEGGFGTVYKGVIGQGE-----IAVKRL-LGKSGQEIKELKNEASVIAQVQH 163
           +F+    +G G FG VY G +   +      AVK L       E+ +   E  ++    H
Sbjct: 30  HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87

Query: 164 KNLVKLLGCCIEKDER-LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLY 222
            N++ LLG C+  +   L++  YM +  L  F+ + T    +       +          
Sbjct: 88  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG----- 142

Query: 223 LHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGY 282
           +   +  + +HRDL A N +LD+    K++DFG+AR ++  + E +   N +       +
Sbjct: 143 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY--DKEFDSVHNKTGAKLPVKW 200

Query: 283 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDL 342
           M+ E      F+ KSDV+SFGVLL E+++       Y   +   I       +  + +  
Sbjct: 201 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFDI---TVYLLQGRRLLQ 255

Query: 343 IDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLL 392
            +   +             + L C   +AE RP+ S++VS ++   S+ +
Sbjct: 256 PEYCPDPL---------YEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 296

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  193 bits (492), Expect = 4e-59
 Identities = 71/309 (22%), Positives = 132/309 (42%), Gaps = 42/309 (13%)

Query: 111 FSAANKLGEGGFGTVYKGV--IGQGEIAVKRL---LGKSGQEIKELKNEASVIAQVQHKN 165
           FS   ++G G FG VY          +A+K++     +S ++ +++  E   + +++H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ 225
            ++  GC + +    L+ EY    + D        ++ L       +  G  QGL YLH 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHS 133

Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
           +    +IHRD+KA NILL +    K+ DFG A I+             +   GT  +M+P
Sbjct: 134 H---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM----------APANSFVGTPYWMAP 180

Query: 286 EYAL---EGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDL 342
           E  L   EG +  K DV+S G+  +E+   K     +   +++ +           I   
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERK--PPLFNMNAMSAL---------YHIAQN 229

Query: 343 IDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM--LTNEA--SSLLPPKQPA 398
               L+   ++E      +    C+Q+  +DRPT   ++    +  E   + ++   Q  
Sbjct: 230 ESPALQSGHWSEYF---RNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRT 286

Query: 399 FCNLRNMES 407
              +R +++
Sbjct: 287 KDAVRELDN 295

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (482), Expect = 9e-58
 Identities = 74/299 (24%), Positives = 111/299 (37%), Gaps = 44/299 (14%)

Query: 115 NKLGEGGFGTVYKGVIGQG-------EIAVKRL-LGKSGQEIKELKNEASVIAQV-QHKN 165
             LG G FG V +              +AVK L       E + L +E  V++ +  H N
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88

Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREI---------------LDWRTRV 210
           +V LLG C      L+I EY     L  FL       I               LD    +
Sbjct: 89  IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148

Query: 211 QIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQ 270
                VA+G+ +L        IHRDL A NILL     +KI DFG+AR +      D   
Sbjct: 149 SFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDI----KNDSNY 201

Query: 271 GNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYA 330
                      +M+PE     +++ +SDV+S+G+ L E+ S   +               
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS-------------PY 248

Query: 331 WDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS 389
             + + +K   +I       S   + +    I   C       RPT   +V ++  + S
Sbjct: 249 PGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (480), Expect = 2e-57
 Identities = 72/308 (23%), Positives = 132/308 (42%), Gaps = 50/308 (16%)

Query: 96  FPLFSFSSVSSATGNFSAANKLGEGGFGTVYKGVIGQG----EIAVKRL-LGKSGQEIKE 150
           +P+  ++       +    + +GEG FG V K  I +     + A+KR+    S  + ++
Sbjct: 4   YPVLDWN-------DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD 56

Query: 151 LKNEASVIAQV-QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFL-------------F 196
              E  V+ ++  H N++ LLG C  +    L  EY P+ +L  FL              
Sbjct: 57  FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 116

Query: 197 DPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGM 256
             +    L  +  +     VA+G+ YL Q    + IHRDL A NIL+ ++  +KI+DFG+
Sbjct: 117 ANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGL 173

Query: 257 ARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNT 316
           +R         E+    +       +M+ E     +++  SDV+S+GVLL EIVS     
Sbjct: 174 SRG-------QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT- 225

Query: 317 GFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPT 376
             Y   +   +   ++       ++   +  +E            +   C +E+  +RP+
Sbjct: 226 -PYCGMTCAEL---YEKLPQGYRLEKPLNCDDEV---------YDLMRQCWREKPYERPS 272

Query: 377 MSDVVSML 384
            + ++  L
Sbjct: 273 FAQILVSL 280

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (480), Expect = 3e-57
 Identities = 78/307 (25%), Positives = 119/307 (38%), Gaps = 49/307 (15%)

Query: 110 NFSAANKLGEGGFGTVYKGVIGQG-------EIAVKRLLGKSGQ-EIKELKNEASVIAQV 161
           N      LG G FG V               ++AVK L  K+   E + L +E  ++ Q+
Sbjct: 38  NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97

Query: 162 -QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKR------------------- 201
             H+N+V LLG C       LI+EY     L  +L    ++                   
Sbjct: 98  GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157

Query: 202 -EILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIV 260
             +L +   +     VA+G+ +L        +HRDL A N+L+      KI DFG+AR +
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDI 214

Query: 261 FGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYR 320
                 D              +M+PE   EGI++IKSDV+S+G+LL EI S   N  +  
Sbjct: 215 ----MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP-YPG 269

Query: 321 TKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDV 380
                     + L  +   +D      EE            I   C    +  RP+  ++
Sbjct: 270 IPVDANF---YKLIQNGFKMDQPFYATEEI---------YIIMQSCWAFDSRKRPSFPNL 317

Query: 381 VSMLTNE 387
            S L  +
Sbjct: 318 TSFLGCQ 324

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 3e-57
 Identities = 75/308 (24%), Positives = 140/308 (45%), Gaps = 33/308 (10%)

Query: 111 FSAANKLGEGGFGTVYKGV-IGQGE-----IAVKRL-LGKSGQEIKELKNEASVIAQVQH 163
           F     LG G FGTVYKG+ I +GE     +A+K L    S +  KE+ +EA V+A V +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 164 KNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYL 223
            ++ +LLG C+    +L I + MP   L  ++ +   ++ +  +  +     +A+G+ YL
Sbjct: 71  PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL 127

Query: 224 HQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYM 283
                 R++HRDL A N+L+    + KI+DFG+A+++      +E + +         +M
Sbjct: 128 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL----GAEEKEYHAEGGKVPIKWM 180

Query: 284 SPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLI 343
           + E  L  I++ +SDV+S+GV + E+++                   +D   +++I  ++
Sbjct: 181 ALESILHRIYTHQSDVWSYGVTVWELMTFGS--------------KPYDGIPASEISSIL 226

Query: 344 DSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQPAFCNLR 403
           +                 I + C    A+ RP   +++   +  A    P +        
Sbjct: 227 EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD--PQRYLVIQGDE 284

Query: 404 NMESSTST 411
            M   + T
Sbjct: 285 RMHLPSPT 292

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 4e-57
 Identities = 65/278 (23%), Positives = 125/278 (44%), Gaps = 37/278 (13%)

Query: 115 NKLGEGGFGTVYKGV--IGQGEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLL 170
            ++G G F TVYKG+      E+A   L  +  +  E +  K EA ++  +QH N+V+  
Sbjct: 15  IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74

Query: 171 GCCIE----KDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQY 226
                    K   +L+ E M + +L  +L    + +++  +      + + +GL +LH  
Sbjct: 75  DSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTR 131

Query: 227 SRVRIIHRDLKASNILL-DKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
           +   IIHRDLK  NI +     + KI D G+A +                + GT  +M+P
Sbjct: 132 TP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--------SFAKAVIGTPEFMAP 182

Query: 286 EYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDS 345
           E   E  +    DV++FG+ +LE+ + +                  +   + +I   + S
Sbjct: 183 EM-YEEKYDESVDVYAFGMCMLEMATSEYPY--------------SECQNAAQIYRRVTS 227

Query: 346 VLEEASFNESLSRYV-HIALLCVQERAEDRPTMSDVVS 382
            ++ ASF++     V  I   C+++  ++R ++ D+++
Sbjct: 228 GVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (474), Expect = 1e-56
 Identities = 76/305 (24%), Positives = 134/305 (43%), Gaps = 38/305 (12%)

Query: 110 NFSAANKLGEGGFGTVYKGVI-------GQGEIAVKRL-LGKSGQEIKELKNEASVIAQV 161
             + + +LG+G FG VY+GV         +  +A+K +    S +E  E  NEASV+ + 
Sbjct: 21  KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF 80

Query: 162 QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLF-------DPTKREILDWRTRVQIIK 214
              ++V+LLG   +    L+I E M    L  +L        +            +Q+  
Sbjct: 81  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 140

Query: 215 GVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTS 274
            +A G+ YL+     + +HRDL A N ++ +D   KI DFGM R +     E +      
Sbjct: 141 EIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI----YETDYYRKGG 193

Query: 275 RISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLW 334
           +      +MSPE   +G+F+  SDV+SFGV+L EI +  +    Y+  S   +       
Sbjct: 194 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ--PYQGLSNEQV---LRFV 248

Query: 335 ISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPP 394
           +   ++D  D+  +             +  +C Q   + RP+  +++S +  E       
Sbjct: 249 MEGGLLDKPDNCPDML---------FELMRMCWQYNPKMRPSFLEIISSIKEEMEP--GF 297

Query: 395 KQPAF 399
           ++ +F
Sbjct: 298 REVSF 302

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 2e-56
 Identities = 65/281 (23%), Positives = 115/281 (40%), Gaps = 30/281 (10%)

Query: 110 NFSAANKLGEGGFGTVYKGV-IGQGEI-AVKRLL--GKSGQEIKELKNEASVIAQVQHKN 165
           ++     +G G +G   K      G+I   K L     +  E + L +E +++ +++H N
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64

Query: 166 LVKLLGCCIEKDERLL--IYEYMPNKSLDCFLFDPTK-REILDWRTRVQIIKGVAQGLLY 222
           +V+     I++    L  + EY     L   +   TK R+ LD    ++++  +   L  
Sbjct: 65  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124

Query: 223 LHQYSRV--RIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTY 280
            H+ S     ++HRDLK +N+ LD   N K+ DFG+ARI+      +          GT 
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL------NHDTSFAKAFVGTP 178

Query: 281 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKII 340
            YMSPE      ++ KSD++S G LL E+ +      F       L           K  
Sbjct: 179 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM--PPFTAFSQKELA----GKIREGKFR 232

Query: 341 DLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVV 381
            +     +E            I    +  +   RP++ +++
Sbjct: 233 RIPYRYSDEL---------NEIITRMLNLKDYHRPSVEEIL 264

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (469), Expect = 3e-56
 Identities = 71/285 (24%), Positives = 115/285 (40%), Gaps = 32/285 (11%)

Query: 110 NFSAANKLGEGGFGTVYKGVI----GQG-EIAVKRL---LGKSGQEIKELKNEASVIAQV 161
           +     KLG+G FG V +G      G+   +AVK L   +    + + +   E + +  +
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68

Query: 162 QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLL 221
            H+NL++L G  +    ++ + E  P  SL   L            T  +    VA+G+ 
Sbjct: 69  DHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGH--FLLGTLSRYAVQVAEGMG 125

Query: 222 YLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYG 281
           YL      R IHRDL A N+LL      KI DFG+ R +   +D   +          + 
Sbjct: 126 YLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM---QEHRKVPFA 179

Query: 282 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIID 341
           + +PE      FS  SD + FGV L E+ +  +                W     ++I+ 
Sbjct: 180 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ--------------EPWIGLNGSQILH 225

Query: 342 LIDSVLEEASFNESLSRYV-HIALLCVQERAEDRPTMSDVVSMLT 385
            ID   E     E   + + ++ + C   + EDRPT   +   L 
Sbjct: 226 KIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (467), Expect = 1e-55
 Identities = 64/280 (22%), Positives = 110/280 (39%), Gaps = 45/280 (16%)

Query: 115 NKLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGC 172
            +LG+G FG VYK          A K +  KS +E+++   E  ++A   H N+VKLL  
Sbjct: 18  GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77

Query: 173 CIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRII 232
              ++   ++ E+    ++D  + +  +   L       + K     L YLH     +II
Sbjct: 78  FYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLHD---NKII 132

Query: 233 HRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL--- 289
           HRDLKA NIL   D + K++DFG++                    GT  +M+PE  +   
Sbjct: 133 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ------RRDSFIGTPYWMAPEVVMCET 186

Query: 290 --EGIFSIKSDVFSFGVLLLEIVSGKK-------NTGFYRTKSLNLIGYAWDLWISNKII 340
             +  +  K+DV+S G+ L+E+   +             +         A     S+   
Sbjct: 187 SKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFK 246

Query: 341 DLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDV 380
           D +                      C+++  + R T S +
Sbjct: 247 DFLKK--------------------CLEKNVDARWTTSQL 266

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 2e-53
 Identities = 60/278 (21%), Positives = 112/278 (40%), Gaps = 27/278 (9%)

Query: 109 GNFSAANKLGEGGFGTVYKGV--IGQGEIAVKRL-LGKSGQEIKELKNEASVIAQVQHKN 165
            ++     LGEG +G V   V  + +  +AVK + + ++    + +K E  +   + H+N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ 225
           +VK  G   E + + L  EY     L   +        +      +    +  G++YLH 
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG 121

Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
                I HRD+K  N+LLD+  N KISDFG+A +       +  +   +++ GT  Y++P
Sbjct: 122 I---GITHRDIKPENLLLDERDNLKISDFGLATVF----RYNNRERLLNKMCGTLPYVAP 174

Query: 286 EYALEGIF-SIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLID 344
           E      F +   DV+S G++L  +++G+                  D       ++   
Sbjct: 175 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY----SDWKEKKTYLNPWK 230

Query: 345 SVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVS 382
            +             + +    + E    R T+ D+  
Sbjct: 231 KIDSAP---------LALLHKILVENPSARITIPDIKK 259

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (451), Expect = 2e-53
 Identities = 72/306 (23%), Positives = 131/306 (42%), Gaps = 34/306 (11%)

Query: 100 SFSSVSSATGNFSAANKLGEGGFGTVYKGV-IGQGEI-AVKRLLGKSGQEIKELKNEASV 157
           S  SV      ++   K+G+G  GTVY  + +  G+  A++++  +   + + + NE  V
Sbjct: 11  SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70

Query: 158 IAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVA 217
           + + ++ N+V  L   +  DE  ++ EY+   S    L D      +D      + +   
Sbjct: 71  MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS----LTDVVTETCMDEGQIAAVCRECL 126

Query: 218 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRIS 277
           Q L +LH     ++IHRD+K+ NILL  D + K++DFG    +         Q   S + 
Sbjct: 127 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI------TPEQSKRSTMV 177

Query: 278 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISN 337
           GT  +M+PE      +  K D++S G++ +E++ G+    +     L  +     L  +N
Sbjct: 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP--YLNENPLRAL----YLIATN 231

Query: 338 KIIDLIDSVLEEASFNESLSR-YVHIALLCVQERAEDRPTMSDVVSM----LTNEASSLL 392
              +L           E LS  +      C+    E R +  +++      +    SSL 
Sbjct: 232 GTPEL--------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLT 283

Query: 393 PPKQPA 398
           P    A
Sbjct: 284 PLIAAA 289

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 5e-53
 Identities = 64/280 (22%), Positives = 111/280 (39%), Gaps = 39/280 (13%)

Query: 110 NFSAANKLGEGGFGTVYKGV--IGQGEIAVKRL---LGKSGQEIKELKNEASVIAQVQHK 164
           +F     LG+G FG VY       +  +A+K L     +      +L+ E  + + ++H 
Sbjct: 7   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66

Query: 165 NLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLH 224
           N+++L G   +     LI EY P  ++   L   +K    D +     I  +A  L Y H
Sbjct: 67  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCH 123

Query: 225 QYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMS 284
                R+IHRD+K  N+LL      KI+DFG +                + + GT  Y+ 
Sbjct: 124 SK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--------SRRTTLCGTLDYLP 172

Query: 285 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLID 344
           PE     +   K D++S GVL  E + GK                    + +N   +   
Sbjct: 173 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKP------------------PFEANTYQETYK 214

Query: 345 SVLE-EASFNESLSRYV-HIALLCVQERAEDRPTMSDVVS 382
            +   E +F + ++     +    ++     RP + +V+ 
Sbjct: 215 RISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (443), Expect = 2e-52
 Identities = 61/277 (22%), Positives = 108/277 (38%), Gaps = 31/277 (11%)

Query: 116 KLGEGGFGTVYKGVIGQGE-----IAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNLVKL 169
            +GEG FG V++G+    E     +A+K     +   ++E    EA  + Q  H ++VKL
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73

Query: 170 LGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRV 229
           +G   E +   +I E      L  FL        LD  + +     ++  L YL      
Sbjct: 74  IGVITE-NPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAYLESK--- 127

Query: 230 RIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL 289
           R +HRD+ A N+L+  +   K+ DFG++R +     ED      S+      +M+PE   
Sbjct: 128 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-----EDSTYYKASKGKLPIKWMAPESIN 182

Query: 290 EGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEE 349
              F+  SDV+ FGV + EI+            +            + + + +  +    
Sbjct: 183 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-----DVIGRIENGERLPMPPNCPPT 237

Query: 350 ASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN 386
                       +   C       RP  +++ + L+ 
Sbjct: 238 L---------YSLMTKCWAYDPSRRPRFTELKAQLST 265

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (443), Expect = 4e-52
 Identities = 75/294 (25%), Positives = 121/294 (41%), Gaps = 45/294 (15%)

Query: 115 NKLGEGGFGTVYKGV---------IGQGEIAVKRL-LGKSGQEIKELKNEASVIAQV-QH 163
             LGEG FG V                 ++AVK L    + +++ +L +E  ++  + +H
Sbjct: 19  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78

Query: 164 KNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLF-------------DPTKREILDWRTRV 210
           KN++ LLG C +     +I EY    +L  +L                   E L  +  V
Sbjct: 79  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138

Query: 211 QIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQ 270
                VA+G+ YL      + IHRDL A N+L+ +D   KI+DFG+AR +       +  
Sbjct: 139 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDI----HHIDYY 191

Query: 271 GNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYA 330
             T+       +M+PE   + I++ +SDV+SFGVLL EI +   +   Y    +  +   
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS--PYPGVPVEEL--- 246

Query: 331 WDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSML 384
           + L      +D   +   E            +   C       RPT   +V  L
Sbjct: 247 FKLLKEGHRMDKPSNCTNEL---------YMMMRDCWHAVPSQRPTFKQLVEDL 291

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 4e-51
 Identities = 76/301 (25%), Positives = 119/301 (39%), Gaps = 45/301 (14%)

Query: 115 NKLGEGGFGTVYKGVIGQG-------EIAVKRL-LGKSGQEIKELKNEASVIAQ-VQHKN 165
             LG G FG V +              +AVK L  G +  E + L +E  ++     H N
Sbjct: 19  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78

Query: 166 LVKLLGCCIEKDERLLI-YEYMPNKSLDCFLF-------------DPTKREILDWRTRVQ 211
           +V LLG C +    L++  E+    +L  +L              +   ++ L     + 
Sbjct: 79  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138

Query: 212 IIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQG 271
               VA+G+ +L      + IHRDL A NILL +    KI DFG+AR +     +D    
Sbjct: 139 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDI----YKDPDYV 191

Query: 272 NTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAW 331
                     +M+PE   + +++I+SDV+SFGVLL EI S   +        + +     
Sbjct: 192 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP----YPGVKIDEEFC 247

Query: 332 DLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN--EAS 389
                   +   D    E              L C       RPT S++V  L N  +A+
Sbjct: 248 RRLKEGTRMRAPDYTTPEM---------YQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298

Query: 390 S 390
           +
Sbjct: 299 A 299

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  168 bits (427), Expect = 4e-49
 Identities = 54/269 (20%), Positives = 105/269 (39%), Gaps = 28/269 (10%)

Query: 116 KLGEGGFGTVYKGV-IGQGEI-AVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCC 173
           +LG G FG V++      G   A K ++     + + ++ E   ++ ++H  LV L    
Sbjct: 33  ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92

Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
            + +E ++IYE+M    L   + D   +  +     V+ ++ V +GL ++H       +H
Sbjct: 93  EDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMH---ENNYVH 147

Query: 234 RDLKASNILLDKDMNS--KISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEG 291
            DLK  NI+     ++  K+ DFG+   +           +    +GT  + +PE A   
Sbjct: 148 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-------SVKVTTGTAEFAAPEVAEGK 200

Query: 292 IFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEAS 351
                +D++S GVL   ++SG   + F        +       + +   ++ DS     S
Sbjct: 201 PVGYYTDMWSVGVLSYILLSGL--SPFGGENDDETLRN-----VKSCDWNMDDSAFSGIS 253

Query: 352 FNESLSRYVHIALLCVQERAEDRPTMSDV 380
                          +      R T+   
Sbjct: 254 -----EDGKDFIRKLLLADPNTRMTIHQA 277

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 2e-48
 Identities = 63/250 (25%), Positives = 101/250 (40%), Gaps = 23/250 (9%)

Query: 110 NFSAANKLGEGGFGTVYKGV--IGQGEIAVKRL---LGKSGQEIKELKNEASVIAQVQHK 164
           +F     LGEG F TV          E A+K L         ++  +  E  V++++ H 
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68

Query: 165 NLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLH 224
             VKL     + ++      Y  N  L  ++         D          +   L YLH
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLH 125

Query: 225 QYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMS 284
                 IIHRDLK  NILL++DM+ +I+DFG A++       +  Q   +   GT  Y+S
Sbjct: 126 GK---GIIHRDLKPENILLNEDMHIQITDFGTAKV----LSPESKQARANSFVGTAQYVS 178

Query: 285 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIG------YAWDLWISNK 338
           PE   E      SD+++ G ++ ++V+G     F       +        Y +      K
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGL--PPFRAGNEYLIFQKIIKLEYDFPEKFFPK 236

Query: 339 IIDLIDSVLE 348
             DL++ +L 
Sbjct: 237 ARDLVEKLLV 246

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  162 bits (410), Expect = 1e-46
 Identities = 57/269 (21%), Positives = 106/269 (39%), Gaps = 28/269 (10%)

Query: 116 KLGEGGFGTVYKGV-IGQGEI-AVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCC 173
           +LG G FG V++ V    G +   K +      +   +KNE S++ Q+ H  L+ L    
Sbjct: 36  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95

Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
            +K E +LI E++    L   +     +  +     +  ++   +GL ++H      I+H
Sbjct: 96  EDKYEMVLILEFLSGGELFDRIAAEDYK--MSEAEVINYMRQACEGLKHMH---EHSIVH 150

Query: 234 RDLKASNILLDKDMNS--KISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEG 291
            D+K  NI+ +    S  KI DFG+A  +    + DE+       + T  + +PE     
Sbjct: 151 LDIKPENIMCETKKASSVKIIDFGLATKL----NPDEI---VKVTTATAEFAAPEIVDRE 203

Query: 292 IFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEAS 351
                +D+++ GVL   ++SG   + F     L  +       +     +  +      S
Sbjct: 204 PVGFYTDMWAIGVLGYVLLSGL--SPFAGEDDLETLQN-----VKRCDWEFDEDAFSSVS 256

Query: 352 FNESLSRYVHIALLCVQERAEDRPTMSDV 380
                          +Q+    R T+ D 
Sbjct: 257 -----PEAKDFIKNLLQKEPRKRLTVHDA 280

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  156 bits (394), Expect = 1e-44
 Identities = 56/250 (22%), Positives = 107/250 (42%), Gaps = 28/250 (11%)

Query: 110 NFSAANKLGEGGFGTVYKGV-IGQGEI-AVKRL---LGKSGQEIKELKNEASVIAQVQHK 164
           +F     LG G FG V+       G   A+K L   +    ++++   +E  +++ V H 
Sbjct: 5   DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 64

Query: 165 NLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLH 224
            ++++ G   +  +  +I +Y+    L   L    +      +     +       L L 
Sbjct: 65  FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------CLALE 118

Query: 225 QYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMS 284
                 II+RDLK  NILLDK+ + KI+DFG A+          +   T  + GT  Y++
Sbjct: 119 YLHSKDIIYRDLKPENILLDKNGHIKITDFGFAK---------YVPDVTYTLCGTPDYIA 169

Query: 285 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIG------YAWDLWISNK 338
           PE      ++   D +SFG+L+ E+++G     FY + ++            +  + +  
Sbjct: 170 PEVVSTKPYNKSIDWWSFGILIYEMLAGYTP--FYDSNTMKTYEKILNAELRFPPFFNED 227

Query: 339 IIDLIDSVLE 348
           + DL+  ++ 
Sbjct: 228 VKDLLSRLIT 237

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 5e-44
 Identities = 56/274 (20%), Positives = 116/274 (42%), Gaps = 39/274 (14%)

Query: 116 KLGEGGFGTVYKGV-IGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCI 174
            LG G FG V++ V     +  + + +   G +   +K E S++   +H+N++ L     
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE 71

Query: 175 EKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHR 234
             +E ++I+E++    +   +        L+ R  V  +  V + L +LH +    I H 
Sbjct: 72  SMEELVMIFEFISGLDIFERINTSAFE--LNEREIVSYVHQVCEALQFLHSH---NIGHF 126

Query: 235 DLKASNILLDKDMNS--KISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGI 292
           D++  NI+     +S  KI +FG AR +  G+       N   +     Y +PE     +
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-------NFRLLFTAPEYYAPEVHQHDV 179

Query: 293 FSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLE-EAS 351
            S  +D++S G L+  ++SG                     +++     +I++++  E +
Sbjct: 180 VSTATDMWSLGTLVYVLLSGIN------------------PFLAETNQQIIENIMNAEYT 221

Query: 352 FNESLSRYVHIALL-----CVQERAEDRPTMSDV 380
           F+E   + + I  +      + +  + R T S+ 
Sbjct: 222 FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEA 255

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  153 bits (386), Expect = 8e-44
 Identities = 54/278 (19%), Positives = 98/278 (35%), Gaps = 23/278 (8%)

Query: 116 KLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCC 173
           K+G G FG +Y G       E+A+K    K+     +L  E+ +   +Q    +  +  C
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP--QLHIESKIYKMMQGGVGIPTIRWC 71

Query: 174 IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH 233
             + +  ++   +   SL+      +++     +T + +   +   + Y+H       IH
Sbjct: 72  GAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIH---SKNFIH 126

Query: 234 RDLKASNIL---LDKDMNSKISDFGMARIVFGGNDEDELQGN-TSRISGTYGYMSPEYAL 289
           RD+K  N L     K     I DFG+A+          +       ++GT  Y S    L
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186

Query: 290 EGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKS-LNLIGYAWDLWISNKIIDLIDSVLE 348
               S + D+ S G +L+    G       +  +         +  +S  I  L      
Sbjct: 187 GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPS 246

Query: 349 EASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTN 386
           E                C   R +D+P  S +  +  N
Sbjct: 247 EF---------ATYLNFCRSLRFDDKPDYSYLRQLFRN 275

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 8e-43
 Identities = 49/210 (23%), Positives = 94/210 (44%), Gaps = 10/210 (4%)

Query: 108 TGNFSAANKLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQE-IKELKNEASVIAQVQHK 164
              ++  + +GEG +G V      + +  +A+K++     Q   +    E  ++ + +H+
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 165 NLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLH 224
           N++ +           +   Y+    +   L+   K + L        +  + +GL Y+H
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126

Query: 225 QYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMS 284
                 ++HRDLK SN+LL+   + KI DFG+AR+    +D        +    T  Y +
Sbjct: 127 S---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL---TEYVATRWYRA 180

Query: 285 PEYALEGIFSIKS-DVFSFGVLLLEIVSGK 313
           PE  L      KS D++S G +L E++S +
Sbjct: 181 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 210

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  149 bits (377), Expect = 1e-42
 Identities = 62/288 (21%), Positives = 121/288 (42%), Gaps = 33/288 (11%)

Query: 108 TGNFSAANKLGEGGFGTVYKGV--IGQGEIAVKRL---LGKSGQEIKELKNEASVIAQVQ 162
           +  +     LG GG   V+         ++AVK L   L +        + EA   A + 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 163 HKNLVKLLGCCIEKDERL----LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQ 218
           H  +V +      +        ++ EY+   +L   +        +  +  +++I    Q
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122

Query: 219 GLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISG 278
            L + HQ     IIHRD+K +NI++      K+ DFG+AR +    +       T+ + G
Sbjct: 123 ALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT---QTAAVIG 176

Query: 279 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNK 338
           T  Y+SPE A       +SDV+S G +L E+++G+    F     +++           +
Sbjct: 177 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP--FTGDSPVSVA---------YQ 225

Query: 339 IIDLIDSVLEEASFNESLSRYV-HIALLCVQERAEDRP-TMSDVVSML 384
            +   +  +  ++ +E LS  +  + L  + +  E+R  T +++ + L
Sbjct: 226 HVR--EDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL 271

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  151 bits (383), Expect = 1e-42
 Identities = 59/255 (23%), Positives = 105/255 (41%), Gaps = 30/255 (11%)

Query: 110 NFSAANKLGEGGFGTVYKGV-IGQGEI-AVKRLLGKSG------QEIKELKNEASVIAQV 161
           +FS    +G GGFG VY       G++ A+K L  K              +   S+++  
Sbjct: 5   DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64

Query: 162 QHKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLL 221
               +V +       D+   I + M    L   L    +  +            +  GL 
Sbjct: 65  DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLE 121

Query: 222 YLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYG 281
           ++H      +++RDLK +NILLD+  + +ISD G+A         D  +       GT+G
Sbjct: 122 HMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC--------DFSKKKPHASVGTHG 170

Query: 282 YMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLI-------GYAWDL 333
           YM+PE   +G+ +   +D FS G +L +++ G      ++TK  + I             
Sbjct: 171 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD 230

Query: 334 WISNKIIDLIDSVLE 348
             S ++  L++ +L+
Sbjct: 231 SFSPELRSLLEGLLQ 245

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  148 bits (375), Expect = 3e-42
 Identities = 40/291 (13%), Positives = 97/291 (33%), Gaps = 23/291 (7%)

Query: 109 GNFSAANKLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNL 166
            ++    ++GEG FG +++G   +   ++A+K        +  +L++E      +     
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFE--PRRSDAPQLRDEYRTYKLLAGCTG 62

Query: 167 VKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQY 226
           +  +    ++    ++   +   SL+  L    ++     +T     K +   +  +H+ 
Sbjct: 63  IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK--FSVKTVAMAAKQMLARVQSIHEK 120

Query: 227 SRVRIIHRDLKASNILLDKDMNS-----KISDFGMARIV-FGGNDEDELQGNTSRISGTY 280
               +++RD+K  N L+ +  +       + DFGM +        +         +SGT 
Sbjct: 121 ---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177

Query: 281 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKII 340
            YMS    L    S + D+ + G + +  + G       +  +              +I 
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN--------KQKYERIG 229

Query: 341 DLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSL 391
           +   S             +            +  P    +  + +     L
Sbjct: 230 EKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 7e-42
 Identities = 62/251 (24%), Positives = 104/251 (41%), Gaps = 26/251 (10%)

Query: 110 NFSAANKLGEGGFGTVYKGV-IGQGEI-AVKRL---LGKSGQEIKELKNEASVIA-QVQH 163
           +F     LG+G FG V+        +  A+K L   +     +++    E  V++   +H
Sbjct: 3   DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62

Query: 164 KNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYL 223
             L  +      K+    + EY+    L   +         D          +  GL +L
Sbjct: 63  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFL 119

Query: 224 HQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYM 283
           H      I++RDLK  NILLDKD + KI+DFGM +    G+ +       +   GT  Y+
Sbjct: 120 HSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT------NTFCGTPDYI 170

Query: 284 SPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLI------GYAWDLWISN 337
           +PE  L   ++   D +SFGVLL E++ G+  + F+      L          +  W+  
Sbjct: 171 APEILLGQKYNHSVDWWSFGVLLYEMLIGQ--SPFHGQDEEELFHSIRMDNPFYPRWLEK 228

Query: 338 KIIDLIDSVLE 348
           +  DL+  +  
Sbjct: 229 EAKDLLVKLFV 239

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  145 bits (368), Expect = 5e-41
 Identities = 56/269 (20%), Positives = 100/269 (37%), Gaps = 25/269 (9%)

Query: 115 NKLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQEIKE-LKNEASVIAQVQHKNLVKLLG 171
           + LG G F  V        Q  +A+K +  K+ +  +  ++NE +V+ +++H N+V L  
Sbjct: 15  DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 74

Query: 172 CCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRI 231
                    LI + +    L   +    ++     R   ++I  V   + YLH    V  
Sbjct: 75  IYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDAVKYLHDLGIVHR 131

Query: 232 IHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEG 291
             +        LD+D    ISDFG++++   G+         S   GT GY++PE   + 
Sbjct: 132 DLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS-------VLSTACGTPGYVAPEVLAQK 184

Query: 292 IFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEAS 351
            +S   D +S GV+   ++ G     FY      L        I     +      ++ S
Sbjct: 185 PYSKAVDCWSIGVIAYILLCGY--PPFYDENDAKLF-----EQILKAEYEFDSPYWDDIS 237

Query: 352 FNESLSRYVHIALLCVQERAEDRPTMSDV 380
                          +++  E R T    
Sbjct: 238 -----DSAKDFIRHLMEKDPEKRFTCEQA 261

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  144 bits (365), Expect = 5e-41
 Identities = 62/289 (21%), Positives = 121/289 (41%), Gaps = 43/289 (14%)

Query: 110 NFSAANKLGEGGFGTVYKGV--IGQGEIAVKRL-----LGKSGQEIKELK----NEASVI 158
           N+     LG G    V + +      E AVK +        S +E++EL+     E  ++
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 159 AQVQ-HKNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVA 217
            +V  H N+++L           L+++ M    L  +L   T++  L  +   +I++ + 
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRALL 120

Query: 218 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRIS 277
           + +  LH   ++ I+HRDLK  NILLD DMN K++DFG +  +  G            + 
Sbjct: 121 EVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK-------LREVC 170

Query: 278 GTYGYMSPEYALEGI------FSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAW 331
           GT  Y++PE     +      +  + D++S GV++  +++G     F+  K + ++    
Sbjct: 171 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS--PPFWHRKQMLMLRM-- 226

Query: 332 DLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDV 380
              I +          ++ S          +    +  + + R T  + 
Sbjct: 227 ---IMSGNYQFGSPEWDDYS-----DTVKDLVSRFLVVQPQKRYTAEEA 267

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 2e-40
 Identities = 65/301 (21%), Positives = 113/301 (37%), Gaps = 53/301 (17%)

Query: 116 KLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQEIKELKN------EASVIAQVQ--HKN 165
            LG GGFG+VY G+       +A+K +      +  EL N      E  ++ +V      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ 225
           +++LL      D  +LI E              T+R  L           V + + + H 
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAVRHCHN 128

Query: 226 YSRVRIIHRDLKASNILLDKD-MNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMS 284
                ++HRD+K  NIL+D +    K+ DFG   ++             +   GT  Y  
Sbjct: 129 C---GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--------DTVYTDFDGTRVYSP 177

Query: 285 PEYAL-EGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLI 343
           PE+          + V+S G+LL ++V G     F   + +      +   +S++   LI
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGD--IPFEHDEEIIRGQVFFRQRVSSECQHLI 235

Query: 344 DSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM--LTNEASSLLPPKQPAFCN 401
                                 C+  R  DRPT  ++ +   + +    +L P++ A  +
Sbjct: 236 RW--------------------CLALRPSDRPTFEEIQNHPWMQD----VLLPQETAEIH 271

Query: 402 L 402
           L
Sbjct: 272 L 272

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 4e-40
 Identities = 59/293 (20%), Positives = 112/293 (38%), Gaps = 35/293 (11%)

Query: 110 NFSAANKLGEGGFGTVYKGV-IGQGEI-AVKRLLGKSGQEIKELKNEASVIAQVQHKNLV 167
           +++    +G G FG VY+      GE+ A+K++L    Q+ +    E  ++ ++ H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 76

Query: 168 KLLGCCIEKDER------LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLL 221
           +L        E+       L+ +Y+P             ++ L        +  + + L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136

Query: 222 YLHQYSRVRIIHRDLKASNILLDKD-MNSKISDFGMARIVFGGNDEDELQGNTSRISGTY 280
           Y+H +    I HRD+K  N+LLD D    K+ DFG A+ +  G        N S I   Y
Sbjct: 137 YIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP------NVSYICSRY 187

Query: 281 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK-----KNTGFYRTKSLNLIGYAWDLWI 335
                       ++   DV+S G +L E++ G+      +      + + ++G      I
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 247

Query: 336 SNKIIDLIDSVLEEASFNESLSRYVH------IALL--CVQERAEDRPTMSDV 380
                +  +    +   +     +        IAL    ++     R T  + 
Sbjct: 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 7e-40
 Identities = 63/299 (21%), Positives = 118/299 (39%), Gaps = 32/299 (10%)

Query: 104 VSSATGNFSAANKLGEGGFGTVYKGVI---GQGEIAVKRLLGKSGQE--IKELKNEASV- 157
           +  A   +    ++GEG +G V+K      G   +A+KR+  ++G+E        E +V 
Sbjct: 2   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61

Query: 158 --IAQVQHKNLVKLLGCCIEKDERLLIYEYMPNKSLDC---FLFDPTKREILDWRTRVQI 212
             +   +H N+V+L   C            +  + +D       D      +   T   +
Sbjct: 62  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 121

Query: 213 IKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGN 272
           +  + +GL +LH +   R++HRDLK  NIL+      K++DFG+ARI          Q  
Sbjct: 122 MFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI-------YSFQMA 171

Query: 273 TSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK-----KNTGFYRTKSLNLI 327
            + +  T  Y +PE  L+  ++   D++S G +  E+   K      +      K L++I
Sbjct: 172 LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 231

Query: 328 G------YAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDV 380
           G      +  D+ +  +      +   E    +       + L C+      R +    
Sbjct: 232 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 1e-39
 Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 20/207 (9%)

Query: 115 NKLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQEIKE-----LKNEASVIAQVQHKNLV 167
           + LGEG F TVYK         +A+K++      E K+        E  ++ ++ H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 168 KLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYS 227
            LL     K    L++++M     D  +       +L        +    QGL YLHQ+ 
Sbjct: 64  GLLDAFGHKSNISLVFDFMET---DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119

Query: 228 RVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEY 287
              I+HRDLK +N+LLD++   K++DFG+A+               +    T  Y +PE 
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSF------GSPNRAYTHQVVTRWYRAPEL 171

Query: 288 ALE-GIFSIKSDVFSFGVLLLEIVSGK 313
                ++ +  D+++ G +L E++   
Sbjct: 172 LFGARMYGVGVDMWAVGCILAELLLRV 198

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 2e-38
 Identities = 63/277 (22%), Positives = 109/277 (39%), Gaps = 37/277 (13%)

Query: 116 KLGEGGFGTVYKGV-IGQGEI-AVKRL------LGKSGQEIKELKNEASVIAQVQHKNLV 167
           +LG G F  V K      G   A K +        + G   ++++ E S++ ++QH N++
Sbjct: 17  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76

Query: 168 KLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYS 227
            L      K + +LI E +    L  F     ++E L      + +K +  G+ YLH   
Sbjct: 77  TLHEVYENKTDVILILELVAGGELFDF---LAEKESLTEEEATEFLKQILNGVYYLHSL- 132

Query: 228 RVRIIHRDLKASNILLDKDMNS----KISDFGMARIVFGGNDEDELQGNTSRISGTYGYM 283
             +I H DLK  NI+L          KI DFG+A  +  GN+          I GT  ++
Sbjct: 133 --QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-------FKNIFGTPEFV 183

Query: 284 SPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLI 343
           +PE        +++D++S GV+   ++SG     F        +       +S    +  
Sbjct: 184 APEIVNYEPLGLEADMWSIGVITYILLSGASP--FLGDTKQETL-----ANVSAVNYEFE 236

Query: 344 DSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDV 380
           D      S     +         + +  + R T+ D 
Sbjct: 237 DEYFSNTS-----ALAKDFIRRLLVKDPKKRMTIQDS 268

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 3e-38
 Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 14/208 (6%)

Query: 110 NFSAANKLGEGGFGTVYKGV-IGQGEI-AVK--RLLGKSGQEIKELKNEASVIAQVQHKN 165
           NF    K+GEG +G VYK      GE+ A+K  RL  ++         E S++ ++ H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 166 LVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ 225
           +VKLL     +++  L++E++          D +    +        +  + QGL + H 
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120

Query: 226 YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSP 285
           +   R++HRDLK  N+L++ +   K++DFG+AR          ++  T  +   +     
Sbjct: 121 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-----GVPVRTYTHEVVTLWYRAPE 172

Query: 286 EYALEGIFSIKSDVFSFGVLLLEIVSGK 313
                  +S   D++S G +  E+V+ +
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  135 bits (339), Expect = 3e-37
 Identities = 60/282 (21%), Positives = 108/282 (38%), Gaps = 27/282 (9%)

Query: 115 NKLGEGGFGTVYKGVIGQGEI-AVKRLLGKSGQE--IKELKNEASVIAQVQHKNLVKLLG 171
            K+GEG +G VYK     GE  A+K++  +   E        E S++ +++H N+VKL  
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67

Query: 172 CCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRI 231
               K   +L++E++                 L+  T    +  +  G+ Y H     R+
Sbjct: 68  VIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDR---RV 121

Query: 232 IHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEG 291
           +HRDLK  N+L++++   KI+DFG+AR          ++  T  I   +           
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAF-----GIPVRKYTHEIVTLWYRAPDVLMGSK 176

Query: 292 IFSIKSDVFSFGVLLLEIVSGK-----KNTGFYRTKSLNLIG----YAWDLWISNKIIDL 342
            +S   D++S G +  E+V+G       +      +   ++G      W         D 
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236

Query: 343 IDSVLEEASFNESLSRYVHIAL----LCVQERAEDRPTMSDV 380
             +V E   +   L       +      ++     R T    
Sbjct: 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 7e-37
 Identities = 54/248 (21%), Positives = 96/248 (38%), Gaps = 21/248 (8%)

Query: 110 NFSAANKLGEGGFGTVYKGV-IGQGEI-AVKRL---LGKSGQEIKELKNEASVIAQVQHK 164
           +F     LG+G FG V        G   A+K L   +  +  E+     E+ V+   +H 
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65

Query: 165 NLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLH 224
            L  L       D    + EY     L   L   ++  +             A+ +  L 
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYG---AEIVSALE 119

Query: 225 QYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMS 284
                 +++RD+K  N++LDKD + KI+DFG+ +                   GT  Y++
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA------TMKTFCGTPEYLA 173

Query: 285 PEYALEGIFSIKSDVFSFGVLLLEIVSGK---KNTGFYRTKSLNLIG-YAWDLWISNKII 340
           PE   +  +    D +  GV++ E++ G+    N    R   L L+    +   +S +  
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAK 233

Query: 341 DLIDSVLE 348
            L+  +L+
Sbjct: 234 SLLAGLLK 241

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 8e-37
 Identities = 51/274 (18%), Positives = 100/274 (36%), Gaps = 34/274 (12%)

Query: 117 LGEGGFGTVYKGV-IGQGEI-AVKRLLGKSGQEIKELKNEASVIAQV-QHKNLVKLLGCC 173
           LG G  G V +       E  A+K L     Q+  + + E  +  +  Q  ++V+++   
Sbjct: 20  LGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDVY 74

Query: 174 ----IEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRV 229
                 +   L++ E +    L   + D    +    R   +I+K + + + YLH    +
Sbjct: 75  ENLYAGRKCLLIVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLHS---I 130

Query: 230 RIIHRDLKASNILLDKDMNS---KISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPE 286
            I HRD+K  N+L      +   K++DFG A+     N              T  Y++PE
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY-------TPYYVAPE 183

Query: 287 YALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSV 346
                 +    D++S GV++  ++ G      + +     I       I     +  +  
Sbjct: 184 VLGPEKYDKSCDMWSLGVIMYILLCGYP---PFYSNHGLAISPGMKTRIRMGQYEFPNPE 240

Query: 347 LEEASFNESLSRYVHIALLCVQERAEDRPTMSDV 380
             E S          +    ++     R T+++ 
Sbjct: 241 WSEVS-----EEVKMLIRNLLKTEPTQRMTITEF 269

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (334), Expect = 4e-36
 Identities = 48/218 (22%), Positives = 99/218 (45%), Gaps = 21/218 (9%)

Query: 109 GNFSAANKLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQE--IKELKNEASVIAQVQHK 164
             +    K+G+G FG V+K        ++A+K++L ++ +E        E  ++  ++H+
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 165 NLVKLLGCCIEKDER--------LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGV 216
           N+V L+  C  K            L++++  +           K  + + +  +Q++   
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML--- 126

Query: 217 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRI 276
              L  L+   R +I+HRD+KA+N+L+ +D   K++DFG+AR       ++      +  
Sbjct: 127 ---LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF--SLAKNSQPNRYTNR 181

Query: 277 SGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGK 313
             T  Y  PE  L E  +    D++  G ++ E+ +  
Sbjct: 182 VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 219

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 8e-35
 Identities = 41/204 (20%), Positives = 86/204 (42%), Gaps = 15/204 (7%)

Query: 115 NKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQE--IKELKNEASVIAQVQHKNLVKLL 170
            K+GEG +GTV+K    +    +A+KR+      E        E  ++ +++HKN+V+L 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 171 GCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVR 230
                  +  L++E+        F                 +   + Q L  L       
Sbjct: 68  DVLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGLGFCHSRN 121

Query: 231 IIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE 290
           ++HRDLK  N+L++++   K+++FG+AR          ++  ++ +   +          
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAF-----GIPVRCYSAEVVTLWYRPPDVLFGA 176

Query: 291 GIFSIKSDVFSFGVLLLEIVSGKK 314
            ++S   D++S G +  E+ +  +
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGR 200

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  127 bits (319), Expect = 9e-34
 Identities = 55/250 (22%), Positives = 98/250 (39%), Gaps = 28/250 (11%)

Query: 110 NFSAANKLGEGGFGTVYKGV--IGQGEIAVKRLLGK---SGQEIKELKNEASVIAQVQHK 164
            F     LG G FG V            A+K L  +     ++I+   NE  ++  V   
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101

Query: 165 NLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLH 224
            LVKL     +     ++ EY+    +   L    +               +     YLH
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLH 158

Query: 225 QYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMS 284
                 +I+RDLK  N+L+D+    +++DFG A+ V          G T  + GT   ++
Sbjct: 159 SL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---------GRTWTLCGTPEALA 206

Query: 285 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDL------WISNK 338
           PE  L   ++   D ++ GVL+ E+ +G     F+  + + +               S+ 
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGY--PPFFADQPIQIYEKIVSGKVRFPSHFSSD 264

Query: 339 IIDLIDSVLE 348
           + DL+ ++L+
Sbjct: 265 LKDLLRNLLQ 274

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 1e-33
 Identities = 68/333 (20%), Positives = 131/333 (39%), Gaps = 40/333 (12%)

Query: 116 KLGEGGFGTVYKGVIGQ--GEIAVKRLL--GKSGQEIKELKNEASVIAQVQHKNLVKLLG 171
            +G G +G V   V G+   ++A+K+L    +S    K    E  ++  ++H+N++ LL 
Sbjct: 25  PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84

Query: 172 CCIEKDERLLIYE-YMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVR 230
                +      + Y+    +   L    K E L       ++  + +GL Y+H      
Sbjct: 85  VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAA---G 141

Query: 231 IIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE 290
           IIHRDLK  N+ +++D   KI DFG+AR         +     +    T  Y +PE  L 
Sbjct: 142 IIHRDLKPGNLAVNEDCELKILDFGLAR---------QADSEMTGYVVTRWYRAPEVILN 192

Query: 291 GI-FSIKSDVFSFGVLLLEIVSGK----------------KNTGFYRTKSLNLIGYAWDL 333
            + ++   D++S G ++ E+++GK                K TG    + +  +      
Sbjct: 193 WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 252

Query: 334 WISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM--LTNEASSL 391
                + +L          N S    V++    +   AE R T  + ++     +   + 
Sbjct: 253 NYMKGLPELEKKDFASILTNAS-PLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTE 311

Query: 392 LPPKQPAFCNLRNMESSTSTTEKSWADCSINEV 424
             P+   + +  + +    T ++ W   +  EV
Sbjct: 312 DEPQVQKYDD--SFDDVDRTLDE-WKRVTYKEV 341

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (301), Expect = 2e-31
 Identities = 59/259 (22%), Positives = 104/259 (40%), Gaps = 31/259 (11%)

Query: 110 NFSAANKLGEGGFGTVYKGVIGQG-----EIAVKRL----LGKSGQEIKELKNEASVIAQ 160
           NF     LG G +G V+      G       A+K L    + +  +  +  + E  V+  
Sbjct: 25  NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84

Query: 161 VQHK-NLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQG 219
           ++    LV L      + +  LI +Y+    L   L    +       T  ++   V + 
Sbjct: 85  IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERF------TEHEVQIYVGEI 138

Query: 220 LLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGT 279
           +L L    ++ II+RD+K  NILLD + +  ++DFG+++       E           GT
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-----RAYDFCGT 193

Query: 280 YGYMSPEYALEGI--FSIKSDVFSFGVLLLEIVSGK--------KNTGFYRTKSLNLIGY 329
             YM+P+    G        D +S GVL+ E+++G         KN+    ++ +     
Sbjct: 194 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP 253

Query: 330 AWDLWISNKIIDLIDSVLE 348
            +   +S    DLI  +L 
Sbjct: 254 PYPQEMSALAKDLIQRLLM 272

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  114 bits (285), Expect = 3e-29
 Identities = 39/211 (18%), Positives = 89/211 (42%), Gaps = 26/211 (12%)

Query: 110 NFSAANKLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQ-HKNL 166
           ++    KLG G +  V++ +      ++ VK L      + K++K E  ++  ++   N+
Sbjct: 36  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL---KPVKKKKIKREIKILENLRGGPNI 92

Query: 167 VKLLGCCIEKDERL--LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLH 224
           + L     +   R   L++E++ N             + L        +  + + L Y H
Sbjct: 93  ITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCH 146

Query: 225 QYSRVRIIHRDLKASNILLD-KDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYM 283
               + I+HRD+K  N+++D +    ++ D+G+A     G +        +    +  + 
Sbjct: 147 S---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-------YNVRVASRYFK 196

Query: 284 SPEYALE-GIFSIKSDVFSFGVLLLEIVSGK 313
            PE  ++  ++    D++S G +L  ++  K
Sbjct: 197 GPELLVDYQMYDYSLDMWSLGCMLASMIFRK 227

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (285), Expect = 6e-29
 Identities = 56/229 (24%), Positives = 88/229 (38%), Gaps = 32/229 (13%)

Query: 101 FSSVSSATGNFSAANK------LGEGGFGTVYKGV--IGQGEIAVKRLL--GKSGQEIKE 150
           F SV      F+   +      +G G  G V      +    +A+K+L    ++    K 
Sbjct: 3   FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKR 62

Query: 151 LKNEASVIAQVQHKNLVKLLGCCI------EKDERLLIYEYMPNKSLDCFLFDPTKREIL 204
              E  ++  V HKN++ LL          E  +  L+ E M          +       
Sbjct: 63  AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------ 116

Query: 205 DWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGN 264
           D      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR      
Sbjct: 117 DHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 173

Query: 265 DEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
                    +    T  Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 174 -------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (280), Expect = 3e-28
 Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 18/205 (8%)

Query: 115 NKLGEGGFGTVYKGV-IGQGEI-AVKRL--LGKSGQEIKELKNEASVIAQVQHKNLVKLL 170
           + +G G +G+V        G   AVK+L    +S    K    E  ++  ++H+N++ LL
Sbjct: 24  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83

Query: 171 GCCIEKDE-RLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRV 229
                          Y+    +   L +  K + L       +I  + +GL Y+H     
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA--- 140

Query: 230 RIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYAL 289
            IIHRDLK SN+ +++D   KI DFG+AR               +    T  Y +PE  L
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLAR---------HTDDEMTGYVATRWYRAPEIML 191

Query: 290 EGI-FSIKSDVFSFGVLLLEIVSGK 313
             + ++   D++S G ++ E+++G+
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGR 216

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  105 bits (261), Expect = 9e-26
 Identities = 43/214 (20%), Positives = 81/214 (37%), Gaps = 23/214 (10%)

Query: 116 KLGEGGFGTVYKGV--IGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCC 173
           KLG G F TV+     +    +A+K +        +  ++E  ++ +V   +  K     
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 174 IEKDERLLIYEYMPNKSLDCF-------------LFDPTKREILDWRTRVQIIKGVAQGL 220
                +LL +      +                 L    +   +      QI K +  GL
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 221 LYLHQYSRVRIIHRDLKASNILLDK-DMNSKISDFGMARIVFGGNDEDELQGNTSRISGT 279
            Y+H+  R  IIH D+K  N+L++  D    +    +A +     +      + +    T
Sbjct: 139 DYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADL----GNACWYDEHYTNSIQT 192

Query: 280 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 313
             Y SPE  L   +   +D++S   L+ E+++G 
Sbjct: 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 91.4 bits (226), Expect = 4e-22
 Identities = 34/205 (16%), Positives = 70/205 (34%), Gaps = 30/205 (14%)

Query: 115 NKLGEGGFGTVYKGVIGQG-EIAVK--RLLGKSGQEIK--------ELKNEASVIAQVQH 163
             +GEG    V+     +  E  VK  ++   S +++K             A   A+ + 
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 164 KNLVKLLGCCIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYL 223
           + L KL G  + K      Y +  N  L   +       +       +++  + + +   
Sbjct: 66  RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEVAKF 119

Query: 224 HQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYM 283
           +      I+H DL   N+L+  +    I DF  +  V      + L+ +   I   +   
Sbjct: 120 YHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFS-- 173

Query: 284 SPEYALEGIFSIKSDVFSFGVLLLE 308
                    +  + D+ S    +L+
Sbjct: 174 -------RTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	432
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.9
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.87
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.12
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.7
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.01
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.95
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.82

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-55  Score=405.48  Aligned_cols=256  Identities=29%  Similarity=0.448  Sum_probs=200.9

Q ss_pred             CCCCcCceeccCCcEEEEEEEECCc-eEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecCC
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMP  187 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~~-~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  187 (432)
                      ++|++.+.||+|+||.||+|.+.++ .||||++.... ...+.+.+|++++++++||||++++++|.+++..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            5789999999999999999998655 79999986543 345679999999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCcc
Q 014024          188 NKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDED  267 (432)
Q Consensus       188 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  267 (432)
                      +|+|.+++...  ...+++..++.++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++......   
T Consensus        84 ~g~L~~~l~~~--~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~---  155 (263)
T d1sm2a_          84 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ---  155 (263)
T ss_dssp             TCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred             CCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCC---
Confidence            99999998653  345899999999999999999999999   9999999999999999999999999998752221   


Q ss_pred             ccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhhh
Q 014024          268 ELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVL  347 (432)
Q Consensus       268 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  347 (432)
                        ........||+.|+|||++.++.++.++|||||||++|||+|+..|+..... .             ..+...+....
T Consensus       156 --~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~-~-------------~~~~~~i~~~~  219 (263)
T d1sm2a_         156 --YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-N-------------SEVVEDISTGF  219 (263)
T ss_dssp             -----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC-H-------------HHHHHHHHHTC
T ss_pred             --ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC-H-------------HHHHHHHHhcC
Confidence              1223345789999999999999999999999999999999996555321111 0             01111122222


Q ss_pred             hhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccc
Q 014024          348 EEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS  389 (432)
Q Consensus       348 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~  389 (432)
                      +...+..++.++.+++..||+.||++|||++||+++|+++..
T Consensus       220 ~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         220 RLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence            223334456788999999999999999999999999998653

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-54  Score=404.28  Aligned_cols=263  Identities=27%  Similarity=0.459  Sum_probs=205.4

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECCceEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEec
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQGEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEY  185 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  185 (432)
                      .++|++.+.||+|+||.||+|+.++ .||||++...  .....+.|.+|+++|++++|||||++++++.+ +..++||||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey   84 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQW   84 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             cccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEec
Confidence            4789999999999999999998754 6999998533  45567889999999999999999999998754 568999999


Q ss_pred             CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCC
Q 014024          186 MPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGND  265 (432)
Q Consensus       186 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  265 (432)
                      +++|+|.+++....  ..+++..+..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+|+.......
T Consensus        85 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~  159 (276)
T d1uwha_          85 CEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG  159 (276)
T ss_dssp             CCEEEHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred             CCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence            99999999996533  34999999999999999999999998   99999999999999999999999999986522111


Q ss_pred             ccccccccccccccCCccChhhhcc---CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhh
Q 014024          266 EDELQGNTSRISGTYGYMSPEYALE---GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDL  342 (432)
Q Consensus       266 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                          ........||+.|+|||++.+   +.++.++|||||||++|||+||+.||........ .............    
T Consensus       160 ----~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~-~~~~~~~~~~~p~----  230 (276)
T d1uwha_         160 ----SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-IIFMVGRGYLSPD----  230 (276)
T ss_dssp             ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-HHHHHHHTSCCCC----
T ss_pred             ----cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH-HHHHHhcCCCCCc----
Confidence                123345679999999999864   4589999999999999999999999854322110 0000000000000    


Q ss_pred             hhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccccCC
Q 014024          343 IDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSL  391 (432)
Q Consensus       343 i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~  391 (432)
                           ....+..++.++.+++.+||+.||++|||++||+++|+.+..+.
T Consensus       231 -----~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~  274 (276)
T d1uwha_         231 -----LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL  274 (276)
T ss_dssp             -----GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             -----chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence                 01122345578899999999999999999999999999876544

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-54  Score=401.99  Aligned_cols=253  Identities=25%  Similarity=0.314  Sum_probs=202.3

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCC-hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEe
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS-GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYE  184 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  184 (432)
                      .++|++.+.||+|+||+||+|++..  ..||+|++.... ....+.+.+|+++|++++||||+++++++.+++..|+|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            4689999999999999999999854  489999986543 3345678999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCC
Q 014024          185 YMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGN  264 (432)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  264 (432)
                      |+++|+|.+++..   +..+++..+..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+|+.....+
T Consensus        84 y~~gg~L~~~l~~---~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~  157 (271)
T d1nvra_          84 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  157 (271)
T ss_dssp             CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             ccCCCcHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence            9999999999953   445999999999999999999999999   9999999999999999999999999998753222


Q ss_pred             CccccccccccccccCCccChhhhccCCC-CchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhh
Q 014024          265 DEDELQGNTSRISGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLI  343 (432)
Q Consensus       265 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i  343 (432)
                      .    .......+||+.|+|||++.+..+ +.++|||||||++|||+||+.||.............             .
T Consensus       158 ~----~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~-------------~  220 (271)
T d1nvra_         158 R----ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW-------------K  220 (271)
T ss_dssp             E----ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHH-------------H
T ss_pred             c----cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHH-------------h
Confidence            1    123345689999999999988776 678999999999999999999986433211111100             0


Q ss_pred             hhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          344 DSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       344 ~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      ............+.++.+|+.+||+.||++|||++|++++
T Consensus       221 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  260 (271)
T d1nvra_         221 EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  260 (271)
T ss_dssp             TTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             cCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            0000011112234567889999999999999999999764

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.9e-54  Score=407.71  Aligned_cols=261  Identities=26%  Similarity=0.422  Sum_probs=202.0

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECCc-----eEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEE
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQG-----EIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLL  181 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~~-----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  181 (432)
                      .++|++.++||+|+||+||+|.+...     .||||.+... .....+.|.+|+++|++++|||||++++++.+.+..++
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i  104 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI  104 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            35688889999999999999997432     4788887543 45566789999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceecc
Q 014024          182 IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVF  261 (432)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  261 (432)
                      ||||+++|+|.+++...  .+.+++.+++.++.|++.||+|||+++   |+||||||+||||+.++.+||+|||+++.+.
T Consensus       105 v~Ey~~~g~L~~~~~~~--~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  179 (299)
T d1jpaa_         105 ITEFMENGSLDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE  179 (299)
T ss_dssp             EEECCTTEEHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEEecCCCcceeeeccc--cCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEcc
Confidence            99999999999988643  345999999999999999999999998   9999999999999999999999999998753


Q ss_pred             CCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchh
Q 014024          262 GGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKII  340 (432)
Q Consensus       262 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                      ..... ..........||+.|+|||.+.++.++.++|||||||++|||+| |+.||......               .+.
T Consensus       180 ~~~~~-~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~---------------~~~  243 (299)
T d1jpaa_         180 DDTSD-PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ---------------DVI  243 (299)
T ss_dssp             -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---------------HHH
T ss_pred             CCCCc-ceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH---------------HHH
Confidence            22111 11112233467899999999999999999999999999999998 89997532211               111


Q ss_pred             hhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccc
Q 014024          341 DLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS  389 (432)
Q Consensus       341 ~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~  389 (432)
                      ..+....+...+..++..+.+|+.+||+.||++|||+.||++.|+.+..
T Consensus       244 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~  292 (299)
T d1jpaa_         244 NAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR  292 (299)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence            2222222333445567789999999999999999999999999987643

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-54  Score=402.58  Aligned_cols=250  Identities=23%  Similarity=0.356  Sum_probs=206.3

Q ss_pred             hCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEec
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEY  185 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  185 (432)
                      .++|++.+.||+|+||+||+|.+.  +..||+|++........+.+.+|+++|++++||||+++++++.+.+..|+||||
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy   98 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence            357999999999999999999975  448999998655555567899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCC
Q 014024          186 MPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGND  265 (432)
Q Consensus       186 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  265 (432)
                      +++|+|.+++..    +.+++..+..++.|++.||+|||++|   |+||||||+|||++.++++||+|||+++.+...  
T Consensus        99 ~~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~--  169 (293)
T d1yhwa1          99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--  169 (293)
T ss_dssp             CTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCST--
T ss_pred             cCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccc--
Confidence            999999998743    34999999999999999999999999   999999999999999999999999999875322  


Q ss_pred             ccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhh
Q 014024          266 EDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDS  345 (432)
Q Consensus       266 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  345 (432)
                          ........||+.|+|||++.++.++.++|||||||++|+|+||+.||.......     .........        
T Consensus       170 ----~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-----~~~~~~~~~--------  232 (293)
T d1yhwa1         170 ----QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-----ALYLIATNG--------  232 (293)
T ss_dssp             ----TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-----HHHHHHHHC--------
T ss_pred             ----cccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH-----HHHHHHhCC--------
Confidence                123345679999999999999999999999999999999999999985322110     000000000        


Q ss_pred             hhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          346 VLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       346 ~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      ......+...+..+.+++.+||+.||++|||+.|++++
T Consensus       233 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H  270 (293)
T d1yhwa1         233 TPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (293)
T ss_dssp             SCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred             CCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00011123345678899999999999999999999875

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.5e-54  Score=405.97  Aligned_cols=259  Identities=27%  Similarity=0.419  Sum_probs=212.9

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEe
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYE  184 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  184 (432)
                      ..++|++.+.||+|+||+||+|.+.+  ..||||++.... ...+++.+|+++|++++|||||+++++|.+++..++|||
T Consensus        15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E   93 (287)
T d1opja_          15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   93 (287)
T ss_dssp             CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence            34678999999999999999999864  379999886443 345789999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCC
Q 014024          185 YMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGN  264 (432)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  264 (432)
                      |+++|+|.+++.... ...+++..+..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++......
T Consensus        94 ~~~~g~l~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~  169 (287)
T d1opja_          94 FMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  169 (287)
T ss_dssp             CCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred             cccCcchHHHhhhcc-ccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence            999999999986532 345999999999999999999999998   9999999999999999999999999998652211


Q ss_pred             CccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhh
Q 014024          265 DEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLID  344 (432)
Q Consensus       265 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  344 (432)
                           ........|++.|+|||++.++.++.++|||||||++|||++|..|+.....              ...+.+.+.
T Consensus       170 -----~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~--------------~~~~~~~i~  230 (287)
T d1opja_         170 -----YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--------------LSQVYELLE  230 (287)
T ss_dssp             -----SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC--------------HHHHHHHHH
T ss_pred             -----ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch--------------HHHHHHHHh
Confidence                 1223345688999999999999999999999999999999998777532111              011122223


Q ss_pred             hhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccc
Q 014024          345 SVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS  389 (432)
Q Consensus       345 ~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~  389 (432)
                      .......+...+.++.+|+..||+.||++|||++||++.|+.+..
T Consensus       231 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         231 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             cCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            323333444566789999999999999999999999999987643

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-54  Score=400.36  Aligned_cols=256  Identities=31%  Similarity=0.461  Sum_probs=207.3

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECCc-eEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecC
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYM  186 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~~-~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  186 (432)
                      .++|++.+.||+|+||.||+|.+.++ .||||++.... ...+.+.+|++++++++|||||++++++.+ +..++||||+
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~   89 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence            46788999999999999999999765 79999986543 345679999999999999999999998755 5679999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCc
Q 014024          187 PNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDE  266 (432)
Q Consensus       187 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  266 (432)
                      ++|+|.+++.... ...+++..++.++.|+++||+|||+++   |+||||||+||||++++.+||+|||+|+.+....  
T Consensus        90 ~~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~--  163 (272)
T d1qpca_          90 ENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE--  163 (272)
T ss_dssp             TTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC--
T ss_pred             CCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCc--
Confidence            9999999875432 234999999999999999999999998   9999999999999999999999999998753221  


Q ss_pred             cccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhh
Q 014024          267 DELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSV  346 (432)
Q Consensus       267 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  346 (432)
                         ........||+.|+|||++.++.++.++|||||||++|||+||..|+......              ......+...
T Consensus       164 ---~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~--------------~~~~~~i~~~  226 (272)
T d1qpca_         164 ---YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--------------PEVIQNLERG  226 (272)
T ss_dssp             ---EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------------HHHHHHHHTT
T ss_pred             ---cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH--------------HHHHHHHHhc
Confidence               12234467899999999999999999999999999999999976664221110              0111111222


Q ss_pred             hhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014024          347 LEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEA  388 (432)
Q Consensus       347 l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~  388 (432)
                      .+...+...+.++.+|+.+||+.||++|||+++|++.|++..
T Consensus       227 ~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f  268 (272)
T d1qpca_         227 YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF  268 (272)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence            222233445678899999999999999999999999998754

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-53  Score=391.89  Aligned_cols=254  Identities=28%  Similarity=0.427  Sum_probs=211.6

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECCc-eEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecC
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYM  186 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~~-~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  186 (432)
                      .++|++.++||+|+||+||+|+..++ .||||++..... ..+.+.+|+.++++++||||++++++|.+++..++||||+
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~   81 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM   81 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred             hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence            36899999999999999999999766 899999865443 3467999999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCc
Q 014024          187 PNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDE  266 (432)
Q Consensus       187 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  266 (432)
                      ++|+|.+++...  ...+++..+.+++.|+++||+|||+.+   |+||||||+||++++++.+||+|||+++......  
T Consensus        82 ~~g~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~--  154 (258)
T d1k2pa_          82 ANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--  154 (258)
T ss_dssp             TTEEHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS--
T ss_pred             CCCcHHHhhhcc--ccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCC--
Confidence            999999997543  345899999999999999999999998   9999999999999999999999999998653221  


Q ss_pred             cccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchhhhhhh
Q 014024          267 DELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDS  345 (432)
Q Consensus       267 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  345 (432)
                         ........||+.|+|||.+.++.++.++|||||||++|||+| |+.||......+               +...+..
T Consensus       155 ---~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~---------------~~~~i~~  216 (258)
T d1k2pa_         155 ---YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---------------TAEHIAQ  216 (258)
T ss_dssp             ---CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH---------------HHHHHHT
T ss_pred             ---ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH---------------HHHHHHh
Confidence               112334678999999999999999999999999999999998 788885433211               1111122


Q ss_pred             hhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014024          346 VLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNE  387 (432)
Q Consensus       346 ~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~  387 (432)
                      ..+...+...+..+.+++.+||+.||++|||+++++++|.++
T Consensus       217 ~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         217 GLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             CCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence            222233444557899999999999999999999999999764

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-53  Score=399.19  Aligned_cols=258  Identities=27%  Similarity=0.395  Sum_probs=209.2

Q ss_pred             hCCCCcCce-eccCCcEEEEEEEECC---c-eEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEE
Q 014024          108 TGNFSAANK-LGEGGFGTVYKGVIGQ---G-EIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLL  181 (432)
Q Consensus       108 ~~~y~~~~~-ig~G~~g~Vy~~~~~~---~-~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  181 (432)
                      .++|.+.+. ||+|+||.||+|.+..   + .||||++... .....+.|.+|+++|++++|||||++++++.+ +..++
T Consensus         7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l   85 (285)
T d1u59a_           7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML   85 (285)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred             ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence            356777774 9999999999998642   2 6999998654 45567789999999999999999999999865 56799


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceecc
Q 014024          182 IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVF  261 (432)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  261 (432)
                      ||||+++|+|.+++...  +..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        86 vmE~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~  160 (285)
T d1u59a_          86 VMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG  160 (285)
T ss_dssp             EEECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             EEEeCCCCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccc
Confidence            99999999999998543  345999999999999999999999998   9999999999999999999999999998763


Q ss_pred             CCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchh
Q 014024          262 GGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKII  340 (432)
Q Consensus       262 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                      ....   .........||+.|+|||++.++.++.++|||||||++|||+| |+.||......               .+.
T Consensus       161 ~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~---------------~~~  222 (285)
T d1u59a_         161 ADDS---YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---------------EVM  222 (285)
T ss_dssp             TCSC---EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---------------HHH
T ss_pred             cccc---ccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH---------------HHH
Confidence            3221   1223344578999999999999999999999999999999998 89998533211               111


Q ss_pred             hhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccc
Q 014024          341 DLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS  389 (432)
Q Consensus       341 ~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~  389 (432)
                      ..+....+...+..++.++.+|+.+||+.||++|||+.+|++.|+....
T Consensus       223 ~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~  271 (285)
T d1u59a_         223 AFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  271 (285)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            2222222233445566789999999999999999999999999987543

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-54  Score=395.53  Aligned_cols=245  Identities=25%  Similarity=0.359  Sum_probs=203.1

Q ss_pred             CCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCCC---hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEE
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKS---GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  183 (432)
                      ++|++.+.||+|+||+||+|++..+  .||+|++....   ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            5799999999999999999998643  79999885321   233567889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCC
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGG  263 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  263 (432)
                      ||+++|+|.+++..   .+.+++..+..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||++..... 
T Consensus        86 Ey~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~-  158 (263)
T d2j4za1          86 EYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS-  158 (263)
T ss_dssp             ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCC-
T ss_pred             eecCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCC-
Confidence            99999999999953   345999999999999999999999999   99999999999999999999999999976421 


Q ss_pred             CCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhh
Q 014024          264 NDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLI  343 (432)
Q Consensus       264 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i  343 (432)
                             .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......      ........      
T Consensus       159 -------~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~~~~i~~~------  219 (263)
T d2j4za1         159 -------SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE------TYKRISRV------  219 (263)
T ss_dssp             -------CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHTT------
T ss_pred             -------CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH------HHHHHHcC------
Confidence                   12344679999999999999999999999999999999999999985322110      00000000      


Q ss_pred             hhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          344 DSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       344 ~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                          ....+...+.++.+++.+||+.||++|||++|++++
T Consensus       220 ----~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h  255 (263)
T d2j4za1         220 ----EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  255 (263)
T ss_dssp             ----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             ----CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence                011223345678899999999999999999999874

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-54  Score=399.10  Aligned_cols=255  Identities=24%  Similarity=0.321  Sum_probs=194.6

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEe--CCeeEE
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIE--KDERLL  181 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~l  181 (432)
                      .++|++.+.||+|+||.||+|++..  ..||+|++...  .....+.+.+|+++|++++||||+++++++.+  .+..|+
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            3689999999999999999999854  37999998544  45566789999999999999999999999865  456799


Q ss_pred             EEecCCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCC--CCeEeccCCCCCEEEcCCCCEEEeecccce
Q 014024          182 IYEYMPNKSLDCFLFDPT-KREILDWRTRVQIIKGVAQGLLYLHQYSR--VRIIHRDLKASNILLDKDMNSKISDFGMAR  258 (432)
Q Consensus       182 v~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~--~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  258 (432)
                      ||||+++|+|.+++.... .+..+++..++.++.|++.||.|||+.+.  .+|+||||||+|||+++++.+||+|||+++
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence            999999999999985422 23469999999999999999999998652  349999999999999999999999999998


Q ss_pred             eccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccc
Q 014024          259 IVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNK  338 (432)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  338 (432)
                      .+...      ........||+.|+|||++.+..++.++|||||||++|||+||+.||......+  ..           
T Consensus       163 ~~~~~------~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~--~~-----------  223 (269)
T d2java1         163 ILNHD------TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE--LA-----------  223 (269)
T ss_dssp             HC-----------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HH-----------
T ss_pred             ecccC------CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH--HH-----------
Confidence            75221      122345689999999999999999999999999999999999999985322110  00           


Q ss_pred             hhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          339 IIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       339 ~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                        ..+........+...+.++.+|+.+||+.||++|||++|++++
T Consensus       224 --~~i~~~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         224 --GKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             --HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             --HHHHcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence              0111100111223345678999999999999999999999875

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-53  Score=397.94  Aligned_cols=259  Identities=27%  Similarity=0.461  Sum_probs=204.6

Q ss_pred             CCCCcCceeccCCcEEEEEEEECCc------eEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEE
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQG------EIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLL  181 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~~------~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  181 (432)
                      +.|++.++||+|+||.||+|.+...      .||||++... .......|.+|++++++++|||||+++|++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            5688889999999999999986432      5899998654 44556679999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceecc
Q 014024          182 IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVF  261 (432)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  261 (432)
                      ||||+.++++.+++...  ...+++..+..++.|++.||+|||+.+   |+||||||+||||+.++.+||+|||+++.+.
T Consensus        87 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          87 ITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             EEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEEecccCcchhhhhcc--cccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence            99999999999887543  245999999999999999999999998   9999999999999999999999999998753


Q ss_pred             CCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhh
Q 014024          262 GGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIID  341 (432)
Q Consensus       262 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (432)
                      .....   ........||+.|+|||++.++.++.++|||||||++|||+||..|+.....              ...+..
T Consensus       162 ~~~~~---~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~--------------~~~~~~  224 (283)
T d1mqba_         162 DDPEA---TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS--------------NHEVMK  224 (283)
T ss_dssp             ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------------HHHHHH
T ss_pred             CCCcc---ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC--------------HHHHHH
Confidence            22111   2223345689999999999999999999999999999999997766532111              011222


Q ss_pred             hhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccc
Q 014024          342 LIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS  389 (432)
Q Consensus       342 ~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~  389 (432)
                      .+....+...+..++..+.+|+.+||+.||++|||+.||++.|+.+..
T Consensus       225 ~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~  272 (283)
T d1mqba_         225 AINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  272 (283)
T ss_dssp             HHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence            233333344455566789999999999999999999999999987654

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-53  Score=397.40  Aligned_cols=251  Identities=25%  Similarity=0.370  Sum_probs=205.2

Q ss_pred             CCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecC
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYM  186 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  186 (432)
                      +.|++.+.||+|+||.||+|++..+  .||+|++........+.+.+|+++|++++|||||++++++.+.+..++||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            5689999999999999999998643  79999997776677788999999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCc
Q 014024          187 PNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDE  266 (432)
Q Consensus       187 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  266 (432)
                      ++|+|.+++...  ...+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+|.....    
T Consensus        92 ~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~----  162 (288)
T d2jfla1          92 AGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR----  162 (288)
T ss_dssp             TTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHH----
T ss_pred             CCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCC----
Confidence            999999987542  245999999999999999999999999   99999999999999999999999999976421    


Q ss_pred             cccccccccccccCCccChhhhc-----cCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhh
Q 014024          267 DELQGNTSRISGTYGYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIID  341 (432)
Q Consensus       267 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (432)
                        .........||+.|+|||++.     +..++.++|||||||++|||+||+.||.......  ..   ... ...... 
T Consensus       163 --~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~--~~---~~i-~~~~~~-  233 (288)
T d2jfla1         163 --TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR--VL---LKI-AKSEPP-  233 (288)
T ss_dssp             --HHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG--HH---HHH-HHSCCC-
T ss_pred             --CcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH--HH---HHH-HcCCCC-
Confidence              112234568999999999984     4568999999999999999999999985432211  00   000 000000 


Q ss_pred             hhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          342 LIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       342 ~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                            ....+...+.++.+|+.+||+.||++|||++|++++
T Consensus       234 ------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h  269 (288)
T d2jfla1         234 ------TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH  269 (288)
T ss_dssp             ------CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             ------CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                  011123345678899999999999999999999875

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-53  Score=398.76  Aligned_cols=263  Identities=28%  Similarity=0.437  Sum_probs=208.7

Q ss_pred             CCCCcCceeccCCcEEEEEEEECCc-eEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecCC
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMP  187 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~~-~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  187 (432)
                      ++|++.+.||+|+||.||+|.+.++ .||||++.... ...+.|.+|+.++++++|+|||++++++.+ +..++||||++
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~   94 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS   94 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence            5799999999999999999999776 89999985443 345789999999999999999999999854 56789999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCcc
Q 014024          188 NKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDED  267 (432)
Q Consensus       188 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  267 (432)
                      +|+|..++.... ...+++.+++.++.|++.||+|||+++   |+||||||+||||++++++||+|||+++......   
T Consensus        95 ~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~---  167 (285)
T d1fmka3          95 KGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE---  167 (285)
T ss_dssp             TCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             CCchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCC---
Confidence            999998885432 234999999999999999999999998   9999999999999999999999999998652211   


Q ss_pred             ccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhhh
Q 014024          268 ELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVL  347 (432)
Q Consensus       268 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  347 (432)
                        ........||+.|+|||++.++.++.++|||||||++|||+||..|+......              ......+....
T Consensus       168 --~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~--------------~~~~~~i~~~~  231 (285)
T d1fmka3         168 --YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------------REVLDQVERGY  231 (285)
T ss_dssp             ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------------HHHHHHHHTTC
T ss_pred             --ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH--------------HHHHHHHHhcC
Confidence              12233467899999999999999999999999999999999987765322211              11112222222


Q ss_pred             hhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccccCCCCCCC
Q 014024          348 EEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSLLPPKQ  396 (432)
Q Consensus       348 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~~~~~  396 (432)
                      +...+..++.++.+++.+||+.||++|||+++|++.|++...+..++.+
T Consensus       232 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~~  280 (285)
T d1fmka3         232 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQ  280 (285)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCC
T ss_pred             CCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCCCC
Confidence            3334455667899999999999999999999999999997766555443

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-53  Score=394.03  Aligned_cols=248  Identities=28%  Similarity=0.404  Sum_probs=199.3

Q ss_pred             ceeccCCcEEEEEEEECC----ceEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEecCCC
Q 014024          115 NKLGEGGFGTVYKGVIGQ----GEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEYMPN  188 (432)
Q Consensus       115 ~~ig~G~~g~Vy~~~~~~----~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  188 (432)
                      ++||+|+||.||+|.+.+    ..||||++...  +....+.+.+|+++|++++|||||+++++|.+ +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            579999999999998643    26999998543  33446789999999999999999999999865 467899999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCccc
Q 014024          189 KSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDEDE  268 (432)
Q Consensus       189 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  268 (432)
                      |+|.+++..   ...+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.+......  
T Consensus        92 g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~--  163 (277)
T d1xbba_          92 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY--  163 (277)
T ss_dssp             EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE--
T ss_pred             CcHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccc--
Confidence            999999853   345999999999999999999999998   999999999999999999999999999875332211  


Q ss_pred             cccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchhhhhhhhh
Q 014024          269 LQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVL  347 (432)
Q Consensus       269 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  347 (432)
                       ........||+.|+|||.+.++.++.++|||||||++|||+| |+.||......               .+...+....
T Consensus       164 -~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~---------------~~~~~i~~~~  227 (277)
T d1xbba_         164 -YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---------------EVTAMLEKGE  227 (277)
T ss_dssp             -EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---------------HHHHHHHTTC
T ss_pred             -cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH---------------HHHHHHHcCC
Confidence             222334578999999999999999999999999999999998 89998532211               1112222222


Q ss_pred             hhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014024          348 EEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNE  387 (432)
Q Consensus       348 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~  387 (432)
                      +...+..++.++.+|+.+||+.||++|||+++|++.|+..
T Consensus       228 ~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~  267 (277)
T d1xbba_         228 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  267 (277)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence            2333445667899999999999999999999999988764

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-53  Score=403.01  Aligned_cols=257  Identities=30%  Similarity=0.427  Sum_probs=206.7

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECCc-------eEEEEEEcCC-ChHhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCe
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQG-------EIAVKRLLGK-SGQEIKELKNEASVIAQV-QHKNLVKLLGCCIEKDE  178 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~~-------~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  178 (432)
                      .++|++.++||+|+||+||+|++.+.       .||+|.+... .......+.+|+.+|.++ +|||||++++++.+.+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence            46899999999999999999987431       5899988544 334456789999999998 89999999999999999


Q ss_pred             eEEEEecCCCCChhhhhcCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCC
Q 014024          179 RLLIYEYMPNKSLDCFLFDPTK--------------------REILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKA  238 (432)
Q Consensus       179 ~~lv~e~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp  238 (432)
                      .++|||||++|+|.+++.....                    ...+++..++.++.|++.||+|||+++   |+||||||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp  192 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA  192 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence            9999999999999999965422                    235899999999999999999999998   99999999


Q ss_pred             CCEEEcCCCCEEEeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCC
Q 014024          239 SNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTG  317 (432)
Q Consensus       239 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~  317 (432)
                      +|||++.++.+||+|||+|+.......    ........||+.|+|||++.++.++.++|||||||++|||+| |+.||.
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~----~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~  268 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSN----YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  268 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTT----SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             hccccccCCeEEEeeccccccccCCCc----eeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence            999999999999999999987532211    112234568999999999999999999999999999999998 899985


Q ss_pred             CccccccchhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014024          318 FYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLT  385 (432)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~  385 (432)
                      ......              ....++....+...+..++.++.+|+.+||+.||++|||++||+++|.
T Consensus       269 ~~~~~~--------------~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         269 GIPVDA--------------NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             TCCCSH--------------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCHHH--------------HHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            332211              111222222223334455678999999999999999999999999985

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-52  Score=387.57  Aligned_cols=249  Identities=25%  Similarity=0.402  Sum_probs=196.3

Q ss_pred             CCC-CcCceeccCCcEEEEEEEECCc--eEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEe----CCee
Q 014024          109 GNF-SAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIE----KDER  179 (432)
Q Consensus       109 ~~y-~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~  179 (432)
                      ++| ++.++||+|+||+||+|.+..+  .||+|++...  .....+.+.+|+++|++++||||+++++++.+    ....
T Consensus         8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~   87 (270)
T d1t4ha_           8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI   87 (270)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred             CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEE
Confidence            344 6677899999999999998654  7999988543  45566789999999999999999999999875    3457


Q ss_pred             EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEc-CCCCEEEeecccce
Q 014024          180 LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLD-KDMNSKISDFGMAR  258 (432)
Q Consensus       180 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~  258 (432)
                      ++||||+++|+|.+++..   ...+++..+..++.|++.||+|||+++ .+|+||||||+|||++ +++.+||+|||+++
T Consensus        88 ~ivmE~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~  163 (270)
T d1t4ha_          88 VLVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  163 (270)
T ss_dssp             EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EEEEeCCCCCcHHHHHhc---cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence            999999999999999953   345999999999999999999999875 3499999999999996 57899999999997


Q ss_pred             eccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccc
Q 014024          259 IVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNK  338 (432)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  338 (432)
                      ...        ........||+.|+|||++.+ .++.++|||||||++|||++|+.||........     .........
T Consensus       164 ~~~--------~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~-----~~~~i~~~~  229 (270)
T d1t4ha_         164 LKR--------ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-----IYRRVTSGV  229 (270)
T ss_dssp             GCC--------TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-----HHHHHTTTC
T ss_pred             ecc--------CCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH-----HHHHHHcCC
Confidence            531        112345689999999998865 699999999999999999999999853322110     000000000


Q ss_pred             hhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          339 IIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       339 ~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      .        ....+.....++.+++.+||+.||++|||++|++++
T Consensus       230 ~--------~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H  266 (270)
T d1t4ha_         230 K--------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  266 (270)
T ss_dssp             C--------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             C--------CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence            0        001111234568899999999999999999999875

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-53  Score=400.81  Aligned_cols=262  Identities=24%  Similarity=0.330  Sum_probs=204.3

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEe
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYE  184 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  184 (432)
                      .++|++.+.||+|+||+||+|.+..  ..||+|++... .....+.+.+|+.+|++++|||||+++++|.+.+..++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            5789999999999999999999853  37999998644 34445788999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCC
Q 014024          185 YMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ-YSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGG  263 (432)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  263 (432)
                      |+++|+|.+++..   ++.+++..+..++.|++.||.|||+ ++   |+||||||+|||+++++.+||+|||+|..+.  
T Consensus        85 y~~gg~L~~~l~~---~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~--  156 (322)
T d1s9ja_          85 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--  156 (322)
T ss_dssp             CCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHH--
T ss_pred             cCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccC--
Confidence            9999999999953   3459999999999999999999997 47   9999999999999999999999999998652  


Q ss_pred             CCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhh--------------
Q 014024          264 NDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGY--------------  329 (432)
Q Consensus       264 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~--------------  329 (432)
                            .......+||+.|+|||++.+..|+.++||||+||++|||++|+.||.............              
T Consensus       157 ------~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (322)
T d1s9ja_         157 ------DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP  230 (322)
T ss_dssp             ------HHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------
T ss_pred             ------CCccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccc
Confidence                  122345689999999999999999999999999999999999999986433211100000              


Q ss_pred             ----------hHHhhhccchhhhhhhhhhhcc----cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          330 ----------AWDLWISNKIIDLIDSVLEEAS----FNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       330 ----------~~~~~~~~~~~~~i~~~l~~~~----~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                                ...........+..+.......    ......++.+++.+||+.||++|||++|+++|
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H  298 (322)
T d1s9ja_         231 RTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  298 (322)
T ss_dssp             ---------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence                      0000000011111111111100    01123578899999999999999999999985

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-53  Score=393.67  Aligned_cols=249  Identities=25%  Similarity=0.315  Sum_probs=200.8

Q ss_pred             CCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC---ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEE
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK---SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  183 (432)
                      ++|++.+.||+|+||+||+|.+..  ..||||++...   .....+.+.+|+++|++++||||+++++++.+.+..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            579999999999999999999853  48999998532   1234567899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCC
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGG  263 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  263 (432)
                      ||+++|+|.+++.   ..+.+++..++.++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+|+.+...
T Consensus        88 Ey~~gg~L~~~~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          88 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EccCCCCHHHhhh---ccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence            9999999999884   3455999999999999999999999999   999999999999999999999999999875322


Q ss_pred             CCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhh
Q 014024          264 NDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLI  343 (432)
Q Consensus       264 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i  343 (432)
                      ..    ........||+.|+|||++.+..++.++|||||||++|||+||+.||.......      ....        +.
T Consensus       162 ~~----~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------~~~~--------i~  223 (288)
T d1uu3a_         162 SK----QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL------IFQK--------II  223 (288)
T ss_dssp             ------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHH--------HH
T ss_pred             Cc----ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH------HHHH--------HH
Confidence            11    122344679999999999999999999999999999999999999985322100      0000        00


Q ss_pred             hhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          344 DSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       344 ~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      ..  ....+.....++.+|+.+||+.||++|||++|++++
T Consensus       224 ~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~  261 (288)
T d1uu3a_         224 KL--EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY  261 (288)
T ss_dssp             TT--CCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred             cC--CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence            00  011222345678899999999999999999997543

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=9.9e-52  Score=397.02  Aligned_cols=256  Identities=21%  Similarity=0.267  Sum_probs=209.0

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEec
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEY  185 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  185 (432)
                      .++|++.+.||+|+||.||+|.+..  ..||+|++........+.+.+|+++|++++||||+++++++.+++..|+||||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            4689999999999999999999853  48999999777666777889999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEc--CCCCEEEeecccceeccCC
Q 014024          186 MPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLD--KDMNSKISDFGMARIVFGG  263 (432)
Q Consensus       186 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~Dfg~a~~~~~~  263 (432)
                      |++|+|.+++...  ...+++.+++.++.||+.||+|||++|   |+||||||+|||++  .++.+||+|||+|..+.. 
T Consensus       108 ~~gg~L~~~~~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~-  181 (352)
T d1koba_         108 LSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP-  181 (352)
T ss_dssp             CCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT-
T ss_pred             CCCChHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCC-
Confidence            9999998887432  334999999999999999999999999   99999999999997  678999999999987532 


Q ss_pred             CCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhh
Q 014024          264 NDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLI  343 (432)
Q Consensus       264 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i  343 (432)
                            ........||+.|+|||++.+..++.++|||||||++|+|+||+.||.......  ......    ...     
T Consensus       182 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--~~~~i~----~~~-----  244 (352)
T d1koba_         182 ------DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE--TLQNVK----RCD-----  244 (352)
T ss_dssp             ------TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH--HHHHHH----HCC-----
T ss_pred             ------CCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHH----hCC-----
Confidence                  122345678999999999999999999999999999999999999985322110  000000    000     


Q ss_pred             hhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--hccc
Q 014024          344 DSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM--LTNE  387 (432)
Q Consensus       344 ~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~--L~~~  387 (432)
                       ...........+.++.+|+.+||+.||.+|||++|++++  +++.
T Consensus       245 -~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         245 -WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             -CCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             -CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence             000011122345678899999999999999999999986  5443

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.8e-51  Score=394.96  Aligned_cols=252  Identities=21%  Similarity=0.310  Sum_probs=207.5

Q ss_pred             hCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEec
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEY  185 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  185 (432)
                      .++|++.+.||+|+||.||+|.+.  +..||+|++........+.+.+|+++|++++|||||++++++.+.+..|+||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            468999999999999999999985  348999999877777788899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEc--CCCCEEEeecccceeccCC
Q 014024          186 MPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLD--KDMNSKISDFGMARIVFGG  263 (432)
Q Consensus       186 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~Dfg~a~~~~~~  263 (432)
                      |++|+|.+++...  .+.+++..+..++.||+.||+|||+++   |+||||||+|||++  .++.+||+|||+++.+.. 
T Consensus       105 ~~gg~L~~~l~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~-  178 (350)
T d1koaa2         105 MSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP-  178 (350)
T ss_dssp             CCSCBHHHHHTCT--TSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCT-
T ss_pred             CCCCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccc-
Confidence            9999999998543  345999999999999999999999999   99999999999995  468899999999987522 


Q ss_pred             CCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhh
Q 014024          264 NDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLI  343 (432)
Q Consensus       264 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i  343 (432)
                            ........||+.|+|||++.+..++.++|||||||++|+|++|+.||......  ......    .....    
T Consensus       179 ------~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--~~~~~i----~~~~~----  242 (350)
T d1koaa2         179 ------KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD--ETLRNV----KSCDW----  242 (350)
T ss_dssp             ------TSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHH----HHTCC----
T ss_pred             ------ccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH--HHHHHH----HhCCC----
Confidence                  12234568999999999999999999999999999999999999998532211  000000    00000    


Q ss_pred             hhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          344 DSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       344 ~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                        ..........+.++.+|+.+||+.||++|||++|++++
T Consensus       243 --~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         243 --NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             --CSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             --CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              00011112334678899999999999999999999996

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.9e-52  Score=395.18  Aligned_cols=245  Identities=26%  Similarity=0.398  Sum_probs=199.4

Q ss_pred             CCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCC---hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEE
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS---GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  183 (432)
                      ..|+.++.||+|+||+||+|.+..  ..||||++....   ....+.+.+|+++|++++|||||++++++.+++..|+||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            358999999999999999999754  379999986442   345567899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCC
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGG  263 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  263 (432)
                      |||++|+|..++.   .+..+++..++.++.|++.||.|||+++   |+||||||+|||+++++.+||+|||++....  
T Consensus        95 E~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~--  166 (309)
T d1u5ra_          95 EYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA--  166 (309)
T ss_dssp             ECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSS--
T ss_pred             EecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccC--
Confidence            9999999987763   2345999999999999999999999999   9999999999999999999999999998641  


Q ss_pred             CCccccccccccccccCCccChhhhcc---CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchh
Q 014024          264 NDEDELQGNTSRISGTYGYMSPEYALE---GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKII  340 (432)
Q Consensus       264 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                              ......||+.|+|||++.+   +.|+.++|||||||++|||++|+.||......     ...         .
T Consensus       167 --------~~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~-----~~~---------~  224 (309)
T d1u5ra_         167 --------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----SAL---------Y  224 (309)
T ss_dssp             --------SBCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHH---------H
T ss_pred             --------CCCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH-----HHH---------H
Confidence                    2234579999999999864   46899999999999999999999998532210     000         0


Q ss_pred             hhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          341 DLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       341 ~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      .+.........+...+..+.+|+.+||+.||++|||++|++++
T Consensus       225 ~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H  267 (309)
T d1u5ra_         225 HIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (309)
T ss_dssp             HHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             HHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence            0111100011122335678899999999999999999999874

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-52  Score=387.47  Aligned_cols=251  Identities=27%  Similarity=0.396  Sum_probs=201.4

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECCceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeC-CeeEEEEecC
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEK-DERLLIYEYM  186 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~  186 (432)
                      .++|++.+.||+|+||.||+|.+.+..||||++....  ..+.+.+|++++++++||||++++++|.+. +..++||||+
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~   83 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   83 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             HHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence            3578889999999999999999998899999986543  456799999999999999999999998654 5689999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCc
Q 014024          187 PNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDE  266 (432)
Q Consensus       187 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  266 (432)
                      ++|+|.+++... ....+++..+++++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++...     
T Consensus        84 ~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~-----  154 (262)
T d1byga_          84 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-----  154 (262)
T ss_dssp             TTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             CCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecC-----
Confidence            999999999542 2234899999999999999999999998   9999999999999999999999999998641     


Q ss_pred             cccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchhhhhhh
Q 014024          267 DELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDS  345 (432)
Q Consensus       267 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  345 (432)
                          .......+|..|+|||++.++.++.++|||||||++|||+| |+.|+.....               .++.+.+..
T Consensus       155 ----~~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~---------------~~~~~~i~~  215 (262)
T d1byga_         155 ----STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---------------KDVVPRVEK  215 (262)
T ss_dssp             -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG---------------GGHHHHHTT
T ss_pred             ----CCCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH---------------HHHHHHHHc
Confidence                22334567889999999999999999999999999999998 6766643221               111222222


Q ss_pred             hhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014024          346 VLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEA  388 (432)
Q Consensus       346 ~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~  388 (432)
                      ..+...+...+.++.+|+.+||+.||++|||+.+++++|+.+.
T Consensus       216 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~  258 (262)
T d1byga_         216 GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  258 (262)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            2333444455678899999999999999999999999998764

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.9e-52  Score=392.88  Aligned_cols=252  Identities=22%  Similarity=0.297  Sum_probs=189.4

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCC-hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEE
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS-GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  183 (432)
                      ..+.|++.+.||+|+||+||+|.+..  ..||+|++.... ....+.+.+|+++|++++||||+++++++.+++..|+||
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm   86 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM   86 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            34679999999999999999999864  479999986543 233456889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEc---CCCCEEEeecccceec
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLD---KDMNSKISDFGMARIV  260 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Dfg~a~~~  260 (432)
                      |||++|+|.+++..   ++.+++..+..++.|++.||+|||+++   |+||||||+|||+.   +++.+||+|||+++..
T Consensus        87 E~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~  160 (307)
T d1a06a_          87 QLVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME  160 (307)
T ss_dssp             CCCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred             eccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEc
Confidence            99999999999954   445999999999999999999999999   99999999999994   5789999999999864


Q ss_pred             cCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchh
Q 014024          261 FGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKII  340 (432)
Q Consensus       261 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                      ..       .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.......  ..    ........ 
T Consensus       161 ~~-------~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~--~~----~~i~~~~~-  226 (307)
T d1a06a_         161 DP-------GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK--LF----EQILKAEY-  226 (307)
T ss_dssp             -------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HH----HHHHTTCC-
T ss_pred             cC-------CCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH--HH----HHHhccCC-
Confidence            21       112344679999999999999999999999999999999999999985322110  00    00000000 


Q ss_pred             hhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          341 DLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       341 ~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                           ..........+.++.+++..||+.||++|||++|++++
T Consensus       227 -----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         227 -----EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             -----CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             -----CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence                 00011122345678899999999999999999999986

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.9e-52  Score=390.63  Aligned_cols=264  Identities=27%  Similarity=0.411  Sum_probs=211.1

Q ss_pred             hHhhhhCCCCcCceeccCCcEEEEEEEECC-------ceEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEE
Q 014024          103 SVSSATGNFSAANKLGEGGFGTVYKGVIGQ-------GEIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCI  174 (432)
Q Consensus       103 ~~~~~~~~y~~~~~ig~G~~g~Vy~~~~~~-------~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  174 (432)
                      +++...++|++.+.||+|+||+||+|+..+       ..||||++... .....+.+.+|+++|++++||||++++++|.
T Consensus         7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~   86 (301)
T d1lufa_           7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA   86 (301)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence            344456789999999999999999998643       37999998654 3445677999999999999999999999999


Q ss_pred             eCCeeEEEEecCCCCChhhhhcCCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 014024          175 EKDERLLIYEYMPNKSLDCFLFDPT---------------------KREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIH  233 (432)
Q Consensus       175 ~~~~~~lv~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH  233 (432)
                      +.+..+++|||+++|+|.+++....                     ....+++..++.++.|++.||+|||+.+   ++|
T Consensus        87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivH  163 (301)
T d1lufa_          87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH  163 (301)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEe
Confidence            9999999999999999999985321                     1234899999999999999999999998   999


Q ss_pred             ccCCCCCEEEcCCCCEEEeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCC
Q 014024          234 RDLKASNILLDKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK  313 (432)
Q Consensus       234 ~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~  313 (432)
                      |||||+|||++.++.+||+|||+++.....+    .........||+.|+|||.+.+..++.++|||||||++|||++|.
T Consensus       164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~  239 (301)
T d1lufa_         164 RDLATRNCLVGENMVVKIADFGLSRNIYSAD----YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG  239 (301)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGG----CBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred             eEEcccceEECCCCcEEEccchhheeccCCc----cccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccC
Confidence            9999999999999999999999998652211    122334567889999999999999999999999999999999996


Q ss_pred             C-CCCCccccccchhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014024          314 K-NTGFYRTKSLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEA  388 (432)
Q Consensus       314 ~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~  388 (432)
                      . ||......  .             +...+........+...+.++.+|+..||+.||++|||+.||+++|+++.
T Consensus       240 ~~p~~~~~~~--e-------------~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         240 LQPYYGMAHE--E-------------VIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             CCTTTTSCHH--H-------------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCCCCCCHH--H-------------HHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            4 55322211  0             11111111122234455678899999999999999999999999998764

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-51  Score=382.90  Aligned_cols=255  Identities=24%  Similarity=0.319  Sum_probs=196.9

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECCc-----eEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEE
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQG-----EIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLL  181 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~~-----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  181 (432)
                      .++|++.+.||+|+||.||+|.+...     .||+|.+... .....+.+.+|+++|++++||||+++++++. .+..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence            36799999999999999999987432     4788887543 4455678999999999999999999999985 467899


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceecc
Q 014024          182 IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVF  261 (432)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  261 (432)
                      ||||+++|+|.+++...  ...+++..++.++.|++.||.|||+++   |+||||||+||++++++.+||+|||+++.+.
T Consensus        85 v~E~~~~g~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~  159 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME  159 (273)
T ss_dssp             EEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEEeccCCcHHhhhhcc--CCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence            99999999999987543  345999999999999999999999999   9999999999999999999999999998652


Q ss_pred             CCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchh
Q 014024          262 GGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKII  340 (432)
Q Consensus       262 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                      ...     ........||+.|+|||++.++.++.++|||||||++|||+| |..||.......               +.
T Consensus       160 ~~~-----~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---------------~~  219 (273)
T d1mp8a_         160 DST-----YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---------------VI  219 (273)
T ss_dssp             ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---------------HH
T ss_pred             CCc-----ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH---------------HH
Confidence            211     123344578999999999999999999999999999999998 788875432211               11


Q ss_pred             hhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014024          341 DLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEA  388 (432)
Q Consensus       341 ~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~  388 (432)
                      ..+........+...+.++.+|+.+||+.||++|||+.||+++|+.+.
T Consensus       220 ~~i~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~  267 (273)
T d1mp8a_         220 GRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  267 (273)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            111111112234455678999999999999999999999999998754

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-51  Score=389.04  Aligned_cols=255  Identities=27%  Similarity=0.413  Sum_probs=203.9

Q ss_pred             CCCCcCceeccCCcEEEEEEEECCc------eEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEE
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQG------EIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLL  181 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~~------~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  181 (432)
                      ++|+++++||+|+||+||+|.+...      +||+|++... .....+.+.+|++++++++|||||+++++|.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            5699999999999999999987432      5899988543 334567899999999999999999999999875 5678


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceecc
Q 014024          182 IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVF  261 (432)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  261 (432)
                      ++||+.+|+|.+++...  ...+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        88 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             EEECCTTCBHHHHHHHT--SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             EEEeccCCccccccccc--ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence            89999999999888643  345999999999999999999999998   9999999999999999999999999998753


Q ss_pred             CCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccchh
Q 014024          262 GGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKII  340 (432)
Q Consensus       262 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                      ....    ........||+.|+|||++.++.++.++|||||||++|||+| |..||.....               ..+.
T Consensus       163 ~~~~----~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~---------------~~~~  223 (317)
T d1xkka_         163 AEEK----EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA---------------SEIS  223 (317)
T ss_dssp             TTCC------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG---------------GGHH
T ss_pred             cccc----cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH---------------HHHH
Confidence            2211    122334568999999999999999999999999999999999 7778753221               1122


Q ss_pred             hhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014024          341 DLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEA  388 (432)
Q Consensus       341 ~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~  388 (432)
                      ..+....+...+..++..+.+|+.+||+.||++|||+.||+++|+.+.
T Consensus       224 ~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~  271 (317)
T d1xkka_         224 SILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  271 (317)
T ss_dssp             HHHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence            233333333344556678999999999999999999999999987754

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-51  Score=387.65  Aligned_cols=257  Identities=26%  Similarity=0.387  Sum_probs=205.3

Q ss_pred             CCCCcCceeccCCcEEEEEEEECCc----eEEEEEEcCC-ChHhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeeEEE
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQG----EIAVKRLLGK-SGQEIKELKNEASVIAQV-QHKNLVKLLGCCIEKDERLLI  182 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv  182 (432)
                      ++|++.++||+|+||.||+|.+.++    .||||++... .....+.+.+|+++|+++ +||||++++++|.+.+..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            6888899999999999999997543    4788887543 344566799999999998 799999999999999999999


Q ss_pred             EecCCCCChhhhhcCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCE
Q 014024          183 YEYMPNKSLDCFLFDP-------------TKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNS  249 (432)
Q Consensus       183 ~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  249 (432)
                      |||+++|+|.++++..             .....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence            9999999999999653             23356999999999999999999999998   9999999999999999999


Q ss_pred             EEeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCC-CCCCccccccchhh
Q 014024          250 KISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK-NTGFYRTKSLNLIG  328 (432)
Q Consensus       250 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~-p~~~~~~~~~~~~~  328 (432)
                      ||+|||+++....       ........||..|+|||.+.++.++.++|||||||++|||++|.. ||......      
T Consensus       167 kl~DfG~a~~~~~-------~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~------  233 (309)
T d1fvra_         167 KIADFGLSRGQEV-------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------  233 (309)
T ss_dssp             EECCTTCEESSCE-------ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------
T ss_pred             EEccccccccccc-------cccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH------
Confidence            9999999976411       122234568999999999999999999999999999999999765 44322110      


Q ss_pred             hhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccccC
Q 014024          329 YAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASS  390 (432)
Q Consensus       329 ~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~  390 (432)
                               .+.+.+....+...+...+.++.+|+.+||+.||++|||+.||+++|+++...
T Consensus       234 ---------~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~  286 (309)
T d1fvra_         234 ---------ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  286 (309)
T ss_dssp             ---------HHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             ---------HHHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence                     11111111122233344567899999999999999999999999999987653

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-50  Score=380.81  Aligned_cols=251  Identities=24%  Similarity=0.331  Sum_probs=202.8

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCC------hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCee
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS------GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDER  179 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  179 (432)
                      .++|++.+.||+|+||+||+|.+..  ..||+|++....      ....+.+.+|+++|++++|||||++++++.+.+..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            4679999999999999999999853  489999985332      22467899999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCC----CEEEeecc
Q 014024          180 LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDM----NSKISDFG  255 (432)
Q Consensus       180 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Dfg  255 (432)
                      |+|||||++|+|.+++..   ++.+++..++.++.|++.||+|||+.+   |+||||||+|||++.++    .+|++|||
T Consensus        89 ~iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG  162 (293)
T d1jksa_          89 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG  162 (293)
T ss_dssp             EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEcCCCccccchhcc---ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence            999999999999999953   345999999999999999999999999   99999999999998776    49999999


Q ss_pred             cceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhh
Q 014024          256 MARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWI  335 (432)
Q Consensus       256 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  335 (432)
                      ++.....+       .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......  .   . ....
T Consensus       163 ~a~~~~~~-------~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~--~---~-~~i~  229 (293)
T d1jksa_         163 LAHKIDFG-------NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--T---L-ANVS  229 (293)
T ss_dssp             TCEECTTS-------CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--H---H-HHHH
T ss_pred             hhhhcCCC-------ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH--H---H-HHHH
Confidence            99875221       12344578999999999999999999999999999999999999985322110  0   0 0000


Q ss_pred             ccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          336 SNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       336 ~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      .... .     .....+...+..+.+|+.+||+.||++|||++|++++
T Consensus       230 ~~~~-~-----~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  271 (293)
T d1jksa_         230 AVNY-E-----FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  271 (293)
T ss_dssp             TTCC-C-----CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             hcCC-C-----CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0000 0     0000111234578899999999999999999999874

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1e-50  Score=384.72  Aligned_cols=242  Identities=25%  Similarity=0.314  Sum_probs=202.9

Q ss_pred             CCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC---ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEE
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK---SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  183 (432)
                      ++|++.+.||+|+||+||+|++..  ..||+|++...   .....+.+.+|+.+|++++||||+++++++.+.+..|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            579999999999999999999854  48999998533   1234567899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCC
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGG  263 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  263 (432)
                      ||+++|+|..++..   +..+++..+..++.|++.||+|||+++   |+||||||+|||++.+|.+||+|||+|+...  
T Consensus        84 E~~~gg~l~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~--  155 (316)
T d1fota_          84 DYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVP--  155 (316)
T ss_dssp             CCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECS--
T ss_pred             eecCCccccccccc---cccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEec--
Confidence            99999999998853   344889999999999999999999999   9999999999999999999999999998752  


Q ss_pred             CCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhh
Q 014024          264 NDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLI  343 (432)
Q Consensus       264 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i  343 (432)
                             ......+||+.|+|||++.+..++.++|||||||++|||+||+.||.....                  .+..
T Consensus       156 -------~~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~------------------~~~~  210 (316)
T d1fota_         156 -------DVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------------------MKTY  210 (316)
T ss_dssp             -------SCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------------------HHHH
T ss_pred             -------cccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH------------------HHHH
Confidence                   223456899999999999999999999999999999999999999853221                  1111


Q ss_pred             hhhhh--hcccHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 014024          344 DSVLE--EASFNESLSRYVHIALLCVQERAEDRP-----TMSDVVSM  383 (432)
Q Consensus       344 ~~~l~--~~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~~  383 (432)
                      ...+.  ...+...+.++.+++.+||+.||.+||     |++++++|
T Consensus       211 ~~i~~~~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         211 EKILNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             HHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             HHHHcCCCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence            11111  112233456788999999999999996     89999875

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-50  Score=387.30  Aligned_cols=248  Identities=21%  Similarity=0.278  Sum_probs=204.3

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC---ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEE
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK---SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLI  182 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  182 (432)
                      .++|++++.||+|+||.||+|++..  ..||+|++...   .....+.+.+|+.+|++++||||+++++++.+.+..|+|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            4689999999999999999999854  48999998543   123456788999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccC
Q 014024          183 YEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFG  262 (432)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  262 (432)
                      |||+++|+|.+++..   .+.+++..++.++.|++.||+|||+++   |+||||||+|||++++|.+||+|||+|+....
T Consensus        84 ~ey~~gg~L~~~~~~---~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~  157 (337)
T d1o6la_          84 MEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             EECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             eeccCCCchhhhhhc---ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccccc
Confidence            999999999999853   445999999999999999999999999   99999999999999999999999999986422


Q ss_pred             CCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhh
Q 014024          263 GNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDL  342 (432)
Q Consensus       263 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                      .      .......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.......  +    .......     
T Consensus       158 ~------~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~--~----~~~i~~~-----  220 (337)
T d1o6la_         158 D------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--L----FELILME-----  220 (337)
T ss_dssp             T------TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--H----HHHHHHC-----
T ss_pred             C------CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH--H----HHHHhcC-----
Confidence            1      123345789999999999999999999999999999999999999985432110  0    0000000     


Q ss_pred             hhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 014024          343 IDSVLEEASFNESLSRYVHIALLCVQERAEDRPT-----MSDVVSM  383 (432)
Q Consensus       343 i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt-----~~evl~~  383 (432)
                           ....+...+.++.+|+..||+.||.+||+     ++|+++|
T Consensus       221 -----~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H  261 (337)
T d1o6la_         221 -----EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             -----CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             -----CCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence                 01122334567889999999999999995     8888875

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-50  Score=379.65  Aligned_cols=257  Identities=27%  Similarity=0.407  Sum_probs=205.4

Q ss_pred             CceeccCCcEEEEEEEECCc-----eEEEEEEcC-CChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeC-CeeEEEEecC
Q 014024          114 ANKLGEGGFGTVYKGVIGQG-----EIAVKRLLG-KSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEK-DERLLIYEYM  186 (432)
Q Consensus       114 ~~~ig~G~~g~Vy~~~~~~~-----~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~  186 (432)
                      .++||+|+||+||+|.+.+.     .||||++.. ......+.|.+|+++|++++||||++++|++.+. ...++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            57899999999999997432     489999864 4566678899999999999999999999998764 5789999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCCc
Q 014024          187 PNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGNDE  266 (432)
Q Consensus       187 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  266 (432)
                      ++|+|.+++....  ..+++..++.++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++........
T Consensus       112 ~~g~l~~~~~~~~--~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         112 KHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             TTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             ecCchhhhhcccc--ccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence            9999999986533  34788999999999999999999998   999999999999999999999999999875332211


Q ss_pred             cccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhhhhh
Q 014024          267 DELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLIDSV  346 (432)
Q Consensus       267 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  346 (432)
                        .........||+.|+|||.+.++.++.++||||||+++|||+||+.|+..... .......             +...
T Consensus       187 --~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~-~~~~~~~-------------i~~g  250 (311)
T d1r0pa_         187 --SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-TFDITVY-------------LLQG  250 (311)
T ss_dssp             --CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHH-------------HHTT
T ss_pred             --cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC-HHHHHHH-------------HHcC
Confidence              12233345789999999999999999999999999999999998888643221 1111111             1111


Q ss_pred             hhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccccCC
Q 014024          347 LEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSL  391 (432)
Q Consensus       347 l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~  391 (432)
                      .+...+..++..+.+|+.+||+.||++|||+.||+++|+.+....
T Consensus       251 ~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~  295 (311)
T d1r0pa_         251 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  295 (311)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             CCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhh
Confidence            111223344567889999999999999999999999999987654

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-51  Score=383.51  Aligned_cols=260  Identities=28%  Similarity=0.398  Sum_probs=198.5

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC-------ceEEEEEEcCC-ChHhHHHHHHHHHHHHhc-CCCceeeeEeEEEeC-C
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ-------GEIAVKRLLGK-SGQEIKELKNEASVIAQV-QHKNLVKLLGCCIEK-D  177 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~-------~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-~  177 (432)
                      .++|++.+.||+|+||.||+|.+.+       +.||+|++... .....+.+.+|...+.++ +|+||+.+++++.+. .
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~   91 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   91 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence            4689999999999999999998632       26899998543 345566788888888877 689999999998765 4


Q ss_pred             eeEEEEecCCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEc
Q 014024          178 ERLLIYEYMPNKSLDCFLFDPT-------------KREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLD  244 (432)
Q Consensus       178 ~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~  244 (432)
                      ..++|||||++|+|.+++....             ....+++..+..++.|++.||+|||+++   |+||||||+|||++
T Consensus        92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~  168 (299)
T d1ywna1          92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS  168 (299)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC
T ss_pred             eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeEC
Confidence            6899999999999999986432             1345899999999999999999999999   99999999999999


Q ss_pred             CCCCEEEeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCC-CCCCccccc
Q 014024          245 KDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK-NTGFYRTKS  323 (432)
Q Consensus       245 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~-p~~~~~~~~  323 (432)
                      +++++||+|||+|+.......    ........||+.|+|||++.++.++.++|||||||++|||+||.. ||.......
T Consensus       169 ~~~~~Kl~DFGla~~~~~~~~----~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~  244 (299)
T d1ywna1         169 EKNVVKICDFGLARDIYKDPD----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  244 (299)
T ss_dssp             GGGCEEECC------CCSCTT----SCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred             CCCcEEEccCcchhhcccccc----ccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH
Confidence            999999999999986432211    123345679999999999999999999999999999999999754 554222110


Q ss_pred             cchhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014024          324 LNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEA  388 (432)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~  388 (432)
                                    .....+....+...+...+.++.+++.+||+.||++|||++||+++|+++.
T Consensus       245 --------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il  295 (299)
T d1ywna1         245 --------------EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  295 (299)
T ss_dssp             --------------HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --------------HHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence                          111122222222333445677899999999999999999999999998764

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-51  Score=380.24  Aligned_cols=256  Identities=25%  Similarity=0.344  Sum_probs=196.6

Q ss_pred             CCCCcCceeccCCcEEEEEEEECC---c--eEEEEEEcCC---ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeE
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQ---G--EIAVKRLLGK---SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERL  180 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~---~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  180 (432)
                      ++|++.+.||+|+||.||+|+...   .  .||||++...   .....+.|.+|+++|++++||||+++++++.+ +..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            579999999999999999998632   1  6899987543   34456789999999999999999999999965 4678


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceec
Q 014024          181 LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIV  260 (432)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  260 (432)
                      +||||+++|++.+++...  .+.+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++..
T Consensus        87 lv~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~  161 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL  161 (273)
T ss_dssp             EEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eeeeeecCcchhhhhhcc--cCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence            999999999999887542  345999999999999999999999998   999999999999999999999999999975


Q ss_pred             cCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCccccccchhhhhHHhhhccch
Q 014024          261 FGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTKSLNLIGYAWDLWISNKI  339 (432)
Q Consensus       261 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  339 (432)
                      ......   ........|+..|+|||.+.+..++.++||||||+++|||+| |+.||......+  .   .         
T Consensus       162 ~~~~~~---~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~--~---~---------  224 (273)
T d1u46a_         162 PQNDDH---YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ--I---L---------  224 (273)
T ss_dssp             CC-CCE---EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--H---H---------
T ss_pred             ccCCCc---ceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH--H---H---------
Confidence            332221   222334567889999999999999999999999999999998 899975322110  0   0         


Q ss_pred             hhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014024          340 IDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNE  387 (432)
Q Consensus       340 ~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~  387 (432)
                      ..+.....+...+...+..+.+|+.+||+.||++|||++||++.|++.
T Consensus       225 ~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         225 HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             HHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            111111112222334557789999999999999999999999999764

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=5e-50  Score=373.90  Aligned_cols=259  Identities=23%  Similarity=0.321  Sum_probs=199.5

Q ss_pred             hCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCC---ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC----e
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGK---SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKD----E  178 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~  178 (432)
                      .++|++.+.||+|+||.||+|.+.  +..||+|++...   +....+.+.+|+++++.++||||+++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            478999999999999999999975  448999998543   3455677999999999999999999999997654    3


Q ss_pred             eEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccce
Q 014024          179 RLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMAR  258 (432)
Q Consensus       179 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  258 (432)
                      .|+||||+++++|.+++..   .+.+++.+++.++.|++.||+|||+++   |+||||||+|||++.++..+++|||.+.
T Consensus        86 ~~lvmE~~~g~~L~~~~~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR  159 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred             EEEEEECCCCCEehhhhcc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence            7899999999999998843   445999999999999999999999999   9999999999999999999999999987


Q ss_pred             eccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccc
Q 014024          259 IVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNK  338 (432)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  338 (432)
                      .......   .........||+.|+|||++.+..++.++|||||||++|||+||+.||......     ...........
T Consensus       160 ~~~~~~~---~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-----~~~~~~~~~~~  231 (277)
T d1o6ya_         160 AIADSGN---SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-----SVAYQHVREDP  231 (277)
T ss_dssp             ECC-------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHCCC
T ss_pred             hhccccc---cccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH-----HHHHHHHhcCC
Confidence            6432221   122344568999999999999999999999999999999999999998532211     00111000000


Q ss_pred             hhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHhccc
Q 014024          339 IIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRP-TMSDVVSMLTNE  387 (432)
Q Consensus       339 ~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RP-t~~evl~~L~~~  387 (432)
                      .       .........+.++.+++.+||+.||++|| |++++++.|..+
T Consensus       232 ~-------~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~  274 (277)
T d1o6ya_         232 I-------PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  274 (277)
T ss_dssp             C-------CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             C-------CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence            0       00011123456788999999999999999 899999888764

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1e-49  Score=382.84  Aligned_cols=244  Identities=23%  Similarity=0.267  Sum_probs=202.8

Q ss_pred             CCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCCC---hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEE
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGKS---GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIY  183 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  183 (432)
                      ++|++++.||+|+||.||+|++.  +..||+|++....   ....+.+.+|+++|+.++||||+++++++.+....++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            68999999999999999999985  3489999985331   233567889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCC
Q 014024          184 EYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGG  263 (432)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  263 (432)
                      ||+.+|+|.+++..   .+.+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.+.  
T Consensus       121 e~~~~g~l~~~l~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~--  192 (350)
T d1rdqe_         121 EYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--  192 (350)
T ss_dssp             ECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECS--
T ss_pred             ccccccchhhhHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecc--
Confidence            99999999999853   345999999999999999999999999   9999999999999999999999999998752  


Q ss_pred             CCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhh
Q 014024          264 NDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLI  343 (432)
Q Consensus       264 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i  343 (432)
                             .......||+.|+|||++.+..++.++|||||||++|||+||+.||.....     .... .        .+.
T Consensus       193 -------~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-----~~~~-~--------~i~  251 (350)
T d1rdqe_         193 -------GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-----IQIY-E--------KIV  251 (350)
T ss_dssp             -------SCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHH-H--------HHH
T ss_pred             -------cccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH-----HHHH-H--------HHh
Confidence                   223456899999999999999999999999999999999999999853211     0000 0        000


Q ss_pred             hhhhhhcccHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 014024          344 DSVLEEASFNESLSRYVHIALLCVQERAEDRP-----TMSDVVSM  383 (432)
Q Consensus       344 ~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~~  383 (432)
                      ..  ....+...+.++.+++.+||+.||.+|+     |++++++|
T Consensus       252 ~~--~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H  294 (350)
T d1rdqe_         252 SG--KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             HC--CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             cC--CCCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence            00  0112233456788999999999999994     89999974

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-50  Score=378.40  Aligned_cols=259  Identities=28%  Similarity=0.411  Sum_probs=206.5

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC---------ceEEEEEEcCCC-hHhHHHHHHHHHHHHhc-CCCceeeeEeEEEeC
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ---------GEIAVKRLLGKS-GQEIKELKNEASVIAQV-QHKNLVKLLGCCIEK  176 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~---------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  176 (432)
                      .++|++.+.||+|+||.||+|+..+         ..||||++.... ......+.+|...+.++ +|||||+++++|.++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            4689999999999999999998632         258999986543 45567888999999888 799999999999999


Q ss_pred             CeeEEEEecCCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEE
Q 014024          177 DERLLIYEYMPNKSLDCFLFDPT-------------KREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILL  243 (432)
Q Consensus       177 ~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll  243 (432)
                      +..++||||+++|+|.+++....             ....+++.+++.++.|++.||+|||+.+   |+||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence            99999999999999999996532             1245899999999999999999999999   9999999999999


Q ss_pred             cCCCCEEEeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHh-CCCCCCCcccc
Q 014024          244 DKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGFYRTK  322 (432)
Q Consensus       244 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~ellt-g~~p~~~~~~~  322 (432)
                      +.++.+||+|||++........    ........||+.|+|||.+.++.++.++||||||+++|||++ |..||......
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~  244 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDY----YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE  244 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCT----TCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             cCCCCeEeccchhhcccccccc----ccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH
Confidence            9999999999999987532221    223445678999999999999999999999999999999998 67776432211


Q ss_pred             ccchhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014024          323 SLNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEA  388 (432)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~  388 (432)
                                     .+.+.+........+...+.++.+|+.+||+.||++|||+.||++.|+++.
T Consensus       245 ---------------~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~  295 (299)
T d1fgka_         245 ---------------ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  295 (299)
T ss_dssp             ---------------HHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---------------HHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence                           111222222222333445577899999999999999999999999998764

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.9e-49  Score=368.93  Aligned_cols=251  Identities=22%  Similarity=0.328  Sum_probs=202.5

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCC---------hHhHHHHHHHHHHHHhcC-CCceeeeEeEEEe
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS---------GQEIKELKNEASVIAQVQ-HKNLVKLLGCCIE  175 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~  175 (432)
                      .++|++.+.||+|+||+||+|++..  ..+|+|++....         ....+.+.+|+.++++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            4789999999999999999999843  489999985442         223456889999999997 9999999999999


Q ss_pred             CCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecc
Q 014024          176 KDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFG  255 (432)
Q Consensus       176 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  255 (432)
                      ++..|+||||+++|+|.+++..   ++.+++.+++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG  155 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG  155 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred             CcceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccch
Confidence            9999999999999999999953   446999999999999999999999999   9999999999999999999999999


Q ss_pred             cceeccCCCCccccccccccccccCCccChhhhcc------CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhh
Q 014024          256 MARIVFGGNDEDELQGNTSRISGTYGYMSPEYALE------GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGY  329 (432)
Q Consensus       256 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~  329 (432)
                      ++......       .......||+.|+|||++.+      ..++.++||||+||++|||++|+.||.......  .   
T Consensus       156 ~a~~~~~~-------~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~--~---  223 (277)
T d1phka_         156 FSCQLDPG-------EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML--M---  223 (277)
T ss_dssp             TCEECCTT-------CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--H---
T ss_pred             heeEccCC-------CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH--H---
Confidence            99875221       12344679999999998863      347899999999999999999999986332110  0   


Q ss_pred             hHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          330 AWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       330 ~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                       .........      ..........+.++.+++.+||+.||++|||++|++++
T Consensus       224 -~~~i~~~~~------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         224 -LRMIMSGNY------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             -HHHHHHTCC------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             -HHHHHhCCC------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence             000000000      00111122345678899999999999999999999875

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-49  Score=375.71  Aligned_cols=245  Identities=22%  Similarity=0.317  Sum_probs=202.5

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEec
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEY  185 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  185 (432)
                      .++|++.+.||+|+||+||+|.+..  ..||+|.+..... ....+.+|+++|++++||||+++++++.+.+..|+||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            4789999999999999999999864  3799999866543 345688999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcC--CCCEEEeecccceeccCC
Q 014024          186 MPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDK--DMNSKISDFGMARIVFGG  263 (432)
Q Consensus       186 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~Dfg~a~~~~~~  263 (432)
                      |++|+|.+++...  ...+++.+++.++.||+.||+|||+.+   |+||||||+|||++.  .+.+||+|||++......
T Consensus        83 ~~gg~L~~~i~~~--~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~  157 (321)
T d1tkia_          83 ISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence            9999999999543  234999999999999999999999999   999999999999985  457999999999875221


Q ss_pred             CCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhhh
Q 014024          264 NDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDLI  343 (432)
Q Consensus       264 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i  343 (432)
                             .......+|+.|+|||...+..++.++|||||||++|+|++|+.||......                  +.+
T Consensus       158 -------~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~------------------~~~  212 (321)
T d1tkia_         158 -------DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ------------------QII  212 (321)
T ss_dssp             -------CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH------------------HHH
T ss_pred             -------CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH------------------HHH
Confidence                   1234467899999999999999999999999999999999999998532211                  111


Q ss_pred             hhhhhhc------ccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          344 DSVLEEA------SFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       344 ~~~l~~~------~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      .......      .....+.++.+|+..||+.||++|||+.|++++
T Consensus       213 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         213 ENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             HHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             HHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            1111110      011234568899999999999999999999984

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-50  Score=377.86  Aligned_cols=274  Identities=22%  Similarity=0.264  Sum_probs=201.3

Q ss_pred             CCCCcCceeccCCcEEEEEEEECCceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC----eeEEEEe
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKD----ERLLIYE  184 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e  184 (432)
                      .+|.+.+.||+|+||.||+|+.++..||||++..... .....+.|+..+.+++||||+++++++.+.+    ..++|||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E   81 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD   81 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence            4577789999999999999999888999999854322 2222344555666789999999999998654    5789999


Q ss_pred             cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEeccCCCCCEEEcCCCCEEEeeccccee
Q 014024          185 YMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQY-----SRVRIIHRDLKASNILLDKDMNSKISDFGMARI  259 (432)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-----~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  259 (432)
                      |+++|+|.+++..    ..++|..++.++.|++.||+|||+.     +..+|+||||||+||||++++.+||+|||+++.
T Consensus        82 y~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~  157 (303)
T d1vjya_          82 YHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             CCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             cccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence            9999999999953    3499999999999999999999974     122499999999999999999999999999997


Q ss_pred             ccCCCCccccccccccccccCCccChhhhccCC------CCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHh
Q 014024          260 VFGGNDEDELQGNTSRISGTYGYMSPEYALEGI------FSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDL  333 (432)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~  333 (432)
                      .......  .........||+.|+|||++.+..      ++.++|||||||+||||+||..|+.................
T Consensus       158 ~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~  235 (303)
T d1vjya_         158 HDSATDT--IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EETTTTE--ECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccCCCcc--eeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence            6443221  122344568999999999987542      67899999999999999999988754333221111100000


Q ss_pred             hhccchh-hhhhhhhh-----hcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccc
Q 014024          334 WISNKII-DLIDSVLE-----EASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS  389 (432)
Q Consensus       334 ~~~~~~~-~~i~~~l~-----~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~  389 (432)
                      ....... ...+..++     .....+....+.+|+.+||+.||++|||+.||++.|+.+..
T Consensus       236 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  297 (303)
T d1vjya_         236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             chHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence            0000000 11111111     11133466779999999999999999999999999987653

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-49  Score=376.77  Aligned_cols=260  Identities=27%  Similarity=0.420  Sum_probs=210.0

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC-------ceEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCee
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ-------GEIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDER  179 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~-------~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  179 (432)
                      .++|++.+.||+|+||.||+|.+.+       ..||||++... .......+.+|++++++++||||+++++++...+..
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~   98 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   98 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence            4688899999999999999998742       37999998644 445556789999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhhhcCC-------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEe
Q 014024          180 LLIYEYMPNKSLDCFLFDP-------TKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKIS  252 (432)
Q Consensus       180 ~lv~e~~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  252 (432)
                      ++||||+++|+|.+++...       .....+++..+..++.|+++||.|||+++   |+||||||+|||+++++++||+
T Consensus        99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~  175 (308)
T d1p4oa_          99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG  175 (308)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred             eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence            9999999999999988532       22234789999999999999999999998   9999999999999999999999


Q ss_pred             ecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCC-CCCCCccccccchhhhhH
Q 014024          253 DFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK-KNTGFYRTKSLNLIGYAW  331 (432)
Q Consensus       253 Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~-~p~~~~~~~~~~~~~~~~  331 (432)
                      |||+++.+....    .........||+.|+|||.+.++.++.++||||||+++|||+||. .|+.....          
T Consensus       176 DFGla~~~~~~~----~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~----------  241 (308)
T d1p4oa_         176 DFGMTRDIYETD----YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN----------  241 (308)
T ss_dssp             CTTCCCGGGGGG----CEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH----------
T ss_pred             ecccceeccCCc----ceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH----------
Confidence            999998652211    122334457899999999999999999999999999999999986 55532211          


Q ss_pred             HhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccc
Q 014024          332 DLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS  389 (432)
Q Consensus       332 ~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~  389 (432)
                           ......+........+..++..+.+++.+||+.||++|||+.+|+++|++...
T Consensus       242 -----~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         242 -----EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             -----HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             -----HHHHHHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence                 01111111111222334455789999999999999999999999999988654

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-49  Score=377.14  Aligned_cols=262  Identities=28%  Similarity=0.378  Sum_probs=212.1

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC-------ceEEEEEEcCC-ChHhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCe
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ-------GEIAVKRLLGK-SGQEIKELKNEASVIAQV-QHKNLVKLLGCCIEKDE  178 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~-------~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  178 (432)
                      .++|++.++||+|+||.||+|++.+       ..||||++... .......+.+|+.+++.+ +|||||+++++|.+.+.
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence            4789999999999999999998622       27999998654 445566789999999999 69999999999999999


Q ss_pred             eEEEEecCCCCChhhhhcCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEE
Q 014024          179 RLLIYEYMPNKSLDCFLFDPT---------------KREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILL  243 (432)
Q Consensus       179 ~~lv~e~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll  243 (432)
                      .++||||+++|+|.++++...               ....+++..+..++.|++.||+|||+++   ++||||||+||++
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~  178 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL  178 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence            999999999999999986432               2235899999999999999999999999   9999999999999


Q ss_pred             cCCCCEEEeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccc
Q 014024          244 DKDMNSKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKS  323 (432)
Q Consensus       244 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~  323 (432)
                      +.++.+|++|||+++.......    ........||+.|+|||.+.++.++.++|||||||++|||+|+..|+.......
T Consensus       179 ~~~~~~ki~DfG~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~  254 (311)
T d1t46a_         179 THGRITKICDFGLARDIKNDSN----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD  254 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTT----SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred             cccCcccccccchheeccCCCc----ceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999987532211    123345688999999999999999999999999999999999555532221111


Q ss_pred             cchhhhhHHhhhccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccc
Q 014024          324 LNLIGYAWDLWISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS  389 (432)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~  389 (432)
                                   .....+++...+...+...+..+.+|+.+||+.||++|||+.+|+++|++...
T Consensus       255 -------------~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~  307 (311)
T d1t46a_         255 -------------SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS  307 (311)
T ss_dssp             -------------HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -------------HHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence                         11222333333333444556789999999999999999999999999987654

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3.6e-49  Score=381.04  Aligned_cols=247  Identities=23%  Similarity=0.252  Sum_probs=196.8

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCC---hHhHHHHH---HHHHHHHhcCCCceeeeEeEEEeCCee
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS---GQEIKELK---NEASVIAQVQHKNLVKLLGCCIEKDER  179 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~---~~~~~~~~---~E~~~l~~l~h~niv~~~~~~~~~~~~  179 (432)
                      .++|++.++||+|+||.||+|++..  ..||+|++....   ......+.   +|+++++.++||||+++++++.+.+..
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            3689999999999999999999854  489999985321   11122233   446677777899999999999999999


Q ss_pred             EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeeccccee
Q 014024          180 LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARI  259 (432)
Q Consensus       180 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  259 (432)
                      |+||||+++|+|.+++..   +..+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+.
T Consensus        83 ~ivmE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~  156 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD  156 (364)
T ss_dssp             EEEECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred             EEEEEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeee
Confidence            999999999999999953   445899999999999999999999999   99999999999999999999999999987


Q ss_pred             ccCCCCccccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccc
Q 014024          260 VFGGNDEDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNK  338 (432)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  338 (432)
                      +..        .......||+.|+|||++.. ..++.++|||||||++|||+||+.||.........             
T Consensus       157 ~~~--------~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~-------------  215 (364)
T d1omwa3         157 FSK--------KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-------------  215 (364)
T ss_dssp             CSS--------SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH-------------
T ss_pred             cCC--------CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH-------------
Confidence            522        12344679999999999975 56899999999999999999999998643321110             


Q ss_pred             hhhhhhhhh--hhcccHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 014024          339 IIDLIDSVL--EEASFNESLSRYVHIALLCVQERAEDRPT-----MSDVVSM  383 (432)
Q Consensus       339 ~~~~i~~~l--~~~~~~~~~~~l~~l~~~cl~~dp~~RPt-----~~evl~~  383 (432)
                        .+.....  ....+...+.++.+|+..||+.||++|||     ++|+++|
T Consensus       216 --~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H  265 (364)
T d1omwa3         216 --EIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  265 (364)
T ss_dssp             --HHHHHSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred             --HHHHhcccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence              0010000  01112234567889999999999999999     6888874

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-49  Score=376.77  Aligned_cols=246  Identities=25%  Similarity=0.339  Sum_probs=199.1

Q ss_pred             CCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCC---hHhHHHHHHHHHHHH-hcCCCceeeeEeEEEeCCeeEEE
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKS---GQEIKELKNEASVIA-QVQHKNLVKLLGCCIEKDERLLI  182 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~lv  182 (432)
                      ++|++.+.||+|+||+||+|.+..  ..||+|++....   ....+.+..|..++. .++||||+++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            689999999999999999999854  489999985431   223455666777665 68999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccC
Q 014024          183 YEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFG  262 (432)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  262 (432)
                      |||+++|+|.+++..   ...+++..+..++.||+.||+|||+++   |+||||||+|||+++++++||+|||+++....
T Consensus        82 mEy~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~  155 (320)
T d1xjda_          82 MEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML  155 (320)
T ss_dssp             EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EeecCCCcHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence            999999999999953   345899999999999999999999999   99999999999999999999999999986422


Q ss_pred             CCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchhhh
Q 014024          263 GNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKIIDL  342 (432)
Q Consensus       263 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                      .      ........||+.|+|||++.+..++.++|||||||++|||+||+.||.......      ........     
T Consensus       156 ~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~------~~~~i~~~-----  218 (320)
T d1xjda_         156 G------DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE------LFHSIRMD-----  218 (320)
T ss_dssp             T------TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHC-----
T ss_pred             c------cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH------HHHHHHcC-----
Confidence            1      223345679999999999999999999999999999999999999985322110      00000000     


Q ss_pred             hhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHH-HHHH
Q 014024          343 IDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMS-DVVS  382 (432)
Q Consensus       343 i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~-evl~  382 (432)
                           ....+...+.++.+|+.+||+.||++|||+. ++++
T Consensus       219 -----~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         219 -----NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             -----CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             -----CCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence                 0111223456788999999999999999995 7865

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-49  Score=369.50  Aligned_cols=257  Identities=21%  Similarity=0.254  Sum_probs=192.0

Q ss_pred             cCceeccCCcEEEEEEEECC--ceEEEEEEcCCChH-----hHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEec
Q 014024          113 AANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSGQ-----EIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEY  185 (432)
Q Consensus       113 ~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  185 (432)
                      .+++||+|+||+||+|.+..  ..||||++......     ..+.+.+|+++|++++||||+++++++.+++..++||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            35789999999999999854  37999988543221     234688999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCC
Q 014024          186 MPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGND  265 (432)
Q Consensus       186 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  265 (432)
                      +.++++..+..   .+..+++..+..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||++......  
T Consensus        82 ~~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~--  153 (299)
T d1ua2a_          82 METDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP--  153 (299)
T ss_dssp             CSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC--
T ss_pred             hcchHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCC--
Confidence            99988776662   3455999999999999999999999999   999999999999999999999999999764221  


Q ss_pred             ccccccccccccccCCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhc---cchh-
Q 014024          266 EDELQGNTSRISGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWIS---NKII-  340 (432)
Q Consensus       266 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~-  340 (432)
                          ........||+.|+|||++.+. .++.++|||||||++|||+||..||......+  ...........   .... 
T Consensus       154 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~--~l~~i~~~~~~~~~~~~~~  227 (299)
T d1ua2a_         154 ----NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD--QLTRIFETLGTPTEEQWPD  227 (299)
T ss_dssp             ----CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCTTTSSS
T ss_pred             ----cccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH--HHHHHHHhcCCCChhhccc
Confidence                1223345799999999998754 57999999999999999999999985432211  10000000000   0000 


Q ss_pred             --hh---h-----hhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          341 --DL---I-----DSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       341 --~~---i-----~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                        ..   .     ..............++.+|+.+||+.||++|||++|+++|
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H  280 (299)
T d1ua2a_         228 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  280 (299)
T ss_dssp             TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence              00   0     0000000011223578899999999999999999999985

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-49  Score=370.05  Aligned_cols=268  Identities=20%  Similarity=0.254  Sum_probs=199.4

Q ss_pred             CCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCCC--hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEe
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGKS--GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYE  184 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  184 (432)
                      ++|++++.||+|+||+||+|.+.  +..||+|++....  ....+.+.+|+++|++++||||+++++++.+++..|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            68999999999999999999985  3489999985442  2335678999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCC
Q 014024          185 YMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGN  264 (432)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  264 (432)
                      |+.++++......  ....+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++..... 
T Consensus        82 ~~~~~~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~-  155 (298)
T d1gz8a_          82 FLHQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-  155 (298)
T ss_dssp             CCSEEHHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC-
T ss_pred             ecCCchhhhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCC-
Confidence            9976655443332  2334999999999999999999999999   999999999999999999999999999865221 


Q ss_pred             CccccccccccccccCCccChhhhccCC-CCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhh-ccc----
Q 014024          265 DEDELQGNTSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWI-SNK----  338 (432)
Q Consensus       265 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~-~~~----  338 (432)
                           ........||+.|+|||.+.... ++.++|||||||++|+|++|+.||......+. +......... .+.    
T Consensus       156 -----~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~~  229 (298)
T d1gz8a_         156 -----VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ-LFRIFRTLGTPDEVVWPG  229 (298)
T ss_dssp             -----SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTTTSTT
T ss_pred             -----cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH-HHHHHHhcCCCchhhccc
Confidence                 22334567999999999887655 58999999999999999999999864322110 0000000000 000    


Q ss_pred             hhhhhh------hhhh---hcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--hcccc
Q 014024          339 IIDLID------SVLE---EASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM--LTNEA  388 (432)
Q Consensus       339 ~~~~i~------~~l~---~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~--L~~~~  388 (432)
                      .....+      ....   .........++.+|+.+||+.||++|||++|++++  ++++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~  290 (298)
T d1gz8a_         230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT  290 (298)
T ss_dssp             GGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             cccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCC
Confidence            000000      0000   00011223567889999999999999999999986  55543

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-49  Score=374.58  Aligned_cols=252  Identities=18%  Similarity=0.244  Sum_probs=195.3

Q ss_pred             hCCCCcCc-eeccCCcEEEEEEEECC--ceEEEEEEcCCChHhHHHHHHHHHHHHhc-CCCceeeeEeEEEe----CCee
Q 014024          108 TGNFSAAN-KLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSGQEIKELKNEASVIAQV-QHKNLVKLLGCCIE----KDER  179 (432)
Q Consensus       108 ~~~y~~~~-~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~----~~~~  179 (432)
                      .++|.+.+ +||+|+||+||+|.+..  ..||+|++...     ..+.+|+.++.++ +||||++++++|.+    ....
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            46898875 69999999999999854  48999998542     4567899987654 89999999999875    3568


Q ss_pred             EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcC---CCCEEEeeccc
Q 014024          180 LLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDK---DMNSKISDFGM  256 (432)
Q Consensus       180 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg~  256 (432)
                      |+|||||+||+|.+++.... ...+++.+++.++.|++.||+|||+.+   |+||||||+|||+++   ++.+||+|||+
T Consensus        85 ~ivmEy~~gg~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~  160 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF  160 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEECCCCCcHHHHHHhcC-CCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence            99999999999999996532 235999999999999999999999999   999999999999985   56799999999


Q ss_pred             ceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhc
Q 014024          257 ARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWIS  336 (432)
Q Consensus       257 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  336 (432)
                      ++.....       .......||+.|+|||++.+..++.++|||||||++|+|+||+.||.......  ...........
T Consensus       161 a~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~--~~~~~~~~i~~  231 (335)
T d2ozaa1         161 AKETTSH-------NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA--ISPGMKTRIRM  231 (335)
T ss_dssp             CEECCCC-------CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------CCCS
T ss_pred             eeeccCC-------CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH--HHHHHHHHHhc
Confidence            9875322       12345679999999999999999999999999999999999999985322111  00000000000


Q ss_pred             cchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          337 NKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       337 ~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      .. .++     ........+.++.+|+.+||+.||++|||+.|++++
T Consensus       232 ~~-~~~-----~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         232 GQ-YEF-----PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             CS-SSC-----CTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CC-CCC-----CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            00 000     001112345678899999999999999999999985

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-49  Score=365.00  Aligned_cols=240  Identities=24%  Similarity=0.359  Sum_probs=194.0

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCCh------HhHHHHHHHHHHHHhcC--CCceeeeEeEEEeCC
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSG------QEIKELKNEASVIAQVQ--HKNLVKLLGCCIEKD  177 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~  177 (432)
                      .++|++.++||+|+||+||+|.+..  ..||+|++.....      .....+.+|+.+|++++  ||||+++++++.+.+
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            4689999999999999999999853  4899998853311      11234678999999997  899999999999999


Q ss_pred             eeEEEEecCCC-CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcC-CCCEEEeecc
Q 014024          178 ERLLIYEYMPN-KSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDK-DMNSKISDFG  255 (432)
Q Consensus       178 ~~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg  255 (432)
                      ..++||||+.+ +++.+++..   +..+++..++.++.|++.||+|||+++   |+||||||+|||++. ++.+||+|||
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG  156 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG  156 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             eEEEEEEeccCcchHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccc
Confidence            99999999976 577777743   345999999999999999999999999   999999999999985 5789999999


Q ss_pred             cceeccCCCCccccccccccccccCCccChhhhccCCC-CchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhh
Q 014024          256 MARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLW  334 (432)
Q Consensus       256 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  334 (432)
                      ++.....        .......||+.|+|||++.+..+ +.++|||||||++|||+||+.||.....             
T Consensus       157 ~a~~~~~--------~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------------  215 (273)
T d1xwsa_         157 SGALLKD--------TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------------  215 (273)
T ss_dssp             TCEECCS--------SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------------
T ss_pred             cceeccc--------ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-------------
Confidence            9986421        12345679999999999987765 6789999999999999999999853210             


Q ss_pred             hccchhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          335 ISNKIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       335 ~~~~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                             +....  ...+...+.++.+++.+||+.||++|||++|++++
T Consensus       216 -------i~~~~--~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  255 (273)
T d1xwsa_         216 -------IIRGQ--VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  255 (273)
T ss_dssp             -------HHHCC--CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -------Hhhcc--cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence                   00000  01112234678899999999999999999999885

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=6.4e-48  Score=361.35  Aligned_cols=261  Identities=21%  Similarity=0.287  Sum_probs=198.4

Q ss_pred             CCCCcCceeccCCcEEEEEEEECCc-eEEEEEEcCCC--hHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEec
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKS--GQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYEY  185 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~~-~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  185 (432)
                      ++|++.++||+|+||+||+|++..+ .||+|++....  ....+.+.+|+.+|++++||||+++++++.+.+..+++||+
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            6899999999999999999998754 89999986543  23356889999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCCC
Q 014024          186 MPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGND  265 (432)
Q Consensus       186 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  265 (432)
                      +.++++..+..   .++.+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+|++|||.+......  
T Consensus        82 ~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~--  153 (286)
T d1ob3a_          82 LDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP--  153 (286)
T ss_dssp             CSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             ehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccC--
Confidence            98888777763   3455999999999999999999999998   999999999999999999999999999875221  


Q ss_pred             ccccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhh---ccchh-
Q 014024          266 EDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWI---SNKII-  340 (432)
Q Consensus       266 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~-  340 (432)
                          ........+++.|+|||.+.+ ..++.++|||||||++|||++|+.||......+  ..........   ..... 
T Consensus       154 ----~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~--~~~~i~~~~~~~~~~~~~~  227 (286)
T d1ob3a_         154 ----VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD--QLMRIFRILGTPNSKNWPN  227 (286)
T ss_dssp             ------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCTTTSTT
T ss_pred             ----ccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH--HHHHHHHhhCCCChhhccc
Confidence                122344568999999999875 457999999999999999999999986432211  0000000000   00000 


Q ss_pred             --hh---------hhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          341 --DL---------IDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       341 --~~---------i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                        ..         ................+.+++.+||+.||++|||++|++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H  281 (286)
T d1ob3a_         228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (286)
T ss_dssp             GGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              00         00000011112234578899999999999999999999864

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-48  Score=363.66  Aligned_cols=263  Identities=22%  Similarity=0.296  Sum_probs=194.2

Q ss_pred             hhCCCCcCceeccCCcEEEEEEEECC--c-eEEEEEEcCC--ChHhHHHHHHHHHHHHhc---CCCceeeeEeEEEe---
Q 014024          107 ATGNFSAANKLGEGGFGTVYKGVIGQ--G-EIAVKRLLGK--SGQEIKELKNEASVIAQV---QHKNLVKLLGCCIE---  175 (432)
Q Consensus       107 ~~~~y~~~~~ig~G~~g~Vy~~~~~~--~-~vavK~~~~~--~~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~---  175 (432)
                      ..++|++++.||+|+||+||+|++..  + .||+|++...  .......+.+|+.+|+.+   +||||++++++|..   
T Consensus         5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            45799999999999999999999842  3 5899988432  222223455677776665   89999999999853   


Q ss_pred             --CCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEee
Q 014024          176 --KDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISD  253 (432)
Q Consensus       176 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  253 (432)
                        ....+++|||++++++......  ....+++..++.++.|++.||+|||+++   |+||||||+|||+++++.+||+|
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~d  159 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD  159 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred             ccCceEEEEEEeccCCchhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecc
Confidence              2467899999998877655433  3344899999999999999999999999   99999999999999999999999


Q ss_pred             cccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHh
Q 014024          254 FGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDL  333 (432)
Q Consensus       254 fg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~  333 (432)
                      ||++....       .........||+.|+|||++.+..++.++||||+||++|||++|+.||......+  ........
T Consensus       160 fg~~~~~~-------~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~~~~i~~~  230 (305)
T d1blxa_         160 FGLARIYS-------FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD--QLGKILDV  230 (305)
T ss_dssp             CCSCCCCC-------GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHH
T ss_pred             hhhhhhhc-------ccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH--HHHHHHHh
Confidence            99987531       1223455789999999999999999999999999999999999999986432211  00000000


Q ss_pred             hhcc---c------h-hhhhh---hhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          334 WISN---K------I-IDLID---SVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       334 ~~~~---~------~-~~~i~---~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                      ....   .      . .....   ..............+.+|+.+||+.||++|||++|++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         231 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             HCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            0000   0      0 00000   000001112234567889999999999999999999986

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=3.9e-46  Score=350.00  Aligned_cols=267  Identities=16%  Similarity=0.201  Sum_probs=207.3

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCChHhHHHHHHHHHHHHhcCC-CceeeeEeEEEeCCeeEEEEe
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSGQEIKELKNEASVIAQVQH-KNLVKLLGCCIEKDERLLIYE  184 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e  184 (432)
                      .++|++.+.||+|+||+||+|++..  ..||+|++.....  ...+.+|++.++.++| +|++.+++++.+....++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            4789999999999999999999753  4899998754432  2457789999999976 899999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcC-----CCCEEEeeccccee
Q 014024          185 YMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDK-----DMNSKISDFGMARI  259 (432)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~Dfg~a~~  259 (432)
                      |+ +++|.+++....  ..+++..+..++.|++.||+|||+++   |+||||||+|||++.     ++.+||+|||+|+.
T Consensus        82 ~~-~~~l~~~~~~~~--~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~  155 (293)
T d1csna_          82 LL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  155 (293)
T ss_dssp             CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             ec-CCCHHHHHHhhc--cchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence            99 689988885433  34999999999999999999999999   999999999999974     57899999999998


Q ss_pred             ccCCCCcccc-ccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccch-hhhhHHhhhcc
Q 014024          260 VFGGNDEDEL-QGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNL-IGYAWDLWISN  337 (432)
Q Consensus       260 ~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~  337 (432)
                      +......... ........||+.|+|||++.+..++.++|||||||++|||+||+.||.......... ...........
T Consensus       156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (293)
T d1csna_         156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST  235 (293)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred             cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence            6443222211 223445689999999999999999999999999999999999999986443321110 00000000000


Q ss_pred             chhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccccCC
Q 014024          338 KIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEASSL  391 (432)
Q Consensus       338 ~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~  391 (432)
                      ..     +.+    ....+.++.+++..|++.+|++||+++.+.+.|++.....
T Consensus       236 ~~-----~~l----~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~  280 (293)
T d1csna_         236 PL-----REL----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL  280 (293)
T ss_dssp             CH-----HHH----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             Ch-----HHh----cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence            00     011    1123467889999999999999999999999888765444

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-46  Score=360.17  Aligned_cols=263  Identities=22%  Similarity=0.300  Sum_probs=194.5

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC------
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKD------  177 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------  177 (432)
                      .++|++++.||+|+||+||+|.+..  ..||+|++...  .....+.+.+|+++|++++|||||+++++|...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            5789999999999999999999863  48999998643  4455678899999999999999999999997654      


Q ss_pred             eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccc
Q 014024          178 ERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMA  257 (432)
Q Consensus       178 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  257 (432)
                      ..|+||||+ +.+|..+..    +..+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+|++|||++
T Consensus        97 ~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a  168 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA  168 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence            469999999 667777663    345999999999999999999999999   999999999999999999999999999


Q ss_pred             eeccCCCCccccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCcccccc-chhh-------
Q 014024          258 RIVFGGNDEDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSL-NLIG-------  328 (432)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~-~~~~-------  328 (432)
                      ...         ........||+.|+|||.+.+ ..++.++||||+||++|+|++|+.||........ ....       
T Consensus       169 ~~~---------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  239 (346)
T d1cm8a_         169 RQA---------DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP  239 (346)
T ss_dssp             EEC---------CSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             ecc---------CCccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCc
Confidence            874         123345679999999999876 4579999999999999999999999864332110 0000       


Q ss_pred             -hhHHhhhccchhhhhhhhh-------hhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--hcccc
Q 014024          329 -YAWDLWISNKIIDLIDSVL-------EEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM--LTNEA  388 (432)
Q Consensus       329 -~~~~~~~~~~~~~~i~~~l-------~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~--L~~~~  388 (432)
                       ..+.... ..........+       ...........+.+|+.+||+.||++|||+.|++++  ++.+.
T Consensus       240 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         240 AEFVQRLQ-SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             HHHHHTCS-CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             HHHHhhhc-chhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence             0000000 00000000000       000111233567899999999999999999999986  55544

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.3e-46  Score=350.50  Aligned_cols=266  Identities=21%  Similarity=0.247  Sum_probs=197.6

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCc-eeeeEeEEEeCCeeEEEEe
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSGQEIKELKNEASVIAQVQHKN-LVKLLGCCIEKDERLLIYE  184 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e  184 (432)
                      .++|++.+.||+|+||.||+|.+..  ..||||++.....  .+++..|+++++.++|+| |+.+.+++.+.+..++|||
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence            4679999999999999999999853  4899998765432  245788999999998766 4555666678888999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEc---CCCCEEEeecccceecc
Q 014024          185 YMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLD---KDMNSKISDFGMARIVF  261 (432)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Dfg~a~~~~  261 (432)
                      |+. +++.+.+...  ...+++..+..++.|++.||+|||+++   |+||||||+|||++   .+..+||+|||+|+.+.
T Consensus        84 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~  157 (299)
T d1ckia_          84 LLG-PSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  157 (299)
T ss_dssp             CCC-CBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred             EcC-Cchhhhhhhc--cCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence            995 5555555332  334999999999999999999999999   99999999999985   45579999999999864


Q ss_pred             CCCCcccc-ccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccchh
Q 014024          262 GGNDEDEL-QGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNKII  340 (432)
Q Consensus       262 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                      ........ ........||+.|+|||.+.+..++.++|||||||++|||+||+.||..............   ...... 
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~---~~~~~~-  233 (299)
T d1ckia_         158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER---ISEKKM-  233 (299)
T ss_dssp             CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHH---HHHHHH-
T ss_pred             ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHH---hhcccC-
Confidence            33222111 1233456899999999999999999999999999999999999999865433211100000   000000 


Q ss_pred             hhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccc
Q 014024          341 DLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSMLTNEAS  389 (432)
Q Consensus       341 ~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~  389 (432)
                      ....+    ......+.++.+++..||+.+|++||+++++.+.|++...
T Consensus       234 ~~~~~----~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~  278 (299)
T d1ckia_         234 STPIE----VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  278 (299)
T ss_dssp             HSCHH----HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred             CCChh----HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence            00000    1112345678899999999999999999999988887643

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-46  Score=358.39  Aligned_cols=264  Identities=19%  Similarity=0.269  Sum_probs=195.2

Q ss_pred             hCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCC-ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC----eeE
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGK-SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKD----ERL  180 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~  180 (432)
                      +++|++++.||+|+||+||+|.+.  +..||||++... .....+.+.+|+++|++++|||++++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            568999999999999999999985  448999998644 3455678899999999999999999999997653    234


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceec
Q 014024          181 LIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIV  260 (432)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  260 (432)
                      ++++++.+|+|.+++..    ..+++..++.++.|++.||+|||+++   |+||||||+|||+++++.+||+|||++...
T Consensus        87 ~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~  159 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA  159 (345)
T ss_dssp             EEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence            55566779999999853    34999999999999999999999999   999999999999999999999999999875


Q ss_pred             cCCCCccccccccccccccCCccChhhhc-cCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhccc-
Q 014024          261 FGGNDEDELQGNTSRISGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISNK-  338 (432)
Q Consensus       261 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-  338 (432)
                      .....   .........||+.|+|||++. +..++.++||||+||++|+|++|+.||......+.  ............ 
T Consensus       160 ~~~~~---~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~--~~~~~~~~~~~~~  234 (345)
T d1pmea_         160 DPDHD---HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ--LNHILGILGSPSQ  234 (345)
T ss_dssp             CGGGC---BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCSCCH
T ss_pred             cCCCc---cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHH--HHHHhhhccCCCh
Confidence            32211   122334567999999999985 45679999999999999999999999864332110  000000000000 


Q ss_pred             ----------hhhhhhhhhhh------cccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          339 ----------IIDLIDSVLEE------ASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       339 ----------~~~~i~~~l~~------~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                                ...........      ........++.+|+.+||+.||++|||+.|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         235 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                      00000000000      0011123467899999999999999999999986

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-46  Score=353.67  Aligned_cols=270  Identities=19%  Similarity=0.261  Sum_probs=195.3

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEe--------
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIE--------  175 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--------  175 (432)
                      .++|++++.||+|+||+||+|++..  ..||||++...  .....+.+.+|+++|++++|+|++++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            5799999999999999999999853  48999987433  33345678899999999999999999999855        


Q ss_pred             CCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecc
Q 014024          176 KDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFG  255 (432)
Q Consensus       176 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  255 (432)
                      .+..++||||+.++++..+..   ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~---~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg  162 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG  162 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTC---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred             CceEEEEEeccCCCccchhhh---cccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence            345799999998887776552   3345899999999999999999999999   9999999999999999999999999


Q ss_pred             cceeccCCCCccccccccccccccCCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCCcccccc-chhhhhHHh
Q 014024          256 MARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSL-NLIGYAWDL  333 (432)
Q Consensus       256 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~-~~~~~~~~~  333 (432)
                      ++........  ..........||+.|+|||++.+. .++.++|||||||++|||++|+.||........ .........
T Consensus       163 ~~~~~~~~~~--~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~  240 (318)
T d3blha1         163 LARAFSLAKN--SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS  240 (318)
T ss_dssp             TCEECCC-------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             eeeecccccc--cccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            9986532211  112233446799999999998765 689999999999999999999999864322110 000000000


Q ss_pred             --------hhccchhhhhhhhhhhcc-c------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014024          334 --------WISNKIIDLIDSVLEEAS-F------NESLSRYVHIALLCVQERAEDRPTMSDVVSMLT  385 (432)
Q Consensus       334 --------~~~~~~~~~i~~~l~~~~-~------~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~  385 (432)
                              .........+........ .      ......+.+|+.+||+.||++|||++|++++-.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpf  307 (318)
T d3blha1         241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF  307 (318)
T ss_dssp             CCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred             CChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChh
Confidence                    000000000000000000 0      011245678999999999999999999998643

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-46  Score=360.83  Aligned_cols=263  Identities=20%  Similarity=0.268  Sum_probs=193.2

Q ss_pred             CCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeC------CeeEE
Q 014024          110 NFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSGQEIKELKNEASVIAQVQHKNLVKLLGCCIEK------DERLL  181 (432)
Q Consensus       110 ~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~l  181 (432)
                      +|+..++||+|+||+||+|++..  ..||||++.....    ...+|+++|++++|+||++++++|...      .+.++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            68889999999999999999854  3899999865432    234799999999999999999998543      34689


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCC-CEEEeecccceec
Q 014024          182 IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDM-NSKISDFGMARIV  260 (432)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~  260 (432)
                      ||||++++++..+.........+++..++.++.|++.||+|||+++   |+||||||+|||++.++ .+||+|||++...
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence            9999987755444332233445999999999999999999999999   99999999999999775 8999999999875


Q ss_pred             cCCCCccccccccccccccCCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhh---------
Q 014024          261 FGGNDEDELQGNTSRISGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYA---------  330 (432)
Q Consensus       261 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~---------  330 (432)
                      ...       .......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+. +....         
T Consensus       174 ~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~-l~~i~~~~g~~~~~  245 (350)
T d1q5ka_         174 VRG-------EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ-LVEIIKVLGTPTRE  245 (350)
T ss_dssp             CTT-------SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH-HHHHHHHHCCCCHH
T ss_pred             cCC-------cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHH-HHHHHHHhCCChHH
Confidence            322       12334579999999998875 5689999999999999999999999864432110 00000         


Q ss_pred             -HHhhhcc----chhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--hccc
Q 014024          331 -WDLWISN----KIIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM--LTNE  387 (432)
Q Consensus       331 -~~~~~~~----~~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~--L~~~  387 (432)
                       +......    ....................++.+|+.+||+.||++|||+.|++++  ++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  309 (350)
T d1q5ka_         246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  309 (350)
T ss_dssp             HHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             hhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence             0000000    0000000000001112234568899999999999999999999975  4444

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=4.7e-45  Score=348.50  Aligned_cols=257  Identities=17%  Similarity=0.261  Sum_probs=195.5

Q ss_pred             hCCCCcCceeccCCcEEEEEEEECC--ceEEEEEEcCCChHhHHHHHHHHHHHHhcC-CCceeeeEeEEEeC--CeeEEE
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIGQ--GEIAVKRLLGKSGQEIKELKNEASVIAQVQ-HKNLVKLLGCCIEK--DERLLI  182 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~~~~lv  182 (432)
                      .++|+++++||+|+||+||+|++..  ..||+|++....   .+.+.+|+++|+.++ ||||+++++++...  ...++|
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v  110 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  110 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence            3689999999999999999999853  489999986543   356889999999995 99999999999754  568999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCC-CEEEeecccceecc
Q 014024          183 YEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDM-NSKISDFGMARIVF  261 (432)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~  261 (432)
                      |||+.+++|..+.      +.+++..+..++.||+.||+|||+++   |+||||||+|||++.++ .+||+|||++....
T Consensus       111 ~e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~  181 (328)
T d3bqca1         111 FEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  181 (328)
T ss_dssp             EECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred             EeecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceecc
Confidence            9999999997764      23999999999999999999999999   99999999999998655 58999999998753


Q ss_pred             CCCCccccccccccccccCCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhh----------
Q 014024          262 GGNDEDELQGNTSRISGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYA----------  330 (432)
Q Consensus       262 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~----------  330 (432)
                      ..       .......+|+.|+|||.+.+. .++.++||||+||++|+|++|+.||..............          
T Consensus       182 ~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~  254 (328)
T d3bqca1         182 PG-------QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD  254 (328)
T ss_dssp             TT-------CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHH
T ss_pred             CC-------CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhh
Confidence            22       123455789999999998765 479999999999999999999999865433111000000          


Q ss_pred             -HHhhhccc-----------hhhhhhhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          331 -WDLWISNK-----------IIDLIDSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       331 -~~~~~~~~-----------~~~~i~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                       ........           ...................++.+|+.+||+.||++|||++|++++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H  319 (328)
T d3bqca1         255 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  319 (328)
T ss_dssp             HHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             00000000           000000111111112234568899999999999999999999874

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-45  Score=345.74  Aligned_cols=262  Identities=19%  Similarity=0.223  Sum_probs=201.3

Q ss_pred             CCCCcCceeccCCcEEEEEEEECCc--eEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeEEEEe
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIGQG--EIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEKDERLLIYE  184 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  184 (432)
                      ++|+++++||+|+||+||+|++..+  .||||++...  .....+++.+|+.+|+.++||||+++++++.+....++++|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            5899999999999999999998543  7999998543  33456789999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccceeccCCC
Q 014024          185 YMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMARIVFGGN  264 (432)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  264 (432)
                      ++.++++..++..   .+.+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||.+...... 
T Consensus        82 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~-  154 (292)
T d1unla_          82 FCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP-  154 (292)
T ss_dssp             CCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSC-
T ss_pred             ecccccccccccc---ccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCC-
Confidence            9999999888753   345899999999999999999999999   999999999999999999999999999875322 


Q ss_pred             CccccccccccccccCCccChhhhccCC-CCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhhcc---chh
Q 014024          265 DEDELQGNTSRISGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWISN---KII  340 (432)
Q Consensus       265 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~  340 (432)
                           ........+++.|+|||.+.... ++.++|||||||++|||++|+.||.......... ..........   ...
T Consensus       155 -----~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~  228 (292)
T d1unla_         155 -----VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL-KRIFRLLGTPTEEQWP  228 (292)
T ss_dssp             -----CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHH-HHHHHHHCCCCTTTCT
T ss_pred             -----CccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHH-HHHHhhcCCCChhhhh
Confidence                 11233345778899999987655 6999999999999999999999974322211111 1010000000   000


Q ss_pred             ---hhh---------hhhhhhcccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          341 ---DLI---------DSVLEEASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       341 ---~~i---------~~~l~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                         ...         ...............+.+|+.+||+.||.+|||++|++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             TGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               000         0000001112334567899999999999999999999885

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-45  Score=347.64  Aligned_cols=251  Identities=22%  Similarity=0.289  Sum_probs=199.2

Q ss_pred             hCCCCcCceeccCCcEEEEEEEEC-----CceEEEEEEcCC----ChHhHHHHHHHHHHHHhcCC-CceeeeEeEEEeCC
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIG-----QGEIAVKRLLGK----SGQEIKELKNEASVIAQVQH-KNLVKLLGCCIEKD  177 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~-----~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~  177 (432)
                      .++|++.+.||+|+||+||+|...     +..||+|++...    .....+.+.+|+++|++++| |||+++++++.+..
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~  102 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  102 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence            367999999999999999999862     337999988533    22334568899999999976 89999999999999


Q ss_pred             eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccc
Q 014024          178 ERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMA  257 (432)
Q Consensus       178 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  257 (432)
                      ..+++|||+.+|+|.+++..   .+.+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       103 ~~~~v~e~~~~~~L~~~i~~---~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a  176 (322)
T d1vzoa_         103 KLHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS  176 (322)
T ss_dssp             EEEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             ceeeeeecccccHHHHHHHh---cccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccch
Confidence            99999999999999999853   334788999999999999999999999   999999999999999999999999999


Q ss_pred             eeccCCCCccccccccccccccCCccChhhhccC--CCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHhhh
Q 014024          258 RIVFGGNDEDELQGNTSRISGTYGYMSPEYALEG--IFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDLWI  335 (432)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  335 (432)
                      ..+...     .........|++.|+|||.+.+.  .++.++|||||||+||+|++|+.||.........          
T Consensus       177 ~~~~~~-----~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~----------  241 (322)
T d1vzoa_         177 KEFVAD-----ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ----------  241 (322)
T ss_dssp             EECCGG-----GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH----------
T ss_pred             hhhccc-----ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH----------
Confidence            865221     12233456799999999999764  4788999999999999999999998543321110          


Q ss_pred             ccchhhhhhhhh--hhcccHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 014024          336 SNKIIDLIDSVL--EEASFNESLSRYVHIALLCVQERAEDRP-----TMSDVVSM  383 (432)
Q Consensus       336 ~~~~~~~i~~~l--~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~~  383 (432)
                          ..+.....  ....+.....++.+++.+||+.||++||     |++|+++|
T Consensus       242 ----~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H  292 (322)
T d1vzoa_         242 ----AEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  292 (322)
T ss_dssp             ----HHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             ----HHHHHhcccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence                00111110  1112334567889999999999999999     47888874

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-44  Score=346.09  Aligned_cols=261  Identities=23%  Similarity=0.211  Sum_probs=190.1

Q ss_pred             hCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEe------CC
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIE------KD  177 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~  177 (432)
                      .++|+++++||+|+||+||+|.+.  +..||||++...  .....+.+.+|+.+|++++||||++++++|..      ..
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~   95 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ   95 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence            478999999999999999999986  448999999644  34556678999999999999999999999964      36


Q ss_pred             eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccc
Q 014024          178 ERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMA  257 (432)
Q Consensus       178 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  257 (432)
                      ..|+||||+.++++..+.      ..+++..++.++.|++.||.|||++|   |+||||||+|||++.++.+|++|||++
T Consensus        96 ~~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~  166 (355)
T d2b1pa1          96 DVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_dssp             EEEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred             eeEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhh
Confidence            789999999776555432      23899999999999999999999999   999999999999999999999999998


Q ss_pred             eeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCccccccc--hh-------h
Q 014024          258 RIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLN--LI-------G  328 (432)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~--~~-------~  328 (432)
                      +....       ........+|+.|+|||++.+..++.++||||+||++|+|++|+.||.........  ..       .
T Consensus       167 ~~~~~-------~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~  239 (355)
T d2b1pa1         167 RTAGT-------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP  239 (355)
T ss_dssp             ---------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred             hcccc-------ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCH
Confidence            76422       22334567899999999999999999999999999999999999998543211000  00       0


Q ss_pred             hhHH--------hhh------ccchhhhhhhhhhhc---ccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014024          329 YAWD--------LWI------SNKIIDLIDSVLEEA---SFNESLSRYVHIALLCVQERAEDRPTMSDVVSML  384 (432)
Q Consensus       329 ~~~~--------~~~------~~~~~~~i~~~l~~~---~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L  384 (432)
                      ..+.        ...      ...............   .......++.+|+.+||+.||++|||++|++++-
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hp  312 (355)
T d2b1pa1         240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP  312 (355)
T ss_dssp             HHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred             HHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCc
Confidence            0000        000      000011111111010   1223456788999999999999999999999863

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-44  Score=346.81  Aligned_cols=258  Identities=22%  Similarity=0.291  Sum_probs=193.5

Q ss_pred             hCCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCC--ChHhHHHHHHHHHHHHhcCCCceeeeEeEEEeC-----Ce
Q 014024          108 TGNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGK--SGQEIKELKNEASVIAQVQHKNLVKLLGCCIEK-----DE  178 (432)
Q Consensus       108 ~~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~  178 (432)
                      .++|++.+.||+|+||+||+|++.  +..||||++...  .....+.+.+|+++|++++|+|++++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            578999999999999999999975  348999998644  344566788999999999999999999998643     34


Q ss_pred             eEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEeecccce
Q 014024          179 RLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKISDFGMAR  258 (432)
Q Consensus       179 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  258 (432)
                      .+++++|+.+|+|.+++..    +.+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+|++|||++.
T Consensus        97 ~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~  169 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR  169 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred             eEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence            4667788889999999843    34999999999999999999999999   9999999999999999999999999997


Q ss_pred             eccCCCCccccccccccccccCCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCCccccccchhhhhHHh----
Q 014024          259 IVFGGNDEDELQGNTSRISGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSLNLIGYAWDL----  333 (432)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~----  333 (432)
                      ..         ........||+.|+|||...+. .++.++|||||||++|+|++|+.||........  .......    
T Consensus       170 ~~---------~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~--~~~i~~~~~~~  238 (348)
T d2gfsa1         170 HT---------DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ--LKLILRLVGTP  238 (348)
T ss_dssp             CC---------TGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCC
T ss_pred             cc---------CcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCC
Confidence            54         2234456789999999987765 468999999999999999999999864322110  0000000    


Q ss_pred             -------hhccchhhhhhhhhhh------cccHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014024          334 -------WISNKIIDLIDSVLEE------ASFNESLSRYVHIALLCVQERAEDRPTMSDVVSM  383 (432)
Q Consensus       334 -------~~~~~~~~~i~~~l~~------~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~  383 (432)
                             ................      .........+.+|+.+||+.||++|||+.|++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H  301 (348)
T d2gfsa1         239 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  301 (348)
T ss_dssp             CHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence                   0000000000000000      0011223567899999999999999999999985

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.3e-39  Score=313.11  Aligned_cols=262  Identities=20%  Similarity=0.210  Sum_probs=191.0

Q ss_pred             CCCCcCceeccCCcEEEEEEEEC--CceEEEEEEcCCChHhHHHHHHHHHHHHhcC-----------CCceeeeEeEEEe
Q 014024          109 GNFSAANKLGEGGFGTVYKGVIG--QGEIAVKRLLGKSGQEIKELKNEASVIAQVQ-----------HKNLVKLLGCCIE  175 (432)
Q Consensus       109 ~~y~~~~~ig~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~~~  175 (432)
                      ++|+++++||+|+||+||+|++.  +..||||++... ....+.+.+|+++++.++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            56999999999999999999985  348999998654 334567888999998875           5789999998864


Q ss_pred             --CCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCCCCCEEEcCCCC----
Q 014024          176 --KDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQ-YSRVRIIHRDLKASNILLDKDMN----  248 (432)
Q Consensus       176 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~----  248 (432)
                        ....+++++++..+..............+++..+..++.|++.||+|||+ .+   |+||||||+|||++.++.    
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred             ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence              35666777776665543333333445568999999999999999999998 77   999999999999986654    


Q ss_pred             --EEEeecccceeccCCCCccccccccccccccCCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCCcccccc--
Q 014024          249 --SKISDFGMARIVFGGNDEDELQGNTSRISGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGFYRTKSL--  324 (432)
Q Consensus       249 --~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlG~il~elltg~~p~~~~~~~~~--  324 (432)
                        ++++|||.+...         ........||+.|+|||++.+..++.++|+||+||++++|++|+.||........  
T Consensus       169 ~~~kl~dfg~s~~~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~  239 (362)
T d1q8ya_         169 IQIKIADLGNACWY---------DEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK  239 (362)
T ss_dssp             EEEEECCCTTCEET---------TBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred             ceeeEeeccccccc---------ccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccc
Confidence              899999999864         2233456799999999999999999999999999999999999999864322110  


Q ss_pred             ---chhhhhHHh-------h-hccchhhh-----------------hhhh--hhhcccHHHHHHHHHHHHHhhccCCCCC
Q 014024          325 ---NLIGYAWDL-------W-ISNKIIDL-----------------IDSV--LEEASFNESLSRYVHIALLCVQERAEDR  374 (432)
Q Consensus       325 ---~~~~~~~~~-------~-~~~~~~~~-----------------i~~~--l~~~~~~~~~~~l~~l~~~cl~~dp~~R  374 (432)
                         .........       . ........                 ....  ............+.+|+.+||+.||.+|
T Consensus       240 ~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R  319 (362)
T d1q8ya_         240 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR  319 (362)
T ss_dssp             HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred             hhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHC
Confidence               000000000       0 00000000                 0000  0112234567789999999999999999


Q ss_pred             CCHHHHHHH
Q 014024          375 PTMSDVVSM  383 (432)
Q Consensus       375 Pt~~evl~~  383 (432)
                      ||++|++++
T Consensus       320 pta~e~L~H  328 (362)
T d1q8ya_         320 ADAGGLVNH  328 (362)
T ss_dssp             BCHHHHHTC
T ss_pred             cCHHHHhcC
Confidence            999999986

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.90  E-value=5.4e-24  Score=185.66  Aligned_cols=162  Identities=17%  Similarity=0.159  Sum_probs=117.9

Q ss_pred             CcCceeccCCcEEEEEEEECCc-eEEEEEEcCCC------------------hHhHHHHHHHHHHHHhcCCCceeeeEeE
Q 014024          112 SAANKLGEGGFGTVYKGVIGQG-EIAVKRLLGKS------------------GQEIKELKNEASVIAQVQHKNLVKLLGC  172 (432)
Q Consensus       112 ~~~~~ig~G~~g~Vy~~~~~~~-~vavK~~~~~~------------------~~~~~~~~~E~~~l~~l~h~niv~~~~~  172 (432)
                      .+.++||+|+||+||+|.+.++ .||||++....                  .........|...+.++.|.+++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            4678999999999999998654 89999864321                  1112345678899999999999888765


Q ss_pred             EEeCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEcCCCCEEEe
Q 014024          173 CIEKDERLLIYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNSKIS  252 (432)
Q Consensus       173 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  252 (432)
                      .    ..+++|||++++.+.+          ++......++.|++.+++|||+.+   |+||||||+|||+++++ ++|+
T Consensus        83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~~li  144 (191)
T d1zara2          83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-IWII  144 (191)
T ss_dssp             E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-EEEC
T ss_pred             c----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCCC-EEEE
Confidence            3    2379999998876543          233345678999999999999999   99999999999998654 8999


Q ss_pred             ecccceeccCCCCccccccccccccccCCccC------hhhhccCCCCchhhhHHHHHHH
Q 014024          253 DFGMARIVFGGNDEDELQGNTSRISGTYGYMS------PEYALEGIFSIKSDVFSFGVLL  306 (432)
Q Consensus       253 Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~t~~~DvwSlG~il  306 (432)
                      |||+|.........              .|..      .+. ..+.|+.++|+||+.--+
T Consensus       145 DFG~a~~~~~~~~~--------------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         145 DFPQSVEVGEEGWR--------------EILERDVRNIITY-FSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CCTTCEETTSTTHH--------------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred             ECCCcccCCCCCcH--------------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence            99999764111000              0111      111 236678899999986544

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.87  E-value=3.8e-09  Score=94.73  Aligned_cols=149  Identities=15%  Similarity=0.103  Sum_probs=107.8

Q ss_pred             hHhhhhCCCCcCceeccCCcEEEEEEEECCceEEEEEEcCCChHhHHHHHHHHHHHHhcC-CCceeeeEeEEEeCCeeEE
Q 014024          103 SVSSATGNFSAANKLGEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQ-HKNLVKLLGCCIEKDERLL  181 (432)
Q Consensus       103 ~~~~~~~~y~~~~~ig~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~l  181 (432)
                      ++....++|++.+..+-++.+.||+...+++.+++|+...........+..|...++.+. +--+.+++.+..+++..++
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~l   87 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEE
Confidence            556666788777665555557899988888889999886554334445778888888774 3336678888888889999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------
Q 014024          182 IYEYMPNKSLDCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYS----------------------------------  227 (432)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~----------------------------------  227 (432)
                      ||++++|.++.+.....     .   ....++.++++.++.||+..                                  
T Consensus        88 v~~~l~G~~~~~~~~~~-----~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (263)
T d1j7la_          88 LMSEADGVLCSEEYEDE-----Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE  159 (263)
T ss_dssp             EEECCSSEEHHHHTTTC-----S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred             EEEeccccccccccccc-----c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence            99999998886654211     1   12345666777777777532                                  


Q ss_pred             ----------------------CCCeEeccCCCCCEEEcCCCCEEEeeccccee
Q 014024          228 ----------------------RVRIIHRDLKASNILLDKDMNSKISDFGMARI  259 (432)
Q Consensus       228 ----------------------~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  259 (432)
                                            ...++|+|+.|.||++++++..-|.||+.+..
T Consensus       160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                  02389999999999999876667999998864

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.12  E-value=1.2e-05  Score=70.71  Aligned_cols=130  Identities=19%  Similarity=0.195  Sum_probs=87.6

Q ss_pred             eeccCCc-EEEEEEEECCc-eEEEEEEcCCChHhHHHHHHHHHHHHhcCC--CceeeeEeEEEeCCeeEEEEecCCCCCh
Q 014024          116 KLGEGGF-GTVYKGVIGQG-EIAVKRLLGKSGQEIKELKNEASVIAQVQH--KNLVKLLGCCIEKDERLLIYEYMPNKSL  191 (432)
Q Consensus       116 ~ig~G~~-g~Vy~~~~~~~-~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~gsL  191 (432)
                      .+..|.. +.||+....++ .+++|.......   ..+..|...++.+..  -.+.+++.+..+++..++||++++|.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            3444443 67899888766 577787654432   346778888887743  3366678888888888999999988776


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------------
Q 014024          192 DCFLFDPTKREILDWRTRVQIIKGVAQGLLYLHQYS--------------------------------------------  227 (432)
Q Consensus       192 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--------------------------------------------  227 (432)
                      .+..        ...   ...+.++.+.|+-||+..                                            
T Consensus        94 ~~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (255)
T d1nd4a_          94 LSSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF  162 (255)
T ss_dssp             TTSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred             cccc--------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence            4321        111   122344555555555321                                            


Q ss_pred             -----------CCCeEeccCCCCCEEEcCCCCEEEeeccccee
Q 014024          228 -----------RVRIIHRDLKASNILLDKDMNSKISDFGMARI  259 (432)
Q Consensus       228 -----------~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  259 (432)
                                 ...++|+|+.|.||+++++..+-|+||+.+..
T Consensus       163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence                       12389999999999999877678999988754

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.70  E-value=5.9e-05  Score=70.88  Aligned_cols=76  Identities=12%  Similarity=0.246  Sum_probs=48.1

Q ss_pred             CceeccCCcEEEEEEEECCc--eEEEEEEcCCC-------hHhHHHHHHHHHHHHhcC-C--CceeeeEeEEEeCCeeEE
Q 014024          114 ANKLGEGGFGTVYKGVIGQG--EIAVKRLLGKS-------GQEIKELKNEASVIAQVQ-H--KNLVKLLGCCIEKDERLL  181 (432)
Q Consensus       114 ~~~ig~G~~g~Vy~~~~~~~--~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~-h--~niv~~~~~~~~~~~~~l  181 (432)
                      .+.||.|....||+..+.++  .+++|.-....       ....+....|.+.|+.+. +  ..+.+++.+  +++..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            45789999999999986543  78888653210       112234556888887763 2  335555544  4556789


Q ss_pred             EEecCCCCCh
Q 014024          182 IYEYMPNKSL  191 (432)
Q Consensus       182 v~e~~~~gsL  191 (432)
                      |||++++..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999977543

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.01  E-value=0.0055  Score=54.87  Aligned_cols=158  Identities=12%  Similarity=0.020  Sum_probs=83.6

Q ss_pred             chhhHhhhhCCCCcCcee-----ccCCcEEEEEEEECCceEEEEEEcCCChHhHHHHHHHHHHHHhcCC-----Cceeee
Q 014024          100 SFSSVSSATGNFSAANKL-----GEGGFGTVYKGVIGQGEIAVKRLLGKSGQEIKELKNEASVIAQVQH-----KNLVKL  169 (432)
Q Consensus       100 ~~~~~~~~~~~y~~~~~i-----g~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-----~niv~~  169 (432)
                      +.+++.....+|.+++..     ..|---+.|+...+++++++|+.....  ..+.+..|++++..+..     |..+..
T Consensus         4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~~   81 (316)
T d2ppqa1           4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPR   81 (316)
T ss_dssp             CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCB
T ss_pred             CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCcEEEEEcCCCC--CHHHHHHHHHHHHhhhhcccccccccee
Confidence            445667777778775544     355567789999888899999885432  22345566777777642     221111


Q ss_pred             E-e--EEEeCCeeEEEEecCCCCChhhhh--------------c----CC--CCCCCCCHH------------------H
Q 014024          170 L-G--CCIEKDERLLIYEYMPNKSLDCFL--------------F----DP--TKREILDWR------------------T  208 (432)
Q Consensus       170 ~-~--~~~~~~~~~lv~e~~~~gsL~~~l--------------~----~~--~~~~~l~~~------------------~  208 (432)
                      . |  +..-......++.+..+......-              +    ..  .........                  .
T Consensus        82 ~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (316)
T d2ppqa1          82 KDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKG  161 (316)
T ss_dssp             TTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTT
T ss_pred             cCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchh
Confidence            0 0  112234556677777664432110              0    00  000000000                  1


Q ss_pred             HHHHHHHHHHHHHHHHhc-CCCCeEeccCCCCCEEEcCCCCEEEeeccccee
Q 014024          209 RVQIIKGVAQGLLYLHQY-SRVRIIHRDLKASNILLDKDMNSKISDFGMARI  259 (432)
Q Consensus       209 ~~~i~~qi~~~l~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  259 (432)
                      ....+......+...+.. -+.++||+|+.++||+++++...-+.||+.+..
T Consensus       162 ~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         162 LREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             HHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence            111111222222222211 123599999999999999888778999998864

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.95  E-value=0.00095  Score=62.35  Aligned_cols=72  Identities=17%  Similarity=0.316  Sum_probs=47.6

Q ss_pred             CceeccCCcEEEEEEEECCc---------eEEEEEEcCCChHhHHHHHHHHHHHHhcCCCce-eeeEeEEEeCCeeEEEE
Q 014024          114 ANKLGEGGFGTVYKGVIGQG---------EIAVKRLLGKSGQEIKELKNEASVIAQVQHKNL-VKLLGCCIEKDERLLIY  183 (432)
Q Consensus       114 ~~~ig~G~~g~Vy~~~~~~~---------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~  183 (432)
                      ++.|+-|-.-.+|+....+.         .+++++.- ..... ....+|..+++.+.-.++ .++++++.+    .+|+
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~~~-idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPETE-SHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCCCH-HHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccchh-hHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence            46788888899999886432         35555543 33222 345679999888853344 467776643    6899


Q ss_pred             ecCCCCCh
Q 014024          184 EYMPNKSL  191 (432)
Q Consensus       184 e~~~~gsL  191 (432)
                      ||++|..+
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEeccccC
Confidence            99988655

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.82  E-value=0.0015  Score=59.18  Aligned_cols=135  Identities=13%  Similarity=0.107  Sum_probs=75.7

Q ss_pred             cEEEEEEEECCc-eEEEEEEcCCChHhHHHHHHHHHHHHhcCCCce--eeeE-----eEEEeCCeeEEEEecCCCCChhh
Q 014024          122 FGTVYKGVIGQG-EIAVKRLLGKSGQEIKELKNEASVIAQVQHKNL--VKLL-----GCCIEKDERLLIYEYMPNKSLDC  193 (432)
Q Consensus       122 ~g~Vy~~~~~~~-~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~~~-----~~~~~~~~~~lv~e~~~~gsL~~  193 (432)
                      .-.||+....++ .+++|...... ...+++..|...+..+...++  +...     ..+...+..+.++++++|..+..
T Consensus        35 EN~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~  113 (325)
T d1zyla1          35 ENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA  113 (325)
T ss_dssp             SSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred             cceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence            457999988666 68888876542 234567788888888742221  1111     12345567788999998754321


Q ss_pred             h----h--------------cC--CCCCCCCCHH-------------------HHHHHHHHHHHHHHHHHh----cCCCC
Q 014024          194 F----L--------------FD--PTKREILDWR-------------------TRVQIIKGVAQGLLYLHQ----YSRVR  230 (432)
Q Consensus       194 ~----l--------------~~--~~~~~~l~~~-------------------~~~~i~~qi~~~l~~LH~----~~~~~  230 (432)
                      .    +              ..  ...+...++.                   ....+...+...++.+..    ..+..
T Consensus       114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~  193 (325)
T d1zyla1         114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL  193 (325)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred             CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence            0    0              00  0111112211                   111122222223333332    22345


Q ss_pred             eEeccCCCCCEEEcCCCCEEEeeccccee
Q 014024          231 IIHRDLKASNILLDKDMNSKISDFGMARI  259 (432)
Q Consensus       231 ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  259 (432)
                      ++|+|+.|.|||++++  ..+.||+.+..
T Consensus       194 liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         194 RLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             eecCCCCcccEEEeCC--ceEEechhccc
Confidence            8999999999999754  45899998864